PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Floegel, M; Kell, CA				Floegel, Mareike; Kell, Christian Alexander			Functional hemispheric asymmetries during the planning and manual control of virtual avatar movements	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; AGE-RELATED-CHANGES; PREMOTOR CORTEX; MOTOR CONTROL; GRIP FORCE; CEREBRAL ASYMMETRIES; REACHING MOVEMENTS; MENTAL ROTATION; TIME-ESTIMATION; NEURAL SYSTEMS	Both hemispheres contribute to motor control beyond the innervation of the contralateral alpha motoneurons. The left hemisphere has been associated with higher-order aspects of motor control like sequencing and temporal processing, the right hemisphere with the transformation of visual information to guide movements in space. In the visuomotor context, empirical evidence regarding the latter has been limited though the right hemisphere's specialization for visuospatial processing is well-documented in perceptual tasks. This study operationalized temporal and spatial processing demands during visuomotor processing and investigated hemispheric asymmetries in neural activation during the unimanual control of a visual cursor by grip force. Functional asymmetries were investigated separately for visuomotor planning and online control during functional magnetic resonance imaging in 19 young, healthy, right-handed participants. The expected cursor movement was coded with different visual trajectories. During planning when spatial processing demands predominated, activity was right-lateralized in a hand-independent manner in the inferior temporal lobe, occipito-parietal border, and ventral premotor cortex. When temporal processing demands overweighed spatial demands, BOLD responses during planning were left-lateralized in the temporo-parietal junction. During online control of the cursor, right lateralization was not observed. Instead, left lateralization occurred in the intraparietal sulcus. Our results identify movement phase and spatiotemporal demands as important determinants of dynamic hemispheric asymmetries during visuomotor processing. We suggest that, within a bilateral visuomotor network, the right hemisphere exhibits a processing preference for planning global spatial movement features whereas the left hemisphere preferentially times local features of visual movement trajectories and adjusts movement online.	[Kell, Christian Alexander] Goethe Univ, Cognit Neurosci Grp, Brain Imaging Ctr, Frankfurt, Germany; Goethe Univ, Dept Neurol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Kell, CA (corresponding author), Goethe Univ, Cognit Neurosci Grp, Brain Imaging Ctr, Frankfurt, Germany.	c.kell@em.uni-frankfurt.de			LOEWE grant of the State of Hesse; Deutsche Forschungsgemeinschaft [KE 1514/2-1]	LOEWE grant of the State of Hesse; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a LOEWE grant of the State of Hesse to CK (NEFF). CK and MF were supported by the Deutsche Forschungsgemeinschaft (KE 1514/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Begliomini C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00167; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Binder E, 2014, NEUROPSYCHOLOGIA, V54, P18, DOI 10.1016/j.neuropsychologia.2013.11.018; Callaert DV, 2011, HUM BRAIN MAPP, V32, P1311, DOI 10.1002/hbm.21110; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Cohen Jacob, 1975, APPL MULTIPLE REGRES; Corballis MC, 1996, NEUROPSYCHOLOGY, V10, P42, DOI 10.1037/0894-4105.10.1.42; Corballis MC, 1997, BRAIN LANG, V57, P100, DOI 10.1006/brln.1997.1835; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; Corballis PM, 2003, BRAIN COGNITION, V53, P171, DOI 10.1016/S0278-2626(03)00103-9; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Cramer SC, 2002, HUM BRAIN MAPP, V16, P197, DOI 10.1002/hbm.10040; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Davis B, 2009, J NEUROSCI, V29, P3182, DOI 10.1523/JNEUROSCI.5793-08.2009; Della-Maggiore V, 2004, J NEUROSCI, V24, P9971, DOI 10.1523/JNEUROSCI.2833-04.2004; Deruelle C, 1997, Laterality, V2, P233, DOI 10.1080/135765097397468; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellermann JM, 1998, J MAGN RESON, V131, P272, DOI 10.1006/jmre.1998.1379; Erdeniz B, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00116; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; FISK JD, 1988, EXP BRAIN RES, V72, P425; Frak V, 2006, THESCIENTIFICWORLDJO, V6, P1805, DOI 10.1100/tsw.2006.291; Frey SH, 2008, PHILOS T R SOC B, V363, P1951, DOI 10.1098/rstb.2008.0008; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GAZZANIG.MS, 1965, BRAIN, V88, P221, DOI 10.1093/brain/88.2.221; Glover S, 2005, J COGNITIVE NEUROSCI, V17, P124, DOI 10.1162/0898929052880066; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; GOODALE MA, 1990, VISION ACTION CONTRO, P14; Grosskopf A, 2006, EXP BRAIN RES, V168, P230, DOI 10.1007/s00221-005-0083-1; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Hammond GR, 2005, NEUROREPORT, V16, P559, DOI 10.1097/00001756-200504250-00008; Hopkins WD, 1997, NEUROPSYCHOLOGIA, V35, P343, DOI 10.1016/S0028-3932(96)00089-9; Ivry RB, 1997, 2 SIDES PERCEPTION; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Keisker B, 2009, HUM BRAIN MAPP, V30, P2453, DOI 10.1002/hbm.20676; Kell CA, 2016, SPEECH MOTOR CONTROL, P25; KIMURA D, 1974, BRAIN, V97, P337, DOI 10.1093/brain/97.1.337; King M, 2014, NEUROIMAGE, V102, P923, DOI 10.1016/j.neuroimage.2014.05.064; Kuhtz-Buschbeck JP, 2008, NEUROIMAGE, V40, P1469, DOI 10.1016/j.neuroimage.2008.01.037; LANCASTER BP, 1999, ANN M SW ED RES ASS; Ludlow L, 2014, J STAT ED, V22, P1, DOI DOI 10.1080/10691898.2014.11889703; Martin K, 2011, NEUROIMAGE, V57, P502, DOI 10.1016/j.neuroimage.2011.04.036; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Milivojevic B, 2009, J COGNITIVE NEUROSCI, V21, P945, DOI 10.1162/jocn.2009.21085; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Mumford JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126255; Neely KA, 2013, HUM BRAIN MAPP, V34, P698, DOI 10.1002/hbm.21467; Ng VWK, 2000, HUM BRAIN MAPP, V10, P80, DOI 10.1002/(SICI)1097-0193(200006)10:2<80::AID-HBM40>3.0.CO;2-2; Nicholls MER, 2002, INT J PSYCHOPHYSIOL, V44, P37, DOI 10.1016/S0167-8760(01)00190-8; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penny W., 2003, RANDOM EFFECTS ANAL; Pohl PS, 2000, NEUROREHAB NEURAL RE, V14, P33, DOI 10.1177/154596830001400104; Poline JB, 2006, CONTRASTS CLASSICAL; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; Rice NJ, 2007, BRAIN RES, V1175, P76, DOI 10.1016/j.brainres.2007.08.009; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rotella MF, 2015, J NEUROPHYSIOL, V113, P1873, DOI 10.1152/jn.00255.2014; Schubotz RI, 2002, NEUROIMAGE, V16, P920, DOI 10.1006/nimg.2002.1183; Schubotz RI, 2002, NEUROIMAGE, V15, P787, DOI 10.1006/nimg.2001.1043; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Stephan KE, 2007, NEUROPSYCHOLOGIA, V45, P209, DOI 10.1016/j.neuropsychologia.2006.07.002; Sterr A, 2009, NEUROSCI LETT, V457, P61, DOI 10.1016/j.neulet.2009.04.013; Sulzer JS, 2011, IEEE ENG MED BIO, P2342, DOI 10.1109/IEMBS.2011.6090655; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; Tretriluxana J, 2009, NEUROREHAB NEURAL RE, V23, P679, DOI 10.1177/1545968309332733; Vaillancourt DE, 2006, J NEUROPHYSIOL, V95, P922, DOI 10.1152/jn.00718.2005; Vaillancourt DE, 2003, J NEUROPHYSIOL, V90, P3330, DOI 10.1152/jn.00394.2003; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; Ward NS, 2008, NEUROBIOL AGING, V29, P1434, DOI 10.1016/j.neurobiolaging.2007.04.017; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Woolley DG, 2010, NEUROIMAGE, V50, P1566, DOI 10.1016/j.neuroimage.2010.01.012	80	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185152	10.1371/journal.pone.0185152	http://dx.doi.org/10.1371/journal.pone.0185152			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957344	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200030
J	Kashani, K; Thongprayoon, C; Cheungpasitporn, W; Iacovella, GM; Akhoundi, A; Albright, RC				Kashani, Kianoush; Thongprayoon, Charat; Cheungpasitporn, Wisit; Iacovella, Gina M.; Akhoundi, Abbasali; Albright, Robert C., Jr.			Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; SODIUM-BICARBONATE; LACTIC-ACIDOSIS; HYPERCARBIC ACIDOSIS; INTERMITTENT; SCORE; CONTRACTILITY; HEMODYNAMICS; DIALYSIS	Background Given the known deleterious effects seen with bicarbonate supplementation for acidemia, we hypothesized that utilizing high bicarbonate concentration replacement solution in continuous venovenous hemofiltration (CVVH) would be independently associated with higher mortality. Methods In a propensity score-matched historical cohort study conducted at a single tertiary care center from December 9, 2006, through December 31, 2009, a total of 287consecutive adult critically ill patients with Stage III acute kidney injury (AKI) requiring CVVH were enrolled. We excluded patients on maintenance dialysis, those who received other modalities of continuous renal replacement therapies, and patients that received a mixed of 22 and 32 mEq/L bicarbonate solution pre-and post-filter. The primary outcome was in-hospital and 90-day mortality rates. Results Among enrollees, 68 were used 32 mEq/L bicarbonate solution, and 219 received 22mEq/L bicarbonate solution for CVVH. Patients on 32 mEq/L bicarbonate solution were more often non-surgical, had lower pH and bicarbonate level but had higher blood potassium and phosphorus levels in comparison with those on 22 mEq/L bicarbonate solution. After adjustment for the baseline characteristics, the use of 32 bicarbonate solution was significantly associated with increased in-hospital (HR = 1.94; 95% CI 1.02-3.79) and 90-day mortality (HR = 1.50; 95% CI 1.03-2.14). There was a significant increase in the hospital (p =.03) and 90- day (p =.04) mortality between the 22 vs. 32 mEq/L bicarbonate solution groups following propensity matching. Conclusion Our data showed there is a strong association between using high bicarbonate solution and mortality independent of severity of illness and comorbid conditions. These findings need to be evaluated further in prospective studies.	[Kashani, Kianoush; Thongprayoon, Charat; Cheungpasitporn, Wisit; Akhoundi, Abbasali; Albright, Robert C., Jr.] Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Kashani, Kianoush; Iacovella, Gina M.] Mayo Clin, Div Pulm & Crit Care, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Kashani, K (corresponding author), Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Kashani, K (corresponding author), Mayo Clin, Div Pulm & Crit Care, Dept Internal Med, Rochester, MN 55905 USA.	Kashani.kianoush@mayo.edu	Thongprayoon, Charat/J-4184-2019; Cheungpasitporn, Wisit/H-8194-2019	Thongprayoon, Charat/0000-0002-8313-3604; Cheungpasitporn, Wisit/0000-0001-9954-9711; Kashani, Kianoush/0000-0003-2184-3683				Adrogue HJ, 1998, NEW ENGL J MED, V338, P26, DOI 10.1056/NEJM199801013380106; Akhoundi A, 2015, BLOOD PURIFICAT, V39, P333, DOI 10.1159/000380903; [Anonymous], 2012, Kidney Int Suppl (2011), V2, P89; ARIEFF AI, 1983, CLIN SCI, V64, P573, DOI 10.1042/cs0640573; Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Bagshaw SM, 2008, CRIT CARE MED, V36, P610, DOI 10.1097/01.CCM.0B013E3181611F552; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; BERENYI KJ, 1975, CIRCULATION, V52, P319, DOI 10.1161/01.CIR.52.2.319; BERSIN RM, 1989, AM J MED, V87, P7, DOI 10.1016/S0002-9343(89)80476-0; COOPER DJ, 1990, ANN INTERN MED, V112, P492, DOI 10.7326/0003-4819-112-7-492; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; GEDEBORG R, 1989, RESUSCITATION, V18, P49, DOI 10.1016/0300-9572(89)90112-3; GROGONO AW, 1986, INT ANESTHESIOL CLIN, V24, P11, DOI 10.1097/00004311-198602410-00003; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; HUSEBY JS, 1981, CHEST, V79, P552, DOI 10.1378/chest.79.5.552; Jaber S, 2008, ANESTHESIOLOGY, V108, P651, DOI 10.1097/ALN.0b013e31816725a6; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; MALDONADO FA, 1993, ANESTHESIOLOGY, V78, P343, DOI 10.1097/00000542-199302000-00019; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; MCELROY WT, 1958, AM J PHYSIOL, V195, P412, DOI 10.1152/ajplegacy.1958.195.2.412; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Payen D, 2009, CRIT CARE MED, V37, P803, DOI 10.1097/CCM.0b013e3181962316; Richardson DE, 2003, FREE RADICAL BIO MED, V35, P1538, DOI 10.1016/j.freeradbiomed.2003.08.019; Rocktaschel J, 2003, INT J ARTIF ORGANS, V26, P19, DOI 10.1177/039139880302600104; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sekhon JS, 2011, J STAT SOFTW, V42, P1; TANG W, 1991, CRIT CARE MED, V19, P218, DOI 10.1097/00003246-199102000-00018; Uehlinger DE, 2005, NEPHROL DIAL TRANSPL, V20, P1630, DOI 10.1093/ndt/gfh880; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Vukmir RB, 1996, AM J EMERG MED, V14, P192, DOI 10.1016/S0735-6757(96)90133-3; Wald R, 2012, CRIT CARE, V16, DOI 10.1186/cc11835; WU DJ, 1990, JPN HEART J, V31, P109; [No title captured]; [No title captured]	41	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185064	10.1371/journal.pone.0185064	http://dx.doi.org/10.1371/journal.pone.0185064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957333	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200027
J	Sashourpour, M; Zahri, S; Radjabian, T; Ruf, V; Pan-Montojo, F; Morshedi, D				Sashourpour, Mandyeh; Zahri, Saber; Radjabian, Tayebeh; Ruf, Viktoria; Pan-Montojo, Francisco; Morshedi, Dina			A study on the modulation of alpha-synuclein fibrillation by Scutellaria pinnatifida extracts and its neuroprotective properties	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; APOPTOSIS INDUCTION; ALZHEIMERS-DISEASE; OLIGOMER FORMATION; PARKINSON-DISEASE; GROWTH-INHIBITION; ANTIOXIDANT; FLAVONOIDS; BAICALEIN	Aggregation of alpha-synuclein (alpha-SN) is a key pathogenic event in Parkinson's disease (PD) leading to dopaminergic degeneration. The identification of natural compounds inhibiting alpha-SN aggregation may have a major role in treating PD. Different Scutellaria species are known as valuable medicinal plants, primarily due to their high flavonoid levels. Scutellaria pinnatifida (S. pinnatifida) is endemic to Iran; however, the knowledge of its pharmaceutical properties is limited. Here we report that S. pinnatifida extracts have an anti-fibrillation effect on alpha-SN aggregation and neuroprotective properties on PC12 and primary dopaminergic neurons. Treatment during alpha-SN fibril formation with S. pinnatifida extracts showed that the extractions performed with dichloromethane (DCMEx) and n-butanol (BuOHEx) strongly inhibited alpha-SN fibrillation. TLC-based analysis revealed that S. pinnatifida contains a great amount of flavonoids with high antioxidant properties as shown using a radical scavenging assay. Further analysis using HPLC and Mass spectroscopy on the DCMEx revealed the presence of baicalein in this extract. We then selected the more efficient extracts based on cell viability and ROS scavenging on PC12 cells and tested their neuroprotective properties on primary dopaminergic neurons. Our results showed the extracts strongly protected against alpha-SN oligomers. Surprisingly, they also neutralized the severe toxicity of paraquat. Therefore, S. pinnatifida may be a potential valuable medicinal herb for further studies related to the treatment of PD.	[Sashourpour, Mandyeh; Zahri, Saber] Mohaghegh Ardabili Univ, Dept Biol, Fac Sci, Ardebil, Iran; [Sashourpour, Mandyeh; Morshedi, Dina] NIGEB, Dept Ind & Environm Biotechnol, Tehran, Iran; [Radjabian, Tayebeh] Shahed Univ, Fac Basic Sci, Dept Biol, Tehran, Iran; [Ruf, Viktoria] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Pan-Montojo, Francisco] LMU, Univ Hosp, Dept Neurol, Munich, Germany; [Pan-Montojo, Francisco] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Mohaghegh Ardabili; Shahed University; University of Munich; University of Munich; University of Munich	Zahri, S (corresponding author), Mohaghegh Ardabili Univ, Dept Biol, Fac Sci, Ardebil, Iran.; Morshedi, D (corresponding author), NIGEB, Dept Ind & Environm Biotechnol, Tehran, Iran.; Pan-Montojo, F (corresponding author), LMU, Univ Hosp, Dept Neurol, Munich, Germany.; Pan-Montojo, F (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	Zahri@uma.ac.ir; francisco.pan-montoio@med.uni-muenchen.de; morsheci@nigeb.ac.ir	Zahri, Saber/AAD-3707-2022; Radjabian, Tayebeh/W-1658-2019	Radjabian, Tayebeh/0000-0001-8280-9409; Morshedi, Dina/0000-0002-0751-8772	Iranian Ministry of Science and Technology; Deutsche Forschungsgesellschaft (DFG) through Munich Excellence Cluster for Systems Neurology; Ministry of Science, Research and Technology of Iran	Iranian Ministry of Science and Technology; Deutsche Forschungsgesellschaft (DFG) through Munich Excellence Cluster for Systems Neurology(German Research Foundation (DFG)); Ministry of Science, Research and Technology of Iran	This project was funded by the Iranian Ministry of Science and Technology (Grant given to SZ) and the Deutsche Forschungsgesellschaft (DFG) through the Munich Excellence Cluster for Systems Neurology (Grant given to F.P-M). MS received a travel grant from the Ministry of Science, Research and Technology of Iran to perform an internship in Munich.; This project was funded by the Iranian Ministry of Science and Technology (Grant given to SZ) and the Deutsche Forschungsgesellschaft (DFG) through the Munich Excellence Cluster for Systems Neurology (Grant given to F.P-M). MS received a travel grant from the Ministry of Science, Research and Technology of Iran to perform an internship in Munich. The authors would like to acknowledge Mr. Farhang Aliakbari for helping in the protein expression and purification and Mr. Esmaeil Eskandary for helping to find the IUCN protection list.	Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; Bader B, 2011, BIOCHEM BIOPH RES CO, V411, P190, DOI 10.1016/j.bbrc.2011.06.135; Bhattacharjee N, 2016, NEUROCHEM INT, V101, P48, DOI 10.1016/j.neuint.2016.10.001; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bodles AM, 2001, J NEUROCHEM, V78, P384, DOI 10.1046/j.1471-4159.2001.00408.x; Boozari M, 2015, ENVIRON TOXICOL PHAR, V39, P307, DOI 10.1016/j.etap.2014.12.002; BORS W, 1990, RADICAL CHEM FLAVONO, P165; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Chen YC, 2000, BIOCHEM PHARMACOL, V59, P1445, DOI 10.1016/S0006-2952(00)00255-0; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Feng J, 2010, J PHARMACEUT BIOMED, V53, P591, DOI 10.1016/j.jpba.2010.04.002; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Ghahreman A., 1999, BIODIVERSITY PLANT S; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Hu Q, 2016, BBA-MOL BASIS DIS, V1862, P1883, DOI 10.1016/j.bbadis.2016.07.008; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Huang KC, 2010, PHARM CHINESE HERBS; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Jameson D. M., 2014, INTRO FLUORESCENCE; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim DH, 2006, MECH AGEING DEV, V127, P719, DOI 10.1016/j.mad.2006.05.002; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Krenna L, 2003, FLAVONOIDS ACHILLEA; LAMAISON JL, 1990, PHARM ACTA HELV, V65, P315; Lamer-Zarawska E, 2010, ADV CLIN EXP MED, V19, P419; Lee HH, 2003, BRAIN RES, V986, P103, DOI 10.1016/S0006-8993(03)03197-4; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; Lindstrom V, 2017, MOL CELL NEUROSCI, V82, P143, DOI 10.1016/j.mcn.2017.04.009; Lu JH, 2011, CHEMBIOCHEM, V12, P615, DOI 10.1002/cbic.201000604; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Meng X, 2010, EFFECTS VARIOUS FLAV; Meng XY, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/650794; Meng XY, 2009, BIOCHEMISTRY-US, V48, P8206, DOI 10.1021/bi900506b; Mohammadi A AJ, 2012, NATURAL PRODUCTS M S, V4, P102; Motaez M, 2015, AVICENNA J PHYTOMEDI, V5, P553; Mousavi SNM, 2015, IRAN J PHARM RES, V14, P215; Murphy DD, 2000, J NEUROSCI, V20, P5214; Mustafa RA, 2010, J FOOD SCI, V75, pC28, DOI 10.1111/j.1750-3841.2009.01401.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Niranjan R, 2014, MOL NEUROBIOL, V49, P28, DOI 10.1007/s12035-013-8483-x; Paillusson S., 2017, ACTA NEUROPATHOL; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Piao HZ, 2004, ARCH PHARM RES, V27, P930, DOI 10.1007/BF02975846; Poblocka-Olech L, 2016, ACTA PHARMACEUT, V66, P543, DOI 10.1515/acph-2016-0038; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Sauvage Severine, 2010, Oriental Pharmacy and Experimental Medicine, V10, P304; Sereikaite J, 2006, ACTA BIOCHIM POL, V53, P87; Shieh DE, 2000, ANTICANCER RES, V20, P2861; Smallwood I, 2012, HDB ORG SOLVENT PROP; Souri E., 2010, IJPR, V3, P55, DOI [DOI 10.22037/IJPR.2010.298, 10.22037/IJPR.2010.298]; Suk K, 2005, NEUROSIGNALS, V14, P23, DOI 10.1159/000085383; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Taebnia N, 2016, LANGMUIR, V32, P13394, DOI 10.1021/acs.langmuir.6b02935; Tai MC, 2005, CNS DRUG REV, V11, P141; Toyoda Y, 2014, BIOL OPEN; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Uversky VN, 2015, CURR PROTEIN PEPT SC, V16, P682, DOI 10.2174/138920371608150828114357; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108	63	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184483	10.1371/journal.pone.0184483	http://dx.doi.org/10.1371/journal.pone.0184483			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957336	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200014
J	Adach, W; Olas, B				Adach, Weronika; Olas, Beata			The role of CORM-2 as a modulator of oxidative stress and hemostatic parameters of human plasma in vitro	PLOS ONE			English	Article							MONOXIDE-RELEASING MOLECULES; CARBON-MONOXIDE; PLATELET MEMBRANES; DISULFIDE GROUPS; CO; COAGULATION; EXPRESSION; SULFHYDRYL; DISEASE	Purpose The main aim of the experiment is to examine the effect of CORM-2, a donor of carbon monoxide (CO), on oxidative stress in human plasma in vitro. In addition, it examines the effects of CORM-2 on the hemostatic parameters of plasma: the activated partial thromboplastin time (APTT), thrombin time (TT) and prothrombin time (PT). Methods Human plasma was incubated for 5 -60 min with different concentrations of CORM-2: 0.1-100 mu M. Following this, various hemostatic factors and biomarkers of oxidative stress were studied. Lipid peroxidation was measured as thiobarbituric acid reactive substance (TBARS) concentration, and the oxidation of amino acid residues in proteins was measured by determining the amounts of carbonyl and thiol groups. Results Two oxidative stress inducers: hydrogen peroxide (H2O2) and the donor of hydroxyl radical (H2O2/Fe) were used. Decrease in protein carbonylation, thiol group oxidation and lipid peroxidation were detected at tested concentrations of CORM-2. Conclusion Our results indicate that CORM-2 may have antioxidant properties in human plasma treated with H2O2 or H2O2/Fe. In addition, our results indicate the anti-coagulant activities of CORM-2 in vitro.	[Adach, Weronika; Olas, Beata] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Lodz, Poland	University of Lodz	Olas, B (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Lodz, Poland.	beata.olas@biol.uni.lodz.pl		Olas, Beata/0000-0002-7048-2952				ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P26, DOI 10.1016/0005-2736(73)90251-4; ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P38, DOI 10.1016/0005-2736(73)90252-6; Babu D, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00031; Bartosz B., 2008, WARSZAWA1, V7, P99; Durante W, 2006, J CELL MOL MED, V10, P672, DOI 10.1111/j.1582-4934.2006.tb00427.x; Foresti R, 2008, INTENS CARE MED, V34, P649, DOI 10.1007/s00134-008-1011-1; Fredenburgh LE, 2015, EUR HEART J, V36, P1512, DOI 10.1093/eurheartj/ehv114; Kshirsagar AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078930; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Liu D, 2016, SYSTEMS ENGINEERING: DESIGN PRINCIPLES AND MODELS, P1; Liu Dadong, 2015, Zhonghua Shao Shang Za Zhi, V31, P354; LUZZATTO E, 1995, FREE RADICAL RES, V23, P453, DOI 10.3109/10715769509065266; Malinowska J, 2012, FOOD CHEM TOXICOL, V50, P4023, DOI 10.1016/j.fct.2012.07.065; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2017, AM J PHYSIOL-CELL PH, V312, pC302, DOI 10.1152/ajpcell.00360.2016; Nielsen VG, 2015, CURR NEUROVASC RES, V12, P31, DOI 10.2174/1567202612666150102150042; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P801, DOI 10.1097/MBC.0000000000000146; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P695, DOI 10.1097/MBC.0000000000000128; Nielsen VG, 2014, THROMB RES, V133, P315, DOI 10.1016/j.thromres.2013.12.004; Nielsen VG, 2012, BLOOD COAGUL FIBRIN, V23, P104, DOI 10.1097/MBC.0b013e32834ea012; Nielsen VG, 2009, CARBON MONOXIDE RELE; Olas B, 2014, CHEM-BIOL INTERACT, V222, P37, DOI 10.1016/j.cbi.2014.08.005; Sandstrom BE, 1997, FREE RADIC BIOL MED; Srisook K, 2006, BIOCHEM PHARMACOL, V71, P307, DOI 10.1016/j.bcp.2005.10.042; Sun BW, 2008, INT J BIOL SCI, V4, P176; Truss NJ, 2011, PHARMACOL THERAPEUT, V132, P196, DOI 10.1016/j.pharmthera.2011.07.001; Tsai MH, 2017, REDOX BIOL, V12, P377, DOI 10.1016/j.redox.2017.02.019; Vreman H.J., 2000, CARBON MONOXIDE TOXI, P19; WACHOWICZ B, 1984, CELL BIOCHEM FUNCT, V2, P167, DOI 10.1002/cbf.290020310; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184787	10.1371/journal.pone.0184787	http://dx.doi.org/10.1371/journal.pone.0184787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950024	Green Published, gold, Green Submitted			2022-12-26	WOS:000411671000015
J	Siska, EK; Weisman, I; Romano, J; Ivics, Z; Izsvak, Z; Barkai, U; Petrakis, S; Koliakos, G				Siska, Evangelia K.; Weisman, Itamar; Romano, Jacob; Ivics, Zoltan; Izsvak, Zsuzsanna; Barkai, Uriel; Petrakis, Spyros; Koliakos, George			Generation of an immortalized mesenchymal stem cell line producing a secreted biosensor protein for glucose monitoring	PLOS ONE			English	Article							GLUCOSE/GALACTOSE-BINDING PROTEIN; PROLIFERATION IN-VITRO; STROMAL CELLS; HLA-G; EXPRESSION; VIVO; DIFFERENTIATION; SENSOR; PLURIPOTENT; DYNAMICS	Diabetes is a chronic disease characterized by high levels of blood glucose. Diabetic patients should normalize these levels in order to avoid short and long term clinical complications. Presently, blood glucose monitoring is dependent on frequent finger pricking and enzyme based systems that analyze the drawn blood. Continuous blood glucose monitors are already on market but suffer from technical problems, inaccuracy and short operation time. A novel approach for continuous glucose monitoring is the development of implantable cell- based biosensors that emit light signals corresponding to glucose concentrations. Such devices use genetically modified cells expressing chimeric genes with glucose binding properties. MSCs are good candidates as carrier cells, as they can be genetically engineered and expanded into large numbers. They also possess immunomodulatory properties that, by reducing local inflammation, may assist long operation time. Here, we generated a novel immortalized human MSC line co-expressing hTERT and a secreted glucose biosensor transgene using the Sleeping Beauty transposon technology. Genetically modified hMSCs retained their mesenchymal characteristics. Stable transgene expression was validated biochemically. Increased activity of hTERT was accompanied by elevated and constant level of stem cell pluripotency markers and subsequently, by MSC immortalization. Furthermore, these cells efficiently suppressed PBMC proliferation in MLR transwell assays, indicating that they possess immunomodulatory properties. Finally, biosensor protein produced by MSCs was used to quantify glucose in cell-free assays. Our results indicate that our immortalized MSCs are suitable for measuring glucose concentrations in a physiological range. Thus, they are appropriate for incorporation into a cell-based, immune-privileged, glucose-monitoring medical device.	[Siska, Evangelia K.; Koliakos, George] Aristotle Univ Thessaloniki, Fac Life Sci, Sch Med, Thessaloniki, Greece; [Siska, Evangelia K.; Petrakis, Spyros; Koliakos, George] Biohellenika SA Biotechnol Co, Thessaloniki, Greece; [Weisman, Itamar; Romano, Jacob; Barkai, Uriel] GluSense Ltd, Rabin Sci Parkm, Rehovot, Israel; [Ivics, Zoltan] Paul Ehrlich Inst, Langen, Germany; [Izsvak, Zsuzsanna] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany; [Siska, Evangelia K.] Biomerieux SA, Parc Technol Delta Sud, Verniolle, France; [Petrakis, Spyros] Ctr Res & Technol Hellas CERTH, Inst Appl Biosci INAB, Thessaloniki, Greece	Aristotle University of Thessaloniki; Paul Ehrlich Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centre for Research & Technology Hellas	Petrakis, S (corresponding author), Biohellenika SA Biotechnol Co, Thessaloniki, Greece.; Petrakis, S (corresponding author), Ctr Res & Technol Hellas CERTH, Inst Appl Biosci INAB, Thessaloniki, Greece.	spetrak@certh.gr	Petrakis, Spyros/AAA-6778-2021; Barkai, Uriel/I-6316-2019; Koliakos, George/AAC-8888-2021	Petrakis, Spyros/0000-0001-9094-3480; Siska, Evangelia/0000-0001-5861-9891	General Secretariat for Research and Technology, Greece [ISR_2789]; Israel Innovation Authority [OCS_51574]	General Secretariat for Research and Technology, Greece(Greek Ministry of Development-GSRT); Israel Innovation Authority	This work was generously supported by the General Secretariat for Research and Technology, Greece, project ISR_2789 to Biohellenika SA and Israel Innovation Authority, project OCS_51574 to Glusense Ltd, under the framework of the Bilateral R&D Cooperation between Greece and Israel 2013-2015. The funders provided support in the form of salaries for authors [EKS, IW, JR, UB, SP] and research materials but had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of all authors are articulated in the author contributions section	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Amiss TJ, 2007, PROTEIN SCI, V16, P2350, DOI 10.1110/ps.073119507; Anderson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076979; [Anonymous], GLOB REP DIAB 2016; Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Belay E, 2010, STEM CELLS, V28, P1760, DOI 10.1002/stem.501; Bronstone Amy, 2016, J Diabetes Sci Technol, V10, P905, DOI 10.1177/1932296816633233; Buntru A, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00074; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Castle Jessica R, 2016, J Diabetes Sci Technol, V10, P1169, DOI 10.1177/1932296816631569; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; DeVries JH, 2016, ACCURACY LONGEVITY I; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dutt-Ballerstadt Ralph, 2013, J Diabetes Sci Technol, V7, P35; Dutt-Ballerstadt Ralph, 2012, J Diabetes Sci Technol, V6, P362; Dutt-Ballerstadt R, 2008, DIABETES TECHNOL THE, V10, P453, DOI 10.1089/dia.2008.0033; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Isa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010900; Jin S, 2011, BIOSENS BIOELECTRON, V26, P3427, DOI 10.1016/j.bios.2011.01.017; Kapetanou M, 2017, FREE RADICAL BIO MED, V103, P226, DOI 10.1016/j.freeradbiomed.2016.12.035; Khan F, 2010, ANAL BIOCHEM, V399, P39, DOI 10.1016/j.ab.2009.11.035; Klinger RY, 2006, P NATL ACAD SCI USA, V103, P2500, DOI 10.1073/pnas.0508184103; La Rocca G, 2013, CURR STEM CELL RES T, V8, P100, DOI 10.2174/1574888X11308010012; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Liu QJ, 2007, BIOSENS BIOELECTRON, V22, P810, DOI 10.1016/j.bios.2006.03.006; Magnuson AM, 2015, P NATL ACAD SCI USA, V112, P1511, DOI 10.1073/pnas.1423769112; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mizutani T, 2010, CLIN CANCER RES, V16, P3964, DOI 10.1158/1078-0432.CCR-10-0548; Mortellaro M, 2014, BIOSENS BIOELECTRON, V61, P227, DOI 10.1016/j.bios.2014.05.022; Petrakis S, 2012, BIOTECHNOL J, V7, P891, DOI 10.1002/biot.201100471; Richter M, 2016, BLOOD, V128, P2206, DOI 10.1182/blood-2016-04-711580; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Veetil JV, 2010, BIOSENS BIOELECTRON, V26, P1650, DOI 10.1016/j.bios.2010.08.052; Vigersky Robert A, 2015, J Diabetes Sci Technol, V9, P320; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang JC, 2016, NAT PROTOC, V11, P327, DOI 10.1038/nprot.2016.016; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; World Health Organization, TOP 10 CAUS DEATH 20; Wu YC, 2001, BIOSENS BIOELECTRON, V16, P277, DOI 10.1016/S0956-5663(01)00138-5; ZUKIN RS, 1977, BIOCHEMISTRY-US, V16, P381, DOI 10.1021/bi00622a007	51	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185498	10.1371/journal.pone.0185498	http://dx.doi.org/10.1371/journal.pone.0185498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949988	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000411671000059
J	Tarjus, A; Maase, M; Jeggle, P; Martinez-Martinez, E; Fassot, C; Loufrani, L; Henrion, D; Hansen, PBL; Kusche-Vihrog, K; Jaisser, F				Tarjus, Antoine; Maase, Martina; Jeggle, Pia; Martinez-Martinez, Ernesto; Fassot, Celine; Loufrani, Laurent; Henrion, Daniel; Hansen, Pernille B. L.; Kusche-Vihrog, Kristina; Jaisser, Frederic			The endothelial aENaC contributes to vascular endothelial function in vivo	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; BLOOD-PRESSURE; NA+ CHANNELS; MICE LACKING; ENAC; CELLS; FLOW; ALDOSTERONE; ADAPTATION; EXPRESSION	The Epithelial Sodium Channel (ENaC) is a key player in renal sodium homeostasis. The expression of alpha beta gamma ENaC subunits has also been described in the endothelium and vascular smooth muscle, suggesting a role in vascular function. We recently demonstrated that endothelial ENaC is involved in aldosterone-modulated endothelial stiffness. Here we explore the functional role of the endothelial aENaC subunit in vascular function in vivo. Compared to littermates, mice with conditional aENaC subunit gene inactivation in the endothelium only (endo-aENaC Knock Out mice) had no difference in their physiological parameters such as systolic blood pressure or heart rate. Acute and long-term renal Na+ handlings were not affected, indicating that endothelial aENaC subunit is not involved in renal sodium balance. Pharmacological inhibition of ENaC with benzamil blunted acetylcholine-induced nitric oxide production in mesenteric arteries from wild type mice but not in endo-aENaC(KO) mice, suggesting a critical role of endothelial ENaC in agonist-induced nitric oxide production. In endo-aENaC(KO) mice, compensatory mechanisms occurred and steady state vascular function was not altered except for flow-mediated dilation. Our data suggest that endothelial aENaC contributes to vascular endothelial function in vivo.	[Tarjus, Antoine; Martinez-Martinez, Ernesto; Jaisser, Frederic] INSERM, U1138, Ctr Rech Cordeliers, Paris, France; [Tarjus, Antoine; Martinez-Martinez, Ernesto; Jaisser, Frederic] Univ Paris 06, Paris, France; [Maase, Martina; Jeggle, Pia; Kusche-Vihrog, Kristina] Univ Munster, Inst Physiol 2, Munster, Germany; [Fassot, Celine; Loufrani, Laurent; Henrion, Daniel] Univ Angers, CNRS, INSERM 1083, UMR 6214, Angers, France; [Hansen, Pernille B. L.] Univ Southern Denmark, Cardiovasc & Renal Res, Odense, Denmark; [Hansen, Pernille B. L.] AstraZeneca, Gothenburg, Sweden; [Jaisser, Frederic] INSERM, Clin Invest Ctr 1433, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Munster; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Southern Denmark; AstraZeneca; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tarjus, A (corresponding author), INSERM, U1138, Ctr Rech Cordeliers, Paris, France.; Tarjus, A (corresponding author), Univ Paris 06, Paris, France.	antoine.tarjus@gmail.com	Jaisser, Frederic/P-4287-2017; Martinez-Martinez, Ernesto/M-1376-2017; Henrion, Daniel/J-8141-2015; Henrion, Daniel/N-7023-2015; Fassot, Celine/K-1494-2015; Henrion, Daniel/AAK-1995-2021	Jaisser, Frederic/0000-0001-9051-1901; Martinez-Martinez, Ernesto/0000-0002-3011-2041; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Hansen, Pernille B. Laerkegaard/0000-0003-0661-1665; Tarjus, Antoine/0000-0002-9867-4585				Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Buchanan CF, 2014, CELL ADHES MIGR, V8, P517, DOI 10.4161/19336918.2014.970001; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Golestaneh N, 2001, BIOCHEM BIOPH RES CO, V280, P1300, DOI 10.1006/bbrc.2001.4275; Guo DQ, 2016, J CELL SCI, V129, P290, DOI 10.1242/jcs.168831; Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Jeggle P, 2013, HYPERTENSION, V61, P1053, DOI 10.1161/HYPERTENSIONAHA.111.199455; Jernigan NL, 2005, AM J PHYSIOL-RENAL, V289, pF891, DOI 10.1152/ajprenal.00019.2005; Kasas S, 2008, PFLUG ARCH EUR J PHY, V456, P13, DOI 10.1007/s00424-008-0448-y; Korte S, 2014, FASEB J, V28, P4015, DOI 10.1096/fj.14-250282; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Kusche-Vihrog K, 2008, PFLUG ARCH EUR J PHY, V455, P849, DOI 10.1007/s00424-007-0341-0; Kusche-Vihrog K, 2011, HYPERTENSION, V57, P231, DOI 10.1161/HYPERTENSIONAHA.110.163444; Liu HB, 2015, BRIT J PHARMACOL, V172, P5634, DOI 10.1111/bph.13185; Loufrani L, 2002, CIRC RES, V91, P1183, DOI 10.1161/01.RES.0000047505.11002.81; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Perez FR, 2009, HYPERTENSION, V53, P1000, DOI 10.1161/HYPERTENSIONAHA.108.128520; Pradervand S, 1999, J AM SOC NEPHROL, V10, P2527; Prince LS, 1998, BIOCHEM J, V336, P705, DOI 10.1042/bj3360705; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Svenningsen P, 2014, PFLUG ARCH EUR J PHY, V466, P2205, DOI 10.1007/s00424-014-1492-4; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Wang S, 2009, MICROCIRCULATION, V16, P276, DOI 10.1080/10739680802653150	29	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185319	10.1371/journal.pone.0185319	http://dx.doi.org/10.1371/journal.pone.0185319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950003	Green Published, gold, Green Submitted			2022-12-26	WOS:000411671000037
J	Solomon-Zemler, R; Sarfstein, R; Werner, H				Solomon-Zemler, Ravid; Sarfstein, Rive; Werner, Haim			Nuclear insulin-like growth factor-1 receptor (IGF1R) displays proliferative and regulatory activities in non-malignant cells	PLOS ONE			English	Article							EXPRESSION; IGF-1R; ANTIBODY; PATHWAY	The insulin-like growth factor-1 receptor (IGF1R) mediates the biological actions of IGF1 and IGF2. The IGF1R is involved in both physiological and pathological activities and is usually overexpressed in most types of cancer. In addition to its classical mechanism of action, recent evidence has shown a nuclear presence of IGF1R, associated with novel genomic/transcriptional types of activities. The present study was aimed at evaluating the hypothesis that nuclear IGF1R localization is not restricted to cancer cells and might constitute a novel physiologically relevant regulatory mechanism. Our data shows that nuclear translocation takes place in a wide array of cells, including normal diploid fibroblasts. In addition, we provide evidence for a synergistic effect of a nuclear translocation blocker along with selective IGF1R inhibitors in terms of decreasing cell proliferation. Given the important role of the IGF1R in mitogenesis, the present results may be of translational relevance in cancer research. In conclusion, results are consistent with the concept that nuclear IGF1R fulfills important physiological and pathological roles.	[Solomon-Zemler, Ravid; Sarfstein, Rive; Werner, Haim] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Werner, Haim] Tel Aviv Univ, Yoran Inst Human Genome Res, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Werner, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.; Werner, H (corresponding author), Tel Aviv Univ, Yoran Inst Human Genome Res, Tel Aviv, Israel.	hwerner@post.tau.ac.il			European Foundation	European Foundation(European Science Foundation (ESF))	This study was supported by a grant from the European Foundation for the study of Diabetes. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed in partial fulfillment of the requirements for a Ph.D. degree by Ravid Solomon-Zemler at the Sackler Faculty of Medicine, Tel Aviv University. This work was supported by a grant from the European Foundation for the Study of Diabetes to H.W. The authors wish to thank Drs. Joy L. Ware, Derek LeRoith and Eli Sprecher for providing cell lines.	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Asmane I, 2012, EUR J CANCER, V48, P3027, DOI 10.1016/j.ejca.2012.05.009; BASERGA R, 1995, CANCER RES, V55, P249; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Deng H, 2011, BIOCHEM BIOPH RES CO, V404, P667, DOI 10.1016/j.bbrc.2010.12.038; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518; KALEKO M, 1990, MOL CELL BIOL, V10, P464, DOI 10.1128/MCB.10.2.464; Lin YC, 2015, CHEM-BIOL INTERACT, V231, P119, DOI 10.1016/j.cbi.2015.01.016; Lin YB, 2017, J CELL PHYSIOL, V232, P2722, DOI 10.1002/jcp.25818; Maloney EK, 2003, CANCER RES, V63, P5073; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Ouban A, 2003, HUM PATHOL, V34, P803, DOI 10.1016/S0046-8177(03)00291-0; Packham S, 2015, ONCOGENE, V34, P2227, DOI 10.1038/onc.2014.165; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Sarfstein R, 2012, J BIOL CHEM, V287, P2766, DOI 10.1074/jbc.M111.281782; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Wang Z, 2015, IEEE ST CONF RES DEV, P1, DOI 10.1109/SCORED.2015.7449302; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251	22	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185164	10.1371/journal.pone.0185164	http://dx.doi.org/10.1371/journal.pone.0185164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945762	gold, Green Published, Green Submitted			2022-12-26	WOS:000411645100026
J	Liu, W; Tang, FL; Lin, S; Zhao, K; Mei, L; Ye, J; Xiong, WC				Liu, Wei; Tang, Fu-Lei; Lin, Sen; Zhao, Kai; Mei, Lin; Ye, Jian; Xiong, Wen-Cheng			Vps35-deficiency impairs SLC4A11 trafficking and promotes corneal dystrophy	PLOS ONE			English	Article							ENDOTHELIAL DYSTROPHY; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; ION-TRANSPORT; ALZHEIMERS-DISEASE; RETROMER COMPLEX; GOLGI RETRIEVAL; VPS35; MUTATIONS; PROTEIN	Vps35 (vacuolar protein sorting 35) is a major component of retromer that selectively promotes endosome-to-Golgi retrieval of transmembrane proteins. Dysfunction of retromer is a risk factor for the pathogenesis of Parkinson's disease (PD) and Alzheimer's disease (AD). However, Vps35/retromer's function in the eye or the contribution of Vps35-deficiency to eye degenerative disorders remains to be explored. Here we provide evidence for a critical role of Vps35 in mouse corneal dystrophy. Vps35 is expressed in mouse and human cornea. Mouse cornea from Vps35 heterozygotes (Vps35(+/-)) show features of dystrophy, such as loss of both endothelial and epithelial cell densities, disorganizations of endothelial, stroma, and epithelial cells, excrescences in the Descemet membrane, and corneal edema. Additionally, corneal epithelial cell proliferation was reduced in Vps35-deficient mice. Intriguingly, cell surface targeting of SLC4A11, a membrane transport protein (OH- /H+ /NH3 /H2O) of corneal endothelium, whose mutations have been identified in patients with corneal dystrophy, was impaired in Vps35-deficient cells and cornea. Taken together, these results suggest that SLC4A11 appears to be a Vps35/retromer cargo, and Vps35-regulation of SLC4A11 trafficking may underlie Vps35/retromer regulation of corneal dystrophy.	[Liu, Wei; Tang, Fu-Lei; Lin, Sen; Zhao, Kai; Mei, Lin; Xiong, Wen-Cheng] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Liu, Wei; Tang, Fu-Lei; Lin, Sen; Zhao, Kai; Mei, Lin; Xiong, Wen-Cheng] Augusta Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; [Liu, Wei; Lin, Sen; Ye, Jian] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Ophthalmol, Chongqing, Peoples R China; [Tang, Fu-Lei; Zhao, Kai; Mei, Lin; Xiong, Wen-Cheng] Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Army Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Xiong, WC (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA.; Xiong, WC (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA.; Ye, J (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Ophthalmol, Chongqing, Peoples R China.; Xiong, WC (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA.	yejian1979@163.com; wxiong@augusta.edu		Xiong, Wen-Cheng/0000-0001-9071-7598	National Institutes of Aging [AG045781, AG051773]	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Aging Grants, AG045781 and AG051773 to W.-C. Xiong.	Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; de Groot REA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076971; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Dhungel N, 2015, NEURON, V85, P76, DOI 10.1016/j.neuron.2014.11.027; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P7, DOI 10.1016/bs.pmbts.2015.04.001; Frausto RF, 2014, INVEST OPHTH VIS SCI, V55, P7821, DOI 10.1167/iovs.14-15021; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Jiao XD, 2007, J MED GENET, V44, P64, DOI 10.1136/jmg.2006.044644; Kao LY, 2016, AM J PHYSIOL-CELL PH, V311, pC820, DOI 10.1152/ajpcell.00233.2016; Kim EK, 2015, PROG MOL BIOL TRANSL, V134, P99, DOI 10.1016/bs.pmbts.2015.05.003; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Kodaganur SG, 2013, MOL VIS, V19, P1694; Lin ZN, 2016, INT J OPHTHALMOL-CHI, V9, P904, DOI 10.18240/ijo.2016.06.20; Liu J, 2012, INVEST OPHTH VIS SCI, V53, P3270, DOI 10.1167/iovs.11-8724; Liu W, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-10; Loganathan SK, 2016, AM J PHYSIOL-CELL PH, V311, pC735, DOI 10.1152/ajpcell.00078.2016; Loganathan SK, 2016, AM J PHYSIOL-CELL PH, V310, pC161, DOI 10.1152/ajpcell.00246.2015; Lopez IA, 2009, J BIOL CHEM, V284, P26882, DOI 10.1074/jbc.M109.008102; Malik BR, 2015, HUM MOL GENET, V24, P6106, DOI 10.1093/hmg/ddv322; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Miura E, 2014, NEUROBIOL DIS, V71, P1, DOI 10.1016/j.nbd.2014.07.014; Patel SP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/475392; Pocha SM, 2011, CURR BIOL, V21, P1111, DOI 10.1016/j.cub.2011.05.007; Rovelet-Lecrux A, 2015, MOL PSYCHIATR, V20, P1046, DOI 10.1038/mp.2015.100; Roy S, 2015, CORNEA, V34, P668, DOI 10.1097/ICO.0000000000000421; Schorderet D, 2015, PROG MOL BIOL TRANSL, V134, P73, DOI 10.1016/bs.pmbts.2015.04.004; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Shei W, 2013, MOL VIS, V19, P1096; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001; Tang FL, 2015, J NEUROSCI, V35, P10613, DOI 10.1523/JNEUROSCI.0042-15.2015; Tian Y, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0156-4; Tsika E, 2014, HUM MOL GENET, V23, P4621, DOI 10.1093/hmg/ddu178; Vedana G, 2016, CLIN OPHTHALMOL, V10, P321, DOI 10.2147/OPTH.S83467; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; Vilas GL, 2012, HUM MUTAT, V33, P419, DOI 10.1002/humu.21655; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Wang CL, 2012, BIOL OPEN, V1, P1248, DOI 10.1242/bio.20122451; Wang W, 2016, J SENSORS, V2016, DOI 10.1155/2016/2646205; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Xia WF, 2013, J CELL BIOL, V200, P821, DOI 10.1083/jcb.201207154; Xiong L, 2016, EBIOMEDICINE, V9, P45, DOI 10.1016/j.ebiom.2016.05.028; Zhu AY, 2014, JAMA OPHTHALMOL, V132, P377, DOI 10.1001/jamaophthalmol.2013.7993; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	52	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184906	10.1371/journal.pone.0184906	http://dx.doi.org/10.1371/journal.pone.0184906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934248	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900060
J	Miller, C; Boegler, K; Carver, S; MacMillan, M; Bielefeldt-Ohmann, H; VandeWoude, S				Miller, Craig; Boegler, Karen; Carver, Scott; MacMillan, Martha; Bielefeldt-Ohmann, Helle; VandeWoude, Sue			Pathogenesis of oral FIV infection	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; SYSTEMIC IMMUNE ACTIVATION; CELL-FREE SIV; HIV-INFECTION; LYMPH-NODES; MICROBIAL TRANSLOCATION; GASTROINTESTINAL-TRACT; VERTICAL TRANSMISSION; COMMENSAL BACTERIA; HOMOSEXUAL-MEN	Feline immunodeficiency virus (FIV) is the feline analogue of human immunodeficiency virus (HIV) and features many hallmarks of HIV infection and pathogenesis, including the development of concurrent oral lesions. While HIV is typically transmitted via parenteral transmucosal contact, recent studies prove that oral transmission can occur, and that saliva from infected individuals contains significant amounts of HIV RNA and DNA. While it is accepted that FIV is primarily transmitted by biting, few studies have evaluated FIV oral infection kinetics and transmission mechanisms over the last 20 years. Modern quantitative analyses applied to natural FIV oral infection could significantly further our understanding of lentiviral oral disease and transmission. We therefore characterized FIV salivary viral kinetics and antibody secretions to more fully document oral viral pathogenesis. Our results demonstrate that: (i) saliva of FIV-infected cats contains infectious virus particles, FIV viral RNA at levels equivalent to circulation, and lower but significant amounts of FIV proviral DNA; (ii) the ratio of FIV RNA to DNA is significantly higher in saliva than in circulation; (iii) FIV viral load in oral lymphoid tissues (tonsil, lymph nodes) is significantly higher than mucosal tissues (buccal mucosa, salivary gland, tongue); (iv) salivary IgG antibodies increase significantly over time in FIV-infected cats, while salivary IgA levels remain static; and, (v) saliva from naive Specific Pathogen Free cats inhibits FIV growth in vitro. Collectively, these results suggest that oral lymphoid tissues serve as a site for enhanced FIV replication, resulting in accumulation of FIV particles and FIV-infected cells in saliva. Failure to induce a virus-specific oral mucosal antibody response, and/or viral capability to overcome inhibitory components in saliva may perpetuate chronic oral cavity infection. Based upon these findings, we propose a model of oral FIV pathogenesis and suggest alternative diagnostic modalities and translational approaches to study oral HIV infection.	[Miller, Craig; Boegler, Karen; MacMillan, Martha; VandeWoude, Sue] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Carver, Scott] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia	Colorado State University; University of Tasmania; University of Queensland	VandeWoude, S (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Sue.Vandewoude@colostate.edu	Carver, Scott/J-7654-2014	Carver, Scott/0000-0002-3579-7588	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI025825]; NIH Training Grants [4T32OD010437-15, 1F32DE026679-01]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI025825 (https://www.niaid.nih.gov/), and by NIH Training Grants 4T32OD010437-15 and 1F32DE026679-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreo SMS, 2004, AIDS RES HUM RETROV, V20, P349, DOI 10.1089/088922204323048087; BABA TW, 1994, AIDS RES HUM RETROV, V10, P351, DOI 10.1089/aid.1994.10.351; Baba TW, 1996, SCIENCE, V272, P1486, DOI 10.1126/science.272.5267.1486; BACH JM, 1994, AIDS RES HUM RETROV, V10, P1731, DOI 10.1089/aid.1994.10.1731; Bagley KC, 2006, CLIN VACCINE IMMUNOL, V13, P106, DOI 10.1128/CVI.13.1.106-115.2006; Baron S, 2000, J INFECT DIS, V181, P498, DOI 10.1086/315251; Baron S, 2001, AIDS RES HUM RETROV, V17, P997, DOI 10.1089/088922201300343672; Bartholomew CF, 2006, AIDS, V20, P631, DOI 10.1097/01.aids.0000210621.13825.75; BASKIN GB, 1988, VET PATHOL, V25, P456, DOI 10.1177/030098588802500609; Beczkowski PM, 2015, VET MICROBIOL, V176, P50, DOI 10.1016/j.vetmic.2014.12.023; BEEBE AM, 1994, J VIROL, V68, P3080, DOI 10.1128/JVI.68.5.3080-3091.1994; Brady LJ, 1996, ORAL MICROBIOL IMMUN, V11, P371, DOI 10.1111/j.1399-302X.1996.tb00198.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Casteleyn C, 2011, CLIN DEV IMMUNOLOGY, V2011; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; de Rozieres S, 2004, J VIROL, V78, P8971, DOI 10.1128/JVI.78.17.8971-8982.2004; De Rozieres S, 2008, J VIROL, V82, P7953, DOI 10.1128/JVI.00337-08; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; DREITZ MJ, 1995, AM J VET RES, V56, P764; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Elder JH, 1998, AIDS RES HUM RETROV, V14, P797, DOI 10.1089/aid.1998.14.797; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Gilbart VL, 2004, SEX TRANSM INFECT, V80, P324, DOI 10.1136/sti.2004.009217; GROOPMAN JE, 1984, SCIENCE, V226, P447, DOI 10.1126/science.6093247; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; ISHIDA T, 1989, J AM VET MED ASSOC, V194, P221; Kenyon JC, 2011, VIRUSES-BASEL, V3, P2192, DOI 10.3390/v3112192; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Leutenegger CM, 1999, VET IMMUNOL IMMUNOP, V71, P291, DOI 10.1016/S0165-2427(99)00100-2; Levy JK, 2004, JAVMA-J AM VET MED A, V225, P1558, DOI 10.2460/javma.2004.225.1558; Li YH, 2014, J CLIN MICROBIOL, V52, P1400, DOI 10.1128/JCM.02954-13; Liem BP, 2013, J VET INTERN MED, V27, P798, DOI 10.1111/jvim.12120; Litster AL, 2014, VET J, V201, P184, DOI 10.1016/j.tvjl.2014.02.030; Liuzzi G, 1996, AIDS, V10, pF51, DOI 10.1097/00002030-199612000-00001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Magden E, 2013, VIROLOGY, V436, P284, DOI 10.1016/j.virol.2012.12.003; Mataftsi M, 2011, ORAL DIS, V17, P13, DOI 10.1111/j.1601-0825.2010.01727.x; MATTEUCCI D, 1993, J CLIN MICROBIOL, V31, P494, DOI 10.1128/JCM.31.3.494-501.1993; MCCLURE HM, 1989, VET IMMUNOL IMMUNOP, V21, P13, DOI 10.1016/0165-2427(89)90126-8; McElrath MJ, 2011, IMMUNITY, V34, P146, DOI 10.1016/j.immuni.2011.02.014; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Milush JM, 2007, J VIROL, V81, P6175, DOI 10.1128/JVI.00042-07; Norris JM, 1999, VET MICROBIOL, V65, P195, DOI 10.1016/S0378-1135(98)00290-9; Obert LA, 2002, J VIROL, V76, P6311, DOI 10.1128/JVI.76.12.6311-6322.2002; Obert LA, 2000, AIDS RES HUM RETROV, V16, P677, DOI 10.1089/088922200308909; ONEIL LL, 1995, AIDS RES HUM RETROV, V11, P171, DOI 10.1089/aid.1995.11.171; Page-Shafer K, 2002, AIDS, V16, P2350, DOI 10.1097/00002030-200211220-00022; PageShafer K, 1997, AM J EPIDEMIOL, V146, P531, DOI 10.1093/oxfordjournals.aje.a009311; PARODI AL, 1994, J COMP PATHOL, V111, P165, DOI 10.1016/S0021-9975(05)80048-9; Pedersen N, 1990, AN MOD AIDS INT TNO; Pedersen NC, 2001, VET IMMUNOL IMMUNOP, V79, P53, DOI 10.1016/S0165-2427(01)00252-5; PEDERSEN NC, 1989, VET IMMUNOL IMMUNOP, V21, P111, DOI 10.1016/0165-2427(89)90134-7; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; POLI A, 1992, J CLIN MICROBIOL, V30, P2038, DOI 10.1128/JCM.30.8.2038-2041.1992; QIAGEN, 2006, PUR TOT DNA AN SAL U; QURESHI MN, 1995, J INFECT DIS, V171, P190, DOI 10.1093/infdis/171.1.190; RICHMAN KM, 1993, J ACQ IMMUN DEF SYND, V6, P402; RIDEOUT BA, 1992, VET PATHOL, V29, P391, DOI 10.1177/030098589202900504; Robinson PG, 2002, ORAL DIS, V8, P91, DOI 10.1034/j.1601-0825.2002.00019.x; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Santos L C, 2001, Braz Dent J, V12, P135; SELLON RK, 1994, J VIROL, V68, P3380, DOI 10.1128/JVI.68.5.3380-3385.1994; SIEBELINK KHJ, 1990, AIDS RES HUM RETROV, V6, P1373, DOI 10.1089/aid.1990.6.1373; SIMS TJ, 1990, J DENT RES, V69, P877, DOI 10.1177/00220345900690031001; Spetz AL, 2013, J INFECT DIS, V207, P1189, DOI 10.1093/infdis/jis477; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Taniwaki SA, 2013, COMP IMMUNOL MICROB, V36, P549, DOI 10.1016/j.cimid.2013.07.001; TerWee JA, 2008, VIROLOGY, V377, P63, DOI 10.1016/j.virol.2008.03.037; Thompson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024020; Troyer RM, 2013, J VIROL, V87, P7940, DOI 10.1128/JVI.00752-13; UELAND K, 1992, VET IMMUNOL IMMUNOP, V33, P301, DOI 10.1016/0165-2427(92)90002-8; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Vidmar L, 1996, LANCET, V347, P1762, DOI 10.1016/S0140-6736(96)90838-7; Wallace JJ, 1997, AM J PUBLIC HEALTH, V87, P470, DOI 10.2105/AJPH.87.3.470; Webber LM, 2000, S AFR MED J, V90, P1004; Weese SJ, 2015, VET RES, V46, DOI 10.1186/s13567-014-0140-5; Willett BJ, 2013, CURR OPIN VIROL, V3, P670, DOI 10.1016/j.coviro.2013.08.003; Wood BA, 2013, J IMMUNOL METHODS, V396, P74, DOI 10.1016/j.jim.2013.08.001; Wood BA, 2011, CLIN VACCINE IMMUNOL, V18, P387, DOI 10.1128/CVI.00289-10; Wood LF, 2013, IMMUNOL REV, V254, P34, DOI 10.1111/imr.12078; YAMAMOTO JK, 1989, J AM VET MED ASSOC, V194, P213; YAMAMOTO JK, 1988, AM J VET RES, V49, P1246; YEUNG SCH, 1993, J PERIODONTOL, V64, P651, DOI 10.1902/jop.1993.64.7.651	92	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185138	10.1371/journal.pone.0185138	http://dx.doi.org/10.1371/journal.pone.0185138			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934316	Green Published, Green Accepted, gold			2022-12-26	WOS:000411339900102
J	Zhao, SP; Li, R; Dai, W; Yu, BL; Chen, LZ; Huang, XS				Zhao, Shui-ping; Li, Rong; Dai, Wen; Yu, Bi-lian; Chen, Lu-zhu; Huang, Xian-sheng			Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPAR alpha signaling pathway	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-HEART-DISEASE; HMG-COA REDUCTASE; CARDIOVASCULAR-DISEASE; DYSLIPIDEMIA; ATORVASTATIN; CHOLESTEROL; MECHANISMS; EXPRESSION	Xuezhikang (XZK), an extract of Chinese red yeast rice, is recommended as an optimal choice for patients with coronary heart disease (CHD) with markedly elevated triglyceride (TG) levels. This study was designed to compare the hypotriglyceridemic effects between XZK and simvastatin. The role of apolipoprotein A5 (apoA5), a key regulator of TG metabolism and a target gene of peroxisome proliferator-activated receptor a (PPAR alpha), was to be identified in XZK-related hypotriglyceridemic actions. For these goals, hypertriglyceridemia of rats was induced by a high-fructose diet. In order to investigate the hypotriglyceridemic effects of XZK and simvastatin on these animals based on an equivalent low-density lipoprotein cholesterol (LDL-C) lowering power, we titrated their doses (XZK 80 mg/kg/d versus simvastatin 1 mg/kg/d) according to plasma LDL-C reduction of rats. Similarly, we titrated the target doses of the two agents (XZK 500 mu g/ml versus simvastatin 10 mu M) according to hepatocyte LDL receptor expressions, and then compared the effects of the two agents on TG and apoA5 of hepatocytes in vitro. Our results showed that XZK (80 mg/kg/d) had higher hypotriglyceridemic performance than simvastatin (1 mg/kg/d) on these animals albeit their equivalent LDL-C lowering power. Higher plasma apoA5 levels and hepatic apoA5 expressions were observed in rats treated with XZK (80 mg/kg/d) than simvastatin (1 mg/kg/d). Further, XZK (80 mg/kg/d) contributed to higher hepatic PPARa expressions of rats than simvastatin (1 mg/kg/d). Although the two agents led to an equivalent up-regulation of LDL receptors of hepatocytes, more TG reduction and apoA5 elevation were detected in hepatocytes treated with XZK (500 mu g/ml) than simvastatin (10 mu M). However, PPARa knockdown eliminated the above effects of XZK on hepatocytes. Therefore, our study indicates that XZK has greater hypotriglyceridemic performance than simvastatin in the setting of an equivalent LDL-C lowering power, which is attributed to more apoA5 up-regulation by this agent via the PPARa signaling pathway.	[Zhao, Shui-ping; Dai, Wen; Yu, Bi-lian; Chen, Lu-zhu; Huang, Xian-sheng] Cent S Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China; [Li, Rong] Cent S Univ, Xiangya Hosp 2, Dept Stomatol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Huang, XS (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China.	initialhxs@163.com						Baroukh N, 2004, ARTERIOSCL THROM VAS, V24, P1297, DOI 10.1161/01.ATV.0000130463.68272.1d; Brautbar A, 2011, ATHEROSCLEROSIS, V219, P737, DOI 10.1016/j.atherosclerosis.2011.08.015; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Henneman P, 2007, ATHEROSCLEROSIS, V193, P129, DOI 10.1016/j.atherosclerosis.2006.05.030; Huang XS, 2009, BRIT J PHARMACOL, V158, P706, DOI 10.1111/j.1476-5381.2009.00350.x; KASIM SE, 1992, J LIPID RES, V33, P1; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Moriarty PM, 2014, J CLIN LIPIDOL, V8, P568, DOI 10.1016/j.jacl.2014.09.002; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Qiu J, 2007, NATURE, V448, P126, DOI 10.1038/448126a; REIHNER E, 1990, NEW ENGL J MED, V323, P224, DOI 10.1056/NEJM199007263230403; Roglans N, 2002, J PHARMACOL EXP THER, V302, P232, DOI 10.1124/jpet.302.1.232; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tai ES, 2008, CURR OPIN LIPIDOL, V19, P349, DOI 10.1097/MOL.0b013e328304b681; Talmud PJ, 2002, HUM MOL GENET; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; Vu-Dac N, 2003, J BIOL CHEM, V278, P17982, DOI 10.1074/jbc.M212191200; Yashiro T, 2012, ATHEROSCLEROSIS, V220, P369, DOI 10.1016/j.atherosclerosis.2011.11.006; Zhao SP, 2014, ATHEROSCLEROSIS, V235, P463, DOI 10.1016/j.atherosclerosis.2014.05.916; Zhao SP, 2004, CIRCULATION, V110, P915, DOI 10.1161/01.CIR.0000139985.81163.CE	29	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184949	10.1371/journal.pone.0184949	http://dx.doi.org/10.1371/journal.pone.0184949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934253	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900063
J	Wilke, ABB; Wilk-da-Silva, R; Marrelli, MT				Bruno Wilke, Andre Barretto; Wilk-da-Silva, Ramon; Marrelli, Mauro Toledo			Microgeographic population structuring of Aedes aegypti (Diptera: Culicidae)	PLOS ONE			English	Article							SAO-PAULO; IMMATURE MOSQUITOS; MUNICIPAL PARKS; SOFTWARE; DENGUE; FEVER; CITY; EVOLUTION; MARKERS; VECTOR	Aedes aegypti is one of the species most favored by changes in the environment caused by urbanization. Its abundance increases rapidly in the face of such changes, increasing the risk of disease transmission. Previous studies have shown that mosquito species that have adapted to anthropogenic environmental changes benefit from urbanization and undergo population expansion. In light of this, we used microsatellite markers to explore how urbanization processes may be modulating Ae. aegypti populations collected from three areas with different levels of urbanization in the city of Sao Paulo, Brazil. Specimens were collected at eleven sites in three areas with different degrees of urbanization in the city of Sao Paulo: conserved, intermediate and urbanized. Ten microsatellite loci were used to characterize the populations from these areas genetically. Our findings suggest that as urbanized areas grow and the human population density in these areas increases, Ae. aegypti populations undergo a major population expansion, which can probably be attributed to the species' adaptability to anthropogenic environmental changes. Our findings reveal a robust association between, on the one hand, urbanization processes and densification of the human population and, on the other, Ae. aegypti population structure patterns and population expansion. This indicates that this species benefits from anthropogenic effects, which are intensified by migration of the human population from rural to urban areas, increasing the risk of epidemics and disease transmission to an ever-increasing number of people.	[Bruno Wilke, Andre Barretto; Wilk-da-Silva, Ramon; Marrelli, Mauro Toledo] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Wilke, ABB (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil.	andrewilke@usp.br	Wilke, Andre B B/J-9973-2014	Wilke, Andre B B/0000-0002-6629-7666	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/15313-4, 2012/19117-2, 2015/01172-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: Grant 2013/15313-4 (www.fapesp.br) MTM; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: Grant 2012/19117-2 (www.fapesp.br) ABBW; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: Grant 2015/01172-5 (www.fapesp.br) RWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CULICIDOLOGIA MED; Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Buhaug H, 2013, GLOBAL ENVIRON CHANG, V23, P1, DOI 10.1016/j.gloenvcha.2012.10.016; Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102; Ceretti W, 2014, J AM MOSQUITO CONTR, V30, P268, DOI 10.2987/14-6403R.1; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Conn JE, 2006, AM J TROP MED HYG, V74, P798, DOI 10.4269/ajtmh.2006.74.798; Cornuet JM, 1996, GENETICS, V144, P2001; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1; Michel AP, 2006, GENETICS, V173, P1389, DOI 10.1534/genetics.106.059667; Mirabello L, 2006, HEREDITY, V97, P438, DOI 10.1038/sj.hdy.6800913; Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167; Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328; NATAL D, 1984, REV SAUDE PUBL, V18, P418, DOI 10.1590/S0034-89101984000500013; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Oliveira EJ, 2006, GENET MOL BIOL, V29, P294, DOI 10.1590/S1415-47572006000200018; Rodriguez-Valle M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0605-4; Rosenthal JK, 2007, ANN ACAD MED SINGAP, V36, P834; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; StatSoft I, 2012, STATISTICA DAT AN SO; Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507; Piccinali RV, 2015, INFECT GENET EVOL, V34, P143, DOI 10.1016/j.meegid.2015.05.030; Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602; World Health Organization, 2012, DENG SEV DENG WHO FA	41	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185150	10.1371/journal.pone.0185150	http://dx.doi.org/10.1371/journal.pone.0185150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931078	gold, Green Published, Green Submitted			2022-12-26	WOS:000411314700073
J	Kanazawa, Y; Nakamura, K; Ishii, T; Aso, T; Yamazaki, H; Omori, K				Kanazawa, Yuji; Nakamura, Kimihiro; Ishii, Toru; Aso, Toshihiko; Yamazaki, Hiroshi; Omori, Koichi			Phonological memory in sign language relies on the visuomotor neural system outside the left hemisphere language network	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; SPOKEN LANGUAGE; PREMOTOR CORTEX; FRONTAL-CORTEX; DEAF SIGNERS; FMRI; PET; PARIETAL; SPEECH; AREAS	Sign language is an essential medium for everyday social interaction for deaf people and plays a critical role in verbal learning. In particular, language development in those people should heavily rely on the verbal short-term memory (STM) via sign language. Most previous studies compared neural activations during signed language processing in deaf signers and those during spoken language processing in hearing speakers. For sign language users, it thus remains unclear how visuospatial inputs are converted into the verbal STM operating in the left-hemisphere language network. Using functional magnetic resonance imaging, the present study investigated neural activation while bilinguals of spoken and signed language were engaged in a sequence memory span task. On each trial, participants viewed a nonsense syllable sequence presented either as written letters or as fingerspelling (4-7 syllables in length) and then held the syllable sequence for 12 s. Behavioral analysis revealed that participants relied on phonological memory while holding verbal information regardless of the type of input modality. At the neural level, this maintenance stage broadly activated the left-hemisphere language network, including the inferior frontal gyrus, supplementary motor area, superior temporal gyrus and inferior parietal lobule, for both letter and fingerspelling conditions. Interestingly, while most participants reported that they relied on phonological memory during maintenance, direct comparisons between letters and fingers revealed strikingly different patterns of neural activation during the same period. Namely, the effortful maintenance of fingerspelling inputs relative to letter inputs activated the left superior parietal lobule and dorsal premotor area, i.e., brain regions known to play a role in visuomotor analysis of hand/arm movements. These findings suggest that the dorsal visuomotor neural system subserves verbal learning via sign language by relaying gestural inputs to the classical left-hemisphere language network.	[Kanazawa, Yuji; Nakamura, Kimihiro; Ishii, Toru; Aso, Toshihiko] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Kanazawa, Yuji; Yamazaki, Hiroshi; Omori, Koichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Nakamura, Kimihiro] Univ Tsukuba, Fac Human Sci, Tsukuba, Ibaraki, Japan	Kyoto University; Kyoto University; University of Tsukuba	Nakamura, K (corresponding author), Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan.; Nakamura, K (corresponding author), Univ Tsukuba, Fac Human Sci, Tsukuba, Ibaraki, Japan.	kimihiro@human.tsukuba.ac.jp	Omori, Koichi/AAU-9017-2021; Aso, Toshihiko/C-2798-2018; YAMAZAKI, HIROSHI/AAR-5628-2021	Omori, Koichi/0000-0003-3404-5461; Aso, Toshihiko/0000-0003-4814-089X; YAMAZAKI, HIROSHI/0000-0003-0301-6350	Japan Society of Logopedics and Phoniatrics; JSPS Kakenhi [16KT0005]; Grants-in-Aid for Scientific Research [16KT0005, 15H05871] Funding Source: KAKEN	Japan Society of Logopedics and Phoniatrics(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Japan Society of Logopedics and Phoniatrics (to YK) and JSPS Kakenhi (16KT0005 to KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Masataka Nakayama (Department of Education, Kyoto University) for his assistance in devising the behavioral tasks. This work was supported by research grants from the Japan Society of Logopedics and Phoniatrics (to YK) and JSPS Kakenhi (16KT0005 to KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2000, JAPANESE NTT DATABAS; Amiez C, 2012, NEUROIMAGE, V59, P3723, DOI 10.1016/j.neuroimage.2011.10.058; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Bavelier D, 2008, CEREB CORTEX, V18, P2263, DOI 10.1093/cercor/bhm248; BELLUGI U, 1972, COGNITION, V1, P173, DOI 10.1016/0010-0277(72)90018-2; Blasi V, 2002, NEURON, V36, P159, DOI 10.1016/S0896-6273(02)00936-4; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buchsbaum B, 2005, BRAIN LANG, V95, P265, DOI 10.1016/j.bandl.2005.01.009; Cai Q, 2010, CEREB CORTEX, V20, P1153, DOI 10.1093/cercor/bhp175; Christophel TB, 2015, NEUROIMAGE, V106, P198, DOI 10.1016/j.neuroimage.2014.11.018; Corina DP, 2006, CORTEX, V42, P529, DOI 10.1016/S0010-9452(08)70393-9; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; Crottaz-Herbette S, 2004, NEUROIMAGE, V21, P340, DOI 10.1016/j.neuroimage.2003.09.019; Ellis AW, 2009, PHILOS T R SOC B, V364, P3675, DOI 10.1098/rstb.2009.0187; Emmorey K, 2005, NEUROIMAGE, V24, P832, DOI 10.1016/j.neuroimage.2004.10.008; Emmorey K, 2007, NEUROIMAGE, V36, P202, DOI 10.1016/j.neuroimage.2007.02.040; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; HANSON VL, 1984, J EXP CHILD PSYCHOL, V37, P378, DOI 10.1016/0022-0965(84)90010-9; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Klein M, 2015, CEREB CORTEX, V25, P1715, DOI 10.1093/cercor/bht350; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Levanen S, 2001, CEREB CORTEX, V11, P506, DOI 10.1093/cercor/11.6.506; MacSweeney M, 2002, J COGNITIVE NEUROSCI, V14, P1064, DOI 10.1162/089892902320474517; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Nakayama M, 2015, J EXP PSYCHOL LEARN, V41, P1570, DOI 10.1037/a0038825; Newman AJ, 2015, P NATL ACAD SCI USA, V112, P11684, DOI 10.1073/pnas.1510527112; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Raboyeau G, 2010, NEUROIMAGE, V49, P2850, DOI 10.1016/j.neuroimage.2009.10.007; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Ronnberg J, 2004, COGNITIVE BRAIN RES, V20, P165, DOI 10.1016/j.cogbrainres.2004.03.002; Ruchkin DS, 1997, COGNITIVE BRAIN RES, V6, P95, DOI 10.1016/S0926-6410(97)00021-9; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Schumacher EH, 1996, NEUROIMAGE, V3, P79, DOI 10.1006/nimg.1996.0009; Sehyr ZS, 2016, J DEAF STUD DEAF ED; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Tamaoka K, 2004, BEHAV RES METH INS C, V36, P531, DOI 10.3758/BF03195600; Tanaka S, 2001, NEUROREPORT, V12, P1171, DOI 10.1097/00001756-200105080-00024; Tanida Y, 2014, MOD RHEUMATOL, P1; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; Wilson M, 1997, MEM COGNITION, V25, P313, DOI 10.3758/BF03211287; Xu JQ, 2013, NEUROIMAGE, V83, P991, DOI 10.1016/j.neuroimage.2013.07.055	49	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0177599	10.1371/journal.pone.0177599	http://dx.doi.org/10.1371/journal.pone.0177599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931014	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700002
J	Zhang, ML; Zeng, XQ; Sanderson, SC; Byalt, VV; Sukhorukov, AP				Zhang, Ming-Li; Zeng, Xiao-Qing; Sanderson, Stewart C.; Byalt, Vyacheslav V.; Sukhorukov, Alexander P.			Insight into Central Asian flora from the Cenozoic Tianshan montane origin and radiation of Lagochilus (Lamiaceae)	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; TRIBE MENTHEAE LAMIACEAE; DIVERSIFICATION RATES; CHLOROPLAST DNA; HISTORICAL BIOGEOGRAPHY; LAMIOIDEAE LAMIACEAE; SUBFAMILY LAMIOIDEAE; PHYLOGENETIC TREES; NONCODING REGIONS; GEOGRAPHIC RANGE	The Tianshan Mountains play a significant role in the Central Asian flora and vegetation. Lagochilus has a distribution concentration in Tianshan Mountains and Central Asia. To investigate generic spatiotemporal evolution, we sampled most Lagochilus species and sequenced six cpDNA locations (rps16, psbA-trnH, matK, trnL-trnF, psbB-psbH, psbK-psbI). We employed BEAST Bayesian inference for dating, and S-DIVA, DEC, and BBM for ancestral area/biome reconstruction. Our results clearly show that the Tianshan Mountains, especially the western Ili-Kirghizia Tianshan, as well as Sunggar and Kaschgar, was the ancestral area. Ancestral biome was mainly in the montane steppe zone of valley and slope at altitudes of 1700-2700 m, and the montane desert zone of foothill and front-hill at 1000-1700 m. Here two sections Inermes and Lagochilus of the genus displayed "uphill" and "downhill" speciation process during middle and later Miocene. The origin and diversification of the genus were explained as coupled with the rapid uplift of the Tianshan Mountains starting in late Oligocene and early Miocene ca. 23.66 similar to 19.33 Ma, as well as with uplift of the Qinghai-Tibetan Plateau (QTP) and Central Asian aridification.	[Zhang, Ming-Li] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Zeng, Xiao-Qing] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Sanderson, Stewart C.] USDA, Forest Serv, Rocky Mt Res Stn, Shrub Sci Lab, Provo, UT USA; [Byalt, Vyacheslav V.] Russian Acad Sci, Komarov Bot Inst, St Petersburg, Russia; [Sukhorukov, Alexander P.] Moscow Lomonosov State Univ, Biol Fac, Moscow, Russia	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Central China Normal University; United States Department of Agriculture (USDA); United States Forest Service; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences; Lomonosov Moscow State University	Zhang, ML (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China.; Zhang, ML (corresponding author), Chinese Acad Sci, Inst Bot, Beijing, Peoples R China.	zhangml@ibcas.ac.cn	Sukhorukov, Alexander/D-2084-2013	Sukhorukov, Alexander/0000-0003-2220-826X	Chinese Academy of Sciences [ZSSD-012]; China National Key Basic Research Program [2014CB954201]; Russian Science Foundation [14-50-00029]	Chinese Academy of Sciences(Chinese Academy of Sciences); China National Key Basic Research Program(National Basic Research Program of China); Russian Science Foundation(Russian Science Foundation (RSF))	This study was funded by Biodiversity Conservation Strategy Program of Chinese Academy of Sciences (ZSSD-012), and China National Key Basic Research Program (2014CB954201). The revision of Lagochilus material in the Moscow herbaria by Alexander P. Sukhorukov was supported by the Russian Science Foundation (grant number 14-50-00029). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Hong-Hu Meng, Kai-Qing Xie and Xiao-Long Jiang for help of DNA experiment, Xiao-Guo Xiang and Jia-Li Yang for help of data processing. This study was funded by Biodiversity Conservation Strategy Program of Chinese Academy of Sciences (ZSSD-012), and China National Key Basic Research Program (2014CB954201).	ASTANOVA S B, 1984, Botanicheskii Zhurnal (St. Petersburg), V69, P1563; Bendiksby M, 2011, TAXON, V60, P471, DOI 10.1002/tax.602015; Bobrov E.G., 1965, BOT ZH, V50, P1053; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Chen H.-L, 2003, J NANJING U NATURAL, V39, P1, DOI DOI 10.3321/3.ISSN:0469-5097.2003.01.001; Doyle J. J., 1987, PHYTOCHEM B, P11; Drew BT, 2013, BOT J LINN SOC, V171, P171, DOI 10.1111/j.1095-8339.2012.01325.x; Drew BT, 2012, AM J BOT, V99, P933, DOI 10.3732/ajb.1100549; Drew BT, 2011, SYST BOT, V36, P1038, DOI 10.1600/036364411X605047; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ELIAS TS, 1983, SCIENCE, V219, P19, DOI 10.1126/science.219.4580.19; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Grubov VI, 1964, PLANTS CENTRAL ASIA, VI; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Guo Zhaojie, 2006, Dizhi Xuebao, V80, P1; Harley RM, 2004, FA GE VAS P, V7, P167; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ikramov MI, 1976, ROD LAGOCHILUS SREDN; Iljin M. M., 1937, SOVETSK BOT, V6, P95; Jamzad Z, 1989, IRANIAN J BOT, V4, P91; [焦莹 Jiao Ying], 2014, [中国新药与临床杂志, Chinese Journal of New Drugs and Clinical Remedies], V33, P204; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Kamelin RV, 1973, FLOROGENITICAL ANAL; Kar R., 1996, PALEOBOTANIST, V43, P43; Kim YI, 2011, J PLANT BIOL, V54, P396, DOI 10.1007/s12374-011-9175-6; Knorring OE, 1954, FLORA URSS, P160; Knorring OE, 1966, NOVITATES SYSTEMATIC, P197; Komarov VL, 1945, VL KOMAROV OPERA SEL, P159; Latypov A, 2011, ADM ADDICTION POLITI; Li HW, 1994, FLORA CHINA, V17, P50; Li J.J., 1998, CHINESE SCI BULL, V43, P1569, DOI DOI 10.1360/CSB1998-43-15-1569; Liu GJ, 1985, B BOT RES, V5, P127; [柳永清 Liu Yongqing], 2004, [地质学报, Acta Geologica Sinica], V78, P319; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Nylinder S, 2012, TAXON, V61, P381, DOI 10.1002/tax.612009; Ooi Kazuyuki, 1995, Journal of Japanese Botany, V70, P328; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Popov MG, 1938, PROBLEMS RELICTS FLO, VI; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056243; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2014, METHODS ECOL EVOL, V5, P701, DOI 10.1111/2041-210X.12199; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reid E, 1926, CATALOGUE CAINOZOIC; Roy T, 2015, AM J BOT, V102, P1721, DOI 10.3732/ajb.1500233; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scheen AC, 2010, ANN MO BOT GARD, V97, P191, DOI 10.3417/2007174; Secotes C, 2015, MAP FOLIOS ATLAS NEO; Shi Y., 1999, ACTA GEOGR SIN CHIN, V54, P20; Shi YF, 1998, SCI CHINA SER D, V28, P263; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tank DC, 2015, NEW PHYTOL, V207, P454, DOI 10.1111/nph.13491; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vassilchenko IT, 1982, BOT ZH, V67, P722; Wikstrom N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126690; Willis K. J., 2002, EVOLUTION PLANTS; Wu SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138697; Wu ZY, 1977, FLORA REIPUBLICAE PO, P525; Wulff E, 1944, HIST PLANT GEOGRAPHY; Xu DH, 2000, THEOR APPL GENET, V101, P724, DOI 10.1007/s001220051537; Yu XQ, 2014, MOL PHYLOGENET EVOL, V77, P183, DOI 10.1016/j.ympev.2014.04.017; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zachos F.E., 2011, BIODIVERSITY HOTSPOT; Zhang MY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168935; Zhang ML, 2014, J INTEGR PLANT BIOL, V56, P1125, DOI 10.1111/jipb.12226; Zhang ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097582; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhang ML, 2014, PHYTOTAXA, V167, P89, DOI 10.11646/phytotaxa.167.1.5; Zuckerwanik TI, 1985, BOT ZH, V70, P1183	79	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0178389	10.1371/journal.pone.0178389	http://dx.doi.org/10.1371/journal.pone.0178389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931016	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700003
J	Zheng, LF; Meng, X; Li, XM; Zhang, Y; Li, C; Xiang, CX; Xing, YY; Xia, YF; Xi, T				Zheng, Lufeng; Meng, Xia; Li, Xiaoman; Zhang, Yan; Li, Cheng; Xiang, Chenxi; Xing, Yingying; Xia, Yufeng; Xi, Tao			miR-125a-3p inhibits ER alpha transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer	FASEB JOURNAL			English	Article						TFF1; c-myc; estrogen response elements	CELL-PROLIFERATION; CROSS-TALK; PHOSPHORYLATION; MECHANISMS; MICRORNA-125A; MIGRATION; MUTATION; GROWTH	Tamoxifen (TAM) is a major adjuvant therapy for patients who are diagnosed with estrogen receptor-alpha (ER)-positive breast cancer; however, TAM resistance occurs often during treatment and the underlying mechanism is unclear. Here, we report that miR-125a-3p inhibits ER alpha transcriptional activity and, thus, ER+ breast cancer cell proliferation, which causes cell-cycle arrest at the G(1)/S stage, inducing apoptosis and suppressing tumor growth by targeting cyclin-dependent kinase 3 (CDK3) in vitro and in vivo. In addition, CDK3 and miR-125a-3p expression levels were measured in 37 cancerous tissues paired with noncancerous samples, and their expression levels were negatively associated with miR-125a-3p level. Of interest, miR-125a-3p level is down-regulated in MCF-7 TAM resistant (TamR) cells. Of more importance, up-regulation of miR-125a-3p resensitizes MCF-7 TamR cells to TAM, which is dependent on CDK3 expression. These results suggest that miR-125a-3p can function as a novel tumor suppressor in ER+ breast cancerby targeting CDK3, which may be a potential therapeutic approach for TamR breast cancer therapy.	[Zheng, Lufeng; Meng, Xia; Zhang, Yan; Li, Cheng; Xiang, Chenxi; Xing, Yingying; Xi, Tao] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zheng, Lufeng; Meng, Xia; Zhang, Yan; Li, Cheng; Xiang, Chenxi; Xing, Yingying; Xi, Tao] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing, Jiangsu, Peoples R China; [Zheng, Lufeng; Xia, Yufeng] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Jiangsu, Peoples R China; [Li, Xiaoman] Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; Nanjing University of Chinese Medicine	Xia, YF; Xi, T (corresponding author), China Pharmaceut Univ, Tongjia Xiang 24, Nanjing 210009, Jiangsu, Peoples R China.	yfxiacpu@126.com; xitao18@hotmail.com		Zheng, Lufeng/0000-0002-2183-4974; Xi, Tao/0000-0001-8065-2639	National Major Special Program of New Drug Research and Development [2013ZX09301303-005]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Qing Lan Project; National Natural Science Foundation of China [81372331]; Fundamental Research Funds for the Central Universities [2015ZD004]	National Major Special Program of New Drug Research and Development; Priority Academic Program Development of Jiangsu Higher Education Institutions; Qing Lan Project(Jiangsu Polytech Institute); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Major Special Program of New Drug Research and Development (Grant 2013ZX09301303-005), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Qing Lan Project, the National Natural Science Foundation of China (Grant 81372331), and the Fundamental Research Funds for the Central Universities (Grant 2015ZD004). The authors declare no conflicts of interest.	Ahmad A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1561-x; Berrondo C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147236; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; Cui J, 2015, ONCOGENE, V34, P4018, DOI 10.1038/onc.2015.201; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Hashiguchi Y, 2012, INT J ONCOL, V40, P1477, DOI 10.3892/ijo.2012.1363; Herynk MH, 2007, CLIN CANCER RES, V13, P3235, DOI 10.1158/1078-0432.CCR-06-2608; Hui R, 2002, CANCER RES, V62, P6916; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Lu JP, 2016, ONCOTARGET, V7, P7012, DOI 10.18632/oncotarget.6875; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; McCartan D, 2012, CANCER RES, V72, P220, DOI 10.1158/0008-5472.CAN-11-1976; Mulrane L, 2013, CANCER RES, V73, P6554, DOI 10.1158/0008-5472.CAN-13-1841; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Ninio-Many Lihi, 2014, Oncoscience, V1, P250; Ninio-Many L, 2013, J CELL SCI, V126, P2867, DOI 10.1242/jcs.123414; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Pillai MM, 2014, BREAST CANCER RES TR, V146, P85, DOI 10.1007/s10549-014-3004-9; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Shen R, 2015, AM J TRANSL RES, V7, P2115; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vrtacnik P, 2014, BIOCHEM MEDICA, V24, P329, DOI 10.11613/BM.2014.035; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Ward A, 2014, J PATHOL, V233, P368, DOI 10.1002/path.4363; Wesierska-Gadek J, 2011, J CELL BIOCHEM, V112, P761, DOI 10.1002/jcb.23004; Yadav V, 2011, MOL CARCINOGEN, V50, P346, DOI 10.1002/mc.20716; Yin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116759; Yu XF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0480-4; Yuan J, 2015, BIOCHEM BIOPH RES CO, V457, P171, DOI 10.1016/j.bbrc.2014.12.078; Zhang H, 2015, ACTA BIOCH BIOPH SIN, V47, P496, DOI 10.1093/abbs/gmv039; Zhao M, 2014, WORLD J CLIN ONCOL, V5, P248, DOI 10.5306/wjco.v5.i3.248; Zheng LF, 2016, MOL CELL ENDOCRINOL, V427, P133, DOI 10.1016/j.mce.2016.03.012; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2	48	40	41	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					588	600		10.1096/fj.201700461RR	http://dx.doi.org/10.1096/fj.201700461RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28939591	Bronze			2022-12-26	WOS:000425146900006
J	Stabeno, PJ; Duffy-Anderson, JT; Eisner, LB; Farley, EV; Heintz, RA; Mordy, CW				Stabeno, P. J.; Duffy-Anderson, J. T.; Eisner, L. B.; Farley, E. V.; Heintz, R. A.; Mordy, C. W.			Return of warm conditions in the southeastern Bering Sea: Physics to fluorescence	PLOS ONE			English	Article							CLIMATE; SHELF; TRANSPORT; ECOSYSTEM; IMPACTS	From 2007 to 2013, the southeastern Bering Sea was dominated by extensive sea ice and below-average ocean temperatures. In 2014 there was a shift to reduced sea ice on the southern shelf and above-average ocean temperatures. These conditions continued in 2015 and 2016. During these three years, the spring bloom at mooring site M4 (57.9 degrees N, 168.9 degrees W) occurred primarily in May, which is typical of years without sea ice. At mooring site M2 (56.9 degrees N, 164.1 degrees W) the spring bloom occurred earlier especially in 2016. Higher chlorophyll fluorescence was observed at M4 than at M2. In addition, these three warm years continued the pattern near St. Matthew Island of high concentrations (>1 mu M) of nitrite occurring during summer in warm years. Historically, the dominant parameters controlling sea-ice extent are winds and air temperature, with the persistence of frigid, northerly winds in winter and spring resulting in extensive ice. After mid-March 2014 and 2016 there were no cold northerly or northeasterly winds. Cold northerly winds persisted into mid-April in 2015, but did not result in extensive sea ice south of 58 degrees N. The apparent mechanism that helped limit ice on the southeastern shelf was the strong advection of warm water from the Gulf of Alaska through Unimak Pass. This pattern has been uncommon, occurring in only one other year (2003) in a 37-year record of estimated transport through Unimak Pass. During years with no sea ice on the southern shelf (e.g. 2001-2005, 2014-2016), the depth-averaged temperature there was correlated to the previous summers ocean temperature.	[Stabeno, P. J.; Mordy, C. W.] NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA; [Duffy-Anderson, J. T.; Eisner, L. B.] NOAA, Alaska Fisheries Sci Ctr, Seattle, WA USA; [Farley, E. V.; Heintz, R. A.] NOAA, Alaska Fisheries Sci Ctr, Juneau, AK USA; [Mordy, C. W.] Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Stabeno, PJ (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	Phyllis.Stabeno@noaa.gov	Mordy, Calvin/J-6808-2017; Farley, E/HHM-4227-2022		National Oceanic and Atmospheric Administration; University of Washington JISAO	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Washington JISAO	The National Oceanic and Atmospheric Administration and the University of Washington JISAO provided support for this project.	[Anonymous], 2016, ECOSYSTEM CONSIDERAT; Bond N, 2015, ECOSYSTEM CONSIDERAT, P90; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; COACHMAN LK, 1986, CONT SHELF RES, V5, P23, DOI 10.1016/0278-4343(86)90011-7; Duffy-Anderson JT, PLOS ONE, V12; Eisner L, 2016, DEEP SEA RES 2; Eisner LB, 2015, SPATIAL TEMPORAL CHA, P181; Eisner LB, 2014, DEEP-SEA RES PT II, V109, P157, DOI 10.1016/j.dsr2.2014.03.004; Gordon LI, 1993, 911 WHPO WOCE HYDR G; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Knap AH, 1996, 19 JFOGS; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Mordy CW, 2010, MAR CHEM, V121, P157, DOI 10.1016/j.marchem.2010.04.004; Napp JM, 2001, FISH OCEANOGR, V10, P61, DOI 10.1046/j.1365-2419.2001.00155.x; PEASE CH, 1980, MON WEATHER REV, V108, P2015, DOI 10.1175/1520-0493(1980)108<2015:EBSIP>2.0.CO;2; Siddon EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084526; Sigler MF, 2014, DEEP-SEA RES PT II, V109, P71, DOI 10.1016/j.dsr2.2013.12.007; Solomon S., 2007, CONTRIBUTION WORKING, P996; Stabeno PJ, 2007, DEEP-SEA RES PT II, V54, P2599, DOI 10.1016/j.dsr2.2007.08.023; Stabeno PJ, 2016, DEEP-SEA RES PT II, V134, P13, DOI 10.1016/j.dsr2.2016.05.010; Stabeno P, 2010, PROG OCEANOGR, V85, P180, DOI 10.1016/j.pocean.2010.02.010; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P14, DOI 10.1016/j.dsr2.2012.02.019; Stabeno PJ, 2002, DEEP-SEA RES PT II, V49, P5919, DOI 10.1016/S0967-0645(02)00326-0; VanPelt T, 2015, BERING SEA PROJECT U	26	57	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185464	10.1371/journal.pone.0185464	http://dx.doi.org/10.1371/journal.pone.0185464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957386	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200064
J	Nakazatol, Y; Kurane, R; Hirose, S; Watanabe, A; Shimoyama, H				Nakazatol, Yuichi; Kurane, Riichi; Hirose, Satoru; Watanabe, Akihisa; Shimoyama, Hiromi			Aging and death-associated changes in serum albumin variability over the course of chronic hemodialysis treatment	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; CHRONIC KIDNEY-DISEASE; INTRAINDIVIDUAL VARIATION; HEMOGLOBIN VARIABILITY; DIALYSIS PATIENTS; NUTRITIONAL PARAMETERS; BIOLOGICAL VARIATION; ALL-CAUSE; FRAILTY; MORTALITY	Background Several epidemiological studies have demonstrated associations between variability in a number of biological parameters and adverse outcomes. As the variability may reflect impaired homeostatic regulation, we assessed albumin variability over time in chronic hemodialysis (HD) patients. Methods Data from 1346 subjects who received chronic HD treatment from May 2001 to February 2015 were analyzed according to three phases of HD treatment: post-HD initiation, during maintenance HD treatment, and before death. The serum albumin values were grouped according to the time interval from HD initiation or death, and the yearly trends for both the albumin levels and the intra-individual albumin variability (quantified by the residual coefficient of variation: Alb-rCV) were examined. The HD initiation and death-associated changes were also analyzed using generalized additive mixed models. Furthermore, the long-term trend throughout the maintenance treatment period was evaluated separately using linear regression models. Results Albumin levels and variability showed distinctive changes during each of the 3 periods. After HD initiation, albumin variability decreased and reached a nadir within a year. During the subsequent maintenance treatment period (interquartile range = 5.2-11.0 years), the log Alb-rCV showed a significant upward trend (mean slope: 0.011 +/- 0.035/year), and its overall mean was -1.49 +/- 0.08 (equivalent to an Alb-rCV of 3.22%). During the 1-2 years before death, this upward trend clearly accelerated, and the mean log Alb-rCV in the last year of life was -1.36 +/- 0.17. The albumin levels and variability were negatively correlated with each other and exhibited exactly opposite movements throughout the course of chronic HD treatment. Different from the albumin levels, albumin variability was not dependent on chronological age but was independently associated with an individual's aging and death process. Conclusion The observed upward trend in albumin variability seems to be consistent with a presumed aging-related decline in homeostatic capacity.	[Nakazatol, Yuichi] Hakuyukai Med Corp, Yuai Nisshin Clin, Div Nephrol, Saitama, Saitama, Japan; [Kurane, Riichi; Shimoyama, Hiromi] Hakuyukai Med Corp, Yuai Clin, Div Nephrol, Saitama, Saitama, Japan; [Hirose, Satoru] Hakuyukai Med Corp, Yuai Mihashi Clin, Div Nephrol, Saitama, Saitama, Japan; [Watanabe, Akihisa] Hakuyukai Med Corp, Yuai Nakagawa Clin, Div Nephrol, Saitama, Saitama, Japan		Nakazatol, Y (corresponding author), Hakuyukai Med Corp, Yuai Nisshin Clin, Div Nephrol, Saitama, Saitama, Japan.	nkzt@hakuyukai.jp	Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836; Nakazato, Yuichi/0000-0001-7541-3799				Arbeev KG, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00003; Boudville NC, 2009, CLIN J AM SOC NEPHRO, V4, P1176, DOI 10.2215/CJN.04920908; Broers NJH, 2015, NEPHROL DIAL TRANSPL, V30, P676, DOI 10.1093/ndt/gfu367; Cohen AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122541; Corte Z, 2015, ANN CLIN BIOCHEM, V52, P53, DOI 10.1177/0004563214545116; Dalrymple LS, 2013, CLIN J AM SOC NEPHRO, V8, P2091, DOI 10.2215/CJN.02870313; Dalrymple LS, 2013, J RENAL NUTR, V23, P91, DOI 10.1053/j.jrn.2012.03.001; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; den Hoedt CH, 2014, CLIN J AM SOC NEPHRO, V9, P318, DOI 10.2215/CJN.04470413; Fedarko NS, 2011, CLIN GERIATR MED, V27, P27, DOI 10.1016/j.cger.2010.08.006; Ferrucci L, 2008, MECH AGEING DEV, V129, P677, DOI 10.1016/j.mad.2008.09.007; Flythe JE, 2013, AM J KIDNEY DIS, V61, P966, DOI 10.1053/j.ajkd.2012.12.023; FRASER CG, 1989, CLIN CHEM, V35, P783; Fried LP, 2009, J GERONTOL A-BIOL, V64, P1049, DOI 10.1093/gerona/glp076; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Gama-Axelsson T, 2012, CLIN J AM SOC NEPHRO, V7, P1446, DOI 10.2215/CJN.10251011; Goldwasser P, 1999, KIDNEY INT, V56, P2260, DOI 10.1046/j.1523-1755.1999.00768.x; Gorostidi M, 2015, J HYPERTENS, V33, pE40, DOI 10.1097/01.hjh.0000467455.93515.1e; HOLZEL WGE, 1987, CLIN CHEM, V33, P1133; HOLZEL WGE, 1987, CLIN CHEM, V33, P670; HOLZEL WGE, 1987, CLIN CHEM, V33, P57; Isaia G, 2009, AGING CLIN EXP RES, V21, P453, DOI 10.1007/BF03327448; Kainz A, 2010, NEPHROL DIAL TRANSPL, V25, P3701, DOI 10.1093/ndt/gfq287; Kalantar-Zadeh K, 2005, NEPHROL DIAL TRANSPL, V20, P1880, DOI 10.1093/ndt/gfh941; Kalyani RR, 2012, J GERONTOL A-BIOL, V67, P1300, DOI 10.1093/gerona/glr141; Kotanko P, 2009, BLOOD PURIFICAT, V27, P38, DOI 10.1159/000167007; Leavey SF, 2000, KIDNEY INT, V58, P2119; Li Q, 2015, AGING CELL, V14, P1103, DOI 10.1111/acel.12402; Lloyd D, 2001, ScientificWorldJournal, V1, P133; Ma WY, 2012, J DIABETES COMPLICAT, V26, P296, DOI 10.1016/j.jdiacomp.2012.03.028; Mendez CE, 2013, DIABETES CARE, V36, P4091, DOI 10.2337/dc12-2430; Michelis R, 2010, BIOCHEM BIOPH RES CO, V401, P137, DOI 10.1016/j.bbrc.2010.09.027; MORGAN DB, 1983, ANN CLIN BIOCHEM, V20, P257, DOI 10.1177/000456328302000501; Nakazato Y, 2015, CLIN EXP NEPHROL, V19, P1165, DOI 10.1007/s10157-015-1108-0; Ram N., 2015, HDB INTRAINDIVIDUAL, P16; Ramsay DS, 2014, PSYCHOL REV, V121, P225, DOI 10.1037/a0035942; Ricos C, 2007, ANN CLIN BIOCHEM, V44, P343, DOI 10.1258/000456307780945633; Ricos C, 2009, BIOCHEM MEDICA, V19, P250; Rocco MV, 2004, KIDNEY INT, V65, P2321, DOI 10.1111/j.1523-1755.2004.00647.x; Selvarajah V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086514; Usvyat LA, 2013, KIDNEY INT, V84, P149, DOI 10.1038/ki.2013.73; Varadhan R, 2008, MECH AGEING DEV, V129, P666, DOI 10.1016/j.mad.2008.09.013; Varadhan R, 2009, J GERONTOL A-BIOL, V64, P682, DOI 10.1093/gerona/glp013; Webb AJS, 2014, STROKE, V45, P2967, DOI 10.1161/STROKEAHA.114.005982; Whittle J, 2016, CLIN J AM SOC NEPHRO, V11, P471, DOI 10.2215/CJN.04660415; Wilhelm-Leen ER, 2009, AM J MED, V122, P664, DOI 10.1016/j.amjmed.2009.01.026; Wood S, 2016, PACKAGE GAMM4; Yang W, 2007, J AM SOC NEPHROL, V18, P3164, DOI 10.1681/ASN.2007010058	49	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185216	10.1371/journal.pone.0185216	http://dx.doi.org/10.1371/journal.pone.0185216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953942	gold, Green Submitted, Green Published			2022-12-26	WOS:000411980300044
J	Lin, XC; Chen, ZY; Jin, L; Gao, WY; Qu, B; Zuo, YJ; Liu, RJ; Yu, MB				Lin, Xianchai; Chen, Ziyan; Jin, Ling; Gao, Wuyou; Qu, Bo; Zuo, Yajing; Liu, Rongjiao; Yu, Minbin			Rasch analysis of the hospital anxiety and depression scale among Chinese cataract patients	PLOS ONE			English	Article							OLDER-ADULTS; MENTAL-HEALTH; EYE; SURGERY; POPULATION; PREVALENCE; SYMPTOMS; VISION; IMPAIRMENT; DISORDERS	Purpose To analyze the validity of the Hospital Anxiety and Depression Scale (HADS) among Chinese cataract population. Methods A total of 275 participants with unilateral or bilateral cataract were recruited to complete the Chinese version of HADS. The patients' demographic and ophthalmic characteristics were documented. Rasch analysis was conducted to examine the model fit statistics, the thresholds ordering of the polytomous items, targeting, person separation index and reliability, local dependency, unidimentionality, differential item functioning (DIF) and construct validity of the HADS individual and summary measures. Results Rasch analysis was performed on anxiety and depression subscales as well as HADS-Total score respectively. The items of original HADS-Anxiety, HADS-Depression and HADSTotal demonstrated evidence of misfit of the Rasch model. Removing items A7 for anxiety subscale and rescoring items D14 for depression subscale significantly improved Rasch model fit. A 12-item higher order total scale with further removal of D12 was found to fit the Rasch model. The modified items had ordered response thresholds. No uniform DIF was detected, whereas notable non-uniform DIF in high-ability group was found. The revised cut-off points were given for the modified anxiety and depression subscales. Conclusion The modified version of HADS with HADS-A and HADS-D as subscale and HADS-T as a higher-order measure is a reliable and valid instrument that may be useful for assessing anxiety and depression states in Chinese cataract population.	[Lin, Xianchai; Chen, Ziyan; Jin, Ling; Gao, Wuyou; Qu, Bo; Zuo, Yajing; Liu, Rongjiao; Yu, Minbin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Yu, MB (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	yuminbin@mail.sysu.edu.cn						Ayaki M, 2015, NEUROPSYCH DIS TREAT, V11, P889, DOI 10.2147/NDT.S81515; Bond T, 2012, APPL RASCH MODEL FUN, P41; Duan XR, 2013, GRAEF ARCH CLIN EXP, V251, P203, DOI 10.1007/s00417-012-2012-x; Eramudugolla R, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00056; Evans JR, 2007, OPHTHALMOLOGY, V114, P283, DOI 10.1016/j.ophtha.2006.10.006; Fenwick EK, 2017, BRIT J OPHTHALMOL, V101, P686, DOI 10.1136/bjophthalmol-2016-308701; Fisher JWP., 2007, RASCH MEAS T, V21; Fraser ML, 2013, PSYCHOGERIATRICS, V13, P237, DOI 10.1111/psyg.12028; Freeman EE, 2009, CAN J OPHTHALMOL, V44, P171, DOI 10.3129/i09-001; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-82; Gough K, 2009, J PAIN SYMPTOM MANAG, V37, P797, DOI 10.1016/j.jpainsymman.2008.04.012; Hong LY, 2016, CURR EYE RES, V41, P590, DOI 10.3109/02713683.2015.1056804; Hu JY, 2017, INT J OPHTHALMOL-CHI, V10, P140, DOI 10.18240/ijo.2017.01.23; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; LAM CLK, 1995, FAM PRACT, V12, P149, DOI 10.1093/fampra/12.2.149; Lambert SD, 2013, PSYCHOL ASSESSMENT, V25, P379, DOI 10.1037/a0031154; Leung C M, 1993, Int J Psychosom, V40, P29; Linacre JM, 1994, RASCH MEASURE T, V7, P28; McGwin G, 2003, OPHTHAL EPIDEMIOL, V10, P303, DOI 10.1076/opep.10.5.303.17323; Meuleners LB, 2013, ACTA OPHTHALMOL, V91, pe445, DOI 10.1111/aos.12124; Palagyi A, 2016, CLIN EXP OPHTHALMOL, V44, P789, DOI 10.1111/ceo.12800; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pop-Jordanova Nada, 2014, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V35, P53; Rasch G., 1960, PROBABILISTIC MODELS; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Tang WK, 2007, PSYCHIAT RES, V150, P97, DOI 10.1016/j.psychres.2006.01.015; Tennant A., 2006, RASCH MEAS T, V20, P1048; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; van der Aa HPA, 2015, INVEST OPHTH VIS SCI, V56, P849, DOI 10.1167/iovs.14-15848; WAINER H, 1987, J EDUC MEAS, V24, P185, DOI 10.1111/j.1745-3984.1987.tb00274.x; Wang C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3930-z; Wang HF, 2016, OPTOMETRY VISION SCI, V93, P1479, DOI 10.1097/OPX.0000000000000960; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zheng YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46453; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185287	10.1371/journal.pone.0185287	http://dx.doi.org/10.1371/journal.pone.0185287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI1DL	28949992	Green Published, gold, Green Submitted			2022-12-26	WOS:000411671000034
J	Li, FK; Gong, AJ; Qiu, LN; Zhang, WW; Li, JR; Liu, Y; Liu, YN; Yuan, HT				Li, FuKai; Gong, AiJun; Qiu, LiNa; Zhang, WeiWei; Li, JingRui; Liu, Yu; Liu, YuNing; Yuan, HuiTing			Simultaneous determination of trace rare-earth elements in simulated water samples using ICP-OES with TODGA extraction/backextraction	PLOS ONE			English	Article							PLASMA-MASS SPECTROMETRY; SOLID-PHASE EXTRACTION; RAY-FLUORESCENCE SPECTROMETRY; ATOMIC EMISSION-SPECTROMETRY; NEUTRON-ACTIVATION ANALYSIS; ONLINE PRECONCENTRATION; ENVIRONMENTAL-SAMPLES; MS; RESIN; DIGLYCOLAMIDE	The determination of trace rare-earth elements (REEs) can be used for the assessment of environmental pollution, and is of great significance to the study of toxicity and toxicology in animals and plants. N, N, N', N'-tetraoctyl diglycolamide (TODGA) is an environmental friendly extractant that is highly selective to REEs. In this study, an analytical method was developed for the simultaneous determination of 16 trace REEs in simulated water samples by inductively coupled plasma optical emission spectroscopy (ICP-OES). With this method, TODGA was used as the extractant to perform the liquid-liquid extraction (LLE) sample pretreatment procedure. All 16 REEs were extracted from a 3 M nitric acid medium into an organic phase by a 0.025 M TODGA petroleum ether solution. A 0.03 M ethylenediaminetetraacetic acid disodium salt (EDTA) solution was used for back-extraction to strip the REEs from the organic phase into the aqueous phase. The aqueous phase was concentrated using a vacuum rotary evaporator and the concentration of the 16 REEs was detected by ICP-OES. Under the optimum experimental conditions, the limits of detection (3 sigma, n = 7) for the REEs ranged from 0.0405 ng mL(-1) (Nd) to 0.5038 ng mL(-1) (Ho). The relative standard deviations (c = 100 ng mL(-1), n = 7) were from 0.5% (Eu) to 4.0% (Tm) with a linear range of 4-1000 ng mL(-1) (R-2 > 0.999). The recoveries of 16 REEs ranged from 95% to 106%. The LLE-ICP-OES method established in this study has the advantages of simple operation, low detection limits, fast analysis speed and the ability to simultaneously determine 16 REEs, thereby acting as a viable alternative for the simultaneous detection of trace amounts of REEs in water samples.	[Li, FuKai; Gong, AiJun; Qiu, LiNa; Zhang, WeiWei; Li, JingRui; Liu, Yu; Liu, YuNing; Yuan, HuiTing] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing, Peoples R China	University of Science & Technology Beijing	Gong, AJ (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing, Peoples R China.	gongaijun5661@ustb.edu.cn		Li, Fukai/0000-0001-7143-4680	Beijing Natural Science Foundation [8172033]; Fundamental Research Funds for the Central Universities of China [FRF-BR-15-015A]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was financially supported by Beijing Natural Science Foundation Program (No. 8172033 to AG), and Fundamental Research Funds for the Central Universities of China (No. FRF-BR-15-015A to AG).	Aniwashi J, 2011, GENET MOL RES, V10, P1075, DOI 10.4238/vol10-2gmr1070; Ansari SA, 2012, CHEM REV, V112, P1751, DOI 10.1021/cr200002f; de Carvalho GGA, 2016, TALANTA, V161, P707, DOI 10.1016/j.talanta.2016.09.027; Berijani S, 2015, J IRAN CHEM SOC, V12, P737, DOI 10.1007/s13738-014-0532-5; Cai DJ, 2011, J VERBRAUCH LEBENSM, V6, P349, DOI 10.1007/s00003-010-0650-7; Connelly NG, 2007, CHEM INT NEWSMAGAZIN, V27, P25; De Vito IE, 1999, TALANTA, V49, P929, DOI 10.1016/S0039-9140(99)00089-2; De Vito IE, 2001, J ANAL ATOM SPECTROM, V16, P275, DOI 10.1039/b008165p; Donard A, 2015, J ANAL ATOM SPECTROM, V30, P2420, DOI 10.1039/c5ja00309a; DULSKI P, 1994, FRESEN J ANAL CHEM, V350, P194, DOI 10.1007/BF00322470; El-Taher A, 2007, APPL RADIAT ISOTOPES, V65, P458, DOI 10.1016/j.apradiso.2006.07.014; Guo XQ, 2014, RSC ADV, V4, P19960, DOI 10.1039/c4ra01576b; Hassanien MM, 2016, MICROCHEM J, V127, P125, DOI 10.1016/j.microc.2016.02.014; Husain M, 2008, DESALINATION, V229, P294, DOI 10.1016/j.desal.2007.10.016; Jia Q, 2008, MICROCHEM J, V89, P82, DOI 10.1016/j.microc.2007.12.005; KARADAS C, 2014, WATER AIR SOIL POLLT, V225; Kumar K, 2014, J RADIOANAL NUCL CH, V301, P667, DOI 10.1007/s10967-014-3221-z; Labrecque C, 2014, ANAL METHODS-UK, V6, P9291, DOI [10.1039/c4ay01911c, 10.1039/C4AY01911C]; Li Y, 2012, J AGR FOOD CHEM, V60, P3033, DOI 10.1021/jf2049646; Li YT, 2016, MICROCHEM J, V126, P194, DOI 10.1016/j.microc.2015.12.006; Li YJ, 2010, J HAZARD MATER, V174, P534, DOI 10.1016/j.jhazmat.2009.09.084; Liang T, 2014, ENVIRON MONIT ASSESS, V186, P1499, DOI 10.1007/s10661-013-3469-8; Pyrzynska K, 2016, TALANTA, V154, P15, DOI 10.1016/j.talanta.2016.03.022; Sereshti H, 2012, ANAL LETT, V45, P1426, DOI 10.1080/00032719.2012.675490; Sitko R, 2005, J ANAL ATOM SPECTROM, V20, P741, DOI 10.1039/b502994e; Su SW, 2014, TALANTA, V119, P458, DOI 10.1016/j.talanta.2013.11.027; Tajabadi F, 2013, MICROCHIM ACTA, V180, P65, DOI 10.1007/s00604-012-0913-3; Wen HR, 1998, PARIS METAL IONS BIO, P199; Yousefi SR, 2014, ANAL METHODS-UK, V6, P3694, DOI 10.1039/c4ay00176a; Zereen F, 2013, MICROCHEM J, V110, P178, DOI 10.1016/j.microc.2013.03.012; Zhang YA, 2015, RSC ADV, V5, P5996, DOI 10.1039/c4ra13333a; Zhao XW, 2010, J RARE EARTH, V28, P79, DOI 10.1016/S1002-0721(10)60342-0; Zhu YB, 2010, J ANAL ATOM SPECTROM, V25, P364, DOI 10.1039/b921214k	33	7	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185302	10.1371/journal.pone.0185302	http://dx.doi.org/10.1371/journal.pone.0185302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945788	Green Submitted, Green Published, gold			2022-12-26	WOS:000411645100042
J	Ying, N; Ju, CJ; Sun, XW; Li, LT; Chang, HB; Song, GP; Li, ZY; Wan, JY; Dai, EY				Ying, Na; Ju, Chuanjing; Sun, Xiuwei; Li, Letian; Chang, Hongbiao; Song, Guangping; Li, Zhongyi; Wan, Jiayu; Dai, Enyong			Lateral flow nucleic acid biosensor for sensitive detection of microRNAs based on the dual amplification strategy of duplex-specific nuclease and hybridization chain reaction	PLOS ONE			English	Article							DNA DETECTION; QUANTIFICATION	MicroRNAs (miRNAs) constitute novel biomarkers for various diseases. Accurate and quantitative analysis of miRNA expression is critical for biomedical research and clinical theranostics. In this study, a method was developed for sensitive and specific detection of miRNAs via dual signal amplification based on duplex specific nuclease (DSN) and hybridization chain reaction (HCR). A reporter probe (RP), comprising recognition sequence (3' end modified with biotin) for a target miRNA of miR-21 and capture sequence (5' end modified with Fam) for HCR product, was designed and synthesized. HCR was initiated by partial sequence of initiator probe (IP), the other part of which can hybridize with capture sequence of RP, and was assembled by hairpin probes modified with biotin (H1-bio and H2-bio). A miR-21 triggered cyclical DSN cleavage of RP, which was immobilized to a streptavidin (SA) coated magnetic bead (MB). The released Fam labeled capture sequence then hybridized with the HCR product to generate a detectable dsDNA. This polymer was then dropped on lateral flow strip and positive result was observed. The proposed method allowed quantitative sequence-specific detection of miR-21 (with a detection limit of 2.1 fM, S/N = 3) in a dynamic range from 100 fM to 100 pM, with an excellent ability to discriminate differences in miRNAs. The method showed acceptable testing recoveries for the determination of miRNAs in serum.	[Ying, Na; Ju, Chuanjing; Sun, Xiuwei; Li, Letian; Chang, Hongbiao; Song, Guangping; Li, Zhongyi; Wan, Jiayu] Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin, Peoples R China; [Ying, Na] China Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Ju, Chuanjing] Gen Hosp FAW, Changchun, Jilin, Peoples R China; [Ju, Chuanjing] Jilin Univ, Hosp 4, Changchun, Jilin, Peoples R China; [Sun, Xiuwei] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Chang, Hongbiao] Changchun Univ Sci & Technol, Sch Life Sci & Technol, Changchun, Jilin, Peoples R China; [Song, Guangping] Heilongjiang Bayi Agr Univ, Daqing, Peoples R China; [Dai, Enyong] Jilin Univ, China Japan Union Hosp, Dept Oncol & Hematol, Changchun, Jilin, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Jilin University; Jilin Agricultural University; Changchun University of Science & Technology; Heilongjiang Bayi Agricultural University; Jilin University	Wan, JY (corresponding author), Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin, Peoples R China.; Dai, EY (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Oncol & Hematol, Changchun, Jilin, Peoples R China.	wanjiayu@hotmail.com; daiey@jlu.edu.cn			Basic Work of Science and Technology Special of China [2013FY113600]; National Key Technologies R&D Program of China [2013BAD12B04]; Science and technology development plans of Jilin Province [20150101105JC]; National Key Research and Development Program of China [2016YFD0501000]	Basic Work of Science and Technology Special of China; National Key Technologies R&D Program of China(National Key Technology R&D Program); Science and technology development plans of Jilin Province; National Key Research and Development Program of China	This study was funded by The Basic Work of Science and Technology Special of China (NO.2013FY113600), National Key Technologies R&D Program of China (No.2013BAD12B04), Science and technology development plans of Jilin Province (20150101105JC) and The National Key Research and Development Program of China (No.2016YFD0501000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Campuzano S, 2014, ANAL BIOANAL CHEM, V406, P27, DOI 10.1007/s00216-013-7459-z; Chen AY, 2016, ANAL CHEM, V88, P3203, DOI 10.1021/acs.analchem.5b04578; Chun HYY, 2011, NUCL ACIDS RES, V39; Cissell KA, 2008, ANAL CHEM, V80, P2319, DOI 10.1021/ac702577a; Degliangeli F, 2014, J AM CHEM SOC, V136, P2264, DOI 10.1021/ja412152x; Deng SL, 2014, J FOOD PROTECT, V77, P1998, DOI 10.4315/0362-028X.JFP-14-086; Ding XJ, 2015, ANAL CHIM ACTA, V874, P59, DOI 10.1016/j.aca.2015.03.021; Driskell JD, 2008, BIOSENS BIOELECTRON, V24, P917, DOI 10.1016/j.bios.2008.07.060; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Hao N, 2015, CHEM COMMUN, V51, P13504, DOI 10.1039/c5cc05350a; He YC, 2014, CHEM COMMUN, V50, P6236, DOI 10.1039/c4cc00705k; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jamali AA, 2014, TRAC-TREND ANAL CHEM, V55, P24, DOI 10.1016/j.trac.2013.10.008; Labib M, 2015, ANAL CHEM, V87, P1395, DOI 10.1021/ac504331c; Li CX, 2015, ANAL CHEM, V87, P4283, DOI 10.1021/ac5047032; Li JJ, 2016, BIOSENS BIOELECTRON, V85, P764, DOI 10.1016/j.bios.2016.05.088; Li JB, 2014, CHEM SOC REV, V43, P506, DOI 10.1039/c3cs60312a; Li RD, 2016, BIOSENS BIOELECTRON, V77, P995, DOI 10.1016/j.bios.2015.10.082; Lin XY, 2013, CHEM COMMUN, V49, P7243, DOI 10.1039/c3cc43224f; Liu P, 2013, ANAL CHEM, V85, P7689, DOI 10.1021/ac4001157; Lv WF, 2016, BIOSENS BIOELECTRON, V83, P250, DOI 10.1016/j.bios.2016.04.053; Ma CP, 2014, ANAL BIOCHEM, V457, P19, DOI 10.1016/j.ab.2014.04.022; Miller DFB, 2013, METHODS, V63, P126, DOI 10.1016/j.ymeth.2013.03.023; Pierce RMDaNA, 2004, PNAS, V101, P4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Wang LC, 2014, ADV INTEL SYS RES, V109, P9, DOI 10.1371/journal.pone.0085683; Wang Q, 2016, BIOSENS BIOELECTRON, V80, P366, DOI 10.1016/j.bios.2016.02.005; Wu H, 2016, BIOSENS BIOELECTRON, V81, P303, DOI 10.1016/j.bios.2016.03.013; Xu FF, 2016, ANAL CHEM, V88, P754, DOI 10.1021/acs.analchem.5b03056; Yin BC, 2012, J AM CHEM SOC, V134, P5064, DOI 10.1021/ja300721s; Yin R, 2016, FOOD CONTROL, V60, P146, DOI 10.1016/j.foodcont.2015.07.030; Zhang XY, 2014, ACS NANO, V8, P3444, DOI 10.1021/nn406339n	35	15	15	11	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185091	10.1371/journal.pone.0185091	http://dx.doi.org/10.1371/journal.pone.0185091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945768	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100022
J	Barille, L; Le Bris, A; Meleder, V; Launeau, P; Robin, M; Louvrou, I; Ribeiro, L				Barille, Laurent; Le Bris, Anthony; Meleder, Vona; Launeau, Patrick; Robin, Marc; Louvrou, Ioanna; Ribeiro, Lourenco			Photosynthetic epibionts and endobionts of Pacific oyster shells from oyster reefs in rocky versus mudflat shores	PLOS ONE			English	Article							MICROPHYTOBENTHOS; BIOMASS; ASSEMBLAGES; EUENDOLITHS; ABUNDANCE; DYNAMICS; INVASION; DIATOMS; VECTOR; FIELD	The Pacific oyster, Crassostrea gigas (Thunberg), is the main bivalve species cultivated in the world. With global warming enabling its reproduction and larval survival at higher latitudes, this species is now recognized as invasive and creates wild oyster reefs globally. In this study, the spatial distribution of photosynthetic assemblages colonizing the shells of wild C. gigas was investigated on both a large scale (two contrasting types of reefs found in mudflats and rocky areas) and a small scale (within individual shells) using a hyperspectral imager. The microspatial distribution of all phototrophs was obtained by mapping the Normalized Difference Vegetation Index (NDVI). Second derivative (delta delta) analyses of hyperspectral images at 462, 524, 571 and 647 nm were subsequently applied to map diatoms, cyanobacteria, rhodophytes and chlorophytes, respectively. A concomitant pigment analysis was carried out by high performance liquid chromatography and completed by taxonomic observations. This study showed that there was high microalgal diversity associated with wild oyster shells and that there were differences in the structure of the phototropic assemblages depending on the type of reef. Namely, vertically-growing oysters in mudflat areas had a higher biomass of epizoic diatoms (hyperspectral proxy at delta(462) nm) and were mainly colonized by species of the genera Navicula, Nitzschia and Hippodonta, which are epipelic or motile epipsammic. The assemblages on the horizontal oysters contained more tychoplanktonic diatoms (e.g. Thalassiosira pseudonana, T. proschkinae and Plagiogrammopsis vanheurckii). Three species of boring cyanobacteria were observed for both types of reef: Mastigocoleus testarum, Leptolyngbya terrebrans, and Hyella caespistosa, but the second derivative analysis at 524 nm showed a significantly higher biomass for the horizontally-growing oysters. There was no biomass difference for the boring chlorophyte assemblages (delta delta(647) nm), with two species: Eugomontia testarum and Ostreobium quekettii observed for both types of reef. This study shows that oyster shells are an idiosyncratic but ubiquitous habitat for phototrophic assemblages. The contribution of these assemblages in terms of	[Barille, Laurent; Le Bris, Anthony; Meleder, Vona; Ribeiro, Lourenco] Univ Nantes, Inst Univ Mer & Littoral FR C 3473, Lab Mer Mol Sante EA2160, Nantes, France; [Le Bris, Anthony; Robin, Marc] Univ Nantes, Inst Univ Mer & Littoral FR C 3473, LETG Geolittomer, CNRS,UMR 6554, Nantes, France; [Launeau, Patrick] Univ Nantes, Inst Univ Mer & Littoral FR C 3473, Lab Planetol & Geodynam, CNRS,UMR 6112, Nantes, France; [Louvrou, Ioanna] Univ Athens, Dept Ecol & Systemat, Fac Biol, Athens, Greece; [Ribeiro, Lourenco] Univ Lisbon, Fac Ciencias, Marine & Environm Sci Ctr, Lisbon, Portugal	Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; National & Kapodistrian University of Athens; Universidade de Lisboa	Barille, L (corresponding author), Univ Nantes, Inst Univ Mer & Littoral FR C 3473, Lab Mer Mol Sante EA2160, Nantes, France.	laurent.barille@univ-nantes.fr	Ribeiro, Lourenço S./A-3978-2012	Ribeiro, Lourenço S./0000-0002-6585-0140; Barille, Laurent/0000-0001-5138-2684; Meleder, Vona/0000-0002-1874-1929	Ministere Francais de la Recherche et de lEnseignement Superieur; Federation de Recherche IUML FRCNRS of the University of Nantes; cluster of excellence LabexMER; IFREMER; Nantes University; Regional Council of the Pays de la Loire	Ministere Francais de la Recherche et de lEnseignement Superieur; Federation de Recherche IUML FRCNRS of the University of Nantes; cluster of excellence LabexMER; IFREMER; Nantes University; Regional Council of the Pays de la Loire(Region Pays de la Loire)	PhD grant was supported by the Ministere Francais de la Recherche et de lEnseignement Superieur and awarded by the Federation de Recherche IUML FRCNRS of the University of Nantes in collaboration with the cluster of excellence LabexMER. Anthony Lebris received the grant. COSELMAR project was supported by IFREMER and Nantes University and co-funded by the Regional Council of the Pays de la Loire. Laurent Barille received the grant.	Barille L, 2007, J EXP MAR BIOL ECOL, V343, P197, DOI 10.1016/j.jembe.2006.11.013; Barille L, 2011, REMOTE SENS ENVIRON, V115, P1034, DOI 10.1016/j.rse.2010.12.008; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Bornet ME, 1889, B SOC BOT FR, V36, pCXLVII; CAMPBELL SE, 1984, HYDROBIOLOGIA, V116, P201, DOI 10.1007/BF00027666; Chennu A, 2013, LIMNOL OCEANOGR-METH, V11, P511, DOI 10.4319/lom.2013.11.511; Cherchi A, 2012, BIOGEOSCIENCES, V9, P4607, DOI 10.5194/bg-9-4607-2012; Choe BH, 2012, ESTUAR COAST SHELF S, V97, P28, DOI 10.1016/j.ecss.2011.11.007; Cognie B, 1999, OCEANOL ACTA, V22, P441, DOI 10.1016/S0399-1784(00)88727-7; Dalelio D, 2010, ALL FLESH IS GRASS, P345; Dame RF, 1993, ROLE BIVALVE FILTER, P245; DREW KM, 1949, NATURE, V164, P748, DOI 10.1038/164748a0; Gade M, 2014, ESTUAR COAST SHELF S, V140, P32, DOI 10.1016/j.ecss.2014.01.007; Gernez P, 2014, J GEOPHYS RES-OCEANS, V119, P7277, DOI 10.1002/2014JC010055; Gillan DC, 2000, J SEA RES, V43, P83, DOI 10.1016/S1385-1101(99)00041-6; Golubic S, 1999, DIVERSITY MARINE CYA, V19, P53; Golubic S, 2003, MICROBIAL ENDOLITHS, P249; Goulletquer P, 1991, AQUACULTURE CRASSOST, P13; GRIZEL H, 1991, J CONSEIL, V47, P399; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haydar D, 2011, MAR ECOL PROG SER, V431, P1, DOI 10.3354/meps09170; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hutchinson N, 2006, AQUAT MICROB ECOL, V42, P187, DOI 10.3354/ame042187; Jeffrey S. W., 1997, PHYTOPLANKTON PIGMEN, P449; Jesus B, 2005, ESTUAR COAST SHELF S, V65, P30, DOI 10.1016/j.ecss.2005.05.005; Jesus B, 2014, REMOTE SENS ENVIRON, V140, P196, DOI 10.1016/j.rse.2013.08.040; Jesus B, 2008, J PHYCOL, V44, P1349, DOI 10.1111/j.1529-8817.2008.00583.x; Kahlert M, 2014, ENVIRON SCI-PROC IMP, V16, P2627, DOI 10.1039/c4em00326h; Kazemipour F, 2012, REMOTE SENS ENVIRON, V127, P1, DOI 10.1016/j.rse.2012.08.016; KORRINGA P., 1951, ARCH NEERLAND ZOOL, V10, P32; Kuhl M, 2008, AQUAT MICROB ECOL, V53, P99, DOI 10.3354/ame01224; Lagerheim G, 1885, OFVERS K VETENSKAPSA, V42, P21; Le Bris A, 2016, ESTUAR COAST SHELF S, V172, P1, DOI 10.1016/j.ecss.2016.01.039; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P149, DOI 10.3354/meps117149; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Marcelino VR, 2016, SCI REP-UK, V6, DOI 10.1038/srep31508; Meleder V, 2003, REMOTE SENS ENVIRON, V88, P386, DOI 10.1016/j.rse.2003.08.009; Meleder V, 2007, J PHYCOL, V43, P1177, DOI 10.1111/j.1529-8817.2007.00423.x; Meleder V, 2013, J PHOTOCH PHOTOBIO B, V129, P115, DOI 10.1016/j.jphotobiol.2013.10.005; Mineur F, 2007, BIOL CONSERV, V137, P237, DOI 10.1016/j.biocon.2007.02.001; Murphy RJ, 2009, J EXP MAR BIOL ECOL, V380, P68, DOI 10.1016/j.jembe.2009.09.002; Murphy RJ, 2006, MAR ECOL PROG SER, V312, P45, DOI 10.3354/meps312045; Murphy RJ, 2005, J EXP MAR BIOL ECOL, V325, P111, DOI 10.1016/j.jembe.2005.04.018; Pantazidou A, 2006, EUR J PHYCOL, V41, P189, DOI 10.1080/09670260600649420; Paterson DM, 1998, LIMNOL OCEANOGR, V43, P1207, DOI 10.4319/lo.1998.43.6.1207; Perkins RG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22343; Radea C, 2010, FOTTEA, V10, P129, DOI 10.5507/fot.2010.007; RAGHUKUMAR C, 1991, PHYCOLOGIA, V30, P303, DOI 10.2216/i0031-8884-30-3-303.1; Ramirez-Reinat EL, 2012, J PHYCOL, V48, P740, DOI 10.1111/j.1529-8817.2012.01157.x; Ribeiro L., 2010, THESIS U LISBON LISB; Ribeiro L, 2013, J PHYCOL, V49, P258, DOI 10.1111/jpy.12031; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Russell BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136260; Sauvage T, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0068-x; Schill SR, 2006, DEV AUTOMATED MAPPIN, P91; Schodduyn R., 1931, Bulletin de l'Institut Oceanographique Monaco, Vno. 568, P1; Seckbach J, 2010, ALL FLESH IS GRASS P, P509; Snoeijs P, 2002, J PHYCOL, V38, P265, DOI 10.1046/j.1529-8817.2002.01105.x; Spilmont N, 2011, ESTUAR COAST SHELF S, V95, P470, DOI 10.1016/j.ecss.2011.10.021; Thomas Y, 2016, J BIOGEOGR, V43, P568, DOI 10.1111/jbi.12665; Thompson RC, 1999, J MAR BIOL ASSOC UK, V79, P551, DOI 10.1017/S0025315498000678; Totti C., 2010, ALL FLESH IS GRASS, P323, DOI DOI 10.1007/978-90-481-9316-5_15; Tribollet A, 2006, J PHYCOL, V42, P292, DOI 10.1111/j.1529-8817.2006.00198.x; Troost K, 2010, J SEA RES, V64, P145, DOI 10.1016/j.seares.2010.02.004; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; WALKER S E, 1992, Palaios, V7, P236, DOI 10.2307/3514934; WILKINSON M, 1974, J EXP MAR BIOL ECOL, V16, P19, DOI 10.1016/0022-0981(74)90070-7; Witkowski A, 2000, DIATOM FLORA MARINE, P925	69	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185187	10.1371/journal.pone.0185187	http://dx.doi.org/10.1371/journal.pone.0185187			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934317	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900115
J	Branch, MR; Hepler, JR				Branch, Mary Rose; Hepler, John R.			Endogenous RGS14 is a cytoplasmic-nuclear shuttling protein that localizes to juxtanuclear membranes and chromatin-rich regions of the nucleus	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; HETEROTRIMERIC G-PROTEINS; SIGNALING 14 RGS14; G-ALPHA-I; TRANSCRIPTION FACTORIES; SYNAPTIC PLASTICITY; COUPLED RECEPTORS; MAMMALIAN-CELLS; GENE-EXPRESSION; LIVE CELLS	Regulator of G protein signaling 14 (RGS14) is a multifunctional scaffolding protein that integrates G protein and H-Ras/MAPkinase signaling pathways to regulate synaptic plasticity important for hippocampal learning and memory. However, to date, little is known about the subcellular distribution and roles of endogenous RGS14 in a neuronal cell line. Most of what is known about RGS14 cellular behavior is based on studies of tagged, recombinant RGS14 ectopically overexpressed in unnatural host cells. Here, we report for the first time a comprehensive assessment of the subcellular distribution and dynamic localization of endogenous RGS14 in rat B35 neuroblastoma cells. Using confocal imaging and 3D-structured illumination microscopy, we find that endogenous RGS14 localizes to subcellular compartments not previously recognized in studies of recombinant RGS14. RGS14 localization was observed most notably at juxtanuclear membranes encircling the nucleus, at nuclear pore complexes (NPC) on both sides of the nuclear envelope and within intranuclear membrane channels, and within both chromatin-poor and chromatin-rich regions of the nucleus in a cell cycle-dependent manner. In addition, a subset of nuclear RGS14 localized adjacent to active RNA polymerase II. Endogenous RGS14 was absent from the plasma membrane in resting cells; however, the protein could be trafficked to the plasma membrane from juxtanuclear membranes in endosomes derived from ER/Golgi, following constitutive activation of endogenous RGS14 G protein binding partners using AlF4-. Finally, our findings show that endogenous RGS14 behaves as a cytoplasmic-nuclear shuttling protein confirming what has been shown previously for recombinant RGS14. Taken together, the findings highlight possible cellular roles for RGS14 not previously recognized that are distinct from the regulation of conventional GPCR-G protein signaling, in particular undefined roles for RGS14 in the nucleus.	[Branch, Mary Rose; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Hepler, JR (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	jhepler@emory.edu		Branch, Mary Rose/0000-0002-3410-1534	National Institutes of Health [5R01NS037112, 1R21 NS087488]; Emory University Integrated Cellular Imaging Microscopy Core; Emory Neuroscience National Institute of Neurological Disorders and Stroke [5P30NS055077]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Integrated Cellular Imaging Microscopy Core; Emory Neuroscience National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01NS037112 and 1R21 NS087488 (to JRH). This research was also supported in part by the Emory University Integrated Cellular Imaging Microscopy Core and the Emory Neuroscience National Institute of Neurological Disorders and Stroke Core Facilities grant, 5P30NS055077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2008, FASEB J, V22, P2821, DOI 10.1096/fj.07-104224; Baas P. W., 2012, CENTROSOME, P309, DOI 10.1007/978-1-62703-035-9_18; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Brown NE, 2015, J BIOL CHEM, V290, P9037, DOI 10.1074/jbc.M114.634329; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Chatterjee TK, 2000, J BIOL CHEM, V275, P29660, DOI 10.1074/jbc.M000330200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Chatterjee TK, 2002, MOL CELL BIOL, V22, P4334, DOI 10.1128/MCB.22.12.4334-4345.2002; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Cremer M, 2001, CHROMATIN CELL NUCL; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Eskiw CH, 2008, J CELL SCI, V121, P1999, DOI 10.1242/jcs.027250; Evans PR, 2014, J COMP NEUROL, V522, P186, DOI 10.1002/cne.23395; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; GOLDENTHAL KL, 1985, J HISTOCHEM CYTOCHEM, V33, P813, DOI 10.1177/33.8.3894499; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harper Jane V., 2004, V296, P157; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2003, BIOCHEMISTRY-US, V42, P811, DOI 10.1021/bi026664y; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hou CH, 2010, CELL, V140, P306, DOI 10.1016/j.cell.2010.01.036; Jagatheesan G, 1999, J CELL SCI, V112, P4651; Jourdain I, 2009, CELL MOTIL CYTOSKEL, V66, P509, DOI 10.1002/cm.20351; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lee JK, 2015, PROG MOL BIOL TRANSL, V133, P153, DOI 10.1016/bs.pmbts.2015.01.005; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Lewis TL, 2013, J CELL BIOL, V202, P837, DOI 10.1083/jcb.201305098; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Lund E, 2013, NUCLEUS-AUSTIN, V4, P424, DOI 10.4161/nucl.26865; Lyssand JS, 2007, FEBS LETT, V581, P5765, DOI 10.1016/j.febslet.2007.11.044; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Margolin W, 2012, J BACTERIOL, V194, P6369, DOI 10.1128/JB.01640-12; Markaki Y, 2010, COLD SH Q B, V75, P475, DOI 10.1101/sqb.2010.75.042; Martin-McCaffrey L, 2005, CELL CYCLE, V4, P953, DOI 10.4161/cc.4.7.1787; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; Morchoisne-Bolhy S, 2015, MOL BIOL CELL, V26, P2343, DOI 10.1091/mbc.E15-02-0060; Muralikrishna B, 2001, J CELL SCI, V114, P4001; NISHI K, 1994, J BIOL CHEM, V269, P6320; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Popken J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124619; Rose JJ, 2000, J NEUROCHEM, V75, P2103, DOI 10.1046/j.1471-4159.2000.0752103.x; Roychowdhury S, 1999, J BIOL CHEM, V274, P13485, DOI 10.1074/jbc.274.19.13485; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Stadler C, 2013, NAT METHODS, V10, P315, DOI [10.1038/NMETH.2377, 10.1038/nmeth.2377]; Stadler C, 2010, J PROTEOMICS, V73, P1067, DOI 10.1016/j.jprot.2009.10.012; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Traver S, 2004, BIOCHEM J, V379, P627, DOI 10.1042/BJ20031889; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zhang JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1099; Zhang P, 2015, LIFE SCI, V129, P35, DOI 10.1016/j.lfs.2015.02.029	65	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184497	10.1371/journal.pone.0184497	http://dx.doi.org/10.1371/journal.pone.0184497			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934222	gold, Green Submitted, Green Published			2022-12-26	WOS:000411339900031
J	Curval, LG; Franca, AD; Fernandes, HJ; Mendes, RP; de Carvalho, LR; Higa, MG; Ferreira, ED; Dorval, MEC				Curval, Larissa Gabrielle; Franca, Adriana de Oliveira; Fernandes, Henrique Jorge; Mendes, Rinaldo Poncio; de Carvalho, Lidia Raquel; Higa, Minoru German; Ferreira, Eduardo de Castro; Cavalheiros Dorval, Maria Elizabeth			Prevalence of intestinal parasites among inmates in Midwest Brazil	PLOS ONE			English	Article							DISEASES; CHILDREN; STATE; CITY	Background Intestinal parasitic infections constitute a public health issue in developing countries, with prevalence rates as high as 90%, a figure set to escalate as the socioeconomic status of affected populations deteriorates. Investigating the occurrence of these infections among inmates is critical, since this group is more vulnerable to the spread of a number of infectious illnesses. Methods This cross-sectional, analytical, quantitative study was conducted in July 2015 at prison facilities located in Midwest Brazil to estimate the prevalence of parasitic infection among inmates. For detection of parasites, 510 stool samples were examined by ether centrifugation and spontaneous sedimentation. Results Eight parasitic species were detected, with an overall prevalence of 20.2% (103/510). Giardia lamblia and Entamoeba histolytica/dispar were the most frequent pathogenic parasites. Endolimax nana was the predominant non-pathogenic species. Nearly half of the subjects (53/103; 51.4%) were positive for mixed infection. Logistic regression revealed that inmates held in closed conditions were more likely to contract parasitic infections than those held in a semi-open regime (OR = 1.97; 95% CI = 1.19-3.25; p = 0.0085). A higher prevalence of parasitic infections was observed among individuals who had received no prophylactic antiparasitic treatment in previous years (OR = 10.2; 95% CI = 5.86-17.66; p < 0.001). The other factors investigated had no direct association with the presence of intestinal parasites. Conclusion Infections caused by directly transmissible parasites were detected. Without adequate treatment and prophylactic guidance, inmates tend to remain indefinitely infected with intestinal parasites, whether while serving time in prison or after release.	[Curval, Larissa Gabrielle; Franca, Adriana de Oliveira; Higa, Minoru German; Cavalheiros Dorval, Maria Elizabeth] Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Campo Grande, MS, Brazil; [Fernandes, Henrique Jorge] Univ Estadual Mato Grosso Sul, Dept Anim Sci, Aquidauana, MS, Brazil; [Mendes, Rinaldo Poncio] Univ Fed Mato Grosso do Sul, Sch Med, Campo Grande, MS, Brazil; [de Carvalho, Lidia Raquel] Univ Estadual Paulista, Dept Biostat, Biosci Inst Botucatu, Botucatu, SP, Brazil; [Ferreira, Eduardo de Castro] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Fundacao Oswaldo Cruz	Curval, LG (corresponding author), Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Campo Grande, MS, Brazil.	larissagabriellecurval@gmail.com	Carvalho, L.R./C-2973-2013; Curval, Larissa Gabrielle/H-1095-2018	Carvalho, L.R./0000-0003-0575-2263; Curval, Larissa Gabrielle/0000-0003-1302-7352; Higa Junior, Minoru German/0000-0001-9794-9439; Ferreira, Eduardo/0000-0002-4073-6704; Franca, Adriana de Oliveira/0000-0002-4994-1958	Fundacao de Desenvolvimento, Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)	Fundacao de Desenvolvimento, Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	The Fundacao de Desenvolvimento, Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) is acknowledged for supporting the UFMS Graduate Program in Infectious and Parasitic Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their thanks for the support provided by Professor Maria Elizabeth Cavalheiros Dorval in granting access to the UFMS Laboratory of Clinical Parasitology Research, as well as for her valuable contribution during the analysis of biological samples. No less importantly, thanks are extended to all the subjects who volunteered to take part in this study. The Fundacao de Desenvolvimento, Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) is also acknowledged for supporting the UFMS Graduate Program in Infectious and Parasitic Diseases.	Abraham RS, 2007, REV BRAS ANAL CLIN, V39, P39; Alemu A, 2011, ASIAN PAC J TROP MED, V4, P661, DOI 10.1016/S1995-7645(11)60168-5; Amuga G, 2006, INT J NAT APPL SCI, V2, P7; Anuar TS, 2014, NATURE, V4101, P1; Assis RD, 2008, REV CEJ, V11, P74; Bica VC, 2011, REV HOSPITAL CLIN PO, V1, P3139; BLAGG W, 1955, AM J TROP MED HYG, V4, P23, DOI 10.4269/ajtmh.1955.4.23; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Pereira Maria das Graças Cabral, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P139; Basso RMC, 2008, REV SOC BRAS MED TRO, V41, P263, DOI 10.1590/S0037-86822008000300008; Campos MR, 2002, REV SAUDE PUBL, V36, P69, DOI 10.1590/S0034-89102002000100011; Colman S, 2013, AJMR, V1, P11, DOI DOI 10.15413/ajmr.2012.0103; da Costa-Macedo L M, 1998, Cad Saude Publica, V14, P851, DOI 10.1590/S0102-311X1998000400027; Dagci H, 2008, PARASITOL RES, V103, P839, DOI 10.1007/s00436-008-1065-6; de Andrade EC, 2011, EPIDEMIOL SERV SAUDE, V20, P337, DOI 10.5123/S1679-49742011000300008; de Souza EA, 2007, CAD SAUDE PUBLICA, V23, P427, DOI 10.1590/S0102-311X2007000200019; Degarege Abraham, 2010, BMC Res Notes, V3, P143, DOI 10.1186/1756-0500-3-143; dos Santos SA, 2010, CIENC SAUDE COLETIVA, V15, P899, DOI 10.1590/S1413-81232010000300033; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Ferreira H, 2006, PUBL UEPG CI BIOL SA, V12, P33; Ferreira MU, 2000, REV SAUDE PUBL, V34, P73, DOI 10.1590/S0034-89102000000700010; Guerrero AFH, 2005, ACTA AMAZONICA, V35, P487; Hoffman WA, 1934, PUERTO RICO J PUB HL, V9, P283; Holveck JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-6; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Leite Seixas Marieli Tavares, 2011, Revista de Patologia Tropical, V40, P304, DOI 10.5216/rpt.v40i4.16762; Lodo M, 2010, REV BRAS CRESCIMENTO, V20, P769; Mamman A.S., 2014, WORLD SC RES J, V2, P67; Mamo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099559; Marques S. M. T., 2005, Parasitologia Latinoamericana, V60, P78; Mehraj V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003680; [Ministerio da Saude Brasil], 2005, PLAN NAC VIG CONTR E; [Ministerio da Saude Brasil], CONS NAC HIV AIDS SI; [Ministerio da Saude Brasil], 2004, PLAN NAC SAUD SIST P; Nwosu BU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090623; OKEEFE MAUREEN L., 2010, ONE YEAR LONGITUDINA, P1; Okolie N., 2008, INTERNET J PARASITIC, V4, P1; Oliveira CLM., 2010, REV BRASILEIRA PROMO, V23, P307; Ortega YR, 1997, CLIN INFECT DIS, V25, P545, DOI 10.1086/513745; Ouattara M, 2010, PLOS NEGLECT TROP D, V4, P1; Roque FC, 2005, NEWSLAB, V69, P152; SCHAPIRO M M, 1959, Trans R Soc Trop Med Hyg, V53, P270, DOI 10.1016/0035-9203(59)90007-0; Takayanagui O M, 2001, Rev Soc Bras Med Trop, V34, P283, DOI 10.1590/S0037-86822001000300010; Teixeira JC, 2012, REV PANAM SALUD PUBL, V32, P419, DOI 10.1590/S1020-49892012001400005; Teixeira SF, 2012, REV CIENTIFICA FAMIN, V7, P37; Uecker M, 2007, RBAC, V39, P15; Uttah EC, 2012, ADV TROPICAL MED PUB, V2, P88; World Health Organization, 2009, LIB CAT IN PUBL DAT	48	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0182248	10.1371/journal.pone.0182248	http://dx.doi.org/10.1371/journal.pone.0182248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934218	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900003
J	Svard, D; Nilsson, M; Lampinen, B; Latt, J; Sundgren, PC; Stomurd, E; Minthon, L; Hansson, O; van Westen, D				Svard, Daniel; Nilsson, Markus; Lampinen, Bjorn; Latt, Jimmy; Sundgren, Pia C.; Stomurd, Erik; Minthon, Lennart; Hansson, Oskar; van Westen, Danielle			The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease	PLOS ONE			English	Article							SMALL VESSEL DISEASE; TRACT; LESIONS; MICROSTRUCTURE; ABNORMALITIES; TRACTOGRAPHY; IMPAIRMENT; INTEGRITY; EXCLUDE; PEOPLE	Diffusion tensor imaging (DTI) has been used to study microstructural white matter alterations in a variety of conditions including normal aging and Alzheimer's disease (AD). White matter hyperintensities (WMH) are common in cognitively healthy elderly as well as in AD and exhibit elevated mean diffusivity (MD) and reduced fractional anisotropy (FA). However, the effect of WMH on statistical analysis of DTI estimates has not been thoroughly studied. In the present study we address this in two ways. First, we investigate the effect of WMH on MD and FA in the dorsal and ventral cingulum, the superior longitudinal fasciculus, and the corticospinal tract, by comparing two matched groups of cognitively healthy elderly (n = 21 + 21) with unequal WMH load. Second, we assess the effects of adjusting for WMH load when comparing MD and FA in prodromal AD subjects (n = 83) to cognitively healthy elderly (n = 132) in the abovementioned white matter tracts. Results showed the WMH in cognitively healthy elderly to have a generally large effect on DTI estimates (Cohen's d = 0.63 to 1.27 for significant differences in MD and -1.06 to -0.69 for FA). These effect sizes were comparable to those of various neurological and psychiatric diseases (Cohen's d = 0.57 to 2.20 for differences in MD and -1.76 to -0.61 for FA). Adjusting for WMH when comparing DTI estimates in prodromal AD subjects to cognitively healthy elderly improved the explanatory power as well as the outcome of the analysis, indicating that some of the differences in MD and FA were largely driven by unequal WMH load between the groups rather than alterations in normal-appearing white matter (NAWM). Thus, our findings suggest that if the purpose of a study is to compare alterations in NAWM between two groups using DTI it may be necessary to adjust the statistical analysis for WMH.	[Svard, Daniel; Sundgren, Pia C.; van Westen, Danielle] Lund Univ, Diagnost Radiol, Lund, Sweden; [Svard, Daniel; Latt, Jimmy; Sundgren, Pia C.; van Westen, Danielle] Skane Univ Hosp, Med Imaging & Physiol, Lund, Sweden; [Nilsson, Markus] Lund Univ, Bioimaging Ctr, Lund, Sweden; [Lampinen, Bjorn] Lund Univ, Med Radiat Phys, Lund, Sweden; [Stomurd, Erik; Minthon, Lennart; Hansson, Oskar] Lund Univ, Clin Memory Res, Malmoo, Sweden; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Lund University; Skane University Hospital	Svard, D (corresponding author), Lund Univ, Diagnost Radiol, Lund, Sweden.; Svard, D (corresponding author), Skane Univ Hosp, Med Imaging & Physiol, Lund, Sweden.	daniel.svard@med.lu.se	Hansson, Oskar/A-7134-2013; Nilsson, Markus/C-6920-2012	Hansson, Oskar/0000-0001-8467-7286; van Westen, Danielle/0000-0001-8649-9874; Sundgren, Pia/0000-0001-9237-1236; Nilsson, Markus/0000-0002-3140-8223	European Research Council; Swedish Research Council; Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University; Crafoord Foundation; Swedish Brain Foundation; Skke University Hospital Foundation; Swedish Alzheimer Association; Stiftelsen for gamla tjnarinnor; Swedish Federal Government under the ALF Agreement	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University; Crafoord Foundation; Swedish Brain Foundation; Skke University Hospital Foundation; Swedish Alzheimer Association; Stiftelsen for gamla tjnarinnor; Swedish Federal Government under the ALF Agreement	The study was supported by the European Research Council, the Swedish Research Council, the Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University, the Crafoord Foundation, the Swedish Brain Foundation, the Skke University Hospital Foundation, the Swedish Alzheimer Association, Stiftelsen for gamla tjnarinnor, and the Swedish Federal Government under the ALF Agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; de Groot M, 2015, ALZHEIMERS DEMENT, V11, P321, DOI 10.1016/j.jalz.2014.06.011; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Gustavsson AM, 2015, CEREBROVASC DIS EXTR, V5, P41, DOI 10.1159/000377710; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Janelidze S, 2016, ANN CLIN TRANSL NEUR, V3, P154, DOI 10.1002/acn3.274; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 1999, STROKE, V30, P393, DOI 10.1161/01.STR.30.2.393; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kodl CT, 2008, DIABETES, V57, P3083, DOI 10.2337/db08-0724; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Launer Lenore J, 2004, Top Magn Reson Imaging, V15, P365, DOI 10.1097/01.rmr.0000168216.98338.8d; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Leritz EC, 2014, HUM BRAIN MAPP, V35, P1085, DOI 10.1002/hbm.22236; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Maillard P, 2014, STROKE, V45, P1721, DOI 10.1161/STROKEAHA.113.004084; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nilsson M, PLOS ONE, V10; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Nucifora PGP, 2012, ACAD RADIOL, V19, P622, DOI 10.1016/j.acra.2012.01.002; Pelletier A, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00255; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Potter GM, 2010, STROKE, V41, P267, DOI 10.1161/STROKEAHA.109.566307; Remy F, 2015, NEUROIMAGE-CLIN, V7, P482, DOI 10.1016/j.nicl.2015.01.014; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Santillo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066932; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schmidt R, 2011, ACTA NEUROPATHOL, V122, P171, DOI 10.1007/s00401-011-0851-x; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Surova Y, 2015, NEURORADIOLOGY, V57, P1079, DOI 10.1007/s00234-015-1563-z; Svard D, 2014, P INT SOC MAG RESON, V22, P1839; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052; Wang F, 2004, AM J PSYCHIAT, V161, P573, DOI 10.1176/appi.ajp.161.3.573; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058887	58	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185239	10.1371/journal.pone.0185239	http://dx.doi.org/10.1371/journal.pone.0185239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934374	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900132
J	Whatmore, AM; Dawson, C; Muchowski, J; Perrett, LL; Stubberfield, E; Koylass, M; Foster, G; Davison, NJ; Quance, C; Sidor, IF; Field, CL; Leger, JS				Whatmore, Adrian M.; Dawson, Claire; Muchowski, Jakub; Perrett, Lorraine L.; Stubberfield, Emma; Koylass, Mark; Foster, Geoffrey; Davison, Nicholas J.; Quance, Christine; Sidor, Inga F.; Field, Cara L.; Leger, Judy St.			Characterisation of North American Brucella isolates from marine mammals	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; DOLPHINS; STRAINS; INFECTION; IDENTIFICATION; NEUROBRUCELLOSIS; DIFFERENTIATION; OSTEOMYELITIS; SEALS; ST27	Extension of known ecological niches of Brucella has included the description of two novel species from marine mammals. Brucella pinnipedialis is associated predominantly with seals, while two major Brucella ceti clades, most commonly associated with porpoises or dolphins respectively, have been identified. To date there has been limited characterisation of Brucella isolates obtained from marine mammals outside Northern European waters, including North American waters. To address this gap, and extend knowledge of the global population structure and host associations of these Brucella species, 61 isolates from marine mammals inhabiting North American waters were subject to molecular and phenotypic characterisation enabling comparison with existing European isolates. The majority of isolates represent genotypes previously described in Europe although novel genotypes were identified in both B. ceti clades. Harp seals were found to carry B. pinnipedialis genotypes previously confined to hooded seals among a diverse repertoire of sequence types (STs) associated with this species. For the first time Brucella isolates were characterised from beluga whales and found to represent a number of distinct B. pinnipedialis genotypes. In addition the known host range of ST27 was extended with the identification of this ST from California sea lion samples. Finally the performance of the frequently used diagnostic tool Bruce-ladder, in differentiating B. ceti and B. pinnipedialis, was critically assessed based on improved knowledge of the global population structure of Brucella associated with marine mammals.	[Whatmore, Adrian M.; Dawson, Claire; Muchowski, Jakub; Perrett, Lorraine L.; Stubberfield, Emma; Koylass, Mark] Anim & Plant Hlth Agcy, FAO WHO Collaborating Ctr Brucellosis, OIE Brucellosis Reference Lab, Addlestone, Surrey, England; [Foster, Geoffrey; Davison, Nicholas J.] SRUC Vet Serv, Scottish Marine Anim Stranding Scheme, Inverness, Scotland; [Quance, Christine] USDA APHIS, Mycobacteria & Brucella Sect, Natl Vet Serv Labs, Ames, IA USA; [Sidor, Inga F.; Field, Cara L.] Myst Aquarium & Inst Explorat, Mystic, CT USA; [Leger, Judy St.] SeaWorld Pk & Entertainment, San Diego, CA USA; [Sidor, Inga F.] Univ New Hampshire, New Hampshire Vet Diagnost Lab, Durham, NH 03824 USA; [Field, Cara L.] Marine Mammal Ctr, Sausalito, CA USA	Animal & Plant Health Agency UK; Food & Agriculture Organization of the United Nations (FAO); United States Department of Agriculture (USDA); University System Of New Hampshire; University of New Hampshire	Whatmore, AM (corresponding author), Anim & Plant Hlth Agcy, FAO WHO Collaborating Ctr Brucellosis, OIE Brucellosis Reference Lab, Addlestone, Surrey, England.	adrian.whatmore@apha.gsi.gov.uk	Whatmore, Adrian M/C-7744-2011; St. Leger, Judy/AAD-3565-2019	Whatmore, Adrian M/0000-0003-4218-156X; St. Leger, Judy/0000-0002-6213-3429; Davison, Nicholas/0000-0001-7286-1836; Stubberfield, Emma/0000-0002-5527-1209; Sidor, Inga/0000-0001-5169-6704; Foster, Geoffrey/0000-0002-5527-758X	UK Department of the Environment, Food and Rural Affairs (Defra)	UK Department of the Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	Brucella research and surveillance activities at APHA are supported by the UK Department of the Environment, Food and Rural Affairs (Defra). We thank Dr Teri Rowles, the veterinarians working with captive collections and the stranded animal network partners in North America that provided material to NVSL facilitating the broad scope of this study. We declare that one author (JSL) is employed by a commercial organisation 'SeaWorld Parks and Entertainment'. This funder provider support in the form of salary for JSL but had no additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alba P, 2013, VET MICROBIOL, V164, P158, DOI 10.1016/j.vetmic.2013.01.023; Ancora M, 2014, GENOME ANNOUNC, V2; Audic S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-200; Bricker BJ, 2000, J CLIN MICROBIOL, V38, P1258, DOI 10.1128/JCM.38.3.1258-1262.2000; Colegrove KM, 2016, DIS AQUAT ORGAN, V119, P1, DOI 10.3354/dao02969; Cvetnic Z, 2016, VET MICROBIOL, V196, P93, DOI 10.1016/j.vetmic.2016.10.013; Dawson CE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-224; EWALT DR, 1994, J VET DIAGN INVEST, V6, P448, DOI 10.1177/104063879400600408; Forbes LB, 2000, J WILDLIFE DIS, V36, P595, DOI 10.7589/0090-3558-36.3.595; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Garcia-Yoldi D, 2006, CLIN CHEM, V52, P779, DOI 10.1373/clinchem.2005.062596; Goertz CEC, 2011, J VET DIAGN INVEST, V23, P845, DOI 10.1177/1040638711407683; Goldstein T, 2009, J WILDLIFE DIS, V45, P91, DOI 10.7589/0090-3558-45.1.91; Gopaul KK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-86; Groussaud P, 2007, J MED MICROBIOL, V56, P1512, DOI 10.1099/jmm.0.47330-0; Guzman-Verri C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00003; Hernandez-Mora G, 2013, REV SCI TECH OIE, V32, P89; Hernandez-Mora G, 2008, EMERG INFECT DIS, V14, P1430, DOI 10.3201/eid1409.071056; Isidoro-Ayza M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0206-7; Jahans KL, 1997, VET MICROBIOL, V57, P373, DOI 10.1016/S0378-1135(97)00118-1; Kang SI, 2011, APPL ENVIRON MICROB, V77, P6726, DOI 10.1128/AEM.00581-11; Maquart M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-145; Maratea J, 2003, J ZOO WILDLIFE MED, V34, P256, DOI 10.1638/02-053; Mayer-Scholl A, 2010, J MICROBIOL METH, V80, P112, DOI 10.1016/j.mimet.2009.10.015; McDonald WL, 2006, J CLIN MICROBIOL, V44, P4363, DOI 10.1128/JCM.00680-06; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; Nielsen O, 2001, J WILDLIFE DIS, V37, P89, DOI 10.7589/0090-3558-37.1.89; Nymo IH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-93; Ohishi K, 2004, MICROBES INFECT, V6, P1199, DOI 10.1016/j.micinf.2004.06.006; ROSS HM, 1994, VET REC, V134, P359, DOI 10.1136/vr.134.14.359-b; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verger JM, 1988, TECHNIQUES BRUCELLOS; Wattam AR, 2014, J BACTERIOL, V196, P920, DOI 10.1128/JB.01091-13; Webber MA., 1993, FAO SPECIES IDENTIFI; Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05; Whatmore AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02049; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Whatmore AM, 2005, J CLIN MICROBIOL, V43, P761, DOI 10.1128/JCM.43.2.761-769.2005; Wu QZ, 2014, J MICROBIOL METH, V100, P99, DOI 10.1016/j.mimet.2014.03.001	42	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184758	10.1371/journal.pone.0184758	http://dx.doi.org/10.1371/journal.pone.0184758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934239	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000411339900043
J	Hariri, BM; McMahon, DB; Chen, B; Adappa, ND; Palmer, JN; Kennedy, DW; Lee, RJ				Hariri, Benjamin M.; McMahon, Derek B.; Chen, Bei; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.			Plant flavones enhance antimicrobial activity of respiratory epithelial cell secretions against Pseudomonas aeruginosa	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; NITRIC-OXIDE PRODUCTION; BITTER TASTE RECEPTORS; MUCIN GENE-EXPRESSION; APICAL SURFACE FLUID; NF-KAPPA-B; ANTIBACTERIAL ACTIVITY; INHIBITORY-ACTIVITY; CHRONIC RHINOSINUSITIS; ANTIBIOTIC-RESISTANCE	Flavones are a class of natural plant secondary metabolites that have anti-inflammatory and anti-bacterial effects. Some flavones also activate the T2R14 bitter taste receptor, which is expressed in motile cilia of the sinonasal epithelium and activates innate immune nitric oxide (NO) production. Flavones may thus be potential therapeutics for respiratory infections. Our objective was to examine the anti-microbial effects of flavones on the common sinonasal pathogens Candida albicans, Staphylococcus aureus, and Pseudomonas aeruginosa, evaluating both planktonic and biofilm growth. Flavones had only very low-level antibacterial activity alone. They did not reduce biofilm formation, but did reduce production of the important P. aeruginosa inflammatory mediator and ciliotoxin pyocyanin. However, flavones exhibited synergy against P. aeruginosa in the presence of antibiotics or recombinant human lysozyme. They also enhanced the efficacy of antimicrobials secreted by cultured and primary human airway cells grown at air-liquid interface. This suggests that flavones may have anti-gram-negative potential as topical therapeutics when combined with antibiotics or in the context of innate antimicrobials secreted by the respiratory or other epithelia. This may have an additive effect when combined with T2R14-activated NO production. Additional studies are necessary to understand which flavone compounds or mixtures are the most efficacious.	[Hariri, Benjamin M.; McMahon, Derek B.; Chen, Bei; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA USA; [Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, RJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA USA.; Lee, RJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA USA.	rjl@mail.med.upenn.edu	Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686	National Institutes of Health [R03DC013862]; Cystic Fibrosis Foundation [LEER16G0]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health (R03DC013862) and Cystic Fibrosis Foundation (LEER16G0) to R.J.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Babu KS, 2006, BIOORG MED CHEM LETT, V16, P221, DOI 10.1016/j.bmcl.2005.09.009; Babu PBR, 2004, CLIN CHIM ACTA, V347, P81, DOI 10.1016/j.cccn.2004.04.006; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Berger JT, 1999, AM J RESP CELL MOL, V20, P500, DOI 10.1165/ajrcmb.20.3.3383; Bhattacharyya N, 2008, ANN OTO RHINOL LARYN, V117, P448, DOI 10.1177/000348940811700608; Bhattacharyya N, 2012, OTOLARYNG HEAD NECK, V146, P307, DOI 10.1177/0194599811426089; BOWES D, 1977, THORAX, V32, P163, DOI 10.1136/thx.32.2.163; Brook I, 2016, EUR J CLIN MICROBIOL; Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4&lt;595::AID-IJC21&gt;3.0.CO;2-5; Chen PH, 2004, EUR ARCH OTO-RHINO-L, V261, P238, DOI 10.1007/s00405-003-0682-z; Cherry Donald K, 2002, Adv Data, P1; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Dajani R, 2005, AM J RESP CELL MOL B; Dao TT, 2004, BIOORG MED CHEM LETT, V14, P1165, DOI 10.1016/j.bmcl.2003.12.087; Dao TT, 2003, ARCH PHARM RES, V26, P581, DOI 10.1007/BF02976703; Dubin RF, 2004, AM J PHYSIOL-LUNG C, V286, pL750, DOI 10.1152/ajplung.00326.2003; Duszyk M, 2001, PFLUG ARCH EUR J PHY, V443, pS45; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; FERRIOLA PC, 1989, BIOCHEM PHARMACOL, V38, P1617, DOI 10.1016/0006-2952(89)90309-2; Gamet-Payrastre L, 1999, GEN PHARMACOL-VASC S, V32, P279, DOI 10.1016/S0306-3623(98)00220-1; Godoy JM, 2011, OTOLARYNG HEAD NECK, V145, P673, DOI 10.1177/0194599811407279; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Harro JM, 2013, GENOME ANNOUNC, V1; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; HINGLEY ST, 1986, INFECT IMMUN, V51, P254, DOI 10.1128/IAI.51.1.254-262.1986; Jiang N, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5020027; Johnson L, 2012, J BACTERIOL, V194, P813, DOI 10.1128/JB.05230-11; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; KANTHAKUMAR K, 1993, INFECT IMMUN, V61, P2848, DOI 10.1128/IAI.61.7.2848-2853.1993; Kavanaugh NL, 2014, MBIO, V5, DOI 10.1128/mBio.01911-14; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P467, DOI 10.2500/ajra.2013.27.3960; Kim JO, 2012, PHYTOTHER RES, V26, P1784, DOI 10.1002/ptr.4650; Kingdom TT, 2004, AM J OTOLARYNG, V25, P323, DOI 10.1016/j.amjoto.2004.03.003; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; Kuroda Y, 2016, BIOSCI BIOTECH BIOCH, V80, P2014, DOI 10.1080/09168451.2016.1184558; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2016, SCI AM, V314, P38; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120; Lee RJ, 2014, J MOL MED, V92, P1235, DOI 10.1007/s00109-014-1222-6; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2013, AM J RHINOL ALLERGY, V27, P283, DOI 10.2500/ajra.2013.27.3911; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lee SH, 2002, ANN OTO RHINOL LARYN, V111, P135, DOI 10.1177/000348940211100205; Levashov PA, 2010, ANAL CHEM, V82, P2161, DOI 10.1021/ac902978u; Liu IX, 2001, J PHARM PHARMACOL, V53, P129, DOI 10.1211/0022357011775118; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Ly Nghi, 2002, Adv Data, P1; Manes RP, 2012, FACIAL PLAST SURG CL, V20, P87, DOI 10.1016/j.fsc.2011.10.010; Marcinkiewicz J, 2013, POL ARCH MED WEWN, V123, P309, DOI 10.20452/pamw.1780; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Mughal EU, 2006, BIOORGAN MED CHEM, V14, P4704, DOI 10.1016/j.bmc.2006.03.031; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Orhan DD, 2010, MICROBIOL RES, V165, P496, DOI 10.1016/j.micres.2009.09.002; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Patil RH, 2016, INFLAMMATION, V39, P138, DOI 10.1007/s10753-015-0232-z; Platz J, 2004, J IMMUNOL, V173, P1219, DOI 10.4049/jimmunol.173.2.1219; Prokhorenko IR, 2009, INT J GEN MED, V2, P33; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; Ray NF, 1999, J ALLERGY CLIN IMMUN, V103, P408, DOI 10.1016/S0091-6749(99)70464-1; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Roland WSU, 2011, J AGR FOOD CHEM, V59, P11764, DOI 10.1021/jf202816u; Sato M, 1996, J ETHNOPHARMACOL, V54, P171, DOI 10.1016/S0378-8741(96)01464-X; Sato Y, 2004, INT J ANTIMICROB AG, V24, P226, DOI 10.1016/j.ijantimicag.2004.02.028; Schrader KK, 2010, TOXINS, V2, P1676, DOI 10.3390/toxins2071676; Schwarzer C, 2008, J BIOL CHEM, V283, P27144, DOI 10.1074/jbc.M709693200; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Seleem D, 2016, ARCH ORAL BIOL; Seo HS, 2014, BIOMOL THER, V22, P525, DOI 10.4062/biomolther.2014.094; Settipane RA, 2013, AM J RHINOL ALLERGY, V27, pS11, DOI 10.2500/ajra.2013.27.3925; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Sikder MA, 2014, PHYTOTHER RES, V28, P62, DOI 10.1002/ptr.4954; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Tan CX, 2015, CHEM BIODIVERS, V12, P259, DOI 10.1002/cbdv.201400181; Tewfik MA, 2007, AM J RHINOL, V21, P680, DOI 10.2500/ajr.2007.21.3103; Uckoo RM, 2015, J AGR FOOD CHEM, V63, P7180, DOI 10.1021/acs.jafc.5b02445; VOSS JG, 1964, J GEN MICROBIOL, V35, P313, DOI 10.1099/00221287-35-2-313; Wang JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15963; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; Wu DL, 2008, INT J ANTIMICROB AG, V32, P421, DOI 10.1016/j.ijantimicag.2008.06.010; Yao J, 2014, IMMUNOLOGY, V143, P241, DOI 10.1111/imm.12305; Yeh CH, 2015, TOXICOL IND HEALTH, V31, P960, DOI 10.1177/0748233713485886; Yeh CH, 2014, ENVIRON TOXICOL, V29, P1162, DOI 10.1002/tox.21847; Zhang XW, 2011, PHARM BIOL, V49, P256, DOI 10.3109/13880209.2010.501803; Zhang Y, 2001, AM J RESP CELL MOL, V25, P196, DOI 10.1165/ajrcmb.25.2.4211	98	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185203	10.1371/journal.pone.0185203	http://dx.doi.org/10.1371/journal.pone.0185203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931063	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700078
J	Ungaro, A; Pech, N; Martin, JF; McCairns, RJS; Mevy, JP; Chappaz, R; Gilles, A				Ungaro, Arnaud; Pech, Nicolas; Martin, Jean-Francois; McCairns, R. J. Scott; Mevy, Jean-Philippe; Chappaz, Remi; Gilles, Andre			Challenges and advances for transcriptome assembly in non-model species	PLOS ONE			English	Article							RNA-SEQ; DE-NOVO; GENERATION; RECONSTRUCTION; STRATEGIES; GENETICS; PANTHER; LENGTH; TOOL	Analyses of high-throughput transcriptome sequences of non-model organisms are based on two main approaches: de novo assembly and genome-guided assembly using mapping to assign reads prior to assembly. Given the limits of mapping reads to a reference when it is highly divergent, as is frequently the case for non-model species, we evaluate whether using blastn would outperform mapping methods for read assignment in such situations (> 15% divergence). We demonstrate its high performance by using simulated reads of lengths corresponding to those generated by the most common sequencing platforms, and over a realistic range of genetic divergence (0% to 30% divergence). Here we focus on gene identification and not on resolving the whole set of transcripts (i.e. the complete transcriptome). For simulated datasets, the transcriptome-guided assembly based on blastn recovers 94.8% of genes irrespective of read length at 0% divergence; however, assignment rate of reads is negatively correlated with both increasing divergence level and reducing read lengths. Nevertheless, we still observe 92.6% of recovered genes at 30% divergence irrespective of read length. This analysis also produces a categorization of genes relative to their assignment, and suggests guidelines for data processing prior to analyses of comparative transcriptomics and gene expression to minimize potential inferential bias associated with incorrect transcript assignment. We also compare the performances of de novo assembly alone vs in combination with a transcriptome-guided assembly based on blastn both via simulation and empirically, using data from a cyprinid fish species and from an oak species. For any simulated scenario, the transcriptome-guided assembly using blastn outperforms the de novo approach alone, including when the divergence level is beyond the reach of traditional mapping methods. Combining de novo assembly and a related reference transcriptome for read assignment also addresses the bias/error in contigs caused by the dependence on a related reference alone. Empirical data corroborate these findings when assembling transcriptomes from the two non-model organisms: Parachondrostoma toxostoma (fish) and Quercus pubescens (plant). For the fish species, out of the 31,944 genes known from D. rerio, the guided and de novo assemblies recover respectively 20,605 and 20,032 genes but the performance of the guided assembly approach is much higher for both the contiguity and completeness metrics. For the oak, out of the 29,971 genes known from Vitis vinifera, the transcriptome-guided and de novo assemblies display similar performance, but the new guided approach detects 16,326 genes where the de novo assembly only detects 9,385 genes.	[Ungaro, Arnaud; Pech, Nicolas; McCairns, R. J. Scott; Chappaz, Remi; Gilles, Andre] Aix Marseille Univ, UMR 7263, Equipe Evolut Genome Environm, CNRS,IRD,IMBE, Marseille, France; [Martin, Jean-Francois] Montpellier SupAgro, UMR Ctr Biol Gest Populat, Montferrier Sur Lez, France; [McCairns, R. J. Scott] Agrocampus Ouest, INRA, ESE, Ecol & Ecosyst Hlth, Rennes, France; [Mevy, Jean-Philippe] Aix Marseille Univ, Equipe Divers Fonctionnement Mol Ecosyst, UMR 7263, CNRS,IRD,IMBE, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); INRAE; Institut Agro; Agrocampus Ouest; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Martin, JF (corresponding author), Montpellier SupAgro, UMR Ctr Biol Gest Populat, Montferrier Sur Lez, France.	jean-francois.martin@supagro.fr	McCairns, R.J. Scott/E-4458-2015; Martin, Jean-Francois/M-9426-2017	McCairns, R.J. Scott/0000-0002-0392-7413; Ungaro, Arnaud/0000-0002-3762-4971; MEVY, Jean-Philippe/0000-0001-5376-0810; Nicolas, Pech/0000-0002-1822-3558; Martin, Jean-Francois/0000-0001-9176-4476	EDF (Electricite de France); different departments of Electricite de France	EDF (Electricite de France)(Electricite de France (EDF)); different departments of Electricite de France	AU was supported by a PhD grant from EDF (Electricite de France). We are grateful to the different departments of Electricite de France for the financial support of the present study: EDF -Recherche et Developpement, Clamart especially Dr Mathieu Le Brun and Laurence Tissote EDF- Unite of Production Mediterranee especially Dr Julie Mosseri and EDF Centre dIngenierie Hydraulique Technolac Chambery especially Dr Agnes Barillier and Frederic Jacob. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7513; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bates D., 2014, R PACKAGE VERSION; Bushmanova E, 2016, BIOINFORMATICS, V32, P2210, DOI 10.1093/bioinformatics/btw218; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Elran R, 2014, MOL ECOL, V23, P4722, DOI 10.1111/mec.12891; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grishkevich V, 2014, GENOME RES, V24, P1497, DOI 10.1101/gr.169722.113; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hipp R Team SQLite Development, 2015, SQLITE DEV; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Huang X, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2923-8; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jain P, 2013, PEERJ, V1, DOI 10.7717/peerj.133; Kuang YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34849; Leder EH, 2015, MOL BIOL EVOL, V32, P674, DOI 10.1093/molbev/msu328; Lu BX, 2013, SCI CHINA LIFE SCI, V56, P143, DOI 10.1007/s11427-013-4442-z; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Nikinmaa M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2974; Nikolenko SI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S7; Ockendon NF, 2016, MOL ECOL RESOUR, V16, P446, DOI 10.1111/1755-0998.12465; Palma-Silva C, 2016, MOL ECOL RESOUR, V16, P1012, DOI 10.1111/1755-0998.12504; Poelstra JW, 2015, MOL ECOL, V24, P4617, DOI 10.1111/mec.13353; Pratlong M, 2015, MOL ECOL RESOUR, V15, P1205, DOI 10.1111/1755-0998.12383; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; R Core Team, 2021, R LANGUAGE ENV STAT; Rana SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153104; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Shi XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1954; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Todd EV, 2016, MOL ECOL, V25, P1224, DOI 10.1111/mec.13526; Torre S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112487; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang S, 2016, BIOINFORMATICS; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolf JBW, 2013, MOL ECOL RESOUR, V13, P559, DOI 10.1111/1755-0998.12109; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	50	27	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185020	10.1371/journal.pone.0185020	http://dx.doi.org/10.1371/journal.pone.0185020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931057	gold, Green Published, Green Submitted			2022-12-26	WOS:000411314700058
J	Choi, S; Cui, CC; Luo, YH; Kim, SH; Ko, JK; Huo, XF; Ma, JJ; Fu, LW; Souza, RF; Korichneva, I; Pan, Z				Choi, Sangyong; Cui, Chaochu; Luo, Yanhong; Kim, Sun-Hee; Ko, Jae-Kyun; Huo, Xiaofang; Ma, Jianjie; Fu, Li-Wu; Souza, Rhonda F.; Korichneva, Irina; Pan, Zui			Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1	FASEB JOURNAL			English	Article						intracellular Ca2+ oscillations; cancer prevention; histidine; redox sensor	INTRACELLULAR CA2+; CRAC CHANNELS; ION CHANNELS; CANCER; RECEPTOR; PERMEATION; EXPRESSION; BINDING; DOMAIN; DAMAGE	Zinc, an essential micronutrient, has a cancer preventive role. Zinc deficiency has been shown to contribute to the progression of esophageal cancer. Orai1, a store-operated Ca2+ entry (SOCE) channel, was previously reported to be highly expressed in tumor tissues removed from patients with esophageal squamous cell carcinoma (ESCC) with poor prognosis, and elevation of its expression contributes to both hyperactive intracellular Ca2+ oscillations and fast cell proliferation in human ESCC cells. However, the molecular basis of cancer preventive functions of zinc and its association with Orai1-mediated cell proliferation remains unknown. The present study shows that zinc supplementation significantly inhibits proliferation of ESCC cell lines and that the effect of zinc is reversible with N,N,N', N'-tetrakis (2-pyridylmethyl) ethylenediamine, a specific Zn2+ chelator, whereas non-tumorigenic esophageal epithelial cells are significantly less sensitive to zinc treatment. Fluorescence live cell imaging revealed that extracellular Zn2+ exerted rapid inhibitory effects on Orai1-mediated SOCE and on intracellular Ca2+ oscillations in the ESCC cells. Knockdown of Orai1 or expression of Orai1 mutants with compromised zinc binding significantly diminished sensitivity of the cancer cells to zinc treatment in both SOCE and cell proliferation analyses. These data suggest that zinc may inhibit cell proliferation of esophageal cancer cells through Orai1-mediated intracellular Ca2+ oscillations and reveal a possible molecular basis for zinc-induced cancer prevention and Orai1-SOCE signaling pathway in cancer cells.	[Choi, Sangyong; Cui, Chaochu; Pan, Zui] Univ Texas Arlington, Coll Nursing & Hlth Innovat, 501 S Nedderman Dr,Life Sci Bldg 241, Arlington, TX 76019 USA; [Choi, Sangyong; Cui, Chaochu; Luo, Yanhong; Kim, Sun-Hee; Ma, Jianjie; Pan, Zui] Ohio State Univ, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Ma, Jianjie] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Cui, Chaochu; Fu, Li-Wu] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Luo, Yanhong] Chongqing Med Univ, Dept Endocrinol, Childrens Hosp, Chongqing, Peoples R China; [Ko, Jae-Kyun] Mutagenex, Suwanee, GA USA; [Huo, Xiaofang; Souza, Rhonda F.] Baylor Univ, Med Ctr, Ctr Esophageal Dis, Dallas, TX USA; [Huo, Xiaofang; Souza, Rhonda F.] Baylor Scott & White Res Inst, Ctr Esophageal Res, Dallas, TX USA; [Korichneva, Irina] Univ Picardie Jules Verne, Dept Pharmacol, Amiens, France	University of Texas System; University of Texas Arlington; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; State Key Lab Oncology South China; Sun Yat Sen University; Chongqing Medical University; Baylor University; Baylor University Medical Center; Baylor Health Care System; Baylor University Medical Center; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Pan, Z (corresponding author), Univ Texas Arlington, Coll Nursing & Hlth Innovat, 501 S Nedderman Dr,Life Sci Bldg 241, Arlington, TX 76019 USA.	zui.pan@uta.edu	Fu, Liwu/AAE-8835-2020; Kim, Sun/GSN-4867-2022; cui, cui/HHM-4146-2022	Cui, Chaochu/0000-0003-0907-9766; Pan, Zui/0000-0003-4105-901X	U.S. National Institutes of Health (NIH) National Cancer Institute [R01-CA185055]; Pelotonia (Columbus, OH, USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK106394]; NATIONAL CANCER INSTITUTE [R01CA185055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106394] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pelotonia (Columbus, OH, USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant R01-CA185055 and funds from Pelotonia (Columbus, OH, USA) (to Z.P.), and by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK106394 (to J.M.). The authors declare no conflicts of interest.	Abnet CC, 2005, JNCI-J NATL CANCER I, V97, P301, DOI 10.1093/jnci/dji042; Alansary D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33347; Peralta FA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071059; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fong LYY, 1999, CANCER LETT, V143, P63, DOI 10.1016/S0304-3835(99)00191-3; Gore A, 2004, J BIOL CHEM, V279, P11106, DOI 10.1074/jbc.M400005200; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Huo XF, 2010, GASTROENTEROLOGY, V139, P194, DOI 10.1053/j.gastro.2010.03.035; Inoue K, 2015, CURR MED CHEM, V22, P1248, DOI 10.2174/0929867322666150209153750; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Ko JK, 2011, FASEB J, V25, P2638, DOI 10.1096/fj.11-181560; MASUOKA J, 1994, J BIOL CHEM, V269, P25557; McNally BA, 2012, J PHYSIOL-LONDON, V590, P4179, DOI 10.1113/jphysiol.2012.233098; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mikata Y, 2005, DALTON T, P545, DOI 10.1039/b411924j; National Cancer Institute Division of Cancer Control and Population Sciences, 2016, SEER STAT FACT SHEET; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; Pan Z, 2017, FRONT BIOSCI-LANDMRK, V22, P623, DOI 10.2741/4507; Pan Zui, 2012, J Vis Exp, DOI 10.3791/3415; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; ROGERS MAM, 1993, CANCER EPIDEM BIOMAR, V2, P305; Taccioli C, 2012, ONCOGENE, V31, P4550, DOI 10.1038/onc.2011.592; Uchida K, 2013, J BIOL CHEM, V288, P25950, DOI 10.1074/jbc.M113.470138; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhu H, 2014, ONCOTARGET, V5, P3455, DOI 10.18632/oncotarget.1903; Zhu L, 2014, RSC ADV, V4, P20398, DOI 10.1039/c4ra00354c	31	41	41	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					404	+		10.1096/fj.201700227RRR	http://dx.doi.org/10.1096/fj.201700227RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928244	Green Published			2022-12-26	WOS:000419172700036
J	Kurt, TD; Aguilar-Calvo, P; Jiang, L; Rodriguez, JA; Alderson, N; Eisenberg, DS; Sigurdson, CJ				Kurt, Timothy D.; Aguilar-Calvo, Patricia; Jiang, Lin; Rodriguez, Jose A.; Alderson, Nazilla; Eisenberg, David S.; Sigurdson, Christina J.			Asparagine and glutamine ladders promote cross-species prion conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; fibril; neurodegeneration; prion; prion disease; steric zipper; transmission	CHRONIC WASTING DISEASE; BANK VOLE; NEURODEGENERATIVE DISEASES; MAMMALIAN PRIONS; AMYLOID FIBRILS; SHEEP SCRAPIE; NMR STRUCTURE; HAMSTER PRP; IN-VITRO; PROTEIN	Prion transmission between species is governed in part by primary sequence similarity between the infectious prion aggregate, PrPSc, and the cellular prion protein of the host, PrPC. A puzzling feature of prion formation is that certain PrPC sequences, such as that of bank vole, can be converted by a remarkably broad array of different mammalian prions, whereas others, such as rabbit, show robust resistance to cross-species prion conversion. To examine the structural determinants that confer susceptibility or resistance to prion conversion, we systematically tested over 40 PrPC variants of susceptible and resistant PrPC sequences in a prion conversion assay. Five key residue positions markedly impacted prion conversion, four of which were in steric zipper segments where side chains from amino acids tightly interdigitate in a dry interface. Strikingly, all five residue substitutions modulating prion conversion involved the gain or loss of an asparagine or glutamine residue. For two of the four positions, Asn and Gln residues were not interchangeable, revealing a strict requirement for either an Asn or Gln residue. Bank voles have a high number of Asn and Gln residues and a high Asn:Gln ratio. These findings suggest that a high number of Asn and Gln residues at specific positions may stabilize -sheets and lower the energy barrier for cross-species prion transmission, potentially because of hydrogen bond networks from side chain amides forming extended Asn/Gln ladders. These data also suggest that multiple PrPC segments containing Asn/Gln residues may act in concert along a replicative interface to promote prion conversion.	[Kurt, Timothy D.; Aguilar-Calvo, Patricia; Alderson, Nazilla; Sigurdson, Christina J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Kurt, Timothy D.; Aguilar-Calvo, Patricia; Alderson, Nazilla; Sigurdson, Christina J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rodriguez, Jose A.; Eisenberg, David S.] UCLA, Howard Hughes Med Inst, DOE Inst, Los Angeles, CA 90095 USA; [Rodriguez, Jose A.; Eisenberg, David S.] UCLA, Inst Mol Biol, Los Angeles, CA 90095 USA; [Rodriguez, Jose A.] UCLA, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Jiang, Lin] UCLA, Dept Neurol, Los Angeles, CA 90095 USA; [Sigurdson, Christina J.] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Davis	Sigurdson, CJ (corresponding author), Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	csigurdson@ucsd.edu			National Institutes of Health [NS069566, NS076896, OD019919, OD017853]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076896, R01NS069566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029430] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019919, T32OD017863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants NS069566 (to C. J. S.), NS076896 (to C. J. S.), OD019919 (to T. D. K.), and OD017853 (to T. D. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; Avbelj M, 2011, BIOCHEM BIOPH RES CO, V413, P521, DOI 10.1016/j.bbrc.2011.08.125; BARLOW RM, 1976, RES VET SCI, V21, P110, DOI 10.1016/S0034-5288(18)33406-4; Bett C, 2012, FASEB J, V26, P2868, DOI 10.1096/fj.11-200923; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CHANDLER RL, 1971, LANCET, V1, P232; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; CLOUSCARD C, 1995, J GEN VIROL, V76, P2097, DOI 10.1099/0022-1317-76-8-2097; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Di Bari MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003219; Di Bari MA, 2008, J GEN VIROL, V89, P2975, DOI 10.1099/vir.0.2008/005520-0; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Espinosa JC, 2016, J VIROL, V90, P10660, DOI 10.1128/JVI.01592-16; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; Koo BW, 2008, PROTEIN ENG DES SEL, V21, P147, DOI 10.1093/protein/gzm076; Krotee P, 2017, ELIFE, V6, DOI 10.7554/eLife.19273; Kurt TD, 2015, J CLIN INVEST, V125, P1485, DOI 10.1172/JCI79408; Kurt TD, 2014, J BIOL CHEM, V289, P10660, DOI 10.1074/jbc.M114.549030; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Mays CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018047; Mompean M, 2016, J PHYS CHEM LETT, V7, P1859, DOI 10.1021/acs.jpclett.6b00699; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Orru CD, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1004983, 10.1371/journal.ppat.1005117]; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; Pirisinu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20443; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Reddy G, 2009, P NATL ACAD SCI USA, V106, P11948, DOI 10.1073/pnas.0902473106; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Watts JC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003990; Watts JC, 2012, P NATL ACAD SCI USA, V109, P3498, DOI 10.1073/pnas.1121556109; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wickner RB, 2000, CURR BIOL, V10, pR335, DOI 10.1016/S0960-9822(00)00460-7; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	62	13	13	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19076	19086		10.1074/jbc.M117.794107	http://dx.doi.org/10.1074/jbc.M117.794107			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28931606	hybrid, Green Published			2022-12-26	WOS:000415848000030
J	Rahman, K; Mandalasi, M; Zhao, P; Sheikh, MO; Taujale, R; Kim, HW; van der Wel, H; Matta, K; Kannan, N; Glushka, JN; Wells, L; West, CM				Rahman, Kazi; Mandalasi, Msano; Zhao, Peng; Sheikh, M. Osman; Taujale, Rahil; Kim, Hyun W.; van der Wel, Hanke; Matta, Khushi; Kannan, Natarajan; Glushka, John N.; Wells, Lance; West, Christopher M.			Characterization of a cytoplasmic glucosyltransferase that extends the core trisaccharide of the Toxoplasma Skp1 E3 ubiquitin ligase subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate structure; E3 ubiquitin ligase; evolution; glycobiology; glycosyltransferase; mass spectrometry (MS); Toxoplasma gondii; cytoplasmic glycosylation	CHEMICAL-SYNTHESIS; PROTEIN; DICTYOSTELIUM; GONDII; GLYCOSYLATION; GLYCOSYLTRANSFERASES; COMPLEXES; FAMILIES; MODEL; SCF	Skp1 is a subunit of the SCF (Skp1/Cullin 1/F-box protein) class of E3 ubiquitin ligases that are important for eukaryotic protein degradation. Unlike its animal counterparts, Skp1 from Toxoplasma gondii is hydroxylated by an O-2-dependent prolyl-4-hydroxylase (PhyA), and the resulting hydroxyproline can subsequently be modified by a five-sugar chain. A similar modification is found in the social amoeba Dictyostelium, where it regulates SCF assembly and O-2-dependent development. Homologous glycosyltransferases assemble a similar core trisaccharide in both organisms, and a bifunctional -galactosyltransferase from CAZy family GT77 mediates the addition of the final two sugars in Dictyostelium, generating Gal1, 3Gal1,3Fuc1,2Gal1,3GlcNAc1-. Here, we found that Toxoplasma utilizes a cytoplasmic glycosyltransferase from an ancient clade of CAZy family GT32 to catalyze transfer of the fourth sugar. Catalytically active Glt1 was required for the addition of the terminal disaccharide in cells, and cytosolic extracts catalyzed transfer of [H-3]glucose from UDP-[H-3]glucose to the trisaccharide form of Skp1 in a glt1-dependent fashion. Recombinant Glt1 catalyzed the same reaction, confirming that it directly mediates Skp1 glucosylation, and NMR demonstrated formation of a Glc1,3Fuc linkage. Recombinant Glt1 strongly preferred the full core trisaccharide attached to Skp1 and labeled only Skp1 in glt1 extracts, suggesting specificity for Skp1. glt1-knock-out parasites exhibited a growth defect not rescued by catalytically inactive Glt1, indicating that the glycan acts in concert with the first enzyme in the pathway, PhyA, in cells. A genomic bioinformatics survey suggested that Glt1 belongs to the ancestral Skp1 glycosylation pathway in protists and evolved separately from related Golgi-resident GT32 glycosyltransferases.	[Rahman, Kazi; Mandalasi, Msano; Kim, Hyun W.; van der Wel, Hanke; Kannan, Natarajan; Wells, Lance; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, 120 E Green St, Athens, GA 30602 USA; [Zhao, Peng; Sheikh, M. Osman; Taujale, Rahil; Glushka, John N.; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Taujale, Rahil; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Rahman, Kazi] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Mandalasi, Msano; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Matta, Khushi] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Rahman, Kazi] NCI, Ctr Canc Res, HIV Dynam & Replicat Program, Frederick, MD 21702 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	West, CM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 120 E Green St, Athens, GA 30602 USA.	westcm@uga.edu		Sheikh, Mohammed/0000-0002-9481-8318; Rahman, Kazi/0000-0003-2986-0007; Wells, Lance/0000-0003-4956-5363; Zhao, Peng/0000-0002-9296-5293; Mandalasi, Msano/0000-0002-5906-7387	Mizutani Foundation for Glycoscience [14-140]; National Institutes of Health [R01-GM084383, P41-GM103490, 8P41-GM103390]; National Institutes of Health Grant [T32-GM107004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM084383, P41GM103490] Funding Source: NIH RePORTER	Mizutani Foundation for Glycoscience; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant 14-140 from the Mizutani Foundation for Glycoscience (to C. M. W.) and National Institutes of Health Grants R01-GM084383 (to C. M. W.), P41-GM103490 (to L. W., senior investigator), and 8P41-GM103390 (Resource for Integrated Glycotechnology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32-GM107004.	Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Blader IJ, 2014, EUKARYOT CELL, V13, P965, DOI 10.1128/EC.00081-14; Bonner JT, 2005, MYCOLOGIA, V97, P178, DOI 10.3852/mycologia.97.1.178; Chinoy ZS, 2015, CHEM-EUR J, V21, P11779, DOI 10.1002/chem.201501598; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Fussy Z, 2017, PROTIST, V168, P80, DOI 10.1016/j.protis.2016.12.001; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Ketcham C, 2004, J BIOL CHEM, V279, P29050, DOI 10.1074/jbc.M313858200; Li ZP, 2011, APPL MICROBIOL BIOT, V91, P1203, DOI 10.1007/s00253-011-3407-z; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; RANA SS, 1981, CARBOHYD RES, V96, P231, DOI 10.1016/S0008-6215(00)81873-X; Ronnols J, 2013, CARBOHYD RES, V380, P156, DOI 10.1016/j.carres.2013.06.026; Schafer CM, 2014, J BIOL CHEM, V289, P9076, DOI 10.1074/jbc.M113.528679; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sheikh MO, 2017, J BIOL CHEM, V292, P18897, DOI 10.1074/jbc.M117.809160; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P206, DOI 10.1093/glycob/cww114; Sheikh MO, 2015, MOL CELL PROTEOMICS, V14, P66, DOI 10.1074/mcp.M114.044560; Sheikh MO, 2014, BIOCHEMISTRY-US, V53, P1657, DOI 10.1021/bi401707y; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Sun SH, 2015, BIOTECHNOL BIOTEC EQ, V29, P105, DOI 10.1080/13102818.2014.988094; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; West CM, 2015, CURR OPIN MICROBIOL, V26, P41, DOI 10.1016/j.mib.2015.04.006; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu YC, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-31; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	34	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18644	18659		10.1074/jbc.M117.809301	http://dx.doi.org/10.1074/jbc.M117.809301			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28928220	Green Published, hybrid			2022-12-26	WOS:000414958100021
J	Yang, XB; Chen, GB; Weng, NP; Mariuzza, RA				Yang, Xinbo; Chen, Guobing; Weng, Nan-ping; Mariuzza, Roy A.			Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; influenza virus; major histocompatibility complex (MHC); protein complex; surface plasmon resonance (SPR); T-cell receptor; epitope	MEMORY REPERTOIRES; RECEPTOR; ALPHA; TCR; MHC; RECOGNITION; EXPANSION; SELECTION; FEATURES; DISTINCT	Influenza A virus (IAV) causes an acute infection in humans that is normally eliminated by CD8(+) cytotoxic T lymphocytes. Individuals expressing the MHC class I molecule HLA-A2 produce cytotoxic T lymphocytes bearing T-cell receptors (TCRs) that recognize the immunodominant IAV epitope GILGFVFTL (GIL). Most GIL-specific TCRs utilize / chain pairs encoded by the TRAV27/TRBV19 gene combination to recognize this relatively featureless peptide epitope (canonical TCRs). However, approximate to 40% of GIL-specific TCRs express a wide variety of other TRAV/TRBV combinations (non-canonical TCRs). To investigate the structural underpinnings of this remarkable diversity, we determined the crystal structure of a non-canonical GIL-specific TCR (F50) expressing the TRAV13-1/TRBV27 gene combination bound to GIL-HLA-A2 to 1.7 resolution. Comparison of the F50-GIL-HLA-A2 complex with the previously published complex formed by a canonical TCR (JM22) revealed that F50 and JM22 engage GIL-HLA-A2 in markedly different orientations. These orientations are distinguished by crossing angles of TCR to peptide-MHC of 29 degrees for F50 versus 69 degrees for JM22 and by a focus by F50 on the C terminus rather than the center of the MHC 1 helix for JM22. In addition, F50, unlike JM22, uses a tryptophan instead of an arginine to fill a critical notch between GIL and the HLA-A2 2 helix. The F50-GIL-HLA-A2 complex shows that there are multiple structurally distinct solutions to recognizing an identical peptide-MHC ligand with sufficient affinity to elicit a broad anti-IAV response that protects against viral escape and T-cell clonal loss.	[Yang, Xinbo; Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Yang, Xinbo; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Chen, Guobing; Weng, Nan-ping] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA.; Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Weng, Nan-ping/AAC-5037-2020; Chen, Guobing/D-9572-2012	Chen, Guobing/0000-0002-2401-6168	US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036900, R37AI036900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000499] Funding Source: NIH RePORTER	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the National Institutes of Health Tetramer Core Facility for providing biotinylated GIL-HLA-A2. The X-ray SER-CAT beamlines at the Advanced Photon Source are supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38. We thank Edwin Pozharski and Swarna Lakshmi Pigudu for generous assistance with X-ray data collection.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Chen G, 2017, CELL REP, V19, P569, DOI 10.1016/j.celrep.2017.03.072; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Deng L, 2012, P NATL ACAD SCI USA, V109, P14960, DOI 10.1073/pnas.1207186109; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garcia KC, 2012, TRENDS IMMUNOL, V33, P429, DOI 10.1016/j.it.2012.05.005; Gil A, 2015, J VIROL, V89, P4102, DOI 10.1128/JVI.03020-14; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Klarenbeek PL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002889; La Gruta NL, 2014, TRENDS IMMUNOL, V35, P396, DOI 10.1016/j.it.2014.06.004; La Gruta NL, 2013, CURR OPIN VIROL, V3, P447, DOI 10.1016/j.coviro.2013.06.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Li HM, 2016, J LEUKOCYTE BIOL, V99, P505, DOI 10.1189/jlb.6A0215-071RR; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638; Miconnet I, 2012, CURR OPIN HIV AIDS, V7, P64, DOI 10.1097/COH.0b013e32834ddcae; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Naumov YN, 2008, J IMMUNOL, V181, P7407, DOI 10.4049/jimmunol.181.10.7407; Naumov YN, 2006, J IMMUNOL, V177, P2006, DOI 10.4049/jimmunol.177.3.2006; Naumov YN, 2011, J IMMUNOL, V186, P6617, DOI 10.4049/jimmunol.1100091; Oelke M, 2003, NAT MED, V9, P619, DOI 10.1038/nm869; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shimizu A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03097; Song I, 2017, NAT STRUCT MOL BIOL, V24, P395, DOI 10.1038/nsmb.3383; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Stewart-Jones GB, 2012, P NATL ACAD SCI USA, V109, pE3483, DOI 10.1073/pnas.1207896109; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yang XB, 2015, J BIOL CHEM, V290, P29106, DOI 10.1074/jbc.M115.691311; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	52	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18618	18627		10.1074/jbc.M117.810382	http://dx.doi.org/10.1074/jbc.M117.810382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28931605	hybrid, Green Published			2022-12-26	WOS:000414958100019
J	Magalhaes, FB; Neto, ALC; Nascimento, MB; Santos, WJT; Medeiros, ZM; Neto, ASL; Costa, DL; Costa, CHN; dos Santos, WLC; de Carvalho, LCP; Oliveira, GGS; Neto, OPD				Magalhaes, Franklin B.; Castro Neto, Artur L.; Nascimento, Marilia B.; Santos, Wagner J. T.; Medeiros, Zulma M.; Lima Neto, Adelino S.; Costa, Dorcas L.; Costa, Carlos H. N.; dos Santos, Washington L. C.; Pontes de Carvalho, Lain C.; Oliveira, Geraldo G. S.; de Melo Neto, Osvaldo P.			Evaluation of a new set of recombinant antigens for the serological diagnosis of human and canine visceral leishmaniasis	PLOS ONE			English	Article							IMMUNE-RESPONSE; TRYPANOSOMA-BRUCEI; EAST-AFRICA; INFANTUM; BRAZIL; PROTEINS; ANTIBODY; K-39; IDENTIFICATION; SERODIAGNOSIS	Current strategies for the control of zoonotic visceral leishmaniasis (VL) rely on its efficient diagnosis in both human and canine hosts. The most promising and cost effective approach is based on serologic assays with recombinant proteins. However, no single antigen has been found so far which can be effectively used to detect the disease in both dogs and humans. In previous works, we identified Leishmania infantum antigens with potential for the serodiagnosis of VL. Here, we aimed to expand the panel of the available antigens for VL diagnosis through another screening of a genomic expression library. Seven different protein-coding gene fragments were identified, five of which encoding proteins which have not been previously studied in Leishmania and rich in repetitive motifs. Poly-histidine tagged polypeptides were generated from six genes and evaluated for their potential for diagnosis of VL by ELISA (Enzyme Linked ImmunoSorbent Assay) with sera from infected humans and dogs. None of those was valid for the detection of human VL (26-52% sensitivity) although their performance was increased in the canine sera (48-91% sensitivity), with one polypeptide useful for the diagnosis of canine leishmaniasis. Next, we assayed a mixture of three antigens, found to be best for human or canine VL, among 13 identified through different screenings. This "Mix" resulted in similar levels of sensitivity for both human (84%) and canine (88%) sera. With improvements, this validates the use of multiple proteins, including antigens identified here, as components of a single system for the diagnosis of both forms of leishmaniasis.	[Magalhaes, Franklin B.] Assoc Caruaruense Ensino Super & Tecn, Caruaru, PE, Brazil; [Castro Neto, Artur L.; Nascimento, Marilia B.; Santos, Wagner J. T.; Medeiros, Zulma M.; de Melo Neto, Osvaldo P.] Fundacao Oswaldo Cruz Fiocruz Pernambuco, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil; [Lima Neto, Adelino S.; Costa, Dorcas L.; Costa, Carlos H. N.] Inst Doencas Trop Natan Portella IDTNP, Teresina, Piaui, Brazil; [dos Santos, Washington L. C.; Pontes de Carvalho, Lain C.; Oliveira, Geraldo G. S.] Fundacao Oswaldo Cruz Fiocruz Bahia, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Neto, OPD (corresponding author), Fundacao Oswaldo Cruz Fiocruz Pernambuco, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.	opmn@cpqam.fiocruz.br	de Sá Oliveira, Geraldo Gileno/AAO-4099-2021; dos Santos, Wagner José Tenório/AAQ-6888-2021; dos-Santos, Washington LC/AAO-4649-2021; dos Santos, Wagner José Tenório/AAE-3702-2022; de Castro Neto, Artur Leonel/L-2193-2015; de Melo Neto, Osvaldo P/B-1366-2015; Medeiros, Zulma/J-5407-2015	de Sá Oliveira, Geraldo Gileno/0000-0001-6065-6480; dos-Santos, Washington LC/0000-0002-5075-1254; dos Santos, Wagner José Tenório/0000-0001-7605-4687; de Castro Neto, Artur Leonel/0000-0002-1356-6703; de Melo Neto, Osvaldo P/0000-0001-5402-7346; Medeiros, Zulma/0000-0002-4434-955X	CNPq; Brazilian Ministry of Health (Grant MCTI/CNPq/MS-SCTIE) [404259/2012]; CNPq [554797]; Brazilian Ministry of Science and Technology (Program RENORBIO); FACEPE; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health (Grant MCTI/CNPq/MS-SCTIE); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Science and Technology (Program RENORBIO); FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work in Dr. de Melo Neto's laboratory was more recently funded with grants provided by the Brazilian funding agency CNPq and the Brazilian Ministry of Health (Grant MCTI/CNPq/MS-SCTIE No.: 404259/2012). The work in Dr. C. H. N. Costa's lab was funded by CNPq (Grant 554797). Fellowships and studentships for the graduate students (FBM, ALCM, MBN, WJTS and ASLN) were provided by CNPq, FACEPE or CAPES. The work carried out at Fiocruz-BA was funded by the Brazilian Ministry of Science and Technology (Program RENORBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abass E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116408; Boarino A, 2005, CLIN DIAGN LAB IMMUN, V12, P647, DOI 10.1128/CDLI.12.5.647-653.2005; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775; Campos RM, 2008, MOL BIOCHEM PARASIT, V160, P157, DOI 10.1016/j.molbiopara.2008.04.013; Camussone C, 2009, CLIN VACCINE IMMUNOL, V16, P899, DOI 10.1128/CVI.00005-09; Castro JG, 2014, REV INST MED TROP SP, V56, P225, DOI 10.1590/S0036-46652014000300008; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Faria AR, 2015, PLOS NEGLECT TROP D, V9, P13; Fonseca AM, 2014, ACTA TROP, V137, P25, DOI 10.1016/j.actatropica.2014.04.028; Gomes YM, 2008, VET J, V175, P45, DOI 10.1016/j.tvjl.2006.10.019; Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; Goto Y, 2010, INFECT IMMUN, V78, P2138, DOI 10.1128/IAI.01102-09; Goto Y, 2009, VET PARASITOL, V160, P215, DOI 10.1016/j.vetpar.2008.10.097; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Harhay MO, 2011, AM J TROP MED HYG, V84, P543, DOI 10.4269/ajtmh.2011.10-0321; Houghton RL, 1998, J INFECT DIS, V177, P1339, DOI 10.1086/515289; Elmahallawy EK, 2014, J INFECT DEV COUNTR, V8, P961, DOI 10.3855/jidc.4310; LEE MGS, 1994, J BIOL CHEM, V269, P8408; Maia C, 2008, VET PARASITOL, V158, P274, DOI 10.1016/j.vetpar.2008.07.028; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Martins-Melo FR, 2014, T ROY SOC TROP MED H, V108, P338, DOI 10.1093/trstmh/tru050; Mettler M, 2005, J CLIN MICROBIOL, V43, P5515, DOI 10.1128/JCM.43.11.5515-5519.2005; Fraga DBM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-136; Noli C, 2014, VET J, V202, P425, DOI 10.1016/j.tvjl.2014.09.002; Oliveira GGS, 2011, AM J TROP MED HYG, V85, P1025, DOI 10.4269/ajtmh.2011.11-0102; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Peixoto HM, 2015, TROP MED INT HEALTH, V20, P334, DOI 10.1111/tmi.12429; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992; RINDISBACHER L, 1993, MOL BIOCHEM PARASIT, V58, P83, DOI 10.1016/0166-6851(93)90093-D; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Rosati S, 2003, CLIN DIAGN LAB IMMUN, V10, P1153, DOI 10.1128/CDLI.10.6.1153-1156.2003; Shakya Nishi, 2011, J Parasit Dis, V35, P104; Singh Om Prakash, 2015, J Parasitol Res, V2015, P239469, DOI 10.1155/2015/239469; Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056; Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002; Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006; Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1; Teixeira MCA, 2007, BIOLOGICALS, V35, P51, DOI 10.1016/j.biologicals.2006.01.005; Valiente-Gabioud AA, 2011, EXP PARASITOL, V127, P672, DOI 10.1016/j.exppara.2010.11.011; Vos Q, 2000, IMMUNOL REV, V176, P154; Webb JR, 1996, J IMMUNOL, V157, P5034; Zinoviev A, 2011, NUCLEIC ACIDS RES, V39, P8404, DOI 10.1093/nar/gkr555	49	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184867	10.1371/journal.pone.0184867	http://dx.doi.org/10.1371/journal.pone.0184867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957332	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200019
J	Tonussi, RL; Silva, RMD; Magalhaes, AFB; Espigolan, R; Peripolli, E; Olivieri, BF; Feitosal, FLB; Lemos, MVA; Berton, MP; Chiaia, HLJ; Pereira, ASC; Lobo, RB; Bezerra, LAF; Magnabosco, CU; Lourenco, DAL; Aguilar, I; Baldi, F				Tonussi, Rafael Lara; de Oliveira Silva, Rafael Medeiros; Braga Magalhaes, Ana Fabricia; Espigolan, Rafael; Peripolli, Elisa; Olivieri, Bianca Ferreira; Braga Feitosal, Fabieli Loise; Antunes Lemos, Marcos Vinicfus; Berton, Mariana Piatto; Justino Chiaia, Hermenegildo Lucas; Cravo Pereira, Angelica Simone; Lobo, Raysildo Barbosa; Framartino Bezerra, Luiz Antonio; Magnabosco, Claudio de Ulhoa; Lourenco, Daniela Andressa Lino; Aguilar, Ignacio; Baldi, Fernando			Application of single step genomic BLUP under different uncertain paternity scenarios using simulated data	PLOS ONE			English	Article							UNKNOWN-PARENT GROUPS; FULL PEDIGREE; US HOLSTEINS; FINAL SCORE; GENETIC EVALUATION; SIRE EVALUATION; INFORMATION; TRAITS; CATTLE; MODEL	The objective of this study was to investigate the application of BLUP and single step genomic BLUP (ssGBLUP) models in different scenarios of paternity uncertainty with different strategies of scaling the G matrix to match the A(22) matrix, using simulated data for beef cattle. Genotypes, pedigree, and phenotypes for age at first calving (AFC) and weight at 550 days (W550) were simulated using heritabilities based on real data (0.12 for AFC and 0.34 for W550). Paternity uncertainty scenarios using 0, 25, 50, 75, and 100% of multiple sires (MS) were studied. The simulated genome had a total length of 2,333 cM, containing 735,293 biallelic markers and 7,000 QTLs randomly distributed over the 29 BTA. It was assumed that QTLs explained 100% of the genetic variance. For QTL, the amount of alleles per loci randomly ranged from two to four. The BLUP model that considers phenotypic and pedigree data, and the ssGBLUP model that combines phenotypic, pedigree and genomic information were used for genetic evaluations. Four ways of scaling the mean of the genomic matrix (G) to match to the mean of the pedigree relationship matrix among genotyped animals (A(22)) were tested. Accuracy, bias, and inflation were investigated for five groups of animals: ALL = all animals; BULL = only bulls; GEN = genotyped animals; FEM = females; and YOUNG = young males. With the BLUP model, the accuracies of genetic evaluations decreased for both traits as the proportion of unknown sires in the population increased. The EBV accuracy reduction was higher for GEN and YOUNG groups. By analyzing the scenarios for YOUNG (from 0 to 100% of MS), the decrease was 87.8 and 86% for AFC and W550, respectively. When applying the ssGBLUP model, the accuracies of genetic evaluation also decreased as the MS in the pedigree for both traits increased. However, the accuracy reduction was less than those observed for BLUP model. Using the same comparison (scenario 0 to 100% of MS), the accuracies reductions were 38 and 44.6% for AFC and W550, respectively. There were no differences between the strategies for scaling the G matrix for ALL, BULL, and FEM groups under the different scenarios with missing pedigree. These results pointed out that the uninformative part of the A(22) matrix and genotyped animals with paternity uncertainty did not influence the scaling of G matrix. On the basis of the results, it is important to have a G matrix in the same scale of the A(22) matrix, especially for the evaluation of young animals in situations with missing pedigree information. In these situations, the ssGBLUP model is an appropriate alternative to obtain a more reliable and less biased estimate of breeding values, especially for young animals with few or no phenotypic records. For accurate and unbiased genomic predictions with ssGBLUP, it is necessary to assure that the G matrix is compatible with the A(22) matrix, even in situations with paternity uncertainty.	[Tonussi, Rafael Lara; de Oliveira Silva, Rafael Medeiros; Braga Magalhaes, Ana Fabricia; Espigolan, Rafael; Peripolli, Elisa; Olivieri, Bianca Ferreira; Braga Feitosal, Fabieli Loise; Antunes Lemos, Marcos Vinicfus; Berton, Mariana Piatto; Justino Chiaia, Hermenegildo Lucas; Baldi, Fernando] Sch Agr & Veterinarian Sci, Dept Anim Sci, Sao Paulo, Brazil; [Cravo Pereira, Angelica Simone] Fac Anim Sci & Food Engn, Dept Nutr & Anim Prod, Pirassununga, Brazil; [Lobo, Raysildo Barbosa] Natl Assoc Breeders & Researchers ANCP, Ribeirao Preto, Brazil; [Framartino Bezerra, Luiz Antonio] Med Sch Ribeirao Preto, Dept Genet, Ribeirao Preto, Brazil; [Magnabosco, Claudio de Ulhoa] Brazilian Agr Res Corp EMBRAPA, Brasilia, DF, Brazil; [Lourenco, Daniela Andressa Lino] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Aguilar, Ignacio] Natl Inst Agr Res, Dept Anim Breeding, Las Brujas, Uruguay	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University System of Georgia; University of Georgia; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA)	Baldi, F (corresponding author), Sch Agr & Veterinarian Sci, Dept Anim Sci, Sao Paulo, Brazil.	fernandobaldiuy@gmail.com	Baldi, Fernando/E-5492-2012; Aguilar, Ignacio/C-2528-2012; Feitosa, Fabieli L. B./D-4996-2014; Magnabosco, Cláudio Ulhoa/ABC-4494-2021; Magalhães, Ana Fabrícia Braga/GLQ-5906-2022	Baldi, Fernando/0000-0003-4094-2011; Feitosa, Fabieli L. B./0000-0003-4218-0348; Magnabosco, Cláudio Ulhoa/0000-0002-7274-0134; Piatto Berton, Mariana/0000-0001-7129-1990; Aguilar, Ignacio/0000-0002-1038-4752; Peripolli, Elisa/0000-0002-0962-6603; Magalhaes, Ana/0000-0003-2063-6957; Lourenco, Daniela/0000-0003-3140-1002	Sao Paulo Research Foundation (FAPESP) [2013/25910-0, 2011/21241-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by the Sao Paulo Research Foundation (FAPESP), 2013/25910-0, Mr Rafael Lara Tonussi, and Sao Paulo Research Foundation (FAPESP), 2011/21241-0, PhD Fernando Baldi.	Aguilar I, 2011, J ANIM BREED GENET, V128, P422, DOI 10.1111/j.1439-0388.2010.00912.x; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Aguilar I., 2014, P 10 WORLD C GENETIC; Berry DP, 2016, ANIM FRONT, V6, P32, DOI 10.2527/af.2016-0005; Brito FV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-80; Cardoso FF, 2003, GENET SEL EVOL, V35, P469, DOI [10.1051/gse:2003035, 10.1186/1297-9686-35-6-469]; Chen CY, 2011, J ANIM SCI, V89, P2673, DOI 10.2527/jas.2010-3555; Chen CY, 2011, J ANIM SCI, V89, P23, DOI 10.2527/jas.2010-3071; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; Espigolan R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-305; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Garrick J. D., 2011, GENET SEL EVOL, V47, P1; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; HENDERSO.CR, 1974, J DAIRY SCI, V57, P963, DOI 10.3168/jds.S0022-0302(74)84993-3; KENNEDY BW, 1981, J DAIRY SCI, V64, P689, DOI 10.3168/jds.S0022-0302(81)82631-8; Koury W, 2010, REV BRAS ZOOTECN, V39, P1015, DOI 10.1590/S1516-35982010000500011; Laureano MMM, 2011, ARQ BRAS MED VET ZOO, V63, P143, DOI 10.1590/S0102-09352011000100022; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Lourenco DAL, 2014, J DAIRY SCI, V97, P3930, DOI 10.3168/jds.2013-7769; Lourenco DAL, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0137-1; Masuda Y, 2016, J DAIRY SCI, V99, P1968, DOI 10.3168/jds.2015-10540; Misztal I, 2013, J ANIM BREED GENET, V130, P252, DOI 10.1111/jbg.12025; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Misztal I., 2002, P 7 WORLD C GEN APPL, P19; Misztal I, 2013, POULTRY SCI, V92, P2530, DOI 10.3382/ps.2012-02739; Nietlisbach P, 2016, HEREDITY, V116, P1, DOI 10.1038/hdy.2015.59; Olson KM, 2011, J DAIRY SCI, V94, P2613, DOI 10.3168/jds.2010-3877; Sargolzaei M, 2009, BIOINFORMATICS, V25, P680, DOI 10.1093/bioinformatics/btp045; Snelling WM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r165; Tsuruta S, 2014, J DAIRY SCI, V97, P5814, DOI 10.3168/jds.2013-7821; Tsuruta S, 2013, J DAIRY SCI, V96, P3332, DOI 10.3168/jds.2012-6272; Tsuruta S, 2011, J DAIRY SCI, V94, P4198, DOI 10.3168/jds.2011-4256; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; WESTELL RA, 1988, J DAIRY SCI, V71, P1310, DOI 10.3168/jds.S0022-0302(88)79688-5; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Wilkinson S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-45; Yokoo MJ, 2012, ARQ BRAS MED VET ZOO, V64, P91, DOI 10.1590/S0102-09352012000100014	38	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0181752	10.1371/journal.pone.0181752	http://dx.doi.org/10.1371/journal.pone.0181752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957330	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200003
J	Khoshnood, B; Dacklin, I; Grabbe, C				Khoshnood, Behzad; Dacklin, Ingrid; Grabbe, Caroline			A proteomics approach to identify targets of the ubiquitin-like molecule Urm1 in Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN CONJUGATION; OXIDATIVE STRESS; SULFUR TRANSFER; MODIFIER URM1; REDUCTASE; REGULATOR; SYSTEM; YEAST; HOMEOSTASIS; URMYLATION	By covalently conjugating to target proteins, ubiquitin-like modifiers (UBLs) act as important regulators of target protein localization and activity, thereby playing a critical role in the orchestration of cellular biology. The most ancient and one of the least studied UBLs is Urm1, a dual-function protein that in parallel to performing similar functions as its prokaryotic ancestors in tRNA modification, also has adopted the capacity to conjugate to cellular proteins analogous to ubiquitin and other UBL modifiers. In order to increase the understanding of Urm1 and its role in multicellular organisms, we have used affinity purification followed by mass spectrometry to identify putative targets of Urm1 conjugation (urmylation) at three developmental stages of the Drosophila melanogaster lifecycle. Altogether we have recovered 79 Urm1-interacting proteins in Drosophila, which include the already established Urm1 binding partners Prx5 and Uba4, together with 77 candidate urmylation targets that are completely novel in the fly. Among these, the majority was exclusively identified during either embryogenesis, larval stages or in adult flies. We further present biochemical evidence that four of these proteins are covalently conjugated by Urm1, whereas the fifth verified Urm1-binding protein appears to interact with Urm1 via non-covalent means. Besides recapitulating the previously established roles of Urm1 in tRNA modification and during oxidative stress, functional clustering of the newly identified Urm1-associated proteins further positions Urm1 in protein networks that control other types of cellular stress, such as immunological threats and DNA damage. In addition, the functional characteristics of several of the candidate targets strongly match the phenotypes displayed by Urm1(n123) null animals, including embryonic lethality, reduced fertility and shortened lifespan. In conclusion, this identification of candidate targets of urmylation significantly increases the knowledge of Urm1 and presents an excellent starting point for unravelling the role of Urm1 in the context of a complex living organism.	[Khoshnood, Behzad; Dacklin, Ingrid; Grabbe, Caroline] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University	Grabbe, C (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	caroline.grabbe@umu.se		Grabbe, Caroline/0000-0002-1758-2217	Swedish Research Council [621-2012-4749]; Swedish Foundation for Strategic Research [ICA08-0035]; Insamlingsstiftelsen for medicinsk forskning vid Umea universitet [Dnr 223-2808-12]; Swedish Foundation for Strategic research (SSF) [ICA08-0035]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Insamlingsstiftelsen for medicinsk forskning vid Umea universitet; Swedish Foundation for Strategic research (SSF)(Swedish Foundation for Strategic Research); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Swedish Research Council, 621-2012-4749, (URL: https://www.vr.se/inenglish.4 12fff4451215cbd83e4800015152.html) to CG; the Swedish Foundation for Strategic Research, ICA08-0035, (URL: http://stratresearch.se/en/) to CG; and Insamlingsstiftelsen for medicinsk forskning vid Umea universitet, Dnr 223-2808-12, (URL:http://stittelse.umu.se/medforsk/) to CG.r We would like to thank several people that made this work possible. First of all those who shared their reagents with us, including Prof. R. Lehmann (Jafracl antibodies) and Prof. T. Preat (pCasper:Crammer-GFP transgenic flies). Secondly, we are highly grateful for the professional help and guidance obtained by the SciLifeLab facility for mass-spectrometry based proteomics in Stockholm/Uppsala, Sweden. We would further like to acknowledge the importance of the Bloomington Drosophila Stock Center (NIH P400D018537) and F1yORF (Zurich ORFeome project) [31] for providing fly stocks. This work was supported by the Swedish Foundation for Strategic research (SSF) (ICA08-0035), The Swedish Research Council (621-2012-4749) and Insamlingsstiftelsen for medicinsk forskning vid Umea universitet (Dnr 223-2808-12).	Ahn HM, 2012, DEV COMP IMMUNOL, V38, P466, DOI 10.1016/j.dci.2012.07.002; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Anjum RS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9163; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; Burroughs AM, 2012, FRONT BIOSCI-LANDMRK, V17, P1433, DOI 10.2741/3996; Burroughs AM, 2008, PROTEINS; Campanale JP, 2017, J CELL SCI, V130, P1201, DOI 10.1242/jcs.188599; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Chiang HS, 2011, FREE RADICAL BIO MED, V51, P688, DOI 10.1016/j.freeradbiomed.2011.05.015; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; DeGennaro M, 2011, DEV CELL, V20, P233, DOI 10.1016/j.devcel.2010.12.007; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Judes A, 2016, MICROB CELL, V3, P423, DOI 10.15698/mic2016.11.539; Judes A, 2015, FEBS LETT, V589, P904, DOI 10.1016/j.febslet.2015.02.024; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Khoshnood B, 2016, CELL MOL LIFE SCI, V73, P1939, DOI 10.1007/s00018-015-2121-x; Kongton K, 2014, DEV COMP IMMUNOL, V44, P389, DOI 10.1016/j.dci.2014.01.007; Kwon SY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005969; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Li ZG, 2017, ARCH VIROL, V162, P603, DOI 10.1007/s00705-016-3130-2; Liu X, 2013, CYTOKINE GROWTH F R, V24, P559, DOI 10.1016/j.cytogfr.2013.07.002; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Maupin-Furlow JA, 2014, ANNU REV MICROBIOL, V68, P155, DOI 10.1146/annurev-micro-091313-103447; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Minniti AN, 2009, AGING CELL, V8, P690, DOI 10.1111/j.1474-9726.2009.00521.x; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; Petroski MD, 2011, P NATL ACAD SCI USA, V108, P1749, DOI 10.1073/pnas.1019043108; R Core Team, 2021, R LANGUAGE ENV STAT; Radyuk SN, 2009, BIOCHEM J, V419, P437, DOI 10.1042/BJ20082003; Ranjan N, 2011, J MOL BIOL, V405, P1040, DOI 10.1016/j.jmb.2010.11.040; Rodriguez-Jato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027479; Roesijadi G, 2007, BIOCHEM BIOPH RES CO, V354, P511, DOI 10.1016/j.bbrc.2007.01.005; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schwertman P, 2016, NAT REV MOL CELL BIO, V17, P379, DOI 10.1038/nrm.2016.58; Shigi N, 2012, J BIOL CHEM, V287, P17568, DOI 10.1074/jbc.M112.359844; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Wang CY, 2001, NAT STRUCT BIOL, V8, P47; Warnes G, 2016, R PACKAGE VERSION 3; Wei HC, 2003, CURR BIOL, V13, P1882, DOI 10.1016/j.cub.2003.09.056; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8	63	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185611	10.1371/journal.pone.0185611	http://dx.doi.org/10.1371/journal.pone.0185611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953965	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300077
J	Welsh, EA; Stewart, PA; Kuenzi, BM; Eschrich, JA				Welsh, Eric A.; Stewart, Paul A.; Kuenzi, Brent M.; Eschrich, James A.			Escape Excel: A tool for preventing gene symbol and accession conversion errors	PLOS ONE			English	Article							NAME ERRORS	Background Microsoft Excel automatically converts certain gene symbols, database accessions, and other alphanumeric text into dates, scientific notation, and other numerical representations. These conversions lead to subsequent, irreversible, corruption of the imported text. A recent survey of popular genomic literature estimates that one-fifth of all papers with supplementary gene lists suffer from this issue. Results Here, we present an open-source tool, Escape Excel, which prevents these erroneous conversions by generating an escaped text file that can be safely imported into Excel. Escape Excel is implemented in a variety of formats (http://www.github.com/pstew/escape_excel), including a command line based Perl script, a Windows-only Excel Add-In, an OS X drag-and-drop application, a simple web-server, and as a Galaxy web environment interface. Test server implementations are accessible as a Galaxy interface (http://apostl.moffitt.org) and simple non-Galaxy web server (http://apostl.moffitt.org:8000/). Conclusions Escape Excel detects and escapes a wide variety of problematic text strings so that they are not erroneously converted into other representations upon importation into Excel. Examples of problematic strings include date-like strings, time-like strings, leading zeroes in front of numbers, and long numeric and alphanumeric identifiers that should not be automatically converted into scientific notation. It is hoped that greater awareness of these potential data corruption issues, together with diligent escaping of text files prior to importation into Excel, will help to reduce the amount of Excel-corrupted data in scientific analyses and publications.	[Welsh, Eric A.; Eschrich, James A.] H Lee Moffitt Canc Ctr & Res Inst, Canc Informat, Tampa, FL 33612 USA; [Stewart, Paul A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA; [Kuenzi, Brent M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL USA; [Kuenzi, Brent M.] Univ S Florida, Canc Biol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Welsh, EA (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Canc Informat, Tampa, FL 33612 USA.	Eric.Welsh@moffitt.org		Kuenzi, Brent/0000-0002-6771-0432	National Cancer Institute Cancer Center Support Grant (CCSG) [P30-CA076292-18]; National Cancer Institute [F99/K00, F99 CA212456]	National Cancer Institute Cancer Center Support Grant (CCSG); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part (EAW) by National Cancer Institute (https://grants.nih.gov/) Cancer Center Support Grant (CCSG) for NCI-designated Cancer Centers, award number P30-CA076292-18, and in part (BMK) by National Cancer Institute F99/K00 Predoctoral to Postdoctoral Transition Award, award number F99 CA212456. Views and opinions of, endorsements by, the author(s) do not reflect those of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Microsoft, 2015, TEXT NUMB CONV UN NU; Zeeberg BR, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-80; Ziemann M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1044-7	4	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185207	10.1371/journal.pone.0185207	http://dx.doi.org/10.1371/journal.pone.0185207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953918	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300043
J	Hayoz, S; Tiwari, PB; Piszczek, G; Uren, A; Brelidze, TI				Hayoz, Sebastien; Tiwari, Purushottam B.; Piszczek, Grzegorz; Uren, Aykut; Brelidze, Tinatin I.			Investigating cyclic nucleotide and cyclic dinucleotide binding to HCN channels by surface plasmon resonance	PLOS ONE			English	Article							ACTIVATED PACEMAKER CHANNELS; CURRENT I-H; STRUCTURAL BASIS; GATED CHANNELS; SINOATRIAL NODE; CATION CHANNELS; HUMAN PROTEINS; ION-CHANNEL; DI-GMP; CAMP	Hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels control cardiac and neuronal rhythmicity. HCN channels contain cyclic nucleotide-binding domain (CNBD) in their C-terminal region linked to the pore-forming transmembrane segment with a Clinker. The C-linker couples the conformational changes caused by the direct binding of cyclic nucleotides to the HCN pore opening. Recently, cyclic dinucleotides were shown to antagonize the effect of cyclic nucleotides in HCN4 but not in HCN2 channels. Based on the structural analysis and mutational studies it has been proposed that cyclic dinucleotides affect HCN4 channels by binding to the C-linker pocket (CLP). Here, we first show that surface plasmon resonance (SPR) can be used to accurately measure cyclic nucleotide binding affinity to the C-linker/CNBD of HCN2 and HCN4 channels. We then used SPR to investigate cyclic dinucleotide binding in HCN channels. To our surprise, we detected no binding of cyclic dinucleotides to the isolated monomeric C-linker/CNBDs of HCN4 channels with SPR. The binding of cyclic dinucleotides was further examined with isothermal calorimetry (ITC), which indicated no binding of cyclic dinucleotides to both monomeric and tetrameric C-linker/CNBDs of HCN4 channels. Taken together, our results suggest that interaction of the C-linker/CNBD with other parts of the channel is necessary for cyclic-dinucleotide binding in HCN4 channels.	[Hayoz, Sebastien; Brelidze, Tinatin I.] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Tiwari, Purushottam B.; Uren, Aykut] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Piszczek, Grzegorz] NHLBI, Biophys Core, NIH, Bldg 10, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Brelidze, TI (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA.	tib5@georgetown.edu	Piszczek, Grzegorz/GYU-2029-2022	Brelidze, Tinatin/0000-0003-3046-8184	Georgetown University and Toulmin Pilot Award from Georgetown University; National Cancer Institute [P30CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338] Funding Source: NIH RePORTER	Georgetown University and Toulmin Pilot Award from Georgetown University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by startup funds provided by Georgetown University and Toulmin Pilot Award from Georgetown University (T.I.B.). The authors thank the Biacore Molecular Interaction Shared Resource at the Lombardi Comprehensive Cancer Center (Georgetown University), which is supported by a grant P30CA51008 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Campbell CT, 2007, BIOMATERIALS, V28, P2380, DOI 10.1016/j.biomaterials.2007.01.047; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fivash M, 1998, CURR OPIN BIOTECH, V9, P97, DOI 10.1016/S0958-1669(98)80091-8; Goldschen-Ohm MP, 2016, ELIFE, V5, DOI 10.7554/eLife.20797; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Nguyen HH, 2015, SENSORS-BASEL, V15, P10481, DOI 10.3390/s150510481; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jorgensen TJ, 2009, J MOL RECOGNIT, V22, P446, DOI 10.1002/jmr.962; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Komagiri Y, 2007, BIOMED RES-TOKYO, V28, P177, DOI 10.2220/biomedres.28.177; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Liao Z, 2012, J GEN PHYSIOL, V140, P557, DOI 10.1085/jgp.201210858; Liao ZD, 2010, J GEN PHYSIOL, V136, P247, DOI 10.1085/jgp.201010488; Lolicato M, 2014, NAT CHEM BIOL, V10, P457, DOI [10.1038/NCHEMBIO.1521, 10.1038/nchembio.1521]; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Malmqvist M, 1999, BIOCHEM SOC T, V27, P335, DOI 10.1042/bst0270335; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Moller S, 2014, ACS CHEM BIOL, V9, P1128, DOI 10.1021/cb400904s; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Ng LCT, 2016, STRUCTURE, V24, P1629, DOI 10.1016/j.str.2016.06.024; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Shi WM, 1999, CIRC RES, V85, pE1; Taraska JW, 2009, P NATL ACAD SCI USA, V106, P16227, DOI 10.1073/pnas.0905207106; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	57	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185359	10.1371/journal.pone.0185359	http://dx.doi.org/10.1371/journal.pone.0185359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950029	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000042
J	Karandrea, S; Yin, HQ; Liang, XM; Slitt, AL; Heart, EA				Karandrea, Shpetim; Yin, Huquan; Liang, Xiaomei; Slitt, Angela L.; Heart, Emma A.			Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; NIGELLA-SATIVA; TOXICOLOGICAL PROPERTIES; SIRT1; DYSLIPIDEMIA; AMPK; BIOAVAILABILITY; INFLAMMATION	Thymoquinone, a natural occurring quinone and the main bioactive component of plant Nigella sativa, undergoes intracellular redox cycling and re-oxidizes NADH to NAD(+). TQ administration (20 mg/kg/bw/day) to the Diet-Induced Obesity (DIO) mice reduced their diabetic phenotype by decreasing fasting blood glucose and fasting insulin levels, and improved glucose tolerance and insulin sensitivity as evaluated by oral glucose and insulin tolerance tests (OGTT and ITT). Furthermore, TQ decreased serum cholesterol levels and liver triglycerides, increased protein expression of phosphorylated Akt, decreased serum levels of inflammatory markers resistin and MCP-1, and decreased NADH/NAD(+) ratio. These changes were paralleled by an increase in phosphorylated SIRT-1 and AMPKa in liver and phosphorylated SIRT-1 in skeletal muscle. TQ also increased insulin sensitivity in insulin-resistant HepG2 cells via a SIRT-1-dependent mechanism. These findings are consistent with the TQ-dependent re-oxidation of NADH to NAD(+), which stimulates glucose and fatty acid oxidation and activation of SIRT-1-dependent pathways. Taken together, these results demonstrate that TQ ameliorates the diabetic phenotype in the DIO mouse model of type 2 diabetes.	[Karandrea, Shpetim; Yin, Huquan; Liang, Xiaomei; Heart, Emma A.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Slitt, Angela L.] Univ Rhode Isl, Dept Pharmaceut Sci, Kingston, RI 02881 USA	State University System of Florida; University of South Florida; University of Rhode Island	Heart, EA (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	eheart@health.usf.edu			National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK-098747]; American Diabetes Association [7-12- BS-073]; Graduate Student Success Fellowship (University of South Florida)	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); Graduate Student Success Fellowship (University of South Florida)	The work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK-098747 and American Diabetes Association Grant No. 7-12- BS-073 (E. A. Heart). Shpetim Karandrea was supported by the Graduate Student Success Fellowship (University of South Florida).	Al-Ali Amein, 2008, J Ayub Med Coll Abbottabad, V20, P25; Ali BH, 2003, PHYTOTHER RES, V17, P299, DOI 10.1002/ptr.1309; Alkharfy KM, 2015, EUR J DRUG METAB PH, V40, P319, DOI 10.1007/s13318-014-0207-8; [Anonymous], 2016, P EUR WIR EW MAY, DOI DOI 10.1109/WCNC.2016.7564893; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; Elmowafy M, 2016, AAPS PHARMSCITECH, V17, P663, DOI 10.1208/s12249-015-0391-0; Fararh KM, 2005, RES VET SCI, V79, P219, DOI 10.1016/j.rvsc.2005.01.001; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Gray JP, 2016, TOXICOL LETT, V262, P1, DOI 10.1016/j.toxlet.2016.08.021; Gray JP, 2016, AM J PHYSIOL-ENDOC M, V310, pE394, DOI 10.1152/ajpendo.00250.2015; Heart E, 2012, TOXICOL APPL PHARM, V258, P216, DOI 10.1016/j.taap.2011.11.002; Ido Y, 2007, ANTIOXID REDOX SIGN, V9, P931, DOI 10.1089/ars.2007.1630; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Khader M, 2009, FOOD CHEM TOXICOL, V47, P129, DOI 10.1016/j.fct.2008.10.019; Kitada M, 2013, DIABETES METAB J, V37, P315, DOI 10.4093/dmj.2013.37.5.315; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; Le PM, 2004, J ETHNOPHARMACOL, V94, P251, DOI 10.1016/j.jep.2004.04.030; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo XT, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/512618; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Neter J, 1992, APPL LINEAR STAT MOD; Nomura S, 2000, CLIN EXP IMMUNOL, V121, P437, DOI 10.1046/j.1365-2249.2000.01324.x; Pari L, 2009, LIFE SCI, V85, P830, DOI 10.1016/j.lfs.2009.10.021; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Piemonti L, 2009, DIABETES CARE, V32, P2105, DOI 10.2337/dc09-0763; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rchid H, 2004, FUND CLIN PHARMACOL, V18, P525, DOI 10.1111/j.1472-8206.2004.00275.x; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; S R, 2013, RHEUMATOL CURR RES, V3, P115, DOI DOI 10.4172/2161-1149.1000115; Sankaranarayanan C, 2011, CHEM-BIOL INTERACT, V190, P148, DOI 10.1016/j.cbi.2011.02.029; Santilli F, 2016, THROMB HAEMOSTASIS, V116, P1089, DOI 10.1160/TH16-06-0471; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Tateya S, 2010, ENDOCRINOLOGY, V151, P971, DOI 10.1210/en.2009-0926; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Wu JZ, 2016, DIABET METAB SYND OB, V9, P145, DOI 10.2147/DMSO.S106087; Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200; Zhu D, 2017, RSC ADV, V7, P1363, DOI 10.1039/c6ra25901d; Zhu D, 2015, J AGR FOOD CHEM, V63, P10903, DOI 10.1021/acs.jafc.5b04533; Zietz B, 2005, DIABETES OBES METAB, V7, P570, DOI 10.1111/j.1463-1326.2004.00436.x	54	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185374	10.1371/journal.pone.0185374	http://dx.doi.org/10.1371/journal.pone.0185374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950020	Green Published, gold, Green Submitted			2022-12-26	WOS:000411671000043
J	Park, JY; Kim, SG; Kim, J; Han, SJ; Oh, S; Choi, JM; Lim, JH; Chung, H; Jung, HC				Park, Jae Yong; Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Oh, Sooyeon; Choi, Ji Min; Lim, Joo Hyun; Chung, Hyunsoo; Jung, Hyun Chae			Risk factors for early metachronous tumor development after endoscopic resection for early gastric cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI ERADICATION; SUBMUCOSAL DISSECTION; CLINICAL-OUTCOMES; NEOPLASMS; SURGERY	Background Metachronous gastric tumor (MGT) is one of major concerns after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). Optimal follow-up strategy has not been yet well-established. The aim of this study was to identify the different clinical features of the patients according to the time interval to development of MGT. Methods Among 1,780 consecutive patients with EGC who underwent ESD between 2005 and 2014, 115 patients with MGT were retrospectively reviewed. MGT was defined as secondary gastric cancer or dysplasia detected > 1 year after initial ESD. Clinicopathological factors associated with early development of MGT were evaluated. Results The median interval to development of MGT was 37 months. In univariate analysis, the median interval to MGT was shorter if EGC lesion was non-elevated type (39.4 vs 57.0 months, p = 0.011), or synchronous primary lesion was absent (39.8 vs 51.4 months, p = 0.050). In multivariate Cox's proportional hazards analysis, the hazard ratios for early occurrence of MGT were 1.966 (95% CI: 1.141 -3.386, p = 0.015) and 1.911 (95% CI: 1.163 - 3.141, p = 0.011), respectively. There was no significant difference in overall survival after diagnosis of MGT between the early occurrence group and the late occurrence group. Conclusions Non-elevated gross type and absence of synchronous gastric tumor were independent risk factors for early development of MGT. Meticulous endoscopic inspection is especially important for the detection of MGT during the early follow-up period in patients with these initial tumor characteristics.	[Park, Jae Yong] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Oh, Sooyeon; Chung, Hyunsoo; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Oh, Sooyeon; Chung, Hyunsoo; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Choi, Ji Min; Lim, Joo Hyun] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Healthcare Res Inst, Dept Internal Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, SG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, SG (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	harley1333@hanmail.net	Chung, Hyunsoo/AAD-3634-2020	Chung, Hyunsoo/0000-0001-5159-357X; Kim, Sang Gyun/0000-0003-1799-9028	Promising-Pioneering Researcher Program through Seoul National University	Promising-Pioneering Researcher Program through Seoul National University	This work was supported by Promising-Pioneering Researcher Program through Seoul National University in 2015 to JYP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2011, BRIT J SURG, V98, P255, DOI 10.1002/bjs.7310; BEDIKIAN AY, 1984, J CLIN ONCOL, V2, P305, DOI 10.1200/JCO.1984.2.4.305; Boda T, 2014, GASTROENT RES PRACT, V2014; Choi IJ, 2014, CLIN ENDOSC, V47, P497, DOI 10.5946/ce.2014.47.6.497; Choi Il Ju, 2009, Korean J Gastroenterol, V54, P67; Choi J, 2015, SURG ENDOSC, V29, P1223, DOI 10.1007/s00464-014-3800-7; Choi MK, 2013, SURG ENDOSC, V27, P4250, DOI 10.1007/s00464-013-3030-4; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Folli S, 2001, JPN J CLIN ONCOL, V31, P495, DOI 10.1093/jjco/hye107; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Han JS, 2011, SCAND J GASTROENTERO, V46, P1099, DOI 10.3109/00365521.2011.591427; Hosokawa O, 2002, ENDOSCOPY, V34, P469, DOI 10.1055/s-2002-32007; Jung DH, 2013, SURG ENDOSC, V27, P3690, DOI 10.1007/s00464-013-2947-y; Kang HY, 2010, SURG ENDOSC, V24, P509, DOI 10.1007/s00464-009-0614-0; Kim SG, 2017, GUT LIVER, V11, P87, DOI 10.5009/gnl15549; Kim YG, 2014, J GASTRIC CANCER, V14, P129, DOI 10.5230/jgc.2014.14.2.129; Kwon YH, 2014, ALIMENT PHARM THER, V39, P609, DOI 10.1111/apt.12633; Lee JH, 2016, SURG ENDOSC, V30, P430, DOI 10.1007/s00464-015-4215-9; Lee YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164339; Lim JH, 2015, GASTRIC CANCER, V18, P817, DOI 10.1007/s10120-014-0438-z; Nakajima Takeshi, 2006, Gastric Cancer, V9, P93, DOI 10.1007/s10120-006-0372-9; Pyo JH, 2016, AM J GASTROENTEROL, V111, P240, DOI 10.1038/ajg.2015.427; Sano T, 2011, GASTRIC CANCER, V14, P97, DOI 10.1007/s10120-011-0040-6; Sasaki S, 2011, ONCOL LETT, V2, P217, DOI 10.3892/ol.2010.231; Seo JH, 2010, DIGESTION, V81, P35, DOI 10.1159/000235921; TATSUTA M, 1979, CANCER, V43, P317, DOI 10.1002/1097-0142(197901)43:1<317::AID-CNCR2820430146>3.0.CO;2-F; Watari J, 2012, INT J CANCER, V130, P2349, DOI 10.1002/ijc.26275; Yoon H, 2016, GUT LIVER, V10, P228, DOI 10.5009/gnl14472; Yoon H, 2013, SURG ENDOSC, V27, P1561, DOI 10.1007/s00464-012-2627-3; Yoon SB, 2016, GASTROINTEST ENDOSC, V83, P1176, DOI 10.1016/j.gie.2015.10.024	33	9	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185501	10.1371/journal.pone.0185501	http://dx.doi.org/10.1371/journal.pone.0185501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950014	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000060
J	Wang, T; Zhu, XH; Dai, F; Li, CF; Huang, DK; Fang, ZH; Zhang, Q; Lu, YX				Wang, Ting; Zhu, Xiaohuan; Dai, Fang; Li, Chaofei; Huang, Dake; Fang, Zhaohui; Zhang, Qiu; Lu, Yunxia			Effects of a standard high-fat diet with or without multiple deficiencies on bone parameters in ovariectomized mature rat	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; INSULIN-RESISTANCE; MINERAL DENSITY; BODY-WEIGHT; OSTEOPOROSIS; MICE; MASS; TURNOVER; OBESITY; MODEL	The aim of this study was to determine the effects of a standard high fat diet (D12451) with or without vitamin D3, phosphorus, and calcium (i.e., high-fat diet [HFD] or high-fat deficient diet [HFDD]) on the bone parameters of ovariectomized female rats. Six-month-old of female Sprauge Dawley (SD) rats were randomly divided into six study groups: sham operation with standard chow diet (SSCD), sham operation with a HFD (SHFD), sham operation with a HFDD (SHFDD), ovariectomized (OVX), OVX with a HFD (OVX-HFD), and OVX with a HFDD (OVX-HFDD). A bilateral ovariectomy was administered to the OVX, OVX-HFD, and OVX-HFDD rats, while the SSCD, SHFD, and SHFDD rats were only given a laparotomy. Multiple analyses concerning the glucose and insulin tolerance, structure, bone strength, bone matrix, and mineralization of the rats were conducted in order to produce a detailed characterization of the effects of a HFD and a HFDD on postmenopausal osteoporotic rats. Seven months of HFD and HFDD feeding resulted in obesity and insulin resistance in female SD rats. A standard HFD increased the bone calcium content and bone strength of OVX rats. Conversely, the serum N-mid osteocalcin (N-MID-OT) and tartrateresistant acid phosphatase (TRAP) levels in the OVX-HFDD group were increased, accompanied by a clear decrease in the bone mineral density (BMD), bone mineral content (BMC), bone calcium and bone strength, as well as reduced osteocalcin expression. A HFDD weakened the activity of the osteoblasts while aggravating bone loss and decreasing bone strength in ovariectomized rats, which may be due to the calcium, phosphorus and vitamin D3 deficiencies in the diet.	[Wang, Ting; Zhu, Xiaohuan; Dai, Fang; Zhang, Qiu] Anhui Med Univ, Affiliated Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China; [Li, Chaofei; Lu, Yunxia] Anhui Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China; [Huang, Dake; Lu, Yunxia] Anhui Med Univ, Coll Basic Med, Comprehens Lab, Hefei, Anhui, Peoples R China; [Fang, Zhaohui] Anhui Univ Tradit Chinese Med, Affilliated Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui University of Chinese Medicine	Zhang, Q (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China.; Lu, YX (corresponding author), Anhui Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China.; Lu, YX (corresponding author), Anhui Med Univ, Coll Basic Med, Comprehens Lab, Hefei, Anhui, Peoples R China.	aynfmkqz87@163.com; wwwdluyx@sina.com	Lu, Yunxia/AAU-6408-2021	Lu, Yunxia/0000-0002-8739-7789				Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; Baek K, 2014, J CELL PHYSIOL, V229, P640, DOI 10.1002/jcp.24487; Beranger GE, 2014, ENDOCRINOLOGY, V155, P1340, DOI 10.1210/en.2013-1688; Bruyere O, 2007, CURR MED RES OPIN, V23, P1939, DOI 10.1185/030079907X219562; Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085; Choudhary D, 2017, BIOMED PHARMACOTHER, V92, P757, DOI 10.1016/j.biopha.2017.05.120; El Wakf AM, 2014, CYTOTECHNOLOGY, V66, P335, DOI 10.1007/s10616-013-9580-4; Fisher JE, 2012, BONE, V50, P1332, DOI 10.1016/j.bone.2012.03.004; Garcia-Gavilan JF, 2017, CLIN NUTR; Gautam J, 2014, BRIT J NUTR, V111, P1811, DOI 10.1017/S0007114514000051; Gilsanz V, 2009, J CLIN ENDOCR METAB, V94, P3387, DOI 10.1210/jc.2008-2422; Gordon RR, 2008, MAMM GENOME, V19, P163, DOI 10.1007/s00335-008-9095-z; Govindarajan P, 2014, AM J PATHOL, V184, P765, DOI 10.1016/j.ajpath.2013.11.011; Halade GV, 2010, J NUTR BIOCHEM, V21, P1162, DOI 10.1016/j.jnutbio.2009.10.002; Iida Tadayuki, 2012, Hiroshima Journal of Medical Sciences, V61, P23; Iwaniec UT, 2009, BONE, V44, P404, DOI 10.1016/j.bone.2008.10.058; Kaivosoia SM, 2008, METABOLISM, V57, P1052, DOI 10.1016/j.metabol.2008.03.007; Kurrat A, 2015, MOL NUTR FOOD RES, V59, P2407, DOI 10.1002/mnfr.201500240; Lee Y. H. D., 2007, SMJ Singapore Medical Journal, V48, P1117; Lin TH, 2016, ACTA BIOMATER, V41, P273, DOI 10.1016/j.actbio.2016.05.038; Lu YX, 2013, LIFE SCI, V92, P1165, DOI 10.1016/j.lfs.2013.05.002; Lv S, 2010, EXP THER MED, V1, P603, DOI 10.3892/etm_00000095; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Melhus G, 2010, CALCIFIED TISSUE INT, V87, P77, DOI 10.1007/s00223-010-9371-2; Nieves JW, 2005, AM J CLIN NUTR, V81, p1232S; Ok HM, 2015, CALCIFIED TISSUE INT, V97, P624, DOI 10.1007/s00223-015-0057-7; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Russell AL, 2017, HORM METAB RES, V49, P457, DOI 10.1055/s-0043-108250; Sahni S, 2015, CURR OSTEOPOROS REP, V13, P245, DOI 10.1007/s11914-015-0272-1; Shanbhogue VV, 2016, J CLIN ENDOCR METAB, V101, P3114, DOI 10.1210/jc.2016-1726; Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020; Sugimoto M, 2013, BONE, V52, P181, DOI 10.1016/j.bone.2012.09.031; Tonks KT, 2017, J CLIN ENDOCR METAB, V102, P1112, DOI 10.1210/jc.2016-3282; Watt J, 2015, TOXICOLOGY, V331, P66, DOI 10.1016/j.tox.2015.03.006; Wu J, 2017, ACTA PHARM SIN  0817; Zaidi M, 2012, ENDOCRINOLOGY, V153, P2070, DOI 10.1210/en.2012-1022; Zhang YY, 2015, INT J CLIN EXP MED, V8, P16352	37	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184983	10.1371/journal.pone.0184983	http://dx.doi.org/10.1371/journal.pone.0184983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950016	Green Published, gold, Green Submitted			2022-12-26	WOS:000411671000020
J	Chen, JN; Huang, M; Cao, FB; Pardha-Saradhi, P; Zou, YB				Chen, Jiana; Huang, Min; Cao, Fangbo; Pardha-Saradhi, P.; Zou, Yingbin			Urea application promotes amino acid metabolism and membrane lipid peroxidation in Azolla	PLOS ONE			English	Article							OXIDATIVE STRESS; ENZYMES; NITROGEN; WATER; ASSIMILATION; TOLERANCE; SALINITY; LEAVES; PLANTS	A pot experiment was conducted to evaluate the effect of urea on nitrogen metabolism and membrane lipid peroxidation in Azolla pinnata. Compared to controls, the application of urea to A. pinnata resulted in a 44% decrease in nitrogenase activity, no significant change in glutamine synthetase activity, 660% higher glutamic-pyruvic transaminase, 39% increase in free amino acid levels, 22% increase in malondialdehyde levels, 21% increase in Na (+)/ K (+)- levels, 16% increase in Ca (2+)/ Mg (2+)- ATPase levels, and 11% decrease in superoxide dismutase activity. In terms of H2O2 detoxifying enzymes, peroxidase activity did not change and catalase activity increased by 64% in urea-treated A. pinnata. These findings suggest that urea application promotes amino acid metabolism and membrane lipid peroxidation in A. pinnata.	[Chen, Jiana; Huang, Min; Cao, Fangbo; Zou, Yingbin] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China; [Pardha-Saradhi, P.] Univ Delhi, Dept Environm Studies, Delhi, India	Hunan Agricultural University; University of Delhi	Huang, M (corresponding author), Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China.	jxhuangmin@163.com		Huang, Min/0000-0002-6944-8538	Earmarked Fund for China Agriculture Research System [CARS-01]	Earmarked Fund for China Agriculture Research System	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; Arora A, 2003, BIOMASS BIOENERG, V24, P175, DOI 10.1016/S0961-9534(02)00133-2; ASHRAF M, 1995, J AGRON CROP SCI, V174, P351, DOI 10.1111/j.1439-037X.1995.tb01122.x; CABAUD P, 1956, AM J CLIN PATHOL, V26, P1101, DOI 10.1093/ajcp/26.9_ts.1101; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chien HF, 2000, PLANT GROWTH REGUL, V36, P1; Cisse M, 2003, PLANT SOIL, V250, P105, DOI 10.1023/A:1022830423154; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; Fahnenstich H, 2008, PLANT SIGNAL BEHAV, V3, P1122, DOI 10.4161/psb.3.12.7040; FOUGERE F, 1991, PLANT PHYSIOL, V96, P1228, DOI 10.1104/pp.96.4.1228; Ge TiDa, 2006, Agricultural Sciences in China, V5, P291, DOI 10.1016/S1671-2927(06)60052-7; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Hafsi C, 2011, ACTA PHYSIOL PLANT, V33, P193, DOI 10.1007/s11738-010-0537-3; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HUBER W, 1973, OECOLOGIA, V13, P271, DOI 10.1007/BF00360516; Ishikawa T, 2010, PLANT CELL PHYSIOL, V51, P9, DOI 10.1093/pcp/pcp162; KOCH B, 1966, PLANT PHYSIOL, V41, P1748, DOI 10.1104/pp.41.10.1748; Kuiper P. J. C., 1984, Salinity tolerance in plants - strategies for crop improvement, P77; LEA PJ, 1992, PR PHYT SOC, V33, P153; LILJENBERG CS, 1992, PROG LIPID RES, V31, P335, DOI 10.1016/0163-7827(92)90012-8; Lumpkin T. A., 1987, Azolla utilization. Proceedings of the Workshop on Azolla Use, Fuzhou, Fujian, China, 13 March-5 April 1985., P89; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; OHNISHI T, 1975, ANAL BIOCHEM, V69, P261, DOI 10.1016/0003-2697(75)90585-0; Pratelli R, 2007, PLANT SIGNAL BEHAV, V2, P182, DOI 10.4161/psb.2.3.3972; Qin JQ, 2013, FIELD CROP RES, V148, P15, DOI 10.1016/j.fcr.2013.04.004; Raja W., 2012, INTERNAT J RES BIOL, V2, P68; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Sadeghi R., 2013, Caspian Journal of Environmental Sciences, V11, P65; Surjus A, 1996, J EXP BOT, V47, P17, DOI 10.1093/jxb/47.1.17; Tewari RK, 2007, J INTEGR PLANT BIOL, V49, P313, DOI 10.1111/j.1744-7909.2007.00358.x; Turner G. L., 1980, Methods for evaluating biological nitrogen fixation., P111; Vlek PLG, 1995, FERT RES, V42, P165, DOI 10.1007/BF00750511; Wagner GM, 1997, BOT REV, V63, P1, DOI 10.1007/BF02857915; Xiao W, 2008, BIOL TRACE ELEM RES, V126, P269, DOI 10.1007/s12011-008-8196-6; Xu JT, 2011, DESALINATION, V280, P58, DOI 10.1016/j.desal.2011.06.050; Xue TL, 2000, AGR FOOD SCI FINLAND, V9, P177, DOI 10.23986/afsci.5659; Yan B, 1996, PLANT SOIL, V179, P261, DOI 10.1007/BF00009336; Yin XL, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2763-9; Yoon YE, 2017, FOOD CHEM, V215, P185, DOI 10.1016/j.foodchem.2016.07.167; Zhang J, 2010, AFR J BIOTECHNOL, V9, P2521	40	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							0185230	10.1371/journal.pone.0185230	http://dx.doi.org/10.1371/journal.pone.0185230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945775	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100033
J	Gentile, LB; Nagamine, MK; Biondi, LR; Sanches, DS; Toyota, F; Giovani, TM; de Jesus, IP; da Fonseca, IIM; Queiroz-Hazarbassanov, N; Diaz, BL; Gomes, CDMS; Daglil, MLZ				Gentile, Luciana B.; Nagamine, Marcia K.; Biondi, Luiz R.; Sanches, Daniel S.; Toyota, Fabio; Giovani, Tatiane M.; de Jesus, Isis P.; da Fonseca, Ivone I. M.; Queiroz-Hazarbassanov, Nicolle; Diaz, Bruno L.; Massoco Salles Gomes, Cristina de O.; Daglil, Maria Lucia Z.			Establishment of primary mixed cell cultures from spontaneous canine mammary tumors: Characterization of classic and new cancer-associated molecules	PLOS ONE			English	Article							ESTROGEN-RELATED-RECEPTOR; MATERNAL STILBESTROL THERAPY; ORPHAN NUCLEAR RECEPTORS; BREAST-CANCER; ERR-GAMMA; EXPRESSION; GROWTH; GENE; MODELS; ALPHA	There are many factors which make canine cancer like cancer in humans. The occurrence of spontaneous mammary tumors in pet dogs, tumor genetics, molecular targets and exposure to the same environmental risk factors are among these factors. Therefore, the study of canine cancer can provide useful information to the oncology field. This study aimed to establish and characterize a panel of primary mixed cell cultures obtained from spontaneous canine mammary tumors. Eight established cell cultures obtained from one normal mammary gland, one complex adenoma, one mixed adenoma, two complex carcinomas and two mixed carcinomas were analyzed. The gene expression levels of classic molecular cancer players such as fibroblast growth factor receptor (FGFR) 2, breast cancer (BRCA) 1, BRCA2 and estrogen receptor (ESR) 1 were evaluated. For the first time, three orphan nuclear receptors, estrogen-related receptors (ERRs) alpha,beta and gamma were studied in canine mammary cancer. The highest expression level of ERR alpha was observed in complex carcinoma-derived cell culture, while the highest levels of ERR beta and gamma were observed in cells derived from a mixed carcinoma. Meanwhile, complex carcinomas presented the highest levels of expression of ESR1, BRCA1 and FGFR2 among all samples. BRCA2 was found exclusively in complex adenoma. The transcription factor GATA3 had its highest levels in mixed carcinoma samples and its lowest levels in complex adenoma. Proliferation assays were also performed to evaluate the mixed cell cultures response to ER ligands, genistein and DES, both in normoxia and hypoxic conditions. Our results demonstrate that morphological and functional studies of primary mixed cell cultures derived from spontaneous canine mammary tumors are possible and provide valuable tool for the study of various stages of mammary cancer development.	[Gentile, Luciana B.; Nagamine, Marcia K.; Biondi, Luiz R.; Sanches, Daniel S.; de Jesus, Isis P.; da Fonseca, Ivone I. M.; Daglil, Maria Lucia Z.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Lab Expt & Comparat Oncol, Sao Paulo, Brazil; [Toyota, Fabio] Vet Hosp Caes & Gatos, Sao Paulo, Brazil; [Giovani, Tatiane M.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Sao Paulo, Brazil; [Queiroz-Hazarbassanov, Nicolle; Massoco Salles Gomes, Cristina de O.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Appl Pharmacol & Toxicol Lab, Sao Paulo, Brazil; [Diaz, Bruno L.] Fed Univ Rio de Janeiro UFRJ, Lab Inflammat, Carlos Chagas Filho Biophys Inst IBCCF, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Gentile, LB; Daglil, MLZ (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Lab Expt & Comparat Oncol, Sao Paulo, Brazil.	lubuffoni@biof.ufrj.br; mlzdagli@usp.br	Biondi, Luiz Roberto/AAG-1110-2022; Biondi, Luiz Roberto/AFK-2807-2022; Diaz, Bruno L./A-5673-2009; Queiroz-Hazarbassanov, Nicolle/Q-6901-2019	Biondi, Luiz Roberto/0000-0002-2677-8182; Biondi, Luiz Roberto/0000-0002-2677-8182; Diaz, Bruno L./0000-0001-8393-3823; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/02400-0, 2011/014177-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Luciana Boffoni Gentile was the recipient of a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), process number 2011/02400-0. This study was sponsored by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), process number 2011/014177-4.	Ariazi EA, 2002, CANCER RES, V62, P6510; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Carvalho MI, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4917387; Cassali G. D., 2011, Brazilian Journal of Veterinary Pathology, V4, P153; Cerliani JP, 2012, BREAST CANCER RES TR, V133, P997, DOI 10.1007/s10549-011-1883-6; Chen F, 1999, GENE, V228, P101, DOI 10.1016/S0378-1119(98)00619-2; Chen S, 2001, J BIOL CHEM, V276, P28465, DOI 10.1074/jbc.M102638200; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Connor EE, 2005, J ENDOCRINOL, V185, P593, DOI 10.1677/joe.1.06139; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; Fang SH, 2009, J SURG RES, V157, P290, DOI 10.1016/j.jss.2008.07.015; Fang Y, 2016, INT J ONCOL, V48, P1016, DOI 10.3892/ijo.2016.3327; Fletcher MNC, 2013, NATURE COMMUNICATION, V4, P1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Haga S, 2001, ONCOL REP, V8, P1215; He Fu-jin, 2002, Zhongguo Zhongyao Zazhi, V27, P936; Heard DJ, 2000, MOL ENDOCRINOL, V14, P382, DOI 10.1210/me.14.3.382; Herbst AL, 1999, AM J OBSTET GYNECOL, V181, P1574, DOI 10.1016/S0002-9378(99)70411-4; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hershey AE, 2005, VET PATHOL, V42, P805, DOI 10.1354/vp.42-6-805; Hoffman MM, 2007, MOL BIOL EVOL, V24, P522, DOI 10.1093/molbev/msl179; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Hovey RC, 1999, J MAMMARY GLAND BIOL, V4, P53, DOI 10.1023/A:1018704603426; Hsu WL, 2010, VET J, V184, P351, DOI 10.1016/j.tvjl.2009.03.022; Ijichi N, 2011, J STEROID BIOCHEM, V123, P1, DOI 10.1016/j.jsbmb.2010.09.002; Jenkins S, 2012, J STEROID BIOCHEM, V129, P191, DOI 10.1016/j.jsbmb.2011.06.003; Knapp DW, 1997, MOL MED TODAY, V3, P8, DOI 10.1016/S1357-4310(96)20031-0; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London CA, 1996, J COMP PATHOL, V115, P399, DOI 10.1016/S0021-9975(96)80074-0; Madhavan S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0150-9; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; Nieto A, 2003, J COMP PATHOL, V128, P260, DOI 10.1053/jcpa.2002.0631; Ozaki K, 2002, VET PATHOL, V39, P557, DOI 10.1354/vp.39-5-557; Porrello A, 2006, J EXP CLIN CANC RES, V25, P97; Pryer NK, 2003, CLIN CANCER RES, V9, P5729; Ribeiro-Silva Alfredo, 2005, J. Bras. Patol. Med. Lab., V41, P197, DOI 10.1590/S1676-24442005000300010; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schwertfeger KL, 2006, J MAMMARY GLAND BIOL, V11, P229, DOI 10.1007/s10911-006-9028-y; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sengupta D, 2014, BRIT J CANCER, V110, P2144, DOI 10.1038/bjc.2014.53; Setoguchi A, 2001, AM J VET RES, V62, P433, DOI 10.2460/ajvr.2001.62.433; Slattery ML, 2013, BREAST CANCER RES TR, V140, P587, DOI 10.1007/s10549-013-2644-5; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Tenhagen M, 2012, ENDOCR-RELAT CANCER, V19, pR115, DOI 10.1530/ERC-12-0060; Tiraby C, 2011, CANCER RES, V71, P2518, DOI 10.1158/0008-5472.CAN-10-1315; Troisi R, 2007, INT J CANCER, V121, P356, DOI 10.1002/ijc.22631; Uifalean A, 2016, MOLECULES, V21, DOI 10.3390/molecules21010013; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Yang C, 1998, CANCER RES, V58, P5695; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Zhang ZP, 2001, MOL CELL ENDOCRINOL, V172, P223, DOI 10.1016/S0303-7207(00)00372-5; Zhang ZP, 2000, J BIOL CHEM, V275, P20837, DOI 10.1074/jbc.M001880200	60	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184228	10.1371/journal.pone.0184228	http://dx.doi.org/10.1371/journal.pone.0184228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945747	gold, Green Published			2022-12-26	WOS:000411645100006
J	Gilmore, S				Gilmore, Stephen			Melanoma screening: Informing public health policy with quantitative modelling	PLOS ONE			English	Article							SKIN-CANCER; GENERAL-PRACTITIONERS; CUTANEOUS MELANOMA; EXCISION RATES; MARKOV-MODEL; LUNG-CANCER; DIAGNOSIS; NUMBER; POPULATION; LESIONS	Australia and New Zealand share the highest incidence rates of melanoma worldwide. Despite the substantial increase in public and physician awareness of melanoma in Australia over the last 30 years-as a result of the introduction of publicly funded mass media campaigns that began in the early 1980s-mortality has steadily increased during this period. This increased mortality has led investigators to question the relative merits of primary versus secondary prevention; that is, sensible sun exposure practices versus early detection. Increased melanoma vigilance on the part of the public and among physicians has resulted in large increases in public health expenditure, primarily from screening costs and increased rates of office surgery. Has this attempt at secondary prevention been effective? Unfortunately epidemiologic studies addressing the causal relationship between the level of secondary prevention and mortality are prohibitively difficult to implement-it is currently unknown whether increased melanoma surveillance reduces mortality, and if so, whether such an approach is cost-effective. Here I address the issue of secondary prevention of melanoma with respect to incidence and mortality (and cost per life saved) by developing a Markov model of melanoma epidemiology based on Australian incidence and mortality data. The advantages of developing a methodology that can determine constraint-based surveillance outcomes are twofold: first, it can address the issue of effectiveness; and second, it can quantify the trade-off between cost and utilisation of medical resources on one hand, and reduced morbidity and lives saved on the other. With respect to melanoma, implementing the model facilitates the quantitative determination of the relative effectiveness and trade-offs associated with different levels of secondary and tertiary prevention, both retrospectively and prospectively. For example, I show that the surveillance enhancement that began in 1982 has resulted in greater diagnostic incidence and reduced mortality, but the reduced mortality carried a significant cost per life saved. I implement the model out to 2028 and demonstrate that the enhanced secondary prevention that began in 1982 becomes increasingly cost-effective over the period 2013-2028. On the other hand, I show that reductions in mortality achieved by significantly enhancing secondary prevention beyond 2013 levels are comparable with those achieved by only modest improvements in late-stage disease survival. Given the ballooning costs of increased melanoma surveillance, I suggest the process of public health policy decision-making-particularly with respect to the publicfunding of melanoma screening and discretionary mole removal-would be better served by incorporating the results of quantitative modelling.	[Gilmore, Stephen] Skin & Canc Fdn, Melbourne, Vic, Australia; [Gilmore, Stephen] Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia	SKIN & CANCER FOUNDATION AUSTRALIA; University of Queensland	Gilmore, S (corresponding author), Skin & Canc Fdn, Melbourne, Vic, Australia.; Gilmore, S (corresponding author), Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia.	s.gilmore1@uq.edu.au			Skin and Cancer Foundation, Victoria, Australia	Skin and Cancer Foundation, Victoria, Australia	The Skin and Cancer Foundation, Victoria, Australia, provided funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnlide I, 2014, ACTA DERM-VENEREOL, V94, P683, DOI 10.2340/00015555-1831; Alexandrescu Doru Traian, 2009, Dermatol Online J, V15, P1; Baade PD, 2008, ARCH DERMATOL, V144, P1468, DOI 10.1001/archderm.144.11.1468; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001540; Brady MS, 2000, CANCER-AM CANCER SOC, V89, P342, DOI 10.1002/1097-0142(20000715)89:2<342::AID-CNCR19>3.0.CO;2-P; Buchanan L., 2013, DERMATOLOGY ONLINE J, V19, P1; Chadeau-Hyam M, 2014, EPIDEMIOLOGY, V25, P28, DOI 10.1097/EDE.0000000000000032; Chouaid C, 2004, BRIT J CANCER, V90, P397, DOI 10.1038/sj.bjc.6601547; Czarnecki D, 2014, ACTA DERM-VENEREOL, V94, P539, DOI 10.2340/00015555-1877; Del Mar CB, 1997, AUST NZ J PUBL HEAL, V21, P751; Dos Santos Silva I, 1999, ANCER EPIDEMIOLGOGY; English DR, 2004, MED J AUSTRALIA, V180, P16, DOI 10.5694/j.1326-5377.2004.tb05766.x; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Gelfand JM, 2011, NEJM J WATCH; Gilmore S, 2010, EXP DERMATOL, V19, P830, DOI 10.1111/j.1600-0625.2010.01112.x; Grob JJ, 2002, ARCH DERMATOL, V138, P1251, DOI 10.1001/archderm.138.9.1251; Guy GP, 2012, AM J PREV MED, V43, P537, DOI 10.1016/j.amepre.2012.07.031; Hansen C, 2009, J AM ACAD DERMATOL, V61, P599, DOI 10.1016/j.jaad.2009.04.021; Moynihan R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001655; Richard MA, 2000, INT J CANCER, V89, P271, DOI 10.1002/1097-0215(20000520)89:3<271::AID-IJC10>3.0.CO;2-7; Richard MA, 2000, INT J CANCER, V89, P280, DOI 10.1002/1097-0215(20000520)89:3<280::AID-IJC11>3.0.CO;2-2; Richard MA, 1999, ARCH DERMATOL, V135, P269, DOI 10.1001/archderm.135.3.269; Rolfe H, 2012, AUSTRALAS J DERMATOL, V53, P240, DOI [10.1111/j.1440-0960.2012.00935.x, 10.1111/j.1440-0960.2012.00933.x]; Sandru A, 2014, J Med Life, V7, P572; Shih STF, 2009, PREV MED, V49, P449, DOI 10.1016/j.ypmed.2009.09.008; Sidhu S, 2012, CLIN EXP DERMATOL, V37, P6, DOI 10.1111/j.1365-2230.2011.04148.x; Tsao HS, 1998, J AM ACAD DERMATOL, V38, P669, DOI 10.1016/S0190-9622(98)70195-1; Wartman D, 2008, CANCER EPIDEM BIOMAR, V17, P469, DOI 10.1158/1055-9965.EPI-07-0301; Weinstock MA, 2016, BR J DERMATOL; Welch HG, 2005, BRIT MED J, V331, P481, DOI 10.1136/bmj.38516.649537.E0; Wernli KJ, 2016, SCREENING SKIN CANC; Whiteman D, ENQUIRY SKIN CANC AU; Whiteman DC, 2016, J INVEST DERMATOL, V136, P1161, DOI 10.1016/j.jid.2016.01.035; Wolff T, 2009, ANN INTERN MED, V150, P194, DOI 10.7326/0003-4819-150-3-200902030-00009	34	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0182349	10.1371/journal.pone.0182349	http://dx.doi.org/10.1371/journal.pone.0182349			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945758	gold, Green Published, Green Submitted			2022-12-26	WOS:000411645100003
J	Kusi, KA; Manu, EA; Gwira, TM; Kyei-Baafour, E; Dickson, EK; Amponsah, JA; Remarque, EJ; Faber, BW; Kocken, CHM; Dodoo, D; Gyan, BA; Awandare, GA; Atuguba, F; Oduro, AR; Koram, KA				Kusi, Kwadwo A.; Manu, Emmanuel A.; Gwira, Theresa Manful; Kyei-Baafour, Eric; Dickson, Emmanuel K.; Amponsah, Jones A.; Remarque, Edmond J.; Faber, Bart W.; Kocken, Clemens H. M.; Dodoo, Daniel; Gyan, Ben A.; Awandare, Gordon A.; Atuguba, Frank; Oduro, Abraham R.; Koram, Kwadwo A.			Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM APICAL-MEMBRANE-ANTIGEN-1; ERYTHROCYTE-BINDING ANTIGEN-175; HETEROLOGOUS STRAINS; SEROLOGICAL MARKERS; MEROZOITE ANTIGENS; ACQUIRED-IMMUNITY; CLINICAL-DISEASE; PROTECTION; RESPONSES; POLYMORPHISM	Introduction Plasmodium falciparum induced antibodies are key components of anti-malarial immunity in malaria endemic areas, but their antigen targets can be polymorphic. Induction of a high proportion of strain-specific antibodies will limit the recognition of a broad diversity of parasite strains by these responses. There are indications that circulating parasite diversity varies with malaria transmission intensity, and this may affect the specificity of elicited anti-malarial antibodies. This study therefore assessed the effect of varying malaria transmission patterns on the specificity of elicited antibody responses and to identify possible antibody correlates of naturally acquired immunity to malaria in children in an area of Ghana with seasonal malaria transmission. Methods This retrospective study utilized plasma samples collected longitudinally at six time points from children aged one to five years. Multiplex assays were used to measure antibody levels against four P. falciparum AMA 1 variants (from the 3D7, FVO, HB3 and CAMP parasite strains) and the 3D7 variant of the EBA 175 region II antigen and the levels compared between symptomatic and asymptomatic children. The relative proportions of cross-reactive and strain-specific antibodies against the four AMA 1 variants per sampling time point were assessed by Bland-Altman plots. The levels of antibodies against allelic AMA1 variants, measured by singleplex and multiplex luminex assays, were also compared. Results The data show that increased transmission intensity is associated with higher levels of cross-reactive antibody responses, most likely a result of a greater proportion of multiple parasite clone infections during the high transmission period. Anti-AMA1 antibodies were however associated with a history of infection rather than protection in this age group. Conclusion The data contribute to understanding the underlying mechanism of the acquisition of strain-transcending antibody immunity following repeated exposure to diverse parasite strains.	[Kusi, Kwadwo A.; Kyei-Baafour, Eric; Dickson, Emmanuel K.; Amponsah, Jones A.; Dodoo, Daniel; Gyan, Ben A.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Coll Hlth Sci, Legon, Ghana; [Kusi, Kwadwo A.; Manu, Emmanuel A.; Gwira, Theresa Manful; Awandare, Gordon A.] Univ Ghana, Dept Biochem Cell & Mol Biol, Coll Basic & Appl Sci, Legon, Ghana; [Kusi, Kwadwo A.; Manu, Emmanuel A.; Gwira, Theresa Manful; Awandare, Gordon A.; Koram, Kwadwo A.] Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens, Legon, Ghana; [Remarque, Edmond J.; Faber, Bart W.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Atuguba, Frank; Oduro, Abraham R.] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana; [Koram, Kwadwo A.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Epidemiol, Coll Hlth Sci, Legon, Ghana; [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands	University of Ghana; University of Ghana; University of Ghana; Ghana Health Service; Navrongo Health Research Center; University of Ghana	Kusi, KA (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Coll Hlth Sci, Legon, Ghana.; Kusi, KA (corresponding author), Univ Ghana, Dept Biochem Cell & Mol Biol, Coll Basic & Appl Sci, Legon, Ghana.; Kusi, KA (corresponding author), Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens, Legon, Ghana.	akusi@noguchi.ug.edu.gh	Eric, Kyei-Baafour/X-7280-2019; Remarque, Ed/AAE-8643-2020; Awandare, Gordon/J-1392-2019; Kusi, Kwadwo Asamoah/J-5941-2019	Eric, Kyei-Baafour/0000-0001-6423-1885; Awandare, Gordon/0000-0002-8793-3641; Kusi, Kwadwo Asamoah/0000-0001-5483-9985; ODURO, ABRAHAM/0000-0002-4191-7419; Kocken, Clemens/0000-0002-4784-1734; Faber, Bart/0000-0001-6808-1204	Division of Microbiology and Immunology Diseases, NIAID, NIH [HHSN266200400016C]; World Bank African Centres of Excellence [ACE02-WACCBIP]	Division of Microbiology and Immunology Diseases, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); World Bank African Centres of Excellence	The original study that collected the samples was funded by the Division of Microbiology and Immunology Diseases, NIAID, NIH (Contract number HHSN266200400016C), awarded to FA and KA Koram. EAM was supported by a Master's fellowship from a World Bank African Centres of Excellence grant (ACE02-WACCBIP) awarded to GAA. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyeman-Budu A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-22; Aubouy A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-12; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Chattopadhyay R, 2003, INFECT IMMUN, V71, P597, DOI 10.1128/IAI.71.2.597-604.2003; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Daou M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0567-9; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Dent AE, 2015, J INFECT DIS, V212, P1429, DOI 10.1093/infdis/jiv224; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-108; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2; Faber BW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164053; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; FORSYTH KP, 1989, AM J TROP MED HYG, V40, P344, DOI 10.4269/ajtmh.1989.40.344; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Iriemenam NC, 2009, VACCINE, V27, P62, DOI 10.1016/j.vaccine.2008.10.025; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Jones TR, 2000, AM J TROP MED HYG, V62, P675, DOI 10.4269/ajtmh.2000.62.675; Kangoye DT, 2016, VACCINE, V34, P160, DOI 10.1016/j.vaccine.2015.10.058; Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63; Kerkhof K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1576-z; Kidima W, 2015, J Parasitol Res, V2015, P721201, DOI 10.1155/2015/721201; Kusi KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167175; Kusi KA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-32; Kusi KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015391; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-40; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Linkov Faina, 2007, Expert Opin Med Diagn, V1, P129, DOI 10.1517/17530059.1.1.129; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; McCarra MB, 2011, PEDIATR INFECT DIS J, V30, P1037, DOI 10.1097/INF.0b013e31822d1451; McGregor IA, 1964, AM J TROP MED HYG S9, V13, P9; McQueen PG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000149; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Oduro AR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-96; Ohas EA, 2004, INFECT IMMUN, V72, P735, DOI 10.1128/IAI.72.2.735-741.2004; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Owusu-Agyei S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-103; Priest JW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004699; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Salem MSOA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-26; Sarr JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-212; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V42, P285, DOI 10.1016/0166-6851(90)90172-I; Toure FS, 2006, CLIN MED RES, V4, P175, DOI [10.3121/cmr.4.3.175, 10.3121/cmr.4.1.1]; Trieu A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007948; WHO, 2016, WORLD MAL REP 2016	59	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185303	10.1371/journal.pone.0185303	http://dx.doi.org/10.1371/journal.pone.0185303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945794	gold, Green Submitted, Green Published			2022-12-26	WOS:000411645100043
J	Lee, YS; Ku, KM; Becker, TM; Juvik, JA				Lee, Young-Sang; Ku, Kang-Mo; Becker, Talon M.; Juvik, John A.			Chemopreventive glucosinolate accumulation in various broccoli and collard tissues: Microfluidic-based targeted transcriptomics for by-product valorization	PLOS ONE			English	Article							QUINONE REDUCTASE-ACTIVITY; OLERACEA VAR. ITALICA; HAIRY ROOT CULTURES; BRASSICA-OLERACEA; DEGRADATION-PRODUCTS; VERTICILLIUM WILT; BIOSYNTHESIS; ARABIDOPSIS; ISOTHIOCYANATES; INDUCTION	Floret, leaf, and root tissues were harvested from broccoli and collard cultivars and extracted to determine their glucosinolate and hydrolysis product profiles using high performance liquid chromatography and gas chromotography. Quinone reductase inducing bioactivity, an estimate of anti-cancer chemopreventive potential, of the extracts was measured using a hepa1c1c7 murine cell line. Extracts from root tissues were significantly different from other tissues and contained high levels of gluconasturtiin and glucoerucin. Targeted gene expression analysis on glucosinolate biosynthesis revealed that broccoli root tissue has elevated gene expression of AOP2 and low expression of FMOGS-OX homologs, essentially the opposite of what was observed in broccoli florets, which accumulated high levels of glucoraphanin. Broccoli floret tissue has significantly higher nitrile formation (%) and epithionitrile specifier protein gene expression than other tissues. This study provides basic information of the glucosinolate metabolome and transcriptome for various tissues of Brassica oleracea that maybe utilized as potential byproducts for the nutraceutical market.	[Lee, Young-Sang] Soonchunhyang Univ, Dept Med Biotechnol, Asan, South Korea; [Ku, Kang-Mo] West Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Becker, Talon M.; Juvik, John A.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	Soonchunhyang University; West Virginia University; University of Illinois System; University of Illinois Urbana-Champaign	Juvik, JA (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	juvik@illinois.edu		Ku, Kang Mo/0000-0002-8588-1163	Soonchunhyang University; West Virginia Agricultural and Forestry Experiment Station [WVA00698, 3327]	Soonchunhyang University; West Virginia Agricultural and Forestry Experiment Station	Young-San Lee was funded by Soonchunhyang University. Kang-Mo Ku was funded by the West Virginia Agricultural and Forestry Experiment Station (WVA00698: Scientific Article No. 3327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2011, SUSTAINABLE AGRICULTURE, VOL 2, P623, DOI 10.1007/978-94-007-0394-0_28; Augustine R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18005; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Becker Talon M, 2016, Diseases, V4, DOI 10.3390/diseases4020022; Bhandari SR, 2015, MOLECULES, V20, P15827, DOI 10.3390/molecules200915827; BIALY Z, 1990, PLANT SOIL, V129, P277, DOI 10.1007/BF00032423; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Burow M, 2008, PHYTOCHEMISTRY, V69, P663, DOI 10.1016/j.phytochem.2007.08.027; Buskov S, 2002, J AGR FOOD CHEM, V50, P690, DOI 10.1021/jf010470s; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; de Saint Laumer JY, 2010, ANAL CHEM, V82, P6457, DOI 10.1021/ac1006574; Dominguez-Perles R, 2010, J FOOD SCI, V75, pC383, DOI 10.1111/j.1750-3841.2010.01606.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Giamoustaris A, 1996, THEOR APPL GENET, V93, P1006, DOI 10.1007/BF00224105; Hanschen FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132931; Ikeda K, 2015, J GEN PLANT PATHOL, V81, P77, DOI 10.1007/s10327-014-0559-6; Kang YH, 2004, METHOD ENZYMOL, V382, P380; Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t; Kastell A, 2015, PLANT MOL BIOL REP, V33, P598, DOI 10.1007/s11105-014-0781-6; Kim HH, 2013, ASIAN J CHEM, V25, P6099, DOI 10.14233/ajchem.2013.14266; Kim SJ, 2013, NAT PROD COMMUN, V8, P217; Ku KM, 2013, J AGR FOOD CHEM, V61, P9623, DOI 10.1021/jf4027734; Ku KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077127; Ku KM, 2015, J AGR FOOD CHEM, V63, P2947, DOI 10.1021/jf505591z; Ku KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103407; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Luang-In V, 2014, MOL NUTR FOOD RES, V58, P875, DOI 10.1002/mnfr.201300377; Matusheski NV, 2006, J AGR FOOD CHEM, V54, P2069, DOI 10.1021/jf0525277; Rose P, 2000, CARCINOGENESIS, V21, P1983, DOI 10.1093/carcin/21.11.1983; Smith LB, 2000, MOL BREEDING, V6, P603, DOI 10.1023/A:1011370525688; Sotelo T, 2015, APPL ENVIRON MICROB, V81, P432, DOI 10.1128/AEM.03142-14; Subbarao KV, 1999, PLANT DIS, V83, P124, DOI 10.1094/PDIS.1999.83.2.124; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; Traka MH, 2013, NEW PHYTOL, V198, P1085, DOI 10.1111/nph.12232; Viturro E, 2014, MICROCHIM ACTA, V181, P1725, DOI 10.1007/s00604-014-1205-x; Wilson EA, 2012, J SEP SCI, V35, P2026, DOI 10.1002/jssc.201200071; Wold S., 1994, CHEMOMETRIC METHODS; Yuan HN, 2009, IND ENG CHEM RES, V48, P5070, DOI 10.1021/ie8015329; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	42	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185112	10.1371/journal.pone.0185112	http://dx.doi.org/10.1371/journal.pone.0185112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945821	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100024
J	Mukaihara, K; Tanabe, Y; Kubota, D; Akaike, K; Hayashi, T; Mogushi, K; Hosoya, M; Sato, S; Kobayashi, E; Okubo, T; Kim, Y; Kohsaka, S; Saito, T; Kaneko, K; Suehara, Y				Mukaihara, Kenta; Tanabe, Yu; Kubota, Daisuke; Akaike, Keisuke; Hayashi, Takuo; Mogushi, Kaoru; Hosoya, Masaki; Sato, Shingo; Kobayashi, Eisuke; Okubo, Taketo; Kim, Youngji; Kohsaka, Shinji; Saito, Tsuyoshi; Kaneko, Kazuo; Suehara, Yoshiyuki			Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma	PLOS ONE			English	Article							MUSCULOSKELETAL ONCOLOGY GROUP; TYROSINE KINASE INHIBITOR; TIVANTINIB ARQ 197; TRANSCRIPTION FACTOR; TISSUE SARCOMA; SELECTIVE INHIBITOR; CYTOTOXIC ACTIVITY; MET INHIBITION; CANCER; ANGIOGENESIS	Background Alveolar soft part sarcoma (ASPS) is an extremely rare metastatic soft tissue tumor with a poor prognosis for which no effective systemic therapies have yet been established. Therefore, the development of novel effective treatment approaches is required. Tyrosine kinases (TKs) are being increasingly used as therapeutic targets in a variety of cancers. The purpose of this study was to identify novel therapeutic target TKs and to clarify the efficacy of TK inhibitors (TKIs) in the treatment of ASPS. Experimental design To identify novel therapeutic target TKs in ASPS, we evaluated the antitumor effects and kinase activity of three TKIs (pazopanib, dasatinib, and cabozantinib) against ASPS cells using an in vitro assay. Based on these results, we then investigated the phosphorylation activities of the identified targets using western blotting, in addition to examining antitumor activity through in vivo assays of several TKIs to determine both the efficacy of these substances and accurate targets. Results In cell proliferation and invasion assays using pazopanib, cabozantinib, and dasatinib, all three TKIs inhibited the cell growth in ASPS cells. Statistical analyses of the cell proliferation and invasion assays revealed that dasatinib had a significant inhibitory effect in cell proliferation assays, and cabozantinib exhibited marked inhibitory effects on cellular functions in both assays. Through western blotting, we also confirmed that cabozantinib inhibited c-MET phosphorylation and dasatinib inhibited SRC phosphorylation in dose-dependent fashion. Mice that received cabozantinib and dasatinib had significantly smaller tumor volumes than control animals, demonstrating the in vivo antitumor activity of, these substances. Conclusions Our findings suggest that cabozantinib and dasatinib may be more effective than pazopanib against ASPS cells. These in vitro and in vivo data suggest that c-MET may be a potential therapeutic target in ASPS, and cabozantinib may be a particularly useful therapeutic option for patients with ASPS, including those with pazopanib-resistant ASPS.	[Mukaihara, Kenta; Tanabe, Yu; Kubota, Daisuke; Akaike, Keisuke; Okubo, Taketo; Kim, Youngji; Kaneko, Kazuo; Suehara, Yoshiyuki] Juntendo Univ, Dept Orthoped Surg, Sch Med, Tokyo, Japan; [Hayashi, Takuo; Saito, Tsuyoshi] Juntendo Univ, Dept Human Pathol, Sch Med, Tokyo, Japan; [Mogushi, Kaoru; Hosoya, Masaki] Juntendo Univ, Ctr Genom & Regenerat Med, Sch Med, Tokyo, Japan; [Sato, Shingo] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Grad Sch, Tokyo, Japan; [Sato, Shingo] Fac Med, Tokyo, Japan; [Kobayashi, Eisuke] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo, Japan; [Kohsaka, Shinji] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Tokyo Medical & Dental University (TMDU); National Cancer Center - Japan; University of Tokyo	Suehara, Y (corresponding author), Juntendo Univ, Dept Orthoped Surg, Sch Med, Tokyo, Japan.	ysuehara@juntendo.ac.jp		HAYASHI, TAKUO/0000-0002-8544-9370; Hosoya, Masaki/0000-0003-1841-2743; Mogushi, Kaoru/0000-0002-2618-8684	Japan Agency for Medical Research and Development [15H04964, 16K15670, 15KK0353, 16H07186]; Grants-in-Aid for Scientific Research [17K10987] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number #15H04964, #16K15670, and #15KK0353 to Y.S. # 16H07186 to K.M.) and Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development to Y.S.; This study was supported by the Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number #15H04964, #16K15670, and #15KK0353 to Y.S. # 16H07186 to K.M.) and Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development to Y.S.	Araujo JC, 2013, LANCET ONCOL, V14, P1307, DOI 10.1016/S1470-2045(13)70479-0; Azizi AA, 2006, LANCET ONCOL, V7, P521, DOI 10.1016/S1470-2045(06)70729-X; Basilico C, 2013, CLIN CANCER RES, V19, P2381, DOI 10.1158/1078-0432.CCR-12-3459; Casanova M, 2000, ANN ONCOL, V11, P1445, DOI 10.1023/A:1026579623136; Christensen JG, 2003, CANCER RES, V63, P7345; Covell DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048023; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Funakoshi Y, 2017, J PEDIAT HEMATOL ONC; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Goldberg JM, 2014, J CLIN ONCOL, V32, pE114, DOI 10.1200/JCO.2013.48.7462; Grullich C, 2014, RECENT RESULTS CANC, V201, P207, DOI 10.1007/978-3-642-54490-3_12; HINDI N, 2015, J CLIN ONCOL S, V33; Hoshino M, 2009, CANCER GENET CYTOGEN, V190, P75, DOI 10.1016/j.cancergencyto.2008.11.014; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jun HJ, 2010, MED ONCOL, V27, P459, DOI 10.1007/s12032-009-9234-8; Katayama R, 2013, CANCER RES, V73, P3087, DOI 10.1158/0008-5472.CAN-12-3256; Kenney S, 2011, J PEDIAT HEMATOL ONC, V33, P360, DOI 10.1097/MPH.0b013e3182002f9f; Kim Y, 2016, ONCOTARGET, V7, P70832, DOI 10.18632/oncotarget.12225; Kobos R, 2013, J PATHOL, V229, P743, DOI 10.1002/path.4158; Kummar S, 2013, J CLIN ONCOL, V31, P2296, DOI 10.1200/JCO.2012.47.4288; Ladanyi M, 2001, ONCOGENE, V20, P48, DOI 10.1038/sj.onc.1204074; Laird AD, 2003, EXPERT OPIN INV DRUG, V12, P51, DOI 10.1517/eoid.12.1.51.21253; Lazar AJ, 2009, HISTOPATHOLOGY, V55, P750, DOI 10.1111/j.1365-2559.2009.03436.x; Lazar AJF, 2007, CLIN CANCER RES, V13, P7314, DOI 10.1158/1078-0432.CCR-07-0174; Li T, 2016, INVEST NEW DRUG, V34, P701, DOI 10.1007/s10637-016-0390-3; LIEBERMAN PH, 1989, CANCER-AM CANCER SOC, V63, P1, DOI 10.1002/1097-0142(19890101)63:1<1::AID-CNCR2820630102>3.0.CO;2-E; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maslikowski BM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-41; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Nakamura T, 2016, CANCER-AM CANCER SOC, V122, P1408, DOI 10.1002/cncr.29961; Nakayama R, 2016, ONCOTARGET, V7, P16581, DOI 10.18632/oncotarget.7667; Ogose A, 2003, ONCOLOGY-BASEL, V65, P7, DOI 10.1159/000071199; OGURA K, 2012, SARCOMA, DOI DOI 10.1155/2012/907179; Pennacchioli E, 2010, ANN SURG ONCOL, V17, P3229, DOI 10.1245/s10434-010-1186-x; Portera CA, 2001, CANCER, V91, P585, DOI 10.1002/1097-0142(20010201)91:3<585::AID-CNCR1038>3.0.CO;2-0; Ranieri G, 2014, CRIT REV ONCOL HEMAT, V89, P322, DOI 10.1016/j.critrevonc.2013.08.012; Read WL, 2016, CASE REP ONCOL, V9, P639, DOI 10.1159/000450545; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Stacchiotti S, 2011, ANN ONCOL, V22, P1682, DOI 10.1093/annonc/mdq644; Stacchiotti S, 2009, CLIN CANCER RES, V15, P1096, DOI 10.1158/1078-0432.CCR-08-2050; Stockwin LH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-22; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tsuda M, 2007, CANCER RES, V67, P919, DOI 10.1158/0008-5472.CAN-06-2855; Wagner AJ, 2012, CANCER-AM CANCER SOC, V118, P5894, DOI 10.1002/cncr.27582; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527	47	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185321	10.1371/journal.pone.0185321	http://dx.doi.org/10.1371/journal.pone.0185321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945796	gold, Green Submitted, Green Published			2022-12-26	WOS:000411645100045
J	Kiang, JG; Smith, JT; Anderson, MN; Elliott, TB; Gupta, P; Balakathiresan, NS; Maheshwari, RK; Knollmann-Ritschel, B				Kiang, Juliann G.; Smith, Joan T.; Anderson, Marsha N.; Elliott, Thomas B.; Gupta, Paridhi; Balakathiresan, Nagaraja S.; Maheshwari, Radha K.; Knollmann-Ritschel, Barbara			Hemorrhage enhances cytokine, complement component 3, and caspase-3, and regulates microRNAs associated with intestinal damage after whole-body gamma-irradiation in combined injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; WOUND TRAUMA; IONIZING IRRADIATION; INCREASES SURVIVAL; MESSENGER-RNA; MICE; BLOOD; ACTIVATION	Hemorrhage following whole-body gamma-irradiation in a combined injury (CI) model increases mortality compared to whole-body gamma-irradiation alone (RI). The decreased survival in CI is accompanied by increased bone marrow injury, decreased hematocrit, and alterations of miRNA in the kidney. In this study, our aim was to examine cytokine homeostasis, susceptibility to systemic bacterial infection, and intestinal injury. More specifically, we evaluated the interleukin-6 (IL-6)-induced stress proteins including C-reactive protein (CRP), complement 3 (C3), Flt-3 ligand, and corticosterone. CD2F1 male mice received 8.75 Gy Co-60 gamma photons (0.6 Gy/min, bilateral) which was followed by a hemorrhage of 20% of the blood volume. In serum, RI caused an increase of IL-1, IL-2, IL-3, IL-5, IL-6, IL-12, IL-13, IL-15, IL17A, IL-18, G-CSF, CM-CSF, eotaxin, IFN-gamma, MCP-1, MIP, RANTES, and TNF-alpha, which were all increased by hemorrhage alone, except IL-9, IL-17A, and MCP-1. Nevertheless, CI further elevated RI-induced increases of these cytokines except for G-CSF, IFN-gamma and RANTES in serum. In the ileum, hemorrhage in the CI model significantly enhanced RI-induced IL-1 beta, IL-3, IL-6, IL-10, IL-12p70, IL-13, IL-18, and TNF-alpha concentrations. In addition, Proteus mirabilis Gram(-) was found in only 1 of 6 surviving RI mice on Day 15, whereas Streptococcus sanguinis Gram(+) and Sphingomonas paucimobilis Gram(-) were detected in 2 of 3 surviving CI mice (with 3 CI mice diseased due to inflammation and infection before day 15) at the same time point. Hemorrhage in the CI model enhanced the RIinduced increases in C3 and decreases in CRP concentrations. However, hemorrhage alone did not alter the basal levels, but hemorrhage in the CI model displayed similar increases in Flt-3 ligand levels as RI did. Hemorrhage alone altered the basal levels of corticosterone early after injury, which then returned to the baseline, but in RI mice and CI mice the increased corticosterone concentration remained elevated throughout the 15 day study. CI increased 8 miRNAs and decreased 10 miRNAs in serum, and increased 16 miRNA and decreased 6 miRNAs in ileum tissue. Among the altered miRNAs, CI increased miR-34 in the serum and ileum which targeted an increased phosphorylation of ERK, p38, and increased NF-gamma B, thereby leading to increased iNOS expression and activation of caspase-3 in the ileum. Further, let-7g/miR-98 targeted the increased phosphorylation of STAT3 in the ileum, which is known to bind to the iNOS gene. These changes may correlate with cell death in the ileum of CI mice. The histopathology displayed blunted villi and villus edema in RI and CI mice. Based on the in silico analysis, miR-15, miR-99, and miR-100 were predicted to regulate IL-6 and TNF. These results suggest that CI-induced alterations of cytokines/chemokines, CRP, and C3 cause a homeostatic imbalance and may contribute to the pathophysiology of the gastrointestinal injury. Inhibitory intervention in these responses may prove therapeutic for CI and improve recovery of the ileal morphologic damage.	[Kiang, Juliann G.; Smith, Joan T.; Anderson, Marsha N.; Elliott, Thomas B.] Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20889 USA; [Kiang, Juliann G.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA; [Kiang, Juliann G.] Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA; [Gupta, Paridhi; Balakathiresan, Nagaraja S.; Maheshwari, Radha K.; Knollmann-Ritschel, Barbara] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	United States Department of Defense; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Kiang, JG (corresponding author), Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20889 USA.; Kiang, JG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA.; Kiang, JG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	juliann.kiang@usuhs.edu	Balakathiresan, Nagaraja Sethuraman/O-3213-2019	Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070	Armed Forces Radiobiology Research Institute Intramural Funding [RAB3AL, RAB33326]	Armed Forces Radiobiology Research Institute Intramural Funding	JGK received the Armed Forces Radiobiology Research Institute Intramural Funding RAB3AL and RAB33326 to conduct experiments presented in this manuscript (URL: www.USUHS.edu/AFRRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Aziz KK, 2012, DIABETES METAB SYND, V6, P77, DOI 10.1016/j.dsx.2012.08.004; Abouheif MM, 2010, RHEUMATOLOGY, V49, P2054, DOI 10.1093/rheumatology/keq247; Barabanova Anzhelika V, 2006, Vojnosanit Pregl, V63, P477, DOI 10.2298/VSP0605477B; Bastard JP, 1999, CIRCULATION, V99, P2221; BAXTER H, 1953, PLAST RECONSTR SURG, V12, P439, DOI 10.1097/00006534-195312000-00007; BERG M, 1994, CYTOKINE, V6, P425, DOI 10.1016/1043-4666(94)90067-1; Biffl WL, 1996, J LEUKOCYTE BIOL, V59, P569, DOI 10.1002/jlb.59.4.569; BROOKS JW, 1952, ANN SURG, V136, P533, DOI 10.1097/00000658-195210000-00018; Chen J, 2016, CELL PHYSIOL BIOCHEM, V39, P2262, DOI 10.1159/000447919; Chen X, 2015, J FORMOS MED ASSOC, V114, P430, DOI 10.1016/j.jfma.2015.01.007; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; DAVIS AK, 1954, ANN SURG, V140, P726, DOI 10.1097/00000658-195411000-00012; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; ELLIOT TB, 1995, INT J RADIAT BIOL, V68, P311, DOI 10.1080/09553009514551241; Fukumoto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090448; Fukumoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058389; GERY I, 1972, J EXP MED, V136, P128, DOI 10.1084/jem.136.1.128; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Ha CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109249; Iijima S, 1982, Acta Pathol Jpn, V32 Suppl 2, P237; Islam A, 2015, RADIAT RES, V184, P273, DOI 10.1667/RR14113.1; KERN S, 1995, BIOL REPROD, V53, P1407, DOI 10.1095/biolreprod53.6.1407; Kiang JG, 2004, CELL RES, V14, P450, DOI 10.1038/sj.cr.7290247; Kiang JG, 2012, NATOHFM223P5118, P1; Kiang JG, 2008, MOL PHARMACOL, V73, P738, DOI 10.1124/mol.107.041079; Kiang JG, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7582079; Kiang Juliann G, 2014, J Cell Sci Ther, V5, DOI 10.4172/2157-7013.1000190; Kiang JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139271; Kiang JG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/215858; Kiang JG, 2014, HEALTH PHYS, V106, P720, DOI 10.1097/HP.0000000000000108; Kiang JG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/481392; Kiang JG, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/821541; Kiang Juliann G, 2010, Adapt Med, V2, P1, DOI 10.4247/AM.2010.ABA004; Kiang JG, 2010, RADIAT RES, V173, P319, DOI 10.1667/RR1892.1; Kishi H, 2000, NEUROSURGERY, V47, P441, DOI 10.1097/00006123-200008000-00034; KORLOF B, 1956, Acta Chir Scand Suppl, V209, P1; Kuby J, 2007, KUBY IMMUNOLOGY, P396; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; LEDNEY GD, 1985, EXPERIENTIA, V41, P614, DOI 10.1007/BF02007684; LEDNEY GD, 1982, EXPERIENTIA, V38, P1228, DOI 10.1007/BF01959756; LEDNEY GD, 1981, EXPERIENTIA, V37, P193, DOI 10.1007/BF01963228; LEDNEY GD, 1982, EXP HEMATOL, V10, P263; Li XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122258; Lu XY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-36; Matsuyama W, 2001, INTERNAL MED, V40, P1254, DOI 10.2169/internalmedicine.40.1254; McDonnel G. M, 1961, WT1428 DEF AT SUPP A; Mettler FA, 2007, HEALTH PHYS, V93, P462, DOI 10.1097/01.HP.0000278843.27969.74; Molyneux G, 2008, INT J EXP PATHOL, V89, P159, DOI 10.1111/j.1365-2613.2008.00580.x; Ni Wen-Juan, 2016, Microrna, V5, P83; NUNOMURA W, 1994, BBA-MOL BASIS DIS, V1227, P74, DOI 10.1016/0925-4439(94)90109-0; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; REED WR, 1994, AM J MED SCI, V308, P9, DOI 10.1097/00000441-199407000-00004; Rusk N, 2008, NAT METHODS, V5, P122, DOI 10.1038/nmeth0208-122a; Sakata H, 2012, BRAIN, V135, P3298, DOI 10.1093/brain/aws259; Sambur M. B., 1994, Radiatsionnaya Biologiya Radioekologiya, V34, P55; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; VALERIOTE FA, 1964, RADIAT RES, V22, P693, DOI 10.2307/3571550; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WodnarFilipowicz A, 1996, BLOOD, V88, P4493, DOI 10.1182/blood.V88.12.4493.bloodjournal88124493	63	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184393	10.1371/journal.pone.0184393	http://dx.doi.org/10.1371/journal.pone.0184393			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934227	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900027
J	Moussa, TAA; Al-Zahrani, HS; Almaghrabi, OA; Abdelmoneim, TS; Fuller, MP				Moussa, Tarek A. A.; Al-Zahrani, Hassan S.; Almaghrabi, Omar A.; Abdelmoneim, Tamer S.; Fuller, Michael P.			Comparative metagenomics approaches to characterize the soil fungal communities of western coastal region, Saudi Arabia	PLOS ONE			English	Article							MYCORRHIZAL FUNGI; DIVERSITY; REVEAL; RHIZOSPHERE; MICROBIOME	A total of 145007 reads were obtained from pyrosequencing for all the 4 samples. The total count ranged from 11,301,014 (Mecca old road) to 23,503,512 bp (Thuwal). A total of 460 fungal species belonging to 133 genera, 58 families, 33 orders, 13 classes and 4 phyla was identified across the four sites. The most abundant phylum at all four sites was Ascomycota followed by Basidiomycota. Four phyla (Ascomycota-99.31%, Basidiomycota-0.59%, Chytridiomycota-0.04%, Glomeromycota-0.03%) were detected in Khulais. Except for Glomeromycota, all phyla were detected at Mecca old road (Ascomycota-74.26%, Basidiomycota-25.71%, Chytridiomycota-0.01%) and Thuwal (Ascomycota-99.59%, Basidiomycota-0.40%, Chytridiomycota-0.002%); while only Ascomycota-90.98% and Basidiomycota-9.01% were detected in Asfan road. At the class level, Sordariomycetes was predominantly observed at Asfan road-59.88%, Khulais-68.26% and Thuwal-94.84%; while Pezizomycetes was dominant at Mecca old road-56.01%, was absent at Asfan road. Agaricomycetes was present only at Mecca old road-25.73%; while Tremello-mycetes-5.77%, Malasseizomycetes-2.13% and Microbotryomycetes-1.10% were found only at Asfan road. The phylogenetic trees revealed that clear genus level differences are visible across all the four sites, with an overall predominance of Thielavia followed by Madurella, Aspergillus, and Gelasinospora. Chaetomium sp., Aspergillus caespitosus and Aspergillus sp. were found in moderate (Mecca old road and Thuwal) to abundant (Asfan road and Khulais) quantities. Thielavia sp., Thielavia hyalocarpa and Madurella sp. are found in moderate quantities at Khulais and Mecca old road, while in abundant levels at Asfan road and Thuwal. Fusarium equisati and F. oxysporum were detected at Thuwal and Khulais. Sordaria araneosa was present at Khulais, while Malasseiza globosa species was detected in moderate quantities across all sites except Khulais.	[Moussa, Tarek A. A.; Al-Zahrani, Hassan S.; Almaghrabi, Omar A.; Abdelmoneim, Tamer S.] King Abdulaziz Univ, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia; [Moussa, Tarek A. A.; Almaghrabi, Omar A.; Abdelmoneim, Tamer S.] Univ Jeddah, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia; [Moussa, Tarek A. A.] Cairo Univ, Bot & Microbiol Dept, Fac Sci, Giza, Egypt; [Abdelmoneim, Tamer S.] Suez Canal Univ, Dept Agr Bot, Fac Agr, Ismailia, Egypt; [Fuller, Michael P.] Plymouth Univ, Sch Biol Sci, Fac Sci & Engn, Plymouth, Devon, England	King Abdulaziz University; University of Jeddah; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Suez Canal University; University of Plymouth	Moussa, TAA (corresponding author), King Abdulaziz Univ, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia.; Moussa, TAA (corresponding author), Univ Jeddah, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia.; Moussa, TAA (corresponding author), Cairo Univ, Bot & Microbiol Dept, Fac Sci, Giza, Egypt.	tarekmoussa@cu.edu.eg	Abdelmoneim, Tamer/AAC-2720-2019; Moussa, Tarek/F-4349-2010	Moussa, Tarek/0000-0002-5612-4366; Abdelmoneim, Tamer/0000-0002-2992-419X; Fuller, Michael/0000-0003-3461-9728	King Abdulaziz University, Jeddah [3-130-36-RG]; DSR	King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under grant no. (3-130-36-RG). The authors, therefore, acknowledge with thanks DSR technical and financial support.; This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under grant no. (3-130-36-RG). The authors, therefore, acknowledge with thanks DSR for technical and financial support.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Alef K, 1995, METHODS APPL SOIL MI; Almazroui M, 2012, INT J CLIMATOL, V32, P953, DOI 10.1002/joc.3446; BAESHEN NA, 2014, BOTHALIA J, V44, P301; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Darfaoui EM, 2010, RESPONSE CLIAMTE CHA, P1; El-Juhany L. I., 2013, World Applied Sciences Journal, V21, P710; El-Komy MH, 2013, PHYTOPATHOLOGY, V103, P39; Elsayed EA, 2013, EVIDENCE BASED COMPL; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Geml J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099852; Geml J, 2010, NEW PHYTOL, V187, P494, DOI 10.1111/j.1469-8137.2010.03283.x; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hedeler C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-426; Hegazy AK, 1998, J ARID ENVIRON, V38, P3, DOI 10.1006/jare.1997.0311; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; Huang CL, 2014, FUNGAL DIVERS, V66, P77, DOI 10.1007/s13225-014-0281-x; Jones EBG, 2009, FUNGAL DIVERS, V35, P1; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kim M, 2013, J MICROBIOL BIOTECHN, V23, P1347, DOI 10.4014/jmb.1306.06068; Kirk PM, 2001, AINSWORTH BISBYS DIC, P9; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Nam YJ, 2015, J GEN APPL MICROBIOL, V61, P67, DOI 10.2323/jgam.61.67; Nguyen HDT, 2008, PERSOONIA, V21, P57, DOI 10.3767/003158508X361334; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Orgiazzi A., 2013, Diversity, V5, P73; Peterson R. L., 2004, Mycorrhizas: anatomy and cell biology; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmit JP, 2007, BIODIVERS CONSERV, V16, P99, DOI 10.1007/s10531-006-9129-3; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Senthilkumaran R, 2012, INT J CURR MICROBIOL, V1, P29; Simoes MF, 2015, GENOM PROTEOM BIOINF, V13, P310, DOI 10.1016/j.gpb.2015.07.002; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; van der Maarel E, 2003, PHYTOCOENOLOGIA, V33, P187, DOI 10.1127/0340-269X/2003/0033-0187; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066829; Wu ZH, 2002, J ENVIRON MONITOR, V4, P377, DOI 10.1039/b200490a; Xu XM, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.22; Yasir M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0398-4	49	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185096	10.1371/journal.pone.0185096	http://dx.doi.org/10.1371/journal.pone.0185096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934322	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900086
J	Nasir, M; Baucom, BR; Georgiou, P; Narayanan, S				Nasir, Md; Baucom, Brian Robert; Georgiou, Panayiotis; Narayanan, Shrikanth			Predicting couple therapy outcomes based on speech acoustic features	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; MARITAL INTERACTION; OBSERVED COMMUNICATION; EMOTION RECOGNITION; THIN SLICES; FOLLOW-UP; PSYCHOTHERAPY; STABILITY; DIVORCE; SATISFACTION	Automated assessment and prediction of marital outcome in couples therapy is a challenging task but promises to be a potentially useful tool for clinical psychologists. Computational approaches for inferring therapy outcomes using observable behavioral information obtained from conversations between spouses offer objective means for understanding relationship dynamics. In this work, we explore whether the acoustics of the spoken interactions of clinically distressed spouses provide information towards assessment of therapy outcomes. The therapy outcome prediction task in this work includes detecting whether there was a relationship improvement or not (posed as a binary classification) as well as discerning varying levels of improvement or decline in the relationship status (posed as a multiclass recognition task). We use each interlocutor's acoustic speech signal characteristics such as vocal intonation and intensity, both independently and in relation to one another, as cues for predicting the therapy outcome. We also compare prediction performance with one obtained via standardized behavioral codes characterizing the relationship dynamics provided by human experts as features for automated classification. Our experiments, using data from a longitudinal clinical study of couples in distressed relations, showed that predictions of relationship outcomes obtained directly from vocal acoustics are comparable or superior to those obtained using human-rated behavioral codes as prediction features. In addition, combining direct signal-derived features with manually coded behavioral features improved the prediction performance in most cases, indicating the complementarity of relevant information captured by humans and machine algorithms. Additionally, considering the vocal properties of the interlocutors in relation to one another, rather than in isolation, showed to be important for improving the automatic prediction. This finding supports the notion that behavioral outcome, like many other behavioral aspects, is closely related to the dynamics and mutual influence of the interlocutors during their interaction and their resulting behavioral patterns.	[Nasir, Md; Georgiou, Panayiotis; Narayanan, Shrikanth] Univ Southern Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Baucom, Brian Robert] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	University of Southern California; Utah System of Higher Education; University of Utah	Georgiou, P (corresponding author), Univ Southern Calif, Dept Elect Engn, Los Angeles, CA 90089 USA.	georgiou@sipi.usc.edu	Narayanan, Shrikanth S/D-5676-2012; Georgiou, Panayiotis Panos/E-8387-2018	Georgiou, Panayiotis Panos/0000-0002-0790-7161	NSF [1059095]; Direct For Computer & Info Scie & Enginr [1029373] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Funding was provided by NSF award 1059095.	Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; Albrechtsen JS, 2009, J EXP SOC PSYCHOL, V45, P1052, DOI 10.1016/j.jesp.2009.05.017; AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Atkins DC, 2005, J CONSULT CLIN PSYCH, V73, P893, DOI 10.1037/0022-006X.73.5.893; BACHOROWSKI JA, 1995, PSYCHOL SCI, V6, P219, DOI 10.1111/j.1467-9280.1995.tb00596.x; Baucom BR, 2015, J CONSULT CLIN PSYCH, V83, P103, DOI 10.1037/a0038005; Baucom BR, 2009, J CONSULT CLIN PSYCH, V77, P160, DOI 10.1037/a0014405; Baucom DH, 2002, HDB COGNITIVE BEHAV, P411; Baucom KJW, 2015, BEHAV RES THER, V65, P18, DOI 10.1016/j.brat.2014.12.004; Baucom KJW, 2011, J CONSULT CLIN PSYCH, V79, P565, DOI 10.1037/a0025121; BENTLER PM, 1978, J CONSULT CLIN PSYCH, V46, P1053, DOI 10.1037/0022-006X.46.5.1053; Bitouk D, 2010, SPEECH COMMUN, V52, P613, DOI 10.1016/j.specom.2010.02.010; Black M., 2011, INTERSPEECH, P89; Black M, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2030; Black MP, 2013, SPEECH COMMUN, V55, P1, DOI 10.1016/j.specom.2011.12.003; Boersma Paul, 2002, GLOT INT, V5, P341; Bone D, 2014, J SPEECH LANG HEAR R, V57, P1162, DOI 10.1044/2014_JSLHR-S-13-0062; Broman C., 2002, J DIVORCE REMARRIAGE, V37, P151; Brown GL, 2012, J TURBUL, V13, P1, DOI 10.1080/14685248.2012.723805; Buehlman K.T., 1992, J FAMILY PSYCHOL, V5, P295, DOI DOI 10.1037/0893-3200.5.3-4.295; Can D, 2016, J COUNS PSYCHOL, V63, P343, DOI 10.1037/cou0000111; Carrere S, 2000, J FAM PSYCHOL, V14, P42, DOI 10.1037/0893-3200.14.1.42; Chakravarthula SN, 2015, INT CONF ACOUST SPEE, P2090, DOI 10.1109/ICASSP.2015.7178339; Christensen A, 2004, J CONSULT CLIN PSYCH, V72, P176, DOI 10.1037/0022-006X.72.2.176; Christensen A, 1995, INTEGRATIVE BEHAV CO; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Curhan JR, 2007, J APPL PSYCHOL, V92, P802, DOI 10.1037/0021-9010.92.3.802; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Epstein N., 1983, COGNITIVE THERAPY CO; Eyben F., 2010, ACM MULTIMEDIA MM, P1459, DOI DOI 10.1145/1873951.1874246; Farrus M., 2007, P 8 ANN C INT SPEECH, P778; France DJ, 2000, IEEE T BIO-MED ENG, V47, P829, DOI 10.1109/10.846676; FRICK RW, 1985, PSYCHOL BULL, V97, P412, DOI 10.1037/0033-2909.97.3.412; Georgiou P. G., 2011, P 2011 JOINT ACM WOR, P7, DOI [DOI 10.1145/2072572.2072576, 10.1145/2072572.2072576]; Georgiou PG, 2011, THATS AGGRAVATING VE, P87; Gibson J., 2011, INTERSPEECH, P1561; Giles H., 1997, ACCOMMODATION THEORY; Giles Howard, 1991, CONTEXTS ACCOMMODATI; Gottman J. M., 2008, CLIN HDB COUPLE THER, P138, DOI DOI 10.1037/0022-006X.61.1.78; Gottman J. M., 2013, MARITAL INTERACTION; GOTTMAN JM, 1993, J CONSULT CLIN PSYCH, V61, P6, DOI 10.1037/0022-006X.61.1.6; GOTTMAN JM, 1992, J PERS SOC PSYCHOL, V63, P221, DOI 10.1037/0022-3514.63.2.221; Gottman JM, 1998, J MARRIAGE FAM, V60, P5, DOI 10.2307/353438; Gottman JM, 2000, J MARRIAGE FAM, V62, P737, DOI 10.1111/j.1741-3737.2000.00737.x; GOTTMAN JM, 1989, J CONSULT CLIN PSYCH, V57, P47, DOI 10.1037/0022-006X.57.1.47; Gottman John Mordechai, 2014, WHAT PREDICTS DIVORC; Grimm M, 2007, SPEECH COMMUN, V49, P787, DOI 10.1016/j.specom.2007.01.010; HALFORD WK, 1993, J CONSULT CLIN PSYCH, V61, P51, DOI 10.1037/0022-006X.61.1.51; Han KJ, 2008, IEEE T AUDIO SPEECH, V16, P1590, DOI 10.1109/TASL.2008.2002085; Harvey, 2006, HDB DIVORCE RELATION, P85; Heavey C., 2002, COUPLES INTERACTION; Heyman RE, 2001, J MARRIAGE FAM, V63, P473, DOI 10.1111/j.1741-3737.2001.00473.x; Heyman RE, 2001, BEHAV THER, V32, P107, DOI 10.1016/S0005-7894(01)80047-2; Heyman RE, 2001, PSYCHOL ASSESSMENT, V13, P5, DOI 10.1037//1040-3590.13.1.5; Heyman RE, 2001, J FAM PSYCHOL, V15, P334, DOI 10.1037/0893-3200.15.2.334; Hillard D., 2003, P 2003 C N AM ASS CO, V2, P34, DOI [DOI 10.3115/1073483.1073495, 10.3115/1073483.1073495]; Howard KI, 1996, AM PSYCHOL, V51, P1059, DOI 10.1037/0003-066X.51.10.1059; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jacobson N.S., 1979, MARITAL THERAPY STRA; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnson SM, 1999, CLIN PSYCHOL-SCI PR, V6, P67, DOI 10.1093/clipsy/6.1.67; Jones J, 1998, COUPLES INTERACTION; Juslin PN., 2005, VOCAL EXPRESSION AFF; KARNEY BR, 1995, PSYCHOL BULL, V118, P3, DOI 10.1037/0033-2909.118.1.3; KELLER MB, 1987, ARCH GEN PSYCHIAT, V44, P540; Kim HK, 2007, J MARRIAGE FAM, V69, P55, DOI 10.1111/j.1741-3737.2006.00343.x; KRIPPEND.K, 1970, EDUC PSYCHOL MEAS, V30, P61, DOI 10.1177/001316447003000105; Kwon OW, 2003, P INT C EUROSPEECH; Lambert MJ, 1994, HDB PSYCHOTHERAPY BE; Lee CC, 2014, COMPUT SPEECH LANG, V28, P518, DOI 10.1016/j.csl.2012.06.006; Lee CC, 2011, SPEECH COMMUN, V53, P1162, DOI 10.1016/j.specom.2011.06.004; Lee CM, 2005, IEEE T SPEECH AUDI P, V13, P293, DOI 10.1109/TSA.2004.838534; LEWIS DD, 1992, SPEECH AND NATURAL LANGUAGE, P212; Li Y, 1998, ICSLP; Lord SP, 2015, J SUBST ABUSE TREAT, V49, P50, DOI 10.1016/j.jsat.2014.08.005; Menezes NM, 2006, PSYCHOL MED, V36, P1349, DOI 10.1017/S0033291706007951; Narayanan S, 2013, P IEEE, V101, P1203, DOI 10.1109/JPROC.2012.2236291; Nasir M, 2015, P INT DRESD GERM; Nasir M, 2015, INT CONF ACOUST SPEE, P1886, DOI 10.1109/ICASSP.2015.7178298; Ntalampiras S, 2012, IEEE T AFFECT COMPUT, V3, P116, DOI 10.1109/T-AFFC.2011.31; Ogles B. M., 1996, ASSESSING OUTCOME CL; Orlinsky DE, 1994, HDB PSYCHOTHERAPY BE; Ozgur A, 2005, LECT NOTES COMPUT SC, V3733, P606; Parris ES, 1996, INT CONF ACOUST SPEE, P685, DOI 10.1109/ICASSP.1996.543213; Pentland A, 2005, COMPUTER, V38, P33, DOI 10.1109/MC.2005.104; Pentland A, 2007, IEEE SIGNAL PROC MAG, V24, P108, DOI 10.1109/MSP.2007.4286569; Pianesi F., 2008, P 10 INT C MULT INT, P53, DOI [10.1145/1452392.1452404, DOI 10.1145/1452392.1452404]; Pittam Jeff, 1994, VOICE SOCIAL INTERAC, V5; Pitts MJ, 2008, HANDB APPL LINGUIST, V2, P15; Salzberg SL, 1997, DATA MIN KNOWL DISC, V1, P317, DOI 10.1023/A:1009752403260; Schuller B., 2007, INTERSPEECH, P2253; Schuller B, 2007, 2007 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING, VOLS 1 AND 2, P596, DOI 10.1109/ASRU.2007.4430180; Schuller B, 2011, COMPUTER ANALYSIS OF HUMAN BEHAVIOR, P227, DOI 10.1007/978-0-85729-994-9_9; Sevier M, 2008, BEHAV THER, V39, P137, DOI 10.1016/j.beth.2007.06.001; SMITH ML, 1977, AM PSYCHOL, V32, P752, DOI 10.1037/0003-066X.32.9.752; SNYDER DK, 1979, J MARRIAGE FAM, V41, P813, DOI 10.2307/351481; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Stanley SM, 2000, J MARRIAGE FAM, V62, P256, DOI 10.1111/j.1741-3737.2000.00256.x; Tseng SY, 2016, P INT SAN FRANC CA; Van Segbroeck M, 2013, INTERSPEECH; Vinciarelli A., 2008, P 10 INT C MULTIMODA, P61, DOI DOI 10.1145/1452392.1452405; Vinciarelli A, 2009, IMAGE VISION COMPUT, V27, P1743, DOI 10.1016/j.imavis.2008.11.007; Vlasenko B, 2007, LECT NOTES COMPUT SC, V4738, P139; Xia W, 2015, P INT DRESD GERM; Xia Wei, 2015, 16 ANN C INT SPEECH; Xiao B, 2013, INT CONF ACOUST SPEE, P3766, DOI 10.1109/ICASSP.2013.6638362	106	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185123	10.1371/journal.pone.0185123	http://dx.doi.org/10.1371/journal.pone.0185123			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934302	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900097
J	Trimpert, C; Wesche, D; de Groot, T; Rodriguez, MMP; Wong, V; van den Berg, DTM; Cheval, L; Ariza, CA; Doucet, A; Stagljar, I; Deen, PMT				Trimpert, Christiane; Wesche, Daniel; de Groot, Theun; Rodriguez, Martha M. Pimentel; Wong, Victoria; van den Berg, Dennis T. M.; Cheval, Lydie; Ariza, Carolina A.; Doucet, Alain; Stagljar, Igor; Deen, Peter M. T.			NDFIP allows NEDD4/NEDD4L-induced AQP2 ubiquitination and degradation	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; EPITHELIAL NA+ CHANNEL; AQUAPORIN-2 WATER CHANNEL; LONG-TERM REGULATION; NEDD4 FAMILY; PROTEIN; EXPRESSION; PATHWAY; LIGASES; ENAC	Regulation of our water homeostasis is fine-tuned by dynamic translocation of Aquaporin-2 (AQP2)-bearing vesicles to and from the plasma membrane of renal principal cells. Whereas binding of vasopressin to its type-2 receptor initiates a cAMP-protein kinase A cascade and AQP2 translocation to the apical membrane, this is counteracted by protein kinase C-activating hormones, resulting in ubiquitination-dependent internalization of AQP2. The proteins targeting AQP2 for ubiquitin-mediated degradation are unknown. In collecting duct mpkCCD cells, siRNA knockdown of NEDD4 and NEDD4L E3 ligases yielded increased AQP2 abundance, but they did not bind AQP2. Membrane Yeast Two-Hybrid assays using full-length AQP2 as bait, identified NEDD4 family interacting protein 2 (NDFIP2) to bind AQP2. NDFIP2 and its homologue NDFIP1 have PY motifs by which they bind NEDD4 family members and bring them close to target proteins. In HEK293 cells, NDFIP1 and NDFIP2 bound AQP2 and were essential for NEDD4/NEDD4L-mediated ubiquitination and degradation of AQP2, an effect not observed with PY-lacking NDFIP1/2 proteins. In mpkCCD cells, downregulation of NDFIP1, NEDD4 and NEDD4L, but not NDFIP2, increased AQP2 abundance. In mouse kidney, Ndfip1 and Ndfip2 mRNA distribution was similar and high in proximal tubules and collecting ducts, which was also found for NDFIP1 proteins. Our results reveal that NEDD4/NEDD4L mediate ubiquitination and degradation of AQP2, but that NDFIP proteins are needed to connect NEDD4/NEDD4L to AQP2. As NDFIP1/2 bind many NEDD4 family E3 ligases, which are implicated in several cellular processes, NDFIP1/2 may be the missing link for AQP2 ubiquitination and degradation from different subcellular locations.	[Trimpert, Christiane; Wesche, Daniel; de Groot, Theun; Rodriguez, Martha M. Pimentel; van den Berg, Dennis T. M.; Ariza, Carolina A.; Deen, Peter M. T.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen, Netherlands; [Rodriguez, Martha M. Pimentel; Wong, Victoria; Stagljar, Igor] Univ Toronto, Dept Biochem & Mol Genet, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Cheval, Lydie; Doucet, Alain] Univ Paris 05, Univ Paris 06, Ctr Rech Cordeliers, Sorbonne Univ,Sorbonne Paris Cite,CNRS,UPMC,INSER, Paris, France	Radboud University Nijmegen; University of Toronto; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Deen, PMT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen, Netherlands.	Peter.Deen@radboudumc.nl	Deen, Peter MT/B-9854-2013; Ariza, Ana Carolina/AAR-2607-2021; Deen, P.M.T./H-8023-2014	Deen, Peter MT/0000-0002-7868-4655; Ariza, Ana Carolina/0000-0002-0302-4062; Deen, P.M.T./0000-0002-7868-4655; CHEVAL, LYDIE/0000-0003-2957-6487; Hubner, Christiane/0000-0003-3637-6395	Marie Curie Intra European Fellowship grant [272375]; Marie Curie Outgoing Fellowship grant [272375]; Kolff internship grant from the Dutch Kidney Foundation [KBS 11.048]	Marie Curie Intra European Fellowship grant; Marie Curie Outgoing Fellowship grant; Kolff internship grant from the Dutch Kidney Foundation	This study was supported by a Marie Curie Intra European Fellowship grant (272375) for CT (ec.europa.eu), a Marie Curie Outgoing Fellowship grant (272375) for TG (ec.europa.eu), and a Kolff internship grant from the Dutch Kidney Foundation (KBS 11.048) for MP (nierstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. H.R.B. Pelham (MRC Laboratory of Molecular Biology, Cambridge, UK) for kindly sharing the NDFIP constructs with us and Prof. O. Staub for providing us with the constructs for NEDD4 and NEDD4L constructs. This study was supported by a Marie Curie Intra European Fellowship grant (272375) for CT, a Marie Curie Outgoing Fellowship grant (272375) for TG, and a Kolff internship grant from the Dutch Kidney Foundation (KBS 11.048) for MP.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Boone M, 2011, AM J PHYSIOL-RENAL, V300, pF761, DOI 10.1152/ajprenal.00247.2010; Boone M, 2010, NEPHROL DIAL TRANSPL, V25, P48, DOI 10.1093/ndt/gfp409; Cheval L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046876; Cheval L, 2011, PHYSIOL GENOMICS, V43, P161, DOI 10.1152/physiolgenomics.00093.2010; de Mattia F, 2004, HUM MOL GENET, V13, P3045, DOI 10.1093/hmg/ddh339; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Foot NJ, 2011, BLOOD, V117, P638, DOI 10.1182/blood-2010-07-295287; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jin HS, 2010, KIDNEY BLOOD PRESS R, V33, P15, DOI 10.1159/000275706; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kang YD, 2015, BIOCHEM J, V472, P71, DOI 10.1042/BJ20141282; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Lee YJ, 2011, AM J PHYSIOL-RENAL, V301, pF883, DOI 10.1152/ajprenal.00117.2011; Loffing-Cueni D, 2006, J AM SOC NEPHROL, V17, P1264, DOI 10.1681/ASN.2005060659; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Rotin D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00212; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; ten Broeke T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016873; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Trimpert C, 2012, NEPHROL DIAL TRANSPL, V27, P4389, DOI 10.1093/ndt/gfs292; Yu Ming-Jiun, MPKCCD TRANSCRIPTOME	43	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0183774	10.1371/journal.pone.0183774	http://dx.doi.org/10.1371/journal.pone.0183774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931009	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700012
J	Ma, D; Gilbert, T; Pignanelli, C; Tarade, D; Noel, M; Mansour, F; Gupta, M; Ma, S; Ropat, J; Curran, C; Vshyvenko, S; Hudlicky, T; Pandey, S				Ma, Dennis; Gilbert, Tyler; Pignanelli, Christopher; Tarade, Daniel; Noel, Megan; Mansour, Fadi; Gupta, Manika; Ma, Sabrina; Ropat, Jesse; Curran, Colin; Vshyvenko, Sergey; Hudlicky, Tomas; Pandey, Siyaram			Exploiting mitochondrial and oxidative vulnerabilities with a synthetic analog of pancratistatin in combination with piperlongumine for cancer therapy	FASEB JOURNAL			English	Article						combination therapy; apoptosis; mitochondria; oxidative stress	BIOLOGICAL EVALUATION; TUMOR-CELLS; APOPTOSIS; GROWTH; PROLIFERATION; DYSFUNCTION; HEXOKINASE; STRESS; DEATH; ROS	Harsh adverse effects as a result of nonspecific targeting of chemotherapeutics currently pose obstacles in cancer therapy; thus, it would be invaluable to devise novel approaches to specifically target cancer cells. The natural compound pancratistatin (PST) has been shown to preferentially induce apoptosis in a variety of cancer cell types. Recently, several analogs of PST were shown to be efficacious in inducing apoptosis in a variety of aggressive cancer cell types via cancer cell mitochondrial targeting; it caused dissipation of mitochondrial membrane potential and decreased oxygen consumption, and with isolated mitochondria, it induced the release of apoptogenic factors. The natural compound piperlongumine has been shown to target the stress response to reactive oxygen species in cancer cells. We explored the combinatorial potential of two small molecules (SVTH-6 and piperlongumine) that target these vulnerabilities in cancer cells. Interestingly, when combined with the PST analog, SVTH-6, an increase in mitochondrial dysfunction was observed, leading to an enhanced cytotoxic effect against several human cancer cell types. Additionally, this combination treatment was effective in reducing cancer cell growth in physiologically more relevant 3-dimensional spheroid cell cultures. This enhanced effect was found to be dependent on reactive oxygen species generation because an antioxidant could rescue cancer cells from this combination treatment. Importantly, noncancerous cells were markedly less sensitive to this combination treatment. Thus, targeting mitochondrial and oxidative stress vulnerabilities of cancer cells could be an effective strategy for cancer therapy.	[Ma, Dennis; Gilbert, Tyler; Pignanelli, Christopher; Tarade, Daniel; Noel, Megan; Mansour, Fadi; Gupta, Manika; Ma, Sabrina; Ropat, Jesse; Curran, Colin; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Vshyvenko, Sergey; Hudlicky, Tomas] Brock Univ, Chem Dept, St Catharines, ON, Canada; [Vshyvenko, Sergey; Hudlicky, Tomas] Brock Univ, Ctr Biotechnol, St Catharines, ON, Canada	University of Windsor; Brock University; Brock University	Pandey, S (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	spandey@uwindsor.ca	Pandey, Siyaram/AAI-5491-2020; Pignanelli, Christopher/N-7183-2019	Pignanelli, Christopher/0000-0001-7120-4818	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship; Ontario Graduate Scholarship; Vanier Canada Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Vanier Canada Graduate Scholarship	The authors gratefully acknowledge A. Dowhayko, P. Tremblay, S. Adams, P. Akbari-Asl, J. Cheema, J. Church, and S. Joshi (all from the University of Windsor) for their initial assistance on this project and their continued support and encouragement. This work was supported, in part, by generous donations by the Knights of Columbus Chapter 9671 (Windsor, ON, Canada), the Windsor Mold Group, and D. and D. Couvillon (in memory of K. Couvillon). Funding from the Natural Sciences and Engineering Research Council of Canada to S.P. and T.H. is gratefully acknowledged. This work was also supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship, an Ontario Graduate Scholarship, and a Vanier Canada Graduate Scholarship awarded to D.M. The authors declare no conflicts of interest.	Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Chen G, 2010, MITOCHONDRION, V10, P614, DOI 10.1016/j.mito.2010.08.001; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Collins J, 2010, J ORG CHEM, V75, P3069, DOI 10.1021/jo1003136; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Earnshaw WC, 1999, NATURE, V397, P387, DOI 10.1038/17015; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griffin C, 2011, INT J ONCOL, V38, P1549, DOI 10.3892/ijo.2011.977; Griffin C, 2011, MOL CANCER THER, V10, P57, DOI 10.1158/1535-7163.MCT-10-0735; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kekre N, 2005, CANCER CHEMOTH PHARM, V56, P29, DOI 10.1007/s00280-004-0941-8; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Ma D., 2012, JOVE-J VIS EXP, V63, P3586; Ma D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42957; Ma D, 2012, INVEST NEW DRUG, V30, P1012, DOI 10.1007/s10637-011-9668-7; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; McLachlan A, 2005, APOPTOSIS, V10, P619, DOI 10.1007/s10495-005-1896-x; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Siedlakowski P, 2008, CANCER BIOL THER, V7, P376, DOI 10.4161/cbt.7.3.5364; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vshyvenko S, 2011, BIOORG MED CHEM LETT, V21, P4750, DOI 10.1016/j.bmcl.2011.06.068; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	35	7	7	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					417	430		10.1096/fj.201700275R	http://dx.doi.org/10.1096/fj.201700275R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928246				2022-12-26	WOS:000419172700037
J	Schweitzer, MD; Salamo, O; Campos, M; Schraufnagel, DE; Sadikot, R; Mirsaeidi, M				Schweitzer, Michael D.; Salamo, Oriana; Campos, Michael; Schraufnagel, Dean E.; Sadikot, Ruxana; Mirsaeidi, Mehdi			Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria	PLOS ONE			English	Article							AVIUM COMPLEX; CYSTIC-FIBROSIS; INDICUS-PRANII; DISEASE; INFECTIONS; DIAGNOSIS; CT	Background Female gender, tall stature, presence of bronchiectasis are associated with pulmonary non-tuberculous mycobacterial (NTM) infections. The biologic relationship between the body habitus and NTM infection is not well defined and the body habitus profile of the patients with NTM and concurrent bronchiectasis is completely unknown. Methods We conducted a case control study at the Miami VA Healthcare System and the University of Illinois Medical Center on patients with pulmonary NTM infections between 2010 and 2015. We compared pulmonary NTM subjects with and without bronchiectasis. NTM infection was confirmed by using the American Thoracic Society/Infectious Disease Society of America criteria. Standard radiological criteria were used to define bronchiectasis in chest CT-scan. Results Two hundred twenty subjects with pulmonary NTM were enrolled in the study. Sixty six subjects (30%) had bronchiectasis on CT scan of the chest. Subjects in the bronchiectasis group included more women (p = 0.002) and were significantly older (p = 0.005). Those patients who had bronchiectasis tended to have a significantly lower weight (less than 50kg) and height <= 155 cm (p < 0.0001 and p = 0.018, respectively). Kaplan-Meier analysis confirmed that subjects who had bronchiectasis were shorter and weighed less, after adjusting for gender. Conclusions This study defines a new sub-phenotype of NTM subjects with bronchiectasis who tend to be short with lower body weight. Further studies are needed to better understand and define the body habitus profiles of this new sub-phenotype and their clinical implications.	[Schweitzer, Michael D.; Salamo, Oriana; Campos, Michael; Mirsaeidi, Mehdi] Miami VA Med Ctr, Dept Med, Sect Pulm, Miami, FL 33125 USA; [Campos, Michael; Mirsaeidi, Mehdi] Univ Miami, Dept Med, Div Pulm & Crit Care, Miami, FL 33146 USA; [Schraufnagel, Dean E.] Univ Illinois, Dept Med, Div Pulm & Crit Care, Chicago, IL USA; [Sadikot, Ruxana] Univ Emory, Dept Med, Div Pulm & Crit Care, Atlanta, GA USA	University of Miami; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mirsaeidi, M (corresponding author), Miami VA Med Ctr, Dept Med, Sect Pulm, Miami, FL 33125 USA.; Mirsaeidi, M (corresponding author), Univ Miami, Dept Med, Div Pulm & Crit Care, Miami, FL 33146 USA.	msm249@med.miami.edu	Campos, Michael/X-2025-2019	Campos, Michael/0000-0001-5485-9062; Schraufnagel, Dean/0000-0003-0063-7223; Mirsaeidi, Mehdi/0000-0001-5298-8442				Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Bonaiti G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/197950; Chan ED, 2010, GENDER MED, V7, P5, DOI 10.1016/j.genm.2010.01.005; COLE PJ, 1986, EUR J RESPIR DIS, V69, P6; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Han XY, 2005, J CLIN MICROBIOL, V43, P4407, DOI 10.1128/JCM.43.9.4407-4412.2005; HARTMAN TE, 1994, RADIOGRAPHICS, V14, P991, DOI 10.1148/radiographics.14.5.7991828; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; Kamada M, 2001, AM J OBSTET GYNECOL, V184, P309, DOI 10.1067/mob.2001.109940; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; King Paul T, 2009, Int J Chron Obstruct Pulmon Dis, V4, P411; Koh WJ, 2005, RADIOLOGY, V235, P282, DOI 10.1148/radiol.2351040371; Diaz LVL, 2017, INT J CHRONIC OBSTR, V12, P2257, DOI 10.2147/COPD.S143424; Medrek SK, 2017, COPD, V14, P484, DOI 10.1080/15412555.2017.1336209; Mirsaeidi M, 2017, CHEST, V151, P947, DOI 10.1016/j.chest.2017.02.013; Mirsaeidi M, 2015, INT J MYCOBACT, V4, P92, DOI 10.1016/j.ijmyco.2015.05.002; Mirsaeidi M, 2014, EUR J INTERN MED, V25, P356, DOI 10.1016/j.ejim.2014.03.008; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Mirsaeidi M, 2013, INT J INFECT DIS, V17, pE1000, DOI 10.1016/j.ijid.2013.03.018; Morrissey BM, 2007, CLIN CHEST MED, V28, P289, DOI 10.1016/j.ccm.2007.02.014; Okumura M, 2008, INTERNAL MED, V47, P1465, DOI 10.2169/internalmedicine.47.1114; Pappalettera M, 2009, CLIN RESPIR J, V3, P126, DOI 10.1111/j.1752-699X.2009.00131.x; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Rahman SA, 2014, MBIO, V5, DOI 10.1128/mBio.02020-14; REICH JM, 1992, CHEST, V101, P1605, DOI 10.1378/chest.101.6.1605; Saini V, 2012, NUCLEIC ACIDS RES, V40, P10832, DOI 10.1093/nar/gks793; Shoemark A, 2007, RESP MED, V101, P1163, DOI 10.1016/j.rmed.2006.11.008; Singh Y, 2014, INT J MED MICROBIOL, V304, P742, DOI 10.1016/j.ijmm.2014.05.006; Strausbaugh SD, 2007, CLIN CHEST MED, V28, P279, DOI 10.1016/j.ccm.2007.02.011; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Velayati AA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/254285; Winthrop KL, 2011, PHARMACOEPIDEM DR S, V20, P229, DOI 10.1002/pds.2049	32	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185095	10.1371/journal.pone.0185095	http://dx.doi.org/10.1371/journal.pone.0185095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957340	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200029
J	Pessoa, R; Sanabani, SS				Pessoa, Rodrigo; Sanabani, Sabri S.			High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naive chronically infected Brazilian blood donors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RIO-DE-JANEIRO; REVERSE-TRANSCRIPTASE; GENOTYPIC RESISTANCE; ANTIRETROVIRAL THERAPY; INDIVIDUALS; FREQUENCY; VARIANTS; DIVERSITY; INTEGRASE	Background An improved understanding of the prevalence of low-abundance transmitted drug-resistance mutations (TDRM) in therapy-naive HIV-1-infected patients may help determine which patients are the best candidates for therapy. In this study, we aimed to obtain a comprehensive picture of the evolving HIV-1 TDRM across the massive parallel sequences (MPS) of the viral entire proviral genome in a well-characterized Brazilian blood donor naive to antiretroviral drugs. Materials and methods The MPS data from 128 samples used in the analysis were sourced from Brazilian blood donors and were previously classified by less-sensitive (LS) or "detuned" enzyme immunoassay as non-recent or longstanding HIV-1 infections. The Stanford HIV Resistance Database (HIVDBv 6.2) and IAS-USA mutation lists were used to interpret the pattern of drug resistance. The minority variants with TDRM were identified using a threshold of >= 1.0% and <= 20% of the reads sequenced. The rate of TDRM in the MPS data of the proviral genome were compared with the corresponding published consensus sequences of their plasma viruses. Results No TDRM were detected in the integrase or envelope regions. The overall prevalence of TDRM in the protease (PR) and reverse transcriptase (RT) regions of the HIV-1 pol gene was 44.5% (57/128), including any mutations to the nucleoside analogue reverse transcriptase inhibitors (NRTI) and non-nucleoside analogue reverse transcriptase inhibitors (NNRTI). Of the 57 subjects, 43 (75.4%) harbored a minority variant containing at least one clinically relevant TDRM. Among the 43 subjects, 33 (76.7%) had detectable minority resistant variants to NRTIs, 6 (13.9%) to NNRTIs, and 16 (37.2%) to PR inhibitors. The comparison of viral sequences in both sources, plasma and cells, would have detected 48 DNA provirus disclosed TDRM by MPS previously missed by plasma bulk analysis. Conclusion Our findings revealed a high prevalence of TDRM found in this group, as the use of MPS drastically increased the detection of these mutations. Sequencing proviral DNA provided additional information about TDRM, which may impact treatment decisions. The overall results emphasize the importance of continuous monitoring.	[Pessoa, Rodrigo; Sanabani, Sabri S.] Univ Sao Paulo, Trop Med Inst Sao Paulo, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil; [Sanabani, Sabri S.] Univ Sao Paulo, Sch Med, Hosp Clin, Dept Pathol,Clin Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Sanabani, SS (corresponding author), Univ Sao Paulo, Trop Med Inst Sao Paulo, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil.; Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Dept Pathol,Clin Lab, Sao Paulo, Brazil.	sabyem_63@yahoo.com	Sanabani, Sabri Saeed/F-5600-2012; Pessôa, Rodrigo/B-7206-2018	Sanabani, Sabri Saeed/0000-0002-8876-8262; 	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo [2014/26983-3, 2014/24596-2]	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo	This work was supported by grants 2014/26983-3, and 2014/24596-2 from the Fundagao de Amparo a Pesquisa do Estado de Sao Paulo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants 2014/26983-3, and 2014/24596-2 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; [Anonymous], 2006, HLTH CAN HIV 1 STRAI; Avila-Rios S, 2015, AIDS RES HUM RETROV, V31, P401, DOI 10.1089/aid.2014.0057; Avila-Rios S, 2011, REV PANAM SALUD PUBL, V30, P641, DOI 10.1590/S1020-49892011001200024; Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Bansode V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-52; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Baxter JD, 2015, HIV MED, V16, P77, DOI 10.1111/hiv.12236; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Bon I, 2007, J CLIN VIROL, V38, P313, DOI 10.1016/j.jcv.2006.12.018; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brindeiro R, 1999, ANTIMICROB AGENTS CH, V43, P1674, DOI 10.1128/AAC.43.7.1674; Buchacz K, 2015, J ANTIMICROB CHEMOTH, V70, P2337, DOI 10.1093/jac/dkv120; Chabria SB, 2014, ANNU REV GENOM HUM G, V15, P295, DOI 10.1146/annurev-genom-091212-153406; Charpentier C, 2010, AIDS, V24, P867, DOI 10.1097/QAD.0b013e3283367796; DiazGranados CA, 2010, INT J INFECT DIS, V14, pE298, DOI 10.1016/j.ijid.2009.05.006; Dudley DM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0122-8; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Frentz D, 2012, AIDS REV, V14, P17; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Holguin A, 2013, CLIN MICROBIOL INFEC, V19, pE523, DOI 10.1111/1469-0691.12264; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Kabamba-Mukadi B, 2010, HIV MED, V11, P483, DOI 10.1111/j.1468-1293.2009.00814.x; Kasang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023091; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Luciani F, 2012, TRENDS BIOTECHNOL, V30, P443, DOI 10.1016/j.tibtech.2012.05.005; Melikian GL, 2014, J ANTIMICROB CHEMOTH, V69, P12, DOI 10.1093/jac/dkt316; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; Novak RM, 2005, CLIN INFECT DIS, V40, P468, DOI 10.1086/427212; Paredes R, 2010, ANTIVIR RES, V85, P245, DOI 10.1016/j.antiviral.2009.09.015; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Pessoa R, 2015, TRANSFUSION, V55, P980, DOI 10.1111/trf.12936; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112674; Pillay D, 2004, ANTIVIR THER, V9, P695; Pilotto JH, 2013, AIDS RES HUM RETROV, V29, P681, DOI [10.1089/aid.2011.0333, 10.1089/AID.2011.0333]; Pires IL, 2004, J CLIN MICROBIOL, V42, P426, DOI 10.1128/JCM.42.1.426-430.2004; Rowley CF, 2016, J ANTIMICROB CHEMOTH, V71, P1361, DOI 10.1093/jac/dkv500; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Shafer RW, 2008, AIDS REV, V10, P67; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Ssemwanga D, 2015, AIDS REV, V17, P3; Truong HHM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025281; Van Laethem K, 1999, J ACQ IMMUN DEF SYND, V22, P107; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Xu HT, 2010, ANTIMICROB AGENTS CH, V54, P2401, DOI 10.1128/AAC.01795-09; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05	62	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185559	10.1371/journal.pone.0185559	http://dx.doi.org/10.1371/journal.pone.0185559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953964	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300076
J	Winther, TL; Torp, SH				Winther, Theo L.; Torp, Sverre H.			The anti-apoptotic protein survivin can improve the prognostication of meningioma patients	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MALIGNANT MENINGIOMAS; ATYPICAL MENINGIOMA; COLORECTAL-CANCER; NUCLEAR SURVIVIN; LABELING INDEX; GENETIC MODEL; EXPRESSION; PROLIFERATION; RECURRENCE	Background The 2016 WHO histopathological grading includes a substantial within-variation in recurrence risk, and is thus insufficient to predict prognosis after initial surgery of patients suffering from meningiomas. The aim of this study was to compare the prognostic value of the histopathological grading and the conventional biomarker MIB-1 with expression of the antiapoptotic protein survivin to see if this biomarker could complement recurrence prediction. Methods Using immunohistochemistry, the expression of MIB-1 and survivin were determined as labeling indices (LIs) in tissue micro arrays from 160 human meningiomas. The accuracy of prognostication was assessed with receiver operator characteristics analyses and standard survival analyses. Results The expression of survivin was significantly associated with both histopathological grade (P = 0.022) and recurrence status (P = 0.035). A survivin LI of 1% was identified as the optimal cutoff value to predict recurrence (P = 0.003), and was proven as more reliable than the histopathological grading (P = 0.497) and MIB-1 expression (P = 0.091). This result was further strengthened in multivariate analyses where survivin expression was revealed as an independent predictor of recurrence-free survival, while the histopathological grading and MIB-1 expression did not reach significance (P >= 0.156). Conclusions These findings suggest that incorporation of survivin in the clinical practice might be useful as complement for the histopathological grading and should further be evaluated in independent prospective studies.	[Winther, Theo L.; Torp, Sverre H.] Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Trondheim, Norway; [Torp, Sverre H.] St Olays Hosp, Dept Pathol & Med Genet, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Winther, TL (corresponding author), Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Trondheim, Norway.	theolw@stud.ntnu.no	Torp, Sverre Helge/AAN-4229-2020	Torp, Sverre Helge/0000-0001-8345-6852	Norwegian University of Science and Technology	Norwegian University of Science and Technology	This study was founded by the Norwegian University of Science and Technology, and 50 000 kr was recieved by TLW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Website: http://www.ntnu.no/.	Abry E, 2010, PATHOL RES PRACT, V206, P810, DOI 10.1016/j.prp.2010.09.002; Adida C, 1998, AM J PATHOL, V152, P43; Akat K, 2003, ACTA NEUROPATHOL, V106, P337, DOI 10.1007/s00401-003-0736-8; Al-Khalaf HH, 2008, BRAIN RES, V1188, P25, DOI 10.1016/j.brainres.2007.10.074; Alahmadi H, 2011, SEMIN DIAGN PATHOL, V28, P314, DOI 10.1053/j.semdp.2011.01.002; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231; Bayram S, 2011, CANCER EPIDEMIOL, V35, P555, DOI 10.1016/j.canep.2011.01.004; Boidot R, 2008, GENE CHROMOSOME CANC, V47, P299, DOI 10.1002/gcc.20533; Borges BD, 2011, CLIN EXP MED, V11, P189, DOI 10.1007/s10238-010-0122-5; Bruna J, 2007, NEUROPATHOLOGY, V27, P114, DOI 10.1111/j.1440-1789.2007.00750.x; Das A, 2003, CANCER LETT, V193, P217, DOI 10.1016/S0304-3835(02)00741-3; Fontaine B, 1991, ANN NY ACAD SCI, V615, P338; Gazouli M, 2009, INT J COLORECTAL DIS, V24, P145, DOI 10.1007/s00384-008-0601-2; Ho DMT, 2002, CANCER, V94, P1538, DOI 10.1002/cncr.10351; Jaiswal PK, 2015, INDIAN J MED RES, V141, P389, DOI 10.4103/0971-5916.159250; Jaiswal PK, 2012, MOL BIOL REP, V39, P5615, DOI 10.1007/s11033-011-1366-1; Joachim T, 2001, INT J CANCER, V94, P218, DOI 10.1002/ijc.1467; Kami K, 2004, SURGERY, V136, P443, DOI 10.1016/j.surg.2004.05.023; Kaur G, 2014, NEURO-ONCOLOGY, V16, P628, DOI 10.1093/neuonc/nou025; Kawasaki H, 1998, CANCER RES, V58, P5071; Kayaselcuk F, 2004, J NEURO-ONCOL, V67, P209, DOI 10.1023/B:NEON.0000021823.05163.2c; Lee SH, 2015, J KOREAN MED SCI, V30, P1157, DOI 10.3346/jkms.2015.30.8.1157; Leone PE, 1999, ONCOGENE, V18, P2231, DOI 10.1038/sj.onc.1202531; Lin H, 2012, MED ONCOL, V29, P1272, DOI 10.1007/s12032-011-9835-x; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu B, 2004, BRIT J CANCER, V91, P537, DOI 10.1038/sj.bjc.6602027; Lusis EA, 2005, J NEURO-ONCOL, V73, P219, DOI 10.1007/s11060-004-5233-y; MENON AG, 1990, CANCER SURV, V9, P689; Olar A, 2015, BRAIN PATHOL, V25, P266, DOI 10.1111/bpa.12174; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008; Perry A, 2016, WHO CLASSIFICATION T, P231; Preusser M, 2005, AM J CLIN PATHOL, V124, P543, DOI 10.1309/PP25GAAFKV82DTG; Ridley L, 2008, NEURO-ONCOLOGY, V10, P675, DOI 10.1215/15228517-2008-036; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Roser F, 2004, J CLIN PATHOL, V57, P1033, DOI 10.1136/jcp.2004.018333; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Shinohara ET, 2005, CANCER-AM CANCER SOC, V103, P1685, DOI 10.1002/cncr.20951; SIMON M, 1995, CANCER RES, V55, P4696; Tamm I, 1998, CANCER RES, V58, P5315; Theodoropoulos GE, 2010, PANCREAS, V39, P976, DOI 10.1097/MPA.0b013e3181d705d4; Torp SH, 2001, CLIN NEUROPATHOL, V20, P190; Vranic A., 2013, ISRN NEUROSCI, V2013; Weber RG, 1997, P NATL ACAD SCI USA, V94, P14719, DOI 10.1073/pnas.94.26.14719; Winther TL, 2016, AM J CLIN PATHOL, V146, P510, DOI [10.1093/AJCP/AQW141, 10.1093/ajcp/aqw141]; Zhen HN, 2005, CANCER-AM CANCER SOC, V104, P2775, DOI 10.1002/cncr.21490	48	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185217	10.1371/journal.pone.0185217	http://dx.doi.org/10.1371/journal.pone.0185217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953948	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300045
J	Mitura, A; Niemczuk, K; Zareba, K; Zajac, M; Laroucau, K; Szymanska-Czerwinska, M				Mitura, Agata; Niemczuk, Krzysztof; Zareba, Kinga; Zajac, Magdalena; Laroucau, Karine; Szymanska-Czerwinska, Monika			Free-living and captive turtles and tortoises as carriers of new Chlamydia spp.	PLOS ONE			English	Article							MOLECULAR EVIDENCE; CHLAMYDOPHILA-PNEUMONIAE; FAMILY CHLAMYDIACEAE; CROCODILES; INFECTION; REPTILES; IDENTIFICATION; MYCOBACTERIA; PROPOSAL; ALIEN	A variety of Chlamydia species belonging to the Chlamydiaceae family have been reported in reptilian hosts but scarce data about their occurrence in turtles and tortoises are available. In this study, research was conducted to acquire information on invasive alien species (IAS) of turtles and indigenous turtles and tortoises, living both free and in captivity, as possible reservoirs of Chlamydiaceae. Analysis of specimens (pharyngeal and cloacal swabs and tissues) from 204 turtles and tortoises revealed an overall Chlamydiaceae prevalence of 18.3% and 28.6% among free-living and captive animals respectively, with variable levels of shedding. Further testing conducted with a species-specific real-time PCR and microarray test was unsuccessful. Subsequently sequencing was applied to genotype the Chlamydiaceae-positive samples. Almost the full lengths of the 16S rRNA and ompA genes as well as the 16S-23S intergenic spacer (IGS) and 23S rRNA domain I were obtained for 14, 20 and 8 specimens respectively. Phylogenetic analysis of 16S rRNA amplicons revealed two distinct branches. Group 1 (10 specimens), specific to freshwater turtles and reported here for the first time, was most closely related to Chlamydia (C.) pneumoniae strains and the newly described Candidatus C. sanzinia. Group 2 (four specimens), detected in Testudo spp. samples, showed highest homology to C. pecorum strains but formed a separate sub-branch. Finally, molecular analysis conducted on positive samples together with their geographical distribution in places distant from each other strongly suggest that Group 1 specimens correspond to a new species in the Chlamydiaceae family. In-depth studies of Chlamydia spp. from turtles and tortoises are needed to further characterise these atypical strains and address arising questions about their pathogenicity and zoonotic potential.	[Mitura, Agata; Niemczuk, Krzysztof; Zareba, Kinga; Szymanska-Czerwinska, Monika] Natl Inst Vet Res, Dept Cattle & Sheep Dis, Pulawy, Poland; [Zajac, Magdalena] Natl Inst Vet Res, Dept Microbiol, Pulawy, Poland; [Laroucau, Karine] Univ Paris Est, Anim Hlth Lab, Bacterial Zoonoses Unit, Anses, Maisons Alfort, France	National Veterinary Institute - National Research Institute; National Veterinary Institute - National Research Institute; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Mitura, A (corresponding author), Natl Inst Vet Res, Dept Cattle & Sheep Dis, Pulawy, Poland.	agata.mitura@piwet.pulawy.pl	Mitura, Agata/ABC-9809-2020; Niemczuk, Krzysztof/AAV-7798-2021; Zaręba-Marchewka, Kinga/AAX-3839-2020; Zajac, Magdalena/Q-1909-2019; Szymańska-Czerwińska, Monika/ABI-7174-2020; Laroucau, Karine/GSO-1980-2022	Niemczuk, Krzysztof/0000-0003-1611-9770; Zaręba-Marchewka, Kinga/0000-0003-0657-4171; Zajac, Magdalena/0000-0002-8155-7614; Szymańska-Czerwińska, Monika/0000-0001-8974-0870; Laroucau, Karine/0000-0001-7605-8602	Polish National Science Centre project "Invasive turtle species as a source and vector of animal and human pathogens" [2013/11/B/NZ7/01690]	Polish National Science Centre project "Invasive turtle species as a source and vector of animal and human pathogens"	This work was supported by the Polish National Science Centre project Invasive turtle species as a source and vector of animal and human pathogens (Grant No. 2013/11/B/NZ7/01690) to AM.	Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bodetti TJ, 2002, SYST APPL MICROBIOL, V25, P146, DOI 10.1078/0723-2020-00086; Bouricha M, 2014, INT J INFECT DIS, V21, P17, DOI 10.1016/j.ijid.2013.11.020; Cadi A, 2004, AQUAT CONSERV, V14, P237, DOI 10.1002/aqc.607; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; Di Ianni F, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0405-x; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Ebani VV, 2012, RES VET SCI, V93, P1136, DOI 10.1016/j.rvsc.2012.05.006; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Frutos MC, 2014, REV ARGENT MICROBIOL, V46, P45, DOI 10.1016/S0325-7541(14)70047-1; Golawska O, 2017, POSTEP MIKROBIOL, V56, P163; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Harris JR, 2010, CLIN INFECT DIS, V50, P554, DOI 10.1086/649932; Hotzel H, 2005, VET RES COMMUN, V29, P71, DOI 10.1007/s11259-005-0838-y; Huchzermeyer FW, 2008, J S AFR VET ASSOC, V79, P99; Huchzermeyer FW, 2002, REV SCI TECH OIE, V21, P265, DOI 10.20506/rst.21.2.1334; HUCHZERMEYER FW, 1994, J S AFR VET ASSOC, V65, P20; Jacobson E, 2002, J VET DIAGN INVEST, V14, P487, DOI 10.1177/104063870201400607; JACOBSON ER, 1990, J WILDLIFE DIS, V26, P572, DOI 10.7589/0090-3558-26.4.572; Jodelko A, 2017, PLOS ONE, V12; Kabeya H, 2015, MICROBIOL IMMUNOL, V59, P507, DOI 10.1111/1348-0421.12287; Kohhepp SJ, 2005, J CLIN MICROBIOL, V43, P3030, DOI 10.1128/JCM.43.6.3030.2005; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Nagano N, 2006, JPN J INFECT DIS, V59, P132; Oi M, 2012, RES VET SCI, V93, P826, DOI 10.1016/j.rvsc.2011.10.001; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Pees M, 2010, EUROSURVEILLANCE, V18; Pudjiatmoko, 1997, INT J SYST BACTERIOL, V47, P425; Rivera S, 2009, J VET DIAGN INVEST, V21, P415, DOI 10.1177/104063870902100402; Robertson T, 2010, VET MICROBIOL, V145, P373, DOI 10.1016/j.vetmic.2010.04.007; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Sariya L, 2015, JPN J VET RES, V63, P5; Soldati G, 2004, VET PATHOL, V41, P388, DOI 10.1354/vp.41-4-388; Szymanska-Czerwinska M, 2013, B VET I PULAWY, V57, P25, DOI 10.2478/bvip-2013-0005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor-Brown A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3055-x; Taylor-Brown A, 2015, VET MICROBIOL, V178, P88, DOI 10.1016/j.vetmic.2015.04.021; Taylor-Brown A, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu009; Thomas V, 2006, ENVIRON MICROBIOL, V8, P2125, DOI 10.1111/j.1462-2920.2006.01094.x; Thompson PE, 1944, J INFECT DIS, V74, P68, DOI 10.1093/infdis/74.1.68; Wasyl D, 2013, VET MICROBIOL; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315; Zimmerman LM, 2013, J EXP BIOL, V216, P633, DOI 10.1242/jeb.078832	44	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185407	10.1371/journal.pone.0185407	http://dx.doi.org/10.1371/journal.pone.0185407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950002	Green Submitted, Green Published, gold			2022-12-26	WOS:000411671000050
J	Melo, HA; Rossoni, DF; Teodoro, U				Melo, Helen Aline; Rossoni, Diogo Francisco; Teodoro, Ueslei			Spatial distribution of cutaneous leishmaniasis in the state of Parana, Brazil	PLOS ONE			English	Article							SOUTHERN BRAZIL; MUNICIPALITY; PSYCHODIDAE; WHITMANI; DIPTERA; VECTOR	The geographic distribution of cutaneous leishmaniasis (CL) makes it a disease of major clinical importance in Brazil, where it is endemic in the state of Parana A. The objective of this study was to analyze the spatial distribution of CL in Parana A between 2001 and 2015, based on data from the Sistema de Informacao de Agravos de Notificacao (Information System for Notifiable Diseases) regarding autochthonous CL cases. Spatial autocorrelation was performed using Moran's Global Index and the Local Indicator of Spatial Association (LISA). The construction of maps was based on categories of association (high-high, low-low, highlow, and low-high). A total of 4,557 autochthonous cases of CL were registered in the state of Parana A, with an annual average of 303.8 (+/- 135.2) and a detection coefficient of 2.91. No correlation was found between global indices and their respective significance in 2001 (I = -0.456, p = 0.676), but evidence of spatial autocorrelation was found in other years (p< 0.05). In the construction and analysis of the cluster maps, areas with a high-high positive association were found in the Ivai-Pirapo, Tibagi, Cinzas-Laranjinha, and Ribeira areas. The state of Parana A should keep a constant surveillance over CL due to the prominent presence of socioeconomic and environmental factors such as the favorable circumstances for the vectors present in peri-urban and agriculture areas.	[Melo, Helen Aline; Teodoro, Ueslei] Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, PR, Brazil; [Rossoni, Diogo Francisco] Univ Estadual Maringa, Dept Stat, Maringa, PR, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Melo, HA (corresponding author), Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, PR, Brazil.	helen_alinemelo@hotmail.com						Anselin L, 2013, SPATIAL ECONOMETRICS; Bivand R, 2015, J STAT SOFTW, V63, P1; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; CAMARA G, 2002, ANAL ESPACIAL DADOS, P1; da Silva AM, 2008, NEOTROP ENTOMOL, V37, P209, DOI 10.1590/S1519-566X2008000200017; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Fonseca ED, 2014, J VECTOR DIS, V51, P271; Instituto Agronomico do Parana, 2002, CARTAS CLIMATICAS PA; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2010, CENS DEM 2010; Instituto Brasileiro de Geografia e Estatistica, 2016, EST POP; Lima Airton Pereira, 2002, An. Bras. Dermatol., V77, P681, DOI 10.1590/S0365-05962002000600005; Lonardoni Maria Valdrinez Campana, 2006, Cad. Saúde Pública, V22, P2713, DOI 10.1590/S0102-311X2006001200020; Lovelock J, 2010, GAIA ALERTA FINAL; Luz E, 2000, ANN TROP MED PARASIT, V94, P623, DOI 10.1080/00034983.2000.11813585; Magalhaes GB, 2012, HYGIEA, V8, P63; Massunari GK, 2009, CAD SAUDE PUBLICA, V25, P97, DOI 10.1590/S0102-311X2009000100010; Medronho Roberto de Andrade, 2003, Rev. bras. epidemiol., V6, P328; Membrive NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047050; Ministerio da Saude (BR), 2016, GUIA VIG SAUD; Mollalo A, 2015, ZOONOSES PUBLIC HLTH, V62, P18, DOI 10.1111/zph.12109; Monteiro WM, 2008, CAD SAUDE PUBLICA, V24, P1291, DOI 10.1590/S0102-311X2008000600010; Monteiro WM, 2009, CAD SAUDE PUBLICA, V25, P1082; Neitzke-Abreu HC, 2014, REV INST MED TROP SP, V56, P391, DOI 10.1590/S0036-46652014000500004; Oliveira DM, 2011, VECTOR-BORNE ZOONOT, V11, P137, DOI 10.1089/vbz.2009.0218; R Development Core Team, 2014, R LANG ENV STAT; Reinhold-Castro KR, 2013, J VECTOR ECOL, V38, P63, DOI 10.1111/j.1948-7134.2013.12009.x; Reinhold-Castro KR, 2008, REV SOC BRAS MED TRO, V41, P269, DOI 10.1590/S0037-86822008000300009; Teodoro U., 2001, Revista de Patologia Tropical, V30, P209; Teodoro U., 1998, REV SOC BRASILEIRA M, V31, P517; Voltarelli EM, 2009, J VENOM ANIM TOXINS, V15, P732, DOI 10.1590/S1678-91992009000400011; Zanzarini Paulo Donizeti, 2005, Cad. Saúde Pública, V21, P1957, DOI 10.1590/S0102-311X2005000600047	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185401	10.1371/journal.pone.0185401	http://dx.doi.org/10.1371/journal.pone.0185401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938013	Green Published, Green Submitted, gold			2022-12-26	WOS:000411524700031
J	Hall, J; Brault, A; Vincent, F; Weng, S; Wang, H; Dumlao, D; Aulabaugh, A; Aivazian, D; Castro, D; Chen, M; Culp, J; Dower, K; Gardner, J; Hawrylik, S; Golenbock, D; Hepworth, D; Horn, M; Jones, L; Jones, P; Latz, E; Li, J; Lin, LL; Lin, W; Lin, D; Lovering, F; Niljanskul, N; Nistler, R; Pierce, B; Plotnikova, O; Schmitt, D; Shanker, S; Smith, J; Snyder, W; Subashi, T; Trujillo, J; Tyminski, E; Wang, GX; Wong, J; Lefker, B; Dakin, L; Leach, K				Hall, Justin; Brault, Amy; Vincent, Fabien; Weng, Shawn; Wang, Hong; Dumlao, Darren; Aulabaugh, Ann; Aivazian, Dikran; Castro, Dana; Chen, Ming; Culp, Jeffrey; Dower, Ken; Gardner, Joseph; Hawrylik, Steven; Golenbock, Douglas; Hepworth, David; Horn, Mark; Jones, Lyn; Jones, Peter; Latz, Eicke; Li, Jing; Lin, Lih-Ling; Lin, Wen; Lin, David; Lovering, Frank; Niljanskul, Nootaree; Nistler, Ryan; Pierce, Betsy; Plotnikova, Olga; Schmitt, Daniel; Shanker, Suman; Smith, James; Snyder, William; Subashi, Timothy; Trujillo, John; Tyminski, Edyta; Wang, Guoxing; Wong, Jimson; Lefker, Bruce; Dakin, Leslie; Leach, Karen			Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay	PLOS ONE			English	Article							CYCLIC GMP-AMP; AICARDI-GOUTIERES-SYNDROME; CYTOSOLIC DNA SENSOR; EXONUCLEASE TREX1; STING PATHWAY; GENE; 2ND-MESSENGER; MUTATIONS; MECHANISM; SYNTHASE	Cyclic GMP-AMP synthase (cGAS) initiates the innate immune system in response to cytosolic dsDNA. After binding and activation from dsDNA, cGAS uses ATP and GTP to synthesize 2'0, 30' -cGAMP (cGAMP), a cyclic dinucleotide second messenger with mixed 20-50 and 30-50 phosphodiester bonds. Inappropriate stimulation of cGAS has been implicated in autoimmune disease such as systemic lupus erythematosus, thus inhibition of cGAS may be of therapeutic benefit in some diseases; however, the size and polarity of the cGAS active site makes it a challenging target for the development of conventional substrate-competitive inhibitors. We report here the development of a high affinity (K-D = 200 nM) inhibitor from a low affinity fragment hit with supporting biochemical and structural data showing these molecules bind to the cGAS active site. We also report a new high throughput cGAS fluorescence polarization (FP)-based assay to enable the rapid identification and optimization of cGAS inhibitors. This FP assay uses Cy5-labelled cGAMP in combination with a novel high affinity monoclonal antibody that specifically recognizes cGAMP with no cross reactivity to cAMP, cGMP, ATP, or GTP. Given its role in the innate immune response, cGAS is a promising therapeutic target for autoinflammatory disease. Our results demonstrate its druggability, provide a high affinity tool compound, and establish a high throughput assay for the identification of next generation cGAS inhibitors.	[Hall, Justin; Brault, Amy; Vincent, Fabien; Wang, Hong; Dumlao, Darren; Aulabaugh, Ann; Chen, Ming; Culp, Jeffrey; Hawrylik, Steven; Lin, Wen; Lin, David; Niljanskul, Nootaree; Pierce, Betsy; Plotnikova, Olga; Schmitt, Daniel; Shanker, Suman; Smith, James; Subashi, Timothy; Trujillo, John; Wong, Jimson] Pfizer, Med Design, Groton, CT 06340 USA; [Weng, Shawn; Nistler, Ryan; Tyminski, Edyta; Wang, Guoxing; Leach, Karen] Pfizer Ctr Therapeut Innovat CTI, Boston, MA USA; [Aivazian, Dikran; Castro, Dana; Horn, Mark; Snyder, William] Pfizer Ctr Therapeut Innovat CTI, San Diego, CA USA; [Dower, Ken; Lin, Lih-Ling] Pfizer, Inflammat & Immunol, Cambridge, MA USA; [Gardner, Joseph] Pfizer, External Res Solut, Groton, CT USA; [Golenbock, Douglas; Latz, Eicke] Univ Massachusetts, Sch Med, Worcester, MA USA; [Hepworth, David; Jones, Lyn; Jones, Peter; Li, Jing; Lovering, Frank; Lefker, Bruce; Dakin, Leslie] Pfizer, Med Design, Cambridge, MA USA; [Latz, Eicke] Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; University of Massachusetts System; University of Massachusetts Worcester; Pfizer; University of Bonn	Hall, J (corresponding author), Pfizer, Med Design, Groton, CT 06340 USA.	justin.hall@pfizer.com	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; Jones, Lyn/0000-0002-8388-5865; Lin, David/0000-0002-5471-9841	Pfizer	Pfizer(Pfizer)	Pfizer provided support in the form of salaries for the following authors: JH, AB, FV, SW, HW, DD, AA, DA, DC, MC, JC, KD, JG, SH, DH, MH, LJ, PJ, JL, LL, WL, DL, FL, NN, RN, BP, OP, DS, SS, JS, WS, TS, JT, ET, GW, JW, BL, LD, KL. Pfizer did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Bose D, 2016, CELL CHEM BIOL, V23, P1539, DOI 10.1016/j.chembiol.2016.10.014; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Chow J, 2015, VIROLOGY, V479, P104, DOI 10.1016/j.virol.2015.02.051; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hall JD, 2016, PROTEIN SCI, V25, P360, DOI 10.1002/pro.2821; Junt T, 2015, NAT REV IMMUNOL, V15, P529, DOI 10.1038/nri3875; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Lee-Kirsch MA, 2016, ANN REV MED; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nyarko E, 2016, ARTHRITIS RHEUMATOL, V68; Perola E, 2012, J CHEM INF MODEL, V52, P1027, DOI 10.1021/ci200613b; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Shestakova TS, 2013, J ORG CHEM, V78, P6975, DOI 10.1021/jo4008207; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tao JL, 2016, IUBMB LIFE, V68, P858, DOI 10.1002/iub.1566; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Vance RE, 2016, IMMUNITY, V45, P227, DOI 10.1016/j.immuni.2016.08.006; Wang Q, 2015, EXPERT OPIN THER TAR, V19, P1397, DOI 10.1517/14728222.2015.1067303; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu XM, 2014, NUCLEIC ACIDS RES, V42, P8243, DOI 10.1093/nar/gku569; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003	37	64	71	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184843	10.1371/journal.pone.0184843	http://dx.doi.org/10.1371/journal.pone.0184843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934246	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900050
J	Piao, L; Fang, YH; Kubler, MM; Donnino, MW; Sharp, WW				Piao, Lin; Fang, Yong-Hu; Kubler, Manfred M.; Donnino, Michael W.; Sharp, Willard W.			Enhanced pyruvate dehydrogenase activity improves cardiac outcomes in a murine model of cardiac arrest	PLOS ONE			English	Article							GLUCOSE-OXIDATION; INDUCED HYPOTHERMIA; MILD HYPOTHERMIA; DICHLOROACETATE; RESUSCITATION; REPERFUSION; INHIBITION; METABOLISM; ISCHEMIA; SURVIVAL	Rationale Post-ischemic changes in cellular metabolism alter myocardial and neurological function. Pyruvate dehydrogenase (PDH), the limiting step in mitochondrial glucose oxidation, is inhibited by increased expression of PDH kinase (PDK) during ischemia/reperfusion injury. This results in decreased utilization of glucose to generate cellular ATP. Post-cardiac arrest (CA) hypothermia improves outcomes and alters metabolism, but its influence on PDH and PDK activity following CA are unknown. We hypothesized that therapeutic hypothermia (TH) following CA is associated with the inhibition of PDK activity and increased PDH activity. We further hypothesized that an inhibitor of PDK activity, dichloroacetate (DCA), would improve PDH activity and post-CA outcomes. Methods and results Anesthetized and ventilated adult female C57BL/6 wild-type mice underwent a 12-minute KCl-induced CA followed by cardiopulmonary resuscitation. Compared to normothermic (37 E C) CA controls, administering TH (30 degrees C) improved overall survival (72-hour survival rate: 62.5% vs. 28.6%, P<0.001), post-resuscitation myocardial function (ejection fraction: 50.9 +/- 3.1% vs. 27.2 +/- 2.0%, P<0.001; aorta systolic pressure: 132.7 +/- 7.3 vs. 72.3 +/- 3.0 mmHg, P<0.001), and neurological scores at 72-hour post CA (9.5 +/- 1.3 vs. 5.4 +/- 1.3, P<0.05). In both heart and brain, CA increased lactate concentrations (1.9-fold and 3.1-fold increase, respectively, P<0.01), decreased PDH enzyme activity (24% and 50% reduction, respectively, P<0.01), and increased PDK protein expressions (1.2-fold and 1.9-fold, respectively, P<0.01). In contrast, post-CA treatment with TH normalized lactate concentrations (P<0.01 and P<0.05) and PDK expressions (P<0.001 and P<0.05), while increasing PDH activity (P<0.01 and P<0.01) in both the heart and brain. Additionally, treatment with DCA (0.2 mg/g body weight) 30 min prior to CA improved both myocardial hemodynamics 2 hours post-CA (aortic systolic pressure: 123 +/- 3 vs. 96 +/- 4 mmHg, P<0.001) and 72-hour survival rates (50% vs. 19%, P<0.05) in normothermic animals. Conclusions Enhanced PDH activity in the setting of TH or DCA administration is associated with improved post-CA resuscitation outcomes. PDH is a promising therapeutic target for improving post-CA outcomes.	[Piao, Lin; Fang, Yong-Hu; Kubler, Manfred M.; Sharp, Willard W.] Univ Chicago, Sect Emergency Med, Chicago, IL 60637 USA; [Piao, Lin; Fang, Yong-Hu; Kubler, Manfred M.; Sharp, Willard W.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA	University of Chicago; University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Sharp, WW (corresponding author), Univ Chicago, Sect Emergency Med, Chicago, IL 60637 USA.; Sharp, WW (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	wsharp@medicine.bsd.uchicago.edu	Sharp, Willard/AAB-9972-2020	Sharp, Willard/0000-0002-7175-3523	NIH [R01HL133675]; University of Chicago Women's Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133675] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Women's Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from NIH grant R01HL133675 and from the University of Chicago Women's Board.; This work was supported by funding from NIH grant R01HL133675 and from the University of Chicago Women's Board.	Azam MA, 2015, AM J PHYSIOL-HEART C, V309, pH1543, DOI 10.1152/ajpheart.00404.2015; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9; Fiskum G, 2008, ANN NY ACAD SCI, V1147, P129, DOI 10.1196/annals.1427.026; Gilbert NF, 2002, ANN THORAC SURG, V74, P1208, DOI 10.1016/S0003-4975(02)03873-0; GINSHAW SL, 1988, ANN EMERG MED, V17, P473, DOI 10.1016/S0196-0644(88)80239-7; Gorecka M, 2016, IRISH IR J MED SCI; Holzer M, 2002, NEW ENGL J MED, V346, P549; Huang CH, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0516-3; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; LEWANDOWSKI ED, 1995, CIRCULATION, V91, P2071, DOI 10.1161/01.CIR.91.7.2071; Li J, 2015, AM J PHYSIOL-HEART C, V308, pH1414, DOI 10.1152/ajpheart.00748.2014; Makino J, 2005, CRIT CARE, V9, pR357, DOI 10.1186/cc3714; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Masoud WGT, 2014, CARDIOVASC RES, V101, P30, DOI 10.1093/cvr/cvt216; Ning XH, 2007, AM J PHYSIOL-HEART C, V293, pH2119, DOI 10.1152/ajpheart.00123.2007; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Piao L, 2010, J MOL MED, V88, P1011, DOI 10.1007/s00109-010-0679-1; PULSINELLI WA, 1982, ANN NEUROL, V11, P499, DOI 10.1002/ana.410110510; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Shao ZH, 2010, AM J PHYSIOL-HEART C, V298, pH2164, DOI 10.1152/ajpheart.00994.2009; Sharp Willard W, 2015, Crit Care Med, V43, pe38, DOI 10.1097/CCM.0000000000000817; SHEU KFR, 1985, ANN NEUROL, V17, P444; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Stanley WC, 1997, CARDIOVASC RES, V33, P243, DOI 10.1016/S0008-6363(96)00245-3; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030; Sun YY, 2016, ONCOTARGET, V7, P31708, DOI 10.18632/oncotarget.9150; Taniguchi M, 2001, AM J PHYSIOL-HEART C, V280, pH1762, DOI 10.1152/ajpheart.2001.280.4.H1762; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Weinberg Guy L, 2007, Expert Rev Cardiovasc Ther, V5, P135, DOI 10.1586/14779072.5.2.135; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; Zhang XW, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1133-0; Zhao DH, 2008, RESUSCITATION, V77, P242, DOI 10.1016/j.resuscitation.2007.10.015; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185046	10.1371/journal.pone.0185046	http://dx.doi.org/10.1371/journal.pone.0185046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934276	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900080
J	Yassin, AK; Gong, JS; Kelly, P; Lu, GW; Guardabassi, L; Wei, LJ; Han, XG; Qiu, HX; Price, S; Cheng, DR; Wang, CM				Yassin, Afrah Kamal; Gong, Jiansen; Kelly, Patrick; Lu, Guangwu; Guardabassi, Luca; Wei, Lanjing; Han, Xiangan; Qiu, Haixiang; Price, Stuart; Cheng, Darong; Wang, Chengming			Antimicrobial resistance in clinical Escherichia coli isolates from poultry and livestock, China	PLOS ONE			English	Article							FOOD ANIMALS; CHICKENS; INTEGRONS; SAMPLES; SWINE	Poultry and livestock are the most important reservoirs for pathogenic Escherichia coli and use of antimicrobials in animal farming is considered the most important factor promoting the emergence, selection and dissemination of antimicrobial-resistant microorganisms. The aim of our study was to investigate antimicrobial resistance in E. coli isolated from food animals in Jiangsu, China. The disc diffusion method was used to determine susceptibility to 18 antimicrobial agents in 862 clinical isolates collected from chickens, ducks, pigs, and cows between 2004 and 2012. Overall, 94% of the isolates showed resistance to at least one drug with 83% being resistance to at least three different classes of antimicrobials. The isolates from the different species were most commonly resistant to tetracycline, nalidixic acid, sulfamethoxazole, trimethoprim/sulfamethoxazole and ampicillin, and showed increasing resistance to amikacin, aztreonam, ceftazidime, cefotaxime, chloramphenicol, ciprofloxacin. They were least resistant to amoxicillin/clavulanic acid (3.4%) and ertapenem (0.2%). MDR was most common in isolates from ducks (44/44, 100%), followed by chickens (568/644, 88.2%), pigs (93/113, 82.3%) and cows (13/61, 21.3%). Our finding that clinical E. coli isolates from poultry and livestock are commonly resistant to multiple antibiotics should alert public health and veterinary authorities to limit and rationalize antimicrobial use in China.	[Yassin, Afrah Kamal; Lu, Guangwu; Qiu, Haixiang; Cheng, Darong; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Yassin, Afrah Kamal] Univ Khartoum, Fac Publ & Environm Hlth, Dept Food Hyg & Safety, Khartoum, Sudan; [Gong, Jiansen] Chinese Acad Agr Sci, Poultry Inst, Yangzhou, Jiangsu, Peoples R China; [Kelly, Patrick; Guardabassi, Luca] Ross Univ, Dept Biomed Sci, Sch Vet Med, Basseterre, St Kitts & Nevi; [Wei, Lanjing] Kansas State Univ, Dept Diagnost Med, Manhattan, KS 66506 USA; [Han, Xiangan] Chinese Acad Agr Sci Shanghai, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Price, Stuart; Wang, Chengming] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	Yangzhou University; University of Khartoum; Chinese Academy of Agricultural Sciences; Kansas State University; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Auburn University System; Auburn University	Cheng, DR; Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.; Wang, CM (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	jsyzcdr@aliyun.com; wangche@auburn.edu		Guardabassi, Luca/0000-0002-2389-5084; Han, Xiangan/0000-0001-5625-637X	National Key R AMP; D Program of China [2016YFD0500804]	National Key R AMP; D Program of China	This project is funded by the National Key R & D Program of China (2016YFD0500804). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2004, J VET MED B, V51, P380, DOI 10.1111/j.1439-0450.2004.00775.x; Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Akhtardanesh B, 2016, VET RES FORUM, V7, P301; Atnafie B, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0938-1; Boyen F, 2010, VET MICROBIOL, V144, P359, DOI 10.1016/j.vetmic.2010.01.010; Chambers Lindsey, 2015, PLoS One, V10, pe0133764, DOI 10.1371/journal.pone.0133764; Chen X, 2014, VET J, V202, P112, DOI 10.1016/j.tvjl.2014.06.016; CLSI, 2013, VET01A4 CLSI; Dai L, 2008, FEMS MICROBIOL LETT, V286, P178, DOI 10.1111/j.1574-6968.2008.01272.x; Fish DN, 2006, CRIT CARE CLIN, V22, P291, DOI 10.1016/j.ccc.2006.02.006; Gong JS, 2013, AVIAN PATHOL, V42, P290, DOI 10.1080/03079457.2013.788129; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; Lei T, 2010, VET MICROBIOL, V146, P85, DOI 10.1016/j.vetmic.2010.04.025; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Lu LM, 2010, ACTA TROP, V113, P20, DOI 10.1016/j.actatropica.2009.08.028; Olowe OA, 2008, AFR J MICROBIOL RES, V2, P8; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; Wang GQ, 2008, VET MICROBIOL, V127, P73, DOI 10.1016/j.vetmic.2007.08.003; Wang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156889; White DG, 2000, J CLIN MICROBIOL, V38, P4593, DOI 10.1128/JCM.38.12.4593-4598.2000; Yang HC, 2004, J CLIN MICROBIOL, V42, P3483, DOI 10.1128/JCM.42.8.3483-3489.2004; Zhang P, 2017, VET MICROBIOL, V203, P49, DOI 10.1016/j.vetmic.2017.02.008; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729	26	58	61	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185326	10.1371/journal.pone.0185326	http://dx.doi.org/10.1371/journal.pone.0185326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934348	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900147
J	Amanzougaghene, N; Fenollar, F; Sangare, AK; Sissoko, MS; Doumbo, OK; Raoult, D; Mediannikov, O				Amanzougaghene, Nadia; Fenollar, Florence; Sangare, Abdoul Karim; Sissoko, Mahamadou S.; Doumbo, Ogobara K.; Raoult, Didier; Mediannikov, Oleg			Detection of bacterial pathogens including potential new species in human head lice from Mali	PLOS ONE			English	Article							HUMAN-BODY LOUSE; BARTONELLA-QUINTANA; COXIELLA-BURNETII; EXPERIMENTAL-MODEL; HUMAN EHRLICHIOSIS; AFRICAN BODY; Q-FEVER; INFECTION; PREVALENCE; CAPITIS	In poor African countries, where no medical and biological facilities are available, the identification of potential emerging pathogens of concern at an early stage is challenging. Head lice, Pediculus humanus capitis, have a short life, feed only on human blood and do not transmit pathogens to their progeny. They are, therefore, a perfect tool for the xenodiagnosis of current or recent human infection. This study assessed the occurrence of bacterial pathogens from head lice collected in two rural villages from Mali, where a high frequency of head lice infestation had previously been reported, using molecular methods. Results show that all 600 head lice, collected from 117 individuals, belonged to clade E, specific to West Africa. Bartonella quintana, the causative agent of trench fever, was identified in three of the 600 (0.5%) head lice studied. Our study also shows, for the first time, the presence of the DNA of two pathogenic bacteria, namely Coxiella burnetii (5.1%) and Rickettsia aeschlimannii (0.6%), detected in human head lice, as well as the DNA of potential new species from the Anaplasma and Ehrlichia genera of unknown pathogenicity. The finding of several Malian head lice infected with B. quintana, C. burnetii, R. aeschlimannii, Anaplasma and Ehrlichia is alarming and highlights the need for active survey programs to define the public health consequences of the detection of these emerging bacterial pathogens in human head lice.	[Amanzougaghene, Nadia; Fenollar, Florence; Raoult, Didier; Mediannikov, Oleg] Aix Marseille Univ, AP HM, CNRS, INSERM,IRD,IHU Mediterranee Infect,URMITE, Marseille, France; [Sangare, Abdoul Karim; Sissoko, Mahamadou S.; Doumbo, Ogobara K.] Univ Bamako, Fac Med & Odontostomatol, Fac Pharm MRTC DEAP FMOS FAPH, Epidemiol Dept Parasit Dis, Bamako, Mali; [Raoult, Didier; Mediannikov, Oleg] Campus Int UCAD IRD, Dakar, Senegal	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University of Bamako	Raoult, D; Mediannikov, O (corresponding author), Aix Marseille Univ, AP HM, CNRS, INSERM,IRD,IHU Mediterranee Infect,URMITE, Marseille, France.; Raoult, D; Mediannikov, O (corresponding author), Campus Int UCAD IRD, Dakar, Senegal.	didier.raoult@gmail.com; olegusss1@gmail.com	RAOULT, Didier/A-8434-2008; Mediannikov, Oleg/H-4018-2015	RAOULT, Didier/0000-0002-0633-5974; Mediannikov, Oleg/0000-0001-6039-2008	IHU Mediterranee Infection	IHU Mediterranee Infection	This study was funded by the IHU Mediterranee Infection (http://en.mediterranee-infectioncom/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzougaghene N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005142; Amanzougaghene N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164659; Angelakis E, 2014, INT J INFECT DIS, V28, P107, DOI 10.1016/j.ijid.2014.05.029; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Angelakis E, 2011, FEMS IMMUNOL MED MIC, V62, P244, DOI 10.1111/j.1574-695X.2011.00804.x; Ashfaq M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14188; Ayyadurai S, 2010, EMERG INFECT DIS, V16, P892, DOI 10.3201/eid1605.091280; BABUDIERI B., 1959, ADVANCES VET SCI, V5, P81; Benslimani A, 2005, EMERG INFECT DIS, V11, P216, DOI 10.3201/eid1102.040668; Bonilla DL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003724; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; Boutellis A, 2013, EMERG INFECT DIS, V19, P796, DOI 10.3201/eid1905.121480; Boutellis A, 2012, VECTOR-BORNE ZOONOT, V12, P564, DOI 10.1089/vbz.2011.0845; BROUQUI P, 1994, EUR J EPIDEMIOL, V10, P695, DOI 10.1007/BF01719283; Brouqui P, 2011, ANNU REV ENTOMOL, V56, P357, DOI 10.1146/annurev-ento-120709-144739; Cutler S, 2012, COMP IMMUNOL MICROB, V35, P17, DOI 10.1016/j.cimid.2011.09.007; Dahmani M, 2017, TICKS TICK-BORNE DIS, V8, P18, DOI 10.1016/j.ttbdis.2016.09.009; Diatta G, 2014, AM J TROP MED HYG, V91, P291, DOI 10.4269/ajtmh.13-0685; Djiba ML, 2013, TROP ANIM HEALTH PRO, V45, P1557, DOI 10.1007/s11250-013-0399-y; Drali Rezak, 2013, PLoS One, V8, pe58088, DOI 10.1371/journal.pone.0058088; Drali R, 2015, AM J TROP MED HYG, V93, P990, DOI 10.4269/ajtmh.14-0686; Drancourt M, 1996, J CLIN MICROBIOL, V34, P1158, DOI 10.1128/JCM.34.5.1158-1160.1996; Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Ehounoud CB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004367; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Fournier PE, 2002, EMERG INFECT DIS, V8, P1515, DOI 10.3201/eid0812.020111; Gatesy J, 1997, MOL PHYLOGENET EVOL, V7, P303, DOI 10.1006/mpev.1997.0402; GIROUD PAUL, 1954, BULL SOC PATHOL EXOT, V47, P764; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Houhamdi L, 2006, AM J TROP MED HYG, V74, P526, DOI 10.4269/ajtmh.2006.74.526; Houhamdi L, 2003, ANN NY ACAD SCI, V990, P617, DOI 10.1111/j.1749-6632.2003.tb07436.x; Houhamdi L, 2006, AM J TROP MED HYG, V74, P525; Houhamdi L, 2006, J INFECT DIS, V194, P1589, DOI 10.1086/508995; Kim JH, 2011, INSECT BIOCHEM MOLEC, V41, P332, DOI 10.1016/j.ibmb.2011.01.011; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Koehler JE, 1997, NEW ENGL J MED, V337, P1876, DOI 10.1056/NEJM199712253372603; La Scola B, 2001, J CLIN MICROBIOL, V39, P1707, DOI 10.1128/JCM.39.5.1707-1709.2001; Li W, PLOS NEGL TROP DIS, V4, pe641; Light JE, 2008, MOL PHYLOGENET EVOL, V47, P1203, DOI 10.1016/j.ympev.2008.03.014; Louw M, 2005, SAMJ S AFR MED J, V95, P948; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Ndip LM, 2009, ANN TROP MED PARASIT, V103, P719, DOI 10.1179/000349809X12554106963753; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Parola P, 2001, EMERG INFECT DIS, V7, P1014, DOI 10.3201/eid0706.010616; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Parola P, 2011, EMERG INFECT DIS, V17, P883, DOI 10.3201/eid1705.100573; Piarroux R, 2013, EMERG INFECT DIS, V19, P505, DOI 10.3201/eid1903.121542; Raoult D, 2006, J INFECT DIS, V193, P112, DOI 10.1086/498534; RAOULT D, 1994, LANCET, V343, P977, DOI 10.1016/S0140-6736(94)90102-3; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Raoult D., 2016, MICROBIOL SPECTR, V4; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Robinson D, 2003, PARASITOL RES, V90, P209, DOI 10.1007/s00436-003-0842-5; Rolain JM, 2002, ANTIMICROB AGENTS CH, V46, P2747, DOI 10.1128/AAC.46.9.2747-2751.2002; Roux V, 1999, J CLIN MICROBIOL, V37, P596, DOI 10.1128/JCM.37.3.596-599.1999; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Sangare AK, 2015, MED SANTE TROP, V25, P189, DOI 10.1684/mst.2015.0442; Sangare AK, 2014, AM J TROP MED HYG, V91, P294, DOI 10.4269/ajtmh.13-0707; Sasaki T, 2006, J MED ENTOMOL, V43, P110, DOI 10.1603/0022-2585(2006)043[0110:FMEOBQ]2.0.CO;2; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Steinmann P, 2005, TROP MED INT HEALTH, V10, P612, DOI 10.1111/j.1365-3156.2005.01420.x; Sunantaraporn S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0742-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UHAA IJ, 1992, AM J TROP MED HYG, V46, P161, DOI 10.4269/ajtmh.1992.46.161; Znazen A, 2005, AM J TROP MED HYG, V72, P503, DOI 10.4269/ajtmh.2005.72.503	67	32	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184621	10.1371/journal.pone.0184621	http://dx.doi.org/10.1371/journal.pone.0184621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931077	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700025
J	Fekry, M; Alshokry, W; Grela, P; Tchorzewski, M; Ahlgren, EC; Soderberg, CA; Gakh, O; Isaya, G; Al-Karadaghi, S				Fekry, Mostafa; Alshokry, Wessen; Grela, Przemyslaw; Tchorzewski, Marek; Ahlgren, Eva-Christina; Soderberg, Christopher A.; Gakh, Oleksandr; Isaya, Grazia; Al-Karadaghi, Salam			SAXS and stability studies of iron-induced oligomers of bacterial frataxin CyaY	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; ESCHERICHIA-COLI CYAY; X-RAY-SCATTERING; SULFUR CLUSTER BIOSYNTHESIS; YEAST FRATAXIN; FRIEDREICH ATAXIA; BINDING-PROPERTIES; 2FE-2S CLUSTERS; PROTEIN; MATURATION	Frataxin is a highly conserved protein found in both prokaryotes and eukaryotes. It is involved in several central functions in cells, which include iron delivery to biochemical processes, such as heme synthesis, assembly of iron-sulfur clusters (ISC), storage of surplus iron in conditions of iron overload, and repair of ISC in aconitase. Frataxin from different organisms has been shown to undergo iron-dependent oligomerization. At least two different classes of oligomers, with different modes of oligomer packing and stabilization, have been identified. Here, we continue our efforts to explore the factors that control the oligomerization of frataxin from different organisms, and focus on E. coli frataxin CyaY. Using small-angle X-ray scattering (SAXS), we show that higher iron-to-protein ratios lead to larger oligomeric species, and that oligomerization proceeds in a linear fashion as a results of iron oxidation. Native mass spectrometry and online size-exclusion chromatography combined with SAXS show that a dimer is the most common form of CyaY in the presence of iron at atmospheric conditions. Modeling of the dimer using the SAXS data confirms the earlier proposed head-to-tail packing arrangement of monomers. This packing mode brings several conserved acidic residues into close proximity to each other, creating an environment for metal ion binding and possibly even mineralization. Together with negative-stain electron microscopy, the experiments also show that trimers, tetramers, pentamers, and presumably higher-order oligomers may exist in solution. Nano-differential scanning fluorimetry shows that the oligomers have limited stability and may easily dissociate at elevated temperatures. The factors affecting the possible oligomerization mode are discussed	[Fekry, Mostafa; Alshokry, Wessen; Ahlgren, Eva-Christina; Al-Karadaghi, Salam] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden; [Fekry, Mostafa] Cairo Univ, Biophys Dept, Fac Sci, Giza, Egypt; [Grela, Przemyslaw; Tchorzewski, Marek] Marie Curie Sklodowska Univ, Dept Mol Biol, Lublin, Poland; [Soderberg, Christopher A.] Lund Univ, MAX Lab 4, Lund, Sweden; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA	Lund University; Egyptian Knowledge Bank (EKB); Cairo University; Maria Curie-Sklodowska University; Lund University; Mayo Clinic; Mayo Clinic	Al-Karadaghi, S (corresponding author), Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden.	Salam.Al-Karadaghi@biochemistry.lu.se	; Al-Karadaghi, Salam/F-1492-2011	Fekry, Mostafa/0000-0003-1818-5683; Grela, Przemyslaw/0000-0002-5930-416X; Tchorzewski, Marek/0000-0002-0718-4223; Al-Karadaghi, Salam/0000-0001-8608-0635	National Institute of Health [AG15709-19]; Vetenskapsradet; European Union Mobility Program Erasmus; The research School in Pharmaceutical Sciences at Lund University	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vetenskapsradet(Swedish Research Council); European Union Mobility Program Erasmus; The research School in Pharmaceutical Sciences at Lund University	Funded by National Institute of Health (https://www.nih.gov), grant AG15709-19 to IG Vetenskapsradet (http://www.vr.se) to SAK; European Union Mobility Program Erasmus (https://ec.europa.eu/programmes/erasmus-plus/) to Mostafa Fekry; The research School in Pharmaceutical Sciences at Lund University (FLAK, http://www.flak.lu.se<http://www.flak.lu.se/>)to Eva-Christina Ahlgren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao A, 2015, NEUROGENETICS; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2004, BIOCHEMISTRY-US, V43, P6511, DOI 10.1021/bi036049+; Ahlgren EC, 2017, PLOS ONE IN PRESS; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Faraj SE, 2013, FEBS OPEN BIO, V3, P310, DOI 10.1016/j.fob.2013.07.004; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gakh O, 2016, J BIOL CHEM, V291, P21296, DOI 10.1074/jbc.M116.738542; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gentry LE, 2013, BIOCHEMISTRY-US, V52, P6085, DOI 10.1021/bi400443n; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Grela P, 2010, BIOCHEMISTRY-US, V49, P924, DOI 10.1021/bi901811s; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Lee MG, 2000, ACTA CRYSTALLOGR D, V56, P920, DOI 10.1107/S0907444900005916; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Soderberg C, STRUCTURE COMPLEX YE; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Uchida T, 2017, BIOCHEMISTRY-US, V56, P2425, DOI 10.1021/acs.biochem.6b01304; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	61	1	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184961	10.1371/journal.pone.0184961	http://dx.doi.org/10.1371/journal.pone.0184961			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931050	gold, Green Published			2022-12-26	WOS:000411314700048
J	Spencer, M; Lenhart, A; Baker, J; Dickens, J; Weissman, A; Read, AJ; Saini, S; Saini, SD				Spencer, Marisa; Lenhart, Adrienne; Baker, Jason; Dickens, Joseph; Weissman, Arlene; Read, Andrew J.; Saini, Seema; Saini, Sameer D.			Primary care physicians are under-testing for celiac disease in patients with iron deficiency anemia: Results of a national survey	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; MANAGEMENT; CHILDREN; UPDATE; HEALTH	Background Iron deficiency anemia (IDA) is a common extra-intestinal manifestation of celiac disease (CD). Little is known about the frequency with which primary care physicians (PCPs) test for CD in patients with IDA. We aimed to describe how PCPs approach testing for CD in asymptomatic patients with IDA. Methods We electronically distributed a survey to PCPs who are members of the American College of Physicians. Respondents were asked whether they would test for CD (serologic testing, refer for esophagogastroduodenoscopy [EGD], or refer to GI) in hypothetical patients with new IDA, including: (1) a young Caucasian man, (2) a premenopausal Caucasian woman, (3) an elderly Caucasian man, and (4) a young African American man. These scenarios were chosen to assess for differences in testing for CD based on age, gender, and race. Multivariable logistic regression was used to identify independent predictors of testing. Results Testing for CD varied significantly according to patient characteristics, with young Caucasian men being the most frequently tested (61% of respondents reporting they would perform serologic testing in this subgroup (p<0.001)). Contrary to guideline recommendations, 80% of respondents reported they would definitely or probably start a patient with positive serologies for CD on a gluten free diet prior to confirmatory upper endoscopy. Conclusions PCPs are under-testing for CD in patients with IDA, regardless of age, gender, race, or postmenopausal status. The majority of PCPs surveyed reported they do not strictly adhere to established guidelines regarding a confirmatory duodenal biopsy in a patient with positive serology for CD.	[Spencer, Marisa; Baker, Jason; Read, Andrew J.; Saini, Seema; Saini, Sameer D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lenhart, Adrienne] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Dickens, Joseph] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Weissman, Arlene] Amer Coll Physicians, Res Ctr, Philadelphia, PA USA; [Saini, Sameer D.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Saini, Seema] Vet Affairs Med Ctr, Ambulatory Care, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; American College of Physicians; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Spencer, M (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	marisaspencer10@gmail.com	Read, Andrew/AAE-8386-2019	Read, Andrew/0000-0001-7336-8496	University of Michigan Department of Gastroenterology	University of Michigan Department of Gastroenterology	Funding was provided by the University of Michigan Department of Gastroenterology.	Bao F, 2012, ARCH PATHOL LAB MED, V136, P735, DOI 10.5858/arpa.2011-0572-RA; Bottaro G, 1999, AM J GASTROENTEROL, V94, P691, DOI 10.1111/j.1572-0241.1999.00938.x; Cannizzaro R, 2014, EUR J GASTROEN HEPAT, V26, P721, DOI 10.1097/MEG.0000000000000100; Cataldo F, 2007, WORLD J GASTROENTERO, V13, P2153, DOI 10.3748/wjg.v13.i15.2153; Cekin AH, 2012, TURK J GASTROENTEROL, V23, P490, DOI 10.4318/tjg.2012.0467; Choung RS, 2015, AM J GASTROENTEROL, V110, P455, DOI 10.1038/ajg.2015.8; CORAZZA GR, 1995, SCAND J GASTROENTERO, V30, P153, DOI 10.3109/00365529509093254; Ertekin V, 2013, TURK J GASTROENTEROL, V24, P334, DOI 10.4318/tjg.2013.0529; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Freeman HJ, 2015, WORLD J GASTROENTERO, V21, P9233, DOI 10.3748/wjg.v21.i31.9233; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Gokce S, 2015, PEDIATR INT, V57, P107, DOI 10.1111/ped.12448; Halfdanarson TR, 2007, BLOOD, V109, P412, DOI 10.1182/blood-2006-07-031104; Hershko C, 2009, SEMIN HEMATOL, V46, P339, DOI 10.1053/j.seminhematol.2009.06.002; Howard MR, 2002, J CLIN PATHOL, V55, P754, DOI 10.1136/jcp.55.10.754; Karnam US, 2004, SOUTH MED J, V97, P30, DOI 10.1097/01.SMJ.0000051059.23259.56; Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276; Li M, 2009, AM J GASTROENTEROL, V104, P154, DOI 10.1038/ajg.2008.8; Nasr Ikram, 2012, Gastrointest Endosc Clin N Am, V22, P695, DOI 10.1016/j.giec.2012.07.012; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; Smukalla Scott, 2014, Clin Adv Hematol Oncol, V12, P100	24	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184754	10.1371/journal.pone.0184754	http://dx.doi.org/10.1371/journal.pone.0184754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931034	gold, Green Published, Green Submitted			2022-12-26	WOS:000411314700033
J	Calle-Bustos, AM; Juan, MC; Garcia-Garcia, I; Abad, F				Calle-Bustos, Andres-Marcelo; Juan, M. -Carmen; Garcia-Garcia, Inmaculada; Abad, Francisco			An augmented reality game to support therapeutic education for children with diabetes	PLOS ONE			English	Article							USABILITY; SYSTEM	Therapeutic education in diabetes helps patients take responsibility for self-control of their disease, and providing technological support systems facilitates this education. In this paper, we present an augmented reality game to support therapeutic education for patients with diabetes. Our game helps children (aged 5-14 years) to learn carbohydrate (carb) content of different foods. The game shows virtual foods on a real dish. The number of carb choices corresponding to the visualized food is also shown (1 carb choice = 10 grams of carbs). A study to determine the effectiveness of the game in terms of learning and perceived satisfaction and usability was carried out. A total of seventy children with diabetes participated in the study. From the results, we observed that the initial knowledge about carb choices of the children who participated in the study was low (a mean of 2 on a scale from 0 to 9). This indicates that therapeutic education for patients with diabetes is needed. When the results for the pre-knowledge questionnaire and the post-knowledge questionnaire were compared, it was shown that the children learned about carb choices by playing our game. We used two post-knowledge questionnaires (one post-knowledge questionnaire that contained the same foods as the pre-knowledge questionnaire and a second post-knowledge questionnaire that contained foods that were different from the ones on the pre-knowledge questionnaire). There were no statistically significant differences between these two different post-knowledge questionnaires. Moreover, the knowledge acquired was independent of gender and age. We also evaluated usability and perceived satisfaction. The children were satisfied with the game and considered that the game offers a high degree of usability. This game could be a valuable therapeutic education tool for patients with diabetes.	[Calle-Bustos, Andres-Marcelo; Juan, M. -Carmen; Abad, Francisco] Univ Politecn Valencia, Inst Univ Automat & Informat Ind, Valencia, Spain; [Garcia-Garcia, Inmaculada] Univ Politecn Valencia, Dept Sistemas Informat & Comp, Valencia, Spain	Universitat Politecnica de Valencia; Universitat Politecnica de Valencia	Juan, MC (corresponding author), Univ Politecn Valencia, Inst Univ Automat & Informat Ind, Valencia, Spain.	mcarmen@dsic.upv.es	Juan, M.-Carmen/I-3585-2015; Abad, Francisco/ABA-6229-2020	Juan, M.-Carmen/0000-0002-8764-1470; 	Conselleria d'Educacio, Investigacio, Cultura i Esport	Conselleria d'Educacio, Investigacio, Cultura i Esport	This publication was partially supported by the Conselleria d'Educacio, Investigacio, Cultura i Esport through the grant for consolidable research groups in favour of the Computer Graphics and Multimedia group of the ai2 (IP. Prof. M. -Carmen Juan) (2017-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcayir M, 2017, EDUC RES REV-NETH, V20, P1, DOI 10.1016/j.edurev.2016.11.002; Aoki N, 2005, DIABETES CARE, V28, P760, DOI 10.2337/diacare.28.3.760; Aoki N, 2004, ST HEAL T, V107, P855; Azuma RT, 1997, PRESENCE-VIRTUAL AUG, V6, P355, DOI 10.1162/pres.1997.6.4.355; Bacca J, 2014, EDUC TECHNOL SOC, V17, P133; Blake MB, 2009, COMPUT EDUC, V53, P966, DOI 10.1016/j.compedu.2009.05.014; Boulos MNK, 2015, JMIR SERIOUS GAMES, V3, DOI 10.2196/games.3930; Brown SJ, 1997, MED INFORM, V22, P77, DOI 10.3109/14639239709089835; Cefalu WT, 2014, DIABETES CARE, V37, P3137, DOI 10.2337/dc14-2329; Chiang THC, 2014, EDUC TECHNOL SOC, V17, P352; Chu HC, 2010, COMPUT EDUC, V55, P1618, DOI 10.1016/j.compedu.2010.07.004; Clark DB, 2011, COMPUT EDUC, V57, P2178, DOI 10.1016/j.compedu.2011.05.007; Dall TM, 2014, DIABETES CARE, V37, P3172, DOI 10.2337/dc14-1036; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; DeShazo J, 2010, DIABETES TECHNOL THE, V12, P815, DOI 10.1089/dia.2010.0030; Deterding S., 2011, P 15 INT ACAD MINDTR, P9; Domhardt Michael, 2015, J Diabetes Sci Technol, V9, P516, DOI 10.1177/1932296815578880; Egenfeldt-Nielsen S, 2013, EDUTAINMENT EXPLORIN; Elliott JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057400; Ferrer-Garcia JC, 2012, AV DIABETOL, V28, P38, DOI 10.1016/j.avdiab.2012.03.003; Furio D, 2015, J COMPUT ASSIST LEAR, V31, P189, DOI 10.1111/jcal.12071; Furio D, 2013, COMPUT EDUC, V64, P24, DOI 10.1016/j.compedu.2012.12.015; Furio D, 2013, COMPUT EDUC, V64, P1, DOI 10.1016/j.compedu.2012.12.001; Glover I., 2013, 2013 PRESENTED EDMED, P1999; Henkemans OAB, 2013, PATIENT EDUC COUNS, V92, P174, DOI 10.1016/j.pec.2013.04.012; Highfield K., 2013, MATH ED YESTERDAY TO, P378; Hung JL, 2012, J COMPUT HIGH EDUC, V24, P1, DOI 10.1007/s12528-011-9044-9; Hwang GJ, 2014, INT J MOBILE LEARNIN, V8, p[83, 12], DOI DOI 10.1504/IJML0.2014.062346; Jones A, 1999, INTERACT COMPUT, V11, P499, DOI 10.1016/S0953-5438(98)00064-2; Juan MC, 2017, IEEE INT CONF ADV LE, P466, DOI 10.1109/ICALT.2017.27; Juan MC, 2016, DIGIT EDUC REV, P234; Juan MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113751; Juan MC, 2005, IEEE COMPUT GRAPH, V25, P31, DOI 10.1109/MCG.2005.143; Klingensmith GJ, 2013, PEDIATR DIABETES, V14, P350, DOI 10.1111/j.1399-5448.2011.00791.x; Lange K, 2014, PEDIATR DIABETES, V15, P77, DOI 10.1111/pedi.12187; Lieberman Debra A, 2012, J Diabetes Sci Technol, V6, P802; Liu PHE, 2013, BRIT J EDUC TECHNOL, V44, pE1, DOI 10.1111/j.1467-8535.2012.01302.x; Marti-Parreno J, 2016, J COMPUT ASSIST LEAR, V32, P663, DOI 10.1111/jcal.12161; Mayes JT, 1999, INTERACT COMPUT, V11, P485, DOI 10.1016/S0953-5438(98)00065-4; Nordisk Novo, 2013, DIABETES VOICE, V58, P4; Schafer I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095035; Shen RM, 2008, BRIT J EDUC TECHNOL, V39, P1073, DOI 10.1111/j.1467-8535.2007.00778.x; Squires D, 1999, INTERACT COMPUT, V11, P467, DOI 10.1016/S0953-5438(98)00063-0; Sun PC, 2008, COMPUT EDUC, V50, P1183, DOI 10.1016/j.compedu.2006.11.007; UNESCO, 2012, INT STAND CLASS ED I; Ward N.D., 2013, J GEOSCIENCE ED, V61, P378; Yoldi C, 2011, AV DIABETOL, V27, P100; Zydney JM, 2016, COMPUT EDUC, V94, P1, DOI 10.1016/j.compedu.2015.11.001	48	27	28	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184645	10.1371/journal.pone.0184645	http://dx.doi.org/10.1371/journal.pone.0184645			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957355	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200016
J	Clawson, GA; Matters, GL; Xin, P; McGovern, C; Wafula, E; dePamphilis, C; Meckley, M; Wong, J; Stewart, L; D'Jamoos, C; Altmann, N; Kawasawa, YI; Du, Z; Honaas, L; Abraham, T				Clawson, Gary A.; Matters, Gail L.; Xin, Ping; McGovern, Christopher; Wafula, Eric; dePamphilis, Claude; Meckley, Morgan; Wong, Joyce; Stewart, Luke; D'Jamoos, Christopher; Altmann, Naomi; Kawasawa, Yuka Imamura; Du, Zhen; Honaas, Loren; Abraham, Thomas			"Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-TYROSINE-PHOSPHATASE; CYCLASE-ASSOCIATED PROTEIN-1; BREAST-CANCER PATIENTS; FATTY-ACID SYNTHASE; POOR-PROGNOSIS; LUNG-CANCER; MALIGNANT PHENOTYPE	Here we describe isolation and characterization of macrophage-tumor cell fusions (MTFs) from the blood of pancreatic ductal adenocarcinoma (PDAC) patients. The MTFs were generally aneuploidy, and immunophenotypic characterizations showed that the MTFs express markers characteristic of PDAC and stem cells, as well as M2-polarized macrophages. Single cell RNASeq analyses showed that the MTFs express many transcripts implicated in cancer progression, LINE1 retrotransposons, and very high levels of several long non-coding transcripts involved in metastasis (such as MALAT1). When cultured MTFs were transplanted orthotopically into mouse pancreas, they grew as obvious well-differentiated islands of cells, but they also disseminated widely throughout multiple tissues in "stealth" fashion. They were found distributed throughout multiple organs at 4, 8, or 12 weeks after transplantation (including liver, spleen, lung), occurring as single cells or small groups of cells, without formation of obvious tumors or any apparent progression over the 4 to 12 week period. We suggest that MTFs form continually during PDAC development, and that they disseminate early in cancer progression, forming "niches" at distant sites for subsequent colonization by metastasis-initiating cells.	[Clawson, Gary A.; Xin, Ping; Meckley, Morgan; Du, Zhen] Penn State Univ, Hershey Med Ctr, Gittlen Canc Res Labs, Hershey, PA 17033 USA; [Clawson, Gary A.; Xin, Ping; Meckley, Morgan; Du, Zhen] Penn State Univ, Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA; [Matters, Gail L.; McGovern, Christopher] PSU, HMC, Dept Biochem & Mol Biol, Hershey, PA USA; [Wafula, Eric; dePamphilis, Claude; Honaas, Loren] Penn State Univ, Eberly Coll, Dept Biol, University Pk, PA 16802 USA; [Wong, Joyce] PSU, HMC, Dept Surg, Hershey, PA USA; [Stewart, Luke; D'Jamoos, Christopher] Fluidigm Corp, Applicat Support, San Francisco, CA USA; [Altmann, Naomi] PSU, Eberly Coll, Dept Stat, University Pk, PA USA; [Kawasawa, Yuka Imamura] PSU, HMC, Inst Personalized Med, Dept Pharmacol & Biochem & Mol Biol, Hershey, PA USA; [Abraham, Thomas] PSU, HMC, Dept Neural & Behav Sci, Hershey, PA USA; [Abraham, Thomas] PSU, HMC, Microscopy Imaging Facil, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Clawson, GA (corresponding author), Penn State Univ, Hershey Med Ctr, Gittlen Canc Res Labs, Hershey, PA 17033 USA.; Clawson, GA (corresponding author), Penn State Univ, Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA.	gac4@psu.edu	Honaas, Loren/GWC-8659-2022; Abraham, Thomas/AAJ-7950-2020; Abraham, Thomas/J-7080-2014	Honaas, Loren/0000-0001-9187-8254; Abraham, Thomas/0000-0003-0750-8774; Matters, Gail/0000-0001-8613-8649	NIH [UL1TR000125, 1S10OD010756-01A1, 1S10OD018124-01A1]; Pennsylvania State Hershey Clinical and Translational Science Institute; National Center for Advancing Translational Science [TL1R000125]; Fluidigm; Gittlen Cancer Research Laboratories; NATIONAL CANCER INSTITUTE [R01CA167535] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000127, UL1TR002014] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State Hershey Clinical and Translational Science Institute; National Center for Advancing Translational Science; Fluidigm; Gittlen Cancer Research Laboratories; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH (UL1TR000125, 1S10OD010756-01A1 and 1S10OD018124-01A1), the Pennsylvania State Hershey Clinical and Translational Science Institute, the National Center for Advancing Translational Science (TL1R000125), and gift funds from the Gittlen Cancer Research Laboratories. Funding was also provided by Fluidigm. This funder provided support in the form of salaries for authors (LSand CD'J) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ali-Rahmani F, 2016, CANCER RES, V76, P1560, DOI 10.1158/0008-5472.CAN-15-2401; Anania MC, 2013, J CLIN ENDOCR METAB, V98, pE1591, DOI 10.1210/jc.2013-1652; Ankeny JS, 2016, BRIT J CANCER, V114, P1367, DOI 10.1038/bjc.2016.121; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bacher R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0927-y; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Bai J, 2015, ONCOTARGET, V6, P25295, DOI 10.18632/oncotarget.4716; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; Barkley LR, 2009, CELL CYCLE, V8, P1577, DOI 10.4161/cc.8.10.8535; Baskin R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17367; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bickeboller M, 2015, ONCOGENE, V34, P1150, DOI 10.1038/onc.2014.40; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Borin TF, 2016, J PINEAL RES, V60, P3, DOI 10.1111/jpi.12270; Brown KE, 2013, CELL CYCLE, V12, P3253, DOI 10.4161/cc.26223; Cano CE, 2012, EMBO MOL MED, V4, P964, DOI 10.1002/emmm.201201255; Capello M, 2016, ONCOTARGET, V7, P5598, DOI 10.18632/oncotarget.6798; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chekhun S. V., 2014, Experimental Oncology, V36, P179; Chen CH, 2015, ONCOTARGET, V6, P15194, DOI 10.18632/oncotarget.3827; Chen CH, 2014, AM J RESP CRIT CARE, V190, P1127, DOI 10.1164/rccm.201408-1505OC; Chen H, 2015, INT J CLIN EXP PATHO, V8, P5798; Chen HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052864; Chen MB, 2011, MOL BIOL REP, V38, P4687, DOI 10.1007/s11033-010-0603-3; Chen XP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/241983; Chen YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18815; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Cheng TC, 2015, ONCOTARGET, V6, P21283, DOI 10.18632/oncotarget.4238; Cheng Z, 2014, GENET MOL RES, V13, P5514, DOI 10.4238/2014.July.25.5; Cheong JY, 2016, GENE, V584, P47, DOI 10.1016/j.gene.2016.03.006; Chong YK, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv326; Clawson GA, 2015, REV CELL BIOL MOL ME; Clawson GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134320; Clawson GA, 2013, SCIENCE, V342, P699, DOI 10.1126/science.1244270; Clawson GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041052; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cordani M, 2017, BBA-REV CANCER, V1867, P19, DOI 10.1016/j.bbcan.2016.11.003; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cristofanilli M, 2004, NEW ENGL J MED, V351, P2453; Cui YZ, 2009, CANCER INVEST, V27, P747, DOI 10.1080/07357900802672746; Damaghi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9752; Datar I, 2015, ONCOTARGET, V6, P39050, DOI 10.18632/oncotarget.5176; Davies JQ, 2011, ONCOL REP, V25, P619, DOI 10.3892/or.2010.1117; de Andrade BAB, 2011, ORAL DIS, V17, P808, DOI 10.1111/j.1601-0825.2011.01841.x; De Smaele E, 2011, NEOPLASIA, V13, P374, DOI 10.1593/neo.101630; Denz A, 2010, J SURG RES, V160, P29, DOI 10.1016/j.jss.2009.03.048; Diao Y, 2015, INT J CLIN EXP PATHO, V8, P6967; Ding JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041942; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Dittmar T, 2013, CURR MOL MED, V13; Du P, 2013, INT J ONCOL, V42, P1249, DOI 10.3892/ijo.2013.1802; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; ESKELINEN M, 1992, SCAND J GASTROENTERO, V27, P39, DOI 10.3109/00365529209011164; ESKELINEN M, 1991, PANCREAS, V6, P90, DOI 10.1097/00006676-199101000-00012; Eun YG, 2013, AM J SURG, V205, P631, DOI 10.1016/j.amjsurg.2012.05.035; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Friedlander TW, 2014, INT J CANCER, V134, P2284, DOI 10.1002/ijc.28561; Friedlander TW, 2013, PHARMACOL THERAPEUT, P0163; Fu XJ, 2015, MOL MED REP, V12, P127, DOI 10.3892/mmr.2015.3359; Funamizu N, 2013, INT J CANC; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gao Q, 2014, GASTROENTEROLOGY, V146, P1397, DOI 10.1053/j.gastro.2014.01.062; Gao X, 2015, J INT TRANSL MED, V3, P1; Gawlik-Rzemieniewska N, 2016, CANCER BIOL THER, V17, P1, DOI 10.1080/15384047.2015.1121348; Gemoll T, 2015, ONCOTARGET, V6, P43869, DOI 10.18632/oncotarget.6103; Gemoll T, 2015, ONCOTARGET, V6, P16517, DOI 10.18632/oncotarget.4140; Glaser J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/379847; Goldenberg DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107927; Gong ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110483; Gornes J, 2009, J HISTOCHEM CYTOCHEM, V57, P79, DOI 10.1369/jhc.2008.952283; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Grover PK, 2014, ANN ONCOL; Gu LN, 2014, TUMOR BIOL, V35, P7831, DOI 10.1007/s13277-014-2035-5; Guan JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.546; Guo DW, 2016, INT J CANCER, V139, P2056, DOI 10.1002/ijc.30278; Guo S, 2015, INT J CLIN EXP PATHO, V8, P5395; Guo XT, 2012, ANAT REC, V295, P2114, DOI 10.1002/ar.22571; Gustschner T, 2013, CANCER RES, V73, P1180; Harouaka R, 2014, PHARMACOL THERAPEUT, V141, P209, DOI 10.1016/j.pharmthera.2013.10.004; He CB, 2016, APMIS, V124, P169, DOI 10.1111/apm.12480; Hou YC, 2014, CANCER-AM CANCER SOC, V120, P2766, DOI 10.1002/cncr.28774; Hua MH, 2015, INT J MOL MED, V35, P941, DOI 10.3892/ijmm.2015.2089; Huang CF, 2016, PATHOL ONCOL RES, V22, P109, DOI 10.1007/s12253-015-9981-0; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Huisman A, 2007, PROSTATE, V67, P248, DOI 10.1002/pros.20507; Huo YM, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0202-1; Ichikawa H, 2013, J PROTEOME RES, V12, P3780, DOI 10.1021/pr400439m; IKUTA S, 1994, J GASTROENTEROL, V29, P727, DOI 10.1007/BF02349278; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Irandoust M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052143; Jeong SM, 2016, BIOCHEM BIOPH RES CO, V471, P373, DOI 10.1016/j.bbrc.2016.02.023; Jezequel P, 2012, INT J CANCER, V131, P426, DOI 10.1002/ijc.26397; Ji LL, 2014, J MOL HISTOL, V45, P573, DOI 10.1007/s10735-014-9582-3; Jiang JH, 2006, J BIOL CHEM, V281, P9482, DOI 10.1074/jbc.M504489200; Jiao F, 2014, ONCOL REP, V32, P2485, DOI 10.3892/or.2014.3518; Kamphues C, 2013, PANCREAS, V42, P807, DOI 10.1097/MPA.0b013e3182773eb6; Kanno H, 2013, NEURO-ONCOLOGY, V15, P853, DOI 10.1093/neuonc/not028; Karamitopoulou E, 2013, EUR J CANCER, V49, P1032, DOI 10.1016/j.ejca.2012.10.022; Karamitopoulou E, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00209; Karlsson E, 2015, BREAST CANCER RES TR, V153, P31, DOI 10.1007/s10549-015-3516-y; Ke Q, 2012, CANCER BIOTHER RADIO, V27, P678, DOI 10.1089/cbr.2012.1191; Kikuchi A, 2013, INT J CANCER, V132, P2295, DOI 10.1002/ijc.27911; Kindrat I, 2016, ONCOTARGET, V7, P1276, DOI 10.18632/oncotarget.6004; Kindt N, 2012, ANTICANCER RES, V32, P4499; Kohsaka S, 2014, NEURO-ONCOLOGY, V16, P960, DOI 10.1093/neuonc/not315; Kolde R., 2013, PHEATMAP PRETTY HEAT; Koong AC, 2000, CANCER RES, V60, P883; Kosaka Y, 2007, INT J ONCOL, V31, P333; Krieg A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130192; Kulemann B, 2015, PANCREAS, V44, P547, DOI 10.1097/MPA.0000000000000324; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Kyriakis JM, 2009, J BIOL CHEM, V284, P10993, DOI 10.1074/jbc.R800085200; Lan CY, 2013, TECHNOL CANCER RES T, V12, P259, DOI 10.7785/tcrt.2012.500312; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lazebnik Y, 2014, CELL CYCLE, V13, P2323, DOI 10.4161/cc.29704; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; Lee SM, 2011, MOL CELLS, V32, P343, DOI 10.1007/s10059-011-0073-z; Lee YK, 2015, HEPATOLOGY, V62, P1174, DOI 10.1002/hep.27976; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li R, 2015, EUR REV MED PHARMACO, V19, P4533; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WS, 2014, GENE, V547, P346, DOI 10.1016/j.gene.2014.06.042; Li YM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.347; Li YS, 2015, CELL PHYSIOL BIOCHEM, V37, P2375, DOI 10.1159/000438591; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Liu JH, 2014, ASIAN PAC J CANCER P, V15, P2971, DOI 10.7314/APJCP.2014.15.7.2971; Liu JH, 2017, FRONT BIOSCI-LANDMRK, V22, P66, DOI 10.2741/4472; Liu K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.51; Liu YH, 2014, PATHOL RES PRACT, V210, P169, DOI 10.1016/j.prp.2013.11.011; Lo MC, 2013, CANC LETT; Long J, 2012, INT J ONCOL, V41, P1662, DOI 10.3892/ijo.2012.1613; Lyu XJ, 2015, ONCOTARGET, V6, P6656, DOI 10.18632/oncotarget.3169; Lyu XJ, 2015, CELL BIOCHEM BIOPHYS, V71, P279, DOI 10.1007/s12013-014-0196-x; Ma X, 2014, TUMOUR BIOL; Ma YL, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0799-3; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Makkonen H, 2008, ONCOGENE, V27, P4865, DOI 10.1038/onc.2008.125; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Markiewicz Aleksandra, 2013, Cancers (Basel), V5, P1485, DOI 10.3390/cancers5041485; Marques E, 2016, ONCOGENE, V35, P1386, DOI 10.1038/onc.2015.196; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Matsumura Y, 2012, CANCER SCI, V103, P1342, DOI 10.1111/j.1349-7006.2012.02275.x; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Morandi F, 2015, ONCOTARGET, V6, P25602, DOI 10.18632/oncotarget.4693; Mossad NA, 2014, TUMOR BIOL, V35, P11559, DOI 10.1007/s13277-014-2467-y; Namiki T, 2011, ONCOTARGET, V2, P695; Namiki T, 2011, P NATL ACAD SCI USA, V108, P6597, DOI 10.1073/pnas.1007694108; Natraian R, 2014, J PATHOL, V232, P5553; Nesmiyanov PP, 2016, IMMUNOBIOLOGY, V221, P6, DOI 10.1016/j.imbio.2015.08.008; Ni P, 2015, INT J CLIN EXP PATHO, V8, P15940; Nikkuni O, 2015, PATHOL ONCOL RES, V21, P1175, DOI 10.1007/s12253-015-9954-3; Noh HS, 2016, ONCOTARGET, V7, P4632, DOI 10.18632/oncotarget.6728; Ocak S, 2014, J THORAC ONCOL, V9, P324, DOI 10.1097/JTO.0000000000000090; Pandey V, 2012, INT J CANCER, V130, P497, DOI 10.1002/ijc.26048; Park SL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju061; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Patani Neill, 2008, Cancer Genomics & Proteomics, V5, P333; Pathania AS, 2015, MOL CANCER, V14, DOI 10.1186/1476-4598-14-6; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Pedersen Irene Munk, 2016, Mob Genet Elements, V6, pe1175537, DOI 10.1080/2159256X.2016.1175537; Peng C, 2016, ONCOGENE, V35, P1170, DOI 10.1038/onc.2015.175; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Ping FM, 2015, INT J CLIN EXP PATHO, V8, P10164; Pizarro JG, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00014; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Poret N, 2015, CANCER RES, V75, P3902, DOI 10.1158/0008-5472.CAN-15-0893; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Principe M, 2015, ONCOTARGET, V6, P11098, DOI 10.18632/oncotarget.3572; Quidville V, 2013, CANCER RES, V73, P2247, DOI 10.1158/0008-5472.CAN-12-2501; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rangasamy D, 2015, CURR MOL MED, V15, P588, DOI 10.2174/1566524015666150831130827; Realini N, 2016, J BIOL CHEM, V291, P2422, DOI 10.1074/jbc.M115.666909; Rello-Varona S, 2012, CELL CYCLE, V11, P170, DOI 10.4161/cc.11.1.18564; Ren DY, 2016, ONCOL LETT, V11, P1621, DOI 10.3892/ol.2016.4138; Renhua G, 2016, J THORAC ONCOL, V11, pS129, DOI 10.1016/S1556-0864(16)30275-1; Rhim AD, 2014, GASTROENTEROLOGY, V146, P647, DOI 10.1053/j.gastro.2013.12.007; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Riese DJ, 2014, SEMIN CELL DEV BIOL, V28, P49, DOI 10.1016/j.semcdb.2014.03.005; Roh JL, 2016, EUR J CANCER, V52, P163, DOI 10.1016/j.ejca.2015.10.056; Rohrbach TD, 2015, INT J ONCOL, V46, P1079, DOI 10.3892/ijo.2014.2799; Ruan J, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0503-9; Rutkowski MJ, 2011, J NEURO-ONCOL, V105, P165, DOI 10.1007/s11060-011-0576-7; Salmi M, 2013, CIRC RES, V112, P1577, DOI 10.1161/CIRCRESAHA.111.300476; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Scharl M, 2012, ANN NY ACAD SCI, V1257, P93, DOI 10.1111/j.1749-6632.2012.06578.x; Schouppe E, 2013, CANC RES; Schulz R, 2014, CURR OPIN ONCOL, V26, P108, DOI 10.1097/CCO.0000000000000036; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Seguin F, 2012, BRIT J CANCER, V107, P077; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Shabo I, 2009, INT J CANCER, V125, P1826, DOI 10.1002/ijc.24506; Sharma MC, 2016, CANCER LETT, V373, P27, DOI 10.1016/j.canlet.2016.01.013; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shimada K, 2014, BREAST CANCER-TOKYO, V21, P715, DOI 10.1007/s12282-013-0447-5; Shindo-Okada N, 2003, BIOCHEM BIOPH RES CO, V312, P889, DOI 10.1016/j.bbrc.2003.10.200; Shrivastava S, 2016, MOL CANCER THER, V15, P471, DOI 10.1158/1535-7163.MCT-15-0581; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Solimini NL, 2013, P NATL ACAD SCI USA, V110, pE407, DOI 10.1073/pnas.1221385110; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Sun YL, 2015, WORLD J GASTROENTERO, V21, P10840, DOI 10.3748/wjg.v21.i38.10840; Sun ZL, 2007, BBA-PROTEINS PROTEOM, V1774, P764, DOI 10.1016/j.bbapap.2007.04.001; Swierczynski J, 2014, WORLD J GASTROENTERO, V20, P2279, DOI 10.3748/wjg.v20.i9.2279; Takahashi K, 2006, INT J ONCOL, V28, P321; Tan C, 2016, MOL CARCINOGEN, V55, P397, DOI 10.1002/mc.22290; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Theocharides APA, 2012, J EXP MED, V209, P1883, DOI 10.1084/jem.20120502; Torres C, 2015, PANCREAS, V44, P302, DOI 10.1097/MPA.0000000000000250; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsavaris N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-264; van Dijk M, 2015, HUM MOL GENET, V24, P5475, DOI 10.1093/hmg/ddv274; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Vizeacoumar FJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.54; Wang D, 2014, ONCOL REP, V31, P1199, DOI 10.3892/or.2013.2946; Wang HY, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-226; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Wang SJ, 2015, ONCOTARGET, V6, P243, DOI 10.18632/oncotarget.2801; Wang T, 2015, ONCOTARGET, V6, P30975, DOI 10.18632/oncotarget.5199; Wang W, 2014, CANCER RES, V74, P497, DOI 10.1158/0008-5472.CAN-13-1224; Wang W, 2013, HISTOPATHOLOGY, V62, P931, DOI 10.1111/his.12101; WANG XF, 2016, SCI REP UK, V6; Wang Y, 2015, ONCOL REP, V34, P2106, DOI 10.3892/or.2015.4157; Wei Y, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/164635; Wermke M, 2015, BLOOD, V125, P3760, DOI 10.1182/blood-2014-07-590646; Whitworth H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038950; Williams KA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004809; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Woo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142642; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Wu TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149361; Wu YC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0455-5; Xie SS, 2015, ONCOL REP, V33, P363, DOI 10.3892/or.2014.3577; Xue H, 2016, ONCOTARGET, V7, P4785, DOI 10.18632/oncotarget.6735; Xynos Ioannis D, 2013, ISRN Gastroenterol, V2013, P490578, DOI 10.1155/2013/490578; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Yamaguchi H, 2008, MOL CARCINOGEN, V47, P739, DOI 10.1002/mc.20423; Yang LX, 2015, PATHOL RES PRACT, V211, P731, DOI 10.1016/j.prp.2015.04.014; Yang WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152165; Yang Y, 2015, LEUKEMIA, V29, P715, DOI 10.1038/leu.2014.255; Yang Y, 2013, EMBO REP, V14, P741, DOI 10.1038/embor.2013.80; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Yu XF, 2014, EXP MOL PATHOL, V96, P188, DOI 10.1016/j.yexmp.2014.02.002; Yu XB, 2016, GENE, V576, P339, DOI 10.1016/j.gene.2015.10.072; Zavareh RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043721; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zeng Wen-Li, 2015, Asian Pac J Cancer Prev, V16, P513; Zhang HJ, 2015, TUMOR BIOL, V36, P9373, DOI 10.1007/s13277-015-3678-6; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhang M, 2014, INT J CLIN EXP PATHO, V7, P487; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]; Zhang XJ, 2014, J SURG RES, V192, P487, DOI 10.1016/j.jss.2014.05.066; Zhao MY, 2015, ONCOTARGET, V6, P15610, DOI 10.18632/oncotarget.3639; Zheng DW, 2016, MOL CARCINOGEN, V55, P300, DOI 10.1002/mc.22279; Zheng ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep26093; Zhou D, 2015, WORLD J GASTROENTERO, V21, P1814, DOI 10.3748/wjg.v21.i6.1814; Zhou H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.186; 2003, DRUGS RES DEV, V4, P198	274	34	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184451	10.1371/journal.pone.0184451	http://dx.doi.org/10.1371/journal.pone.0184451			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957348	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200013
J	Elffers, TW; de Mutsert, R; Lamb, HJ; de Roos, A; van Dijk, KW; Rosendaal, FR; Jukema, JW; Trompet, S				Elffers, Theodora W.; de Mutsert, Renee; Lamb, Hildo J.; de Roos, Albert; van Dijk, Ko Willems; Rosendaal, Frits R.; Jukema, J. Wouter; Trompet, Stella			Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women	PLOS ONE			English	Article							ADIPOSE-TISSUE; METABOLICALLY HEALTHY; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; GENDER-DIFFERENCES; ABDOMINAL FAT; MEN; ACCUMULATION; DISEASE	Background Body fat distribution is, next to overall obesity, an important risk factor for cardiometabolic outcomes in the general population. In particular, visceral adipose tissue ( VAT) is strongly associated with cardiometabolic risk factors. Since it is unclear whether body fat distribution is also important in men and women with obesity we investigated the associations between measures of body fat distribution and cardiometabolic risk factors in men and women with obesity. Methods In this cross-sectional analysis of obese men and women ( BMI >= 30 kg/m(2)) included in the Netherlands Epidemiology of Obesity Study, waist: hip ratio(WHR), waist circumference, and MRI-based abdominal subcutaneous adipose tissue (aSAT) and VAT were determined. Associations between measures of body fat distribution and presence of >= 1 risk factor, such as hypertension or hypertriglyceridemia, were examined using logistic regression analyses; stratified by sex and adjusted for age, ethnicity, education, tobacco smoking, alcohol consumption, physical activity and depending on the association additionally for total body fat or VAT. Results We included 2,983 obese individuals (57% women) with a mean age of 56 and standard deviation (SD) of 6 and mean BMI of 34.0 kg/m(2) (4.0), after exclusion of individuals with missing values of cardiometabolic risk factors (n = 33). 241 individuals were obese without other cardiometabolic risk factors. In obese women, all measures of body fat distribution except aSAT (OR per SD: 0.76, 95% CI: 0.53, 1.10) were associated with having >= 1 cardiometabolic risk factor, of which VAT most strongly associated (5.77; 3.02, 11.01). In obese men, associations of body fat distribution and the presence of cardiometabolic risk factors were attenuated. (e.g. VAT: 1.42; 0.84, 2.41). Conclusions In obese women, but less so in men, measures of body fat distribution, of which VAT most strongly, are associated with cardiometabolic risk factors.	[Elffers, Theodora W.; de Mutsert, Renee; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Elffers, Theodora W.; Jukema, J. Wouter; Trompet, Stella] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Lamb, Hildo J.; de Roos, Albert] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Elffers, TW (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.; Elffers, TW (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.	t.w.elffers@lumc.nl	Jukema, J. Wouter/ABD-6503-2021; Lamb, Hildo/ABE-1171-2021; Rosendaal, Frits/Q-3842-2017; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021; Elffers, Theodora/V-3065-2017	Jukema, J. Wouter/0000-0002-3246-8359; Lamb, Hildo/0000-0002-6969-2418; Rosendaal, Frits/0000-0003-2558-7496; van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; Elffers, Theodora/0000-0002-6304-0507	Leiden University Medical Centre; Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'	Leiden University Medical Centre; Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'	The NEO study is supported by the participating Departments, the Division and the Board of Directors of the Leiden University Medical Centre, and by the Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'.	Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Bluher M, 2012, CURR OPIN ENDOCRINOL, V19, P341, DOI 10.1097/MED.0b013e328357f0a3; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Boonchaya-Anant P, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0441-1; Chandra A, 2014, J AM COLL CARDIOL, V64, P997, DOI 10.1016/j.jacc.2014.05.057; de Mutsert R, 2013, EUR J EPIDEMIOL, V28, P513, DOI 10.1007/s10654-013-9801-3; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flint DJ, 2006, J ENDOCRINOL, V191, P101, DOI 10.1677/joe.1.06939; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Karelis AD, 2011, NAT REV ENDOCRINOL, V7, P699, DOI 10.1038/nrendo.2011.181; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; MAURIEGE P, 1987, EUR J CLIN INVEST, V17, P156, DOI 10.1111/j.1365-2362.1987.tb02395.x; Meinhardt UJ, 2006, CLIN ENDOCRINOL, V65, P413, DOI 10.1111/j.1365-2265.2006.02676.x; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; REBUFFESCRIVE M, 1989, METABOLISM, V38, P453, DOI 10.1016/0026-0495(89)90198-4; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Tanaka S, 2004, INT J OBESITY, V28, P320, DOI 10.1038/sj.ijo.0802545; TONG Y, 1989, MOL CELL ENDOCRINOL, V67, P11, DOI 10.1016/0303-7207(89)90225-6; Toth MJ, 2000, INT J OBESITY, V24, P226, DOI 10.1038/sj.ijo.0801118; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1	41	79	84	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185403	10.1371/journal.pone.0185403	http://dx.doi.org/10.1371/journal.pone.0185403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957363	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200053
J	Liew, JWY; Loh, KS; Ahmad, A; Lim, KL; Daud, WRW				Liew, Joy Wei Yi; Loh, Kee Shyuan; Ahmad, Azizan; Lim, Kean Long; Daud, Wan Ramli Wan			Synthesis and characterization of modified kappa-carrageenan for enhanced proton conductivity as polymer electrolyte membrane	PLOS ONE			English	Article							METHYLENE PHOSPHONIC CHITOSAN; CELLULOSE DERIVATIVES; COMPLEXES; HYDROGELS; BLEND; CELL	Polymer electrolyte membranes based on the natural polymer kappa-carrageenan were modified and characterized for application in electrochemical devices. In general, pure kappa-carrageenan membranes show a low ionic conductivity. New membranes were developed by chemically modifying kappa-carrageenan via phosphorylation to produce O-methylene phosphonic kappa-carrageenan (OMPC), which showed enhanced membrane conductivity. The membranes were prepared by a solution casting method. The chemical structure of OMPC samples were characterized using Fourier transform infrared spectroscopy (FTIR), H-1 nuclear magnetic resonance (H-1 NMR) spectroscopy and P-31 nuclear magnetic resonance (P-31 NMR) spectroscopy. The conductivity properties of the membranes were investigated by electrochemical impedance spectroscopy (EIS). The characterization demonstrated that the membranes had been successfully produced. The ionic conductivity of kappa-carrageenan and OMPC were 2.79 x 10(-6) S cm(-1) and 1.54 x 10(-5) S cm(-1), respectively. The hydrated membranes showed a two orders of magnitude higher ionic conductivity than the dried membranes.	[Liew, Joy Wei Yi; Loh, Kee Shyuan; Lim, Kean Long; Daud, Wan Ramli Wan] Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi, Selangor, Malaysia; [Ahmad, Azizan] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Chem Sci & Food Technol, Bangi, Selangor, Malaysia; [Daud, Wan Ramli Wan] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Loh, KS (corresponding author), Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi, Selangor, Malaysia.	ksloh@ukm.edu.my	Daud, Wan Ramli Wan/GQA-6740-2022; Daud, Wan Ramli/B-3635-2013; Loh, Kee Shyuan/B-3648-2016; liew, joy/GXG-6715-2022; Loh, Kee Shyuan/N-6132-2019; Lim, Kean Long/A-1809-2009	Daud, Wan Ramli Wan/0000-0002-1023-456X; Daud, Wan Ramli/0000-0002-1023-456X; Loh, Kee Shyuan/0000-0002-2555-7521; Loh, Kee Shyuan/0000-0002-2555-7521; Lim, Kean Long/0000-0002-7227-5391	Ministry of Education Malaysia [LRGS/2013/UKM-UKM/TP/01]; Universiti Kebangsaan Malaysia (UKM) [GUP-2016-038]	Ministry of Education Malaysia; Universiti Kebangsaan Malaysia (UKM)	This research work is jointly financially supported by the Ministry of Education Malaysia through the Long-term Research Grant Scheme (LRGS/2013/UKM-UKM/TP/01) and the Universiti Kebangsaan Malaysia (UKM) through the University Research Grants (GUP-2016-038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad LV, 2011, RADIAT PHYS CHEM, V80, P977, DOI 10.1016/j.radphyschem.2011.04.006; Abad L.V., 2013, WORLD ACAD SCI ENG T, V77, P422; Al Sagheer FA, 2009, CARBOHYD POLYM, V77, P410, DOI 10.1016/j.carbpol.2009.01.032; Aliste AJ, 2000, RADIAT PHYS CHEM, V57, P305, DOI 10.1016/S0969-806X(99)00471-5; Alves VD, 2010, CARBOHYD POLYM, V79, P269, DOI 10.1016/j.carbpol.2009.08.002; Binsu VV, 2006, REACT FUNCT POLYM, V66, P1619, DOI 10.1016/j.reactfunctpolym.2006.06.003; Campo VL, 2009, CARBOHYD POLYM, V77, P167, DOI 10.1016/j.carbpol.2009.01.020; Choi JH, 2005, LWT-FOOD SCI TECHNOL, V38, P417, DOI 10.1016/j.lwt.2004.07.004; Datta P, 2012, CARBOHYD POLYM, V87, P1354, DOI 10.1016/j.carbpol.2011.09.023; Sanchez-Garcia MD, 2010, J AGR FOOD CHEM, V58, P12847, DOI 10.1021/jf102764e; Freile-Pelegrin Y, 2011, J AQUAT FOOD PROD T, V20, P73, DOI 10.1080/10498850.2010.541590; Fujishima M, 2008, ELECTROCHEM COMMUN, V10, P1482, DOI 10.1016/j.elecom.2008.07.040; Goktepe F, 2008, J NON-CRYST SOLIDS, V354, P3637, DOI 10.1016/j.jnoncrysol.2008.03.023; Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8; Idris NH, 2005, IONICS, V11, P375, DOI 10.1007/BF02430249; Jeeju PP, 2012, MATER CHEM PHYS, V134, P803, DOI 10.1016/j.matchemphys.2012.03.072; Jumaah FN, 2015, IONICS, V21, P1311, DOI 10.1007/s11581-014-1306-x; Kadir MFZ, 2011, SPECTROCHIM ACTA A, V78, P1068, DOI 10.1016/j.saa.2010.12.051; Ko YG, 2010, SOLID STATE IONICS, V181, P1178, DOI 10.1016/j.ssi.2010.06.036; Lebouc F, 2005, POLYMER, V46, P319, DOI 10.1016/j.polymer.2004.11.017; Ma SF, 2012, INT J GREEN ENERGY, V9, P13, DOI 10.1080/15435075.2011.617018; Mobarak NN, 2013, ELECTROCHIM ACTA, V92, P161, DOI 10.1016/j.electacta.2012.12.126; Mobarak NN, 2012, SOLID STATE IONICS, V224, P51, DOI 10.1016/j.ssi.2012.07.010; Murata K, 2000, ELECTROCHIM ACTA, V45, P1501, DOI 10.1016/S0013-4686(99)00365-5; Cabello SDP, 2014, J POWER SOURCES, V265, P345, DOI 10.1016/j.jpowsour.2014.04.093; Ramesh S, 2012, CARBOHYD POLYM, V87, P701, DOI 10.1016/j.carbpol.2011.08.047; Ramos VM, 2003, CARBOHYD POLYM, V52, P39, DOI 10.1016/S0144-8617(02)00264-3; Rudhziah S, 2015, ELECTROCHIM ACTA, V175, P162, DOI 10.1016/j.electacta.2015.02.153; Rudhziah S, 2015, IND CROP PROD, V72, P133, DOI 10.1016/j.indcrop.2014.12.051; Santo VE, 2009, BIOMACROMOLECULES, V10, P1392, DOI 10.1021/bm8014973; Saxena A, 2006, J COLLOID INTERF SCI, V303, P484, DOI 10.1016/j.jcis.2006.07.061; Smitha B, 2005, EUR POLYM J, V41, P1859, DOI 10.1016/j.eurpolymj.2005.02.018; Tranquilan-Aranilla C, 2012, CARBOHYD POLYM, V87, P1810, DOI 10.1016/j.carbpol.2011.10.009; van Herk T, 2005, ADV SYNTH CATAL, V347, P1155, DOI 10.1002/adsc.200505072; Volod'ko AV, 2014, CARBOHYD POLYM, V101, P1087, DOI 10.1016/j.carbpol.2013.10.049; Wan Y, 2003, MACROMOL CHEM PHYSIC, V204, P850, DOI 10.1002/macp.200390056; Yahya M.Z.A., 2006, J APPL SCI, V6, P3150; Yu GL, 2002, CARBOHYD RES, V337, P433, DOI 10.1016/S0008-6215(02)00009-5; Zhao D, 2012, J APPL POLYM SCI, V125, pE299, DOI 10.1002/app.36834; Zhu DW, 2010, J MATER SCI-MATER M, V21, P223, DOI 10.1007/s10856-009-3849-3	40	39	39	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185313	10.1371/journal.pone.0185313	http://dx.doi.org/10.1371/journal.pone.0185313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957374	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200044
J	Lapbenjakul, S; Thapana, W; Twilprawat, P; Muangmai, N; Kanchanaketu, T; Temsiripong, Y; Unajak, S; Peyachoknagul, S; Srikulnath, K				Lapbenjakul, Sorravis; Thapana, Watcharaporn; Twilprawat, Panupon; Muangmai, Narongrit; Kanchanaketu, Thiti; Temsiripong, Yosapong; Unajak, Sasimanas; Peyachoknagul, Surin; Srikulnath, Kornsorn			High genetic diversity and demographic history of captive Siamese and Saltwater crocodiles suggest the first step toward the establishment of a breeding and reintroduction program in Thailand	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; CROCODYLUS-MORELETII; CONSERVATION UNITS; STATISTICAL TESTS; DNA; HYBRIDIZATION; SOFTWARE; POROSUS; TRANSLOCATIONS; IDENTIFICATION	The Siamese crocodile (Crocodylus siamensis) and Saltwater crocodile (C. porosus) are two of the most endangered animals in Thailand. Their numbers have been reduced severely by hunting and habitat fragmentation. A reintroduction plan involving captive-bred populations that are used commercially is important and necessary as a conservation strategy to aid in the recovery of wild populations. Here, the genetic diversity and population structure of 69 individual crocodiles, mostly members of captive populations, were analyzed using both mitochondrial D-loop DNA and microsatellite markers. The overall haplotype diversity was 0.924-0.971 and the mean expected heterozygosity across 22 microsatellite loci was 0.578-0.701 for the two species. This agreed with the star-like shaped topology of the haplotype network, which suggests a high level of genetic diversity. The mean ratio of the number of alleles to the allelic range (M ratio) for the populations of both species was considerably lower than the threshold of 0.68, which was interpreted as indicative of a historical genetic bottleneck. Microsatellite markers provided evidence of introgression for three individual crocodiles, which suggest that hybridization might have occurred between C. siamensis and C. porosus. D-loop sequence analysis detected bi-directional hybridization between male and female individuals of the parent species. Therefore, identification of genetically non-hybrid and hybrid individuals is important for long-term conservation management. Relatedness values were low within the captive populations, which supported their genetic integrity and the viability of a breeding and reintroduction management plan. This work constitutes the first step in establishing an appropriate source population from a scientifically managed perspective for an in situ/ex situ conservation program and reintroduction of crocodile individuals to the wild in Thailand.	[Lapbenjakul, Sorravis; Thapana, Watcharaporn; Twilprawat, Panupon; Peyachoknagul, Surin; Srikulnath, Kornsorn] Kasetsart Univ, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Fac Sci, Bangkok, Thailand; [Lapbenjakul, Sorravis; Thapana, Watcharaporn; Muangmai, Narongrit; Srikulnath, Kornsorn] Kasetsart Univ, Anim Breeding & Genet Consortium, ABG KU, Bangkok, Thailand; [Thapana, Watcharaporn; Peyachoknagul, Surin; Srikulnath, Kornsorn] Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, CASTNAR, Bangkok, Thailand; [Muangmai, Narongrit] Kasetsart Univ, Dept Fishery Biol, Fac Fisheries, Bangkok, Thailand; [Kanchanaketu, Thiti] Kasetsart Univ, Fac Liberal Arts & Sci, Dept Sci, Div Genet, Kamphaeng Saen Campus, Kamphaeng Saen, Nakhon Pathom, Thailand; [Temsiripong, Yosapong] Sriracha Moda Co Ltd, R&D Ctr, Sriracha, Chonburi, Thailand; [Unajak, Sasimanas] Kasetsart Univ, Dept Biochem, Fac Sci, Bangkok, Thailand; [Peyachoknagul, Surin] Naresuan Univ, Fac Sci, Dept Biol, Muang Phitsanulok, Phitsanulok, Thailand; [Srikulnath, Kornsorn] Ctr Excellence Agr Biotechnol AG BIO PERDO CHE, Bangkok, Thailand	Kasetsart University; Kasetsart University; Kasetsart University; Kasetsart University; Kasetsart University; Kasetsart University; Naresuan University	Srikulnath, K (corresponding author), Kasetsart Univ, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Fac Sci, Bangkok, Thailand.; Srikulnath, K (corresponding author), Kasetsart Univ, Anim Breeding & Genet Consortium, ABG KU, Bangkok, Thailand.; Srikulnath, K (corresponding author), Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, CASTNAR, Bangkok, Thailand.; Srikulnath, K (corresponding author), Ctr Excellence Agr Biotechnol AG BIO PERDO CHE, Bangkok, Thailand.	kornsorn.s@ku.ac.th	Muangmai, Narongrit/W-4073-2019; Unajak, Sasimanas/AAM-4340-2021; Srikulnath, Kornsorn/GLU-1326-2022	Muangmai, Narongrit/0000-0001-7954-7348; Srikulnath, Kornsorn/0000-0002-5985-7258; Unajak, Sasimanas/0000-0002-3242-3978	Kasetsart University Research and Development Institute (KURDI) [80.60]; Graduate School, Kasetsart University [10/2557, PM4/2558]; Special Track Staff (STS) [STS1/2558]; Science Research Fund (ScRF) from the Faculty of Science, Kasetsart University [ScRF-S19-2558]; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand) [10/2559]; National Research Council of Thailand (NRCT); Graduate School, Kasetsart University; Science Achievement Scholarship of Thailand (SAST) from the Office of the Higher Education Commission, Thailand [5717400381]; Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE)	Kasetsart University Research and Development Institute (KURDI); Graduate School, Kasetsart University; Special Track Staff (STS); Science Research Fund (ScRF) from the Faculty of Science, Kasetsart University; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Graduate School, Kasetsart University; Science Achievement Scholarship of Thailand (SAST) from the Office of the Higher Education Commission, Thailand; Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE)	This study was financially supported by grants from Kasetsart University Research and Development Institute (KURDI; grant no. 80.60), Kasetsart University 72 year anniversary graduate scholarship (no. 10/2557) from the Graduate School, Kasetsart University, Professor Motivation (PM; no. PM4/2558), Special Track Staff (STS; no. STS1/2558), and the Science Research Fund (ScRF; no. ScRF-S19-2558) from the Faculty of Science, Kasetsart University, the Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand; no. 10/2559), the graduate scholarship provided by the National Research Council of Thailand (NRCT) as of fiscal year 2017, the Graduate School, Kasetsart University, and the Science Achievement Scholarship of Thailand (SAST; no. 5717400381) from the Office of the Higher Education Commission, Thailand. This research is also partially supported by the Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Yosapong Temsiripong is employed by Sriracha Moda Co., Ltd. Sriracha Moda Co., Ltd provided support in the form of salary for author YT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.; We thank the crocodile farm members of the Crocodile Co-operatives of Thailand (COCOT), Department of Fisheries, Ministry of Agriculture and Cooperatives (Thailand), and Faculty of Veterinary Science, Mahidol University (Thailand) for advice on sample preparation. We are also grateful to Siwapech Sillapaprayoon (Kasetsart University, Thailand) for helpful discussions. This research is partially supported from graduate scholarship provided by the National Research Council of Thailand (NRCT) as of fiscal year 2017, the Graduate School, Kasetsart University and the Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE).	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Barrow D, 2016, SPO 8 3 BIOPSY POLE; Benavides E, 2012, ZOO BIOL, V31, P107, DOI 10.1002/zoo.20397; Benbouza Halima, 2006, Biotechnologie Agronomie Societe et Environnement, V10, P77; Chavananikul V, 1998, RES REPORT KARYOTYPE; Clement M., 2002, P 16 INT PARALLEL DI, P7; COHEN M M, 1970, Cytogenetics (Basel), V9, P81, DOI 10.1159/000130080; Cornuet JM, 1996, GENETICS, V144, P2001; Crocodile Specialist Group, 1996, IUCN RED LIST THREAT; Department of International Trade Promotion Ministry of Commerce, 2017, STATISTICS; Dinets V, 2013, COPEIA, P517, DOI 10.1643/CE-12-125; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzsimmons NN, 2002, J EXP ZOOL, V294, P373, DOI 10.1002/jez.10201; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Funk SM, 2006, CONSERV GENET, V7, P651, DOI 10.1007/s10592-005-9068-7; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jelden DC, 2005, CROCODILE CONSERVATI; Lacy RC, 1995, ZOO BIOL, V14, P565, DOI 10.1002/zoo.1430140609; Li Yan, 2007, Journal of Genetics and Genomics, V34, P119, DOI 10.1016/S1673-8527(07)60013-7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin G, 2015, BEHAV MODIFICATION W; Meganathan PR, 2010, MOL PHYLOGENET EVOL, V57, P393, DOI 10.1016/j.ympev.2010.06.011; Meraner A, 2014, ECOL EVOL, V4, P1313, DOI 10.1002/ece3.931; Milan-Garcia Y, 2015, HEREDITY, V114, P272, DOI 10.1038/hdy.2014.96; Miles LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-339; Miles LG, 2009, CONSERV GENET, V10, P963, DOI 10.1007/s10592-008-9600-7; Milian-Garcia Y, 2011, J EXP ZOOL PART A, V315A, P358, DOI 10.1002/jez.683; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nwafili Sylvanus A., 2016, Archives of Polish Fisheries, V24, P85; Park S.D.E., 2001, THESIS; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Platt Steven G., 2002, Natural History Bulletin of the Siam Society, V50, P7; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez O, 2006, CONSERV GENET, V7, P861, DOI 10.1007/s10592-006-9123-z; Ratanakorn P, 1994, CROCODILES PROCEEDIN, P35; Ray DA, 2004, CONSERV GENET, V5, P449, DOI 10.1023/B:COGE.0000041024.96928.fe; Ray DA, 2002, J EXP ZOOL, V294, P334, DOI 10.1002/jez.10198; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Cedeno-Vazquez JR, 2008, J EXP ZOOL PART A, V309A, P661, DOI 10.1002/jez.473; Ross F.D., 1983, P305; Ross J. P., 1998, CROCODILES STATUS SU; Russello MA, 2007, CONSERV GENET, V8, P777, DOI 10.1007/s10592-006-9225-7; Simpson BK, 2010, CROCODILES STATUS SU, P120; Srikulnath Kornsorn, 2015, Genomics & Informatics, V13, P102, DOI 10.5808/GI.2015.13.4.102; Srikulnath K, 2012, MOL BIOL REP, V39, P4709, DOI 10.1007/s11033-011-1263-7; Starr A, 2010, NEWSLETTER IUCN SSC, V28, P5; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; Supikamolseni A, 2015, GENET MOL RES, V14, P13981, DOI 10.4238/2015.October.29.18; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Temsiripong Y., 2001, CSG NEWSLETTER, V20, P10; Temsiripong Yosapong, 2007, Re-introduction News, V26, P55; Thang NQ, 1994, CROCODILES, P141; Thorbjarnarson J., 1992, CROCODILES ACTION PL; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Weaver JP, 2008, J EXP ZOOL PART A, V309A, P649, DOI 10.1002/jez.471; Witzenberger KA, 2011, BIODIVERS CONSERV, V20, P1843, DOI 10.1007/s10531-011-0074-4; Wongsongsarn C., 2010, ANN SURVEY REPORT SI; Youngprapakorn P., 1990, SAMUTPRAKAN CROCODIL, P3	70	17	17	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184526	10.1371/journal.pone.0184526	http://dx.doi.org/10.1371/journal.pone.0184526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953895	Green Submitted, gold, Green Published			2022-12-26	WOS:000411980300014
J	Trevisan, B; Primon, JF; Marques, FPL				Trevisan, Bruna; Primon, Juliana F.; Marques, Fernando P. L.			Systematics and diversification of Anindobothrium Marques, Brooks & Lasso, 2001 (Eucestoda: Rhinebothriidea)	PLOS ONE			English	Article							MULTIPLE-SEQUENCE ALIGNMENT; FRESH-WATER STINGRAYS; ACANTHOBOTHRIUM CESTODA TETRAPHYLLIDEA; BOCAS-DEL-TORO; N. SP CESTODA; PHYLOGENETIC-RELATIONSHIPS; CRYPTIC DIVERSITY; CYCLOPHYLLIDEA HYMENOLEPIDIDAE; MOLECULAR DIFFERENTIATION; HISTORICAL BIOGEOGRAPHY	Tapeworms of the genus Anindobothrium Marques, Brooks & Lasso, 2001 are found in both marine and Neotropical freshwater stingrays of the family Potamotrygonidae. The patterns of host association within the genus support the most recent hypothesis about the history of diversification of potamotrygonids, which suggests that the ancestor of freshwater lineages of the Potamotrygonidae colonized South American river systems through marine incursion events. Despite the relevance of the genus Anindobothrium to understand the history of colonization and diversification of potamotrygonids, no additional efforts were done to better investigate the phylogenetic relationship of this taxon with other lineages of cestodes since its erection. This study is a result of recent collecting efforts to sample members of the genus in marine and freshwater potamotrygonids that enabled the most extensive documentation of the fauna of Anindobothrium parasitizing species of Styracura de Carvalho, Loboda & da Silva, Potamotrygon schroederi Ferna A ndez-Ye A pez, P. orbignyi (Castelnau) and P. yepezi Castex & Castello from six different countries, representing the eastern Pacific Ocean, Caribbean Sea, and river basins in South America (Rio Negro, Orinoco, and Maracaibo). The newly collected material provided additional specimens for morphological studies and molecular samples for subsequent phylogenetic analyses that allowed us to address the phylogenetic position of Anindobothrium and provide molecular and morphological evidence to recognize two additional species for the genus. The taxonomic actions that followed our analyses included the proposition of a new family, Anindobothriidae fam. n., to accommodate the genus Anindobothriumin the order Rhinebothriidea Healy, Caira, Jensen, Webster & Littlewood, 2009 and the description of two new species-one from the eastern Pacific Ocean, A. carrioni sp. n., and the other from the Caribbean Sea, A. inexpectatum sp. n. In addition, we also present a redescription of the type species of the genus, A. anacolum (Brooks, 1977) Marques, Brooks & Lasso, 2001, and of A. lisae Marques, Brooks & Lasso, 2001. Finally, we discuss the paleogeographical events mostly linked with the diversification of the genus and the protocols adopted to uncover cryptic diversity in Anindobothrium.	[Trevisan, Bruna] Univ Sao Paulo, Curso Posgrad, Inst Biociencias, Sao Paulo, SP, Brazil; [Trevisan, Bruna; Primon, Juliana F.; Marques, Fernando P. L.] Univ Sao Paulo, Dept Zool, Inst Biociencias, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Trevisan, B (corresponding author), Univ Sao Paulo, Curso Posgrad, Inst Biociencias, Sao Paulo, SP, Brazil.; Trevisan, B (corresponding author), Univ Sao Paulo, Dept Zool, Inst Biociencias, Sao Paulo, SP, Brazil.	bruna.trevisan@usp.br	Marques, Fernando/J-3629-2012	Marques, Fernando/0000-0002-4281-8711; Trevisan, Bruna/0000-0002-7872-985X	NSF PBI grant [DEB 0818696, DEB 0818823]; State University of New York College at Oneonta Research Foundation; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2014/10220-0]	NSF PBI grant(National Science Foundation (NSF)); State University of New York College at Oneonta Research Foundation; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported in part with funds from NSF PB&I grants DEB 0818696 and DEB 0818823; grants from the State University of New York College at Oneonta Research Foundation; and by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grant #2014/10220-0.r We would like to thank Dr. Janine N. Caira (University of Connecticut, Storrs, CT, U.S.A.) for providing material from her personal collection and for conducting SEM sections at UCONN. We thank Dr. Janine Caira, Dr. Kirsten Jensen (University of Kansas, Lawrence, KS, U.S.A.), M.Sc. Veronica M. Bueno (University of Connecticut, Storrs, CT, U.S.A.) and Dr. Joana Cielocha (University of Kansas, Lawrence, KS, U.S.A.) for their help during the collecting trip to Belize; and to Dr. Bjoern C. Schaeffner (Universidade de Sao Paulo, Sao Paulo, SP, Brazil) and Dr. Florian B. Reyda (State University of New York College of Oneonta, Oneonta, New York, U.S.A.) for their help during the field trip to Panama. We appreciated the help and hospitality of Otto Castillo and Luis Sanchez (UNELLEZ, Guanare) during the collecting trips inVenezuela. We are indebted to Dr. Angel Javier Vega and M.Sc. Leysi del Carmem from Centro Regional Universitario de Veraguas-Universidad de Panama (Santiago de Veraguas, Veraguas, Panama) for facilitating our field trip in Panama and for the assistance during the field trip on that country. We thank Dr. Anna J. Phillips from the National Museum of Natural History (Smithsonian Institution, Washington, D.C., U.S.A.) and Dr. Gabor Racz from the Harold W. Manter Laboratory (University of Nebraska, Lincoln, Nebraska, U.S.A.) for the loan of the type material of Anindobothrium anacolum, and also Dr. Marcelo Knoff from the Colecao Helmintologica do Instituto Oswaldo Cruz (Rio de Janeiro, RJ, Brazil) for allowing us to examine the type material of A. lisae. We also would like to thank B.Sc. Beatriz V. Freire for her help in gathering the molecular data. Finally, we appreciated comments and criticisms provided by Dr. Bjoern C. Schaeffner, Florian Reyda, Kirsten Jensen and Veronica M. Bueno on earlier versions of this manuscript. This work was supported in part with funds from NSF PB&I grants DEB 0818696 and DEB 0818823; grants from the State University of New York College at Oneonta Research Foundation; and by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grant # 2014/10220-0. Any opinions, findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Agrawal N, 2008, BIOSCI TRENDS, V2, P128; Aschliman NC, 2011, BATOID TREE LIFE REC; Bernot JP, 2015, J PARASITOL, V101, P167, DOI 10.1645/14-571.1; Beveridge I, 2014, INT J PARASITOL, V44, P859, DOI 10.1016/j.ijpara.2014.06.001; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Binkiene R, 2015, PARASITOL RES, V114, P209, DOI 10.1007/s00436-014-4180-6; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; BROOKS DR, 1977, P HELM SOC WASH, V44, P51; Caira JN, 2014, INT J PARASITOL, V44, P55, DOI 10.1016/j.ijpara.2013.10.004; Caira JN, 2011, PARASITOLOGY, V138, P1675, DOI 10.1017/S0031182011000643; Caira JN, 2001, INT J PARASITOL, V31, P960, DOI 10.1016/S0020-7519(01)00206-5; Caira JN, 2016, GLOBAL CESTODE DATAB; Carus JV, 1863, HDB ZOOLOGIE, P422, DOI DOI 10.5962/BHL.TITLE.1399; Carvalho MD, 2016, ZOOTAXA, V4175, P201; Chervy L, 2009, FOLIA PARASIT, V56, P199, DOI 10.14411/fp.2009.025; Chilton NB, 2007, PARASITOL RES, V100, P1187, DOI 10.1007/s00436-006-0388-4; Clopton RE, 2004, COMP PARASITOL, V71, P130, DOI 10.1654/4151; Clouse RM, 2014, ZOOTAXA, V3814, P177, DOI 10.11646/zootaxa.3814.2.2; Coates AG, 2005, CARIBB J SCI, V41, P374; Coates AG, 2003, GEOL SOC AM BULL, V115, P271, DOI 10.1130/0016-7606(2003)115<0271:ENHOTC>2.0.CO;2; Cook LG, 2010, INVERTEBR SYST, V24, P322, DOI 10.1071/IS10011; Cutmore SC, 2011, FOLIA PARASIT, V58, P187, DOI 10.14411/fp.2011.019; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Carvalho MR, 2016, ZOOTAXA, V4167, P1, DOI 10.11646/zootaxa.4167.1.1; De Carvalho MR, 2004, B AM MUS NAT HIST, P1; de Chambrier A, 2009, J PARASITOL, V95, P160, DOI 10.1645/GE-1594.1; Melo FTD, 2011, MEM I OSWALDO CRUZ, V106, P670, DOI 10.1590/S0074-02762011000600005; Ekman S., 1953, P417; Esselstyn JA, 2007, BIOL J LINN SOC, V90, P761, DOI 10.1111/j.1095-8312.2007.00776.x; Euzet L., 1953, 14 INT C ZOOL 1956 P, P347; Euzet L., 1863, KEYS CESTODE PARASIT, P149; Euzet L, 1980, MEMOIRE SOC ZOOLO 40, V3, P239; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Fontenelle JP, 2017, ZOOTAXA, V4310, P1, DOI 10.11646/zootaxa.4310.1.1; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Fyler CA, 2010, INVERTEBR SYST, V24, P419, DOI 10.1071/IS10034; Fyler CA, 2011, COMP PARASITOL, V78, P4, DOI 10.1654/4454.1; Fyler CA, 2009, FOLIA PARASIT, V56, P107, DOI 10.14411/fp.2009.016; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goodman M., 1982, Acta Zoologica Fennica, P19; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Grant T, 2008, MOL PHYLOGENET EVOL, V49, P405, DOI 10.1016/j.ympev.2008.04.023; Grant T, 2008, CLADISTICS, V24, P1051, DOI 10.1111/j.1096-0031.2008.00231.x; Greiman SE, 2013, J PARASITOL, V99, P1045, DOI 10.1645/13-302.1; Greiman SE, 2012, PARASITOL INT, V61, P343, DOI 10.1016/j.parint.2012.01.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanzelova V, 2005, PARASITOL INT, V54, P207, DOI 10.1016/j.parint.2005.05.001; Haukisalmi V, 2014, ZOOTAXA, V3873, P371, DOI 10.11646/zootaxa.3873.4.3; Haukisalmi V, 2010, ZOOL SCR, V39, P631, DOI 10.1111/j.1463-6409.2010.00444.x; Healy CJ, 2009, INT J PARASITOL, V39, P497, DOI 10.1016/j.ijpara.2008.09.002; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Jaiswara R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075930; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Jia WZ, 2012, ACTA TROP, V123, P154, DOI 10.1016/j.actatropica.2012.04.006; Jorger KM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-59; Jordan DS, 1908, AM NAT, V42, P73, DOI 10.1086/278905; Karanovic T, 2016, SYST BIOL, V65, P304, DOI 10.1093/sysbio/syv088; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kuchta R, 2006, J PARASITOL, V92, P126, DOI 10.1645/GE-3511.1; Kuchta R, 2008, J PARASITOL, V94, P500, DOI 10.1645/GE-1425.1; Kuchta R, 2012, ZOOTAXA, P1; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lajus D, 2015, ECOL EVOL, V5, P2374, DOI 10.1002/ece3.1521; Lavikainen A, 2016, INT J PARASITOL, V46, P361, DOI 10.1016/j.ijpara.2016.01.009; Lee MSY, 2003, SYST BIOL, V52, P15, DOI 10.1080/10635150390132650; Leigh EG, 2014, BIOL REV, V89, P148, DOI 10.1111/brv.12048; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Lovejoy NR, 1996, ZOOL J LINN SOC-LOND, V117, P207, DOI 10.1006/zjls.1996.0038; Machado DJ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0642-9; Makarikov AA, 2015, PARASITOL RES, V114, P2107, DOI 10.1007/s00436-015-4399-x; Makarikov AA, 2013, ZOOTAXA, V3608, P401, DOI 10.11646/zootaxa.3608.6.1; Marques FPL, 2016, J PARASITOL, V102, P249, DOI 10.1645/15-894; Marques FPL, 2001, J PARASITOL, V87, P666, DOI 10.1645/0022-3395(2001)087[0666:ANGETI]2.0.CO;2; Marques FPL, 2000, THESIS; Marques JF, 2007, PARASITOLOGY, V134, P1057, DOI 10.1017/S0031182007002491; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Meireles CM, 1999, GENET MOL BIOL, V22, P337, DOI 10.1590/S1415-47571999000300009; Morard R, 2016, SYST BIOL, V65, P925, DOI 10.1093/sysbio/syw031; Morard R, 2013, PALAEOGEOGR PALAEOCL, V391, P13, DOI 10.1016/j.palaeo.2013.05.011; Nakao M, 2013, INT J PARASITOL, V43, P427, DOI 10.1016/j.ijpara.2012.11.014; Naylor GJP, 2012, CRC MAR BIOL SER, P31; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Pante E, 2015, MOL ECOL, V24, P525, DOI 10.1111/mec.13048; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Parsons S, 2000, J EXP BIOL, V203, P2641; de Leon GPP, 2018, J HELMINTHOL, V92, P197, DOI [10.1017/S0022149X17000189, 10.1017/s0022149x17000189]; de Leon GPP, 2010, J PARASITOL, V96, P453, DOI 10.1645/GE-2260.1; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Phillips AJ, 2014, FOLIA PARASIT, V61, P441, DOI 10.14411/fp.2014.058; Pleijel F, 2008, MOL PHYLOGENET EVOL, V48, P369, DOI 10.1016/j.ympev.2008.03.024; R Core Team, 2021, R LANGUAGE ENV STAT; Randhawa HS, 2008, SYST PARASITOL, V70, P41, DOI 10.1007/s11230-007-9122-6; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Renner SS, 2016, SYST BIOL, V65, P1085, DOI 10.1093/sysbio/syw032; Reyda FB, 2008, J PARASITOL, V94, P684, DOI 10.1645/GE-1230.1; Reyda FB, 2016, FOLIA PARASIT, V63, DOI 10.14411/fp.2016.038; Reyda FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022604; Robertson DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102918; Ruhnke TR, 2013, SYST PARASITOL, V85, P37, DOI 10.1007/s11230-013-9411-1; Ruhnke TR, 2015, ZOOTAXA, V3904, P51, DOI 10.11646/zootaxa.3904.1.3; Ruhnke Timothy R., 2011, Bulletin of the University of Nebraska State Museum, V25, P1; Ruhnke TR, 2009, PLANETARY BIODIVERSI, P327; Schaeffner BC, 2011, SYST PARASITOL, V80, P1, DOI 10.1007/s11230-011-9309-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scholz T, 2014, PARASITOL INT, V63, P841, DOI 10.1016/j.parint.2014.07.015; Swofford D., 1990, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1992, GENETICS, V132, P619; Tkach VV, 2013, ZOOTAXA, V3691, P389, DOI 10.11646/zootaxa.3691.3.7; Trevisan B, 2017, ZOOTAXA, V4300, P421, DOI 10.11646/zootaxa.4300.3.5; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Vermes Braun M., 1894, KLASSEN ORDNUNGEN TH, P927; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Wheeler WC, 2003, CLADISTICS, V19, P261, DOI 10.1016/S0748-3007(03)00049-5; Wheeler WC, 2003, CLADISTICS, V19, P254, DOI 10.1016/S0748-3007(03)00047-1; Wheeler WC, 2006, DYNAMIC HOMOLOGY PHY; Zwickl D. J, 2006, GENETIC ALGORITHM AP	134	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184632	10.1371/journal.pone.0184632	http://dx.doi.org/10.1371/journal.pone.0184632			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953933	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300017
J	Boyer, PH; Boulanger, N; Nebbak, A; Collin, E; Jaulhac, B; Almeras, L				Boyer, Pierre H.; Boulanger, Nathalie; Nebbak, Amira; Collin, Elodie; Jaulhac, Benoit; Almeras, Lionel			Assessment of MALDI-TOF MS biotyping for Borrelia burgdorferi sl detection in Ixodes ricinus	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; LYME BORRELIOSIS; SPECIES DETERMINATION; DEVELOPMENTAL-STAGES; TICK VECTORS; SENSU-LATO; IDENTIFICATION; DISEASE; EXPRESSION	Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDITOF MS) has been demonstrated to be useful for tick identification at the species level. More recently, this tool has been successfully applied for the detection of bacterial pathogens directly in tick vectors. The present work has assessed the detection of Borrelia burgdorferi sensu lato in Ixodes ricinus tick vector by MALDI-TOF MS. To this aim, experimental infection model of I. ricinus ticks by B. afzelii was carried out and specimens collected in the field were also included in the study. Borrelia infectious status of I. ricinus ticks was molecularly controlled using half-idiosome to classify specimens. Among the 39 ticks engorged on infected mice, 14 were confirmed to be infected by B. afzelii. For field collection, 14.8% (n = 12/81) I. ricinus ticks were validated molecularly as infected by B. burgdorferi sl. To determine the body part allowing the detection of MS protein profile changes between noninfected and B. afzelii infected specimens, ticks were dissected in three compartments (i.e. 4 legs, capitulum and half-idiosome) prior to MS analysis. Highly reproducible MS spectra were obtained for I. ricinus ticks according to the compartment tested and their infectious status. However, no MS profile change was found when paired body part comparison between non-infected and B. afzelii infected specimens was made. Statistical analyses did not succeed to discover, per body part, specific MS peaks distinguishing Borrelia-infected from non-infected ticks whatever their origins, laboratory reared or field collected. Despite the unsuccessful of MALDI-TOF MS to classify tick specimens according to their B. afzelii infectious status, this proteomic tool remains a promising method for rapid, economic and accurate identification of tick species. Moreover, the singularity of MS spectra between legs and half-idiosome of I. ricinus could be used to reinforce this proteomic identification by submission of both these compartments to MS.	[Boyer, Pierre H.; Boulanger, Nathalie; Collin, Elodie; Jaulhac, Benoit] Univ Strasbourg, Federat Med Translat Strasbourg, VBP EA 7290, Early Bacterial Virulence Lyme Borreliosis Grp, Strasbourg, France; [Boulanger, Nathalie; Jaulhac, Benoit] Hop Univ Strasbourg, French Natl Reference Ctr Borrelia, Strasbourg, France; [Nebbak, Amira; Almeras, Lionel] Aix Marseille Univ, URMITE, Inst Hosp Univ Mediterrane Infect, UM63,CNRS 7278,IRD 198,Inserm 1095, 19-21 Blvd Jean Moulin, Marseille, France; [Nebbak, Amira] USTHB, Fac Sci Biol, Lab Biodiversite & Environm Interact Genomes, Algiers, Algeria; [Almeras, Lionel] Inst Rech Biomed Armees, Unite Parasitol & Entomol, Dept Malad Infect, Marseille, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University Science & Technology Houari Boumediene; UDICE-French Research Universities; Aix-Marseille Universite	Boulanger, N (corresponding author), Univ Strasbourg, Federat Med Translat Strasbourg, VBP EA 7290, Early Bacterial Virulence Lyme Borreliosis Grp, Strasbourg, France.; Boulanger, N (corresponding author), Hop Univ Strasbourg, French Natl Reference Ctr Borrelia, Strasbourg, France.	nboulanger@unistra.fr	BOYER, Pierre/AAL-6569-2020; NEBBAK, Amira/AAU-9609-2021; Alméras, Lionel/ABD-9797-2021; Boulanger, Nathalie/ABF-1353-2020	NEBBAK, Amira/0000-0002-1060-0152; 				BEATI L, 1994, AM J TROP MED HYG, V51, P138, DOI 10.4269/ajtmh.1994.51.138; Boyer PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2212-7; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Cutler SJ, 2016, MOL CELL PROBE, P22; Diarra AZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005762; Dieme C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0544-0; Dunham-Ems SM, 2009, J CLIN INVEST, V119, P3652, DOI 10.1172/JCI39401; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Ferquel E, 2006, APPL ENVIRON MICROB, V72, P3074, DOI 10.1128/AEM.72.4.3074-3078.2006; Fotso AF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002984; GUY EC, 1991, J CLIN PATHOL, V44, P610, DOI 10.1136/jcp.44.7.610; Hidri N, 2012, CLIN MICROBIOL INFEC, V18, pE531, DOI 10.1111/1469-0691.12016; Jacquet M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2187-4; Kahl Olaf, 2002, P29, DOI 10.1079/9780851996325.0029; Karger A, 2012, TICKS TICK-BORNE DIS, V3, P78, DOI 10.1016/j.ttbdis.2011.11.002; Kern A, 2011, VECTOR-BORNE ZOONOT, V11, P1343, DOI 10.1089/vbz.2010.0197; Kumsa B, 2016, PARASITOL RES, V115, P4199, DOI 10.1007/s00436-016-5197-9; Lafri I, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004351; MBOW ML, 1994, IMMUNOLOGY, V82, P596; Nebbak A, 2017, MED VET ENTOMOL; Nebbak A, 2016, PROTEOMICS, V16, P3148, DOI 10.1002/pmic.201600287; Perez-Eid C., 2007, LAVOISIER; Piesman J, 2001, J CLIN MICROBIOL, V39, P4145, DOI 10.1128/JCM.39.11.4145-4148.2001; Rijpkema S, 1996, EXP APPL ACAROL, V20, P23; Rudenko N, 2007, INSECT MOL BIOL, V16, P501, DOI 10.1111/j.1365-2583.2007.00745.x; Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2; Schnell G, 2015, MOL CELL PROTEOMICS, V14, P1254, DOI 10.1074/mcp.M114.046540; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Tonetti N, 2015, TICKS TICK-BORNE DIS, V6, P334, DOI 10.1016/j.ttbdis.2015.02.007; Uhlmann KR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-392; Van Treuren W, 2015, APPL ENVIRON MICROB, V81, P6200, DOI 10.1128/AEM.01562-15; Yssouf A, 2016, FUTURE MICROBIOL, V11, P549, DOI 10.2217/fmb.16.5; Yssouf A, 2015, TICKS TICK-BORNE DIS, V6, P579, DOI 10.1016/j.ttbdis.2015.04.013; Yssouf A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003473; Yssouf A, 2014, PARASITOL RES, V113, P2375, DOI 10.1007/s00436-014-3876-y; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185430	10.1371/journal.pone.0185430	http://dx.doi.org/10.1371/journal.pone.0185430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950023	Green Published, gold, Green Submitted			2022-12-26	WOS:000411671000052
J	Larson, EC; Novis, CL; Martins, LJ; Macedo, AB; Kimball, KE; Bosque, A; Planelles, V; Barrows, LR				Larson, Erica C.; Novis, Camille L.; Martins, Laura J.; Macedo, Amanda B.; Kimball, Kadyn E.; Bosque, Alberto; Planelles, Vicente; Barrows, Louis R.			Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro	PLOS ONE			English	Article							LONG TERMINAL REPEAT; TRANSCRIPTIONAL ACTIVATION; REPLICATION; INFECTION; RECOGNITION; MACROPHAGES; EXPRESSION; RESERVOIR; INDUCTION; PROTEIN	Following proviral integration into the host cell genome and establishment of a latent state, the human immunodeficiency virus type 1 (HIV-1) can reenter a productive life cycle in response to various stimuli. HIV-1 reactivation occurs when transcription factors, such as nuclear factor-.B (NF-.B), nuclear factor of activated T cells (NFAT), and activator protein -1 (AP-1), bind cognate sites within the long terminal repeat (LTR) region of the HIV-1 provirus to promote transcription. Interestingly, pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) can reactivate latent HIV-1 through activation of the transcription factor NF-.B. Some PRRs are expressed on central memory CD4 + T cells (TCM), which in HIV-1 patients constitute the main reservoir of latent HIV-1. Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), interacts with PRRs through membrane components. However, the ability of Mtb to reactivate latent HIV1 has not been extensively studied. Here we show that phosphatidylinositol mannoside 6 (PIM6), a component of the Mtb membrane, in addition to whole bacteria in co-culture, can reactivate HIV-1 in a primary TCM cell model of latency. Using a JLAT model of HIV-1 latency, we found this interaction to be mediated through Toll-like receptor-2 (TLR-2). Thus, we describe a mechanism by which Mtb can exacerbate HIV-1 infection. We hypothesize that chronic Mtb infection can drive HIV-1 reactivation. The phenomenon described here could explain, in part, the poor prognosis that characterizes HIV-1/Mtb co-infection.	[Larson, Erica C.; Barrows, Louis R.] Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA; [Novis, Camille L.; Martins, Laura J.; Macedo, Amanda B.; Kimball, Kadyn E.; Bosque, Alberto; Planelles, Vicente] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Macedo, Amanda B.; Bosque, Alberto] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; George Washington University	Barrows, LR (corresponding author), Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA.	lbarrows@pharm.utah.edu	Bosque, Alberto/H-7267-2019	Bosque, Alberto/0000-0002-8800-2160; Martins, Laura/0000-0001-8535-5350	National Institute of Allergy and Infectious Diseases of the NIH [R21AI124823, R01 AI124722]; University of Utah Flow Cytometry Facility in addition to the National Cancer Institute [5P30CA042014-24]; American Foundation for Pharmaceutical Education Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124722] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Utah Flow Cytometry Facility in addition to the National Cancer Institute; American Foundation for Pharmaceutical Education Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the NIH under award number R21AI124823 to L.R.B. and V.P. and R01 AI124722 to A.B. This work was supported by the University of Utah Flow Cytometry Facility in addition to the National Cancer Institute through Award Number 5P30CA042014-24. Support for E.C.L. was provided by the American Foundation for Pharmaceutical Education Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafica A, 2003, J IMMUNOL, V171, P1123, DOI 10.4049/jimmunol.171.3.1123; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Bernier R, 1998, J GEN VIROL, V79, P1353, DOI 10.1099/0022-1317-79-6-1353; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bosque A, 2011, METHODS, V53, P54, DOI 10.1016/j.ymeth.2010.10.002; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Chapman NM, 2013, CELL SIGNAL, V25, P639, DOI 10.1016/j.cellsig.2012.11.026; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; Donovan RM, 1996, J INFECT DIS, V174, P401, DOI 10.1093/infdis/174.2.401; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GAYNOR R, 1992, AIDS, V6, P347, DOI 10.1097/00002030-199204000-00001; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hernandez JC, 2012, AIDS RES HUM RETROV, V28, P1313, DOI 10.1089/aid.2011.0297; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Lancioni CL, 2011, INFECT IMMUN, V79, P663, DOI 10.1128/IAI.00806-10; Larson EC, 2016, AIDS RES HUM RETROV, V32, P1171, DOI 10.1089/aid.2016.0067; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; LEDERMAN MM, 1994, J ACQ IMMUN DEF SYND, V7, P727; Li Q, 2012, J LEUKOCYTE BIOL, V91, P311, DOI 10.1189/jlb.0711364; Martins LJ, 2016, AIDS RES HUM RETROV, V32, P187, DOI 10.1089/aid.2015.0106; Matthews K, 2012, EUR J IMMUNOL, V42, P147, DOI 10.1002/eji.201141927; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mortaz E, 2015, J CLIN IMMUNOL, V35, P1, DOI 10.1007/s10875-014-0103-7; Mwandumba HC, 2004, J IMMUNOL, V172, P4592, DOI 10.4049/jimmunol.172.7.4592; Novis CL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-119; Nusbaum RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21522; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Ranjbar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006116; Reuter MA, 2010, J VIROL, V84, P8549, DOI 10.1128/JVI.02303-09; Rodriguez ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080938; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Scanga CA, 2007, J INFECT DIS, V195, P246, DOI 10.1086/510244; Scheller C, 2004, J BIOL CHEM, V279, P21897, DOI 10.1074/jbc.M311609200; Schlaepfer E, 2011, J IMMUNOL, V186, P4314, DOI 10.4049/jimmunol.1003174; SHATTOCK RJ, 1994, J GEN VIROL, V75, P849, DOI 10.1099/0022-1317-75-4-849; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Thayil SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041093; Thibault S, 2009, VIROLOGY, V389, P20, DOI 10.1016/j.virol.2009.04.019; Toossi T, 2001, J ACQ IMMUN DEF SYND, V28, P1, DOI 10.1097/00042560-200109010-00001; Toossi Z, 1999, CLIN EXP IMMUNOL, V117, P324; Verrier JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020553; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; WHO, 2015, HIV ASS TUB; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185162	10.1371/journal.pone.0185162	http://dx.doi.org/10.1371/journal.pone.0185162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949981	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000027
J	Moon, S; Oh, CM; Choi, MK; Park, YK; Chun, S; Choi, M; Yu, JM; Yoo, HJ				Moon, Shinje; Oh, Chang-Myung; Choi, Moon-Ki; Park, Yoo-Kyung; Chun, Sukyung; Choi, Minkyung; Yu, Jae Myung; Yoo, Hyung Joon			The influence of physical activity on risk of cardiovascular disease in people who are obese but metabolically healthy	PLOS ONE			English	Article							HEART-FAILURE; FAT; BROWN; AGE	The metabolic outcomes of metabolically healthy obesity (MHO) remain controversial. The aim of the present study was to determine the effect of physical activity on the cardiovascular disease (CVD) outcomes of MHO. The study included participants who were followed for 10 years and recruited from the Korean Genome and Epidemiology Study (KoGES), a population-based cohort study. Participants with previously recorded CVDs or cancer, or who had received steroids or anticoagulants at baseline were excluded. A total of 8144 participants (3,942 men and 4,202 women) fulfilled inclusion criteria. In a multivariate Cox regression model adjusted for age and sex, MHO participants were not at elevated risk of CVD compared with their metabolically healthy non-obese (MHNO) counterparts (HR, 1.28; 95% CI, 0.96-1.71), although both the non-obese (HR, 1.50; 95% CI, 1.19-1.90) and obese (HR, 1.85; 95% CI, 1.48-2.30) participants with metabolic abnormalities were at elevated risk. However, in the subgroup analysis by physical activity, physically inactive MHO participants had a significantly higher HR for CVD events compared to active MHNO participants (HR, 1.54; 95% CI, 1.03-2.30), while active MHO participants were not at elevated risk (HR, 1.15; 95% CI, 0.70-1.89). Physically inactive MHO participants had significantly increased risk of CVD compared to physically active MHNO participants whereas physically active MHO participants did not.	[Moon, Shinje; Choi, Moon-Ki; Park, Yoo-Kyung; Yu, Jae Myung; Yoo, Hyung Joon] Hallym Univ, Div Endocrinol & Metab, Coll Med, Chunchon, South Korea; [Oh, Chang-Myung; Chun, Sukyung; Choi, Minkyung] CHA Univ, Div Endocrinol & Metab, CHA Bundang Med Ctr, Sch Med, Pangyo, Seongnam, South Korea	Hallym University; Pochon Cha University	Yu, JM; Yoo, HJ (corresponding author), Hallym Univ, Div Endocrinol & Metab, Coll Med, Chunchon, South Korea.	jaemyungyu@hallym.or.kr; hjoonyoo@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Chun, sukyung/0000-0001-8331-8521	Korean Diabetes Association, Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016S-1, 2016R1A6A3A04010466]	Korean Diabetes Association, Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the grant (C.M.O., 2016S-1) from the Korean Diabetes Association, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A6A3A04010466 to C.M.O). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bener A, 2013, J OBES, V2013, DOI 10.1155/2013/269038; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Choi SH, 2011, DIABETES CARE, V34, P944, DOI 10.2337/dc10-0644; Cronin CG, 2012, RADIOLOGY, V263, P836, DOI 10.1148/radiol.12100683; Dinas PC, 2015, CLIN ENDOCRINOL, V82, P147, DOI 10.1111/cen.12620; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Karelis AD, 2011, NAT REV ENDOCRINOL, V7, P699, DOI 10.1038/nrendo.2011.181; Korean Society for the Study of Obesity (KSSO), 2016, 2016 OB FACT SHEET; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040; Morkedal B, 2014, J AM COLL CARDIOL, V63, P1071, DOI 10.1016/j.jacc.2013.11.035; Ogorodnikova AD, 2012, OBESITY, V20, P651, DOI 10.1038/oby.2011.243; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Rahman M, 2010, OBSTET GYNECOL, V115, P982, DOI 10.1097/AOG.0b013e3181da9423; Rey-Lopez JP, 2014, OBES REV, V15, P781, DOI 10.1111/obr.12198; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Shimizu I, 2015, DIABETES, V64, P3984, DOI 10.2337/dbi15-0013; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Solomon CG, 1997, AM J CLIN NUTR, V66, P1044, DOI 10.1093/ajcn/66.4.1044S; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Vatten LJ, 2014, J AM COLL CARDIOL, V63, P8; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; Way KL, 2016, DIABETES METAB J, V40, P253, DOI 10.4093/dmj.2016.40.4.253; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2012, WORLD HLTH STAT 2012; Yoo HK, 2013, KOREAN J FAM MED, V34, P19, DOI 10.4082/kjfm.2013.34.1.19; Zanovec Michael, 2009, Int J Exerc Sci, V2, P175	38	15	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185127	10.1371/journal.pone.0185127	http://dx.doi.org/10.1371/journal.pone.0185127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949994	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000025
J	Poblaciones, MJ; Damon, P; Rengel, Z				Poblaciones, Maria J.; Damon, Paul; Rengel, Zed			Foliar zinc biofortification effects in Lolium rigidum and Trifolium subterraneum grown in cadmium-contaminated soil	PLOS ONE			English	Article							TOXICITY; PLANTS; WHEAT; ACCUMULATION; HUMANS; FIELD; GRAIN; IRON; BIOAVAILABILITY; FERTILIZATION	Zinc (Zn) is an important micronutrient that can alleviate cadmium (Cd) toxicity to plants and limit Cd entry into the food chain. However, little is known about the Zn-Cd interactions in pasture plants. We characterized the effects of foliar Zn application and Cd uptake by ryegrass (Lolium rigidum L.) and clover (Trifolium subterraneum L.) grown on Cd-contaminated soils; all combinations of foliar Zn applications (0, 0.25 and 0.5% (w/v) ZnSO4 center dot 7H(2)O) and soil Cd concentrations (0, 2.5 and 5 mg Cd kg(-1)) were tested. For both plant species, soil concentrations of DTPA-extractable Cd and Zn increased with an increase in the Cd and Zn treatments, respectively. Compared with L. rigidum, T. subterraneum accumulated, respectively, 3.3-and 4.1-fold more Cd in the 2.5-Cd and 5-Cd treatments and about 1.3-, 2.3-and 2.8-fold more Zn in the No-Zn, 0.25-Zn and 0.5-Zn treatments. Also, DTPA-Zn concentration was higher in soil after T. subterraneum than L. rigidum growth regardless of Zn applications. Foliar application of 0.25% (w/v) Zn significantly decreased the total Cd concentration in shoots of both species grown in the Cd-contaminated soil and ameliorated the adverse effects of Cd exposure on root growth, particularly in T. subterraneum.	[Poblaciones, Maria J.] Univ Extremadura, Dept Agron & Forest Environm Engn, Badajoz, Spain; [Poblaciones, Maria J.; Damon, Paul; Rengel, Zed] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia	Universidad de Extremadura; University of Western Australia	Poblaciones, MJ (corresponding author), Univ Extremadura, Dept Agron & Forest Environm Engn, Badajoz, Spain.; Poblaciones, MJ (corresponding author), Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia.	majops@unex.es	Poblaciones, Maria J./K-5106-2014; Poblaciones, Maria J/AAA-6673-2019	Poblaciones, Maria J./0000-0002-1559-2382; Poblaciones, Maria J/0000-0002-1559-2382; D, Paul/0000-0001-5620-1571	Ministry of Education, Culture and Sport of Spain (Program: Jose Castillejo) [CAS14/00146]	Ministry of Education, Culture and Sport of Spain (Program: Jose Castillejo)	Financial support was provided by the Ministry of Education, Culture and Sport of Spain (Program: Jose Castillejo, CAS14/00146) for Dr. Poblacioness stay in the School of Earth and Environment at the University of Western Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiloglu A., 2002, ARCH AGRON SOIL SCI, V48, P553; Akay A, 2007, BANGLADESH J BOTANY, V36, P13; Alloway BJ, 2009, ENVIRON GEOCHEM HLTH, V31, P537, DOI 10.1007/s10653-009-9255-4; Alloway B. J., 2008, ZINC SOILS CROP NUTR, DOI DOI 10.1016/S0065-2113(06)94003-6; [Anonymous], 2008, BIOL TRACE ELEM RES, V124, P110; Arienzo M, 2004, SCI TOTAL ENVIRON, V319, P13, DOI 10.1016/S0048-9697(03)00435-2; BAKER AJM, 1994, RESOUR CONSERV RECY, V11, P41, DOI 10.1016/0921-3449(94)90077-9; Bidar G, 2009, ENVIRON SCI POLLUT R, V16, P42, DOI 10.1007/s11356-008-0021-4; Bolan NS, 2013, ADV AGRON, V119, P183, DOI 10.1016/B978-0-12-407247-3.00004-4; BRENNAN RF, 1992, FERT RES, V31, P215, DOI 10.1007/BF01063295; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; Cherif J, 2011, J ENVIRON SCI, V23, P837, DOI 10.1016/S1001-0742(10)60415-9; Choppala G, 2014, CRIT REV PLANT SCI, V33, P374, DOI 10.1080/07352689.2014.903747; Ekmekci Y, 2008, J PLANT PHYSIOL, V165, P600, DOI 10.1016/j.jplph.2007.01.017; Fahad S, 2015, CLEAN-SOIL AIR WATER, V43, P1433, DOI 10.1002/clen.201400376; Fernandez V, 2009, CRIT REV PLANT SCI, V28, P36, DOI 10.1080/07352680902743069; Graham RD, 2012, ADV AGRON, V115, P1, DOI 10.1016/B978-0-12-394276-0.00001-9; Grant C.A, 2011, PEDOLOGIST, V54, P143, DOI [10.18920/pedologist.54.3_143, DOI 10.18920/PEDOLOGIST.54.3_143]; Han YL, 2007, ECOTOXICOLOGY, V16, P557, DOI 10.1007/s10646-007-0162-0; Haslett BS, 2001, ANN BOT-LONDON, V87, P379, DOI 10.1006/anbo.2000.1349; HAUG W, 1983, J SCI FOOD AGR, V34, P1423, DOI 10.1002/jsfa.2740341217; HAWF LR, 1967, PLANT SOIL, V27, P249, DOI 10.1007/BF01373393; Koleli N, 2004, ENVIRON POLLUT, V131, P453, DOI 10.1016/j.envpol.2004.02.012; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Luo HJ, 2011, ECOTOXICOLOGY, V20, P770, DOI 10.1007/s10646-011-0628-y; Manoj Kumari, 2011, Journal of Phytology, V3, P43; Marchiol L, 1996, J ENVIRON QUAL, V25, P562, DOI 10.2134/jeq1996.00472425002500030022x; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Matovic V, 2011, ARH HIG RADA TOKSIKO, V62, P65, DOI 10.2478/10004-1254-62-2011-2075; MORRIS ER, 1989, BIOL TRACE ELEM RES, V19, P107, DOI 10.1007/BF02925452; National Research Council NRC, 2001, REF INT VIT A VIT K, P37; Nursita Ayulungit Intan, 2005, Australasian Journal of Ecotoxicology, V11, P73; OTT EA, 1966, J ANIM SCI, V25, P419, DOI 10.2527/jas1966.252419x; PERKINS DJ, 1961, BIOCHEM J, V80, P668, DOI 10.1042/bj0800668; Poblaciones MJ, 2016, FOOD CHEM, V212, P427, DOI 10.1016/j.foodchem.2016.05.189; Saifullah, 2016, ENVIRON SCI POLLUT R, V23, P16432, DOI 10.1007/s11356-016-6822-y; Saifullah, 2014, ENVIRON EARTH SCI, V71, P1663, DOI 10.1007/s12665-013-2570-1; Sarwar N, 2015, ECOTOX ENVIRON SAFE, V122, P528, DOI 10.1016/j.ecoenv.2015.09.011; Sarwar N, 2010, J SCI FOOD AGR, V90, P925, DOI 10.1002/jsfa.3916; Shute T, 2006, SCI TOTAL ENVIRON, V371, P63, DOI 10.1016/j.scitotenv.2006.07.034; SIMS JT, 1991, SOIL SCI SOC AM BOOK, V4, P427, DOI DOI 10.2136/SSSAB00KSER4.2ED.C12; Stravinskiene V, 2014, POL J ENVIRON STUD, V23, P1355; Taspinar MS, 2011, TOXICOL IND HEALTH, V27, P73, DOI 10.1177/0748233710381888; Weiss W. P, 2000, CURSO NUTR GANADO LE, P1; Zhang YQ, 2010, J AGR FOOD CHEM, V58, P12268, DOI 10.1021/jf103039k	46	3	4	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185395	10.1371/journal.pone.0185395	http://dx.doi.org/10.1371/journal.pone.0185395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950025	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000047
J	Xiong, L; Chen, XC; Liu, N; Wang, Z; Miao, BL; Gan, WD; Li, DM; Guo, HQ				Xiong, Lei; Chen, Xiancheng; Liu, Ning; Wang, Zhen; Miao, Baolei; Gan, Weidong; Li, Dongmei; Guo, Hongqian			PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue	PLOS ONE			English	Article							TFE3 GENE FUSIONS; TRANSCRIPTION FACTOR E3; IN-SITU-HYBRIDIZATION; BREAK-APART FISH; CATHEPSIN-K; TRANSLOCATION CARCINOMAS; EXPRESSION; NEOPLASMS; PRCC; ADULTS	PRCC-TFE3 renal cell carcinoma (RCC) is one of the most common types of Xp11.2 translocation renal cell carcinoma (tRCC), of which the diagnosis mainly relies on reverse transcription-polymerase chain reaction (RT-PCR) or chromosomal analysis in fresh frozen samples. Herein, we developed a new dual-fusion fluorescence in situ hybridization (FISH) probe to succinctly identify PRCC-TFE3 RCC in paraffin-embedded tissue. We immunohistochemically analyzed TFE3 and cathepsin K expression in 23 cases of Xp11.2 tRCC which had been confirmed by break-apart TFE3 FISH probe. Next, the dual-fusion FISH assay was performed on these selected cases. Twenty typical cases of clear renal cell carcinoma and 20 cases of papillary renal cell carcinoma were collected as control groups. Seven cases were finally confirmed as PRCC-TFE3 RCC by FISH detection, emerging dual-fusion signals, of which 2 cases were identified as PRCC-TFE3 RCC by RT-PCR previously. All remaining cases were negative for the PRCC-TFE3 rearrangement by FISH. The TFE3 immunohistochemistry was positive in 22/23 cases and the cathepsin K was positive in 16/23 cases. All 7 PRCC-TFE3 RCCs showed positive cathepsin K immunoreactivity. Our results reveal that PRCC-TFE3 dual-fusion FISH probe is an efficient and concise technique for diagnosing PRCC-TFE3 RCC in paraffin-embedded tissue.	[Xiong, Lei; Liu, Ning; Wang, Zhen; Miao, Baolei; Gan, Weidong; Guo, Hongqian] Nanjing Univ, Inst Urol, Med Sch, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Xiancheng] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Crit Care Med, Med Sch, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Med Sch, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Med Sch, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Gan, WD (corresponding author), Nanjing Univ, Inst Urol, Med Sch, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Med Sch, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Med Sch, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	gwd@nju.edu.cn; lidm@nju.edu.cn	冬梅, 李/AHI-8180-2022	冬梅, 李/0000-0003-3819-355X; Liu, Ning/0000-0002-7283-7294				Argani P, 2002, AM J SURG PATHOL, V26, P1553, DOI 10.1097/00000478-200212000-00003; Argani P, 2003, PATHOLOGY, V35, P492, DOI 10.1080/00313020310001619901; Argani P, 2003, AM J SURG PATHOL, V27, P750, DOI 10.1097/00000478-200306000-00005; Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Argani P, 2016, WHO CLASSIFICATION T, P33; Argani P, 2007, AM J SURG PATHOL, V31, P1149, DOI 10.1097/PAS.0b013e318031ffff; Argani P, 2017, AM J SURG PATHOL, V41, P655, DOI 10.1097/PAS.0000000000000835; Argani P, 2016, AM J SURG PATHOL, V40, P723, DOI 10.1097/PAS.0000000000000631; Argani P, 2015, SEMIN DIAGN PATHOL, V32, P103, DOI 10.1053/j.semdp.2015.02.003; Argani P, 2010, AM J SURG PATHOL, V34, P1395, DOI 10.1097/PAS.0b013e3181f17ac0; ARTANDI SE, 1995, NUCLEIC ACIDS RES, V23, P3865, DOI 10.1093/nar/23.19.3865; Camparo P, 2008, AM J SURG PATHOL, V32, P656, DOI 10.1097/PAS.0b013e3181609914; Chen XC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000873; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; DEJONG B, 1986, CANCER GENET CYTOGEN, V21, P165, DOI 10.1016/0165-4608(86)90042-7; Dijkhuizen T, 1998, CANCER GENET CYTOGEN, V104, P74; Ellis CL, 2014, MODERN PATHOL, V27, P875, DOI 10.1038/modpathol.2013.208; Gaillot-Durand L, 2013, PATHOL RES PRACT, V209, P83, DOI 10.1016/j.prp.2012.10.013; Green WM, 2013, AM J SURG PATHOL, V37, P1150, DOI 10.1097/PAS.0b013e31828a69ae; Heimann P, 2001, CANCER RES, V61, P4130; Hirobe M, 2016, INT J UROL, V23, P140, DOI 10.1111/iju.13007; Klatte T, 2012, AM J CLIN PATHOL, V137, P761, DOI 10.1309/AJCPQ6LLFMC4OXGC; Komai Y, 2009, CLIN CANCER RES, V15, P1170, DOI 10.1158/1078-0432.CCR-08-1183; Macher-Goeppinger S, 2012, MODERN PATHOL, V25, P308, DOI 10.1038/modpathol.2011.169; Malouf GG, 2014, CLIN CANCER RES, V20, P4129, DOI 10.1158/1078-0432.CCR-13-3036; Martignoni G, 2009, MODERN PATHOL, V22, P1016, DOI 10.1038/modpathol.2009.58; Martignoni G, 2011, MODERN PATHOL, V24, P1313, DOI 10.1038/modpathol.2011.93; MELONI AM, 1993, CANCER GENET CYTOGEN, V65, P1, DOI 10.1016/0165-4608(93)90050-V; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Rao Q, 2013, AM J SURG PATHOL, V37, P804, DOI 10.1097/PAS.0b013e31827e17cb; Rao Q, 2012, AM J SURG PATHOL, V36, P1327, DOI 10.1097/PAS.0b013e31825aafb5; Rao Q, 2011, INT J SURG PATHOL, V19, P170, DOI 10.1177/1066896909354337; Ross H, 2010, PATHOLOGY, V42, P369, DOI 10.3109/00313021003767348; SHIPLEY JM, 1995, CYTOGENET CELL GENET, V71, P280, DOI 10.1159/000134127; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Skalsky YM, 2001, ONCOGENE, V20, P178, DOI 10.1038/sj.onc.1204056; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; Weterman MAJ, 1996, CYTOGENET CELL GENET, V75, P2, DOI 10.1159/000134444; Weterman MAJ, 2000, ONCOGENE, V19, P69, DOI 10.1038/sj.onc.1203255; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Zhong MH, 2012, AM J SURG PATHOL, V36, P654, DOI 10.1097/PAS.0b013e31824f24a6	41	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185337	10.1371/journal.pone.0185337	http://dx.doi.org/10.1371/journal.pone.0185337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949976	gold, Green Published, Green Submitted			2022-12-26	WOS:000411671000039
J	Zhai, SY; Song, GX; Qin, YC; Ye, XY; Lee, J				Zhai, Shiyan; Song, Genxin; Qin, Yaochen; Ye, Xinyue; Lee, Jay			Modeling the impacts of climate change and technical progress on the wheat yield in inland China: An autoregressive distributed lag approach	PLOS ONE			English	Article							WINTER-WHEAT; FERTILIZER MANAGEMENT; CROP YIELD; DIFFERENT IRRIGATION; REGRESSION-MODELS; USE EFFICIENCY; SILAGE MAIZE; GRAIN-YIELD; GROWTH; AGRICULTURE	This study aims to evaluate the impacts of climate change and technical progress on the wheat yield per unit area from 1970 to 2014 in Henan, the largest agricultural province in China, using an autoregressive distributed lag approach. The bounded F-test for cointegration among the model variables yielded evidence of a long-run relationship among climate change, technical progress, and the wheat yield per unit area. In the long run, agricultural machinery and fertilizer use both had significantly positive impacts on the per unit area wheat yield. A 1% increase in the aggregate quantity of fertilizer use increased the wheat yield by 0.19%. Additionally, a 1% increase in machine use increased the wheat yield by 0.21%. In contrast, precipitation during the wheat growth period (from emergence to maturity, consisting of the period from last October to June) led to a decrease in the wheat yield per unit area. In the short run, the coefficient of the aggregate quantity of fertilizer used was negative. Land size had a significantly positive impact on the per unit area wheat yield in the short run. There was no significant short-run or long-run impact of temperature on the wheat yield per unit area in Henan Province. The results of our analysis suggest that climate change had a weak impact on the wheat yield, while technical progress played an important role in increasing the wheat yield per unit area. The results of this study have implications for national and local agriculture policies under climate change. To design well-targeted agriculture adaptation policies for the future and to reduce the adverse effects of climate change on the wheat yield, climate change and technical progress factors should be considered simultaneously. In addition, adaptive measures associated with technical progress should be given more attention.	[Zhai, Shiyan; Qin, Yaochen] Henan Univ, Henan Collaborat Innovat Ctr Yellow River Civiliz, Coll Environm & Planning, Lab Geospatial Technol Middle & Lower Yellow Rive, Kaifeng, Peoples R China; [Zhai, Shiyan; Song, Genxin] East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China; [Ye, Xinyue; Lee, Jay] Kent State Univ, Dept Geog, Kent, OH 44242 USA	Henan University; East China Normal University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Zhai, SY (corresponding author), Henan Univ, Henan Collaborat Innovat Ctr Yellow River Civiliz, Coll Environm & Planning, Lab Geospatial Technol Middle & Lower Yellow Rive, Kaifeng, Peoples R China.; Zhai, SY (corresponding author), East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China.	zsycenu@hotmail.com	Ye, Xinyue/A-7677-2011	Ye, Xinyue/0000-0001-8838-9476	National Natural Science Foundation of China [41301149]; China Postdoctoral Science Foundation of the fifty-seventh batch of funds [2015M570626]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation of the fifty-seventh batch of funds(China Postdoctoral Science Foundation)	This work was supported by: 1.National Natural Science Foundation of China (Grant NO. 41301149), https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; 2.China Postdoctoral Science Foundation of the fifty-seventh batch of funds (Grant NO. 2015M570626), http://rsc.henu.edu.cn/info/1072/1287.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acaravci A, 2010, ENERGY, V35, P5412, DOI 10.1016/j.energy.2010.07.009; Administration C.M., 2012, CHIN GROUND CLIM DAT; [Anonymous], 2012, THESIS; Arshed N., 2016, INT J EC FINANCIAL R, V2, P183; Asumadu-Sarkodie S, 2016, ENVIRON SCI POLLUT R, V23, P10968, DOI 10.1007/s11356-016-6252-x; Ben-Ari T, 2016, AGR FOREST METEOROL, V220, P130, DOI 10.1016/j.agrformet.2016.01.009; BROWN RL, 1975, J ROY STAT SOC B MET, V37, P149; Chami DE, 2015, AGR SYST, V140, P19, DOI DOI 10.1016/J.AGSY.2015.08.008; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Conradt T, 2016, AGR FOREST METEOROL, V216, P68, DOI 10.1016/j.agrformet.2015.10.003; Duan RD, 2011, THESIS; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; FAO, FAO STAT DAT; Fuinhas JA, 2012, ENERG ECON, V34, P511, DOI 10.1016/j.eneco.2011.10.003; Ghosh S, 2010, ENERG POLICY, V38, P3008, DOI 10.1016/j.enpol.2010.01.040; Gomann H, 2015, PROCEDIA ENVIRON SCI, V29, P119, DOI 10.1016/j.proenv.2015.07.197; Gornott C, 2016, AGR FOREST METEOROL, V217, P89, DOI 10.1016/j.agrformet.2015.10.005; [郭建平 Guo Jianping], 2015, [应用气象学报, Journal of Applied Meteorolgical Science], V26, P1; Guo ZJ, 2015, FIELD CROP RES, V180, P100, DOI 10.1016/j.fcr.2015.05.015; Guo ZJ, 2014, FIELD CROP RES, V166, P102, DOI 10.1016/j.fcr.2014.06.004; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Hartmann TE, 2015, FIELD CROP RES, V174, P30, DOI 10.1016/j.fcr.2015.01.006; Henan statistical Bureau, 2014, HEN STAT YB 2014; [黄维 Huang Wei], 2010, [地理科学进展, Progress in Geography], V29, P677; Jalota SK, 2014, AGR SYST, V131, P77, DOI 10.1016/j.agsy.2014.07.009; Janjua PZ, 2014, NJAS-WAGEN J LIFE SC, V68, P13, DOI 10.1016/j.njas.2013.11.002; Kaur H, 2012, INDIAN J AGR SCI, V82, P213; Leadley PW, 1992, PLANT ECOL, p[104, 3]; Li KeNan, 2012, Acta Agronomica Sinica, V38, P1483; Li SA, 2010, AGR FOREST METEOROL, V150, P1412, DOI 10.1016/j.agrformet.2010.07.003; [李彤霄 LI Tong-xiao], 2009, [中国农业气象, Chinese Journal of Agrometeorology], V30, P143; Li ZH, 2015, EUR J AGRON, V71, P53, DOI 10.1016/j.eja.2015.08.006; Licker R, 2013, AGR FOREST METEOROL, V176, P25, DOI 10.1016/j.agrformet.2013.02.010; Liu J, 2007, IRRIGATION SCI, V26, P21, DOI 10.1007/s00271-007-0069-9; Liu RJ, 2015, AGR SYST, V132, P167, DOI 10.1016/j.agsy.2014.10.002; Liu YN, 2015, J INTEGR AGR, V14, P1184, DOI 10.1016/S2095-3119(14)60867-4; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Martin MMS, 2015, AGR FOREST METEOROL, V202, P51, DOI 10.1016/j.agrformet.2014.11.003; Meng QF, 2016, PEDOSPHERE, V26, P137, DOI 10.1016/S1002-0160(15)60030-3; Meza FJ, 2009, CLIMATIC CHANGE, V94, P143, DOI [10.1007/s10584-009-9544-z, 10.1007/s10584-009-9544-Z]; Mishra A, 2013, SCI TOTAL ENVIRON, V468, pS132, DOI 10.1016/j.scitotenv.2013.05.080; Montesino-San Martin M, 2014, AGR FOREST METEOROL, V187, P1, DOI 10.1016/j.agrformet.2013.11.009; Nkoro E., 2016, J STAT ECONOMETRIC M, V5, P63; Ozdogan M, 2011, AGR ECOSYST ENVIRON, V141, P1, DOI 10.1016/j.agee.2011.02.001; Ozturk I, 2013, ENERG ECON, V36, P262, DOI 10.1016/j.eneco.2012.08.025; Pesaran M.H., 1999, ECONOMET SOC MONOGR, P371, DOI DOI 10.1017/CCOL521633230.011; Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616; Potgieter A, 2013, CLIMATIC CHANGE, V117, P163, DOI 10.1007/s10584-012-0543-0; Reilly J, 2003, CLIMATIC CHANGE, V57, P43, DOI 10.1023/A:1022103315424; Saadi S, 2015, AGR WATER MANAGE, V147, P103, DOI 10.1016/j.agwat.2014.05.008; Siddiqui R, 2012, PAKISTAN DEV REV, P261, DOI DOI 10.30541/v51i4IIpp.261-276; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Tao FL, 2013, AGR FOREST METEOROL, V170, P146, DOI 10.1016/j.agrformet.2011.10.003; Tao FL, 2014, AGR FOREST METEOROL, V189, P91, DOI 10.1016/j.agrformet.2014.01.013; Tao FL, 2012, EUR J AGRON, V43, P201, DOI 10.1016/j.eja.2012.07.005; Tao FL, 2008, CLIM RES, V38, P83, DOI 10.3354/cr00771; Tian WM, 2000, J PROD ANAL, V13, P159, DOI 10.1023/A:1007805015716; Tong CL, 2003, AGR ECOSYST ENVIRON, V95, P523, DOI 10.1016/S0167-8809(02)00182-2; Wang CY, 2014, FIELD CROP RES, V165, P138, DOI 10.1016/j.fcr.2014.04.011; Wang J., 2011, THESIS; Wang XX, 2013, AGR WATER MANAGE, V129, P95, DOI 10.1016/j.agwat.2013.07.010; Webb LB, 2008, CLIM RES, V36, P99, DOI 10.3354/cr00740; Wilcox J, 2014, FIELD CROP RES, V156, P180, DOI 10.1016/j.fcr.2013.11.008; Xiong W, 2014, AGR ECOSYST ENVIRON, V196, P125, DOI 10.1016/j.agee.2014.06.014; Yang W.-D., 2007, THESIS; You LZ, 2009, AGR FOREST METEOROL, V149, P1009, DOI 10.1016/j.agrformet.2008.12.004; Zhang TY, 2013, INT J CLIMATOL, V33, P699, DOI 10.1002/joc.3463; Zhang XB, 2016, GEODERMA, V265, P176, DOI 10.1016/j.geoderma.2015.11.027; Zhao Jun-fang, 2010, Yingyong Shengtai Xuebao, V21, P2922	72	36	36	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							0184474	10.1371/journal.pone.0184474	http://dx.doi.org/10.1371/journal.pone.0184474			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI1DL	28950027	Green Submitted, gold, Green Published			2022-12-26	WOS:000411671000010
J	Torres, R; Samudio, R; Carrera, JP; Young, J; Marquez, R; Hurtado, L; Weaver, S; Chaves, LF; Tesh, R; Caceres, L				Torres, Rolando; Samudio, Rafael; Carrera, Jean-Paul; Young, Josue; Marquez, Ricardo; Hurtado, Lisbeth; Weaver, Scott; Fernando Chaves, Luis; Tesh, Robert; Caceres, Lorenzo			Enzootic mosquito vector species at equine encephalitis transmission foci in the Republica de Panama	PLOS ONE			English	Article							ARTHROPOD-BORNE VIRUSES; AMAZON BASIN REGION; LOWER CAURA RIVER; SAO-PAULO STATE; CULEX MELANOCONION; CUTANEOUS LEISHMANIASIS; AEDES-SCAPULARIS; VENEZUELAN ENCEPHALITIS; ENCEPHALOMYELITIS VIRUS; ALMIRANTE PANAMA	The identification of mosquito vector species present at arboviral enzootic transmission foci is important to understand transmission eco-epidemiology and to propose and implement prevention and control strategies that reduce vector-borne equine encephalitis transmission. The goal of this study was to identify mosquito species potentially involved in the transmission of enzootic equine encephalitis, in relation to their abundance and diversity at three endemic regions in the Republica de Panama A. We sampled adult mosquitoes during the dry and rainy season of Panama A. We employed CDC light traps with octanol, EV traps with CO2 and Trinidad 17 traps baited with live hamsters. Traps were deployed in the peridomicile and extradomicile of houses from 18: 00 to 6: 00 h. We estimated the abundance and diversity of sampled species. We collected a total of 4868 mosquitoes, belonging to 45 species and 11 genera, over 216 sampling nights. Culex Melanoconion) pedroi, a major Venezuelan equine encephalitis vector was relatively rare (< 2.0% of all sampled mosquitoes). We also found Cx. Mel) adamesi, Cx. Mel) crybda, Cx. Mel) ocossa, Cx. Mel) spissipes, Cx. Mel) taeniopus, Cx. Mel) vomerifer, Aedes scapularis, Ae. angustivittatus, Coquillettidia venezuelensis, Cx. nigripalpus, Cx. declarator, Mansonia titillans, M. pseudotitillans and Psorophora ferox all species known to be vectorially competent for the transmission of arboviruses. Abundance and diversity of mosquitoes in the sampled locations was high, when compared with similar surveys in temperate areas. Information from previous reports about vectorial competence /capacity of the sampled mosquito species suggest that sampled locations have all the elements to support enzootic outbreaks of Venezuelan and Eastern equine encephalitides.	[Torres, Rolando; Young, Josue; Marquez, Ricardo; Caceres, Lorenzo] Inst Commemorat Gorgas Estudios Salud, Dept Entomol Med, Ciudad De Panama, Panama; [Samudio, Rafael] Mastozool Soc Panama, Ciudad De Panama, Panama; [Carrera, Jean-Paul] Inst Commemorat Gorgas Estudios Salud, Dept Genom & Prote, Ciudad De Panama, Panama; [Hurtado, Lisbeth] Inst Commemorat Gorgas Estudios Salud, Dept Anal Epidemiol & Bioestadist, Ciudad De Panama, Panama; [Weaver, Scott; Tesh, Robert] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Weaver, Scott; Tesh, Robert] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Fernando Chaves, Luis] Univ Nacl, PIET, Escuela Med Vet, Heredia, Costa Rica; [Fernando Chaves, Luis] Univ Costa Rica, CIET, San Pedro, De Montes Oca, Costa Rica	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Universidad Nacional Costa Rica; Universidad Costa Rica	Caceres, L (corresponding author), Inst Commemorat Gorgas Estudios Salud, Dept Entomol Med, Ciudad De Panama, Panama.	lcaceres@gorgas.gob.pa	Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764; Hurtado, Lisbeth/0000-0003-4722-0417; Marquez, Ricardo/0000-0002-5169-3551; Caceres Carrera, Lorenzo/0000-0002-2025-6893; Carrera, Jean-Paul/0000-0002-1459-2858	Ministry of Economy and Finance of Panama	Ministry of Economy and Finance of Panama	The study was funded by the Ministry of Economy and Finance of Panama to LC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adames A, 1979, REV MED PANAMA, V4, P246; Adames A J, 1993, Rev Med Panama, V18, P106; Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50; AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986; Alba Salas Rosa, 2001, American Journal of Tropical Medicine and Hygiene, V64, P84; Arechiga-Ceballos N, 2015, REV SCI TECH OIE, V34, P491, DOI 10.20506/rst.34.2.2374; Atasheva S, 2015, J VIROL, V89, P71, DOI 10.1128/JVI.02252-14; Atasheva S, 2013, J VIROL, V87, P2023, DOI 10.1128/JVI.02881-12; Autoridad Nacional Del Ambiente, 2010, ATL AMB REP PAN; Barrera R, 2002, AM J TROP MED HYG, V67, P324, DOI 10.4269/ajtmh.2002.67.324; Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002; Calzada JE, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0987-6; Calzada JE, 2015, PARASITOLOGY, V142, P1202, DOI 10.1017/S0031182015000475; Calzada JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053289; Carrera JP, 2015, AM J TROP MED HYG, V93, P1014, DOI 10.4269/ajtmh.15-0117; Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628; CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227; Chaves L.F., 2017, INVERTEBRATES GLOBAL, P126, DOI [10.1002/9781119070894.ch8, DOI 10.1002/9781119070894.CH8]; Chaves LF, 2004, ACTA TROP, V92, P219, DOI 10.1016/j.actatropica.2004.08.001; Chaves LF, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00088.1; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; Chaves LF, 2016, INT J BIOMETEOROL, V60, P1727, DOI 10.1007/s00484-016-1162-7; Chaves LF, 2016, ACTA TROP, V153, P7, DOI 10.1016/j.actatropica.2015.10.001; COIMBRA TLM, 1993, INTERVIROLOGY, V36, P144, DOI 10.1159/000150333; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; CUPP EW, 1979, AM J TROP MED HYG, V28, P1060, DOI 10.4269/ajtmh.1979.28.1060; Day JF, 1999, J MED ENTOMOL, V36, P176, DOI 10.1093/jmedent/36.2.176; Deardorff ER, 2010, AM J TROP MED HYG, V82, P1047, DOI 10.4269/ajtmh.2010.09-0556; Dickerman R. W., 1986, VENEZUELAN EQUINE EN; Dutary B E, 1984, Rev Med Panama, V9, P200; Eastwood G, 2016, AM J TROP MED HYG, V94, P786, DOI 10.4269/ajtmh.15-0445; Edman J.D., 1988, Miscellaneous Publications of the Entomological Society of America, P43; Chaves LF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-164; Ferro C, 2003, EMERG INFECT DIS, V9, P49; Ferro C, 2008, BIOMEDICA, V28, P234, DOI 10.7705/biomedica.v28i2.94; Forattini O.P., 2002, CULICIDOLOGIA MED ID; FORATTINI OP, 1989, REV SAUDE PUBL, V23, P9, DOI 10.1590/S0034-89101989000100003; FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007; FORATTINI OP, 1988, REV SAUDE PUBL, V22, P84, DOI 10.1590/S0034-89101988000200003; GALINDO P, 1966, AM J TROP MED HYG, V15, P385, DOI 10.4269/ajtmh.1966.15.385; GALINDO P, 1956, AM J TROP MED HYG, V5, P1022, DOI 10.4269/ajtmh.1956.5.1022; GALINDO P, 1971, SCIENCE, V172, P594, DOI 10.1126/science.172.3983.594; Galindo P., 1972, Venezuelan encephalitis-proceedings of the workshop-symposium on Venezuelan encephalitis virus., P249; GALINDO P, 1951, AM J TROP MED, V31, P98; Galindo P, 1983, Rev Med Panama, V8, P89; Galindo P, 1978, REV MED PANAMA, V3, P1; Gonzalez Kadir, 2015, Tropical Medicine and Health, V43, P75, DOI 10.2149/tmh.2014-30; GRAYSON MA, 1968, AM J EPIDEMIOL, V88, P80, DOI 10.1093/oxfordjournals.aje.a120870; Groot H., 1996, Biomedica, V16, P331; GROOT H, 1959, AM J TROP MED HYG, V8, P175, DOI 10.4269/ajtmh.1959.8.175; Guimaraes AE, 2000, REV SAUDE PUBL, V34, P243, DOI 10.1590/S0034-89102000000300006; Herve JP, 1986, ASPECTOS ECOLOGICOS, P409; Hidrometeorologia Dd, 2014, EST SIT FIS, P38; Hoshi T, 2014, J AM MOSQUITO CONTR, V30, P260, DOI 10.2987/14-6432R.1; JOHNSON KM, 1968, AM J TROP MED HYG, V17, P432, DOI 10.4269/ajtmh.1968.17.432; Kesler RA, 1937, VET B, V31, P19; Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13; Krebs CJ, 1998, ECOLOGICAL METHODOLO, V2; Lane J., 1953, NEOTROPICAL CULICIDA, V2; Loaiza JR, 2008, J MED ENTOMOL, V45, P841, DOI 10.1603/0022-2585(2008)45[841:SCADOA]2.0.CO;2; LOPES J, 1995, REV SAUDE PUBL, V29, P183, DOI 10.1590/S0034-89101995000300005; Mendez W, 2001, J MED ENTOMOL, V38, P813, DOI 10.1603/0022-2585-38.6.813; Molaei G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004347; Navia-Gine WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081788; O'Guinn ML, 2004, AM J TROP MED HYG, V70, P164, DOI 10.4269/ajtmh.2004.70.164; Obaldia N., 1991, Notas Veterinarias, V1, P4; Parra-Henao G, 2012, BIOMEDICA, V32, P252, DOI 10.1590/S0120-41572012000300013; Petrov A, 2014, ZH MIKROBIOLOGII EPI, P103; Powers AM, 1997, J VIROL, V71, P6697, DOI 10.1128/JVI.71.9.6697-6705.1997; Quiroz E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000472; Reisen WK, 2014, INFECT GENET EVOL, V28, P573, DOI 10.1016/j.meegid.2013.11.025; Rubio-Palis Y, 2013, MEM I OSWALDO CRUZ, V108, P220, DOI 10.1590/0074-0276108022013015; Rubio-Palis Y, 2010, B MALARIOL SALUD AMB, V50, P95; Sallum MAM, 1996, J AM MOSQUITO CONTR, V12, P517; SANMARTIN C, 1973, B OFIC SANIT PANAM, V74, P108; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; SRIHONGSE SUNTHORN, 1967, MOSQUITO NEWS, V27, P74; SUDIA WD, 1971, MOSQ NEWS, V31, P350; Taira Katsuya, 2012, Medical Entomology and Zoology, V63, P289, DOI 10.7601/mez.63.289; Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2; Turell MJ, 2000, J MED ENTOMOL, V37, P835, DOI 10.1603/0022-2585-37.6.835; VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007; Velasquez G, 2013, EVIDENCE PRESENCE W; Vittor AY, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004554; Wang EY, 1999, J VIROL, V73, P4266, DOI 10.1128/JVI.73.5.4266-4271.1999; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008	91	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185491	10.1371/journal.pone.0185491	http://dx.doi.org/10.1371/journal.pone.0185491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937995	Green Submitted, gold, Green Published			2022-12-26	WOS:000411524700036
J	Asahi, H; Inoue, SI; Niikura, M; Kunigo, K; Suzuki, Y; Kobayashi, F; Sendo, F				Asahi, Hiroko; Inoue, Shin-Ichi; Niikura, Mamoru; Kunigo, Keisuke; Suzuki, Yutaka; Kobayashi, Fumie; Sendo, Fujiro			Profiling molecular factors associated with pyknosis and developmental arrest induced by an opioid receptor antagonist and dihydroartemisinin in Plasmodium falciparum	PLOS ONE			English	Article							GLUTATHIONE-REDUCTASE INHIBITION; RESISTANCE REVERSER; ANTIMALARIAL ACTION; ARTEMISININ; CHLOROQUINE; MALARIA; SENSITIVITY; GROWTH; DELTA; 7-BENZYLIDENENALTREXONE	Malaria continues to be a devastating disease, largely caused by Plasmodium falciparum infection. We investigated the effects of opioid and cannabinoid receptor antagonists on the growth of intraerythrocytic P. falciparum. The delta opioid receptor antagonist 7-benzylide-nenaltrexone (BNTX) and the cannabinoid receptor antagonists rimonaband and SR144528 caused growth arrest of the parasite. Notably BNTX and the established antimalarial drug dihydroartemisinin induced prominent pyknosis in parasite cells after a short period of incubation. We compared genome-wide transcriptome profiles in P. falciparum with different degrees of pyknosis in response to drug treatment, and identified 11 transcripts potentially associated with the evoking of pyknosis, of which three, including glutathione reductase (PfGR), triose phosphate transporter (PfoTPT), and a conserved Plasmodium membrane protein, showed markedly different gene expression levels in accordance with the degree of pyknosis. Furthermore, the use of specific inhibitors confirmed PfGR but not PfoTPT as a possible factor contributing to the development of pyknosis. A reduction in total glutathione levels was also detected in association with increased pyknosis. These results further our understanding of the mechanisms responsible for P. falciparum development and the antimalarial activity of dihydroartemisinin, and provide useful information for the development of novel antimalarial agents.	[Asahi, Hiroko; Inoue, Shin-Ichi; Niikura, Mamoru; Kobayashi, Fumie] Kyorin Univ, Sch Med, Dept Infect Dis, Div Trop Dis & Parasitol, Tokyo, Japan; [Kunigo, Keisuke; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan; [Sendo, Fujiro] Geriatr Hlth Serv Facil, Miyuki Oka, Yamagata, Japan	Kyorin University; University of Tokyo	Asahi, H (corresponding author), Kyorin Univ, Sch Med, Dept Infect Dis, Div Trop Dis & Parasitol, Tokyo, Japan.	isseix20@ks.kyorin-u.ac.jp	niikura, mamoru/ABG-5467-2021; Inoue, Shin-Ichi/P-2911-2018	Inoue, Shin-Ichi/0000-0003-1244-826X; Niikura, Mamoru/0000-0002-1647-2745	Japan Society for the Promotion of Science [15K08451]; Strategic International Research Cooperative Program (SICP) from the Japan Agency for Medical Research and Development; Asia-Africa S & T Strategic Cooperation Promotion Program; Special Coordination Funds for Promoting Science & Technology, Core-to-Core Program; Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic International Research Cooperative Program (SICP) from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Asia-Africa S & T Strategic Cooperation Promotion Program; Special Coordination Funds for Promoting Science & Technology, Core-to-Core Program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant in Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinaid/) to FK (No. 15K08451) and by a Strategic International Research Cooperative Program (SICP) from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/en/) to FK. The authors also gratefully acknowledge the support from the Asia-Africa S & T Strategic Cooperation Promotion Program by the Special Coordination Funds for Promoting Science & Technology, Core-to-Core Program, B. Asia-Africa Science Platforms by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinald/) to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA K, 1985, P NATL ACAD SCI USA, V82, P2543, DOI 10.1073/pnas.82.8.2543; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Asahi H, 2005, EXP PARASITOL, V109, P7, DOI 10.1016/j.exppara.2004.10.002; ASAHI H, 1994, PARASITOLOGY, V109, P397, DOI 10.1017/S0031182000080641; Asahi H, 2012, MALARIA PARASITES, P73; Asahi H, 2016, CURR TOP MED CHEM, V16, P3048, DOI 10.2174/1568026616999160215151704; Asahi H, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-167; Asahi H, 2013, CAN J MICROBIOL, V59, P485, DOI 10.1139/cjm-2013-0166; Asahi H, 2011, EXP PARASITOL, V127, P708, DOI 10.1016/j.exppara.2010.11.001; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Banerjee T, 2012, MOL BIOCHEM PARASIT, V186, P44, DOI 10.1016/j.molbiopara.2012.09.008; Bannister L, 2003, TRENDS PARASITOL, V19, P209, DOI 10.1016/S1471-4922(03)00086-2; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; Ben Mamoun C, 2010, DRUG DEVELOP RES, V71, P44, DOI 10.1002/ddr.20347; Benitez-Rangel E, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.37; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; Deharo E, 2003, BIOCHEM PHARMACOL, V66, P809, DOI 10.1016/S0006-2952(03)00396-4; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Desgrouas C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-327; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; Gendron L, 2016, PHARMACOL REV, V68, P631, DOI 10.1124/pr.114.008979; Ginsburg H, 2003, REDOX REP, V8, P276, DOI 10.1179/135100003225002907; Himi T, 2002, LIFE SCI, V70, P1235, DOI 10.1016/S0024-3205(01)01503-X; JESSEN F, 1986, J MEMBRANE BIOL, V92, P195, DOI 10.1007/BF01869388; Kehr S, 2011, ANTIOXID REDOX SIGN, V15, P2855, DOI 10.1089/ars.2011.4029; Lehane AM, 2012, INT J PARASITOL-DRUG, V2, P47, DOI 10.1016/j.ijpddr.2011.11.001; Lim L, 2010, FEBS LETT, V584, P549, DOI 10.1016/j.febslet.2009.11.097; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Miyata Y, 2012, BIOORG MED CHEM LETT, V22, P5174, DOI 10.1016/j.bmcl.2012.06.085; Miyata Y, 2011, BIOORG MED CHEM LETT, V21, P4710, DOI 10.1016/j.bmcl.2011.06.085; Muller S, 2015, MOLECULES, V20, P10511, DOI 10.3390/molecules200610511; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; Thanh NV, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1680-8; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; PEGORARO S, 2017, NAT COMMUN, V8; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; RUMPHO ME, 1988, PLANT PHYSIOL, V86, P1193, DOI 10.1104/pp.86.4.1193; Seefeldt T, 2009, J BIOL CHEM, V284, P2729, DOI 10.1074/jbc.M802683200; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Teuscher F, 2012, ANTIMICROB AGENTS CH, V56, P428, DOI 10.1128/AAC.05456-11; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Vega-Rodriguez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128212; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10111; WHO, 2016, WORLD MAL REP 2016; WHO, 2020, REP ANT DRUG EFF RES; Witt KA, 2001, J PHARMACOL EXP THER, V298, P848; Zaveri NT, 2015, ACS CHEM NEUROSCI, V6, P646, DOI 10.1021/cn500367b; Zhao Y, 2009, FREE RADICAL BIO MED, V47, P176, DOI 10.1016/j.freeradbiomed.2009.04.022; Zhao Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P56, DOI 10.1016/j.abb.2009.03.001	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184874	10.1371/journal.pone.0184874	http://dx.doi.org/10.1371/journal.pone.0184874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934264	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900054
J	Cedeno, RJ; Nakauka-Ddamba, A; Yousefi, M; Sterling, S; Leu, NA; Li, N; Pehrson, JR; Lengner, CJ				Cedeno, Ryan James; Nakauka-Ddamba, Angela; Yousefi, Maryam; Sterling, Stephanie; Leu, Nicolae Adrian; Li, Ning; Pehrson, John R.; Lengner, Christopher Joachim			The histone variant macroH2A confers functional robustness to the intestinal stem cell compartment	PLOS ONE			English	Article							INACTIVE X-CHROMOSOME; EPIGENETIC REGULATOR; TUMOR-SUPPRESSOR; CORE HISTONE; CANCER; EXPRESSION; CHROMATIN; GENE; TRANSCRIPTION; LGR5	A stem cell's epigenome directs cell fate during development, homeostasis, and regeneration. Epigenetic dysregulation can lead to inappropriate cell fate decisions, aberrant cell function, and even cancer. The histone variant macroH2A has been shown to influence gene expression, guide cell fate, and safeguard against genotoxic stress. Interestingly, mice lacking functional macroH2A histones (hereafter referred to as macroH2A DKO) are viable and fertile; yet suffer from increased perinatal death and reduced weight and size compared to wildtype (WT). Here, we ask whether the ostensible reduced vigor of macroH2A DKO mice extends to intestinal stem cell (ISC) function during homeostasis, regeneration, and oncogenesis. Lgr5-eGFP-IRES-CreERT2 or Hopx-CreERT2::Rosa26-LSL-tdTomato ISC reporter mice or the C57BL/6J-Apc(min)/J murine intestinal adenoma model were bred into a macroH2A DKO or strain-matched WT background and assessed for ISC functionality, regeneration and tumorigenesis. High-dose (12Gy) whole-body gamma-irradiation was used as an injury model. We show that macroH2A is dispensable for intestinal homeostasis and macroH2A DKO mice have similar numbers of active crypt-base columnar ISCs (CBCs). MacroH2A DKO intestine exhibits impaired regeneration following injury, despite having significantly more putative reserve ISCs. DKO reserve ISCs disproportionately undergo apoptosis compared to WT after DNA damage infliction. Interestingly, a macroH2A DKO background does not significantly increase tumorigenesis in the Apc(min) model of intestinal adenoma. We conclude that macroH2A influences reserve ISC number and function during homeostasis and regeneration. These data suggest macroH2A enhances reserve ISC survival after DNA damage and thus confers functional robustness to the intestinal epithelium.	[Cedeno, Ryan James; Nakauka-Ddamba, Angela; Yousefi, Maryam; Sterling, Stephanie; Leu, Nicolae Adrian; Li, Ning; Pehrson, John R.; Lengner, Christopher Joachim] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Cedeno, Ryan James; Yousefi, Maryam] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Program, Philadelphia, PA 19104 USA; [Sterling, Stephanie; Leu, Nicolae Adrian; Lengner, Christopher Joachim] Univ Penn, Sch Vet Med, Ctr Anim Transgenesis, Philadelphia, PA 19104 USA; [Lengner, Christopher Joachim] Univ Penn, Ctr Mol Studies Digest & Liver Dis, Philadelphia, PA 19104 USA; [Lengner, Christopher Joachim] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lengner, CJ (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA.; Lengner, CJ (corresponding author), Univ Penn, Sch Vet Med, Ctr Anim Transgenesis, Philadelphia, PA 19104 USA.; Lengner, CJ (corresponding author), Univ Penn, Ctr Mol Studies Digest & Liver Dis, Philadelphia, PA 19104 USA.; Lengner, CJ (corresponding author), Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA.	lengner@vet.upenn.edu			National Cancer Institute [R01CA168654]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK106309]; NATIONAL CANCER INSTITUTE [R01CA168654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Cancer Institute under project number R01CA168654, as well as a grant from the National Institute of Diabetes and Digestive and Kidney Diseases under project number R01DK106309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Asfaha S, 2015, CELL STEM CELL, V16, P627, DOI 10.1016/j.stem.2015.04.013; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barzily-Rokni M, 2011, NUCLEIC ACIDS RES, V39, P1326, DOI 10.1093/nar/gkq994; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Cantarino N, 2013, CANCER LETT, V336, P247, DOI 10.1016/j.canlet.2013.03.022; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Chang CC, 2005, DEV BIOL, V278, P367, DOI 10.1016/j.ydbio.2004.11.032; Chang EY, 2008, BIOCHEMISTRY-US, V47, P13726, DOI 10.1021/bi8016944; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; Changolkar LN, 2006, MOL CELL BIOL, V26, P4410, DOI 10.1128/MCB.02258-05; Chen HS, 2014, NAT STRUCT MOL BIOL, V21, P981, DOI 10.1038/nsmb.2903; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11; Douet J, 2017, J CELL SCI; Doyen CM, 2006, MOL CELL BIOL, V26, P1156, DOI 10.1128/MCB.26.3.1156-1164.2006; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Lavigne MD, 2015, CELL REP, V11, P1090, DOI 10.1016/j.celrep.2015.04.022; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li N, 2016, GASTROENTEROLOGY, V151, P298, DOI 10.1053/j.gastro.2016.04.049; Li N, 2014, STEM CELL REP, V3, P876, DOI 10.1016/j.stemcr.2014.09.011; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Mermoud JE, 2001, EXP CELL RES, V268, P245, DOI 10.1006/excr.2001.5277; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; Pehrson JR, 2014, MOL CELL BIOL, V34, P4523, DOI 10.1128/MCB.00794-14; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sporn JC, 2012, AM J PATHOL, V180, P2516, DOI 10.1016/j.ajpath.2012.02.027; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Xu C, 2012, FEBS LETT, V586, P3920, DOI 10.1016/j.febslet.2012.09.030; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yanai H, 2017, SCI REP-UK, V7, DOI 10.1038/srep41838; Yildirim O, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004515; Yousefi M, 2016, J CELL BIOL, V215, P401, DOI 10.1083/jcb.201604119; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	64	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185196	10.1371/journal.pone.0185196	http://dx.doi.org/10.1371/journal.pone.0185196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934364	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900118
J	Robinson, DP; Jaidah, MY; Bach, SS; Rohner, CA; Jabado, RW; Ormond, R; Pierce, SJ				Robinson, David P.; Jaidah, Mohammed Y.; Bach, Steffen S.; Rohner, Christoph A.; Jabado, Rima W.; Ormond, Rupert; Pierce, Simon J.			Some like it hot: Repeat migration and residency of whale sharks within an extreme natural environment	PLOS ONE			English	Article							RHINCODON-TYPUS; DIVING BEHAVIOR; NINGALOO REEF; INDIAN-OCEAN; GULF; AGGREGATION; TELEMETRY; MOVEMENT; PATTERNS; SEA	The Arabian Gulf is the warmest sea in the world and is host to a globally significant population of the whale shark Rhincodon typus. To investigate regional whale shark behaviour and movements, 59 satellite-linked tags were deployed on whale sharks in the Al Shaheen area off Qatar from 2011-14. Four different models of tag were used throughout the study, each model able to collect differing data or quantities of data. Retention varied from one to 227 days. While all tagged sharks crossed international maritime boundaries, they typically stayed within the Arabian Gulf. Only nine sharks dispersed through the narrow Strait of Hormuz into the Gulf of Oman. Most sharks stayed close to known or suspected feeding aggregation sites over summer months, but dispersed throughout the Arabian Gulf in winter. Sharks rarely ventured into shallow areas (< 40 m depth). A single, presumably pregnant female shark was the sole animal to disperse a long distance, crossing five international maritime boundaries in 37 days before the tag detached at a distance of approximately 2644 km from the tagging site, close to the Yemeni-Somali border. No clear space-use differentiation was evident between years, for sharks of different sizes, or between sexes. Whale sharks spent the most time (similar to n 66%) in temperatures of 24-30 degrees C and in shallow waters < 100 m depth (similar to 60%). Sharks spent relatively more time in cooler (X-2 = 121.692; p< 0.05) and deeper (X-2 = 46.402; p< 0.05) water at night. Sharks rarely made dives deeper than 100 m, reflecting the bathymetric constraints of the Gulf environment. Kernel density analysis demonstrated that the tagging site at Al Shaheen was the regional hotspot for these sharks, and revealed a probable secondary aggregation site for whale sharks in nearby Saudi Arabian waters. Analysis of visual re-sightings data of tagged sharks revealed that 58% of tagged individuals were re-sighted back in Al Shaheen over the course of this study, with 40% recorded back at Al Shaheen in the year following their initial identification. Two sharks were confirmed to return to Al Shaheen in each of the five years of study.	[Robinson, David P.; Ormond, Rupert] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Jaidah, Mohammed Y.] Qatar Minist Environm, Doha, Qatar; [Bach, Steffen S.] North Oil Co, Doha, Qatar; [Rohner, Christoph A.; Pierce, Simon J.] Marine Megafauna Fdn, Truckee, CA USA; [Jabado, Rima W.] Gulf Elasmo Project, Dubai, U Arab Emirates; [Ormond, Rupert] Marine Conservat Int, Edinburgh, Midlothian, Scotland	Heriot Watt University	Robinson, DP (corresponding author), Heriot Watt Univ, Edinburgh, Midlothian, Scotland.	sharkwatcharabia@gmail.com	Pierce, Simon J./A-7621-2010	Pierce, Simon J./0000-0002-9375-5175; Robinson, David/0000-0003-2572-9271; Rohner, Christoph/0000-0001-8760-8972; Jabado, Rima/0000-0001-6239-6723	MORTC; North Oil Company (NOC); Save Our Seas Foundation; Shark Foundation; Aqua-Firma; Waterlust	MORTC; North Oil Company (NOC); Save Our Seas Foundation; Shark Foundation; Aqua-Firma; Waterlust	Logistics for this project were provided by the Qatar Ministry of Municipality and Environment (QMMOE) and, Maersk Oil Research and Technology Centre (MORTC). SB acted as an independent researcher throughout this study with financial support in the form of a salary from the MORTC. The journal publication fees for this manuscript were provided by the North Oil Company (NOC). The MORTC or NOC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of SBs salary and research materials. DPRs work on this manuscript was supported by two small grants from the Save Our Seas Foundation. Many thanks to the Save Our Seas Foundation, Al Ghurair Foods and the Emirates Diving Association, Emirates Natural History Group and, Le Meridien Al Aqah Beach Resort for providing financial support for individual satellite tags. Christoph Rohner and Simon Pierces contribution to this project were supported by private trusts, the Shark Foundation, Aqua-Firma, and Waterlust	Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Berumen ML, 2014, PLOS ONE, V9; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Cagua EF, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0092; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Gleiss AC, 2009, FISH RES, V97, P11, DOI 10.1016/j.fishres.2008.12.012; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Hanfee F, 2001, GENTLE GIANTS SEA IN; Hearn A.R., 2013, ANIM BIOTELEMETRY, V1, P1, DOI [10.1186/2050-3385-1-11, DOI 10.1186/2050-3385-1-11]; Hearn AR, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2991-y; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Jabado R., 2012, MARINE ECOSYSTEMS UN; MacLeod C., 2013, INTRO USING GIS MARI; Marcus L, 2016, MAR ECOL PROG SER, V554, P115, DOI 10.3354/meps11807; Marrero D, 2014, PLOS ONE, V9; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Norman B, 2016, RHINCODON TYPUS IUCN; Norman B., 2007, EC IMPORTANCE CONSER; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Ramirez-Macias Deni, 2012, Endangered Species Research, V18, P115, DOI 10.3354/esr00437; Robinson DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158593; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Rohner C, 2013, MARINE ECOLOGY PROGR, V493, P1; Rohner C, 2014, PEER J, V22; Rohner CA, 2015, J PLANKTON RES, V37, P352, DOI 10.1093/plankt/fbv010; Rowat D, 2008, ENVIRON BIOL FISH, V82, P215, DOI 10.1007/s10641-007-9280-z; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Schmidt Jennifer V., 2010, Endangered Species Research, V12, P117, DOI 10.3354/esr00300; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Speed CW, 2008, J FISH BIOL, V72, P1488, DOI 10.1111/j.1095-8649.2008.01810.x; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Tyminski JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142156; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753	38	26	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185360	10.1371/journal.pone.0185360	http://dx.doi.org/10.1371/journal.pone.0185360			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934371	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900150
J	Carney, SM; Gomathinayagam, S; Leuba, SH; Trakselis, MA				Carney, Sean M.; Gomathinayagam, Shivasankari; Leuba, Sanford H.; Trakselis, Michael A.			Bacterial DnaB helicase interacts with the excluded strand to regulate unwinding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA replication; DNA-protein interaction; nucleic acid enzymology; single-molecule biophysics; DnaB; steric exclusion and wrapping; unwinding	SINGLE-MOLECULE FRET; ESCHERICHIA-COLI; REPLICATIVE HELICASE; HEXAMERIC HELICASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; BRANCH MIGRATION; STRUCTURAL BASIS; PROTEIN HEXAMER; MCM HELICASE	Replicative hexameric helicases are thought to unwind duplex DNA by steric exclusion (SE) where one DNA strand is encircled by the hexamer and the other is excluded from the central channel. However, interactions with the excluded strand on the exterior surface of hexameric helicases have also been shown to be important for DNA unwinding, giving rise to the steric exclusion and wrapping (SEW) model. For example, the archaeal Sulfolobus solfataricus minichromosome maintenance (SsoMCM) helicase has been shown to unwind DNA via a SEW mode to enhance unwinding efficiency. Using single-molecule FRET, we now show that the analogous Escherichia coli (Ec) DnaB helicase also interacts specifically with the excluded DNA strand during unwinding. Mutation of several conserved and positively charged residues on the exterior surface of EcDnaB resulted in increased interaction dynamics and states compared with wild type. Surprisingly, these mutations also increased the DNA unwinding rate, suggesting that electrostatic contacts with the excluded strand act as a regulator for unwinding activity. In support of this, experiments neutralizing the charge of the excluded strand with a morpholino substrate instead of DNA also dramatically increased the unwinding rate. Of note, although the stability of the excluded strand was nearly identical for EcDnaB and SsoMCM, these enzymes are from different superfamilies and unwind DNA with opposite polarities. These results support the SEW model of unwinding for EcDnaB that expands on the existing SE model of hexameric helicase unwinding to include contributions from the excluded strand to regulate the DNA unwinding rate.	[Carney, Sean M.; Leuba, Sanford H.; Trakselis, Michael A.] Univ Pittsburgh, Mol Biophys & Struct Biol Program, Pittsburgh, PA 15260 USA; [Gomathinayagam, Shivasankari; Trakselis, Michael A.] Baylor Univ, Dept Chem & Biochem, One Bear Pl 97365, Waco, TX 76798 USA; [Leuba, Sanford H.] Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA 15261 USA; [Carney, Sean M.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School	Trakselis, MA (corresponding author), Baylor Univ, Dept Chem & Biochem, One Bear Pl 97365, Waco, TX 76798 USA.	michael_trakselis@baylor.edu	Trakselis, Michael/V-3806-2019	Leuba, Sanford/0000-0003-0278-7997; Trakselis, Michael/0000-0001-7054-8475; Carney, Sean/0000-0002-2674-1064	Baylor University; University of Pittsburgh; American Cancer Society Research Scholar Grant [RSG-11-049-01-DMC]; National Science Foundation Division of Molecular and Cellular Biosciences [NSF1613534]; National Institutes of Health [AI081571, GM068406]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068406] Funding Source: NIH RePORTER	Baylor University; University of Pittsburgh(University of Pittsburgh); American Cancer Society Research Scholar Grant(American Cancer Society); National Science Foundation Division of Molecular and Cellular Biosciences(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Baylor University, The University of Pittsburgh, American Cancer Society Research Scholar Grant RSG-11-049-01-DMC (to M. A. T.), National Science Foundation Division of Molecular and Cellular Biosciences Grant NSF1613534 (to M. A. T.), and National Institutes of Health Grants AI081571 and GM068406 (to S. H. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abelson J, 2010, NAT STRUCT MOL BIOL, V17, P504, DOI 10.1038/nsmb.1767; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10929, DOI 10.1021/bi990049l; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Fagerburg MV, 2011, METHODS MOL BIOL, V749, P273, DOI 10.1007/978-1-61779-142-0_19; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Graham BW, 2016, J BIOL CHEM, V291, P12467, DOI 10.1074/jbc.M116.719591; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Graham JE, 2017, CELL, V169, P1201, DOI 10.1016/j.cell.2017.05.041; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Nhieu GTV, 2013, NAT COMMUN, V4, DOI [10.1038/ncomms3495, 10.1038/ncomms2561]; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Jeong YJ, 2013, NUCLEIC ACIDS RES, V41, P4219, DOI 10.1093/nar/gkt133; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1997, BIOCHEMISTRY-US, V36, P10320, DOI 10.1021/bi970712a; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Khan I, 2016, J BIOL CHEM, V291, P14324, DOI 10.1074/jbc.M115.712026; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Lee SJ, 2014, P NATL ACAD SCI USA, V111, pE827, DOI 10.1073/pnas.1322254111; Manhart CM, 2015, J BIOL CHEM, V290, P10828, DOI 10.1074/jbc.M115.642066; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6187, DOI 10.1093/nar/gks254; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Rasband W., 2006, IMAGEJ; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sambrook J., 2001, MOL CLONING LAB MANU; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Schauer GD, 2014, NUCLEIC ACIDS RES, V42, P11687, DOI 10.1093/nar/gku819; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Trakselis M.A., 2016, F1000RES, V5; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356	49	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19001	19012		10.1074/jbc.M117.814178	http://dx.doi.org/10.1074/jbc.M117.814178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939774	Green Published, hybrid			2022-12-26	WOS:000415848000023
J	Oka, S; Hirata, T; Suzuki, W; Naito, D; Chen, YB; Chin, A; Yaginuma, H; Saito, T; Nagarajan, N; Zhai, PY; Bhat, S; Schesing, K; Shao, D; Hirabayashi, Y; Yodoi, J; Sciarretta, S; Sadoshima, J				Oka, Shin-ichi; Hirata, Tsuyoshi; Suzuki, Wataru; Naito, Daichi; Chen, Yanbin; Chin, Adave; Yaginuma, Hiroaki; Saito, Toshiro; Nagarajan, Narayani; Zhai, Peiyong; Bhat, Santosh; Schesing, Kevin; Shao, Dan; Hirabayashi, Yoko; Yodoi, Junji; Sciarretta, Sebastiano; Sadoshima, Junichi			Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart; mechanistic target of rapamycin (mTOR); oxidative stress; redox regulation; thioredoxin	CARDIAC-HYPERTROPHY; MAMMALIAN TARGET; PATHWAY; MITOCHONDRIAL; COMPLEX; DISEASE; HEART; INHIBITION; ACTIVATION; APOPTOSIS	Thioredoxin 1 (Trx1) is a 12-kDa oxidoreductase that catalyzes thiol-disulfide exchange reactions to reduce proteins with disulfide bonds. As such, Trx1 helps protect the heart against stresses, such as ischemia and pressure overload. Mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that regulates cell growth, metabolism, and survival. We have shown previously that mTOR activity is increased in response to myocardial ischemia-reperfusion injury. However, whether Trx1 interacts with mTOR to preserve heart function remains unknown. Using a substrate-trapping mutant of Trx1 (Trx1C35S), we show here that mTOR is a direct interacting partner of Trx1 in the heart. In response to H2O2 treatment in cardiomyocytes, mTOR exhibited a high molecular weight shift in non-reducing SDS-PAGE in a 2-mercaptoethanol-sensitive manner, suggesting that mTOR is oxidized and forms disulfide bonds with itself or other proteins. The mTOR oxidation was accompanied by reduced phosphorylation of endogenous substrates, such as S6 kinase (S6K) and 4E-binding protein 1 (4E-BP1) in cardiomyocytes. Immune complex kinase assays disclosed that H2O2 treatment diminished mTOR kinase activity, indicating that mTOR is inhibited by oxidation. Of note, Trx1 overexpression attenuated both H2O2-mediated mTOR oxidation and inhibition, whereas Trx1 knockdown increased mTOR oxidation and inhibition. Moreover, Trx1 normalized H2O2-induced down-regulation of metabolic genes and stimulation of cell death, and an mTOR inhibitor abolished Trx1-mediated rescue of gene expression. H2O2-induced oxidation and inhibition of mTOR were attenuated when Cys-1483 of mTOR was mutated to phenylalanine. These results suggest that Trx1 protects cardiomyocytes against stress by reducing mTOR at Cys-1483, thereby preserving the activity of mTOR and inhibiting cell death.	[Oka, Shin-ichi; Hirata, Tsuyoshi; Suzuki, Wataru; Naito, Daichi; Chin, Adave; Yaginuma, Hiroaki; Saito, Toshiro; Nagarajan, Narayani; Zhai, Peiyong; Bhat, Santosh; Schesing, Kevin; Shao, Dan; Sadoshima, Junichi] Rutgers Biomed & Hlth Sci, Dept Cell Biol & Mol Med, 185 S Orange Ave,MSB G609, Newark, NJ 07101 USA; [Chen, Yanbin] Soochow Univ, Affiliated Hosp 1, Dept Resp Med, 899 Pinghai Rd, Suzhou 215000, Peoples R China; [Hirabayashi, Yoko] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Ctr Biol Safety & Res, Tokyo 1588501, Japan; [Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Infect & Prevent,Sakyo Ku, Kyoto 6068397, Japan; [Sciarretta, Sebastiano] Univ Rome, Dept Med Surg Sci & Biotechnol, I-04100 Latina, Italy	Rutgers State University New Brunswick; Rutgers State University Medical Center; Soochow University - China; National Institute of Health Sciences - Japan; Kyoto University	Sadoshima, J (corresponding author), Rutgers Biomed & Hlth Sci, Dept Cell Biol & Mol Med, 185 S Orange Ave,MSB G609, Newark, NJ 07101 USA.	sadoshju@njms.rutgers.edu	Masutani, Hiroshi/B-5114-2014; saito, toshiro/AAW-8979-2021; Sciarretta, Sebastiano/K-5161-2016	saito, toshiro/0000-0003-0845-9265; Sadoshima, Junichi/0000-0003-3724-4132; Sciarretta, Sebastiano/0000-0002-8633-6896	Public Health Service [HL67724, HL91469, HL102738, HL112330, AG23039]; Leducq Foundation Transatlantic Network of Excellence; American Heart Association [12SDG11890014, 17GRNT33440031]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112330, R01HL102738, R01HL091469, R01HL067724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Leducq Foundation Transatlantic Network of Excellence(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Public Health Service Grants HL67724, HL91469, HL102738, HL112330, and AG23039 (to J. S.) and by the Leducq Foundation Transatlantic Network of Excellence (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Scientist Development Grant 12SDG11890014 and Grant-in-Aid 17GRNT33440031 from the American Heart Association.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ago T, 2006, ANTIOXID REDOX SIGN, V8, P1635, DOI 10.1089/ars.2006.8.1635; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Du CY, 2016, INT J BIOCHEM CELL B, V79, P1, DOI 10.1016/j.biocel.2016.08.006; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Huang CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29196; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Matsushima S, 2016, J CLIN INVEST, V126, P3403, DOI 10.1172/JCI85624; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nagarajan N, 2017, FREE RADICAL BIO MED, V109, P125, DOI 10.1016/j.freeradbiomed.2016.12.020; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Powis G, 2007, CURR OPIN PHARMACOL, V7, P392, DOI 10.1016/j.coph.2007.04.003; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rosner M, 2010, AMINO ACIDS, V38, P223, DOI 10.1007/s00726-008-0230-7; Sanchez-Villamil JP, 2016, INT J BIOCHEM CELL B, V81, P323, DOI 10.1016/j.biocel.2016.08.045; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Seo G, 2011, FREE RADICAL RES, V45, P389, DOI 10.3109/10715762.2010.535530; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; Simon MC, 2008, ANNU REV PHYSIOL, V70, P51, DOI 10.1146/annurev.physiol.70.113006.100526; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; Wu CG, 2011, ANTIOXID REDOX SIGN, V15, P2565, DOI 10.1089/ars.2010.3831; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yang YF, 2015, CIRC RES, V117, P891, DOI 10.1161/CIRCRESAHA.115.306624; Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhang LQ, 2009, FREE RADICAL BIO MED, V46, P1500, DOI 10.1016/j.freeradbiomed.2009.03.001	36	30	30	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18988	19000		10.1074/jbc.M117.807735	http://dx.doi.org/10.1074/jbc.M117.807735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939765	Green Published, hybrid			2022-12-26	WOS:000415848000022
J	Hu, ZY; Chen, B; Zhang, JP; Ma, YY				Hu, Zhan-ying; Chen, Bo; Zhang, Jing-pu; Ma, Yuan-yuan			Up-regulation of autophagy-related gene 5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinson's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein; autophagy; neurodegenerative disease; Parkin; Parkinson disease; PTEN-induced putative kinase 1 (PINK1); zebrafish; atg5	LIVE TRANSGENIC ZEBRAFISH; ALPHA-SYNUCLEIN; MOUSE MODEL; IN-VIVO; PINK1; MPTP; MITOPHAGY; MECHANISMS; APOPTOSIS; NEURODEGENERATION	Parkinson's disease (PD) is one of the most epidemic neurodegenerative diseases and is characterized by movement disorders arising from loss of midbrain dopaminergic (DA) neurons. Recently, the relationship between PD and autophagy has received considerable attention, but information about the mechanisms involved is lacking. Here, we report that autophagy-related gene 5 (ATG5) is potentially important in protecting dopaminergic neurons in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model in zebrafish. Using analyses of zebrafish swimming behavior, in situ hybridization, immunofluorescence, and expressions of genes and proteins related to PD and autophagy, we found that the ATG5 expression level was decreased and autophagy flux was blocked in this model. The ATG5 down-regulation led to the upgrade of PD-associated proteins, such as -synuclein, Parkin, and PINK1, aggravation of MPTP-induced PD-mimicking pathological locomotor behavior, DA neuron loss labeled by tyrosine hydroxylase (TH) or dopamine transporter (DAT), and blocked autophagy flux in the zebrafish model. ATG5 overexpression alleviated or reversed these PD pathological features, rescued DA neuron cells as indicated by elevated TH/DAT levels, and restored autophagy flux. The role of ATG5 in protecting DA neurons was confirmed by expression of the human atg5 gene in the zebrafish model. Our findings reveal that ATG5 has a role in neuroprotection, and up-regulation of ATG5 may serve as a goal in the development of drugs for PD prevention and management.	[Zhang, Jing-pu] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; Peking Union Med Coll, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, JP (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China.	zhangjingpu@imb.pumc.edu.cn	Hu, Zhanying/AAE-8790-2019	Hu, Zhanying/0000-0002-4169-7778	National Natural Science Foundation of China [81173043]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81321004]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2016-I2M-2-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences Initiative for Innovative Medicine	This work was supported by National Natural Science Foundation of China Grant 81173043, Foundation for Innovative Research Groups of the National Natural Science Foundation of China Grant 81321004, and Chinese Academy of Medical Sciences Initiative for Innovative Medicine Grant 2016-I2M-2-006). The authors declare that they have no conflicts of interest with the contents of this article.	Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Arnold MC, 2016, ARCH ENVIRON CON TOX, V70, P311, DOI 10.1007/s00244-015-0235-7; Barodia SK, 2017, BRAIN RES BULL, V133, P51, DOI 10.1016/j.brainresbull.2016.12.004; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; Chen DF, 2013, NEUROSCI LETT, V538, P49, DOI 10.1016/j.neulet.2013.01.044; Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143; Colasanti T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.211; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; da Fonseca TL, 2015, BIOMOLECULES, V5, P435, DOI 10.3390/biom5020435; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Emamzadeh FN, 2016, J RES MED SCI, V21, P165, DOI 10.4103/1735-1995.181989; Gallegos S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00059; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Garcia-Garcia A, 2013, TOXICOL SCI, V136, P166, DOI 10.1093/toxsci/kft188; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Haque ME, 2012, J BIOL CHEM, V287, P23162, DOI 10.1074/jbc.M112.346437; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hu ZY, 2011, AUTOPHAGY, V7, P1514, DOI 10.4161/auto.7.12.18040; Israeli E, 2009, J NEUROCHEM, V108, P465, DOI 10.1111/j.1471-4159.2008.05776.x; Jellinger KA, 2010, J CELL MOL MED, V14, P457, DOI 10.1111/j.1582-4934.2010.01010.x; Kanaan NM, 2012, J PARKINSON DIS, V2, P249, DOI 10.3233/JPD-012138; Kesidou E, 2013, NEURAL REGEN RES, V8, P2275, DOI 10.3969/j.issn.1673-5374.2013.24.007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; L'Episcopo F, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-83; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li JJ, 2015, ONCOTARGET, V6, P40480, DOI 10.18632/oncotarget.5803; Longhena F, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5012129; Lv XH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06010; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; Ma MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37130; Giraldez-Perez RM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0176-9; Martinez-Vicente M, 2015, SEMIN CELL DEV BIOL, V40, P115, DOI 10.1016/j.semcdb.2015.03.005; Meredith GE, 2009, EXP NEUROL, V219, P334, DOI 10.1016/j.expneurol.2009.06.005; Miki Y, 2016, BRAIN PATHOL, V26, P359, DOI 10.1111/bpa.12297; Milanese C, 2012, J BIOL CHEM, V287, P2971, DOI 10.1074/jbc.M111.308312; Mizushima N, 2002, SEIKAGAKU, V74, P523; Murakami T, 2007, J NEUROL NEUROSUR PS, V78, P653, DOI 10.1136/jnnp.2006.100123; Nah J, 2015, MOL CELLS, V38, P381, DOI 10.14348/molcells.2015.0034; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nardin A, 2016, CURR NEUROPHARMACOL, V14, P250, DOI 10.2174/1570159X13666151030104414; Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008; Norris KL, 2015, J BIOL CHEM, V290, P13862, DOI 10.1074/jbc.M114.634063; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Toni M, 2015, MAR DRUGS, V13, P6665, DOI 10.3390/md13116665; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Varga M, 2014, CELL DEATH DIFFER, V21, P547, DOI 10.1038/cdd.2013.175; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Wen L, 2008, DEV BIOL, V314, P84, DOI 10.1016/j.ydbio.2007.11.012; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Xi YW, 2011, CURR NEUROL NEUROSCI, V11, P274, DOI 10.1007/s11910-011-0182-2; Xilouri M, 2016, MOVEMENT DISORD, V31, P178, DOI 10.1002/mds.26477; Xu M, 2016, FRONT BIOSCI-LANDMRK, V21, P696, DOI 10.2741/4415; Yokoyama H, 2011, ACTA NEUROBIOL EXP, V71, P269; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang H, 2015, MOL NEUROBIOL, V51, P89, DOI 10.1007/s12035-014-8787-5	70	45	48	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18062	18074		10.1074/jbc.M116.764795	http://dx.doi.org/10.1074/jbc.M116.764795			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28928221	Green Published, hybrid			2022-12-26	WOS:000414458200007
J	Hagey, TJ; Harte, S; Vickers, M; Harmon, LJ; Schwarzkopf, L				Hagey, Travis J.; Harte, Scott; Vickers, Mathew; Harmon, Luke J.; Schwarzkopf, Lin			There's more than one way to climb a tree: Limb length and microhabitat use in lizards with toe pads	PLOS ONE			English	Article							GEKKOTAN ADHESIVE SYSTEM; PERCH DIAMETER; ANOLIS LIZARDS; TRADE-OFFS; LOCOMOTOR PERFORMANCE; HABITAT USE; MORPHOLOGICAL-DIFFERENTIATION; HINDLIMB KINEMATICS; FRICTIONAL ADHESION; SPRINT PERFORMANCE	Ecomorphology links microhabitat and morphology. By comparing ecomorphological associations across clades, we can investigate the extent to which evolution can produce similar solutions in response to similar challenges. While Anolis lizards represent a well-studied example of repeated convergent evolution, very few studies have investigated the ecomorphology of geckos. Similar to anoles, gekkonid lizards have independently evolved adhesive toe pads and many species are scansorial. We quantified gecko and anole limb length and microhabitat use, finding that geckos tend to have shorter limbs than anoles. Combining these measurements with microhabitat observations of geckos in Queensland, Australia, we observed geckos using similar microhabitats as reported for anoles, but geckos with relatively longer limbs were using narrower perches, differing from patterns observed in anoles and other lizards. We also observed arboreal geckos with relatively shorter proximal limb segments as compared to rock-dwelling and terrestrial geckos, similar to patterns observed for other lizards. We conclude that although both geckos and anoles have adhesive pads and use similar microhabitats, their locomotor systems likely complement their adhesive pads in unique ways and result in different ecomorphological patterns, reinforcing the idea that species with convergent morphologies still have idiosyncratic characteristics due to their own separate evolutionary histories.	[Hagey, Travis J.] Michigan State Univ, BEACON Ctr Evolut Act, E Lansing, MI 48824 USA; [Harte, Scott; Vickers, Mathew; Schwarzkopf, Lin] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Vickers, Mathew] Commonwealth Sci & Ind Res Org, Ctr Trop Biol & Climate Change, Townsville, Qld, Australia; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Michigan State University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Idaho; University of Idaho	Hagey, TJ (corresponding author), Michigan State Univ, BEACON Ctr Evolut Act, E Lansing, MI 48824 USA.	hageyt@egr.msu.edu	Hagey, Travis J/H-5140-2019; Schwarzkopf, Lin/C-1242-2012	Schwarzkopf, Lin/0000-0002-1009-670X; Harmon, Luke/0000-0002-4985-5750; Hagey, Travis/0000-0002-3960-6814	National Geographic Society; Waitt Institute [W216-12]; BEACON Center for the Study of Evolution in Action [302, 429]; BEACON Center for the Study of Evolution in Action via the University of Idaho's Institute for Bioinformatics and Evolutionary Studies (IBEST) [302, 429]	National Geographic Society(National Geographic Society); Waitt Institute; BEACON Center for the Study of Evolution in Action; BEACON Center for the Study of Evolution in Action via the University of Idaho's Institute for Bioinformatics and Evolutionary Studies (IBEST)	We received funding from the National Geographic Society and the Waitt Institute (#W216-12) for TLH to travel to Australia and conduct field observations. The BEACON Center for the Study of Evolution in Action (Request #302, #429) provided financial support to TJH.; We received helpful comments from multiple anonymous reviewers. We received funding from the National Geographic Society and the Waitt Institute (#W216-12) and the BEACON Center for the Study of Evolution in Action (Request #302, #429) via the University of Idaho's Institute for Bioinformatics and Evolutionary Studies (IBEST). We constructed custom field equipment with the assistance of the Autumn lab, Mitch Day, the McGowan lab, and the UI Facilities and Mechanical Engineering Departments. While in Australia, we received assistance from the Schwarzkopf lab and the James Cook University Biology department staff and motor pool, the Australian Wildlife Conservancy, and lastly the Queensland landowners who allowed us access to their properties. None of the authors declare any conflicts of interest. Data have been made available in the Supporting information (S1 and S2 Tables).	Aerts P, 2000, NETH J ZOOL, V50, P261, DOI 10.1163/156854200505865; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469; Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486; Autumn K, 2002, Q REV BIOL, V77, P383, DOI 10.1086/344413; BAUER A M, 1990, Memoirs of the Queensland Museum, V29, P299; Bauer A.M., 1996, African Journal of Herpetology, V45, P8, DOI 10.1080/21564574.1996.9649959; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Birn-Jeffery AV, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0144-2; Brown D, 2012, ZOOTAXA, P1; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Carillo de Espinoza N., 1990, Amphibia-Reptilia, V11, P1, DOI 10.1163/156853890X00267; Clemente CJ, 2009, J ZOOL, V278, P270, DOI 10.1111/j.1469-7998.2009.00559.x; Clemente CJ, 2013, J EXP BIOL, V216, P3854, DOI 10.1242/jeb.089060; Cole NC, 2005, BIOL CONSERV, V125, P467, DOI 10.1016/j.biocon.2005.04.017; Collins CE, 2015, FUNCT ECOL, V29, P66, DOI 10.1111/1365-2435.12312; Conroy CJ, 2009, J AM ASSOC LAB ANIM, V48, P28; Crandell KE, 2014, ZOOLOGY, V117, P363, DOI 10.1016/j.zool.2014.05.001; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; Fischer MS, 2010, ZOOLOGY, V113, P67, DOI 10.1016/j.zool.2009.07.001; Foster KL, 2012, J EXP BIOL, V215, P2288, DOI 10.1242/jeb.069856; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039429, 10.1371/journal.pone.0035982]; Gardner AS, 1984, EVOLUTIONARY ECOLOGY; Goodman BA, 2007, EVOL ECOL RES, V9, P527; Goodman BA, 2009, EVOLUTION, V63, P1279, DOI 10.1111/j.1558-5646.2009.00621.x; Goodman BA, 2008, ECOLOGY, V89, P3462, DOI 10.1890/07-2093.1; GOULD SJ, 1971, AM NAT, V105, P113, DOI 10.1086/282710; Grandcolas P, 2009, MEM MUS NAT HIST NAT, V198, P13; Hagey TJ, 2013, MECH DIVERSITY ECOLO; Hagey TJ, 2016, J EXP BIOL, V219, P1603, DOI 10.1242/jeb.129940; Hagey TJ, 2014, ZOOMORPHOLOGY, V133, P111, DOI 10.1007/s00435-013-0207-2; Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102; Harmon LJ, 2007, OIKOS, V116, P1863, DOI 10.1111/j.0030-1299.2007.15958.x; Higham TE, 2004, J EXP BIOL, V207, P233, DOI 10.1242/jeb.00763; Higham TE, 2010, BIOL J LINN SOC, V101, P860, DOI 10.1111/j.1095-8312.2010.01539.x; Huber G, 2007, ACTA BIOMATER, V3, P607, DOI 10.1016/j.actbio.2007.01.007; Irschick DJ, 1998, EVOLUTION, V52, P219, DOI 10.1111/j.1558-5646.1998.tb05155.x; Irschick DJ, 1997, ECOLOGY, V78, P2191, DOI 10.2307/2265955; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Johnson MK, 2005, CAN J ZOOL, V83, P1511, DOI 10.1139/Z05-112; Jones ZM, 2012, J EXP BIOL, V215, P2096, DOI 10.1242/jeb.067413; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Kohlsdorf T, 2001, J MORPHOL, V248, P151, DOI 10.1002/jmor.1026; Krause C, 2013, J EXP BIOL, V216, P1448, DOI 10.1242/jeb.082586; Lamb T, 2010, P R SOC B, V273, P855; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; LOSOS JB, 1989, J EXP BIOL, V145, P23; Losos JB, 1996, ANIM BEHAV, V51, P593, DOI 10.1006/anbe.1996.0063; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; LOSOS JB, 1994, SYST BIOL, V43, P117, DOI 10.2307/2413584; LOSOS JB, 1993, FUNCT ECOL, V7, P281, DOI 10.2307/2390206; Macrini TE, 1998, BIOL J LINN SOC, V63, P579, DOI 10.1006/bijl.1997.0203; Macrini TE, 2003, J HERPETOL, V37, P52, DOI 10.1670/0022-1511(2003)037[0052:EDITCB]2.0.CO;2; Mattingly WB, 2004, ECOLOGY, V85, P1111, DOI 10.1890/03-0293; Melville J, 2006, P ROY SOC B-BIOL SCI, V273, P557, DOI 10.1098/rspb.2005.3328; MILES DB, 1994, LIZARD ECOLOGY, P207; Oliver PM, 2016, ZOOTAXA, V4088, P151, DOI 10.11646/zootaxa.4088.2.1; Oliver PM, 2012, MOL PHYLOGENET EVOL, V63, P255, DOI 10.1016/j.ympev.2011.12.013; Ord TJ, 2014, OECOLOGIA, V175, P651, DOI 10.1007/s00442-014-2921-y; Orme C.D.L., 2011, CAPER COMP ANAL PHYL; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Persson BNJ, 2007, J ADHES SCI TECHNOL, V21, P1145, DOI 10.1163/156856107782328335; Pesika NS, 2009, J ADHESION, V85, P512, DOI 10.1080/00218460902996390; PETERSON JA, 1984, J ZOOL, V202, P1; PIANKA ER, 1978, COPEIA, P691; Pugno NM, 2008, BIOSYSTEMS, V94, P218, DOI 10.1016/j.biosystems.2008.06.009; Pyron RA, 2014, ECOL LETT, V17, P13, DOI 10.1111/ele.12168; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; RStudio Team, 2015, RSTUDIO INT DEV ENV; RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302; Russell AP, 2007, CAN J ZOOL, V85, P1228, DOI 10.1139/Z07-103; Russell AP, 2015, J MORPHOL, V276, P1311, DOI 10.1002/jmor.20420; Russell AP, 2014, ACTA ZOOL-STOCKHOLM, V95, P299, DOI 10.1111/azo.12028; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; Russell AP, 2001, COMP BIOCHEM PHYS A, V131, P89, DOI 10.1016/S1095-6433(01)00469-X; RUSSELL AP, 1979, COPEIA, P1, DOI 10.2307/1443723; Sadlier R. A., 2005, Memoirs of the Queensland Museum, V51, P573; Schulte JA, 2004, J EVOLUTION BIOL, V17, P408, DOI 10.1046/j.1420-9101.2003.00659.x; SINERVO B, 1991, ECOLOGY, V72, P1225, DOI 10.2307/1941096; Sistrom M, 2012, J EVOLUTION BIOL, V25, P647, DOI 10.1111/j.1420-9101.2012.02460.x; Spezzano LC, 2004, J EXP BIOL, V207, P2115, DOI 10.1242/jeb.00995; Thompson GG, 2005, AMPHIBIA-REPTILIA, V26, P65, DOI 10.1163/1568538053693323; Thompson GG, 2008, AUST J ZOOL, V56, P351, DOI 10.1071/ZO08030; Vanhooydonck B, 2005, BIOL J LINN SOC, V85, P385, DOI 10.1111/j.1095-8312.2005.00495.x; Vanhooydonck B, 2001, J EVOLUTION BIOL, V14, P46, DOI 10.1046/j.1420-9101.2001.00260.x; Vitt LJ, 1997, P NATL ACAD SCI USA, V94, P3828, DOI 10.1073/pnas.94.8.3828; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Wang ZY, 2011, CHINESE SCI BULL, V56, P573, DOI 10.1007/s11434-010-4082-7; Wang ZY, 2010, SCI CHINA TECHNOL SC, V53, P1688, DOI 10.1007/s11431-010-3188-0; Yamaguchi T, 2009, J PHYS CHEM B, V113, P3622, DOI 10.1021/jp8067415; Zaaf A, 2001, ZOOMORPHOLOGY, V121, P45, DOI 10.1007/s004350100044; Zaaf A, 1999, ZOOMORPHOLOGY, V119, P9, DOI 10.1007/s004350050077; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x; Zhuang MNV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153520	98	11	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184641	10.1371/journal.pone.0184641	http://dx.doi.org/10.1371/journal.pone.0184641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953920	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000411980300019
J	Wagensveld, IM; Blokker, BM; Wielopolski, PA; Renken, NS; Krestin, GP; Hunink, MG; Oosterhuis, JW; Weustink, AC				Wagensveld, Ivo M.; Blokker, Britt M.; Wielopolski, Piotr A.; Renken, Nomdo S.; Krestin, Gabriel P.; Hunink, Myriam G.; Oosterhuis, J. Wolter; Weustink, Annick C.			Total-body CT and MR features of postmortem change in in-hospital deaths	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY FINDINGS; QUANTITATIVE-ANALYSIS; VIRTUAL AUTOPSY; MYOCARDIAL-INFARCTION; INTRAHEPATIC GAS; SUDDEN-DEATH; RIGOR-MORTIS; VIRTOPSY; TRAUMA; FEASIBILITY	Objectives To evaluate the frequency of total-body CT and MR features of postmortem change in in-hospital deaths. Materials and methods In this prospective blinded cross-sectional study, in-hospital deceased adult patients underwent total-body postmortem CT and MR followed by image-guided biopsies. The presence of PMCT and PMMR features related to postmortem change was scored retrospectively and correlated with postmortem time interval, post-resuscitation status and intensive care unit (ICU) admittance. Results Intravascular air, pleural effusion, periportal edema, and distended intestines occurred more frequently in patients who were resuscitated compared to those who were not. Postmortem clotting was seen less often in resuscitated patients (p = 0.002). Distended intestines and loss of grey-white matter differentiation in the brain showed a significant correlation with postmortem time interval ( p = 0.001, p<0.001). Hyperdense cerebral vessels, intravenous clotting, subcutaneous edema, fluid in the abdomen and internal livores of the liver were seen more in ICU patients. Longer postmortem time interval led to a significant increase in decomposition related changes ( p = 0.026). Conclusions There is a wide variety of imaging features of postmortem change in in-hospital deaths. These imaging features vary among clinical conditions, increase with longer postmortem time interval and must be distinguished from pathologic changes.	[Wagensveld, Ivo M.; Blokker, Britt M.; Wielopolski, Piotr A.; Krestin, Gabriel P.; Hunink, Myriam G.; Weustink, Annick C.] Erasmus Univ, Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Zuid Holland, Netherlands; [Wagensveld, Ivo M.; Blokker, Britt M.; Oosterhuis, J. Wolter; Weustink, Annick C.] Erasmus Univ, Dept Pathol, Med Ctr, Rotterdam, Zuid Holland, Netherlands; [Renken, Nomdo S.] Reinier de Graaf Gasthuis, Dept Radiol, Delft, Zuid Holland, Netherlands; [Hunink, Myriam G.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Reinier de Graaf Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Wagensveld, IM (corresponding author), Erasmus Univ, Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Zuid Holland, Netherlands.; Wagensveld, IM (corresponding author), Erasmus Univ, Dept Pathol, Med Ctr, Rotterdam, Zuid Holland, Netherlands.	i.wagensveld@erasmusmc.nl			Erasmus MC health care efficiency [2010-10112]; Stichting Coolsingel (NL) [255]; Erasmus MC vriendenfonds [104117]	Erasmus MC health care efficiency; Stichting Coolsingel (NL); Erasmus MC vriendenfonds	The following funders supported this work: Erasmus MC health care efficiency, 2010-10112; Stichting Coolsingel (NL), 255; Erasmus MC vriendenfonds, 104117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampanozi G, 2015, LEGAL MED-TOKYO, V17, P493, DOI 10.1016/j.legalmed.2015.10.008; Arthurs OJ, 2015, INT J LEGAL MED, V129, P1113, DOI 10.1007/s00414-015-1189-z; Arthurs OJ, 2015, PEDIATR RADIOL, V45, P527, DOI 10.1007/s00247-014-3166-y; Blokker BM, 2015, EUR RADIOL; Bruguier C, 2013, INT J LEGAL MED, V127, P639, DOI 10.1007/s00414-013-0840-9; Burke M, 2015, AM J FOREN MED PATH, V36, P224, DOI 10.1097/PAF.0000000000000180; Burke M, 2012, FORENSIC SCI MED PAT, V8, P367, DOI 10.1007/s12024-012-9347-9; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Charlier P, 2012, EUR J RADIOL, V81, P639, DOI 10.1016/j.ejrad.2011.01.054; Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005; Crooijmans HJA, 2014, J MAGN RESON IMAGING, V40, P915, DOI 10.1002/jmri.24460; Dirnhofer R, 2006, RADIOGRAPHICS, V26, P1305, DOI 10.1148/rg.265065001; Eggen MD, 2012, MAGN RESON MED, V67, P1703, DOI 10.1002/mrm.23194; Egger C, 2012, INT J LEGAL MED, V126, P559, DOI 10.1007/s00414-012-0686-6; Egger C, 2012, INT J LEGAL MED, V126, P3, DOI 10.1007/s00414-010-0542-5; Eriksson A, 2016, EUR J RADIOL; Fischer F, 2012, FORENSIC SCI INT, V214, P118, DOI 10.1016/j.forsciint.2011.07.033; Flach Patricia M, 2014, AJR Am J Roentgenol, V202, pW325, DOI 10.2214/AJR.12.10283; Gaensbacher S, 2012, EUR J EPIDEMIOL, V27, P577, DOI 10.1007/s10654-012-9709-3; Gebhart FTF, 2012, FORENSIC SCI INT, V222, P162, DOI 10.1016/j.forsciint.2012.05.020; Germerott T, 2010, LEGAL MED-TOKYO, V12, P276, DOI 10.1016/j.legalmed.2010.07.001; Hyodoh H, 2012, JPN J RADIOL, V30, P840, DOI 10.1007/s11604-012-0134-z; Jackowski C, 2006, INVEST RADIOL, V41, P572, DOI 10.1097/01.rli.0000221323.38443.8d; Jackowski C, 2006, INT J LEGAL MED, V120, P233, DOI 10.1007/s00414-005-0023-4; Jackowski C, 2005, FORENSIC SCI INT, V149, P11, DOI 10.1016/j.forsciint.2004.05.019; Jackowski C, 2007, J TRAUMA, V62, P979, DOI 10.1097/01.ta.0000198733.22654.de; Jackowski C, 2006, EUR HEART J, V27, P2459, DOI 10.1093/eurheartj/ehl255; Jackowski C, 2013, J AM COLL CARDIOL, V62, P617, DOI 10.1016/j.jacc.2013.01.089; Jackowski C, 2013, EUR RADIOL, V23, P1266, DOI 10.1007/s00330-012-2728-3; Jackowski C, 2012, FORENSIC SCI INT, V214, pE16, DOI 10.1016/j.forsciint.2011.07.010; Kanazawa A, 2014, LEGAL MED-TOKYO, V16, P297, DOI 10.1016/j.legalmed.2014.05.004; Klein WM, 2015, PEDIATR RADIOL, V45, P517, DOI 10.1007/s00247-014-3258-8; Kobayashi M, 1996, FORENSIC SCI INT, V82, P243, DOI 10.1016/S0379-0738(96)02005-1; Kobayashi T, 2010, JPN J RADIOL, V28, P8, DOI 10.1007/s11604-009-0373-9; KROMPECHER T, 1981, FORENSIC SCI INT, V17, P19, DOI 10.1016/0379-0738(81)90184-5; Levy AD, 2007, RADIOLOGY, V243, P862, DOI 10.1148/radiol.2433061009; Levy AD, 2010, AM J FOREN MED PATH, V31, P12, DOI 10.1097/PAF.0b013e3181c65e1a; Michiue T, 2012, FORENSIC SCI INT, V220, P232, DOI 10.1016/j.forsciint.2012.03.007; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Okuda T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-86; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Roberts ISD, 2003, HISTOPATHOLOGY, V42, P424, DOI 10.1046/j.1365-2559.2003.01614.x; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Ruder TD, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130567; Scheurer E, 2011, AM J NEURORADIOL, V32, P1518, DOI 10.3174/ajnr.A2508; Scholing M, 2009, EUR RADIOL, V19, P2333, DOI 10.1007/s00330-009-1440-4; Schwendener N, 2013, FORENSIC SCI INT, V225, P67, DOI 10.1016/j.forsciint.2012.09.002; Shiotani S, 2004, FORENSIC SCI INT, V139, P39, DOI 10.1016/j.forsciint.2003.09.016; Shiotani S, 2011, LEGAL MED-TOKYO, V13, P151, DOI 10.1016/j.legalmed.2010.12.008; Shiotani Seiji, 2003, Radiat Med, V21, P29; Shiotani S, 2010, JPN J RADIOL, V28, P1, DOI 10.1007/s11604-009-0372-x; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Smith AB, 2012, AM J NEURORADIOL, V33, P1387, DOI 10.3174/ajnr.A2966; Takahashi N, 2013, FORENSIC SCI INT, V225, P27, DOI 10.1016/j.forsciint.2012.04.037; Takahashi N, 2010, AM J ROENTGENOL, V195, pW388, DOI 10.2214/AJR.10.4442; Takahashi N, 2010, JPN J RADIOL, V28, P349, DOI 10.1007/s11604-010-0430-4; Thali Michael J., 2007, Legal Medicine, V9, P100, DOI 10.1016/j.legalmed.2006.11.011; Thali MJ, 2005, J FORENSIC SCI, V50, P428; Thali MJ, 2003, FORENSIC SCI INT, V134, P109, DOI 10.1016/S0379-0738(03)00137-3; Turnbull A, 2015, LANCET, V386, P2141, DOI 10.1016/S0140-6736(15)01049-1; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; Yamazaki K., 2003, LEGAL MED-TOKYO, V5, P338; Zech WD, 2015, EUR RADIOL, V25, P2381, DOI 10.1007/s00330-015-3588-4	63	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185115	10.1371/journal.pone.0185115	http://dx.doi.org/10.1371/journal.pone.0185115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953923	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300035
J	Chen, L; Yang, WJ; Guo, YJ; Chen, W; Zheng, P; Zeng, JS; Tong, WS				Chen, Lei; Yang, Wenjin; Guo, Yijun; Chen, Wei; Zheng, Ping; Zeng, Jinsong; Tong, Wusong			Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis	PLOS ONE			English	Article							LONG NONCODING RNAS; ANTIINFLAMMATORY THERAPIES; ROLES	Atherosclerosis is universally recognized as a chronic lipid-induced inflammation of the vessel wall. Oxidized low density lipoprotein (oxLDL)drives the onset of atherogenesis involving macrophages and endothelial cells (ECs).Our earlier work showed that expression of long noncoding RNA-growth arrest-specific 5 (lncRNA GAS5) was significantly increased in the plaque of atherosclerosis collected from patients and animal models. In this study, we found that knockdown of lncRNA GAS5 reduced the apoptosis of THP-1 cells treated with oxLDL. On the contrary, overexpression of lncRNA GAS5 significantly elevated the apoptosis of THP-1 cells after oxLDL stimulation. The expressions of apoptotic factors including Caspases were changed with lncRNA GAS5 levels. Moreover, lncRNA GAS5 was found in THP-1 derived-exosomes after oxLDL stimulation. Exosomes derived from lncRNA GAS5-overexpressing THP-1 cells enhanced the apoptosis of vascular endothelial cells after taking up these exosomes. However, exosomes shed by lncRNA GAS5 knocked-down THP-1 cells inhibited the apoptosis of endothelial cells. These findings reveal the function of lncRNA GAS5 in atherogenesis which regulates the apoptosis of macrophages and endothelial cells via exosomes and suggest that suppressing the lncRNA GAS5 might be an effective way for the therapy of atherosclerosis.	[Chen, Lei; Yang, Wenjin; Guo, Yijun; Chen, Wei; Zheng, Ping; Zeng, Jinsong; Tong, Wusong] Peoples Hosp Pudong New Area, Dept Neurosurg, Shanghai, Peoples R China		Tong, WS (corresponding author), Peoples Hosp Pudong New Area, Dept Neurosurg, Shanghai, Peoples R China.	tongws0599@163.com			Shanghai Pudong New Area health system excellent young medical talents training plan [PWRq2016-29]; Pudong New Area Science and Technology Development Fund [PKJ2015-Y29]	Shanghai Pudong New Area health system excellent young medical talents training plan; Pudong New Area Science and Technology Development Fund	This research was funded by Shanghai Pudong New Area health system excellent young medical talents training plan (No. PWRq2016-29) and Pudong New Area Science and Technology Development Fund (PKJ2015-Y29) to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahadi A, 2016, GENOM DATA, V9, P7, DOI 10.1016/j.gdata.2016.05.010; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Arase M, 2014, CANCER SCI, V105, P974, DOI 10.1111/cas.12454; Aryal B, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0407-3; Ayari H, 2013, ANN BIOL CLIN-PARIS, V71, P381, DOI 10.1684/abc.2013.0868; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Bianchessi V, 2015, J MOL CELL CARDIOL, V81, P62, DOI 10.1016/j.yjmcc.2015.01.012; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Chen L, 2016, GENE, V592, P43, DOI 10.1016/j.gene.2016.07.023; Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426; De Jong OG, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00608; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Khan R, 2015, ATHEROSCLEROSIS, V240, P497, DOI 10.1016/j.atherosclerosis.2015.04.783; Krell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098561; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120550; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Ma HD, 2012, SCI WORLD J, DOI 10.1100/2012/541786; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; MEHTA A, 1995, ARTERIOSCL THROM VAS, V15, P2076, DOI 10.1161/01.ATV.15.11.2076; Novak J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/275867; Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927; Saha P, 2009, CURR OPIN PHARMACOL, V9, P109, DOI 10.1016/j.coph.2008.12.017; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Toba H, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0386-9; Williams GT, 2011, BIOCHEM SOC T, V39, P482, DOI 10.1042/BST0390482; Zhou T, 2016, ATHEROSCLEROSIS, V248, P51, DOI 10.1016/j.atherosclerosis.2016.02.025	27	176	188	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185406	10.1371/journal.pone.0185406	http://dx.doi.org/10.1371/journal.pone.0185406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945793	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100058
J	Bakker, H; Gerardy-Schahn, R				Bakker, Hans; Gerardy-Schahn, Rita			A sweet development in Notch regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The transmembrane signaling protein Notch, which is crucial for embryonic cell fate decisions, has 36 extracellular EGF domains that are glycosylated in variable and complex ways. A new study shows that O-fucose and O-glucose stabilize the repeats but that extension of glucose by xylose weakens stability, explained by the binding of the glycan to a protein groove. This work shows how different types of glycosylation can distinctly influence protein stability and structure.	[Bakker, Hans; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Clin Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany	Hannover Medical School	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Clin Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Gerardy-Schahn.Rita@mh-hannover.de	Bakker, Hans/AAA-1623-2020; Bakker, Hans/A-1787-2017	Bakker, Hans/0000-0002-1364-9154; Bakker, Hans/0000-0002-1364-9154	Deutsche Forschungsgemeinschaft [BA4091/5-1]; Cluster of Excellence REBIRTH [EXC 62/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence REBIRTH	This work was supported by Deutsche Forschungsgemeinschaft Grant BA4091/5-1 and Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy, EXC 62/2). The authors declare that they have no conflicts of interest with the contents of this article.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Servian-Morilla E, 2016, EMBO MOL MED, V8, P1289, DOI 10.15252/emmm.201505815; Takeuchi H, 2017, J BIOL CHEM, V292, P15964, DOI 10.1074/jbc.M117.800102; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049	10	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15974	15975		10.1074/jbc.H117.800102	http://dx.doi.org/10.1074/jbc.H117.800102			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28939751	hybrid, Green Published			2022-12-26	WOS:000411512200033
J	Al-Ahmad, MM; Amir, N; Dhanasekaran, S; John, A; Abdulrazzaq, YM; Ali, BR; Bastaki, SMA				Al-Ahmad, Mohammad M.; Amir, Naheed; Dhanasekaran, Subramanian; John, Anne; Abdulrazzaq, Yousef M.; Ali, Bassam R.; Bastaki, Salim M. A.			Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis	PLOS ONE			English	Article							CAFFEINE URINARY METABOLITES; NAT2 PHENOTYPES; JAPANESE POPULATION; TURKISH POPULATION; 5'-FLANKING REGION; DRUG-INTERACTIONS; ENZYMES; RISK; PHARMACOGENETICS; SCHIZOPHRENIA	Cytochrome P450 1A2 (CYP1A2) is one of the CYP450 mixed-function oxidase system that is of clinical importance due to the large number of drug interactions associated with its induction and inhibition. In addition, significant inter-individual differences in the elimination of drugs metabolized by CYP1A2 enzyme have been observed which are largely due to the highly polymorphic nature of CYP1A2 gene. However, there are limited studies on CYP1A2 phenotypes and CYP1A2 genotypes among Emiratis and thus this study was carried out to fill this gap. Five hundred and seventy six non-smoker Emirati subjects were asked to consume a soft drink containing caffeine (a non-toxic and reliable probe for predicting CYP1A2 phenotype) and then provide a buccal swab along with a spot urine sample. Taq-Man Real Time PCR was used to determine the CYP1A2 genotype of each individual. Phenotyping was carried out by analyzing the caffeine metabolites using High Performance Liquid Chromatography (HPLC) analysis. We found that 1.4%, 16.3% and 82.3% of the Emirati subjects were slow, intermediate and rapid CYP1A2 metabolizers, respectively. In addition, we found that 1.4% of the subjects were homozygote for derived alleles while 16.1% were heterozygote and 82.5% were homozygote for the ancestral allele. The genotype frequency of the ancestral allele, CYP1A2* 1A/* 1A, is the highest in this population, followed by CYP1A2 * 1A/* 1C and CYP1A2 * 1A/* 1K genotypes, with frequencies of 0.825, 0.102 and 0.058, respectively. The degree of phenotype/genotype concordance was equal to 81.6%. The CYP1A2* 1C/* 1C and CYP1A2* 3/* 3 genotypes showed significantly the lowest enzyme phenotypic activity. The frequency of slow activity CYP1A2 enzyme alleles is very low among Emiratis which correlates with the presence of low frequencies of derived alleles in CYP1A2 gene.	[Al-Ahmad, Mohammad M.; Amir, Naheed; Dhanasekaran, Subramanian; Bastaki, Salim M. A.] UAE Univ, Coll Med & Hlth Sci, Dept Pharmacol, Abu Dhabi, U Arab Emirates; [John, Anne; Ali, Bassam R.] UAE Univ, Coll Med & Hlth Sci, Dept Pathol, Abu Dhabi, U Arab Emirates; [Abdulrazzaq, Yousef M.] UAE Univ, Coll Med & Hlth Sci, Dept Pediat, Abu Dhabi, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	Bastaki, SMA (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Pharmacol, Abu Dhabi, U Arab Emirates.	sbastaki@uaeu.ac.ae	Abdulrazzaq, Yousef M./G-5069-2017; amir, naheed/AAP-5152-2020	Abdulrazzaq, Yousef M./0000-0001-5853-6578; Ali, Bassam R/0000-0003-1306-6618; Alahmad, Mohammad M./0000-0003-0344-4056	Emirates Foundation for Philanthropy [21M059]; Emirates Foundation; UAEU [21M059]	Emirates Foundation for Philanthropy; Emirates Foundation; UAEU	This study was funded (AAMD/HREC No: 21M059) by the Emirates Foundation for Philanthropy.; We thank the departments of Pharmacology and Pathology lab staff at the United Arab Emirates University for their assistance in this study. We also thank the Emirates Foundation, and UAEU for funding this research (AAMD/HREC No: 21M059).	Abdulrazzaq YM, 1997, CLIN GENET, V51, P167; Afonina I, 1997, NUCLEIC ACIDS RES, V25, P2657, DOI 10.1093/nar/25.13.2657; Aklillu E, 2003, MOL PHARMACOL, V64, P659, DOI 10.1124/mol.64.3.659; Al-Gazali L, 2010, HUM MUTAT, V31, P505, DOI 10.1002/humu.21232; Altayli E, 2009, INT UROL NEPHROL, V41, P259, DOI 10.1007/s11255-008-9444-6; Bilgen T, 2008, RUSS J GENET+, V44, P989, DOI 10.1134/S1022795408080140; Blaszkewicz M, 2004, ANAL HAZARDOUS SUBST, V9; Bolt HM, 2005, ARCH TOXICOL, V79, P196, DOI 10.1007/s00204-004-0622-8; Browning SL, 2010, PHARMACOGENET GENOM, V20, P647, DOI 10.1097/FPC.0b013e32833e90eb; BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003; Chevalier D, 2001, Hum Mutat, V17, P355, DOI 10.1002/humu.49; Chida M, 1999, JPN J CANCER RES, V90, P899, DOI 10.1111/j.1349-7006.1999.tb00832.x; Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135; Ghotbi R, 2007, EUR J CLIN PHARMACOL, V63, P537, DOI 10.1007/s00228-007-0288-2; Grabar PB, 2008, EUR J CLIN PHARMACOL, V64, P871, DOI 10.1007/s00228-008-0498-2; Guengerich FP, 1999, MUTAT RES-FUND MOL M, V428, P115, DOI 10.1016/S1383-5742(99)00039-3; Guessous I, 2012, HUM MOL GENET, V21, P1; Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625; Hamdy SI, 2003, BRIT J CLIN PHARMACO, V55, P321, DOI 10.1046/j.1365-2125.2003.01787.x; Heard-Bay F, 1999, PERSPECTIVES UAE, P254; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Laika B, 2010, PHARMACOGENOMICS J, V10, P20, DOI 10.1038/tpj.2009.32; Lin KM, 2010, PHARMACOGENOMICS, V11, P1535, DOI [10.2217/pgs.10.128, 10.2217/PGS.10.128]; Muscat JE, 2008, BIOCHEM PHARMACOL, V76, P929, DOI 10.1016/j.bcp.2008.07.024; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; NAKAJIMA M, 1994, CANCER EPIDEM BIOMAR, V3, P413; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Obase Y, 2003, CLIN PHARMACOL THER, V73, P468, DOI 10.1016/S0009-9236(03)00013-4; Olkkola KT, 2005, ANESTH ANALG, V100, P1352, DOI 10.1213/01.ANE.0000148123.79437.F9; Popat RA, 2011, EUR J NEUROL, V18, P756, DOI 10.1111/j.1468-1331.2011.03353.x; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qumsieh RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028943; Saruwatari J, 2002, CLIN PHARMACOL THER, V72, P200, DOI 10.1067/mcp.2002.126173; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Spina E, 2007, BASIC CLIN PHARMACOL, V100, P4, DOI 10.1111/j.1742-7843.2007.00017.x; Suzuki H, 2008, CARCINOGENESIS, V29, P1184, DOI 10.1093/carcin/bgn085; TANG BK, 1994, PHARMACOGENETICS, V4, P117, DOI 10.1097/00008571-199406000-00002; Tay JKX, 2007, PROG NEURO-PSYCHOPH, V31, P1297, DOI 10.1016/j.pnpbp.2007.05.013; Tiwari AK, 2005, PHARMACOGENOMICS J, V5, P60, DOI 10.1038/sj.tpj.6500282; Wang B, 2009, CURR MED CHEM, V16, P4066, DOI 10.2174/092986709789378198; Wang ZY, 2015, THER CLIN RISK MANAG, V11, P449, DOI 10.2147/TCRM.S80437; Woolhouse NM, 1997, PHARMACOGENETICS, V7, P73, DOI 10.1097/00008571-199702000-00010; Yilmaz SG, 2017, OMICS, V21, P177, DOI 10.1089/omi.2016.0188; Zhou HJ, 2004, ARCH BIOCHEM BIOPHYS, V422, P23, DOI 10.1016/j.abb.2003.11.019; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	47	12	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183424	10.1371/journal.pone.0183424	http://dx.doi.org/10.1371/journal.pone.0183424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934216	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900011
J	Mahasa, KJ; Eladdadi, A; de Pillis, L; Ouifki, R				Mahasa, Khaphetsi Joseph; Eladdadi, Amina; de Pillis, Lisette; Ouifki, Rachid			Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; NEWCASTLE-DISEASE-VIRUS; SELECTIVE REPLICATION; ANTITUMOR IMMUNITY; CANCER-TREATMENT; CELLS; IMMUNOTHERAPY; INNATE; SUPPRESSION; ADENOVIRUS	In the present paper, we address by means of mathematical modeling the following main question: How can oncolytic virus infection of some normal cells in the vicinity of tumor cells enhance oncolytic virotherapy? We formulate a mathematical model describing the interactions between the oncolytic virus, the tumor cells, the normal cells, and the antitumoral and antiviral immune responses. The model consists of a system of delay differential equations with one (discrete) delay. We derive the model's basic reproductive number within tumor and normal cell populations and use their ratio as a metric for virus tumor-specificity. Numerical simulations are performed for different values of the basic reproduction numbers and their ratios to investigate potential trade-offs between tumor reduction and normal cells losses. A fundamental feature unravelled by the model simulations is its great sensitivity to parameters that account for most variation in the early or late stages of oncolytic virotherapy. From a clinical point of view, our findings indicate that designing an oncolytic virus that is not 100% tumor-specific can increase virus particles, which in turn, can further infect tumor cells. Moreover, our findings indicate that when infected tissues can be regenerated, oncolytic viral infection of normal cells could improve cancer treatment.	[Mahasa, Khaphetsi Joseph] Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, South Africa; [Eladdadi, Amina] Coll St Rose, Albany, NY USA; [de Pillis, Lisette] Harvey Mudd Coll, Claremont, CA 91711 USA; [Ouifki, Rachid] Univ Pretoria, Dept Math & Appl Math, Pretoria, South Africa	National Research Foundation - South Africa; Stellenbosch University; Claremont Colleges; Harvey Mudd College; University of Pretoria	Mahasa, KJ (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, South Africa.	mahasa@aims.ac.za	Ouifki, Rachid/A-4064-2017	Ouifki, Rachid/0000-0001-7697-1792; dePillis, Lisette/0000-0002-9839-3636; Mahasa, Khaphetsi Joseph/0000-0003-0017-3780	Society for Mathematical Biology (SMB)	Society for Mathematical Biology (SMB)	We thank Prof. Peter Hinow and the anonymous referee for their helpful comments and suggestions that helped in the revision of this paper. KJ Mahasa would like to acknowledge and thank the Society for Mathematical Biology (SMB) for granting him the SMB Landahl-Busenberg Award to present this research at the SMB2017 annual meeting in Salt Lake City in Utah, USA.	Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Alkayyal AA, 2016, J TAIBAH UNIV MED SC, V11, P187, DOI 10.1016/j.jtumed.2016.04.002; Alvarez-Breckenridge CA, 2015, CURR OPIN VIROL, V13, P25, DOI 10.1016/j.coviro.2015.03.015; Baba A. I., 2007, COMP ONCOLOGY, P119; Bajzer Z, 2008, J THEOR BIOL, V252, P109, DOI 10.1016/j.jtbi.2008.01.016; Bridle BW, 2010, MOL THER, V18, P1430, DOI 10.1038/mt.2010.98; Bridle BW, 2009, MOL THER, V17, P1814, DOI 10.1038/mt.2009.154; Carolan LA, 2016, J VIROL, V90, P2838, DOI 10.1128/JVI.02797-15; Cassady KA, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020043; Chang W, 2003, ANAL IMMUNOTHERAPY C; Chiocca EA, 2014, CANCER IMMUNOL RES, V2, P295, DOI 10.1158/2326-6066.CIR-14-0015; Crittenden MR, 2005, IMMUNOLOGY, V114, P11, DOI 10.1111/j.1365-2567.2004.02001.x; Crivelli JJ, 2012, J BIOL DYNAM, V6, P104, DOI 10.1080/17513758.2011.613486; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; de Pillis LG, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P1661; de Pillis L, 2013, DISCRETE CONT DYN-B, V18, P915, DOI 10.3934/dcdsb.2013.18.915; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; Downs-Canner S, 2016, MOL THER, V24, P1492, DOI 10.1038/mt.2016.101; Eftimie R, 2016, B MATH BIOL, V78, P2091, DOI 10.1007/s11538-016-0214-9; Eftimie R, 2011, B MATH BIOL, V73, P2932, DOI 10.1007/s11538-011-9653-5; Eftimie R, 2011, B MATH BIOL, V73, P2, DOI 10.1007/s11538-010-9526-3; El-Shemi AG, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0353-8; Enderling H, 2014, CURR PHARM DESIGN, V20, P4934; Fiola C, 2006, INT J CANCER, V119, P328, DOI 10.1002/ijc.21821; Friedman A, 2006, CANCER RES, V66, P2314, DOI 10.1158/0008-5472.CAN-05-2661; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Greiner J, 2006, BLOOD, V108, P4109, DOI 10.1182/blood-2006-01-023127; Guo ZS, 2008, BBA-REV CANCER, V1785, P217, DOI 10.1016/j.bbcan.2008.02.001; Hastie E, 2012, J GEN VIROL, V93, P2529, DOI 10.1099/vir.0.046672-0; Hoeller C, 2016, CANCER IMMUNOL IMMUN, V65, P1015, DOI 10.1007/s00262-016-1860-3; Jha BK, 2013, MOL THER, V21, P1749, DOI 10.1038/mt.2013.112; Kaufman HL, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-11; Kim PS, 2015, MATH BIOSCI ENG, V12, P841, DOI 10.3934/mbe.2015.12.841; Kirschner D, 1998, J MATH BIOL, V37, P235, DOI 10.1007/s002850050127; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Ku-Carrillo RA, 2016, APPL MATH MODEL, V40, P4908, DOI 10.1016/j.apm.2015.12.018; Kwon OJ, 2011, J CONTROL RELEASE, V155, P317, DOI 10.1016/j.jconrel.2011.06.014; Lemay CG, 2012, MOL THER, V20, P1791, DOI 10.1038/mt.2012.128; Leveille S, 2011, J VIROL, V85, P12160, DOI 10.1128/JVI.05703-11; Lichty BD, 2004, HUM GENE THER, V15, P821, DOI 10.1089/1043034041839208; Macnamara C, 2015, J THEOR BIOL, V377, P1, DOI 10.1016/j.jtbi.2015.04.004; Marchini A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010009; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Matveeva OV, 2015, MOL THER-ONCOLYTICS, V2, DOI 10.1038/mto.2015.17; Melen GJ, 2016, CANCER LETT, V371, P161, DOI 10.1016/j.canlet.2015.11.036; Miller AC, 2014, VIRUS ADAPT TREAT, V6, P11; Msaouel P, 2012, CURR PHARM BIOTECHNO, V13, P1732, DOI 10.2174/138920112800958896; Msaouel P, 2009, CURR OPIN MOL THER, V11, P43; Okamoto KW, 2014, J THEOR BIOL, V358, P166, DOI 10.1016/j.jtbi.2014.04.030; Paiva LR, 2009, CANCER RES, V69, P1205, DOI 10.1158/0008-5472.CAN-08-2173; Parato KA, 2012, MOL THER, V20, P749, DOI 10.1038/mt.2011.276; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Ribacka C, 2008, CURR GENE THER, V8, P88, DOI 10.2174/156652308784049372; Rommelfanger DM, 2012, GENE THER, V19, P543, DOI 10.1038/gt.2011.132; Ruf B, 2015, MOL THER-ONCOLYTICS, V2, DOI 10.1038/mto.2015.18; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Smith TT, 2014, ONCOLYTIC VIROTHER, V3, P21, DOI 10.2147/OV.S52749; Tollefson AE, 1996, J VIROL, V70, P2296, DOI 10.1128/JVI.70.4.2296-2306.1996; Tong AW, 2012, CURR PHARM BIOTECHNO, V13, P1750; Turnbull S, 2015, VIRUSES-BASEL, V7, P6291, DOI 10.3390/v7122938; Vaha-Koskela M, 2014, BIOMEDICINES, V2, P163, DOI 10.3390/biomedicines2020163; Wein LM, 2003, CANCER RES, V63, P1317; Wiesel M, 2009, APMIS, V117, P356, DOI 10.1111/j.1600-0463.2009.02459.x; Willmon C, 2009, MOL THER, V17, P1667, DOI 10.1038/mt.2009.194; Wodarz D, 2001, CANCER RES, V61, P3501; Wodarz D, 2014, J VIROL, V88, P13240, DOI 10.1128/JVI.02096-14; Wodarz D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004271; Woller N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00188; Wollmann G, 2010, J VIROL, V84, P1563, DOI 10.1128/JVI.02040-09; Workenhe ST, 2015, FUTURE ONCOL, V11, P675, DOI 10.2217/fon.14.254; Workenhe ST, 2014, MOL THER, V22, P251, DOI 10.1038/mt.2013.220; Wu JT, 2001, B MATH BIOL, V63, P731, DOI 10.1006/bulm.2001.0245; Yarbro CH, 2011, CANC NURSING	74	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184347	10.1371/journal.pone.0184347	http://dx.doi.org/10.1371/journal.pone.0184347			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934210	gold, Green Published			2022-12-26	WOS:000411339900026
J	Qian, C; Wong, CWY; Wu, ZL; He, QM; Xia, HM; Tam, PKH; Wong, KKY; Lui, VCH				Qian, Chen; Wong, Carol Wing Yan; Wu, Zhongluan; He, Qiuming; Xia, Huimin; Tam, Paul Kwong Hang; Wong, Kenneth Kak Yuen; Lui, Vincent Chi Hang			Stage specific requirement of platelet-derived growth factor receptor-alpha in embryonic development	PLOS ONE			English	Article							PROTEASE-ACTIVATED LIGAND; CARDIAC NEURAL CREST; PDGF BETA-RECEPTOR; CRANIOFACIAL MUSCLES; CELL-DEVELOPMENT; DEFICIENT MICE; MOUSE EMBRYO; TUBE DEFECTS; EVOLUTION; MORPHOGENESIS	Background Platelet-derived growth factor receptor alpha (PDGFR alpha) is a cell-surface receptor tyrosine kinase for platelet-derived growth factors. Correct timing and level of Pdgfra expression is crucial for embryo development, and deletion of Pdgfra caused developmental defects of multiple endoderm and mesoderm derived structures, resulting in a complex phenotypes including orofacial cleft, spina bifida, rib deformities, and omphalocele in mice. However, it is not clear if deletion of Pdgfra at different embryonic stages differentially affects these structures. Purpose To address the temporal requirement of Pdgfra in embryonic development. Methods We have deleted the Pdgfra in Pdgfra-expressing tissues at different embryonic stages in mice, examined and quantified the developmental anomalies. Results Current study showed that (i) conditional deletion of Pdgfra at different embryonic days (between E7.5 and E10.5) resulted in orofacial cleft, spina bifida, rib cage deformities, and omphalocele, and (ii) the day of Pdgfra deletion influenced the combinations, incidence and severities of these anomalies. Deletion of Pdgfra caused apoptosis of Pdgfra-expressing tissues, and developmental defects of their derivatives. Conclusion Orofacial cleft, spina bifida and omphalocele are among the commonest skeletal and abdominal wall defects of newborns, but their genetic etiologies are largely unknown. The remarkable resemblance of our conditional Pdgfra knockout embryos to theses human congenital anomalies, suggesting that dysregulated PDGFRA expression could cause these anomalies in human. Future work should aim at defining (a) the regulatory elements for the expression of the human PDGFRA during embryonic development, and (b) if mutations / sequence variations of these regulatory elements cause these anomalies.	[Qian, Chen; Wong, Carol Wing Yan; Wu, Zhongluan; Tam, Paul Kwong Hang; Wong, Kenneth Kak Yuen; Lui, Vincent Chi Hang] Univ Hong Kong, Dept Surg, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [He, Qiuming; Xia, Huimin] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Pediat Surg, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; Guangzhou Medical University	Lui, VCH (corresponding author), Univ Hong Kong, Dept Surg, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	vchlui@hku.hk	Wong, Kenneth K. Y./B-9920-2008; /C-4359-2009	/0000-0002-1758-8854	Health and Medical Research Fund, HKSAR [02132306]; Seed Fund for Basic Research, HKU [201411159117]	Health and Medical Research Fund, HKSAR; Seed Fund for Basic Research, HKU	This work is partly supported by the Health and Medical Research Fund, HKSAR (Project No.: 02132306) and Seed Fund for Basic Research, HKU (Project No.: 201411159117) to VCHL.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Au KS, 2005, AM J MED GENET A, V139A, P194, DOI 10.1002/ajmg.a.31002; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bleyl SB, 2007, EUR J HUM GENET, V15, P950, DOI 10.1038/sj.ejhg.5201872; Bleyl SB, 2010, HUM MOL GENET, V19, P1286, DOI 10.1093/hmg/ddq005; Bostrom H, 2002, DEV DYNAM, V223, P155, DOI 10.1002/dvdy.1225.abs; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Bronner ME, 2012, DEV BIOL, V366, P1, DOI 10.1016/j.ydbio.2012.03.011; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Carter TC, 2011, AM J MED GENET A, V155A, P14, DOI 10.1002/ajmg.a.33755; Chan WY, 2004, DEVELOPMENT, V131, P3367, DOI 10.1242/dev.01197; COULY GF, 1992, DEVELOPMENT, V114, P1; Fan Q, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002402; HEIDARAN MA, 1991, J BIOL CHEM, V266, P20232; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Joosten PHLJ, 2002, BBA-MOL BASIS DIS, V1588, P254, DOI 10.1016/S0925-4439(02)00175-8; Joosten PHLJ, 2001, NAT GENET, V27, P215, DOI 10.1038/84867; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karlsson L, 2000, DEVELOPMENT, V127, P3457; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; KOHLER N, 1974, EXP CELL RES, V87, P297, DOI 10.1016/0014-4827(74)90484-4; Kontges G, 1996, DEVELOPMENT, V122, P3229; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Le Douarin NM, 2012, CURR OPIN GENET DEV, V22, P381, DOI 10.1016/j.gde.2012.06.001; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Rattanasopha S, 2012, EUR J HUM GENET, V20, P1058, DOI 10.1038/ejhg.2012.55; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Saga Y, 1999, DEVELOPMENT, V126, P3437; Sambasivan R, 2011, DEVELOPMENT, V138, P2401, DOI 10.1242/dev.040972; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Sauka-Spengler T, 2006, CURR OPIN GENET DEV, V16, P360, DOI 10.1016/j.gde.2006.06.006; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Soriano P, 1997, DEVELOPMENT, V124, P2691; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; WESTERMARK B, 1976, EXP CELL RES, V98, P170, DOI 10.1016/0014-4827(76)90476-6; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Zhu FP, 2004, MOL GENET METAB, V81, P127, DOI 10.1016/j.ymgme.2003.11.003	47	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184473	10.1371/journal.pone.0184473	http://dx.doi.org/10.1371/journal.pone.0184473			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934221	Green Submitted, gold, Green Published			2022-12-26	WOS:000411339900030
J	Schlichting, D; Sommerfeld, C; Muller-Graf, C; Selhorst, T; Greiner, M; Gerofke, A; Ulbig, E; Gremse, C; Spolders, M; Schafft, H; Lahrssen-Wiederholt, M				Schlichting, Daniela; Sommerfeld, Christine; Mueller-Graf, Christine; Selhorst, Thomas; Greiner, Matthias; Gerofke, Antje; Ulbig, Ellen; Gremse, Carl; Spolders, Markus; Schafft, Helmut; Lahrssen-Wiederholt, Monika			Copper and zinc content in wild game shot with lead or non-lead ammunition - implications for consumer health protection	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; RED DEER; RIFLE BULLETS; HEAVY-METALS; ROE DEER; MEAT; TISSUES; MUSCLE; BOAR; SPECTROMETRY	The aim of this study was to examine the contamination of game meat with copper and zinc and establish whether the use of alternative (non-lead) ammunition can lead to higher or unsafe levels of copper and zinc in the meat of roe deer, wild boar and red deer. The research project "Safety of game meat obtained through hunting" (LEMISI) was conducted in Germany with the purpose of examining the entry of lead as well as copper and zinc into the meat of hunted game when using either lead or non-lead ammunition. The outcome of this study shows that the usage of both lead-based ammunition and alternative non-lead ammunition results in the entry of copper and zinc into the edible parts of the game. Using non-lead ammunition does not entail dangerously elevated levels of copper and zinc, so replacing lead ammunition with alternative ammunition does not introduce a further health problem with regard to these metals. The levels of copper and zinc in game meat found in this study are in the range found in previous studies of game. The content of copper and zinc in game meat is also comparable to those regularly detected in meat and its products from livestock (pig, cattle, sheep) for which the mean human consumption rate is much higher. From the viewpoint of consumer health protection, the use of non-lead ammunition does not pose an additional hazard through copper and zinc contamination. A health risk due to the presence of copper and zinc in game meat at typical levels of consumer exposure is unlikely for both types of ammunition.	[Schlichting, Daniela; Sommerfeld, Christine; Mueller-Graf, Christine; Selhorst, Thomas; Greiner, Matthias; Gerofke, Antje; Ulbig, Ellen; Gremse, Carl; Spolders, Markus; Schafft, Helmut; Lahrssen-Wiederholt, Monika] German Fed Inst Risk Assessment, Berlin, Germany	Federal Institute for Risk Assessment	Schlichting, D (corresponding author), German Fed Inst Risk Assessment, Berlin, Germany.	Daniela.Schlichting@bfr.bund.de	; Greiner, Matthias/D-2812-2013	Gremse, Carl/0000-0002-9936-4255; Greiner, Matthias/0000-0003-4974-5970; Gerofke, Antje/0000-0001-6270-3869; Muller-Graf, Christine/0000-0002-0122-7528	Federal Ministry of Food and Agriculture (BMEL) in Germany; European Poultry, Egg and Game Association (EPEGA); Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)	Federal Ministry of Food and Agriculture (BMEL) in Germany; European Poultry, Egg and Game Association (EPEGA); Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)	The study was supported mainly by the Federal Ministry of Food and Agriculture (BMEL) in Germany (http://www.bmel.de) but also by the listed Lander (Mecklenburg-Western Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hesse, North Rhine-Westphalia, Hamburg and Bremen) and organisms (European Poultry, Egg and Game Association (EPEGA), Deutscher Jagdverband e.V. (DJV, German Hunting Association), Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association), Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters), Verband der Hersteller von Jagd-, Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition), Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)). A lot of people helped obtaining the data: the hunters, game traders and others, but were not employed or contracted to do so. The funders had no active role in study design, analysis, decision to publish or preparation of the manuscript.; We would like to express our thanks for the support and funding provided by the Federal Ministry of Food and Agriculture (BMEL) in Germany (http://www.bmel.de) but also by the listed Lander (Mecklenburg-Western Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hesse, North Rhine-Westphalia, Hamburg and Bremen) and organisms (European Poultry, Egg and Game Association (EPEGA), Deutscher Jagdverband e.V. (DJV, German Hunting Association), Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association), Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters), Verband der Hersteller von Jagd-, Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition), Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)). A lot of people helped obtaining the data: the hunters, game traders and others, but were not employed or contracted to do so. The funders had no active role in study design, analysis, decision to publish or preparation of the manuscript. A lot of people were involved in this project and we would like to thank them for their valuable contributions, especially Dr. Niels Bandick.	Amici A, 2012, ITAL J ANIM SCI, V11, DOI 10.4081/ijas.2012.e65; Bilandzic N, 2012, FOOD CONTROL, V27, P284, DOI 10.1016/j.foodcont.2012.03.020; Borges DLG, 2006, GRAPHITE FURNACE ATO; Chen JR, 2001, ANAL CHIM ACTA, V450, P215, DOI 10.1016/S0003-2670(01)01367-8; Dannenberger D, 2013, MEAT SCI, V94, P39, DOI 10.1016/j.meatsci.2012.12.010; Garcia MHD, 2011, J ENVIRON SCI HEAL A, V46, P109, DOI 10.1080/10934529.2011.532422; EFSA (European Food Safety Authority), 2014, EFSA J, V12, P3870; Ertl K, 2016, FOOD ADDIT CONTAM B, V9, P120, DOI 10.1080/19393210.2016.1151464; FALANDYSZ J, 1994, SCI TOTAL ENVIRON, V141, P59, DOI 10.1016/0048-9697(94)90018-3; Falandysz J, 2005, FOOD ADDIT CONTAM A, V22, P141, DOI 10.1080/02652030500047273; Federal Office of Consumer Protection and Food Safety (BVL), 2015, FED OFF CONS PROT FO; Federal Office of Consumer Protection and Food Safety (BVL), 2011, FED OFF CONS PROT FO; Federal Office of Consumer Protection and Food Safety (BVL), 2008, FED OFF CONS PROT FO; Federal Office of Consumer Protection and Food Safety (BVL), 2013, FED OFF CONS PROT FO; Federal Office of Consumer Protection and Food Safety (BVL), 2001, LEB MON 2001; Gasparik J, 2004, J ENVIRON SCI HEAL A, V39, P2105, DOI 10.1081/ESE-120039378; Gasparik J, 2012, J ENVIRON SCI HEAL A, V47, P1212, DOI 10.1080/10934529.2012.672065; German Federal Institute for Risk Assessment (BfR), 2014, RES PROJ SAF GAM MEA; Haldimann M, 2002, EUR FOOD RES TECHNOL, V215, P375, DOI 10.1007/s00217-002-0581-3; Hofbauer P, 2011, GAME MEAT HYGIENE IN FOCUS: MICROBIOLOGY, EPIDEMIOLOGY, RISK ANALYSIS AND QUALITY ASSURANCE, P273; Hou X., 2006, INDUCTIVELY COUPLED; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Irschik I, 2014, COMPOSITION BULLETS, P363; Irschik I, 2013, EUR J WILDLIFE RES, V59, P129, DOI 10.1007/s10344-012-0656-9; Jarzynska G, 2011, ENVIRON INT, V37, P882, DOI 10.1016/j.envint.2011.02.017; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Lahrssen-Wiederhott M, 2015, FLEISCHWIRTSCHAFT, V95, P99; Lazarus M, 2008, FOOD ADDIT CONTAM A, V25, P270, DOI 10.1080/02652030701364923; Muller-Graf C, 2017, GAME MEAT HYGIENE: FOOD SAFETY AND SECURITY, P201, DOI 10.3920/978-90-8686-840-7_12; Muthers S, 2010, METEOROL Z, V19, P641, DOI 10.1127/0941-2948/2010/0485; Nardi EP, 2009, FOOD CHEM, V112, P727, DOI 10.1016/j.foodchem.2008.06.010; Paulsen P, 2015, J FOOD SAF FOOD QUAL, V66, P128, DOI 10.2376/0003-925X-66-128; R-Core-Team, 2015, LANG ENV STAT COMP; Roslewska A, 2012, J ELEMENTOL, DOI DOI 10.5601/JELEM.2015.20.943; Sachs L, 2009, ENCY MEASUREMENT STA, V3, P103; Sager M., 2005, Ernahrung, V29, P199; Scientific Committee on Food, 2006, TOL UPP INT LEV VIT; STRMISKOVA G, 1992, NAHRUNG, V36, P307, DOI 10.1002/food.19920360316; Morales JSV, 2011, FOOD ADDIT CONTAM A, V28, P1021, DOI 10.1080/19440049.2011.583282; Volk F, 2012, LEBENSMITTELHYGIENIS	41	15	15	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184946	10.1371/journal.pone.0184946	http://dx.doi.org/10.1371/journal.pone.0184946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934259	gold, Green Submitted, Green Published			2022-12-26	WOS:000411339900061
J	Tumiotto, C; Riviere, L; Bellecave, P; Recordon-Pinson, P; Vilain-Parce, A; Guidicelli, GL; Fleury, H				Tumiotto, Camille; Riviere, Lionel; Bellecave, Pantxika; Recordon-Pinson, Patricia; Vilain-Parce, Alice; Guidicelli, Gwenda-Line; Fleury, Herve		Provir Latitude 45 Collaborating	Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA	PLOS ONE			English	Article							CLASS-I; RESISTANCE MUTATIONS; NEURAL-NETWORKS; RESERVOIR; THERAPY; SIZE; CURE	One of the strategies for curing viral HIV-1 is a therapeutic vaccine involving the stimulation of cytotoxic CD8-positive T cells (CTL) that are Human Leucocyte Antigen (HLA)-restricted. The lack of efficiency of previous vaccination strategies may have been due to the immunogenic peptides used, which could be different from a patient's virus epitopes and lead to a poor CTL response. To counteract this lack of specificity, conserved epitopes must be targeted. One alternative is to gather as many data as possible from a large number of patients on their HIV-1 proviral archived epitope variants, taking into account their genetic background to select the best presented CTL epitopes. In order to process big data generated by Next-Generation Sequencing (NGS) of the DNA of HIV-infected patients, we have developed a software package called TutuGenetics. This tool combines an alignment derived either from Sanger or NGS files, HLA typing, target gene and a CTL epitope list as input files. It allows automatic translation after correction of the alignment obtained between the HxB2 reference and the reads, followed by automatic calculation of the MHC IC50 value for each epitope variant and the HLA allele of the patient by using NetMHCpan 3.0, resulting in a csv file as output result. We validated this new tool by comparing Sanger and NGS (454, Roche) sequences obtained from the proviral DNA of patients at success of ART included in the Provir Latitude 45 study and showed a 90% correlation between the quantitative results of NGS and Sanger. This automated analysis combined with complementary samples should yield more data regarding the archived CTL epitopes according to the patients' HLA alleles and will be useful for screening epitopes that in theory are presented efficiently to the HLA groove, thus constituting promising immunogenic peptides for a therapeutic vaccine.	[Tumiotto, Camille; Riviere, Lionel; Bellecave, Pantxika; Recordon-Pinson, Patricia; Vilain-Parce, Alice; Fleury, Herve] CHU Bordeaux, Lab Virol, Bordeaux, France; [Tumiotto, Camille; Riviere, Lionel; Bellecave, Pantxika; Recordon-Pinson, Patricia; Vilain-Parce, Alice; Fleury, Herve] CNRS, UMR 5234, Bordeaux, France; [Guidicelli, Gwenda-Line] CHU Bordeaux, Lab Immunol, Bordeaux, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Fleury, H (corresponding author), CHU Bordeaux, Lab Virol, Bordeaux, France.; Fleury, H (corresponding author), CNRS, UMR 5234, Bordeaux, France.	herve.fleury@u-bordeaux.fr	Recordon-Pinson, Patricia/AAV-1295-2021; Tumiotto, Camille/AAD-5003-2022; Tumiotto, Camille/V-5960-2019	Recordon-Pinson, Patricia/0000-0001-6002-0941; 	Merck Avenir [DS-2016-0005]	Merck Avenir	This study has been funded by Merck company, GERMATAN, and is now funded by Merck Avenir (ref DS-2016-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Barton K, 2016, TRENDS MICROBIOL, V24, P345, DOI 10.1016/j.tim.2016.01.006; Bellecave P, 2016, AIDS RES HUM RETROV, V32, P85, DOI [10.1089/aid.2015.0201, 10.1089/AID.2015.0201]; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deng K, 2015, NATURE; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Llano A, 2013, HIV MOL IMMUNOLOGY, V2013; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Papuchon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100452; Papuchon J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069029; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Rask TS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1032-7; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Vandrovcova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100475	24	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185211	10.1371/journal.pone.0185211	http://dx.doi.org/10.1371/journal.pone.0185211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934310	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900126
J	Boot, A; Oosting, J; van Eendenburg, JDH; Kuppen, PJK; Morreau, H; van Wezel, T				Boot, Arnoud; Oosting, Jan; van Eendenburg, Jaap D. H.; Kuppen, Peter J. K.; Morreau, Hans; van Wezel, Tom			Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines	PLOS ONE			English	Article							DNA METHYLATION; COLON-CANCER; EXPRESSION; PHENOTYPE; GENOME	Genetic and epigenetic alterations mark colorectal cancer (CRC). Global hypomethylation is observed in nearly all CRC, but a distinct subset of CRC show the CpG Island Methylator Phenotype (CIMP). These tumors show DNA hypermethylation of a specific subset of CpG islands, resulting in transcriptional downregulation of nearby genes. Recently we reported the establishment of novel CRC cell lines derived from primary and metastatic CRC tissues. In this study we describe the DNA methylation profiling of these low passage CRC cell lines. We generated global DNA methylation profiles with Infinium HumanMethylation450 Bead-Chips and analysed them in conjunction with matching gene expression profiles. Multidimensional scaling of the DNA methylation and gene expression datasets showed that BRAF mutated cell lines form a distinct group. In this group we investigated the 706 loci which we have previously identified to be hypermethylated in BRAF mutant CRC. We validated the significant findings in the The Cancer Genome Atlas colon adenocarcinoma data-set. Our analysis identified ELOVL5, FAM127B, MTERF1, ZNF606 to be subject to transcriptional downregulation through DNA hypermethylation in CRC. We further investigated ELOVL5 with qPCR and immunohistochemical staining, validating our results, but did not find a clear relation between ELOVL5 expression and tumor stage or relapse free survival. ELOVL5, FAM127B, MTERF1, ZNF606 are involved in important cellular processes such as apoptosis, lipogenesis and the downstream transcriptional effect of the MAPK-pathway. We have identified a DNA methylation profile regulating key cellular processes in CRC, resulting in a growth advantage to the tumor cells.	[Boot, Arnoud; Oosting, Jan; van Eendenburg, Jaap D. H.; Morreau, Hans; van Wezel, Tom] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Kuppen, Peter J. K.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Wezel, T (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	t.van_wezel@lumc.nl	Kuppen, Peter/J-2342-2016; van Wezel, Tom/Z-3092-2019; van Wezel, Tom/AAL-5626-2021	Kuppen, Peter/0000-0002-0294-3251; van Wezel, Tom/0000-0001-5773-7730; Boot, Arnoud/0000-0002-7717-7416	EUROTRANS-BIO project FAST-SEQ	EUROTRANS-BIO project FAST-SEQ	This work was supported by the EUROTRANS-BIO project FAST-SEQ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng YW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0254-7; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dihal AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079898; Fang MG, 2014, MOL CELL, V55, P904, DOI 10.1016/j.molcel.2014.08.010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kaneda A, 2011, CANCER SCI, V102, P18, DOI 10.1111/j.1349-7006.2010.01712.x; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Lee DW, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0106-0; Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2; Mitchell SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-54; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ni C, 2015, CANCER LETT, V356, P579, DOI 10.1016/j.canlet.2014.10.002; Ou Y, 2005, BIOCHEM BIOPH RES CO, V333, P1034, DOI 10.1016/j.bbrc.2005.05.192; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Schalkwyk LC, 2013, BMC GENOMICS, V14, P293; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Serra RW, 2014, ELIFE, V3, DOI 10.7554/eLife.02313; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shikama A, 2015, BIOCH BIOPHYS RES CO; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Terzioglu M, 2013, CELL METAB, V17, P618, DOI 10.1016/j.cmet.2013.03.006; van Roon EH, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-2; Voorneveld PW, 2017, GASTROENTEROLOGY; Zaytseva YY, 2014, CARCINOGENESIS, V35, P1341, DOI 10.1093/carcin/bgu042; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	32	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184900	10.1371/journal.pone.0184900	http://dx.doi.org/10.1371/journal.pone.0184900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931069	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700041
J	Conte-Grand, C; Britz, R; Dahanukar, N; Raghavan, R; Pethiyagoda, R; Tan, HH; Hadiaty, RK; Yaakob, NS; Ruber, L				Conte-Grand, Cecilia; Britz, Ralf; Dahanukar, Neelesh; Raghavan, Rajeev; Pethiyagoda, Rohan; Tan, Heok Hui; Hadiaty, Renny K.; Yaakob, Norsham S.; Ruber, Lukas			Barcoding snakeheads (Teleostei, Channidae) revisited: Discovering greater species diversity and resolving perpetuated taxonomic confusions	PLOS ONE			English	Article							FRESH-WATER FISHES; SINGLE-LOCUS DATA; PHYLOGENETIC ANALYSES; SEQUENCE DATA; DATA SETS; DELIMITATION; MODELS; RARITY; GMYC	Snakehead fishes of the family Channidae are predatory freshwater teleosts from Africa and Asia comprising 38 valid species. Snakeheads are important food fishes (aquaculture, live food trade) and have been introduced widely with several species becoming highly invasive. A channid barcode library was recently assembled by Serrao and co-workers to better detect and identify potential and established invasive snakehead species outside their native range. Comparing our own recent phylogenetic results of this taxonomically confusing group with those previously reported revealed several inconsistencies that prompted us to expand and improve on previous studies. By generating 343 novel snakehead coxI sequences and combining them with an additional 434 coxI sequences from GenBank we highlight several problems with previous efforts towards the assembly of a snakehead reference barcode library. We found that 16.3% of the channid coxI sequences deposited in GenBank are based on misidentifications. With the inclusion of our own data we were, however, able to solve these cases of perpetuated taxonomic confusion. Different species delimitation approaches we employed (BIN, GMYC, and PTP) were congruent in suggesting a potentially much higher species diversity within snakeheads than currently recognized. In total, 90 BINs were recovered and within a total of 15 currently recognized species multiple BINs were identified. This higher species diversity is mostly due to either the incorporation of undescribed, narrow range, endemics from the Eastern Himalaya biodiversity hotspot or the incorporation of several widespread species characterized by deep genetic splits between geographically well-defined lineages. In the latter case, over-lumping in the past has deflated the actual species numbers. Further integrative approaches are clearly needed for providing a better taxonomic understanding of snakehead diversity, new species descriptions and taxonomic revisions of the group.	[Conte-Grand, Cecilia; Ruber, Lukas] Naturhistor Museum Burgergemeinde Bern, Bern, Switzerland; [Britz, Ralf] Nat Hist Museum, Dept Nat Hist Museum, London, England; [Dahanukar, Neelesh] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Dahanukar, Neelesh] Zoo Outreach Org, Syst Ecol & Conservat Lab, Coimbatore, Tamil Nadu, India; [Raghavan, Rajeev] Kerala Univ Fisheries & Ocean Studies, Dept Fisheries Resource Management, Kochi, Kerala, India; [Pethiyagoda, Rohan] Australian Museum, Ichthyol Sect, Sydney, NSW, Australia; [Tan, Heok Hui] Natl Univ Singapore, Lee Kong Chian Nat Hist Museum, Singapore, Singapore; [Hadiaty, Renny K.] Indonesian Inst Sci, Res Ctr Biol, Museum Zool Bogoriense, Cibinong, Indonesia; [Yaakob, Norsham S.] Forest Res Inst Malaysia, Kuala Lumpur, Malaysia; [Ruber, Lukas] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	Natural History Museum London; Indian Institute of Science Education & Research (IISER) Pune; Kerala University of Fisheries & Ocean Studies; Australian Museum; National University of Singapore; Bogor Zoology Museum; Indonesian Institute of Sciences; Institute Penyelidikan Perhutanan Malaysia; University of Bern	Ruber, L (corresponding author), Naturhistor Museum Burgergemeinde Bern, Bern, Switzerland.	lukas.ruber@nmbe.ch	Raghavan, Rajeev/ABD-8719-2021; Dahanukar, Neelesh/B-2816-2012; Rüber, Lukas/D-5436-2013	Dahanukar, Neelesh/0000-0001-7162-9023; Rüber, Lukas/0000-0003-0125-008X; Pethiyagoda, Rohan/0000-0001-7215-9617	Mohammed Bin Zayed Species Conservation Fund [1225670]; North of England Zoological Society-Chester Zoo; Department of Science and Technology (DST), Government of India [IFA12-LSBM-21]; National University of Singapore (NUS) [R-264-001-004-272, R-154-000-318-112, R-154-000-270-112, R-347-000-198-490]; Natural Environmental Research Council (NERC) [NE/F003749/1]; National Geographic [8509-08]; NERC [NE/F003749/1] Funding Source: UKRI; Natural Environment Research Council [NE/F003749/1] Funding Source: researchfish	Mohammed Bin Zayed Species Conservation Fund; North of England Zoological Society-Chester Zoo; Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); National University of Singapore (NUS)(National University of Singapore); Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Geographic(National Geographic Society); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Mohammed Bin Zayed Species Conservation Fund, http://www.speciesconservation.org, (Project 1225670) and North of England Zoological Society-Chester Zoo, http://www.chesterzoo.org (RR); Department of Science and Technology (DST), Government of India for an Inspire Research Grant, http://www. inspire-dst.gov.in [IFA12-LSBM-21] (ND); National University of Singapore, http://www.nus.edu.sg, (NUS, R-264-001-004-272, R-154-000-318-112, R-154-000-270-112, R-347-000-198-490) (HH); Natural Environmental Research Council (NERC, NE/F003749/1) (LR, RB); National Geographic, http://www.nationalgeographic.com/explorers/grants-programs/cre-application/, (8509-08) (LR) and North of England Zoological Society-Chester Zoo, http://www.chesterzoo.org (LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; Ahrens D, 2016, SYST BIOL, V65, P478, DOI 10.1093/sysbio/syw002; [Anonymous], 2021, SPLITS SPECIES LIMIT; Benziger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021272; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; BONOU C A, 1985, Revue d'Hydrobiologie Tropicale, V18, P267; Britz R, 2017, ZOOTAXA IN PRESS; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2015, J ZOOL SYST EVOL RES, V53, P259, DOI 10.1111/jzs.12103; Collins RA, 2014, SYST BIOL, V63, P1005, DOI 10.1093/sysbio/syu060; Courtenay RW, 2004, US GEOLOGICAL SURVEY, V1251; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dellicour S, 2015, SYST BIOL, V64, P900, DOI 10.1093/sysbio/syu130; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Flot JF, 2015, SYST BIOL, V64, P897, DOI 10.1093/sysbio/syv071; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Jayarama KC, 2010, FRESHWATER FISHES IN; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; Khedkar GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101460; Lakra WS, 2010, BIOCHEM SYST ECOL, V38, P1212, DOI 10.1016/j.bse.2010.12.012; Lakra WS, 2016, MITOCHONDRIAL DNA A, V27, P4510, DOI 10.3109/19401736.2015.1101540; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li X, 2006, ICHTHYOL RES, V53, P148, DOI 10.1007/s10228-005-0321-3; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murray AM, 2006, J PALEONTOL, V80, P1172, DOI 10.1666/0022-3360(2006)80[1172:ANCTCF]2.0.CO;2; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pethiyagoda R., 1991, FRESHWATER FISHES SR, DOI DOI 10.1093/sysbio/syw095; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Raghavan R, 2013, BIOL CONSERV, V164, P158, DOI 10.1016/j.biocon.2013.04.019; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; ROBERTS TR, 1975, ZOOL J LINN SOC-LOND, V57, P249, DOI 10.1111/j.1096-3642.1975.tb01893.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Scott David, 2013, Management of Biological Invasions, V4, P265; Serrao NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099546; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tan HH, 2013, RAFFLES B ZOOL, V61, P893; Tan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052089; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; TEUGELS G G, 1984, Cybium, V8, P1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2014, SYST BIOL, V63, P993, DOI 10.1093/sysbio/syu052; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhu SR, 2013, BIOCHEM SYST ECOL, V51, P117, DOI 10.1016/j.bse.2013.08.011	58	45	50	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184017	10.1371/journal.pone.0184017	http://dx.doi.org/10.1371/journal.pone.0184017			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931084	gold, Green Submitted, Green Published			2022-12-26	WOS:000411314700013
J	Randles, D; Harlow, I; Inzlicht, M				Randles, Daniel; Harlow, Iain; Inzlicht, Michael			A pre-registered naturalistic observation of within domain mental fatigue and domain-general depletion of self-control	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; EGO-DEPLETION; LIMITED RESOURCE; SLEEP-WAKE; TESTS	Self-control is often believed to operate as if it were a finite, domain-general resource. However, recent attempts to demonstrate this under transparent conditions have failed to yield positive results. In the current study, we monitor two groups of students (N1 = 8,867, N2 = 8,754) over separate 17-week intervals with 24-hour coverage, as they engage in voluntary learning and self-testing using an online program. We use daily behavior to assess whether time-of-day effects support domain-general theories of self-control. Additionally, we assess whether mental fatigue emerges within task during prolonged persistent effort. Results reveal within-task fatigue emerges within an hour on-task. However, there is a negligible effect on ability throughout the day. Additionally, time-of-day has no detrimental effect on motivation; rather there is a strong tendency to increase learning time at night. Results are consistent with theories indicating people lose motivation within a specific task, but at odds with theories that argue for a domain-general self-control resource.	[Randles, Daniel; Inzlicht, Michael] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Harlow, Iain] Cerego, Learning & Data Sci Grp, San Francisco, CA USA; [Inzlicht, Michael] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada	University of Toronto; University of Toronto	Randles, D (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.	michael.inzlicht@utoronto.ca			Social Sciences and Humanities Research Council of Canada [RN242784-BFP-SSHRC-01045]; Cerego, a private corporation; Cerego; Social Sciences and Humanities Research Council; Natural Sciences and Engineering Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Cerego, a private corporation; Cerego; Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The 1st author (Daniel Randles) received financial support provided by the Social Sciences and Humanities Research Council of Canada, Banting Postdoctoral Fellowship (RN242784-BFP-SSHRC-01045). The 2nd author (lain Harlow) received financial support provided by Cerego, a private corporation. Cerego provided support in the form of salary and supplied data (gathered during their normal business operation). The 3rd author acknowledges support from the Social Sciences and Humanities Research Council and Natural Sciences and Engineering Research Council of Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, beyond what was previously described. The specific roles of all authors are articulated in the "author contributions" section.	[Anonymous], 2021, ELEMENTS EVOLUTIONAR; Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Carter EC, 2015, J EXP PSYCHOL GEN, V144, P796, DOI 10.1037/xge0000083; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; Hagger MS, 2016, PERSPECT PSYCHOL SCI, V11, P546, DOI 10.1177/1745691616652873; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hopstaken JF, 2015, PSYCHOPHYSIOLOGY, V52, P305, DOI 10.1111/psyp.12339; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Intons-Peterson MJ, 1998, J EXP PSYCHOL LEARN, V24, P362, DOI 10.1037/0278-7393.24.2.362; Lurquin JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147770; Monk TH, 2005, J BIOL RHYTHM, V20, P366, DOI 10.1177/0748730405277378; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Sievertsen HH, 2016, P NATL ACAD SCI USA, V113, P2621, DOI 10.1073/pnas.1516947113; Yoon IY, 2003, J AM GERIATR SOC, V51, P1085, DOI 10.1046/j.1532-5415.2003.51356.x	17	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0182980	10.1371/journal.pone.0182980	http://dx.doi.org/10.1371/journal.pone.0182980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931013	Green Submitted, gold, Green Published			2022-12-26	WOS:000411314700007
J	Huang, S; Ge, XT; Yu, JW; Han, ZL; Yin, ZY; Li, Y; Chen, FL; Wang, HC; Zhang, JN; Lei, P				Huang, Shan; Ge, Xintong; Yu, Jinwen; Han, Zhaoli; Yin, Zhenyu; Li, Ying; Chen, Fanglian; Wang, Haichen; Zhang, Jianning; Lei, Ping			Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons	FASEB JOURNAL			English	Article						extracellular vesicles; glia cells; polarization; PDE4B; mTOR signaling	MESENCHYMAL STROMAL CELLS; EXTRACELLULAR VESICLES; PHOSPHODIESTERASE 4B; IN-VITRO; PATHWAY; POLARIZATION; APOPTOSIS; DISEASE; AKT; NEUROINFLAMMATION	Neuronal inflammation is the characteristic pathologic change of acute neurologic impairment and chronic traumatic encephalopathy after traumatic brain injury (TBI). Inhibiting the excessive inflammatory response is essential for improving the neurologic outcome. To clarify the regulatory mechanism of microglial exosomes on neuronal inflammation in TBI, we focused on studying the impact of microglial exosomal miRNAs on injured neurons in this research. We used a repetitive (r) TBI mousemodel and harvested the injured brain extracts from the acute to the chronic phase of TBI to treat cultured BV2 microglia in vitro. The microglial exosomes were collected for miRNA microarray analysis, which showed that the expression level of miR-124-3p increased most apparently in the miRNAs. We found that miR-124-3p promoted the anti-inflamed M2 polarization in microglia, and microglial exosomal miR-124-3p inhibited neuronal inflammation in scratch-injured neurons. Further, the mammalian target of rapamycin (mTOR) signaling was implicated as being involved in the regulation of miR-124-3p by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Using the mTOR activator MHY1485 we confirmed that the inhibitory effect of exosomalmiR-124-3p on neuronal inflammation was exerted by suppressing the activity of mTOR signaling. PDE4B was predicted to be the target gene of miR-124-3p by pathway analysis. We proved that it was directly targeted by miR-124-3p with a luciferase reporter assay. Using a PDE4B overexpressed lentivirus transfection system, we suggested that miR-124-3p suppressed the activity of m TOR signaling mainly through inhibiting the expression of PDE4B. In addition, exosomal miR-124-3p promoted neurite outgrowth after scratch injury, characterized by an increase on the number of neurite branches and total neurite length, and a decreased expression on RhoA and neurodegenerative proteins [A beta-peptide and p-Tau]. It also improved the neurologic outcome and inhibited neuro-inflammation in mice with rTBI. Taken together, increased miR-124-3p in microglial exosomes after TBI can inhibit neuronal inflammation and contribute to neurite outgrowth via their transfer into neurons. miR-124-3p exerted these effects by targeting PDE4B, thus inhibiting the activity of mTOR signaling. Therefore, miR-124-3p could be a promising therapeutic target for interventions of neuronal inflammation after TBI. miRNAs manipulated microglial exosomes may provide a novel therapy for TBI and other neurologic diseases.	[Huang, Shan; Ge, Xintong; Yu, Jinwen; Yin, Zhenyu; Lei, Ping] Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin, Peoples R China; [Huang, Shan; Ge, Xintong; Yu, Jinwen; Han, Zhaoli; Yin, Zhenyu; Li, Ying; Chen, Fanglian; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Huang, Shan; Yu, Jinwen; Yin, Zhenyu; Li, Ying; Chen, Fanglian; Zhang, Jianning] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China; [Ge, Xintong; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Han, Zhaoli; Lei, Ping] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Anshan Rd, Tianjin 300054, Peoples R China; [Wang, Haichen] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA	Tianjin Medical University; Tianjin Medical University; Duke University	Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Geriatr, Anshan Rd, Tianjin 300054, Peoples R China.	leiping1974@163.com	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of China [81501055, 81471252, 81772060]; Tianjin Municipal Science and Technology Commission Natural Fund Project [13JCYBJC23700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission Natural Fund Project	This work was supported by Grants 81501055, 81471252, and 81772060 from the National Natural Science Foundation of China, and Grant 13JCYBJC23700 from the Tianjin Municipal Science and Technology Commission Natural Fund Project. The authors appreciate Chunsheng Kang, Lei Han, Anling Zhang, Li Liu, Weiyun Cui, and Lei Zhou (Tianjin Neurological Institute) for their technical support. The authors declare no conflicts of interest.	Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bai R., 2017, NEUROCHEM RES; Bai RJ, 2017, MED SCI MONITOR, V23, P1707, DOI 10.12659/MSM.901124; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chen ZQ, 2014, CANCER LETT, V350, P43, DOI 10.1016/j.canlet.2014.04.010; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chopp M, 2015, EXPERT OPIN EMERG DR, V20, P523, DOI 10.1517/14728214.2015.1061993; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cunha C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6986175; Dadsetan S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00106; Edwards P, 2005, LANCET, V365, P1957; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Glebov K, 2015, GLIA, V63, P626, DOI 10.1002/glia.22772; Gong X, 2016, AM J TRANSL RES, V8, P2127; Goto T, 2013, BIOORG MED CHEM LETT, V23, P3325, DOI 10.1016/j.bmcl.2013.03.104; Gurney ME, 2015, NEUROTHERAPEUTICS, V12, P49, DOI 10.1007/s13311-014-0309-7; Han RR, 2016, EXP NEUROL, V280, P106, DOI 10.1016/j.expneurol.2016.04.005; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hartmann H, 2015, CELL TISSUE RES, V362, P9, DOI 10.1007/s00441-015-2183-y; Hooper C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-144; Hu XK, 2016, MOL MED REP, V14, P3662, DOI 10.3892/mmr.2016.5729; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kim J, 2015, GENE, V558, P173, DOI 10.1016/j.gene.2015.01.001; Kim SW, 2011, CLIN CANCER RES, V17, P6723, DOI 10.1158/1078-0432.CCR-11-0770; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li DJ, 2016, FASEB J, V30, P3388, DOI 10.1096/fj.201600495R; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Naganuma K, 2009, BIOORG MED CHEM LETT, V19, P3174, DOI 10.1016/j.bmcl.2009.04.121; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Takano T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00044-2; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Wang YJ, 2016, ONCOTARGET, V7, P13328, DOI 10.18632/oncotarget.7798; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yu AY, 2017, IMMUNOL LETT, V182, P1, DOI 10.1016/j.imlet.2016.12.003; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhang H, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/7498706; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang YQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-253; Zhang Y, 2017, MOL NEUROBIOL, V54, P2659, DOI 10.1007/s12035-016-9851-0; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	64	170	177	10	100	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					512	528		10.1096/fj.201700673R	http://dx.doi.org/10.1096/fj.201700673R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28935818				2022-12-26	WOS:000419172700045
J	Tu, JW; Stoner, S; Fromm, PD; Wang, TY; Chen, D; Tuckermann, J; Cooper, MS; Seibel, MJ; Zhou, H				Tu, Jinwen; Stoner, Shihani; Fromm, Phillip D.; Wang, Tingyu; Chen, Di; Tuckermann, Jan; Cooper, Mark S.; Seibel, Markus J.; Zhou, Hong			Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damage	FASEB JOURNAL			English	Article						glucocorticoid receptor; arthritis; AIA mode; STIA model	RHEUMATOID-ARTHRITIS; ARTICULAR CHONDROCYTES; TRANSGENIC DISRUPTION; RECEPTOR; OSTEOARTHRITIS; CHEMOKINES; CARTILAGE; MICE; OSTEOBLASTS; NEUTROPHILS	Previous studies demonstrated that endogenous glucocorticoid signaling in osteoblasts promotes inflammation in murine immune arthritis. The current study determined whether disruption of endogenous glucocorticoid signaling in chondrocytes also modulates the course and severity of arthritis. Tamoxifen-inducible chondrocyte-targetedglucocorticoidreceptor- knockout (chGRKO) mice were generated by breeding GR(flox)/(flox) mice with tamoxifen-inducible collagen 2a1 Cre (Col2a1-CreER(T2)) mice. Antigen-induced arthritis (AIA) and K/BxN serum transfer-induced arthritis (STIA) were induced in both chGRKO mice and their Cre-negative GR(flox)/(flox) littermates [wild type (WT)]. Arthritis was assessed by measurement of joint swelling and histology of joints collected at d 14. Neutrophil activity and gene expression patterns associated with cartilage damage were also evaluated. In both arthritis models clinical (joint swelling) and histologic indices of inflammatory activity were significantly greater in chGRKO than in WT mice. The STIA model was characterized by early up-regulation of CXCR2/CXCR2 ligand gene expression in ankle tissues, and significant and selective expansion of splenic CXCR2(+) neutrophils in chGRKO arthritic compared to WT arthritic mice. At later stages, gene expression of enzymes involved in cartilage degradation was up-regulatedin chGRKO but not WT arthritic mice. Therefore, we summarize that chondrocytes actively mitigate local joint inflammation, cartilage degradation and systemic neutrophil activity via a glucocorticoid-dependent pathway.	[Tu, Jinwen; Stoner, Shihani; Wang, Tingyu; Seibel, Markus J.; Zhou, Hong] ANZAC Res Inst, Bone Res Program, Sydney, NSW, Australia; [Tu, Jinwen; Cooper, Mark S.] ANZAC Res Inst, Adrenal Steroid Lab, Sydney, NSW, Australia; [Fromm, Phillip D.] ANZAC Res Inst, Dendrit Cell Res, Sydney, NSW, Australia; [Tu, Jinwen; Cooper, Mark S.; Seibel, Markus J.; Zhou, Hong] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia; [Wang, Tingyu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Pharm, Shanghai, Peoples R China; [Chen, Di] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Tuckermann, Jan] Univ Ulm, Inst Comparat Mol Endocrinol, Ulm, Germany; [Cooper, Mark S.; Seibel, Markus J.; Zhou, Hong] Concord Hosp, Dept Endocrinol & Metab, Sydney, NSW, Australia	University of Sydney; ANZAC Research Institute; University of Sydney; ANZAC Research Institute; University of Sydney; ANZAC Research Institute; University of Sydney; Shanghai Jiao Tong University; Rush University; Ulm University; Concord Repatriation General Hospital	Tu, JW; Zhou, H (corresponding author), Univ Sydney, Bone Res Program, ANZAC Res Inst, Gate 3 Hosp Rd, Sydney, NSW 2139, Australia.	jinwen.tu@sydney.edu.au; h.zhou@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Chen, Di/AAJ-3665-2021	Cooper, Mark/0000-0003-3112-7728; Zhou, Hong/0000-0001-5899-9660; Seibel, Markus J/0000-0002-2701-378X	National Health and Medical Research Council (NHMRC) of Australia [APP1087271]; Rebecca L. Cooper Medical Research Foundation/Equipment; Deutsche Forschungsgemeinschaft [SFB 1149, INST 40/492-1, TU 220/6-2]; Natural Science Foundation of China [81572104]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation/Equipment; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank M. Khalil and the staff of the Molecular Physiology Unit at Australian and New Zealand Army Corps (ANZAC) Research Institute for their excellent animal care. The authors acknowledge the facilities and the scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility (Australian Centre for Microscopy and Microanalysis, University of Sydney). A. Vu (Dendritic Cell Research, ANZAC Research Institute) is also acknowledged for flow cytometry support. This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (Project Grant APP1087271 to H.Z., M.J.S., and M.S.C).; a Rebecca L. Cooper Medical Research Foundation/Equipment grant to H.Z. and M.J.S.; Deutsche Forschungsgemeinschaft (SFB 1149 Trauma INST 40/492-1 and Priority Program Osteoimmunology TU 220/6-2) to J.T., and Natural Science Foundation of China Grant 81572104 to T.W. The authors declare no conflicts of interest.	Baschant U, 2011, P NATL ACAD SCI USA, V108, P19317, DOI 10.1073/pnas.1105857108; Bendele A, 1999, ARTHRITIS RHEUM, V42, P498, DOI 10.1002/1529-0131(199904)42:3<498::AID-ANR15>3.0.CO;2-A; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Buttgereit F, 2011, ARTHRITIS RHEUM-US, V63, P1, DOI 10.1002/art.30070; Buttgereit F, 2009, ARTHRITIS RHEUM-US, V60, P1998, DOI 10.1002/art.24619; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; DIBATTISTA JA, 1993, J CLIN ENDOCR METAB, V76, P1128, DOI 10.1210/jc.76.5.1128; Dimitrova P, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3926; Fromm PD, 2012, J IMMUNOL, V188, P6258, DOI 10.4049/jimmunol.1100977; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Hardy RS, 2014, ANN NY ACAD SCI, V1318, P18, DOI 10.1111/nyas.12389; Henneicke H, 2011, BONE, V49, P733, DOI 10.1016/j.bone.2011.06.013; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; Huh YH, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.88; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Lee H, 2006, NAT BIOTECHNOL, V24, P1279, DOI 10.1038/nbt1248; McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Niedermeier M, 2010, BEST PRACT RES CL RH, V24, P527, DOI 10.1016/j.berh.2010.02.002; Pap T, 2015, NAT REV RHEUMATOL, V11, P606, DOI 10.1038/nrrheum.2015.95; PECCOUD J, 1990, EMBO J, V9, P4215, DOI 10.1002/j.1460-2075.1990.tb07869.x; Sherwood J, 2015, ANN RHEUM DIS, V74, P2207, DOI 10.1136/annrheumdis-2014-205546; Spies CM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-31; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Talbot J, 2015, ARTHRITIS RHEUMATOL, V67, P1751, DOI 10.1002/art.39117; Tu JW, 2016, AM J PATHOL, V186, P1293, DOI 10.1016/j.ajpath.2015.12.025; Tu JW, 2014, BONE, V69, P12, DOI 10.1016/j.bone.2014.08.016; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Zhou H, 2013, BONE RES, V1, DOI 10.4248/BR201302001; Zhu M, 2008, OSTEOARTHR CARTILAGE, V16, P129, DOI 10.1016/j.joca.2007.08.001; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	31	13	14	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					478	487		10.1096/fj.201700659R	http://dx.doi.org/10.1096/fj.201700659R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928247				2022-12-26	WOS:000419172700042
J	Shibayama, N; Ohki, M; Tame, JRH; Park, SY				Shibayama, Naoya; Ohki, Mio; Tame, Jeremy R. H.; Park, Sam-Yong			Direct observation of conformational population shifts in crystalline human hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; conformational change; cooperativity; hemoglobin; oxygen transport; protein conformation; X-ray crystallography; allostery	X-RAY-DIFFRACTION; OXYGEN EQUILIBRIUM PROPERTIES; 82-BETA-2 LYSYL RESIDUES; QUATERNARY STRUCTURE; AFFINITY CONFORMATIONS; ALLOSTERIC TRANSITION; LIGANDED HEMOGLOBIN; HYBRID HEMOGLOBINS; SINGLE-CRYSTALS; HUMAN ADULT	Although X-ray crystallography is the most commonly used technique for studying the molecular structure of proteins, it is not generally able to monitor the dynamic changes or global domain motions that often underlie allostery. These motions often prevent crystal growth or reduce crystal order. We have recently discovered a crystal form of human hemoglobin that contains three protein molecules allowed to express a full range of quaternary structures, whereas maintaining strong X-ray diffraction. Here we use this crystal form to investigate the effects of two allosteric effectors, phosphate and bezafibrate, by tracking the structures and functions of the three hemoglobin molecules following the addition of each effector. The X-ray analysis shows that the addition of either phosphate or bezafibrate not only induces conformational changes in a direction from a relaxed-state to a tense-state, but also within relaxed-state populations. The microspectrophotometric O-2 equilibrium measurements on the crystals demonstrate that the binding of each effector energetically stabilizes the lowest affinity conformer more strongly than the intermediate affinity one, thereby reducing the O-2 affinity of tense-state populations, and that the addition of bezafibrate causes an approximate to 5-fold decrease in the O-2 affinity of relaxed-state populations. These results show that the allosteric pathway of hemoglobin involves shifts of populations rather than a unidirectional conversion of one quaternary structure to another, and that minor conformers of hemoglobin may have a disproportionate effect on the overall O-2 affinity.	[Shibayama, Naoya] Jichi Med Univ, Div Biophys, Dept Physiol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Ohki, Mio; Tame, Jeremy R. H.; Park, Sam-Yong] Yokohama City Univ, Grad Sch Med Life Sci, Drug Design Lab, 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan	Jichi Medical University; Yokohama City University	Shibayama, N (corresponding author), Jichi Med Univ, Div Biophys, Dept Physiol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	shibayam@jichi.ac.jp		Shibayama, Naoya/0000-0002-2208-1126; Tame, Jeremy/0000-0002-9341-7280	Japan Society for the Promotion of Science (JSPS) [JP15H01646, JP16K07326]; Grants-in-Aid for Scientific Research [15K21719, 26105001] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP15H01646 (to N. S.) and JP16K07326 (to N. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1968, J CRYST GROWTH, DOI [rg/10.1016/00220248(68)900717, DOI 10.1016/0022-0248(68)90071-7]; ARNONE A, 1986, J MOL BIOL, V188, P693, DOI 10.1016/S0022-2836(86)80015-8; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Biswal BK, 2001, CURR SCI INDIA, V81, P1100; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bricogne G., 2011, BUSTER VERSION 2 10, V10, P2; Bruno S, 2001, PROTEIN SCI, V10, P2401, DOI 10.1110/ps.20501; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COBAU WG, 1985, BIOPHYS J, V47, P781, DOI 10.1016/S0006-3495(85)83981-3; Colombo MF, 1999, BIOCHEMISTRY-US, V38, P11741, DOI 10.1021/bi9905361; DEREWENDA Z, 1990, J MOL BIOL, V211, P515, DOI 10.1016/0022-2836(90)90262-K; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Henry ER, 2015, BIOPHYS J, V109, P1264, DOI 10.1016/j.bpj.2015.04.037; IMAI K, 1979, J MOL BIOL, V133, P233, DOI 10.1016/0022-2836(79)90532-1; JONES CM, 1992, BIOCHEMISTRY-US, V31, P6692, DOI 10.1021/bi00144a008; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LEE AWM, 1983, P NATL ACAD SCI-BIOL, V80, P7055, DOI 10.1073/pnas.80.23.7055; LUISI B, 1990, J MOL BIOL, V214, P7, DOI 10.1016/0022-2836(90)90139-D; LUISI B, 1989, J MOL BIOL, V206, P723, DOI 10.1016/0022-2836(89)90579-2; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEHANNA AS, 1990, BIOCHEMISTRY-US, V29, P3944, DOI 10.1021/bi00468a022; MINTON A P, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1418, DOI 10.1073/pnas.71.4.1418; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mozzarelli A, 1997, PROTEIN SCI, V6, P484; MOZZARELLI A, 1991, NATURE, V351, P416, DOI 10.1038/351416a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Park SY, 2004, BIOCHEMISTRY-US, V43, P8711, DOI 10.1021/bi049932w; Patskovska LN, 2005, ACTA CRYSTALLOGR D, V61, P566, DOI 10.1107/S0907444905004622; PERRELLA M, 1990, BIOPHYS CHEM, V37, P211, DOI 10.1016/0301-4622(90)88020-S; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; PERUTZ MF, 1986, J AM CHEM SOC, V108, P1064, DOI 10.1021/ja00265a036; Ren Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077141; Ringe D, 1986, Methods Enzymol, V131, P389; RIVETTI C, 1993, BIOCHEMISTRY-US, V32, P2888, DOI 10.1021/bi00062a021; Safo MK, 2005, BIOCHEMISTRY-US, V44, P8347, DOI 10.1021/bi050412q; SCHUMACHER MA, 1995, NATURE, V375, P84, DOI 10.1038/375084a0; Seixas FAV, 1999, ACTA CRYSTALLOGR D, V55, P1914, DOI 10.1107/S0907444999009750; Sen U, 2004, BIOCHEMISTRY-US, V43, P12477, DOI 10.1021/bi048903i; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; Shibayama N, 1999, J MOL BIOL, V285, P1383, DOI 10.1006/jmbi.1998.2407; SHIBAYAMA N, 1986, J MOL BIOL, V192, P331, DOI 10.1016/0022-2836(86)90368-2; SHIBAYAMA N, 1986, J MOL BIOL, V192, P323, DOI 10.1016/0022-2836(86)90367-0; SHIBAYAMA N, 1995, BIOCHEMISTRY-US, V34, P4773, DOI 10.1021/bi00014a035; SHIBAYAMA N, 1991, BIOCHEMISTRY-US, V30, P8158, DOI 10.1021/bi00247a010; Shibayama N, 2001, FEBS LETT, V492, P50, DOI 10.1016/S0014-5793(01)02225-6; Shibayama N., 2011, HEMOGLOBIN RECENT DE, P138; Shibayama N, 2014, J AM CHEM SOC, V136, P5097, DOI 10.1021/ja500380e; Shibayama N, 2011, J BIOL CHEM, V286, P33661, DOI 10.1074/jbc.M111.266056; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SZABO A, 1972, J MOL BIOL, V72, P163, DOI 10.1016/0022-2836(72)90077-0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	56	8	8	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18258	18269		10.1074/jbc.M117.781146	http://dx.doi.org/10.1074/jbc.M117.781146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28931607	Green Published, hybrid			2022-12-26	WOS:000414458200023
J	Fujii, T; Reuben, JM; Huo, L; Fernandez, JRE; Gong, Y; Krupa, R; Suraneni, MV; Graf', RP; Lee, J; Greene, S; Rodriguez, A; Dugan, L; Louw, J; Lim, B; Barcenas, CH; Marx, AN; Tripathy, D; Wang, YP; Landers, M; Dittamore, R; Ueno, NT				Fujii, Takeo; Reuben, James M.; Huo, Lei; Fernandez, Jose Rodrigo Espinosa; Gong, Yun; Krupa, Rachel; Suraneni, Mahipal V.; Graf', Ryon P.; Lee, Jerry; Greene, Stephanie; Rodriguez, Angel; Dugan, Lyndsey; Louw, Jessica; Lim, Bora; Barcenas, Carlos H.; Marx, Angela N.; Tripathy, Debu; Wang, Yipeng; Landers, Mark; Dittamore, Ryan; Ueno, Naoto T.			Androgen receptor expression on circulating tumor cells in metastatic breast cancer	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; PIK3CA MUTATIONAL STATUS; SURVIVAL; PROGRESSION; CHEMOTHERAPY; SUBTYPES; GROWTH; TRIAL	Purpose Androgen receptor (AR) is frequently detected in breast cancers, and AR-targeted therapies are showing activity in AR-positive (AR+) breast cancer. However, the role of AR in breast cancers is still not fully elucidated and the biology of AR in breast cancer remains incompletely understood. Circulating tumor cells (CTCs) can serve as prognostic and diagnostic tools, prompting us to measure AR protein expression and conduct genomic analyses on CTCs in patients with metastatic breast cancer. Methods Blood samples from patients with metastatic breast cancer were deposited on glass slides, subjected to nuclear staining with DAPI, and reacted with fluorescent-labeled antibodies to detect CD45, cytokeratin (CK), and biomarkers of interest (AR, estrogen receptor [ER], and HER2) on all nucleated cells. The stained slides were scanned and enumerated by non-enrichment- based non-biased approach independent of cell surface epithelial cell adhesion molecule (EpCAM) using the Epic Sciences CTC platform. Data were analyzed using established digital pathology algorithms. Results Of 68 patients, 51 (75%) had at least 1 CTC, and 49 of these 51 (96%) had hormone-receptor- positive (HR+)/HER2-negative primary tumors. AR was expressed in CK+ CTCs in 10 patients. Of these 10 patients, 3 also had ER expression in CK+ CTCs. Single cell genomic analysis of 78 CTCs from 1 of these 3 patients identified three distinct copy number patterns. AR+ cells had a lower frequency of chromosomal changes than ER+ and HER2+ cells. Conclusions CTC enumeration and analysis using no enrichment or selection provides a non-biased approach to detect AR expression and chromosomal aberrations in CTCs in patients with metastatic breast cancer. The heterogeneity of intrapatient AR expression in CTCs leads to the new hypothesis that patients with AR+ CTCs have heterogeneous disease with multiple drivers. Further studies are warranted to investigate the clinical applicability of AR+ CTCs and their heterogeneity.	[Fujii, Takeo; Fernandez, Jose Rodrigo Espinosa; Lim, Bora; Barcenas, Carlos H.; Marx, Angela N.; Tripathy, Debu; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Huo, Lei; Gong, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Krupa, Rachel; Suraneni, Mahipal V.; Graf', Ryon P.; Lee, Jerry; Greene, Stephanie; Rodriguez, Angel; Dugan, Lyndsey; Louw, Jessica; Wang, Yipeng; Landers, Mark; Dittamore, Ryan] Epic Sci, Dept Translat Res, La Jolla, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ueno, NT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA.	nueno@mdanderson.org	Fujii, Takeo/GYJ-8304-2022; Fujii, Takeo/AAX-4717-2021; , 0000-0002-4182-6058/F-9978-2014	, 0000-0002-4182-6058/0000-0002-4182-6058; Espinosa Fernandez, Jose Rodrigo/0000-0002-0005-5672; Graf, Ryon/0000-0002-8065-4148	Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program; MD Anderson Cancer Center's Cancer Center Support Grant from the National Cancer Institute [CA016672]; Epic Sciences	Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program; MD Anderson Cancer Center's Cancer Center Support Grant from the National Cancer Institute; Epic Sciences	This study was funded by the Morgan Welch Inflammatory Breast Cancer Research Program; a grant from the State of Texas Rare and Aggressive Breast Cancer Research Program; MD Anderson Cancer Center's Cancer Center Support Grant from the National Cancer Institute, CA016672, which supports the Biostatistics Shared Resource; and Epic Sciences. The Morgan Welch Inflammatory Breast Cancer Research Program and the National Cancer Institute had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Epic Sciences provided support in the form of salaries for authors RK, MVS, RPG, JLee, SG, AR, LD, JLouw, YW, ML, and RD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Epic Sciences employees contributed to study design (RD), data collection and analysis (RK, MVS, RPG, JLee, SG, AR, LD, JLouw, YW, ML, and RD), decision to publish (RD), and preparation of the manuscript (RK, MVS, RPG, JLee, SG, AR, LD, JLouw, YW, ML, and RD).	Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Anantharaman A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2758-3; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Chang C, 2014, ONCOGENE, V33, P3225, DOI 10.1038/onc.2013.274; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Collins LC, 2011, MODERN PATHOL, V24, P924, DOI 10.1038/modpathol.2011.54; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Amicis F, 2010, BREAST CANCER RES TR, V121, P1, DOI 10.1007/s10549-009-0436-8; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Elebro K, 2015, CLIN CANCER RES, V21, P3640, DOI 10.1158/1078-0432.CCR-14-2564; Fehm T, 2010, BREAST CANCER RES TR, V124, P403, DOI 10.1007/s10549-010-1163-x; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Graf RP, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-1740; Greene SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165089; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Guiu S, 2015, FUTURE ONCOL, V11, P2283, DOI 10.2217/fon.15.102; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hilborn E, 2016, BRIT J CANCER, V114, P248, DOI 10.1038/bjc.2015.464; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Keilty D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081740; Kono M, 2017, JAMA ONCOLOGY; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lianidou ES, 2013, BRIT J CANCER, V108, P2426, DOI 10.1038/bjc.2013.265; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lu D, 2015, AM ASS CANC RES AACR; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Markou A, 2014, CLIN CANCER RES, V20, P5823, DOI 10.1158/1078-0432.CCR-14-0149; Marrinucci D, 2010, J ONCOL, V2010, P1, DOI DOI 10.1016/S1470-2045(07)70140-7; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; McDaniel AS, 2016, BJU INT; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P190, DOI 10.1038/nrclinonc.2009.23; Parker JS, 2015 ASCO ANN M CHIC; Pestrin M, 2015, MOL ONCOL, V9, P749, DOI 10.1016/j.molonc.2014.12.001; Peters AA, 2009, CANCER RES, V69, P6131, DOI 10.1158/0008-5472.CAN-09-0452; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Punnoose EA, 2015, BRIT J CANCER, V113, P1225, DOI 10.1038/bjc.2015.332; Reyes EE, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0313-z; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Scher H. I., 2016, ASCO 2016 GEN CANC S; Scher HI, 2016, JAMA ONCOL, V2, P1441, DOI 10.1001/jamaoncol.2016.1828; Smerage JB, 2014, J CLIN ONCOL, V32, P3483, DOI 10.1200/JCO.2014.56.2561; Takagi K, 2010, ENDOCR-RELAT CANCER, V17, P415, DOI 10.1677/ERC-09-0257; Traina T, 2015 ASCO ANN M CHIC; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Tsang JYS, 2014, ANN SURG ONCOL, V21, P2218, DOI 10.1245/s10434-014-3629-2; Turner-Ivey B, 2014, NEOPLASIA, V16, P644, DOI 10.1016/j.neo.2014.07.007; Vera-Badillo FE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt319; Werner Shannon L, 2015, J Circ Biomark, V4, P3, DOI 10.5772/60725; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	54	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185231	10.1371/journal.pone.0185231	http://dx.doi.org/10.1371/journal.pone.0185231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957377	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200036
J	Shrestha, S; Kamel, F; Umbach, DM; Freeman, LEB; Koutros, S; Alavanja, M; Sandler, DP; Chen, HL				Shrestha, Srishti; Kamel, Freya; Umbach, David M.; Freeman, Laura E. Beane; Koutros, Stella; Alavanja, Michael; Sandler, Dale P.; Chen, Honglei			Nonmotor symptoms and Parkinson disease in United States farmers and spouses	PLOS ONE			English	Article							GENDER-DIFFERENCES; SEX-DIFFERENCES; RISK; PREVALENCE; MOTOR; DEPRESSION; IMPAIRMENT; DISORDERS; ANXIETY; ONSET	Objectives Few studies have evaluated the presence of multiple nonmotor symptoms (NMS) in relation to Parkinson disease (PD). Therefore, we examined cross-sectional associations between individual and multiple NMS and PD in the Agricultural Health Study. Methods 20,473 male farmers and 16,259 female spouses provided information on six NMS (reduced sense of smell, dream-enacting behavior, daytime sleepiness, infrequent bowel movement, depression, and anxiety) in the cohort's 2013-2015 follow-up survey. 191 men and 68 women reported physician-diagnosed PD. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) using multivariable logistic regression models separately by sex. Results NMS were each associated with PD, with the strongest association for reduced sense of smell in men and dream-enacting behavior in women. The number of NMS showed a strong dose-response relationship with PD, particularly in men. ORs were 5.5 (95% CI 3.4-8.8) for one, 17 (95% CI 10.4-28.0) for two, and 53.4 (95% CI 33.2-86.1) for three or more NMS in men; the corresponding ORs were 4.6 (95% CI 2.3-9.5), 6.7 (95% CI 2.9-15.6), and 23.6 (95% CI 10.7-52.4) in women (PNMS-interaction-with-sex = 0.07). Conclusions The number of NMS was associated with PD in a dose-response manner and the association appeared stronger in men than in women. These findings should be further investigated in population-based prospective studies.	[Shrestha, Srishti; Kamel, Freya; Sandler, Dale P.; Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Umbach, David M.] NIEHS, Biostat & Computat Biol Branch, POB 12233, Res Triangle Pk, NC 27709 USA; [Freeman, Laura E. Beane; Koutros, Stella; Alavanja, Michael] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chen, Honglei] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Michigan State University; Michigan State University College of Human Medicine	Chen, HL (corresponding author), NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.; Chen, HL (corresponding author), Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	hchen@epi.msu.edu	Freeman, Laura E. Beane/C-4468-2015; Shrestha, Srishti/ABF-6248-2021; Koutros, Stella/W-5788-2019	Freeman, Laura E. Beane/0000-0003-1294-4124; Koutros, Stella/0000-0001-5294-5485; Chen, Honglei/0000-0003-3446-7779	Intramural NIH HHS [Z01 ES049030, Z01 ES049028, Z01 CP010119, Z01 ES101986] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIACP010119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams-Carr KL, 2016, J NEUROL NEUROSUR PS, V87, P710, DOI 10.1136/jnnp-2015-311680; Adler CH, 2016, MOVEMENT DISORD, V31, P1114, DOI 10.1002/mds.26605; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Chen HL, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/2047-9158-4-1; Chen HL, 2014, MOVEMENT DISORD, V29, P1316, DOI 10.1002/mds.25950; Claassen DO, 2010, NEUROLOGY, V75, P494, DOI 10.1212/WNL.0b013e3181ec7fac; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Fang F, 2010, MOVEMENT DISORD, V25, P1157, DOI 10.1002/mds.23092; Gaenslen A, 2011, MOVEMENT DISORD, V26, P653, DOI 10.1002/mds.23499; Gao JJ, 2011, AM J EPIDEMIOL, V173, P1032, DOI 10.1093/aje/kwq478; Gao X, 2011, AM J EPIDEMIOL, V174, P546, DOI 10.1093/aje/kwr119; Gillies GE, 2014, FRONT NEUROENDOCRIN, V35, P370, DOI 10.1016/j.yfrne.2014.02.002; Guo XY, 2013, PARKINSONISM RELAT D, V19, P961, DOI 10.1016/j.parkreldis.2013.06.009; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Huang XM, 2015, MOVEMENT DISORD, V30, P552, DOI 10.1002/mds.26152; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Liu R, 2015, NEUROLOGY, V84, P2107, DOI 10.1212/WNL.0000000000001609; Martinez-Martin P, 2012, J NEUROL, V259, P1639, DOI 10.1007/s00415-011-6392-3; Mollenhauer B, 2013, NEUROLOGY, V81, P1226, DOI 10.1212/WNL.0b013e3182a6cbd5; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Nalls MA, 2015, LANCET NEUROL, V14, P1002, DOI 10.1016/S1474-4422(15)00178-7; Picillo M, 2016, PARKINSONISM RELAT D, V27, P89, DOI 10.1016/j.parkreldis.2016.04.001; Picillo M, 2014, PARKINSONISM RELAT D, V20, P850, DOI 10.1016/j.parkreldis.2014.04.023; Picillo M, 2013, J NEUROL, V260, P2849, DOI [10.1007/s00415-013-7085-x, 10.1007/s00415-013-6851-0]; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; Postuma RB, 2015, NEUROLOGY, V84, P1104, DOI 10.1212/WNL.0000000000001364; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Ross G Webster, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS199, DOI 10.1016/S1353-8020(11)70062-1; Solla P, 2012, J NEUROL SCI, V323, P33, DOI 10.1016/j.jns.2012.07.026; Song Y, 2014, NEUROL SCI, V35, P1991, DOI 10.1007/s10072-014-1879-1; Szewczyk-Krolikowski K, 2014, PARKINSONISM RELAT D, V20, P99, DOI 10.1016/j.parkreldis.2013.09.025; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Weisskopf MG, 2003, MOVEMENT DISORD, V18, P646, DOI 10.1002/mds.10425	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185510	10.1371/journal.pone.0185510	http://dx.doi.org/10.1371/journal.pone.0185510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953962	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300072
J	Kral, R; Osima, M; Borgen, TT; Vestgaard, R; Richardsen, E; Bjornerem, A				Kral, Rita; Osima, Marit; Borgen, Tove T.; Vestgaard, Roald; Richardsen, Elin; Bjornerem, Ashild			Increased cortical porosity and reduced cortical thickness of the proximal femur are associated with nonvertebral fracture independent of Fracture Risk Assessment Tool and Garvan estimates in postmenopausal women	PLOS ONE			English	Article							INDIVIDUALIZING 5-YEAR; BONE; PROBABILITY; AREA; FRAX; MEN	The Fracture Risk Assessment Tool (FRAX) and Garvan Calculator have improved the individual prediction of fracture risk. However, additional bone measurements that might enhance the predictive ability of these tools are the subject of research. There is increasing interest in cortical parameters, especially cortical porosity. Neither FRAX nor Garvan include measurements of cortical architecture, important for bone strength, and providing independent information beyond the conventional approaches. We tested the hypothesis that cortical parameters are associated with fracture risk, independent of FRAX and Garvan estimates. This nested case-control study included 211 postmenopausal women aged 54-94 years with nonvertebral fractures, and 232 controls from the Tromso Study in Norway. We assessed FRAX and Garvan 10-year risk estimates for fragility fracture, and quantified femoral subtrochanteric cortical porosity, thickness, and area from computed tomography images using StrAx1.0 software. Per standard deviation higher cortical porosity, thinner cortices, and smaller cortical area, the odds ratio (95% confidence interval) for fracture was 1.71 (1.38-2.11), 1.79 (1.44-2.23), and 1.52 (1.19-1.95), respectively. Cortical porosity and thickness, but not area, remained associated with fracture when adjusted for FRAX and Garvan estimates. Adding cortical porosity and thickness to FRAX or Garvan resulted in greater area under the receiver operating characteristic curves. When using cortical porosity (>80th percentile) or cortical thickness (<20th percentile) combined with FRAX (threshold >20%), 45.5% and 42.7% of fracture cases were identified, respectively. Using the same cutoffs for cortical porosity or thickness combined with Garvan (threshold >25%), 51.2% and 48.3% were identified, respectively. Specificity for all combinations ranged from 81.0-83.6%. Measurement of cortical porosity or thickness identified 20.4% and 17.5% additional fracture cases that, were unidentified using FRAX alone, and 16.6% and 13.7% fracture cases unidentified using Garvan alone. In conclusion, cortical parameters may help to improve identification of women at risk for fracture.and 48.3% were identified, respectively. Specificity for all combinations ranged from 81.0-83.6%. Measurement of cortical porosity or thickness identified 20.4% and 17.5% additional fracture cases that, were unidentified using FRAX alone, and 16.6% and 13.7% fracture cases unidentified using Garvan alone. In conclusion, cortical parameters may help to improve identification of women at risk for fracture.	[Kral, Rita; Bjornerem, Ashild] Univ Hosp North Norway, Dept Obstet & Gynaecol, Tromso, Norway; [Kral, Rita; Bjornerem, Ashild] UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Osima, Marit] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Osima, Marit] Univ Hosp North Norway, Dept Orthopaed Surg, Tromso, Norway; [Borgen, Tove T.] Hosp Drammen, Vestre Viken Hosp Trust, Dept Rheumatol, Drammen, Norway; [Vestgaard, Roald] Univ Hosp North Norway, Div Internal Med, Tromso, Norway; [Richardsen, Elin] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Richardsen, Elin] Univ Hosp North Norway, Dept Pathol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Bjornerem, A (corresponding author), Univ Hosp North Norway, Dept Obstet & Gynaecol, Tromso, Norway.; Bjornerem, A (corresponding author), UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway.	ashild.bjornerem@uit.no			North Norwegian Health Authorities [5645, 9167, 9168, 10295, 12156]	North Norwegian Health Authorities	The North Norwegian Health Authorities funded the study (ID 5645, 9167, ID 9168, ID 10295, ID 12156) but they had no role in design and conduct of the study; in the collection, analyses, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Ahmed LA, 2015, OSTEOPOROSIS INT, V26, P2137, DOI 10.1007/s00198-015-3118-x; Ahmed LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107695; Bala Y, 2014, J BONE MINER RES, V29, P1356, DOI 10.1002/jbmr.2167; Bell KL, 1999, BONE, V24, P57, DOI 10.1016/S8756-3282(98)00143-4; Bjornerem A, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.77; Bolland MJ, 2011, J BONE MINER RES, V26, P420, DOI 10.1002/jbmr.215; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Hernlund E., 2013, ARCH OSTEOPOROS, V8; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Leslie WD, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0145-0; McCloskey EV, 2016, CURR OPIN RHEUMATOL, V28, P433, DOI 10.1097/BOR.0000000000000304; McCloskey EV, 2015, CALCIFIED TISSUE INT, V96, P500, DOI 10.1007/s00223-015-9980-x; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; Ohlsson C, 2017, J CLIN ENDOCR METAB, V102, P516, DOI 10.1210/jc.2016-3177; Peeters G, 2009, BEST PRACT RES CL RH, V23, P797, DOI 10.1016/j.berh.2009.09.004; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sandhu SK, 2010, OSTEOPOROSIS INT, V21, P863, DOI 10.1007/s00198-009-1026-7; Shigdel R., 2016, THESIS; Shigdel R, 2016, J BONE MINER RES, V31, P758, DOI 10.1002/jbmr.2751; Shigdel R, 2015, BONE, V81, P1, DOI 10.1016/j.bone.2015.06.016; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Sundh D, 2016, J INTERN MED, V280, P496, DOI 10.1111/joim.12514; Sundh D, 2015, J BONE MINER RES, V30, P1692, DOI 10.1002/jbmr.2509; van Geel TACM, 2014, MATURITAS, V77, P174, DOI 10.1016/j.maturitas.2013.10.021; van Geel TACM, 2011, ANN RHEUM DIS, V70, P92, DOI 10.1136/ard.2010.131813; Zebaze R, 2013, BONE, V54, P8, DOI 10.1016/j.bone.2013.01.007; Zebaze R, 2016, J BONE MINER RES, V31, P1827, DOI 10.1002/jbmr.2855; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	32	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185363	10.1371/journal.pone.0185363	http://dx.doi.org/10.1371/journal.pone.0185363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945789	Green Published, gold			2022-12-26	WOS:000411645100051
J	Alahnomi, RA; Zakaria, Z; Ruslan, E; Ab Rashid, SR; Bahar, AAM; Shaaban, A				Alahnomi, Rammah A.; Zakaria, Z.; Ruslan, E.; Ab Rashid, S. R.; Bahar, Amyrul Azuan Mohd; Shaaban, Azizah			Microwave bio-sensor based on symmetrical split ring resonator with spurline filters for therapeutic goods detection	PLOS ONE			English	Article							DEFECTED GROUND STRUCTURE; HARMONIC SUPPRESSION; PERMITTIVITY	A novel symmetrical split ring resonator (SSRR) based microwave sensor with spurline filters for detecting and characterizing the properties of solid materials has been developed. Due to the weak perturbation in the interaction of material under test (MUT) and planar microwave sensor, spurline filters were embedded to the SSRR microwave sensor which effectively enhanced Q-factor with suppressing the undesired harmonic frequency. The spurline filter structures force the presented sensor to resonate at a fundamental frequency of 2.2 GHz with the capabilities of suppressing rejected harmonic frequency and miniaturization in circuit size. A wide bandwidth rejection is achieved by using double spurlines filters with high Q-factor achievement (up to 652.94) compared to single spurline filter. The new SSRR sensor with spurline filters displayed desired properties such as high sensitivity, accuracy, and performance with a 1.3% typical percentage error in the measurement results. Furthermore, the sensor has been successfully applied for detecting and characterizing solid materials (such as Roger 5880, Roger 4350, and FR4) and evidently demonstrated that it can suppress the harmonic frequency effectively. This novel design with harmonic suppression is useful for various applications such as food industry (meat, fruit, vegetables), biological medicine (derived from proteins and other substances produced by the body), and Therapeutic goods (antiseptics, vitamins, anti-psychotics, and other medicines).	[Alahnomi, Rammah A.; Zakaria, Z.; Ab Rashid, S. R.; Bahar, Amyrul Azuan Mohd] Univ Tek Malaysia Melaka UTeM, Ctr Telecommun Res & Innovat CeTRI, Durian Tunggal, Melaka, Malaysia; [Ruslan, E.] Univ Tek Malaysia Melaka UTeM, Fac Technol Engn, Durian Tunggal, Melaka, Malaysia; [Shaaban, Azizah] Univ Tek Malaysia Melaka UTeM, Fac Mfg Engn, Dept Mat Engn, Durian Tunggal, Melaka, Malaysia	University Teknikal Malaysia Melaka; University Teknikal Malaysia Melaka; University Teknikal Malaysia Melaka	Alahnomi, RA; Zakaria, Z (corresponding author), Univ Tek Malaysia Melaka UTeM, Ctr Telecommun Res & Innovat CeTRI, Durian Tunggal, Melaka, Malaysia.	alrammah89@gmail.com; zahriladha@utem.edu.my	Ruslan, Eliyana/ABG-4527-2021; Zakaria, Zahriladha/AAR-8298-2020; Bahar, Amyrul Azuan Mohd/S-3620-2016; Alahnomi, Rammah/AAF-2206-2020	Ruslan, Eliyana/0000-0003-1323-9101; Zakaria, Zahriladha/0000-0003-1467-405X; Alahnomi, Rammah/0000-0001-9224-4130	UTeM Zamalah Scheme; Centre for Research and Innovation Management (CRIM); Universiti Teknikal Malaysia Melaka (UTeM); Ministry of Higher Education Malaysia (MOHE) [FRGS/1/2015/SG02/FKEKK/03/F00265]	UTeM Zamalah Scheme; Centre for Research and Innovation Management (CRIM); Universiti Teknikal Malaysia Melaka (UTeM); Ministry of Higher Education Malaysia (MOHE)(Ministry of Education, Malaysia)	This work was supported by UTeM Zamalah Scheme and funded by Centre for Research and Innovation Management (CRIM), Universiti Teknikal Malaysia Melaka (UTeM), and the Ministry of Higher Education Malaysia (MOHE) under research grant number FRGS/1/2015/SG02/FKEKK/03/F00265. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AS, 2015, MOB INF SYST, V2015, P1, DOI 10.1155/2015/641027; Alahnomi R.A., 2015, INT J APPL ENG RES, V10, P18395; Alahnomi RA, 2015, 2015 IEEE JORD C APP, P3; Alahnomi RA, 2016, MICROW OPT TECHN LET, V58, P2106, DOI 10.1002/mop.29979; Angkawisittpan N., 2012, ELECT REV, P178; Angkawisittpan N., 2012, INT J PHYS SCI, V7, P31; Ansari MAH, 2015, IEEE SENS J, V15, P7181, DOI 10.1109/JSEN.2015.2469683; Boybay MS, 2012, IEEE T INSTRUM MEAS, V61, P3039, DOI 10.1109/TIM.2012.2203450; Chen L. F., 2004, MICROWAVE ELECT MEAS; Il Kwon Kim, 2006, 2006 IEEE Antennas and Propagation Society International Symposium (IEEE Cat. No. 06CH37758C), P1483; Jilani MT, 2016, MICROW OPT TECHN LET, V58, P4, DOI 10.1002/mop.29487; Kulkarni S, 2015, IEEE T MICROW THEORY, V63, P2411, DOI 10.1109/TMTT.2015.2451110; Lee CS, 2014, IEEE MICROW WIREL CO, V24, P563, DOI 10.1109/LMWC.2014.2318900; Li Ke, 2011, Proceedings of the 2011 IEEE International Conference on Microwave Technology & Computational Electromagnetics (ICMTCE 2011), P233, DOI 10.1109/ICMTCE.2011.5915498; Lim JS, 2001, IEEE MICROW WIREL CO, V11, P170, DOI 10.1109/7260.916333; Liu HW, 2005, IEEE MICROW WIREL CO, V15, P55, DOI 10.1109/LMWC.2004.842809; Pozar DM, 2012, MICROWAVE ENG; RoyChoudhury S, 2016, BIOSENS BIOELECTRON; Rusni IM, 2014, SENSORS-BASEL, V14, P13134, DOI 10.3390/s140713134; Sun X, 2003, IEEE; Sung YJ, 2004, IEEE MICROW WIREL CO, V14, P7, DOI 10.1109/LMWC.2003.821499; Woo DJ, 2005, IEEE T MICROW THEORY, V53, P2139, DOI 10.1109/TMTT.2005.848772; Yatao Peng, 2013, Progress In Electromagnetics Research C, V36, P159; Zhou JH, 2013, INT CONF MEASURE, P234, DOI 10.1109/MIC.2013.6757955	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185122	10.1371/journal.pone.0185122	http://dx.doi.org/10.1371/journal.pone.0185122			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934301	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900096
J	Bragazzi, NL; Alicino, C; Trucchi, C; Paganino, C; Barberis, I; Martini, M; Sticchi, L; Trinka, E; Brigo, F; Ansaldi, F; Icardi, G; Orsi, A				Bragazzi, Nicola Luigi; Alicino, Cristiano; Trucchi, Cecilia; Paganino, Chiara; Barberis, Ilaria; Martini, Mariano; Sticchi, Laura; Trinka, Eugen; Brigo, Francesco; Ansaldi, Filippo; Icardi, Giancarlo; Orsi, Andrea			Global reaction to the recent outbreaks of Zika virus: Insights from a Big Data analysis	PLOS ONE			English	Article							DIGITAL DISEASE DETECTION; EBOLA OUTBREAK; UNITED-STATES; WEB; BEHAVIOR; TWITTER; TRENDS	Objective The recent spreading of Zika virus represents an emerging global health threat. As such, it is attracting public interest worldwide, generating a great amount of related Internet searches and social media interactions. The aim of this research was to understand Zika-related digital behavior throughout the epidemic spreading and to assess its consistence with real-world epidemiological data, using a behavioral informatics and analytics approach. Methods In this study, the global web-interest and reaction to the recently occurred outbreaks of the Zika Virus were analyzed in terms of tweets and Google Trends (GT), Google News, You-Tube, and Wikipedia search queries. These data streams were mined from 1 st January 2004 to 31 st October 2016, with a focus on the period November 2015-October 2016. This analysis was complemented with the use of epidemiological data. Spearman's correlation was performed to correlate all Zika-related data. Moreover, a multivariate regression was performed using Zika-related search queries as a dependent variable, and epidemiological data, number of inhabitants in 2015 and Human Development Index as predictor variables. Results Overall 3,864,395 tweets, 284,903 accesses to Wikipedia pages dedicated to the Zika virus were analyzed during the study period. All web-data sources showed that the main spike of researches and interactions occurred in February 2016 with a second peak in August 2016. All novel data streams-related activities increased markedly during the epidemic period with respect to pre-epidemic period when no web activity was detected. Correlations between data from all these web platforms resulted very high and statistically significant. The countries in which web searches were particularly concentrated are mainly from Central and South Americas. The majority of queries concerned the symptoms of the Zika virus, its vector of transmission, and its possible effect to babies, including microcephaly. No statistically significant correlation was found between novel data streams and global real-world epidemiological data. At country level, a correlation between the digital interest towards the Zika virus and Zika incidence rate or microcephaly cases has been detected. Conclusions An increasing public interest and reaction to the current Zika virus outbreak was documented by all web-data sources and a similar pattern of web reactions has been detected. The public opinion seems to be particularly worried by the alert of teratogenicity of the Zika virus. Stakeholders and health authorities could usefully exploited these internet tools for collecting the concerns of public opinion and reply to them, disseminating key information.	[Bragazzi, Nicola Luigi; Alicino, Cristiano; Trucchi, Cecilia; Paganino, Chiara; Barberis, Ilaria; Martini, Mariano; Sticchi, Laura; Ansaldi, Filippo; Icardi, Giancarlo; Orsi, Andrea] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Sticchi, Laura; Icardi, Giancarlo; Orsi, Andrea] IRCCS, Osped Policlin San Martino, Teaching Hosp, Hyg Unit, Genoa, Italy; [Trinka, Eugen] Paracelsus Med Univ, Ctr Cognit Neurosci, Dept Neurol, Christian Doppler Klin, Salzburg, Austria; [Trinka, Eugen] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth Technol Assessment, Hall iT, Innsbruck, Austria; [Brigo, Francesco] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy; [Brigo, Francesco] Univ Verona, Dept Neurol Biomed & Movement Sci, Verona, Italy	University of Genoa; Paracelsus Private Medical University; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; Ospedale Franz Tappeiner; University of Verona	Alicino, C (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	cristiano.alicino@unige.it	Orsi, Andrea/AAC-7431-2022; Bragazzi, Nicola Luigi/G-1672-2011; PAN, ZEQIANG/X-6341-2018; Martini, Mariano/GXF-0253-2022; Brigo, Francesco/H-6513-2013	Orsi, Andrea/0000-0002-2433-9610; Bragazzi, Nicola Luigi/0000-0001-8409-868X; Martini, Mariano/0000-0001-5703-0858; Trinka, Eugen/0000-0002-5950-2692; Brigo, Francesco/0000-0003-0928-1577				Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9; Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3; Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1; Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253; Hossain L, 2016, EPIDEMIOL INFECT, V144, P2136, DOI 10.1017/S095026881600039X; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Khattab A., 2016, 2016 IEEE Sensors Applications Symposium (SAS), P1, DOI 10.1109/SAS.2016.7479827; Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025; Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Segev E, 2016, PUBLIC UNDERST SCI; Sharma M, 2016, AM J INFECT CONTROL; Smallwood C., 2015, COMPLETE GUIDE USING; Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Valero N, 2015, INVEST CLIN, V56, P241; Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376; Wojda TR, 2015, J GLOB INFECT DIS, V7, P127, DOI 10.4103/0974-777X.170495; Wong R, 2017, J PUBLIC HEALTH MAN, V23, pE16, DOI 10.1097/PHH.0000000000000342; World Health Organization, 2016, ZIK VIR MICR GUILL B	33	37	38	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185263	10.1371/journal.pone.0185263	http://dx.doi.org/10.1371/journal.pone.0185263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934352	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900134
J	Zheng, XY; Soroush, F; Long, J; Hall, ET; Adishesha, PK; Bhattacharya, S; Kiani, MF; Bhalla, V				Zheng, Xiaoyi; Soroush, Fariborz; Long, Jin; Hall, Evan T.; Adishesha, Puneeth K.; Bhattacharya, Sanchita; Kiani, Mohammad F.; Bhalla, Vivek			Murine glomerular transcriptome links endothelial cell-specific molecule-1 deficiency with susceptibility to diabetic nephropathy	PLOS ONE			English	Article							KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; NATURAL-HISTORY; RENAL INJURY; INFLAMMATION; EXPRESSION; ABNORMALITIES; AMELIORATION; CYTOKINES; SURVIVAL	Diabetic nephropathy (DN) is the leading cause of kidney disease; however, there are no early biomarkers and no cure. Thus, there is a large unmet need to predict which individuals will develop nephropathy and to understand the molecular mechanisms that govern this susceptibility. We compared the glomerular transcriptome from mice with distinct susceptibilities to DN at four weeks after induction of diabetes, but before histologic injury, and identified differential regulation of genes that modulate inflammation. From these genes, we identified endothelial cell specific molecule-1 (Esm-1), as a glomerular-enriched determinant of resistance to DN. Glomerular Esm-1 mRNA and protein were lower in DN-susceptible, DBA/2, compared to DN-resistant, C57BL/6, mice. We demonstrated higher Esm-1 secretion from primary glomerular cultures of diabetic mice, and high glucose was sufficient to increase Esm-1 mRNA and protein secretion in both strains of mice. However, induction was significantly attenuated in DN-susceptible mice. Urine Esm-1 was also significantly higher only in DN-resistant mice. Moreover, using intravital microscopy and a biomimetic microfluidic assay, we showed that Esm-1 inhibited rolling and transmigration in a dose-dependent manner. For the first time we have uncovered glomerular-derived Esm-1 as a potential non-invasive biomarker of DN. Esm-1 inversely correlates with disease susceptibility and inhibits leukocyte infiltration, a critical factor in protecting the kidney from DN.	[Zheng, Xiaoyi; Long, Jin; Hall, Evan T.; Adishesha, Puneeth K.; Bhalla, Vivek] Stanford Univ, Dept Med, Div Nephrol, Sch Med, Stanford, CA 94305 USA; [Soroush, Fariborz; Kiani, Mohammad F.] Temple Univ, Dept Mech Engn, Coll Engn, Philadelphia, PA 19122 USA; [Bhattacharya, Sanchita] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California San Francisco	Bhalla, V (corresponding author), Stanford Univ, Dept Med, Div Nephrol, Sch Med, Stanford, CA 94305 USA.	vbhalla@stanford.edu	Soroush, Fariborz/O-1778-2019; Soroush, Fariborz/K-7873-2019	Soroush, Fariborz/0000-0003-2742-1684; Bhalla, Vivek/0000-0002-5420-9657; Hall, Evan/0000-0002-0305-7745	Larry L. Hillblom Foundation Postdoctoral Fellowship [2014-D-021-FEL]; National Institutes of Health Grant [1R01GM114359]; Shriners Hospitals for Children [86400]; National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases - Pilot and Feasbility Grant; Diabetic Complications Consortium [3U24DK076169-08S4]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114359] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation Postdoctoral Fellowship; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases - Pilot and Feasbility Grant; Diabetic Complications Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported Larry L. Hillblom Foundation Postdoctoral Fellowship (2014-D-021-FEL) to Xiaoyi Zheng; National Institutes of Health Grant (1R01GM114359) to Mohammad F. Kiani; The Shriners Hospitals for Children (86400); National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases - Pilot and Feasbility Grant sponsored by the Diabetic Complications Consortium (3U24DK076169-08S4) to Vivek Bhalla; Holmgren Family Foundation Philanthropic gift for diabetes research in the Division of Nephrology, Department of Medicine, Stanford University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758; Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099; Brunskill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012034; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Cong R, 2006, BIOCHEM BIOPH RES CO, V346, P535, DOI 10.1016/j.bbrc.2006.05.153; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guo M, 2005, J ANAT, V207, P813, DOI 10.1111/j.1469-7580.2005.00492.x; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Gurley SB, 2011, AM J PHYSIOL-RENAL, V298, pF788; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; Huang JQ, 2009, ENDOCRINOLOGY, V150, P5557, DOI 10.1210/en.2009-0442; Huang WJ, 2015, CLIN ENDOCRINOL, V82, P229, DOI 10.1111/cen.12576; Janssen U, 1998, J AM SOC NEPHROL, V9, P1805; Ju W, 2016, PEDIAT NEPHROLOGY; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim JH, 2004, KIDNEY INT, V66, P1826, DOI 10.1111/j.1523-1755.2004.00956.x; Kiyici S, 2006, ARCH MED RES, V37, P998, DOI 10.1016/j.arcmed.2006.06.002; Kosugi T, 2007, LAB INVEST, V87, P903, DOI 10.1038/labinvest.3700599; Kothary N, 2011, J AM ACAD DERMATOL, V65, P546, DOI 10.1016/j.jaad.2010.05.033; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; Lamberti G, 2015, MICROVASC RES, V99, P19, DOI 10.1016/j.mvr.2015.02.004; Lamberti G, 2014, ANAL CHEM, V86, P8344, DOI 10.1021/ac5018716; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Maezawa Y, 2015, J DIABETES INVEST, V6, P3, DOI 10.1111/jdi.12255; Mikkelsen ME, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.077; Moon JY, 2012, AM J NEPHROL, V35, P164, DOI 10.1159/000334928; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; OSTERBY R, 1992, DIABETOLOGIA, V35, P803, DOI 10.1007/BF00399925; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Rodrigues KF, 2015, DIABETES-METAB RES, V31, P479, DOI 10.1002/dmrr.2639; Rossing P, 1996, BRIT MED J, V313, P779; Sanders JSF, 2011, SEMIN RESP CRIT CARE, V32, P328, DOI 10.1055/s-0031-1279829; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Soroush F, 2016, J LEUKOC BIOL; Sun Y, 2009, AM J NEPHROL, V29, P558, DOI 10.1159/000191469; Velez MG, 2012, NEPHROLOGY THERAPEUT, pS2; Verzola D, 2014, KIDNEY INT, V86, P1229, DOI 10.1038/ki.2014.116; Wang Y, 2012, J IMMUNOL, V188, P222, DOI 10.4049/jimmunol.1002958; Whiteside C, 2009, EXP DIABETES RES, DOI 10.1155/2009/910783; Wu XY, 2007, AM J PHYSIOL-RENAL, V293, pF1262, DOI 10.1152/ajprenal.00445.2006; Yilmaz MI, 2014, KIDNEY INT, V86, P1213, DOI 10.1038/ki.2014.227; You HN, 2013, AM J PHYSIOL-RENAL, V305, pF1719, DOI 10.1152/ajprenal.00141.2013; Zhang HY, 2008, AM J PHYSIOL-RENAL, V295, pF1071, DOI 10.1152/ajprenal.90208.2008; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	57	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185250	10.1371/journal.pone.0185250	http://dx.doi.org/10.1371/journal.pone.0185250			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934365	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900133
J	Zhou, Z; Cong, PH; Tian, Y; Zhu, YM				Zhou, Zhe; Cong, Peihua; Tian, Yi; Zhu, Yanmin			Using RNA-seq data to select reference genes for normalizing gene expression in apple roots	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; QUANTITATIVE-PCR; RT-PCR; IDENTIFICATION; VALIDATION; ALIGNMENT; GENOME; TOOL	Gene expression in apple roots in response to various stress conditions is a less-explored research subject. Reliable reference genes for normalizing quantitative gene expression data have not been carefully investigated. In this study, the suitability of a set of 15 apple genes were evaluated for their potential use as reliable reference genes. These genes were selected based on their low variance of gene expression in apple root tissues from a recent RNA-seq data set, and a few previously reported apple reference genes for other tissue types. Four methods, Delta Ct, geNorm, NormFinder and BestKeeper, were used to evaluate their stability in apple root tissues of various genotypes and under different experimental conditions. A small panel of stably expressed genes, MDP0000095375, MDP0000147424, MDP0000233640, MDP0000326399 and MDP0000173025 were recommended for normalizing quantitative gene expression data in apple roots under various abiotic or biotic stresses. When the most stable and least stable reference genes were used for data normalization, significant differences were observed on the expression patterns of two target genes, MdLecRLK5 (MDP0000228426, a gene encoding a lectin receptor like kinase) and MdMAPK3 (MDP0000187103, a gene encoding a mitogen-activated protein kinase). Our data also indicated that for those carefully validated reference genes, a single reference gene is sufficient for reliable normalization of the quantitative gene expression. Depending on the experimental conditions, the most suitable reference genes can be specific to the sample of interest for more reliable RT-qPCR data normalization.	[Zhou, Zhe; Cong, Peihua; Tian, Yi] Chinese Acad Agr Sci, Inst Pomol, Xingcheng, Liaoning, Peoples R China; [Zhu, Yanmin] ARS, USDA, Tree Fruit Res Lab, Wenatchee, WA 98801 USA	Chinese Academy of Agricultural Sciences; Institute of Pomology, CAAS; United States Department of Agriculture (USDA)	Cong, PH (corresponding author), Chinese Acad Agr Sci, Inst Pomol, Xingcheng, Liaoning, Peoples R China.; Zhu, YM (corresponding author), ARS, USDA, Tree Fruit Res Lab, Wenatchee, WA 98801 USA.	congph@163.com; yanmin.zhu@ars.usda.gov			USDA; Washington Tree Fruit Research Commission	USDA(United States Department of Agriculture (USDA)); Washington Tree Fruit Research Commission	This work was supported by USDA base fund and the research fund from Washington Tree Fruit Research Commission.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borges AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111399; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bowen JH, 29 INT HORT C HORT S, P179; Bowen J, 2014, TREE GENET GENOMES, V10, P751, DOI 10.1007/s11295-014-0720-6; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hoang VL, 2016, PEERJ, V4; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanubile A, 2015, MOL PLANT MICROBE IN, V28, P546, DOI 10.1094/MPMI-09-14-0269-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; Mazzola M, 1997, PHYTOPATHOLOGY, V87, P582, DOI 10.1094/PHYTO.1997.87.6.582; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shin SB, 2016, PHYSIOL MOL PLANT P, V94, P16, DOI 10.1016/j.pmpp.2016.03.003; Shin SB, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.53; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stanton KA, 2017, G3-GENES GENOM GENET, V7, P1085, DOI 10.1534/g3.116.038075; Sun HP, 2016, PLANT PHYSIOL BIOCH, V108, P286, DOI 10.1016/j.plaphy.2016.07.022; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Zhu Y, 2017, INT J PLANT GENOM	44	29	31	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185288	10.1371/journal.pone.0185288	http://dx.doi.org/10.1371/journal.pone.0185288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934340	Green Submitted, gold, Green Published			2022-12-26	WOS:000411339900141
J	Dowell, AC; Cobby, E; Wen, KS; Devall, AJ; During, V; Anderson, J; James, ND; Cheng, KK; Zeegers, MP; Bryan, RT; Taylor, GS				Dowell, Alexander C.; Cobby, Ellen; Wen, Kaisheng; Devall, Adam J.; During, Vinnie; Anderson, Jane; James, Nicholas D.; Cheng, Kar K.; Zeegers, Maurice P.; Bryan, Richard T.; Taylor, Graham S.			Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; IL-17; RECURRENCE; EXPRESSION; CYTOKINES; PROGRESSION; PROGNOSIS; SURVIVAL; THERAPY	The tumour immune microenvironment is considered to influence cancer behaviour and outcome. Using a panel of markers for innate and adaptive immune cells we set out to characterise and understand the bladder tumour microenvironment of 114 patients from a prospective multicentre cohort of newly-diagnosed bladder cancer patients, followed-up for 4.33 +/- 1.71 years. We found IL-17-positive cells were significantly increased in primary and concomitant carcinoma in situ (CIS), p<0.0001, a highly malignant lesion which is the most significant single risk factor for disease progression. Further characterisation of the tumour immunophenotype identified IL-17+ cells as predominantly mast cells rather than T-cells, in contrast to most other tumour types. Expression of the IL-17-receptor in bladder tumours, and functional effects and gene expression changes induced by IL-17 in bladder tumour cells in vitro suggest a role in tumour behaviour. Finally, we assessed the effects of IL-17 in the context of patient outcome, following intravesical BCG immunotherapy which is the standard of care; higher numbers of IL-17+ cells were associated with improved event-free survival (p = 0.0449, HR 0.2918, 95% CI 0.08762-0.9721) in patients with primary and concomitant CIS (n = 41), we propose a model of IL-17+ Mast cells mechanism of action. Thus, in the context of bladder CIS, IL-17+ mast cells predict favourable outcome following BCG immunotherapy indicative of a novel mechanism of BCG immunotherapy in UBC and could form the basis of a stratified approach to treatment.	[Dowell, Alexander C.; Taylor, Graham S.] Univ Birmingham, Inst Immunol & Immunotherapy, Vincent Dr, Birmingham, W Midlands, England; [Cobby, Ellen] Royal Shrewsbury Hosp, Shrewsbury, Salop, England; [Wen, Kaisheng; During, Vinnie; Anderson, Jane; James, Nicholas D.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Devall, Adam J.] Univ Birmingham, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Public Hlth Bldg, Edgbaston, England; [Cheng, Kar K.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Zeegers, Maurice P.] Maastricht Univ, Nutr & Translat Res Metab Sch NUTRIM, Maastricht, Netherlands; [Zeegers, Maurice P.] Maastricht Univ, Care & Publ Hlth Res Inst, Sch CAPHRI, Maastricht, Netherlands; [Zeegers, Maurice P.; Bryan, Richard T.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Birmingham	Bryan, RT (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England.	r.t.bryan@bham.ac.uk	Bryan, Richard T/AAJ-9325-2021; Cheng, Kar/AAL-8899-2021; Devall, Adam/AAC-9646-2022	Bryan, Richard T/0000-0003-2853-4293; Cheng, Kar/0000-0002-1516-1857; Zeegers, Maurice/0000-0002-2387-083X; Dowell, Alexander/0000-0002-1909-7047; Taylor, Graham/0000-0002-4807-2797	Birmingham Cancer Research UK Centre Development Fund [DF-21/TC/0710]	Birmingham Cancer Research UK Centre Development Fund	This work was supported by the Birmingham Cancer Research UK Centre Development Fund DF-21/TC/0710. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abol-Enein H, 2005, EUR UROL, V48, P202, DOI 10.1016/j.eururo.2005.04.006; Amicarella F, 2015, GUT; Antoni S., 2016, EUR UROL; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Bryan RT, 2013, BJU INT, V112, P169, DOI 10.1111/bju.12032; Chavan S, 2014, EUR UROL, V66, P59, DOI 10.1016/j.eururo.2013.10.001; Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Di Pierro GB, 2012, CURR GENOMICS, V13, P395, DOI 10.2174/138920212801619232; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Kamat AM, 2016, EUR UROL, V69, P197, DOI 10.1016/j.eururo.2015.06.023; Keijsers RRMC, 2014, EXP DERMATOL, V23, P799, DOI 10.1111/exd.12487; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lin LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028984; Lin Y, 2015, CLIN TRANSL ONCOL, V17, P50, DOI 10.1007/s12094-014-1197-3; Liu XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106834; Liu XX, 2014, FUTURE ONCOL, V10, P1443, DOI [10.2217/fon.14.79, 10.2217/FON.14.79]; Liu YB, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0174-8; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; Mrabet-Dahbi S, 2009, EXP DERMATOL, V18, P437, DOI 10.1111/j.1600-0625.2009.00878.x; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102; Noordenbos T, 2016, J LEUKOCYTE BIOL, V100, P453, DOI 10.1189/jlb.3HI1215-542R; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Otto W, 2012, WORLD J UROL, V30, P875, DOI 10.1007/s00345-012-0974-2; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Sibilano R, 2012, J IMMUNOL, V189, P120, DOI 10.4049/jimmunol.1200009; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Suurmond J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3466; Sylvester RJ, 2005, UROLOGY, V66, P90, DOI 10.1016/j.urology.2005.06.135; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Sylvester RJ, 2005, J UROLOGY, V174, P86, DOI 10.1097/01.ju.0000162059.64886.1c; Takeuchi A, 2011, EUR J IMMUNOL, V41, P246, DOI 10.1002/eji.201040773; Thalmann GN, 2000, J UROLOGY, V164, P2129, DOI 10.1016/S0022-5347(05)66983-2; Thalmann GN, 1997, J UROLOGY, V158, P1340, DOI 10.1016/S0022-5347(01)64210-1; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Wallace DMA, 2002, BJU INT, V89, P868, DOI 10.1046/j.1464-410X.2002.02776.x; Wang B, 2013, CANCER IMMUNOL IMMUN, V62, P1575, DOI 10.1007/s00262-013-1460-4; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Zeegers MP, 2010, BJU INT, V105, P784, DOI 10.1111/j.1464-410X.2009.08849.x; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195; Zuiverloon TCM, 2016, EUR UROL, V69, P201, DOI 10.1016/j.eururo.2015.07.010; Zuiverloon TCM, 2012, EUR UROL, V61, P128, DOI 10.1016/j.eururo.2011.09.026; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	57	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184841	10.1371/journal.pone.0184841	http://dx.doi.org/10.1371/journal.pone.0184841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931051	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700038
J	Li, O; Xiao, R; Sun, LH; Guan, CL; Kong, DD; Hu, XF				Li, Ou; Xiao, Rong; Sun, Lihua; Guan, Chenglin; Kong, Dedong; Hu, Xiufang			Bacterial and diazotrophic diversities of endophytes in Dendrobium catenatum determined through barcoded pyrosequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; PLANT-GROWTH; SPHINGOMONAS-PAUCIMOBILIS; ASSOCIATIVE CYANOBACTERIA; NITROGEN-FIXATION; GENETIC DIVERSITY; NIFH GENES; SP NOV.; ROOTS; ORCHID	As an epiphyte orchid, Dendrobium catenatum relies on microorganisms for requisite nutrients. Metagenome pyrosequencing based on 16S rRNA and nifH genes was used to characterize the bacterial and diazotrophic communities associated with D. catenatum collected from 5 districts in China. Based on Meta-16S rRNA sequencing, 22 bacterial phyla and 699 genera were identified, distributed as 125 genera from 8 phyla and 319 genera from 10 phyla shared by all the planting bases and all the tissues, respectively. The predominant Proteobacteria varied from 71.81% (GZ) to 96.08% (YN), and Delftia (10.39-38.42%), Burkholderia (2.71-15.98%), Escherichia/Shigella (4.90-25.12%), Pseudomonas (2.68-30.72%) and Sphingomonas (1.83-2.05%) dominated in four planting bases. Pseudomonas (17.94-22.06%), Escherichia/Shigella (6.59-11.59%), Delftia (9.65-22.14%) and Burkholderia (3.12-11.05%) dominated in all the tissues. According to Meta-nifH sequencing, 4 phyla and 45 genera were identified, while 17 genera and 24 genera from 4 phyla were shared by all the planting bases and all the tissues, respectively. Burkholderia and Bradyrhizobium were the most popular in the planting bases, followed by Methylovirgula and Mesorhizobium. Mesorhizobium was the most popular in different tissues, followed by Bei-jerinckia, Xanthobacter, and Burkholderia. Among the genera, 39 were completely overlapped with the results based on the 16S rRNA gene. In conclusion, abundant bacteria and diazotrophs were identified in common in different tissues of D. catenatum from five planting bases, which might play a great role in the supply of nutrients such as nitrogen. The exact abundance of phylum and genus on the different tissues from different planting bases need deeper sequencing with more samples.	[Li, Ou; Xiao, Rong; Guan, Chenglin; Hu, Xiufang] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Sun, Lihua] Zhejiang Acad Med Sci, Hangzhou, Zhejiang, Peoples R China; [Kong, Dedong] Zhejiang Univ, Agr Expt Stn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Zhejiang Academy of Medical Sciences; Zhejiang University	Hu, XF (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.; Kong, DD (corresponding author), Zhejiang Univ, Agr Expt Stn, Hangzhou, Zhejiang, Peoples R China.	ntzx@zju.edu.cn; huxiuf@zstu.edu.cn			National Natural Science Foundation of China [81673537]; Zhejiang Natural Science Foundation of China [LY16C030002, LY15C010005]; Key research and development projects of Zhejiang Province [2015C02030]; Zhejiang Province Public Agricultural Project [2014C32117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation of China; Key research and development projects of Zhejiang Province; Zhejiang Province Public Agricultural Project	The research is supported by National Natural Science Foundation of China (81673537), Zhejiang Natural Science Foundation of China (LY16C030002 & LY15C010005), Key research and development projects of Zhejiang Province (2015C02030), and Zhejiang Province Public Agricultural Project (2014C32117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research is supported by National Natural Science Foundation of China (81673537), Zhejiang Natural Science Foundation of China (LY16C030002 & LY15C010005), Key research and development projects of Zhejiang Province (2015C02030), and Zhejiang Province Public Agricultural Project (2014C32117). We are grateful to Dr. Greg Duns for his valuable comments on the manuscript.	Ahmad F, 2008, MICROBIOL RES, V163, P173, DOI 10.1016/j.micres.2006.04.001; Araujo WL, 2001, CAN J MICROBIOL, V47, P229, DOI 10.1139/cjm-47-3-229; Asis CA, 2004, LETT APPL MICROBIOL, V38, P19, DOI 10.1046/j.1472-765X.2003.01434.x; Balachandar D, 2008, BRAZ J MICROBIOL, V39, P68, DOI [10.1590/S1517-83822008000100017, 10.1590/S1517-838220080001000017]; Baldani JI, 2005, AN ACAD BRAS CIENC, V77, P549, DOI 10.1590/S0001-37652005000300014; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Banerjee MR, 2009, Unite states patent US, Patent No. 7491535; Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Berg G., 2015, PRINCIPLES PLANT MIC, P419, DOI [DOI 10.1007/978-3-319-08575-3_44, 10.1007/978-3-319-08575-3_44]; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bolhuis H, 2010, ISME J, V4, P121, DOI 10.1038/ismej.2009.99; BOTTOMLEY PJ, 1990, APPL ENVIRON MICROB, V56, P533, DOI 10.1128/AEM.56.2.533-540.1990; BOWEN GD, 1979, SOIL BIOL BIOCHEM, V11, P119, DOI 10.1016/0038-0717(79)90087-7; Brundrett M.C., 2006, MICROBIAL ROOT ENDOP, P281; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chinese Pharmacopoeia Commission, 2005, PHARMACOPOEIA PEOPLE; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; CORPE WA, 1982, DEV IND MICROBIOL, V23, P483; da Silva JAT, 2015, PLANTA, V242, P1, DOI 10.1007/s00425-015-2301-9; Dalton DA, 2004, FEMS MICROBIOL ECOL, V49, P469, DOI 10.1016/j.femsec.2004.04.010; De Meyer SE, 2015, SOIL BIOL BIOCHEM, V83, P1, DOI 10.1016/j.soilbio.2015.01.002; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelhard M, 2000, ENVIRON MICROBIOL, V2, P131, DOI 10.1046/j.1462-2920.2000.00078.x; Frey-Klett P, 2005, NEW PHYTOL, V168, P4, DOI 10.1111/j.1469-8137.2005.01553.x; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Graff A, 2003, SYST APPL MICROBIOL, V26, P445, DOI 10.1078/072320203322497482; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Hoppe B, 2016, SCI REP-UK, V6, DOI 10.1038/srep10498; Hou XQ, 2009, J INTEGR PLANT BIOL, V51, P374, DOI 10.1111/j.1744-7909.2008.00777.x; Hsueh PR, 1998, CLIN INFECT DIS, V26, P676, DOI 10.1086/514595; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Iguchi Hiroyuki, 2015, Microorganisms, V3, P137, DOI 10.3390/microorganisms3020137; Jacquemyn H, 2013, MICROBIOLOGYOPEN, V2, P644, DOI 10.1002/mbo3.103; Jarabo-Lorenzo A, 2003, SYST APPL MICROBIOL, V26, P611, DOI 10.1078/072320203770865927; Jones WE, 1998, ANN BOT-LONDON, V82, P189, DOI 10.1006/anbo.1998.0664; Kang YS, 2007, INT J SYST EVOL MICR, V57, P2849, DOI 10.1099/ijs.0.65262-0; Kenzaka T, 2001, J HEALTH SCI, V47, P353, DOI 10.1248/jhs.47.353; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; LEIFERT C, 1989, J APPL BACTERIOL, V67, P353, DOI 10.1111/j.1365-2672.1989.tb02505.x; Li M, 2012, SYST APPL MICROBIOL, V35, P239, DOI 10.1016/j.syapm.2012.02.004; LIDSTROMOCONNOR ME, 1983, J GEN MICROBIOL, V129, P3139; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu DeGuo, 2011, Guizhou Agricultural Sciences, P169; Ma YN, 2017, CURR PHARM ANAL, V13; Madhaiyan M, 2007, INT J SYST EVOL MICR, V57, P326, DOI 10.1099/ijs.0.64603-0; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; MCINROY JA, 1995, PLANT SOIL, V173, P337, DOI 10.1007/BF00011472; Mehnaz S, 2006, MICROB ECOL, V51, P326, DOI 10.1007/s00248-006-9039-7; MEYER JR, 1986, SOIL BIOL BIOCHEM, V18, P185, DOI 10.1016/0038-0717(86)90025-8; Morel MA, 2011, ARCH MICROBIOL, V193, P63, DOI 10.1007/s00203-010-0632-2; Mosin O, 2014, EUR J MOL BIOTECHNOL, V5, P131, DOI DOI 10.13187/ejmb.2014.5.131; Mulet M, 2009, MOL CELL PROBE, V23, P140, DOI 10.1016/j.mcp.2009.02.001; Nouioui I, 2011, ANTON LEEUW INT J G, V100, P579, DOI 10.1007/s10482-011-9613-y; Omer ZS, 2004, FEMS MICROBIOL ECOL, V47, P319, DOI 10.1016/S0168-6496(04)00003-0; Peix A, 2001, SOIL BIOL BIOCHEM, V33, P103, DOI 10.1016/S0038-0717(00)00120-6; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Prasannakumar SP, 2015, LETT APPL MICROBIOL, V61, P460, DOI 10.1111/lam.12479; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Rai AN, 2000, NEW PHYTOL, V147, P449, DOI 10.1046/j.1469-8137.2000.00720.x; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Sahoo K, 2009, INDIAN J MAR SCI, V38, P249; Sandrasagaran UM, 2014, PAK J BOT, V46, P719; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shekhovtsova N. V., 2013, Advances in Bioscience and Biotechnology, V4, P35; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SMALL FJ, 1995, J BACTERIOL, V177, P6170, DOI 10.1128/jb.177.21.6170-6175.1995; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stovold GE, 2001, AUSTRALAS PLANT PATH, V30, P73, DOI 10.1071/AP00066; Tsavkelova EA, 2005, MICROBIOLOGY+, V74, P46, DOI 10.1007/s11021-005-0027-6; Tsavkelova EA, 2003, MICROBIOLOGY+, V72, P86, DOI 10.1023/A:1022286225013; Tsavkelova EA, 2003, MICROBIOLOGY+, V72, P92, DOI 10.1023/A:1022238309083; Tsavkelova E, 2011, BACTERIA IN AGROBIOLOGY: PLANT GROWTH RESPONSES, P221, DOI 10.1007/978-3-642-20332-9_11; Tsavkelova EA, 2007, MICROBIOL RES, V162, P69, DOI 10.1016/j.micres.2006.07.014; vandenBergh ERE, 1996, J BACTERIOL, V178, P888, DOI 10.1128/jb.178.3.888-893.1996; Videira SS, 2009, FEMS MICROBIOL LETT, V293, P11, DOI 10.1111/j.1574-6968.2008.01475.x; Vijayabaskar P., 2011, ADV BIOL RES, V5, P99; Vyas P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-174; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weber OB, 1999, PLANT SOIL, V210, P103, DOI 10.1023/A:1004623523179; Wiegel J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P290, DOI 10.1007/0-387-30745-1_16; Xavier LJC, 2003, SOIL BIOL BIOCHEM, V35, P471, DOI 10.1016/S0038-0717(03)00003-8; Xiao CH, 2010, J BASIC MICROB, V50, P373, DOI 10.1002/jobm.200900317; Xie CH, 2006, INT J SYST EVOL MICR, V56, P889, DOI 10.1099/ijs.0.64056-0; Yang SJ, 2014, MICROB BIOTECHNOL, V7, P611, DOI 10.1111/1751-7915.12148; Yu J, 2013, APPL MICROBIOL BIOT, V97, P9825, DOI 10.1007/s00253-013-5294-y; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105	96	13	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184717	10.1371/journal.pone.0184717	http://dx.doi.org/10.1371/journal.pone.0184717			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931073	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700030
J	Zhang, F; Virshup, DM; Cheong, JK				Zhang, F.; Virshup, D. M.; Cheong, J. K.			Oncogenic RAS-induced CK1 alpha drives nuclear FOXO proteolysis	ONCOGENE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; SYNTHETIC LETHAL INTERACTIONS; CANCER-CELLS; SELECTIVE INHIBITORS; MULTIPLE-MYELOMA; HUMAN COLON; FACTOR AFX; E3 LIGASE; PHASE-I; KINASE	Evasion of forkhead box O (FOXO) family of longevity-related transcription factors-mediated growth suppression is necessary to promote cancer development. Since somatic alterations or mutations and transcriptional dysregulation of the FOXO genes are infrequent in human cancers, it remains unclear how these tumour suppressors are eliminated from cancer cells. The protein stability of FOXO3A is regulated by Casein Kinase 1 alpha (CK1 alpha) in an oncogenic RAS-specific manner, but whether this mode of regulation extends to related FOXO family members is unknown. Here we report that CK1 alpha similarly destabilizes FOXO4 in RASmutant cells by phosphorylation at serines 265/268. The CK1 alpha-dependent phosphoregulation of FOXO4 is primed, in part, by the PI3K/AKT effector axis of oncogenic RAS signalling. In addition, mutant RAS coordinately elevates proteasome subunit expression and proteolytic activity to eradicate nuclear FOXO4 proteins from RAS-mutant cancer cells. Importantly, dual inhibition of CK1 alpha and the proteasome synergistically inhibited the growth of multiple RAS-mutant human cancer cell lines of diverse tissue origin by blockade of nuclear FOXO4 degradation and induction of caspase-dependent apoptosis. Our findings challenge the current paradigm that nuclear export regulates the proteolysis of FOXO3A/4 tumour suppressors in the context of cancer and illustrates how oncogenic RAS-mediated degradation of FOXOs, via post-translational mechanisms, blocks these important tumour suppressors.	[Zhang, F.; Virshup, D. M.; Cheong, J. K.] Duke NUS Med Sch, Programme Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore; [Virshup, D. M.] Natl Univ Singapore, Dept Biochem, Singapore, Singapore; [Virshup, D. M.] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA	National University of Singapore; National University of Singapore; Duke University	Virshup, DM; Cheong, JK (corresponding author), Duke NUS Med Sch, Programme Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	david.virshup@duke-nus.edu.sg; jitkong.cheong@duke-nus.edu.sg	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X	Singapore Ministry of Health's National Medical Research Council under its NMRC-CBRG New Investigator Grant [NMRC/BNIG/1078/2012]; Duke-NUS-St. Baldrick's Foundation Pediatric Cancer Research Fund [Duke-NUSSBF/2015/0004]; Singapore Ministry of Education Academic Research Fund (AcRF) Tier 2 grant [MOE2016-T2-2-052]; Singapore Agency for Science, Technology and Research (A*STAR); Singapore Ministry of Health (MOH) under its Duke-NUS Signature Research Program; National Research Foundation under its Singapore Translational Research (STaR) Investigator Award; Singapore Ministry of Health's National Medical Research Council [NMRC/STaR/0017/2013]	Singapore Ministry of Health's National Medical Research Council under its NMRC-CBRG New Investigator Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Duke-NUS-St. Baldrick's Foundation Pediatric Cancer Research Fund; Singapore Ministry of Education Academic Research Fund (AcRF) Tier 2 grant(Ministry of Education, Singapore); Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health (MOH) under its Duke-NUS Signature Research Program(Ministry of Education, SingaporeMinistry of Health-SingaporeNational University of Singapore); National Research Foundation under its Singapore Translational Research (STaR) Investigator Award(National Research Foundation, Singapore); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	We thank Chun Wei Chan, Edison and Yun Ka Wong (Duke-NUS) for their excellent technical support. We are greatly indebted to Christopher Counter (Duke), William Kaelin (Harvard), Koji Itahana (Duke-NUS), Sujoy Ghosh (Duke-NUS) and John Chua (NUS) for reagents and helpful discussions. This research is supported by the Singapore Ministry of Health's National Medical Research Council under its NMRC-CBRG New Investigator Grant (NMRC/BNIG/1078/2012), a Duke-NUS-St. Baldrick's Foundation Pediatric Cancer Research Fund (Duke-NUSSBF/2015/0004) and the Singapore Ministry of Education Academic Research Fund (AcRF) Tier 2 grant (MOE2016-T2-2-052) awarded to JKC. DMV is supported by the Singapore Agency for Science, Technology and Research (A*STAR) and the Singapore Ministry of Health (MOH) under its Duke-NUS Signature Research Program Grant, as well as the National Research Foundation under its Singapore Translational Research (STaR) Investigator Award and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC/STaR/0017/2013).	Alexander TB, 2016, J CLIN ONCOL, V34, P4094, DOI 10.1200/JCO.2016.67.5066; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Azmi AS, 2013, HAEMATOLOGICA, V98, P1098, DOI 10.3324/haematol.2012.074781; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; Cheong JK, 2015, J CLIN INVEST, V125, P1401, DOI 10.1172/JCI78018; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; De Ruiter ND, 2001, MOL CELL BIOL, V21, P8225, DOI 10.1128/MCB.21.23.8225-8235.2001; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dobson M, 2011, BBA-MOL CELL RES, V1813, P1453, DOI 10.1016/j.bbamcr.2011.05.001; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Feoktistova Maria, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087379; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gounder MM, 2016, J CLIN ONCOL, V34, P3166, DOI 10.1200/JCO.2016.67.6346; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper JW, 2016, NATURE, V537, P328, DOI 10.1038/nature19947; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Kato S, 2008, J BIOL CHEM, V283, P35464, DOI 10.1074/jbc.M801011200; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lantermann AB, 2015, CANCER RES, V75, P1; Lapalombella R, 2012, BLOOD, V120, P4621, DOI 10.1182/blood-2012-05-429506; Li J, 2016, ONCOTARGET, V7, P25585, DOI 10.18632/oncotarget.8339; Lin LH, 2014, INT J ONCOL, V44, P557, DOI 10.3892/ijo.2013.2205; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Razak ARA, 2016, J CLIN ONCOL, V34, P4142, DOI 10.1200/JCO.2015.65.3949; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Su LN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-378; Sun QX, 2013, P NATL ACAD SCI USA, V110, P1303, DOI 10.1073/pnas.1217203110; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Trinh DL, 2013, BLOOD, V121, P3666, DOI 10.1182/blood-2013-01-479865; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Wang GJ, 2015, BIOCHEM BIOPH RES CO, V459, P629, DOI 10.1016/j.bbrc.2015.02.160; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yu WJ, 2017, LEUKEMIA LYMPHOMA, V58, P428, DOI 10.1080/10428194.2016.1190968; Zhang W, 2016, CELL REP, V15, P349, DOI 10.1016/j.celrep.2016.03.021; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zhou W, 2009, GASTROENTEROLOGY, V137, P1403, DOI 10.1053/j.gastro.2009.06.049; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	81	16	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					363	376		10.1038/onc.2017.334	http://dx.doi.org/10.1038/onc.2017.334			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28945225	Green Published, hybrid			2022-12-26	WOS:000422753900009
J	Challasivakanaka, S; Zhen, J; Smith, ME; Reith, MEA; Foster, JD; Vaughan, RA				Challasivakanaka, Sathya; Zhen, Juan; Smith, Margaret E.; Reith, Maarten E. A.; Foster, James D.; Vaughan, Roxanne A.			Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine transporter; extracellular-signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); phosphorylation; protein kinase C (PKC); methamphetamine; phospho-specific antibody; proline directed phosphorylation; rotating disc electrode voltammetry	PROLINE-DIRECTED PHOSPHORYLATION; NEUROTRANSMITTER TRANSPORTERS; RAT STRIATUM; MECHANISMS; SUBSTRATE; EXPRESSION; SPECIFICITY; INHIBITORS; RECEPTORS; DISORDER	The dopamine transporter (DAT) controls the spatial and temporal dynamics of dopamine neurotransmission through reuptake of extracellular transmitter and is a target for addictive compounds such as cocaine, amphetamine (AMPH), and methamphetamine (METH). Reuptake is regulated by kinase pathways and drug exposure, allowing for fine-tuning of clearance in response to specific conditions, and here we examine the impact of transporter ligands on DAT residue Thr-53, a proline-directed phosphorylation site previously implicated in AMPH-stimulated efflux mechanisms. Our findings show that Thr-53 phosphorylation is stimulated in a transporter-dependent manner by AMPH and METH in model cells and rat striatal synaptosomes, and in striatum of rats given subcutaneous injection of METH. Rotating disc electrode voltammetry revealed that initial rates of uptake and AMPH-induced efflux were elevated in phosphorylation-null T53A DAT relative to WT and charge-substituted T53D DATs, consistent with functions related to charge or polarity. These effects occurred without alterations of surface transporter levels, and mutants also showed reduced cocaine analog binding affinity that was not rescued by Zn2+. Together these findings support a role for Thr-53 phosphorylation in regulation of transporter kinetic properties that could impact DAT responses to amphetamines and cocaine.	[Challasivakanaka, Sathya; Smith, Margaret E.; Foster, James D.; Vaughan, Roxanne A.] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Zhen, Juan; Reith, Maarten E. A.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Reith, Maarten E. A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	University of North Dakota Grand Forks; New York University; New York University	Vaughan, RA (corresponding author), 1301 N Columbia Rd, Grand Forks, ND 58201 USA.	roxanne.vaughan@med.und.edu	ChallaSivaKanaka, Sathyavathi/AAL-7212-2021; Reith, Maarten E./AAD-2303-2019; Zhen, Juan/E-8593-2016	ChallaSivaKanaka, Sathyavathi/0000-0001-8487-5485; Reith, Maarten E./0000-0002-1900-842X; Zhen, Juan/0000-0002-6111-9692	COBRE program of the National Center for Research Resources through National Institutes of Health [P20 GM104360]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA031991, R01DA019676, R01DA013147] Funding Source: NIH RePORTER	COBRE program of the National Center for Research Resources through National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The University of North Dakota was supported by the COBRE program of the National Center for Research Resources through Grant P20 GM104360 from the National Institutes of Health.	Alyea RA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-59; Bermingham DP, 2016, PHARMACOL REV, V68, P888, DOI 10.1124/pr.115.012260; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Bruss M, 1999, J NEURAL TRANSM, V106, P657, DOI 10.1007/s007020050187; Calipari ES, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13877; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chen NH, 1998, J NEUROCHEM, V71, P653; Chen NH, 2000, MOL BRAIN RES, V75, P208, DOI 10.1016/S0169-328X(99)00288-0; Dehnes Y, 2014, NEUROCHEM INT, V73, P4, DOI 10.1016/j.neuint.2014.02.003; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Foster JD, 2017, J CHEM NEUROANAT, V83, P10, DOI 10.1016/j.jchemneu.2016.10.004; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Jones KT, 2012, J NEUROCHEM, V123, P700, DOI 10.1111/jnc.12007; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kitayama S, 1998, BBA-MOL CELL RES, V1404, P305, DOI 10.1016/S0167-4889(98)00071-8; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Mao LM, 2013, BRAIN RES, V1494, P101, DOI 10.1016/j.brainres.2012.11.038; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Moron JA, 2003, J NEUROSCI, V23, P8480; Norgaard-Nielsen K, 2006, HANDB EXP PHARM, V175, P1; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Shi X, 2006, NEUROSCIENCE, V138, P1289, DOI 10.1016/j.neuroscience.2005.12.024; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Sweeney CG, 2017, J BIOL CHEM, V292, P1302, DOI 10.1074/jbc.M116.762872; Thompson AC, 2000, J NEUROSCI, V20, P9333; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Wang Q, 2016, NEUROSCI LETT, V622, P78, DOI 10.1016/j.neulet.2016.04.051; Xie T, 2000, J NEUROSCI, V20, P7838	51	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19066	19075		10.1074/jbc.M117.787002	http://dx.doi.org/10.1074/jbc.M117.787002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939767	Green Published, hybrid			2022-12-26	WOS:000415848000029
J	Dai, DL; Wen, FQ; Zhou, SM; Su, Z; Liu, GS; Wang, MB; Zhou, JL; He, FS				Dai, Dongling; Wen, Feiqiu; Zhou, Shaoming; Su, Zhe; Liu, Guosheng; Wang, Mingbang; Zhou, Jianli; He, Fusheng			Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; TRIGLYCERIDE TRANSFER PROTEIN; NOREPINEPHRINE TRANSPORTER; INSULIN SENSITIVITY; METABOLIC SYNDROME; RISK-FACTORS; DISEASE; POLYMORPHISMS; SUSCEPTIBILITY; ADOLESCENTS	Objective We used targeted next-generation sequencing to investigate whether genetic variants of lipid metabolism-related genes are associated with increased susceptibility to nonalcoholic fatty liver disease ( NAFLD) in obese children. Methods A cohort of 100 obese children aged 6 to 18 years were divided into NAFLD and nonNAFLD groups and subjected to hepatic ultrasound, anthropometric, and biochemical analyses. We evaluated the association of genetic variants with NAFLD susceptibility by investigating the single nucleotide polymorphisms in each of 36 lipid-metabolism-related genes. The panel genes were assembled for target region sequencing. Correlations between single nucleotide variations, biochemical markers, and clinical phenotypes were analyzed. Results 97 variants in the 36 target genes per child were uncovered. Twenty-six variants in 16 genes were more prevalent in NAFLD subjects than in in-house controls. The mutation rate of MTTP rs2306986 and SLC6A2 rs3743788 was significantly higher in NAFLD subjects than in non-NAFLD subjects ( OR: 3.879; P = 0.004; OR: 6.667, P = 0.005). Logistic regression analysis indicated the MTTP variant rs2306986 was an independent risk factor for NAFLD ( OR: 23.468, P = 0.044). Conclusions The results of this study, examining a cohort of obese children, suggest that the genetic variation at MTTP rs2306986 was associated with higher susceptibility to NAFLD. This may contribute to the altered lipid metabolism by disruption of assembly and secretion of lipoprotein, leading to reducing fat export from the involved hepatocytes.	[Dai, Dongling; Wen, Feiqiu; Zhou, Shaoming; Su, Zhe] Shenzhen Childrens Hosp, Shenzhen, Peoples R China; [Dai, Dongling; Liu, Guosheng; Zhou, Jianli] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wang, Mingbang] Fudan Univ, Key Lab Birth Defects, Childrens Hosp, Shanghai, Peoples R China; [Wang, Mingbang; He, Fusheng] Shenzhen Following Precis Med Res Inst, Shenzhen, Peoples R China	Jinan University; Fudan University	Wen, FQ; Zhou, SM (corresponding author), Shenzhen Childrens Hosp, Shenzhen, Peoples R China.	fwen621@126.com; zhousm15d@aliyun.com	Wang, Mingbang/F-4457-2018	Wang, Mingbang/0000-0002-5989-5377	Shenzhen Innovation and Technology Committee [JCYJ20150403100317080]	Shenzhen Innovation and Technology Committee	This study was funded by Shenzhen Innovation and Technology Committee (Grant number JCYJ20150403100317080).	Abdelmalek MF, 2006, CLIN GASTROENTEROL H, V4, P1162, DOI 10.1016/j.cgh.2006.06.001; Achmad E, 2015, ABDOM IMAGING, V40, P3084, DOI 10.1007/s00261-015-0506-9; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Bedogni G, 2016, CHILD OBES, V12, P426, DOI 10.1089/chi.2016.0141; Bernard S, 2000, DIABETOLOGIA, V43, P995, DOI 10.1007/s001250051481; Bonisch H, 2006, HANDB EXP PHARM, V175, P485; Bradbury Michael W, 2004, Clin Liver Dis, V8, P639, DOI 10.1016/j.cld.2004.04.005; Brouwers MCGJ, 2009, GASTROENTEROLOGY, V137, P1536, DOI 10.1053/j.gastro.2009.03.065; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Daly AK, 2011, EXPERT REV GASTROENT, V5, P253, DOI [10.1586/egh.11.18, 10.1586/EGH.11.18]; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; Day CP, 2010, DIGEST DIS, V28, P255, DOI 10.1159/000282098; Di Filippo M, 2012, J LIPID RES, V53, P548, DOI 10.1194/jlr.M020024; Duarte MASM, 2011, J PEDIAT-BRAZIL, V87, P150, DOI [10.2223/JPED.2065, 10.1590/S0021-75572011000200011]; Eberle D, 2004, DIABETES, V53, P2153, DOI 10.2337/diabetes.53.8.2153; Ebstein RP, 2000, EUR J PHARMACOL, V410, P205, DOI 10.1016/S0014-2999(00)00852-9; El-Koofy NM, 2011, SAUDI J GASTROENTERO, V17, P265, DOI 10.4103/1319-3767.82582; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; Friedel S, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-17; de Armas MGG, 2015, MED CLIN-BARCELONA, V144, P55, DOI 10.1016/j.medcli.2014.02.018; Hsiao PJ, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0242-6; Hsiao PJ, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-54; Klannemark M, 1998, DIABETOLOGIA, V41, P1516, DOI 10.1007/s001250051099; Kodhelaj K, 2014, MINERVA PEDIATR, V66, P23; Li L, 2014, GENET MOL RES, V13, P10150, DOI 10.4238/2014.December.4.9; Li Rong-shan, 2005, Zhonghua Yi Xue Za Zhi, V85, P2492; Lin YC, 2011, ANN HEPATOL, V10, P125, DOI 10.1016/S1665-2681(19)31560-1; Lin YC, 2010, PEDIATR NEONATOL, V51, P149, DOI 10.1016/S1875-9572(10)60028-9; Loomba R, 2008, GASTROENTEROLOGY, V134, P953, DOI 10.1053/j.gastro.2008.01.037; Lu JF, 2014, HUM IMMUNOL, V75, P1062, DOI 10.1016/j.humimm.2014.09.004; Macavei B, 2016, EUR REV MED PHARMACO, V20, P5081; Min Wen-jiao, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P388, DOI 10.3760/cma.j.issn.1003-9406.2009.04.006; Min WJ, 2009, PSYCHOPHARMACOLOGY, V205, P409, DOI 10.1007/s00213-009-1550-3; Moreno-Navarrete JM, 2009, OBESITY, V17, P1755, DOI 10.1038/oby.2009.65; Musso G, 2010, J NUTR BIOCHEM, V21, P834, DOI 10.1016/j.jnutbio.2009.06.007; Namikawa C, 2004, J HEPATOL, V40, P781, DOI 10.1016/j.jhep.2004.01.028; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3082, DOI 10.3748/wjg.v17.i26.3082; Passaro A, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-112; Peng XE, 2014, LIVER INT, V34, P118, DOI 10.1111/liv.12220; Pereira IVA, 2011, EXPERT REV GASTROENT, V5, P245, DOI [10.1586/EGH.11.22, 10.1586/egh.11.22]; Phillips CM, 2010, J LIPID RES, V51, P3500, DOI 10.1194/jlr.M008474; Phillips JL, 2015, ACTA NEUROPSYCHIATR, V27, P353, DOI 10.1017/neu.2015.25; Pozzato C, 2010, J PEDIATR GASTR NUTR, V51, P331, DOI 10.1097/MPG.0b013e3181d70468; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; RAIZADA MK, 1988, NEUROCHEM RES, V13, P297, DOI 10.1007/BF00972477; Riancho JA, 2011, MOL GENET METAB, V104, P670, DOI 10.1016/j.ymgme.2011.08.013; Sanders RH, 2015, EUR J PEDIATR, V174, P715, DOI 10.1007/s00431-015-2551-3; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Shang XR, 2015, J PEDIATR GASTR NUTR, V60, P669, DOI 10.1097/MPG.0000000000000662; Sharma M, 2013, MOL BIOL REP, V40, P6261, DOI 10.1007/s11033-013-2738-5; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Siqueira ERF, 2012, BRAZ J MED BIOL RES, V45, P72, DOI 10.1590/S0100-879X2011007500160; Stan S, 2005, J LIPID RES, V46, P320, DOI 10.1194/jlr.M400346-JLR200; Tomeno W, 2015, J GASTROEN HEPATOL, V30, P1009, DOI 10.1111/jgh.12897; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Wang YF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000778; Watt KD, 2013, AM J TRANSPLANT, V13, P2450, DOI 10.1111/ajt.12355; Youssef NA, 2013, LIVER INT, V33, P1062, DOI 10.1111/liv.12165; Yu GI, 2011, INFLAMM RES, V60, P1099, DOI 10.1007/s00011-011-0372-z; Zegers D, 2016, CLIN RES HEPATOL GAS, V40, P333, DOI 10.1016/j.clinre.2015.09.001	61	9	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185396	10.1371/journal.pone.0185396	http://dx.doi.org/10.1371/journal.pone.0185396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953935	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300061
J	Elliott, SM; Brigham, ME; Lee, KE; Banda, JA; Choy, SJ; Gefell, DJ; Minarik, TA; Moore, JN; Jorgenson, ZG				Elliott, Sarah M.; Brigham, Mark E.; Lee, Kathy E.; Banda, Jo A.; Choy, Steven J.; Gefell, Daniel J.; Minarik, Thomas A.; Moore, Jeremy N.; Jorgenson, Zachary G.			Contaminants of emerging concern in tributaries to the Laurentian Great Lakes: I. Patterns of occurrence	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; WASTE-WATER CONTAMINANTS; 2-BUTOXYETHYL PHOSPHATE TBOEP; ORGANIC CONTAMINANTS; FLAME RETARDANTS; PHARMACEUTICALS; SEDIMENTS; FISH; MUSSELS; RECONNAISSANCE	Human activities introduce a variety of chemicals to the Laurentian Great Lakes including pesticides, pharmaceuticals, flame retardants, plasticizers, and solvents (collectively referred to as contaminants of emerging concern or CECs) potentially threatening the vitality of these valuable ecosystems. We conducted a basin-wide study to identify the presence of CECs and other chemicals of interest in 12 U.S. tributaries to the Laurentian Great Lakes during 2013 and 2014. A total of 292 surface-water and 80 sediment samples were collected and analyzed for approximately 200 chemicals. A total of 32 and 28 chemicals were detected in at least 30% of water and sediment samples, respectively. Concentrations ranged from 0.0284 (indole) to 72.2 (cholesterol) mu g/L in water and 1.75 (diphenhydramine) to 20,800 mu g/kg (fluoranthene) in sediment. Cluster analyses revealed chemicals that frequently co-occurred such as pharmaceuticals and flame retardants at sites receiving similar inputs such as wastewater treatment plant effluent. Comparison of environmental concentrations to water and sediment-quality benchmarks revealed that polycyclic aromatic hydrocarbon concentrations often exceeded benchmarks in both water and sediment. Additionally, bis(2-ethylhexyl) phthalate and dichlorvos concentrations exceeded water-quality benchmarks in several rivers. Results from this study can be used to understand organism exposure, prioritize river basins for future management efforts, and guide detailed assessments of factors influencing transport and fate of CECs in the Great Lakes Basin.	[Elliott, Sarah M.; Brigham, Mark E.] US Geol Survey, Mounds View, MN 55112 USA; [Lee, Kathy E.] US Geol Survey, Grand Rapids, MI USA; [Banda, Jo A.] US Fish & Wildlife Serv, Columbus, OH USA; [Choy, Steven J.] US Fish & Wildlife Serv, Madison, WI USA; [Gefell, Daniel J.] US Fish & Wildlife Serv, Cortland, NY USA; [Minarik, Thomas A.] Metropolitan Water Reclamat Dist Greater Chicago, Cicero, IL USA; [Moore, Jeremy N.] US Fish & Wildlife Serv, Chubbuck, ID USA; [Jorgenson, Zachary G.] St Cloud State Univ, Dept Biol, St Cloud, MN 56301 USA; [Jorgenson, Zachary G.] US Fish & Wildlife Serv, Bloomington, MN USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; Minnesota State Colleges & Universities; Saint Cloud State University; United States Department of the Interior; US Fish & Wildlife Service	Elliott, SM (corresponding author), US Geol Survey, Mounds View, MN 55112 USA.	selliott@usgs.gov		Elliott, Sarah/0000-0002-1414-3024; Brigham, Mark/0000-0001-7412-6800	U.S. Fish and Wildlife Service; Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team	MEB and KEL (U.S. Geological Survey) received funding from the U.S. Fish and Wildlife Service for this project. Funding was provided from the Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team. In-kind support from the Metropolitan Water Reclamation District of Greater Chicago is acknowledged.	[Anonymous], [No title captured]; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Baldwin AK, 2016, SCI TOTAL ENVIRON, V554, P42, DOI 10.1016/j.scitotenv.2016.02.137; Barber LB, 2015, SCI TOTAL ENVIRON, V517, P195, DOI 10.1016/j.scitotenv.2015.02.035; Barber LB, 2013, ENVIRON SCI TECHNOL, V47, P2177, DOI 10.1021/es303720g; Blair BD, 2013, CHEMOSPHERE, V93, P2116, DOI 10.1016/j.chemosphere.2013.07.057; Booij K, 2002, CHEMOSPHERE, V46, P683, DOI 10.1016/S0045-6535(01)00232-6; BURKHARDT MR, 2006, DETERMINATION WASTEW; Childress C.J., 1999, NEW REPORTING PROCED; Ciocan CM, 2010, ENVIRON POLLUT, V158, P2977, DOI 10.1016/j.envpol.2010.05.025; Clement RE, 2012, ANAL BIOANAL CHEM, V404, P2639, DOI 10.1007/s00216-012-6300-4; Coquery M, 2009, ENVIRON POLLUT, V157, P1721; Crago J, 2016, GEN COMP ENDOCR, V232, P185, DOI 10.1016/j.ygcen.2015.12.030; Dodder NG, 2014, MAR POLLUT BULL, V81, P340, DOI 10.1016/j.marpolbul.2013.06.041; Elliott S.M., 2016, CHEM EMERGING CONCER; Elliott SM, 2015, CHEM EMERGING CONCER; Fischer J.M., 2015, US GEOLOGICAL SURVEY, V905, P42, DOI DOI 10.3133/DS905; Focazio MJ, 2008, SCI TOTAL ENVIRON, V402, P201, DOI 10.1016/j.scitotenv.2008.02.021; Foreman W. T., 2012, DETERMINATION STEROI; Furlong E.T., 2014, BOOK, V5, DOI DOI 10.3133/TM5B10; Gauthier PT, 2014, AQUAT TOXICOL, V154, P253, DOI 10.1016/j.aquatox.2014.05.026; Giraudo M, 2015, CHEMOSPHERE, V132, P159, DOI 10.1016/j.chemosphere.2015.03.028; Glassmeyer ST, 2005, ENVIRON SCI TECHNOL, V39, P5157, DOI 10.1021/es048120k; Great Lakes Commission, 2015, ANN REP GREAT LAK RE; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Kinney CA, 2006, ENVIRON TOXICOL CHEM, V25, P317, DOI 10.1897/05-187R.1; Kinney CA, 2006, ENVIRON SCI TECHNOL, V40, P7207, DOI 10.1021/es0603406; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Lee K.E., 2015, US GEOLOGICAL SURVEY, V910, P14; Lee K.E., 2012, US GEOLOGICAL SURVEY, V723, P26; Lee KE, 2009, US GEOLOGICAL SURVEY; Li A, 2006, ENVIRON SCI TECHNOL, V40, P7528, DOI 10.1021/es0609506; Loos R, 2013, WATER RES, V47, P6475, DOI 10.1016/j.watres.2013.08.024; Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020; Ma ZY, 2016, CHEMOSPHERE, V144, P1920, DOI 10.1016/j.chemosphere.2015.10.049; Mcgee MR, 2009, AQUAT TOXICOL, V91, P355, DOI 10.1016/j.aquatox.2008.12.002; Moreirinha C, 2011, ARCH ENVIRON CON TOX, V61, P211, DOI 10.1007/s00244-010-9610-6; Niemuth NJ, 2015, CHEMOSPHERE, V135, P38, DOI 10.1016/j.chemosphere.2015.03.060; Nilsen E, 2014, J AM WATER RESOUR AS, V50, P291, DOI 10.1111/jawr.12161; O'Toole S, 2006, J GREAT LAKES RES, V32, P361, DOI 10.3394/0380-1330(2006)32[361:SMIFFU]2.0.CO;2; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Palace VP, 2006, ENVIRON TOXICOL CHEM, V25, P1114, DOI 10.1897/04-557R1.1; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; Reiner JL, 2011, POLYCYCLIC MUSKS WAT, P335; Route WT, 2014, ENVIRON SCI TECHNOL, V48, P12516, DOI 10.1021/es501859a; Route WT, 2014, ENVIRON SCI TECHNOL, V48, P6653, DOI 10.1021/es501055d; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schultz MM, 2013, ENVIRON INT, V61, P138, DOI 10.1016/j.envint.2013.08.006; Servos MR, 2005, SCI TOTAL ENVIRON, V336, P155, DOI 10.1016/j.scitotenv.2004.05.025; Shappell NW, 2010, AQUAT TOXICOL, V100, P1, DOI 10.1016/j.aquatox.2010.07.005; Song WL, 2005, ENVIRON SCI TECHNOL, V39, P3474, DOI 10.1021/es048291p; Song WL, 2004, ENVIRON SCI TECHNOL, V38, P3286, DOI 10.1021/es035297q; Song WL, 2005, ENVIRON SCI TECHNOL, V39, P5600, DOI 10.1021/es050631z; Stahl LL, 2014, SCI TOTAL ENVIRON, V499, P185, DOI 10.1016/j.scitotenv.2014.07.126; Thomas LM, 2017, PLOS ONE; U. S. Environmental Protection Agency, 2017, CHEM DASHB; Venier M, 2010, CHEMOSPHERE, V80, P1234, DOI 10.1016/j.chemosphere.2010.05.043; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; WIDNR, 2003, CONS BAS SED QUAL GU; Writer JH, 2010, SCI TOTAL ENVIRON, V409, P100, DOI 10.1016/j.scitotenv.2010.07.018; Yang RQ, 2012, ENVIRON SCI TECHNOL, V46, P3119, DOI 10.1021/es204141p; Zaugg SD, 2006, DETERMINATION WASTEW	62	65	65	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0182868	10.1371/journal.pone.0182868	http://dx.doi.org/10.1371/journal.pone.0182868			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953889	Green Submitted, gold, Green Published			2022-12-26	WOS:000411980300005
J	Rabell, M; Meisinger, C; Peters, A; Holle, R; Laxy, M				Rabell, Matthias; Meisinger, Christa; Peters, Annette; Holle, Rolf; Laxy, Michael			The longitudinal association between change in physical activity, weight, and health-related quality of life: Results from the population-based KORA S4/F4/FF4 cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; DOETINCHEM COHORT; ADULT-POPULATION; GERMANY; OBESITY; COSTS; TIME	Introduction Longitudinal evidence on the association between physical activity (PA) or weight and health-related quality of life (HRQL) is sparse and studies describe inconclusive results. The aim of this study was to examine longitudinal associations between change in PA and HRQL as between change in weight and HRQL respectively. Methods Analyses are based on data from the KORA S4 cohort study (1999-2001; n = 4,261, mean age 49.0 +/- 13.3 years) and the two follow-up examinations (F4: 2006-2008; FF4: 2013-2014). Information on PA was collected in standardized interviews. Weight was measured objectively. Mental and physical components of HRQL were assessed via the SF-12 questionnaire. First, change in HRQL was regressed on change in PA and weight. Second, hierarchical linear models were fitted, which allowed estimation of between-subject and within-subject effects. Analyses were adjusted for the covariates sex, baseline diseases, and education. Results A change to a physically more active lifestyle is positively associated with physical and mental HRQL. Although weight gain is associated with impairments in physical HRQL, the data show an inverse relationship between weight gain and mental HRQL. The results were consistent for both the change score analyses and the hierarchical linear models. Discussion Our findings stress the importance of interventions on PA/weight. Nonetheless, more research is needed to reveal the causal relationship between PA/weight and HRQL.	[Rabell, Matthias] Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany; [Rabell, Matthias] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol IBE, Munich, Germany; [Rabell, Matthias; Holle, Rolf; Laxy, Michael] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Meisinger, Christa; Peters, Annette] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany	Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Rabell, M (corresponding author), Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany.; Rabell, M (corresponding author), Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol IBE, Munich, Germany.; Rabell, M (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	matthias.rabel@tum.de	Holle, Rolf/D-9333-2013; Meisinger, Christine/B-5358-2014; Peters, Annette/A-6117-2011	Holle, Rolf/0000-0001-5395-2695; Peters, Annette/0000-0001-6645-0985	German Federal Ministry of Education and Research; State of Bavaria; Helmholtz Zentrum Munchen-German Research Center for Environmental Health; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of the LMU innovative	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Helmholtz Zentrum Munchen-German Research Center for Environmental Health(Helmholtz Association); Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of the LMU innovative	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of the LMU innovative.	Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Blacklock Rachel E, 2007, J Phys Act Health, V4, P138; Bullinger M., 2000, BUNDESGESUNDHEITSBLA, V43, P190, DOI DOI 10.1007/S001030050034; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; Capehorn MS, 2016, CURRENT OBESITY REPO, P1; Doring N, 2015, PREV MED, V75, P12, DOI 10.1016/j.ypmed.2015.03.007; Ellert U, 2013, BUNDESGESUNDHEITSBLA, V56, P643, DOI 10.1007/s00103-013-1700-y; Elmer PJ, 2004, INT J OBESITY, V28, P1365, DOI 10.1038/sj.ijo.0802774; Hedeker D, 2004, QUANTITATIVE METHODO; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hopman WM, 2007, QUAL LIFE RES, V16, P1595, DOI 10.1007/s11136-007-9273-6; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Laxy M, 2014, INT J PUBLIC HEALTH, V59, P279, DOI 10.1007/s00038-013-0506-x; Leon-Munoz LM, 2005, INT J OBESITY, V29, P1385, DOI 10.1038/sj.ijo.0803049; May AM, 2010, AM J CLIN NUTR, V92, P491, DOI 10.3945/ajcn.2010.29404; Milder IEJ, 2014, J EPIDEMIOL COMMUN H, V68, P471, DOI 10.1136/jech-2013-203127; Pucci GCMF, 2012, REV SAUDE PUBL, V46, P166, DOI 10.1590/S0034-89102012000100021; Muller-Nordhorn J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093071; Organization WH, 2009, GLOB HLTH RISKS MORT; Pratt M, 2000, PHYSICIAN SPORTSMED, V28, P63, DOI 10.3810/psm.2000.10.1237; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Smolkowski K., 2015, GAIN SCORE ANAL 2013; Soltoft F, 2009, QUAL LIFE RES, V18, P1293, DOI 10.1007/s11136-009-9541-8; STENDER M, 1991, SOZ PRAVENTIV MED, V36, P176, DOI 10.1007/BF01352697; Tessier S, 2007, PREV MED, V44, P202, DOI 10.1016/j.ypmed.2006.11.012; Verkleij SPJ, 2013, EUR J PUBLIC HEALTH, V23, P285, DOI 10.1093/eurpub/cks058; Wang R, 2012, EUR J PUBLIC HEALTH, V22, P497, DOI 10.1093/eurpub/ckr080; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Warkentin LM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0175-5; Wendel-Vos GCW, 2004, QUAL LIFE RES, V13, P667, DOI 10.1023/B:QURE.0000021313.51397.33; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yates N, 2016, OBESITY FACTS, V9, P397, DOI 10.1159/000452248	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185205	10.1371/journal.pone.0185205	http://dx.doi.org/10.1371/journal.pone.0185205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953956	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300042
J	Bertoli, S; Leone, A; Krakauer, NY; Bedogni, G; Vanzulli, A; Redaelli, VI; De Amicis, R; Vignati, L; Krakauer, JC; Battezzati, A				Bertoli, Simona; Leone, Alessandro; Krakauer, Nir Y.; Bedogni, Giorgio; Vanzulli, Angelo; Redaelli, Valentino Ippocrates; De Amicis, Ramona; Vignati, Laila; Krakauer, Jesse C.; Battezzati, Alberto			Association of Body Shape Index (ABSI) with cardio-metabolic risk factors: A cross-sectional study of 6081 Caucasian adults	PLOS ONE			English	Article							FAT-FREE MASS; ANTHROPOMETRIC MEASURES; WAIST CIRCUMFERENCE; OBESITY	A Body Shape Index (ABSI) was specifically developed as a transformation of waist circumference (WC), statistically independent of BMI to better evaluate the relative contribution of WC to central obesity and clinical outcomes. Previous studies have found ABSI is associated with total mortality and cardiovascular events. However, no study has specifically evaluated the joint contribution of ABSI and BMI to cardio-metabolic outcomes (high triglycerides, low HDL, high fasting glucose and high blood pressure). With this aim, we performed a retrospective study on 6081 Caucasian adults. Subjects underwent a medical interview, anthropometric measurements, blood sampling, measurement of blood pressure, and measurement of visceral abdominal fat thickness (VAT) by ultrasound. Generalized linear models (GLM) were used to evaluate the sex and age adjusted association of ABSI with binary and continuous cardio-metabolic risk factors. Four pre-specified GLM were evaluated for each outcome: M1 = ABSI, BMI and ABSI*BMI interaction, M2 = ABSI and BMI, M3 = ABSI alone and M4 = BMI alone. Bayesian Information Criterion (BIC) was calculated and used to identify the best predictive model. ABSI and BMI contributed independently to all outcomes. Compared to BMI alone, the joint use of BMI and ABSI yielded significantly improved associations for having high triglycerides (BIC = 5261 vs. 5286), low HDL (BIC = 5371 vs. 5381), high fasting glucose (BIC = 6328 vs. 6337) but not high blood pressure (BIC = 6580 vs. 6580). The joint use of BMI and ABSI was also more strongly associated with VAT than BMI alone (BIC = 22930 vs. 23479). In conclusion, ABSI is a useful index for evaluating the independent contribution of WC, in addition to that of BMI, as a surrogate for central obesity on cardio-metabolic risk.	[Bertoli, Simona; Leone, Alessandro; Bedogni, Giorgio; Redaelli, Valentino Ippocrates; De Amicis, Ramona; Vignati, Laila; Battezzati, Alberto] Univ Milan, Dept Food Environm & Nutr Sci DeFENS, ICANS, Milan, Italy; [Krakauer, Nir Y.] CUNY City Coll, Dept Civil Engn, New York, NY USA; [Vanzulli, Angelo] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Milan, Italy; [Vanzulli, Angelo] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Krakauer, Jesse C.] Metro Detroit Diabet & Endocrinol, Southfield, MI USA	University of Milan; City University of New York (CUNY) System; City College of New York (CUNY); IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Milan	Bertoli, S (corresponding author), Univ Milan, Dept Food Environm & Nutr Sci DeFENS, ICANS, Milan, Italy.	simona.bertoli@unimi.it	Vanzulli, Angelo/X-4175-2019; Battezzati, Alberto/J-1717-2012; Bedogni, Giorgio/K-1911-2018; DE AMICIS, RAMONA/AFY-2040-2022; Leone, Alessandro/F-4769-2015; Bertoli, Simona/K-2805-2018; Krakauer, Jesse/AAV-2692-2021; DE AMICIS, RAMONA/S-5585-2019	Vanzulli, Angelo/0000-0002-2452-3370; Bedogni, Giorgio/0000-0002-1495-9306; DE AMICIS, RAMONA/0000-0003-0403-5465; Leone, Alessandro/0000-0001-8063-8490; BERTOLI, SIMONA/0000-0001-5867-8074	ICANS	ICANS	This study was supported by ICANS internal grants. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; ARMELLINI F, 1993, INT J OBESITY, V17, P209; ARMELLINI F, 1990, J CLIN ULTRASOUND, V18, P563, DOI 10.1002/jcu.1870180707; Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98; Bertoli S, 2016, NUTR J, V15, DOI 10.1186/s12937-015-0120-2; Bertoli S, 2015, CLIN NUTR, V34, P1266, DOI 10.1016/j.clnu.2015.10.003; Biolo G, 2015, CLIN NUTR, V34, P323, DOI 10.1016/j.clnu.2014.03.015; Boniface D., 2013, EUR J PUBLIC HLTH S1, V23; Bouchi R, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000188; Bozorgmanesh M, 2016, EUR J NUTR, V55, P147, DOI 10.1007/s00394-015-0833-1; Cheung Yin Bun, 2014, PLoS One, V9, pe85421, DOI 10.1371/journal.pone.0085421; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Dhana K, 2016, MATURITAS, V88, P96, DOI 10.1016/j.maturitas.2016.03.018; Dhana K, 2016, J EPIDEMIOL COMMUN H, V70, P90, DOI 10.1136/jech-2014-205257; Dhana K, 2015, HEART, V101, P377, DOI 10.1136/heartjnl-2014-306704; Duncan MJ, 2013, ANN HUM BIOL, V40, P163, DOI 10.3109/03014460.2012.752861; Haghighatdoost F, 2014, NUTRITION, V30, P636, DOI 10.1016/j.nut.2013.10.021; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; Krakauer JC, 2016, CASE REP MED, V2016, DOI 10.1155/2016/1526175; Krakauer N. Y., 2014, Journal of Obesity & Weight Loss Therapy, V4, P216; Krakauer NY, 2016, J OBES, V2016, DOI 10.1155/2016/8094275; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Leone A, 2016, BRIT J NUTR, V116, P1984, DOI 10.1017/S0007114516004141; Lohmann TG, 1988, ANTHROPOMETRIC STAND; Long J.S., 2006, REGRESSION MODELS CA; Maessen Martijn F H, 2014, PLoS One, V9, pe107212, DOI 10.1371/journal.pone.0107212; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; Park SH, 2014, CLIN NUTR, V33, P668, DOI 10.1016/j.clnu.2013.08.008; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Rothney MP, 2013, OBESITY, V21, P1798, DOI 10.1002/oby.20223; Siervo M, 2016, EUR J NUTR, V55, P1755, DOI 10.1007/s00394-015-0993-z; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Soldati L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-34; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Spadafranca A, 2015, CLIN NUTR, V34, P674, DOI 10.1016/j.clnu.2014.07.014	39	54	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185013	10.1371/journal.pone.0185013	http://dx.doi.org/10.1371/journal.pone.0185013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945809	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100015
J	Euskirchen, P; Radke, J; Schmidt, MS; Heuling, ES; Kadikowski, E; Maricos, M; Knab, F; Grittner, U; Zerbe, N; Czabanka, M; Dieterich, C; Miletic, H; Mork, S; Koch, A; Endres, M; Harms, C				Euskirchen, Philipp; Radke, Josefine; Schmidt, Marc Soeren; Heuling, Eva Schulze; Kadikowski, Eric; Maricos, Meron; Knab, Felix; Grittner, Ulrike; Zerbe, Norman; Czabanka, Marcus; Dieterich, Christoph; Miletic, Hrvoje; Mork, Sverre; Koch, Arend; Endres, Matthias; Harms, Christoph			Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma	PLOS ONE			English	Article							IMAGE-ANALYSIS; RNA-SEQ; GLIOMAS; INVASION; DIFFERENTIATION; PHENOTYPES; REVEALS; GROWTH; TUMORS; LINES	The transcription factor ZEB1 has gained attention in tumor biology of epithelial cancers because of its function in epithelial-mesenchymal transition, DNA repair, stem cell biology and tumor-induced immunosuppression, but its role in gliomas with respect to invasion and prognostic value is controversial. We characterized ZEB1 expression at single cell level in 266 primary brain tumors and present a comprehensive dataset of high grade gliomas with Ki67, p53, IDH1, and EGFR immunohistochemistry, as well as EGFR FISH. ZEB1 protein expression in glioma stem cell lines was compared to their parental tumors with respect to gene expression subtypes based on RNA-seq transcriptomic profiles. ZEB1 is widely expressed in glial tumors, but in a highly variable fraction of cells. In glioblastoma, ZEB1 labeling index is higher in tumors with EGFR amplification or IDH1 mutation. Co-labeling studies showed that tumor cells and reactive astroglia, but not immune cells contribute to the ZEB1 positive population. In contrast, glioma cell lines constitutively express ZEB1 irrespective of gene expression subtype. In conclusion, our data indicate that immune infiltration likely contributes to differential labelling of ZEB1 and confounds interpretation of bulk ZEB1 expression data.	[Euskirchen, Philipp; Endres, Matthias] Charite, Dept Neurol, Berlin, Germany; [Euskirchen, Philipp; Schmidt, Marc Soeren; Heuling, Eva Schulze; Kadikowski, Eric; Maricos, Meron; Knab, Felix; Endres, Matthias; Harms, Christoph] Charite, Dept Expt Neurol, Berlin, Germany; [Euskirchen, Philipp; Radke, Josefine; Koch, Arend; Harms, Christoph] BIH, Berlin, Germany; [Radke, Josefine; Koch, Arend] Charite, Dept Neuropathol, Berlin, Germany; [Radke, Josefine; Koch, Arend] German Canc Consortium DKTK, Partner Site Charite Berlin, Berlin, Germany; [Grittner, Ulrike; Endres, Matthias; Harms, Christoph] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Grittner, Ulrike] Charite, Dept Biostat & Clin Epidemiol, Berlin, Germany; [Zerbe, Norman] Charite, Dept Pathol, Berlin, Germany; [Czabanka, Marcus] Charite, Dept Neurosurg, Berlin, Germany; [Dieterich, Christoph] Max Planck Inst Biol Ageing, Computat RNA Biol & Ageing Grp, Cologne, Germany; [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway; [Miletic, Hrvoje; Mork, Sverre] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Endres, Matthias] Deutsch Zentrum Herz Kreislauf Forsch DZHK, Standort Berlin, Berlin, Germany; [Endres, Matthias] DZNE, Standort Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Bergen; University of Bergen; Haukeland University Hospital; German Centre for Cardiovascular Research; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Euskirchen, P (corresponding author), Charite, Dept Neurol, Berlin, Germany.; Euskirchen, P (corresponding author), Charite, Dept Expt Neurol, Berlin, Germany.; Euskirchen, P (corresponding author), BIH, Berlin, Germany.	philipp.euskirchen@charite.de	Grittner, Ulrike/I-2026-2019; Dieterich, Christoph/ABF-8459-2021; Radke, Josefine/GQH-8274-2022; Euskirchen, Philipp/AFL-2848-2022; Harms, Christoph/HIK-2989-2022; Mörk, Sverre Jarl/AAW-1330-2020; Harms, Christoph/AAD-7895-2021	Grittner, Ulrike/0000-0003-2595-0224; Radke, Josefine/0000-0001-9860-2007; Euskirchen, Philipp/0000-0002-9138-805X; Harms, Christoph/0000-0002-2063-2860; Zerbe, Norman/0000-0002-0314-3037; Knab, Felix/0000-0002-7240-5926; Endres, Matthias/0000-0001-6520-3720	Berliner Krebsgesellschaft [EUFF-2012-36]; Einstein Foundation Berlin [EZK-2012-157]; Charite-Universitatsmedizin Berlin; Berlin Institute of Health	Berliner Krebsgesellschaft; Einstein Foundation Berlin; Charite-Universitatsmedizin Berlin; Berlin Institute of Health	This work was supported by Berliner Krebsgesellschaft (EUFF-2012-36, to PE and CH) and the Einstein Foundation Berlin (EZK-2012-157, to PE). JR and PE are participants of the BIH-Charite Clinician Scientist Program funded by the Charite-Universitatsmedizin Berlin and the Berlin Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Janet Lips, Petra Matylewski and Randi Koll for excellent technical support, as well as Peter Hufnagl for access to slide scanners. JR and PE are participants of the BIH-Charite Clinician Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health.	Amankulor NM, 2017, GENE DEV, V31, P774, DOI 10.1101/gad.294991.116; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bates D., 2014, ARXIV14065823STAT; Berghoff AS, 2017, NEUROONCOLOGY; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; CHEN L, 2014, IEEE IJCNN, P1, DOI DOI 10.1038/NC0MMS6241; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Euskirchen P, 2011, EXP CELL RES, V317, P2864, DOI 10.1016/j.yexcr.2011.09.002; Gabrusiewicz K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85841; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Heuling ES, 2017, MOL CANC RES; Joseph JV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.395; Joseph JV, 2015, CANCER LETT, V359, P107, DOI 10.1016/j.canlet.2015.01.010; Kahlert U, 2012, CANC LETT; Kahlert U, 2014, BRAIN PATHOL; Klein R, 2001, ACTA NEUROPATHOL, V101, P245; Kohanbash G, 2017, J CLIN INVEST, V127, P1425, DOI 10.1172/JCI90644; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Louis DN, 2016, ACTA NEUROPATHOL, V1-18; MORANTZ RA, 1979, J NEUROSURG, V50, P305, DOI 10.3171/jns.1979.50.3.0305; Nesvick CL, 2016, J NEUROONCOL; Nordfors K, 2015, J CLIN PATHOL, V68, P905, DOI 10.1136/jclinpath-2015-202868; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; ROSSI ML, 1987, ACTA NEUROPATHOL, V74, P269, DOI 10.1007/BF00688191; Siebzehnrubl FA, 2013, EMBO MOL MED, V5, P1196, DOI 10.1002/emmm.201302827; Singh DK, 2017, CELL REP, V18, P961, DOI 10.1016/j.celrep.2016.12.064; Singh SK, 2016, CELL REP; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Talasila KM, 2013, ACTA NEUROPATHOL, V125, P683, DOI 10.1007/s00401-013-1101-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Zerbe N, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S16; Zhang L, 2016, ONCOGENE; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013	48	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185376	10.1371/journal.pone.0185376	http://dx.doi.org/10.1371/journal.pone.0185376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945795	gold, Green Published, Green Submitted			2022-12-26	WOS:000411645100054
J	Hernandez, C; Mella, C; Navarro, G; Olivera-Nappa, A; Araya, J				Hernandez, Cecilia; Mella, Carlos; Navarro, Gonzalo; Olivera-Nappa, Alvaro; Araya, Jaime			Protein complex prediction via dense subgraphs and false positive analysis	PLOS ONE			English	Article							INTERACTION NETWORKS; SACCHAROMYCES-CEREVISIAE; BIOLOGICAL NETWORKS; IDENTIFICATION; DATABASE; YEAST; INTERACTOME; CLIQUES	Many proteins work together with others in groups called complexes in order to achieve a specific function. Discovering protein complexes is important for understanding biological processes and predict protein functions in living organisms. Large-scale and throughput techniques have made possible to compile protein-protein interaction networks (PPI networks), which have been used in several computational approaches for detecting protein complexes. Those predictions might guide future biologic experimental research. Some approaches are topology-based, where highly connected proteins are predicted to be complexes; some propose different clustering algorithms using partitioning, overlaps among clusters for networks modeled with unweighted or weighted graphs; and others use density of clusters and information based on protein functionality. However, some schemes still require much processing time or the quality of their results can be improved. Furthermore, most of the results obtained with computational tools are not accompanied by an analysis of false positives. We propose an effective and efficient mining algorithm for discovering highly connected subgraphs, which is our base for defining protein complexes. Our representation is based on transforming the PPI network into a directed acyclic graph that reduces the number of represented edges and the search space for discovering subgraphs. Our approach considers weighted and unweighted PPI networks. We compare our best alternative using PPI networks from Saccharomyces cerevisiae (yeast) and Homo sapiens (human) with state-of-the-art approaches in terms of clustering, biological metrics and execution times, as well as three gold standards for yeast and two for human. Furthermore, we analyze false positive predicted complexes searching the PDBe (Protein Data Bank in Europe) database in order to identify matching protein complexes that have been purified and structurally characterized. Our analysis shows that more than 50 yeast protein complexes and more than 300 human protein complexes found to be false positives according to our prediction method, i. e., not described in the gold standard complex databases, in fact contain protein complexes that have been characterized structurally and documented in PDBe. We also found that some of these protein complexes have recently been classified as part of a Periodic Table of Protein Complexes.	[Hernandez, Cecilia; Mella, Carlos; Araya, Jaime] Univ Concepcion, Comp Sci, Concepcion, Chile; [Hernandez, Cecilia; Navarro, Gonzalo] Univ Chile, Ctr Biotechnol & Bioengn CeBiB, Dept Comp Sci, Santiago, Chile; [Olivera-Nappa, Alvaro] Univ Chile, Ctr Biotechnol & Bioengn CeBiB, Dept Chem Engn & Biotechnol, Santiago, Chile	Universidad de Concepcion; Universidad de Chile; Universidad de Chile	Hernandez, C (corresponding author), Univ Concepcion, Comp Sci, Concepcion, Chile.; Hernandez, C (corresponding author), Univ Chile, Ctr Biotechnol & Bioengn CeBiB, Dept Comp Sci, Santiago, Chile.	cecihernandez@udec.cl	Olivera-Nappa, Alvaro/GPS-5388-2022; Olivera-Nappa, Alvaro/H-3769-2013	Olivera-Nappa, Alvaro/0000-0001-6053-7019; Olivera-Nappa, Alvaro/0000-0001-6053-7019; Hernandez, Cecilia/0000-0003-1301-6987	Conicyt, Chile [FB0001, Fondecyt 1141311]; Center for Biotechnology and Bioengineering (CeBiB); Fondecyt, Conicyt, Chile [1141311]	Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Center for Biotechnology and Bioengineering (CeBiB); Fondecyt, Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funded with basal funds FB0001 Conicyt, Chile, and Fondecyt 1141311 Conicyt, Chile.; Funded by Center for Biotechnology and Bioengineering (CeBiB), Basal Center FB0001, Conicyt, Chile; and Fondecyt Grant 1141311, Conicyt, Chile. We also thank the reviewers for their comments, which helped improve the quality of the presentation.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ahnert SE, 2015, SCIENCE, V350, DOI 10.1126/science.aaa2245; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Friedel CC, 2009, J COMPUT BIOL, V16, P971, DOI 10.1089/cmb.2009.0023; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hu AL, 2013, IEEE ACM T COMPUT BI, V10, P780, DOI 10.1109/TCBB.2013.37; Hu LX, 2015, BMC GENOMICS, V16, DOI [10.1186/s12859-015-0583-3, 10.1186/s12864-015-1799-3]; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji JZ, 2014, IEEE T KNOWL DATA EN, V26, P261, DOI 10.1109/TKDE.2012.225; Kikugawa S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S7; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krumsiek J, 2008, BIOINFORMATICS, V24, P2115, DOI 10.1093/bioinformatics/btn376; Li Xiao-Li, 2007, Comput Syst Bioinformatics Conf, V6, P157; Li XY, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0069-z; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Pellegrini M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1191-6; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rahman MS, 2013, FIT VULNERABLE UNPUB, P1; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tang XW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/354539; Tumuluru P, 2015, SURVEY IDENTIFICATIO, P57; Wang JX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S2-S10; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957; Wuchty Stefan, 2006, P165; Zhang XF, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-186, 10.1186/1471-2105-15-335]; Zhao F, 2010, BIOINFORMATICS, V26, pi310, DOI 10.1093/bioinformatics/btq193	41	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0183460	10.1371/journal.pone.0183460	http://dx.doi.org/10.1371/journal.pone.0183460			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937982	Green Submitted, Green Published, gold			2022-12-26	WOS:000411524700002
J	Tudorancea, I; Porumb, V; Trandabat, A; Neaga, D; Tamba, B; Iliescu, R; Dimofte, GM				Tudorancea, Ionut; Porumb, Vlad; Trandabat, Alexandru; Neaga, Decebal; Tamba, Bogdan; Iliescu, Radu; Dimofte, Gabriel M.			New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves	PLOS ONE			English	Article							FIBRILLATION CATHETER ABLATION; WHOLE-BODY HYPERTHERMIA; INTRAPERITONEAL CHEMOTHERAPY; TEMPERATURE DISTRIBUTION; CANCER-THERAPY; RATIONALE; ANTENNA; RADIOTHERAPY; THRESHOLDS; DOSIMETRY	Purpose Our aim was to develop a new experimental model for in vivo hyperthermia using non-directional microwaves, applicable to small experimental animals. We present an affordable approach for targeted microwave heat delivery to an isolated liver lobe in rat, which allows rapid, precise and stable tissue temperature control. Materials and methods A new experimental model is proposed. We used a commercial available magnetron generating 2450 MHz, with 4.4V and 14A in the filament and 4500V anodic voltage. Modifications were required in order to adjust tissue heating such as to prevent overheating and to allow for fine adjustments according to real-time target temperature. The heating is controlled using a virtual instrument application implemented in LabView (R) and responds to 0.1 degrees C variations in the target. Ten healthy adult male Wistar rats, weighing 250-270 g were used in this study. The middle liver lobe was the target for controlled heating, while the rest of the living animal was protected. Results In vivo microwave delivery using our experimental setting is safe for the animals. Target tissue temperature rises from 30 degrees C to 40 degrees C with 3.375 degrees C/second (R-2 = 0.9551), while the increment is lower it the next two intervals (40-42 degrees C and 42-44 degrees C) with 0.291 degrees C/s (R-2 = 0.9337) and 0.136 degrees C/s (R-2 = 0.7894) respectively, when testing in sequences. After reaching the desired temperature, controlled microwave delivery insures a very stable temperature during the experiments. Conclusions We have developed an inexpensive and easy to manufacture system for targeted hyperthermia using non-directional microwave radiation. This system allows for fine and stable temperature adjustments within the target tissue and is ideal for experimental models testing below or above threshold hyperthermia	[Tudorancea, Ionut] Grigore T Popa Univ Med & Pharm, Dept Physiol, Iasi, Romania; [Porumb, Vlad; Dimofte, Gabriel M.] Grigore T Popa Univ Med & Pharm, Dept Surg, Iasi, Romania; [Porumb, Vlad; Dimofte, Gabriel M.] Reg Inst Oncol, Dept Surg, Iasi, Romania; [Trandabat, Alexandru] Gheorghe Asachi Tech Univ, Fac Elect Engn, Iasi, Romania; [Neaga, Decebal] Reg Inst Oncol, Dept Engn, Iasi, Romania; [Tamba, Bogdan; Iliescu, Radu] Grigore T Popa Univ Med & Pharm, Dept Pharmacol, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Regional Institute of Oncology IASI; Regional Institute of Oncology IASI; Grigore T Popa University of Medicine & Pharmacy	Porumb, V (corresponding author), Grigore T Popa Univ Med & Pharm, Dept Surg, Iasi, Romania.; Porumb, V (corresponding author), Reg Inst Oncol, Dept Surg, Iasi, Romania.	porumbvlad@ymail.com	Dimofte, Mihail Gabriel/GXG-4768-2022; Trandabat, Alexandru Florentin/C-7999-2011; Tamba, Bogdan Ionel/J-6231-2014; Iliescu, Radu/C-5116-2011	Trandabat, Alexandru Florentin/0000-0001-7280-7653; Tamba, Bogdan Ionel/0000-0001-9868-1999; Iliescu, Radu/0000-0002-9124-577X	ERA-Net EuroNanoMed JTC program	ERA-Net EuroNanoMed JTC program	This work was developed within the research grant CheTherDel (Chemo-hyperthermal Delivery-Combined chemo-hyperthermal control of hepatic tumors, based on microwave-activated subendothelial-targeted nano-assemblies), funded by ERA-Net EuroNanoMed JTC 2011 program.	Baronzio GF, 2006, CANC TREATMENT PRIME; Bollemeijer JG, 1998, LAB INVESTIGATIONS, V227, P271; Brace CL, 2009, CURR PROBL DIAGN RAD, V38, P61, DOI 10.1067/j.cpradiol.2007.08.011; Carrafiello Gianpaolo, 2008, Int J Surg, V6 Suppl 1, pS65, DOI 10.1016/j.ijsu.2008.12.028; Chakaravarthi G, 2015, INT J HYPERTHER, V31, P737, DOI 10.3109/02656736.2015.1068957; Chatterjee DK, 2011, THER DELIV, V2, P1001, DOI 10.4155/TDE.11.72; CHEUNG AY, 1984, CANCER RES, V44, P4736; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Diakite M, 2013, MAGN RESON MED, V69, P1122, DOI 10.1002/mrm.24322; Duck F.A., 1990, MED PHYS, V18; Gao SY, 2016, ONCOTARGET, V7, P57367, DOI 10.18632/oncotarget.10350; Goldberg SN, 1996, ACAD RADIOL, V3, P212, DOI 10.1016/S1076-6332(96)80443-0; HERMAN TS, 1982, J NATL CANCER I, V68, P487; Horsman MR, 2007, CLIN ONCOL-UK, V19, P418, DOI 10.1016/j.clon.2007.03.015; HUME SP, 1985, RADIOTHER ONCOL, V3, P165, DOI 10.1016/S0167-8140(85)80021-9; Ibitoye ZA, 2015, MED ENG PHYS, V37, P384, DOI 10.1016/j.medengphy.2015.01.015; Ichinoseki-Sekine N, 2007, BRIT J SPORT MED, V41, P425, DOI 10.1136/bjsm.2006.032540; Issels R, 1999, ONKOLOGIE, V22, P374, DOI 10.1159/000026986; Jauchem James R., 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P79, DOI 10.1515/jbcpp-2015-0011; Kano E, 1987, Gan No Rinsho, V33, P1657; Kok HP, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0503-8; Lieberman Shari, 2009, REV WHOLE BODY HYPER; MAETA M, 1987, CANCER-AM CANCER SOC, V59, P1101, DOI 10.1002/1097-0142(19870315)59:6<1101::AID-CNCR2820590610>3.0.CO;2-G; Mallory M, 2016, CRIT REV ONCOL HEMAT, V97, P56, DOI 10.1016/j.critrevonc.2015.08.003; Mathe G., 2001, 24 INT C CLIN HYP RO; Morimura Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P1510, DOI 10.1001/archopht.122.10.1510; Okmen Z, 2000, J MICROWAVE POWER EE, V35, P225; Planinsic G, 2008, EUR J PHYS, V29, P369, DOI 10.1088/0143-0807/29/2/017; RAMASWAMY H, 1991, J FOOD SCI, V56, P550, DOI 10.1111/j.1365-2621.1991.tb05321.x; Rettenmaier MA, 2015, INT J HYPERTHER, V31, P396, DOI 10.3109/02656736.2015.1007399; Rijnen Z, 2015, INT J HYPERTHER, P1; Singh LP, 2015, INT J CURR PHARM CLI, V5, P184; Suvernev AV, 1995, VISCERAL TUMORS TOMS, P97; SUZUKI T, 1995, TOHOKU J EXP MED, V177, P39, DOI 10.1620/tjem.177.39; Vargas Hernan I, 2014, ANN SURG ONCOL, V11, P139; Verhaart RF, 2015, INT J HYPERTHER, V31, P686, DOI 10.3109/02656736.2015.1052855; Vernon CC, 1996, INT J RADIAT ONCOL, V35, P731; Vertrees RA, 2002, PERFUSION-UK, V17, P279, DOI 10.1191/0267659102pf588oa; Wappling-Raaholt B, 2002, J MICROWAVE POWER EE, V37, P97; Wehner H, 2001, INT J HYPERTHER, V17, P19, DOI 10.1080/02656730150201561; Winkler R, TWISTED SHIELDED TAL; Witkamp AJ, 2001, CANCER TREAT REV, V27, P365, DOI 10.1053/ctrv.2001.0232; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527; Zhai F, 2016, ELECTROMAGN BIOL MED, V35, P8, DOI 10.3109/15368378.2014.954289; Zhang HJ, 2013, INT J HYPERTHER, V29, P582, DOI 10.3109/02656736.2013.803606	47	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184810	10.1371/journal.pone.0184810	http://dx.doi.org/10.1371/journal.pone.0184810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934251	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900046
J	Bollas, A; Shahriyari, L				Bollas, Audrey; Shahriyari, Leili			The role of backward cell migration in two-hit mutants' production in the stem cell niche	PLOS ONE			English	Article							IMMORTAL STRAND HYPOTHESIS; MONOCLONAL CONVERSION; MUTATION-SELECTION; CANCER INITIATION; DYNAMICS; CRYPT; PROLIFERATION; SEGREGATION; MODEL	It has been discovered that there are two stem cell groups in the intestinal crypts: central stem cells (CeSCs), which are at the very bottom of the crypt, and border stem cells (BSCs), which are located between CeSCs and transit amplifying cells (TAs). Moreover, backward cell migration from BSCs to CeSCs has been observed. Recently, a bi-compartmental stochastic model, which includes CeSCs and BSCs, has been developed to investigate the probability of two-hit mutant production in the stem cell niche. In this project, we improve this stochastic model by adding the probability of backward cell migration to the model. The model suggests that the probability of two-hit mutant production increases when the frequency of backward cell migration increases. Furthermore, a small non-zero probability of backward cell migration leads to the largest range of optimal values for the frequency of symmetric divisions and the portion of divisions at each stem cell compartment in terms of delaying 2-hit mutant production. Moreover, the probability of two-hit mutant production is more sensitive to the probability of symmetric divisions than to the rate of backward cell migrations. The highest probability of two-hit mutant production corresponds to the case when all stem cell's divisions are asymmetric.	[Bollas, Audrey] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA; [Shahriyari, Leili] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Shahriyari, L (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	shahriyari.1@mbi.osu.edu			Mathematical Biosciences Institute; National Science Foundation [DMS 1440386]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	This research has been supported in part by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS 1440386 (https://www.nsf.gov, LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PLOS COMPUTATIONAL B, V10; Bravo R, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-66; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; Ding DC, 2015, CELL TRANSPLANT, V24, P339, DOI 10.3727/096368915X686841; Durrett R, 2016, J MATH BIOL, V72, P1369, DOI 10.1007/s00285-015-0912-1; Fletcher AG, 2012, J THEOR BIOL, V300, P118, DOI 10.1016/j.jtbi.2012.01.021; Ganta C, 2009, CANCER RES, V69, P1815, DOI 10.1158/0008-5472.CAN-08-2750; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Kagawa Y, 2014, J GASTROENTEROL, V49, P263, DOI 10.1007/s00535-013-0887-x; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komarova NL, 2007, MATH MOD METH APPL S, V17, P1647, DOI 10.1142/S021820250700242X; Komarova NL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0014; Komarova NL, 2003, J THEOR BIOL, V223, P433, DOI 10.1016/S0022-5193(03)00120-6; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Liu XF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03173; Maurya DK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-590; Mirams GR, 2012, J THEOR BIOL, V312, P143, DOI 10.1016/j.jtbi.2012.08.002; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Nowak MA, 2002, P NATL ACAD SCI USA, P99; Pin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037115; POTTEN CS, 1992, GUT, V33, P71, DOI 10.1136/gut.33.1.71; Potten CS, 2002, J CELL SCI, V115, P2381; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rodriguez-Brenes IA, 2011, P NATL ACAD SCI USA, V108, P18983, DOI 10.1073/pnas.1107621108; Shahriyari L, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa5a61; Shahriyari L., 2016, BIORXIV; Shahriyari L, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0977; Shahriyari L, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0141-6; Shahriyari L, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/5/055001; Shahriyari L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076195; Shirayeh AM, 2016, ARXIV161004089; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Traulsen A, 2010, BIOESSAYS, V32, P1003, DOI 10.1002/bies.201000025; Werner B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0349; Wodarz D, 2014, DYNAMICS CANC MATH F	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184651	10.1371/journal.pone.0184651	http://dx.doi.org/10.1371/journal.pone.0184651			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931019	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700027
J	Kenchington, EL; Baillie, SM; Kenchington, TJ; Bentzen, P				Kenchington, Ellen L.; Baillie, Shauna M.; Kenchington, Trevor J.; Bentzen, Paul			Barcoding Atlantic Canada's mesopelagic and upper bathypelagic marine fishes	PLOS ONE			English	Article							BENTHOSEMA-GLACIALE; NORTH-ATLANTIC; SEXUAL-DIMORPHISM; DNA; RIDGE; LANTERNFISH; SPECIATION; UTILITY; MYCTOPHIFORMES; HIGHLIGHTS	DNA barcode sequences were developed from 557 mesopelagic and upper bathypelagic teleost specimens collected in waters off Atlantic Canada. Confident morphological identifications were available for 366 specimens, of 118 species and 93 genera, which yielded 328 haplotypes. Five of the species were novel to the Barcode of Life Database ( BOLD). Most of the 118 species conformed to expectations of monophyly and the presence of a "barcode gap", though some known weaknesses in existing taxonomy were confirmed and a deficiency in published keys was revealed. Of the specimens for which no firm morphological identification was available, 156 were successfully identified to species, and a further 11 to genus, using their barcode sequences and a combination of distance-and character-based methods. The remaining 24 specimens were from species for which no reference barcode is yet available or else ones confused by apparent misidentification of publicly available sequences in BOLD. Addition of the new sequences to those previously in BOLD contributed support to recent taxonomic revisions of Chiasmodon and Poromitra, while it also revealed 18 cases of potential cryptic speciation. Most of the latter appear to result from genetic divergence among populations in different ocean basins, while the general lack of strong horizontal environmental gradients within the deep sea has allowed morphology to be conserved. Other examples of divergence appear to distinguish individuals living under the sub-tropical gyre of the North Atlantic from those under that ocean's sub-polar gyre. In contrast, the available sequences for two myctophid species, Benthosema glaciale and Notoscopelus elongatus, showed genetic structuring on finer geographic scales. The observed structure was not consistent with recent suggestions that "resident" populations of myctophids can maintain allopatry despite the mixing of ocean waters. Rather, it indicates that the very rapid speciation characteristic of the Myctophidae is both on-going and detectable using barcodes.	[Kenchington, Ellen L.; Kenchington, Trevor J.] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Baillie, Shauna M.; Bentzen, Paul] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University	Kenchington, EL (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	Ellen.Kenchington@dfo-mpo.gc.ca		Bentzen, Paul/0000-0003-4288-7730				Aliabadian M, 2014, CONTRIB ZOOL, V83, P79, DOI 10.1163/18759866-08301004; BADCOCK J, 1988, B MAR SCI, V42, P16; BADCOCK J, 1981, DEEP-SEA RES, V28, P1477, DOI 10.1016/0198-0149(81)90093-5; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bower AS, 2008, J PHYS OCEANOGR, V38, P104, DOI 10.1175/2007JPO3686.1; Catul V, 2011, REV FISH BIOL FISHER, V21, P339, DOI 10.1007/s11160-010-9176-4; Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574; Davis MP, 2014, MAR BIOL, V161, P1139, DOI 10.1007/s00227-014-2406-x; Denton JSS, 2015, EVOLUTION, V69, P2425, DOI 10.1111/evo.12743; Denton JSS, 2014, MOL PHYLOGENET EVOL, V76, P270, DOI 10.1016/j.ympev.2014.02.009; DeVaney SC, 2009, NORTHEAST NAT, V16, P409, DOI 10.1656/045.016.n308; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Fock HO, 2004, DEEP-SEA RES PT I, V51, P953, DOI 10.1016/j.dsr.2004.03.004; FRANCIS MP, 1981, NEW ZEAL J ZOOL, V8, P403, DOI 10.1080/03014223.1981.10430620; Gaither MR, 2016, FISH FISH, V17, P664, DOI 10.1111/faf.12136; Gordeeva N, 2014, J ICHTHYOL+, V54, P642, DOI DOI 10.1134/S003294521406006X; Gordeeva N. V., 2011, J ICHTHYOL+, V51, P152, DOI DOI 10.1134/S0032945211020032; Gordeeva NV, 2014, J ICHTHYOL, V54, P882; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; Herring PJ, 2000, PHILOS T ROY SOC B, V355, P1273, DOI 10.1098/rstb.2000.0682; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Johnson GD, 2009, BIOL LETTERS, V5, P235, DOI 10.1098/rsbl.2008.0722; Kenchington T. J., 2009, Canadian Technical Report of Fisheries and Aquatic Sciences, V2853, P1; Kenchington TJ, 2014, CAN TECH REP FISH AQ, V3114; Kotlyar A. N., 2009, J ICHTHYOL+, V49, P421; Kotlyar A. N., 2008, J ICHTHYOL+, V48, P553, DOI DOI 10.1134/S0032945208080018; Kotlyar A. N., 2009, J ICHTHYOL+, V49, P563; Kotlyar A. N., 2008, J ICHTHYOL+, V48, P479, DOI DOI 10.1134/S0032945208070011; Kotlyar A. N., 2009, J ICHTHYOL+, V49, P710, DOI DOI 10.1134/S0032945209090021; Kotlyar A. N., 2010, J ICHTHYOL+, V50, P231, DOI DOI 10.1134/S0032945210030033; Krishnamurthy PK, 2012, BIODIVERS CONSERV, V21, P1901, DOI 10.1007/s10531-012-0306-2; Kristoffersen JB, 2009, MAR BIOL RES, V5, P596, DOI 10.1080/17451000903042479; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavoue A S, 2009, BIOL J LINN SOC, V98, P923; Lavoue S, 2008, MOL PHYLOGENET EVOL, V47, P1111, DOI 10.1016/j.ympev.2007.12.002; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Marshall N. B., 1954, P380; McCusker MR, 2013, MOL ECOL RESOUR, V13, P177, DOI 10.1111/1755-0998.12043; Melo MRS, 2009, COPEIA, P583, DOI 10.1643/CI-08-048; Miya M, 1997, NATURE, V389, P803, DOI 10.1038/39774; Moore JA, 2003, NORTHEAST NAT, V10, P159, DOI 10.1656/1092-6194(2003)010[0159:AALODF]2.0.CO;2; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Oliveira LM, 2016, J FISH BIOL, V89, P2741, DOI 10.1111/jfb.13169; Olteanu M, 2013, MOL ECOL RESOUR, V13, P976, DOI 10.1111/1755-0998.12047; Priede IG, 2013, DEEP-SEA RES PT II, V98, P220, DOI 10.1016/j.dsr2.2013.06.012; Prokofiev A. M., 2009, J ICHTHYOL, V49, P899, DOI DOI 10.1134/S0032945209100063; Prokofiev AM, 2010, J ICHTHYOL, V50, P503; Prokofiev AM, 2014, J ICHTHYOL, V54, P631, DOI DOI 10.1134/S0032945214060137; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Robinson C, 2010, DEEP-SEA RES PT II, V57, P1504, DOI 10.1016/j.dsr2.2010.02.018; Sarkar IN, 2002, J BIOMED INFORM, V35, P111, DOI 10.1016/S1532-0464(02)00504-X; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Smith PJ, 2011, J FISH BIOL, V78, P355, DOI 10.1111/j.1095-8649.2010.02846.x; Brandao JHSG, 2016, BIOCHEM SYST ECOL, V65, P214, DOI 10.1016/j.bse.2016.02.012; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Suneetha KB, 2001, SARSIA, V86, P203, DOI 10.1080/00364827.2001.10420476; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Sutton TT, 2013, J FISH BIOL, V83, P1508, DOI 10.1111/jfb.12263; Svendsen FM, 2013, MAR BIODIVERS, V43, P407, DOI 10.1007/s12526-013-0168-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tunnicliffe V., 2010, MARINE ECOLOGY, V31, P1; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Winterbottom R, 2014, ZOOKEYS, P79, DOI 10.3897/zookeys.381.6445; Zahuranec B. J., 2000, SMITHS CONTR ZOOL, V607, P69; Zahuranec B, 2012, MAR GENOM, V7, P7, DOI 10.1016/j.margen.2012.05.001; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	73	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185173	10.1371/journal.pone.0185173	http://dx.doi.org/10.1371/journal.pone.0185173			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931082	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700075
J	Peng, LQ; Zhao, H; Liu, S; Yuan, YP; Yuan, CY; Mwamunyi, MJ; Pearce, D; Yao, LJ				Peng, Li-Qin; Zhao, Hong; Liu, Song; Yuan, Ya-Pei; Yuan, Cheng-Yan; Mwamunyi, Mercy-Julian; Pearce, David; Yao, Li-Jun			Lack of serum- and glucocorticoid-inducible kinase 3 leads to podocyte dysfunction	FASEB JOURNAL			English	Article						cell viability; podocin; proteinuria	PKB/SGK-RESISTANT GSK3; TARGETED MICE LACKING; PUROMYCIN AMINONUCLEOSIDE; UP-REGULATION; DIABETIC CONDITIONS; ISOFORM SGK3; IN-VITRO; INJURY; ACTIVATION; KIDNEY	Serum- and glucocorticoid-inducible kinase 3 (SGK3) is a downstream mediator of PI3K, which is essential for maintaining the functional integrity of podocytes. However, little is known about the role of SGK3 in podocyte function. Herein, we demonstrated that SGK3 contributes to the maintenance of podocyte integrity. Conditionally immortalized mouse podocyte cells (MPCs) were treated with puromycin aminonucleoside (PAN). PAN treatment inhibited the activity of SGK3 and the expression of podocin. Short hairpin RNA (shRNA)-mediated knockdown of SGK3 also reduced podocin expression in the absence of PAN. Adriamycin (ADR)-treated mice developed proteinuria and had decreased renal glomerular SGK3 expression in comparison to control mice. Consistent with a role for SGK3 in the ADR effect, SGK3 knockout (KO) mice had markedly reduced kidney podocin expression and significantly elevated proteinuria compared with wild-type mice. Electron microscopy revealed that SGK3 KO mice displayed partial effacement of podocyte foot processes. Further, a SGK3 target protein, glycogen synthase kinase-3 (GSK3), was discovered to be dramatically activated in PAN and SGK3 shRNA-treated MPCs and in SGK3 KO mice. Taken together, these data strongly suggest that SGK3 plays a significant role in regulating podocyte function, likely by controlling the expression and activity of GSK3.	[Peng, Li-Qin; Liu, Song; Yuan, Ya-Pei; Yuan, Cheng-Yan; Mwamunyi, Mercy-Julian; Yao, Li-Jun] Huazhong Univ Sci & Technol, Union Hosp, Dept Nephrol, Tongji Med Coll, Jiefang Rd 1277, Wuhan 430022, Hubei, Peoples R China; [Zhao, Hong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Trauma Surg, Wuhan, Hubei, Peoples R China; [Pearce, David] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Pearce, David] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yao, LJ (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Nephrol, Tongji Med Coll, Jiefang Rd 1277, Wuhan 430022, Hubei, Peoples R China.	drylj@hotmail.com			National Nature Science foundation of China [81370818]	National Nature Science foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Zi-Fang Li (Union Hospital, Tongji Medical College, Huazhong University of Science and Technology) for help in revising the manuscript. This work was supported by the National Nature Science foundation of China (Grant 81370818). The authors declare no conflicts of interest.	Ahmed M, 2016, CELL PHYSIOL BIOCHEM, V38, P359, DOI 10.1159/000438636; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bhandaru M, 2011, KIDNEY INT, V80, P61, DOI 10.1038/ki.2011.67; Boehmer C, 2007, FEBS LETT, V581, P5586, DOI 10.1016/j.febslet.2007.11.006; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Bohmer C, 2010, CELL PHYSIOL BIOCHEM, V25, P723, DOI 10.1159/000315092; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Dai FY, 2002, BIOCHEM BIOPH RES CO, V293, P1191, DOI 10.1016/S0006-291X(02)00349-2; Dong N, 2017, INT UROL NEPHROL, V49, P1489, DOI 10.1007/s11255-017-1622-y; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Foller M, 2011, J AM SOC NEPHROL, V22, P873, DOI 10.1681/ASN.2010070757; Fogo AB, 2003, SEMIN NEPHROL, V23, P161, DOI 10.1053/snep.2003.50015; Fogo AB, 2015, NAT REV NEPHROL, V11, P76, DOI 10.1038/nrneph.2014.216; Friedrich B, 2002, KIDNEY BLOOD PRESS R, V25, P303, DOI 10.1159/000066794; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Grahammer F, 2006, AM J PHYSIOL-REG I, V290, pR945, DOI 10.1152/ajpregu.00484.2005; Ha TS, 2015, DIABETES-METAB RES, V31, P50, DOI 10.1002/dmrr.2562; Henke G, 2002, KIDNEY BLOOD PRESS R, V25, P370, DOI 10.1159/000068699; Huang DY, 2006, AM J PHYSIOL-RENAL, V291, pF1264, DOI 10.1152/ajprenal.00299.2005; Huang DY, 2004, J AM SOC NEPHROL, V15, P885, DOI 10.1097/01.ASN.0000120368.59693.A8; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kang HG, 2010, NEPHRON EXP NEPHROL, V115, pE1, DOI 10.1159/000286518; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kumar JM, 1999, J AM SOC NEPHROL, V10, P2488; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Li CB, 2016, J PATHOL, V239, P23, DOI 10.1002/path.4692; Li XZ, 2015, J AM SOC NEPHROL, V26, P2361, DOI 10.1681/ASN.2014040405; Liang YX, 2015, BIOCHEM BIOPH RES CO, V463, P70, DOI 10.1016/j.bbrc.2015.05.020; Liu GY, 2015, PHARMACOLOGY, V95, P193, DOI 10.1159/000381314; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Mariappan MM, 2014, J BIOL CHEM, V289, P35363, DOI 10.1074/jbc.M114.587840; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Nasir O, 2009, IUBMB LIFE, V61, P768, DOI 10.1002/iub.209; Paeng J, 2014, APOPTOSIS, V19, P1678, DOI 10.1007/s10495-014-1037-5; Pasham V, 2011, J GASTROENTEROL, V46, P305, DOI 10.1007/s00535-010-0348-8; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Ren Q, 2016, J RECEPT SIG TRANSD, V36, P288, DOI 10.3109/10799893.2015.1101137; Sandu C, 2005, PFLUG ARCH EUR J PHY, V451, P437, DOI 10.1007/s00424-005-1474-7; Schmid E, 2012, CELL PHYSIOL BIOCHEM, V30, P1423, DOI 10.1159/000343330; Sobiesiak M, 2009, J IMMUNOL, V183, P4395, DOI 10.4049/jimmunol.0803017; Strutz-Seebohm N, 2006, PFLUG ARCH EUR J PHY, V452, P276, DOI 10.1007/s00424-005-0032-7; Tessier M, 2006, J BIOL CHEM, V281, P23978, DOI 10.1074/jbc.M604333200; Trepiccione F, 2011, KIDNEY INT, V80, P13, DOI 10.1038/ki.2011.60; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Yaddanapudi S, 2011, J CLIN INVEST, V121, P3965, DOI 10.1172/JCI58552; Yang SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074871; Yao LJ, 2011, MOL ENDOCRINOL, V25, P2106, DOI 10.1210/me.2010-0329; Zheng CX, 2008, KIDNEY INT, V74, P596, DOI 10.1038/ki.2008.203; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9	50	4	4	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					576	587		10.1096/fj.201700393RR	http://dx.doi.org/10.1096/fj.201700393RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28935820	Bronze, Green Published			2022-12-26	WOS:000425146900005
J	Kim, SK; Kleimeyer, JP; Ahmed, MA; Avins, AL; Fredericson, M; Dragoo, JL; Ioannidis, JPA				Kim, Stuart K.; Kleimeyer, John P.; Ahmed, Marwa A.; Avins, Andrew L.; Fredericson, Michael; Dragoo, Jason L.; Ioannidis, John P. A.			Two genetic loci associated with ankle injury	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; PREVENTION; REPLICATION; SPRAIN; LOCALIZATION; METAANALYSIS; BASKETBALL; PLAYERS; SPORTS	Ankle injuries, including sprains, strains and other joint derangements and instability, are common, especially for athletes involved in indoor court or jumping sports. Identifying genetic loci associated with these ankle injuries could shed light on their etiologies. A genome-wide association screen was performed using publicly available data from the Research Program in Genes, Environment and Health (RPGEH) including 1,694 cases of ankle injury and 97,646 controls. An indel (chr21:47156779:D) that lies close to a collagen gene, COL18A1, showed an association with ankle injury at genome-wide significance (p = 3.8x10(-8); OR = 1.99; 95% CI = 1.75-2.23). A second DNA variant (rs13286037 on chromosome 9) that lies within an intron of the transcription factor gene NFIB showed an association that was nearly genome-wide significant (p = 5.1x10(-8); OR = 1.63; 95% CI = 1.46-1.80). The ACTN3 R577X mutation was previously reported to show an association with acute ankle sprains, but did not show an association in this cohort. This study is the first genomewide screen for ankle injury that yields insights regarding the genetic etiology of ankle injuries and provides DNA markers with the potential to inform athletes about their genetic risk for ankle injury.	[Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Kleimeyer, John P.; Fredericson, Michael; Dragoo, Jason L.] Stanford Univ, Dept Orthopaed Surg, Med Ctr, Stanford, CA 94305 USA; [Ahmed, Marwa A.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Avins, Andrew L.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Kaiser Permanente; Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu	Ioannidis, John P. A./G-9836-2011	Fredericson, Michael/0000-0001-9826-2348; Ioannidis, John P./0000-0003-3118-6859; kim, stuart/0000-0001-8887-5095	NIH [5RO1AG025941]; Robert Wood Johnson Foundation; Ellison Medical Foundation; Wayne and Gladys Valley Foundation; Kaiser Permanente; National Institutes of Health [RC2 AG036607]; NATIONAL INSTITUTE ON AGING [RC2AG036607, R01AG025941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Ellison Medical Foundation(Lawrence Ellison Foundation); Wayne and Gladys Valley Foundation; Kaiser Permanente; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (5RO1AG025941) to SKK. Participant enrollment, survey and sample collection for the RPGEH were supported by grants from the Robert Wood Johnson Foundation, the Ellison Medical Foundation, the Wayne and Gladys Valley Foundation, and Kaiser Permanente. Development of genotypic data was supported by grant RC2 AG036607 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Kaiser Permanente Northern California RPGEH team for access to data and assistance in data management. This work was supported by grants from the NIH (5RO1AG025941). Data for this study were provided by the Kaiser Permanente Research Program on Genes, Environment and Health (RPGEH). Participant enrollment, survey and sample collection for the RPGEH were supported by grants from the Robert Wood Johnson Foundation, the Ellison Medical Foundation, the Wayne and Gladys Valley Foundation, and Kaiser Permanente. Development of genotypic data was supported by grant RC2 AG036607 from the National Institutes of Health. Information about data access can be obtained at: http://www.ncbi.nlm.nih.gov/projects/gap/cgibin/study.cgi?study id=phs000674.vl.pl and https://researchbank.kaiserpermanente.org/for-researchers/.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Doherty C, 2014, SPORTS MED, V44, P123, DOI 10.1007/s40279-013-0102-5; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Jorgenson E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10130; Kim SK, 2016, PLOS ONE, V12; Kim SK, 2017, INT J SPORT IN PRESS; Kim S, 2017, INT J SPORTS MED, V38, P508, DOI 10.1055/s-0043-106190; Makeyev AV, 2000, GENOMICS, V67, P301, DOI 10.1006/geno.2000.6244; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; McGuine TA, 2011, AM J SPORT MED, V39, P1840, DOI 10.1177/0363546511406242; OH SP, 1994, GENOMICS, V19, P494, DOI 10.1006/geno.1994.1098; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; QIAN F, 1995, GENOMICS, V28, P66, DOI 10.1006/geno.1995.1107; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roos AK, 2017, INT J SPORTS MED, V38, P501, DOI 10.1055/s-0043-104853; Shang XY, 2015, J SPORT SCI, V33, P1775, DOI 10.1080/02640414.2015.1012098; Shawen SB, 2016, CLIN SPORT MED, V35, P697, DOI 10.1016/j.csm.2016.05.012; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Taylor JB, 2015, SPORTS HEALTH, V7, P392, DOI 10.1177/1941738115593441; Thacker SB, 1999, AM J SPORT MED, V27, P753, DOI 10.1177/03635465990270061201; Wedderkopp N, 1999, SCAND J MED SCI SPOR, V9, P41	30	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185355	10.1371/journal.pone.0185355	http://dx.doi.org/10.1371/journal.pone.0185355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957384	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200050
J	Namukwaya, E; Murray, SA; Downing, J; Leng, M; Grant, L				Namukwaya, Elizabeth; Murray, Scott A.; Downing, Julia; Leng, Mhoira; Grant, Liz			'I think my body has become addicted to those tablets'. Chronic heart failure patients' understanding of and beliefs about their illness and its treatment: A qualitative longitudinal study from Uganda	PLOS ONE			English	Article							HEALTH; LITERACY; OUTCOMES; AFRICA	Background Patients with heart failure in Uganda present for health care with advanced structural heart disease, have repeated hospitalizations and poorly controlled disease symptoms. The reasons for these are unclear. Literature from other settings shows that patients' understanding of their illness and their beliefs influence their health related behaviour. The study aimed to explore the beliefs of patients with heart failure, their understanding of their illness and its treatment, and how this influenced their health related behaviour to inform future health education programs, information and palliative care services. Methods Serial qualitative in-depth interviews were conducted with Heart Failure patients who were purposively sampled and recruited in Mulago National Referral Hospital until thematic saturation was reached. In-depth interviews were conducted at three time points over the course of their illness with intervals of 3 months between interviews. A grounded theory approach was used in data analysis. The University of Edinburgh ethics committee, Mulago Hospital Research Ethics committee and the Uganda National Council of Science and Technology (Reference numbers D/GC/178; MREC 33, SS 3083 respectively) approved the research. Results A total of 40 face to face qualitative longitudinal interviews (36-patient alone, 4 paired-patient and family carer), were conducted with 21 patients. The findings revealed that heart failure patients were unaware of the symptoms of the illness and their definition of illness differed from that of health professionals. Patients understood their diagnosis, cause of illness, prognosis and the importance of the medicines differently from health professionals, and had insufficient information on self-care. Lay beliefs were used to explain many aspects of the illness and treatments. All these influenced where patients sought care and their adherence to treatment, self-care and follow up leading to uncontrolled disease. Conclusion There is a high level of health illiteracy among heart failure patients in Uganda. Patients rely on lay beliefs to make health decisions and medical information is often miscomprehended. There is an urgent need for health education using culturally appropriate information.	[Namukwaya, Elizabeth; Downing, Julia; Leng, Mhoira] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Murray, Scott A.] Univ Edinburgh, Sch Med, Primary Palliat Care Res Grp, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Grant, Liz] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Global Hlth Acad, Edinburgh, Midlothian, Scotland	Makerere University; University of Edinburgh; University of Edinburgh	Namukwaya, E (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.	liznam2002@yahoo.co.uk		leng, mhoira/0000-0003-1449-0437; Downing, Julia/0000-0002-3450-785X; Namukwaya, Elizabeth/0000-0001-5241-2742; Murray, Scott A/0000-0002-6649-9428; Grant, Liz/0000-0001-7248-7792	University of Edinburgh college of medicine and veterinary medicine student funding services; Diana fund [URN 6649/3220]; palliative care unit in Department of medicine Makerere University college of Health Sciences	University of Edinburgh college of medicine and veterinary medicine student funding services; Diana fund; palliative care unit in Department of medicine Makerere University college of Health Sciences	This work was part of EN PhD research. EN got a Charles Darwin scholarship with a Gordon Lennie bursary (no grant number) from the University of Edinburgh college of medicine and veterinary medicine student funding services and the Diana fund (URN 6649/3220) for tuition and living expenses in Edinburgh. The research was funded by the palliative care unit in Department of medicine Makerere University college of Health Sciences. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Arksey H., 1999, INTERVIEWING SOCIAL; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Atulomah BC, 2012, OZEAN J SOCIAL SCI, V3, P95; Braun V., 2022, THEMATIC ANAL PRACTI; Breckenridge JP, 2012, GROUNDED THEORY REV, V11, P64; Burt RS, 2005, BROKERAGE CLOSURE IN; BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x; Calnan M, 1987, HLTH AND ILLNESS; Creswell J. W., 2007, QUALITATIVE INQUIRY; Crotty, 1998, FDN SOCIAL RES MEANI; Damasceno Albertino, 2012, Arch Intern Med, V172, P1386; Denzin N, 1998, LANDSCAPE QUALITATIV; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Dixit S, 2008, PSYCHOL DEV SOC, V20, P1, DOI 10.1177/097133360702000101; Gareth W, 2013, LAY KNOWLEDGE; Glaser B.G, 1978, THEORETICAL SENSITIV; Hirani SP, 2005, HEART, V91, P1235, DOI 10.1136/hrt.2003.025262; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Kimani KN, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000077; Kleinman A, 2006, FOCUS; Klindtworth K, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0124-y; Kuule JK, 2009, SAMJ S AFR MED J, V99, P876; Lip GYH, 2004, HEART, V90, P1016, DOI 10.1136/hrt.2003.025742; Liu MH, 2014, J NURS RES, V22, P136, DOI [10.1097/jnr.0000000000000024, 10.1097/JNR.0000000000000024]; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Metra M, 2007, EUR J HEART FAIL, V9, P684, DOI 10.1016/j.ejheart.2007.04.003; Morgan Karen, 2014, BMC Psychol, V2, P50, DOI 10.1186/s40359-014-0050-3; Okello E, 2013, CARDIOVASC J AFR, V24, P80, DOI [10.5830/CVJA-2013-004, 10.5830/cvja-2013-004]; Oyoo GO, 1999, E AFR MED J, V76, P23; Peterson PN, 2011, JAMA-J AM MED ASSOC, V305, P1695, DOI 10.1001/jama.2011.512; Sabuni LP, 2007, QUAL HEALTH RES, V17, P1280, DOI 10.1177/1049732307307864; Saldana J., 2018, QUALITATIVE RES ANAL; Selman L, 2015, CURR OPIN SUPPORT PA, V9, P20, DOI 10.1097/SPC.0000000000000107; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Tabuti JRS, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-35; THOMSON R, 2003, INT J SOCIAL RES MET, V0006; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Uskul AK., 2010, HEALTH PSYCHOL, V2, P347	38	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0182876	10.1371/journal.pone.0182876	http://dx.doi.org/10.1371/journal.pone.0182876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957338	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200006
J	Midekisa, A; Holl, F; Savory, DJ; Andrade-Pacheco, R; Gething, PW; Bennett, A; Sturrock, HJW				Midekisa, Alemayehu; Holl, Felix; Savory, David J.; Andrade-Pacheco, Ricardo; Gething, Peter W.; Bennett, Adam; Sturrock, Hugh J. W.			Mapping land cover change over continental Africa using Landsat and Google Earth Engine cloud computing	PLOS ONE			English	Article							TIME-SERIES; SURFACE REFLECTANCE; NEXT-GENERATION; FOREST COVER; CLASSIFICATION; MULTISENSOR; SCIENCE; IMAGES; MODIS	Quantifying and monitoring the spatial and temporal dynamics of the global land cover is critical for better understanding many of the Earth's land surface processes. However, the lack of regularly updated, continental-scale, and high spatial resolution (30 m) land cover data limit our ability to better understand the spatial extent and the temporal dynamics of land surface changes. Despite the free availability of high spatial resolution Landsat satellite data, continental-scale land cover mapping using high resolution Landsat satellite data was not feasible until now due to the need for high-performance computing to store, process, and analyze this large volume of high resolution satellite data. In this study, we present an approach to quantify continental land cover and impervious surface changes over a long period of time (15 years) using high resolution Landsat satellite observations and Google Earth Engine cloud computing platform. The approach applied here to overcome the computational challenges of handling big earth observation data by using cloud computing can help scientists and practitioners who lack high-performance computational resources.	[Midekisa, Alemayehu; Holl, Felix; Savory, David J.; Andrade-Pacheco, Ricardo; Bennett, Adam; Sturrock, Hugh J. W.] Univ Calif San Francisco, Global Hlth Grp, Malaria Eliminat Initiat, San Francisco, CA 94143 USA; [Gething, Peter W.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Oxford, England	University of California System; University of California San Francisco; University of Oxford	Midekisa, A (corresponding author), Univ Calif San Francisco, Global Hlth Grp, Malaria Eliminat Initiat, San Francisco, CA 94143 USA.	alemayshu.midekisa@ucsf.edu	Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022; Holl, Felix/Y-9648-2019	Gething, Peter/0000-0001-6759-5449; Holl, Felix/0000-0002-4020-9509; Sturrock, Hugh/0000-0002-0029-3101; Midekisa, Alemayehu/0000-0003-2558-6952	Bill and Melinda Gates Foundation [OPP1132900, OPP1089413, OPP1116450, OPP1068048, OPP1106023]; Novartis Foundation for Sustainable Development; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID; European Union; MRC [MR/K00669X/1] Funding Source: UKRI; Medical Research Council [MR/K00669X/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novartis Foundation for Sustainable Development; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.M., F.H., D.J.S., R.A, A.B. and H.J.W.S. and are funded by grants from the Bill and Melinda Gates Foundation (Numbers OPP1132900, OPP1089413, and OPP1116450), the Novartis Foundation for Sustainable Development, and a gift from the Parker Foundation. P.W.G. is a Career Development Fellow (No. K00669X) jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, also part of the EDCTP2 program supported by the European Union, and receives support from the Bill and Melinda Gates Foundation (No. OPP1068048, No. OPP1106023).	Arino O, 2008, ESA BULL-EUR SPACE, P24; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bwangoy JRB, 2010, REMOTE SENS ENVIRON, V114, P73, DOI 10.1016/j.rse.2009.08.004; Chen J, 2015, ISPRS J PHOTOGRAMM, V103, P7, DOI 10.1016/j.isprsjprs.2014.09.002; Clark ML, 2016, ISPRS J PHOTOGRAMM, V119, P228, DOI 10.1016/j.isprsjprs.2016.06.007; Costa MH, 2003, J HYDROL, V283, P206, DOI 10.1016/S0022-1694(03)00267-1; DeFries R, 1997, REMOTE SENS ENVIRON, V60, P228, DOI 10.1016/S0034-4257(96)00119-8; DeVries B, 2015, REMOTE SENS ENVIRON, V161, P107, DOI 10.1016/j.rse.2015.02.012; Donchyts G, 2016, NAT CLIM CHANGE, V6, P810, DOI 10.1038/nclimate3111; Dong JW, 2015, REMOTE SENS ENVIRON, V160, P99, DOI 10.1016/j.rse.2015.01.004; Dong JW, 2012, REMOTE SENS ENVIRON, V127, P60, DOI 10.1016/j.rse.2012.08.022; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gessner U, 2015, REMOTE SENS ENVIRON, V164, P282, DOI 10.1016/j.rse.2015.03.029; Giri C, 2013, INT J APPL EARTH OBS, V25, P30, DOI [10, 10.1016/j.jag.2013.03.005]; Gounaridis D, 2016, INT J APPL EARTH OBS, V51, P1, DOI 10.1016/j.jag.2016.04.002; Hansen MC, 2014, REMOTE SENS ENVIRON, V140, P466, DOI 10.1016/j.rse.2013.08.014; Hansen MC, 2011, REMOTE SENS LETT, V2, P279, DOI 10.1080/01431161.2010.519002; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Linard C, 2013, APPL GEOGR, V44, P23, DOI 10.1016/j.apgeog.2013.07.009; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; Mellander C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139779; Midekisa A, 2014, WATER RESOUR RES, V50, P8791, DOI 10.1002/2014WR015634; Nemani R, 2011, INT ARCH PHOTOGRAMM, V38-8, P17; Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5; Patel NN, 2015, INT J APPL EARTH OBS, V35, P199, DOI 10.1016/j.jag.2014.09.005; Patz JA, 2004, GEOPHYS MONOGR SER, V153, P159, DOI 10.1029/153GM13; Pielke RA, 2011, WIRES CLIM CHANGE, V2, P828, DOI 10.1002/wcc.144; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Savory DJ, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070713; Schroeder TA, 2014, REMOTE SENS ENVIRON, V154, P61, DOI 10.1016/j.rse.2014.08.005; Tulbure MG, 2013, ISPRS J PHOTOGRAMM, V79, P44, DOI 10.1016/j.isprsjprs.2013.01.010; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; Wright C, 2007, REMOTE SENS ENVIRON, V107, P582, DOI 10.1016/j.rse.2006.10.019; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Xiong J, 2017, ISPRS J PHOTOGRAMM, V126, P225, DOI 10.1016/j.isprsjprs.2017.01.019; Yan L, 2015, REMOTE SENS ENVIRON, V158, P478, DOI 10.1016/j.rse.2014.11.024; Zhu Z, 2015, REMOTE SENS ENVIRON, V162, P67, DOI 10.1016/j.rse.2015.02.009	40	84	86	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184926	10.1371/journal.pone.0184926	http://dx.doi.org/10.1371/journal.pone.0184926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953943	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300025
J	Wang, SC; Hu, T; Wang, Z; Li, N; Zhou, LH; Liao, LS; Wang, M; Liao, LB; Wang, H; Zeng, LP; Fan, CL; Zhou, HK; Xiong, K; Huang, JF; Chen, D				Wang, Shuchao; Hu, Tu; Wang, Zhen; Li, Na; Zhou, Lihong; Liao, Lvshuang; Wang, Mi; Liao, Libin; Wang, Hui; Zeng, Leping; Fan, Chunling; Zhou, Hongkang; Xiong, Kun; Huang, Jufang; Chen, Dan			Macroglia-derived thrombospondin 2 regulates alterations of presynaptic proteins of retinal neurons following elevated hydrostatic pressure	PLOS ONE			English	Article							GANGLION-CELLS; UP-REGULATION; ASTROCYTES; GLAUCOMA; SYNAPTOGENESIS; PROGRESSION; MODULATION; PLASTICITY; CHANNELS; SUBUNIT	Many studies on retinal injury and repair following elevated intraocular pressure suggest that the survival ratio of retinal neurons has been improved by various measures. However, the visual function recovery is far lower than expected. The homeostasis of retinal synapses in the visual signal pathway is the key structural basis for the delivery of visual signals. Our previous studies found that complicated changes in the synaptic structure between retinal neurons occurred much earlier than obvious degeneration of retinal ganglion cells in rat retinae. The lack of consideration of these earlier retinal synaptic changes in the rescue strategy may be partly responsible for the limited visual function recovery with the types of protective methods for retinal neurons used following elevated intraocular pressure. Thus, research on the modulatory mechanisms of the synaptic changes after elevated intraocular pressure injury may give new light to visual function rescue. In this study, we found that thrombospondin 2, an important regulator of synaptogenesis in central nervous system development, was distributed in retinal macroglia cells, and its receptor alpha 2 delta-1 was in retinal neurons. Cell cultures including mixed retinal macroglia cells/neuron cultures and retinal neuron cultures were exposed to elevated hydrostatic pressure for 2 h. The expression levels of glial fibrillary acidic protein (the marker of activated macroglia cells), thrombospondin 2, alpha 2 delta-1 and presynaptic proteins were increased following elevated hydrostatic pressure in mixed cultures, but the expression levels of postsynaptic proteins were not changed. SiRNA targeting thrombospondin 2 could decrease the upregulation of presynaptic proteins induced by the elevated hydrostatic pressure. However, in retinal neuron cultures, elevated hydrostatic pressure did not affect the expression of presynaptic or postsynaptic proteins. Rather, the retinal neuron cultures with added recombinant thrombospondin 2 protein upregulated the level of presynaptic proteins. Finally, gabapentin decreased the expression of presynaptic proteins in mixed cultures by blocking the interaction of thrombospondin 2 and alpha 2 delta-1. Taken together, these results indicate that activated macroglia cells may participate in alterations of presynaptic proteins of retinal neurons following elevated hydrostatic pressure, and macroglia-derived thrombospondin 2 may modulate these changes via binding to its neuronal receptora alpha 2 delta-1.	[Wang, Shuchao; Hu, Tu; Wang, Zhen; Li, Na; Zhou, Lihong; Liao, Lvshuang; Wang, Mi; Liao, Libin; Wang, Hui; Zeng, Leping; Fan, Chunling; Zhou, Hongkang; Xiong, Kun; Huang, Jufang; Chen, Dan] Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China	Central South University	Huang, JF; Chen, D (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China.	huangjufang@csu.edu.cn; chendan0101@csu.edu.cn	Jufang, Huang/AAW-1847-2020	Jufang, Huang/0000-0002-9161-1055	National Natural Science Foundation of China [81400399, 81371011]; Project of Innovation-driven Plan of Central South University [2015CXS022]; National Key Technologies Research and Development Program of China [2012BAK14B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Innovation-driven Plan of Central South University; National Key Technologies Research and Development Program of China(National Key Technology R&D Program)	This study was supported by National Natural Science Foundation of China (No. 81400399, NO.81371011). www.nsfc.gov.cn; the Project of Innovation-driven Plan of Central South University (NO. 2015CXS022). http://www.csu.edu.cn; National Key Technologies Research and Development Program of China (No. 2012BAK14B03). http://program.most.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Bachleda AR, 2016, INVEST OPHTH VIS SCI, V57, P1488, DOI 10.1167/iovs.15-17994; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Crawford DC, 2012, J NEUROSCI, V32, P13100, DOI 10.1523/JNEUROSCI.2604-12.2012; Crish SD, 2013, NEUROSCIENCE, V229, P55, DOI 10.1016/j.neuroscience.2012.10.069; Crosby ND, 2016, ANN BIOMED ENG, V44, P3215, DOI 10.1007/s10439-016-1639-x; Crosby ND, 2015, EXP NEUROL, V264, P111, DOI 10.1016/j.expneurol.2014.11.015; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Farrell SR, 2014, VISUAL NEUROSCI, V31, P47, DOI 10.1017/S0952523813000588; Farrell SR, 2010, J NEUROPHYSIOL, V104, P1347, DOI 10.1152/jn.00098.2010; Flugel-Koch C, 2004, EXP EYE RES, V79, P649, DOI 10.1016/j.exer.2004.07.005; Fu QL, 2009, CELL MOL NEUROBIOL, V29, P575, DOI 10.1007/s10571-009-9349-7; Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200; Harris JJ, 2015, CURR BIOL, V25, P3151, DOI 10.1016/j.cub.2015.10.063; Huang JF, 2013, EXP EYE RES, V111, P36, DOI 10.1016/j.exer.2013.03.012; Huang JF, 2012, NEURAL REGEN RES, V7, P1234, DOI 10.3969/j.issn.1673-5374.2012.16.005; Huang YC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004760; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Jayakumar AR, 2014, J NEUROCHEM, V131, P333, DOI 10.1111/jnc.12810; Jiang YL, 2009, MOL CELL NEUROSCI, V41, P113, DOI 10.1016/j.mcn.2009.02.006; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Li N, 2016, NEUROTOX RES, V30, P392, DOI 10.1007/s12640-016-9624-6; Liu CT, 2006, CELL IMMUNOL, V244, P19, DOI 10.1016/j.cellimm.2007.02.003; Lo FS, 2011, J NEUROPHYSIOL, V106, P2876, DOI 10.1152/jn.00312.2011; Luo X, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/864871; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Marrone DF, 2002, BRAIN RES REV, V38, P291, DOI 10.1016/S0165-0173(01)00147-3; McCann P, 2016, INVEST OPHTH VIS SCI, V57, P2729, DOI 10.1167/iovs.15-18595; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moore KB, 2015, NEURAL REGEN RES, V10, P1013, DOI 10.4103/1673-5374.160092; Morquette JB, 2008, J NEURO-OPHTHALMOL, V28, P144, DOI 10.1097/WNO.0b013e318177edf0; Nunez-Parra A, 2013, P NATL ACAD SCI USA, V110, P14777, DOI 10.1073/pnas.1310686110; Park HYL, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0053-2; Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002; Phamduong E, 2014, ACS CHEM NEUROSCI, V5, P106, DOI 10.1021/cn400172n; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Shang L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-63; Shen HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164035; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vieira-Potter VJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3801570; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Yang JH, 2016, ELIFE, V5, DOI 10.7554/eLife.15043; Zhou LH, 2014, NEURAL REGEN RES, V9, P385, DOI 10.4103/1673-5374.128240	53	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185388	10.1371/journal.pone.0185388	http://dx.doi.org/10.1371/journal.pone.0185388			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953973	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300058
J	Ernstgard, L; Dwivedi, AM; Lundstrom, JN; Johanson, G				Ernstgard, Lena; Dwivedi, Aishwarya M.; Lundstrom, Johan N.; Johanson, Gunnar			Measures of odor and lateralization thresholds of acrolein, crotonaldehyde, and hexanal using a novel vapor delivery technique	PLOS ONE			English	Article							SENSORY IRRITATION; WOOD PELLETS; ALDEHYDES; TRPA1; FORMALDEHYDE; SENSITIVITY; INTENSITY; EMISSIONS; EXPOSURE; HUMANS	Introduction Humans are exposed to aldehydes in a variety of environmental situations. Aldehydes generally have a strong odor and are highly irritating to the mucous membranes. Knowledge about odor perception and especially irritation potency in humans is thus essential in risk assessment and regulation, e.g. setting occupational exposure limits. However, data on odor and irritation are lacking or limited for several aldehydes. The aim of the study was to determine the odor and lateralization thresholds of some commonly occurring aldehydes. Acrolein and crotonaldehyde where chosen as they are formed when organic material is heated or burned, e. g. during cigarette smoking. n-Hexanal was also included as it is emitted from wood pellets and fibreboard. Material and methods To study odor and lateralization thresholds of these aldehydes, a novel, inexpensive olfactometer was designed to enable delivery of reliable and stable test concentrations and thus valid measures of thresholds. The delivery system consists of seven syringe pumps, each connected to a Tedlar bag containing a predefined concentration of the tested aldehyde vapor. To validate the threshold measures, a test-retest was performed with a separate method, namely odor delivery via amber bottles. Twenty healthy naive individuals were tested. Results The median odor thresholds of acrolein, crotonaldehyde and hexanal were 17, 0.8, and 97 ppb, respectively. No lateralization threshold could be identified for acrolein (highest tested concentration was 2 940 ppb in 5 subjects), whereas the medians were 3 and 390 ppb for the latter two. In addition, odor thresholds for n-hexanal were also determined using two methods where similar results were obtained, suggesting that the olfactometer presentation method is valid. Conclusion We found olfactory detection and lateralization thresholds (except for acrolein) in alliance with, or lower than, previously reported in naive subjects. The new olfactometer allows better control of presentations timing and vapor concentration.	[Ernstgard, Lena; Dwivedi, Aishwarya M.; Johanson, Gunnar] Karolinska Inst, Inst Environm Med, Work Environm Toxicol, Stockholm, Sweden; [Lundstrom, Johan N.] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ernstgard, L (corresponding author), Karolinska Inst, Inst Environm Med, Work Environm Toxicol, Stockholm, Sweden.	Lena.Ernstgard@ki.se	Lundström, Johan N./AAK-5002-2020; Lundström, Johan N/E-9482-2014; Johanson, Gunnar/A-3745-2015	Lundström, Johan N./0000-0002-3529-8981; Lundström, Johan N/0000-0002-3529-8981; Ernstgard, Lena/0000-0003-2217-3394; Johanson, Gunnar/0000-0002-8759-9567	Swedish Research Council for Health, Working Life and Welfare, FORTE [2013-0044]	Swedish Research Council for Health, Working Life and Welfare, FORTE	LE was funded by Swedish Research Council for Health, Working Life and Welfare, FORTE, no 2013-0044 (http://forte.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta S, 2017, TOXICOL APPL PHARM, V324, P45, DOI 10.1016/j.taap.2017.03.007; Amoore JE, 1983, J APPL TOXICOL, V3, P272, DOI 10.1002/jat.2550030603; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; [Anonymous], 2003, ODOR MEAS REV; Arshadi M, 2009, ANN OCCUP HYG, V53, P797, DOI 10.1093/annhyg/mep058; BEAUCHAMP RO, 1985, CRC CR REV TOXICOL, V14, P309, DOI 10.3109/10408448509037461; Brown SK, 1999, INDOOR AIR, V9, P209, DOI 10.1111/j.1600-0668.1999.t01-1-00008.x; Cometto-Muniz JE, 1998, INT ARCH OCC ENV HEA, V71, P105, DOI 10.1007/s004200050256; Dwivedi AM, 2015, INHAL TOXICOL, V27, P810, DOI 10.3109/08958378.2015.1115567; Ernstgard L, 2006, J OCCUP ENVIRON MED, V48, P573, DOI 10.1097/01.jom.0000215235.42071.68; Escalera J, 2008, J BIOL CHEM, V283, P24136, DOI 10.1074/jbc.M710280200; FERON VJ, 1991, MUTAT RES, V259, P363, DOI 10.1016/0165-1218(91)90128-9; HALL G, 1983, LEBENSM WISS TECHNOL, V16, P354; KOBAL G, 1991, SMELL TASTE HLTH DIS, P255; Lotsch J, 1998, CHEM SENSES, V23, P755, DOI 10.1093/chemse/23.6.755; Lundstrom JN, 2003, CHEM SENSES, V28, P643, DOI 10.1093/chemse/bjg057; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; Ni JQ, 2012, CHEMOSPHERE, V89, P769, DOI 10.1016/j.chemosphere.2012.04.061; Smeets MAM, 2006, INT ARCH OCC ENV HEA, V79, P299, DOI 10.1007/s00420-005-0053-8; STEINHAGEN WH, 1984, TOXICOL APPL PHARM, V72, P495, DOI 10.1016/0041-008X(84)90126-1; STEVENS JC, 1988, CHEM SENSES, V13, P643, DOI 10.1093/chemse/13.4.643; Svedberg URA, 2004, ANN OCCUP HYG, V48, P339, DOI 10.1093/annhyg/meh015; TROFIMOV L V, 1962, Gig Tr Prof Zabol, V6, P34; WEBERTSCHOPP A, 1977, INT ARCH OCC ENV HEA, V40, P117, DOI 10.1007/BF00575156; Wise PM, 2012, CHEM SENSES, V37, P509, DOI 10.1093/chemse/bjs002; Yrieix C, 2010, CHEMOSPHERE, V79, P414, DOI 10.1016/j.chemosphere.2010.01.062; Zheng L, 2010, PERCEPT MOTOR SKILL, V111, P210, DOI 10.2466/13.24.27.PMS.111.4.210-228	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185479	10.1371/journal.pone.0185479	http://dx.doi.org/10.1371/journal.pone.0185479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950007	gold, Green Published, Green Submitted			2022-12-26	WOS:000411671000057
J	Lampa, M; Arlt, H; He, T; Ospina, B; Reeves, J; Zhang, BL; Murtie, J; Deng, GJ; Barberis, C; Hoffmann, D; Cheng, H; Pollard, J; Winter, C; Richon, V; Garcia-Escheverria, C; Adrian, F; Wiederschain, D; Srinivasan, L				Lampa, Michael; Arlt, Heike; He, Timothy; Ospina, Beatriz; Reeves, Jason; Zhang, Bailin; Murtie, Joshua; Deng, Gejing; Barberis, Claude; Hoffmann, Dietmar; Cheng, Hong; Pollard, Jack; Winter, Christopher; Richon, Victoria; Garcia-Escheverria, Carlos; Adrian, Francisco; Wiederschain, Dmitri; Srinivasan, Lakshmi			Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition	PLOS ONE			English	Article							MECHANISM; ACTIVATION; TARGET; GLIOMA; ANALOG	Tumor cells display fundamental changes in metabolism and nutrient uptake in order to utilize additional nutrient sources to meet their enhanced bioenergetic requirements. Glutamine (Gln) is one such nutrient that is rapidly taken up by tumor cells to fulfill this increased metabolic demand. A vital step in the catabolism of glutamine is its conversion to glutamate by the mitochondrial enzyme glutaminase (GLS). This study has identified GLS a potential therapeutic target in breast cancer, specifically in the basal subtype that exhibits a deregulated glutaminolysis pathway. Using inducible shRNA mediated gene knockdown, we discovered that loss of GLS function in triple-negative breast cancer (TNBC) cell lines with a deregulated glutaminolysis pathway led to profound tumor growth inhibition in vitro and in vivo. GLS knockdown had no effect on growth and metabolite levels in non-TNBC cell lines. We rescued the anti-tumor effect of GLS knockdown using shRNA resistant cDNAs encoding both GLS isoforms and by addition of an a-ketoglutarate (aKG) analog thus confirming the critical role of GLS in TNBC. Pharmacological inhibition of GLS with the small molecule inhibitor CB-839 reduced cell growth and led to a decrease in mammalian target of rapamycin (mTOR) activity and an increase in the stress response pathway driven by activating transcription factor 4 (ATF4). Finally, we found that GLS inhibition synergizes with mTOR inhibition, which introduces the possibility of a novel therapeutic strategy for TNBC. Our study revealed that GLS is essential for the survival of TNBC with a deregulated glutaminolysis pathway. The synergistic activity of GLS and mTOR inhibitors in TNBC cell lines suggests therapeutic potential of this combination for the treatment of vulnerable subpopulations of TNBC.	[Lampa, Michael; Arlt, Heike; He, Timothy; Ospina, Beatriz; Reeves, Jason; Zhang, Bailin; Murtie, Joshua; Deng, Gejing; Hoffmann, Dietmar; Cheng, Hong; Pollard, Jack; Winter, Christopher; Richon, Victoria; Adrian, Francisco; Wiederschain, Dmitri; Srinivasan, Lakshmi] Sanofi, Oncol, Cambridge, MA 02139 USA; [Barberis, Claude] Sanofi, Integrated Drug Discovery Platform, Waltham, MA USA; [Garcia-Escheverria, Carlos] Sanofi, Res Platforms, Vitry Sur Seine, France	Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; Sanofi France	Srinivasan, L (corresponding author), Sanofi, Oncol, Cambridge, MA 02139 USA.	luxme508@gmail.com		Srinivasan, Lakshmi/0000-0003-1351-7407	Sanofi	Sanofi(Sanofi-Aventis)	The research was entirely funded by Sanofi. The funder provided support in the form of salaries for authors [ML, HA, TH, BO, JR BZ, JM, GD, CB, DH, HC, JP, CW, VR, CGE, FA, DW and LS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Budczies J, 2015, INT J CANCER, V136, P1619, DOI 10.1002/ijc.29152; Budczies J, 2013, J PROTEOMICS, V94, P279, DOI 10.1016/j.jprot.2013.10.002; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chia SK, 2012, CLIN CANCER RES, V18, P4465, DOI 10.1158/1078-0432.CCR-12-0286; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; de la Rosa V, 2009, NEUROCHEM INT, V55, P76, DOI 10.1016/j.neuint.2009.02.021; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Fathi AT, 2015, SEMIN HEMATOL, V52, P165, DOI 10.1053/j.seminhematol.2015.03.002; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gross M CJ, 2016, AACR ANN M NEW ORL U; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARTMAN SC, 1973, J BIOL CHEM, V248, P8506; Hartwick EW, 2012, J ENZYM INHIB MED CH, V27, P861, DOI 10.3109/14756366.2011.622272; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Incorporation CB, 2014, USA patent, Patent No. [US 2014/0369961 A1, 0369961]; Jacque N, 2015, BLOOD; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lyssiotis CA, 2013, CELL CYCLE, V12, P1987, DOI 10.4161/cc.25307; MEDINA MA, 1992, MOL CELL BIOCHEM, V113, P1; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohka F, 2014, TUMOR BIOL, V35, P5911, DOI 10.1007/s13277-014-1784-5; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Robert F, 2009, CHEM BIOL DRUG DES, V74, P57, DOI 10.1111/j.1747-0285.2009.00827.x; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; SHAPIRO RA, 1979, J BIOL CHEM, V254, P2835; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Straetemans R, 2005, BIOMETRICAL J, V47, P299, DOI 10.1002/bimj.200410124; Thomas AG, 2013, BIOCHEM BIOPH RES CO, V438, P243, DOI 10.1016/j.bbrc.2013.06.110; Ulanet DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115144; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	53	76	78	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185092	10.1371/journal.pone.0185092	http://dx.doi.org/10.1371/journal.pone.0185092			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950000	Green Submitted, Green Published, gold			2022-12-26	WOS:000411671000023
J	Yunga, ST; Kayatani, AK; Fogako, J; Leke, RJI; Leke, RGF; Taylor, DW				Yunga, Samuel Tassi; Kayatani, Alexander K.; Fogako, Josephine; Leke, Robert J. I.; Leke, Rose G. F.; Taylor, Diane W.			Timing of the human prenatal antibody response to Plasmodium falciparum antigens	PLOS ONE			English	Article							CORD BLOOD; IMMUNE-RESPONSES; GERMINAL CENTERS; FC-RECEPTOR; MALARIA; RISK; SYNCYTIOTROPHOBLAST; TRANSMISSION; PREVALENCE; INFECTION	Plasmodium falciparum (Pf)-specific T-and B-cell responses may be present at birth; however, when during fetal development antibodies are produced is unknown. Accordingly, cord blood samples from 232 preterm (20-37 weeks of gestation) and 450 term (>= 37 weeks) babies were screened for IgM to Pf blood-stage antigens MSP1, MSP2, AMA1, EBA175 and RESA. Overall, 25% [95% CI = 22-28%] of the 682 newborns were positive for IgM to >= 1 Pf antigens with the earliest response occurring at 22 weeks. Interestingly, the odds of being positive for cord blood Pf IgM decreased with gestational age (adjusted OR [95% CI] at 20-31 weeks = 2.55 [1.14-5.85] and at 32-36 weeks = 1.97 [0.92-4.29], with >= 37 weeks as reference); however, preterm and term newborns had similar levels of Pf IgM and recognized a comparable breadth of antigens. Having cord blood Pf IgM was associated with placental malaria (adjusted OR [95% CI] = 2.37 [1.25-4.54]). To determine if in utero exposure occurred via transplacental transfer of Pf-IgG immune complexes (IC), IC containing MSP1 and MSP2 were measured in plasma of 242 mother-newborn pairs. Among newborns of ICpositive mothers (77/242), the proportion of cord samples with Pf IC increased with gestational age but was not associated with Pf IgM, suggesting that fetal B cells early in gestation had not been primed by IC. Finally, when cord mononuclear cells from 64 term newborns were cultured in vitro, only 11% (7/64) of supernatants had Pf IgM; whereas, 95% (61/64) contained secreted Pf IgG. These data suggest fetal B cells are capable of making Pf-specific IgM from early in the second trimester and undergo isotype switching to IgG towards term.	[Yunga, Samuel Tassi; Kayatani, Alexander K.; Taylor, Diane W.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Fogako, Josephine; Leke, Rose G. F.] Univ Yaounde I, Biotechnol Ctr, Yaounde, Cameroon; [Leke, Robert J. I.; Leke, Rose G. F.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon	University of Hawaii System; University of Hawaii Manoa; University of Yaounde I; University of Yaounde I	Taylor, DW (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	dwtaylor@hawaii.edu	Yunga, Samuel Tassi/I-1936-2019	Yunga, Samuel Tassi/0000-0003-3631-2156	FIC NIH HHS [D43 TW009074] Funding Source: Medline; NIAID NIH HHS [U01 AI043888] Funding Source: Medline; NIGMS NIH HHS [P30 GM114737] Funding Source: Medline; NIMHD NIH HHS [U54 MD007584] Funding Source: Medline	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599; Achidi E A, 1997, Afr J Med Med Sci, V26, P167; Achidi EA, 2005, INT J INFECT DIS, V9, P159, DOI 10.1016/j.ijid.2004.06.012; ACHIDI EA, 1995, PARASITE IMMUNOL, V17, P535, DOI 10.1111/j.1365-3024.1995.tb00884.x; ALBARZANJI AJ, 1976, J CLIN PATHOL, V29, P675, DOI 10.1136/jcp.29.8.675; AlNassar KE, 1996, FORENSIC SCI INT, V78, P131, DOI 10.1016/0379-0738(95)01881-6; [Anonymous], 2004, STRATEGIC FRAMEWORK; BARZANJI AJ, 1978, EARLY HUM DEV, V1, P363, DOI 10.1016/0378-3782(78)90044-0; Baskin B, 1998, CLIN EXP IMMUNOL, V112, P44; Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028; BHAT NM, 1992, INT IMMUNOL, V4, P243, DOI 10.1093/intimm/4.2.243; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BOFILL M, 1985, J IMMUNOL, V134, P1531; Brent L., 2015, IMMUNOLOGY, V1958; Brickley EB, 2015, J INFECT DIS, V211, P436, DOI 10.1093/infdis/jiu454; Brustoski K, 2005, INFECT IMMUN, V73, P7988, DOI 10.1128/IAI.73.12.7988-7995.2005; Carlier Y, 2012, ACTA TROP, V121, P55, DOI 10.1016/j.actatropica.2011.10.018; CORKILL JA, 1989, ARCH DIS CHILD, V64, P541, DOI 10.1136/adc.64.4.541; CostaCarvalho BT, 1996, BRAZ J MED BIOL RES, V29, P201; Crocker IP, 2004, PLACENTA, V25, P273, DOI 10.1016/j.placenta.2003.09.010; DAVIES NP, 1992, ARCH DIS CHILD-FETAL, V67, P399, DOI 10.1136/adc.67.4_Spec_No.399; Deloron P, 1997, CLIN EXP IMMUNOL, V110, P212; Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950; Egwunyenga O. A., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P741; Fievet N, 1996, PARASITE IMMUNOL, V18, P483, DOI 10.1046/j.1365-3024.1996.d01-19.x; FONDJO E, 1992, B SOC PATHOL EXOT, V85, P57; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; GODFREY KM, 1991, BRIT J OBSTET GYNAEC, V98, P886, DOI 10.1111/j.1471-0528.1991.tb13510.x; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; GRANGEOTKEROS L, 1988, J INFECT DIS, V158, P138, DOI 10.1093/infdis/158.1.138; Griffin DO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00122; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Gude NM, 2004, GROWTH FUNCTION NORM, P397; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; HORN GT, 1989, NUCLEIC ACIDS RES, V17, P2140, DOI 10.1093/nar/17.5.2140; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Jakobsen PH, 1998, IMMUNOLOGY, V93, P264, DOI 10.1046/j.1365-2567.1998.00421.x; King CL, 2002, J IMMUNOL, V168, P356, DOI 10.4049/jimmunol.168.1.356; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Leke RGF, 2011, CLIN INFECT DIS, V53, P231, DOI 10.1093/cid/cir383; Macchiaverni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139064; MAENO Y, 1993, AM J TROP MED HYG, V49, P574, DOI 10.4269/ajtmh.1993.49.574; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; May K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007986; McNamara H, 2014, PAEDIATR PERINAT EP, V28, P97, DOI 10.1111/ppe.12104; Metenou S, 2007, J IMMUNOLOGY; Miller RL, 2001, AM J RESP CRIT CARE, V164, P995, DOI 10.1164/ajrccm.164.6.2011107; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Paloczi K, 1998, BONE MARROW TRANSPL, V22, pS89; Rechavi E, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0072; Redd SC, 1996, AM J TROP MED HYG, V55, P57, DOI 10.4269/ajtmh.1996.55.57; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rothstein TL, 2013, ANN NY ACAD SCI, V1285, P97, DOI 10.1111/nyas.12137; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Simister NE, 1998, HUMAN PLACENTAL FC R, P145; Stanisic DI, 2015, INFECT IMMUN, V83, P646, DOI 10.1128/IAI.02398-14; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc; Tena-Tomas C, 2007, PARASITOL RES, V101, P1045, DOI 10.1007/s00436-007-0585-9; THEOFILOPOULOS AN, 1981, AM J REPROD IMMUNOL, V1, P92, DOI 10.1111/j.1600-0897.1981.tb00024.x; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Uneke CJ, 2007, PARASITOL RES, V101, P835, DOI 10.1007/s00436-007-0577-9; Walker PGT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2605; Wittenbrink N, 2002, Dev Immunol, V9, P177, DOI 10.1080/1044667031000137665; World Health Organization, 2015, FACT SHEETS, P363; Xi GL, 2003, INFECT IMMUN, V71, P1242, DOI 10.1128/IAI.71.3.1242-1246.2003	74	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184571	10.1371/journal.pone.0184571	http://dx.doi.org/10.1371/journal.pone.0184571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950009	Green Submitted, gold, Green Published			2022-12-26	WOS:000411671000011
J	Battaglia, ME; Martin, MV; Lechner, L; Martinez-Noel, GMA; Salerno, GL				Battaglia, Marina E.; Victoria Martin, Maria; Lechner, Leandra; Martinez-Noel, Giselle M. A.; Salerno, Graciela L.			The riddle of mitochondrial alkaline/neutral invertases: A novel Arabidopsis isoform mainly present in reproductive tissues and involved in root ROS production	PLOS ONE			English	Article							HIGHER-PLANT MITOCHONDRIA; ABIOTIC STRESS TOLERANCE; SUCROSE METABOLISM; ABSCISIC-ACID; CYTOSOLIC INVERTASE; NEUTRAL INVERTASES; IMAGE-ANALYSIS; GROWTH; ROLES; THALIANA	Alkaline/neutral invertases (A/N-Inv), glucosidases that irreversibly hydrolyze sucrose into glucose and fructose, play significant roles in plant growth, development, and stress adaptation. They occur as multiple isoforms located in the cytosol or organelles. In Arabidopsis thaliana, two mitochondrial A/N-Inv genes (A/N-InvA and A/N-InvC) have already been investigated. In this study, we functionally characterized A/N-InvH, a third Arabidopsis gene coding for a mitochondrial-targeted protein. The phenotypic analysis of knockout mutant plants (invh) showed a severely reduced shoot growth, while root development was not affected. The emergence of the first floral bud and the opening of the first flower were the most affected stages, presenting a significant delay. A/N-InvH transcription is markedly active in reproductive tissues. It is also expressed in the elongation and apical meristem root zones. Our results show that A/N-InvH expression is not evident in photosynthetic tissues, despite being of relevance in developmental processes and mitochondrial functional status. NaCl and mannitol treatments increased A/N-InvH expression twofold in the columella root cap. Moreover, the absence of A/N-InvH prevented ROS formation, not only in invh roots of salt-and ABA-treated seedlings but also in invh control roots. We hypothesize that this isoform may take part in the ROS/sugar (sucrose or its hydrolysis products) signaling pathway network, involved in reproductive tissue development, cell elongation, and abiotic stress responses.	[Salerno, Graciela L.] INBIOTEC CONICET, Inst Invest Biodiversidad & Biotecnol, Mar Del Plata, Buenos Aires, Argentina; FIBA, Mar Del Plata, Buenos Aires, Argentina		Salerno, GL (corresponding author), INBIOTEC CONICET, Inst Invest Biodiversidad & Biotecnol, Mar Del Plata, Buenos Aires, Argentina.	gsalerno@fiba.org.ar	Battaglia, Marina E/AAC-1418-2021; martin, viky/GMX-1010-2022; Martínez-Noel, Giselle/AAP-2281-2020	Battaglia, Marina E/0000-0002-4300-4285; Martínez-Noel, Giselle/0000-0001-6468-3013; Salerno, Graciela/0000-0001-9177-4199; Martin, Maria Victoria/0000-0001-6015-7059	ANPCyT [PICT 2012 1288]; Universidad Nacional de Mar del Plata [15/ E693 EXA 743/15]; FIBA	ANPCyT(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata); FIBA	This research was funded by grants from ANPCyT (PICT 2012 1288), www.agencia.mincyt.gob.ar/, Universidad Nacional de Mar del Plata (15/ E693 EXA 743/15), www.mdp.edu.ar/, and FIBA, www.fiba.org.ar.; We are very thankful to C. Fernandez, Natalia Almada and Gonzalo Calo for technical assistance. This research was funded by grants from ANPCyT (PICT 1288), Universidad Nacional de Mar del Plata (15/E693 EXA 743/15), and FIBA.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Battaglia M, 2014, PLANT PHYSIOL, V164, P1430, DOI 10.1104/pp.113.230896; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bocock PN, 2008, PLANTA, V227, P565, DOI 10.1007/s00425-007-0639-3; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Bond JE, 1993, PLANT RESPONSES ENV; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Chen Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138540; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Dahro B, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0761-0; Dai H, 1998, EUR J CELL BIOL, V75, P198, DOI 10.1016/S0171-9335(98)80062-9; Distefano AM, 2017, J CELL BIOL; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Estrada-Navarrete G, 2007, NAT PROTOC, V2, P1819, DOI 10.1038/nprot.2007.259; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Hawkins John, 2006, Journal of Bioinformatics and Computational Biology, V4, P1, DOI 10.1142/S0219720006001771; He JN, 2012, PLANT CELL, V24, P1815, DOI 10.1105/tpc.112.098707; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang SB, 2016, PLANT PHYSIOL, V171, P1551, DOI 10.1104/pp.16.00166; Hyun TK, 2011, PLANT OMICS, V4, P391; Ji XM, 2005, J MOL EVOL, V60, P615, DOI 10.1007/s00239-004-0242-1; Keunen E, 2013, PLANT CELL ENVIRON, V36, P1242, DOI 10.1111/pce.12061; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; Lo YS, 2004, INT J PLANT SCI, V165, P949, DOI 10.1086/423884; Lou Y, 2007, PLANT CELL, V19, P163, DOI 10.1105/tpc.106.045658; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Martin ML, 2013, PLANTA, V237, P813, DOI 10.1007/s00425-012-1794-8; Martin MV, 2014, BIOPROTOCOL, V4; Meschini EP, 2008, MOL PLANT MICROBE IN, V21, P459, DOI 10.1094/MPMI-21-4-0459; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Murayama S, 2007, PLANTA, V225, P1193, DOI 10.1007/s00425-006-0430-x; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nonis A, 2008, PLANTA, V229, P129, DOI 10.1007/s00425-008-0815-0; Cordoba JP, 2016, J EXP BOT, V67, P1589, DOI 10.1093/jxb/erv556; Pratibha P, 2017, PLANT PHYSIOL, V174, P258, DOI 10.1104/pp.16.01482; Qi XP, 2007, PLANT MOL BIOL, V64, P575, DOI 10.1007/s11103-007-9177-4; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Rhoads DM, 2011, ADVAN PL BIO, V1, P411; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Sambrook J., 2001, MOL CLONING LAB MANU; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sturm A, 1999, PLANT PHYSIOL, V121, P1, DOI 10.1104/pp.121.1.1; Subbaiah CC, 2006, J BIOL CHEM, V281, P15625, DOI 10.1074/jbc.M600355200; Swanson S, 2010, PHYSIOL PLANTARUM, V138, P384, DOI 10.1111/j.1399-3054.2009.01313.x; Szarka A, 2008, PLANTA, V228, P765, DOI 10.1007/s00425-008-0778-1; Thelander M, 2009, ANNU PLANT REV, V36, P211, DOI 10.1111/b.9781405181891.2009.00009.x; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Vargas W, 2003, PLANTA, V216, P951, DOI 10.1007/s00425-002-0943-x; Vargas WA, 2008, PLANTA, V227, P795, DOI 10.1007/s00425-007-0657-1; Vargas WA, 2007, PLANTA, V226, P1535, DOI 10.1007/s00425-007-0590-3; Vargas WA, 2010, PLANT SCI, V178, P1, DOI 10.1016/j.plantsci.2009.09.015; Martin MV, 2013, PLANT CELL, V25, P1573, DOI 10.1105/tpc.113.109306; Vishwakarma K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00161; Wang Y, 2014, J EXP BOT, V65, P4159, DOI 10.1093/jxb/eru190; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Welham T, 2009, J EXP BOT, V60, P3353, DOI 10.1093/jxb/erp169; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Xie J, 2016, J BIOL CHEM, V291, P25667, DOI 10.1074/jbc.M116.759290; Yao Y, 2015, PLANT MOL BIOL REP, V33, P304, DOI 10.1007/s11105-014-0743-z	69	11	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185286	10.1371/journal.pone.0185286	http://dx.doi.org/10.1371/journal.pone.0185286			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945799	Green Submitted, Green Published, gold			2022-12-26	WOS:000411645100041
J	Li, L; Zheng, SH; Brinckmann, JA; Fu, J; Zeng, R; Huang, LF; Chen, SL				Li, Lin; Zheng, Sihao; Brinckmann, Josef A.; Fu, Juan; Zeng, Rui; Huang, Linfang; Chen, Shilin			Chemical and genetic diversity of Astragalus mongholicus grown in different eco-climatic regions	PLOS ONE			English	Article							IDENTIFICATION	Astragalus mongholicus Bunge (Fabaceae) is an important plant source of the herbal drug known as Radix Astragali, which is used worldwide as a medicinal ingredient and a component of food supplement. Russian Federation, Mongolia, Kazakhstan, and China are the main natural distribution areas of A. mongholicus in the world. However, the quality of medicinal plant varies among different locations. As for A. mongholicus, limited literature focused on its biodiversity mechanism. Here, we combined the chemometric analysis of chemical components with genetic variation, as well as climatic and edaphic traits, to reveal the biodiversity mechanism of A. mongholicus. Results showed that the detected chemical, genetic and climatic traits comprehensively contributed to the quality diversity of A. mongholicus. The eight main chemical components, as well as the inorganic elements of P, B and Na were all significant chemical factors. The precipitation and sunshine duration were the main distinguishing climatic factors. The inorganic elements As, Mn, P, Se and Pb were the distinguishing edaphic factors. The systematic method was firstly established for this medicinal plant in order to illustrate the formation of diversity in terms of quality, and provide scientific evidence for geographic indications and climatic adaptation in production and in the clinical application of herbal medicinal plants.	[Li, Lin; Zheng, Sihao; Fu, Juan; Huang, Linfang] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Li, Lin; Zheng, Sihao; Fu, Juan; Huang, Linfang] Peking Union Med Coll, Beijing, Peoples R China; [Brinckmann, Josef A.] Tradit Med, Sustainabil Dept, Sebastopol, CA USA; [Zeng, Rui] Southwest Univ Nationalities, Chengdu, Sichuan, Peoples R China; [Chen, Shilin] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Southwest Minzu University; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Huang, LF (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.; Huang, LF (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	lfhuang@implad.ac.cn	Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198; BRINCKMANN, JOSEF/0000-0002-5944-3776	National Natural Science Foundation of China [81274013, 81473315]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-12M-3-015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS)	Funding from the National Natural Science Foundation of China (Nos. 81274013 and 81473315) and CAMS Innovation Fund for Medical Sciences (CIFMS, No. 2016-12M-3-015) is gratefully acknowledged (website: www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Traditional Medicinals provided support in the form of salaries for author JAB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bai X Z Y., 2012, CHIN J MOD APPL PHAR, V29, P4; BIAN YYJ, 2006, J CHINESE PHARM SCI, V41, P5, DOI DOI 10.1093/MOLBEV/MST197; Brinckmann JA, 2015, WORLD J TRADITIONAL, V1, P16, DOI DOI 10.15806/j.issn.2311-8571.2014.0020; Chen SL, 2015, SCIENCE, V347, pS27; Chen X Z M. R., 2008, TIANJIN PHARM, V20, P2; DUAN LX, MOL PLANT, V5, P376, DOI DOI 10.1186/1471-2164-13-195; Feng Shan-shan, 2014, Yaoxue Xuebao, V49, P260; Fu J, 2013, J ASIAN NAT PROD RES, V15, P687, DOI 10.1080/10286020.2013.778832; GE YLQ, 2009, CHINESE J PHARM ANAL, V29, P7, DOI DOI 10.3964/J.ISSN.1000-0593(2011)05-1258-04; Guo BL Z L. T., 2009, CHINA J CHINESE MAT, V34, P3; He Pan, 2013, Yaoxue Xuebao, V48, P1595; Huang LF L W. T., 2013, ACTA ECOLOGICA SINIC, V33, P12; Huang LF Z S. H., 2014, SCI SINICA, V44, P11; Huang RS Q D. J., 2012, CHINESE TRADITIONAL, V43, P4; JIAO F, 2007, RECOMMENDATIONS PROT; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Lei Lian-Di, 2008, Zhongguo Zhong Yao Za Zhi, V33, P255; LI L, 2016, MOL BASEL SWITZERLAN, V21; Liu BW, 2012, SPECTROSC SPECT ANAL, V32, P2981, DOI 10.3964/j.issn.1000-0593(2012)11-2981-06; Liu J, 2011, BIOL PHARM BULL, V34, P1404, DOI 10.1248/bpb.34.1404; LIU WJS, 2013, J BEIJING U TRAD CHI, V36, P4, DOI DOI 10.1016/J.JEP.2012.01.048; Qian D H L., 2009, CHINA J CHINESE MAT, V34, P4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang ZQ J J. M., 2010, CHINESE J PHARM ANAL, V30, P4; Xiao WL, 2011, J AGR FOOD CHEM, V59, P1548, DOI 10.1021/jf1028174; Yao XL P C. Y, 2012, CHINESE J PHARM ANAL, V32, P4; Yuan YF, 2011, SPECTROSC SPECT ANAL, V31, P1258, DOI 10.3964/j.issn.1000-0593(2011)05-1258-04; Yuan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-195; Zhang Qiang, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3203; Zhang XM, 2007, LISHIZHEN MED MAT ME, V18, P2; Zhao ZZ, 2012, J ETHNOPHARMACOL, V140, P476, DOI 10.1016/j.jep.2012.01.048; ZHENG S, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1016/J.GENE.2008.10.012; Zheng SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098061	33	15	17	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184791	10.1371/journal.pone.0184791	http://dx.doi.org/10.1371/journal.pone.0184791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945770	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100010
J	Choi, J; Kwon, J; Shin, JW; Lee, J; Lee, S; Kook, MS				Choi, Jaewan; Kwon, Junki; Shin, Joong Won; Lee, Jiyun; Lee, Saem; Kook, Michael S.			Quantitative optical coherence tomography angiography of macular vascular structure and foveal avascular zone in glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OCULAR PERFUSION-PRESSURE; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; HEAD BLOOD-FLOW; RISK-FACTOR; NONINVASIVE VISUALIZATION; CIRCADIAN FLUCTUATION; INTRAOCULAR-PRESSURE; DIABETIC-RETINOPATHY	Objective The study aimed to evaluate the quantitative characteristics of the macular vessel density (VD) and foveal avascular zone (FAZ) in glaucoma using optical coherence tomography angiography (OCT-A). Design Cross-sectional, age-and sex-matched case-control study. Methods Fifty-two eyes of 52 patients with primary open angle glaucoma and 52 eyes from 52 healthy participants were recruited retrospectively. OCT-A was performed on a 3 x 3-mm macular region centered on the fovea. OCT-A scans were manually graded to define the FAZ. Paraf-oveal VD in superficial and deep retina were analyzed in the circular-and quadrant-segmented zone. The FAZ parameters included size, perimeter, and circularity index. The regression analysis among VD and FAZ-related parameters and ocular parameters was performed, and the diagnostic ability was calculated with refractive error adjusted. Results For both groups, the mean age and the sex ratio was not different between groups. With refractive error adjusted, the average macular VD was lower in glaucoma than in the control group for superficial (P = 0.013), deep (P < 0.001), and the whole retina (P = 0.002). There were increased FAZ perimeter and decreased FAZ circularity index in glaucoma when compared with controls (P < 0.001). In the multivariate regression models, FAZ circularity index were significantly associated with decreased peripapillary RNFL thickness (P = 0.007) and macular GCIPL thickness (P = 0.009) measured by OCT. The refractive-error adjusted area under receiver operating characteristics was highest for FAZ circularity index (0.905; 95% CI, 0.844-0.966), followed by temporal deep retinal VD (0.870; 95% CI, 0.803-0.937) and FAZ perimeter (0.858; 95% CI, 0.784-0.932). Conclusions Decreased macular VD, increased FAZ perimeter, and decreased FAZ circularity index were observed in eyes with glaucoma using OCT-A. With refractive error adjusted, these parameters showed considerable diagnostic value for glaucoma. FAZ circularity index may be a novel biomarker representing disruption of the parafoveal capillary network in glaucoma, as supported by its association with structural parameters.	[Choi, Jaewan; Lee, Saem] Cent Seoul Eye Ctr, Seoul, South Korea; [Kwon, Junki; Shin, Joong Won; Lee, Jiyun; Kook, Michael S.] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kook, MS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea.	mskook@amc.seoul.kr						Abe RY, 2016, OPHTHALMOLOGY, V123, P552, DOI 10.1016/j.ophtha.2015.10.046; Adhi M, 2016, INVEST OPHTH VIS SCI, V57, pOCT486, DOI 10.1167/iovs.15-18907; Al-Sheikh M, 2017, INVEST OPHTH VIS SCI, V58, P2063, DOI 10.1167/iovs.16-21289; AREND O, 1991, BRIT J OPHTHALMOL, V75, P514, DOI 10.1136/bjo.75.9.514; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; Banitt M, 2013, CURR OPIN OPHTHALMOL, V24, P125, DOI 10.1097/ICU.0b013e32835d9245; Bojikian KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154691; Browning DJ, 2012, ANATOMY PATHOLOGIC A, P12; CARTER CJ, 1990, OPHTHALMOLOGY, V97, P49; CARTWRIGHT MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P898; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615; Choi J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141905; Choi J, 2013, INVEST OPHTH VIS SCI, V54, P6150, DOI 10.1167/iovs.13-12093; Conrath J, 2005, EYE, V19, P322, DOI 10.1038/sj.eye.6701456; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di G, 2016, GRAEF ARCH CLIN EXP, V254, P873, DOI 10.1007/s00417-015-3143-7; Domalpally A, 2013, OPHTHALMOLOGY, V120, P2666, DOI 10.1016/j.ophtha.2013.07.047; Flammer J, 1998, PROG RETIN EYE RES, V17, P267, DOI 10.1016/S1350-9462(97)00006-2; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Freiberg FJ, 2016, GRAEF ARCH CLIN EXP, V254, P1051, DOI 10.1007/s00417-015-3148-2; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; HAMARD P, 1994, BRIT J OPHTHALMOL, V78, P449, DOI 10.1136/bjo.78.6.449; Harris A, 1998, SURV OPHTHALMOL, V42, P509, DOI 10.1016/S0039-6257(98)00011-3; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kaiser HJ, 1997, AM J OPHTHALMOL, V123, P320, DOI 10.1016/S0002-9394(14)70127-8; Kang JW, 2016, RETINA PHILADELPHIA; Kim DY, 2012, INVEST OPHTH VIS SCI, V53, P85, DOI 10.1167/iovs.11-8249; Kim HJ, 2016, INVEST OPHTH VIS SCI, V57, P4799, DOI 10.1167/iovs.16-19214; Kim TW, 2013, CURR EYE RES, V38, P903, DOI 10.3109/02713683.2013.800888; Kuehlewein L, 2015, INVEST OPHTH VIS SCI, V56, P3984, DOI 10.1167/iovs.15-16510; Kwon J, 2017, INVEST OPHTH VIS SCI, V58, P1637, DOI 10.1167/iovs.16-21079; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Leveque PM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6956717; Mammo Z, 2016, AM J OPHTHALMOL, V170, P41, DOI 10.1016/j.ajo.2016.07.015; Mendis KR, 2010, INVEST OPHTH VIS SCI, V51, P5864, DOI 10.1167/iovs.10-5333; Nicolela MT, 1996, AM J OPHTHALMOL, V122, P775, DOI 10.1016/S0002-9394(14)70373-3; Okada M, 2014, OPHTHALMOLOGY, V121, P763, DOI 10.1016/j.ophtha.2013.09.049; Muniz JAPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115291; Polska E, 2004, BRIT J OPHTHALMOL, V88, P533, DOI 10.1136/bjo.2003.028480; Rao HL, 2016, AM J OPHTHALMOL, V171, P75, DOI 10.1016/j.ajo.2016.08.030; ROJANAPONGPUN P, 1993, GRAEF ARCH CLIN EXP, V231, P375, DOI 10.1007/BF00919643; SCHULZER M, 1992, OPHTHALMOLOGY, V99, P1468; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Shiga Y, 2016, CURR EYE RES, V41, P1447, DOI 10.3109/02713683.2015.1127974; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sommer A, 2011, ARCH OPHTHALMOL-CHIC, V129, P785, DOI 10.1001/archophthalmol.2011.117; Spraul CW, 2002, VISION RES, V42, P923, DOI 10.1016/S0042-6989(02)00022-6; Sung KR, 2011, INVEST OPHTH VIS SCI, V52, P737, DOI 10.1167/iovs.10-5351; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Tan CS, 2016, INVEST OPHTH VIS SCI, V57, pOCT224, DOI 10.1167/iovs.15-18869; Tan CS, 2016, AM J OPHTHALMOL, V165, P201, DOI 10.1016/j.ajo.2016.02.035; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Weinreb R N, 1994, J Glaucoma, V3 Suppl 1, pS55; WOLF S, 1993, OPHTHALMOLOGY, V100, P1561; XU H, 2016, MEDICINE, V95; Yarmohammadi A., 2016, OPHTHALMOLOGY; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944; Yousefi S, 2014, PHYS MED BIOL, V59, P6693, DOI 10.1088/0031-9155/59/22/6693; Yousefi S, 2013, BIOMED OPT EXPRESS, V4, P1214, DOI 10.1364/BOE.4.001214	60	70	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184948	10.1371/journal.pone.0184948	http://dx.doi.org/10.1371/journal.pone.0184948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934255	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900062
J	Serrano-Aroca, A; Deb, S				Serrano-Aroca, Angel; Deb, Sanjukta			Synthesis of irregular graphene oxide tubes using green chemistry and their potential use as reinforcement materials for biomedical applications	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; FILMS; FABRICATION; LIGHTWEIGHT; IONS	Micrometer length tubes of graphene oxide (GO) with irregular form were synthesised following facile and green metal complexation reactions. These materials were obtained by crosslinking of GO with calcium, zinc or strontium chlorides at three different temperatures (24, 34 and 55 degrees C) using distilled water as solvent for the compounds and following a remarkably simple and low-cost synthetic method, which employs no hazardous substances and is conducted without consumption of thermal or sonic energy. These irregular continuous GO networks showed a very particular interconnected structure by Field Emission Scanning Electron Microscopy with Energy-Disperse X-Ray Spectroscopy for elemental analysis and High-resolution Transmission Electron Microscopy with Scanning Transmission Electron Microscope Dark Field Imaging, and were analysed by Raman Spectroscopy. To demonstrate the potential use of these 3D GO networks as reinforcement materials for biomedical applications, two composites of calcium alginate with irregular tubes of GO and with single GO nanosheets were prepared with the same amount of GO and divalent atoms and analysed. Thus, the dynamic-mechanical modulus of the composites synthesised with the 3D crosslinked GO networks showed a very significant mechanical improvement due to marked microstructural changes confirmed by confocal microscopy, differential scanning calorimetry and Fourier transform infrared spectroscopy.	[Serrano-Aroca, Angel] Univ Catolica Valencia San Vicente Martir, Fac Vet & Ciencias Aplicadas, Bioengn & Cellular Therapy Grp, C Guillem Castro 94, Valencia, Spain; [Deb, Sanjukta] Kings Coll London, Div Tissue Engn & Biophoton, Dent Inst, Guys Hosp, Tower Wing, London, England	Universidad Catolica de Valencia San Vicente Martir; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Serrano-Aroca, A (corresponding author), Univ Catolica Valencia San Vicente Martir, Fac Vet & Ciencias Aplicadas, Bioengn & Cellular Therapy Grp, C Guillem Castro 94, Valencia, Spain.	angel.serrano@ucv.es	Serrano-Aroca, Ángel/H-3809-2015	Serrano-Aroca, Ángel/0000-0002-9953-3848	Universidad Catolica de Valencia "San Vicente Martir" [2015-162-001UCV, 2017-231-001UCV]	Universidad Catolica de Valencia "San Vicente Martir"	This work was supported by the 2015-162-001UCV and 2017-231-001UCV grants from the Universidad Catolica de Valencia "San Vicente Martir."	Annabi N, 2016, ADV MATER, V28, P40, DOI 10.1002/adma.201503255; [Anonymous], 2014, GRAPHENE OXIDE PHYS; [Anonymous], GRAPHENE OXIDE; Bai H, 2011, J PHYS CHEM C, V115, P5545, DOI 10.1021/jp1120299; Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191; Boyd D, 2006, J MATER SCI-MATER M, V17, P489, DOI 10.1007/s10856-006-8930-6; Cancado LG, 2011, NANO LETT, V11, P3190, DOI 10.1021/nl201432g; Cao L, 2017, MAT SCI ENG C-MATER, V79, P697, DOI 10.1016/j.msec.2017.05.056; Cha C., 2014, TISSUE ENG; Criado A, 2015, ANGEW CHEM INT EDIT, V54, P10734, DOI 10.1002/anie.201501473; Doran PM, 2013, BIOPROCESS ENGINEERING PRINCIPLES, 2ND EDITION, P1; DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7; Faghihi S, 2014, J APPL PHYS, P115; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Foo ME, 2017, BIOMED PHARMACOTHER, V94, P354, DOI 10.1016/j.biopha.2017.07.122; Geng Z, 2016, MAT SCI ENG C-MATER, V58, P467, DOI 10.1016/j.msec.2015.08.061; Ghadim EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079254; Giusca CE, 2015, CARBON, V86, P188, DOI 10.1016/j.carbon.2015.01.035; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Gupta A, 2006, NANO LETT, V6, P2667, DOI 10.1021/nl061420a; He YQ, 2012, CARBOHYD POLYM, V88, P1100, DOI 10.1016/j.carbpol.2012.01.071; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Ionita M, 2013, CARBOHYD POLYM, V94, P339, DOI 10.1016/j.carbpol.2013.01.065; Kahlert JU, 2016, CHEM COMMUN, V52, P1290, DOI 10.1039/c5cc07611k; Kaplan D. L., 1998, BIOPOLYMERS RENEWABL; Kemp KC, 2012, FUNCTIONALIZATION GR, DOI [10.1021/cr3000412, DOI 10.1021/CR3000412]; Li H, 2013, SCIENCE, V342, P95, DOI 10.1126/science.1236686; Lin Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep11662; Liu YT, 2011, CARBON, V49, P3371, DOI 10.1016/j.carbon.2011.03.055; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Park M, 2011, CARBON, V49, P811, DOI 10.1016/j.carbon.2010.10.019; Park S, 2008, ACS NANO, V2, P572, DOI 10.1021/nn700349a; Parlak O, 2017, NANO ENERGY, V34, P570, DOI 10.1016/j.nanoen.2017.03.004; Paz E, 2017, MAT SCI ENG C-MATER, V77, P1003, DOI 10.1016/j.msec.2017.03.269; Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7; Rao KS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04237; Ratner B.D., 2012, BIOMATERIALS SCI INT; Rhim JW, 2004, LEBENSM-WISS TECHNOL, V37, P323, DOI 10.1016/j.lwt.2003.09.008; Sartori C, 1997, POLYMER, V38, P43, DOI 10.1016/S0032-3861(96)00458-2; Schuchardt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08839; Serrano-Aroca A, 2017, SCI REP IN PRESS; Shen XP, 2016, GREEN CHEM, V18, P53, DOI 10.1039/c5gc02396c; Shin SR, 2016, ADV DRUG DELIVER REV, V105, P255, DOI 10.1016/j.addr.2016.03.007; Silva EL, 2017, ADV MATER INTERFACES, V4, DOI 10.1002/admi.201700019; Sitko R, 2013, DALTON T, V42, P5682, DOI 10.1039/c3dt33097d; Solanki A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01553; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Stengl V, 2014, CARBON, V67, P336, DOI 10.1016/j.carbon.2013.10.003; Tiginyanu I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32913; Vauchel P, 2008, FOOD BIOPROCESS TECH, V1, P297, DOI 10.1007/s11947-008-0082-x; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449; Xie H, 2017, DENT MATER, V33, P765, DOI 10.1016/j.dental.2017.04.008; Xie RH, 2016, CARBOHYD POLYM, V138, P222, DOI 10.1016/j.carbpol.2015.11.042; Yadav M, 2014, CARBOHYD POLYM, V110, P18, DOI 10.1016/j.carbpol.2014.03.037; Yin PT, 2015, CHEM REV, V115, P2483, DOI 10.1021/cr500537t; Zactiti EM, 2009, PACKAG TECHNOL SCI, V22, P349, DOI 10.1002/pts.860; Zhang HJ, 2015, RSC ADV, V5, P89073, DOI 10.1039/c5ra19637j; Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522; Zhao G, 2011, FEW LAYERED GRAPHENE, P10454; Zhao GX, 2011, DALTON T, V40, P10945, DOI 10.1039/c1dt11005e	63	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185235	10.1371/journal.pone.0185235	http://dx.doi.org/10.1371/journal.pone.0185235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934354	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900131
J	Teruya, K; Oguma, A; Nishizawa, K; Kamitakahara, H; Dohura, K				Teruya, Kenta; Oguma, Ayumi; Nishizawa, Keiko; Kamitakahara, Hiroshi; Dohura, Katsumi			DPyrene conjugation and spectroscopic analysis of hydroxypropyl methylcellulose compounds successfully demonstrated a local dielectric difference associated with in vivo anti-prion activity	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; DIBLOCK METHYLCELLULOSE; FLUORESCENCE PROBE; PHAGOCYTIC UPTAKE; AQUEOUS-SOLUTION; PARTICLE-SIZE; DERIVATIVES; CELLULOSE; MICE	Our previous study on prion-infected rodents revealed that hydroxypropyl methylcellulose compounds (HPMCs) with different molecular weights but similar composition and degree of substitution have different levels of long-lasting anti-prion activity. In this study, we searched these HPMCs for a parameter specifically associated with in vivo anti-prion activity by analyzing in vitro chemical properties and in vivo tissue distributions. Infrared spectroscopic and thermal analyses revealed no differences among HPMCs, whereas pyrene conjugation and spectroscopic analysis revealed that the fluorescence intensity ratio of peak III/peak I correlated with anti-prion activity. This correlation was more clearly demonstrated in the anti-prion activity of the 1-year pre-infection treatment than that of the immediate postinfection treatment. In addition, the intensity ratio of peak III/peak I negatively correlated with the macrophage uptake level of HPMCs in our previous study. However, the in vivo distribution pattern was apparently not associated with anti-prion activity and was different in the representative tissues. These findings suggest that pyrene conjugation and spectroscopic analysis are powerful methods to successfully demonstrate local dielectric differences in HPMCs and provide a feasible parameter denoting the long-lasting anti-prion activity of HPMCs in vivo.	[Teruya, Kenta; Oguma, Ayumi; Nishizawa, Keiko; Dohura, Katsumi] Tohoku Univ, Dept Neurochem, Grad Sch Med, Sendai, Miyagi, Japan; [Kamitakahara, Hiroshi] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Kyoto, Kyoto, Japan	Tohoku University; Kyoto University	Dohura, K (corresponding author), Tohoku Univ, Dept Neurochem, Grad Sch Med, Sendai, Miyagi, Japan.	doh-ura@med.tohoku.ac.jp	Kamitakahara, Hiroshi/L-6710-2018; Teruya, Kenta/L-1530-2019	Kamitakahara, Hiroshi/0000-0002-0130-1919; 	Japan Agency for Medical Research and Development [15ek0109012h0002, 16ek0109012h0003]; Ministry of Health, Labor and Welfare [nanchi-ippan-H26-017]; Japan Society for the Promotion of Science [22390172]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from Japan Agency for Medical Research and Development (15ek0109012h0002, 16ek0109012h0003) (http://www.amed.go.jp/en/), Ministry of Health, Labor and Welfare (nanchi-ippan-H26-017) (http://www.mhlw.go.jp/english/index.html) and Japan Society for the Promotion of Science (22390172) (https://www.jsps.go.jp/english/index.html) to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama E, 2007, J COLLOID INTERF SCI, V311, P438, DOI 10.1016/j.jcis.2007.03.009; ASANO H, 1989, COLLOID POLYM SCI, V267, P935, DOI 10.1007/BF01410343; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; Bruce ME, 2000, IMMUNOL TODAY, V21, P442, DOI 10.1016/S0167-5699(00)01696-0; Burdock GA, 2007, FOOD CHEM TOXICOL, V45, P2341, DOI 10.1016/j.fct.2007.07.011; DONG DC, 1984, CAN J CHEM, V62, P2560, DOI 10.1139/v84-437; Evertsson H, 1997, MACROMOLECULES, V30, P2377, DOI 10.1021/ma961552y; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Ford JL, 1999, INT J PHARM, V179, P209, DOI 10.1016/S0378-5173(98)00339-1; FORSTER T, 1969, ANGEW CHEM INT EDIT, V8, P333, DOI 10.1002/anie.196903331; Giles K, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a023747; GORZINSKI SJ, 1986, DRUG CHEM TOXICOL, V9, P83, DOI 10.3109/01480548608998268; Hifumi H, 2016, INT J PHARMACEUT, V515, P57, DOI 10.1016/j.ijpharm.2016.09.085; ILLUM L, 1986, INT J PHARM, V29, P53; Iwasaki Y, 2017, NEUROPATHOLOGY, V37, P174, DOI 10.1111/neup.12355; Joshi SC, 2011, MATERIALS, V4, P1861, DOI 10.3390/ma4101861; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Kenward AG, 2007, BIOCHEMISTRY-US, V46, P4261, DOI 10.1021/bi602473r; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; KNIGHT HF, 1952, J AM PHARM ASSOC SCI, V41, P427, DOI 10.1002/jps.3030410807; Kulicke WM, 2005, MACROMOL SYMP, V223, P151, DOI 10.1002/masy.200550511; Makino K, 2003, COLLOID SURFACE B, V27, P33, DOI 10.1016/S0927-7765(02)00042-5; Muller RH, 1997, PHARMACEUT RES, V14, P18, DOI 10.1023/A:1012043131081; Nakagawa A, 2012, LANGMUIR, V28, P12609, DOI 10.1021/la3026528; Nakagawa A, 2011, J POLYM SCI POL CHEM, V49, P4964, DOI 10.1002/pola.24952; Nakagawa A, 2011, J POLYM SCI POL PHYS, V49, P1539, DOI 10.1002/polb.22343; NAKAJIMA A, 1971, B CHEM SOC JPN, V44, P3272, DOI 10.1246/bcsj.44.3272; [Nutrient Sources added to Food (ANS) EFSA Panel on Food Additives], 2015, EFSA J, V13, P4088, DOI DOI 10.2903/j.efsa.2015.4088; OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Raeber A J, 2001, Dev Immunol, V8, P291, DOI 10.1155/2001/95404; Salman H, 2006, EXP BIOL MED, V231, P112; SARKAR N, 1995, CARBOHYD POLYM, V27, P177, DOI 10.1016/0144-8617(95)00061-B; Sim Valerie L., 2009, Infectious Disorders - Drug Targets, V9, P81; Stewart LA, 2008, NEUROLOGY, V70, P1272, DOI 10.1212/01.wnl.0000308955.25760.c2; Teruya K, 2016, COLD SPRING HARBOR P, V7; Teruya K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006045; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; WINNIK FM, 1987, J PHYS CHEM-US, V91, P594, DOI 10.1021/j100287a021	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185357	10.1371/journal.pone.0185357	http://dx.doi.org/10.1371/journal.pone.0185357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934337	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900149
J	Weyrauch, AK; Jakob, M; Schierhorn, A; Klosgen, RB; Hinderberger, D				Weyrauch, Anna Katharina; Jakob, Mario; Schierhorn, Angelika; Kloesgen, Ralf Bernd; Hinderberger, Dariush			Purification of rabbit serum histidine-proline-rich glycoprotein via preparative gel electrophoresis and characterization of its glycosylation patterns	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; HIGH-AFFINITY; BLOOD-PLASMA; BINDS; CARBOXYMETHYLCELLULOSE; SEQUENCE; CADMIUM; HEME; ZINC	Histidine-Proline-rich Glycoprotein (HPRG) is a plasma protein of vertebrates and several marine bivalves. Due to its multidomain structure consisting of several regions HPRG can interact with a variety of ligands, however the exact physiological role has not been discovered yet. Past purification approaches out of plasma or serum often led to co-purification of other proteins so that for a profound understanding of the function it is important to obtain a protein of high purity. Recent purification strategies were based upon metale chelate affinity chromatography followed by anion exchange chromatography or size exclusion chromatography, respectively. A large amount of serum albumin, the major plasma protein, also elutes from metale chelate affinity chromatography columns. Separation of rabbit HPRG from rabbit serum albumin could not be achieved via the above named methods by us. We present a method of purification of rabbit serum HPRG by means of metal affinity chromatography and preparative gel electrophoresis, which makes it possible to obtain HPRG practically devoid of impurities as assessed by mass spectrometry analysis. Moreover, we characterize the amount of glycosylation of HPRG and-to the best of our knowledge for the first time-the glycosylation pattern of rabbit HPRG.	[Weyrauch, Anna Katharina; Hinderberger, Dariush] Martin Luther Univ Halle Wittenberg, Div Phys Chem, Inst Chem, Halle An Der Saale, Saxony Anhalt, Germany; [Jakob, Mario; Kloesgen, Ralf Bernd] Martin Luther Univ Halle Wittenberg, Div Plant Physiol, Inst Biol, Halle An Der Saale, Saxony Anhalt, Germany; [Schierhorn, Angelika] Martin Luther Univ Halle Wittenberg, Serv Unit Mass Spectrometry, Inst Biochem & Biotechnol, Halle An Der Saale, Saxony Anhalt, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Hinderberger, D (corresponding author), Martin Luther Univ Halle Wittenberg, Div Phys Chem, Inst Chem, Halle An Der Saale, Saxony Anhalt, Germany.	dariush.hinderberger@chemie.uni-halle.de	Hinderberger, Dariush/B-7865-2008					Abebe AT, 2007, COMP BIOCHEM PHYS B, V147, P74, DOI 10.1016/j.cbpb.2006.12.010; Borza DB, 1996, BIOCHEMISTRY-US, V35, P1925, DOI 10.1021/bi952061t; Castellanos-Serra L, 1999, ELECTROPHORESIS, V20, P732, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<732::AID-ELPS732>3.3.CO;2-H; GUTHANS SL, 1982, ARCH BIOCHEM BIOPHYS, V218, P320, DOI 10.1016/0003-9861(82)90350-2; Hauer RS, 2013, BBA-MOL CELL RES, V1833, P957, DOI 10.1016/j.bbamcr.2013.01.030; HAUPT H, 1972, H-S Z PHYSIOL CHEM, V353, P1125, DOI 10.1515/bchm2.1972.353.2.1125; HEIMBURGER N, 1972, H-S Z PHYSIOL CHEM, V353, P1133, DOI 10.1515/bchm2.1972.353.2.1133; Hennis B, 1991, EVALUATION SITES SYN; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Jones AL, 2004, J BIOL CHEM, V279, P30114, DOI 10.1074/jbc.M401996200; Kassaar O, 2014, BLOOD, V123, P1948, DOI 10.1182/blood-2013-11-535963; KOIDE T, 1987, FEBS LETT, V216, P17, DOI 10.1016/0014-5793(87)80748-2; KOIDE T, 1982, FEBS LETT, V141, P222, DOI 10.1016/0014-5793(82)80052-5; KOIDE T, 1986, BIOCHEMISTRY-US, V25, P2220, DOI 10.1021/bi00356a055; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; LEUNG LLK, 1986, J CLIN INVEST, V77, P1305, DOI 10.1172/JCI112435; LIJNEN HR, 1980, J BIOL CHEM, V255, P214; LODISH HF, 1993, J BIOL CHEM, V268, P20598; Miller I, 2004, PROTEOMICS, V4, P257, DOI 10.1002/pmic.200300546; MORGAN WT, 1978, BIOCHIM BIOPHYS ACTA, V535, P319, DOI 10.1016/0005-2795(78)90098-3; MORGAN WT, 1981, BIOCHEMISTRY-US, V20, P1054, DOI 10.1021/bi00508a002; Nair PS, 1999, ARCH BIOCHEM BIOPHYS, V366, P8, DOI 10.1006/abbi.1999.1196; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patel KK, 2013, IUBMB LIFE, V65, P550, DOI 10.1002/iub.1168; Poon IKH, 2011, BLOOD, V117, P2093, DOI 10.1182/blood-2010-09-303842; Poon IKH, 2010, INT J BIOCHEM CELL B, V42, P1507, DOI 10.1016/j.biocel.2010.05.008; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ronca F, 2015, BIOCHIMIE, V118, P207, DOI 10.1016/j.biochi.2015.09.024; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Simantov R, 2001, J CLIN INVEST, V107, P45, DOI 10.1172/JCI9061; SMITH A, 1985, THROMB RES, V40, P653, DOI 10.1016/0049-3848(85)90303-2; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TSUTSUI K, 1982, J BIOL CHEM, V257, P3925; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wakabayashi S, 2013, INT REV CEL MOL BIO, V304, P467, DOI 10.1016/B978-0-12-407696-9.00009-9; Wang BL, 2014, J AM SOC MASS SPECTR, V25, P729, DOI 10.1007/s13361-013-0823-6; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	39	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184968	10.1371/journal.pone.0184968	http://dx.doi.org/10.1371/journal.pone.0184968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934288	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900067
J	Zarychta-Wisniewska, W; Burdzinska, A; Zagozdzon, R; Dybowski, B; Butrym, M; Gajewski, Z; Paczek, L				Zarychta-Wisniewska, Weronika; Burdzinska, Anna; Zagozdzon, Radoslaw; Dybowski, Bartosz; Butrym, Marta; Gajewski, Zdzislaw; Paczek, Leszek			In vivo imaging system for explants analysis-A new approach for assessment of cell transplantation effects in large animal models	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PRECURSOR CELLS; VITRO; DIFFERENTIATION; THERAPY; AUTOFLUORESCENCE	Introduction Despite spectacular progress in cellular transplantology, there are still many concerns about the fate of transplanted cells. More preclinical studies are needed, especially on large animal models, to bridge the translational gap between basic research and the clinic. Herein, we propose a novel approach in analysis of cell transplantation effects in large animals explants using in vivo imaging system (IVIS (R)) or similar equipment. Material and methods In the in vitro experiment cells labeled with fluorescent membrane dyes: DID (far red) or PKH26 (orange) were visualized with IVIS (R). The correlation between the fluorescence signal and cell number with or without addition of minced muscle tissue was calculated. In the ex vivo study urethras obtained from goats after intraurethral cells (n = 9) or PBS (n = 4) injections were divided into 0.5 cm cross-slices and analyzed by using IVIS (R). Automatic algorithm followed or not by manual setup was used to separate specific dye signal from tissue autofluorescence. The results were verified by systematic microscopic analysis of standard 10 mu m specimens prepared from slices before and after immunohistochemical staining. Comparison of obtained data was performed using diagnostic test function. Results Fluorescence signal strength in IVIS (R) was directly proportional to the number of cells regardless of the dye used and detectable for minimum 0.25x10(6) of cells. DID-derived signal was much less affected by the background signal in comparison to PKH26 in in vitro test. Using the IVIS (R) to scan explants in defined arrangement resulted in precise localization of DID but not PKH26 positive spots. Microscopic analysis of histological specimens confirmed the specificity (89%) and sensitivity (80%) of IVIS (R) assessment relative to DID dye. The procedure enabled successful immunohistochemical staining of specimens derived from analyzed slices. Conclusions The IVIS (R) system under appropriate conditions of visualization and analysis can be used as a method for ex vivo evaluation of cell transplantation effects. Presented protocol allows for evaluation of cell delivery precision rate, enables semi-quantitative assessment of signal, preselects material for further analysis without interfering with the tissue properties. Far red dyes are appropriate fluorophores to cell labeling for this application.	[Zarychta-Wisniewska, Weronika; Burdzinska, Anna; Butrym, Marta; Paczek, Leszek] Med Univ Warsaw, Transplantat Inst, Dept Immunol Transplant Med & Internal Dis, Warsaw, Poland; [Zagozdzon, Radoslaw] Med Univ Warsaw, Transplantat Inst, Dept Clin Immunol, Warsaw, Poland; [Zagozdzon, Radoslaw; Paczek, Leszek] Polish Acad Sci, Inst Biochem & Biophys, Dept Bioinformat, Warsaw, Poland; [Dybowski, Bartosz] Med Univ Warsaw, Dept Urol, Warsaw, Poland; [Butrym, Marta] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden; [Gajewski, Zdzislaw] Warsaw Univ Life Sci, WULS SGGW, Fac Vet Med, Vet Res Ctr,Dept Large Anim Dis Clin, Warsaw, Poland; [Gajewski, Zdzislaw] Warsaw Univ Life Sci, WULS SGGW, Fac Vet Med, Ctr Biomed Res, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Warsaw; Lund University; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Burdzinska, A (corresponding author), Med Univ Warsaw, Transplantat Inst, Dept Immunol Transplant Med & Internal Dis, Warsaw, Poland.	anna.burdzinska@wum.edu.pl	Gajewski, Zdzislaw/N-1481-2016; Zagozdzon, Radoslaw/AAC-4298-2019; Zarychta-Wiśniewska, Weronika/A-7389-2019; Burdzinska, Anna/Q-2402-2016	Gajewski, Zdzislaw/0000-0001-8779-5050; Zagozdzon, Radoslaw/0000-0002-7957-2372; Zarychta-Wiśniewska, Weronika/0000-0002-1383-2151; Burdzinska, Anna/0000-0001-7148-5971; Paczek, Leszek/0000-0003-0160-3009	Foundation for Polish Science; European Union	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union(European Commission)	This study was supported within Parent Bridge program of the Foundation for Polish Science, co-financed by the European Union under the European Regional Development Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badra S, 2013, J UROLOGY, V190, P1938, DOI 10.1016/j.juro.2013.04.052; Bouchlaka MN, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1143996; Burdzinska A, 2016, ANAT REC; Burdzinska A, 2013, UROLOGY, V82, DOI 10.1016/j.urology.2013.03.030; Carr LK, 2013, J UROLOGY, V189, P595, DOI 10.1016/j.juro.2012.09.028; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Corcos J, 2011, NEUROUROL URODYNAM, V30, P447, DOI 10.1002/nau.20998; Davis AS, 2014, J HISTOCHEM CYTOCHEM, V62, P405, DOI 10.1369/0022155414531549; Drost AC, 2009, ANN NY ACAD SCI, V1176, P135, DOI 10.1111/j.1749-6632.2009.04610.x; Eberli D, 2012, CELL TRANSPLANT, V21, P2089, DOI 10.3727/096368911X623835; ELBERGER AJ, 1990, J HISTOCHEM CYTOCHEM, V38, P735, DOI 10.1177/38.5.2110209; Gabr H, 2015, CELL TRANSPLANT, V24, P1813, DOI 10.3727/096368914X683025; Gandolfi F, 2011, THERIOGENOLOGY, V75, P1416, DOI 10.1016/j.theriogenology.2011.01.026; Guenoun J, 2013, CONTRAST MEDIA MOL I, V8, P165, DOI 10.1002/cmmi.1513; Gunetti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045538; Haas SJP, 2000, ACTA HISTOCHEM, V102, P273, DOI 10.1078/S0065-1281(04)70035-5; Harding J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt171; Holzer N, 2005, NEUROMUSCULAR DISORD, V15, P237, DOI 10.1016/j.nmd.2004.11.001; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Kulesza A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161693; Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030; Li P, 2013, STEM CELLS DEV, V22, P340, DOI 10.1089/scd.2012.0357; Mitterberger M, 2008, EUR UROL, V53, P169, DOI 10.1016/j.eururo.2007.07.026; Mohtasebi MS, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/457614; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Pietzner J, 2013, HUM MOL GENET, V22, P493, DOI 10.1093/hmg/dds448; Spikins D, 2005, NAT BIOTECHNOL, V435, P969; Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350; Xu H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3258838; Xue Gai, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P910, DOI 10.3760/cma.j.issn.1007-3418.2014.12.007; Yiou R, 2002, BJU INT, V89, P298, DOI 10.1046/j.1464-4096.2001.01618.x; Yukawa H, 2015, CELL MED, V7, P75, DOI 10.3727/215517914X685169	35	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184588	10.1371/journal.pone.0184588	http://dx.doi.org/10.1371/journal.pone.0184588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931067	gold, Green Published, Green Submitted			2022-12-26	WOS:000411314700023
J	Grimaldo, L; Sandoval, A; Garza-Lopez, E; Felix, R				Grimaldo, Lizbeth; Sandoval, Alejandro; Garza-Lopez, Edgar; Felix, Ricardo			Involvement of Parkin in the ubiquitin proteasome system-mediated degradation of N-type voltage-gated Ca2+ channels	PLOS ONE			English	Article							CALCIUM-CHANNELS; CA(V)2.2	N-type calcium (Ca(V)2.2) channels are widely expressed in the brain and the peripheral nervous system, where they play important roles in the regulation of transmitter release. Although Ca(V)2.2 channel expression levels are precisely regulated, presently little is known regarding the molecules that mediate its synthesis and degradation. Previously, by using a combination of biochemical and functional analyses, we showed that the complex formed by the light chain 1 of the microtubule-associated protein 1B (LC1-MAP1B) and the ubiquitin-proteasome system (UPS) E2 enzyme UBE2L3, may interact with the Ca(V)2.2 channels promoting ubiquitin-mediated degradation. The present report aims to gain further insights into the possible mechanism of degradation of the neuronal Ca(V)2.2 channel by the UPS. First, we identified the enzymes UBE3A and Parkin, members of the UPS E3 ubiquitin ligase family, as novel Ca(V)2.2 channel binding partners, although evidence to support a direct protein-protein interaction is not yet available. Immunoprecipitation assays confirmed the interaction between UBE3A and Parkin with Ca(V)2.2 channels heterologously expressed in HEK-293 cells and in neural tissues. Parkin, but not UBE3A, overexpression led to a reduced Ca(V)2.2 protein level and decreased current density. Electrophysiological recordings performed in the presence of MG132 prevented the actions of Parkin suggesting enhanced channel proteasomal degradation. Together these results unveil a novel functional coupling between Parkin and the Ca(V)2.2 channels and provide a novel insight into the basic mechanisms of Ca-V channels protein quality control and functional expression.	[Grimaldo, Lizbeth; Garza-Lopez, Edgar; Felix, Ricardo] Natl Polytech Inst Cinvestav IPN, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City, DF, Mexico; [Sandoval, Alejandro] UNAM, Fac Super Studies Iztacala, Tlalnepantla, Mexico; [Garza-Lopez, Edgar] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; University of Iowa	Felix, R (corresponding author), Natl Polytech Inst Cinvestav IPN, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City, DF, Mexico.	rfelix@cinvestav.mx	Grimaldo, Lizbeth/O-4264-2019; Felix, Ricardo/A-6989-2008	Felix, Ricardo/0000-0002-5383-7176; Garza Lopez-Hinton, Edgar/0000-0003-0243-0816; GRIMALDO, LIZBETH/0000-0003-0410-4192; Sandoval, Alejandro/0000-0002-8558-6033	National Council for Science and Technology (Conacyt, Mexico) [221660]; Conacyt	National Council for Science and Technology (Conacyt, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was entirely supported by funds from The National Council for Science and Technology (Conacyt, Mexico), grant 221660 to RF. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was entirely supported by funds from The National Council for Science and Technology (Conacyt, Mexico), grant 221660 to RF. There was no additional external funding received for this study. We thank Mercedes Urban for expert technical assistance. Doctoral fellowship from Conacyt to LG is gratefully acknowledged.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Avila G, 2004, CELL MOL NEUROBIOL, V24, P317, DOI 10.1023/B:CEMN.0000022765.52109.26; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Felix R, 2017, GEN PHYSIOL BIOPHYS, V36, P1, DOI 10.4149/gpb_2016037; Felix Ricardo, 2013, Wiley Interdiscip Rev Membr Transp Signal, V2, P207; Fu SJ, 2017, J NEUROSCI, V37, P2485, DOI 10.1523/JNEUROSCI.3070-16.2017; Gandini MA, 2014, COLD SPRING HARB PRO, V4, P389; Gandini MA, 2014, CHANNELS, V8, P452, DOI 10.4161/19336950.2014.949162; Gandini MA, 2014, PFLUG ARCH EUR J PHY, V466, P2113, DOI 10.1007/s00424-014-1476-4; Gregory FD, 2011, NAT NEUROSCI, V14, P1109, DOI 10.1038/nn.2895; Haas KF, 2008, BBA-GENE REGUL MECH, V1779, P495, DOI 10.1016/j.bbagrm.2007.12.010; Henriquez DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053123; Jung T, 2012, PROG MOL BIOL TRANSL, V109, P1, DOI 10.1016/B978-0-12-397863-9.00001-8; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lipscombe D, 2013, TRENDS NEUROSCI, V36, P598, DOI 10.1016/j.tins.2013.06.008; Marangoudakis S, 2012, J NEUROSCI, V32, P10365, DOI 10.1523/JNEUROSCI.0851-11.2012; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Page KM, 2016, J BIOL CHEM, V291, P20402, DOI 10.1074/jbc.M116.737270; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rougier JS, 2015, PFLUG ARCH EUR J PHY, V467, P1919, DOI 10.1007/s00424-014-1636-6; Rougier JS, 2011, J BIOL CHEM, V286, P8829, DOI 10.1074/jbc.M110.166520; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tsai NP, 2014, BBA-MOL CELL RES, V1843, P2838, DOI 10.1016/j.bbamcr.2014.08.006; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Weiss N, 2017, NEURONAL SI IN PRESS; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185289	10.1371/journal.pone.0185289	http://dx.doi.org/10.1371/journal.pone.0185289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957379	gold, Green Submitted, Green Published			2022-12-26	WOS:000411985200041
J	Heijmans, N; van Lieshout, J; Wensing, M				Heijmans, Naomi; van Lieshout, Jan; Wensing, Michel			Social network composition of vascular patients and its associations with health behavior and clinical risk factors	PLOS ONE			English	Article							OLDER-ADULTS; PHYSICAL HEALTH; SUPPORT; DEPRESSION; QUALITY; CONSUMPTION; INTEGRATION; MEDICATION; MANAGEMENT; ADHERENCE	Background This study aimed to explore linkages of patients' social network composition with health behaviors and clinical risk factors. Methods/Design This observational study was embedded in a project aimed at improving cardiovascular risk management (CRVM) in primary care. 657 vascular patients (227 with cardiovascular disease, 380 at high vascular risk), mean age 72.4 (SD 9.4) years, were recruited as were individuals patients considered important for dealing with their disease, so called alters (n = 487). Network composition was measured with structured patient questionnaires. Both patients and alters completed questionnaires to measure health behavior (habits for physical activity, diet, and smoking). Clinical risk factors (systolic blood pressure, LDL cholesterol level, and body mass index) were extracted from patients' medical records. Six logistic regression analyses, using generalized estimating equations, were used to test three hypothesized effects of network composition (having alters with healthful behaviors, without depression, and with specialized knowledge) on six outcomes, adjusted for demographic, personal and psychological characteristics. Results Having alters with overall healthful behavior was related to healthful patient diet (OR 2.14, 95% CI: 1.52-3.02). Having non-smoking alters in networks was related to reduced odds for patient smoking (OR 0.17, 95% CI: 0.05-0.60). No effects of presence of non-depressed alters were found. Presence of alters with specialized knowledge on CVRM was inversely related to healthful diet habits of patients (OR 0.47, 95% CI 0.24-0.89). No significant associations between social network composition and clinical risk factors were found. Discussion Diet and smoking, but not physical exercise and clinical risk factors, were associated with social network composition of patients with vascular conditions. In this study of vascular patients, controlling for both personal and psychological factors, fewer network influences were found compared to previous research. Further research is needed to examine network structure characteristics as well as the role of psychological factors to enhance understanding health behavior of patients involved in CVRM.	[Heijmans, Naomi; van Lieshout, Jan] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Wensing, Michel] Heidelberg Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Radboud University Nijmegen; Ruprecht Karls University Heidelberg	Heijmans, N (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands.	Naomi.Heijmans@radboudumc.nl	Van Lieshout, J./L-4490-2015; Wensing, Michel/H-8113-2014	Wensing, Michel/0000-0001-6569-8137	European Union Seventh Framework Programme [258837]; ZonMw [200310011]	European Union Seventh Framework Programme(European Commission); ZonMw(Netherlands Organization for Health Research and Development)	This study is funded by the European Union Seventh Framework Programme (FP7) within the theme HEALTH.2013.3.1-1 under grant agreement no 258837 and by ZonMw, project no 200310011. MW received both fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by the European Union Seventh Framework Programme (FP7) within the theme HEALTH.2013.3.1-1 under grant agreement no 258837 and by ZonMw, project no 200310011.	[Anonymous], 2012, HUISARTS WET, V55, P14; Ashida S, 2008, J AGING HEALTH, V20, P872, DOI 10.1177/0898264308324626; Bauer LK, 2012, AM J CARDIOL, V109, P1266, DOI 10.1016/j.amjcard.2011.12.017; Berkman LF, 2004, AM J EPIDEMIOL, V159, P167, DOI 10.1093/aje/kwh020; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Campbell SM, 2008, EUR J CARDIOV PREV R, V15, P509, DOI 10.1097/HJR.0b013e328302f44d; Chan YK, 2006, J HAPPINESS STUDIES, V7; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Christakis Nicholas A, 2009, Nor Epidemiol, V19, P5; Cohen S, 2001, Adv Mind Body Med, V17, P5, DOI 10.1054/ambm.2000.0244; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Dunbar SB, 2008, J CARDIOVASCULAR NUR, V23; Eikelenboom N, 2015, BR J GEN PR IN PRESS; Flatt JD, 2012, FAM COMMUNITY HEALTH, V35, P312, DOI 10.1097/FCH.0b013e3182666650; Gallant MP, 2007, RES AGING, V29, P375, DOI 10.1177/0164027507303169; Golden J, 2009, PSYCHOL HEALTH MED, V14, P280, DOI 10.1080/13548500902730135; Graven LJ, 2014, INT J NURS STUD, V51, P320, DOI 10.1016/j.ijnurstu.2013.06.013; Heijmans N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-265; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Holt-Lunstad J, 2007, ANN BEHAV MED, V33, P278, DOI 10.1007/BF02879910; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Huntink E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-433; Kashima Y, 2013, SOC NETWORKS, V35, P711, DOI 10.1016/j.socnet.2013.06.002; Keating NL, 2011, CANCER-AM CANCER SOC, V117, P3045, DOI 10.1002/cncr.25849; Kroenke CH, 2017, PSYCHO-ONCOLOGY, V26, P544, DOI 10.1002/pon.4059; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langford CPH, 1997, J ADV NURS, V25, P95, DOI 10.1046/j.1365-2648.1997.1997025095.x; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Moore AR, 2014, J CROSS-CULT GERONTO, V29, P329, DOI 10.1007/s10823-014-9238-5; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Rantanen A, 2004, J CLIN NURS, V13, P158, DOI 10.1046/j.1365-2702.2003.00847.x; Reeves D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098340; Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859; Rocco L., 2012, IS SOCIAL CAPITAL GO; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Segal-Isaacson CJ, 2004, DIABETES EDUCATOR, V30, P774, DOI 10.1177/014572170403000512; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Strully KW, 2012, SOC SCI MED, V74, P1125, DOI 10.1016/j.socscimed.2011.12.033; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; Vaartjes I, 2013, HART VAATZIEKTEN NED; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Vassilev I, 2011, CHRONIC ILLN, V7, P60, DOI 10.1177/1742395310383338; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-103	51	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185341	10.1371/journal.pone.0185341	http://dx.doi.org/10.1371/journal.pone.0185341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957372	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200045
J	Lee, HJ; Hong, JS; Lin, CJ; Kao, YH; Chang, FC; Luo, CB; Chu, WF				Lee, Han-Jui; Hong, Jia-Sheng; Lin, Chung-Jung; Kao, Yi-Hsuan; Chang, Feng-Chi; Luo, Chao-Bao; Chu, Wei-Fa			Automatic flow analysis of digital subtraction angiography using independent component analysis in patients with carotid stenosis	PLOS ONE			English	Article							CEREBRAL-CIRCULATION TIME; HYPERPERFUSION SYNDROME; BLOOD-FLOW; HEMODYNAMIC SEGMENTATION; QUANTITATIVE-ANALYSIS; COMPUTED-TOMOGRAPHY; PERFUSION IMAGES; FLAT-DETECTOR; ARTERY; CONTRAST	Purpose Current time D density curve analysis of digital subtraction angiography (DSA) provides intravascular flow information but requires manual vasculature selection. We developed an angiographic marker that represents cerebral perfusion by using automatic independent component analysis. Materials and methods We retrospectively analyzed the data of 44 patients with unilateral carotid stenosis higher than 70% according to North American Symptomatic Carotid Endarterectomy Trial criteria. For all patients, magnetic resonance perfusion (MRP) was performed one day before DSA. Fixed contrast injection protocols and DSA acquisition parameters were used before stenting. The cerebral circulation time (CCT) was defined as the difference in the time to peak between the parietal vein and cavernous internal carotid artery in a lateral angiogram. Both anterior-posterior and lateral DSA views were processed using independent component analysis, and the capillary angiogram was extracted automatically. The full width at half maximum of the time D density curve in the capillary phase in the anterior-posterior and lateral DSA views was defined as the angiographic mean transient time (aMTT; i.e., aMTT(AP) and aMTT(Lat)). The correlations between the degree of stenosis, CCT, aMTT(AP) and aMTT(Lat), and MRP parameters were evaluated. Results The degree of stenosis showed no correlation with CCT, aMTT(AP), aMTT(Lat), or any MRP parameter. CCT showed a strong correlation with aMTT(AP) (r = 0.67) and aMTT(Lat) (r = 0.72). Among the MRP parameters, CCT showed only a moderate correlation with MTT (r = 0.67) and Tmax (r = 0.40). aMTT(AP) showed a moderate correlation with Tmax (r = 0.42) and a strong correlation with MTT (r = 0.77). aMTT(Lat) also showed similar correlations with Tmax (r = 0.59) and MTT (r = 0.73). Conclusion Apart from vascular anatomy, aMTT estimates brain parenchyma hemodynamics from DSA and is concordant with MRP. This process is completely automatic and provides immediate measurement of quantitative peritherapeutic brain parenchyma changes during stenting.	[Lee, Han-Jui; Lin, Chung-Jung; Chang, Feng-Chi; Luo, Chao-Bao; Chu, Wei-Fa] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lee, Han-Jui; Lin, Chung-Jung; Chang, Feng-Chi; Luo, Chao-Bao; Chu, Wei-Fa] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hong, Jia-Sheng; Kao, Yi-Hsuan] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, CJ (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.; Lin, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	bcjlin@gmail.com		Lin, Chung Jung/0000-0003-2370-6316				Aikawa H, 2010, NEUROL MED-CHIR, V50, P269, DOI 10.2176/nmc.50.269; Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Calamante F, 2013, PROG NUCL MAG RES SP, V74, P1, DOI 10.1016/j.pnmrs.2013.04.002; Calamante F, 2010, STROKE, V41, P1169, DOI 10.1161/STROKEAHA.110.580670; Fang H, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0560-0; Golitz P, 2013, CLIN NEURORADIOL, V23, P113, DOI 10.1007/s00062-012-0184-8; Greitz T., 1956, ACTA RADIOLOGICA; Guo WY, 2017, AM J NEURORADIOL, V38, P132, DOI 10.3174/ajnr.A4960; Huang TC, 2012, J VASC SURG, V56, P812, DOI 10.1016/j.jvs.2012.02.041; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Iwata T, 2011, NEUROSURGERY, V68, P649, DOI 10.1227/NEU.0b013e3182077ed8; Kao YH, 2003, MAGNET RESON MED, V49, P885, DOI 10.1002/mrm.10440; Kao YH, 2008, J MAGN RESON IMAGING, V28, P1125, DOI 10.1002/jmri.21537; Kefayati S, 2013, MED ENG PHYS, V35, P898, DOI 10.1016/j.medengphy.2012.08.020; Kudo K, 2009, RADIOLOGY, V251, P241, DOI 10.1148/radiol.2511080983; Lieber BB, 2009, MED PHYS, V36, P5064, DOI 10.1118/1.3243079; Lin CJ, 2014, AM J NEURORADIOL, V35, P1132, DOI 10.3174/ajnr.A3838; Lin CJ, 2012, AM J NEURORADIOL, V33, P1685, DOI 10.3174/ajnr.A3049; Lin CJ, 2016, J NEURORADIOLOGY, V43, P290, DOI 10.1016/j.neurad.2016.02.002; Lin CJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003529; Liu C, 2011, IEEE T PATTERN ANAL, V33, P978, DOI 10.1109/TPAMI.2010.147; Lythgoe DJ, 2000, MAGN RESON IMAGING, V18, P1, DOI 10.1016/S0730-725X(99)00112-5; Martel AL, 2001, MED IMAGE ANAL, V5, P29, DOI 10.1016/S1361-8415(00)00032-3; Narita S, 2013, J STROKE CEREBROVASC, V22, P615, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.015; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pereira VM, 2014, AM J NEURORADIOL, V35, P156, DOI 10.3174/ajnr.A3662; Petkova M, 2009, J MAGN RESON IMAGING, V29, P7, DOI 10.1002/jmri.21483; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; RANEY R, 1949, J NEUROSURG, V6, P222, DOI 10.3171/jns.1949.6.3.0222; Scalzo F, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/2478324; Shpilfoygel SD, 2000, MED PHYS, V27, P2008, DOI 10.1118/1.1288669; Soinne L, 2003, STROKE, V34, P1655, DOI 10.1161/01.STR.0000075605.36068.D9; Strother CM, 2010, AM J NEURORADIOL, V31, P919, DOI 10.3174/ajnr.A2020; Struffert T, 2015, AM J NEURORADIOL, V36, P1964, DOI 10.3174/ajnr.A4383; Struffert T, 2014, EUR RADIOL, V24, P1257, DOI 10.1007/s00330-014-3136-7; Teng MMH, 2016, AM J NEURORADIOL, V37, P1883, DOI 10.3174/ajnr.A4813; WILCOX BR, 1970, ANN SURG, V171, P24, DOI 10.1097/00000658-197001000-00004; Wu TH, 2013, COMPUT METH PROG BIO, V111, P693, DOI 10.1016/j.cmpb.2013.06.012; Xiang J, 2014, AM J NEURORADIOL, V35, P1849, DOI 10.3174/ajnr.A3710; ZUKERBERG LR, 1991, AM J SURG PATHOL, V15, P126, DOI 10.1097/00000478-199102000-00004	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185330	10.1371/journal.pone.0185330	http://dx.doi.org/10.1371/journal.pone.0185330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949999	Green Submitted, Green Published, gold			2022-12-26	WOS:000411671000038
J	van Ginkel, WG; van Vliet, D; Burgerhof, JGM; de Blaauw, P; Gozalbo, MER; Heiner-Fokkema, MR; van Spronsen, FJ				van Ginkel, Willem G.; van Vliet, Danique; Burgerhof, Johannes G. M.; de Blaauw, Pim; Gozalbo, M. Estela Rubio; Heiner-Fokkema, M. Rebecca; van Spronsen, Francjan J.			Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1	PLOS ONE			English	Article							TRANSPORT; BARRIER; RESTRICTION; DEFICIENCY; FORMULA; LAT1	Introduction Hereditary Tyrosinemia type 1 (HT1) is a rare metabolic disease caused by a defect in the tyrosine degradation pathway. Current treatment consists of 2-(2-nitro-4-trifluoromethylbenoyl)-1,3-cyclohexanedione (NTBC) and a tyrosine and phenylalanine restricted diet. Recently, neuropsychological deficits have been seen in HT1 patients. These deficits are possibly associated with low blood phenylalanine concentrations and/or high blood tyrosine concentrations. Therefore, the aim of the present study was threefold. Firstly, we aimed to calculate how the plasma amino acid profile in HT1 patients may influence the presumptive brain influx of all large neutral amino acids (LNAA). Secondly, we aimed to investigate the effect of phenylalanine supplementation on presumptive brain phenylalanine and tyrosine influx. Thirdly, we aimed to theoretically determine minimal target plasma phenylalanine concentrations in HT1 patient to ensure adequate presumptive brain phenylalanine influx. Methods Data of plasma LNAA concentrations were obtained. In total, 239 samples of 9 HT1 children, treated with NTBC, diet, and partly with phenylalanine supplementation were collected together with 596 samples of independent control children. Presumptive brain influx of all LNAA was calculated, using Michaelis-Menten parameters (K-m) and V-max-values obtained from earlier articles. Results In HT1 patients, plasma concentrations and presumptive brain influx of tyrosine were higher. However, plasma and especially brain influx of phenylalanine were lower in HT1 patients.Phenylalanine supplementation did not only tend to increase plasma phenylalanine concentrations, but also presumptive brain phenylalanine influx, despite increased plasma tyrosine concentrations. However, to ensure sufficient brain phenylalanine influx in HT1 patients, minimal plasma phenylalanine concentrations may need to be higher than considered thus far. Conclusion This study clearly suggests a role for disturbed brain LNAA biochemistry, which is not well reflected by plasma LNAA concentrations. This could play a role in the pathophysiology of the neuropsychological impairments in HT1 patients and may have therapeutic implications.	[van Ginkel, Willem G.; van Vliet, Danique; van Spronsen, Francjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Metab Dis, Groningen, Netherlands; [Burgerhof, Johannes G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [de Blaauw, Pim; Heiner-Fokkema, M. Rebecca] Univ Med Ctr Groningen, Univ Groningen, Dept Lab Med, Groningen, Netherlands; [Gozalbo, M. Estela Rubio] Maastricht Univ, Dept Pediat, Med Ctr, Maastricht, Netherlands; [Gozalbo, M. Estela Rubio] Maastricht Univ, Lab Genet Metab Dis, Med Ctr, Maastricht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Maastricht University; Maastricht University	van Spronsen, FJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Metab Dis, Groningen, Netherlands.	f.j.van.spronsen@umcg.nl	Rubio-Gozalbo, M Estela/H-1833-2011; Burgerhof, Johannes G/B-2455-2013	Burgerhof, Johannes G/0000-0003-3827-9601; Rubio-Gozalbo, M. Estela/0000-0001-7182-4056				Bendadi F, 2014, J PEDIATR-US, V164, P398, DOI 10.1016/j.jpeds.2013.10.001; Coughlin CR, 2015, MOL GENET METAB, V116, P35, DOI 10.1016/j.ymgme.2015.05.011; Daly A, 2012, J HUM NUTR DIET, V25, P111, DOI 10.1111/j.1365-277X.2011.01215.x; de Laet C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-8; De Laet C, 2011, DEV MED CHILD NEUROL, V53, P962, DOI 10.1111/j.1469-8749.2011.04048.x; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; FERNSTROM JD, 1972, SCIENCE, V178, P414, DOI 10.1126/science.178.4059.414; HARGREAVES KM, 1988, J BIOL CHEM, V263, P19392; Holme E, 1998, J INHERIT METAB DIS, V21, P507, DOI 10.1023/A:1005410820201; Killian DM, 2001, NEUROSCI LETT, V306, P1, DOI 10.1016/S0304-3940(01)01810-9; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Masurel-Paulet A, 2008, J INHERIT METAB DIS, V31, P81, DOI 10.1007/s10545-008-0793-1; Pardridge WM, 1998, NEUROCHEM RES, V23, P635, DOI 10.1023/A:1022482604276; Pohorecka Monika, 2012, Pediatr Endocrinol Diabetes Metab, V18, P96; Russo PA, 2001, PEDIATR DEVEL PATHOL, V4, P212, DOI 10.1007/s100240010146; Schulze A, 2001, MOL GENET METAB, V74, P413, DOI 10.1006/mgme.2001.3257; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; Strauss KA, 2011, MOL GENET METAB, V104, P93, DOI 10.1016/j.ymgme.2011.07.003; Strauss KA, 2010, MOL GENET METAB, V99, P333, DOI 10.1016/j.ymgme.2009.12.007; Thimm E, 2012, J INHERIT METAB DIS, V35, P263, DOI 10.1007/s10545-011-9394-5; Thimm E, 2011, MOL GENET METAB, V102, P122, DOI 10.1016/j.ymgme.2010.11.003; van Ginkel WG, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0472-5; van Vliet D, 2014, JIMD REP; van Vliet D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143833; van Vliet D, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-7; Vogel KR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-73; Wilson CJ, 2000, J INHERIT METAB DIS, V23, P677, DOI 10.1023/A:1005666426079	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185342	10.1371/journal.pone.0185342	http://dx.doi.org/10.1371/journal.pone.0185342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949985	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000040
J	Zhang, X; Hu, WL; Chen, F; Liu, JQ; Yang, YH; Wang, LJ; Duan, HL; Si, JM				Zhang, Xu; Hu, Weiling; Chen, Fei; Liu, Jiquan; Yang, Yuanhang; Wang, Liangjing; Duan, Huilong; Si, Jianmin			Gastric precancerous diseases classification using CNN with a concise model	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; CANCER	Gastric precancerous diseases (GPD) may deteriorate into early gastric cancer if misdiagnosed, so it is important to help doctors recognize GPD accurately and quickly. In this paper, we realize the classification of 3-class GPD, namely, polyp, erosion, and ulcer using convolutional neural networks (CNN) with a concise model called the Gastric Precancerous Disease Network (GPDNet). GPDNet introduces fire modules from SqueezeNet to reduce the model size and parameters about 10 times while improving speed for quick classification. To maintain classification accuracy with fewer parameters, we propose an innovative method called iterative reinforced learning (IRL). After training GPDNet from scratch, we apply IRL to fine-tune the parameters whose values are close to 0, and then we take the modified model as a pretrained model for the next training. The result shows that IRL can improve the accuracy about 9% after 6 iterations. The final classification accuracy of our GPDNet was 88.90%, which is promising for clinical GPD recognition.	[Zhang, Xu; Liu, Jiquan; Yang, Yuanhang; Duan, Huilong] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xu; Liu, Jiquan; Yang, Yuanhang; Duan, Huilong] Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou, Zhejiang, Peoples R China; [Hu, Weiling; Si, Jianmin] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Hu, Weiling; Chen, Fei; Wang, Liangjing; Si, Jianmin] Zhejiang Univ, Inst Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Chen, Fei; Wang, Liangjing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Liu, JQ (corresponding author), Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou, Zhejiang, Peoples R China.; Liu, JQ (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou, Zhejiang, Peoples R China.	liujq@zju.edu.cn		Chen, Fei/0000-0002-6826-7153; liu, jiquan/0000-0001-5994-6472	National Natural Science Foundation of China [31470955, 81401733]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31470955 to Mr Jiquan Liu)(http://www.nsfc.gov.cn/) and the National Natural Science Foundation of China (No. 81401733 to Weiling Hu)(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531, DOI 10.6004/jnccn.2013.0070; Albarqouni S, 2016, IEEE T MED IMAGING, V35, P1313, DOI 10.1109/TMI.2016.2528120; Hafner M, 2015, BILDVERARBEITUNG FUR DIE MEDIZIN 2015: ALGORITHMEN - SYSTEME - ANWENDUNGEN, P365, DOI 10.1007/978-3-662-46224-9_63; Han S., ARXIV160704381; Hatner M, 2009, INF TECN APPL BIOM 2; Hatner M, 2010, INF TECHN APPL BIOM; Iandola F.N., ARXIV160207360; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Li B, 2010, AUT LOG ICAL 2010 IE; Li BP, 2009, IMAGE VISION COMPUT, V27, P1336, DOI 10.1016/j.imavis.2008.12.003; Litjens G., ARXIV170205747; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Miao S, 2016, IEEE T MED IMAGING, V35, P1352, DOI 10.1109/TMI.2016.2521800; Paik DS, 2004, IEEE T MED IMAGING, V23, P661, DOI 10.1109/TMI.2004.826362; Pereira S, 2016, IEEE T MED IMAGING, V35, P1240, DOI 10.1109/TMI.2016.2538465; Ribeiro E, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6584725; Seebock P., 2015, THESIS; Setio AAA, 2016, IEEE T MED IMAGING, V35, P1160, DOI 10.1109/TMI.2016.2536809; Shen D, 2017, ANN REV BIOMEDICAL E; Shen X, 2012, COMM COMP ICSPCC 201; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Summers RM, 2005, GASTROENTEROLOGY, V129, P1832, DOI 10.1053/j.gastro.2005.08.054; Tajbakhsh N, 2015, 2015 IEEE 12 INT S B; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Tartar A, 2013, 2013 35 ANN INT C IE; Vilarino F, 2009, BILDVERARBEITUNG MED, V22, P346; Wan L., 2013, ICML; Weck MN, 2006, CANCER EPIDEM BIOMAR, V15, P1083, DOI 10.1158/1055-9965.EPI-05-0931; Yao K, 2013, ANN GASTROENTEROL, V26, P11; Zhang R, 2016, IEEE J BIOMEDICAL HL; Zheng CH, 2009, IEEE T INF TECHNOL B, V13, P599, DOI 10.1109/TITB.2009.2018115; Zhu R, 2015, 2015 8 INT C IM SIGN	34	32	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185508	10.1371/journal.pone.0185508	http://dx.doi.org/10.1371/journal.pone.0185508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950010	Green Submitted, Green Published, gold			2022-12-26	WOS:000411671000061
J	Arevalo-Herrera, M; Rengifo, L; Lopez-Perez, M; Arce-Plata, MI; Garcia, J; Herrera, S				Arevalo-Herrera, Myriam; Rengifo, Lina; Lopez-Perez, Mary; Arce-Plata, Maria I.; Garcia, Jhon; Herrera, Socrates			Complicated malaria in children and adults from three settings of the Colombian Pacific Coast: A prospective study	PLOS ONE			English	Article							PLASMODIUM-VIVAX MALARIA; FALCIPARUM; PROFILE; THROMBOCYTOPENIA; MUNICIPALITIES; INFECTIONS; PREGNANCY; PAPUA	Background Complicated malaria remains an important public health problem, particularly in endemic settings where access to health services is limited and consequently malaria fatal outcomes occur. Few publications describing the clinical course and outcomes of complicated malaria in Latin America are found in the literature. This prospective study approached the clinical and laboratory characteristics of hospitalized patients with complicated malaria in different endemic areas of the Colombian Pacific Coast with the aim to provide epidemiological knowledge and guide to further reducing malaria severity and mortality. Methods and findings A prospective, descriptive hospital-based study was conducted in 323 complicated malaria patients (median age 20 years) enrolled in Quibdo A, Tumaco and Cali between 2014 and 2016. Clinical evaluation was performed and laboratory parameters were assessed during hospitalization. Plasmodium falciparum was the most common parasite species (70%), followed by P. vivax (28%), and mixed malaria (Pf/Pv; 1.9%). Overall, predominant laboratory complications were severe thrombocytopenia (43%), hepatic dysfunction (40%), and severe anaemia (34%). Severe thrombocytopenia was more common in adults (52%) regardless of parasite species. Severe anaemia was the most frequent complication in children <= 10 years (72%) and was most commonly related to P. vivax infection (p < 0.001); whereas liver dysfunction was more frequent in older patients (54%) with P. falciparum (p < 0.001). Two deaths due to P. vivax and P. falciparum each were registered. Treatment provision before recruitment hindered qPCR confirmation of parasite species in some cases. Conclusions The study identified a high prevalence of complicated malaria in the Pacific Coast, together with more frequent severe anaemia in children infected by P. vivax and hepatic dysfunction in adults with P. falciparum. Results indicated the need for earlier diagnosis and treatment to prevent complications development as well as more effective attention at hospital level, in order to rapidly identify and appropriately treat these severe clinical conditions. The study describes epidemiological profiles of the study region and identified the most common complications on which clinicians must focus on to prevent mortality.	[Arevalo-Herrera, Myriam; Rengifo, Lina; Lopez-Perez, Mary; Arce-Plata, Maria I.; Garcia, Jhon; Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia; [Arevalo-Herrera, Myriam] Univ Valle, Fac Hlth, Cali, Colombia	Universidad del Valle	Arevalo-Herrera, M (corresponding author), Caucaseco Sci Res Ctr, Cali, Colombia.; Arevalo-Herrera, M (corresponding author), Univ Valle, Fac Hlth, Cali, Colombia.	marevalo@inmuno.org	Lopez-Perez, Mary/E-5059-2016	Lopez-Perez, Mary/0000-0002-9876-0248; Garcia Ortiz, Jhon Alexander/0000-0001-7133-3839	NIAID/NIH [U19A1089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by NIAID/NIH (Contract # U19A1089702) for the establishment of the Latin American ICEMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour N, 2014, J RES MED SCI, V19, P164; Abdallah JF, 2013, SEVERE PLASMODIUM TA; [Anonymous], REV BRAS EPIDEMIOL; Arboleda M, 2012, BIOMEDICA, V32, P58, DOI 10.1590/S0120-41572012000500008; Arevalo-Herrera M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0678-3; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Caicedo MA, 2017, CHARACTERIZING MALAR, V11; Chaparro-Narvaez PE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1323-5; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Forero DA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-165; Pineros JG, 2013, AM J TROP MED HYG, V89, P520, DOI 10.4269/ajtmh.12-0205; Pineros-Jimenez JG, 2008, BIOMEDICA, V28, P471, DOI 10.7705/biomedica.v28i4.53; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gonzalez L., 2000, ACTA MED COLOMB, V25, P163; Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007; Gupta Narendra Kumar, 2013, Trop Parasitol, V3, P58, DOI 10.4103/2229-5070.113914; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; INS, 2016, B EPIDEMIOLOGICO SEM; INS, 2015, VIG RUT EV MUN; INS, 2015, B EPIDEMIOLOGICO SEM; INS, 2014, B EPIDEMIOLOGICO SEM; IVIGILA, 2016, SEMANA, V52; Jadhav U M, 2004, J Assoc Physicians India, V52, P615; Kochar DK, 2010, PLATELETS, V21, P623, DOI 10.3109/09537104.2010.505308; Kovacs SD, 2015, DRUG SAFETY, V38, P165, DOI 10.1007/s40264-014-0261-9; Kunuanunua TS, 2015, J TROP PEDIATRICS, V61, P272, DOI 10.1093/tropej/fmv029; Lacerda M, 2012, MALARIA J, V11, DOI 10.1186; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Martinez-Salazar EL, 2014, REV SOC BRAS MED TRO, V47, P341, DOI 10.1590/0037-8682-0078-2014; Lopez ML, 2004, ACTA MED COLOMB, V29, P80; Medina-Morales DA, 2016, J INFECT PUBLIC HEAL, V9, P172, DOI 10.1016/j.jiph.2015.09.001; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; [MinSalud Ministerio de la Proteccion Social. Colombia], 2010, GUIA AT CLIN MAL; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; O'Brien AT, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-404; PAHO, 2017, EP AL INCR CAS MAL; Ramirez JF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1554-5; Seednet, 2005, YITP; Siqueira AM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0302-y; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Castano AT, 2006, IATREIA, V19, P339; Tobon-Castano A, 2012, BIOMEDICA, V32, P79, DOI 10.1590/S0120-41572012000500010; Val F, 2017, AM J TROP MED HYG; Wassmer SC, 2015, AM J TROP MED HYG, V93, P42, DOI 10.4269/ajtmh.14-0841; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; WHO, 2016, WORLD MAL REP 2016; World Health Organization, 2015, GUID TREATM MAL, Vthird	47	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185435	10.1371/journal.pone.0185435	http://dx.doi.org/10.1371/journal.pone.0185435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945797	gold, Green Published, Green Submitted			2022-12-26	WOS:000411645100060
J	Lee, SJ; Lee, DG				Lee, Seung-Jae; Lee, Dong-Geun			Distribution of atherosclerotic stenosis determining early neurologic deterioration in acute ischemic stroke	PLOS ONE			English	Article							INTRACRANIAL ATHEROSCLEROSIS; DISEASE; RISK; PREDICTORS; OCCLUSION; IMPACT	Background and purpose Early neurologic deterioration (END) during the acute stage of stroke is clinically important because of its association with poor outcomes. The purpose of this study was (1) to investigate variables associated with END, (2) to determine the distribution of atherosclerotic stenosis associated with END, and (3) to clarify the relationship between END and clinical outcomes. Methods 516 patients with acute ischemic stroke were included. The median follow-up period was 31.7 months. END was defined as a >= 2 point increase in the National Institutes of Health Stroke Scale (NIHSS), >= 1 point increase in level of consciousness or motor item of the NIHSS, or the development of any new neurological deficits during the first 72 hours of hospitalization. A signal loss on 1.5-T magnetic resonance angiography exceeding 50% was considered to be significant for the categorization of stenosis pattern. Results The prevalence of END was 19.0%. END was associated with intracranial atherosclerotic stenosis (IAS) together with large artery atherosclerosis (LAA) subtype. In particular, stenosis of basilar artery or posterior cerebral artery was independently associated with END. Lesion growth or hypoperfusion was more accountable for END in patients with IAS, whereas intracerebral hemorrhage or edema/herniation was more frequently observed in END patients without IAS. Patients with END had a higher rate of mortality, but a similar rate of further vascular events compared to patients without END. Conclusion Pre-stroke IAS and LAA subtype could determine the development of END during the acute stage of ischemic stroke.	[Lee, Seung-Jae] Soonchunhyang Univ, Dept Neurol, Bucheon Hosp, Bucheon, South Korea; [Lee, Dong-Geun] Sejong Gen Hosp, Dept Neurol, Bucheon, South Korea	Soonchunhyang University; Sejong General Hospital	Lee, SJ (corresponding author), Soonchunhyang Univ, Dept Neurol, Bucheon Hosp, Bucheon, South Korea.	neurosj@catholic.ac.kr		Lee, Seung-Jae/0000-0003-2299-4870	Soonchunhyang University	Soonchunhyang University	This work was supported by the Soonchunhyang University Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bang OY, 2014, J STROKE, V16, P27, DOI 10.5853/jos.2014.16.1.27; Cho AH, 2012, J NEUROL SCI, V312, P127, DOI 10.1016/j.jns.2011.08.004; Chung JW, 2015, J HYPERTENS, V33, P2099, DOI 10.1097/HJH.0000000000000675; Jeong HG, 2015, STROKE, V46, P687, DOI 10.1161/STROKEAHA.114.007466; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim YD, 2016, J STROKE CEREBROVASC, V25, P819, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.003; Kwan J, 2006, QJM-INT J MED, V99, P625, DOI 10.1093/qjmed/hcl082; Lee SJ, 2015, EUR NEUROL, V73, P271, DOI 10.1159/000381336; Lee SJ, 2011, ARCH GERONTOL GERIAT, V53, pE129, DOI 10.1016/j.archger.2010.07.008; Miyamoto N, 2013, J STROKE CEREBROVASC, V22, P205, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.018; Molina CA, 2001, STROKE, V32, P1079, DOI 10.1161/01.STR.32.5.1079; Ogasawara K, 2002, STROKE, V33, P1857, DOI 10.1161/01.STR.0000019511.81583.A8; Ogata T, 2009, J NEUROL SCI, V287, P147, DOI 10.1016/j.jns.2009.08.006; Ois A, 2008, CEREBROVASC DIS, V25, P151, DOI 10.1159/000113732; Park JH, 2007, EUR J NEUROL, V14, P379, DOI 10.1111/j.1468-1331.2007.01682.x; Park MG, 2016, J STROKE, V18, P73, DOI 10.5853/jos.2015.01417; Petrone L, 2016, CEREBROVASC DIS, V41, P87, DOI 10.1159/000442577; Pu YH, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00125; Ryoo S, 2012, NEUROLOGY, V78, P888, DOI 10.1212/WNL.0b013e31824c4699; Siegler JE, 2016, J STROKE, V18, P203, DOI 10.5853/jos.2016.00073; Siegler JE, 2013, J STROKE CEREBROVASC, V22, pE207, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.006; Thanvi B, 2008, POSTGRAD MED J, V84, P412, DOI 10.1136/pgmj.2007.066118; Wang C, 2015, CLIN APPL THROMB-HEM, V21, P453, DOI 10.1177/1076029614551823; Weimar C, 2005, ARCH NEUROL-CHICAGO, V62, P393, DOI 10.1001/archneur.62.3.393; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x	28	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185314	10.1371/journal.pone.0185314	http://dx.doi.org/10.1371/journal.pone.0185314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945817	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100044
J	Vandenbroucke, L; Doyen, M; Le Lous, M; Beuchee, A; Loget, P; Carrault, G; Pladys, P				Vandenbroucke, Laurent; Doyen, Matthieu; Le Lous, Maela; Beuchee, Alain; Loget, Philippe; Carrault, Guy; Pladys, Patrick			Chorioamnionitis following preterm premature rupture of membranes and fetal heart rate variability	PLOS ONE			English	Article							NEONATAL SEPSIS; NECROTIZING ENTEROCOLITIS; INFECTION; INFLAMMATION; INFANTS; WOMEN; PPROM	Introduction The objective of this study was to identify prenatal markers of histological chorioamnionitis (HC) during pPROM using fetal computerized cardiotocography (cCTG). Materials and methods Retrospective review of medical records from pregnant women referred for pPROM between 26 and 34 weeks, in whom placental histology was available, in a tertiary level obstetric service over a 5-year period. Fetal heart rate variability was assessed using cCTG. Patients were included if they were monitored at least six times in the 72 hours preceding delivery. Clinical and biological cCTG parameters during the pPROM latency period were compared between cases with or without HC. Results In total, 222 pPROM cases were observed, but cCTG data was available in only 23 of these cases (10 with and 13 without HC) after exclusion of co-morbidities which may potentially perturb fetal heart rate variability measures. Groups were comparable for maternal age, parity, gestational age at pPROM, pPROM duration and neonatal characteristics (p > 0.1). Baseline fetal heart rate was higher in the HC group [median 147.3 bpm IQR (144.2-149.2) vs. 141.3 bpm (137.1-145.4) in no HC group; p = 0.02]. The number of low variation episodes [6.4, (3.5-15.3) vs. 2.3 (1-5.2); p = 0.04] was also higher in the HC group, whereas short term variations were lower in the HC group [7.1 ms (6-7.4) vs. 8.1 ms (7.4-9); p = 0.01] within 72 hours before delivery. Differences were especially discriminant within 24 hours before delivery, with less short-term variation [5 ms (3.7-5.9) vs. 7.8 ms (5.4-8.7); p = 0.007] and high variation episodes [3.9 (4.9-3.2) vs. 0.8 (1.5-0.2); p < 0.001] in the HC group. Conclusion These results show differences in fetal heart rate variability, suggesting that cCTG could be used clinically to diagnoses chorioamnionitis during the pPROM latency period.	[Vandenbroucke, Laurent; Beuchee, Alain; Carrault, Guy; Pladys, Patrick] INSERM, UMR1099, Signal & Image Proc Lab, SEPIA Team, Rennes, France; [Vandenbroucke, Laurent; Le Lous, Maela] CHU Rennes, Univ Hosp Rennes, Dept Obstet, Rennes, France; [Vandenbroucke, Laurent; Doyen, Matthieu; Carrault, Guy; Pladys, Patrick] INSERM, U1414, Clin Invest Ctr, Rennes, France; [Vandenbroucke, Laurent; Doyen, Matthieu; Le Lous, Maela; Beuchee, Alain; Carrault, Guy; Pladys, Patrick] Univ Rennes 1, Fac Med, Rennes, France; [Beuchee, Alain; Pladys, Patrick] CHU Rennes, Univ Hosp Rennes, Dept Pediat, Rennes, France; [Loget, Philippe] CHU Rennes, Dept Anat Pathol, Univ Hosp Rennes, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Vandenbroucke, L (corresponding author), INSERM, UMR1099, Signal & Image Proc Lab, SEPIA Team, Rennes, France.; Vandenbroucke, L (corresponding author), CHU Rennes, Univ Hosp Rennes, Dept Obstet, Rennes, France.; Vandenbroucke, L (corresponding author), INSERM, U1414, Clin Invest Ctr, Rennes, France.; Vandenbroucke, L (corresponding author), Univ Rennes 1, Fac Med, Rennes, France.	laurent.vandenbroucke@chu-rennes.fr	Le Lous, Maela/ABC-6246-2020; carrault, guy/ABC-4463-2020; Beuchée, Alain/AAB-7024-2021; Doyen, Matthieu/ABG-3233-2021	Le Lous, Maela/0000-0001-6823-2279; carrault, guy/0000-0003-1482-2067; Beuchée, Alain/0000-0003-0064-7085; 	CORECT (clinical and translational research committee) of Rennes University Hospital	CORECT (clinical and translational research committee) of Rennes University Hospital	This study received grants from the CORECT (clinical and translational research committee) of Rennes University Hospital for data analysis.	[Anonymous], 2013, Obstet Gynecol, V122, P918, DOI 10.1097/01.AOG.0000435415.21944.8f; Beuchee A, 2009, NEONATOLOGY, V96, P109, DOI 10.1159/000208792; Buhimschi CS, 2008, AM J PERINAT, V25, P359, DOI 10.1055/s-2008-1078761; Buscicchio G, 2006, J MATERN-FETAL NEO M, V19, P39, DOI 10.1080/14767050500361505; Buscicchio G, 2010, J MATERN-FETAL NEO M, V23, P335, DOI 10.3109/14767050903258712; DAWES GS, 1991, J PERINAT MED, V19, P47, DOI 10.1515/jpme.1991.19.1-2.47; Durosier LD, 2015, PHYSIOL MEAS, V36, DOI 10.1088/0967-3334/36/10/2089; Ericson JE, 2015, CLIN PERINATOL, V42, P155, DOI 10.1016/j.clp.2014.10.011; Fehlert E, 2016, BJOG, V37, pS81; Garzoni L, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00057; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Griffin MP, 2007, PEDIATR RES, V61, P222, DOI 10.1203/01.pdr.0000252438.65759.af; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Griffin MP, 2003, PEDIATR RES, V53, P920, DOI 10.1203/01.PDR.0000064904.05313.D2; Herry CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153515; Kapaya H, 2015, J MATERN-FETAL NEO M, V28, P1664, DOI 10.3109/14767058.2014.964202; Lake DE, 2014, J CLIN MONIT COMPUT, V28, P329, DOI 10.1007/s10877-013-9530-x; Liu HL, 2016, PEDIATR CRIT CARE ME, V17, pE165, DOI 10.1097/PCC.0000000000000643; Pacora P, 2002, J Matern Fetal Neonatal Med, V11, P18, DOI 10.1080/713605445; Pasquier JC, 2005, EUR J OBSTET GYN R B, V121, P164, DOI 10.1016/j.ejogrb.2004.12.015; Popowski T, 2011, GYNECOL OBSTET FERTI, V39, P302, DOI 10.1016/j.gyobfe.2010.11.006; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Stone ML, 2013, J PERINATOL, V33, P847, DOI 10.1038/jp.2013.63; Sullivan BA, 2014, J PEDIATR-US, V164, P775, DOI 10.1016/j.jpeds.2013.11.038; Tsiartas P, 2013, J MATERN-FETAL NEO M, V26, P1332, DOI 10.3109/14767058.2013.784741	25	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184924	10.1371/journal.pone.0184924	http://dx.doi.org/10.1371/journal.pone.0184924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945767	Green Submitted, gold, Green Published			2022-12-26	WOS:000411645100013
J	Chen, CT; Liu, CY; Yu, YB; Liu, CJ; Hsiao, LT; Gau, JP; Chiou, TJ; Liu, JH; Liu, YC				Chen, Chien-Ting; Liu, Chun-Yu; Yu, Yuan-Bin; Liu, Chia-Jen; Hsiao, Liang-Tsai; Gau, Jyh-Pyng; Chiou, Tzeon-Jye; Liu, Jing-Hwang; Liu, Yao-Chung			Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT PROJECT; HEPATITIS-C; CHRONIC GVHD; CLINICAL-TRIALS; ADULT PATIENTS; SEVERITY; CRITERIA; IMPACT; CHILDREN; SURVIVAL	Chronic graft-versus-host-disease (cGvHD) is a serious complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Among various organ-specific cGvHD, the cGvHD of liver is less well-characterized. In this study, we applied the National Institutes of Health 2014 scoring criteria of cGvHD to analyze a retrospective cohort of 362 allo-HSCT recipients focusing on cGvHD of liver. The overall incidence of liver cGvHD with a score of 3 by 1.5 years post-transplant was 5.8% (21/362). Poor outcome, in terms of overall survival (OS), were observed in patients with scores of 3 liver cGvHD, comparing to those with scores less than 3 (hazard ratio [HR] 2.037, 95% confidence interval [CI] 1.123-3.696, P = 0.019). In multivariate analysis, male gender (HR 4.004, P = 0.042) and chronic hepatitis C virus (HCV) infection status (HR 19.087, P < 0.001) were statistically significant risk factors for scores of 3 liver cGvHD. Our results indicate that liver cGvHD with scores of 3 has a grave prognosis following allo-HSCT, and that HCV carrier status and male are risk factors. Early recognition of this devastating complication might help in prompt immunosuppressive therapy and reducing late poor outcome.	[Chen, Chien-Ting; Yu, Yuan-Bin; Liu, Chia-Jen; Hsiao, Liang-Tsai; Gau, Jyh-Pyng; Liu, Jing-Hwang; Liu, Yao-Chung] Taipei Vet Gen Hosp, Div Hematol, Dept Med, Taipei, Taiwan; [Chen, Chien-Ting; Liu, Chun-Yu; Yu, Yuan-Bin; Liu, Chia-Jen; Hsiao, Liang-Tsai; Gau, Jyh-Pyng; Chiou, Tzeon-Jye; Liu, Jing-Hwang; Liu, Yao-Chung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Med Oncol, Dept Oncol, Taipei, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei, Taiwan; [Yu, Yuan-Bin] Far Eastern Mem Hosp, Div Hematol & Oncol, New Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Far Eastern Memorial Hospital	Liu, YC (corresponding author), Taipei Vet Gen Hosp, Div Hematol, Dept Med, Taipei, Taiwan.; Liu, YC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	ycliu17@vghtpe.gov.tw						Arai S, 2011, BLOOD, V118, P4242, DOI 10.1182/blood-2011-03-344390; Arai Y, 2016, BONE MARROW TRANSPL, V51, P96, DOI 10.1038/bmt.2015.205; Baird K, 2013, BIOL BLOOD MARROW TR, V19, P632, DOI 10.1016/j.bbmt.2013.01.013; Bresters D, 2008, BONE MARROW TRANSPL, V41, P27, DOI 10.1038/sj.bmt.1705887; Brook G, 2010, INT J STD AIDS, V21, P669, DOI 10.1258/ijsa.2010.010234; Carlens S, 1998, BONE MARROW TRANSPL, V22, P755, DOI 10.1038/sj.bmt.1701423; Cho BS, 2009, LEUKEMIA, V23, P78, DOI 10.1038/leu.2008.276; Couriel D, 2006, BIOL BLOOD MARROW TR, V12, P375, DOI 10.1016/j.bbmt.2006.02.003; Dhingra S, 2016, WORLD J GASTROENTERO, V22, P1357, DOI 10.3748/wjg.v22.i4.1357; Dudek AZ, 2003, BIOL BLOOD MARROW TR, V9, P657, DOI 10.1016/S1083-8791(03)00242-8; Elderman M, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0075-9; Evans AT, 2015, AM J SURG PATHOL, V39, P212, DOI 10.1097/PAS.0000000000000345; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Gallardo D, 2006, LEUKEMIA, V20, P1461, DOI 10.1038/sj.leu.2404263; Gratwohl A, 2009, CANCER-AM CANCER SOC, V115, P4715, DOI 10.1002/cncr.24531; GUMBER SC, 1995, ANN INTERN MED, V123, P615, DOI 10.7326/0003-4819-123-8-199510150-00008; Inamoto Y, 2013, BLOOD, V121, P5098, DOI 10.1182/blood-2012-10-464198; Jacobsohn DA, 2012, BLOOD, V120, P2545, DOI 10.1182/blood-2012-04-424135; Jagasia MH, 2014, BIOL BLOOD MARROW TR; Konuma T, 2014, BONE MARROW TRANSPL, V49, P634, DOI 10.1038/bmt.2014.10; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lim ABM, 2015, BONE MARROW TRANSPL, V50, P566, DOI 10.1038/bmt.2014.313; Liu YC, 2015, BRIT J HAEMATOL, V169, P737, DOI 10.1111/bjh.13357; Martires KJ, 2011, BLOOD, V118, P4250, DOI 10.1182/blood-2011-04-350249; Nakasone H, 2013, AM J HEMATOL, V88, P477, DOI 10.1002/ajh.23436; Nishio N, 2009, BONE MARROW TRANSPL, V44, P303, DOI 10.1038/bmt.2009.33; Perez-Simon JA, 2008, BIOL BLOOD MARROW TR, V14, P1163, DOI 10.1016/j.bbmt.2008.07.015; Pidala J, 2013, BIOL BLOOD MARROW TR, V19, P784, DOI 10.1016/j.bbmt.2013.02.001; Pidala J, 2009, BLOOD, V114, P7, DOI 10.1182/blood-2008-10-182592; Ramos CA, 2009, HAEMATOL-HEMATOL J, V94, P249, DOI 10.3324/haematol.13756; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Ruutu T, 2014, BONE MARROW TRANSPL, V49, P168, DOI 10.1038/bmt.2013.107; Skert C, 2006, HAEMATOL-HEMATOL J, V91, P258; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; Strasser SI, 2000, HEPATOLOGY, V32, P1265, DOI 10.1053/jhep.2000.20067; Subbarao G, 2006, PEDIATR TRANSPLANT, V10, P682, DOI 10.1111/j.1399-3046.2006.00532.x	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185210	10.1371/journal.pone.0185210	http://dx.doi.org/10.1371/journal.pone.0185210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934311	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900125
J	Gomez-Mora, E; Massanella, M; Garcia, E; Giles, D; Bernado, M; Urrea, V; Carrillo, J; Ouchi, D; Puig, J; Negredo, E; Clotet, B; Blanco, J; Cabrera, C				Gomez-Mora, Elisabet; Massanella, Marta; Garcia, Elisabet; Giles, David; Bernado, Marta; Urrea, Victor; Carrillo, Jorge; Ouchi, Dan; Puig, Jordi; Negredo, Eugenia; Clotet, Bonaventura; Blanco, Julia; Cabrera, Cecilia			Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4(+) T-cell immune recovery	PLOS ONE			English	Article							IMMUNOGLOBULIN-G ANTIBODY; LINKED IMMUNOSORBENT-ASSAY; PRIMARY CMV INFECTION; PREGNANT-WOMEN; ANTIRETROVIRAL THERAPY; IGG AVIDITY; PREDICT MORTALITY; HOMOSEXUAL MEN; NORFOLK COHORT; HEART-DISEASE	Some HIV-infected c-ART-suppressed individuals show incomplete CD4(+) T-cell recovery, abnormal T-cell activation and higher mortality. One potential source of immune activation could be coinfection with cytomegalovirus (CMV). IgG and IgM levels, immune activation, inflammation and T-cell death in c-ART-suppressed individuals with CD4(+) T-cell counts >350 cells/mu L (immunoconcordant, n = 133) or <350 cells/mu L (immunodiscordant, n = 95) were analyzed to evaluate the effect of CMV humoral response on immune recovery. In total, 27 HIV-uninfected individuals were included as controls. In addition, the presence of CMV IgM antibodies was retrospectively analyzed in 58 immunoconcordant individuals and 66 immunodiscordant individuals. Increased CMV IgG levels were observed in individuals with poor immune reconstitution (p = 0.0002). Increased CMV IgG responses were significantly correlated with lower nadir and absolute CD4(+) T-cell counts. In contrast, CMV IgG responses were positively correlated with activation (HLA-DR+) and death markers in CD4(+) T-cells and activated memory CD8(+) T-cells (CD45RA(-)CD38(+)). Longitudinal subanalysis revealed an increased frequency of IgM(+) samples in individuals with poor CD4(+) T-cell recovery, and an association was observed between retrospective IgM positivity and the current level of IgG. The magnitude of the humoral immune response to CMV is associated with nadir CD4(+) T-cell counts, inflammation, immune activation and CD4(+) T-cell death, thus suggesting that CMV infection may be a relevant driving force in the increased morbidity/mortality observed in HIV+ individuals with poor CD4(+) T-cell recovery.	[Gomez-Mora, Elisabet; Massanella, Marta; Garcia, Elisabet; Urrea, Victor; Carrillo, Jorge; Ouchi, Dan; Clotet, Bonaventura; Blanco, Julia; Cabrera, Cecilia] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa AIDS Res Inst, Inst Recerca Germans Trias & Pujol IGTP, Barcelona, Spain; [Massanella, Marta] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Ctr Rech CHUM, Montreal, PQ, Canada; [Giles, David; Bernado, Marta] Biokit, Barcelona, Spain; [Puig, Jordi; Negredo, Eugenia; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita SIDA, Barcelona, Spain; [Negredo, Eugenia; Clotet, Bonaventura; Blanco, Julia] Univ Vic, Cent Catalunya, UVIC UCC, Vic, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Universite de Montreal; Hospital Germans Trias i Pujol; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Cabrera, C (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa AIDS Res Inst, Inst Recerca Germans Trias & Pujol IGTP, Barcelona, Spain.	ccabrera@irsicaixa.es	Ouchi, Dan/R-5319-2019; Blanco, Julià/A-5347-2008; Carrillo, Jorge/AAL-9481-2021; Cabrera, Cecilia/S-1113-2019; Urrea, Victor/ABF-9634-2021; Massanella, Marta/P-8619-2016	Ouchi, Dan/0000-0002-8630-152X; Blanco, Julià/0000-0002-2225-0217; Carrillo, Jorge/0000-0003-0221-5948; Cabrera, Cecilia/0000-0002-9941-6828; Massanella, Marta/0000-0002-3326-151X; Urrea, Victor/0000-0002-2577-856X; Negredo, Eugenia/0000-0001-5298-1734	Ministerio de Sanidad y Politica Social [EC11-045]; Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA' [RD12/0017/0002]; Spanish Institute de Salud Carlos III (ISCIII) [RD12/0017/0002]; European Fund for Regional Development (FEDER); ISCIII; Health Department of the Catalan Government (Generalitat de Catalunya); Biokit	Ministerio de Sanidad y Politica Social(Spanish Government); Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA'; Spanish Institute de Salud Carlos III (ISCIII); European Fund for Regional Development (FEDER)(European Commission); ISCIII(Instituto de Salud Carlos III); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Biokit	This work was supported by the EC11-045 project (Ministerio de Sanidad y Politica Social) and the Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA' (RD12/0017/0002). Grant RD12/0017/0002 is co-funded by the Spanish Institute de Salud Carlos III (ISCIII) and the European Fund for Regional Development (FEDER). C.C. and J.B. are supported by the ISCIII and the Health Department of the Catalan Government (Generalitat de Catalunya). DG and MB are employees of Biokit. Biokit provided support in the form of salaries for the authors [DG and MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arias RA, 2013, J VIROL, V87, P4486, DOI 10.1128/JVI.02425-12; Brunt SJ, 2016, AIDS RES HUM RETROV, V32, P567, DOI [10.1089/aid.2015.0328, 10.1089/AID.2015.0328]; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Daiminger A, 1999, J CLIN VIROL, V13, P161, DOI 10.1016/S1386-6532(99)00028-1; DETELS R, 1987, INT J EPIDEMIOL, V16, P271, DOI 10.1093/ije/16.2.271; Dollard SC, 2011, CLIN VACCINE IMMUNOL, V18, P1895, DOI 10.1128/CVI.05228-11; Erlandson KM, 2015, AIDS RES HUM RETROV, V31, P905, DOI [10.1089/aid.2015.0085, 10.1089/AID.2015.0085]; Freeman M.L., 2015, CLIN INFECT DIS; Gianella S, 2014, J INFECT DIS, V209, P452, DOI 10.1093/infdis/jit434; Gianella S, 2013, J INFECT DIS, V207, P898, DOI 10.1093/infdis/jis777; Gianella S, 2012, J VIROL, V86, P1307, DOI 10.1128/JVI.06077-11; Gkrania-Klotsas E, 2013, CLIN INFECT DIS, V56, P1421, DOI 10.1093/cid/cit083; Gkrania-Klotsas E, 2012, J INFECT DIS, V206, P1897, DOI 10.1093/infdis/jis620; GrangeotKeros L, 1997, J INFECT DIS, V175, P944, DOI 10.1086/513996; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hummel M, 2002, J CLIN VIROL, V25, pS123; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Kaye S, 2008, J INFECT DIS, V197, P1307, DOI 10.1086/586715; Lazzarotto T, 1997, CLIN DIAGN LAB IMMUN, V4, P469, DOI 10.1128/CDLI.4.4.469-473.1997; Lazzarotto T, 1999, CLIN DIAGN LAB IMMUN, V6, P127, DOI 10.1128/CDLI.6.1.127-129.1999; Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Longenecker CT, 2014, AIDS, V28, P969, DOI 10.1097/QAD.0000000000000158; Lurain NS, 2016, AIDS RES HUM RETROV, V32, P134, DOI [10.1089/aid.2015.0169, 10.1089/AID.2015.0169]; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Massanella M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0601-2; Massanella M, 2013, EXPERT REV CLIN IMMU, V9, P1135, DOI 10.1586/1744666X.2013.842897; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; MCVOY MA, 1989, J INFECT DIS, V160, P1, DOI 10.1093/infdis/160.1.1; Munro SC, 2005, J CLIN MICROBIOL, V43, P4713, DOI 10.1128/JCM.43.9.4713-4718.2005; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; NIELSEN SL, 1988, J CLIN MICROBIOL, V26, P654, DOI 10.1128/JCM.26.4.654-661.1988; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Patel EU, 2017, AIDS, V31, P807, DOI [10.1097/qad.0000000000001412, 10.1097/QAD.0000000000001412]; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Prince HE, 2014, CLIN VACCINE IMMUNOL, V21, P1377, DOI 10.1128/CVI.00487-14; RCT, 2016, LANG ENV STAT COMP; REVELLO MG, 1991, J VIROL METHODS, V35, P315, DOI 10.1016/0166-0934(91)90073-9; REYNOLDS DW, 1973, NEW ENGL J MED, V289, P1, DOI 10.1056/NEJM197307052890101; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schaftenaar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099243; Sheth PM, 2006, J INFECT DIS, V193, P45, DOI 10.1086/498576; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Slyker J, 2014, CLIN INFECT DIS, V58, P564, DOI 10.1093/cid/cit727; Slyker JA, 2012, J VIROL, V86, P11373, DOI 10.1128/JVI.00790-12; Smith DM, 2016, CLIN INFECT DIS; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Springer KL, 2004, J ANTIMICROB CHEMOTH, V54, P582, DOI 10.1093/jac/dkh396; STAGNO S, 1985, J CLIN MICROBIOL, V21, P930, DOI 10.1128/JCM.21.6.930-935.1985; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; van der Heiden M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26892; Varani Stefania, 2011, Herpesviridae, V2, P6, DOI 10.1186/2042-4280-2-6	56	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184433	10.1371/journal.pone.0184433	http://dx.doi.org/10.1371/journal.pone.0184433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934217	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900028
J	Lovric, G; Oikonomidis, IV; Mokso, R; Stampanoni, M; Roth-Kleiner, M; Schittny, JC				Lovric, Goran; Oikonomidis, Ioannis Vogiatzis; Mokso, Rajmund; Stampanoni, Marco; Roth-Kleiner, Matthias; Schittny, Johannes C.			Automated computer-assisted quantitative analysis of intact murine lungs at the alveolar scale	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; FUNCTIONAL RESIDUAL CAPACITY; DENDRITIC MICROSTRUCTURES; MORPHOLOGICAL EVOLUTION; REGIONAL VENTILATION; PHASE; RESOLUTION; IMAGE; CT; TOMOGRAPHY	Using state-of-the-art X-ray tomographic microscopy we can image lung tissue in three dimensions in intact animals down to a micrometer precision. The structural complexity and hierarchical branching scheme of the lung at this level of details, however, renders the extraction of biologically relevant quantities particularly challenging. We have developed a methodology for a detailed description of lung inflation patterns by measuring the size and the local curvature of the parenchymal airspaces. These quantitative tools for morphological and topological analyses were applied to high-resolution murine 3D lung image data, inflated at different pressure levels under immediate post mortem conditions. We show for the first time direct indications of heterogeneous intra-lobar and inter-lobar distension patterns at the alveolar level. Furthermore, we did not find any indication that a cyclic opening-and-collapse (recruitment) of a large number of alveoli takes place.	[Lovric, Goran] Ecole Polytech Fed Lausanne, Ctr Imagerie BioMed, CH-1015 Lausanne, Switzerland; [Lovric, Goran; Oikonomidis, Ioannis Vogiatzis; Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5234 Villigen, Switzerland; [Lovric, Goran; Stampanoni, Marco] Swiss Fed Inst Technol, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Oikonomidis, Ioannis Vogiatzis; Schittny, Johannes C.] Univ Bern, Inst Anat, CH-3012 Bern, Switzerland; [Mokso, Rajmund] Lund Univ, Max Lab 4, SE-22100 Lund, Sweden; [Roth-Kleiner, Matthias] Univ Hosp Lausanne CHUV, Clin Neonatol, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Lund University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lovric, G (corresponding author), Ecole Polytech Fed Lausanne, Ctr Imagerie BioMed, CH-1015 Lausanne, Switzerland.; Lovric, G (corresponding author), Paul Scherrer Inst, Swiss Light Source, CH-5234 Villigen, Switzerland.; Lovric, G (corresponding author), Swiss Fed Inst Technol, Inst Biomed Engn, CH-8092 Zurich, Switzerland.	goran.lovric@psi.ch	Schittny, Johannes C/U-2956-2017; Lovric, Goran/J-9358-2013; Lovric, Goran/AID-6860-2022; Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/GRR-9695-2022; Stampanoni, Marco/J-4099-2013; Mokso, Rajmund/J-5557-2013	Schittny, Johannes C/0000-0003-4025-3961; Lovric, Goran/0000-0002-0833-4043; Lovric, Goran/0000-0002-0833-4043; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Mokso, Rajmund/0000-0002-2245-2775	National Competence Center in Biomedical Imaging (NCCBI) [1126.0076]; Swiss National Science Foundation (SNF) [CR2312-135550];  [310030-153468]	National Competence Center in Biomedical Imaging (NCCBI); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); 	The study was supported by the National Competence Center in Biomedical Imaging (NCCBI, http://www.nccbi.ch/), grant No. 1126.0076 (M.S), and the Swiss National Science Foundation (SNF, http://www.snf.ch/), grant No. CR2312-135550 (M.S.) with partial contribution from grant No. 310030-153468 (J.C.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge F. Arcadu, D. Pelt, S.F. Barre and G. Mikuljan for their help at the experiment, J. Fife, M. Kagias and K. Mader for fruitful discussions. This study was supported by the National Competence Center in Biomedical Imaging (NCCBI), grant No.1126.0076, and the Swiss National Science Foundation (SNF), grant No. CR23I2-135550 with partial contribution from grant No. 310030-153468.	Abbena E, 2006, TXB MATH; Adam JF, 2009, CLIN EXP PHARMACOL P, V36, P95, DOI 10.1111/j.1440-1681.2008.05043.x; Albert SP, 2009, J APPL PHYSIOL, V106, P757, DOI 10.1152/japplphysiol.90735.2008; Babin D, 2013, PHYS MED BIOL, V58, P8041, DOI 10.1088/0031-9155/58/22/8041; Barre SF, 2016, AM J PHYSIOL-LUNG C, V311, pL1082, DOI 10.1152/ajplung.00325.2016; Barre SF, 2014, PHYSL REPORTS, V2, P1; Bayat S, 2008, EUR J RADIOL, V68, pS78, DOI 10.1016/j.ejrad.2008.04.043; Chang S, 2016, SCI REPORTS, V1, P8760; Chang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01304; David Cohen-Steiner, 2003, P 19 ANN S COMP GEOM, P312, DOI DOI 10.1145/777792.777839; Dubsky S, 2012, J R SOC INTERFACE, V9, P2213, DOI 10.1098/rsif.2012.0116; Duong T, 2007, J STAT SOFTW, V21, P1, DOI 10.18637/jss.v021.i07; Escolar JD, 2004, HISTOL HISTOPATHOL, V19, P159, DOI 10.14670/HH-19.159; Fife JL, 2009, ACTA MATER, V57, P2418, DOI 10.1016/j.actamat.2009.01.036; Haberthur D, 2010, J SYNCHROTRON RADIAT, V17, P590, DOI 10.1107/S0909049510019618; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hooper SB, 2009, CLIN EXP PHARMACOL P, V36, P117, DOI 10.1111/j.1440-1681.2008.05109.x; Howells MR, 2009, J ELECTRON SPECTROSC, V170, P1, DOI 10.1016/j.elspec.2009.01.004; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Irvine S, 2014, OPT EXPRESS, V22, P27257, DOI 10.1364/OE.22.027257; Kang N, 2012, IEEE COMPUT GRAPH, V32, P29, DOI 10.1109/MCG.2012.65; Kitchen MJ, 2004, PHYS MED BIOL, V49, P4335, DOI 10.1088/0031-9155/49/18/010; Kuijpers NCW, 2002, MATER CHARACT, V48, P379, DOI 10.1016/S1044-5803(02)00289-9; Lavoue Guillaume, 2012, Proceedings of the International Conference on Computer Graphics Theory and Applications (GRAPP 2012) and International Conference on Information Visualization Theory and Applications (IVAPP 2012), P206; Leong AFT, 2014, BIOMED OPT EXPRESS, V5, P4024, DOI 10.1364/BOE.5.004024; Leong AFT, 2013, OPT EXPRESS, V21, P27905, DOI 10.1364/OE.21.027905; Levine JA, 2012, IEEE COMPUT GRAPH, V32, P22, DOI 10.1109/MCG.2012.91; Lewis RA, 2005, PHYS MED BIOL, V50, P5031, DOI 10.1088/0031-9155/50/21/006; Liu YX, 2014, IEEE T BIO-MED ENG, V61, P2057, DOI 10.1109/TBME.2014.2313564; Lovric G, 2016, PHYS MEDICA, V32, P1771, DOI 10.1016/j.ejmp.2016.08.012; Lovric G, 2013, J APPL CRYSTALLOGR, V46, P856, DOI 10.1107/S0021889813005591; Marone F, 2012, J SYNCHROTRON RADIAT, V19, P1029, DOI 10.1107/S0909049512032864; Mendoza R, 2003, METALL MATER TRANS A, V34, P481, DOI 10.1007/s11661-003-0084-2; Mertens M, 2009, CRIT CARE MED, V37, P2604, DOI 10.1097/CCM.0b013e3181a5544d; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; MIYAMOTO K, 1994, RES PATTERN FORMATIO, P507; Mokso R, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/494004; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Porra L, 2004, J APPL PHYSIOL, V96, P1899, DOI 10.1152/japplphysiol.00866.2003; Porra L, 2011, CRIT CARE MED, V39, P1731, DOI 10.1097/CCM.0b013e318218a375; R Core Team, 2018, R LANG ENV STAT COMP; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Schittny JC, 2017, CELL TISSUE RES, V367, P427, DOI 10.1007/s00441-016-2545-0; Schroeder W., 2006, VISUALIZATION TOOLKI, V4th; Sera T, 2008, PHYS MED BIOL, V53, P4285, DOI 10.1088/0031-9155/53/16/005; Siew ML, 2009, J APPL PHYSIOL, V106, P1487, DOI 10.1152/japplphysiol.91591.2008; Smaldone GC, 2012, J APPL PHYSIOL, V113, P1945, DOI 10.1152/japplphysiol.00545.2012; Stahr CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29438; Suhonen H, 2008, PHYS MED BIOL, V53, P775, DOI 10.1088/0031-9155/53/3/016; Szilvasi-Nagy M, 2008, J GEOM GRAPH, V12, P63; Taubin G, 2000, STAR P EUROGRAPHICS; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; Tran H, 2013, J MATER SCI, V48, P3198, DOI 10.1007/s10853-012-7100-0; Tschanz SA, 2009, J APPL PHYSIOL, V117, P89; Unglert CI, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126015; Vasilescu DM, 2012, P NATL ACAD SCI USA, P1; Vasilescu DM, 2013, J APPL PHYSIOL, V114, P716, DOI 10.1152/japplphysiol.00855.2012; Wang GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089252; Weibel ER, 2009, SWISS MED WKLY, V139, P375, DOI smw-12270; Xiao XH, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2744224	64	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183979	10.1371/journal.pone.0183979	http://dx.doi.org/10.1371/journal.pone.0183979			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934236	Green Published, Green Accepted, gold			2022-12-26	WOS:000411339900015
J	Minoura, K; Yamada, M; Mizoguchi, T; Kaneko, T; Nishiyama, K; Ozminskyj, M; Koshizuka, T; Wada, I; Suzutani, T				Minoura, Kiyoshi; Yamada, Miho; Mizoguchi, Takashi; Kaneko, Toshihiro; Nishiyama, Kyoko; Ozminskyj, Mari; Koshizuka, Tetsuo; Wada, Ikuo; Suzutani, Tatsuo			Antibacterial effects of the artificial surface of nanoimprinted moth-eye film	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY	The antibacterial effect of a nanostructured film, known as "moth-eyefilm," was investigated. The moth-eye film has artificially formed nano-pillars, consisting of hydrophilic resin with urethane acrylate and polyethylene glycol (PEG) derivatives, all over its surface that replicates a moth's eye. Experiments were performed to compare the moth-eye film with a flat-surfaced film produced from the same materials. The JIS Z2801 film-covering method revealed that the two films produced a decrease in Staphylococcus aureus and Esherichia coli titers of over 5 and 3 logs, respectively. There was no marked difference in the antibacterial effects of the two surfaces. However, the antibacterial effects were reduced by immersion of the films in water. These results indicated that a soluble component(s) of the resin possessed the antibacterial activity, and this component was identified as PEG derivatives by time-of-flight secondary ion mass spectrometry (TOF-SIMS) and Fourier transform infrared spectroscopy (FT-IR). When a small volume of bacterial suspension was dropped on the films as an airborne droplet model, both films showed antibacterial effects, but that of the moth-eye film was more potent. It was considered that the moth-eye structure allowed the bacteria-loaded droplet to spread and allow greater contact between the bacteria and the film surface, resulting in strong adherence of the bacteria to the film and synergistically enhanced bactericidal activity with chemical components. The antibacterial effect of the moth-eye film has been thus confirmed under a bacterial droplet model, and it appears attractive due to its antibacterial ability, which is considered to result not only from its chemical make-up but also from physical adherence.	[Minoura, Kiyoshi; Yamada, Miho] Sharp Co Ltd, Display Device Co, Dev Grp, LCD Technol Dev Ctr, Tenri, Nara, Japan; [Mizoguchi, Takashi] Sharp Co Ltd, Display Device Co, Dev Grp, New Business Promot Ctr, Tenri, Nara, Japan; [Kaneko, Toshihiro] Sharp Co Ltd, Display Device Co, Dev Grp, Next Generat IGZO Technol Dev Ctr, Tenri, Nara, Japan; [Nishiyama, Kyoko; Ozminskyj, Mari; Koshizuka, Tetsuo; Suzutani, Tatsuo] Fukushima Med Univ, Inst Biomed Sci, Dept Microbiol, Sch Med, Fukushima, Japan; [Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Sch Med, Fukushima, Japan	Hisense; Sharp Corporation; Hisense; Sharp Corporation; Hisense; Sharp Corporation; Fukushima Medical University; Fukushima Medical University	Minoura, K (corresponding author), Sharp Co Ltd, Display Device Co, Dev Grp, LCD Technol Dev Ctr, Tenri, Nara, Japan.	minoura.kiyoshi@sharp.co.jp		Koshizuka, Tetsuo/0000-0003-2783-2520; Minoura, Kiyoshi/0000-0002-5236-3087	Sharp Corporation	Sharp Corporation	Financial statement Sharp Corporation provided support in the form of salaries for authors [KM, MY, TM and T. Kaneko], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; CLAPHAM PB, 1973, NATURE, V244, P281, DOI 10.1038/244281a0; Desrousseaux C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135632; Dickson MN, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4922157; Graham MV, 2014, COATINGS, V4, P37, DOI 10.3390/coatings4010037; Gunawan C, 2013, SMALL, V9, P3554, DOI 10.1002/smll.201300761; Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5; Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017; Ivanova EP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3838; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; Kim S, 2015, ACS APPL MATER INTER, V7, P326, DOI 10.1021/am506254r; Minoura K, 2014, World patent, Patent No. [WO2014/038288 A1, 2014038288]; Nowlin Kyle, 2015, J R Soc Interface, V12, P20140999, DOI 10.1098/rsif.2014.0999; Park B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025880; Rizzello L, 2013, NANOMEDICINE-UK, V8, P807, DOI [10.2217/NNM.13.63, 10.2217/nnm.13.63]; Shirotake S, 2008, CHEM PHARM BULL, V56, P137, DOI 10.1248/cpb.56.137; Taguchi T., 2010, SID S DIG TECH PAP, V41, P1196; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; Yamada M, 2015, World patent, Patent No. [WO2015/163018 A1, 2015163018]; Yamada M, 2016, World patent, Patent No. [WO2016/080245 A1, 2016080245]	21	21	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185366	10.1371/journal.pone.0185366	http://dx.doi.org/10.1371/journal.pone.0185366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934372	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900152
J	Shaqura, M; Mohamed, DM; Aboryag, NB; Bedewi, L; Dehe, L; Treskatsch, S; Shakibaei, M; Schafer, M; Mousa, SA				Shaqura, Mohammed; Mohamed, Doaa M.; Aboryag, Noureddin B.; Bedewi, Lama; Dehe, Lukas; Treskatsch, Sascha; Shakibaei, Mehdi; Schaefer, Michael; Mousa, Shaaban A.			Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats	PLOS ONE			English	Article							CELL-DEATH; OXIDATIVE STRESS; CYTOCHROME-C; APOPTOSIS; DYSFUNCTION; PRESSURE; METAANALYSIS; MECHANISMS; PROGNOSIS; MORTALITY	Heart failure has emerged as a disease with significant public health implications. Following progression of heart failure, heart and liver dysfunction are frequently combined in hospitalized patients leading to increased morbidity and mortality. Here, we investigated the underlying pathological alterations in liver injury following heart failure. Heart failure was induced using a modified infrarenal aortocaval fistula (ACF) in male Wistar rats. Sham operated and ACF rats were compared for their morphometric and hemodynamic data, for histopathological and ultrastructural changes in the liver as well as differences in the expression of apoptotic factors. ACF-induced heart failure is associated with light microscopic signs of apparent congestion of blood vessels, increased apoptosis and breakdown of hepatocytes and inflammatory cell inifltration were observed. The glycogen content depletion associated with the increased hepatic fibrosis, lipid globule formation was observed in ACF rats. Moreover, cytoplasmic organelles are no longer distinguishable in many ACF hepatocytes with degenerated fragmented rough endoplasmic reticulum, shrunken mitochondria and heavy cytoplasm vacuolization. ACF is associated with the upregulation of the hepatic TUNEL-positive cells and proapoptotic factor Bax protein concomitant with the mitochondrial leakage of cytochrome C into the cell cytoplasm and the transfer of activated caspase 3 from the cytoplasm into the nucleus indicating intrinsic apoptotic events. Taken together, the results demonstrate that ACF-induced congestive heart failure causes liver injury which results in hepatocellular apoptotic cell death mediated by the intrinsic pathway of mitochondrial cytochrome C leakage and subsequent transfer of activated caspase 3 into to the nucleus to initiate overt DNA fragmentation and cell death.	[Shaqura, Mohammed; Mohamed, Doaa M.; Aboryag, Noureddin B.; Bedewi, Lama; Dehe, Lukas; Treskatsch, Sascha; Schaefer, Michael; Mousa, Shaaban A.] Campus Virchow Klinikum, Charite Univ Berlin, Dept Anaesthesiol & Intens Care Med, Berlin, Germany; [Shakibaei, Mehdi] Ludwig Maximilians Univ Munchen, Dept Anat, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Mousa, SA (corresponding author), Campus Virchow Klinikum, Charite Univ Berlin, Dept Anaesthesiol & Intens Care Med, Berlin, Germany.	shaaban.mousa@charite.de	Treskatsch, Sascha/ABB-2449-2021; Mohamed, Doaa/AAI-4658-2021; Schäfer, Michael/AAB-1395-2020; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Mohamed, Doaa/0000-0003-1144-3184; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Schaefer, Michael/0000-0002-1581-706X; Treskatsch, Sascha/0000-0002-0549-7680; Shaqura, Mohammed/0000-0002-4289-2188; Dehe, Lukas/0000-0002-8690-4005				Allen LA, 2016, JAMA CARDIOLOGY; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Bechmann LP, 2008, LIVER INT, V28, P713, DOI 10.1111/j.1478-3231.2007.01566.x; Behroozaghdam M, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.24609; BENEDETTI A, 1988, LIVER, V8, P172; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Canbay A, 2009, Z GASTROENTEROL, V47, P807, DOI 10.1055/s-0028-1109058; Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfail.2007.04.008; de Silva R, 2006, EUR HEART J, V27, P569, DOI 10.1093/eurheartj/ehi696; Deng JX, 2008, FREE RADICAL BIO MED, V44, P375, DOI 10.1016/j.freeradbiomed.2007.09.023; Donati A, 2016, CURR OPIN ANESTHESIO, V29, P172, DOI 10.1097/ACO.0000000000000296; Fadda E, 2008, BBA-BIOENERGETICS, V1777, P277, DOI 10.1016/j.bbabio.2007.11.010; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; GARCIA R, 1990, CARDIOVASC RES, V24, P430, DOI 10.1093/cvr/24.5.430; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Guo Y, 2013, J BUON, V18, P477; Gurwitz JH, 2013, AM J MED, V126, P393, DOI 10.1016/j.amjmed.2012.10.022; Herzer K, 2011, ANN HEPATOL, V10, P174, DOI 10.1016/S1665-2681(19)31566-2; Horvath B, 2017, GASTROENTEROL RES, V10, P182, DOI 10.14740/gr875e; LEIST M, 1995, AM J PATHOL, V146, P1220; Li CP, 2014, GENET MOL RES, V13, P3991, DOI 10.4238/2014.May.23.10; Liu Y, 2012, EUR J CANCER, V48, P2125, DOI 10.1016/j.ejca.2012.02.009; Losser MR, 1996, SEMIN LIVER DIS, V16, P357, DOI 10.1055/s-2007-1007249; Louie CY, 2015, MODERN PATHOL, V28, P932, DOI 10.1038/modpathol.2015.40; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mayer P., 1981, MITTHEILUNGEN ZOOLOG, V10, P170; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Mousa SA, 2004, ENDOCRINOLOGY, V145, P1331, DOI 10.1210/en.2003-1287; Mousa SA, 2016, PAIN, V157, P910, DOI 10.1097/j.pain.0000000000000459; Mueller S, 2016, WORLD J GASTROENTERO, V22, P10482, DOI 10.3748/wjg.v22.i48.10482; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Saha DC, 2007, J AM ASSOC LAB ANIM, V46, P74; Seervi M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.90; Shaqura M, 2014, NEUROPHARMACOLOGY, V85, P142, DOI 10.1016/j.neuropharm.2014.05.026; SHERLOCK S, 1950, Postgrad Med J, V26, P472; Toledo FD, 2014, ARCH TOXICOL, V88, P1695, DOI 10.1007/s00204-014-1219-5; Treskatsch S, 2015, INT J CARDIOL, V197, P327, DOI 10.1016/j.ijcard.2015.06.067; Treskatsch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087531; Tsamandas AC, 2003, MODERN PATHOL, V16, P1273, DOI 10.1097/01.MP.0000097367.56816.5E; TSUNODA K, 1986, CIRC RES, V59, P256, DOI 10.1161/01.RES.59.3.256; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Yang M, 2014, LIVER TRANSPLANT, V20, P1372, DOI 10.1002/lt.23958; Yip WW, 2006, SEMIN DIAGN PATHOL, V23, P149, DOI 10.1053/j.semdp.2006.11.002; Zhao X, 1997, Zhonghua Nei Ke Za Zhi, V36, P658	46	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184161	10.1371/journal.pone.0184161	http://dx.doi.org/10.1371/journal.pone.0184161			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934226	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900020
J	Stacy, NI; Isaza, R; Wiedner, E				Stacy, Nicole I.; Isaza, Ramiro; Wiedner, Ellen			First report of changes in leukocyte morphology in response to inflammatory conditions in Asian and African elephants (Elephas maximus and Loxodonta africana)	PLOS ONE			English	Article							ACUTE-PHASE PROTEIN; CLINICAL INFECTION; DISEASE; VALUES	Although the hematology of healthy elephants has been well-described, published information on hematological changes during disease is limited. The objective of this study was to describe qualitative morphological changes in the leukocytes of Asian and African elephants (Elephas maximus and Loxodonta africana) diagnosed with a variety of inflammatory conditions. Twenty-five of 27 elephants had morphological changes in their leukocytes, although only 16 of these had a concurrent inflammatory leukogram. Morphological changes included heterophil left-shifting with or without concurrent dysgranulopoiesis, toxicity, or hypersegmentation, reactive lymphocytes, plasma cells, and/or vacuolated monocytes. Although the observed leukocyte morphological changes are non-specific, their early recognition upon blood film evaluation may provide important, clinically-relevant information, particularly if the leukogram is normal. This case series is the first description of qualitative morphological changes in the leukocytes of elephants in association with inflammation.	[Stacy, Nicole I.; Isaza, Ramiro] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA; [Wiedner, Ellen] The Wilds, Cumberland, OH USA	State University System of Florida; University of Florida	Stacy, NI (corresponding author), Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA.	stacyn@ufl.edu		Stacy, Nicole/0000-0003-4258-4414				ALLEN JL, 1985, J ZOO ANIM MED, V16, P98, DOI 10.2307/20094754; Fuery A, 2016, J ZOO WILDLIFE MED, V47, P319, DOI 10.1638/2015-0074.1; Fuery A, 2016, J ZOO WILDLIFE MED, V47, P311, DOI 10.1638/2015-0072.1; Guyton AC, 2015, GUYTON HALL TXB MED, P455; Harr KE, 2010, SCHALMS VET HEMATOLO, Vsixth, P942; Harr K, 2006, J ZOO WILDLIFE MED, V37, P151, DOI 10.1638/05-023.1; Harr Kendal, 2001, P209; Harvey J.W., 2011, VET HEMATOLOGY DIAGN; Isaza R, 2014, J VET DIAGN INVEST, V26, P616, DOI 10.1177/1040638714543923; Landolfi JA, 2010, J ZOO WILDLIFE MED, V41, P445, DOI 10.1638/2009-0163.1; Richman Laura K., 2012, P496; Richman LK, 2000, J WILDLIFE DIS, V36, P1, DOI 10.7589/0090-3558-36.1.1; Schalm OW, 1975, VET HEMATOLOGY, P271; Schmitt DL, 2000, J ZOO WILDLIFE MED, V31, P518, DOI 10.1638/1042-7260(2000)031[0518:UOFFTT]2.0.CO;2; Stanton JJ, 2013, J ZOO WILDLIFE MED, V44, P605, DOI 10.1638/2012-0174R1.1; Swami SK, 2016, ANIM BIOTECHNOL, V27, P66, DOI 10.1080/10495398.2015.1088449	16	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185277	10.1371/journal.pone.0185277	http://dx.doi.org/10.1371/journal.pone.0185277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934325	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900139
J	Tudesq, JJ; Dunyach-Remy, C; Combescure, C; Doncesco, R; Laureillard, D; Lavigne, JP; Sotto, A				Tudesq, Jean-Jacques; Dunyach-Remy, Catherine; Combescure, Christophe; Doncesco, Regine; Laureillard, Didier; Lavigne, Jean-Philippe; Sotto, Albert			Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients	PLOS ONE			English	Article							IMMUNE ACTIVATION; SYSTEMIC INFLAMMATION; BACTERIAL-DNA; PLASMA-LEVELS; HEPATITIS-C; VIRUS; INDIVIDUALS; PROGRESSION; COINFECTION; FIBROSIS	Microbial translocation (MT) is characterized by bacterial products passing into the blood through the gut barrier and is a key phenomenon in the pathophysiology of Human Immunodeficiency Virus (HIV) infection. MT is also associated with liver damage in Hepatitis C Virus (HCV) patients. The aim of the study was to assess MT in plasma of HIV-HCV co-infected patients. 16S rDNA (16 S Ribosomal DNA subunit) marker and other markers of MT such as Lipopolysaccharide (LPS)-binding protein (LBP), soluble CD14 (sCD14), intestinal fatty acid binding protein (I-FABP) were used. Clinical, biological and immunological characteristics of the population were studied in order to correlate them with the intensity of the MT. We demonstrate that indirect markers of MT, LBP and CD14s, and a marker of intestinal permeability (I-FABP) are significantly higher in HIV-HCV co-infected patients than in healthy controls (17.0 vs 2.6 mu g/mL, p < 0.001; 1901.7 vs 1255.0 ng/mL, p = 0.018); 478.3 vs 248.1 pg/mL, p < 0.001, respectively), while a direct marker of MT (16S rDNA copies) is not different between these two populations. However, plasma 16S rDNA was significantly higher in co-infected patients with long-standing HIV infections (RGM = 1.47 per 10 years, CI95% = [1.04: 2.06], p = 0.03). Our findings show that in HIV-HCV co-infected patients, plasma 16S rDNA levels, directly reflecting MT, seem to be linked to the duration of HIV infection, while elevated levels of LBP and sCD14 reflect only a persistence of immune activation. The levels of these markers were not correlated with HCV evolution.	[Tudesq, Jean-Jacques; Dunyach-Remy, Catherine; Laureillard, Didier; Lavigne, Jean-Philippe; Sotto, Albert] Montpellier Univ, INSERM, Nimes, France; [Dunyach-Remy, Catherine; Lavigne, Jean-Philippe] Nimes Univ Hosp, Dept Microbiol, Nimes, France; [Combescure, Christophe] Univ Geneva, Div Clin Epidemiol, Dept Hlth & Community Med, Geneva, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Geneva, Switzerland; [Doncesco, Regine; Laureillard, Didier; Sotto, Albert] Nimes Univ Hosp, Dept Infect Dis, Nimes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes; University of Geneva; University of Geneva; Universite de Montpellier; CHU de Nimes	Dunyach-Remy, C (corresponding author), Montpellier Univ, INSERM, Nimes, France.; Dunyach-Remy, C (corresponding author), Nimes Univ Hosp, Dept Microbiol, Nimes, France.	catherine.remy@chu-nimes.fr	Sotto, Albert/AFJ-9023-2022; Tudesq, Jean-Jacques/ABG-1918-2020; Lavigne, Jean-Philippe/E-1756-2014	Tudesq, Jean-Jacques/0000-0003-4879-8106; Lavigne, Jean-Philippe/0000-0002-9484-0304; Laureillard, Didier/0000-0002-0104-9047; Sotto, Albert/0000-0002-6463-9386; Dunyach-Remy, Catherine/0000-0001-6884-470X				Abad-Fernandez M, 2013, JAIDS-J ACQ IMM DEF, V64, P149, DOI 10.1097/QAI.0b013e31829a2f12; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Baroncelli S, 2009, J CLIN VIROL, V46, P367, DOI 10.1016/j.jcv.2009.09.011; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Bonacini M, 2004, AIDS, V18, P2039, DOI 10.1097/00002030-200410210-00008; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Ferri E, 2010, J INFECT DIS, V202, P176, DOI 10.1086/653215; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Kramski M, 2011, J CLIN MICROBIOL, V49, P3691, DOI 10.1128/JCM.01018-11; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Nystrom J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118643; Psomas C, 2013, BLOOD, V122, P2282, DOI 10.1182/blood-2013-06-507012; Sacchi P, 2015, DIGEST LIVER DIS, V47, P218, DOI 10.1016/j.dld.2014.11.012; Shmagel KV, 2016, HIV MED, V17, P581, DOI 10.1111/hiv.12357; Steele AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097171; Zhu Y, 2013, WORLD J GASTROENTERO, V19, P8963, DOI 10.3748/wjg.v19.i47.8963	21	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183372	10.1371/journal.pone.0183372	http://dx.doi.org/10.1371/journal.pone.0183372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934209	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900010
J	Bright, FM; Vink, R; Byard, RW; Duncan, JR; Krous, HF; Paterson, DS				Bright, Fiona M.; Vink, Robert; Byard, Roger W.; Duncan, Jhodie R.; Krous, Henry F.; Paterson, David S.			Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex	PLOS ONE			English	Article							RAT IN-VITRO; TRACTUS-SOLITARIUS; INFERIOR OLIVE; DEVELOPMENTAL ABNORMALITIES; PREBOTZINGER COMPLEX; RESPIRATORY NETWORK; BARORECEPTOR REFLEX; EXPRESSING NEURONS; MEDULLA-OBLONGATA; CEREBELLAR	Sudden infant death syndrome (SIDS) involves failure of arousal to potentially life threatening events, including hypoxia, during sleep. While neuronal dysfunction and abnormalities in neurotransmitter systems within the medulla oblongata have been implicated, the specific pathways associated with autonomic and cardiorespiratory failure are unknown. The neuropeptide substance P (SP) and its tachykinin neurokinin-1 receptor (NK1R) have been shown to play an integral role in the modulation of homeostatic function in the medulla, including regulation of respiratory rhythm generation, integration of cardiovascular control, and modulation of the baroreceptor reflex and mediation of the chemoreceptor reflex in response to hypoxia. Abnormalities in SP neurotransmission may therefore result in autonomic dysfunction during sleep and contribute to SIDS deaths. [125 I] Bolton Hunter SP autoradiography was used to map the distribution and density of the SP, NK1R to 13 specific nuclei intimately related to cardiorespiratory function and autonomic control in the human infant medulla of 55 SIDS and 21 control (non-SIDS) infants. Compared to controls, SIDS cases exhibited a differential, abnormal developmental profile of the SP/NK1R system in the medulla. Furthermore the study revealed significantly decreased NK1R binding within key medullary nuclei in SIDS cases, principally in the nucleus tractus solitarii (NTS) and all three subdivisions of the inferior portion of the olivo-cerebellar complex; the principal inferior olivary complex (PIO), medial accessory olive (MAO) and dorsal accessory olive (DAO). Altered NK1R binding was significantly influenced by prematurity and male sex, which may explain the increased risk of SIDS in premature and male infants. Abnormal NK1R binding in these medullary nuclei may contribute to the defective interaction of critical medullary mechanisms with cerebellar sites, resulting in an inability of a SIDS infant to illicit appropriate respiratory and motor responses to life threatening challenges during sleep. These observations support the concept that abnormalities in a multi-neurotransmitter network within key nuclei of the medullary homeostatic system may underlie the pathogenesis of a subset of SIDS cases.	[Bright, Fiona M.; Byard, Roger W.] Univ Adelaide, Discipline Anat & Pathol, Adelaide Med Sch, Adelaide, SA, Australia; [Bright, Fiona M.; Paterson, David S.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bright, Fiona M.; Paterson, David S.] Harvard Med Sch, Boston, MA 02115 USA; [Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Duncan, Jhodie R.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Krous, Henry F.] Childrens Hospital San Diego, Dept Pathol, San Diego, CA USA	University of Adelaide; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of South Australia; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bright, FM (corresponding author), Univ Adelaide, Discipline Anat & Pathol, Adelaide Med Sch, Adelaide, SA, Australia.; Bright, FM (corresponding author), Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA.; Bright, FM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	fiona.bright@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Bright, Fiona/ABE-8441-2020	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Bright, Fiona/0000-0002-1255-2350	River's Gift SIDS charity Australia, as part of an International SIDS research fellowship; River's Gift	River's Gift SIDS charity Australia, as part of an International SIDS research fellowship; River's Gift	Study was funded and supported in full by River's Gift SIDS charity Australia, as part of an International SIDS research fellowship awarded to Dr Fiona M Bright, http://www.riversgift.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by River's Gift SIDS charity Australia as part of an International SIDS fellowship awarded to FMB. The authors sincerely thank River's Gift for their support. The authors acknowledge Dr. Felicia Tratchenberg, and Ryan Harrison from New England Research Institutes (NERI), Watertown, MA, USA, for assistance with statistical analysis of data and thank the San Diego Medical Examiner system for assistance in the accrual of tissue specimens.	Abdala APL, 2006, BRAIN RES, V1119, P165, DOI 10.1016/j.brainres.2006.08.059; Azizi SA, 2007, NEUROSCIENTIST, V13, P616, DOI 10.1177/1073858407299286; Broadbelt KG, 2011, J NEUROPATH EXP NEUR, V70, P799, DOI 10.1097/NEN.0b013e31822c09bc; Coffman KA, 2011, P NATL ACAD SCI USA, V108, P16068, DOI 10.1073/pnas.1107904108; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Doi A, 2010, J NEUROSCI, V30, P8251, DOI 10.1523/JNEUROSCI.5361-09.2010; Doi A, 2008, RESP PHYSIOL NEUROBI, V164, P96, DOI 10.1016/j.resp.2008.06.007; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Garcia AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060695; GILLIS RA, 1980, BRAIN RES, V181, P476, DOI 10.1016/0006-8993(80)90633-2; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Gregg KV, 1997, J CHEM NEUROANAT, V12, P211, DOI 10.1016/S0891-0618(96)00207-4; Harper RM, 2000, PEDIATR RES, V48, P140, DOI 10.1203/00006450-200008000-00004; Harper RM, 2000, BRAIN RES BULL, V53, P125, DOI 10.1016/S0361-9230(00)00317-8; Holley HS, 2012, RESP PHYSIOL NEUROBI, V180, P79, DOI 10.1016/j.resp.2011.10.012; Kinney Hannah C, 2009, Dev Psychobiol, V51, P223, DOI 10.1002/dev.20367; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Kinney H, 2009, ACTA NEUROPATHOL, V117, P247, DOI 10.1007/s00401-009-0490-7; KINNEY HC, 1992, J NEUROPATH EXP NEUR, V51, P115, DOI 10.1097/00005072-199203000-00001; KINNEY HC, 1983, PEDIATRICS, V72, P181; Kinney HC, 2002, J NEUROPATH EXP NEUR, V61, P427, DOI 10.1093/jnen/61.5.427; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Lavezzi AM, 2011, NEUROPATHOLOGY, V31, P405, DOI 10.1111/j.1440-1789.2010.01190.x; Lessard A, 2010, EXP NEUROL, V223, P634, DOI 10.1016/j.expneurol.2010.02.013; Massari VJ, 1998, BRAIN RES, V785, P329, DOI 10.1016/S0006-8993(97)01335-8; Mazzone SB, 1999, BRAIN RES, V826, P139, DOI 10.1016/S0006-8993(99)01247-0; Mehboob R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00320; Mehboob R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00082; Morgado-Valle C, 2004, J PHYSIOL-LONDON, V555, P783, DOI 10.1113/jphysiol.2003.060350; MORILAK DA, 1988, NEUROSCI LETT, V94, P131, DOI 10.1016/0304-3940(88)90283-2; Nattie EE, 2004, J PHYSIOL-LONDON, V556, P235, DOI 10.1113/jphysiol.2003.059766; Nichols NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088161; Olszewski J., 1954, CYTOARCHITECHTURE HU; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; QUIRION R, 1986, J NEUROSCI, V6, P2187; Seagard JL, 2000, J AUTONOM NERV SYST, V78, P77, DOI 10.1016/S0165-1838(99)00060-0; Shvarev YN, 2006, EUR J NEUROSCI, V24, P2253, DOI 10.1111/j.1460-9568.2006.05087.x; Sridhar R, 2003, PEDIATR PULM, V36, P113, DOI 10.1002/ppul.10287; TAKASHIMA S, 1985, EXP NEUROL, V90, P580, DOI 10.1016/0014-4886(85)90155-4; Telgkamp P, 2002, J NEUROPHYSIOL, V88, P206, DOI 10.1152/jn.2002.88.1.206; Wenninger JM, 2004, J APPL PHYSIOL, V97, P1620, DOI 10.1152/japplphysiol.00952.2003; YAMAMOTO Y, 1985, ACTA PHYSIOL SCAND, V124, P449, DOI 10.1111/j.1748-1716.1985.tb07681.x	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184958	10.1371/journal.pone.0184958	http://dx.doi.org/10.1371/journal.pone.0184958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931039	Green Published, gold, Green Accepted			2022-12-26	WOS:000411314700047
J	Karasik, A; Ledwitch, KV; Aranyi, T; Varadi, A; Roberts, A; Szeri, F				Karasik, Agnes; Ledwitch, Kaitlyn Victoria; Aranyi, Tamas; Varadi, Andras; Roberts, Arthur; Szeri, Flora			Boosted coupling of ATP hydrolysis to substrate transport upon cooperative estradiol-17-beta-D-glucuronide binding in a Drosophila ATP binding cassette type-C transporter	FASEB JOURNAL			English	Article						E(2)G transport; kinetic modeling; COPASI; allosteric cooperativity; Drosophila MRP	MULTIDRUG-RESISTANCE PROTEIN; ABC TRANSPORTER; STRUCTURAL BASIS; ORGANIC-ANIONS; P-GLYCOPROTEIN; HUMAN LIVER; 2ND DOMAIN; MRP1; GENE; EXPRESSION	ATP binding cassette type-C (ABCC) transporters move molecules across cell membranes upon hydrolysis of ATP; however, their coupling of ATP hydrolysis to substrate transport remains elusive. Drosophila multidrug resistance-associated protein (DMRP) is the functional ortholog of human long ABCC transporters, with similar substrate and inhibitor specificity, but higher activity. Exploiting its high activity, we kinetically dissected the catalytic mechanism of DMRP by using E-2-D-glucuronide (E(2)G), the physiologic substrate of human ABCC. We examined the DMRP-mediated interdependence of ATP and E(2)G in biochemical assays. We observed E(2)G-dependent ATPase activity to be biphasic at subsaturating ATP concentrations, which implies at least 2 E(2)G binding sites on DMRP. Furthermore, transport measurements indicated strong nonreciprocal cooperativity between ATP and E(2)G. In addition to confirming these findings, our kinetic modeling with the Complex Pathway Simulator indicated a 10-fold decrease in the E(2)G-mediated activation of ATP hydrolysis upon saturation of the second E(2)G binding site. Surprisingly, the binding of the second E(2)G allowed for substrate transport with a constant rate, which tightly coupled ATP hydrolysis to transport. In summary, we show that the second E(2)G binding-similar to human ABCC2-allosterically stimulates transport activity of DMRP. Our data suggest that this is achieved by a significant increase in the coupling of ATP hydrolysis to transport.	[Karasik, Agnes; Aranyi, Tamas; Varadi, Andras; Szeri, Flora] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Ledwitch, Kaitlyn Victoria; Roberts, Arthur] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Szeri, Flora] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University System of Georgia; University of Georgia; Jefferson University	Szeri, F (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Act Transport Prot Res Grp, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.; Szeri, F (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	szeri.flora@ttk.mta.hu	Szeri, Flóra/L-6162-2019; Aranyi, Tamas/AAJ-9629-2021; Szeri, Flora/AAD-3907-2021	Szeri, Flóra/0000-0003-2572-6820; Aranyi, Tamas/0000-0002-2087-6275; Szeri, Flora/0000-0003-2572-6820; Ledwitch, Kaitlyn/0000-0003-3791-7392	Hungarian Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [104227, 114336]; Hungarian National Research, Development, and Innovation Office [VKSz14-1-2015-0155]; Fulbright Research Scholar by the J. William Fulbright Foreign Scholarship Board; U.S. National Institutes of Health, National Cancer Institute [R01-CA204846-01A1]; NATIONAL CANCER INSTITUTE [R01CA204846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER	Hungarian Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Research, Development, and Innovation Office; Fulbright Research Scholar by the J. William Fulbright Foreign Scholarship Board; U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Steven Robinow (University of Hawaii, Honolulu, HI, USA) for sharing the plasmid with the wild-type DMRP sequence, and for the primary Ab against DMRP. The authors also thank Karoly Liliom (Semmelweis University, Budapest, Hungary) and Gergely Szakacs (Hungarian Academy of Sciences) for their insightful comments. The assistance of Gyorgyi Demeter (Hungarian Academy of Sciences) is greatly acknowledged. This work was supported by the Hungarian Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) (Grants 104227 and 114336), Grant VKSz14-1-2015-0155 from the Hungarian National Research, Development, and Innovation Office, a grant from the Fulbright Research Scholar by the J. William Fulbright Foreign Scholarship Board, and U.S. National Institutes of Health, National Cancer Institute Grant R01-CA204846-01A1. The authors declare no conflicts of interest.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bodo A, 2003, TOXICOL LETT, V140, P133, DOI 10.1016/S0378-4274(02)00497-6; Bodo A, 2003, J BIOL CHEM, V278, P23529, DOI 10.1074/jbc.M303515200; Bridges CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073559; Chahine S, 2012, ARCH INSECT BIOCHEM, V81, P228, DOI 10.1002/arch.21066; Chen ZS, 2003, MOL PHARMACOL, V63, P351, DOI 10.1124/mol.63.2.351; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cui YH, 1999, MOL PHARMACOL, V55, P929; Davydov DR, 2005, BIOPHYS J, V89, P418, DOI 10.1529/biophysj.104.058479; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Donner MG, 2001, HEPATOLOGY, V34, P351, DOI 10.1053/jhep.2001.26213; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gerk PM, 2004, DRUG METAB DISPOS, V32, P1139, DOI 10.1124/dmd.104.000372; Grailles M, 2003, GENE, V307, P41, DOI 10.1016/S0378-1119(03)00455-4; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hitzl M, 2003, J PHARMACOL EXP THER, V304, P524, DOI 10.1124/jpet.102.043547; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hopper-Borge EA, 2011, CANCER RES, V71, P3649, DOI 10.1158/0008-5472.CAN-10-3623; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hou YX, 2003, J BIOL CHEM, V278, P3599, DOI 10.1074/jbc.M210480200; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Keppler D, 1997, BIOL CHEM, V378, P787; Ledwitch KV, 2016, BIOCHEM PHARMACOL, V118, P96, DOI 10.1016/j.bcp.2016.08.013; Ledwitch KV, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150317; Li QL, 2016, J INVEST DERMATOL, V136, P550, DOI 10.1016/j.jid.2015.10.065; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; MAYER R, 1995, J CELL BIOL, V131, P137, DOI 10.1083/jcb.131.1.137; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Perez C, 2017, SCI REP-UK, V7, DOI 10.1038/srep46641; Prince L, 2014, TOXICOL SCI, V140, P425, DOI 10.1093/toxsci/kfu095; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Roberts AG, 2011, BIOCHEMISTRY-US, V50, P10804, DOI 10.1021/bi200924t; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Scheffer GL, 2002, LAB INVEST, V82, P193, DOI 10.1038/labinvest.3780411; Segel IH., 1993, ENZYME KINETICS BEHA; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szakacs G, 2001, BIOCHEM J, V356, P71, DOI 10.1042/0264-6021:3560071; Szeri F, 2009, BBA-BIOMEMBRANES, V1788, P402, DOI 10.1016/j.bbamem.2008.11.007; Takikawa H, 1996, HEPATOLOGY, V23, P607; Tarnay JN, 2004, INSECT MOL BIOL, V13, P539, DOI 10.1111/j.0962-1075.2004.00512.x; Timachi MH, 2017, ELIFE, V6, DOI 10.7554/eLife.20236; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Vore M, 1997, DRUG METAB REV, V29, P183, DOI 10.3109/03602539709037580; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yang RY, 2003, J BIOL CHEM, V278, P30764, DOI 10.1074/jbc.M304118200; Zeng H, 2000, CANCER RES, V60, P4779; Zhang XJC, 2016, PROTEIN CELL, V7, P17, DOI 10.1007/s13238-015-0211-z	65	1	1	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					669	680		10.1096/fj.201700606R	http://dx.doi.org/10.1096/fj.201700606R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28939593	Green Accepted, Green Published, Bronze			2022-12-26	WOS:000425146900012
J	Fu, LN; Wang, YQ; Tan, J; Xu, J; Gao, QY; Chen, YX; Fang, JY				Fu, L-N; Wang, Y-Q; Tan, J.; Xu, J.; Gao, Q-Y; Chen, Y-X; Fang, J-Y			Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms	ONCOGENE			English	Article							HISTONE DEMETHYLATION; RAS-ERK; PROTEIN; DEPRIVATION; GENE; PHOSPHORYLATION; EXPRESSION; STABILITY; PATHWAY; STRESS	Metabolic stress is a common phenomenon in solid tumors. Compensatory mechanisms to overcome metabolic stress (glucose deprivation) are vital to tumor cell survival. The histone demethylase Jumonji domain-containing protein 2B (JMJD2B) is vital for the growth and progression of various cancers. However, the role of JMJD2B during glucose deprivation remains unclear. Our aim was to examine the function of JMJD2B in glucose-deprived colon cancer cells and the involvement of extracellular signal-regulated kinase (ERK) and glucose transporter 1 (GLUT1). Our study demonstrated that JMJD2B expression was upregulated via ERK phosphorylation during glucose deprivation. Further, the cell viability assay showed that the effect of p-ERK on the viability of colon cancer cells was at least partly dependent on JMJD2B expression. Glucose deprivation increased interaction between JMJD2B and p-ERK, as demonstrated by the co-immunoprecipitation and fluorescence assays. Glucose deprivation also resulted in phosphorylation of JMJD2B by p-ERK, as shown by the immunoprecipitation assay and western blotting analysis. In addition, the phosphorylation of JMJD2B via p-ERK at Thr305, Ser352, Ser566 and Thr1065 contribute to JMJD2B stability. p-ERK stabilizes the JMJD2B protein level by protecting JMJD2B from ubiquitination and proteasome degradation. We found that knockdown of JMJD2B significantly impaired colon cancer cell viability, which is accompanied by a significant reduction in glucose uptake and lactate production. Furthermore, knockdown of JMJD2B after glucose deprivation caused decreased level of GLUT1 through increasing H3K9 tri-methylation levels on its promoter, demonstrated by chromatin immunoprecipitation assay. Moreover, targeting JMJD2B in xenograft tumors also decreased the GLUT1 level. Finally, a positive correlation was observed between p-ERK, JMJD2B and GLUT1 expression in 85 human colon cancer tissue specimens. These results indicated that p-ERK-mediated phosphorylation and stabilization of JMJD2B during glucose deprivation contributes to its role in glucose uptake and cell viability, which may be modulated through epigenetically upregulation of GLUT1.	Minist Hlth, State Key Lab Oncogenes & Related Genes, Div Gastroenterol & Hepatol, Key Lab Gastroenterol & Hepatol, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Inst Digest Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University	Chen, YX (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes,Minist Hl, Key Lab Gastroenterol & Hepatol,Sch Med,Shanghai, Div Gastroenterol & Hepatol,Renji Hosp,Renji Hosp, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.	yingxuanchen71@sjtu.edu.cn			National Key Technology RD Program [2014BAI09B05]; National Natural Science Foundation of China [81572303, 81302085, 81530072]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine [20152210]; Program of Shanghai Academic/Technology Research Leader [15XD1502600]	National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine; Program of Shanghai Academic/Technology Research Leader	This project was supported by the National Key Technology R&D Program (No. 2014BAI09B05), the National Natural Science Foundation of China (No. 81572303 to CYX, No. 81302085 to GQY and No. 81530072 to FJY), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (No. 20152210) & Program of Shanghai Academic/Technology Research Leader (No. 15XD1502600).	Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Calvo MB, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/205357; Bramanti V, 2016, J NEUROSCI RES, V94, P90, DOI 10.1002/jnr.23678; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen L, 2014, BRIT J CANCER, V110, P1014, DOI 10.1038/bjc.2013.808; Chen XQ, 2005, J NEUROSCI RES, V79, P798, DOI 10.1002/jnr.20396; Cheng MB, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002026; Ciccarelli R, 2007, MOL PHARMACOL, V71, P1369, DOI 10.1124/mol.106.031617; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Eckert A, 2008, ONCOGENE, V27, P1155, DOI 10.1038/sj.onc.1210732; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Fu LN, 2012, CARCINOGENESIS, V33, P1664, DOI 10.1093/carcin/bgs217; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Huang C, 2015, ONCOL REP, V33, P875, DOI 10.3892/or.2014.3655; Ipenberg I, 2013, J BIOL CHEM, V288, P14681, DOI 10.1074/jbc.C113.462770; Katoh M, 2004, INT J ONCOL, V24, P1623; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Kim SH, 2014, STEM CELL RES, V13, P1, DOI 10.1016/j.scr.2014.04.001; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Liang CY, 2011, NUCLEIC ACIDS RES, V39, P4151, DOI 10.1093/nar/gkr040; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Toyokawa G, 2011, CANCER PREV RES, V4, P2051, DOI 10.1158/1940-6207.CAPR-11-0290; Traves PG, 2012, J IMMUNOL, V188, P1402, DOI 10.4049/jimmunol.1101781; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhao EH, 2016, CELL REP, V14, P506, DOI 10.1016/j.celrep.2015.12.053; Zhao L, 2013, CLIN CANCER RES, V19, P6419, DOI 10.1158/1078-0432.CCR-13-0254	52	19	20	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					389	402		10.1038/onc.2017.345	http://dx.doi.org/10.1038/onc.2017.345			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28945223				2022-12-26	WOS:000422753900011
J	Shen, D; Podolnikova, NP; Yakubenko, VP; Ardell, CL; Balabiyev, A; Ugarova, TP; Wang, X				Shen, Di; Podolnikova, Nataly P.; Yakubenko, Valentin P.; Ardell, Christopher L.; Balabiyev, Arnat; Ugarova, Tatiana P.; Wang, Xu			Pleiotrophin, a multifunctional cytokine and growth factor, induces leukocyte responses through the integrin Mac-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; cell migration; integrin; nuclear magnetic resonance (NMR); pleiotrophin; CD11b; CD18; Mac-1; M2	HEPARIN-BINDING CYTOKINE; MOLECULE HB-GAM; CELL-MIGRATION; ALPHA(M)BETA(2) MAC-1; A-DOMAIN; IN-VIVO; MIDKINE; EXPRESSION; IDENTIFICATION; RECEPTOR	Pleiotrophin (PTN) is a multifunctional, cationic, glycosaminoglycan-binding cytokine and growth factor involved in numerous physiological and pathological processes, including tissue repair and inflammation-related diseases. PTN has been shown to promote leukocyte responses by inducing their migration and expression of inflammatory cytokines. However, the mechanisms through which PTN mediates these responses remain unclear. Here, we identified the integrin Mac-1 (M2, CD11b/CD18) as the receptor mediating macrophage adhesion and migration to PTN. We also found that expression of Mac-1 on the surface of human embryonic kidney (HEK) 293 cells induced their adhesion and migration to PTN. Accordingly, PTN promoted Mac-1-dependent cell spreading and initiated intracellular signaling manifested in phosphorylation of Erk1/2. While binding to PTN, Mac-1 on Mac-1-expressing HEK293 cells appears to cooperate with cell-surface proteoglycans because both anti-Mac-1 function-blocking mAb and heparin were required to block adhesion. Moreover, biolayer interferometry and NMR indicated a direct interaction between the I-M domain, the major ligand-binding region of Mac-1, and PTN. Using peptide libraries, we found that in PTN the I-M domain bound sequences enriched in basic and hydrophobic residues, indicating that PTN conforms to the general principle of ligand-recognition specificity of the I-M domain toward cationic proteins/peptides. Finally, using recombinant PTN-derived fragments, we show that PTN contains two distinct Mac-1-binding sites in each of its constitutive domains. Collectively, these results identify PTN as a ligand for the integrin Mac-1 on the surface of leukocytes and suggest that this interaction may play a role in inflammatory responses.	[Shen, Di; Wang, Xu] Arizona State Univ, Sch Mol, Tempe, AZ 85287 USA; [Podolnikova, Nataly P.; Balabiyev, Arnat; Ugarova, Tatiana P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Yakubenko, Valentin P.; Ardell, Christopher L.] East Tennessee State Univ, Quillen Coll Med, Johnson City, TN 37614 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; East Tennessee State University	Wang, X (corresponding author), Arizona State Univ, Sch Mol, Tempe, AZ 85287 USA.; Ugarova, TP (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Tatiana.Ugarova@asu.edu; xuwang@asu.edu	Di, Shen/AAK-7950-2021; Shen, Di/AGZ-1567-2022	Balabiyev, Arnat/0000-0002-8904-598X; Wang, Xu/0000-0002-7369-677X	National Institutes of Health [GM118339, GM118518, HL63199, DK102020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK102020, R01DK102020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118518, R21GM118339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118339 (to X. W.), GM118518 (to X. W.), HL63199 (to T. P. U.), and DK102020 (to V. P. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achour A, 2008, BIOCHIMIE, V90, P1791, DOI 10.1016/j.biochi.2008.04.010; Ajroud K, 2004, J BIOL CHEM, V279, P25483, DOI 10.1074/jbc.M402901200; Besse S, 2013, CYTOKINE, V62, P44, DOI 10.1016/j.cyto.2013.02.002; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Ding ZM, 1999, J IMMUNOL, V163, P5029; Forsyth CB, 2001, J EXP MED, V193, P1123, DOI 10.1084/jem.193.10.1123; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gonzalez-Castillo C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00443; Hatziapostolou M, 2005, PROSTATE, V65, P151, DOI 10.1002/pros.20270; Himburg HA, 2014, J CLIN INVEST, V124, P4753, DOI 10.1172/JCI76838; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Jager R, 1997, INT J CANCER, V73, P537; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kadomatsu Kenji, 2005, Nagoya J Med Sci, V67, P71; Kilpelainen I, 2000, J BIOL CHEM, V275, P13564, DOI 10.1074/jbc.275.18.13564; Kong Y, 2012, INT J COLORECTAL DIS, V27, P287, DOI 10.1007/s00384-011-1344-z; Koutsioumpa M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0287-3; Koutsioumpa M, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-4; Kramer A, 1998, METH MOL B, V87, P25; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lishko VK, 2016, RES REP BIOCHEM, V6, P39, DOI 10.2147/RRBC.S107070; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mentlein R, 2002, J NEUROCHEM, V83, P747, DOI 10.1046/j.1471-4159.2002.01179.x; Mikelis C, 2009, FASEB J, V23, P1459, DOI 10.1096/fj.08-117564; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Muramatsu T, 2014, BRIT J PHARMACOL, V171, P814, DOI 10.1111/bph.12353; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; Ochiai K, 2004, LIVER INT, V24, P484, DOI 10.1111/j.1478-3231.2004.0990.x; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Paveliev M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33916; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Podolnikova NP, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0027-0; Podolnikova NP, 2015, BIOCHEMISTRY-US, V54, P1408, DOI 10.1021/bi5013782; RAULO E, 1994, J BIOL CHEM, V269, P12999; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; Ryan E, 2016, FEBS J, V283, P1488, DOI 10.1111/febs.13686; Sato W, 2001, J IMMUNOL, V167, P3463, DOI 10.4049/jimmunol.167.6.3463; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Silver K, 2012, GROWTH FACTORS, V30, P258, DOI 10.3109/08977194.2012.693920; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; TAKE M, 1994, J BIOCHEM-TOKYO, V116, P1063, DOI 10.1093/oxfordjournals.jbchem.a124628; Weber D, 2000, CANCER RES, V60, P5284; Weckbach LT, 2014, BLOOD, V123, P1887, DOI 10.1182/blood-2013-06-510875; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Yeh HJ, 1998, J NEUROSCI, V18, P3699; Yokoi H, 2012, KIDNEY INT, V81, P160, DOI 10.1038/ki.2011.305; Yu Yong, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P289; Yu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069883; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733	62	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18848	18861		10.1074/jbc.M116.773713	http://dx.doi.org/10.1074/jbc.M116.773713			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939773	Green Published, hybrid			2022-12-26	WOS:000415848000011
J	Murakami, M; Tsubokura, M; Ono, K; Nomura, S; Oikawa, T				Murakami, Michio; Tsubokura, Masaharu; Ono, Kyoko; Nomura, Shuhei; Oikawa, Tomoyoshi			Additional risk of diabetes exceeds the increased risk of cancer caused by radiation exposure after the Fukushima disaster	PLOS ONE			English	Article							COST-EFFECTIVENESS; PERCEPTION; JAPAN; ACCIDENT; ANXIETY	The 2011 Fukushima disaster led to increases in multiple risks (e.g., lifestyle diseases and radiation exposure) and fear among the public. Here, we assessed the additional risks of cancer caused by radiation and diabetes related to the disaster and the cost-effectiveness of countermeasures against these conditions. Our study included residents of the cities of Minamisoma and Soma (10-40 km and 35-50 km north of the Fukushima Daiichi (N degrees 1) Nuclear Power Station, respectively). We used the loss of life expectancy (LLE) as an indicator to compare risks between radiation exposure and diabetes. We also estimated the cost-effectiveness of radiation-related countermeasures, including restricted food distribution, decontamination, and whole-body counter tests and interventions. Metformin therapy was selected as a representative management for diabetes. The diabetes-related LLEs among residents were 4.1 (95% confidence interval: 1.4-6.8) x 10(-2) years for the whole population and 8.0 (2.7-13.2) x 10(-2) years for 40s to 70s in a scenario that considered the additional incidence of diabetes during the first 10 years. The cancer-related LLEs caused by lifetime exposure to radiation were 0.69 (2.5-97.5 percentile: 0.61-0.79) x 10(-2) years for the whole population and 0.24 (0.20-0.29) x 10(-2) years for 40s to 70s. The diabetes-related LLEs among residents in the above-mentioned scenario were 5.9-fold and 33-fold higher than those attributed to average radiation among the whole population and among the 40s to 70s age groups, respectively. The costs per life-years saved of the radiation countermeasures (i.e., restricted food distribution, decontamination, and whole-body counter tests and interventions) were >1 to >4 orders of magnitude higher than those of general heath checkups and conventional management for diabetes. Our findings indicate that countermeasures to mitigate diabetes are warranted. Policy-makers' and individuals' understanding of multiple risks after any disaster will be essential to saving the lives of victims.	[Murakami, Michio] Fukushima Med Univ, Sch Med, Dept Hlth Risk Commun, 1 Hikarigaoka, Fukushima, Fukushima, Japan; [Murakami, Michio] Fukushima Med Univ, Radiat Med Sci Ctr, Fukushima Hlth Management Survey, 1 Hikarigaoka, Fukushima, Fukushima, Japan; [Tsubokura, Masaharu; Oikawa, Tomoyoshi] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, 2-54-6 Takami,Haramachi, Minamisoma, Fukushima, Japan; [Tsubokura, Masaharu] Soma Cent Hosp, Dept Radiat Protect, 3-5-18 Okinouchi, Soma, Fukushima, Japan; [Ono, Kyoko] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, 16-1,Onogawa, Tsukuba, Ibaraki, Japan; [Nomura, Shuhei] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, Norfolk Pl, London, England; [Nomura, Shuhei] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1,Hongo, Tokyo, Japan	Fukushima Medical University; Fukushima Medical University; National Institute of Advanced Industrial Science & Technology (AIST); Imperial College London; University of Tokyo	Murakami, M (corresponding author), Fukushima Med Univ, Sch Med, Dept Hlth Risk Commun, 1 Hikarigaoka, Fukushima, Fukushima, Japan.; Murakami, M (corresponding author), Fukushima Med Univ, Radiat Med Sci Ctr, Fukushima Hlth Management Survey, 1 Hikarigaoka, Fukushima, Fukushima, Japan.	michio@fmu.ac.jp	Nomura, Shuhei/HCH-5356-2022; Ono, Kyoko/J-4346-2018; Tsubokura, Masaharu/AAV-4364-2021	Ono, Kyoko/0000-0001-8100-3905; Tsubokura, Masaharu/0000-0001-8027-202X; Nomura, Shuhei/0000-0002-2963-7297	JSPS KAKENHI grant [JP16H05894]	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI grant number JP16H05894. https:// www.jsps.go.jp/english/index.html. MM receives the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Ebner DK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011641; FISCHHOFF B, 1978, J EXP PSYCHOL HUMAN, V4, P330, DOI 10.1037/0096-1523.4.2.330; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Gigerenzer G, 2006, RISK ANAL, V26, P347, DOI 10.1111/j.1539-6924.2006.00753.x; Graham J. D., 1997, RISK VS RISK TRADEOF; Hacking I, 2006, EMERGENCE PROBABILIT; Hino Y, 2016, TOHOKU J EXP MED, V239, P333, DOI 10.1620/tjem.239.333; ICRP, 1959, ICRP PUBL; Kahneman D., 2011, THINKING FAST SLOW; Kato M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007736; Kishimoto A, 2003, CHEMOSPHERE, V53, P291, DOI 10.1016/S0045-6535(03)00054-7; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Ministry of Education Culture Sports Science and Technology, 2011, RES RAD 134CS 137CS; Ministry of Health Labour and Welfare, 2012, THE 21 LIF TABL; Ministry of Health Labour and Welfare, 2015, BRIEF SUMM NAT HLTH; Miyazaki M, 2016, SCIENCE, V352, P666, DOI 10.1126/science.352.6286.666-b; Murakami M, 2017, ASIA-PAC J PUBLIC HE, V29, p74S, DOI 10.1177/1010539516681841; Murakami M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165594; Murakami M, 2016, RADIAT PROT DOSIM, V171, P156, DOI 10.1093/rpd/ncw211; Murakami M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137906; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nakayachi K, 2015, J RISK RES, V18, P156, DOI 10.1080/13669877.2013.875936; Nomura S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010080; Nomura S, 2015, ENVIRON SCI TECHNOL, V49, P1009, DOI 10.1021/es503504y; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Normile D, 2016, SCIENCE, V351, P1022, DOI 10.1126/science.351.6277.1022; Oe M, 2016, PSYCHIAT CLIN NEUROS, V70, P245, DOI 10.1111/pcn.12387; Ohira T, 2017, ASIA-PAC J PUBLIC HE, V29, p47S, DOI 10.1177/1010539517695436; Radiation Medical Science Center for the Fukushima Health Management Survey Fukushima Medical University, 2015, 21 PREF OV COMM M FU; Satoh H, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/627390; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Sugimoto A, 2014, ENVIRON HEALTH PERSP, V122, P587, DOI 10.1289/ehp.1306848; Tsubokura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129114; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, UNSCEAR 2013 GEN ASS; Wake N, 2000, DIABETES RES CLIN PR, V48, P201, DOI 10.1016/S0168-8227(00)00122-4; World Health Organization, 2012, PREL DOS EST NUCL AC; Yasutaka T, 2016, J ENVIRON RADIOACTIV, V151, P512, DOI 10.1016/j.jenvrad.2015.05.012	41	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185259	10.1371/journal.pone.0185259	http://dx.doi.org/10.1371/journal.pone.0185259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957385	gold, Green Submitted, Green Published			2022-12-26	WOS:000411985200039
J	Vargas, VE; Gurung, S; Grant, B; Hyatt, K; Singleton, K; Myers, SM; Saunders, D; Njoku, C; Towner, R; Myers, DA				Vargas, Vladimir E.; Gurung, Sunam; Grant, Benjamin; Hyatt, Kimberly; Singleton, Krista; Myers, Sarah M.; Saunders, Debra; Njoku, Charity; Towner, Rheal; Myers, Dean A.			Gestational hypoxia disrupts the neonatal leptin surge and programs hyperphagia and obesity in male offspring in the Sprague-Dawley rat	PLOS ONE			English	Article							DEVELOPMENTAL ORIGINS; NUTRIENT RESTRICTION; PROTEIN RESTRICTION; METABOLIC SYNDROME; MATERNAL HYPOXIA; PLASMA LEPTIN; DIET; EXPRESSION; RESISTANCE; UNDERNUTRITION	The effect of gestational hypoxia on the neonatal leptin surge, development of hypothalamic arcuate nuclei (ARH) projections and appetite that could contribute to the programming of offspring obesity is lacking. We examined the effect of 12% O-2 from gestational days 15-19 in the Sprague-Dawley rat on post-weaning appetite, fat deposition by MRI, adipose tissue cytokine expression, the neonatal leptin surge, ARH response to exogenous leptin, and alpha MSH projections to the paraventricular nucleus (PVN) in response to a high fat (HFD) or control diet (CD) in male offspring. Normoxia (NMX) and Hypoxia (HPX) offspring exhibited increased food intake when fed a HFD from 5-8 weeks post-birth; HPX offspring on the CD had increased food intake from weeks 5-7 vs. NMX offspring on a CD. HPX offspring on a HFD remained hyperphagic through 23 weeks. Body weight were the same between offspring from HPX vs. NMX dams from 4-12 weeks of age fed a CD or HFD. By 14-23 weeks of age, HPX offspring fed the CD or HFD as well as male NMX offspring fed the HFD were heavier vs. NMX offspring fed the CD. HPX offspring fed a CD exhibited increased abdominal adiposity (MRI) that was amplified by a HFD. HPX offspring fed a HFD exhibited the highest abdominal fat cytokine expression. HPX male offspring had higher plasma leptin from postnatal day (PN) 6 through 14 vs. NMX pups. HPX offspring exhibited increased basal c-Fos labeled cells in the ARH vs. NMX pups on PN16. Leptin increased c-Fos staining in the ARH in NMX but not HPX offspring at PN16. HPX offspring had fewer aMSH fibers in the PVN vs. NMX offspring on PN16. In conclusion, gestational hypoxia impacts the developing ARH resulting in hyperphagia contributing to adult obesity on a control diet and exacerbated by a HFD.	[Vargas, Vladimir E.; Grant, Benjamin; Hyatt, Kimberly; Singleton, Krista; Myers, Sarah M.; Myers, Dean A.] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet, Oklahoma City, OK 73019 USA; [Vargas, Vladimir E.; Grant, Benjamin; Hyatt, Kimberly; Singleton, Krista; Myers, Sarah M.; Myers, Dean A.] Univ Oklahoma, Hlth Sci Ctr, Dept Gynecol, Oklahoma City, OK 73019 USA; [Gurung, Sunam] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Saunders, Debra; Njoku, Charity; Towner, Rheal] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, 825 NE 13th St, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Myers, DA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Obstet, Oklahoma City, OK 73019 USA.; Myers, DA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Gynecol, Oklahoma City, OK 73019 USA.	Dean-myers@ouhsc.edu		Towner, Rheal/0000-0001-7368-8983	National Institutes of Health [R01-HD050620]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health grant number R01-HD050620 to DAM.	Adachi K, 2004, AM J PHYSIOL-REG I, V287, pR209, DOI 10.1152/ajpregu.00701.2003; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Barker DJP, 2005, HORM RES, V64, P2, DOI 10.1159/000089311; Benoit C, 2013, J ENDOCRINOL, V218, P35, DOI 10.1530/JOE-12-0561; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Camm EJ, 2011, FASEB J, V25, P420, DOI 10.1096/fj.10-158188; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desai M, 2007, AM J OBSTET GYNECOL, V196, P555, DOI 10.1016/j.ajog.2006.11.036; Devaskar SU, 1997, BIOCHEM BIOPH RES CO, V238, P44, DOI 10.1006/bbrc.1997.7237; Dolinsky VW, 2011, DIABETES, V60, P2274, DOI 10.2337/db11-0374; Ducsay CA, 2006, AM J PHYSIOL-REG I, V291, pR1406, DOI 10.1152/ajpregu.00077.2006; Ducsay CA, 2013, AM J PHYSIOL-REG I, V304, pR435, DOI 10.1152/ajpregu.00377.2012; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Garteiser P, 2013, METABOLISM, V62, P1686, DOI 10.1016/j.metabol.2013.06.009; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Granado M, 2011, ENDOCRINOLOGY, V152, P4116, DOI 10.1210/en.2011-1233; JONES AP, 1984, J NUTR, V114, P1484; Julian CG, 2011, CLIN CHEST MED, V32, P21, DOI 10.1016/j.ccm.2010.10.008; Lai ZB, 2011, HYPERTENSION, V57, P505, DOI 10.1161/HYPERTENSIONAHA.110.163329; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Li HP, 2013, INT J CLIN EXP PATHO, V6, P650; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MOORE LG, 1986, J APPL PHYSIOL, V60, P1401, DOI 10.1152/jappl.1986.60.4.1401; Myers DA, 2005, AM J PHYSIOL-REG I, V289, pR1707, DOI 10.1152/ajpregu.00343.2005; Myers DA, 2005, AM J PHYSIOL-REG I, V288, pR1178, DOI 10.1152/ajpregu.00697.2004; Myers DA, 2008, AM J PHYSIOL-REG I, V294, pR1312, DOI 10.1152/ajpregu.00004.2008; Myers DA, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/681306; Nathanielsz PW, 2006, ILAR J, V47, P73, DOI 10.1093/ilar.47.1.73; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Scarpace PJ, 2009, AM J PHYSIOL-REG I, V296, pR493, DOI 10.1152/ajpregu.90669.2008; Shepard JD, 2008, BEHAV BRAIN RES, V186, P239, DOI 10.1016/j.bbr.2007.08.013; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; VARVARIGOU A, 1994, J PEDIATR-US, V124, P480, DOI 10.1016/S0022-3476(94)70380-9; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Williams SJ, 2005, J PHYSIOL-LONDON, V565, P125, DOI 10.1113/jphysiol.2005.084889; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185272	10.1371/journal.pone.0185272	http://dx.doi.org/10.1371/journal.pone.0185272			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957383	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200040
J	Haga, IA; de Andrade, FS; Bruschi, DP; Recco-Pimentel, SM; Giaretta, AA				Haga, Isabelle Aquemi; de Andrade, Felipe Silva; Bruschi, Daniel Pacheco; Recco-Pimentel, Shirlei Maria; Giaretta, Ariovaldo Antonio			Unrevealing the leaf frogs Cerrado diversity: A new species of Pithecopus (Anura, Arboranae, Phyllomedusidae) from the Mato Grosso state, Brazil	PLOS ONE			English	Article							HYPOCHONDRIALIS GROUP; R-PACKAGE; RECOMMENDATIONS; ALIGNMENT; PATTERNS; REGION	The Neotropical frog genus Pithecopus comprises currently 10 species. A recent molecular phylogeny suggested the existence of two subclades within it, one of them including P. palliatus, P. azureus, P. hypochondrialis, and P. nordestinus (lowland species). Herein we describe a new species of this subclade from Pontal do Araguaia, in the Brazilian Cerrado in the Mato Grosso state. Recognition of the new species is supported by adult morphology, advertisement call and molecular data. The new species differs from Pithecopus highland species by its smaller head width and lack of the reticulate pattern on flanks. From lowland species, the new form differs by being significantly smaller in snout vent-length, advertisement call with the greatest number of pulses, and high genetic distance. Interestingly, we also report on occurrence of P. hypochondrialis (its sister species) at an adjacent site (about 3km). Also, we report on the occurrence of the new species in the Chapada dos Guimaraes and Santa Terezinha, both also in the Mato Grosso state.	[Haga, Isabelle Aquemi; de Andrade, Felipe Silva; Giaretta, Ariovaldo Antonio] UFU, LTSAN, Fac Ciencias Integradas Pontal FACIP, Ituiutaba, MG, Brazil; [Haga, Isabelle Aquemi; de Andrade, Felipe Silva] Univ Estadual Campinas UNICAMP, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil; [de Andrade, Felipe Silva] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Anim, Lab Hist Nat Anfibios Brasileiros LaHNAB, Campinas, SP, Brazil; [Bruschi, Daniel Pacheco; Recco-Pimentel, Shirlei Maria] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Estrutural & Func, Campinas, SP, Brazil; [Bruschi, Daniel Pacheco] Univ Fed Parana UFPR, Dept Genet, Setor Ciencias Biol, Curitiba, Parana, Brazil	Universidade Federal de Uberlandia; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do Parana	Haga, IA (corresponding author), UFU, LTSAN, Fac Ciencias Integradas Pontal FACIP, Ituiutaba, MG, Brazil.; Haga, IA (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil.	hagaisabelle@gmail.com	de Andrade, Felipe Silva/M-3125-2013; de Andrade, Felipe Silva/M-6253-2019	de Andrade, Felipe Silva/0000-0003-0514-142X; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Sao Paulo Research Foundation (FAPESP) [2015/10728-7, 2010/17464-1, 2012/12169-7, 2006/60055-0, 2008/50325-5, 2011/51694-7, 2014/23388-7]; Conselho Nacional de Desenvolvimento Cientffico e Tecnologico (CNPq) [446935/2014-0, 152548/2011-4]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ- 01724-14]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);  [305261/2010-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientffico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided scholarships to IAN and FSA. Sao Paulo Research Foundation (FAPESP) provides a PhD scholarship [Process #2015/10728-7] to FSA. Conselho Nacional de Desenvolvimento Cientffico e Tecnologico (CNPq) gave a research grant [Processes #446935/2014-0, and #152548/2011-4] and a fellowship [Process #305261/2010-0] to AAG. The Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) provided grants [Process #APQ- 01724-14] to MG. Sao Paulo Research Foundation (FAPESP) [Process #2010/17464-1, and #2012/12169-7], Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the grants to DPB. Sao Paulo Research Foundation (FAPESP) provided grants [Processes #2006/60055-0, #2008/50325-5, #2011/51694-7, and #2014/23388-7] to SMRP.	[Anonymous], 2014, TRACER V1 6; [Anonymous], 1999, BONNER ZOOLOGISCHE B; Antoniazzi MM, 2013, J ZOOL, V291, P42, DOI 10.1111/jzo.12044; Berneck BVM, 2017, ZOOKEYS, P115, DOI 10.3897/zookeys.642.10401; Bioacoustics Research Program, 2014, RAV PRO INT SOUND AN; BOKERMANN W. C. A., 1965, REV BRASIL BIOL, V25, P257; Brandao RA, 2002, J HERPETOL, V36, P571, DOI 10.2307/1565926; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruschi DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105608; Bruschi DP, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-70; Bruschi DP, 2012, HEREDITAS, V149, P34, DOI 10.1111/j.1601-5223.2010.02236.x; Caramaschi Ulisses, 2006, Arquivos do Museu Nacional Rio de Janeiro, V64, P159; Clemente-Carvalho RBG, 2012, HERPETOLOGICA, V68, P365, DOI 10.1655/HERPETOLOGICA-D-11-00085.1; de Andrade FS, 2016, SALAMANDRA, V52, P107; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; deCope P.azurea, 2006, ARQ MUS NAC, V64, P159; DUELLMAN W E, 1974, Herpetologica, V30, P105; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Diniz JAF, 2008, ZOOL STUD, V47, P146; Faivovich J, 2010, CLADISTICS, V26, P227, DOI 10.1111/j.1096-0031.2009.00287.x; Frost D.R., 2017, AMPHIBIAN SPECIES WO; GATESY J, 1993, MOL PHYLOGENET EVOL, V2, P152, DOI 10.1006/mpev.1993.1015; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Goloboff P.A., 2003, TREE ANAL USING NEW; Haga IA, 2017, PHYLLOMEDUSA, V16, P47, DOI 10.11606/issn.2316-9079.v16i1p47-56; Heyer WR, 1990, ARQ ZOOL, V31, P235; Hothorn T, 2008, J STAT SOFTW, V28, P1; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Korkmaz S, 2014, R J, V6, P151, DOI 10.32614/rj-2014-031; LUTZ B, 1966, COPEIA, P236; Maja P, 2004, METODOLOSKI ZVEZKI, V1, P143; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; R Core Team, 2021, R LANGUAGE ENV STAT; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Silva JF, 2006, J BIOGEOGR, V33, P536, DOI 10.1111/j.1365-2699.2005.01422.x; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdujo PH, 2013, ECOGRAPHY, V36, P708, DOI 10.1111/j.1600-0587.2012.07374.x; Valdujo Paula Hanna, 2012, South American Journal of Herpetology, V7, P63; Watters JL, 2016, ZOOTAXA, V4072, P477, DOI 10.11646/zootaxa.4072.4.6	46	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184631	10.1371/journal.pone.0184631	http://dx.doi.org/10.1371/journal.pone.0184631			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953911	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300016
J	Qin, J; Zhang, JN; Wang, FM; Wang, JH; Zheng, Z; Yin, CC; Chen, H; Shi, AN; Zhang, B; Chen, PY; Zhang, MC				Qin, Jun; Zhang, Jianan; Wang, Fengmin; Wang, Jinghua; Zheng, Zhi; Yin, Changcheng; Chen, Hao; Shi, Ainong; Zhang, Bo; Chen, Pengyin; Zhang, Mengchen			iTRAQ protein profile analysis of developmental dynamics in soybean [Glycine max (L.) Merr.] leaves	PLOS ONE			English	Article							KYOTO ENCYCLOPEDIA; REVEALS; IDENTIFICATION; TECHNOLOGIES; DATABASE; STRESS; GENES; KEGG	Zao5241 is an elite soybean [Glycine max (L.) Merr.] line and backbone parent. In this study, we employed iTRAQ to analyze the proteomes and protein expression profiles of Zao5241 during leaf development. We identified 1,245 proteins in all experiments, of which only 45 had been previously annotated. Among overlapping proteins between three biological replicates, 598 proteins with 2 unique peptides identified were reliably quantified. The protein datasets were classified into 36 GO functional terms, and the photosynthesis term was most significantly enriched. A total of 113 proteins were defined as being differentially expressed during leaf development; 41 proteins were found to be differently expressed between two and four week old leaves, and 84 proteins were found to be differently expressed between two and six week old leaves, respectively. Cluster analysis of the data revealed dynamic proteomes. Proteins annotated as electron carrier activity were greatly enriched in the peak expression profiles, and photosynthesis proteins were negatively modulated along the whole time course. This dataset will serve as the foundation for a systems biology approach to understanding photosynthetic development.	[Qin, Jun; Wang, Fengmin; Wang, Jinghua; Zhang, Mengchen] Hebei Acad Agr & Forestry Sci, North China Key Lab Biol & Genet Improvement Soyb, Natl Soybean Improvement Ctr,Minist Agr, Cereal & Oil Crop Inst,Shijiazhuang Sub Ctr, Shijiazhuang, Hebei, Peoples R China; [Qin, Jun; Shi, Ainong; Chen, Pengyin] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA; [Zhang, Jianan; Zheng, Zhi] Hebei Acad Agr & Forestry Sci, Minor Cereal Crops Lab Hebei Prov, Inst Millet Crops, Natl Foxtail Millet Improvement Ctr, Shijiazhuang, Hebei, Peoples R China; [Yin, Changcheng; Chen, Hao] Beijing Prot Innovat, B-8 Beijing Airport Ind Zone, Beijing, Peoples R China; [Zhang, Bo] Virginia Tech, Dept Crop Soil & Environm Sci, Blacksburg, VA USA	Hebei Academy of Agricultural & Forestry Sciences; Ministry of Agriculture & Rural Affairs; University of Arkansas System; University of Arkansas Fayetteville; Hebei Academy of Agricultural & Forestry Sciences; Virginia Polytechnic Institute & State University	Zhang, MC (corresponding author), Hebei Acad Agr & Forestry Sci, North China Key Lab Biol & Genet Improvement Soyb, Natl Soybean Improvement Ctr,Minist Agr, Cereal & Oil Crop Inst,Shijiazhuang Sub Ctr, Shijiazhuang, Hebei, Peoples R China.	mengchenzhang@hotmail.com	Zheng, Zhi/C-4110-2017; Shi, Ainong/L-6384-2017	Zheng, Zhi/0000-0002-1493-1995; Shi, Ainong/0000-0002-1066-7920	Natural Science Fund for Distinguished Young Scholars of Hebei Province [C2014301035]; National Natural Science Foundation of China [31100880]; Key Project of the Natural Science Foundation of Hebei Province [C2012301020]	Natural Science Fund for Distinguished Young Scholars of Hebei Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Natural Science Foundation of Hebei Province	This study was supported by the Natural Science Fund for Distinguished Young Scholars of Hebei Province (C2014301035), National Natural Science Foundation of China (31100880), the Key Project of the Natural Science Foundation of Hebei Province (C2012301020).	Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Chen SX, 2006, PROTEOMICS, V6, P5504, DOI 10.1002/pmic.200600143; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Fountoulakis M, 2004, MASS SPECTROM REV, V23, P231, DOI 10.1002/mas.10075; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Ji W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00573; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; [梁宇 Liang Yu], 2004, [植物生态学报, Acta Phytoecologica Sinica], V28, P114; Liu GT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-110; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; MEYER Y, 1988, ELECTROPHORESIS, V9, P704, DOI 10.1002/elps.1150091105; Natale DA, 2000, GENOME BIOL, V1; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peng Z, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-760; Qin J, 2016, MOL GENET GENOMICS, V291, P1595, DOI 10.1007/s00438-016-1202-3; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Sinclair JB, 1982, COMPENDIUM SOYBEAN D; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tacken MGJ, 2000, J GEN VIROL, V81, P209, DOI 10.1099/0022-1317-81-1-209; Tausta SL, 2014, J EXP BOT, V65, P3543, DOI 10.1093/jxb/eru152; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Wang P, 2012, J FOOD AGRIC ENVIRON, V10, P550; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xie Xiu-Zhi, 2011, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V27, P616; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0181910	10.1371/journal.pone.0181910	http://dx.doi.org/10.1371/journal.pone.0181910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953898	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300002
J	Shields, MC; Bowers, MR; Fulcer, MM; Bollig, MK; Rock, PJ; Sutton, BR; Vrailas-Mortimer, AD; Lochmuller, H; Whittaker, RG; Horvath, R; Reist, NE				Shields, Mallory C.; Bowers, Matthew R.; Fulcer, McKenzie M.; Bollig, Madelyn K.; Rock, Patrick J.; Sutton, Bryan R.; Vrailas-Mortimer, Alysia D.; Lochmuller, Hanns; Whittaker, Roger G.; Horvath, Rita; Reist, Noreen E.			Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTIONS; PHOSPHOLIPID-BINDING; MEMBRANE PENETRATION; CALCIUM-BINDING; NERVOUS-SYSTEM; C(2)A DOMAIN; C-2 DOMAIN	During chemical transmission, the function of synaptic proteins must be coordinated to efficiently release neurotransmitter. Synaptotagmin 2, the Ca2+ sensor for fast, synchronized neurotransmitter release at the human neuromuscular junction, has recently been implicated in a dominantly inherited congenital myasthenic syndrome associated with a non-progressive motor neuropathy. In one family, a proline residue within the C2B Ca2+-binding pocket of synaptotagmin is replaced by a leucine. The functional significance of this residue has not been investigated previously. Here we show that in silico modeling predicts disruption of the C2B Ca2+-binding pocket, and we examine the in vivo effects of the homologous mutation in Drosophila. When expressed in the absence of native synaptotagmin, this mutation is lethal, demonstrating for the first time that this residue plays a critical role in synaptotagmin function. To achieve expression similar to human patients, the mutation is expressed in flies carrying one copy of the wild type synaptotagmin gene. We now show that Drosophila carrying this mutation developed neurological and behavioral manifestations similar to those of human patients and provide insight into the mechanisms underlying these deficits. Our Drosophila studies support a role for this synaptotagmin point mutation in disease etiology.	[Shields, Mallory C.; Bowers, Matthew R.; Fulcer, McKenzie M.; Bollig, Madelyn K.; Reist, Noreen E.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Shields, Mallory C.; Bowers, Matthew R.; Reist, Noreen E.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Rock, Patrick J.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA; [Sutton, Bryan R.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Vrailas-Mortimer, Alysia D.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Vrailas-Mortimer, Alysia D.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA; [Lochmuller, Hanns; Horvath, Rita] Newcastle Univ, Inst Med Genet, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Whittaker, Roger G.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Colorado State University; Colorado State University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Denver; Illinois State University; Newcastle University - UK; Newcastle University - UK	Reist, NE (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.; Reist, NE (corresponding author), Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA.	reist@colostate.edu	Horvath, Rita/AAY-7042-2020	Horvath, Rita/0000-0002-9841-170X; Reist, Noreen/0000-0002-1647-3166; Shields, Mallory/0000-0002-3331-9910; Whittaker, Roger/0000-0002-3403-0182	Thornburg Graduate Research Excellence Award; National Science Foundation [1257363]; Colorado State University Libraries Open Access Research and Scholarship Fund; Medical Research Council UK [G1002274, ID 98482]; European Union Seventh Framework Programme [(FP7)] [305444, 305121]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR063634]; MRC [MR/N025431/1, G1000848] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063634] Funding Source: NIH RePORTER; Medical Research Council [MR/N025431/1, G1000848, MR/N027302/1] Funding Source: researchfish	Thornburg Graduate Research Excellence Award; National Science Foundation(National Science Foundation (NSF)); Colorado State University Libraries Open Access Research and Scholarship Fund; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Seventh Framework Programme [(FP7)]; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MCS is funded by the Thornburg Graduate Research Excellence Award (no available website). NER is funded by the National Science Foundation (1257363) (www.nsf.gov) and the Colorado State University Libraries Open Access Research and Scholarship Fund (libguides.colostate.edu/oars). HL is funded by the Medical Research Council UK (G1002274, ID 98482) (http://www.mrc.ac.uk/), by the European Union Seventh Framework Programme [(FP7/2007-2013) under grant agreement number 305444 (RD-Connect) and 305121 (Neuromics)]. RH is a Wellcome Trust Investigator (109915/Z/15/Z) (https://wellcome.ac.uk/funding/). BRS is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR063634). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Baker K, 2015, J CLIN INVEST, V125, P1670, DOI 10.1172/JCI79765; BELLEMARE F, 1983, J NEUROPHYSIOL, V50, P1380, DOI 10.1152/jn.1983.50.6.1380; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; Dodge FA, COOPERATIVE ACTION C; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Herrmann DN, 2014, AM J HUM GENET, V95, P332, DOI 10.1016/j.ajhg.2014.08.007; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jackman SL, 2017, NEURON, V94, P447, DOI 10.1016/j.neuron.2017.02.047; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; MARQUEZE B, 1995, J NEUROSCI, V15, P4906; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Paddock BE, 2011, J NEUROSCI, V31, P2248, DOI 10.1523/JNEUROSCI.3153-09.2011; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Striegel AR, 2012, J NEUROSCI, V32, P1253, DOI 10.1523/JNEUROSCI.4652-11.2012; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Vrailas-Mortimer AD, 2014, J BIOL RHYTHM, V29, P411, DOI 10.1177/0748730414555183; Whittaker RG, 2015, NEUROLOGY, V85, P1964, DOI 10.1212/WNL.0000000000002185; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; YAO KM, 1994, J NEUROCHEM, V63, P41; Yoshihara M, 2010, P NATL ACAD SCI USA, V107, P14869, DOI 10.1073/pnas.1000606107	49	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184817	10.1371/journal.pone.0184817	http://dx.doi.org/10.1371/journal.pone.0184817			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953919	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300023
J	Yu, KZ; Quirk, JG; Djuric, PM				Yu, Kezi; Quirk, J. Gerald; Djuric, Petar M.			Dynamic classification of fetal heart rates by hierarchical Dirichlet process mixture models	PLOS ONE			English	Article								In this paper, we propose an application of non-parametric Bayesian (NPB) models for classification of fetal heart rate (FHR) recordings. More specifically, we propose models that are used to differentiate between FHR recordings that are from fetuses with or without adverse outcomes. In our work, we rely on models based on hierarchical Dirichlet processes (HDP) and the Chinese restaurant process with finite capacity (CRFC). Two mixture models were inferred from real recordings, one that represents healthy and another, non-healthy fetuses. The models were then used to classify new recordings and provide the probability of the fetus being healthy. First, we compared the classification performance of the HDP models with that of support vector machines on real data and concluded that the HDP models achieved better performance. Then we demonstrated the use of mixture models based on CRFC for dynamic classification of the performance of (FHR) recordings in a real-time setting.	[Yu, Kezi; Djuric, Petar M.] SUNY Stony Brook, Dept Elect & Comp Engn, Stony Brook, NY 11794 USA; [Quirk, J. Gerald] SUNY Stony Brook, Dept Obstet Gynecol & Reprod Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Djuric, PM (corresponding author), SUNY Stony Brook, Dept Elect & Comp Engn, Stony Brook, NY 11794 USA.	petar.djuric@stonybrook.edu		Djuric, Petar M./0000-0001-7791-3199	National Institutes of Health (US) [1R21HD080025-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080025] Funding Source: NIH RePORTER	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (US) 1R21HD080025-01A1 (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BAYESIAN NONPARAMETR; Banta HD, 2001, OBSTET GYNECOL SURV, V56, P707; Chudacek V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-16; Dash S, 2014, IEEE T BIO-MED ENG, V61, P2796, DOI 10.1109/TBME.2014.2330556; De Haan J, 1971, EUR J OBSTET GYN R B, V3, P95; Djuric PM, 2015, EUR SIGNAL PR CONF, P2786, DOI 10.1109/EUSIPCO.2015.7362892; Freeman R, 2012, ACS SYM SER, V1112, P1; Garite TJ, 2000, AM J OBSTET GYNECOL, V183, P1049, DOI 10.1067/mob.2000.110632; Georgieva A, 2013, NEURAL COMPUT APPL, V22, P85, DOI 10.1007/s00521-011-0743-y; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goncalves H, 2006, MED BIOL ENG COMPUT, V44, P847, DOI 10.1007/s11517-006-0105-6; Hruban L, 2015, J EVAL CLIN PRACT, V21, P694, DOI 10.1111/jep.12368; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Karmakar CK, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-17; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Macones GA, 2008, JOGNN-J OBST GYN NEO, V37, P510, DOI 10.1111/j.1552-6909.2008.00284.x; MARTIN JA, 2002, NATL VITAL STAT REP, V52, P1; NEAL RM, 1992, FUND THEOR, V50, P197; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Rooth G, 1987, INT J GYNECOL OBSTET, V25, P159, DOI [DOI 10.1016/0020-7292(87)90012-9, 10.1016/0020-7292 (87)90012-9]; Signorini MG, 2003, IEEE T BIO-MED ENG, V50, P365, DOI 10.1109/TBME.2003.808824; Spilka J, 2012, BIOMED SIGNAL PROCES, V7, P350, DOI 10.1016/j.bspc.2011.06.008; Teh Y. W., 2012, J AM STAT ASSOC, V101, P1566; Wei XM, 2017, 2017 IEEE CONFERENCE ON ENERGY INTERNET AND ENERGY SYSTEM INTEGRATION (EI2); Xu L, 2014, PHYSIOL MEAS, V35, P1357, DOI 10.1088/0967-3334/35/7/1357; Yu KZ, 2016, INT CONF ACOUST SPEE, P4383, DOI 10.1109/ICASSP.2016.7472505; Yu K, 2016, INT CONF ACOUST SPEE, P709, DOI 10.1109/ICASSP.2016.7471767	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185417	10.1371/journal.pone.0185417	http://dx.doi.org/10.1371/journal.pone.0185417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953927	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300065
J	Doijen, J; Van Loy, T; De Haes, W; Landuyt, B; Luyten, W; Schoofs, L; Schols, D				Doijen, Jordi; Van Loy, Tom; De Haes, Wouter; Landuyt, Bart; Luyten, Walter; Schoofs, Liliane; Schols, Dominique			Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MAMMALIAN-CELLS; T-LYMPHOCYTES; BETA-ARRESTIN; LIGAND; ACTIVATION; PATHWAY; PROGRESSION; DISCOVERY; MIGRATION	The chemokine receptor 4 (CXCR4) and 7 (CXCR7) are G-protein-coupled receptors involved in various diseases including human cancer. As such, they have become important targets for therapeutic intervention. Cell-based receptor assays, able to detect agents that modulate receptor activity, are of key importance for drug discovery. We evaluated the potential of cellular electric impedance for this purpose. Dose-dependent and specific stimulation of CXCR4 was detected upon addition of its unique chemokine ligand CXCL12. The response magnitude correlated with the CXCR4 expression level. G(alpha i) coupling and signaling contributed extensively to the impedance response, whereas G alpha q-and G(beta gamma)-related events had only minor effects on the impedance profile. CXCR7 signaling could not be detected using impedance measurements. However, increasing levels of CXCR7 expression significantly reduced the CXCR4-mediated impedance readout, suggesting a regulatory role for CXCR7 on CXCR4-mediated signaling. Taken together, cellular electric impedance spectroscopy can represent a valuable alternative pharmacological cell-based assay for the identification of molecules targeting CXCR4, but not for CXCR7 in the absence of CXCR4.	[Doijen, Jordi; De Haes, Wouter; Landuyt, Bart; Luyten, Walter; Schoofs, Liliane] Katholieke Univ Leuven, Inst Zool, Lab Funct Genom & Prote, Leuven, Belgium; [Doijen, Jordi; Van Loy, Tom; Schols, Dominique] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium	KU Leuven; KU Leuven	Schols, D (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium.	dominique.schols@kuleuven.be	schoofs, liliane/ABD-2943-2020; Schols, Dominique/S-9057-2017; Schols, Dominique/AAC-1309-2021; Van Loy, Tom/E-2374-2018; Schoofs, Liliane/F-2815-2010	Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850; Van Loy, Tom/0000-0003-2524-7264; Doijen, Jordi/0000-0002-1707-0174; Schoofs, Liliane/0000-0002-1673-432X	FWO [G.485.08]; KU Leuven [PF/10/018]; KU Leuven Research Council [C14/15/049]; Flemish Research Funds [SB/151105]	FWO(FWO); KU Leuven(KU Leuven); KU Leuven Research Council(KU Leuven); Flemish Research Funds	Jordi Doijen is an SB PhD fellow (SB/151105) at FWO (Flemish Research Funds; http://www.fwo.be). The authors acknowledge research grants from FWO (Grant no. G.485.08), the KU Leuven (PF/10/018), the KU Leuven Research Council (Grant no. C14/15/049; http://www. kuleuven.be) and an European Research Council (ERC) Advanced Grant (Grant no. 340318; https://erc.europa.eu/funding/advanced-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barbero S, 2003, CANCER RES, V63, P1969; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hatse S, 2001, MOL PHARMACOL, V60, P164, DOI 10.1124/mol.60.1.164; Hirshman CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1468, DOI 10.1152/ajpcell.2001.281.5.C1468; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kammermann M, 2011, BIOCHEM BIOPH RES CO, V412, P419, DOI 10.1016/j.bbrc.2011.07.087; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mishra RK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30155; Nambi P, 2003, ASSAY DRUG DEV TECHN, V1, P305, DOI 10.1089/15406580360545116; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Peters MF, 2009, J BIOMOL SCREEN, V14, P246, DOI 10.1177/1087057108330115; Princen K, 2003, CYTOM PART A, V51A, P35, DOI 10.1002/cyto.a.10008; Promega Corporation, 2009, FUGENE R HD TRANSF R; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Soon CF, 2012, INT IEEE EMBS C BIOM; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Uemura T, 2006, BRIT J PHARMACOL, V148, P61, DOI 10.1038/sj.bjp.0706711; van Hout A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176057; Verhofstede C, 2012, CURR OPIN HIV AIDS, V7, P432, DOI 10.1097/COH.0b013e328356f6f2; Watts AO, 2012, BIOCHEM BIOPH RES CO, V419, P412, DOI 10.1016/j.bbrc.2012.02.036; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	44	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185354	10.1371/journal.pone.0185354	http://dx.doi.org/10.1371/journal.pone.0185354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945785	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100050
J	Greenberg, MB; Osigian, CJ; Cavuoto, KM; Chang, TC				Greenberg, Matthew B.; Osigian, Carla J.; Cavuoto, Kara M.; Chang, Ta C.			Clinical management outcomes of childhood glaucoma suspects	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; PEDIATRIC GLAUCOMA; CHILDREN	Purpose To investigate the outcomes of childhood glaucoma suspects. Design Retrospective case series. Methods Records of childhood glaucoma suspects were identified using financial claims data; medical history, baseline biometric and exam findings were recorded. Conversion from suspect to glaucoma was determined based on the Childhood Glaucoma Research Network criteria. The study adheres to the tenets of the Declarations of Helsinki. Results 214 subjects were enrolled, with median age at initial presentation of 6.37 years (interquartertile range: Q1 = 2.46, Q3 = 8.90). 22 (10.2%) subjects developed glaucoma, 64 (29.9%) had ocular hypertension but no glaucoma, 9 (4.2%) had high-risk condition or syndrome without either ocular hypertension or glaucoma after a mean follow up of 39 +/-34 months. Neither a family history of glaucoma nor patient gender was significantly different between the groups. 40.2% of subjects (86 of 214) had two or more episodes of intraocular pressure (IOP) > 21 mmHg, among which 25.6% (22 of 86) developed glaucoma after a mean duration of 32.8 +/-33.5 months. Conclusions Up to 25% of children with 2 or more episodes of elevated IOP may develop glaucoma. In 50% of suspects who converted to glaucoma, elevated IOP was not present at the initial evaluation. There is no significant difference in gender, family history, or baseline central corneal thickness between suspects who developed glaucoma compared to the rest. While suspects who converted to glaucoma had higher average, maximum and minimum IOP measurements, there is no clear cutoff between the groups.	[Greenberg, Matthew B.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Osigian, Carla J.; Cavuoto, Kara M.; Chang, Ta C.] Bascom Palmer Eye Inst, Miami, FL 33136 USA	University of Miami; Bascom Palmer Eye Institute	Chang, TC (corresponding author), Bascom Palmer Eye Inst, Miami, FL 33136 USA.	tchang@med.miami.edu						Bayoumi NHL, 2016, J GLAUCOMA, V25, P497, DOI 10.1097/IJG.0000000000000323; Beck A., 2013, WGA CONSENSUS SERIES, V9, P3; Brandt JD, 2012, OPHTHALMOLOGY, V119, P437, DOI 10.1016/j.ophtha.2011.03.018; Brandt JD, 2004, AM J OPHTHALMOL, V137, P348, DOI 10.1016/j.ajo.2003.09.038; Hoguet A, 2016, INDIAN J OPHTHALMOL, V64, P118, DOI 10.4103/0301-4738.179716; Kong LK, 2012, J AAPOS, V16, P501, DOI 10.1016/j.jaapos.2012.09.004; Lopes JF, 2007, J PEDIAT OPHTH STRAB, V44, P112, DOI 10.3928/01913913-20070301-05; Lopez JP, 2011, J PEDIAT OPHTH STRAB, V48, P108, DOI 10.3928/01913913-20100518-03; Whitson Jess T, 2005, Eye Contact Lens, V31, P221, DOI 10.1097/01.ICL.0000152487.16012.40	9	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185546	10.1371/journal.pone.0185546	http://dx.doi.org/10.1371/journal.pone.0185546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945815	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100064
J	Donocik, K; Hartman-Petrycka, M; Lebiedowska, A; Blonska-Fajfrowska, B				Donocik, Karolina; Hartman-Petrycka, Magdalena; Lebiedowska, Agata; Blonska-Fajfrowska, Barbara			Alterations in the ability to maintain balance as a result of stochastic resonance whole body vibration in women	PLOS ONE			English	Article							NOISE; RELIABILITY	Purpose A vertical posture makes it difficult to maintain balance especially in the elderly. Loss of balance leads to falls and injuries. In the present study, we evaluated whether balance maintenance can be improved with the use of stochastic resonance whole body vibration (SRWBV). Methods An examination of balance, involving 187 women aged 19-74 years, was conducted using double-plate posturography pre and post SR-WBV. The SR-WBV trainings were performed using the SRT Zeptor Medical-plus noise device. The entire study lasted 6 weeks, with a total of 12 training sessions, each consisting of nine 45 second series, with a 45 second pause between them. Results Post SR-WBV there was a reduction in the value of: the resultant mean velocity (MV) of the movement of COP (centre of pressure) for both lower limbs (B) and in the right lower limb (R) during the test with eyes closed (EC), the mean velocity and mean amplitude (MA) of the movement of COP along the x-axis (ML) of the left lower limb (L) during the test with eyes open (EO) and closed and some additional parameters. Negative correlations between age/ index of improvement of MV-EC-B, MV-EC-L and MVML-EC-L, and BMI/index of improvement of MV-EC-B, MVML-EC-B appeared. Height correlated positively with the index of improvement of MV-EC-B and MVML-EC-B. Conclusions As a result of SR-WBV, the left leg is more stable along the x-axis and the disproportion between the stability of both legs is reduced. Consequently, body stability is higher. The SRWBV is more effective in younger, taller and slimmer women. SR-WBV parameters should be optimized so that the training is more beneficial for elderly and shorter women, and for women with a higher BMI.	[Donocik, Karolina; Hartman-Petrycka, Magdalena; Lebiedowska, Agata; Blonska-Fajfrowska, Barbara] Med Univ Silesia, Sch Pharm, Dept Basic Biomed Sci, Div Lab Med, Katowice, Poland	Medical University Silesia	Lebiedowska, A (corresponding author), Med Univ Silesia, Sch Pharm, Dept Basic Biomed Sci, Div Lab Med, Katowice, Poland.	alebiedowska@sum.edu.pl		Hartman-Petrycka, Magdalena/0000-0003-3986-3295; Blonska-Fajfrowska, Barbara/0000-0003-4727-1265; Lebiedowska, Agata/0000-0003-3752-4679	Medical University of Silesia [KNW-2001/N/5/N, KNW-2-001/N/6/N, KNW-2-001/N/7/N]	Medical University of Silesia	This work was funded by the Medical University of Silesia, contract numbers: KNW-2001/N/5/N; KNW-2-001/N/6/N; KNW-2-001/N/7/N.	Blaszczyk J.W., 2005, GERONTOLOL POL, V13, P25; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Chang YC, 2017, J SPORT MED PHYS FIT, V57, P660, DOI 10.23736/S0022-4707.16.05728-5; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; Dittrich M., 2012, DEUTSCHER ARZTE VERL, V1, P60; Elfering A, 2014, WORKPLACE HEALTH SAF, V62, P187, DOI 10.3928/21650799-20140422-04; Elfering A, 2013, WORLD J ORTHOP, V4, P291, DOI 10.5312/wjo.v4.i4.291; Elfering A, 2013, SAF HEALTH WORK, V4, P149, DOI 10.1016/j.shaw.2013.07.002; Fallon JB, 2004, J NEUROPHYSIOL, V91, P2429, DOI 10.1152/jn.00928.2003; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gassner H, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/386495; Haas C. T., 2008, CURRENT RESULTS STRE, V2, P105; Haas CT, 2006, FORSCHUNG FRANKFURT, V4, P19; Hartmann P, 2012, PHYSOSCIENCE, V8, P6, DOI 10.1055/s-0031-1281836; Held-Ziolkowska M., 2006, MAG ORL, V2, P47; Kowalczyk A, 2015, J ED HLTH SPORT, V5, P413; Kubiczkowa J, 1974, OTOLARYNGOLOGY-POL, V38, P279; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Moghadam M, 2011, GAIT POSTURE, V33, P651, DOI 10.1016/j.gaitpost.2011.02.016; Ocetkiewicz T., 2006, GERONTOL POL, V14, P144; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Piekarzewska M, 2015, HLTH STATUS POLISH P, P6; Pierchala K, 2013, POL PRZ OTORYNOLARYN, V2, P1; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Rogan S, 2016, J GERONTOL GERIATR R, V5, P1; Rogan S, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0021-4; Rogan S, 2014, AGING CLIN EXP RES, V26, P519, DOI 10.1007/s40520-014-0212-4; Rogan S, 2014, RES SPORTS MED, V22, P294, DOI 10.1080/15438627.2014.919504; Schlee G, 2012, NEUROSCI LETT, V506, P70, DOI 10.1016/j.neulet.2011.10.051; Strzelecki A., 2011, GERONTOL POL, V19, P134; Swanenburg J, 2010, GAIT POSTURE, V31, P317, DOI 10.1016/j.gaitpost.2009.11.013; Swanenburg J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-162; Turbanski Stephan, 2005, Res Sports Med, V13, P243; Wilcynski J., 2007, ANTROPOMOTORICS, V17, P97; Wojtyniak B, 2016, HLTH SIT POL POP ITS	38	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185179	10.1371/journal.pone.0185179	http://dx.doi.org/10.1371/journal.pone.0185179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938021	Green Published, Green Submitted, gold			2022-12-26	WOS:000411524700021
J	Beuscher, S; Kruger, S; Ehrmann, W; Schmiedl, G; Milker, Y; Arz, H; Schulz, H				Beuscher, Sarah; Krueger, Stefan; Ehrmann, Werner; Schmiedl, Gerhard; Milker, Yvonne; Arz, Helge; Schulz, Hartmut			End-member modelling as a tool for climate reconstruction-An Eastern Mediterranean case study	PLOS ONE			English	Article							CLAY MINERAL DISTRIBUTION; DEEP-SEA FAN; AEGEAN SEA; SAHARAN DUST; CHEMICAL-COMPOSITION; LATE QUATERNARY; PLIOCENE SEDIMENTS; SURFACE SEDIMENTS; SUSPENDED MATTER; MARINE-SEDIMENTS	The Eastern Mediterranean Sea is a sink for terrigenous sediments from North Africa, Europe and Asia Minor. Its sediments therefore provide valuable information on the climate dynamics in the source areas and the associated transport processes. We present a high-resolution dataset of sediment core M40/4_SL71, which was collected SW of Crete and spans the last ca. 180 kyr. We analysed the clay mineral composition, the grain size distribution within the silt fraction, and the abundance of major and trace elements. We tested the potential of end-member modelling on these sedimentological datasets as a tool for reconstructing the climate variability in the source regions and the associated detrital input. For each dataset, we modelled three end members. All end members were assigned to a specific provenance and sedimentary process. In total, three end members were related to the Saharan dust input, and five were related to the fluvial sediment input. One end member was strongly associated with the sapropel layers. The Saharan dust end members of the grain size and clay mineral datasets generally suggest enhanced dust export into the Eastern Mediterranean Sea during the dry phases with short-term increases during Heinrich events. During the African Humid Periods, dust export was reduced but may not have completely ceased. The loading patterns of two fluvial end members show a strong relationship with the Northern Hemisphere insolation, and all fluvial end members document enhanced input during the African Humid Periods. The sapropel end member most likely reflects the fixation of redox-sensitive elements within the anoxic sapropel layers. Our results exemplify that end-member modelling is a valuable tool for interpreting extensive and multidisciplinary datasets.	[Beuscher, Sarah; Krueger, Stefan; Ehrmann, Werner; Milker, Yvonne] Univ Leipzig, Inst Geophys & Geol, Leipzig, Germany; [Schmiedl, Gerhard; Milker, Yvonne] Univ Hamburg, Centrum Erdsyst Forsch & Nachhaltigkeit, Hamburg, Germany; [Arz, Helge] Leibniz Inst Ostseeforsch, Rostock, Germany; [Schulz, Hartmut] Univ Tubingen, Fachbereich Geowissensch, Tubingen, Germany	Leipzig University; University of Hamburg; Leibniz Institut fur Ostseeforschung Warnemunde; Eberhard Karls University of Tubingen	Beuscher, S (corresponding author), Univ Leipzig, Inst Geophys & Geol, Leipzig, Germany.	sarah.beuscher@uni-leipzig.de	Arz, Helge/A-6659-2013; Schmiedl, Gerhard/E-6644-2017	Schmiedl, Gerhard/0000-0002-2177-6858; Arz, Helge Wolfgang/0000-0002-1997-1718	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG); DFG; University of Leipzig within the programme of Open Access Publishing	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Leipzig within the programme of Open Access Publishing	We thank the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) for providing financial support to carry out the project, and also acknowledge the support of the DFG and the University of Leipzig within the programme of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSU AE, 1995, PALAEOGEOGR PALAEOCL, V116, P71, DOI 10.1016/0031-0182(94)00092-M; BISCAYE PE, 1965, GEOL SOC AM BULL, V76, P803, DOI 10.1130/0016-7606(1965)76[803:MASORD]2.0.CO;2; Blanchet CL, 2013, EARTH PLANET SC LETT, V364, P98, DOI 10.1016/j.epsl.2013.01.009; Boere AC, 2011, GEOBIOLOGY, V9, P377, DOI 10.1111/j.1472-4669.2011.00290.x; Caley T, 2011, QUATERNARY SCI REV, V30, P3705, DOI 10.1016/j.quascirev.2011.09.015; Caquineau S, 1998, GEOPHYS RES LETT, V25, P983, DOI 10.1029/98GL00569; CHESTER R, 1977, MAR GEOL, V24, P201, DOI 10.1016/0025-3227(77)90028-7; Collins JA, 2013, CLIM PAST, V9, P1181, DOI 10.5194/cp-9-1181-2013; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; Dekov VM, 1997, SCI TOTAL ENVIRON, V201, P195, DOI 10.1016/S0048-9697(97)84057-0; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Ehrmann W, 2007, PALAEOGEOGR PALAEOCL, V249, P36, DOI 10.1016/j.palaeo.2007.01.004; Ehrmann W, 2007, INT J EARTH SCI, V96, P769, DOI 10.1007/s00531-006-0119-1; Ehrmann W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170989; Ehrmann W, 2016, CLIM PAST, V12, P713, DOI 10.5194/cp-12-713-2016; Ehrmann W, 2013, GLOBAL PLANET CHANGE, V107, P186, DOI 10.1016/j.gloplacha.2013.05.010; Emeis KC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2000PA000617; Engelstaedter S, 2006, EARTH-SCI REV, V79, P73, DOI 10.1016/j.earscirev.2006.06.004; Foucault A, 2000, PALAEOGEOGR PALAEOCL, V158, P311, DOI 10.1016/S0031-0182(00)00056-0; Frignani M, 2005, MAR GEOL, V222, P113, DOI 10.1016/j.margeo.2005.06.016; GANOR E, 1991, ATMOS ENVIRON A-GEN, V25, P2665, DOI 10.1016/0960-1686(91)90196-E; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Goudie AS, 2001, EARTH-SCI REV, V56, P179, DOI 10.1016/S0012-8252(01)00067-8; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Grobe H, 2003, GEOGRAPHIC INFORM SY; Guerzoni S, 1997, DEEP-SEA RES PT II, V44, P631, DOI 10.1016/S0967-0645(96)00096-3; Hamann Y, 2008, MAR GEOL, V248, P97, DOI 10.1016/j.margeo.2007.10.009; Hamann Y, 2009, QUATERNARY RES, V71, P453, DOI 10.1016/j.yqres.2009.01.001; Hammer O., 2001, PALAEONTOLOGICAL STA, V4; Hieke W, 1998, CRUISE NO 40, P99; Itambi AC, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2007PA001570; Jolly D, 1998, QUATERNARY SCI REV, V17, P629, DOI 10.1016/S0277-3791(98)00015-8; Just J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004146; Kotthoff U, 2008, QUATERNARY SCI REV, V27, P832, DOI 10.1016/j.quascirev.2007.12.001; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Krom MD, 1999, MAR GEOL, V160, P45, DOI 10.1016/S0025-3227(99)00015-8; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lezine AM, 2011, QUATERNARY SCI REV, V30, P3001, DOI 10.1016/j.quascirev.2011.07.006; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Lykousis V, 2002, J MARINE SYST, V33, P313, DOI 10.1016/S0924-7963(02)00064-7; MALDONADO A, 1981, SEDIMENTOLOGY, V28, P21, DOI 10.1111/j.1365-3091.1981.tb01659.x; Marino G, 2015, NATURE, V522, P197, DOI 10.1038/nature14499; Mattsson JO, 1996, J ARID ENVIRON, V32, P111, DOI 10.1006/jare.1996.0011; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Moreno T, 2006, CHEMOSPHERE, V65, P261, DOI 10.1016/j.chemosphere.2006.02.052; Mulitza S, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001637; NIHLEN T, 1995, Z GEOMORPHOL, V39, P341; NIHLEN T, 1995, TELLUS B, V47, P365, DOI 10.1034/j.1600-0889.47.issue3.7.x; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Passier HF, 1997, GEOLOGY, V25, P519, DOI 10.1130/0091-7613(1997)025<0519:PCMASI>2.3.CO;2; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Poulos SE, 2009, CONT SHELF RES, V29, P2045, DOI 10.1016/j.csr.2008.11.010; PYE K, 1992, EARTH SURF PROCESSES, V17, P271, DOI 10.1002/esp.3290170306; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renssen H, 2006, QUATERN INT, V150, P95, DOI 10.1016/j.quaint.2005.01.001; Revel M, 2010, QUATERNARY SCI REV, V29, P1342, DOI 10.1016/j.quascirev.2010.02.006; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; ROSSIGNOLSTRICK M, 1983, NATURE, V304, P46, DOI 10.1038/304046a0; Sartori R, 1975, SUSPENDED MINERAL MA, V23, P309; Scerri EML, 2014, QUATERNARY SCI REV, V101, P207, DOI 10.1016/j.quascirev.2014.07.019; Scheuvens D, 2013, EARTH-SCI REV, V116, P170, DOI 10.1016/j.earscirev.2012.08.005; SCHUTZ L, 1982, ATMOS ENVIRON, V16, P171, DOI 10.1016/0004-6981(82)90324-9; Seidel M, 2015, MATH GEOSCI, V47, P995, DOI 10.1007/s11004-015-9609-7; SUTHERLAND HE, 1984, MAR GEOL, V56, P79, DOI 10.1016/0025-3227(84)90007-0; TOMADIN L, 1991, MAR GEOL, V100, P35, DOI 10.1016/0025-3227(91)90222-P; Tomadin L., 1981, SEDIMENTARY BASINS M, P313; Tomadin L., 2000, ATTI ACCAD NAZ LIN, V11, P161, DOI [10.1007/BF02904649, DOI 10.1007/BF02904649]; VENKATARATHNAM K, 1971, MAR GEOL, V11, P261, DOI 10.1016/0025-3227(71)90028-4; WALLING DE, 1989, HYDROBIOLOGIA, V176, P125, DOI 10.1007/BF00026549; WEAVER CE, 1977, SEDIMENT GEOL, V17, pR9, DOI 10.1016/0037-0738(77)90062-8; Wehausen R, 1999, MAR GEOL, V153, P161, DOI 10.1016/S0025-3227(98)00083-8; Wehausen R, 2000, PALAEOGEOGR PALAEOCL, V158, P325, DOI 10.1016/S0031-0182(00)00057-2; Weldeab S, 2003, PALAEOGEOGR PALAEOCL, V191, P169, DOI 10.1016/S0031-0182(02)00711-3; Weldeab S, 2002, CHEM GEOL, V186, P139, DOI 10.1016/S0009-2541(01)00415-6; Weldeab S, 2002, GEOCHIM COSMOCHIM AC, V66, P3585, DOI 10.1016/S0016-7037(02)00954-7; Weldeab S, 2014, PALAEOGEOGR PALAEOCL, V410, P200, DOI 10.1016/j.palaeo.2014.06.001; Weltje GJ, 1997, MATH GEOL, V29, P503, DOI 10.1007/BF02775085; Yarincik KM, 2000, PALEOCEANOGRAPHY, V15, P593, DOI 10.1029/1999PA000401; Zhao YL, 2012, QUATERNARY SCI REV, V57, P58, DOI 10.1016/j.quascirev.2012.10.009	80	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185136	10.1371/journal.pone.0185136	http://dx.doi.org/10.1371/journal.pone.0185136			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934332	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900101
J	Demmler, KM; Klasen, S; Nzuma, JM; Qaim, M				Demmler, Kathrin M.; Klasen, Stephan; Nzuma, Jonathan M.; Qaim, Matin			Supermarket purchase contributes to nutrition-related non-communicable diseases in urban Kenya	PLOS ONE			English	Article							INSTRUMENTAL VARIABLES; TRANSITION; INCOME; DIET; CONSUMPTION; REVOLUTION; HOUSEHOLDS; INDONESIA; PATTERNS; OBESITY	Background While undernutrition and related infectious diseases are still pervasive in many developing countries, the prevalence of non-communicable diseases (NCD), typically associated with high body mass index (BMI), is rapidly rising. The fast spread of supermarkets and related shifts in diets were identified as possible factors contributing to overweight and obesity in developing countries. Potential effects of supermarkets on people's health have not been analyzed up till now. Objective This study investigates the effects of purchasing food in supermarkets on people's BMI, as well as on health indicators such as fasting blood glucose (FBG), blood pressure (BP), and the metabolic syndrome. Design This study uses cross-section observational data from urban Kenya. Demographic, anthropometric, and bio-medical data were collected from 550 randomly selected adults. Purchasing food in supermarkets is defined as a binary variable that takes a value of one if any food was purchased in supermarkets during the last 30 days. In a robustness check, the share of food purchased in supermarkets is defined as a continuous variable. Instrumental variable regressions are applied to control for confounding factors and establish causality. Results Purchasing food in supermarkets contributes to higher BMI (+1.8 kg/m(2)) (P< 0.01) and an increased probability (+20 percentage points) of being overweight or obese (P< 0.01). Purchasing food in supermarkets also contributes to higher levels of FBG (+ 0.3 mmol/L) (P< 0.01) and a higher likelihood (+ 16 percentage points) of suffering from pre-diabetes (P< 0.01) and the metabolic syndrome (+7 percentage points) (P< 0.01). Effects on BP could not be observed. Conclusions Supermarkets and their food sales strategies seem to have direct effects on people's health. In addition to increasing overweight and obesity, supermarkets contribute to nutrition-related NCDs. Effects of supermarkets on nutrition and health can mainly be ascribed to changes in the composition of people's food choices.	[Demmler, Kathrin M.; Qaim, Matin] Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Germany; [Klasen, Stephan] Univ Goettingen, Dept Econ, Gottingen, Germany; [Nzuma, Jonathan M.] Univ Nairobi, Dept Agr Econ, Nairobi, Kenya	University of Gottingen; University of Gottingen; University of Nairobi	Demmler, KM (corresponding author), Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Germany.	kathrin-maria.demmler@agr.uni-goettingen.de	Nzuma, Jonathan/AAV-8401-2020; Qaim, Matin/P-4489-2016	Qaim, Matin/0000-0003-4143-0763	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [RTG 1666]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This work was financially supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) under grant number RTG 1666, see http://www.dfg.de/en/index.jsp. DFG had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Andersson C. I. M., 2015, American Journal of Agricultural Economics, V97, P1247, DOI 10.1093/ajae/aav006; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; [Anonymous], 2015, GLOB HLTH OBS IND ES; Asfaw A, 2008, DEV POLICY REV, V26, P227, DOI 10.1111/j.1467-7679.2008.00407.x; Asfaw A, 2011, HEALTH ECON, V20, P184, DOI 10.1002/hec.1579; Bommer C, 2017, LANCET DIABETES ENDO, V5, P423, DOI 10.1016/S2213-8587(17)30097-9; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; Chege CGK, 2015, WORLD DEV, V72, P394, DOI 10.1016/j.worlddev.2015.03.016; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Demmler KM, 2017, WORLD DEV; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Di Falco S, 2011, AM J AGR ECON, V93, P825, DOI 10.1093/ajae/aar006; Duflo E, 2001, AM ECON REV, V91, P795, DOI 10.1257/aer.91.4.795; Food and Agriculture Organisation of the United Nations, 2015, M 2015 INT HUNG TARG; Gruber J, 2000, J POLIT ECON, V108, P1162, DOI 10.1086/317682; Hawkes C, 2008, DEV POLICY REV, V26, P657, DOI 10.1111/j.1467-7679.2008.00428.x; Herman WH, 2013, DIABETES CARE, V36, P775, DOI 10.2337/dc13-0270; Hill R. C., 2008, PRINCIPLES ECONOMETR; Institute of Medicine (U.S.) and Institute of Medicine, 2005, DIET REF INT EN CARB; International Diabetes Federation, 2015, DIABETES ATLAS, V7th; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Kenya National Bureau of Statistics, 2010, POP DISTR ADM UN; Kimenju SC, 2016, FOOD SECUR, V8, P571, DOI 10.1007/s12571-016-0566-x; Kimenju SC, 2015, PUBLIC HEALTH NUTR, V18, P3224, DOI 10.1017/S1368980015000919; Leigh JP, 2004, J CLIN EPIDEMIOL, V57, P284, DOI 10.1016/j.jclinepi.2003.08.006; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Mergenthaler M, 2009, FOOD POLICY, V34, P426, DOI 10.1016/j.foodpol.2009.03.009; Minot N, 2015, B INDONES ECON STUD, V51, P375, DOI 10.1080/00074918.2015.1104410; Minten B, 2012, QUIET REVOLUTION STA; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; Planet Retail, 2016, COUNTR REP KEN; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Popkin B, 2007, AGR ECON-BLACKWELL, V37, P199, DOI 10.1111/j.1574-0862.2007.00245.x; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Popkin BM, 2014, FOOD POLICY, V47, P91, DOI 10.1016/j.foodpol.2014.05.001; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Qaim M, 2017, P NUTR SOC, V76, P12, DOI 10.1017/S0029665116000598; Reardon T, 2012, P NATL ACAD SCI USA, V109, P12332, DOI 10.1073/pnas.1003160108; Rischke R, 2015, FOOD POLICY, V52, P9, DOI 10.1016/j.foodpol.2015.02.001; Roemling C, 2013, ECON HUM BIOL, V11, P563, DOI 10.1016/j.ehb.2013.07.001; Tessier S, 2008, J NUTR, V138, P768, DOI 10.1093/jn/138.4.768; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Timmer CP, 2009, WORLD DEV, V37, P1812, DOI 10.1016/j.worlddev.2008.08.022; Toiba H, 2015, B INDONES ECON STUD, V51, P389, DOI 10.1080/00074918.2015.1111997; Umberger WJ, 2015, AM J AGR ECON, V97, P510, DOI 10.1093/ajae/aau111; Vellakkal S, 2015, J NUTR, V145, P1942, DOI 10.3945/jn.115.211250; WHO, 2013, WHODCOWHD20132; Wooldridge J.M., 2015, INTRO ECONOMETRICS M; World Economic Forum Harvard School of Public Health, 2011, GLOBAL EC BURDEN NON; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2022, GLOB HLTH OBS; World Health Organization (WHO), 2014, WHO EUR NUTR BOD MAS; Zhou YJ, 2015, FOOD POLICY, V55, P92, DOI 10.1016/j.foodpol.2015.07.001	61	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185148	10.1371/journal.pone.0185148	http://dx.doi.org/10.1371/journal.pone.0185148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934333	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900105
J	Janggen, C; Grani, C; Brunner, J; Trachsel, LD; Windecker, S; Eser, P; Raber, L; Wilhelm, M				Janggen, Christoph; Grani, Christoph; Brunner, Jonas; Trachsel, Lukas D.; Windecker, Stephan; Eser, Prisca; Raber, Lorenz; Wilhelm, Matthias			Sports engagement and age at first myocardial infarction in men under 55 years of age	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR RISK; INFLAMMATORY MARKERS; PHYSICAL-ACTIVITY; SUDDEN-DEATH; ATHEROSCLEROSIS; EXERCISE; SMOKING; MECHANISMS	Objective Low levels of physical activity in childhood are associated with clustering of cardiovascular risk factors (CVRF) as predisposition for atherosclerosis. We assessed the association between sports engagement and age at first myocardial infarction (MI) in a cohort of men under 55 years of age. Methods The Bern percutaneous coronary intervention Registry (NCT 02241291) was analyzed from March 2009 until January 2012. Male patients with first MI, age 18 to 54 years and body mass index <= 25kg/m(2) were included. Patients were stratified into two groups based on their starting age with organized sports >= 1 h/week outside school (EARLY: <18, CONTROL: >= 18 years or never). We assessed age at time of first MI, CVRF, and volume of sports training. Results Of 4,394 consecutive patients, 123 fulfilled the inclusion criteria (EARLY n = 81, CONTROL n = 42). Age at the time of first MI was 3 years younger in the EARLY compared to the CONTROL group (46.8 +/- 6.0 vs. 49.8 +/- 4.6 years, p = 0.006). Total lifetime training hours, and average yearly training hours, both, before and after age 18, were significantly greater in the EARLY group. Years of training <18 years were weakly inversely correlated with age at first MI (r(2) = 0.075, p = 0.002). The proportion of sports-related MI was not different between EARLY and CONTROL (13.6% vs. 11.9%). Patients in the EARLY group had fewer CVRF (2 vs. 3; p = 0.001). Prevalence of smoking was equally high in both groups (63.0% and 64.3%). Conclusions In our patients aged 54 and younger, the first MI occurred 3 years earlier in those who started regular sports activity before age 18, despite a more active lifestyle and favorable CVRF profile.	[Janggen, Christoph; Grani, Christoph; Brunner, Jonas; Trachsel, Lukas D.; Windecker, Stephan; Eser, Prisca; Raber, Lorenz; Wilhelm, Matthias] Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland	University of Bern; University Hospital of Bern	Wilhelm, M (corresponding author), Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland.	matthias.wilhelm@insel.ch	Eser, Prisca/AAE-3758-2021; Wilhelm, Matthias/AAS-9456-2020	Wilhelm, Matthias/0000-0003-4541-3995; Grani, Christoph/0000-0001-6029-0597				Ahmadi N, 2015, BRAIN INJURY, V29, P1635, DOI 10.3109/02699052.2015.1075149; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Anton MM, 2006, ATHEROSCLEROSIS, V185, P201, DOI 10.1016/j.atherosclerosis.2005.05.034; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BERLIN I, 1990, EUR J CLIN PHARMACOL, V38, P57, DOI 10.1007/BF00314804; Burke AP, 1999, JAMA-J AM MED ASSOC, V281, P921, DOI 10.1001/jama.281.10.921; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; Gilman SE, 2003, J EPIDEMIOL COMMUN H, V57, P802, DOI 10.1136/jech.57.10.802; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kvaavik E, 2009, PEDIATRICS, V123, pE80, DOI 10.1542/peds.2008-1118; Laitinen TT, 2012, CIRCULATION, V125, P1971, DOI 10.1161/CIRCULATIONAHA.111.073585; Lamprecht M, 2008, SPORT SCHWEIZ 2008 S; Merghani A, 2017, CIRCULATION; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; Mohlenkamp S, 2008, EUR HEART J, V29, P1903, DOI 10.1093/eurheartj/ehn163; Niessner A, 2006, ATHEROSCLEROSIS, V186, P160, DOI 10.1016/j.atherosclerosis.2005.06.047; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Ribeiro F, 2010, INT J CARDIOL, V141, P214, DOI 10.1016/j.ijcard.2009.09.548; Roberts R, 2007, CAN J CARDIOL, V23, p7A, DOI 10.1016/S0828-282X(07)71000-0; Roberts R, 2012, CLIN CARDIOL, V35, P536, DOI 10.1002/clc.22002; Rowe GC, 2014, CIRCULATION, V129, P798, DOI 10.1161/CIRCULATIONAHA.113.001590; Schuler G, 2013, EUR HEART J, V34, P1790, DOI 10.1093/eurheartj/eht111; Schwartz Robert S, 2014, Mo Med, V111, P89; Swardfager W, 2012, AM HEART J, V163, P666, DOI 10.1016/j.ahj.2011.12.017; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Taylor BA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004498; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Toss F, 2013, AM HEART J, V165, P164, DOI 10.1016/j.ahj.2012.10.030; Wang YY, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-179; Wilhelm M, 2014, SCAND J MED SCI SPOR, V24, P519, DOI 10.1111/sms.12030; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184035	10.1371/journal.pone.0184035	http://dx.doi.org/10.1371/journal.pone.0184035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934213	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900018
J	Kan, JL; Liu, TL; Ma, N; Li, H; Li, XG; Wang, JY; Zhang, BL; Chang, YH; Lin, J				Kan, Jialiang; Liu, Tingli; Ma, Na; Li, Hui; Li, Xiaogang; Wang, Jinyan; Zhang, Baolong; Chang, Youhong; Lin, Jing			Transcriptome analysis of Callery pear (Pyrus calleryana) reveals a comprehensive signalling network in response to Alternaria alternata	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE FAMILY; ARABIDOPSIS; TOLERANCE; BIOSYNTHESIS; LIPOXYGENASE; EXPRESSION; MECHANISM; PROTEINS; TCP15	The pear is an important temperate fruit worldwide that is produced by a group of species in the genus Pyrus. Callery pear (Pyrus calleryana Decne) is characterized by high resistance to multiple diseases, good adaptability, and high ornamental value, and is therefore widely planted in pear orchards for edible fruit production or as stock. Plant pathogens are a major threat to pear yield. Black spot disease, caused by the filamentous fungus Alternaria alternata, is one of the most serious diseases in pear. Elucidation of resistant genes to black spot disease is extremely important for understanding the underlying mechanisms as well as for the development of resistant cultivars. In this study, high-throughput single-strand RNA-sequencing was used to compare the transcriptome profiles of Callery pear leaves before and after A. alternata incubation for 7 days. The analysis yielded 73.3 Gb of clean data that were mapped onto the reference genome of the Chinese pear, and differentially expressed gene(DEG) s were identified with | log2FC| >= 1. Functional annotation demonstrated that black spot disease promoted great changes in the overall metabolism, and enrichment analysis of gene ontology terms showed that most of them are closely linked to signalling network and photosynthesis. Specifically, the genes included mainly transcription factors and genes involved in calcium signalling and ethylene and jasmonate pathways. Eight members of the ethylene response factor transcription factor gene family Group IX, including ERF1, ERF7, and ERF105, were up-regulated to 2.03-3.37-fold compared with CK, suggesting their role in the defence response to pathogen infection. Additionally, multiple transcription factors involved in biotic stresses, such as NAC78, NAC2, MYB44, and bHLH28, were up-regulated. Furthermore, we identified 144 long non-coding (lnc) RNAs, providing new insight into the involvement of lncRNAs in the response to black spot disease. Our study provides valuable data on the molecular genetics and functional genomic mechanisms of resistance to black spot disease in Callery pear. A good understanding of the molecular response to this disease will allow the development of durable and environmentally friendly control strategies.	[Kan, Jialiang; Ma, Na; Li, Hui; Li, Xiaogang; Chang, Youhong; Lin, Jing] Jiangsu Acad Agr Sci, Jiangsu Key Lab Hort Crop Genet Improvement, Inst Hort, Nanjing, Jiangsu, Peoples R China; [Liu, Tingli; Wang, Jinyan; Zhang, Baolong] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences	Chang, YH; Lin, J (corresponding author), Jiangsu Acad Agr Sci, Jiangsu Key Lab Hort Crop Genet Improvement, Inst Hort, Nanjing, Jiangsu, Peoples R China.	cyh@jass.ac.cn; lj84390224@126.com			Jiangsu Agricultural Science and Technology Independent Innovation Fund of China [CX(15)1023]; Outstanding Youth Fund of Jiangsu Province [BK20160016]	Jiangsu Agricultural Science and Technology Independent Innovation Fund of China; Outstanding Youth Fund of Jiangsu Province	This study was funded by the Jiangsu Agricultural Science and Technology Independent Innovation Fund of China (CX(15)1023) and the Outstanding Youth Fund of Jiangsu Province (BK20160016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Jiangsu Agricultural Science and Technology Independent Innovation Fund of China (CX(15)1023) and the Outstanding Youth Fund of Jiangsu Province (BK20160016). We thank the staff of Nanjing Huasequen Biotechnologies Co, Ltd., China for help with the bioinformatics analysis.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Baudry A, 1993, PLANT DIS, P77; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; BOHLMANN H, 1988, EMBO J, V7, P1559, DOI 10.1002/j.1460-2075.1988.tb02980.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolt S, 2017, PLANT CELL ENVIRON, V40, P108, DOI 10.1111/pce.12838; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Duyvesteijn RGE, 2005, MOL MICROBIOL, V57, P1051, DOI 10.1111/j.1365-2958.2005.04751.x; EPPLE P, 1995, PLANT PHYSIOL, V109, P813, DOI 10.1104/pp.109.3.813; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gil-Amado JA, 2013, PLANT CELL PHYSIOL, V54, P244, DOI 10.1093/pcp/pcs179; Gladman NP, 2016, PLANT CELL, V28, P1279, DOI 10.1105/tpc.15.01022; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Han L, 2012, INT J ONCOL, V40, P2004, DOI 10.3892/ijo.2012.1413; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-311; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li Y, 2004, CRIT REV PLANT SCI, V23, P381, DOI 10.1080/07352680490505123; Li Y, 2016, CHINESE AGR SCI B, V32, P150; Lucero LE, 2015, PLANT J, V84, P267, DOI 10.1111/tpj.12992; Morishita T, 2009, PLANT CELL PHYSIOL, V50, P2210, DOI 10.1093/pcp/pcp159; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; SANADA T, 1988, J JPN SOC HORTIC SCI, V57, P159; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; SIMMONS EG, 1993, MYCOTAXON, V48, P109; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Tan HW, 2015, GENOME, V58, P463, DOI 10.1139/gen-2015-0074; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vannini C, 2006, PHYSIOL MOL PLANT P, V69, P26, DOI 10.1016/j.pmpp.2006.12.005; Viola IL, 2016, PLANT PHYSIOL, V170, P74, DOI 10.1104/pp.15.01016; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Xu YY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1887-4; Yabuta Y, 2011, PLANT SCI, V181, P421, DOI 10.1016/j.plantsci.2011.07.001; Yi X, 2015, NUCLEIC ACIDS RES, V43, pD982, DOI 10.1093/nar/gku1162	46	14	15	9	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184988	10.1371/journal.pone.0184988	http://dx.doi.org/10.1371/journal.pone.0184988			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934298	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900073
J	Ma, XL; Kuete, M; Gu, XL; Zhou, H; Xiong, CL; Li, HG				Ma, Xiulan; Kuete, Martin; Gu, Xiuli; Zhou, Hui; Xiong, Chengliang; Li, Honggang			Recurrent deletions of the X chromosome linked CNV64, CNV67, and CNV69 shows geographic differences across China and no association with idiopathic infertility in men	PLOS ONE			English	Article							GENETIC-FACTORS; HAN CHINESE; GENOME; MUTATIONS	A recent study found that three recurrent deletions of X chromosome linked copy number variations (CNVs), CNV64, CNV67 and CNV69 were associated with idiopathic male infertility in Spanish and Italian populations, especially CNV67 resembling the azoospermia factor deletions. That merits further investigations among different populations. This study was conducted to examine the prevalence of the three CNVs deletions and their associations with idiopathic male infertility in Chinese Han population. The present study included a large population of 1550 Chinese Han subjects recruited between 2014 and 2016. In total, 714 infertile participants were diagnosed as idiopathic infertility with different conditions (288 with non-obstructive azoospermia, 210 oligozoospermia and 216 asthenospermia) and 836 fertile participants (vasectomized men). The fertile participants were recruited from the representative areas: the north (Hebei and Shanxi), center (Hubei and Jiangsu), and south (Guangdong) of China. All patients were recruited from Hubei province. A multiplex PCR system was established to screen the deletion of the three CNVs, and deletion was confirmed by general PCR. Similar rates of these deletions were observed in infertile men and fertile participants (Hubei), and among the different conditions of infertility. Moreover, CNV64 and CNV67 map distribution geographically differed across China. The three CNVs in fertile groups of other regions were similar, except for Guangdong. No association between the three CNVs deletions and idiopathic male infertility was observed. CNV67 is rare in central China, albeit large sample size study for confirmation is warranted. It seems that the association between these CNVs deletions and idiopathic male infertility is ethnic dependent. There is still need to screen the CNVs deletions in other ethnicities. We suggested to consider the stratification patterns and geographic differences when prescribing CNVs deletions screening as a test in male infertility.	[Ma, Xiulan; Kuete, Martin; Zhou, Hui; Xiong, Chengliang; Li, Honggang] Huazhong Univ Sci & Technol, Family Planning Res Inst, Ctr Reprod Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Kuete, Martin] Univ Montagnes, Fac Hlth Sci, Bangante, Cameroon; [Gu, Xiuli; Zhou, Hui; Xiong, Chengliang; Li, Honggang] Tongji Reprod Med Hosp, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, HG (corresponding author), Huazhong Univ Sci & Technol, Family Planning Res Inst, Ctr Reprod Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China.; Li, HG (corresponding author), Tongji Reprod Med Hosp, Wuhan, Hubei, Peoples R China.	lhgyx@hotmail.com			National Natural Science Foundation of China [81571493]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81571493).; This work was supported by the National Natural Science Foundation of China (Grant No. 81571493). The authors thank all the volunteers who participated in this study, as well as the clinical staff from the five centers who helped to collect the patient histories and the blood samples. We also thank all the research members of the Family Planning Research Institute of Tongji Medical College for their valuable guidance and contributions.	Aston KI, 2014, ANDROLOGY-US, V2, P315, DOI 10.1111/j.2047-2927.2014.00188.x; BANSAL SK, 2016, SCI REP UK, V6; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chianese C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097746; Chylikova B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156102; Giachini C, 2010, INT J ANDROL, V33, P90; Giachini C, 2009, J CLIN ENDOCR METAB, V94, P4016, DOI 10.1210/jc.2009-1029; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Hu ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4857; Hu ZB, 2012, NAT GENET, V44, P183, DOI 10.1038/ng.1040; Ji ZY, 2016, ASIAN J ANDROL; Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Knauff EAH, 2011, FERTIL STERIL, V95, P1584, DOI 10.1016/j.fertnstert.2011.01.018; Krausz C., 2012, PLOS ONE, P7; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Lo Giacco D, 2014, J MED GENET, V51, P340, DOI 10.1136/jmedgenet-2013-101988; Lopes A, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/487695; Ma Q, 2016, REPROD SCI, V23, P1434, DOI 10.1177/1933719116641758; Massart A, 2012, ASIAN J ANDROL, V14, P40, DOI 10.1038/aja.2011.67; Mukherjee A, 2015, ANIM BIOTECHNOL, V26, P65, DOI 10.1080/10495398.2014.887020; Sato Y, 2015, HUM REPROD, V30, P1510, DOI 10.1093/humrep/dev088; Song SH, 2012, GENE, V506, P248, DOI 10.1016/j.gene.2012.06.030; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stouffs K, 2012, BBA-MOL BASIS DIS, V1822, P1864, DOI 10.1016/j.bbadis.2012.05.012; Suo C, 2012, EUR J HUM GENET, V20, P102, DOI 10.1038/ejhg.2011.139; Trarbach EB, 2011, ASIAN J ANDROL, V13, P203, DOI 10.1038/aja.2010.115; Tuttelmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019426; World Health Organization, 2010, WHO LAB MAN EX HUM S; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yan JH, 2011, EUR J OBSTET GYN R B, V159, P371, DOI 10.1016/j.ejogrb.2011.07.033; Yu JM, 2012, HUM REPROD, V27, P25, DOI 10.1093/humrep/der377; Zhou XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139485; Zhou XY, 2015, PLOS ONE, V10	35	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185084	10.1371/journal.pone.0185084	http://dx.doi.org/10.1371/journal.pone.0185084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934280	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900084
J	Turino, C; Bertran, S; Gavalda, R; Teixido, I; Woehrle, H; Rue, M; Solsona, F; Escarrabill, J; Colls, C; Garcia-Altes, A; de Batlle, J; de-la-Torre, MS; Barbe, F				Turino, Cecilia; Bertran, Sandra; Gavalda, Ricard; Teixido, Ivan; Woehrle, Holger; Rue, Montserrat; Solsona, Francesc; Escarrabill, Joan; Colls, Cristina; Garcia-Altes, Anna; de Batlle, Jordi; Sanchez de-la-Torre, Manuel; Barbe, Ferran			Characterization of the CPAP-treated patient population in Catalonia	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; ASSOCIATION; HYPERTENSION; ACCIDENTS; DISEASE; HEALTH; ASTHMA	There are different phenotypes of obstructive sleep apnoea (OSA), many of which have not been characterised. Identification of these different phenotypes is important in defining prognosis and guiding the therapeutic strategy. The aim of this study was to characterise the entire population of continuous positive airway pressure (CPAP)-treated patients in Catalonia and identify specific patient profiles using cluster analysis. A total of 72,217 CPAP-treated patients who contacted the Catalan-Health System (Cat-Salut) during the years 2012 and 2013 were included. Six clusters were identified, classified as "Neoplastic patients" (Cluster 1, 10.4%), "Metabolic syndrome patients" (Cluster 2, 27.7%), "Asthmatic patients" (Cluster 3, 5.8%), "Musculoskeletal and joint disorder patients" (Cluster 4, 10.3%), "Patients with few comorbidities" (Cluster 5, 35.6%) and "Oldest and cardiac disease patients" (Cluster 6, 10.2%). Healthcare facility use and mortality were highest in patients from Cluster 1 and 6. Conversely, patients in Clusters 2 and 4 had low morbidity, mortality and healthcare resource use. Our findings highlight the heterogeneity of CPAP-treated patients, and suggest that OSA is associated with a different prognosis in the clusters identified. These results suggest the need for a comprehensive and individualised approach to CPAP treatment of OSA.	[Turino, Cecilia; Bertran, Sandra; de Batlle, Jordi; Sanchez de-la-Torre, Manuel; Barbe, Ferran] Hosp Univ Arnau Vilanova & Santa Maria, Grp Translat Res Resp Med, IRBLleida, Lleida, Spain; [Turino, Cecilia; Bertran, Sandra; de Batlle, Jordi; Sanchez de-la-Torre, Manuel; Barbe, Ferran] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Gavalda, Ricard] UPC BarcelonaTech, Dept Comp Sci, Barcelona, Spain; [Teixido, Ivan; Solsona, Francesc] Univ Lleida, Dept Comp Sci, Lleida, Spain; [Teixido, Ivan; Solsona, Francesc] Univ Lleida, INSPIRES, Lleida, Spain; [Woehrle, Holger] Resp Ctr Ulm, Sleep & Ventilat Ctr Blaubeuren, Ulm, Germany; [Rue, Montserrat] IRBLleida, Unit Bioestat & Epidemiol, Lleida, Spain; [Escarrabill, Joan] Hosp Clin Barcelona, Chron Care Program, Barcelona, Spain; [Escarrabill, Joan] Minist Hlth, Master Plan Resp Dis, Barcelona, Spain; [Escarrabill, Joan] REDISSEC, Barcelona, Spain; [Colls, Cristina; Garcia-Altes, Anna] Govt Catalonia, Publ Hlth Dept, Barcelona, Spain	University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Politecnica de Catalunya; Universitat de Lleida; Universitat de Lleida; University of Barcelona; Hospital Clinic de Barcelona	Barbe, F (corresponding author), Hosp Univ Arnau Vilanova & Santa Maria, Grp Translat Res Resp Med, IRBLleida, Lleida, Spain.; Barbe, F (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.	febarbe.lleida.ics@gencat.cat	Rue, Montserrat/B-5663-2009; de la Torre, Manuel Sanchez/B-5578-2009; Sánchez-de-la-Torre, Manuel/AAC-9514-2022; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; Barbé, Ferran/A-5988-2010; de Batlle, Jordi/G-6724-2016; Solsona, Francesc/AAR-4195-2020	Rue, Montserrat/0000-0002-7862-9365; de la Torre, Manuel Sanchez/0000-0002-5695-348X; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; Barbé, Ferran/0000-0002-2340-8928; de Batlle, Jordi/0000-0003-3500-6608; Gavalda, Ricard/0000-0003-4736-7179	Spanish Respiratory Society (SEPAR); Associacio Lleidatana de Respiratori (ALLER); ResMed	Spanish Respiratory Society (SEPAR); Associacio Lleidatana de Respiratori (ALLER); ResMed	This study was supported by the Spanish Respiratory Society (SEPAR), Associacio Lleidatana de Respiratori (ALLER) and ResMed, a company that provides diagnostic services and treatment for sleep apnoea. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ResMed paid the salaries of the author HW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157318; Barbe F, 1998, AM J RESP CRIT CARE, V158, P18, DOI 10.1164/ajrccm.158.1.9709135; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Catala R, 2016, ARCH BRONCONEUMOL, V52, P461, DOI 10.1016/j.arbres.2016.02.005; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Gozal D, 2016, SLEEP, V39, P1493, DOI 10.5665/sleep.6004; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; Howell S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-96; Jennum P, 2017, SLEEP MED, V36, P62, DOI 10.1016/j.sleep.2017.04.018; Kent BD, 2015, J THORAC DIS, V7, P1343, DOI 10.3978/j.issn.2072-1439.2015.08.11; Lacedonia D, 2016, J SLEEP RES, V25, P724, DOI 10.1111/jsr.12429; Madama D, 2016, REV PORT PNEUMOL, V22, P6, DOI 10.1016/j.rppnen.2015.08.005; Martinez-Garcia MA, 2009, SLEEP MED, V10, P104, DOI 10.1016/j.sleep.2007.11.009; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Pamidi Sushmita, 2012, Front Neurol, V3, P126; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Sanchez-de-la-Torre M, 2013, LANCET RESP MED, V1, P61, DOI 10.1016/S2213-2600(12)70051-6; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Teodorescu M, 2015, JAMA-J AM MED ASSOC, V313, P156, DOI 10.1001/jama.2014.17822; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Trzepizur W, 2013, CHEST, V143, P1584, DOI 10.1378/chest.12-1652; Ye LC, 2014, EUR RESPIR J, V44, P1600, DOI 10.1183/09031936.00032314	24	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185191	10.1371/journal.pone.0185191	http://dx.doi.org/10.1371/journal.pone.0185191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934303	Green Submitted, gold, Green Published			2022-12-26	WOS:000411339900117
J	Waldron, AL; Cahan, SH; Franklyn, CS; Ebert, AM				Waldron, Ashley L.; Cahan, Sara Helms; Franklyn, Christopher S.; Ebert, Alicia M.			A single Danio rerio hars gene encodes both cytoplasmic and mitochondrial histidyl-tRNA synthetases	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUBCELLULAR-LOCALIZATION; CELL-MIGRATION; PREDICTION; MYOSITIS	Histidyl tRNA Synthetase (HARS) is a member of the aminoacyl tRNA synthetase (ARS) family of enzymes. This family of 20 enzymes is responsible for attaching specific amino acids to their cognate tRNA molecules, a critical step in protein synthesis. However, recent work highlighting a growing number of associations between ARS genes and diverse human diseases raises the possibility of new and unexpected functions in this ancient enzyme family. For example, mutations in HARS have been linked to two different neurological disorders, Usher Syndrome Type IIIB and Charcot Marie Tooth peripheral neuropathy. These connections raise the possibility of previously undiscovered roles for HARS in metazoan development, with alterations in these functions leading to complex diseases. In an attempt to establish Danio rerio as a model for studying HARS functions in human disease, we characterized the Danio rerio hars gene and compared it to that of human HARS. Using a combination of bioinformatics, molecular biology, and cellular approaches, we found that while the human genome encodes separate genes for cytoplasmic and mitochondrial HARS protein, the Danio rerio genome encodes a single hars gene which undergoes alternative splicing to produce the respective cytoplasmic and mitochondrial versions of Hars. Nevertheless, while the HARS genes of humans and Danio differ significantly at the genomic level, we found that they are still highly conserved at the amino acid level, underscoring the potential utility of Danio rerio as a model organism for investigating HARS function and its link to human diseases in vivo.	[Waldron, Ashley L.; Cahan, Sara Helms; Ebert, Alicia M.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Franklyn, Christopher S.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Ebert, AM (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	amebert@uvm.edu		Waldron, Ashley/0000-0003-3177-0983	National Institute of General Medical Sciences [GM54899]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences GM54899 (https://www.nigms.nih.gov/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova J, 2015, RNA BIOL; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Brozkova SD, BRAIN; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cunniff B, 2016, MOL BIOL CELL, V27, P2662, DOI 10.1091/mbc.E16-05-0286; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Fukui H, 2009, CIRC RES, V104, P1253, DOI 10.1161/CIRCRESAHA.108.191189; Grallert B, 2013, BIOCHEM SOC T, V41, P1687, DOI 10.1042/BST20130210; Guo M, 2010, NATURE REV MOL CELL; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kabashi E, 2011, BBA-MOL BASIS DIS, V1812, P335, DOI 10.1016/j.bbadis.2010.09.011; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee YH, 2017, CELL MOL LIFE SCI, V74, P2663, DOI 10.1007/s00018-017-2491-3; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Lu JM, 2015, FLY, V9, P53, DOI 10.1080/19336934.2015.1101196; Malissovas N, 2016, HUM MOL GENET, V25, P1528, DOI 10.1093/hmg/ddw031; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MATHEWS MB, 1983, NATURE, V304, P177, DOI 10.1038/304177a0; Mirando AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13160; Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106; Natsoulis G, 1986, CELL; Park S, P NATL ACAD SCI, V105, P11043; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210; Wei N, 2014, MOL CELL, V56, P323, DOI 10.1016/j.molcel.2014.09.006; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003	43	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185317	10.1371/journal.pone.0185317	http://dx.doi.org/10.1371/journal.pone.0185317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934368	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900145
J	Mrowinski, MJ; Fronczak, P; Fronczak, A; Ausloos, M; Nedic, O				Mrowinski, Maciej J.; Fronczak, Piotr; Fronczak, Agata; Ausloos, Marcel; Nedic, Olgica			Artificial intelligence in peer review: How can evolutionary computation support journal editors?	PLOS ONE			English	Article								With the volume of manuscripts submitted for publication growing every year, the deficiencies of peer review (e.g. long review times) are becoming more apparent. Editorial strategies, sets of guidelines designed to speed up the process and reduce editors' workloads, are treated as trade secrets by publishing houses and are not shared publicly. To improve the effectiveness of their strategies, editors in small publishing groups are faced with undertaking an iterative trial-and-error approach. We show that Cartesian Genetic Programming, a nature-inspired evolutionary algorithm, can dramatically improve editorial strategies. The artificially evolved strategy reduced the duration of the peer review process by 30%, without increasing the pool of reviewers (in comparison to a typical human-developed strategy). Evolutionary computation has typically been used in technological processes or biological ecosystems. Our results demonstrate that genetic programs can improve real-world social systems that are usually much harder to understand and control than physical systems.	[Mrowinski, Maciej J.; Fronczak, Piotr; Fronczak, Agata] Warsaw Univ Technol, Fac Phys, Koszykowa 75, PL-00662 Warsaw, Poland; [Ausloos, Marcel] Univ Leicester, Sch Management, Univ Rd, Leicester LE1 7RH, Leics, England; [Nedic, Olgica] Univ Belgrade, Inst Applicat Nucl Energy INEP, Banatska 31b, Belgrade, Serbia; [Nedic, Olgica] Serbian Chem Soc, Karnegijeva 4-3, Belgrade 11120, Serbia	Warsaw University of Technology; University of Leicester; University of Belgrade	Mrowinski, MJ (corresponding author), Warsaw Univ Technol, Fac Phys, Koszykowa 75, PL-00662 Warsaw, Poland.	mrow@if.pw.edu.pl	Fronczak, Agata/AAT-6002-2021; Nedic, Olgica/H-3843-2019; Ausloos, Marcel/AAC-8812-2020; Fronczak, Piotr/GLS-8248-2022	Nedic, Olgica/0000-0003-2042-0056; Ausloos, Marcel/0000-0001-9973-0019; Fronczak, Piotr/0000-0003-4452-9718; Mrowinski, Maciej/0000-0002-3952-0260; Fronczak, Agata/0000-0002-4301-3288	COST Action [TD1306]	COST Action(European Cooperation in Science and Technology (COST))	This publication is supported by the COST Action TD1306 "New frontiers of peer review" (http:/www.cost.eu/COST Actions/tdp/TD1306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication is supported by the COST Action TD1306 "New frontiers of peer review".	Ausloos M, 2016, PHYSICA A, V456, P197, DOI 10.1016/j.physa.2016.03.032; Ausloos M, 2016, SCIENTOMETRICS, V106, P347, DOI 10.1007/s11192-015-1704-5; Baker D, 2002, RES SCI EDUC, V32, P171, DOI 10.1023/A:1016073927593; Bourke-Waite A, 2015, INSIGHTS, V28, P93, DOI 10.1629/uksg.243; Cawley V., 2011, INT J SOCIAL SCI HUM, V1, P205; Miller J. F., 2000, Genetic Programming and Evolvable Machines, V1, P7, DOI 10.1023/A:1010016313373; Miller J.F., 2011, CARTESIAN GENETIC PR; MILLER JF, 2000, GENETIC PROGRAMMING, V0001, P00259, DOI DOI 10.1023/A:1010066330916; Mrowinski MJ, 2016, SCIENTOMETRICS, V107, P271, DOI 10.1007/s11192-016-1871-z; Mulligan A, 2013, J AM SOC INF SCI TEC, V64, P132, DOI 10.1002/asi.22798; Nguyen VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132557; Nicholas D, 2015, LEARN PUBL, V28, P15, DOI 10.1087/20150104; Powell K, 2016, NATURE, V530, P148, DOI 10.1038/530148a; Resnik DB, 2008, SCI ENG ETHICS, V14, P305, DOI 10.1007/s11948-008-9059-4; Squazzoni F, 2011, JASSS-J ARTIF SOC S, V14, DOI 10.18564/jasss.1821; Wager E, 2006, ETHICS WHAT IS IT NA; Ware M., 2008, PEER REV SCHOLARLY J, V28, P2; Ware Mark, 2015, COPYRIGHT FAIR USE S	18	18	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184711	10.1371/journal.pone.0184711	http://dx.doi.org/10.1371/journal.pone.0184711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931033	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700029
J	Tian, L; Liu, LR; Yin, YH; Huang, MC; Chen, YB; Xu, XL; Wu, PZ; Li, MR; Wu, GJ; Jiang, HW; Chen, YP				Tian, Lu; Liu, Leru; Yin, Yehu; Huang, Mingchao; Chen, Yanbo; Xu, Xinlan; Wu, Pingzhi; Li, Meiru; Wu, Guojiang; Jiang, Huawu; Chen, Yaping			Heterogeneity in the expression and subcellular localization of POLYOL/MONOSACCHARIDE TRANSPORTER genes in Lotus japonicus	PLOS ONE			English	Article							MONOSACCHARIDE TRANSPORTER; TRANSMEMBRANE TOPOLOGY; MANNITOL DEHYDROGENASE; SORBITOL TRANSPORTERS; SUGAR-TRANSPORT; MEMBRANE; SUCROSE; PHLOEM; CELERY; IDENTIFICATION	Polyols can serve as a means for the translocation of carbon skeletons and energy between source and sink organs as well as being osmoprotective solutes and antioxidants which may be involved in the resistance of some plants to biotic and abiotic stresses. Polyol/Mono-saccharide transporter (PLT) proteins previously identified in plants are involved in the loading of polyols into the phloem and are reported to be located in the plasma membrane. The functions of PLT proteins in leguminous plants are not yet clear. In this study, a total of 14 putative PLT genes (LjPLT1-14) were identified in the genome of Lotus japonicus and divided into 4 clades based on phylogenetic analysis. Different patterns of expression of LjPLT genes in various tissues were validated by qRT-PCR analysis. Four genes (LjPLT3, 4, 11, and 14) from clade II were expressed at much higher levels in nodule than in other tissues. Moreover, three of these genes (LjPLT3, 4, and 14) showed significantly increased expression in roots after inoculation with Mesorhizobium loti. Three genes (LjPLT1, 3, and 9) responded when salinity and/or osmotic stresses were applied to L. japonicus. Transient expression of GFP-LjPLT fusion constructs in Arabidopsis and Nicotiana benthamiana protoplasts indicated that the LjPLT1, LjPLT6 and LjPLT7 proteins are localized to the plasma membrane, but LjPLT2 (clade IV), LjPLT3, 4, 5 (clade II) and LjPLT8 (clade III) proteins possibly reside in the Golgi apparatus. The results suggest that members of the LjPLT gene family may be involved in different biological processes, several of which may potentially play roles in nodulation in this nitrogen-fixing legume.	[Tian, Lu; Liu, Leru; Yin, Yehu; Huang, Mingchao; Chen, Yanbo; Xu, Xinlan; Wu, Pingzhi; Li, Meiru; Wu, Guojiang; Jiang, Huawu; Chen, Yaping] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Tian, Lu; Liu, Leru; Yin, Yehu; Huang, Mingchao; Chen, Yanbo; Xu, Xinlan; Wu, Pingzhi; Li, Meiru; Wu, Guojiang; Jiang, Huawu; Chen, Yaping] Chinese Acad Sci, South China Bot Garden, Guangdong Prov Key Lab Appl Bot, Guangzhou, PR, Peoples R China; [Tian, Lu; Liu, Leru; Yin, Yehu; Huang, Mingchao; Chen, Yanbo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, YP (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.; Chen, YP (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangdong Prov Key Lab Appl Bot, Guangzhou, PR, Peoples R China.	chenyp@scbg.ac.cn			National Natural Science Foundation of China [31572195, 31570242]; Natural Science Foundation of Guangdong [2014A030313713]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (Guojiang Wu, No. 31572195; Yaping Chen, No. 31570242) and the Natural Science Foundation of Guangdong (Yaping Chen, No. 2014A030313713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Natural Science Foundation of China (31572195; 31570242) and the Natural Science Foundation of Guangdong (2014A030313713). The authors are grateful to Mr. Ce Fang, Miss. Nannan Huang, Mr. Gong Wang, Miss. Yong Zhu and Mr. Xuegang Sun for help of the confocal microscope.	BIELESKI RL, 1985, AUST J PLANT PHYSIOL, V12, P657, DOI 10.1071/PP9850657; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Buckhout T.J., 1996, PHOTOASSIMILATE DIST, P229; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cao H, 2011, J EXP BOT, V62, P4595, DOI 10.1093/jxb/err178; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; Conde A, 2015, J EXP BOT, V66, P889, DOI 10.1093/jxb/eru446; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1766, DOI 10.1093/pcp/pcr121; DAIE J, 1986, J AM SOC HORTIC SCI, V111, P216; DAIE J, 1987, PLANTA, V171, P474, DOI 10.1007/BF00392294; DAVIS JM, 1988, PLANT PHYSIOL, V86, P129, DOI 10.1104/pp.86.1.129; Desbrosses GG, 2005, PLANT PHYSIOL, V137, P1302, DOI 10.1104/pp.104.054957; Doidy J, 2012, TRENDS PLANT SCI, V17, P413, DOI 10.1016/j.tplants.2012.03.009; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Dusotoit-Coucaud A, 2010, PLANT CELL PHYSIOL, V51, P1878, DOI 10.1093/pcp/pcq151; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan RC, 2009, PLANT PHYSIOL, V150, P1880, DOI 10.1104/pp.109.141374; Aguayo MF, 2013, PLANT SCI, V205, P63, DOI 10.1016/j.plantsci.2013.01.012; Gao ZF, 2003, PLANT PHYSIOL, V131, P1566, DOI 10.1104/pp.102.016725; Gendre D, 2015, PROTOPLASMA, V252, P385, DOI 10.1007/s00709-014-0693-1; Hamilton AJ, 1999, MED MYCOL, V37, P375, DOI 10.1046/j.1365-280X.1999.00208.x; Hedrich R, 2015, CURR OPIN PLANT BIOL, V25, P63, DOI 10.1016/j.pbi.2015.04.008; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; Johnson DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-64; Jordan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23502; Juchaux-Cachau M, 2007, PLANT PHYSIOL, V145, P62, DOI 10.1104/pp.107.103143; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kalliampakou KI, 2011, MOL MEMBR BIOL, V28, P1, DOI 10.3109/09687688.2010.500626; Klepek YS, 2005, PLANT CELL, V17, P204, DOI 10.1105/tpc.104.026641; Klepek YS, 2010, J EXP BOT, V61, P537, DOI 10.1093/jxb/erp322; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Noiraud N, 2001, PLANT PHYSIOL BIOCH, V39, P717, DOI 10.1016/S0981-9428(01)01292-X; Noiraud N, 2001, PLANT CELL, V13, P695, DOI 10.1105/tpc.13.3.695; Pereira I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088180; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Ramsperger-Gleixner M, 2004, PLANT PHYSIOL, V134, P147, DOI 10.1104/pp.103.027136; Reinders A, 2005, J BIOL CHEM, V280, P1594, DOI 10.1074/jbc.M410831200; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seidel T, 2004, J BIOTECHNOL, V112, P165, DOI 10.1016/j.jbiotec.2004.04.027; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Watari J, 2004, PLANT CELL PHYSIOL, V45, P1032, DOI 10.1093/pcp/pch121; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Wienkoop S, 2003, PLANT PHYSIOL, V131, P1080, DOI 10.1104/pp.102.015362; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290	48	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185269	10.1371/journal.pone.0185269	http://dx.doi.org/10.1371/journal.pone.0185269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931056	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700079
J	Hazarika, M; Borah, D; Bora, P; Silva, AR; Das, P				Hazarika, Munmi; Borah, Debajit; Bora, Popymita; Silva, Ana R.; Das, Pankaj			Biogenic synthesis of palladium nanoparticles and their applications as catalyst and antimicrobial agent	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; CROSS-COUPLING REACTION; PD NANOPARTICLES; IN-SITU; GREEN SYNTHESIS; HETEROGENEOUS CATALYST; METAL NANOPARTICLES; RECYCLABLE CATALYST; SELECTIVE OXIDATION; HEXAVALENT CHROMIUM	This paper describes a simple in-situ process of synthesizing highly dispersed palladium nanoparticles (PdNPs) using aqueous leaf extract of GarciniapedunculataRoxb as bioreductant and starch (0.3%) as bio-stabilizer. The PdNPs are characterized by techniques like FTIR, TEM, SEM-EDX, XRD and XPS analysis. It is worthnoting thatwhen the synthesis of nanoparticles was carried out in absence of starch, agglomeration of particles has been noticed. The starch-assisted PdNPs showed excellent aqueous-phase catalytic activities for three important reactions: the Suzuki-Miyaura cross-coupling reactions of aryl halides (aryl bromides and iodides) with arylboronic acids; selective oxidations of alcohols to corresponding carbonyl compounds; and reduction of toxic Cr(VI) to nontoxic Cr(III). Our catalyst could be reused up to four cycles without much compromising with its activity. Furthermore, the material also demonstrated excellent antimicrobial and anti-biofilm activities against a novel multidrug resistant clinical bacterial isolate Cronobactersakazakii strain AMD04. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of PdNPswere found to be 0.06 and 0.12 mM respectively.	[Hazarika, Munmi; Das, Pankaj] Dibrugarh Univ, Dept Chem, Dibrugarh, Assam, India; [Borah, Debajit; Bora, Popymita] Dibrugarh Univ, Ctr Biotechnol & Bioinformat, Dibrugarh, Assam, India; [Silva, Ana R.] Univ Aveiro, CICECO Aveiro Inst Mat, Aveiro, Portugal	Dibrugarh University; Dibrugarh University; Universidade de Aveiro	Das, P (corresponding author), Dibrugarh Univ, Dept Chem, Dibrugarh, Assam, India.	pankajd29@yahoo.com	Silva, Ana Rosa/F-6174-2011	Silva, Ana Rosa/0000-0002-1673-2164	Department of Biotechnology [MED/2013/23]; UGC, New Delhi	Department of Biotechnology; UGC, New Delhi(University Grants Commission, India)	The Department of Biotechnology is gratefully acknowledged for financial support (Grant no:MED/2013/23) under DBT-Twinning programme and also for providing Delcon as well as IBT hub facility to the Centre for Biotechnology and Bioinformatics, Dibrugarh University. The UGC, New Delhi has also been acknowledged for the SAP-DRS-I grant awarded to the Department of Chemistry.; The Department of Biotechnology is gratefully acknowledged for financial support (Grant no: MED/2013/23) under DBT-Twinning programme and also for providing Delcon as well as IBT hub facility to the Centre for Biotechnology and Bioinformatics, Dibrugarh University. The UGC, New Delhi has also been acknowledged for the SAP-DRS-I grant awarded to the Department of Chemistry. The service of SAIF, NEHU, Shillong was gratefully acknowledged for TEM analysis. Dr. S. Pramanik was acknowledged for English editing in the revised manuscript.	Adams CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085981; Aditya T, 2015, CHEM COMMUN, V51, P9410, DOI 10.1039/c5cc01131k; Akhtar MS, 2013, ACS SUSTAIN CHEM ENG, V1, P591, DOI 10.1021/sc300118u; Bankar A, 2010, MATER LETT, V64, P1951, DOI 10.1016/j.matlet.2010.06.021; Basavegowda N, 2015, NEW J CHEM, V39, P972, DOI 10.1039/c4nj01543f; Brun M, 1999, J ELECTRON SPECTROSC, V104, P55, DOI 10.1016/S0368-2048(98)00312-0; Costa NJS, 2012, NANOSCALE, V4, P5826, DOI 10.1039/c2nr31165h; Das P, 2016, COORDIN CHEM REV, V311, P1, DOI 10.1016/j.ccr.2015.11.010; Dauthal P, 2016, IND ENG CHEM RES, V55, P9557, DOI 10.1021/acs.iecr.6b00861; Davis SE, 2013, GREEN CHEM, V15, P17, DOI 10.1039/c2gc36441g; Duran N, 2007, J BIOMED NANOTECHNOL, V3, P203, DOI 10.1166/jbn.2007.022; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Gogoi N, 2017, CATAL LETT, V147, P539, DOI 10.1007/s10562-016-1937-9; Indian Herbal Remedies, 2004, RAT W THER AYURV OTH; Kalidhasan S, 2016, COORDIN CHEM REV, V317, P157, DOI 10.1016/j.ccr.2016.03.004; Kelly MA, 2015, FUNDAMENTALS SCI RES; Khan M, 2014, DALTON T, V43, P9026, DOI 10.1039/c3dt53554a; Lennox AJJ, 2014, CHEM SOC REV, V43, P412, DOI 10.1039/c3cs60197h; Li ZP, 2010, J PHYS CHEM C, V114, P723, DOI 10.1021/jp907745v; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Mondal M, 2016, CHEMISTRYSELECT, V1, P4645, DOI 10.1002/slct.201600385; Mudoi T., 2012, International Journal of PharmTech Research, V4, P334; Narayanan KB, 2011, ADV COLLOID INTERFAC, V169, P59, DOI 10.1016/j.cis.2011.08.004; Nasrollahzadeh M, 2016, J COLLOID INTERF SCI, V469, P191, DOI 10.1016/j.jcis.2016.02.024; Nasrollahzadeh M, 2016, J COLLOID INTERF SCI, V462, P243, DOI 10.1016/j.jcis.2015.09.065; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Parker HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087192; Parmeggiani C, 2012, GREEN CHEM, V14, P547, DOI 10.1039/c2gc16344f; Pramanik S, 2017, CHEMISTRYSELECT, V2, P4577, DOI 10.1002/slct.201700714; Qazi F, 2016, RSC ADV, V6, P60277, DOI 10.1039/c6ra11695g; Qazi SJS, 2009, J COLLOID INTERF SCI, V338, P105, DOI 10.1016/j.jcis.2009.06.006; Rana S, 2015, APPL CATAL A-GEN, V505, P539, DOI 10.1016/j.apcata.2015.07.018; Sadik OA, 2014, J CHEM EDUC, V91, P269, DOI 10.1021/ed300229r; Sahu D, 2016, CATAL COMMUN, V86, P32, DOI 10.1016/j.catcom.2016.08.005; Sahu D, 2015, RSC ADV, V5, P3512, DOI 10.1039/c4ra11186a; Saikia PK, 2016, RSC ADV, V6, P110011, DOI 10.1039/c6ra22788k; Sarmah M, 2017, CATAL COMMUN, V90, P31, DOI 10.1016/j.catcom.2016.10.034; Sarmah M, 2016, RSC ADV, V6, P28981, DOI 10.1039/c6ra00454g; Shabbir S, 2017, J ORGANOMET CHEM, V846, P296, DOI 10.1016/j.jorganchem.2017.07.003; Shaik MR, 2017, MOLECULES, V22, DOI 10.3390/molecules22010165; Sheldon RA, 2015, CATAL TODAY, V247, P4, DOI 10.1016/j.cattod.2014.08.024; Singha S, 2011, DALTON T, V40, P7130, DOI 10.1039/c1dt10697j; Takeoka H, 2014, POLYM J, V46, P704, DOI 10.1038/pj.2014.44; U. S. Department of Health and Human Services-Food and Drug Administration, 2015, Q3D EL IMP GUID IND; Vishnukumar P, 2017, CHEMBIOENG REV, V4, P18, DOI 10.1002/cben.201600017; Wahab R, 2016, RSC ADV, V6, P32328, DOI 10.1039/c6ra05297e; Wahab R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19950; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Xin X, 2014, PLOS ONE, V9; Yu QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26667	52	69	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184936	10.1371/journal.pone.0184936	http://dx.doi.org/10.1371/journal.pone.0184936			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957342	Green Submitted, gold, Green Published			2022-12-26	WOS:000411985200023
J	Martinez-Martinez, N; Martinez-Alonso, E; Tomas, M; Neumuller, J; Pavelka, M; Martinez-Menarguez, JA				Martinez-Martinez, Narcisa; Martinez-Alonso, Emma; Tomas, Monica; Neumueller, Josef; Pavelka, Margit; Martinez-Menarguez, Jose A.			A new insight into the three-dimensional architecture of the Golgi complex: Characterization of unusual structures in epididymal principal cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; ELECTRON TOMOGRAPHY; MAMMALIAN GOLGI; APPARATUS; RAT; TRANSPORT; DYNAMICS; REVEALS; TUBULES; SITES	Principal epididymal cells have one of the largest and more developed Golgi complex of mammalian cells. In the present study, we have used this cell as model for the study of the three-dimensional architecture of the Golgi complex of highly secretory and endocytic cells. Electron tomography demonstrated the presence in this cell type of some unknown or very unusual Golgi structures such as branched cisternae, pocket-like cisternal invaginations or tubular connections. In addition, we have used this methodology and immunoelectron microscopy to analyze the close relationship between this organelle and both the endoplasmic reticulum and microtubules, and to describe in detail how these elements interact with compact and non-compact regions of the ribbon.	[Martinez-Martinez, Narcisa; Martinez-Alonso, Emma; Martinez-Menarguez, Jose A.] Univ Murcia, Biomed Res Inst Murcia IMIB Arrixaca UMU, Dept Cell Biol & Histol, Murcia, Spain; [Martinez-Martinez, Narcisa] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, York Ave, New York, NY 10021 USA; [Tomas, Monica] Univ Valencia, Med Sch, Dept Human Anat & Embryol, Valencia, Spain; [Neumueller, Josef; Pavelka, Margit] Med Univ Vienna, Dept Cell & Dev Biol, Ctr Anat & Cell Biol, Schwarzspanierstr 17, Vienna, Austria	University of Murcia; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Valencia; Medical University of Vienna	Martinez-Menarguez, JA (corresponding author), Univ Murcia, Biomed Res Inst Murcia IMIB Arrixaca UMU, Dept Cell Biol & Histol, Murcia, Spain.	jamartin@um.es	CABALLERO, MONICA TOMAS/R-1275-2017; ALONSO, EMMA MARTINEZ/L-7468-2014	CABALLERO, MONICA TOMAS/0000-0003-2696-1726; ALONSO, EMMA MARTINEZ/0000-0002-8121-0442				Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Beznoussenko GV, 2014, ELIFE, V3, DOI 10.7554/eLife.02009; Bouchet-Marquis C, 2008, J MICROSC-OXFORD, V230, P308, DOI 10.1111/j.1365-2818.2008.01988.x; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Day KJ, 2013, HISTOCHEM CELL BIOL, V140, P239, DOI 10.1007/s00418-013-1128-3; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; De Matteis MA, 2015, CURR OPIN CELL BIOL, V35, P43, DOI 10.1016/j.ceb.2015.04.001; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Gurel PS, 2014, CURR BIOL, V24, pR660, DOI 10.1016/j.cub.2014.05.033; HERMO L, 1991, ANAT RECORD, V229, P159, DOI 10.1002/ar.1092290203; Hermo L, 1998, HISTOCHEM CELL BIOL, V109, P431, DOI 10.1007/s004180050246; JA M-M, 2013, INTRAGOLGI TRANSPORT; Klumperman J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005181; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Luini A, 2016, CURR OPIN CELL BIOL, V39, P37, DOI 10.1016/j.ceb.2016.01.014; Marsh BJ, 2005, BBA-MOL CELL RES, V1744, P273, DOI 10.1016/j.bbamcr.2005.04.002; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Marsh BJ, 2013, METHOD CELL BIOL, V118, P259, DOI 10.1016/B978-0-12-417164-0.00016-1; Martinez-Alonso E, 2005, TRAFFIC, V6, P32, DOI 10.1111/j.1600-0854.2004.00242.x; Martinez-Alonso E, 2013, HISTOCHEM CELL BIOL, V140, P327, DOI 10.1007/s00418-013-1114-9; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MartinezMenarguez JA, 1996, EUR J CELL BIOL, V71, P137; Mironov AA, 2016, TISSUE CELL; Mironov AA, 2008, GOLGI APPARATUS STAT; Mogelsvang S, 2004, TRAFFIC, V5, P338, DOI 10.1111/j.1398-9219.2004.00186.x; Papanikou E, 2014, CURR OPIN CELL BIOL, V29, P74, DOI 10.1016/j.ceb.2014.04.010; Ranftler C, 2016, HIST CHEM CELL BIOLO; Rios RM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0462; Robaire B, 1988, PHYSL REPROD; Fernandez-Fernandez MR, 2017, J CELL SCI, V130, P83, DOI 10.1242/jcs.188060; Zeuschner D, 2006, NAT CELL BIOL, V8, P377, DOI 10.1038/ncb1371	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185557	10.1371/journal.pone.0185557	http://dx.doi.org/10.1371/journal.pone.0185557			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957389	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200085
J	Matus, V; Valenzuela, JG; Hidalgo, P; Pozo, LM; Panes, O; Wozniak, A; Mezzano, D; Pereira, J; Saez, CG				Matus, Valeria; Guillermo Valenzuela, J.; Hidalgo, Patricia; Maria Pozo, L.; Panes, Olga; Wozniak, Aniela; Mezzano, Diego; Pereira, Jaime; Saez, Claudia G.			Human platelet interaction with E-coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4	PLOS ONE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; MESSENGER-RNA; BACTERIAL LPS; SHIGA-TOXIN; IN-VIVO; ACTIVATION; EXPRESSION; INFECTION; INFLAMMATION; THROMBIN	Platelets have a major role in clotting activation and contribute to the innate immune response during systemic infections. Human platelets contain tissue factor (TF) and express functional Toll-like receptor 4 (TLR4). However, the role of TLR4 in triggering the procoagulant properties of platelets, upon challenge with bacteria, is yet unknown. Our hypothesis is that E. coli O111-TLR4 interaction activates platelets and elicits their procoagulant activity. We demonstrated that the strain, but not ultrapure LPS, increased surface P-selectin expression, platelet dependent TF procoagulant activity (TF-PCA) and prompted a faster thrombin generation (TG). Blockade of TLR4 resulted in decreased platelet activation, TF-PCA and TG, revealing the participation of this immune receptor on the procoagulant response of platelets. Our results provide a novel mechanism by which individuals with bacterial infections would have an increased incidence of blood clots. Furthermore, the identification of platelet TF and TLR4 as regulators of the effect of E. coli O111 might represent a novel therapeutic target to reduce the devastating consequences of the hemostatic disorder during sepsis.	[Matus, Valeria; Guillermo Valenzuela, J.; Hidalgo, Patricia; Maria Pozo, L.; Panes, Olga; Mezzano, Diego; Pereira, Jaime; Saez, Claudia G.] Pontificia Univ Catolica Chile, Sch Med, Dept Hematol Oncol, Santiago, Chile; [Wozniak, Aniela] Pontificia Univ Catolica Chile, Sch Med, Dept Clin Lab, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Saez, CG (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Hematol Oncol, Santiago, Chile.	saez@med.puc.cl	Saez, Claudia/HCI-4472-2022; Mezzano, Diego/G-4142-2013	Saez, Claudia/0000-0001-7183-1491; Mezzano, Diego/0000-0003-2448-9288	"Fondo Nacional de Desarrollo Cientifico y Tecnologico", FONDECYT Chile [1130835]	"Fondo Nacional de Desarrollo Cientifico y Tecnologico", FONDECYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by "Fondo Nacional de Desarrollo Cientifico y Tecnologico", FONDECYT Chile, Award Number 1130835, Grant Recipient: Valeria Matus R, PhD.	Arbesu I, 2016, J THROMB HAEMOST, V14, P2241, DOI 10.1111/jth.13495; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Baker M, 2011, NATURE, V475, P123, DOI 10.1038/475123a; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Brambilla M, 2015, THROMB HAEMOSTASIS, V114, P579, DOI 10.1160/TH14-10-0830; Brooks JT, 2004, CLIN INFECT DIS, V38, P190, DOI 10.1086/380634; Camera M, 2003, ARTERIOSCL THROM VAS, V23, P1690, DOI 10.1161/01.ATV.0000085629.23209.AA; Celes MRN, 2013, PATHOBIOLOGY, V80, P70, DOI 10.1159/000341640; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; CHONG BH, 1989, BRIT J HAEMATOL, V73, P235, DOI 10.1111/j.1365-2141.1989.tb00258.x; Cognasse F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00083; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cox D, 2011, J THROMB HAEMOST, V9, P1097, DOI 10.1111/j.1538-7836.2011.04264.x; Ding N, 2014, CIRC-CARDIOVASC GENE, V7, P615, DOI 10.1161/CIRCGENETICS.113.000398; Ford I, 1997, PLATELETS, V8, P285; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Freudenberg MA, 2001, MICROBES INFECT, V3, P1213, DOI 10.1016/S1286-4579(01)01481-2; Harrison P, 2016, PLATELETS, V27, P1, DOI 10.3109/09537104.2015.1129225; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; Jenne CN, 2015, PLATELETS, V26, P286, DOI 10.3109/09537104.2015.1010441; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kappelmayer J, 2013, J THROMB HAEMOST, V11, P775, DOI 10.1111/jth.12151; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Kim KS, 2012, CURR OPIN INFECT DIS, V25, P273, DOI 10.1097/QCO.0b013e3283521eb0; Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Moriarty RD, 2016, J THROMB HAEMOST, V14, P797, DOI 10.1111/jth.13226; Panes O, 2007, BLOOD, V109, P5242, DOI 10.1182/blood-2006-06-030619; Panes O, 2017, ATHEROSCLEROSIS, V257, P164, DOI 10.1016/j.atherosclerosis.2016.12.019; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rank A, 2010, THROMB RES, V126, pE255, DOI 10.1016/j.thromres.2010.07.012; Rollin J, 2016, THROMB HAEMOSTASIS, V116, P799, DOI 10.1160/TH16-02-0109; Rondina MT, 2011, J THROMB HAEMOST, V9, P748, DOI 10.1111/j.1538-7836.2011.04208.x; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shiraki R, 2004, THROMB RES, V113, P379, DOI 10.1016/j.thromres.2004.03.023; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Vandijck DM, 2010, HEART LUNG, V39, P21, DOI 10.1016/j.hrtlng.2009.07.005; Vidal M, 2005, J CLIN MICROBIOL, V43, P5362, DOI 10.1128/JCM.43.10.5362-5365.2005; Ward JR, 2005, THROMB HAEMOSTASIS, V94, P831, DOI 10.1160/TH05-01-0009; Watahiki M, 2014, J CLIN MICROBIOL, V52, P2757, DOI 10.1128/JCM.00420-14	44	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185431	10.1371/journal.pone.0185431	http://dx.doi.org/10.1371/journal.pone.0185431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957360	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200057
J	Nagaoka, T; Uzawa, K; Seki, Y; Chocano, DM				Nagaoka, Tomohito; Uzawa, Kazuhiro; Seki, Yuji; Chocano, Daniel Morales			Pacopampa: Early evidence of violence at a ceremonial site in the northern Peruvian highlands	PLOS ONE			English	Article							ADULT SKELETAL AGE; AURICULAR SURFACE; PUBIC BONE; TRAUMA; DEATH; METAMORPHOSIS; POPULATION; ILIUM; ANDES	Objectives Pacopampa, a ceremonial complex in Peru's northern highlands, reveals early evidence of trauma in the Middle to Late Formative Period coinciding with the emergence of social stratification in the area. We examine the prevalence of trauma in human remains found at the site and present evidence of the circumstances surrounding the deaths of individuals who lived during the early stages of Andean civilization. Materials and methods The materials are the remains of 104 individuals (38 non-adult and 66 adult) from the Middle to Late Formative Periods. We explored trauma macroscopically and recorded patterns based on skeletons' locations, age at death, sex, social class, and chronology. Results We detected trauma in remains over the Middle to Late Formative Periods. While the prevalence of trauma was minimal in the Middle Formative Period, skeletons from the subsequent era exhibit more severe disturbances. However, all the skeletons show signs of healing and affected individuals experienced a low degree of trauma. Discussion Given the archaeological context (the remains were recovered from sites of ceremonial practices), as well as the equal distribution of trauma among both sexes and a lack of defensive architecture, it is plausible that rituals, rather than organized warfare or raids, caused most of the exhibited trauma. Pacopampa was home to a complex society founded on ritual activity in a ceremonial center: this is indicated by the presence of ritual violence in a society that built impressively large, ceremonial architecture and developed social stratification without any political control of surplus agricultural goods.	[Nagaoka, Tomohito] St Marianna Univ, Dept Anat, Sch Med, Kawasaki, Kanagawa, Japan; [Uzawa, Kazuhiro] Univ East Asia, Fac Human Sci, Shimonoseki, Yamaguchi, Japan; [Seki, Yuji] Natl Museum Ethnol, Suita, Osaka, Japan; [Chocano, Daniel Morales] Univ Nacl Mayor San Marcos, Lima, Peru	Saint Marianna University; Universidad Nacional Mayor de San Marcos	Nagaoka, T (corresponding author), St Marianna Univ, Dept Anat, Sch Med, Kawasaki, Kanagawa, Japan.	nagaoka@mananna-u.ac.jp			JSPS KAKENHI [23222003, 16H02729, 16H05639]; Grants-in-Aid for Scientific Research [16H02729, 16H05639] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by JSPS KAKENHI Grant Numbers 23222003, 16H02729 and 16H05639.	Arkush E, 2013, J ARCHAEOL RES, V21, P307, DOI 10.1007/s10814-013-9065-1; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Blom DE, 1999, EARLY SETTLEMENT CHI, p[133, 117]; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Buckberry JL, 2002, AM J PHYS ANTHROPOL, V119, P231, DOI 10.1002/ajpa.10130; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC; BURGER R, 1991, J FIELD ARCHAEOL, V18, P275, DOI 10.1179/009346991791548654; Burger R. L., 1992, CHAVIN ORIGINS ANDEA; Burger RL, 2016, LAT AM ANTIQ, V27, P22, DOI 10.7183/1045-6635.27.1.22; Cagigao ET, 2009, NAT SCI ARCHAEOL, P141, DOI 10.1007/978-3-540-87438-6_9; CARNEIRO RL, 1970, SCIENCE, V169, P733, DOI 10.1126/science.169.3947.733; Cook G., 2001, RITUAL SACRIFICE ANC, P1; Donnan C. B., 1976, MOCHE ART ICONOGRAPH; Engel F. A., 1963, T AM PHILOS SOC, V53, P1, DOI DOI 10.2307/1005956; Feldman R.A., 1985, EARLY CEREMONIAL ARC, P71; Gillespie RM, 1998, THESIS; Grauer AL, 1996, AM J PHYS ANTHROPOL, V100, P531, DOI 10.1002/(SICI)1096-8644(199608)100:4<531::AID-AJPA7>3.0.CO;2-T; Grieder T. E., 1988, GALGADA PRECERAMIC C; Izumi S, 1972, BULLETIN, V3; Izumi S., 1972, ANDES 4 EXCAVATIONS; Kellner C. M., 2002, THESIS; Klaus DK, 2016, RITUAL VIOLENCE ANCI, P1; Kunos CA, 1999, AM J PHYS ANTHROPOL, V110, P303, DOI 10.1002/(SICI)1096-8644(199911)110:3<303::AID-AJPA4>3.0.CO;2-O; Larsen C.S, 2015, BIOARCHAEOLOGY INTER, DOI DOI 10.1016/j.bone.2012.05.023; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lumbreras L., 1981, PREHISTORY AYACUCHO, VII, P167; Matsumura Hirofumi, 1997, Bulletin of the National Science Museum Series D (Anthropology), V23, P1; Morales D, 1980, DIOS FELINO PACOPAMP; Nagaoka T, 2017, ANAT SCI INT; Nagaoka T, 2015, FORENSIC SCI INT, V248, DOI 10.1016/j.forsciint.2015.01.009; Nagaoka T, 2012, ANAT SCI INT, V87, P234, DOI 10.1007/s12565-011-0120-z; Nagaoka T, 2012, INT J LEGAL MED, V126, P703, DOI 10.1007/s00414-012-0718-2; Onuki Y., 1995, KUNTUR WASI CERRO BL; Pearsall DM, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P105, DOI 10.1007/978-0-387-74907-5_7; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Quilter J., 1989, LIFE DEATH PALOMA SO; Rick John W., 2008, CHAVIN ART ARCHITECT, P3; Rockwood C., 1991, FRACTURES ADULTS; Sakaue K, 2006, ANTHROPOL SCI, V114, P59, DOI 10.1537/ase.00098; SCHEUER JL, 1980, ANN HUM BIOL, V7, P257, DOI 10.1080/03014468000004301; Schniz H, 1951, ROENTGEN DIAGNOSTICS, V1; Seki Y, 2014, SENRI ETHNOLOGICAL S, V89, P1; Seki Y., 2014, CTR CEREMONIAL ANDIN, V89, P175; Seki Y., 2005, PERPECTIVAS LATINOAM, P110; Seki Y, 2010, B ARQUEOLOGIA PUCP, V12, P69; Shady R., 2009, ANDEAN CIVILIZATION, P99; Shimada M., 1982, FORMATIVE PERIOD CAJ, P289; Solis RS, 2001, SCIENCE, V292, P723, DOI 10.1126/science.1059519; Stahl PW, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P121, DOI 10.1007/978-0-387-74907-5_8; Standen VG, 2000, AM J PHYS ANTHROPOL, V112, P239, DOI 10.1002/(SICI)1096-8644(2000)112:2<239::AID-AJPA9>3.0.CO;2-3; Tello J.C., 1956, ARQUEOLOGIA VALLE CA; TELLO JC, 1923, INCA, V1, P93; Terada K., 1985, FORMATIVE PERIOD CAJ; Todd TW, 1921, AM J PHYS ANTHROPOL, V4, P1, DOI 10.1002/ajpa.1330040102; Todd TW, 1920, AM J PHYS ANTHROPOL, V3, P285, DOI 10.1002/ajpa.1330030301; Torres-Rouff C, 2006, AM J PHYS ANTHROPOL, V130, P60, DOI 10.1002/ajpa.20315; Tsurumi E, 2015, MUNDO ANTES, V8, P141; Tung TA, 2008, AM J PHYS ANTHROPOL, V136, P294, DOI 10.1002/ajpa.20812; Tung TA, 2007, AM J PHYS ANTHROPOL, V133, P941, DOI 10.1002/ajpa.20565; Tung Tiffiny A., 2012, VIOLENCE RITUAL WARI; Ubelaker D.H., 1989, MANUALS ARCHEOLOGY S, V2; Uzawa K., 2010, B ARQUEOLOGIA PUCP, V12, P249; Valdez LM, 2009, J ANTHROPOL RES, V65, P389, DOI 10.3998/jar.0521004.0065.302; Verano J. W., 2001, RITUAL SACRIFICE ANC, P165; Vergara Enrique, 1985, EARLY CEREMONIAL ARC, P165; WAKEBE T, 1990, Nagasaki Igakkai Zasshi, V65, P805; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; WALKER PL, 1989, AM J PHYS ANTHROPOL, V80, P313, DOI 10.1002/ajpa.1330800305	71	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185421	10.1371/journal.pone.0185421	http://dx.doi.org/10.1371/journal.pone.0185421			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957380	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200055
J	Blixt, NC; Faulkner, BK; Astleford, K; Lelich, R; Schering, J; Spencer, E; Gopalakrishnan, R; Jensen, ED; Mansky, KC				Blixt, Nicholas C.; Faulkner, Bora K.; Astleford, Kristina; Lelich, Rosemary; Schering, Jacob; Spencer, Ekaterina; Gopalakrishnan, Rajaram; Jensen, Eric D.; Mansky, Kim C.			Class II and IV HDACs function as inhibitors of osteoclast differentiation	PLOS ONE			English	Article							MICROTUBULE DYNAMIC INSTABILITY; DEACETYLASE 6 HDAC6; HISTONE DEACETYLASE; TUBULIN DEACETYLASE; IN-VIVO; ACETYLATION; RECEPTOR; PATHWAY; PROTEIN; CELLS	Histone deacetylases (HDACs) are negative regulators of transcription and have been shown to regulate specific changes in gene expression. In vertebrates, eighteen HDACs have thus far been identified and subdivided into four classes (I-IV). Key roles for several HDACs in bone development and biology have been elucidated through in vitro and in vivo models. By comparison, there is a paucity of data on the roles of individual HDACs in osteoclast formation and function. In this study, we investigated the gene expression patterns and the effects of suppressing individual class II (Hdac4, 5, 6, 9, and 10) and class IV (Hdac11) HDACs during osteoclast differentiation. We demonstrated that HDAC class II and IV members are differentially expressed during osteoclast differentiation. Additionally, individual shRNA-mediated suppression of Hdac4, 5, 9, 10 and 11 expression resulted in increased multinucleated osteoclast size and demineralization activity, with little to no change in the overall number of multinucleated osteoclasts formed compared with control shRNA-treated cells. We also detected increased expression of genes highly expressed in osteoclasts, including c-Fos, Nfatc1, Dc-stamp and Cathepsin K. These observations indicate that HDACs cooperatively regulate shared targets in a non-redundant manner.	[Blixt, Nicholas C.; Faulkner, Bora K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Astleford, Kristina; Lelich, Rosemary; Schering, Jacob; Spencer, Ekaterina; Mansky, Kim C.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA; [Gopalakrishnan, Rajaram; Jensen, Eric D.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mansky, KC (corresponding author), Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA.; Jensen, ED (corresponding author), Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA.	jens0709@umn.edu; kmansky@umn.edu		Mansky, Kim/0000-0002-2826-5030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061352, T32AR050938] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR061352, T32 AR050938] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akisaka T, 2011, J HISTOCHEM CYTOCHEM, V59, P630, DOI 10.1369/0022155411405334; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Asthana J, 2013, J BIOL CHEM, V288, P22516, DOI 10.1074/jbc.M113.489328; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cantley MD, 2011, J CELL PHYSIOL, V226, P3233, DOI 10.1002/jcp.22684; Cheng F, 2014, MOL IMMUNOL, V60, P44, DOI 10.1016/j.molimm.2014.02.019; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Duplan MB, 2014, MOL CELL BIOL, V34, P16, DOI 10.1128/MCB.00578-13; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Huang EY, 2000, GENE DEV, V14, P45; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin ZX, 2015, MOL ENDOCRINOL, V29, P730, DOI 10.1210/me.2014-1365; Jin ZX, 2013, MOL ENDOCRINOL, V27, P325, DOI 10.1210/me.2012-1302; Kim JH, 2011, BIOCHEM J, V436, P253, DOI 10.1042/BJ20110062; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Morrison BE, 2008, EXP BIOL MED, V233, P980, DOI 10.3181/0802-RM-48; Nakamura T, 2005, J IMMUNOL, V175, P5809, DOI 10.4049/jimmunol.175.9.5809; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Stemig M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123843; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	52	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185441	10.1371/journal.pone.0185441	http://dx.doi.org/10.1371/journal.pone.0185441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953929	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300069
J	Mali, T; Kuuskeri, J; Shah, F; Lundell, TK				Mali, Tuulia; Kuuskeri, Jaana; Shah, Firoz; Lundell, Taina Kristina			Interactions affect hyphal growth and enzyme profiles in combinations of coniferous wood-decaying fungi of Agaricomycetes	PLOS ONE			English	Article							WHITE-ROT FUNGI; NORWAY SPRUCE LOGS; DEGRADING ENZYMES; PICEA-ABIES; CERIPORIOPSIS-SUBVERMISPORA; OXALATE DECARBOXYLASE; INHABITING FUNGI; PHLEBIA-RADIATA; OXALIC-ACID; LIGNIN	Fomitopsis pinicola is a species of Polyporales frequently encountered in Nordic temperate and boreal forests. In nature, the fungus causes destructive brown rot in wood, colonizing tree trunks often occupied by other Basidiomycota species. We mimicked these species-species interactions by introducing F. pinicola to five white rot species, all common saprotrophs of Norway spruce. Hyphal interactions and mycelial growth in various combinations were recorded, while activities of lignocellulose-acting CAZymes and oxidoreductases were followed in co-cultures on two different carbon-source media. Of the species, Phlebia radiata and Trichaptum abietinum were the strongest producers of lignin-modifying oxidoreductases (laccase, manganese peroxidase) when evaluated alone, as well as in co-cultures, on the two different growth media (low-nitrogen liquid medium containing ground coniferous wood, and malt extract broth). F. pinicola was an outstanding producer of oxalic acid (up to 61 mM), whereas presence of P. radiata prevented acidification of the growth environment in the liquid malt-extract cultures. When enzyme profiles of the species combinations were clustered, time-dependent changes were observed on wood-supplemented medium during the eight weeks of growth. End-point acidity and production of mycelium, oxalic acid and oxidoreductase activities, in turn clustered the fungal combinations into three distinct functional groups, determined by the presence of F. pinicola and P. radiata, by principal component analysis. Our findings indicate that combinations of wood-decay fungi have dramatic dynamic effects on the production of lignocellulose-active enzymes, which may lead to divergent degradative processes of dead wood and forest litter.	[Mali, Tuulia; Kuuskeri, Jaana; Shah, Firoz; Lundell, Taina Kristina] Univ Helsinki, Microbiol & Biotechnol, Dept Food & Environm Sci, Viikki Campus, Helsinki, Finland	University of Helsinki	Lundell, TK (corresponding author), Univ Helsinki, Microbiol & Biotechnol, Dept Food & Environm Sci, Viikki Campus, Helsinki, Finland.	taina.lundell@helsinki.fi	Shah, Firoz/D-4534-2018; Lundell, Taina/ABA-8393-2021; Shah, Firoz/AAO-7771-2020	Shah, Firoz/0000-0001-7833-7832; Lundell, Taina/0000-0003-3899-1658; Shah, Firoz/0000-0001-7833-7832; Kuuskeri, Jaana/0000-0002-5838-2086; Mali, Tuulia/0000-0002-4283-5482	Academy of Finland [285676]; Finnish Cultural Foundation [161103]	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This study was supported by the Academy of Finland, grant number 285676 to TL, and the Finnish Cultural Foundation, grant number 161103 to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MYCOLOGIA, V105, P1428; Arantes V, 2011, J IND MICROBIOL BIOT, V38, P541, DOI 10.1007/s10295-010-0798-2; Arnstadt T, 2016, FOREST ECOL MANAG, V382, P129, DOI 10.1016/j.foreco.2016.10.004; Baldrian P, 2004, FEMS MICROBIOL ECOL, V50, P245, DOI 10.1016/j.femsec.2004.07.005; Baldrian P, 2017, FEMS MICROBIOL REV, V41, P109, DOI 10.1093/femsre/fuw040; Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Chi YJ, 2007, INT BIODETER BIODEGR, V59, P32, DOI 10.1016/j.ibiod.2006.06.025; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Eichlerova I, 2015, FUNGAL ECOL, V13, P10, DOI 10.1016/j.funeco.2014.08.002; Escutia MR, 2005, APPL ENVIRON MICROB, V71, P3608, DOI 10.1128/AEM.71.7.3608-3616.2005; ESPEJO E, 1991, APPL ENVIRON MICROB, V57, P1980, DOI 10.1128/AEM.57.7.1980-1986.1991; Everitt B, 2011, USE R, P1, DOI 10.1007/978-1-4419-9650-3; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fox J., 2019, R COMPANION APPL REG, V.; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hiscox J, 2016, ENVIRON MICROBIOL, V18, P1954, DOI 10.1111/1462-2920.13141; Hiscox J, 2010, FUNGAL GENET BIOL, V47, P562, DOI 10.1016/j.fgb.2010.03.007; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Holmer L, 1997, OIKOS, V79, P77, DOI 10.2307/3546092; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Jonsson MT, 2008, J ECOL, V96, P1065, DOI 10.1111/j.1365-2745.2008.01411.x; Jordan CR, 1996, HOLZFORSCHUNG, V50, P312, DOI 10.1515/hfsg.1996.50.4.312; Kaavat Niemela T., 2005, NORRLINIA, V13; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; Kotiranta H, 2009, NORRLINIA, V19, P1; Kubartova A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv032; Kubartova A, 2009, MICROB ECOL, V58, P98, DOI 10.1007/s00248-008-9458-8; Kuuskeri J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0608-9; Kuuskeri J, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0538-x; Lindner DL, 2011, FUNGAL ECOL, V4, P449, DOI 10.1016/j.funeco.2011.07.001; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LUNDELL T, 1994, FEBS LETT, V348, P291, DOI 10.1016/0014-5793(94)00627-X; Lundell TK, 2014, ADV BOT RES, V70, P329, DOI 10.1016/B978-0-12-397940-7.00011-2; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Maechler M, 2016, FINDING GROUPS DATA; Makela M, 2002, ENZYME MICROB TECH, V30, P542, DOI 10.1016/S0141-0229(02)00012-1; Makela MR, 2010, APPL MICROBIOL BIOT, V87, P801, DOI 10.1007/s00253-010-2650-z; Mattila H, 2017, BIORESOURCE TECHNOL, V225, P254, DOI 10.1016/j.biortech.2016.11.082; Nagy LG, 2016, MOL BIOL EVOL, V33, P959, DOI 10.1093/molbev/msv337; Noll L, 2016, FOREST ECOL MANAG, V378, P181, DOI 10.1016/j.foreco.2016.07.035; Ottosson E, 2014, FUNGAL ECOL, V11, P17, DOI 10.1016/j.funeco.2014.03.003; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Park N, 2014, INT J BIOL MACROMOL, V70, P583, DOI 10.1016/j.ijbiomac.2014.06.019; Rajala T, 2015, FUNGAL ECOL, V18, P48, DOI 10.1016/j.funeco.2015.08.007; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Rajala T, 2011, FUNGAL ECOL, V4, P437, DOI 10.1016/j.funeco.2011.05.005; Rajala T, 2010, CAN J FOREST RES, V40, P2384, DOI 10.1139/X10-176; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Rytioja J., 2014, MICROBIOL MOL BIOL R, V78, P614, DOI [DOI 10.1128/MMBR.00035-14, 10.1128/MMBR.00035-14]; Rytioja J, 2014, FUNGAL GENET BIOL, V72, P91, DOI 10.1016/j.fgb.2013.12.008; Score AJ, 1997, INT BIODETER BIODEGR, V39, P225, DOI 10.1016/S0964-8305(97)00012-7; Sippola AL, 1999, FOREST ECOL MANAG, V115, P183, DOI 10.1016/S0378-1127(98)00398-3; Steffen KT, 2000, APPL MICROBIOL BIOT, V54, P819, DOI 10.1007/s002530000473; Tang JD, 2013, APPL ENVIRON MICROB, V79, P1523, DOI 10.1128/AEM.02916-12; Team R, 2016, LANG ENV STAT COMP R; Watanabe T, 2005, ENZYME MICROB TECH, V37, P68, DOI 10.1016/j.enzmictec.2005.01.032; Wickham H, 2016, RSTUDIO R CORE TEAM; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodward S, 2008, BR MYCOL SY, V28, P125	64	25	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185171	10.1371/journal.pone.0185171	http://dx.doi.org/10.1371/journal.pone.0185171			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953947	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300039
J	Sultan, M; Ben-Ari, Z; Masoud, R; Pappo, O; Harats, D; Kamari, Y; Safran, M				Sultan, Maya; Ben-Ari, Ziv; Masoud, Rula; Pappo, Orit; Harats, Dror; Kamari, Yehuda; Safran, Michel			Interleukin-1 alpha and Interleukin-1 beta play a central role in the pathogenesis of fulminant hepatic failure in mice	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; TUMOR-NECROSIS-FACTOR; RECEPTOR ANTAGONIST; D-GALACTOSAMINE/LIPOPOLYSACCHARIDE; STERILE INFLAMMATION; DISTINCT PATHWAYS; GENE-EXPRESSION; CELLS; APOPTOSIS; INJURY	Background and aims Fulminant hepatitis failure (FHF) is marked by the sudden loss of hepatic function, with a severe life-threatening course in persons with no prior history of liver disease. Interleukin ( IL)-1 alpha and IL-1 beta are key inflammatory cytokines but little is known about their role in the development of FHF. The aim of this study was to assess the involvement of IL-1 alpha and IL1 beta in the progression of LPS/GalN-induced FHF. Methods WT, IL-1 alpha or IL-1 beta deficient mice were injected with LPS/GalN. Blood and liver tissue were collected at different time points, FHF related pathways were examined. Results After FHF induction the survival of both IL-1 alpha and IL-1 beta KO mice was longer than that of WT mice. Lower serum liver enzyme levels, demonstrated reduced hepatic injury in the IL-1 alpha and IL-1 beta KO mice. Histologically detected liver injury and apoptotic hepatocytes were significantly reduced in the IL-1 alpha and IL-1 beta KO mice compared to WT mice. Reduced hepatic I kappa B levels and upregulated NF kappa B activity in WT mice remained inhibited in IL-1 alpha and IL-1 beta KO mice. Hepatic expression levels of TNF alpha and IL-6 were significantly increased in WT mice but not in IL-1 alpha and IL-1 beta KO mice. Conclusions IL-1 alpha and IL-1 beta play a central role in the pathogenesis of LPS/GalN-induced FHF. These interleukins are associated with the activation of NF.B signaling, upregulation of the pro-inflammatory cytokines and liver damage and apoptosis. Since neither IL-1 alpha nor IL-1 beta depletions completely rescued the phenotype, we believe that IL-1 alpha and IL-1 beta have a similar and probably complementary role in FHF progression.	[Sultan, Maya; Ben-Ari, Ziv; Masoud, Rula; Safran, Michel] Chaim Sheba Med Ctr, Liver Res Lab, Ramat Gan, Israel; [Ben-Ari, Ziv] Chaim Sheba Med Ctr, Liver Dis Ctr, Ramat Gan, Israel; [Ben-Ari, Ziv; Harats, Dror; Kamari, Yehuda] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Pappo, Orit] Chaim Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel; [Harats, Dror; Kamari, Yehuda] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Ramat Gan, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Safran, M (corresponding author), Chaim Sheba Med Ctr, Liver Res Lab, Ramat Gan, Israel.	Michal.safran@sheba.health.gov.il			Sheba Talipot Medical Leadership program	Sheba Talipot Medical Leadership program	The study was partly supported by the Sheba Talipot Medical Leadership program (Yehuda Kamari). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Aviv Shaish for critical review of the manuscript and Dr. Michal Kandel-Kfir for technical assistance. The study was partly supported by the Sheba Talipot Medical Leadership program (Yehuda Kamari).	Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Bandman O, 2002, ANN NY ACAD SCI, V975, P77, DOI 10.1111/j.1749-6632.2002.tb05943.x; Ben Ari Z, 2012, CELL PHYSIOL BIOCHEM, V29, P41, DOI 10.1159/000337585; Ben-Ari Z, 2011, TRANSPLANTATION, V92, P18, DOI 10.1097/TP.0b013e31821cdea5; Bernal W, 2014, NEW ENGL J MED, V370, P1170, DOI 10.1056/NEJMc1400974; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Chen EQ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0380-9; Chosay JG, 1997, AM J PHYSIOL-GASTR L, V272, pG1195, DOI 10.1152/ajpgi.1997.272.5.G1195; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Furuya S, 2015, J SURG RES, V199, P487, DOI 10.1016/j.jss.2015.05.060; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Galun E, 2002, BBA-MOL CELL RES, V1592, P345, DOI 10.1016/S0167-4889(02)00326-9; GRANOWITZ EV, 1992, BLOOD, V79, P2356; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kamari Y, 2011, BIOCHEM BIOPH RES CO, V405, P197, DOI 10.1016/j.bbrc.2011.01.008; LEIST M, 1995, AM J PATHOL, V146, P1220; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; MARTICH GD, 1991, J EXP MED, V173, P1021, DOI 10.1084/jem.173.4.1021; MUTO Y, 1988, LANCET, V2, P72; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Pollock AS, 2003, FASEB J, V17, P203, DOI 10.1096/fj.02-0602com; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Rolando N, 1996, SEMIN LIVER DIS, V16, P389, DOI 10.1055/s-2007-1007252; Sass DA, 2005, LIVER TRANSPLANT, V11, P594, DOI 10.1002/lt.20435; SEKIYAMA KD, 1994, CLIN EXP IMMUNOL, V98, P71; Shemesh S, 2012, ATHEROSCLEROSIS, V222, P329, DOI 10.1016/j.atherosclerosis.2011.12.010; Shinoda M, 2007, J SURG RES, V137, P130, DOI 10.1016/j.jss.2006.08.009; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Waseern T, 2008, SURGERY, V143, P334, DOI 10.1016/j.surg.2007.09.039; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Xiong QB, 1999, LIFE SCI, V65, P421, DOI 10.1016/S0024-3205(99)00263-5; Yan CL, 2008, LIVER INT, V28, P959, DOI 10.1111/j.1478-3231.2008.01775.x; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	41	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184084	10.1371/journal.pone.0184084	http://dx.doi.org/10.1371/journal.pone.0184084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953903	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300010
J	Teder, T; Lohelaid, H; Samel, N				Teder, Tarvi; Lohelaid, Helike; Samel, Nigulas			Structural and functional insights into the reaction specificity of catalase-related hydroperoxide lyase: A shift from lyase activity to allene oxide synthase by site-directed mutagenesis	PLOS ONE			English	Article							LIPOXYGENASE FUSION PROTEIN; CATALYTIC-ACTIVITY; CORAL; PATHWAY; ACID; PEROXIDASE; MUTATION; IDENTIFICATION; BIOSYNTHESIS; METABOLISM	Two highly identical fusion proteins, an allene oxide synthase-lipoxygenase (AOS-LOX) and a hydroperoxide lyase-lipoxygenase (HPL-LOX), were identified in the soft coral Cap-nella imbricata. Both enzymes initially catalyze the formation of 8R-hydroperoxy-eicosatetraenoic acid (8R-HpETE) from arachidonic acid by the C-terminal lipoxygenase (LOX) domain. Despite the fact that the defined catalytically important residues of N-terminal catalase-related allene oxide synthase (cAOS) domain are also conserved in C. imbricata hydroperoxide lyase (cHPL), their reaction specificities differ. In the present study, we tested which of the amino acid substitutions around the active site of cHPL are responsible for a control in the reaction specificity. The possible candidates were determined via comparative sequence and structural analysis of the substrate channel and the heme region of coral cAOSs and C. imbricata cHPL. The amino acid replacements in cHPL-R56G, ME59-60LK, P65A, F150L, YS176-177NL, I357V, and SSSAGE155-160PVKEGD-with the corresponding residues of cAOS were conducted by site-directed mutagenesis. Although all these mutations influenced the catalytic efficiency of cHPL, only F150L and YS176-177NL substitutions caused a shift in the reaction specificity from HPL to AOS. The docking analysis of P. homomalla cAOS with 8R-HpETE substrate revealed that the Leu150 of cAOS interacts with the C5-C6 double bond and the Leu177 with the hydrophobic tail of 8R-HpETE. We propose that the corresponding residues in cHPL, Phe150 and Ser177, are involved in a proper coordination of the epoxy allylic radical intermediate necessary for aldehyde formation in the hydroperoxide lyase reaction.	[Teder, Tarvi; Lohelaid, Helike; Samel, Nigulas] Tallinn Univ Technol, Dept Chem & Biotechnolgy, Tallinn, Estonia	Tallinn University of Technology	Samel, N (corresponding author), Tallinn Univ Technol, Dept Chem & Biotechnolgy, Tallinn, Estonia.	nigulas.samel@ttu.ee	Samel, Nigulas/A-1420-2019; Lõhelaid, Helike/G-5425-2013; Teder, Tarvi/M-6893-2018	Lõhelaid, Helike/0000-0002-6885-8666; Teder, Tarvi/0000-0002-8489-3955	Institutional Research Funding of the Estonian Ministry of Education and Research [IUT19-9]; Estonian Science Foundation Grant [9410]	Institutional Research Funding of the Estonian Ministry of Education and Research; Estonian Science Foundation Grant	This work was supported by the Institutional Research Funding IUT19-9 of the Estonian Ministry of Education and Research and the Estonian Science Foundation Grant 9410 (both to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; CROMBIE L, 1991, J CHEM SOC PERK T 1, P581, DOI 10.1039/p19910000581; De Luna P, 2013, J PHYS CHEM B, V117, P14635, DOI 10.1021/jp408486n; Ermilova VS, 2013, DOKL BIOCHEM BIOPHYS, V452, P251, DOI 10.1134/S1607672913050128; FLORIS R, 1995, J AM CHEM SOC, V117, P3907, DOI 10.1021/ja00119a003; Gao B, 2008, ARCH BIOCHEM BIOPHYS, V477, P285, DOI 10.1016/j.abb.2008.07.011; Gerwick WH, 1996, LIPIDS, V31, P1215, DOI 10.1007/BF02587906; Gilbert NC, 2008, BIOCHEMISTRY-US, V47, P10665, DOI 10.1021/bi800751p; Griffiths G, 2015, FREE RADICAL RES, V49, P565, DOI 10.3109/10715762.2014.1000318; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; HAMBERG M, 1989, J AM OIL CHEM SOC, V66, P1445, DOI 10.1007/BF02661968; HECKER M, 1989, J BIOL CHEM, V264, P141; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Hughes RK, 2009, CHEMBIOCHEM, V10, P1122, DOI 10.1002/cbic.200800633; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Lakshmipathi P, 2002, ORG LETT, V4, P451, DOI 10.1021/ol017164k; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lohelaid H, 2015, CORAL REEFS, V34, P143, DOI 10.1007/s00338-014-1238-y; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Lohelaid H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089215; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Nagai M, 2014, CHIRALITY, V26, P438, DOI 10.1002/chir.22273; Neri F, 1999, BIOCHEMISTRY-US, V38, P7819, DOI 10.1021/bi982811+; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2016, J LIPID RES, V57, P1518, DOI 10.1194/jlr.M068981; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roncone R, 2005, J BIOL INORG CHEM, V10, P11, DOI 10.1007/s00775-004-0606-4; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Teder T, 2015, J BIOL CHEM, V290, P19823, DOI 10.1074/jbc.M115.660282; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Toporkova Ya. Yu., 2010, Moscow University Biological Sciences Bulletin, V65, P155, DOI 10.3103/S0096392510040085; Tosha T, 2006, J BIOL CHEM, V281, P12610, DOI 10.1074/jbc.M600061200; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067	39	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185291	10.1371/journal.pone.0185291	http://dx.doi.org/10.1371/journal.pone.0185291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953966	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300052
J	Somayaji, R; Elliott, JA; Persaud, R; Lim, M; Goodman, L; Sibbald, RG				Somayaji, Ranjani; Elliott, James A.; Persaud, Reneeka; Lim, Morgan; Goodman, Laurie; Sibbald, R. Gary			The impact of team based interprofessional comprehensive assessments on the diagnosis and management of diabetic foot ulcers: A retrospective cohort study	PLOS ONE			English	Article							GLOBAL BURDEN; CARE; MORTALITY; PREVALENCE; COSTS	Background Diabetic foot ulcers (DFU) are increasingly prevalent, and associated with significant morbidity, mortality, and cost. An interprofessional approach to DFU management is critical given the etiological complexity involved. This study aimed to assess the impact of an interprofessional team approach on DFU diagnosis and management for a cohort of patients receiving treatment in an Ontario Canada home care setting. Methods A retrospective cohort study of patients attending a large regional Community Care Access Centre (CCAC) between February 11, 2013-September 30, 2014 was conducted. Following CCAC referral, patients were assessed by an interprofessional team at the Toronto Regional Wound Healing Centre (TRWHC). Those aged > 18 years with a DFU of > 6 weeks duration were included. The primary outcome was the precision of the initial diagnosis relating to DFU etiology (i.e. neuropathic, ischemic or mixed etiology). Secondary outcomes included wound healing, and infection parameters. Analysis was completed with STATA 13.1 (College Stn., TX) of pre-determined outcomes with 2 sided a of 0.05. Results A total of 308 patients were screened, and 49 patients (67.3% male) of mean age 64.2 years (SD 13.7) with a diagnosis of DFU > 6 weeks duration were included for analysis. Of these, 95% were referred with unspecified DFU, and were reclassified to a precise diagnosis relating to etiology, including neuropathy, ischemia or neuroischemic etiology following TRWHC assessment (p < 0.001). For secondary outcomes post-assessment, healability assessment was conducted for a greater proportion of patients (100% versus 44%, p < 0.001). Infection was identified in a greater number of patients (p = 0.04), and of the 35 patients, 94.5% had deep and surrounding infection, and 88.0% were initiated on systemic antibiotics. Vascular insufficiency was diagnosed in an additional 14.3% of the cohort (p = 0.03). Offloading/footwear assessment was conducted in all patients compared with 30.6% prior to referral (p < 0.001) Dressing change frequency decreased significantly following TRWHC assessment (pre: 4.31/week; post: 3.54/week; p = 0.03). Pain scores decreased (2.18 to 1.67) on the numerical rating scale but this was not statistically significant at the final TRWHC assessment. Notably, 36.7% (18/49) reported improved quality of life by the second TRWHC encounter. Conclusions Interprofessional care teams are associated with improved diagnostic acumen and wound healing outcomes over conventional community care services. Initiatives including best practice interprofessional diabetic foot care pathways are recommended with timely vascular management of ischemia, treatment of deep and surrounding infection as well as the availability of foot care and footwear.	[Somayaji, Ranjani] Univ Calgary, Dept Med, Calgary, AB, Canada; [Elliott, James A.; Persaud, Reneeka; Sibbald, R. Gary] Toronto Reg Wound Healing Clin, Mississauga, ON, Canada; [Lim, Morgan] Trillium Hlth Partners, Inst Better Hlth, Mississauga, ON, Canada; [Lim, Morgan] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Goodman, Laurie] Humber River Hosp, Toronto, ON, Canada; [Sibbald, R. Gary] Trillium Hlth Partners, Mississauga, ON, Canada; [Sibbald, R. Gary] Univ Toronto, Dalla Lana Fac Publ Hlth, Toronto, ON, Canada; [Sibbald, R. Gary] Womens Coll Hosp, Wound Healing Clin, Div Dermatol, Dept Med, Toronto, ON, Canada	University of Calgary; University of Toronto; Trillium Health Partners; University of Toronto; University of Toronto; Trillium Health Partners; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Somayaji, R (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	ranjani.somayaji@albertahealthservices.ca		Elliott, James/0000-0001-7150-6074	Alberta Innovates [201610405] Funding Source: researchfish	Alberta Innovates		Abbas Zulfiqarali G, 2007, Int Wound J, V4, P305; Alva ML, 2015, DIABETIC MED, V32, P459, DOI 10.1111/dme.12647; [Anonymous], 2014, J WOUND CARE, V23, pS1; Antoniu SA, 2012, EXPERT OPIN DRUG DEL, V9, P333, DOI 10.1517/17425247.2012.660480; Bharara M, 2009, INT WOUND J, V6, P2, DOI 10.1111/j.1742-481X.2009.00587.x; Booth GL, 2003, ARCH INTERN MED, V163, P101, DOI 10.1001/archinte.163.1.101; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Campbell Karen, 2006, Healthc Manage Forum, V19, P16; Frykberg R G, 1998, Adv Wound Care, V11, P71; GIBBONS GW, 1993, ARCH SURG-CHICAGO, V128, P576; Granick M, 1998, ADV WOUND CARE, V11, P3; Harrison MB, 2005, CAN MED ASSOC J, V172, P1447, DOI 10.1503/cmaj.1041441; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2014, IDF DIAB ATL 7 ED, P1; Jeffcoate W, 2005, LANCET, V365, P1527, DOI 10.1016/S0140-6736(05)66437-9; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lipscombe LL, 2010, CAN MED ASSOC J, V182, pE1, DOI 10.1503/cmaj.090495; Lowe J, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/920124; Moulik PK, 2003, DIABETES CARE, V26, P491, DOI 10.2337/diacare.26.2.491; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Robbins JM, 2008, J AM PODIAT MED ASSN, V98, P489, DOI 10.7547/0980489; Rodrigues I, 2006, OSTOMY WOUND MANAG, V52, P46; Secretariat MA, 2009, ONTARIO HLTH TECHNOL, P9; Shannon RJ, 2007, WOUND CARE CANADA, V5, P53; Sibbald RG, 2015, ADV SKIN WOUND CARE, V28, P466, DOI 10.1097/01.ASW.0000470851.27030.98; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Sumpio BE, 2010, J VASC SURG, V51, P1504, DOI 10.1016/j.jvs.2010.04.010; Trubiani G, 2011, TORONTO HLTH EC TECH, P1; Vu T, 2007, FAM PRACT, V24, P372, DOI 10.1093/fampra/cmm024; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20; World Health Organization, DIABETES; Wu SC, 2007, VASC HEALTH RISK MAN, V3, P65	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185251	10.1371/journal.pone.0185251	http://dx.doi.org/10.1371/journal.pone.0185251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949996	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000031
J	Gschwantler-Kaulich, D; Weingartshofer, S; Grunt, TW; Mairhofer, M; Tan, Y; Gamper, J; Singer, CF				Gschwantler-Kaulich, Daphne; Weingartshofer, Sigrid; Grunt, Thomas W.; Mairhofer, Mario; Tan, Yen; Gamper, Jutta; Singer, Christian F.			Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro	PLOS ONE			English	Article							INDUCED BONE LOSS; POSTMENOPAUSAL WOMEN; ADJUVANT THERAPY; BISPHOSPHONATE USE; ANTITUMOR-ACTIVITY; ENDOCRINE THERAPY; ZO-FAST; METAANALYSIS; MANAGEMENT; RISK	Background Zoledronic acid (ZA) has antiresorptive effects and protects from bone metastasis in women with early breast cancer. In addition, in postmenopausal women with endocrine responsive breast cancer ZA prolongs DFS. The exact mechanism is still unclear. We have therefore investigated the effect of increasing concentrations of ZA in breast cancer cell lines in the absence or presence of estradiol to mimic the hormonal environment in vitro. Materials and methods Using assays for cell proliferation (EZ4U, BrdU) and cell death (Annexin/PI), we have analyzed the dose-dependent antiproliferative and pro-apoptotic effects of ZA in two hormone sensitive cell lines (MCF-7 and T47D) and a hormone insensitive, triple negative cell line (MDA-MB-231) in the presence of 0, 1 and 10 nM estradiol. Results In the absence of estradiol, ZA exerts dose-dependent antiproliferative and pro-apoptotic antitumor effects in both, hormone sensitive (MCF-7, T47D) and -insensitive (MDA-MB-231) breast cancer cell lines (p<0.0001). In the presence of estradiol, the antitumoral effect of ZA was significantly decreased only in the hormone sensitive MCF-7 and T47D cell lines (p = 0.0008 and p = 0.0008, respectively). Conclusion We have demonstrated that estradiol impairs the antiproliferative and proapoptotic effect of ZA in hormone sensitive, but not in hormone insensitive breast cancer cell lines. Our findings provide a possible explanation for the differential effect of ZA on DFS in pre- and postmenopausal patients with hormone sensitive early breast cancer, which has been demonstrated clinically. We further hypothesize that endocrine insensitive tumors such as triple negative breast cancer (TNBC) should benefit from ZA irrespective of their menopausal status.	[Gschwantler-Kaulich, Daphne; Weingartshofer, Sigrid; Tan, Yen; Singer, Christian F.] Med Univ Vienna, Dept Obstet & Gynecol, Ctr Comprehens Canc, Vienna, Austria; [Grunt, Thomas W.] Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Div Clin Oncol, Vienna, Austria; [Grunt, Thomas W.] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Mairhofer, Mario] Ctr Adv Bioanal GmbH CBL, Linz, Austria; [Tan, Yen] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Gamper, Jutta] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; QIMR Berghofer Medical Research Institute; Medical University of Vienna	Gschwantler-Kaulich, D (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Ctr Comprehens Canc, Vienna, Austria.	daphne.gschwantler@kaulch.at	Tan, Yen/AAW-2357-2021	Tan, Yen/0000-0003-1063-5352; Mairhofer, Mario/0000-0002-7218-6284; Grunt, Thomas/0000-0002-9899-5063	Austrian Society of Endocrinological Oncology (OEGEO)	Austrian Society of Endocrinological Oncology (OEGEO)	This research has received a research grant from the Austrian Society of Endocrinological Oncology (OEGEO). Center for Advanced Bioanalysis GmbH LTD provided support in the form of salaries for one of our co-authors [MM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1; Body JJ, 2007, OSTEOPOROSIS INT, V18, P1439, DOI 10.1007/s00198-007-0439-4; Brunner-Kubath C, 2011, BREAST CANCER RES TR, V129, P387, DOI 10.1007/s10549-010-1232-1; Brufsky A, 2008, ONCOLOGIST, V13, P503, DOI 10.1634/theoncologist.2007-0206; Brufsky AM, 2012, CANCER-AM CANCER SOC, V118, P1192, DOI 10.1002/cncr.26313; Chlebowski RT, 2010, J CLIN ONCOL, V28, P3582, DOI 10.1200/JCO.2010.28.2095; Clezardin P, 2012, ANTI-CANCER AGENT ME, V12, P102, DOI 10.2174/187152012799014977; Coleman R, 2015, LANCET, V386, P1353, DOI 10.1016/S0140-6736(15)60908-4; Coleman R, 2013, ANN ONCOL, V24, P398, DOI 10.1093/annonc/mds277; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Gnant M, 2015, ANN ONCOL, V26, P313, DOI 10.1093/annonc/mdu544; Gnant M, 2009, CLIN BREAST CANCER, V9, pS18, DOI 10.3816/CBC.2009.s.002; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Gralow JR, 2013, J NATL COMPR CANC NE, V11, pS1; Hadji P, 2011, ANN ONCOL, V22, P2546, DOI 10.1093/annonc/mdr017; HALL DG, 1994, J BONE MINER RES, V9, P221; He MF, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-80; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Hines SL, 2010, BREAST, V19, P92, DOI 10.1016/j.breast.2009.12.001; Hines SL, 2009, BREAST CANCER RES TR, V117, P603, DOI 10.1007/s10549-009-0332-2; Kroep JR, 2016, EUR J CANCER, V54, P57, DOI 10.1016/j.ejca.2015.10.011; Leal T, 2010, CLIN BREAST CANCER, V10, P471, DOI 10.3816/CBC.2010.n.062; Lee SA, 2011, BREAST CANCER RES TR, V130, P863, DOI 10.1007/s10549-011-1728-3; Liu YP, 2012, CLIN BREAST CANCER, V12, P276, DOI 10.1016/j.clbc.2012.04.003; Llombart A, 2012, CLIN BREAST CANCER, V12, P40, DOI 10.1016/j.clbc.2011.08.002; Montaville P, 2002, J BIOL CHEM, V277, P24684, DOI 10.1074/jbc.M109595200; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Neville-Webbe HL, 2006, TUMOR BIOL, V27, P92, DOI 10.1159/000092489; Newcomb PA, 2010, BRIT J CANCER, V102, P799, DOI 10.1038/sj.bjc.6605555; Ormerod MG, 1998, ANAL CELL PATHOL, V17, P103, DOI 10.1155/1998/842306; Ottewell PD, 2014, CLIN CANCER RES, V20, P2922, DOI 10.1158/1078-0432.CCR-13-1246; Reid DM, 2008, CANCER TREAT REV, V34, pS3, DOI 10.1016/j.ctrv.2008.03.007; Rennert G, 2017, CLIN CANCER RES, V23, P1684, DOI 10.1158/1078-0432.CCR-16-0547; Rennert G, 2010, J CLIN ONCOL, V28, P3577, DOI 10.1200/JCO.2010.28.1113; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Valachis A, 2013, ONCOLOGIST, V18, P353, DOI 10.1634/theoncologist.2012-0261; Verdijk R, 2007, CANCER LETT, V246, P308, DOI 10.1016/j.canlet.2006.03.011; Vincenzi B, 2005, J INTERF CYTOK RES, V25, P144, DOI 10.1089/jir.2005.25.144; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004; Wong MHF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003474.pub3; Yan TT, 2012, EUR J CANCER, V48, P187, DOI 10.1016/j.ejca.2011.10.021	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185566	10.1371/journal.pone.0185566	http://dx.doi.org/10.1371/journal.pone.0185566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945801	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100065
J	Steinbacher, P; Wanzenbock, J; Brandauer, M; Holper, R; Landertshammer, J; Mayr, M; Platzl, C; Stoiber, W				Steinbacher, Peter; Wanzenboeck, Josef; Brandauer, Magdalena; Holper, Raphael; Landertshammer, Jasmin; Mayr, Magdalena; Platzl, Christian; Stoiber, Walter			Thermal experience during embryogenesis contributes to the induction of dwarfism in whitefish Coregonus lavaretus	PLOS ONE			English	Article							MUSCLE-FIBER RECRUITMENT; GENETIC ARCHITECTURE; TEMPERATURE; GROWTH; PLASTICITY; CELLULARITY; LARVAL; DIVERGENCE; POPULATION; EXPRESSION	Ecotype pairs provide well-suited model systems for study of intraspecific phenotypical diversification of animals. However, little is still known about the processes that account for the development of different forms and sizes within a species, particularly in teleosts. Here, embryos of a normal-growing 'large' form and a dwarf form of whitefish Coregonus lavaretus were incubated at two temperatures that are usually experienced at their own spawning sites (2 degrees C for the normal and 6 degrees C for the dwarf form). All fish were subjected to similar thermal treatment after hatching. The present data demonstrate for the first time that different thermal experience in embryonic life has lasting effects on body and muscle growth of this ecotype pair and contributes to the development of the dwarf form. Thus, juvenile fish of the regular form are much smaller and have less muscle mass when pre-hatching thermal conditions were similar to those typical for the spawning sites of the dwarf form (6 degrees C) than when subjected to conditions of their own spawning sites (2 degrees C). Surprisingly, fish of the dwarf form exhibit a similar pattern of response to thermal history (2 degrees-fish much larger than 6 degrees-fish), indicating that in their case, normal spawning site temperature (6 degrees C) is indeed likely to act as a growth limiting factor. Results also demonstrate that the hypertrophic and hyperplastic muscle growth modes are similarly affected by thermal history. Immunolabelling experiments for Pax7, H3P and Mef2 provide evidence that the cellular mechanisms behind the increased growth rates after cold incubation in both ecotypes are increased proliferation and reduced differentiation rates of muscle precursor cells. This is of major significance to aspects of ecological and developmental biology and from the evolutionary perspective.	[Steinbacher, Peter; Brandauer, Magdalena; Holper, Raphael; Landertshammer, Jasmin; Mayr, Magdalena; Platzl, Christian; Stoiber, Walter] Univ Salzburg, Div Anim Struct & Funct, Dept Cell Biol & Physiol, Salzburg, Austria; [Wanzenboeck, Josef] Univ Innsbruck, Res Inst Limnol Mondsee, Mondsee, Austria	Salzburg University; University of Innsbruck	Steinbacher, P (corresponding author), Univ Salzburg, Div Anim Struct & Funct, Dept Cell Biol & Physiol, Salzburg, Austria.	peter.steinbacher@sbg.ac.at	Wanzenböck, Josef/AFR-9001-2022	Wanzenböck, Josef/0000-0002-9186-5565; Steinbacher, Peter/0000-0001-8033-5190	Austrian Science Foundation [P23739]; Austrian Science Foundation (FWF) [P23739]	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Foundation, www.tvf.ac.at, P23739. PS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Josef Poigner (Altmunster, Austria) for help in catching the fish and Thomas Oberlercher and Wolfgang Hauer (BAW Institute of Water Ecology, Fisheries Biology and Lake Research, Scharfling, Austria) for help in rearing the fish. Special thanks go to Wolfgang Trutschnigg, Arne Bathke (Department of Mathematics, University of Salzburg, Austria) and Roman Fuchs (Department of Ecology and Evolution, University of Salzburg, Austria) for providing expert assistance in statistics. The work was supported by Austrian Science Foundation (FWF) grant P23739.	Alami-Durante H, 2007, CELL TISSUE RES, V327, P553, DOI 10.1007/s00441-006-0321-2; Albokhadaim I, 2007, J EXP BIOL, V210, P1735, DOI 10.1242/jeb.003194; Ayala MD, 2016, FISH PHYSIOL BIOCHEM, V42, P1027, DOI 10.1007/s10695-015-0194-y; Bernatchez L, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P175; Bock P., 1984, SEMIDUNNSCHNITT; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Campos C, 2013, EPIGENETICS-US, V8, P389, DOI 10.4161/epi.24178; Cingi S, 2010, J FISH BIOL, V76, P502, DOI 10.1111/j.1095-8649.2009.02502.x; Cote J, 2016, J EVOLUTION BIOL, V29, P1593, DOI 10.1111/jeb.12896; Douglas MR, 1999, MOL ECOL, V8, P589, DOI 10.1046/j.1365-294x.1999.00581.x; Douglas MR, 2005, COPEIA, P347, DOI 10.1643/CG-04-128R; Fernandes JMO, 2007, J EXP BIOL, V210, P3461, DOI 10.1242/jeb.009183; Fuentes EN, 2014, COMP BIOCHEM PHYS B, V176, P48, DOI 10.1016/j.cbpb.2014.07.003; Galloway T. F., 1999, Journal of Fish Biology, V55, P26, DOI 10.1111/j.1095-8649.1999.tb01044.x; Georga I, 2010, J MORPHOL, V271, P1319, DOI 10.1002/jmor.10874; Hamann H, 1954, BEITRAGE BIOL ERMITT; Hanel R, 1996, J FISH BIOL, V48, P937; Hudson AG, 2007, ADV LIMNOL, V60, P111; Johnston IA, 2000, J EXP BIOL, V203, P2553; Johnston IA, 1998, J EXP BIOL, V201, P623; Johnston IA, 2005, BIOL LETT-UK, V1, P419, DOI 10.1098/rsbl.2005.0377; Johnston IA, 2001, MAR ECOL PROG SER, V213, P285, DOI 10.3354/meps213285; Johnston IA, 2003, J EXP BIOL, V206, P1337, DOI 10.1242/jeb.00262; Johnston IA, 2004, J EXP BIOL, V207, P4343, DOI 10.1242/jeb.01292; Johnston IA, 2009, J EXP BIOL, V212, P1781, DOI 10.1242/jeb.029918; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Lahnsteiner B, 2004, ANN ZOOL FENN, V41, P75; Landry L, J EVOL BIOL, V20, P971; Macqueen DJ, 2008, BIOL LETTERS, V4, P294, DOI 10.1098/rsbl.2007.0620; Marschallinger J, 2009, DEV DYNAM, V238, P2442, DOI 10.1002/dvdy.22049; Martell DJ, 2007, J EXP BIOL, V210, P1170, DOI 10.1242/jeb.002188; NATHANAILIDES C, 1995, CAN J FISH AQUAT SCI, V52, P675, DOI 10.1139/f95-068; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ohlberger J, 2008, FUNCT ECOL, V22, P501, DOI 10.1111/j.1365-2435.2008.01391.x; Ohlberger J, 2013, AM NAT, V182, P359, DOI 10.1086/671169; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; Rogers SM, 2007, GENETICS, V175, P375, DOI 10.1534/genetics.106.061457; St-Cyr J, 2008, MOL ECOL, V17, P1850, DOI 10.1111/j.1365-294X.2008.03696.x; Steinbacher P, 2008, DEV DYNAM, V237, P3233, DOI 10.1002/dvdy.21745; Steinbacher P, 2006, DEV DYNAM, V235, P3132, DOI 10.1002/dvdy.20950; Steinbacher P, 2011, J EXP BIOL, V214, P1791, DOI 10.1242/jeb.050096; Steinmann P., 1950, SCHWEIZ Z HYDROL, V12, P340, DOI DOI 10.1007/BF02489885; Stoiber W, 2002, J EXP BIOL, V205, P2349; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; WANZENBOCK J., 2002, WATER AIR SOIL POLL, P227, DOI DOI 10.1023/A:1020356008923	47	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185384	10.1371/journal.pone.0185384	http://dx.doi.org/10.1371/journal.pone.0185384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945823	gold, Green Published, Green Submitted			2022-12-26	WOS:000411645100056
J	Wang, Y; Hu, YD; He, DQ; Chen, SY; Li, SM; Lan, D; Ren, P; Lin, ZP; Liu, YP				Wang, Ye; Hu, Yaodong; He, Daqian; Chen, Shiyi; Li, Siming; Lan, Dan; Ren, Peng; Lin, Zhenping; Liu, Yiping			Contribution of both positive selection and relaxation of selective constraints to degeneration of flyability during geese domestication	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; ARTIFICIAL SELECTION; OXYGEN-CONSUMPTION; EVOLUTION; HEMOGLOBIN; BIRDS; POLYMORPHISM; ORIGIN; FLIGHT; GENES	Flyability is the most discrepant trait between modern-day geese and their wild ancestors, and the degeneration of flyability is a key marker of the successful domestication of wild geese. In light of the relatively short history of domestic geese, intense artificial selection is thought to play an important role in the degeneration of flyability. However, the underlying mechanism behind this phenomenon has seldom been investigated. In this study, we applied a molecular evolutionary approach to the evaluation of partial breeds of domestic geese in order to look for genes involved in the selection pressure toward degeneration of flyability. The haplotype networks, pairwise fixation index (FST) values, and analysis of molecular variance results all clearly illustrated a population variance between Landes geese and partial Chinese domestic geese. We also detected signatures of positive artificial selection in the COX2 and COX3 genes, and related selection in the HBB gene. Our results support the independent origins of partial European domestic geese and Chinese domestic geese. In addition, both positive artificial selection and the relaxation of functional constraints appeared to play important roles in the degeneration of flyability in domestic geese.	[Wang, Ye; Hu, Yaodong; Chen, Shiyi; Lan, Dan; Ren, Peng; Liu, Yiping] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu Campus, Chengdu, Sichuan, Peoples R China; [He, Daqian] Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai, PR, Peoples R China; [Li, Siming] Jiangxi Acad Agr Sci, Inst Anim Husb & Vet Sci, Nanchang, Jiangxi, Peoples R China; [Lin, Zhenping] Shantou Baisha Res Inst Original Species Poultry, Shantou, Guangdong, Peoples R China	Sichuan Agricultural University; Shanghai Academy of Agricultural Sciences	Liu, YP (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu Campus, Chengdu, Sichuan, Peoples R China.	liuyp578@yahoo.com	he, daqian/HGC-6979-2022	Liu, Yi-ping/0000-0003-1477-9097; Wang, Ye/0000-0002-5423-6196	National Natural Science Foundation of China [31172181, 31660663]; National Waterfowl Industrial Technology System [CARS-43-4, 2016YFD0500510]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Waterfowl Industrial Technology System	This work was funded by the National Natural Science Foundation of China (Nos. 31172181 and 31660663) and the National Waterfowl Industrial Technology System (No. CARS-43-4 and 2016YFD0500510).	[Anonymous], 2005, DOC ARCHAEOBIOL, P249; BISHOP CM, 1995, J EXP BIOL, V198, P2153; Bishop KL, 2008, Q REV BIOL, V83, P153, DOI 10.1086/587825; Burga A, 2017, SCIENCE, V356, DOI 10.1126/science.aal3345; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Ericsson Per G.P., 2004, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Follmann K, 1998, BIOCHEM MOL BIOL INT, V45, P1047; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gifford R, 2005, J VIROL, V79, P6478, DOI 10.1128/JVI.79.10.6478-6486.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2010, HEREDITY, V105, P274, DOI 10.1038/hdy.2009.191; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maina JN, 2000, J EXP BIOL, V203, P3045; Mannermaa K, 2014, GOOSE DOMESTICATION, P3096; McCracken KG, 2010, MOL PHYLOGENET EVOL, V56, P649, DOI 10.1016/j.ympev.2010.04.034; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; Pacelli C, 2011, MITOCHONDRION, V11, P334, DOI 10.1016/j.mito.2010.12.004; Scott GR, 2006, RESP PHYSIOL NEUROBI, V154, P284, DOI 10.1016/j.resp.2006.02.012; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Shen YY, 2009, GENOME RES, V19, P1760, DOI 10.1101/gr.093138.109; Shi XW, 2006, BIOCHEM GENET, V44, P237, DOI 10.1007/s10528-006-9028-z; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Sun J, 2014, J POULT SCI, V51, P130, DOI 10.2141/jpsa.0120152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMAS SP, 1972, J EXP BIOL, V57, P317; Wang MS, 2016, CELL RES, V26, P556, DOI 10.1038/cr.2016.44; Ward S, 2002, J EXP BIOL, V205, P3347; Weber RE, 2002, AM J PHYSIOL-REG I, V283, pR1052, DOI 10.1152/ajpregu.00292.2002	34	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185328	10.1371/journal.pone.0185328	http://dx.doi.org/10.1371/journal.pone.0185328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945805	Green Published, gold			2022-12-26	WOS:000411645100046
J	Dong, K; Cao, YB; Siercke, B; Wilber, M; McCalla, SG				Dong, Kun; Cao, Yunbai; Siercke, Beatrice; Wilber, Matthew; McCalla, Scott G.			Advising caution in studying seasonal oscillations in crime rates	PLOS ONE			English	Article							SPATIAL-PATTERNS; HUMAN VIOLENCE; MODELS; RAPE; TEMPERATURE; AGGRESSION; BURGLARY; DYNAMICS; HOTSPOTS	Most types of crime are known to exhibit seasonal oscillations, yet the annual variations in the amplitude of this seasonality and their causes are still uncertain. Using a large collection of data from the Houston and Los Angeles Metropolitan areas, we extract and study the seasonal variations in aggravated assault, break in and theft from vehicles, burglary, grand theft auto, rape, robbery, theft, and vandalism for many years from the raw daily data. Our approach allows us to see various long term and seasonal trends and aberrations in crime rates that have not been reported before. We then apply an ecologically motivated stochastic differential equation to reproduce the data. Our model relies only on social interaction terms, and not on any exigent factors, to reproduce both the seasonality, and the seasonal aberrations observed in our data set. Furthermore, the stochasticity in the system is sufficient to reproduce the variations seen in the seasonal oscillations from year to year. Researchers should be very careful about trying to correlate these oscillations with external factors.	[Dong, Kun] Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA; [Cao, Yunbai] Univ Wisconsin, Dept Math, Madison, WI 53706 USA; [Siercke, Beatrice] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Wilber, Matthew] Harvey Mudd Coll, Dept Math, Claremont, CA 91711 USA; [McCalla, Scott G.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; Claremont Colleges; Harvey Mudd College; Montana State University System; Montana State University Bozeman	McCalla, SG (corresponding author), Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA.	scott.mccalla@montana.edu		McCalla, Scott/0000-0003-0093-4658	NSF DMS [DMS-1045536, DMS-1312344, DMS-0968309]; ARO MURI [W911NF-11-1-0332, FA9550-10-1-0569]	NSF DMS(National Science Foundation (NSF)); ARO MURI(MURI)	This research was supported by NSF DMS grants DMS-1045536, DMS-1312344, DMS-0968309 (https://www.nsf.gov/div/index.jsp?div=DMS), by ARO MURI grant W911NF-11-1-0332 (https://www.ari.army.mil/www/default.cfm?pagee=472), and by AFOSR MURI grant FA9550-10-1-0569 (http://www.wpatb.af.mil/Welcome/Fact-Sheets/Display/Article/842111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank P.J. Brantingham for leading us towards studying seasonal crime with a stochastic model. The Los Angeles data set was provided courtesy of P.J. Brantingham and the LAPD. Finally, we would like to thank J.H. von Brecht for his support in every aspect of this research program. This research originated as a summer REU in the California Research Training Program in Computational and Applied Mathematics at UCLA. This research was supported by NSF grants DMS-1045536, DMS-1312344, DMS-0968309, by ARO MURI grant W911NF-11-1- 0332, and by AFOSR MURI grant FA9550-10-1-0569.	ANDERSON CA, 1989, PSYCHOL BULL, V106, P74, DOI 10.1037/0033-2909.106.1.74; Baumer E, 1996, BRIT J CRIMINOL, V36, P579; Berglund N., 2002, STOCH DYNAM, V2, P327, DOI DOI 10.1142/S0219493702000455; Brantingham PJ, 2012, CRIMINOLOGY, V50, P851, DOI 10.1111/j.1745-9125.2012.00281.x; Chaturapruek S, 2013, SIAM J APPL MATH, V73, P1703, DOI 10.1137/120895408; COHN EG, 1990, BRIT J CRIMINOL, V30, P51, DOI 10.1093/oxfordjournals.bjc.a047980; Daly K, 2010, CRIME JUSTICE, V39, P565, DOI 10.1086/653101; DEUTSCH SJ, 1978, INT J COMP APPL CRIM, V0002; Eisenman I, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016164; Elsner J., 1996, SINGULAR SPECTRUM AN; FARRELL G, 1994, BRIT J CRIMINOL, V34, P487, DOI 10.1093/oxfordjournals.bjc.a048449; Felson M, 2010, EUR J APPL MATH, V21, P275, DOI 10.1017/S0956792510000070; Hegemann RA, 2011, PHYSICA A, V390, P3894, DOI 10.1016/j.physa.2011.05.040; Hipp JR, 2004, SOC FORCES, V82, P1333, DOI 10.1353/sof.2004.0074; Hird C., 2007, SEASONALITY RECORDED; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kelly L., 2005, GAP CHASM ATTRITION; KOSS MP, 1992, J SOC ISSUES, V48, P61, DOI 10.1111/j.1540-4560.1992.tb01157.x; Kuske R, 2007, J THEOR BIOL, V245, P459, DOI 10.1016/j.jtbi.2006.10.029; Levitt SD, 2004, J ECON PERSPECT, V18, P163, DOI 10.1257/089533004773563485; Lotka AJ, 1910, J PHYS CHEM-US, V14, P271, DOI 10.1021/j150111a004; McDowall D, 2012, J QUANT CRIMINOL, V28, P389, DOI 10.1007/s10940-011-9145-7; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; MICHAEL RP, 1983, SOC BIOL, V30, P263; Mohler GO, 2011, J AM STAT ASSOC, V106, P100, DOI 10.1198/jasa.2011.ap09546; Moorcroft PR, 2006, P ROY SOC B-BIOL SCI, V273, P1651, DOI 10.1098/rspb.2005.3439; Newby JM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.114101; Pino NW, 1999, SEX ROLES, V40, P979, DOI 10.1023/A:1018837524712; Quetelet Lambert Adolphe Jacques, 1842, TREATISE MAN DEV HIS; Short MB, 2010, SIAM J APPL DYN SYST, V9, P462, DOI 10.1137/090759069; Short MB, 2009, J QUANT CRIMINOL, V25, P325, DOI 10.1007/s10940-009-9068-8; Short MB, 2010, P NATL ACAD SCI USA, V107, P3961, DOI 10.1073/pnas.0910921107; Smith LM, 2012, DISCRETE CONT DYN-A, V32, P3223, DOI 10.3934/dcds.2012.32.3223; Sutherland E.H., 1992, PRINCIPLES CRIMINOLO, V1st; VAUTARD R, 1989, PHYSICA D, V35, P395, DOI 10.1016/0167-2789(89)90077-8; Volterra V., 1928, Journal du Conseil Copenhague, P3; Zimring WDSFE, 2006, GREAT AM CRIME DECLI	38	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185432	10.1371/journal.pone.0185432	http://dx.doi.org/10.1371/journal.pone.0185432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28938022	gold, Green Published, Green Submitted			2022-12-26	WOS:000411524700033
J	Gotz, TI; Lahmer, G; Strnad, V; Bert, C; Hensel, B; Tome, AM; Lang, EW				Goetz, Th. I.; Lahmer, G.; Strnad, V.; Bert, Ch.; Hensel, B.; Tome, A. M.; Lang, E. W.			A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patients	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; SINGULAR-SPECTRUM ANALYSIS; INTERSTITIAL BRACHYTHERAPY; SIMULTANEOUS LOCALIZATION; MUTUAL-INFORMATION; TIME-SERIES; DYNAMICS; IRRADIATION; PEARSONS; PROSTATE	During High Dose Rate Brachytherapy (HDR-BT) the spatial position of the radiation source inside catheters implanted into a female breast is determined via electromagnetic tracking (EMT). Dwell positions and dwell times of the radiation source are established, relative to the patient's anatomy, from an initial X-ray-CT-image. During the irradiation treatment, catheter displacements can occur due to patient movements. The current study develops an automatic analysis tool of EMT data sets recorded with a solenoid sensor to assure concordance of the source movement with the treatment plan. The tool combines machine learning techniques such as multi-dimensional scaling (MDS), ensemble empirical mode decomposition (EEMD), singular spectrum analysis (SSA) and particle filter (PF) to precisely detect and quantify any mismatch between the treatment plan and actual EMT measurements. We demonstrate that movement artifacts as well as technical signal distortions can be removed automatically and reliably, resulting in artifact-free reconstructed signals. This is a prerequisite for a highly accurate determination of any deviations of dwell positions from the treatment plan.	[Goetz, Th. I.; Lang, E. W.] Univ Regensburg, CIML, Biophys, D-93040 Regensburg, Germany; [Goetz, Th. I.; Lahmer, G.; Strnad, V.; Bert, Ch.] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Tome, A. M.] Univ Aveiro, DETI, IEETA, P-3810193 Aveiro, Portugal; [Goetz, Th. I.; Hensel, B.] Univ Erlangen Nurnberg, Ctr Med Phys & Engn, D-91052 Erlangen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Regensburg; University of Erlangen Nuremberg; Universidade de Aveiro; University of Erlangen Nuremberg	Gotz, TI (corresponding author), Univ Regensburg, CIML, Biophys, D-93040 Regensburg, Germany.; Gotz, TI (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany.; Gotz, TI (corresponding author), Univ Erlangen Nurnberg, Ctr Med Phys & Engn, D-91052 Erlangen, Germany.	theresa.goetz@biologie.uni-regensburg.de	Hensel, Bernhard/C-6995-2013; Bert, Christoph/C-2585-2013	Bert, Christoph/0000-0002-8539-6600; Tome, Ana Maria/0000-0002-1210-0266				Abdi H, 2007, METRIC MULTIDIMENSIO; Al-Subari K, 2015, J NEUROSCI METH, V253, P193, DOI 10.1016/j.jneumeth.2015.06.020; Al-Subari K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119489; Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; [Anonymous], 2017, MULT SCAL APPL EL TR; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Ashby FG, 2007, SCHOLARPEDIA, V2; Bailey T, 2006, IEEE ROBOT AUTOM MAG, V13, P108, DOI 10.1109/MRA.2006.1678144; Balachandran R, 2009, P SPIE MED IM VIS IM; Bert C, 2016, J CONTEMP BRACHYTHER, V8, P448, DOI 10.5114/jcb.2016.63356; Bharat S, 2014, BRACHYTHERAPY, V13, P640, DOI 10.1016/j.brachy.2014.05.012; Borg I., 2005, SPRINGER SERIES STAT, V2; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Cha S, 2007, CITY, V1, DOI DOI 10.1007/S00167-009-0884-Z; Cox T. F, 1994, MULTIDIMENSIONAL SCA; Damato AL, 2014, MED PHYS, V41, DOI 10.1118/1.4894710; Danilchenko A, 2010, LECT NOTES COMPUT SC, V6363, P587; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; Egghe L, 2009, J AM SOC INF SCI TEC, V60, P1027, DOI 10.1002/asi.21009; Elekta, FLEX EM TRACK RES MA; Franz AM, 2014, IEEE T MED IMAGING, V33, P1702, DOI 10.1109/TMI.2014.2321777; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Golyandina N., 2001, ANAL TIME SERIES STR, DOI DOI 10.1201/9781420035841; Gotz TI, 2017, PHYS MED BI IN PRESS; Harris TJ, 2010, PHYSICA D, V239, P1958, DOI 10.1016/j.physd.2010.07.005; Hassani H., 2007, DATA SCI J, V5, P239, DOI DOI 10.6339/JDS.2007.05(2).396; Hauke J, 2011, QUAEST GEOGR, V30, P87, DOI 10.2478/v10117-011-0021-1; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kellermeier M, 2016, ESTRO 35, P58; Kellermeier M, 2016, BRACHYTHERAPY, V15, pS39; Kellermeier M, 2017, J APPL CLIN MED PHYS, V18, P211, DOI 10.1002/acm2.12021; Kindratenko V. V., 2000, Virtual Reality, V5, P169, DOI 10.1007/BF01409422; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Liu JS, 1999, SEQUENTIAL MONTE CAR; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Okamoto H, 2014, J RADIAT RES, V55, P780, DOI 10.1093/jrr/rru001; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; PIKE ER, 1984, IEE PROC-F, V131, P660, DOI 10.1049/ip-f-1.1984.0100; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Poulin E, 2016, BRACHYTHERAPY, V15, P102, DOI 10.1016/j.brachy.2015.09.010; Sadjadi H, 2016, IEEE T BIO-MED ENG, V63, P1771, DOI 10.1109/TBME.2015.2502138; Shannon Claude E., 1948, MATH THEORY COMMUNIC, V27, P379; Strnad V, 2016, LANCET, V387, P229, DOI 10.1016/S0140-6736(15)00471-7; Strnad V, 2015, RADIOTHER ONCOL, V115, P342, DOI 10.1016/j.radonc.2015.06.010; Taneja I. J., 1995, ADV IMAG ELECT PHYS, V91, P37, DOI DOI 10.1016/S1076-5670(08)70106-X; Teixeira AR, 2006, COMPUT METH PROG BIO, V83, P125, DOI 10.1016/j.cmpb.2006.06.003; Teixeira AR, 2009, IEEE T INSTRUM MEAS, V58, P2433, DOI 10.1109/TIM.2009.2016385; Tome AM, 2010, STAT INTERFACE, V3, P345; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; VAUTARD R, 1989, PHYSICA D, V35, P395, DOI 10.1016/0167-2789(89)90077-8; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Zeiler A, 2010, RECENT ADV BIOMEDICA, P27; Zhou J, 2015, CANCER MANAG RES, V7, P199, DOI 10.2147/CMAR.S46042	58	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183608	10.1371/journal.pone.0183608	http://dx.doi.org/10.1371/journal.pone.0183608			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934238	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900012
J	Ling, YH; Xu, LN; Zhu, L; Sui, MH; Zheng, Q; Li, WY; Liu, Y; Fang, FG; Zhang, XR				Ling, Yinghui; Xu, Lina; Zhu, Long; Sui, Menghua; Zheng, Qi; Li, Wenyong; Liu, Yong; Fang, Fugui; Zhang, Xiaorong			Identification and analysis of differentially expressed long non-coding RNAs between multiparous and uniparous goat (Capra hircus) ovaries	PLOS ONE			English	Article							MICRORNAS; GENES; TRANSCRIPTS; MULTIPLE; CELLS; SEQ; FSH	Long non-coding RNAs (lncRNAs) play important roles in almost all biological processes. However, there is little information on the effects of lncRNAs on ovulation and lambing rates. In the present study, we used high-throughput RNA sequencing to identify differentially expressed lncRNAs between the ovaries of multiparous (Mul) and uniparous (Uni) Anhui White goats. Among the 107,255,422 clean reads, 183,754 lncRNAs were significantly differentially expressed between the Uni and Mul. Among them, 455 lncRNAs were co-expressed between the two samples, whereas, 157,523 lncRNAs were uniquely expressed in the Uni, and 25,776 uniquely lncRNAs were expressed in the Mul. Through Cis role analysis, 24 lncRNAs were predicted to overlap with cis-regulatory elements, which involved in Progesterone-mediated oocyte maturation, Steroid biosynthesis, Oocyte meiosis, and gonadotropin-releasing hormone (GnRH) signaling pathway. These 4 pathways were related to ovulation, and the KEGG pathway analysis on target genes of the differentially expressed lncRNAs confirmed this results. In addition, 10 lncRNAs harbored precursors of 40 miRNAs, such as TCONS_00320849 related to a mature miRNA sequence, miR-365a, which was reported to be related to proliferation, were annotated in the precursor analysis of miRNAs. The present expand the understanding of lncRNA biology and contribute to the annotation of the goat genome. The study will provide a resource for lncRNA studies of ovulation and lambing.	[Ling, Yinghui; Zhu, Long; Sui, Menghua; Zheng, Qi; Fang, Fugui; Zhang, Xiaorong] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China; [Ling, Yinghui; Zhu, Long; Sui, Menghua; Zheng, Qi; Fang, Fugui; Zhang, Xiaorong] Local Anim Genet Resources Conservat & Biobreedin, Hefei, Anhui, Peoples R China; [Xu, Lina] Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Anhui, Peoples R China; [Li, Wenyong; Liu, Yong] Fuyang Normal Univ, Key Lab Embryo Dev & Reprod Regulat Anhui Prov, Fuyang, Anhui, Peoples R China	Anhui Agricultural University; Anhui Academy of Agricultural Sciences; Fuyang Normal University	Fang, FG; Zhang, XR (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China.; Fang, FG; Zhang, XR (corresponding author), Local Anim Genet Resources Conservat & Biobreedin, Hefei, Anhui, Peoples R China.	332792872@qq.com; zhangxiaorong01@163.com			National Natural Science Foundation of China [31772566, 31472096]; Natural Science Foundation of Anhui Province [1708085MC61]; Key Research Projects of Natural Science in Anhui Colleges and Universities [KJ2017A334]; Agricultural Science and Technology Innovation Program of China [ASTIP-1A513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Key Research Projects of Natural Science in Anhui Colleges and Universities; Agricultural Science and Technology Innovation Program of China	This research was supported by the National Natural Science Foundation of China (31772566, 31472096), the Natural Science Foundation of Anhui Province (1708085MC61), the Key Research Projects of Natural Science in Anhui Colleges and Universities (KJ2017A334) and the Agricultural Science and Technology Innovation Program of China (ASTIP-1A513).	Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115; Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bernhardt ML, 2011, BIOL REPROD, V84, P526, DOI 10.1095/biolreprod.110.086488; Boulanger L, 2014, CURR BIOL, V24, P404, DOI 10.1016/j.cub.2013.12.039; Caballero J, 2015, REPROD FERT DEVELOP, V27, P40, DOI 10.1071/RD14338; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Corsini E, 2002, TOXICOL IN VITRO, V16, P427, DOI 10.1016/S0887-2333(02)00023-1; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Eswards CA, 2007, CURR OPIN CELL BOIL, V19, P281; Ganguly A, 2013, RES VET SCI, V95, P374, DOI 10.1016/j.rvsc.2013.03.013; Gayen S, 2016, P NATL ACAD SCI USA, V113, pE309, DOI 10.1073/pnas.1515971113; Gholkar AA, 2016, CELL REP, V14, P180, DOI 10.1016/j.celrep.2015.12.035; Gordon Carmichael, 2012, FASEB J, V26, P203; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hadjimichael C, 2016, STEM CELL REP, V6, P292, DOI 10.1016/j.stemcr.2016.01.004; Herndon MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126527; Jena SC, 2014, MOL REPROD DEV, V81, P350, DOI 10.1002/mrd.22303; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lakhotia SC, 2015, J GENET, V94, P575, DOI 10.1007/s12041-015-0566-1; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ling YH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-339; Luan XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113211; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; MESSINIS IE, 1990, HUM REPROD, V5, P153, DOI 10.1093/oxfordjournals.humrep.a137060; Moqadam FA, 2014, LEUKEMIA, V28, P1008, DOI 10.1038/leu.2013.308; Moskowitz A, 2009, INVEST OPHTH VIS SCI, V50, P950, DOI 10.1167/iovs.08-2544; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strozzi F, 2009, ANIM GENET, V40, P125, DOI 10.1111/j.1365-2052.2008.01780.x; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VANDERMEER M, 1994, HUM REPROD, V9, P1612, DOI 10.1093/oxfordjournals.humrep.a138761; Wang F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07146; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xie PG, 2015, INT J CLIN EXP MED, V8, P14764; Yue MH, 2016, BBA-GENE REGUL MECH, V1859, P112, DOI 10.1016/j.bbagrm.2015.07.015; Zhou WH, 2015, IRAN J BASIC MED SCI, V18, P1027	49	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183163	10.1371/journal.pone.0183163	http://dx.doi.org/10.1371/journal.pone.0183163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934224	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900006
J	Mandle, L; Wolny, S; Bhagabati, N; Helsingen, H; Hamel, P; Bartlett, R; Dixon, A; Horton, R; Lesk, C; Manley, D; De Mel, M; Bader, D; Myint, SNW; Myint, W; Mon, MS				Mandle, Lisa; Wolny, Stacie; Bhagabati, Nirmal; Helsingen, Hanna; Hamel, Perrine; Bartlett, Ryan; Dixon, Adam; Horton, Radley; Lesk, Corey; Manley, Danielle; De Mel, Manishka; Bader, Daniel; Myint, Sai Nay Won; Myint, Win; Mon, Myat Su			Assessing ecosystem service provision under climate change to support conservation and development planning in Myanmar	PLOS ONE			English	Article							BIODIVERSITY; PEOPLE	Inclusion of ecosystem services (ES) information into national-scale development and climate adaptation planning has yet to become common practice, despite demand from decision makers. Identifying where ES originate and to whom the benefits flow-under current and future climate conditions-is especially critical in rapidly developing countries, where the risk of ES loss is high. Here, using Myanmar as a case study, we assess where and how ecosystems provide key benefits to the country's people and infrastructure. We model the supply of and demand for sediment retention, dry-season baseflows, flood risk reduction and coastal storm protection from multiple beneficiaries. We find that locations currently providing the greatest amount of services are likely to remain important under the range of climate conditions considered, demonstrating their importance in planning for climate resilience. Overlap between priority areas for ES provision and biodiversity conservation is higher than expected by chance overall, but the areas important for multiple ES are under-represented in currently designated protected areas and Key Biodiversity Areas. Our results are contributing to development planning in Myanmar, and our approach could be extended to other contexts where there is demand for national-scale natural capital information to shape development plans and policies.	[Mandle, Lisa; Wolny, Stacie; Hamel, Perrine] Stanford Univ, Dept Biol, Nat Capital Project, Stanford, CA 94305 USA; [Mandle, Lisa; Wolny, Stacie; Hamel, Perrine] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Bhagabati, Nirmal; Bartlett, Ryan; Dixon, Adam] World Wildlife Fund, 1250 24th St,NW, Washington, DC 20037 USA; [Helsingen, Hanna; Myint, Sai Nay Won; Myint, Win] World Wide Fund Nat, Yangon, Myanmar; [Dixon, Adam] Univ Maryland Baltimore Cty, Dept Geog & Environm Syst, Baltimore, MD 21228 USA; [Horton, Radley; Lesk, Corey; Manley, Danielle; De Mel, Manishka; Bader, Daniel] Columbia Univ, Earth Inst, Ctr Climate Syst Res, New York, NY USA; [Horton, Radley; Lesk, Corey; Manley, Danielle; De Mel, Manishka; Bader, Daniel] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Mon, Myat Su] Minist Nat Resources & Environm Conservat, Forest Dept, Nay Pyi Taw, Myanmar	Stanford University; Stanford University; World Wildlife Fund; World Wildlife Fund; University System of Maryland; University of Maryland Baltimore County; Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Mandle, L (corresponding author), Stanford Univ, Dept Biol, Nat Capital Project, Stanford, CA 94305 USA.; Mandle, L (corresponding author), Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA.	lmandle@stanford.edu		Mandle, Lisa/0000-0002-1420-8529; Horton, Radley/0000-0002-5574-9962	Leona M. and Harry B. Helmsley Charitable Trust	Leona M. and Harry B. Helmsley Charitable Trust	This work was supported with funding from the Leona M. and Harry B. Helmsley Charitable Trust (http://helmsleytrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADB (Asian Development Bank), 2012, SUPP MYANM REF INCL, P5; ADB (Asian Development Bank), 2016, BAS 2016 STAT; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 1997, WORLD MANGROVE ATLAS; [Anonymous], 2013, MYANM BIOD CONS INV; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Bank World, 2015, MYANM EMP PEOPL INCL; Barbier EB, 2016, RESOUR ENERGY ECON, P1; BirdLife International Conservation International WCS Myanmar, 2013, KEY BIOD AR MYANM; Boerema A, 2017, J APPL ECOL, V54, P358, DOI 10.1111/1365-2664.12696; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Cubasch U, CLIMATE CHANGE 2013; Droogers P., 2002, Irrigation and Drainage Systems, V16, P33, DOI 10.1023/A:1015508322413; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Emerton L., 2013, EC VALUE FOREST ECOS; Food and Agriculture Organization of the United Nations ( FAO ), 2012, COUNTR PROGR FRAM 20; Gaughan AE, 2013, PLOS ONE, P8; Goldstein JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179008; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; Guannel G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158094; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Hamel P, 2017, ECOSYST SERV, V24, P1, DOI 10.1016/j.ecoser.2016.12.008; Hamel P, 2015, SCI TOTAL ENVIRON, V524, P166, DOI 10.1016/j.scitotenv.2015.04.027; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Horton R, 2015, KNOWLEDGE BASE CLIMA, V1336, P36, DOI DOI 10.1111/NYAS.12593; Horton R., 2016, ASSESSING CLIMATE RI, P88; IPCC, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; IUCN, 2016, GUID US GLOB STAND I, VFirst; Jones HP, 2012, NAT CLIM CHANGE, V2, P504, DOI 10.1038/NCLIMATE1463; Keeler BL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600219; Kreft S., GLOBAL CLIMATE RISK; Langhans SD, 2014, ECOL INDIC, V45, P494, DOI 10.1016/j.ecolind.2014.05.014; Latt KT, 2011, MYANMAR PROTECTED AR; Lehner B., 2011, GLOBAL RESERVOIR DAM, P1; Lentz EE, 2016, NATURE CLIMATE CHANG, P1; Mandle L, 2015, FRONT ECOL ENVIRON, V13, P309, DOI 10.1890/140337; McKenzie E, 2014, ENVIRON PLANN C, V32, P320, DOI 10.1068/c12292j; MIMU (Myanmar Information Management Unit), 2015, FLOOD AFF VILL LIST; Ministry of Immigration and Population (2015a), 2015, 2014 MYANM POP HOUS; MoNREC (Ministry of Natural Resources and Environmental Conservation), 2016, MYAN CLIM CHANG STRA; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Myanmar News Agency, 2016, WORLD ENV DAY CEL NA; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; NASA National Aeronautics and Space Administration, 2015, NEX GLOB DAIL DOWNSC; National Environmental Conservation Committee (NECC) Ministry of Environmental Conservation and Forestry Department of Meterology and Hydrology Ministry of Transport & United Nations Environment Programme, 2012, WEATHER SHOWS EVIDEN; Nay Pyi Taw Myanmar, 2016, NAT LAND US POL; Neugarten RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168575; NRCS, 2004, NAT ENG HDB 630, P79; Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295; Park CE, 2015, J CLIMATE, V28, P2884, DOI 10.1175/JCLI-D-13-00753.1; Pollescha NL, 2016, ECOL ECON, V130, P195, DOI 10.1016/j.ecolecon.2016.06.018; Posner SM, 2016, P NATL ACAD SCI USA, V113, P1760, DOI 10.1073/pnas.1502452113; Rao M, 2013, AMBIO, V42, P789, DOI 10.1007/s13280-013-0423-5; Reddy SMW, 2015, ECOSYST SERV, V12, P94, DOI 10.1016/j.ecoser.2014.12.001; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Runting RK, 2016, GLOB CHANG BIOL; Sharp R, 2015, INVEST 3 2 0 USERS G; Srinivasan UT, 2010, CLIM POLICY, V10, P298, DOI 10.3763/cpol.2009.0652; Stocker T. F., 2013, CLIMATE CHANGE 2013; Tallis H., 2012, INCLUSIVE WEALTH REP; Tignor M., 2013, CLIMATE CHANGE 2013; UNDP, 2015, HUMAN DEV REPORT 201; [UNDP (United Nations Development Programme). MOAI (Ministry of Agriculture and Irrigation) FAO (Food and Agriculture Organization)], 2005, DIG AGR ATL UN MYANM; UNEP-WCMC, 2010, GLOB DISTR WARM WAT; UNEP-WCMC Short FT, 2005, GLOB DISTR SEAGR VER; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Webb EL, 2014, GLOBAL ENVIRON CHANG, V24, P321, DOI 10.1016/j.gloenvcha.2013.10.007	68	22	23	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184951	10.1371/journal.pone.018495	http://dx.doi.org/10.1371/journal.pone.018495			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934282				2022-12-26	WOS:000411339900064
J	Temu, TM; Lane, KA; Shen, CY; Ng'ang'a, L; Akwanalo, CO; Chen, PS; Emonyi, W; Heckbert, SR; Koech, MM; Manji, I; Vatta, M; Velazquez, EJ; Wessel, J; Kimaiyo, S; Inui, TS; Bloomfield, GS				Temu, Tecla M.; Lane, Kathleen A.; Shen, Changyu; Ng'ang'a, Loise; Akwanalo, Constantine O.; Chen, Peng-Sheng; Emonyi, Wilfred; Heckbert, Susan R.; Koech, Myra M.; Manji, Imran; Vatta, Matteo; Velazquez, Eric J.; Wessel, Jennifer; Kimaiyo, Sylvester; Inui, Thomas S.; Bloomfield, Gerald S.			Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya	PLOS ONE			English	Article							RHEUMATIC HEART-DISEASE; GLOBAL BURDEN; FOLLOW-UP; REGISTRY; COUNTRIES; EPIDEMIOLOGY; MANAGEMENT; DESIGN; REMEDY; RATIONALE	Background Atrial fibrillation (AF) is a major contributor to the global cardiovascular disease burden. The clinical profile and outcomes of AF patients with valvular heart diseases in sub-Saharan Africa (SSA) have not been adequately described. We assessed clinical features and 12-month outcomes of patients with valvular AF (vAF) in comparison to AF patients without valvular heart disease (nvAF) in western Kenya. Methods We performed a cohort study with retrospective data gathering to characterize risk factors and prospective data collection to characterize their hospitalization, stroke and mortality rates. Results The AF patients included 77 with vAF and 69 with nvAF. The mean (SD) age of vAF and nvAF patients were 37.9(14.5) and 69.4(12.3) years, respectively. There were significant differences (p< 0.001) between vAF and nvAF patients with respect to female sex (78% vs. 55%), rates of hypertension (29% vs. 73%) and heart failure (10% vs. 49%). vAF patients were more likely to be taking anticoagulation therapy compared to those with nvAF (97% vs. 76%; p< 0.01). After 12-months of follow-up, the overall mortality, hospitalization and stroke rates for vAF patients were high, at 10%, 34% and 5% respectively, and were similar to the rates in the nvAF patients (15%, 36%, and 5%, respectively). Conclusion Despite younger age and few comorbid conditions, patients with vAF in this developing country setting are at high risk for nonfatal and fatal outcomes, and are in need of interventions to improve short and long-term outcomes.	[Temu, Tecla M.] Univ Nairobi, Dept Med Microbiol, Coll Hlth Sci, Nairobi, Kenya; [Lane, Kathleen A.] Indiana Univ Sch Med, Dept Biostat, Indiana Univ, Indianapolis, IN 46202 USA; [Shen, Changyu] Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA; [Shen, Changyu] Harvard Med Sch, Boston, MA USA; [Ng'ang'a, Loise; Velazquez, Eric J.; Bloomfield, Gerald S.] Duke Univ, Dept Med, Duke Clin Res Inst, Durham, NC USA; [Ng'ang'a, Loise; Velazquez, Eric J.; Bloomfield, Gerald S.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Akwanalo, Constantine O.; Emonyi, Wilfred; Koech, Myra M.; Manji, Imran; Kimaiyo, Sylvester] Moi Teaching & Referral Hosp, Div Med, Eldoret, Kenya; [Akwanalo, Constantine O.; Emonyi, Wilfred; Manji, Imran; Kimaiyo, Sylvester; Inui, Thomas S.] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Chen, Peng-Sheng; Vatta, Matteo; Inui, Thomas S.] Indiana Univ, Baptist Healthcare Ctr, Indianapolis, IN 46204 USA; [Chen, Peng-Sheng; Vatta, Matteo; Wessel, Jennifer] Indiana Univ, Dept Med, Indianapolis, IN USA; [Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Kimaiyo, Sylvester] Moi Univ, Dept Med, Sch Med, Coll Hlth Sci, Eldoret, Kenya	University of Nairobi; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Duke University; Duke University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Washington; University of Washington Seattle; Moi University	Temu, TM (corresponding author), Univ Nairobi, Dept Med Microbiol, Coll Hlth Sci, Nairobi, Kenya.	Tecla_Temu@alumni.brown.edu	Manji, Imran/K-8514-2019	Manji, Imran/0000-0001-8715-9804; Temu, Tecla/0000-0002-0056-4143; Wessel, Jennifer/0000-0002-7031-0085	NIH [R42DA043391, P01HL78931, R01HL71140]; Medtronic-Zipes Endowment of Indiana University; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative; Fogarty International Center of the National Institutes of Health (NIH) [R25TW009345]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic-Zipes Endowment of Indiana University; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative; Fogarty International Center of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported in part by NIH Grants R42DA043391, P01HL78931, R01HL71140, a Medtronic-Zipes Endowment of Indiana University and the Indiana University Health-Indiana University School of Medicine Strategic Research Initiative. TT has been supported by award from Fogarty International Center of the National Institutes of Health (NIH) R25TW009345. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Bloomfield GS, 2015, AM HEART J, V170, P455, DOI 10.1016/j.ahj.2015.06.008; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Engelgau MM, 2016, GLOB HEART, V11, P5, DOI 10.1016/j.gheart.2015.12.016; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Healey JS, 2016, LANCET, V388, P1161, DOI 10.1016/S0140-6736(16)30968-0; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Karthikeyan G, 2012, AM HEART J, V163, P535, DOI 10.1016/j.ahj.2012.01.003; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Moran A, 2013, PROG CARDIOVASC DIS, V56, P234, DOI 10.1016/j.pcad.2013.09.019; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Ntep-Gweth M, 2010, EUROPACE, V12, P482, DOI 10.1093/europace/euq006; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118; Shavadia J, 2013, CARDIOVASC J AFR, V24, P6, DOI 10.5830/CVJA-2012-064; Sliwa K, 2010, HEART, V96, P1878, DOI 10.1136/hrt.2010.206938; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Wen-Hang QI, 2005, INT J CARDIOL, V105, P283, DOI 10.1016/j.ijcard.2004.12.042; Zubaid M, 2011, CIRC-CARDIOVASC QUAL, V4, P477, DOI 10.1161/CIRCOUTCOMES.110.959700; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449; Zuhlke L, 2016, CIRCULATION, V134, P1456, DOI 10.1161/CIRCULATIONAHA.116.024769	23	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185204	10.1371/journal.pone.0185204	http://dx.doi.org/10.1371/journal.pone.0185204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934312	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900121
J	McBirney, M; King, SE; Pappalardo, M; Houser, E; Unkefer, M; Nilsson, E; Sadler-Riggleman, I; Beck, D; Winchester, P; Skinner, MK				McBirney, Margaux; King, Stephanie E.; Pappalardo, Michelle; Houser, Elizabeth; Unkefer, Margaret; Nilsson, Eric; Sadler-Riggleman, Ingrid; Beck, Daniel; Winchester, Paul; Skinner, Michael K.			Atrazine induced epigenetic transgenerational inheritance of disease, lean phenotype and sperm epimutation pathology biomarkers	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; ADULT-ONSET DISEASE; ENVIRONMENTAL-FACTORS; PRENATAL EXPOSURE; RISK-ASSESSMENT; ADIPOSE-TISSUE; HEALTH-RISK; RATS; OBESITY; MICE	Ancestral environmental exposures to a variety of environmental toxicants and other factors have been shown to promote the epigenetic transgenerational inheritance of adult onset disease. The current study examined the potential transgenerational actions of the herbicide atrazine. Atrazine is one of the most commonly used herbicides in the agricultural industry, in particular with corn and soy crops. Outbred gestating female rats were transiently exposed to a vehicle control or atrazine. The F1 generation offspring were bred to generate the F2 generation and then the F2 generation bred to generate the F3 generation. The F1, F2 and F3 generation control and atrazine lineage rats were aged and various pathologies investigated. The male sperm were collected to investigate DNA methylation differences between the control and atrazine lineage sperm. The F1 generation offspring (directly exposed as a fetus) did not develop disease, but weighed less compared to controls. The F2 generation (grand-offspring) was found to have increased frequency of testis disease and mammary tumors in males and females, early onset puberty in males, and decreased body weight in females compared to controls. The transgenerational F3 generation rats were found to have increased frequency of testis disease, early onset puberty in females, behavioral alterations (motor hyperactivity) and a lean phenotype in males and females. The frequency of multiple diseases was significantly higher in the transgenerational F3 generation atrazine lineage males and females. The transgenerational transmission of disease requires germline (egg or sperm) epigenetic alterations. The sperm differential DNA methylation regions (DMRs), termed epimutations, induced by atrazine were identified in the F1, F2 and F3 generations. Gene associations with the DMRs were identified. For the transgenerational F3 generation sperm, unique sets of DMRs (epimutations) were found to be associated with the lean phenotype or testis disease. These DMRs provide potential biomarkers for transgenerational disease. The etiology of disease appears to be in part due to environmentally induced epigenetic transgenerational inheritance, and epigenetic biomarkers may facilitate the diagnosis of the ancestral exposure and disease susceptibility. Observations indicate that although atrazine does not promote disease in the directly exposed F1 generation, it does have the capacity to promote the epigenetic transgenerational inheritance of disease.	[McBirney, Margaux; King, Stephanie E.; Pappalardo, Michelle; Houser, Elizabeth; Unkefer, Margaret; Nilsson, Eric; Sadler-Riggleman, Ingrid; Beck, Daniel; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Washington, DC 99164 USA; [Winchester, Paul] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Washington State University; Indiana University System; Indiana University-Purdue University Indianapolis	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Washington, DC 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020		Gerber Foundation [3631]; John Templeton Foundation [50183]; National Institutes of Health [ES012974]; Gerber Foundation grant; John Templeton Foundation grant; NIH grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	Gerber Foundation; John Templeton Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerber Foundation grant; John Templeton Foundation grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by: Gerber Foundation (3631) to PW MKS; John Templeton Foundation (50183) to MKS; and National Institutes of Health (ES012974) to MKS.; We acknowledge Dr. Millissia Ben Maamar, Ms. Hannah Kimbel, Ms. Deepika Kubsad, Ms. Marlee Lawley, Ms. Heidi Skinner, Mr. Ryan Thompson, Ms. Jayleana Barton, Mr. Ryan Feser, Ms. Mackenzie Hastings, and Ms. Jennifer Madrid Thorson for technical assistance and Ms. Heather Johnson for assistance in preparation of the manuscript. We thank Dr. Gerlinde Metz, University of Lethbridge, Canada, for behavioral data analysis advice. This study was supported by a Gerber Foundation grant to PW and MKS, John Templeton Foundation grant to MKS and NIH grant to MKS.	Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Chen JY, 2013, J ENVIRON SCI HEAL B, V48, P637, DOI 10.1080/03601234.2013.777308; Chusyd DE, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davis LK, 2011, REPROD TOXICOL, V32, P43, DOI 10.1016/j.reprotox.2011.04.004; Doyle TJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106104; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eldridge JC, 2008, REV ENVIRON CONTAM T, V196, P147, DOI 10.1007/978-0-387-78444-1_6; Eldridge JC, 1999, STEROIDS, V64, P672, DOI 10.1016/S0039-128X(99)00051-3; Fraites MJP, 2011, REPROD TOXICOL, V32, P52, DOI 10.1016/j.reprotox.2011.04.003; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hao CX, 2016, NUCLEIC ACIDS RES, V44, P9784, DOI 10.1093/nar/gkw840; Haque MM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2748-5; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jowa L, 2011, J ENVIRON SCI HEAL C, V29, P91, DOI 10.1080/10590501.2011.577681; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 2013, HORM BEHAV, V64, P250, DOI 10.1016/j.yhbeh.2013.03.014; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lin ZM, 2013, NEUROTOXICOL TERATOL, V39, P26, DOI 10.1016/j.ntt.2013.06.002; Magnusdottir E, 2012, CURR OPIN GENET DEV, V22, P466, DOI 10.1016/j.gde.2012.06.002; Manikkam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102091; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Marques BG, 1998, AM J PHYSIOL-REG I, V275, pR1898, DOI 10.1152/ajpregu.1998.275.6.R1898; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McCarrey JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168038; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morris DL, 2016, TRANSL RES, V172, P1, DOI 10.1016/j.trsl.2016.02.010; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Narotsky MG, 2001, REPROD TOXICOL, V15, P61, DOI 10.1016/S0890-6238(00)00111-8; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Parent AS, 2016, ENDOCR DEV, V29, P174, DOI 10.1159/000438885; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salian S, 2009, LIFE SCI, V85, P11, DOI 10.1016/j.lfs.2009.04.005; Sass JB, 2006, INT J OCCUP ENV HEAL, V12, P260; Schneider P, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00043; Schuster A, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvw001; Scialli AR, 2014, BIRTH DEFECTS RES B, V101, P199, DOI 10.1002/bdrb.21099; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Shnorhavorian M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170085; Skinner MK, 2015, EPIGENETICS-US, V10, P762, DOI 10.1080/15592294.2015.1062207; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Song Y, 2014, BIOMED ENVIRON SCI, V27, P281, DOI 10.3967/bes2014.050; Taylor JA, 2011, J STEROID BIOCHEM, V127, P83, DOI 10.1016/j.jsbmb.2011.07.005; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; UGAZIO G, 1991, RES COMMUN CHEM PATH, V74, P349; United States GS, 2006, QUAL OUR NAT WAT PES; Victor-Costa AB, 2010, REPROD TOXICOL, V29, P323, DOI 10.1016/j.reprotox.2009.12.006; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Walters JL, 2015, TOXICOL APPL PHARM, V289, P185, DOI 10.1016/j.taap.2015.09.026; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Wolstenholme JT, 2013, HORM BEHAV, V64, P833, DOI 10.1016/j.yhbeh.2013.09.007; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Xie F, 2012, CELL PHYSIOL BIOCHEM, V29, P111, DOI 10.1159/000337592	86	85	87	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184306	10.1371/journal.pone.0184306	http://dx.doi.org/10.1371/journal.pone.0184306			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931070	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700018
J	Mei, SY; Karimnezhad, A; Forest, M; Bickel, DR; Greenwood, CMT				Mei, Shuyan; Karimnezhad, Ali; Forest, Marie; Bickel, David R.; Greenwood, Celia M. T.			The performance of a new local false discovery rate method on tests of association between coronary artery disease (CAD) and genome-wide genetic variants	PLOS ONE			English	Article							COMMON SNPS; REPLICATION; HYPOTHESIS; VALIDATION; INFERENCE; POWER	The maximum entropy (ME) method is a recently-developed approach for estimating local false discovery rates (LFDR) that incorporates external information allowing assignment of a subset of tests to a category with a different prior probability of following the null hypothesis. Using this ME method, we have reanalyzed the findings from a recent large genomewide association study of coronary artery disease (CAD), incorporating biologic annotations. Our revised LFDR estimates show many large reductions in LFDR, particularly among the genetic variants belonging to annotation categories that were known to be of particular interest for CAD. However, among SNPs with rare minor allele frequencies, the reductions in LFDR were modest in size.	[Mei, Shuyan; Greenwood, Celia M. T.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Karimnezhad, Ali] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Karimnezhad, Ali; Bickel, David R.] Univ Ottawa, Fac Med, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Karimnezhad, Ali; Bickel, David R.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Forest, Marie; Greenwood, Celia M. T.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Bickel, David R.] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada	McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Lady Davis Institute; McGill University; University of Ottawa; McGill University; McGill University	Greenwood, CMT (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Greenwood, CMT (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.; Greenwood, CMT (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.; Greenwood, CMT (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	celia.greenwood@mcgill.ca		Greenwood, Celia/0000-0002-2427-5696; Abbas-Aghababazadeh, Farnoosh/0000-0001-6427-9379	CIHR Operating grant [123508]; Canadian Institutes of Health Research; NSER Coperating grant	CIHR Operating grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSER Coperating grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded primarily by CIHR Operating grant #123508, awarded to DB and CG by the Canadian Institutes of Health Research, and also by an NSER Coperating grant to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AK made his contributions while a postdoctoral fellow at the University of Ottawa with DB. This work was funded primarily by CIHR Operating grant # 123508 to DB, and also by an NSERC operating grant to CG. We would like to acknowledge the substantial assistance of Majid Nikpay with providing the data and annotations, and assisting with understanding of these data.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aghababazadah FA, 2016, WORKING PAPER; [Anonymous], WORKING PAPER; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickel DR, 2015, INT J APPROX REASON, V66, P53, DOI 10.1016/j.ijar.2015.07.012; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B., 2010, LARGE SCALE INFERENC; Efron B, 2015, LOCFDR VIGNETTE; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Greenwood CMT, 2007, GENET EPIDEMIOL, V31, P396, DOI 10.1002/gepi.20220; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Karimnezhad A, INCORPORATING UNPUB; Karimnezhad A, 2016, WORKING PAPER; Konig IR, 2011, BRIEF BIOINFORM, V12, P253, DOI 10.1093/bib/bbq074; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Li C, 2008, HUM HERED, V65, P129, DOI 10.1159/000109730; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nikpay M, 2017, CARDIOVASC RES; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Padilla M, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1807; Scheid S, 2005, BIOINFORMATICS, V21, P2921, DOI 10.1093/bioinformatics/bti436; Sinha R, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S23; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang Y, 2013, IEEE ACM T COMPUT BI, V10, P98, DOI 10.1109/TCBB.2012.140; Yang ZY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-87	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185174	10.1371/journal.pone.0185174	http://dx.doi.org/10.1371/journal.pone.0185174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931044	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700076
J	Moura, ARSS; Kretz, CB; Ferreira, IE; Nunes, AMPB; de Moraes, JC; Reis, MG; McBride, AJA; Wang, X; Campos, LC				Silva Simoes Moura, Ana Rafaela; Kretz, Cecilia Batmalle; Ferreira, Italo Eustaquio; Pithon Borges Nunes, Amelia Maria; de Moraes, Jose Cassio; Reis, Mitermayer Galvao; Alexander McBride, Alan John; Wang, Xin; Campos, Leila Carvalho			Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil	PLOS ONE			English	Article							PREDICTED STRAIN COVERAGE; SEROGROUP-B; MULTICOMPONENT VACCINE; HIGH PREVALENCE; DISEASE; CARRIAGE; DIVERSITY; RECOMMENDATIONS; EPIDEMIOLOGY; 4CMENB	Characterization of meningococci isolated from the pharynx is essential towards understanding the dynamics of meningococcal carriage and disease. Meningococcal isolates, collected from adolescents resident in Salvador, Brazil during 2014, were characterized by multilocus sequence typing, genotyping or whole-genome sequencing. Most were nongroupable (61.0%), followed by genogroups B (11.9%) and Y (8.5%). We identified 34 different sequence types (STs), eight were new STs, distributed among 14 clonal complexes (cc), cc1136 represented 20.3% of the nongroupable isolates. The porA and fetA genotypes included P1.18,25 - 37 (11.9%), P1.18-1,3 (10.2%); F5-5 (23.7%), F4-66 (16.9%) and F1-7 (13.6%). The porB class 3 protein and the fHbp subfamily A (variants 2 and 3) genotypes were found in 93.0 and 71.0% of the isolates, respectively. NHBA was present in all isolates, and while most lacked NadA (94.9%), we detected the hyperinvasive lineages B: P1.19,15: F5-1: ST-639 (cc32); C: P1.22,14 - 6: F3-9: ST-3780 (cc103) and W: P1.5,2: F1-1: ST-11 (cc11). This is the first report on the genetic diversity and vaccine antigen prevalence among N. meningitidis carriage isolates in the Northeast of Brazil. This study highlights the need for ongoing characterization of meningococcal isolates following the introduction of vaccines and for determining public health intervention strategies.	[Silva Simoes Moura, Ana Rafaela; Ferreira, Italo Eustaquio; Pithon Borges Nunes, Amelia Maria; Reis, Mitermayer Galvao; Alexander McBride, Alan John; Campos, Leila Carvalho] FIOCRUZ BA, Inst Goncalo Moniz, Lab Patol & Biol Mol, Salvador, BA, Brazil; [Kretz, Cecilia Batmalle; Wang, Xin] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Atlanta, GA USA; [de Moraes, Jose Cassio] Fac Ciencias Med Santa Casa Sao Paulo, Sao Paulo, Brazil; [Alexander McBride, Alan John] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Nucleo Biotecnol, Pelotas, RS, Brazil	Fundacao Oswaldo Cruz; Centers for Disease Control & Prevention - USA; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Federal de Pelotas	Campos, LC (corresponding author), FIOCRUZ BA, Inst Goncalo Moniz, Lab Patol & Biol Mol, Salvador, BA, Brazil.	lccampos@bahia.fiocruz.br	McBride, Alan/D-4106-2012; Reis, Mitermayer/AAO-9742-2020; MORAES, JOSE C/H-6788-2012; Campos, Leila/AAO-3207-2021	McBride, Alan/0000-0001-9682-540X; Reis, Mitermayer/0000-0002-3051-9060; Campos, Leila/0000-0001-9150-464X; Kruemmel, Ana Rafaela/0000-0002-7406-1223	Ministerio da Saude, Brazil [TC335/2013]; Fundacao de Amparo a Pesquisa do Estado da Bahia FAPESB [SUS 007/2014]	Ministerio da Saude, Brazil; Fundacao de Amparo a Pesquisa do Estado da Bahia FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	This work was supported by Ministerio da Saude, Brazil (http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/svs) (grant number TC335/2013) [LCC], and Fundacao de Amparo a Pesquisa do Estado da Bahia FAPESB (http://www.fapesb.ba.gov.br) (grant number SUS 007/2014) [LCC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2014, EPIDEMIOL INFECT, V142, P2461, DOI 10.1017/S0950268814001149; Cardoso CW, 2012, VACCINE, V30, P5541, DOI 10.1016/j.vaccine.2012.06.044; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Claus H, 2012, VACCINE, V30, P155, DOI 10.1016/j.vaccine.2011.11.050; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; de Filippis I, 2005, DIAGN MICR INFEC DIS, V53, P161, DOI 10.1016/j.diagmicrobio.2005.06.015; de Filippis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033016; de Moraes JC, 2015, PEDIATR INFECT DIS J, V34, P1197, DOI 10.1097/INF.0000000000000853; Diaz J, 2016, J INFECT PUBLIC HLTH; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Gasparini R, 2014, J CLIN MICROBIOL, V52, P1901, DOI 10.1128/JCM.03584-13; Gorla MCO, 2012, ENFERM INFEC MICR CL, V30, P56, DOI 10.1016/j.eimc.2011.07.022; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jounio U, 2012, J CLIN MICROBIOL, V50, P264, DOI 10.1128/JCM.05385-11; Kretz CB, 2016, EMERG INFECT DIS, V22, P1762, DOI 10.3201/eid2210.160468; Lemos APS, 2010, J INFECTION, V60, P209, DOI 10.1016/j.jinf.2009.11.014; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Moreno J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135497; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Safadi MAP, 2014, EMERG INFECT DIS, V20, P806, DOI 10.3201/eid2005.130948; Nunes AMPB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166475; Russell Joanne E, 2004, Emerg Infect Dis, V10, P674; Safadi MAP, 2013, EXPERT REV VACCINES, V12, P903, DOI 10.1586/14760584.2013.814879; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; de Lemos APS, 2007, J CLIN MICROBIOL, V45, P1266, DOI 10.1128/JCM.02510-06; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe M, 2010, P NATL ACAD SCI USA, V107, P6811, DOI 10.1073/pnas.0912115107; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Wasko I, 2016, VACCINE, V34, P510, DOI 10.1016/j.vaccine.2015.11.070; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	49	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185038	10.1371/journal.pone.0185038	http://dx.doi.org/10.1371/journal.pone.0185038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931058	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700063
J	Mukhopadhyay, A; Tai, BC; Remani, D; Phua, J; Cove, ME; Kowitlawakul, Y				Mukhopadhyay, Amartya; Tai, Bee Choo; Remani, Deepa; Phua, Jason; Cove, Matthew Edward; Kowitlawakul, Yanika			Age related inverse dose relation of sedatives and analgesics in the intensive care unit	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; CRITICALLY-ILL PATIENTS; LONG-TERM MORTALITY; DAILY INTERRUPTION; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; PROPOFOL; PHARMACOKINETICS; MULTICENTER; MIDAZOLAM	Sedative and analgesic practices in intensive care units (ICUs) are frequently based on anesthesia regimes but do not take account of the important patient related factors. Pharmacologic properties of sedatives and analgesics change when used as continuous infusions in ICU compared to bolus or short-term infusions during anesthesia. In a prospective observational cohort study, we investigated the association between patient related factors and sedatives/analgesics doses in patients on mechanical ventilation (MV) and their association with cessation of sedation/analgesia. We included patients expected to receive MV for at least 24 hours and excluded those with difficulty in assessing the depth of sedation. We collected data for the first 72 hours or until extubation, whichever occurred first. Multivariate analysis of variance, multivariate regression as well as logistic regression were used. The final cohort (N = 576) was predominantly male (64%) with mean (SD) age 61.7 (15.6) years, weight 63.4 (18.2) Kg, Acute Physiology and Chronic Health Evaluation II score 28.2 (8) and 30% hospital mortality. Increasing age was associated with reduced propofol and fentanyl doses requirements, adjusted to the weight (p<0.001). Factors associated with higher propofol and fentanyl doses were vasopressor use (Relative mean difference (RMD) propofol 1.56 (95% confidence interval (CI) 1.28-1.90); fentanyl 1.48 (1.25-1.76) and central venous line placement (CVL, RMD propofol 1.64 (1.15-2.33); fentanyl 1.41 (1.03-1.91). Male gender was also associated with higher propofol dose (RMD 1.27 (1.06-1.49). Sedation cessation was less likely to occur in restrained patients (Odds Ratio, OR 0.48 (CI 0.30-0.78) or those receiving higher sedative/analgesic doses (OR propofol 0.98 (CI 0.97-0.99); fentanyl 0.99 (CI 0.98-0.997), independent of depth of sedation. In conclusion, increasing age is associated with the use of lower doses of sedative/analgesic in ICU, whereas CVL and vasopressor use were associated with higher doses.	[Mukhopadhyay, Amartya; Remani, Deepa; Phua, Jason; Cove, Matthew Edward] Natl Univ Hlth Syst, Univ Med Cluster, Div Resp & Crit Care Med, Singapore, Singapore; [Mukhopadhyay, Amartya; Phua, Jason; Cove, Matthew Edward] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Tai, Bee Choo] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Tai, Bee Choo; Kowitlawakul, Yanika] Natl Univ Hlth Syst, Singapore, Singapore; [Kowitlawakul, Yanika] Natl Univ Singapore, Alice Lee Ctr Nursing Studies, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Mukhopadhyay, A (corresponding author), Natl Univ Hlth Syst, Univ Med Cluster, Div Resp & Crit Care Med, Singapore, Singapore.; Mukhopadhyay, A (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.	amartya.mukherjee@gmail.com	Cove, Matthew/AAP-5051-2020	Cove, Matthew/0000-0003-3805-4680; Mukhopadhyay, Amartya/0000-0002-9747-5277				Absalom AR, 2009, BRIT J ANAESTH, V103, P26, DOI 10.1093/bja/aep143; Ahlers SJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6789; Aissaoui Y, 2005, ANESTH ANALG, V101, P1470, DOI 10.1213/01.ANE.0000182331.68722.FF; Barash PG, 2009, CLIN ANESTH, P148; Barr J, 2001, ANESTHESIOLOGY, V95, P286, DOI 10.1097/00000542-200108000-00007; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BLOUIN RT, 1993, ANESTHESIOLOGY, V79, P1177, DOI 10.1097/00000542-199312000-00007; Boumendil A, 2007, INTENS CARE MED, V33, P1252, DOI 10.1007/s00134-007-0621-3; Carson SS, 2006, CRIT CARE MED, V34, P1326, DOI 10.1097/01.CCM.0000215513.63207.7F; Gelinas C, 2009, J PAIN SYMPTOM MANAG, V37, P58, DOI 10.1016/j.jpainsymman.2007.12.022; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; GREENBLATT DJ, 1984, ANESTHESIOLOGY, V61, P27, DOI 10.1097/00000542-198461010-00006; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kazama T, 2001, ANESTHESIOLOGY, V94, P205, DOI 10.1097/00000542-200102000-00007; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P595, DOI 10.1017/S1355617707070749; Lichtenbelt BJ, 2004, CLIN PHARMACOKINET, V43, P577, DOI 10.2165/00003088-200443090-00002; Martin Jorg, 2010, Ger Med Sci, V8, pDoc02, DOI 10.3205/000091; Mehta S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1405-3; Mehta S, 2009, CRIT CARE CLIN, V25, P471, DOI 10.1016/j.ccc.2009.04.001; Ong BKC, 2002, ANN ACAD MED SINGAP, V31, P707; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Reigle J, 1996, AACN Clin Issues, V7, P585, DOI 10.1097/00044067-199611000-00014; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Schuttler J, 2000, ANESTHESIOLOGY, V92, P727, DOI 10.1097/00000542-200003000-00017; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Silverstein JH, 2008, GERIATRIC ANESTHESIO, P209; SINGLETON MA, 1988, BRIT J ANAESTH, V60, P619, DOI 10.1093/bja/60.6.619; Tanios MA, 2009, J CRIT CARE, V24, P66, DOI 10.1016/j.jcrc.2008.03.037; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; Vuyk J, 2001, BRIT J ANAESTH, V86, P183, DOI 10.1093/bja/86.2.183; Wunsch H, 2009, CRIT CARE MED, V37, P3031, DOI 10.1097/CCM.0b013e3181b02eff	36	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185212	10.1371/journal.pone.0185212	http://dx.doi.org/10.1371/journal.pone.0185212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957364	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200033
J	Rahbar, E; Ainsworth, HC; Howard, TD; Hawkins, GA; Ruczinski, I; Mathias, R; Seeds, MC; Sergeant, S; Hixson, JE; Herrington, DM; Langefeld, CD; Chilton, FH				Rahbar, Elaheh; Ainsworth, Hannah C.; Howard, Timothy D.; Hawkins, Gregory A.; Ruczinski, Ingo; Mathias, Rasika; Seeds, Michael C.; Sergeant, Susan; Hixson, James E.; Herrington, David M.; Langefeld, Carl D.; Chilton, Floyd H.			Uncovering the DNA methylation landscape in key regulatory regions within the FADS cluster	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CORONARY-ARTERY-DISEASE; GENETIC-VARIANTS; CARDIOVASCULAR-DISEASE; ARACHIDONIC-ACID; PROSTATE-CANCER; RISK-FACTORS; ASSOCIATION; METABOLISM; POLYMORPHISMS	Genetic variants near and within the fatty acid desaturase (FADS) cluster are associated with polyunsaturated fatty acid (PUFA) biosynthesis, levels of several disease biomarkers and risk of human disease. However, determining the functional mechanisms by which these genetic variants impact PUFA levels remains a challenge. Utilizing an Illumina 450K array, we previously reported strong allele-specific methylation (ASM) associations (p = 2.69x10(-29)) between a single nucleotide polymorphism (SNP) rs174537 and DNA methylation of CpG sites located in the putative enhancer region between FADS1 and FADS2, in human liver tissue. However, this array only featured 20 CpG sites within this 12kb region. To better understand the methylation landscape within this region, we conducted bisulfite sequencing of the region between FADS1 and FADS2. Liver tissues from 50 male subjects (27 European Americans, 23 African Americans) were obtained from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study, and used to ascertain the genotype at rs174537 and methylation status across the region of interest. Associations between rs174537 genotype and methylation status of 136 CpG sites were determined. Age-adjusted linear regressions were used to assess ASM associations with rs174537 genotype. The majority of CpG sites (117 out of 136, 86%) exhibited high levels of methylation with the greatest variability observed at three key regulatory regions-the promoter regions for FADS1 and FADS2 and a putative enhancer site between the two genes. Eight CpG sites within the putative enhancer region displayed significant (FDR p < 0.05) ASM associations with rs174537. These data support the concept that both genetic and epigenetic factors regulate PUFA biosynthesis, and raise fundamental questions as to how genetic variants such as rs174537 impact DNA methylation in distant regulatory regions, and ultimately the capacity of tissues to synthesize PUFAs.	[Rahbar, Elaheh] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27157 USA; [Ainsworth, Hannah C.; Langefeld, Carl D.] Wake Forest Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC USA; [Howard, Timothy D.; Hawkins, Gregory A.; Langefeld, Carl D.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Ruczinski, Ingo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Mathias, Rasika] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Seeds, Michael C.] Wake Forest Sch Med, Sect Mol Med, Dept Internal Med, Winston Salem, NC USA; [Sergeant, Susan] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Hixson, James E.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Herrington, David M.] Wake Forest Sch Med, Div Cardiol, Dept Internal Med, Winston Salem, NC USA; [Chilton, Floyd H.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Wake Forest University; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Wake Forest University; Wake Forest University	Rahbar, E (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27157 USA.; Chilton, FH (corresponding author), Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA.	erahbar@wakehealth.edu; schilten@wakehealth.edu		Hixson, James/0000-0002-0849-9315	National Institutes of Health [P50-AT002782, R01-AT008621, 5U01HL080443-04]; WFU Center for Public Health Genomics; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT008621] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080443, K25HL133611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WFU Center for Public Health Genomics; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to acknowledge Dr. Rahbar's startup funds and extramural funding from the National Institutes of Health P50-AT002782, R01-AT008621, and 5U01HL080443-04 for supporting this work and to the WFU Center for Public Health Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Dr. Rahbar's startup funds and extramural funding from the National Institutes of Health P50-AT002782, R01-AT008621 and 5U01HL080443-04 for supporting this work; and to the WFU Center for Public Health Genomics. We also acknowledge James E. Hixson and David M. Herrington for their contributions and support of the original PDAY study.	Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Berquin IM, 2011, CANCER METAST REV, V30, P295, DOI 10.1007/s10555-011-9299-7; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Brookes KJ, 2006, BIOL PSYCHIAT, V60, P1053, DOI 10.1016/j.biopsych.2006.04.025; Cheatham CL, 2015, NUTR RES, V35, P948, DOI 10.1016/j.nutres.2015.09.005; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Cui T, 2016, PROSTATE, V76, P1182, DOI 10.1002/pros.23205; Freemantle E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042696; Gillingham LG, 2013, AM J CLIN NUTR, V97, P195, DOI 10.3945/ajcn.112.043117; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Harslof LBS, 2013, AM J CLIN NUTR, V97, P1403, DOI 10.3945/ajcn.113.058685; Hester AG, 2014, J BIOL CHEM, V289, P22482, DOI 10.1074/jbc.M114.579557; Hoile SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109896; Hong SH, 2013, CLIN INTERV AGING, V8, P585, DOI 10.2147/CIA.S42096; Howard TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097510; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2013, BRIT J NUTR, V109, P1196, DOI 10.1017/S0007114512003108; Lattka E, 2011, AM J CLIN NUTR, V93, P382, DOI 10.3945/ajcn.110.004515; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Lupu DS, 2015, NUTR RES, V35, P939, DOI 10.1016/j.nutres.2015.09.004; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Mathias Rasika A, 2014, Curr Nutr Rep, V3, P139; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Porenta SR, 2013, CANCER PREV RES, V6, P1212, DOI 10.1158/1940-6207.CAPR-13-0131; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Rzehak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013261; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Steer CD, 2012, HUM MOL GENET, V21, P1504, DOI 10.1093/hmg/ddr588; Strong JP, 1997, ANN NY ACAD SCI, V811, P226, DOI 10.1111/j.1749-6632.1997.tb52004.x; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson BA, 2012, FASEB J, V26; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156; Xie L, 2009, J NUTRIGENET NUTRIGE, V2, P243, DOI 10.1159/000255636	46	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0180903	10.1371/journal.pone.0180903	http://dx.doi.org/10.1371/journal.pone.0180903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957329	Green Submitted, gold, Green Published			2022-12-26	WOS:000411985200002
J	Carins Murphy, MR; Jordan, GJ; Brodribb, TJ				Carins Murphy, Madeline R.; Jordan, Gregory J.; Brodribb, Timothy J.			Ferns are less dependent on passive dilution by cell expansion to coordinate leaf vein and stomatal spacing than angiosperms	PLOS ONE			English	Article							DICHOTOMOUS VENATION; FOLIAR VENATION; GAS-EXCHANGE; LAND PLANTS; EVOLUTION; SIZE; ACCLIMATION; ONTOGENY; DENSITY; CO2	Producing leaves with closely spaced veins is a key innovation linked to high rates of photosynthesis in angiosperms. A close geometric link between veins and stomata in angiosperms ensures that investment in enhanced venous water transport provides the strongest net carbon return to the plant. This link is underpinned by "passive dilution" via expansion of surrounding cells. However, it is not known whether this 'passive dilution' mechanism is present in plant lineages other than angiosperms and is another key feature of the angiosperms' evolutionary success. Consequently, we sought to determine whether the 'passive dilution' mechanism is; (i) exclusive to the angiosperms, (ii) a conserved mechanism that evolved in the common ancestor of ferns and angiosperms, or (iii) has evolved continuously over time. To do this we first we assessed the plasticity of vein and stomatal density and epidermal cell size in ferns in response to light environment. We then compared the relationships between these traits found among ferns with modelled relationships that assume vein and stomatal density respond passively to epidermal cell expansion, and with those previously observed in angiosperms. Vein density, stomatal density and epidermal cell size were linked in ferns with remarkably similar relationships to those observed in angiosperms, except that fern leaves had fewer veins per stomata. However, plasticity was limited in ferns and stomatal spacing was dependent on active stomatal differentiation as well as passive cell expansion. Thus, ferns (like angiosperms) appear to coordinate vein and stomatal density with epidermal cell expansion to some extent to maintain a constant ratio between veins and stomata in the leaf. The different general relationships between vein density and stomatal density in ferns and angiosperms suggests the groups have different optimum balances between the production of vein tissue dedicated to water supply and stomatal tissue for gas exchange.	[Carins Murphy, Madeline R.; Jordan, Gregory J.; Brodribb, Timothy J.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia	University of Tasmania	Brodribb, TJ (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	timothyb@utas.edu.au	Brodribb, Timothy John/C-6797-2013; Murphy, Madeline R Carins/K-8086-2013; Jordan, Gregory/B-3932-2013	Brodribb, Timothy John/0000-0002-4964-6107; Murphy, Madeline R Carins/0000-0003-4370-9485; Jordan, Gregory/0000-0002-6033-2766	Australian Research Council [DP 120101686]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (http://www.arc.gov.au/) [DP 120101686 to T.J.B]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum S, 2014, ECOLOGICAL OBSERVATI, V140, P1235; [Anonymous], 1960, [No title captured], DOI DOI 10.1097/00010694-196008000-00031; [Anonymous], 2014, R LANG ENV STAT COMP; BENHAM DM, 1992, AM FERN J, V82, P47, DOI 10.2307/1547377; Bennett MD, 2012, PTERIDOPHYTE DNA C V; Bennett MD, 2012, ANGIOSPERM DNA C VAL; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Boyce CK, 2009, P ROY SOC B-BIOL SCI, V276, P1771, DOI 10.1098/rspb.2008.1919; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2013, NEW PHYTOL, V199, P559, DOI 10.1111/nph.12300; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2017, PLANT CELL ENVIRON, V40, P872, DOI 10.1111/pce.12817; Brodribb TJ, 2011, NEW PHYTOL, V192, P437, DOI 10.1111/j.1469-8137.2011.03795.x; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Cantrill D, 1995, ALCHERINGA, V19, P243, DOI 10.1080/03115519508619508; Carins Murphy MR, 2016, ANN BOT-LONDON, V118, P1127, DOI 10.1093/aob/mcw167; Carins Murphy MR, 2014, PLANT CELL ENVIRON, V37, P124, DOI 10.1111/pce.12136; Carins Murphy MR, 2012, PLANT CELL ENVIRON, V35, P1407, DOI 10.1111/j.1365-3040.2012.02498.x; CHOW WS, 1990, AUST J PLANT PHYSIOL, V17, P665; Clark J, 2016, NEW PHYTOL, V210, P1072, DOI 10.1111/nph.13833; de Boer HJ, 2016, NEW PHYTOL, V210, P1219, DOI 10.1111/nph.13929; Evans-Fitz Gerald C, 2016, FRONT PLANT SCI, V7; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hoshizaki BJ, 1999, AM FERN J, V89, P1, DOI 10.2307/1547452; Leitch IJ, 2005, ANN BOT-LONDON, V95, P207, DOI 10.1093/aob/mci014; McElwain JC, 2016, NEW PHYTOL, V209, P94, DOI 10.1111/nph.13579; McGlone MS, 2005, NEW ZEAL J ECOL, V29, P165; MIRSKY AE, 1951, J GEN PHYSIOL, V34, P451, DOI 10.1085/jgp.34.4.451; Page CN, 2004, EVOLUTION PLANT PHYS, P447; Pantin F, 2012, NEW PHYTOL, V196, P349, DOI 10.1111/j.1469-8137.2012.04273.x; Parris BS, 2001, BRITTONIA, V53, P270, DOI 10.1007/BF02812702; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1985, PLANTA, V165, P158, DOI 10.1007/BF00395038; PRAY TR, 1955, AM J BOT, V42, P698, DOI 10.2307/2438644; PRAY TR, 1955, AM J BOT, V42, P18, DOI 10.2307/2438589; PRAY TR, 1960, AM J BOT, V47, P319, DOI 10.2307/2439217; PRAY TR, 1962, AM J BOT, V49, P464, DOI 10.2307/2439415; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Salisbury EJ, 1928, PHILOS T R SOC LON B, V216, P1, DOI 10.1098/rstb.1928.0001; Sharpe J.M., 2010, FERN ECOLOGY, P1, DOI DOI 10.1017/CBO9780511844898.002; Singh C, 2013, ECOLOGY FERN WEALTH, V2, P327; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; WS R., 1997, IMAGEJ; Zhang SB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102724, 10.1371/journal.pone.0084682]; Zhang XC, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P65; ZURAKOWSKI KA, 1988, AM J BOT, V75, P1559, DOI 10.2307/2444706	48	3	3	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185648	10.1371/journal.pone.0185648	http://dx.doi.org/10.1371/journal.pone.0185648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953931	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000411980300078
J	Couch, CS; Burns, JHR; Liu, G; Steward, K; Gutlay, TN; Kenyon, J; Eakin, CM; Kosaki, RK				Couch, Courtney S.; Burns, John H. R.; Liu, Gang; Steward, Kanoelani; Gutlay, Tiffany Nicole; Kenyon, Jean; Eakin, C. Mark; Kosaki, Randall K.			Mass coral bleaching due to unprecedented marine heatwave in Papahanaumokuakea Marine National Monument (Northwestern Hawaiian Islands)	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; INDIAN-OCEAN; ULTRAVIOLET-RADIATION; THERMAL TOLERANCE; REEF FISHES; IMPACTS; MORTALITY; RECOVERY; COMMUNITIES	2014 marked the sixth and most widespread mass bleaching event reported in the Northwestern Hawaiian Islands, home to the Papahanaumokuakea Marine National Monument (PMNM), the world's second largest marine reserve. This event was associated with an unusual basin-scale warming in the North Pacific Ocean, with an unprecedented peak intensity of around 20 degrees C-weeks of cumulative heat stress at Lisianksi Island. In situ bleaching surveys and satellite data were used to evaluate the relative importance of potential drivers of bleaching patterns in 2014, assess the subsequent morality and its effects on coral communities and 3D complexity, test for signs of regional acclimation, and investigate long-term change in heat stress in PMNM. Surveys conducted at four island/atoll (French Frigate Shoals, Lisianski Island, Pearl and Hermes Atoll, and Midway Atoll) showed that in 2014, percent bleaching varied considerably between islands/atolls and habitats (back reef/fore reef and depth), and was up to 91% in shallow habitats at Lisianski. The percent bleaching during the 2014 event was best explained by a combination of duration of heat stress measured by Coral Reef Watch's satellite Degree Heating Week, relative community susceptibility (bleaching susceptibility score of each taxon * the taxon's abundance relative to the total number of colonies), depth and region. Mean coral cover at permanent Lisianski monitoring sites decreased by 68% due to severe losses of Montipora dilatata complex, resulting in rapid reductions in habitat complexity. Spatial distribution of the 2014 bleaching was significantly different from the 2002 and 2004 bleaching events likely due to a combination of differences in heat stress and local acclimatization. Historical satellite data demonstrated heat stress in 2014 was unlike any previous event and that the exposure of corals to the bleaching-level heat stress has increased significantly in the northern PMNM since 1982, highlighting the increasing threat of climate change to reefs.	[Couch, Courtney S.; Burns, John H. R.; Gutlay, Tiffany Nicole] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Couch, Courtney S.] NOAA, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96818 USA; [Liu, Gang; Eakin, C. Mark] NOAA, Coral Reef Watch, NESDIS, STAR, College Pk, MD USA; [Liu, Gang] Global Sci & Technol Inc, Greenbelt, MD USA; [Steward, Kanoelani] Univ Hawaii, Marine Sci Program, Hilo, HI 96720 USA; [Kenyon, Jean] US Fish & Wildlife Serv, Honolulu, HI USA; [Kosaki, Randall K.] NOAA Papahanaumokuakea Marine Natl Monument, Honolulu, HI USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); University of Hawaii System; University Hawaii Hilo; United States Department of the Interior; US Fish & Wildlife Service; National Oceanic Atmospheric Admin (NOAA) - USA	Couch, CS (corresponding author), Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.; Couch, CS (corresponding author), NOAA, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96818 USA.	courtney.s.couch@noaa.gov	Liu, Gang/E-7921-2011; Eakin, C. Mark/F-5585-2010	Kosaki, Randall/0000-0003-1363-5702; Eakin, C. Mark/0000-0002-5987-0858	NOAA/NOS-HIMB [MOA-2009-039]; US Environmental Protection Agency (EPA) [FP-91768001-0]; ESPCoR Hawai'i (EPS-0903833) Track-I research grant; NOAA Coral Reef Conservation Program to Coral Reef Watch to CME; National Environmental Satellite, Data, and Information Service (NESDIS)	NOAA/NOS-HIMB; US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); ESPCoR Hawai'i (EPS-0903833) Track-I research grant; NOAA Coral Reef Conservation Program to Coral Reef Watch to CME; National Environmental Satellite, Data, and Information Service (NESDIS)	This study was supported by NOAA/NOS-HIMB agreement code MOA-2009-039 to provide salary to CSC, the STAR Fellowship Assistance Agreement no. FP-91768001-0 awarded by the US Environmental Protection Agency (EPA) to provide salary to JB. Funding was also provided by the ESPCoR Hawai'i (EPS-0903833) Track-I research grant to The University of Hawaii to provide salary to JB and KS, the NOAA Coral Reef Conservation Program to Coral Reef Watch to CME and the National Environmental Satellite, Data, and Information Service (NESDIS) for CME. This manuscript has not been formally reviewed by the EPA and the EPA does not endorse any products or commercial services mentioned in this publication. The scientific results and conclusions, as well as any views or opinions expressed herein, are those of the authors and do not necessarily reflect the views of NOAA or the Department of Commerce. Global Science & Technology Inc. provided support in the form of salaries for GL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aeby GS, 2003, CORAL REEFS, V22, P256, DOI 10.1007/s00338-003-0309-2; Alemu JB I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083829; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; BAHR KD, 2015, PEER J, V3, P93148; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Banzon VF, 2014, J CLIMATE, V27, P8221, DOI 10.1175/JCLI-D-14-00293.1; Bay RA, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.044; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns JHR, 2015, PEERJ, V3, DOI 10.7717/peerj.1077; Burns JHR, 2016, METHODS OCEANOGR, V15, P49, DOI DOI 10.1016/J.MIO.2016.04.001; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Castillo KD, 2012, NAT CLIM CHANGE, V2, P756, DOI [10.1038/nclimate1577, 10.1038/NCLIMATE1577]; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; Cochran WG., 1963, SAMPLING TECHNIQUES; Coffroth M.A., 1990, Elsevier Oceanography Series, V52, P141; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Cunning R, 2016, MAR ECOL PROG SER, V551, P131, DOI 10.3354/meps11733; Darling ES, 2017, CORAL REEFS, V36, P561, DOI 10.1007/s00338-017-1539-z; Day T, 2007, AM NAT, V171, pE72; Donlon CJ, 2012, REMOTE SENS ENVIRON, V116, P140, DOI 10.1016/j.rse.2010.10.017; Eakin C., 2016, REEF ENCOUNTER, V31, P20, DOI DOI 10.1007/S00338-019-01844-2; Eakin C. M., 2009, V205, P41; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Edmunds PJ, 2008, MAR ECOL PROG SER, V361, P307, DOI 10.3354/meps07556; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Forsman ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015021; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; GLEASON DF, 1993, NATURE, V365, P836, DOI 10.1038/365836a0; GLEASON MG, 1993, CORAL REEFS, V12, P193, DOI 10.1007/BF00334479; Glynn P., 2015, BIOEROSION CORAL REE, P67, DOI DOI 10.1007/978-94-017-7249-5_4; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Heenan A, 2017, FISH MONITORING BRIE; Heron S, 2015, 145 NOAA NESDIS COLL; Heron SF, 2016, SCI REPORTS, P6; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Kenyon Jean C., 2006, Atoll Research Bulletin, P505; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lasagna R, 2010, FACIES, V56, P1, DOI 10.1007/s10347-009-0193-5; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Liu G, 2013, 143 NOAA NESDIS COLL; Liu G, 2014, REMOTE SENS-BASEL, V6, P11579, DOI 10.3390/rs61111579; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; Meehan WJ, 1997, J TOXICOL ENV HEALTH, V50, P529; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Morri C, 2015, MAR POLLUT BULL, V98, P188, DOI 10.1016/j.marpolbul.2015.06.050; Muscatine L, 1981, OCEANOGRAPHY, V26; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070443; RODGERS KS, 2017, PEER J, V5, P93148; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Seneca FO, 2015, MOL ECOL, V24, P1467, DOI 10.1111/mec.13125; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Swain T, 2017, CONFUCIANISM IN CHINA: AN INTRODUCTION, P1; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; [UK Met Office Office PO. DAAC], 2005, GHRSST LEV 4 OSTIA G; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Wilkinson C, 1999, AMBIO, V28, P188; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	88	69	69	4	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185121	10.1371/journal.pone.0185121	http://dx.doi.org/10.1371/journal.pone.0185121			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953909	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300037
J	Markovits, H; Gauthier, E; Gagnon-St-Pierre, E; Benenson, JF				Markovits, Henry; Gauthier, Evelyne; Gagnon-St-Pierre, Emilie; Benenson, Joyce F.			High status males invest more than high status females in lower status same-sex collaborators	PLOS ONE			English	Article							MALE CHIMPANZEES; CONSEQUENCES; COOPERATION; STRATEGIES; DOMINANCE; EVOLUTION; SCIENCE; WOMEN; RANK	Studies on human cooperation using economic games rarely include ecologically relevant factors. In studies on non-human primates however, both status and sex typically influence patterns of cooperation. Across primate species, high status individuals are more likely to cooperate, though this depends on the species-specific social structure of each sex. Based on human social structure, we predict that higher status males who interact more in hierarchical groups than females, will invest more than high status females in valued same-sex peers after successful cooperation. Across three studies, 187 male and 188 female participants cooperated with a (fictitious) same-sex partner who varied in competence. Participants then divided a reward between themselves and their partner. High status was induced in three different ways in each study, social influence, leadership and power. No overall sex difference in reward sharing was observed. Consistent with the hypothesis however, across all three studies, high status males invested more than high status females in cooperative partners, suggesting that high status males intuitively evaluate sharing rewards with samesex partners as more beneficial.	[Markovits, Henry; Gauthier, Evelyne; Gagnon-St-Pierre, Emilie] Univ Quebec, Dept Psychol, Succ Ctr Ville, Montreal, PQ, Canada; [Benenson, Joyce F.] Emmanuel Coll, Fac Sci, Boston, MA USA; [Benenson, Joyce F.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	University of Quebec; University of Quebec Montreal; Harvard University	Markovits, H (corresponding author), Univ Quebec, Dept Psychol, Succ Ctr Ville, Montreal, PQ, Canada.	henry.markovits@gmail.com			Social Sciences and Humanities Research Council of Canada [24753]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Preparation of this manuscript was supported by an Insight grant #24753 from the Social Sciences and Humanities Research Council of Canada to H. M. and J. F. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aries E, 1996, MEN WOMEN INTERACTIO; Balliet D, 2011, PSYCHOL BULL, V137, P881, DOI 10.1037/a0025354; BARGH JA, 1995, J PERS SOC PSYCHOL, V68, P768, DOI 10.1037/0022-3514.68.5.768; Bediou B, 2012, SOC JUSTICE RES, V25, P25, DOI 10.1007/s11211-012-0151-1; Benenson JF, 2008, INT J PRIMATOL, V29, P1019, DOI 10.1007/s10764-008-9283-4; Benenson JF, 2014, CURR BIOL, V24, pR190, DOI 10.1016/j.cub.2013.12.047; Benenson JF, 2011, PSYCHOL SCI, V22, P538, DOI 10.1177/0956797611402511; Benenson JF, 2009, P ROY SOC B-BIOL SCI, V276, P2589, DOI 10.1098/rspb.2009.0314; Bissonnette A, 2014, BEHAV ECOLOGY; Bissonnette A, 2015, BEHAVIOUR, V152, P1, DOI 10.1163/1568539X-00003241; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; CHARLESWORTH WR, 1987, CHILD DEV, V58, P191, DOI 10.2307/1130301; Cheng JT, 2013, J PERS SOC PSYCHOL, V104, P103, DOI 10.1037/a0030398; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; David-Barrett T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118329; DEWAAL F, 1982, CHIMPANZEE POLITICS; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; Ellemers N, 2004, BRIT J SOC PSYCHOL, V43, P315, DOI 10.1348/0144666042037999; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Foot Hugh C., 1980, FRIENDSHIP SOCIAL RE, P293; Frohlich N, 2004, PUBLIC CHOICE, V119, P91, DOI 10.1023/B:PUCH.0000024169.08329.eb; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Magee JC, 2005, LEAS ORG MAN SERIES, P275; Markovits H, 2001, CHILD DEV, V72, P879, DOI 10.1111/1467-8624.00321; Mast MS, 2004, SWISS J PSYCHOL, V63, P107, DOI 10.1024/1421-0185.63.2.107; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Omark D.R., 1975, PSYCHOL ANTHR, P289; Plott Charles R., 2008, HDB EXPT EC RESULTS, V1, P509, DOI DOI 10.1016/S1574-0722(07)00057-1; SAVINWILLIAMS RC, 1979, CHILD DEV, V50, P923, DOI 10.1111/j.1467-8624.1979.tb02451.x; SAVINWILLIAMS RC, 1980, J YOUTH ADOLESCENCE, V9, P75, DOI 10.1007/BF02088381; TESSER A, 1988, J PERS SOC PSYCHOL, V54, P49, DOI 10.1037/0022-3514.54.1.49; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P3; von Neumann J., 2004, THEORY GAMES EC BEHA; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1	42	3	3	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185408	10.1371/journal.pone.0185408	http://dx.doi.org/10.1371/journal.pone.0185408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953938	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300062
J	Martinez-Vargas, J; Ventura, J; Machuca, A; Munoz-Munoz, F; Fernandez, MC; Soto-Navarrete, MT; Duran, AC; Fernandez, B				Martinez-Vargas, Jessica; Ventura, Jacint; Machuca, Angela; Munoz-Munoz, Francesc; Carmen Fernandez, Maria; Teresa Soto-Navarrete, Maria; Carmen Duran, Ana; Fernandez, Borja			Cardiac, mandibular and thymic phenotypical association indicates that cranial neural crest underlies bicuspid aortic valve formation in hamsters	PLOS ONE			English	Article							MORPHOLOGICAL INTEGRATION; KNOWLEDGE GAPS; CELLS; EVOLUTIONARY; MODULARITY; MALFORMATIONS; INDIVIDUALS; SYSTEM; HETEROGENEITY; MORPHOGENESIS	Bicuspid aortic valve (BAV) is the most prevalent human congenital cardiac malformation. It may appear isolated, associated with other cardiovascular malformations, or forming part of syndromes. Cranial neural crest (NC) defects are supposed to be the cause of the spectrum of disorders associated with syndromic BAV. Experimental studies with an inbred hamster model of isolated BAV showed that alterations in the migration or differentiation of the cardiac NC cells in the embryonic cardiac outflow tract are most probably responsible for the development of this congenital valvular defect. We hypothesize that isolated BAV is not the result of local, but of early alterations in the behavior of the NC cells, thus also affecting other cranial NC-derived structures. Therefore, we tested whether morphological variation of the aortic valve is linked to phenotypic variation of the mandible and the thymus in the hamster model of isolated BAV, compared to a control strain. Our results show significant differences in the size and shape of the mandible as well as in the cellular composition of the thymus between the two strains, and in mandible shape regarding the morphology of the aortic valve. Given that both the mandible and the thymus are cranial NC derivatives, and that the cardiac NC belongs to the cephalic domain, we propose that the causal defect leading to isolated BAV during embryonic development is not restricted to local alterations of the cardiac NC cells in the cardiac outflow tract, but it is of pleiotropic or polytopic nature. Our results suggest that isolated BAV may be the forme fruste of a polytopic syndrome involving the cranial NC in the hamster model and in a proportion of affected patients.	[Martinez-Vargas, Jessica; Ventura, Jacint; Munoz-Munoz, Francesc] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Cerdanyola Del Valles, Spain; [Machuca, Angela; Carmen Fernandez, Maria; Teresa Soto-Navarrete, Maria; Carmen Duran, Ana; Fernandez, Borja] Univ Malaga, Fac Ciencias, Dept Biol Anim, Malaga, Spain; [Carmen Fernandez, Maria; Carmen Duran, Ana; Fernandez, Borja] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Fernandez, Borja] CIBERCV Enfermedades Cardiovasc, Malaga, Spain	Autonomous University of Barcelona; Universidad de Malaga; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Ventura, J (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Cerdanyola Del Valles, Spain.	jacint.ventura.queija@uab.cat	Muñoz Muñoz, Francesc/L-1997-2014; /AAG-9282-2020; Corujo, Francisco Borja Fernández/AAG-8258-2020; Soto-Navarrete, Maria Teresa/AAG-7163-2020; Martinez-Vargas, Jessica/G-2064-2019	Muñoz Muñoz, Francesc/0000-0003-2084-0368; Corujo, Francisco Borja Fernández/0000-0001-9179-910X; Fernandez, M. Carmen/0000-0002-9051-8668; Ventura, Jacint/0000-0001-7527-1532; Martinez-Vargas, Jessica/0000-0003-4689-5228	Junta de Andalucia (Sevilla, Spain) [P10-6068/2010, PI-0689/2010]	Junta de Andalucia (Sevilla, Spain)(Junta de Andalucia)	This work was supported by Grants P10-6068/2010 and PI-0689/2010 from Junta de Andalucia (Sevilla, Spain).	Andelfinger G, 2002, AM J HUM GENET, V71, P663, DOI 10.1086/342360; Atchley William R., 1993, P207; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; BAILEY DW, 1986, J HERED, V77, P17, DOI 10.1093/oxfordjournals.jhered.a110159; Basso C, 2004, AM J CARDIOL, V93, P661, DOI 10.1016/j.amjcard.2003.11.031; BLAU JN, 1965, NATURE, V208, P564, DOI 10.1038/208564a0; Bodey B, 1997, IN VIVO, V11, P61; Bodey B, 2000, IN VIVO, V14, P407; Bodey B, 1996, IN VIVO, V10, P39; BRONNERFRASER M, 1995, EXP CELL RES, V218, P405, DOI 10.1006/excr.1995.1173; Burgio G, 2012, G3-GENES GENOM GENET, V2, P1257, DOI 10.1534/g3.112.003285; Chai Y, 2000, DEVELOPMENT, V127, P1671; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; CHEVERUD JM, 1991, J CRAN GENET DEV BIO, V11, P122; Collins MJ, 2008, J CLIN PATHOL, V61, P530, DOI 10.1136/jcp.2007.051904; Creazzo TL, 1998, ANNU REV PHYSIOL, V60, P267, DOI 10.1146/annurev.physiol.60.1.267; Della Corte A, 2014, J THORAC CARDIOV SUR, V147, P1749, DOI 10.1016/j.jtcvs.2014.01.021; Dryden IL, 1998, STAT SHAPE ANAL, V3820; Duran A C, 1995, J Heart Valve Dis, V4, P581; Duran AC, 2015, J ANAT, V226, P501, DOI 10.1111/joa.12317; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044; Fernandez MC, 2000, LAB ANIM-UK, V34, P145, DOI 10.1258/002367700780457545; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; GIUSTI S, 1991, Giornale Italiano di Cardiologia, V21, P189; Good P, 1994, PERMUTATION TESTS PR; Janossy G, 1986, Curr Top Pathol, V75, P89; Jiang XB, 2000, DEVELOPMENT, V127, P1607; John AS, 2009, AM J MED GENET A, V149A, P939, DOI 10.1002/ajmg.a.32770; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; KAPPETEIN AP, 1991, J THORAC CARDIOV SUR, V102, P830, DOI 10.1016/S0022-5223(19)33931-5; Keyte AL, 2014, BIRTH DEFECTS RES C, V102, P309, DOI 10.1002/bdrc.21076; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 1998, P ROY SOC B-BIOL SCI, V265, P1255, DOI 10.1098/rspb.1998.0427; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; KURATANI S, 1990, ARCH HISTOL CYTOL, V53, P267, DOI 10.1679/aohc.53.267; Laforest B, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/180297; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; Lewin MB, 2004, PEDIATRICS, V114, P691, DOI 10.1542/peds.2003-0782-L; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Loffredo CA, 2004, AM J MED GENET A, V124A, P225, DOI 10.1002/ajmg.a.20366; Makki N, 2012, HUM MOL GENET, V21, P26, DOI 10.1093/hmg/ddr434; Mangini A, 2010, EUR J CARDIO-THORAC, V37, P1015, DOI 10.1016/j.ejcts.2009.11.048; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Martinez-Maza C, 2012, J ANAT, V220, P472, DOI 10.1111/j.1469-7580.2012.01488.x; Mathieu P, 2015, J PATHOL CLIN RES, V1, P195, DOI 10.1002/cjp2.21; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McElhinney DB, 2002, CIRCULATION, V106, P2567, DOI 10.1161/01.CIR.0000037221.45902.69; Michelena HI, 2014, CIRCULATION, V129, P2691, DOI 10.1161/CIRCULATIONAHA.113.007851; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Miyabara S, 1997, AM J MED GENET, V68, P135, DOI 10.1002/(SICI)1096-8628(19970120)68:2<135::AID-AJMG3>3.0.CO;2-O; MOERMAN P, 1987, BRIT HEART J, V58, P274; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Munoz-Munoz F, 2011, J EVOLUTION BIOL, V24, P1763, DOI 10.1111/j.1420-9101.2011.02312.x; NODEN DM, 1988, DEVELOPMENT, V103, P121; Opitz JM, 1993, BIRTH DEFECTS ORIG A, V29, P1; Phillips HM, 2013, CARDIOVASC RES, V99, P452, DOI 10.1093/cvr/cvt132; Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073; Raica M, 2006, ANN ANAT, V188, P345, DOI 10.1016/j.aanat.2006.01.012; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; Roberts WC, 2012, MEDICINE, V91, P287, DOI 10.1097/MD.0b013e3182764b84; Rohlf FJ, 2001, TPSDIG V 1 31 PC PRO, V1; Sans-Coma V., 1993, CARDIOL YOUNG, V3, P132, DOI DOI 10.1017/S1047951100001396; Sans-Coma V, 2012, J ANAT, V220, P92, DOI 10.1111/j.1469-7580.2011.01440.x; SANSCOMA V, 1994, ACTA ANAT, V149, P255; SansComa V, 1996, ANAT RECORD, V244, P490, DOI 10.1002/(SICI)1097-0185(199604)244:4<490::AID-AR7>3.0.CO;2-Z; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Scambler Peter James, 1994, Seminars in Developmental Biology, V5, P303, DOI 10.1006/sedb.1994.1039; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Siman CM, 2000, TERATOLOGY, V61, P355, DOI 10.1002/(SICI)1096-9926(200005)61:5<355::AID-TERA7>3.0.CO;2-W; Sperling JS, 2015, INT J CARDIOL, V184, P1, DOI 10.1016/j.ijcard.2015.02.013; Thomas PS, 2010, DEV BIOL, V340, P613, DOI 10.1016/j.ydbio.2010.02.021; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	81	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0183556	10.1371/journal.pone.0183556	http://dx.doi.org/10.1371/journal.pone.0183556			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953926	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300008
J	Wang, S; Li, W; Chang, KK; Liu, J; Guo, QQ; Sun, HF; Jiang, M; Zhang, H; Chen, J; Hu, JD				Wang, Shun; Li, Wei; Chang, Keke; Liu, Juan; Guo, Qingqian; Sun, Haifeng; Jiang, Min; Zhang, Hao; Chen, Jing; Hu, Jiandong			Localized surface plasmon resonance-based abscisic acid biosensor using aptamerfunctionalized gold nanoparticles	PLOS ONE			English	Article							FREE COLORIMETRIC DETECTION; TRAP MASS-SPECTROMETRY; PLANT HORMONES; LABEL-FREE; OPTICAL-PROPERTIES; AU NANOPARTICLES; APTAMER; PHYTOHORMONE; SELECTION; PROTEIN	Abscisic acid (ABA) plays an important role in abiotic stress response and physiological signal transduction resisting to the adverse environment. Therefore, it is very essential for the quantitative detection of abscisic acid (ABA) due to its indispensable role in plant physiological activities. Herein, a new detection method based on localized surface plasmon resonance (LSPR) using aptamer-functionalized gold nanoparticles (AuNPs) is developed without using expensive instrument and antibody. In the presence of ABA, ABA specifically bind with their aptamers to form the ABA-aptamer complexes with G-quadruplex-like structure and lose the ability to stabilize AuNPs against NaCl-induced aggregation. Meanwhile, the changes of the LSPR spectra of AuNP solution occur and therefore the detection of ABA achieved. Under optimized conditions, this method showed a good linear range covering from 5x10(-7) M to 5x10(-5) M with a detection limit of 0.33 mu M. In practice, the usage of this novel method has been demonstrated by its application to detect ABA from fresh leaves of rice with the relative error of 6.59%-7.93% compared with ELISA bioassay. The experimental results confirmed that this LSPR-based biosensor is simple, selective and sensitive for the detection of ABA. The proposed LSPR method could offer a new analytical platform for the detection of other plant hormones by changing the corresponding aptamer.	[Wang, Shun; Chang, Keke; Guo, Qingqian; Sun, Haifeng; Zhang, Hao; Chen, Jing; Hu, Jiandong] Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Henan, Peoples R China; [Wang, Shun; Li, Wei; Chang, Keke; Guo, Qingqian; Sun, Haifeng; Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China; [Li, Wei] Henan Agr Univ, Coll Sci, Zhengzhou, Henan, Peoples R China; [Liu, Juan] Henan Agr Univ, Coll Agron, Zhengzhou, Henan, Peoples R China; [Jiang, Min] Henan Agr Univ, Coll Life Sci, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Henan, Peoples R China.; Hu, JD (corresponding author), State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China.	jiandonghu@163.com						Ashaduzzaman M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44027; Bosco R, 2013, J AGR FOOD CHEM, V61, P10940, DOI 10.1021/jf4034305; Chen YY, 2011, BIOSENS BIOELECTRON, V26, P3160, DOI 10.1016/j.bios.2010.12.019; Chen ZB, 2013, ANAL CHIM ACTA, V787, P189, DOI 10.1016/j.aca.2013.05.020; Du GS, 2016, ANAL BIOCHEM, V514, P2, DOI 10.1016/j.ab.2016.09.006; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gomez-Cadenas A, 2015, CURR PROTEIN PEPT SC, V16, P413, DOI 10.2174/1389203716666150330130102; Gomez-Grana S, 2015, CHEM MATER, V27, P8310, DOI 10.1021/acs.chemmater.5b03620; Gong X, 2014, ANAL CHIM ACTA, V828, P80, DOI 10.1016/j.aca.2014.04.028; Grozio A, 2013, NUCLEIC ACID THER, V23, P322, DOI 10.1089/nat.2013.0418; Hill HD, 2006, NAT PROTOC, V1, P324, DOI 10.1038/nprot.2006.51; Izumi Y, 2009, ANAL CHIM ACTA, V648, P215, DOI 10.1016/j.aca.2009.07.001; Kim JE, 2016, BIOSENS BIOELECTRON, V80, P543, DOI 10.1016/j.bios.2016.02.015; Kim YS, 2010, BIOSENS BIOELECTRON, V26, P1644, DOI 10.1016/j.bios.2010.08.046; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Lee YH, 2012, LANGMUIR, V28, P321, DOI 10.1021/la204047a; Li F, 2009, ANALYST, V134, P1355, DOI 10.1039/b900900k; Li HX, 2004, P NATL ACAD SCI USA, V101, P14036, DOI 10.1073/pnas.0406115101; Li HX, 2004, J AM CHEM SOC, V126, P10958, DOI 10.1021/ja048749n; Li HX, 2004, ANAL CHEM, V76, P5414, DOI 10.1021/ac049173n; Li Q, 2010, CHINESE CHEM LETT, V21, P472, DOI 10.1016/j.cclet.2009.12.005; Li YW, 2008, ANAL BIOANAL CHEM, V391, P2869, DOI 10.1007/s00216-008-2214-6; Li ZJ, 2015, BIOSENS BIOELECTRON, V68, P668, DOI 10.1016/j.bios.2015.01.062; Liu X, 2003, J CHROMATOGR A, V1021, P209, DOI 10.1016/j.chroma.2003.09.004; Lopez-Carbonell M, 2009, PLANT PHYSIOL BIOCH, V47, P256, DOI 10.1016/j.plaphy.2008.12.016; Lu QM, 2015, J CHROMATOGR B, V992, P8, DOI 10.1016/j.jchromb.2015.04.014; Luo C, 2015, RSC ADV, V5, P10994, DOI 10.1039/c4ra14833a; Maye MM, 2003, ANAL CHIM ACTA, V496, P17, DOI 10.1016/S0003-2670(03)00986-3; McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014; Miransari M, 2014, ENVIRON EXP BOT, V99, P110, DOI 10.1016/j.envexpbot.2013.11.005; Mishra P, 2017, NANO ENERGY, V39, P601, DOI 10.1016/j.nanoen.2017.06.023; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Pavlov V, 2004, J AM CHEM SOC, V126, P11768, DOI 10.1021/ja046970u; Polavarapu L, 2014, J MATER CHEM C, V2, P7460, DOI 10.1039/c4tc01142b; Shiohara A, 2014, NANOSCALE, V6, P9817, DOI 10.1039/c4nr02648a; Song KM, 2011, ANAL BIOCHEM, V415, P175, DOI 10.1016/j.ab.2011.04.007; Storhoff JJ, 1998, J AM CHEM SOC, V120, P1959, DOI 10.1021/ja972332i; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wang RZ, 2009, ANAL LETT, V42, P2893, DOI 10.1080/00032710903201909; Wei H, 2007, CHEM COMMUN, P3735, DOI 10.1039/b707642h; Wu ZS, 2010, ANAL CHEM, V82, P3890, DOI 10.1021/ac100422h; Zheng Y, 2011, SENSOR ACTUAT B-CHEM, V156, P95, DOI 10.1016/j.snb.2011.03.077	43	9	9	6	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185530	10.1371/journal.pone.0185530	http://dx.doi.org/10.1371/journal.pone.0185530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953934	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300073
J	Adeyemi, O; Alvarez-Laviada, A; Schultz, F; Ibrahim, E; Trauner, M; Williamson, C; Glukhov, AV; Gorelik, J				Adeyemi, Oladipupo; Alvarez-Laviada, Anita; Schultz, Francisca; Ibrahim, Effendi; Trauner, Michael; Williamson, Catherine; Glukhov, Alexey V.; Gorelik, Julia			Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis	PLOS ONE			English	Article							INTRAHEPATIC CHOLESTASIS; BILE-ACID; IN-VITRO; RAT CARDIOMYOCYTES; ELECTROPHYSIOLOGICAL PROPERTIES; CA2+ CHANNEL; FETAL HEART; PREGNANCY; SODIUM; HEMODYNAMICS	Background Increased maternal serum bile acid concentrations in intrahepatic cholestasis of pregnancy (ICP) are associated with fetal cardiac arrhythmias. Ursodeoxycholic acid (UDCA) has been shown to demonstrate anti-arrhythmic properties via preventing ICP-associated cardiac conduction slowing and development of reentrant arrhythmias, although the cellular mechanism is still being elucidated. Methods High-resolution fluorescent optical mapping of electrical activity and electrocardiogram measurements were used to characterize effects of UDCA on one-day-old neonatal and adult female Langendorff-perfused rat hearts. ICP was modelled by perfusion of taurocholic acid (TC, 400 mu M). Whole-cell calcium currents were recorded from neonatal rat and human fetal cardiomyocytes. Results TC significantly prolonged the PR interval by 11.0 +/- 3.5% (P<0.05) and slowed ventricular conduction velocity (CV) by 38.9 +/- 5.1% (P<0.05) exclusively in neonatal and not in maternal hearts. A similar CV decline was observed with the selective T-type calcium current (I-Ca, T) blocker mibefradil 1 mu M (23.0 +/- 6.2%, P<0.05), but not with the L-type calcium current (I-Ca, L) blocker nifedipine 1 mu M (6.9 +/- 6.6%, NS). The sodium channel blocker lidocaine (30 mu M) reduced CV by 60.4 +/- 4.5% (P<0.05). UDCA co-treatment was protective against CV slowing induced by TC and mibefradil, but not against lidocaine. UDCA prevented the TC-induced reduction in the ICa, T density in both isolated human fetal (-10.2 +/- 1.5 versus -5.5 +/- 0.9 pA/pF, P<0.05) and neonatal rat ventricular myocytes (-22.3 +/- 1.1 versus -9.6 +/- 0.8 pA/pF, P<0.0001), whereas UDCA had limited efficacy on the I-Ca, L. Conclusion Our findings demonstrate that I-Ca, T plays a significant role in ICP-associated fetal cardiac conduction slowing and arrhythmogenesis, and is an important component of the fetus-specific anti-arrhythmic activity of UDCA.	[Adeyemi, Oladipupo; Alvarez-Laviada, Anita; Schultz, Francisca; Ibrahim, Effendi; Glukhov, Alexey V.; Gorelik, Julia] Imperial Coll London, Natl Heart & Lung Inst, Dept Cardiovasc Sci, London, England; [Schultz, Francisca; Williamson, Catherine] Imperial Coll London, Inst Reprod & Dev Biol, London, England; [Ibrahim, Effendi] MARA Technol Univ, Fac Med, Sungai Buloh, Malaysia; [Trauner, Michael] Med Univ Vienna, Dept Med 3, Vienna, Austria; [Williamson, Catherine] Kings Coll London, Womens Hlth Acad Ctr, London, England; [Glukhov, Alexey V.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA	Imperial College London; Imperial College London; Medical University of Vienna; University of London; King's College London; University of Wisconsin System; University of Wisconsin Madison	Glukhov, AV; Gorelik, J (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Dept Cardiovasc Sci, London, England.; Glukhov, AV (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA.	aglukhov@medicine.wisc.edu; j.gorelik@ic.ac.uk		Gorelik, Julia/0000-0003-1148-9158; Trauner, Michael/0000-0002-1275-6425; Schultz, Francisca/0000-0002-8923-2128	National Institute for Health Research (NIHR) Biomedical Research Centres based at Imperial College Healthcare NHS Trust and Imperial College London and at Guy's and St Thomas' NHS Foundation Trust; HRUK; Universiti Teknologi MARA in Malaysia; NIH grant [R01-HL126802]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126802] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR) Biomedical Research Centres based at Imperial College Healthcare NHS Trust and Imperial College London and at Guy's and St Thomas' NHS Foundation Trust; HRUK; Universiti Teknologi MARA in Malaysia; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Tissue samples were provided by the Imperial College Healthcare NHS Trust Tissue Bank. The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centres based at Imperial College Healthcare NHS Trust and Imperial College London and at Guy's and St Thomas' NHS Foundation Trust-CW, HRUK-JG, Universiti Teknologi MARA in Malaysia-El, NIH grant R01-HL126802-JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Al Inizi S, 2006, INT J GYNECOL OBSTET, V93, P53, DOI 10.1016/j.ijgo.2005.12.030; ANDERSON KP, 1990, CIRCULATION, V81, P1024, DOI 10.1161/01.CIR.81.3.1024; Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Bahrle S, 1998, J HEART LUNG TRANSPL, V17, P592; Baruch Y, 1999, AM J GASTROENTEROL, V94, P3000, DOI 10.1111/j.1572-0241.1999.01450.x; BINAH O, 1987, N-S ARCH PHARMACOL, V335, P160; Brites D, 1998, EUR J OBSTET GYN R B, V80, P31, DOI 10.1016/S0301-2115(98)00086-4; Ferron L, 2002, J MOL CELL CARDIOL, V34, P533, DOI 10.1006/jmcc.2002.1535; Fouad YM, 2014, WORLD J HEPATOL, V6, P41, DOI 10.4254/wjh.v6.i1.41; Geenes V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083828; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glukhov AV, 2010, AM J PHYSIOL-HEART C, V299, pH482, DOI 10.1152/ajpheart.00756.2009; Gorelik J, 2004, BJOG-INT J OBSTET GY, V111, P867, DOI 10.1111/j.1471-0528.2004.00166.x; Gorelik J, 2003, BJOG-INT J OBSTET GY, V110, P467, DOI 10.1016/S1470-032(03)02973; Joutsiniemi T, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0324-0; Kadir SHSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009689; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; KOTAKE H, 1989, BRIT J PHARMACOL, V98, P357, DOI 10.1111/j.1476-5381.1989.tb12604.x; Lee WY, 1999, ARCH PHARM RES, V22, P479, DOI 10.1007/BF02979156; Leuranguer V, 2000, AM J PHYSIOL-HEART C, V279, pH2540, DOI 10.1152/ajpheart.2000.279.5.H2540; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; Niwa N, 2004, AM J PHYSIOL-HEART C, V286, pH2257, DOI 10.1152/ajpheart.01043.2003; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Rainer PP, 2013, HEART, V99, P1685, DOI 10.1136/heartjnl-2013-304163; Rajesh KG, 2005, J MOL CELL CARDIOL, V39, P766, DOI 10.1016/j.yjmcc.2005.07.014; Scalia S, 2000, J PHARM PHARMACOL, V52, P383, DOI 10.1211/0022357001774129; Schiedermaier P, 2000, DIGESTION, V61, P107, DOI 10.1159/000007742; Schultz F, 2016, PROG BIOPHYS MOL BIO, V120, P149, DOI 10.1016/j.pbiomolbio.2016.01.003; Shaw RM, 1997, CIRC RES, V81, P727; Strehlow SL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.035; von Haehling S, 2012, J AM COLL CARDIOL, V59, P585, DOI 10.1016/j.jacc.2011.10.880; Williamson C, 2001, CLIN SCI, V100, P363, DOI 10.1042/CS20000164; Williamson C, 2014, OBSTET GYNECOL, V124, P120, DOI 10.1097/AOG.0000000000000346; Wong F, 1999, CLIN SCI, V96, P467, DOI 10.1042/CS19980275	35	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183167	10.1371/journal.pone.0183167	http://dx.doi.org/10.1371/journal.pone.0183167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934223	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900007
J	Berger, HR; Nyman, AKG; Morken, TS; Vettukattil, R; Brubakk, AM; Wideroe, M				Berger, Hester Rijkje; Nyman, Axel K. G.; Morken, Tora Sund; Vettukattil, Riyas; Brubakk, Ann-Mari; Wideroe, Marius			Early metabolite changes after melatonin treatment in neonatal rats with hypoxic-ischemic brain injury studied by in-vivo H-1 MR spectroscopy	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE DMSO; IMMATURE RAT; WHITE-MATTER; CELL-DEATH; NEUROPROTECTION; GLUTATHIONE; HYPOTHERMIA; MECHANISMS; INFANT; DAMAGE	Melatonin is a promising neuroprotective agent after perinatal hypoxic-ischemic (HI) brain injury. We used in-vivo H-1 magnetic resonance spectroscopy to investigate effects of melatonin treatment on brain metabolism after HI. Postnatal day 7 Sprague-Dawley rats with unilateral HI brain injury were treated with either melatonin 10 mg/kg dissolved in phosphatebuffered saline (PBS) with 5% dimethyl sulfoxide (DMSO) or vehicle (5% DMSO and/or PBS) directly and at 6 hours after HI. H-1 MR spectra from the thalamus in the ipsilateral and contralateral hemisphere were acquired 1 day after HI. Our results showed that injured animals had a distinct metabolic profile in the ipsilateral thalamus compared to sham with low concentrations of total creatine, choline, N-acetyl aspartate (NAA), and high concentrations of lipids. A majority of the melatonin-treated animals had a metabolic profile characterized by higher total creatine, choline, NAA and lower lipid levels than other HI animals. When comparing absolute concentrations, melatonin treatment resulted in higher glutamine levels and lower lipid concentrations compared to DMSO treatment as well as higher macromolecule levels compared to PBS treatment day 1 after HI. DMSO treated animals had lower concentrations of glucose, creatine, phosphocholine and macromolecules compared to sham animals. In conclusion, the neuroprotective effects of melatonin were reflected in a more favorable metabolic profile including reduced lipid levels that likely represents reduced cell injury. Neuroprotective effects may also be related to the influence of melatonin on glutamate/glutamine metabolism. The modulatory effects of the solvent DMSO on cerebral energy metabolism might have masked additional beneficial effects of melatonin.	[Berger, Hester Rijkje; Morken, Tora Sund; Brubakk, Ann-Mari] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Berger, Hester Rijkje] St Olavs Univ Hosp HF, Dept Pediat, Trondheim, Norway; [Nyman, Axel K. G.; Vettukattil, Riyas; Wideroe, Marius] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Morken, Tora Sund] St Olavs Univ Hosp HF, Dept Ophthalmol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Berger, HR (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway.	hester.berger@ntnu.no		Vettukattil, Riyas/0000-0002-2152-4933	Medical Faculty at the Norwegian University of Science and Technology (NTNU)	Medical Faculty at the Norwegian University of Science and Technology (NTNU)	The work was financially supported by a grant from the Medical Faculty at the Norwegian University of Science and Technology (NTNU).	Ahn SY, 2013, J KOREAN MED SCI, V28, P1071, DOI 10.3346/jkms.2013.28.7.1071; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Berger HR, 2016, J NEUROCHEM, V136, P339, DOI 10.1111/jnc.13420; Cheong JLY, 2006, AM J NEURORADIOL, V27, P1546; Colella M, 2016, EARLY HUM DEV, V102, P1, DOI 10.1016/j.earlhumdev.2016.09.001; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Hassell K. J., 2013, FETAL MATERN MED REV, V24, P76, DOI DOI 10.1017/S0965539513000089; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Jacobs S. E., 2013, COCHRANE DB SYST REV, P1; Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7; Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4; Malisza KL, 1999, NMR BIOMED, V12, P31, DOI 10.1002/(SICI)1099-1492(199902)12:1<31::AID-NBM544>3.0.CO;2-M; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; McLean C, 2004, SEMIN PERINATOL, V28, P425, DOI 10.1053/j.semperi.2004.10.005; Morken TS, 2014, STROKE, V45, P2777, DOI 10.1161/STROKEAHA.114.005341; MUJSCE DJ, 1990, PEDIATR RES, V27, P450, DOI 10.1203/00006450-199005000-00007; Nasrallah FA, 2008, J NEUROSCI RES, V86, P208, DOI 10.1002/jnr.21477; Osredkar D, 2014, RESUSCITATION, V85, P567, DOI 10.1016/j.resuscitation.2013.12.006; Palmer C, 2003, FETAL NEONATAL BRAIN; Panigrahy A, 2010, PEDIATR RADIOL, V40, P3, DOI 10.1007/s00247-009-1450-z; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; PukaSundvall M, 1997, BRAIN RES, V750, P325, DOI 10.1016/S0006-8993(97)00024-3; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; Robertson NJ, 2012, J PEDIATR-US, V160, P544, DOI 10.1016/j.jpeds.2011.12.052; Sanmartin-Suarez C, 2011, J PHARMACOL TOX MET, V63, P209, DOI 10.1016/j.vascn.2010.10.004; Stelmashook EV, 2011, INT J NEUROSCI, V121, P415, DOI 10.3109/00207454.2011.570464; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; van de Looij Y, 2011, MAGN RESON MED, V65, P305, DOI 10.1002/mrm.22617; Vannucci RC, 2004, J CEREBR BLOOD F MET, V24, P1090, DOI 10.1097/01.WCB.0000133250.03953.63; Volpe J.J., 2008, NEUROLOGY NEWBORN; Wallin C, 2000, DEV BRAIN RES, V125, P51, DOI 10.1016/S0165-3806(00)00112-7; Welin AK, 2007, PEDIATR RES, V61, P153, DOI 10.1203/01.pdr.0000252546.20451.1a; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447	40	8	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185202	10.1371/journal.pone.0185202	http://dx.doi.org/10.1371/journal.pone.0185202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934366	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900120
J	Tsuchiya, S; Buhr, ED; Higashide, T; Sugiyama, K; Van Gelder, RN				Tsuchiya, Shunsuke; Buhr, Ethan D.; Higashide, Tomomi; Sugiyama, Kazuhisa; Van Gelder, Russell N.			Light entrainment of the murine intraocular pressure circadian rhythm utilizes non-local mechanisms	PLOS ONE			English	Article							DEEP BRAIN PHOTORECEPTOR; AQUEOUS-HUMOR DYNAMICS; PERIPHERAL-TISSUES; HEALTHY-ADULTS; MOUSE; MICE; MELANOPSIN; RABBITS; OSCILLATORS; RECEPTORS	Purpose Intraocular pressure (IOP) is known to have a strong circadian rhythm, yet how light/dark cycles entrain this rhythm is unknown. The purpose of this study was to assess whether, like the retina, the mammalian ciliary body and IOP clocks have an intrinsic ability to entrain to light/dark cycles. Methods Iris-ciliary body complexes were obtained from period2:luciferase (PER2::LUC) mice and cultured to measure bioluminescence rhythmicity. Pairs of the iris-ciliary body complex were exposed to antiphasic 9:15 h light/dark cycle in vitro. After 4 days of exposure to light/dark cycles, bioluminescence was recorded to establish their circadian phases. In addition, pairs of the iris-ciliary body complex co-cultured with the retinas or corneas of wild-type mice were also investigated. The IOP circadian changes of free-running Opn4(-/-); rd1/rd1 mice whose behavior was antiphasic to wild-type were measured by a rebound tonometry, and compared with wild-type mice. Opn3, Opn4, and Opn5 mRNA expression in the iris-ciliary body were analyzed using RT-PCR. Results The iris/ciliary body complex expressed Opn3, Opn4, and Opn5 mRNA; however, unlike in retina and cornea, neither the iris-CB complex nor the co-cultured complex was directly entrained by light-dark cycle in vitro. The diurnal IOP change of Opn4(-/-); rd1/rd1 mice showed an antiphasic pattern to wild-type mice and their rhythms followed the whole-animal behavioral rhythm. Conclusions Despite expressing mRNA for several non-visual opsins, circadian rhythms of the iris-ciliary body complex of mice do not entrain directly to light-dark cycles ex vivo. Unlike retina, the iris/ciliary body clocks of blind mice remain synchronized to the organismal behavioral rhythm rather than local light-dark cycles. These results suggest that IOP rhythm entrainment is mediated by a systemic rather than local signal in mice.	[Tsuchiya, Shunsuke; Buhr, Ethan D.; Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; [Tsuchiya, Shunsuke; Higashide, Tomomi; Sugiyama, Kazuhisa] Kanazawa Univ, Dept Ophthalmol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kanazawa University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA.; Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.; Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA.	russvg@uw.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Buhr, Ethan/0000-0002-9250-6644	National Institutes of Health [P30 EY001730]; Research to Prevent Blindness; Mark J. Daily, MD Research Fund; Japan Society for the Promotion of Science [17K11420]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Mark J. Daily, MD Research Fund; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by National Institutes of Health P30 EY001730, an unrestricted grant from Research to Prevent Blindness, the Mark J. Daily, MD Research Fund, and Japan Society for the Promotion of Science Grant-in-Aid for scientific research 17K11420.	Aihara M, 2003, EXP EYE RES, V77, P681, DOI 10.1016/j.exer.2003.08.011; Aihara M, 2008, INVEST OPHTH VIS SCI, V49, P929, DOI 10.1167/iovs.07-0386; Alcantara-Contreras S, 2011, NEUROSCI LETT, V494, P61, DOI 10.1016/j.neulet.2011.02.056; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P492, DOI 10.1001/archopht.1963.00960050494011; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Blackshaw S, 1999, J NEUROSCI, V19, P3681; BRASLOW RA, 1987, INVEST OPHTH VIS SCI, V28, P1730; Buhr ED, 2015, P NATL ACAD SCI USA, V112, P13093, DOI 10.1073/pnas.1516259112; Buhr ED, 2014, P NATL ACAD SCI USA, V111, P8625, DOI 10.1073/pnas.1323350111; Dalvin LA, 2015, INVEST OPHTH VIS SCI, V56, P2657, DOI 10.1167/iovs.15-16449; De Moraes CG, 2016, OPHTHALMOLOGY; Dibner C., 2010, ANN REV PHYSL; GREGORY DS, 1990, INVEST OPHTH VIS SCI, V31, P715; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; LIU JHK, 1995, J OCUL PHARMACOL TH, V11, P379, DOI 10.1089/jop.1995.11.379; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4050, DOI 10.1167/iovs.06-0183; Maslenikow Z, 1904, Z AUGENHEILKD, V11, P564; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moore CG, 1996, CURR EYE RES, V15, P185, DOI 10.3109/02713689608997412; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Nakane Y, 2014, CURR BIOL, V24, pR596, DOI 10.1016/j.cub.2014.05.038; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Nau CB, 2013, INVEST OPHTH VIS SCI, V54, P7623, DOI [10.1167/iovs.13-12690, 10.1167/iovs.12-12690]; Nissila J, 2012, J COMP PHYSIOL A, V198, P833, DOI 10.1007/s00359-012-0754-x; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; ROWLAND JM, 1981, CURR EYE RES, V1, P169, DOI 10.3109/02713688109001822; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; Sidler-Huguenin A, 1898, BEITR AUGENHEILKD, V32; Sit AJ, 2008, INVEST OPHTH VIS SCI, V49, P1473, DOI 10.1167/iovs.07-1139; Stokes J, 2000, INVEST OPHTH VIS SCI, V41, P1629; Tsuchiya S, 2017, CURR EYE RES, V42, P1013, DOI 10.1080/02713683.2016.1264605; Van Gelder RN, 2003, SCIENCE, V300, P1534, DOI 10.1126/science.1085446; Wang WH, 2005, INVEST OPHTH VIS SCI, V46, P4617, DOI 10.1167/iovs.05-0781; Wilensky J T, 1991, Trans Am Ophthalmol Soc, V89, P757; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhao M, 2010, INVEST OPHTH VIS SCI, V51, P3145, DOI 10.1167/iovs.09-4415	40	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184790	10.1371/journal.pone.0184790	http://dx.doi.org/10.1371/journal.pone.0184790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934261	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900044
J	William, D; Mokri, P; Lamp, N; Linnebacher, M; Classen, CF; Erbersdobler, A; Schneider, B				William, Doreen; Mokri, Poroshista; Lamp, Nora; Linnebacher, Michael; Classen, Carl Friedrich; Erbersdobler, Andreas; Schneider, Bjoern			Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ONCOGENE AMPLIFICATION; HUMAN GLIOMAS; PHASE-III; EXPRESSION; TRIAL; DNA; CYCLOOXYGENASE-2; TEMOZOLOMIDE; MAINTENANCE	Glioblastoma multiforme (GBM) is the most common and lethal brain tumor in adults. It is known that amplification of the epidermal growth factor receptor gene (EGFR) occurs in approximately 40% of GBM, leading to enhanced activation of the EGFR signaling pathway and promoting tumor growth. Although GBM mutations are stably maintained in GBM in vitro models, rapid loss of EGFR gene amplification is a common observation during cell culture. To maintain EGFR amplification in vitro, heterotopic GBM xenografts with elevated EGFR copy number were cultured under varying serum conditions and EGF concentrations. EGFR copy numbers were assessed over several passages by quantitative PCR and chromogenic in situ hybridization. As expected, in control assays with 10% FCS, cells lost EGFR amplification with increasing passage numbers. However, cells cultured under serum free conditions stably maintained elevated copy numbers. Furthermore, EGFR protein expression positively correlated with genomic amplification levels. Although elevated EGFR copy numbers could be maintained over several passages in vitro, levels of EGFR amplification were variable and dependent on the EGF concentration in the medium. In vitro cultures of GBM cells with elevated EGFR copy number and corresponding EGFR protein expression should prove valuable preclinical tools to gain a better understanding of EGFR driven glioblastoma and assist in the development of new improved therapies.	[William, Doreen; Mokri, Poroshista; Classen, Carl Friedrich] Univ Med Rostock, Children & Adolescents Hosp, Rostock, Germany; [Lamp, Nora; Erbersdobler, Andreas; Schneider, Bjoern] Univ Med Rostock, Inst Pathol, Rostock, Germany; [Linnebacher, Michael] Univ Med Rostock, Dept Gen Surg Mol Oncol & Immunotherapy, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	William, D (corresponding author), Univ Med Rostock, Children & Adolescents Hosp, Rostock, Germany.	doreen.william@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021; William, Doreen/AHA-1288-2022	Linnebacher, Michael/0000-0001-8054-1402; 				Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; Chen C, 2015, J NEURO-ONCOL, V122, P595, DOI 10.1007/s11060-015-1752-y; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dijkstra JR, 2012, J MOL DIAGN, V14, P187, DOI 10.1016/j.jmoldx.2012.01.002; DOLECEK TA, 2005, NEUROONCOLOGY S5, V14, P1, DOI DOI 10.1093/NEUONC/N0S218; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; HUMPHREY PA, 1988, CANCER RES, V48, P2231; Kircher SM, 2016, CANCER J, V22, P182, DOI 10.1097/PPO.0000000000000192; Lee EQ, 2015, CLIN CANCER RES, V21, P3610, DOI 10.1158/1078-0432.CCR-14-3220; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lyustikman Y, 2008, NEOPLASIA, V10, P501, DOI 10.1593/neo.08206; Maletzki C, 2016, ONCOTARGET, V7, P53583, DOI 10.18632/oncotarget.10677; Matsuda H, 2005, FORENSIC SCI INT, V152, P109, DOI 10.1016/j.forsciint.2004.07.019; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; McCoach CE, 2016, DRUG TODAY, V52, P561, DOI 10.1358/dot.2016.52.10.2541343; MULERIS M, 1994, ONCOGENE, V9, P2717; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nikolaev S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6690; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pollo B, 2011, NEUROL SCI, V32, pS209, DOI 10.1007/s10072-011-0802-2; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Shinojima N, 2003, CANCER RES, V63, P6962; Shono T, 2001, CANCER RES, V61, P4375; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thorne AH, 2016, NEURO-ONCOLOGY, V18, P914, DOI 10.1093/neuonc/nov319; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; Westphal M, 2015, EUR J CANCER, V51, P522, DOI 10.1016/j.ejca.2014.12.019; William D, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1128-5; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185208	10.1371/journal.pone.0185208	http://dx.doi.org/10.1371/journal.pone.0185208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934307	gold, Green Submitted, Green Published			2022-12-26	WOS:000411339900123
J	Zheng, YM; Jit, M; Wu, JT; Yang, J; Leung, K; Liao, QH; Yu, HJ				Zheng, Yaming; Jit, Mark; Wu, Joseph T.; Yang, Juan; Leung, Kathy; Liao, Qiaohong; Yu, Hongjie			Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China	PLOS ONE			English	Article							CHILDREN; BURDEN	Background Hand, foot and mouth disease (HFMD) is a common illness in China that mainly affects infants and children. The objective of this study is to assess the economic cost and health-related quality of life associated with HFMD in China. Method A telephone survey of caregivers were conducted in 31 provinces across China. Caregivers of laboratory-confirmed HFMD patients who were registered in the national HFMD enhanced surveillance database during 2012-2013 were invited to participate in the survey. Total costs included direct medical costs (outpatient care, inpatient care and self-medication), direct non-medical costs (transportation, nutrition, accommodation and nursery), and indirect costs for lost income associated with caregiving. Health utility weights elicited using EuroQol EQ-5D-3L and EQ-Visual Analogue Scale (VAS) were used to calculate associated loss in quality adjusted life years (QALYs). Results The subjects comprised 1136 mild outpatients, 1124 mild inpatients, 1170 severe cases and 61 fatal cases. The mean total costs for mild outpatients, mild inpatients, severe cases and fatal cases were $201 (95% CI $187, $215), $1072 (95% CI $999, $1144), $3051 (95% CI $2905, $3197) and $2819 (95% CI $2068, $3571) respectively. The mean QALY losses per HFMD episode for mild outpatients, mild inpatients and severe cases were 3.6 (95% CI 3.4, 3,9), 6.9 (95% CI 6.4, 7.4) and 13.7 (95% CI 12.9, 14.5) per 1000 persons. Cases who were diagnosed with EV-A71 infection and had longer duration of illness were associated with higher total cost and QALY loss. Conclusion HFMD poses a high economic and health burden in China. Our results provide economic and health utility data for cost-effectiveness analysis for HFMD vaccination in China.	[Zheng, Yaming; Yang, Juan; Liao, Qiaohong] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Jit, Mark] Publ Hlth England, Modelling & Econ Unit, London, England; [Jit, Mark] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Wu, Joseph T.; Leung, Kathy] Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Yu, Hongjie] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China	Chinese Center for Disease Control & Prevention; Public Health England; University of London; London School of Hygiene & Tropical Medicine; University of Hong Kong; World Health Organization; Fudan University	Yu, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.	cfetpyhj@vip.sina.com	Leung, Kathy/D-5605-2017; Wu, Joseph/ABD-5880-2021; Jit, Mark/HDM-7797-2022; Yu, Hongjie/GZK-5351-2022; Wu, Joseph Tsz Kei/C-4450-2009	Leung, Kathy/0000-0003-4777-388X; Wu, Joseph Tsz Kei/0000-0002-3155-5987; Jit, Mark/0000-0001-6658-8255	National Science Fund for Distinguished Young Scholars [81525023]; WHO Study on Seasonal Influenza Vaccine Use in China Program; Diagnosis Standard for National Notifiable Disease Program; Study on Suitable Technology for Early Detection and Automatic Early Warning of Outbreak of Infectious Diseases; National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); WHO Study on Seasonal Influenza Vaccine Use in China Program; Diagnosis Standard for National Notifiable Disease Program; Study on Suitable Technology for Early Detection and Automatic Early Warning of Outbreak of Infectious Diseases; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the National Science Fund for Distinguished Young Scholars (No. 81525023) (http://www.nsfc.gov.cn/publish/portal1/) (HY), WHO Study on Seasonal Influenza Vaccine Use in China Program (HY), Diagnosis Standard for National Notifiable Disease Program (HY), Study on Suitable Technology for Early Detection and Automatic Early Warning of Outbreak of Infectious Diseases (HY), National Institute of General Medical Sciences grant U54GM088558 (JTW). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	[Anonymous], 2016, HFMD SURV SUMM W PAC; [Anonymous], EXCH RAT 2013; China Food and Drug Administration, CHIN FOOD DRUG ADM A; [Chinese Center for Disease Control and Prevention Division of infectious disease], 2016, INF DIS REP; Gan ZK, 2015, HUM VACC IMMUNOTHER, V11, P2400, DOI 10.1080/21645515.2015.1059980; General office of Ministry of Health, 2010, HFMD CLIN DIAGN TREA; He T, 2012, SHANGHAI J PREVENTIV, V24, P476; Herdman M, 2016, VALUE HEALTH, V19, P255, DOI 10.1016/j.jval.2015.11.003; Karimi M, 2016, PHARMACOECONOMICS, V34, P645, DOI 10.1007/s40273-016-0389-9; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Ma T, 2014, PREV MED TRIB, V20, P484; Ma Ying, 2012, THESIS; Martin Alan, 2008, J Med Econ, V11, P471, DOI 10.3111/13696990802321047; National Bureau of Statistics of People Republic of China, GDP PER CAP 2013; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; [秦玉君 QIN Yu-jun], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P1319; Shi P, 2014, CHIN J DIS CONTROL P, V18, P577; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; The central peoples government of Peoples Republic OF China, NOT STAFF WORK HOURS; Thorrington D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135672; Thorrington D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105153; Wang ZL, 2016, EPIDEMIOL INFECT, V144, P138, DOI 10.1017/S0950268815001569; Wu JT, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001975; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang TianChi, 2012, Disease Surveillance, V27, P520; Yu Shicheng, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P271; Yuan GP, 2013, SHANGHAI J PREV MED, V25, P577	29	9	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184266	10.1371/journal.pone.0184266	http://dx.doi.org/10.1371/journal.pone.0184266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934232	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900025
J	Belkacem, N; Serafini, N; Wheeler, R; Derrien, M; Boucinha, L; Couesnon, A; Cerf-Bensussan, N; Boneca, IG; Di Santo, JP; Taha, MK; Bourdet-Sicard, REL				Belkacem, Nouria; Serafini, Nicolas; Wheeler, Richard; Derrien, Muriel; Boucinha, Lilia; Couesnon, Aurelie; Cerf-Bensussan, Nadine; Boneca, Ivo Gomperts; Di Santo, James P.; Taha, Muhamed-Kkeir; Bourdet-Sicard, Raphaelle			Lactobacillus paracasei feeding improves immune control of influenza infection in mice	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; FERMENTED DAIRY PRODUCT; CASEI DN-114 001; VIRUS INFECTION; MICROBIOTA; DURATION; CONSUMPTION; PROBIOTICS; EFFICACY; BACTERIA	Respiratory tract infections such as flu cause severe morbidity and mortality and are among the leading causes of death in children and adults worldwide. Commensal microbiota is critical for orchestrating tissue homeostasis and immunity in the intestine. Probiotics represent an interesting source of immune modulators and several clinical studies have addressed the potential beneficial effects of probiotics against respiratory infections. Therefore, we have investigated the mechanisms of protection conferred by L. paracasei CNCM I-1518 strain in a mouse model of influenza infection. Notably, local myeloid cells accumulation is generated in the lungs after seven days feeding with L. paracasei prior to viral infection. L. paracaseifed mice showed reduced susceptibility to the influenza infection, associated with less accumulation of inflammatory cells in the lungs, faster viral clearance and general health improvement. Interestingly, Allobaculum was significantly increased in L. paracaseifed mice 7 days after influenza infection, even if the gut microbiota composition was not altered overall. L. paracasei-purified peptidoglycan partially recapitulated the protective phenotype observed with the entire bacteria. Collectively, our results demonstrate that oral consumption of L. paracasei CNCM I-1518 modulates lung immunity was associated with an improved control of influenza infection. These results further extend the beneficial role for certain lactobacilli to alleviate the burden of respiratory tract infections.	[Belkacem, Nouria; Taha, Muhamed-Kkeir] Inst Pasteur, Invas Bacterial Infect Unit, Paris, France; [Belkacem, Nouria; Boucinha, Lilia; Couesnon, Aurelie; Bourdet-Sicard, Raphaelle] Bioaster, Paris, France; [Serafini, Nicolas; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, Paris, France; [Serafini, Nicolas; Di Santo, James P.] INSERM, U1223, Paris, France; [Wheeler, Richard; Boneca, Ivo Gomperts] Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, Dept Microbiol, Paris, France; [Wheeler, Richard; Boneca, Ivo Gomperts] INSERM, Paris, France; [Derrien, Muriel] DanoneNutricia Res, Palaiseau, France; [Couesnon, Aurelie; Cerf-Bensussan, Nadine] Univ Paris 05, Sorbonne Paris Cite, INSERM, U1163,Lab Intestinal Immun, Paris, France; [Couesnon, Aurelie; Cerf-Bensussan, Nadine] Inst Imagine, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Taha, MK (corresponding author), Inst Pasteur, Invas Bacterial Infect Unit, Paris, France.; Bourdet-Sicard, REL (corresponding author), Bioaster, Paris, France.	mktaha@pasteur.fr; Raphaelle.BOURDET-SICARD@danone.com	Derrien, Muriel/AAS-6845-2021; Cerf-Bensussan, nadine/H-9505-2017; Di Santo, James P/M-4298-2014; SERAFINI, nicolas/S-5675-2019; Boneca, Ivo G/H-1677-2014; WHEELER, Richard/AAB-8262-2022	Derrien, Muriel/0000-0001-8841-9153; Cerf-Bensussan, nadine/0000-0003-0665-1245; Di Santo, James P/0000-0002-7146-1862; SERAFINI, nicolas/0000-0002-7440-4353; Boneca, Ivo G/0000-0001-8122-509X; WHEELER, Richard/0000-0002-9249-2377	CI IMMUNOBIOTIC [1307014/00 IRT BAP301]; Danone [30000221]; Institut Pasteur; Danone Nutricia Research; Bioaster	CI IMMUNOBIOTIC; Danone(Danone Nutricia); Institut Pasteur(European Commission); Danone Nutricia Research(Danone Nutricia); Bioaster	The study was supported by the following grants: CI IMMUNOBIOTIC 1307014/00 IRT BAP301, Danone 30000221 as well as by the Institut Pasteur. In addition to funding, Danone Nutricia Research and Bioaster provided coordination and management. In addition, Danone Nutricia Research made available Lactobacilli strains and performed Microbiota analysis. The funders had no role in study design, decision to publish, or preparation of the manuscript. MD and RBS are employed by Danone Nutricia Research. Danone Nutricia Research provided support in the form of salaries for authors MD and RBS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso JM, 2003, FEMS MICROBIOL LETT, V222, P99, DOI 10.1016/S0378-1097(03)00252-0; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins JW, 2014, J INFECT DIS, V210, P1029, DOI 10.1093/infdis/jiu205; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; de Araujo GV, 2015, J PEDIAT-BRAZIL, V91, P413, DOI 10.1016/j.jped.2015.03.002; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; GRAVENSTEIN S, 1994, J AM GERIATR SOC, V42, P245, DOI 10.1111/j.1532-5415.1994.tb01746.x; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Guillemard E, 2010, BRIT J NUTR, V103, P58, DOI 10.1017/S0007114509991395; Guillemard E, 2010, J AM COLL NUTR, V29, P455, DOI 10.1080/07315724.2010.10719882; Hao QK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006895.pub3; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; He Y, 2017, CRIT REV MICROBIOL, V43, P81, DOI [10.1080/1040841X.2016.1176988, 10.1080/1040841x.2016.1176988]; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kawase M, 2012, FEMS IMMUNOL MED MIC, V64, P280, DOI 10.1111/j.1574-695X.2011.00903.x; King S, 2014, BRIT J NUTR, V112, P41, DOI 10.1017/S0007114514000075; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Merenstein D, 2010, EUR J CLIN NUTR, V64, P669, DOI 10.1038/ejcn.2010.65; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Nagai T, 2011, INT IMMUNOPHARMACOL, V11, P2246, DOI 10.1016/j.intimp.2011.09.012; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Szatanik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022210; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; Wheeler RM, 2014, J ADV NURS, V70, P350, DOI 10.1111/jan.12197; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; Zarantonelli ML, 2013, CELL HOST MICROBE, V13, P735, DOI 10.1016/j.chom.2013.04.016	53	51	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e184976	10.1371/journal.pone.0184976	http://dx.doi.org/10.1371/journal.pone.0184976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931041	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700051
J	Youn, H; Lee, HK; Sohn, HR; Park, UH; Kim, EJ; Youn, B; Um, SJ				Youn, H.; Lee, H-K; Sohn, H-R; Park, U-H; Kim, E-J; Youn, B.; Um, S-J			RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells	ONCOGENE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; EMBRYONAL CARCINOMA-CELLS; BCL-2 RELATED GENE; RETINOIC ACID; DIFFERENTIATION; CANCER; EXPRESSION; RECEPTORS; APOPTOSIS; GROWTH	Retinoic acid (RA) has broad clinical applications for the treatment of various cancers, particularly acute promyelocytic leukemia. However, RA-based therapy is limited by relapse in patients associated with RA resistance, the mechanism of which is poorly understood. Here, we suggest a new molecular mechanism of RA resistance by a repressor, named RA resistance factor (RaRF). RaRF suppressed transcriptional activity of the RA receptor (RAR) by directly interacting with and sequestering RAR to the nucleolus in response to RA. RaRF was highly expressed in RA-resistant leukemia cells and its expression was strongly correlated with RA sensitivity. MCL1 was upregulated by RA treatment upon RaRF depletion, accompanying leukemic myeloblast differentiation, which is negatively regulated by ectopic RaRF expression. Collectively, we propose that RaRF may be a factor in the resistance mechanism and thus a potential target for leukemia therapy using RA.	[Youn, H.; Lee, H-K; Sohn, H-R; Park, U-H; Um, S-J] Sejong Univ, Dept Integrat Biosci & Biotechnol, 209 Neungdong Ro, Seoul 05006, South Korea; [Kim, E-J] Dankook Univ, Dept Mol Biol, Cheonan Si, Chungnam, South Korea; [Youn, B.] Pusan Natl Univ, Dept Biol Sci, Busan 46241, South Korea	Sejong University; Dankook University; Pusan National University	Kim, EJ; Um, SJ (corresponding author), Sejong Univ, Dept Integrat Biosci & Biotechnol, 209 Neungdong Ro, Seoul 05006, South Korea.	nbrejk@dankook.ac.kr; umsj@sejong.ac.kr		LEE, HYE KYUNG/0000-0002-7785-5942	Korea Food Research Institute; Basic Science Research Program through NRF grant, Republic of Korea [2014R1A2A1A11052685, 2016R1D1A1B03931405]	Korea Food Research Institute; Basic Science Research Program through NRF grant, Republic of Korea	We would like to thank Dr Masahiro Kizaki (Division of Hematology and Clinical Laboratories, Keio University School of Medicine, Japan) and Dr Chi-Dug Kang (Pusan National University School of Medicine, Korea) for providing UF-1 and NB4 cells, respectively. This study was supported in part by a grant from the Korea Food Research Institute (to SJU) and a grant of the Basic Science Research Program through NRF grant (2014R1A2A1A11052685 to SJU and 2016R1D1A1B03931405 to HY), Republic of Korea.	Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Berghofer-Hochheimer Y, 1998, J CELL BIOCHEM, V69, P1, DOI 10.1002/(SICI)1097-4644(19980401)69:1<1::AID-JCB1>3.0.CO;2-X; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; CHAMBON P, 1995, RECENT PROG HORM RES, V50, P317; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; DE LUCA LM, 1991, FASEB J, V5, P2924; DEGOS L, 1995, BLOOD, V85, P2643, DOI 10.1182/blood.V85.10.2643.bloodjournal85102643; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Gerbi SA, 2003, CURR OPIN CELL BIOL, V15, P318, DOI 10.1016/S0955-0674(03)00049-8; GRIGNANI F, 1994, BLOOD, V83, P10; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Gushima M, 2010, MOL CELL ENDOCRINOL, V319, P14, DOI 10.1016/j.mce.2010.01.006; Han HS, 2004, INT J CANCER, V109, P58, DOI 10.1002/ijc.11643; Hasina R, 2006, ONCOGENE, V25, P588, DOI 10.1038/sj.onc.1209070; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lall R, 2009, CELL BIOL INT, V33, P447, DOI 10.1016/j.cellbi.2009.01.015; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; Martindill DMJ, 2008, CELL CYCLE, V7, P17, DOI 10.4161/cc.7.1.5228; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; O'Malley B, 2008, MOL ENDOCRINOL, V22, P2751, DOI 10.1210/me.2008-0297; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Okita H, 1998, BBA-GENE STRUCT EXPR, V1398, P335, DOI 10.1016/S0167-4781(98)00059-1; Okuno M, 2004, CURR CANCER DRUG TAR, V4, P285, DOI 10.2174/1568009043333023; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Oren T, 2003, LEUKEMIA LYMPHOMA, V44, P1881, DOI 10.1080/1042819031000116661; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Schlenk RF, 2005, LEUKEMIA, V19, P978, DOI 10.1038/sj.leu.2403766; Schulz M, 2001, BIOCHEM BIOPH RES CO, V280, P476, DOI 10.1006/bbrc.2000.4141; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Um SJ, 2003, INT J CANCER, V107, P1038, DOI 10.1002/ijc.11489; Um SJ, 2014, BIOCHEM BIOPH RES CO, V444, P605, DOI 10.1016/j.bbrc.2014.01.105; Um SJ, 2012, BIOCHEM BIOPH RES CO, V418, P290, DOI 10.1016/j.bbrc.2012.01.013; Umezawa A, 1996, CELL STRUCT FUNCT, V21, P143, DOI 10.1247/csf.21.143; Wang R, 2016, CLIN CANCER RES, V22, P1211, DOI 10.1158/1078-0432.CCR-15-0663; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; Yang J, 2013, APOPTOSIS, V18, P1403, DOI 10.1007/s10495-013-0872-0; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; Zhuang J, 2006, CELL DEATH DIFFER, V13, P1263, DOI 10.1038/sj.cdd.4401952	50	2	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					352	362		10.1038/onc.2017.329	http://dx.doi.org/10.1038/onc.2017.329			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28945224				2022-12-26	WOS:000422753900008
J	Yun, MR; Choi, HM; Kang, HN; Lee, Y; Joo, HS; Kim, DH; Kim, HR; Hong, MH; Yoon, SO; Cho, BC				Yun, M. R.; Choi, H. M.; Kang, H. N.; Lee, Yw; Joo, H-S; Kim, D. H.; Kim, H. R.; Hong, M. H.; Yoon, S. O.; Cho, B. C.			ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma	ONCOGENE			English	Article							I PI3K INHIBITOR; PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR; EPITHELIAL-MESENCHYMAL TRANSITION; PHASE-I; BUPARLISIB BKM120; LUNG-CANCER; EGFR INHIBITORS; DOSE-ESCALATION; METASTATIC HEAD; COMBINATION	Hyperactivation of phosphatidylinositol 3-kinase (PI3K) pathway occurs frequently in head and neck squamous cell carcinoma (HNSCC). However, clinical outcomes of targeting the PI3K pathway have been underwhelming. In present study, we investigated the resistant mechanisms and potential combination therapeutic strategy to overcome adaptive resistance to PI3K inhibitor in HNSCC. Treatment of NVP-BKM120, a pan-PI3K inhibitor, led to upregulation of interleukin-6 (IL-6) and subsequent activation of either extracellular signal-regulated kinase (ERK) or signal transducers and activators of transcription 3 (STAT3), causing modest antitumor effects on the growth of HNSCC cells. Blockade of autocrine IL-6 signaling with siRNA or neutralizing antibody for IL-6 receptor (IL-6R) completely abolished NVP-BKM120-induced activation of ERK and STAT3 as well as expression of c-Myc oncogene, which resulted in enhanced sensitivity to NVP-BKM120. Moreover, when compared with a pharmacologic inhibitor or silencing of STAT3, trametinib, a MEK inhibitor, in combination with NVP-BKM120 yielded more potent anti-proliferative effects by inhibiting S phase transition, arresting cells at G0/G1 phase, and downregulating IL-6 and c-Myc expression. Furthermore, as compared with either agent alone, combination of NVP-BKM120 with trametinib or tocilizumab, a humanized anti-IL-6R antibody, significantly suppressed tumor growth in NVP-BKM120-resistant patient-derived tumor xenograft (PDTX) models, which was also confirmed in PDTX-derived cell lines. Collectively, these results suggested that IL-6/ERK signaling is closely involved in adaptive resistance of NVP-BKM120 in HNSCC cells, providing a rationale for a novel combination therapy to overcome resistance to PI3K inhibitors.	[Yun, M. R.; Kang, H. N.; Joo, H-S; Kim, D. H.; Cho, B. C.] JEUK Co Ltd, JEUK Inst Canc Res, Gumi, Kyungbuk, South Korea; [Yun, M. R.; Choi, H. M.; Kang, H. N.; Lee, Yw; Kim, H. R.; Hong, M. H.; Cho, B. C.] Yonsei Univ, Div Med Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea; [Yoon, S. O.] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, BC (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Yonsei Canc Ctr,Div Med Oncol, 50 Yonsei Ro, Seoul 120752, South Korea.	cbc1971@yuhs.ac		Kim, Hye Ryun/0000-0002-1842-9070; Hong, Min Hee/0000-0003-3490-2195; Cho, Byoung Chul/0000-0002-5562-270X	National Research Foundation of Korea (NRF) - Korea government [NRF-2014R1A1A1006865, 2015R1A2A1A15055817]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) funded by the Korea government (NRF-2014R1A1A1006865 to MR Yun and 2015R1A2A1A15055817 to BC Cho).	Awad Mark M, 2014, Clin Adv Hematol Oncol, V12, P429; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bhattacharya N, 2009, J ORAL PATHOL MED, V38, P759, DOI 10.1111/j.1600-0714.2009.00781.x; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Brachmann SM, 2012, MOL CANCER THER, V11, P1747, DOI 10.1158/1535-7163.MCT-11-1021; Du L, 2012, J ONCOL, V2012, DOI 10.1155/2012/450179; Eichten A, 2016, CANCER RES, V76, P2327, DOI 10.1158/0008-5472.CAN-15-1443; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fallahi-Sichani M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20166796; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Giudice FS, 2013, J CARCINOG MUTAGEN, V2, P5; Grana B, 2011, J CLIN ONCOL, V29; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Haddad R, 2013, LANCET ONCOL, V14, P257, DOI 10.1016/S1470-2045(13)70011-1; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Heo TH, 2016, ONCOTARGET, V7, P15460, DOI 10.18632/oncotarget.7102; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; Hyman DM, 2015, CANCER CHEMOTH PHARM, V75, P747, DOI 10.1007/s00280-015-2693-z; Jimeno A, 2015, ORAL ONCOL, V51, P383, DOI 10.1016/j.oraloncology.2014.12.013; Kim HS, 2015, CLIN CANCER RES, V21, P544, DOI 10.1158/1078-0432.CCR-14-1756; Kim HR, 2015, CO CLIN TRIALS DEMON; Kim SM, 2012, MOL CANCER THER, V11, P2254, DOI 10.1158/1535-7163.MCT-12-0311; Klempner SJ, 2013, CANCER DISCOV, V3, P1345, DOI 10.1158/2159-8290.CD-13-0063; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Leon X, 2005, CLIN ONCOL-UK, V17, P418, DOI 10.1016/j.clon.2005.02.014; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lovly CM, 2014, CLIN CANCER RES, V20, P2249, DOI 10.1158/1078-0432.CCR-13-1610; Ma PF, 2016, THERANOSTICS, V6, P1232, DOI 10.7150/thno.14409; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Massarelli E, 2015, ANN ONCOL, V26, P1476, DOI 10.1093/annonc/mdv194; Michmerhuizen Nicole L, 2016, Otorhinolaryngol Head Neck Surg, V1, P44; Miller A, 2015, ONCOGENE, V34, P1510, DOI 10.1038/onc.2014.99; Mohan S, 2015, CLIN CANCER RES, V21, P3946, DOI 10.1158/1078-0432.CCR-14-3377; Munster PN, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.3018; Nagasaki T, 2014, RECEPTORS CLIN INVES, V1, pe202; Neel DS, 2013, CLIN CANCER RES, V19, P3, DOI 10.1158/1078-0432.CCR-12-3232; Patel JD, 2014, J CLIN ONCOL, V32, P129, DOI 10.1200/JCO.2013.53.7076; Ren H, 2016, ONCOTARGET, V7, P67277, DOI 10.18632/oncotarget.11645; Ren H, 2012, CANCER LETT, V325, P139, DOI 10.1016/j.canlet.2012.06.018; Rodon J, 2014, INVEST NEW DRUG, V32, P670, DOI 10.1007/s10637-014-0082-9; Roper J, 2014, CANCER LETT, V347, P204, DOI 10.1016/j.canlet.2014.02.018; Rosell R, 2013, TRANSL LUNG CANCER R, V2, P152, DOI 10.3978/j.issn.2218-6751.2012.12.08; Scherzad A, 2015, INT J ONCOL, V47, P391, DOI 10.3892/ijo.2015.3009; Shapiro GI, 2014, CLIN CANCER RES, V20, P233, DOI 10.1158/1078-0432.CCR-13-1777; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi YJ, 2011, J BIOL CHEM, V286, P67, DOI 10.1074/jbc.M110.153221; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sos ML, 2014, CELL REP, V8, P1037, DOI 10.1016/j.celrep.2014.07.010; Stanam A, 2015, MOL ONCOL, V9, P1371, DOI 10.1016/j.molonc.2015.03.008; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun SY, 2014, CANCER RES, V74, P7546, DOI 10.1158/0008-5472.CAN-14-0826; Vansteenkiste JF, 2015, J THORAC ONCOL, V10, P1319, DOI 10.1097/JTO.0000000000000607; Vermorken JB, 2008, CANCER-AM CANCER SOC, V112, P2710, DOI 10.1002/cncr.23442; Von Hoff DD, 2010, J CLIN ONCOL, V28, P2541; Vyse S, 2017, J MOL BIOL, V429, P1767, DOI 10.1016/j.jmb.2017.04.018; Wei W, 2016, CANCER CELL, V29, P563, DOI 10.1016/j.ccell.2016.03.012; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yang L, 2014, BIOCHEM BIOPH RES CO, V453, P582, DOI 10.1016/j.bbrc.2014.09.129; Zhang H, 2015, ONCOTARGET, V6, P3085, DOI 10.18632/oncotarget.3099	62	20	21	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					377	388		10.1038/onc.2017.339	http://dx.doi.org/10.1038/onc.2017.339			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28945228				2022-12-26	WOS:000422753900010
J	Saeed, WK; Jun, DW; Jang, K; Chae, YJ; Lee, JS; Kang, HT				Saeed, Wager K.; Jun, Dae Won; Jang, Kiseok; Chae, Yeon Ji; Lee, Jai Sun; Kang, Hyeon Tae			Does necroptosis have a crucial role in hepatic ischemia-reperfusion injury?	PLOS ONE			English	Article							NECROTIC CELL-DEATH; ISCHEMIA/REPERFUSION INJURY; REACTIVE OXYGEN; CYCLOSPORINE-A; NECROSTATIN-1; NECROSIS; CONTRIBUTES; DAMAGE; MODEL	Background Previous studies have demonstrated protective effects of anti-receptor interacting protein kinase 1 (RIP1), a key necroptosis molecule. However, it is uncertain whether necroptosis has a crucial role in hepatic IR injury. Therefore, we evaluated the role of necroptosis in hepatic IR injury. Method The IR mice underwent 70% segmental IR injury induced by the clamping of the hepatic artery and portal vein for 1 hr followed by reperfusion for 4 hr. The key necroptosis molecules (RIP1, RIP3, and MLKL) and other key molecules of regulated necrosis (PGAM5 and caspase-1) were evaluated in the warm IR injury model. A RIP1 inhibitor (necrostain-1s) and/or an anti-mitochondrial permeability transition (MPT)-mediated necrosis mediator (cyclosporine A, CyA) were administered before clamping. Necrotic injury was quantified using Suzuki's scoring system. qRT-PCR and western blot were performed to evaluate RIP1, RIP3, MLKL and PGAM5 expressions. Results RIP1, RIP3, MLKL and PGAM5 expression did not change in the hepatic IR injury model. Moreover, Nec1s pretreatment did not improve histology or biochemical markers. The overall Suzuki score (cytoplasmic vacuolization, sinusoidal congestion and hepatocytes necrosis) was increased in the RIP3((-/-)) mice compared to the IR group (3.5 vs. 5, p = 0.026). CyA pretreatment and/or RIP3((-/-)) mice decreased Bax/Bcl2 expression; however, it did lead to an overall change in the levels of AST, ALT and LDH or necrotic injury. The Bax/Bcl2 ratio and the expression of caspase-1 and caspase-3 did not increase in our hepatic IR injury model. Conclusion Key necroptosis molecules did not increase in the necrosis-dominant hepatic IR injury model. Anti-necroptosis and/or cyclosporine-A treatment did not have an overall protective effect on necrosis-dominant hepatic IR injury.	[Saeed, Wager K.; Jun, Dae Won] Hanyang Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Jun, Dae Won; Chae, Yeon Ji; Lee, Jai Sun; Kang, Hyeon Tae] Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Translat Med, Seoul, South Korea; [Jang, Kiseok] Hanyang Univ, Sch Med, Dept Pathol, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University	Jun, DW (corresponding author), Hanyang Univ, Sch Med, Dept Internal Med, Seoul, South Korea.; Jun, DW (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Translat Med, Seoul, South Korea.	noshin@hanyang.ac.kr	Jang, Kiseok/P-2048-2015; Jun, Dae Won/O-4529-2017	Jang, Kiseok/0000-0002-6585-3990; Jun, Dae Won/0000-0002-2875-6139; Kang, Hyeon Tae/0000-0002-4771-3388; saeed, waqar khalid/0000-0002-7888-9108	National Research Foundation of Korea [2011-0007127]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from National Research Foundation of Korea 2011-0007127.	Abe Y, 2009, FREE RADICAL BIO MED, V46, P1, DOI 10.1016/j.freeradbiomed.2008.09.029; Arshad MI, 2015, J MOL MED, V93, P867, DOI 10.1007/s00109-015-1270-6; Chavez-Valdez R, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/257563; Dara L, 2015, HEPATOLOGY, V62, P1847, DOI 10.1002/hep.27939; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Deutsch M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.126; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Gunther C, 2016, J CLIN INVEST, V126, P4346, DOI 10.1172/JCI87545; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; Hong JM, 2016, TOXICOL APPL PHARM, V308, P1, DOI 10.1016/j.taap.2016.08.010; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Rosentreter D, 2015, SHOCK, V44, P72, DOI 10.1097/SHK.0000000000000371; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Saeed WK, 2014, WORLD J GASTROENTERO, V20, P12526, DOI 10.3748/wjg.v20.i35.12526; Saxton NE, 2002, J HEPATOL, V36, P241, DOI 10.1016/S0168-8278(01)00248-3; Takemoto K, 2014, FEBS OPEN BIO, V4, P777, DOI 10.1016/j.fob.2014.08.007; Tsoulfas G, 2012, J SURG RES, V176, pE1, DOI 10.1016/j.jss.2011.06.012; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Yang M, 2014, LIVER TRANSPLANT, V20, P1372, DOI 10.1002/lt.23958	25	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184752	10.1371/journal.pone.0184752	http://dx.doi.org/10.1371/journal.pone.0184752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957350	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200018
J	Gonzalez-Moron, D; Vishnopolska, S; Consalvo, D; Medina, N; Marti, M; Cordoba, M; Vazquez-Dusefante, C; Claverie, S; Rodriguez-Quiroga, SA; Vega, P; Silva, W; Kochen, S; Kauffman, MA				Gonzalez-Moron, Dolores; Vishnopolska, Sebastian; Consalvo, Damian; Medina, Nancy; Marti, Marcelo; Cordoba, Marta; Vazquez-Dusefante, Cecilia; Claverie, Santiago; Alejandro Rodriguez-Quiroga, Sergio; Vega, Patricia; Silva, Walter; Kochen, Silvia; Andres Kauffman, Marcelo			Germline and somatic mutations in cortical malformations: Molecular defects in Argentinean patients with neuronal migration disorders	PLOS ONE			English	Article							PERIVENTRICULAR NODULAR HETEROTOPIA; VARIANTS; GENOME; GENE; DISCOVERY; FRAMEWORK; PHENOTYPE; FILAMIN	Neuronal migration disorders are a clinically and genetically heterogeneous group of malformations of cortical development, frequently responsible for severe disability. Despite the increasing knowledge of the molecular mechanisms underlying this group of diseases, their genetic diagnosis remains unattainable in a high proportion of cases. Here, we present the results of 38 patients with lissencephaly, periventricular heterotopia and subcortical band heterotopia from Argentina. We performed Sanger and Next Generation Sequencing (NGS) of DCX, FLNA and ARX and searched for copy number variations by MLPA in PAFAH1B1, DCX, POMT1, and POMGNT1. Additionally, somatic mosaicism at 5% or higher was investigated by means of targeted high coverage NGS of DCX, ARX, and PAFAH1B1. Our approach had a diagnostic yield of 36%. Pathogenic or likely pathogenic variants were identified in 14 patients, including 10 germline (five novel) and 4 somatic mutations in FLNA, DCX, ARX and PAFAH1B1 genes. This study represents the largest series of patients comprehensively characterized in our population. Our findings reinforce the importance of somatic mutations in the pathophysiology and diagnosis of neuronal migration disorders and contribute to expand their phenotype-genotype correlations.	[Gonzalez-Moron, Dolores; Medina, Nancy; Cordoba, Marta; Vazquez-Dusefante, Cecilia; Alejandro Rodriguez-Quiroga, Sergio; Vega, Patricia; Andres Kauffman, Marcelo] UBA, Hosp JM Ramos Mejia, Ctr Univ Neurol Jose Maria Ramos Mejia, Consultorio & Lab Neurogenet,Fac Med, Buenos Aires, DF, Argentina; [Gonzalez-Moron, Dolores; Medina, Nancy; Cordoba, Marta; Vazquez-Dusefante, Cecilia; Alejandro Rodriguez-Quiroga, Sergio; Vega, Patricia; Andres Kauffman, Marcelo] UBA, Hosp JM Ramos Mejia, Div Neurol, Fac Med, Buenos Aires, DF, Argentina; [Gonzalez-Moron, Dolores; Cordoba, Marta] UBA, CONICET, Fac Med, IBCN Eduardo de Robertis, Buenos Aires, DF, Argentina; [Vishnopolska, Sebastian; Marti, Marcelo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Vishnopolska, Sebastian; Marti, Marcelo] Univ Buenos Aires, CONICET, Inst Quim Biol, Fac Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Consalvo, Damian; Claverie, Santiago] UBA, Hosp JM Ramos Mejia, Fac Med, Ctr Univ Neurol Jose Maria Ramos Mejia, Buenos Aires, DF, Argentina; [Consalvo, Damian; Claverie, Santiago] UBA, Hosp JM Ramos Mejia, Fac Med, Div Neurol, Buenos Aires, DF, Argentina; [Silva, Walter] Hosp Italiano Buenos Aires, Consultorio Epilepsias Refractarias, Secc Neurofisiol & Epilepsia, Serv Neurol Infantil, Buenos Aires, DF, Argentina; [Kochen, Silvia] UBA, Hosp JM Ramos Mejia, Fac Med, Ctr Epilepsia,Div Neurol, Buenos Aires, DF, Argentina; [Andres Kauffman, Marcelo] Univ Austral, CONICET, Programa Med Precis & Genom Clin, Fac Ciencias Biomed,Inst Invest Med Traslac, Derqui, Argentina	Hospital Ramos Mejia; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gonzalez-Moron, D (corresponding author), UBA, Hosp JM Ramos Mejia, Ctr Univ Neurol Jose Maria Ramos Mejia, Consultorio & Lab Neurogenet,Fac Med, Buenos Aires, DF, Argentina.; Gonzalez-Moron, D (corresponding author), UBA, Hosp JM Ramos Mejia, Div Neurol, Fac Med, Buenos Aires, DF, Argentina.; Gonzalez-Moron, D (corresponding author), UBA, CONICET, Fac Med, IBCN Eduardo de Robertis, Buenos Aires, DF, Argentina.	doloresgm@gmail.com	Vishnopolska, Sebastian/HDM-8462-2022	Vishnopolska, Sebastian/0000-0002-1729-9948; Cordoba, Marta/0000-0002-2814-1636; Kauffman, Marcelo/0000-0003-1680-5092	Agencia nacional de promocion cientifica y tecnologica (PICT-Probitec with Leloir Institute); Fiorini Foundation; CONICET, Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)	Agencia nacional de promocion cientifica y tecnologica (PICT-Probitec with Leloir Institute); Fiorini Foundation; CONICET, Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012-2014), the Agencia nacional de promocion cientifica y tecnologica (PICT-Probitec with Leloir Institute) and the Fiorini Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for financial support from the CONICET, Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012-2014) as well as from the Agencia nacional de promocion cientifica y tecnologica (PICT-Probitec with Leloir Institute) and the Fiorini Foundation.	Kauffman MA, 2012, MOL BIOL REP, V39, P6655, DOI 10.1007/s11033-012-1471-9; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; D'Agostino MD, 2002, BRAIN, V125, P2507, DOI 10.1093/brain/awf248; de Wit MCY, 2011, CLIN RES CARDIOL, V100, P45, DOI 10.1007/s00392-010-0206-y; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gonzalez G, 2013, AM J NEURORADIOL, V34, P877, DOI 10.3174/ajnr.A3312; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Hertecant J, 2016, META GENE, V9, P124, DOI 10.1016/j.mgene.2016.05.004; Jamuar SS, 2015, PEDIATR CLIN N AM, V62, P571, DOI 10.1016/j.pcl.2015.03.002; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Mandelstam SA, 2013, AM J NEURORADIOL, V34, P432, DOI 10.3174/ajnr.A3427; Matsumoto N, 2001, EUR J HUM GENET, V9, P5, DOI 10.1038/sj.ejhg.5200548; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Parrini E, 2016, MOL SYNDROMOL, V7, P220, DOI 10.1159/000448639; Qin L, 2016, J MOL DIAGN, V18, P446, DOI 10.1016/j.jmoldx.2016.01.002; Quelin C, 2012, NEUROGENETICS, V13, P367, DOI 10.1007/s10048-012-0339-4; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; van Ninnwegen KJM, 2016, CLIN CHEM, V62, P1458, DOI 10.1373/clinchem.2016.258632; Zillhardt JL, 2016, EUR J HUM GENET, V24, P611, DOI 10.1038/ejhg.2015.192	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185103	10.1371/journal.pone.0185103	http://dx.doi.org/10.1371/journal.pone.0185103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953922	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300034
J	Nuzhat, S; Ahmed, T; Kawser, CA; Khan, AI; Islam, SMR; Shahrin, L; Shahunja, KM; Shahid, AMSB; Al Imran, A; Chisti, MJ				Nuzhat, Sharika; Ahmed, Tahmeed; Kawser, Chowdhury Ali; Khan, Azharul Islam; Islam, S. M. Rafiqul; Shahrin, Lubaba; Shahunja, K. M.; Shahid, Abu S. M. S. B.; Al Imran, Abdullah; Chisti, Mohammod Jobayer			Age specific fast breathing in under-five diarrheal children in an urban hospital: Acidosis or pneumonia?	PLOS ONE			English	Article							SEVERELY MALNOURISHED CHILDREN; DEVELOPING-COUNTRIES; CLINICAL-FEATURES; BANGLADESH; MANAGEMENT; DIAGNOSIS; MORTALITY; DEHYDRATION; HYPOXEMIA; INFANTS	Background Children with diarrhea often present with fast breathing due to metabolic acidosis from dehydration. On the other hand, age specific fast breathing is the cornerstone for the diagnosis of pneumonia following classification of pneumonia recommended by the World Health Organization (WHO). Correction of metabolic acidosis by rehydrating the diarrheal children requires time, which delays early initiation of appropriate antimicrobials for pneumonia and thereby increases the risk of deaths. We need to further investigate the simple clinical features other than fast breathing which might help us in earliest diagnosis of pneumonia in children with diarrhea Thus, the objective of our study was to identify other contributing clinical features that may independently help for early diagnosis of pneumonia in diarrheal children who present with age specific fast breathing. Methods This was an unmatched case-control study. Diarrheal children aged 0-59 months, admitted to Dhaka Hospital of the International Centre for Diarrheal Disease Research, Bangladesh (icddr, b) during January 2014 to December 2014 having age specific fast breathing (<2 month >= 60 breath/min, 2-11 months >= 50 breaths/min, >11-59 months >= 40 breaths/min) were studied. The study children with clinical and radiological pneumonia constituted the cases (n = 276) and those without pneumonia constituted the controls (n = 446). Comparison of clinical features and outcomes between the cases and the controls was made. Results The distribution of acidosis among the cases and the controls was comparable (35% vs. 41%, p = 0.12). The cases had proportionately higher deaths compared to the controls, however, the difference was not statistically significant (3% vs. 1%; p = 0.23). In logistic regression analysis after adjusting for potential confounders, the cases were independently associated with cough (OR = 62.19, 95% CI = 27.79-139.19; p<0.01) and chest wall indrawing (OR = 31.05, 95% CI = 13.43-71.82; p<0.01) and less often had severe acute malnutrition (OR = 0.33, 95% CI = 0.13-0.79; p<0.01). The sensitivity and specificity of cough were 83% (78-87%) and 93% (91-96%). The sensitivity and specificity for lower chest wall indrawing were 65% (59-71%) and 95% (93-97%). However, the sensitivity and specificity of cough and lower chest wall indrawing combined were 94% (89-97%) and 99% (97 - 100%). Conclusion and significance Thus, diarrheal children having fast breathing who present with cough and/or lower chest wall indrawing, irrespective of presence or absence of metabolic acidosis, are more likely to have radiological pneumonia. The results underscore the importance of early identification of these simple clinical features that may help to minimize potential delay due to rehydration in initiating prompt treatment of pneumonia in order to reduce fatal consequences in such children.	[Nuzhat, Sharika; Ahmed, Tahmeed; Khan, Azharul Islam; Islam, S. M. Rafiqul; Shahrin, Lubaba; Shahunja, K. M.; Shahid, Abu S. M. S. B.; Al Imran, Abdullah; Chisti, Mohammod Jobayer] Icddr B, NCSD, Dhaka, Bangladesh; [Kawser, Chowdhury Ali] BSMMU, Dept Pediat, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Bangabandhu Sheikh Mujib Medical University (BSMMU)	Chisti, MJ (corresponding author), Icddr B, NCSD, Dhaka, Bangladesh.	chisti@icddrb.org	Shahunja, K M/AAR-6229-2020; Chisti, Mohammod J/A-7216-2018; Shahrin, Lubaba/AAF-1019-2020	Shahunja, K M/0000-0002-9345-206X; Shahrin, Lubaba/0000-0002-5676-3280; Chisti, Mohammod/0000-0001-9958-3071	International Centre for Diarrhoeal Disease Research, Bangladesh [Gr-00233]	International Centre for Diarrhoeal Disease Research, Bangladesh	This research study was funded by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddreb; grant no Gr-00233) and its donors, which provide unrestricted support to icddreb for its operations and research. Current donors providing support include: Government of the Peoples Republic of Bangladesh; the Department of Foreign Affairs, Trade and Development (DFATD), Canada; Swedish International Development Cooperation Agency (Sida) and the Department for International Development (UK Aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SM, 1986, SCAND J INFECT DIS, V18, P65, DOI 10.3109/00365548609032308; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; Bhutta ZA, 2013, PEDIATRICS, V131, P634, DOI 10.1542/peds.2012-3737; Blot SI, 2007, CRIT CARE MED, V35, P2509, DOI 10.1097/01.CCM.0000287587.43801.9C; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cherian T, 1997, PEDIATR INFECT DIS J, V16, P490, DOI 10.1097/00006454-199705000-00007; Chisti MJ, 2010, ANN TROP PAEDIATR, V30, P311, DOI 10.1179/146532810X12858955921230; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Chisti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039164; Chisti MJ, 2012, TROP MED INT HEALTH, V17, P106, DOI 10.1111/j.1365-3156.2011.02890.x; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Organization WH, 2013, POCK BOOK HOSP CAR C; Pio A, 2003, B WORLD HEALTH ORGAN, V81, P298; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; RICHARDS L, 1993, PEDIATR INFECT DIS J, V12, P5, DOI 10.1097/00006454-199301000-00003; Saha D, 2014, J HEALTH POPUL NUTR, V32, P14; UNICEF, 2022, DEM WSPOLCZ DZIETN; WANG F, 1986, NEW ENGL J MED, V315, P1591, DOI 10.1056/NEJM198612183152506; World Health Organization, 2013, POCK BOOK HOSP CAR C	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185414	10.1371/journal.pone.0185414	http://dx.doi.org/10.1371/journal.pone.0185414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953928	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300064
J	Gofama, MM; Verma, H; Abdullahi, H; Molodecky, NA; Craig, KT; Urua, UA; Garba, MA; Alhaji, MA; Weldon, WC; Oberste, MS; Braka, F; Muhammad, AJG; Sutter, RW				Gofama, Mustapha Modu; Verma, Harish; Abdullahi, Hamisu; Molodecky, Natalie A.; Craig, Kehinde T.; Urua, Utibe-Abasi; Garba, Mohammed Ashir; Alhaji, Mohammed Arab; Weldon, William C.; Oberste, M. Steven; Braka, Fiona; Muhammad, Ado J. G.; Sutter, Roland W.			Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern Nigeria	PLOS ONE			English	Article							VACCINE; SEROPREVALENCE; TRANSMISSION; INTERRUPTION; CHILDREN; INDIA; KANO	Background Nigeria remains one of only three polio-endemic countries in the world. In 2016, after an absence of 2 years, wild poliovirus serotype 1 was again detected in North-Eastern Nigeria. To better guide programmatic action, we assessed the immunity status of infants and children in Borno and Yobe states, and evaluated the impact of recently introduced inactivated poliovirus vaccine (IPV) on antibody seroprevalence. Methods and findings We conducted a facility-based study of seroprevalence to poliovirus serotypes 1, 2 and 3 among health-seeking patients in two sites each of Borno and Yobe States. Enrolment was conducted amongst children 6-9 and 36-47 months of age attending the paediatrics outpatient department of the selected hospitals in the two states between 11 January and 5 February 2016. Detailed demographic and immunization history of the child was taken and an assessment of the child's health and nutritional state was conducted via physical examination. Blood was collected to test for levels of neutralizing antibody titres against the three poliovirus serotypes. The seroprevalence in the two age groups, potential determinants of seropositivity and the impact of one dose of IPV on humoral immunity were assessed. A total of 583 subjects were enrolled and provided sufficient quantities of serum for testing. Among 6-9-month-old infants, the seroprevalence was 81% (74-87%), 86% (79-91%), and 72% (65-79%) in Borno State, and 75% (67-81%), 74% (66-81%) and 69% (61-76%) in Yobe States, for serotypes-1, 2 and 3, respectively. Among children aged 36-47 months, the seroprevalence was > 90% in both states for all three serotypes, with the exception of type 3 seroprevalence in Borno [ 87% (80-91%)]. Median reciprocal anti-polio neutralizing antibody titers were consistently > 900 for serotypes 1 and 2 across age groups and states; with lower estimates for serotype 3, particularly in Borno. IPV received in routine immunization was found to be a significant determinant of seropositivity and anti-polio neutralizing antibodies among 6-9-month-old infants for serotypes 1 and 3, but demonstrated a nonsignificant positive association for serotype 2. Children receiving IPV through SIAs demonstrated significantly higher anti-polio neutralizing antibodies for serotypes 1 and 3. Conclusions The seroprevalence to poliovirus remains suboptimal in both Borno and Yobe States in Nigeria. The low seroprevalence facilitated the continued transmission of both wild serotype 1 and serotype 2 circulating vaccine-derived poliovirus detected in Borno State in 2016. Further efforts are necessary to improve the immunity status of these populations to ensure sufficient population immunity to interrupt transmission.	[Gofama, Mustapha Modu; Garba, Mohammed Ashir; Alhaji, Mohammed Arab] Univ Maiduguri, Teaching Hosp, Maiduguri, Nigeria; [Verma, Harish; Molodecky, Natalie A.; Sutter, Roland W.] WHO, Geneva, Switzerland; [Abdullahi, Hamisu; Craig, Kehinde T.; Braka, Fiona] WHO, Abuja, Nigeria; [Urua, Utibe-Abasi; Muhammad, Ado J. G.] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria; [Weldon, William C.; Oberste, M. Steven] Ctr Dis Control & Prevent, Atlanta, GA USA	World Health Organization; World Health Organization; Centers for Disease Control & Prevention - USA	Molodecky, NA (corresponding author), WHO, Geneva, Switzerland.	n.molodecky@imperial.ac.uk		Mustapha, Modu Gofama/0000-0001-8510-0905	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ahmad M, 2016, INDIA SEROPREVALE S1, V53; El-Sayed N, 2007, VACCINE, V25, P5062, DOI 10.1016/j.vaccine.2007.04.022; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Etsano A, 2016, MMWR-MORBID MORTAL W, V65, P770, DOI 10.15585/mmwr.mm6530a4; Giwa FJ, 2012, VACCINE, V30, P6759, DOI 10.1016/j.vaccine.2012.09.023; GPEI, 2017, WILD POL; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Iliyasu Z, 2016, VACCINE, V34, P5125, DOI 10.1016/j.vaccine.2016.08.058; Iliyasu Z, 2014, VACCINE, V32, P1414, DOI 10.1016/j.vaccine.2013.08.060; Mangal TD, 2014, LANCET GLOB HEALTH, V2, pE90, DOI 10.1016/S2214-109X(13)70168-2; Nemat A, 2015, PAK J MED SCI, V31, P403, DOI 10.12669/pjms.312.5366; Parker EPK, 2014, J INFECT DIS, V210, P853, DOI 10.1093/infdis/jiu182; R Core Team, 2013, R LANG ENV STAT COMP; Roberts L, 2017, SCIENCE, V356, P18, DOI 10.1126/science.356.6333.18; Sutter RW, 2010, LANCET, V376; US Census Bureau, 2014, CENS SURV PROC SYSGT; Weldon WC, 2016, METHODS MOL BIOL, V1387, P145, DOI 10.1007/978-1-4939-3292-4_8; World Health Organization, 1991, REP WHO INF CONS POL; World Health Organization, 2016, WHO CHILD GROWTH STA	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185284	10.1371/journal.pone.0185284	http://dx.doi.org/10.1371/journal.pone.0185284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949979	Green Submitted, Green Published, gold			2022-12-26	WOS:000411671000033
J	Wagner, AL; Boulton, ML; Gillespie, BW; Zhang, Y; Ding, YX; Carlson, BF; Luo, XY; Montgomery, JP; Wang, XX				Wagner, Abram L.; Boulton, Matthew L.; Gillespie, Brenda W.; Zhang, Ying; Ding, Yaxing; Carlson, Bradley F.; Luo, Xiaoyan; Montgomery, JoLynn P.; Wang, Xiexiu			Risk factors for measles among adults in Tianjin, China: Who should be controls in a case-control study?	PLOS ONE			English	Article							POPULATION; PROGRESS	Background Control groups in previous case-control studies of vaccine-preventable diseases have included people immune to disease. This study examines risk factors for measles acquisition among adults 20 to 49 years of age in Tianjin, China, and compares findings using measles IgG antibody-negative controls to all controls, both IgG-negative and IgGpositive. Methods Measles cases were sampled from a disease registry, and controls were enrolled from community registries in Tianjin, China, 2011 - 2015. Through a best subsets selection procedure, we compared which variables were selected at different model sizes when using IgG-negative controls or all controls. We entered risk factors for measles in two separate logistic regression models: one with measles IgG-negative controls and the other with all controls. Results The study included 384 measles cases and 1,596 community controls (194 IgG-negative). Visiting a hospital was an important risk factor. For specialty hospitals, the odds ratio (OR) was 4.53 (95% confidence interval (CI): 1.28, 16.03) using IgG-negative controls, and OR = 5.27 (95% CI: 2.73, 10.18) using all controls. Variables, such as age or length of time in Tianjin, were differentially selected depending on the control group. Individuals living in Tianjin <= 3 years had 2.87 (95% CI: 1.46, 5.66) times greater odds of measles case status compared to all controls, but this relationship was not apparent for IgG-negative controls. Conclusions We recommend that case-control studies examining risk factors for infectious diseases, particularly in the context of transmission dynamics, consider antibody-negative controls as the gold standard.	[Wagner, Abram L.; Boulton, Matthew L.; Carlson, Bradley F.; Montgomery, JoLynn P.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Boulton, Matthew L.] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gillespie, Brenda W.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Zhang, Ying; Ding, Yaxing; Luo, Xiaoyan; Wang, Xiexiu] Tianjin Ctr Dis Control & Prevent, Inst Human Communicable Dis Control & Prevent, Tianjin, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Tianjin Center for Disease Control & Prevention	Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	awag@umich.edu	Wagner, Abram/X-6379-2019	Wagner, Abram/0000-0003-4691-7802; Boulton, Matthew/0000-0002-0565-9010; Carlson, Bradley/0000-0002-9616-5613	National Institutes of Health, National Institute for Allergy and Infectious Diseases [U01-AI-088671]	National Institutes of Health, National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the National Institutes of Health, National Institute for Allergy and Infectious Diseases [U01-AI-088671]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton ML, 2016, VACCINE, V34, P3037, DOI 10.1016/j.vaccine.2016.04.094; Chen JunLei, 2013, Chinese Preventive Medicine, V14, P509; Chen WanGeng, 2011, Occupation and Health, V27, P312; Downes F, 1992, 92 GEN M AM SOC MICR; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; Liang Z, 2014, POPUL DEV REV, V40, P695, DOI 10.1111/j.1728-4457.2014.00007.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Rothman K. J., 2008, MODERN EPIDEMIOLOGY, P116; Standardization Administration of the Peoples Republic of China, 1995, DIAGN CRIT PRINC MAN; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Wang LX, 2003, J INFECT DIS, V187, pS252, DOI 10.1086/368045; Wang ZL, 2009, J TELEMED TELECARE, V15, P23, DOI 10.1258/jtt.2008.080508; Wang ZhongZhan, 2015, Chinese Preventive Medicine, V16, P438; WHO, 2016, MEASL FACT SHEET; Xiong C, 2006, CHINESE J VACCINES I, V10, P350; Zhang DL, 2015, VACCINE, V33, P4100, DOI 10.1016/j.vaccine.2015.06.066; Zhao Y, 2013, CHINESE GEOGR SCI, V23, P492, DOI 10.1007/s11769-013-0616-7; Zheng JS, 2010, VACCINE, V28, pA84, DOI 10.1016/j.vaccine.2010.02.039; ZHU X, 2008, CHIN J VACC IMMUN, V14, P398	22	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185465	10.1371/journal.pone.0185465	http://dx.doi.org/10.1371/journal.pone.0185465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950011	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000054
J	Yan, Y; Williams, SB; Murdock, LL; Baributsa, D				Yan, Yan; Williams, Scott B.; Murdock, Larry L.; Baributsa, Dieudonne			Hermetic storage of wheat and maize flour protects against red flour beetle (Tribolium castaneum Herbst)	PLOS ONE			English	Article							PHOSPHINE RESISTANCE; STORED-PRODUCT; GRAIN	Hermetic storage is used to protect grain against insect pests, but its utility is not limited to whole grains. We evaluated hermetically-sealed, polyethylene terephthalate (PET) bottles for preserving wheat and maize flour against red flour beetle (RFB, Tribolium castaneum, Herbst) population growth. Flours infested with RFB and kept in sealed PET bottles experienced much less weight loss over a three-month storage period than infested flour kept in unsealed bottles. RFB populations in wheat flour kept in sealed bottles did not increase, while populations in unsealed bottles grew about 50-fold during the same three-month period. Flour in sealed bottles had lower levels of oxygen and moisture than flour stored in unsealed bottles. Similar trends were observed for oxygen and moisture levels in maize flour held in hermetically sealed bottles. Hermetically-sealed bottles were effective in preventing RFB population growth and preserving maize and wheat flour. Farmers, consumers and food processors can safely store grain flour in hermetic sealed containers.	[Yan, Yan] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Williams, Scott B.] Spensa Technol Inc, W Lafayette, IN USA; [Murdock, Larry L.; Baributsa, Dieudonne] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Baributsa, D (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	dbaribut@purdue.edu		Baributsa, Dieudonne/0000-0003-4170-8948; Yan, Yan/0000-0002-4994-2651	PICS3 Project - by Bill and Melinda Gates Foundation to Purdue University) [43010000 8000061439]	PICS3 Project - by Bill and Melinda Gates Foundation to Purdue University)	This study was supported by funds from the PICS3 Project (Grant number 43010000 8000061439- by Bill and Melinda Gates Foundation to Purdue University). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleki A, 2011, EGYPT J BIOL PEST CO, V21, P159; Arbogast Richard T., 1991, FDA Technical Bulletin, V4, P131; BAILEY S. W., 1965, Journal of Stored Products Research, V1, P25, DOI 10.1016/0022-474X(65)90005-6; Baloch Umar K., 1999, WHEAT POSTHARVEST OP; Banks H.J., 1990, FOOD PRESERVATION MO, P93; Baoua IB, 2012, J STORED PROD RES, V51, P81, DOI 10.1016/j.jspr.2012.07.003; Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bosly HA, 2012, TOXICOL IND HEALTH, V30, P304; CENKOWSKI S, 2000, CANADIAN AGR ENG, V42, P1; Cheng WN, 2012, J INSECT PHYSIOL, V58, P792, DOI 10.1016/j.jinsphys.2012.02.005; Fardisi M, 2013, J STORED PROD RES, V52, P74, DOI 10.1016/j.jspr.2012.12.001; Fiedler JL, 2014, ANN NY ACAD SCI, V1312, P26, DOI 10.1111/nyas.12266; Fields PG, 2002, ANNU REV ENTOMOL, V47, P331, DOI 10.1146/annurev.ento.47.091201.145217; Flingelli G, 2012, P 9 INT C CONTR ATM; Hamed M, 1985, SARHAD J AGR; International A, APPR METH AN; Lessard F.F., 1990, FOOD PRESERVATION MO, P21; Murdock LL, 2014, J STORED PROD RES, V58, P1, DOI 10.1016/j.jspr.2014.04.007; Murdock LL, 2012, J STORED PROD RES, V49, P166, DOI 10.1016/j.jspr.2012.01.002; Navarro S., 2006, INSECT MANAGEMENT FO, P105, DOI [10.1016/B978-1-891127-46-5.50016-7, DOI 10.1016/B978-1-891127-46-5.50016-7]; Navarro S, 2012, CONTROLLED MODIFIED, P191; Navarro S, 2012, J PEST SCI, V85, P301, DOI 10.1007/s10340-012-0424-3; Pimentel MAG, 2009, J STORED PROD RES, V45, P71, DOI 10.1016/j.jspr.2008.09.001; Sanon A, 2011, J STORED PROD RES, V47, P210, DOI 10.1016/j.jspr.2011.02.003; Subramanyam B, 1999, PEST CONTROL, V67; UNEP, 2006, HDB MONTR PROT SUBST; UNEP, 2002, MONT PROT SUBST DEPL; Williams SB, 2017, J STORED PROD RES, V71, P125, DOI 10.1016/j.jspr.2016.12.008; World Bank, 2011, MISS FOOD CAS POSTH; Yakubu A., 2011, African Journal of Agricultural Research, V6, P3311; Zhang CL, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/918305	31	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185386	10.1371/journal.pone.0185386	http://dx.doi.org/10.1371/journal.pone.0185386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949983	gold, Green Submitted, Green Published			2022-12-26	WOS:000411671000045
J	Liao, HF; Pan, CH; Chou, PY; Chen, YF; Wu, TS; Sheu, MJ; Wo, CH				Liao, Hsien-Feng; Pan, Chun-Hsu; Chou, Pei-Yu; Chen, Yi-Fong; Wu, Tian-Shung; Sheu, Ming-Jyh; Wo, Chieh-Hsi			Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PI3K/AKT SIGNALING PATHWAY; MATRIX METALLOPROTEINASES; AKT OVEREXPRESSION; CANCER-CELLS; DENBINOBIN; INHIBITORS; INVASION; TUMOR; PROLIFERATION	Background Chemotherapy insensitivity continues to pose significant challenges for treating non-small cell lung cancer (NSCLC). The purposes of this study were to investigate whether 3,6-dimethoxy-1,4,5,8-phenanthrenetetraone (NCKU-21) has potential activity to induce effective toxicological effects in different ethnic NSCLC cell lines, A549 and CL1-5 cells, and to examine its anticancer mechanisms. Methods Mitochondrial metabolic activity and the cell-cycle distribution were analyzed using an MTT assay and flow cytometry in NCKU-21-treated cells. NCKU-21-induced cell apoptosis was verified by Annexin V-FITC/propidium iodide (PI) double-staining and measurement of caspase-3 activity. Western blotting and wound-healing assays were applied to respectively evaluate regulation of signaling pathways and cell migration by NCKU-21. Molecular interactions between target proteins and NCKU-21 were predicted and performed by molecular docking. A colorimetric screening assay kit was used to evaluate potential regulation of matrix metalloproteinase-9 (MMP-9) activity by NCKU-21. Results Results indicated that NCKU-21 markedly induced cytotoxic effects that reduced cell viability via cell apoptosis in tested NSCLC cells. Activation of AMP-activated protein kinase (AMPK) and p53 protein expression also increased in both NSCLC cell lines stimulated with NCKU-21. However, repression of PI3K-AKT activation by NCKU-21 was found in CL1-5 cells but not in A549 cells. In addition, increases in phosphatidylserine externalization and caspase-3 activity also confirmed the apoptotic effect of NCKU-21 in both NSCLC cell lines. Moreover, cell migration and translational levels of the gelatinases, MMP-2 and MMP-9, were obviously reduced in both NSCLC cell lines after incubation with NCKU-21. Experimental data obtained from molecular docking suggested that NCKU-21 can bind to the catalytic pocket of MMP-9. However, the in vitro enzyme activity assay indicated that NCKU-21 has the potential to increase MMP-9 activity. Conclusions Our results suggest that NCKU-21 can effectively reduce cell migration and induce apoptosis in A549 and CL1-5 cells, the toxicological effects of which may be partly modulated through PI3K-AKT inhibition, AMPK activation, an increase in the p53 protein, and gelatinase inhibition.	[Liao, Hsien-Feng; Chen, Yi-Fong] China Med Univ, Canc Biol & Drug Discovery, Taichung, Taiwan; [Liao, Hsien-Feng; Chen, Yi-Fong] Acad Sinica, Taichung, Taiwan; [Liao, Hsien-Feng] Lees Med Corp, Yuanli Lees Gen Hosp, Dept Pharm, Miaoli, Taiwan; [Pan, Chun-Hsu; Wo, Chieh-Hsi] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Chou, Pei-Yu] Hung Kuang Univ, Dept Nursing, Taichung, Taiwan; [Chou, Pei-Yu] Tunghai Univ, Sports Recreat & Hlth Management Continuing Studi, Bachelors Degree Complet Program, Taichung, Taiwan; [Wu, Tian-Shung] Natl Cheng Kung Univ, Dept Chem, Tainan, Taiwan; [Wu, Tian-Shung] Natl Cheng Kung Univ, Dept Pharm, Tainan, Taiwan; [Sheu, Ming-Jyh] China Med Univ, Sch Pharm, Taichung, Taiwan	China Medical University Taiwan; Academia Sinica - Taiwan; Taipei Medical University; Hungkuang University; Tunghai University; National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan	Wo, CH (corresponding author), Taipei Med Univ, Sch Pharm, Taipei, Taiwan.; Wu, TS (corresponding author), Natl Cheng Kung Univ, Dept Chem, Tainan, Taiwan.; Wu, TS (corresponding author), Natl Cheng Kung Univ, Dept Pharm, Tainan, Taiwan.; Sheu, MJ (corresponding author), China Med Univ, Sch Pharm, Taichung, Taiwan.	tswu@mail.ncku.edu.tw; hsumj@mail.cmu.edu.tw; chhswu@tmu.edu.tw	Pan, Chun-Hsu/H-4358-2019	Pan, Chun-Hsu/0000-0001-8700-583X; Chen, Yi-Fong/0000-0002-9545-1191; Liao, Hsien-Feng/0000-0002-8747-5097	National Science Council, Taiwan [NSC 101-2320-B-039-023, NSC102-2113-M006-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grants (NSC 101-2320-B-039-023 and NSC102-2113-M006-001) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Bae IH, 2009, CANCER LETT, V277, P22, DOI 10.1016/j.canlet.2008.11.022; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Chou PY, 2011, AM J CHINESE MED, V39, P803, DOI 10.1142/S0192415X11009214; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Huang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025928; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kuo CT, 2008, TOXICOL LETT, V177, P48, DOI 10.1016/j.toxlet.2007.12.009; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Liu HE, 2011, SHOCK, V35, P191, DOI 10.1097/SHK.0b013e3181f0e9a8; Lu TL, 2014, AM J CHINESE MED, V42, P1539, DOI 10.1142/S0192415X14500967; Meuillet EJ, 2010, MOL CANCER THER, V9, P706, DOI 10.1158/1535-7163.MCT-09-0985; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Nuti E, 2015, J MED CHEM, V58, P7224, DOI 10.1021/acs.jmedchem.5b00367; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Papazafiropoulou A, 2009, HIPPOKRATIA, V13, P76; Pfannschmidt J, 2007, LUNG CANCER, V55, P371, DOI 10.1016/j.lungcan.2006.10.017; Rahman R, 2010, J ONCOL, V2010, DOI 10.1155/2010/251231; Rehman G, 2014, ARCH PHARM, V347, P457, DOI 10.1002/ardp.201300402; Sanchez-Duffhues G, 2008, BIOCHEM PHARMACOL, V76, P1240, DOI 10.1016/j.bcp.2008.09.006; Sanchez-Duffhues G, 2009, BIOCHEM PHARMACOL, V77, P1401, DOI 10.1016/j.bcp.2009.01.004; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Thangaraj S, 2011, TETRAHEDRON, V67, P6166, DOI 10.1016/j.tet.2011.06.054; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai AC, 2011, J NUTR BIOCHEM, V22, P625, DOI 10.1016/j.jnutbio.2010.04.014; Vakana E, 2012, J CELL BIOCHEM, V113, P404, DOI 10.1002/jcb.23369; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang XX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/908636; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Yang N, 2014, ONCOL REP, V31, P2651, DOI 10.3892/or.2014.3120	45	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185021	10.1371/journal.pone.0185021	http://dx.doi.org/10.1371/journal.pone.0185021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945763	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100017
J	Piscitelli, A; Tarallo, V; Guarino, L; Sannia, G; Birolo, L; Pezzella, C				Piscitelli, Alessandra; Tarallo, Vincenzo; Guarino, Lucia; Sannia, Giovanni; Birolo, Leyla; Pezzella, Cinzia			New lipases by mining of Pleurotus ostreatus genome	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; HETEROLOGOUS EXPRESSION; PURIFICATION; ENZYMOLOGY; ELEMENT; CLONING; MOTIF	The analysis of Pleurotus ostreatus genome reveals the presence of automatically annotated 53 lipase and 34 carboxylesterase putative coding-genes. Since no biochemical or physiological data are available so far, a functional approach was applied to identify lipases from P. ostreatus. In the tested growth conditions, four lipases were found expressed, with different patterns depending on the used C source. Two of the four identified proteins (PleoLip241 and PleoLip369), expressed in both analysed conditions, were chosen for further studies, such as an in silico analysis and their molecular characterization. To overcome limits linked to native production, a recombinant expression approach in the yeast Pichia pastoris was applied. Different expression levels were obtained: PleoLip241 reached a maximum activity of 4000 U/L, whereas PleoLip369 reached a maximum activity of 700 U/L. Despite their sequence similarity, these enzymes exhibited different substrate specificity and diverse stability at pH, temperature, and presence of metals, detergents and organic solvents. The obtained data allowed classifying PleoLip241 as belonging to the "true lipase" family. Indeed, by phylogenetic analysis the two proteins fall in different clusters. PleoLip241 was used to remove the hydrophobic layer from wool surface in order to improve its dyeability. The encouraging results obtained with lipase treated wool led to forecast PleoLip241 applicability in this field.	[Piscitelli, Alessandra; Tarallo, Vincenzo; Guarino, Lucia; Sannia, Giovanni; Birolo, Leyla; Pezzella, Cinzia] Univ Napoli Federico II, Dipartimento Sci Chim, Naples, Italy	University of Naples Federico II	Piscitelli, A (corresponding author), Univ Napoli Federico II, Dipartimento Sci Chim, Naples, Italy.	apiscite@unina.it	Pezzella, Cinzia/L-2753-2014; Piscitelli, Alessandra/J-8414-2013	Tarallo, Vincenzo/0000-0001-8158-1326; BIROLO, Leila/0000-0002-0915-7501; SANNIA, Giovanni/0000-0002-7986-6223; Piscitelli, Alessandra/0000-0002-3818-6539	Universita degli Studi di Napoli Federico II	Universita degli Studi di Napoli Federico II	V. T. and L. G. acknowledge Universita degli Studi di Napoli Federico II for doctoral fellowships.; V. T. and L. G. acknowledge University degli Studi di Napoli Federico II for doctoral fellowships. The authors thank Dr. Thierry Tron, Aix Marseille Universite, for hosting Dr. Tarallo in his laboratory. The authors also thank Dr. Frederic Carriere, CNRS, Aix-Marseille Universite, for the helpful discussions.	Abada Emad Abd El-Moniem, 2008, Pak J Biol Sci, V11, P1100, DOI 10.3923/pjbs.2008.1100.1106; Aloulou A, 2006, BBA-MOL CELL BIOL L, V1761, P995, DOI 10.1016/j.bbalip.2006.06.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argenton F, 1996, EUR J BIOCHEM, V238, P591, DOI 10.1111/j.1432-1033.1996.0591w.x; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Borrelli GM, 2015, INT J MOL SCI, V16, P20774, DOI 10.3390/ijms160920774; Brabcova J, 2010, YEAST, V27, P1029, DOI 10.1002/yea.1812; Castanera R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006108; Feng J, 2011, MICROBIOL RES, V166, P618, DOI 10.1016/j.micres.2010.12.002; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; Ghori MI, 2011, BRAZ J MICROBIOL, V42, P22, DOI 10.1590/S1517-83822011000100003; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Griebeler N, 2011, FOOD BIOPROCESS TECH, V4, P578, DOI 10.1007/s11947-008-0176-5; Gurr SJ, 1987, GENE STRUCTURE EUKAR, P93; Kantouch A., 2005, J NAT FIBERS, V2, P35, DOI [10.1300/J395v02n02_03, DOI 10.1300/J395V02N02_03]; Karp SG, 2012, BIORESOURCE TECHNOL, V114, P735, DOI 10.1016/j.biortech.2012.03.058; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krugener S, 2009, J MOL CATAL B-ENZYM, V57, P16, DOI 10.1016/j.molcatb.2008.06.014; Kumar S, 2005, PROTEIN EXPRES PURIF, V41, P38, DOI 10.1016/j.pep.2004.12.010; Lin ES, 2005, ENZYME MICROB TECH, V37, P261, DOI 10.1016/j.enzmictec.2005.03.012; Litvintseva AP, 2002, APPL ENVIRON MICROB, V68, P1305, DOI 10.1128/AEM.68.3.1305-1311.2002; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Murillo J, 2012, QUIM NOVA, V35, P1173; Nakagawa Y, 2001, J BACTERIOL, V183, P745, DOI 10.1128/JB.183.2.745-751.2001; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PADGETT RA, 1984, SCIENCE, V225, P898, DOI 10.1126/science.6206566; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Pezzella C, 2013, APPL MICROBIOL BIOT, V97, P705, DOI 10.1007/s00253-012-3980-9; Piscitelli A, 2017, BIOSENS BIOELECTRON, V87, P816, DOI 10.1016/j.bios.2016.09.052; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Sanchez-Carbente MDR, 2017, MICROBIOLOGYOPEN; Sanishvili R, 2003, J BIOL CHEM, V278, P26039, DOI 10.1074/jbc.M303867200; Shu CH, 2006, PROCESS BIOCHEM, V41, P734, DOI 10.1016/j.procbio.2005.09.007; Singh MK, 2014, J MOL CATAL B-ENZYM, V110, P92, DOI 10.1016/j.molcatb.2014.10.010; Singh R, 2006, APPL MICROBIOL BIOT, V70, P679, DOI 10.1007/s00253-005-0138-z; Soden DM, 2003, J APPL MICROBIOL, V95, P553, DOI 10.1046/j.1365-2672.2003.02012.x; Su HF, 2016, J MICROBIOL BIOTECHN, V26, P1067, DOI 10.4014/jmb.1511.11068; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Treger JM, 1998, BIOCHEM BIOPH RES CO, V243, P13, DOI 10.1006/bbrc.1997.8061; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; Verma N., 2012, International Research Journal of Biological Sciences, V1, P88; Vici AC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01083; Wang Z.S., 1991, MUSHROOM SCI, V13, P3; Yan QJ, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0501-6; Zelena K, 2009, BIOTECHNOL LETT, V31, P395, DOI 10.1007/s10529-008-9870-7; Zhu J., 2000, FUJIAN J AGR SCI, V15, P46	47	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185377	10.1371/journal.pone.0185377	http://dx.doi.org/10.1371/journal.pone.0185377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945798	Green Submitted, Green Published, gold			2022-12-26	WOS:000411645100055
J	Dockx, R; Peremans, K; Vlerick, L; Van Laeken, N; Saunders, JH; Polis, I; De Vosf, F; Baeken, C				Dockx, Robrecht; Peremans, Kathelijne; Vlerick, Lise; Van Laeken, Nick; Saunders, Jimmy H.; Polis, Ingeborgh; De Vosf, Filip; Baeken, Chris			Anaesthesia, not number of sessions, influences the magnitude and duration of an aHF-rTMS in dogs	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CEREBRAL-BLOOD-FLOW; CORTICAL EFFECTIVE CONNECTIVITY; ACCELERATED HF-RTMS; PREFRONTAL CORTEX; MAJOR DEPRESSION; DOPAMINE RELEASE; BINDING INDEX; BRAIN; IMPACT	Background Currently, the rat has been a useful animal model in brain stimulation research. Nevertheless, extrapolating results from rodent repetitive Transcranial Magnetic Stimulation (rTMS) research to humans contains several hurdles. This suggests the desperate need for a large animal model in translational rTMS research. The dog would be a valid choice, not only due to the fact that humans and dogs share a neurophysiological background, but a similar neuropathological background as well. Hypothesis In order to evaluate the feasibility of the canine rTMS animal model, this study aimed to evaluate the neurophysiological response in dogs on a, clinically used, accelerated high frequency (aHF) rTMS protocol. This aHF-rTMS (20 Hz) protocol was performed under anaesthesia or sedation and either 20 sessions or 5 sessions were given to each dog. Methods 21 healthy dogs were randomly subjected to one of the four aHF-rTMS protocols (1 sham and 3 active protocols). For each dog, the perfusion indices (PI), of a [99m Tc] HMPAO scan at 4 time points, for the left frontal cortex (stimulation target) were calculated for each protocol. Results Concerning sham stimulation, the average PI remained at the baseline level. The main result was the presence of a direct transitory increase in rCBF at the stimulation site, both under anaesthesia and sedation. Nevertheless the measured increase in rCBF was higher but shorter duration under sedation. The magnitude of this increase was not influenced by number of sessions. No changes in rCBF were found in remote brain regions. Conclusion This study shows that, despite the influence of anaesthesia and sedation, comparable and clinically relevant effects on the rCBF can be obtained in dogs. Since less methodological hurdles have to be overcome and comparable results can be obtained, it would be acceptable to put the dog forward as an alternative translational rTMS animal model.	[Dockx, Robrecht; Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, Ghent Expt Psychiat GHEP Lab, Ghent, East Flanders, Belgium; [Peremans, Kathelijne; Vlerick, Lise; Saunders, Jimmy H.] Univ Ghent, Fac Vet Med, Dept Vet Med Imaging & Small Anim Orthopaed, Merelbeke, East Flanders, Belgium; [Van Laeken, Nick; De Vosf, Filip] Univ Ghent, Fac Pharmaceut Sci, Dept Pharmaceut Anal, Lab Radiopharm, Ghent, East Flanders, Belgium; [Polis, Ingeborgh] Univ Ghent, Fac Vet Med, Dept Small Anim, Merelbeke, East Flanders, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Dockx, R (corresponding author), Univ Ghent, Dept Psychiat & Med Psychol, Ghent Expt Psychiat GHEP Lab, Ghent, East Flanders, Belgium.	robrechtdockx@ugent.be	Baeken, Chris/D-6790-2013		Ghent University Special Research Fund [01J05715]	Ghent University Special Research Fund(Ghent University)	Ghent University Special Research Fund (01J05715) funded this research (DVM Robrecht Dockx).	Adriaens A, 2013, VET RADIOL ULTRASOUN, V54, P403, DOI 10.1111/vru.12028; Amaya F, 2010, CLIN NEUROPHYSIOL, V121, P2143, DOI 10.1016/j.clinph.2010.03.058; Amendt HL, 2016, VET J, V217, P40, DOI 10.1016/j.tvjl.2016.06.006; Avery DH, 2006, BIOL PSYCHIAT, V59, P187, DOI 10.1016/j.biopsych.2005.07.003; Baeken C, 2015, BRAIN STIMUL, V8, P808, DOI 10.1016/j.brs.2015.01.415; Baeken C, 2014, WORLD J BIOL PSYCHIA, V15, P286, DOI 10.3109/15622975.2013.872295; Baeken C, 2013, J AFFECT DISORDERS, V151, P625, DOI 10.1016/j.jad.2013.07.008; Ben-Shachar D, 1999, BRAIN RES, V816, P78, DOI 10.1016/S0006-8993(98)01119-6; BenShachar D, 1997, J NEURAL TRANSM, V104, P191, DOI 10.1007/BF01273180; Brakemeier EL, 2008, J AFFECT DISORDERS, V108, P59, DOI 10.1016/j.jad.2007.09.007; Brakemeier EL, 2007, J PSYCHIATR RES, V41, P395, DOI 10.1016/j.jpsychires.2006.01.013; Catafau AM, 2001, PSYCHIAT RES-NEUROIM, V106, P151, DOI 10.1016/S0925-4927(01)00079-8; Conelea CA, 2017, J AFFECT DISORDERS, V217, P42, DOI 10.1016/j.jad.2017.03.063; De Decker S, 2011, JAVMA-J AM VET MED A, V238, P81, DOI 10.2460/javma.238.1.81; Diefenbach GJ, 2013, J AFFECT DISORDERS, V151, P365, DOI 10.1016/j.jad.2013.05.094; Dockx R, 2015, EUR J NUCL MED MOL I, V42, pS290; Dockx R, 2017, PEERJ IN PRESS; Dockx R, PROOF CONCEPT UNPUB; Dorward NL, 2002, BRIT J NEUROSURG, V16, P110, DOI 10.1080/02688690220131705; Eren I, 2003, PSYCHIAT RES-NEUROIM, V123, P135, DOI 10.1016/S0925-4927(03)00062-3; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; FLEISCHMANN A, 1995, BRAIN RES, V699, P130, DOI 10.1016/0006-8993(95)01018-Q; Fregni F, 2006, INT J NEUROPSYCHOPH, V9, P641, DOI 10.1017/S1461145705006280; George MS, 1999, HUM PSYCHOPHARM CLIN, V14, P161, DOI 10.1002/(SICI)1099-1077(199904)14:3<161::AID-HUP73>3.0.CO;2-2; George MS, 1999, ARCH GEN PSYCHIAT, V56, P300, DOI 10.1001/archpsyc.56.4.300; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Huang CC, 2008, PSYCHONEUROENDOCRINO, V33, P821, DOI 10.1016/j.psyneuen.2008.03.006; Irimajiri M, 2010, J VET MED SCI, V72, P1, DOI 10.1292/jvms.09-0048; Kanno M, 2004, J NEUROL SCI, V217, P73, DOI 10.1016/j.jns.2003.08.013; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; Keck ME, 2000, J PSYCHIAT RES, V34, P265, DOI 10.1016/S0022-3956(00)00028-5; Knoch D, 2006, NEUROIMAGE, V31, P641, DOI 10.1016/j.neuroimage.2005.12.025; LeBlanc AK, 2014, SEMIN NUCL MED, V44, P47, DOI 10.1053/j.semnuclmed.2013.08.004; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Levkovitz Y, 2001, NEUROBIOL AGING, V22, P255, DOI 10.1016/S0197-4580(00)00195-0; Lisanby SH, 2001, BIOL PSYCHIAT, V49, P460, DOI 10.1016/S0006-3223(00)01110-0; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Muller PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091065; NEWBERG LA, 1983, ANESTHESIOLOGY, V59, P23, DOI 10.1097/00000542-198307000-00005; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Ohnishi T, 2004, BIOL PSYCHIAT, V55, P484, DOI 10.1016/j.biopsych.2003.09.016; Richieri R, 2011, EUR J NUCL MED MOL I, V38, P1715, DOI 10.1007/s00259-011-1850-9; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Rumi DO, 2005, BIOL PSYCHIAT, V57, P162, DOI 10.1016/j.biopsych.2004.10.029; Sabesan P, 2015, WORLD J PSYCHIATR, V5, P170, DOI 10.5498/wjp.v5.i2.170; Sachdev PS, 2002, BIOL PSYCHIAT, V51, P474, DOI 10.1016/S0006-3223(01)01298-7; Salinas FS, 2011, NEUROIMAGE, V57, P1393, DOI 10.1016/j.neuroimage.2011.05.065; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Shively CA, 2009, AM J PRIMATOL, V71, P715, DOI 10.1002/ajp.20720; Su MY, 1998, NEUROBIOL AGING, V19, P479, DOI 10.1016/S0197-4580(98)00081-5; Tang A, 2015, NEUROSCIENTIST, DOI 1073858415618897; Teneback CC, 1999, J NEUROPSYCH CLIN N, V11, P426; Terraneo A, 2016, EUR NEUROPSYCHOPHARM, V26, P37, DOI 10.1016/j.euroneuro.2015.11.011; Vahabzadeh-Hagh AM, 2012, NEUROMODULATION, V15, P296, DOI 10.1111/j.1525-1403.2012.00482.x; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; Valero-Cabre A, 2007, EXP BRAIN RES, V176, P603, DOI 10.1007/s00221-006-0639-8; Vermeire S, 2009, BRAIN IMAGING BEHAV, V3, P342, DOI 10.1007/s11682-009-9076-1; Vermeire ST, 2009, J NUCL MED, V50, P284, DOI 10.2967/jnumed.108.055731; Waelbers T, 2009, EUR J NUCL MED MOL I, V36, pS469; Waelbers T, 2015, J VET BEHAV, V10, P332, DOI 10.1016/j.jveb.2015.03.009; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009	65	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185362	10.1371/journal.pone.0185362	http://dx.doi.org/10.1371/journal.pone.0185362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937993	Green Published, gold			2022-12-26	WOS:000411524700028
J	Ahmad, AA; Stulberg, MJ; Mershon, JP; Mollov, DS; Huang, Q				Ahmad, Abdelmonim Ali; Stulberg, Michael J.; Mershon, John Patrick; Mollov, Dimitre S.; Huang, Qi			Molecular and biological characterization of phi Rs551, a filamentous bacteriophage isolated from a race 3 biovar 2 strain of Ralstonia solanacearum	PLOS ONE			English	Article							PSEUDOMONAS-SOLANACEARUM; GENOMIC CHARACTERIZATION; PHI-RSM; PHYTOPATHOGEN; VIRULENCE; SEQUENCE; TOMATO; GENES; PHAGE; BIOCONTROL	A filamentous bacteriophage, designated phi Rs551, was isolated and purified from the quarantine and select agent phytopathogen Ralstonia solanacearum race 3 biovar 2 strain UW551 (phylotype IIB sequevar 1) grown under normal culture conditions. Electron microscopy suggested that phi Rs551 is a member of the family Inoviridae, and is about 1200 nm long and 7 nm wide phi Rs551 has a genome of 7929 nucleotides containing 14 open reading frames, and is the first isolated virion that contains a resolvase (ORF13) and putative type-2 phage repressor (ORF14). Unlike other R. solanacearum phages isolated from soil, the genome sequence of phi Rs551 is not only 100% identical to its prophage sequence in the deposited genome of R. solanacearum strain UW551 from which the phage was isolated, but is also surprisingly found with 100% identity in the deposited genomes of 10 other phylotype II sequevar 1 strains of R. solanacearum. Furthermore, it is homologous to genome RS-09-161, resulting in the identification of a new prophage, designated RSM10, in a R. solanacearum strain from India. When ORF13 and a core attP site of phi Rs551 were either deleted individually or in combination, phage integration was not observed, suggesting that similar to other filamentous R. solanacearum phi RSM phages, phi Rs551 relies on its resolvase and the core att sequence for site-directed integration into its susceptible R. solanacearum strain. The integration occurred four hours after phage infection. Infection of a susceptible R. solanacearum strain RUN302 by phi Rs551 resulted in less fluidal colonies and EPS production, and reduced motilities of the bacterium. Interestingly, infection of RUN302 by phi Rs551 also resulted in reduced virulence, rather than enhanced or loss of virulence caused by other phi RSM phages. Study of bacteriophages of R. solanacearum would contribute to a better understanding of the phage-bacterium-environment interactions in order to develop integrated management strategies to combat R. solanacearum.	[Ahmad, Abdelmonim Ali; Stulberg, Michael J.; Mershon, John Patrick; Huang, Qi] USDA ARS, Floral & Nursery Plants Res Unit, US Natl Arboretum, Beltsville, MD 20705 USA; [Ahmad, Abdelmonim Ali] Menia Univ, Fac Agr, Dept Plant Pathol, El Minia, Egypt; [Mollov, Dimitre S.] USDA ARS, Natl Germplasm Resources Lab, Beltsville, MD USA; [Stulberg, Michael J.] USDA, CPHST Beltsville Lab, APHIS, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA); Egyptian Knowledge Bank (EKB); Minia University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Huang, Q (corresponding author), USDA ARS, Floral & Nursery Plants Res Unit, US Natl Arboretum, Beltsville, MD 20705 USA.	qi.huang@ars.usda.gov	Ahmad, Abdelmonim Ali/AAY-5762-2020	Ahmad, Abdelmonim/0000-0001-9857-8385; Mollov, Dimitre/0000-0002-4750-6194; Stulberg, Michael/0000-0001-8640-1291	U. S. Department of Agriculture, Agricultural Research Service	U. S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was financially supported by the U. S. Department of Agriculture, Agricultural Research Service.; This research was financially supported by the U. S. Department of Agriculture, Agricultural Research Service. We thank Joseph Mowery and the Beltsville Electron and Confocal Microscope Unit for technical assistance. We also thank John Hartung in the U. S. and Ahmed Askora in Egypt for critical review of our manuscript.	Addy HS, 2012, PHYTOPATHOLOGY, V102, P469, DOI 10.1094/PHYTO-11-11-0319-R; Addy HS, 2012, PHYTOPATHOLOGY, V102, P244, DOI 10.1094/PHYTO-10-11-0277; Ahmad AA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00321; ALLEN C, 1991, MOL PLANT MICROBE IN, V4, P147, DOI 10.1094/MPMI-4-147; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askora A, 2009, VIROLOGY, V384, P69, DOI 10.1016/j.virol.2008.11.007; Askora A, 2014, MOL GENET GENOMICS, V289, P589, DOI 10.1007/s00438-014-0835-3; Askora A, 2011, J BIOSCI BIOENG, V111, P109, DOI 10.1016/j.jbiosc.2010.10.001; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bhunchoth A, 2015, J APPL MICROBIOL, V118, P1023, DOI 10.1111/jam.12763; Cellier G, 2012, APPL ENVIRON MICROB, V78, P2367, DOI 10.1128/AEM.06123-11; Clarke CR, 2015, PHYTOPATHOLOGY, V105, P597, DOI 10.1094/PHYTO-12-14-0373-R; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; Fujiwara A, 2011, APPL ENVIRON MICROB, V77, P4155, DOI 10.1128/AEM.02847-10; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Jeong KS, 2008, PLANT PATHOLOGY J, V24, P143, DOI 10.5423/PPJ.2008.24.2.143; Kawasaki T, 2007, J BIOSCI BIOENG, V104, P451, DOI 10.1263/jbb.104.451; Kawasaki T, 2007, J BACTERIOL, V189, P5792, DOI 10.1128/JB.00540-07; Kawasaki T, 2016, VIROLOGY, V492, P73, DOI 10.1016/j.virol.2016.02.011; Kawasaki T, 2009, J BACTERIOL, V191, P422, DOI 10.1128/JB.01263-08; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; KELMAN A, 1994, BACTERIAL WILT, P1; Liu HL, 2001, MICROBIOL-SGM, V147, P3215, DOI 10.1099/00221287-147-12-3215; Murugaiyan S, 2011, J APPL MICROBIOL, V110, P296, DOI 10.1111/j.1365-2672.2010.04882.x; Ramesh R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00323-14; ROBERTS DP, 1988, J BACTERIOL, V170, P1445, DOI 10.1128/jb.170.4.1445-1451.1988; Sambrook J., 2001, MOL CLONING LAB MANU; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Stulberg MJ, 2016, J MICROBIOL METH, V123, P101, DOI 10.1016/j.mimet.2016.02.010; Stulberg MJ, 2015, PLANT DIS, V99, P333, DOI 10.1094/PDIS-05-14-0483-RE; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Thi BVT, 2015, ARCH VIROL; Van TTB, 2014, MICROBIOL IMMUNOL, V58, P697, DOI 10.1111/1348-0421.12203; Wilson SR, 1994, ORIGINS LIFE CENTRAL, P11; Xu J, 2011, J BACTERIOL, V193, P4261, DOI 10.1128/JB.05384-11; Yamada T., 2012, BACTERIOPHAGES; Yamada T, 2007, MICROBIOL-SGM, V153, P2630, DOI 10.1099/mic.0.2006/001453-0; Yamada T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00325	40	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185034	10.1371/journal.pone.0185034	http://dx.doi.org/10.1371/journal.pone.0185034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934297	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900077
J	Akhter, S; Chakraborty, S; Moutinho, D; Alvarez-Coiradas, E; Rosa, I; Vinuela, J; Dominguez, E; Garcia, A; Requena, JR				Akhter, Shamim; Chakraborty, Sandipan; Moutinho, Daniela; Alvarez-Coiradas, Elia; Rosa, Isaac; Vinuela, Juan; Dominguez, Eduardo; Garcia, Angel; Requena, Jesus R.			The human VGF-derived bioactive peptide TLQP-21 binds heat shock 71 kDa protein 8 (HSPA8) on the surface of SH-SY5Y cells	PLOS ONE			English	Article							INDUCE PENILE ERECTION; SECONDARY STRUCTURE; NEUROPEPTIDE VGF; RECEPTOR C3AR1; EARLY PHASE; MALE RATS; PREDICTION; PREVENTS; IDENTIFICATION; CONTRIBUTES	VGF (non-acronymic) is a secreted chromogranin/secretogranin that gives rise to a number of bioactive peptides by a complex proteolysis mechanism. VGF-derived peptides exert an extensive array of biological effects in energy metabolism, mood regulation, pain, gastric secretion function, reproduction and, perhaps, cancer. It is therefore surprising that very little is known about receptors and binding partners of VGF-derived peptides and their downstream molecular mechanisms of action. Here, using affinity chromatography and mass spectrometry-based protein identification, we have identified the heat shock cognate 71 kDa protein A8 (HSPA8) as a binding partner of human TLQP-21 on the surface of human neuro-blastomaSH-SY5Y cells. Binding of TLQP-21 to membrane associated HSPA8 in live SHSY5Y cells was further supported by cross-linking to live cells. Interaction between HSPA8 and TLQP-21 was confirmed in vitro by label-free Dynamic Mass Redistribution (DMR) studies. Furthermore, molecular modeling studies show that TLQP-21 can be docked into the HSPA8 peptide binding pocket. Identification of HSPA8 as a cell surface binding partner of TLQP-21 opens new avenues to explore the molecular mechanisms of its physiological actions, and of pharmacological modulation thereof.	[Akhter, Shamim; Moutinho, Daniela; Rosa, Isaac; Garcia, Angel; Requena, Jesus R.] Univ Santiago de Compostela, IDIS, CIMUS Biomed Res Inst, Santiago De Compostela, Spain; [Akhter, Shamim] Khulna Univ, Biotechnol & Genet Engn Discipline, Khulna, Bangladesh; [Chakraborty, Sandipan] Univ Calcutta, Dept Microbiol, Kolkata, India; [Alvarez-Coiradas, Elia; Dominguez, Eduardo] Univ Santiago de Compostela, IDIS, BioFarma Res Grp, CIMUS, Santiago De Compostela, Spain; [Vinuela, Juan] Santiago Univ Hosp, Immunol Lab, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Khulna University; University of Calcutta; Universidade de Santiago de Compostela	Requena, JR (corresponding author), Univ Santiago de Compostela, IDIS, CIMUS Biomed Res Inst, Santiago De Compostela, Spain.	jesus.requena@usc.es	Dominguez, Eduardo/AAD-6578-2020; Chakraborty, Sandipan/T-8968-2017; Garcia, Angel/F-6736-2016; Requena, Jesús/ABH-2344-2020; Moutinho, Daniela/Y-7010-2019	Dominguez, Eduardo/0000-0003-3359-5867; Chakraborty, Sandipan/0000-0001-8759-1074; Garcia, Angel/0000-0003-1176-5917; Vinuela, Juan Evaristo/0000-0001-7778-901X; Moutinho, Daniela/0000-0002-8554-4765; Requena, Jesus/0000-0003-1954-4975	ERANET-NEURON grant DISCover through the Spanish funding partner Instituto de Salud Carlos III [PI09/2688]; European Community Erasmus Mundus EXPERTS II Predoctoral Fellowship; ERANET-NEURON grant DISCover [ISCIII PI09/2688]; Erasmus Mundus EXPERTS II Predoctoral Fellowship	ERANET-NEURON grant DISCover through the Spanish funding partner Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Community Erasmus Mundus EXPERTS II Predoctoral Fellowship; ERANET-NEURON grant DISCover; Erasmus Mundus EXPERTS II Predoctoral Fellowship	This work was supported by ERANET-NEURON grant DISCover through the Spanish funding partner Instituto de Salud Carlos III (www.isciii.es), grant: PI09/2688 to JRR. SA is the recipient of a European Community Erasmus Mundus EXPERTS II Predoctoral Fellowship (http://www.expertsasia.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by ERANET-NEURON grant DISCover (ISCIII PI09/2688). SA is the recipient of an Erasmus Mundus EXPERTS II Predoctoral Fellowship. Authors gratefully acknowledge Dr. Soumalee Basu (Department of Microbiology, University of Calcutta, India) for providing us the computational facility at Centre for High Performance Computing for Modern Biology, Ballygunge Science College, University of Calcutta, India.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bartolomucci A, 2008, Eat Weight Disord, V13, pe49; Bartolomucci A, 2009, GENES NUTR, V4, P49, DOI 10.1007/s12263-009-0110-0; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Cero C, 2014, STRUCTURE, V22, P1744, DOI 10.1016/j.str.2014.10.001; Chakraborty S, 2015, CHEM BIOL DRUG DES, V86, P938, DOI 10.1111/cbdd.12541; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Chen YC, 2013, J BIOL CHEM, V288, P34638, DOI 10.1074/jbc.M113.510917; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Fairbanks CA, 2014, PAIN, V155, P1229, DOI 10.1016/j.pain.2014.03.012; Fishelson Z, 2001, INT IMMUNOL, V13, P983, DOI 10.1093/intimm/13.8.983; Fitter S, 2017, STEM CELLS, V35, P940, DOI 10.1002/stem.2560; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Muller S, 2008, ARTHRITIS RHEUM-US, V58, P3873, DOI 10.1002/art.24027; Nesvizhskii A.I., 2007, METHODS MOL BIOL, V367, P87, DOI DOI 10.1385/1-59745-275-0:87; Page N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005273; Pinilla L, 2011, AM J PHYSIOL-ENDOC M, V300, pE837, DOI 10.1152/ajpendo.00598.2010; Portela-Gomes GM, 2010, REGUL PEPTIDES, V165, P12, DOI 10.1016/j.regpep.2010.02.011; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Ramos A, 2014, HUM MOL GENET, V23, P5859, DOI 10.1093/hmg/ddu303; Razzoli M, 2012, BEHAV BRAIN RES, V229, P333, DOI 10.1016/j.bbr.2012.01.038; Riedl MS, 2009, J NEUROSCI, V29, P13377, DOI 10.1523/JNEUROSCI.1127-09.2009; Rindi G, 2007, J CLIN ENDOCR METAB, V92, P2811, DOI 10.1210/jc.2007-0035; Rizzi R, 2008, NEUROSCI LETT, V441, P129, DOI 10.1016/j.neulet.2008.06.018; ROSSI A, 1992, INT J DEV NEUROSCI, V10, P527, DOI 10.1016/0736-5748(92)90053-3; Rozek W, 2013, TUMOR BIOL, V34, P1773, DOI 10.1007/s13277-013-0716-0; Sarrio S, 2000, MOL CELL BIOL, V20, P5164, DOI 10.1128/MCB.20.14.5164-5174.2000; Severini C, 2009, BRIT J PHARMACOL, V157, P984, DOI 10.1111/j.1476-5381.2009.00192.x; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sibilia V, 2012, AMINO ACIDS, V42, P1261, DOI 10.1007/s00726-010-0818-6; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Succu S, 2005, NEUROPHARMACOLOGY, V49, P1017, DOI 10.1016/j.neuropharm.2005.05.015; Succu S, 2004, EUR J NEUROSCI, V20, P3035, DOI 10.1111/j.1460-9568.2004.03781.x; TAKENAKA IM, 1995, J BIOL CHEM, V270, P19839, DOI 10.1074/jbc.270.34.19839; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Thakker-Varia S, 2010, J NEUROSCI, V30, P9368, DOI 10.1523/JNEUROSCI.5987-09.2010; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; TRANI E, 1995, J NEUROCHEM, V65, P2441; Watson Elizabeth, 2009, BMC Physiology, V9, P19, DOI 10.1186/1472-6793-9-19; Wiersma VR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00007; Zimmer R, 2013, ANN RHEUM DIS, V72, P1830, DOI 10.1136/annrheumdis-2012-202460	54	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185176	10.1371/journal.pone.0185176	http://dx.doi.org/10.1371/journal.pone.0185176			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934328	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900112
J	Chinkhumba, J; De Allegri, M; Mazalale, J; Brenner, S; Mathanga, D; Muula, AS; Robberstad, B				Chinkhumba, Jobiba; De Allegri, Manuela; Mazalale, Jacob; Brenner, Stephan; Mathanga, Don; Muula, Adamson S.; Robberstad, Bjarne			Household costs and time to seek care for pregnancy related complications: The role of results-based financing	PLOS ONE			English	Article							HEALTH-CARE; MATERNAL MORTALITY; PERFORMANCE; SATISFACTION; PERCEPTIONS; INCENTIVES; HOSPITALS; QUALITY; ILLNESS; INCOME	Results-based financing (RBF) schemes-including performance based financing (PBF) and conditional cash transfers (CCT)-are increasingly being used to encourage use and improve quality of institutional health care for pregnant women in order to reduce maternal and neonatal mortality in low-income countries. While there is emerging evidence that RBF can increase service use and quality, little is known on the impact of RBF on costs and time to seek care for obstetric complications, although the two represent important dimensions of access. We conducted this study to fill the existing gap in knowledge by investigating the impact of RBF (PBF+CCT) on household costs and time to seek care for obstetric complications in four districts in Malawi. The analysis included data on 2,219 women with obstetric complications from three waves of a population-based survey conducted at baseline in 2013 and repeated in 2014(midline) and 2015(endline). Using a before and after approach with controls, we applied generalized linear models to study the association between RBF and household costs and time to seek care. Results indicated that receipt of RBF was associated with a significant reduction in the expected mean time to seek care for women experiencing an obstetric complication. Relative to non-RBF, time to seek care in RBF areas decreased by 27.3% (95% CI: 28.4-25.9) at midline and 34.2% (95% CI: 37.8-30.4) at endline. No substantial change in household costs was observed. We conclude that the reduced time to seek care is a manifestation of RBF induced quality improvements, prompting faster decisions on care seeking at household level. Our results suggest RBF may contribute to timely emergency care seeking and thus ultimately reduce maternal and neonatal mortality in beneficiary populations.	[Chinkhumba, Jobiba; Mazalale, Jacob; Mathanga, Don; Muula, Adamson S.] Univ Malawi, Sch Publ Hlth & Family Med, Dept Publ Hlth, Coll Med, Blantyre, Malawi; [Chinkhumba, Jobiba; Robberstad, Bjarne] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [De Allegri, Manuela; Mazalale, Jacob; Brenner, Stephan] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	University of Malawi; University of Bergen; Ruprecht Karls University Heidelberg	Chinkhumba, J (corresponding author), Univ Malawi, Sch Publ Hlth & Family Med, Dept Publ Hlth, Coll Med, Blantyre, Malawi.; Chinkhumba, J (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	jchinkhumba@mac.medcol.mw	Mazalale, Jacob/AAE-3204-2022; Robberstad, Bjarne/AAG-9322-2020; Muula, Adamson/AAF-1153-2020; Mazalale, Jacob/D-8972-2018	Mazalale, Jacob/0000-0001-9856-1268; Robberstad, Bjarne/0000-0002-0708-2016; Mazalale, Jacob/0000-0001-9856-1268	Norwegian Ministry of Foreign Affairs [MWI 12/0010]; United States Agency for International Development under Translating Research into Action [GHS-A-00-09-00015-00]	Norwegian Ministry of Foreign Affairs; United States Agency for International Development under Translating Research into Action(United States Agency for International Development (USAID))	This research project is funded through a grant by the Norwegian Ministry of Foreign Affairs to the Government of Malawi under Programme Title MWI 12/0010 Effect Evaluation of Performance Based Financing in Health Sector. The Malawi College of Medicine as implementing institution is recipient of this grant. This study was co-funded by the United States Agency for International Development under Translating Research into Action, Cooperative Agreement No. GHS-A-00-09-00015-00. This study is made possible by the support of the American People through the United States Agency for International Development (USAID). The findings of this study are the sole responsibility of study team and do not necessarily reflect the views of USAID or the United States Government.; This research project is funded through a grant by the Norwegian Ministry of Foreign Affairs to the Government of Malawi under Programme Title MWI 12/0010 Effect Evaluation of Performance Based Financing in Health Sector. The Malawi College of Medicine as implementing institution is recipient of this grant.; This study was co-funded by the United States Agency for International Development under Translating Research into Action, Cooperative Agreement No. GHS-A-00-09-00015-00. This study is made possible by the support of the American People through the United States Agency for International Development (USAID). The findings of this study are the sole responsibility of study team and do not necessarily reflect the views of USAID or the United States Government.	Andaleeb SS, 2001, SOC SCI MED, V52, P1359, DOI 10.1016/S0277-9536(00)00235-5; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bayarsaikhan D, 2016, INT H HEALTHCARE, V2; Binyaruka P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135013; Blough DK., 2000, HLTH SERV OUTCOMES R, V1, P185, DOI [DOI 10.1023/A:1012597123667, 10.1023/A%3A1012597123667, DOI 10.1023/A%3A1012597123667]; Bonfrer I, 2014, SOC SCI MED, V123, P96, DOI 10.1016/j.socscimed.2014.11.004; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Brenner S, 2015, FINAL RESULTS RBF4MN; Brenner S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-180; Brighton A, 2013, INT J GYNECOL OBSTET, V120, P224, DOI 10.1016/j.ijgo.2012.09.017; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Dangal G., 2014, NEPAL J OBSTET GYNEC, V17, P8; De Walque D, 2012, 5973 WORLD BANK DEV; Echoka Elizabeth, 2014, Pan Afr Med J, V17 Suppl 1, P4, DOI 10.11694/pamj.supp.2014.17.1.3042; Eichler R, 2014, J HEALTH POPUL NUTR, P36; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Honda A, 2011, REPROD HEALTH MATTER, V19, P10, DOI 10.1016/S0968-8080(11)37559-3; Hussein J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001264; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Kambala C, 2011, MALAWI MED J, V23, P1; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Maine D, 1991, SAFE MOTHERHOOD PROG; Manning W, 2013, IHEA WORLD C SYDN AU; Mazalale J, 2015, TROP MED INT HEALTH; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Meessen B, 2011, B WORLD HEALTH ORGAN, V89, P153, DOI 10.2471/BLT.10.077339; Mihaylova B, 2011, HEALTH ECON, V20, P897, DOI 10.1002/hec.1653; Ministry of Health, 2014, MAL NAT HLTH ACC SUB; Nahar S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-11; National Statistical Office, 2014, MAL MDG ENDL SURV 20; Orenstein LAV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046638; Srivastava A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0525-0; Stanton ME, 2013, J HEALTH POPUL NUTR, V31, P1; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thorsen VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052090; Turcotte-Tremblay AM, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0103-9; Ugwu NU, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0050-7; Varian H, 2005, INTERMEDIATE MICROEC, P141; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wilhelm DJ, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1652-7; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038467	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0182326	10.1371/journal.pone.0182326	http://dx.doi.org/10.1371/journal.pone.0182326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934320	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900004
J	de Castro-Catala, M; Mora-Solano, A; Kwapil, TR; Cristobal-Narvaez, P; Sheinbaum, T; Racioppi, A; Barrantes-Vidal, N; Rosa, A				de Castro-Catala, Marta; Mora-Solano, Aurea; Kwapil, Thomas R.; Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Racioppi, Anna; Barrantes-Vidal, Neus; Rosa, Araceli			The genome-wide associated candidate gene ZNF804A and psychosis-proneness: Evidence of sex-modulated association	PLOS ONE			English	Article							WISCONSIN SCHIZOTYPY SCALES; O-METHYLTRANSFERASE COMT; SCHIZOPHRENIA SUSCEPTIBILITY; BIPOLAR DISORDER; NEUROCOGNITIVE PERFORMANCE; DIMENSIONAL STRUCTURE; RISK VARIANT; SHORT FORMS; BRAIN; RS1344706	Background The Zinc finger protein 804A (ZNF804A) is a promising candidate gene for schizophrenia and the broader psychosis phenotype that emerged from genome-wide association studies. It is related to neurodevelopment and associated to severe symptoms of schizophrenia and alterations in brain structure, as well as positive schizotypal personality traits in non-clinical samples. Moreover, a female-specific association has been observed between ZNF804A and schizophrenia. Aim The present study examined the association of two ZNF804A polymorphisms (rs1344706 and rs7597593) with the positive dimension of schizotypy and psychotic-like experiences in a sample of 808 non-clinical subjects. Additionally, we wanted to explore whether the sexual differences reported in schizophrenia are also present in psychosis-proneness. Results Our results showed an association between rs7597593 and both schizotypy and psychoticlike experiences. These associations were driven by females, such those carrying the C allele had higher scores in the positive dimension of both variables compared to TT allele homozygotes. Conclusion The findings of the present study support the inclusion of ZNF804 variability in studies of the vulnerability for the development of psychopathology in non-clinical samples and consideration of sex as a moderator of this association.	[de Castro-Catala, Marta; Mora-Solano, Aurea; Rosa, Araceli] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Seccio Zool & Antropol Biol, Barcelona, Spain; [de Castro-Catala, Marta; Rosa, Araceli] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Kwapil, Thomas R.; Barrantes-Vidal, Neus] Univ North Carolina Greensboro, Dept Psychol, Greensboro, NC USA; [Kwapil, Thomas R.] Univ Illinois Champaign Urbana, Dept Psychol, Champaign, IL USA; [Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Racioppi, Anna; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Fac Psicol, Dept Psicol Clin & Salut, Barcelona, Spain; [Barrantes-Vidal, Neus] St Pere Claver Fundacio Sanitaria, Barcelona, Spain; [Barrantes-Vidal, Neus; Rosa, Araceli] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain	University of Barcelona; University of Barcelona; University of North Carolina; University of North Carolina Greensboro; University of Illinois System; University of Illinois Urbana-Champaign; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Rosa, A (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Seccio Zool & Antropol Biol, Barcelona, Spain.; Rosa, A (corresponding author), Univ Barcelona, Inst Biomed, Barcelona, Spain.; Rosa, A (corresponding author), Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain.	araceli.rosa@ub.edu	Cristóbal-Narváez, Paula/AFU-7048-2022; Sheinbaum, Tamara/A-8008-2016; Rosa, Araceli/Q-2099-2016; Barrantes-Vidal, Neus/A-9578-2013; Racioppi, Anna/ABC-8658-2020; de Castro-Catala, Marta/E-2246-2019; Kwapil, Thomas/I-3163-2019; Cristóbal-Narváez, Paula/K-3265-2017; Kwapil, Thomas R./L-1127-2014	Cristóbal-Narváez, Paula/0000-0001-8184-6347; Sheinbaum, Tamara/0000-0002-2268-7697; Rosa, Araceli/0000-0001-6935-3785; Barrantes-Vidal, Neus/0000-0002-8671-1238; Racioppi, Anna/0000-0002-5575-2811; de Castro-Catala, Marta/0000-0002-5550-4885; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Kwapil, Thomas R./0000-0003-1116-5954	Spanish Ministry of Economy and Competitiveness [PSI2011-30321-C02-01, PSI2011-30321-C02-02, PSI2014-54009-R, PSI2014-56303-REDT-PROMOSAM]; Fundacio la Marato de TV3 [091110]; Comissionat per a Universitats i Recerca of the Generalitat de Catalunya [2014SGR1070, 2014SGR1636]; Academia Research Award (ICREA) from the Catalan Government	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacio la Marato de TV3; Comissionat per a Universitats i Recerca of the Generalitat de Catalunya(Generalitat de Catalunya); Academia Research Award (ICREA) from the Catalan Government	This work was supported by research projects funded by the Spanish Ministry of Economy and Competitiveness (PSI2011-30321-C02-01 and C02-02, PSI2014-54009-R, Red de Excelencia PSI2014-56303-REDT-PROMOSAM: Investigacion en Procesos, Mecanismos y Tratamientos Psicologicos para la Promocion de la Salud Mental), Fundacio la Marato de TV3 (091110), Comissionat per a Universitats i Recerca of the Generalitat de Catalunya (2014SGR1070 and 2014SGR1636). N. Barrantes-Vidal is funded by the Academia Research Award (ICREA) from the Catalan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191; Chang H, 2017, ZNF804A CLIN ASS BIO, P14; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124597; Cummings E, 2010, SCHIZOPHR RES, V122, P273, DOI 10.1016/j.schres.2010.05.022; de Castro-Catala M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/829237; Deans PJM, 2016, BIOL PSYCHIAT, P1053; del Re EC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.117; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; Eckblad M.L., 1982, REVISED SOCIAL ANHED; Fanous AH, 2007, MOL PSYCHIATR, V12, P958, DOI 10.1038/sj.mp.4001996; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Godar SC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00071; Gross GM, 2015, SCHIZOPHR RES, V166, P80, DOI 10.1016/j.schres.2015.05.016; Gross GM, 2012, SCHIZOPHR RES, V134, P267, DOI 10.1016/j.schres.2011.11.032; Gurung R, 2015, PSYCHOL MED, V45, P2461, DOI 10.1017/S0033291715000537; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; Hatzimanolis A, 2015, AM J MED GENET B, V168, P392, DOI 10.1002/ajmg.b.32323; Hess JL, 2014, AM J MED GENET B, V165, P28, DOI 10.1002/ajmg.b.32207; Hill MJ, 2011, MOL PSYCHIATR, V16, P787, DOI 10.1038/mp.2011.21; Hill MJ, 2012, AM J PSYCHIAT, V169, P1301, DOI 10.1176/appi.ajp.2012.11121845; Hill MJ, 2012, HUM MOL GENET, V21, P1018, DOI 10.1093/hmg/ddr532; Hinna KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132456; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Kwapil TR, 2008, SCHIZOPHRENIA BULL, V34, P444, DOI 10.1093/schbul/sbm098; Kwapil TR, 2013, J ABNORM PSYCHOL, V122, P807, DOI 10.1037/a0033759; Laruelle M, 2014, CURR OPIN PHARMACOL, V14, P97, DOI 10.1016/j.coph.2014.01.001; Li M, 2012, AM J MED GENET B, V159B, P794, DOI 10.1002/ajmg.b.32084; Mallas EJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1570; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Paulus FM, 2013, HUM BRAIN MAPP, V34, P304, DOI 10.1002/hbm.21434; R Development Core Team, 2008, LANG ENV STAT COMP; Rao SQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41140; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ros-Morente A, 2010, ACTAS ESP PSIQUIATRI, V38, P33; Ros-Morente A, 2011, ACTAS ESP PSIQUIATRI, V39, P95; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; Stefanis NC, 2013, SCHIZOPHRENIA BULL, V39, P1252, DOI 10.1093/schbul/sbs110; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Sun Y, 2015, SCHIZOPHR RES, V162, P124, DOI 10.1016/j.schres.2015.01.036; Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Walters JTR, 2010, ARCH GEN PSYCHIAT, V67, P692, DOI 10.1001/archgenpsychiatry.2010.81; Wang J, 2016, NEUROSCI LETT, V618, P14, DOI 10.1016/j.neulet.2016.02.048; Wang TY, 2014, INT J NEUROPSYCHOPH, V17, P211, DOI 10.1017/S1461145713001296; Wang Y, 2010, PSYCHIAT RES, V179, P147, DOI 10.1016/j.psychres.2009.03.029; Wassink TH, 2012, ARCH GEN PSYCHIAT, V69, P885, DOI 10.1001/archgenpsychiatry.2011.2116; Wei QL, 2015, AM J MED GENET B, V168, P265, DOI 10.1002/ajmg.b.32308; Wheeler B, 2010, LMPERM PERMUTATION T; Wickramasinghe A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.198; Yasuda Y, 2011, NEUROSCI LETT, V495, P216, DOI 10.1016/j.neulet.2011.03.069; Zhang FY, 2011, BIOL PSYCHIAT, V69, P914, DOI 10.1016/j.biopsych.2011.01.003	55	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185072	10.1371/journal.pone.0185072	http://dx.doi.org/10.1371/journal.pone.0185072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931092	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700068
J	Deng, J; Gao, H; Gao, Z; Zhao, HX; Yang, Y; Wu, QF; Wu, B; Jiang, CJ				Deng, Jie; Gao, Hua; Gao, Zhen; Zhao, Huaxian; Yang, Ying; Wu, Qiaofen; Wu, Bo; Jiang, Chengjian			Identification and molecular characterization of a metagenome-derived L-lysine decarboxylase gene from subtropical soil microorganisms	PLOS ONE			English	Article							ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; CADAVERINE PRODUCTION; STRUCTURE PREDICTION; GENOME SEQUENCE; HAFNIA-ALVEI; BIOSYNTHESIS; PEPTIDOGLYCAN; FERMENTATION; EXPRESSION	L-lysine decarboxylase (LDC, EC 4.1.1.18) is a key enzyme in the decarboxylation of Llysine to 1,5-pentanediamine and efficiently contributes significance to biosynthetic capability. Metagenomic technology is a shortcut approach used to obtain new genes from uncultured microorganisms. In this study, a subtropical soil metagenomic library was constructed, and a putative LDC gene named ldc1E was isolated by function-based screening strategy through the indication of pH change by L-lysine decarboxylation. Amino acid sequence comparison and homology modeling indicated the close relation between Ldc1E and other putative LDCs. Multiple sequence alignment analysis revealed that Ldc1E contained a highly conserved motif Ser-X-His-Lys (Pxl), and molecular docking results showed that this motif was located in the active site and could combine with the cofactor pyridoxal 5'-phosphate. The ldc1E gene was subcloned into the pET-30a(+) vector and highly expressed in Escherichia coli BL21 (DE3) pLysS. The recombinant protein was purified to homogeneity. The maximum activity of Ldc1E occurred at pH 6.5 and 40 degrees C using L-lysine monohydrochloride as the substrate. Recombinant Ldc1E had apparent K-m, k(cat), and k(cat)/K-m values of 1.08 +/- 0.16 mM, 5.09 +/- 0.63 s(-1), and 4.73x10 3 s(-1) M-1, respectively. The specific activity of Ldc1E was 1.53 +/- 0.06 U mg(-1) protein. Identifying a metagenome-derived LDC gene provided a rational reference for further gene modifications in industrial applications.	[Deng, Jie; Gao, Hua; Gao, Zhen; Zhao, Huaxian; Wu, Qiaofen; Jiang, Chengjian] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Yang, Ying; Wu, Bo] Guangxi Univ Nationalities, Coll Ocean & Biotechnol, Nanning, Guangxi, Peoples R China	Guangxi University; Guangxi Minzu University	Jiang, CJ (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China.	jiangcj0520@gmail.com		Jiang, Chengjian/0000-0001-6887-7560	National Natural Science Foundation of China [31760437, 21262003]; Excellent Teaching Program of Guangxi High Education-Program of Advantageous and Characteristic Specialty (Excellent Undergraduate Major)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Teaching Program of Guangxi High Education-Program of Advantageous and Characteristic Specialty (Excellent Undergraduate Major)	This research was supported by the National Natural Science Foundation of China (Grant No. 31760437, 21262003) (CJJ), and the 2016 Excellent Teaching Program of Guangxi High Education-Program of Advantageous and Characteristic Specialty (Excellent Undergraduate Major) (CJJ).	Abbott SL, 2003, J CLIN MICROBIOL, V41, P2348, DOI 10.1128/JCM.41.6.2348-2357.2003; Alexopoulos E, 2008, ACTA CRYSTALLOGR F, V64, P700, DOI 10.1107/S1744309108018757; Andreeva A, 2016, BIOCHEM SOC T, V44, P937, DOI 10.1042/BST20160053; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bhatia SK, 2016, REV ENVIRON SCI BIO, V15, P639, DOI 10.1007/s11157-016-9415-9; Brady SF, 2000, J AM CHEM SOC, V122, P12903, DOI 10.1021/ja002990u; Bunsupa S, 2012, PLANT CELL, V24, P1202, DOI 10.1105/tpc.112.095885; Burgmann H, 2001, J MICROBIOL METH, V45, P7, DOI 10.1016/S0167-7012(01)00213-5; Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005; FECKER LF, 1986, MOL GEN GENET, V203, P177, DOI 10.1007/BF00330400; Flores FJ, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-5; GANI D, 1991, PHILOS T ROY SOC B, V332, P131, DOI 10.1098/rstb.1991.0041; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hintze BJ, 2016, PROTEINS, V84, P1177, DOI 10.1002/prot.25039; Hirao T, 2000, J BACTERIOL, V182, P1154, DOI 10.1128/JB.182.4.1154-1157.2000; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kandiah E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24601; Kanjee U, 2010, JOVE-J VIS EXP, V46, P2094; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Kim JY, 2016, J MICROBIOL BIOTECHN, V26, P909, DOI 10.4014/jmb.1602.02012; Kim YH, 2015, J MICROBIOL BIOTECHN, V25, P2110, DOI 10.4014/jmb.1505.05063; Kind S, 2014, METAB ENG, V25, P113, DOI 10.1016/j.ymben.2014.05.007; Kind S, 2011, METAB ENG, V13, P617, DOI 10.1016/j.ymben.2011.07.006; Kind S, 2010, METAB ENG, V12, P341, DOI 10.1016/j.ymben.2010.03.005; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Lemonnier M, 1998, MICROBIOL-SGM, V144, P751, DOI 10.1099/00221287-144-3-751; Li M, 2014, J IND MICROBIOL BIOT, V41, P701, DOI 10.1007/s10295-014-1409-4; Li NQ, 2016, ENG LIFE SCI, V16, P299, DOI 10.1002/elsc.201500037; Li NQ, 2014, BIOTECHNOL BIOPROC E, V19, P965, DOI 10.1007/s12257-014-0352-6; Li YD, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-85; Ma WC, 2015, BIOTECHNOL LETT, V37, P799, DOI 10.1007/s10529-014-1753-5; Malet H, 2014, ELIFE, V3, DOI 10.7554/eLife.03653; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Meneses C, 2016, MOLECULES, V21, DOI 10.3390/molecules21070831; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; MOMANY C, 1995, J MOL BIOL, V252, P643, DOI 10.1006/jmbi.1995.0526; MOMANY C, 1995, PROTEIN SCI, V4, P849; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Qian ZG, 2011, BIOTECHNOL BIOENG, V108, P93, DOI 10.1002/bit.22918; Sagong HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166667; Schneider J, 2011, APPL MICROBIOL BIOT, V91, P17, DOI 10.1007/s00253-011-3252-0; Sugawara A, 2014, J BIOSCI BIOENG, V118, P496, DOI 10.1016/j.jbiosc.2014.04.013; Takatsuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1, DOI 10.1271/bbb.68.1; Takatsuka Y, 1999, BIOSCI BIOTECH BIOCH, V63, P1063, DOI 10.1271/bbb.63.1063; Tsuge Y, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0411-0; Uria AR, 2016, ADV FOOD NUTR RES, V78, P1, DOI 10.1016/bs.afnr.2016.05.001; Voget S, 2003, APPL ENVIRON MICROB, V69, P6235, DOI 10.1128/AEM.69.10.6235-6242.2003; Wang C, 2015, BIOTECHNOL BIOPROC E, V20, P439, DOI 10.1007/s12257-014-0690-4; Yoon H, 2015, TOX RESEARCH, V31, P299, DOI 10.5487/TR.2015.31.3.299	50	8	10	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185060	10.1371/journal.pone.0185060	http://dx.doi.org/10.1371/journal.pone.0185060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931053	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700066
J	Talakoub, O; Marquez-Chin, C; Popovic, MR; Navarro, J; Fonoff, ET; Hamani, C; Wong, W				Talakoub, Omid; Marquez-Chin, Cesar; Popovic, Milos R.; Navarro, Jessie; Fonoff, Erich T.; Hamani, Clement; Wong, Willy			Reconstruction of reaching movement trajectories using electrocorticographic signals in humans	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; LOCAL-FIELD POTENTIALS; ARM MOVEMENTS; MAGNETOENCEPHALOGRAPHIC SIGNALS; MOTOR CORTEX; HAND; MONKEY; REPRESENTATION; RECORDINGS; KINEMATICS	In this study, we used electrocorticographic (ECoG) signals to extract the onset of arm movement as well as the velocity of the hand as a function of time. ECoG recordings were obtained from three individuals while they performed reaching tasks in the left, right and forward directions. The ECoG electrodes were placed over the motor cortex contralateral to the moving arm. Movement onset was detected from gamma activity with near perfect accuracy (> 98%), and a multiple linear regression model was used to predict the trajectory of the reaching task in three-dimensional space with an accuracy exceeding 85%. An adaptive selection of frequency bands was used for movement classification and prediction. This demonstrates the efficacy of developing a real-time brain-machine interface for arm movements with as few as eight ECoG electrodes.	[Talakoub, Omid; Wong, Willy] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Talakoub, Omid; Popovic, Milos R.; Wong, Willy] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Marquez-Chin, Cesar; Popovic, Milos R.] Univ Hlth Network, Toronto Rehabil Inst, Rehabil Engn Lab, Toronto, ON, Canada; [Marquez-Chin, Cesar] Univ Hlth Network, Toronto Rehabil Inst, Neural Engn Lab, Toronto, ON, Canada; [Navarro, Jessie; Fonoff, Erich T.] Univ Sao Paulo, Med Sch, Dept Neurol, Div Funct Neurosurg,Inst Psychiat,Hosp Clin, Sao Paulo, Brazil; [Hamani, Clement] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; Universidade de Sao Paulo; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wong, W (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada.; Wong, W (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	willy.wong@utoronto.ca	Fonoff, Erich Talamoni/E-4327-2012	Fonoff, Erich Talamoni/0000-0001-7831-9941; Popovic, Milos R/0000-0002-2837-2346; Wong, Willy/0000-0002-3900-3140; Marquez-Chin, Cesar/0000-0002-9916-4122	Natural Sciences and Engineering Research Council [249669, 458039]; CRANIA; Toronto Rehabilitation Institute's Foundation; PVE/CNPq - PVECNPq/CNDCT [400201/2012]; PVE/CNPq-PVE CNPq/CNDCT [400201/2012]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRANIA; Toronto Rehabilitation Institute's Foundation; PVE/CNPq - PVECNPq/CNDCT; PVE/CNPq-PVE CNPq/CNDCT	This project was funded by the Natural Sciences and Engineering Research Council (Grants #249669 and #458039), CRANIA Project, Toronto Rehabilitation Institute's Foundation, and PVE/CNPq - PVECNPq/CNDCT (Grant#400201/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the Natural Sciences and Engineering Research Council (Grants #249669 and #458039), CRANIA Project, Toronto Rehabilitation Institute's Foundation, and PVE/CNPq-PVE CNPq/CNDCT (Grant#400201/2012).	Anderson NR, 2012, EXP BRAIN RES, V223, P1, DOI 10.1007/s00221-012-3226-1; Averbeck BB, 2005, J NEUROPHYSIOL, V93, P508, DOI 10.1152/jn.00357.2004; Bai O, 2008, J NEURAL ENG, V5, P24, DOI 10.1088/1741-2560/5/1/003; Bai O, 2011, CLIN NEUROPHYSIOL, V122, P364, DOI 10.1016/j.clinph.2010.07.010; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Bougrain L, 2009, J NEURAL ENG; Bradberry TJ, 2008, IEEE ENG MED BIO, P5306, DOI 10.1109/IEMBS.2008.4650412; Chen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083534; Chin CM, 2007, J NEURAL ENG, V4, P146, DOI 10.1088/1741-2560/4/2/014; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; Georgopoulos AP, 2005, EXP BRAIN RES, V167, P132, DOI 10.1007/s00221-005-0028-8; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Graimann B, 2004, IEEE T BIO-MED ENG, V51, P954, DOI 10.1109/TBME.2004.826671; Graimann B, 2003, IEEE T NEUR SYS REH, V11, P276, DOI 10.1109/TNSRE.2003.816863; Heldman DA, 2006, IEEE T NEUR SYS REH, V14, P180, DOI 10.1109/TNSRE.2006.875549; HOGAN N, 1984, J NEUROSCI, V4, P2745; Jiang N, 2015, CLIN NEUROPHYSIOL, V126, P154, DOI 10.1016/j.clinph.2014.05.003; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Levine SP, 2000, IEEE T REHABIL ENG, V8, P180, DOI 10.1109/86.847809; Liang NY, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00091; Mehring C, 2004, J PHYSIOL-PARIS, V98, P498, DOI 10.1016/j.jphysparis.2005.09.016; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Milekovic T, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046003; Nakanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072085; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Talakoub O, 2016, SCI REP-UK, V6, DOI 10.1038/srep34930; Talakoub O, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00431; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Teixeira Manoel Jacobsen, 2013, Acta Neurochir Suppl, V117, P73, DOI 10.1007/978-3-7091-1482-7_12; Townsend BR, 2006, J NEUROPHYSIOL, V96, P2578, DOI 10.1152/jn.01086.2005; Waldert S, 2009, J PHYSIOL-PARIS, V103, P244, DOI 10.1016/j.jphysparis.2009.08.007; Wang Zuoguan, 2012, Front Neuroeng, V5, P15, DOI 10.3389/fneng.2012.00015; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Yeom HG, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026006; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001; Zhuang J, 2010, IEEE T BIO-MED ENG, V57, P1774, DOI 10.1109/TBME.2010.2047015	49	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0182542	10.1371/journal.pone.0182542	http://dx.doi.org/10.1371/journal.pone.0182542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931054	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700004
J	Fraaije, RGA; Moinier, S; van Gogh, I; Timmers, R; van Deelen, JJ; Verhoeven, JTA; Soons, MB				Fraaije, Rob G. A.; Moinier, Sophie; van Gogh, Iris; Timmers, Robert; van Deelen, Joost J.; Verhoeven, Jos T. A.; Soons, Merel B.			Spatial patterns of water-dispersed seed deposition along stream riparian gradients	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; LIFE-HISTORY TRAITS; BENTHIC INVERTEBRATES; VEGETATION PATTERNS; INDICATOR VALUES; WINTER FLOW; DRIFT LINES; RESTORATION; DIVERSITY; RIVERS	Riparian ecosystems along streams naturally harbour a high plant diversity with many increasingly endangered species. In our current heavily modified and fragmented catchments, many of these species are sensitive to dispersal limitation. Better understanding of riparian plant dispersal pathways is required to predict species (re-) colonization potential and improve success rates of stream and riparian zone conservation and restoration. Dispersal by water (hydrochory) is an important mechanism for longitudinal and lateral dispersal of riparian species. Crucially for recruitment potential, it also influences the elevation along the riparian hydrological gradient where seeds become deposited. Due to the complex interplay between abiotic and biotic factors, however, it remains unclear how exactly patterns in seed deposition are formed. We compared hydrochorous and non-hydrochorous seed deposition, and quantified patterns of seed deposition along the bare substrate of newly created stream riparian gradients. Water levels were monitored and seed deposition was measured with seed traps along the full range of riparian hydrological conditions (from permanently flooded to never flooded). Average seed numbers and species richness were significantly higher in flooded than in non-flooded seed traps (5.7 and 1.5 times higher, respectively). Community-weighted trait means indicated that typically water-dispersed seeds were more dominant in flooded than in non-flooded seed traps and gradually decreased in concentration from the channel to the upland. Moreover, highly buoyant seeds accumulated at the average water line, and clear elevational sorting of non-buoyant seeds occurred within the floodplain. These results establish a critical role of flooding in shaping patterns of seed deposition along the riparian gradient, delivering many seeds of typical riparian species to riparian zones and depositing them at species-specific elevations as influenced by seed traits, suggesting species-specific dispersal pathways. This shows that hydrochory likely has important consequences for riparian vegetation development and that flooding forms a key process for successful restoration.	[Fraaije, Rob G. A.; Moinier, Sophie; van Gogh, Iris; Timmers, Robert; van Deelen, Joost J.; Verhoeven, Jos T. A.; Soons, Merel B.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Padualaan 8, Utrecht, Netherlands	Utrecht University	Fraaije, RGA (corresponding author), Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Padualaan 8, Utrecht, Netherlands.	robfraaije@gmail.com	Soons, Merel/C-6216-2009	Fraaije, Rob/0000-0001-7887-9359; Timmers, Robert/0000-0003-2901-509X	Agentschap NL (Rijksdienst voor Ondernemend Nederland); Foundation for Applied Water Research (STOWA); waterboard 'Aa Maas'; waterboard 'de Dommel'; waterboard 'Vechtstromen'	Agentschap NL (Rijksdienst voor Ondernemend Nederland); Foundation for Applied Water Research (STOWA); waterboard 'Aa Maas'; waterboard 'de Dommel'; waterboard 'Vechtstromen'	This research was supported by the waterboards 'Aa & Maas', 'de Dommel' and 'Vechtstromen' and co-funded by Agentschap NL (Rijksdienst voor Ondernemend Nederland), the Foundation for Applied Water Research (STOWA) and personal grants to M. B. Soons (Netherlands Organization for Scientific Research, NWO-ALW Meervoud and Vidi grants).	Andersson E, 2000, J BIOGEOGR, V27, P1095, DOI 10.1046/j.1365-2699.2000.00481.x; Baattrup-Pedersen A, 2013, RIVER RES APPL, V29, P855, DOI 10.1002/rra.2573; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BarratSegretain MH, 1996, VEGETATIO, V123, P13, DOI 10.1007/BF00044885; Bischoff A, 2002, BIOL CONSERV, V104, P25, DOI 10.1016/S0006-3207(01)00151-3; Boedeltje G, 2004, J ECOL, V92, P786, DOI 10.1111/j.0022-0477.2004.00906.x; Boedeltje G, 2003, J ECOL, V91, P855, DOI 10.1046/j.1365-2745.2003.00820.x; Boedeltje G, 2002, AQUAT BOT, V72, P121, DOI 10.1016/S0304-3770(01)00224-8; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brederveld RJ, 2011, J APPL ECOL, V48, P1241, DOI 10.1111/j.1365-2664.2011.02026.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcada EA, 2015, PERSPECT PLANT ECOL, V17, P434, DOI 10.1016/j.ppees.2015.09.001; Calcada EA, 2015, LANDSCAPE ECOL, V30, P2133, DOI 10.1007/s10980-015-0236-y; Calcada EA, 2013, J APPL ECOL, V50, P1152, DOI 10.1111/1365-2664.12132; Cappers R. T. J, 2006, DIGITAL SEED ATLAS N; Chambert S, 2009, RIVER RES APPL, V25, P48, DOI 10.1002/rra.1093; COOPS H, 1995, FRESHWATER BIOL, V34, P13, DOI 10.1111/j.1365-2427.1995.tb00418.x; DEVRIES JJ, 1976, J HYDROL, V29, P43, DOI 10.1016/0022-1694(76)90004-4; DIEKMANN M, 1995, ECOGRAPHY, V18, P178, DOI 10.1111/j.1600-0587.1995.tb00339.x; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; DIETRICH WE, 1982, WATER RESOUR RES, V18, P1615, DOI 10.1029/WR018i006p01615; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1; Ellenberg H., 1988, VEGETATION ECOLOGY C; Fraaije RGA, 2015, J ECOL, V103, P1634, DOI 10.1111/1365-2745.12460; Fraaije RGA, 2015, FUNCT ECOL, V29, P971, DOI 10.1111/1365-2435.12441; Goodson JM, 2003, RIVER RES APPL, V19, P317, DOI 10.1002/rra.707; Gurnell AM, 2006, J VEG SCI, V17, P665, DOI 10.1111/j.1654-1103.2006.tb02490.x; Gurnell A, 2008, J ECOL, V96, P553, DOI 10.1111/j.1365-2745.2008.01358.x; Gurnell A, 2007, EARTH SURF PROC LAND, V32, P1257, DOI 10.1002/esp.1554; Gurnell AM, 2007, GEOMORPHOLOGY, V89, P9, DOI 10.1016/j.geomorph.2006.07.012; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hill M. O., 1999, ELLENBERGS INDICATOR; Jahnig SC, 2010, J APPL ECOL, V47, P671, DOI 10.1111/j.1365-2664.2010.01807.x; Jahnig SC, 2009, J APPL ECOL, V46, P406, DOI 10.1111/j.1365-2664.2009.01611.x; Jansson R, 2005, J ECOL, V93, P1094, DOI 10.1111/j.1365-2745.2005.01057.x; Johansson ME, 1996, J VEG SCI, V7, P593, DOI 10.2307/3236309; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Knevel IC, 2003, J VEG SCI, V14, P611, DOI 10.1111/j.1654-1103.2003.tb02188.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lorenz AW, 2013, HYDROBIOLOGIA, V704, P489, DOI 10.1007/s10750-012-1326-3; Malmqvist B, 2002, ENVIRON CONSERV, V29, P134, DOI 10.1017/S0376892902000097; Merritt DM, 2010, ECOL MONOGR, V80, P609, DOI 10.1890/09-1533.1; Merritt DM, 2002, ECOL APPL, V12, P1071, DOI 10.1890/1051-0761(2002)012[1071:PGHARH]2.0.CO;2; Merritt DM, 2006, RIVER RES APPL, V22, P1, DOI 10.1002/rra.890; Moggridge HL, 2010, RIVER RES APPL, V26, P512, DOI 10.1002/rra.1273; Moggridge HL, 2009, J VEG SCI, V20, P465, DOI 10.1111/j.1654-1103.2009.05498.x; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nilsson C, 2002, ECOLOGY, V83, P2878, DOI 10.1890/0012-9658(2002)083[2878:DIRFBR]2.0.CO;2; NILSSON C, 1990, CAN J BOT, V68, P735, DOI 10.1139/b90-097; NILSSON C, 1991, CAN J BOT, V69, P2631, DOI 10.1139/b91-328; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Oksanen J, 2015, VEGAN COMMUNITY ECOL, V2, P2; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Palmer MA, 2014, ANNU REV ECOL EVOL S, V45, P247, DOI 10.1146/annurev-ecolsys-120213-091935; Poulsen JB, 2014, ECOL ENG, V66, P120, DOI 10.1016/j.ecoleng.2013.05.010; Riis T, 2014, ECOL ENG, V66, P103, DOI 10.1016/j.ecoleng.2013.05.006; Sarneel JM, 2014, J VEG SCI, V25, P262, DOI 10.1111/jvs.12074; Sarneel JM, 2012, J VEG SCI, V23, P517, DOI 10.1111/j.1654-1103.2011.01367.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Seiwa K, 2008, PLANT ECOL, V198, P27, DOI 10.1007/s11258-007-9382-x; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Silvertown J, 2015, J ECOL, V103, P93, DOI 10.1111/1365-2745.12332; Soomers H, 2013, ECOSYSTEMS, V16, P434, DOI 10.1007/s10021-012-9619-y; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Soons MB, 2006, APPL VEG SCI, V9, P271, DOI 10.1658/1402-2001(2006)9[271:WDIFWK]2.0.CO;2; Soons MB, 2017, FUNCT ECOL, V31, P499, DOI 10.1111/1365-2435.12771; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; van Leeuwen CHA, 2014, J ECOL, V102, P998, DOI 10.1111/1365-2745.12250; Verdonschot PFM, 2002, HYDROBIOLOGIA, V478, P131, DOI 10.1023/A:1021026630384; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; Vogt K, 2007, AQUAT BOT, V86, P385, DOI 10.1016/j.aquabot.2007.01.009; Vogt K, 2006, BASIC APPL ECOL, V7, P422, DOI 10.1016/j.baae.2006.05.007; Wubs ERJ, 2016, FRESHWATER BIOL, V61, P580, DOI 10.1111/fwb.12736	79	12	12	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185247	10.1371/journal.pone.0185247	http://dx.doi.org/10.1371/journal.pone.0185247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957365	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200038
J	Kumar, R; Pitcher, TJ; Varkey, DA				Kumar, Rajeev; Pitcher, Tony J.; Varkey, Divya A.			Ecosystem approach to fisheries: Exploring environmental and trophic effects on Maximum Sustainable Yield (MSY) reference point estimates	PLOS ONE			English	Article							MILLE LACS LAKE; STOCK ASSESSMENT; SMALLMOUTH BASS; LONG-TERM; IMPACTS; CLIMATE; TEMPERATURE; SINGLE; BURBOT; CISCO	We present a comprehensive analysis of estimation of fisheries Maximum Sustainable Yield (MSY) reference points using an ecosystem model built for Mille Lacs Lake, the second largest lake within Minnesota, USA. Data from single-species modelling output, extensive annual sampling for species abundances, annual catch-survey, stomach-content analysis for predatory-prey interactions, and expert opinions were brought together within the framework of an Ecopath with Ecosim (EwE) ecosystem model. An increase in the lake water temperature was observed in the last few decades; therefore, we also incorporated a temperature forcing function in the EwE model to capture the influences of changing temperature on the species composition and food web. The EwE model was fitted to abundance and catch time-series for the period 1985 to 2006. Using the ecosystem model, we estimated reference points for most of the fished species in the lake at single-species as well as ecosystem levels with and without considering the influence of temperature change; therefore, our analysis investigated the trophic and temperature effects on the reference points. The paper concludes that reference points such as MSY are not stationary, but change when (1) environmental conditions alter species productivity and (2) fishing on predators alters the compensatory response of their prey. Thus, it is necessary for the management to re-estimate or re-evaluate the reference points when changes in environmental conditions and/or major shifts in species abundance or community structure are observed.	[Kumar, Rajeev; Pitcher, Tony J.; Varkey, Divya A.] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada	University of British Columbia	Kumar, R (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada.	r.kumar@oceans.ubc.ca			Minnesota Department of Natural Resources	Minnesota Department of Natural Resources	This work was supported by the Minnesota Department of Natural Resources (http://www.dnr.state.mn.us/index.html) TJP - HYMT UBC code: 17R69668. MNDNR supported the design of the study, and provided data required for the analyses.	Ahrens RNM, 2012, FISH FISH, V13, P41, DOI 10.1111/j.1467-2979.2011.00432.x; Brunel T, 2010, ICES J MAR SCI, V67, P1051, DOI 10.1093/icesjms/fsp297; Charles AT, 1998, FISH RES, V37, P37, DOI 10.1016/S0165-7836(98)00125-8; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; COLBY PJ, 1969, LIMNOL OCEANOGR, V14, P958, DOI 10.4319/lo.1969.14.6.0958; Dickey-Collas M, 2014, ICES J MAR SCI, V71, P128, DOI 10.1093/icesjms/fst075; Drake MT, 2007, MILLE LACS LAKE WALL; Dunlop ES, 2006, T AM FISH SOC, V135, P1175, DOI 10.1577/T05-218.1; EDSALL TA, 1970, T AM FISH SOC, V99, P526, DOI 10.1577/1548-8659(1970)99<526:TTOYCC>2.0.CO;2; Edwards EA., 1983, FWSOBS821036 US DEP; Funnell E, 2012, SMALLMOUTH BASS ONTA; Gislason H, 1999, ICES J MAR SCI, V56, P571, DOI 10.1006/jmsc.1999.0492; Haddon M., 2011, MODELLING QUANTITATI; Hilborn R, 2011, FISH RES, V108, P235, DOI 10.1016/j.fishres.2010.12.030; Hofmann N, 2002, T AM FISH SOC, V131, P1164, DOI 10.1577/1548-8659(2002)131<1164:TPACTL>2.0.CO;2; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; Hurtado-Ferro F, 2010, ICES J MAR SCI, V67, P2012, DOI 10.1093/icesjms/fsq126; Ivan LN, 2011, T AM FISH SOC, V140, P1078, DOI 10.1080/00028487.2011.603976; Jackson JR, 2008, AM FISH S S, V59, P131; Jacobsen NS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2701; Jacobson PC, 2008, T AM FISH SOC, V137, P1464, DOI 10.1577/T07-148.1; Jones R, 2013, MITIG ADAPT STRAT GL, V18, P731, DOI 10.1007/s11027-012-9385-3; Jones T, 2006, MILLE LACS LAKE CREE; Kahle D, 2013, R J, V5, P144; Kumar R, 2016, ECOL MODEL, V331, P68, DOI 10.1016/j.ecolmodel.2016.01.019; Kumar R, 2013, N AM J FISH MANAGE, V33, P669, DOI 10.1080/02755947.2013.785992; Large SI, 2013, ICES J MAR SCI, V70, P755, DOI 10.1093/icesjms/fst067; LARKIN PA, 1977, T AM FISH SOC, V106, P1, DOI 10.1577/1548-8659(1977)106<1:AEFTCO>2.0.CO;2; Latta W. C., 1995, DISTRIBUTION ABUNDAN; Levin PS, 2013, ICEJ MARINE SCI J; Mace PM, 2001, FISH FISH, V2, P2, DOI 10.1046/j.1467-2979.2001.00033.x; Mackinson S, 2009, ECOL MODEL, V220, P2972, DOI 10.1016/j.ecolmodel.2008.10.021; Madsen R, 2005, PRELIMINARY YELLOW P; MNDNR, 1997, POT TARG CURR YIELD; NCDC, 2014, NAT OC ATM ADM; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Punt A., 2001, CONSERVATION EXPLOIT, P41; Radomski P, 2003, N AM J FISH MANAGE, V23, P1329, DOI 10.1577/M01-231AM; Schwarz CJ, 2006, ANAL MARK RECAPTURE; Scott W.B., 1973, Bulletin Fish Res Bd Canada, V184, P1; Shuter BJ, 2012, AQUAT SCI, V74, P637, DOI 10.1007/s00027-012-0274-3; Sissenwine MM, 2014, ICES J MAR SCI, V71, P153, DOI 10.1093/icesjms/fst236; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Stapanian MA, 2010, FISH FISH, V11, P34, DOI 10.1111/j.1467-2979.2009.00340.x; Travers-Trolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094286; Walters C, 2000, ECOSYSTEMS, V3, P70, DOI 10.1007/s100210000011; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Wayte SE, 2013, FISH RES, V142, P47, DOI 10.1016/j.fishres.2012.07.009; Wolff M, 2012, MAR ECOL PROG SER, V448, P7, DOI 10.3354/meps09542; Wuellner MR, 2010, N AM J FISH MANAGE, V30, P445, DOI 10.1577/M09-066.1	53	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e018557	10.1371/journal.pone.0185575	http://dx.doi.org/10.1371/journal.pone.0185575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957387	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200088
J	Lander, JM; Supp, DM; He, H; Martin, LJ; Chen, XT; Weirauch, MT; Boyce, ST; Kopan, R				Lander, Julie M.; Supp, Dorothy M.; He, Hua; Martin, Lisa J.; Chen, Xiaoting; Weirauch, Matthew T.; Boyce, Steven T.; Kopan, Raphael			Analysis of chromatin accessibility in human epidermis identifies putative barrier dysfunction-sensing enhancers	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; GENOME-WIDE ASSOCIATION; AGGRAVATES EXPERIMENTAL ASTHMA; ATOPIC-DERMATITIS; HUMAN KERATINOCYTES; EOSINOPHILIC ESOPHAGITIS; REGULATORY ELEMENTS; NETHERTON SYNDROME; TSLP EXPRESSION; SKIN BARRIER	To identify putative gene regulatory regions that respond to epidermal injury, we mapped chromatin dynamics in a stratified human epidermis during barrier maturation and disruption. Engineered skin substitutes (ESS) cultured at the air-liquid interface were used as a model of developing human epidermis with incomplete barrier formation. The epidermal barrier stabilized following engraftment onto immunocompromised mice, and was compromised again upon injury. Modified formaldehyde-assisted isolation of regulatory elements (FAIRE) was used to identify accessible genomic regions characteristic of monolayer keratinocytes, ESS in vitro, grafted ESS, and tape-stripped ESS graft. We mapped differentiation- and maturation-associated changes in transcription factor binding sites enriched at each stage and observed overrepresentation of AP-1 gene family motifs in barrier-deficient samples. Transcription of TSLP, an important effector of immunological memory in response to allergen exposure, was dramatically elevated in our barrier-deficient samples. We identified dynamic DNA elements that correlated with TSLP induction and may contain enhancers that regulate TSLP. Two dynamic regions were located near the TSLP promoter and overlapped with allergy-associated SNPs rs17551370 and rs2289877, strongly implicating these loci in the regulation of TSLP expression in allergic disease. Additional dynamic chromatin regions similar to 250kb upstream of the TSLP promoter were found to be in high linkage disequilibrium with allergic disease SNPs. Taken together, these results define dynamic chromatin accessibility changes during epidermal development and dysfunction.	[Lander, Julie M.; Weirauch, Matthew T.; Kopan, Raphael] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA; [Supp, Dorothy M.; Boyce, Steven T.] Shriners Hosp Children, Res Dept, Cincinnati, OH USA; [Supp, Dorothy M.; Boyce, Steven T.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [He, Hua; Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA; [Chen, Xiaoting; Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Kopan, R (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA.	rafi.kopan@gmail.com	Supp, Dorothy/ABQ-7999-2022; Kopan, Raphael/AFG-3275-2022; Martin, Lisa/E-2425-2016; Weirauch, Matthew/M-5459-2019; Kopan, Raphael/AAF-1357-2022	Supp, Dorothy/0000-0002-2429-6630; Martin, Lisa/0000-0001-8702-9946; 	National Cancer Institute Award [P50 CA094056]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER	National Cancer Institute Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute (www.cancer.gov) Award P50 CA094056 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Agrawal R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0433-9; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Bao XM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0840-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Birben E, 2014, INT ARCH ALLERGY IMM, V163, P185, DOI 10.1159/000358488; Bjerkan L, 2015, MUCOSAL IMMUNOL, V8, P49, DOI 10.1038/mi.2014.41; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Boyce S T, 1999, Methods Mol Med, V18, P365, DOI 10.1385/0-89603-516-6:365; Boyce ST, 1998, MED BIOL ENG COMPUT, V36, P791, DOI 10.1007/BF02518886; Boyce St, 2017, PIGMENT CELL MELANOM; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Cavazza A, 2016, STEM CELL REP, V6, P618, DOI 10.1016/j.stemcr.2016.03.003; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Cunningham TJ, 2017, J CLIN INVEST, V127, P106, DOI 10.1172/JCI89820; Danso MO, 2014, J INVEST DERMATOL, V134, P1941, DOI 10.1038/jid.2014.83; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2016, J CLIN INVEST, V126, P1458, DOI 10.1172/JCI83724; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Furio L, 2014, J EXP MED, V211, P499, DOI 10.1084/jem.20131797; Ganti KP, 2017, P NATL ACAD SCI USA, V114, pE951, DOI 10.1073/pnas.1620697114; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gerhold CB, 2014, TRENDS CELL BIOL, V24, P619, DOI 10.1016/j.tcb.2014.06.004; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Han HW, 2017, IMMUNOL REV, V278, P116, DOI 10.1111/imr.12546; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Honzke S, 2016, J INVEST DERMATOL, V136, P631, DOI 10.1016/j.jid.2015.11.007; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Jia XY, 2014, FEBS LETT, V588, P3047, DOI 10.1016/j.febslet.2014.06.018; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Klingenberg JM, 2010, J INVEST DERMATOL, V130, P587, DOI 10.1038/jid.2009.295; KOPAN R, 1987, J CELL BIOL, V105, P427, DOI 10.1083/jcb.105.1.427; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Kumari V, 2015, BRIT J DERMATOL, V172, P951, DOI 10.1111/bjd.13465; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee KH, 2011, EXP DERMATOL, V20, P149, DOI 10.1111/j.1600-0625.2010.01203.x; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li YJ, 2004, INT J BIOCHEM CELL B, V36, P1411, DOI 10.1016/j.biocel.2003.11.003; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Myers JMB, 2014, J ALLERGY CLIN IMMUN, V134, P891, DOI 10.1016/j.jaci.2014.03.037; Myers JMB, 2010, J INVEST DERMATOL, V130, P430, DOI 10.1038/jid.2009.300; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Oh IY, 2014, J INVEST DERMATOL, V134, P2371, DOI 10.1038/jid.2014.44; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Quigley DA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r5; Quigley DA, 2009, NATURE, V458, P505, DOI 10.1038/nature07683; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roan F, 2012, J LEUKOCYTE BIOL, V91, P877, DOI 10.1189/jlb.1211622; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Rubin AJ, 2017, NAT GENET; Samochocki Z, 2013, J AM ACAD DERMATOL, V69, P238, DOI 10.1016/j.jaad.2013.03.014; Sato-Deguchi E, 2012, BRIT J DERMATOL, V167, P77, DOI 10.1111/j.1365-2133.2012.10917.x; Schmuth M, 2015, J DTSCH DERMATOL GES, V13, P1119, DOI 10.1111/ddg.12827; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Simon Jeremy M, 2013, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2126s102; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Takai T, 2014, METHOD ENZYMOL, V535, P371, DOI 10.1016/B978-0-12-397925-4.00021-3; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; van den Bogaard EH, 2014, J INVEST DERMATOL, V134, P719, DOI 10.1038/jid.2013.417; Verstraete K, 2014, NAT STRUCT MOL BIOL, V21, P375, DOI 10.1038/nsmb.2794; Vu AT, 2011, J INVEST DERMATOL, V131, P2205, DOI 10.1038/jid.2011.185; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, P985, DOI 10.1016/j.jaci.2010.09.002; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wells A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1262; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Xie Y, 2012, J DERMATOL SCI, V66, P233, DOI 10.1016/j.jdermsci.2012.03.007; Yates S, 2002, WOUND REPAIR REGEN, V10, P5, DOI 10.1046/j.1524-475X.2002.10902.x; Yockey LJ, 2013, J INVEST DERMATOL, V133, P2714, DOI 10.1038/jid.2013.228; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106	97	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184500	10.1371/journal.pone.0184500	http://dx.doi.org/10.1371/journal.pone.0184500			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953906	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300013
J	Moon, MH; Beck, KS; Moon, YK; Park, JK; Sung, SW				Moon, Mi Hyoung; Beck, Kyongmin Sarah; Moon, Young Kyu; Park, Jae Kil; Sung, Sook Whan			Incidence and clinical features of the incidentally found vascular stump thrombus during routine follow up after oncologic lung surgery	PLOS ONE			English	Article							PULMONARY VEIN STUMP; VENOUS THROMBOEMBOLISM; HELICAL CT; LOBECTOMY; RISK	Objectives We aimed to evaluate the incidence and clinical features of vascular stump thrombus after oncologic lung surgery. Methods A retrospective analysis of records from our institutional database dated between 2009 and 2016 was performed. Data regarding demographics, clinical presentation, medication use, operative findings, pathology, and radiologic findings were retrieved. Results The study cohort consisted of 648 oncologic surgeries for primary lung cancer. The incidence of thrombus in the entire population was 5.7% (37/648). Most thrombi were incidentally found on follow-up chest computed tomography scans. Univariate Cox proportional hazard analysis showed that age (p = 0.02), adjuvant therapy (p <0.001), neoadjuvant therapy (p = 0.04), left-sided surgery (p = 0.02), complex surgery greater than simple lobectomy or segmentectomy (p <0.001), advanced stages (p <0.001), non-adenocarcinoma (p = 0.003), and thoracotomy approach (p = 0.009) were associated with an increased risk of vascular stump thrombus. There were no embolic events in our cohort, except for a case of pulmonary thromboembolism. During follow-up, 43.2% (16/37) of thrombi had completely resolved, 48.6% (18/37) showed partial regression and stabilization, and 8.1% (3/37) had progressed. Conclusions The incidence of vascular stump thrombus in our study was not negligible. The clinical course of stump thrombus appears to be benign in most cases. Anticoagulation may be used with caution based on an individual basis depending on each patient's risk factors.	[Moon, Mi Hyoung; Moon, Young Kyu; Park, Jae Kil; Sung, Sook Whan] Catholic Univ Korea, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Beck, Kyongmin Sarah] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Sung, SW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	swsung@catholic.ac.kr		Sung, Sook Whan/0000-0002-8480-0915; Beck, Kyongmin/0000-0002-9262-1001				Agzarian J, 2016, J THORAC CARDIOV SUR, V151, P992, DOI 10.1016/j.jtcvs.2015.11.038; Barbetakis N, 2011, ANN THORAC SURG, V91, pE44, DOI 10.1016/j.athoracsur.2010.12.037; Chuang T H, 1966, Ann Thorac Surg, V2, P290; Gosselin MV, 1998, RADIOLOGY, V208, P209, DOI 10.1148/radiology.208.1.9646815; Ichimura H, 2014, ANN THORAC CARDIOVAS, V20, P613, DOI 10.5761/atcs.cr.13-00079; ICHINOSE Y, 1991, CHEST, V100, P693, DOI 10.1378/chest.100.3.693; Joshi M, 2009, THROMB J, V7, DOI 10.1186/1477-9560-7-7; Kilic D, 2007, GEN THORAC CARDIOVAS, V55, P287, DOI 10.1007/s11748-007-0124-8; Kim SY, 2005, AM J ROENTGENOL, V185, P985, DOI 10.2214/AJR.04.1515; Kwek BH, 2005, RADIOLOGY, V237, P338, DOI 10.1148/radiol.2371041686; Lazopoulos A, 2015, ANN THORAC SURG, V100, P330, DOI 10.1016/j.athoracsur.2015.03.048; Ohtaka K, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/s13019-014-0159-8; Ohtaka K, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-5; Ohtaka K, 2013, ANN THORAC SURG, V95, P1924, DOI 10.1016/j.athoracsur.2013.03.005; Ohtaka K, 2012, J THORAC CARDIOV SUR, V143, pE3, DOI 10.1016/j.jtcvs.2011.09.025; Streiff MB, 2010, THROMB RES, V125, pS128, DOI 10.1016/S0049-3848(10)70030-X; Tesselaar MET, 2007, CURR OPIN PULM MED, V13, P362, DOI 10.1097/MCP.0b013e328209413c; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Winston CB, 1996, RADIOLOGY, V201, P23, DOI 10.1148/radiology.201.1.8816515; Yang Y, 2012, J SURG ONCOL, V106, P736, DOI 10.1002/jso.23190	20	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185140	10.1371/journal.pone.0185140	http://dx.doi.org/10.1371/journal.pone.0185140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953945	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300038
J	Ansari, M				Ansari, Mukhtar			Evaluation of community pharmacies regarding dispensing practices of antibiotics in two districts of central Nepal	PLOS ONE			English	Article							SAUDI-ARABIA; KNOWLEDGE; INDIA	Objective To evaluate the status of community pharmacies, their staff, and practices toward dispensing antibiotics. Design Cross-sectional, prospective. Place and duration of study Community pharmacies in two districts of central Nepal, from March 2016 to May 2016. Methods A systematic random sampling approach was adopted to sample 161 community pharmacies. Data on the registration status of pharmacies, qualification or training of dispensing staff, and the practice of dispensing antibiotics were collected using a pre-tested questionnaire. Face to face interviews were carried out by a previously trained interviewer. Data were analyzed for descriptive and inferential statistics using IBM SPSS Statistics 21. Results Among 161 community pharmacies, 25% were not registered and most of them were located in rural areas. It was typical (66.5%) to dispense antibiotics without prescription and most (91.4%) of the staffs involved in dispensing were non-pharmacists. Furthermore, the study revealed common practices of replacing one brand of antibiotic with other brands (66%), dispensing incomplete courses of antibiotics (73%), and not giving any advice regarding antibiotic use (39%) or completion of a full course of therapy (80%). There were significant (p < 0.001) relationships between the location of pharmacies (rural vs urban) and the qualifications of the pharmacy staff. Conclusion Dispensing antibiotics without prescription and by non-pharmacists are common in this region. The study also found several issues regarding the irrational use of antibiotics. Thus, there is an urgent need to address these issues and promote the informed use of antibiotics.	[Ansari, Mukhtar] Univ Hail, Coll Pharm, Dept Clin Pharm, Hail, Saudi Arabia	University Ha'il	Ansari, M (corresponding author), Univ Hail, Coll Pharm, Dept Clin Pharm, Hail, Saudi Arabia.	mukhtaransari@hotmail.com	ansari, mukhtar/A-1506-2017	ansari, mukhtar/0000-0002-5247-6356				Ahmad A, 2014, ANN MED HEALTH SCI R, V4, P73, DOI 10.4103/2141-9248.138012; Alshakka M., 2016, J PHARM PRACT COMMUN, V2, P88, DOI [10.5530/jppcm.2016.3.5, DOI 10.5530/JPPCM.2016.3.5]; [Anonymous], 2011, WORLD HLTH STAT; Ansari M., 2013, INDIAN J PHARM PRACT, V6, P62; Ansari M, 2012, NATL J LAB MED, V1, P29; Belkina T, 2014, J INFECT DEV COUNTR, V8, P424, DOI 10.3855/jidc.3866; Bhuvan KC, 2013, AUSTRALAS MED J, V6, P100, DOI 10.4066/AMJ.2013.1544; Chapman C, 2011, AUST PRESCR, V34, P34; Nga DTT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-6; Gokcekus L, 2012, INT J CLIN PHARM-NET, V34, P312, DOI 10.1007/s11096-011-9605-z; Gupta R P, 2013, J Nepal Health Res Counc, V11, P144; Gyawali S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-190; Hadi MA, 2016, INT J INFECT DIS, V47, P95, DOI 10.1016/j.ijid.2016.06.003; Kafle K K, 2013, J Nepal Health Res Counc, V11, P198; KAFLE KK, 1992, SOC SCI MED, V35, P1015, DOI 10.1016/0277-9536(92)90241-H; Lowe RF., 2009, S MED REV, V2, P35; Luitel NP, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-014-0030-5; Miller R, 2016, HLTH POLICY PLANNING; Ministry of Health and Population, 2014, NAT ANT TREATM GUID; Palaian Subish, 2010, Pharmacy Pract (Granada), V8, P201; Population Division M. o. H. a. P.  Government of Nepal, 2012, NEP DEM HLTH SURV 20; Poudel A, 2009, J CLIN DIAGN RES, V3, P1408; Roche C, 2014, PHARMACY, V2, P74, DOI 10.3390/pharmacy2010074; Seeberg J, 2012, MED ANTHROPOL Q, V26, P182, DOI 10.1111/j.1548-1387.2012.01200.x; Toklu HZ, 2015, INTEGR PHARM RES PRA, V4, P127, DOI 10.2147/IPRP.S70406; Vu DH, 2012, INT J TUBERC LUNG D, V16, P1625, DOI 10.5588/ijtld.12.0295	26	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							0183907	10.1371/journal.pone.0183907	http://dx.doi.org/10.1371/journal.pone.0183907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949990	Green Submitted, Green Published, gold			2022-12-26	WOS:000411671000005
J	Basak, P; Maitra-Majee, S; Das, JK; Mukherjee, A; Dastidar, SG; Choudhury, PP; Majumder, AL				Basak, Papri; Maitra-Majee, Susmita; Das, Jayanta Kumar; Mukherjee, Abhishek; Dastidar, Shubhra Ghosh; Choudhury, Pabitra Pal; Majumder, Arun Lahiri			An evolutionary analysis identifies a conserved pentapeptide stretch containing the two essential lysine residues for rice L-myo-inositol 1-phosphate synthase catalytic activity	PLOS ONE			English	Article							COARCTATA ROXB. TATEOKA; HALOPHYTIC WILD-RICE; INOSITOL-1-PHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; SALT TOLERANCE; ARCHAEOGLOBUS-FULGIDUS; MOLECULAR-CLONING; AMINO-GROUPS; MECHANISM; CYCLASE	A molecular evolutionary analysis of a well conserved protein helps to determine the essential amino acids in the core catalytic region. Based on the chemical properties of amino acid residues, phylogenetic analysis of a total of 172 homologous sequences of a highly conserved enzyme, L-myo-inositol 1-phosphate synthase or MIPS from evolutionarily diverse organisms was performed. This study revealed the presence of six phylogenetically conserved blocks, out of which four embrace the catalytic core of the functional protein. Further, specific amino acid modifications targeting the lysine residues, known to be important for MIPS catalysis, were performed at the catalytic site of a MIPS from monocotyledonous model plant, Oryza sativa (OsMIPS1). Following this study, OsMIPS mutants with deletion or replacement of lysine residues in the conserved blocks were made. Based on the enzyme kinetics performed on the deletion/ replacement mutants, phylogenetic and structural comparison with the already established crystal structures from non-plant sources, an evolutionarily conserved peptide stretch was identified at the active pocket which contains the two most important lysine residues essential for catalytic activity.	[Basak, Papri; Maitra-Majee, Susmita; Mukherjee, Abhishek; Majumder, Arun Lahiri] Bose Inst, Div Plant Biol, Centenary Campus, Kolkata, W Bengal, India; [Das, Jayanta Kumar; Choudhury, Pabitra Pal] Indian Stat Inst, Appl Stat Unit, Kolkata, W Bengal, India; [Dastidar, Shubhra Ghosh] Bose Inst, Bioinformat Ctr, Centenary Campus, Kolkata, W Bengal, India; [Maitra-Majee, Susmita] Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India	Department of Science & Technology (India); Bose Institute; Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Science & Technology (India); Bose Institute; University of Delhi	Majumder, AL (corresponding author), Bose Inst, Div Plant Biol, Centenary Campus, Kolkata, W Bengal, India.	lahiri@mail.jcbose.ac.in		Das, Jayanta Kumar/0000-0002-7630-7194	Department of Atomic Energy [10/25/2010/RRF-RD-II/3118]; Department of Biotechnology [BT/AB/05/02/2007-III]; Council of Scientific & Industrial Research [09/015(0447)/2012-EMR-I]	Department of Atomic Energy(Department of Atomic Energy (DAE)); Department of Biotechnology; Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by: 1. Department of Atomic Energy - D.O. No. 10/25/2010/RRF-R&D-II/3118, ALM; 2. Department of Biotechnology- BT/AB/05/02/2007-III, ALM; 3. Council of Scientific & Industrial Research- 09/015(0447)/2012-EMR-I, PB.	BARNETT JEG, 1968, BIOCHEM J, V108, P125, DOI 10.1042/bj1080125; BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Butzin NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084300; Chen LJ, 2000, BIOCHEMISTRY-US, V39, P12415, DOI 10.1021/bi001517q; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Das JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167651; Das-Chatterjee A, 2006, FEBS LETT, V580, P3980, DOI 10.1016/j.febslet.2006.06.033; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; Dayhoff MO., 1978, ATLAS PROTEIN SEQ S3, P29; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; GHOSH M, 1994, BIOCHEM J, V298, P295, DOI 10.1042/bj2980295; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Jin XS, 2004, J BIOL CHEM, V279, P13889, DOI 10.1074/jbc.M308986200; Jin XS, 2003, ACTA CRYSTALLOGR D, V59, P1154, DOI 10.1107/S0907444903008205; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LOEWUS MW, 1977, J BIOL CHEM, V252, P7221; Majee M, 2004, J BIOL CHEM, V279, P28539, DOI 10.1074/jbc.M310138200; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Majumder AL, 2003, FEBS LETT, V553, P3, DOI 10.1016/S0014-5793(03)00974-8; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Neelon K, 2005, J BIOL CHEM, V280, P11475, DOI 10.1074/jbc.M500469200; Neelon K, 2011, BIOPHYS J, V101, P2816, DOI 10.1016/j.bpj.2011.10.038; Nelson DE, 1998, PLANT CELL, V10, P753; Nesbo CL, 2001, MOL BIOL EVOL, V18, P362, DOI 10.1093/oxfordjournals.molbev.a003812; Norman RA, 2002, STRUCTURE, V10, P393, DOI 10.1016/S0969-2126(02)00718-9; Patra B, 2007, PLANTA, V225, P1547, DOI 10.1007/s00425-006-0441-7; PELTON PD, 1992, J BIOL CHEM, V267, P5916; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PLAPP BV, 1971, J BIOL CHEM, V246, P939; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; SHERMAN WR, 1969, J BIOL CHEM, V244, P5703; Simon AL, 2002, P NATL ACAD SCI USA, V99, P2912, DOI 10.1073/pnas.042692299; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	40	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185351	10.1371/journal.pone.0185351	http://dx.doi.org/10.1371/journal.pone.0185351			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950028	gold, Green Published, Green Submitted			2022-12-26	WOS:000411671000041
J	Dudczig, S; Currie, PD; Jusuf, PR				Dudczig, Stefanie; Currie, Peter David; Jusuf, Patricia Regina			Developmental and adult characterization of secretagogin expressing amacrine cells in zebrafish retina	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; CONE BIPOLAR CELLS; CA2+-BINDING PROTEIN; ALZHEIMERS-DISEASE; DANIO-RERIO; CONTAINING NEURONS; MAMMALIAN RETINA; MORPHOLOGICAL CLASSIFICATION; HUMAN HIPPOCAMPUS; NERVOUS-SYSTEM	Calcium binding proteins show stereotypical expression patterns within diverse neuron types across the central nervous system. Here, we provide a characterization of developmental and adult secretagogin-immunolabelled neurons in the zebrafish retina with an emphasis on co-expression of multiple calcium binding proteins. Secretagogin is a recently identified and cloned member of the F-hand family of calcium binding proteins, which labels distinct neuron populations in the retinas of mammalian vertebrates. Both the adult distribution of secretagogin labeled retinal neurons as well as the developmental expression indicative of the stage of neurogenesis during which this calcium binding protein is expressed was quantified. Secretagogin expression was confined to an amacrine interneuron population in the inner nuclear layer, with monostratified neurites in the center of the inner plexiform layer and a relatively regular soma distribution (regularity index > 2.5 across central-peripheral areas). However, only a subpopulation (similar to 60%) co-labeled with gamma-aminobutyric acid as their neurotransmitter, suggesting that possibly two amacrine subtypes are secretagogin immunoreactive. Quantitative co-labeling analysis with other known amacrine subtype markers including the three main calcium binding proteins parvalbumin, calbindin and calretinin identifies secretagogin immunoreactive neurons as a distinct neuron population. The highest density of secretagogin cells of similar to 1800 cells / mm(2) remained relatively evenly along the horizontal meridian, whilst the density dropped of to 125 cells / mm(2) towards the dorsal and ventral periphery. Thus, secretagogin represents a new amacrine label within the zebrafish retina. The developmental expression suggests a possible role in late stage differentiation. This characterization forms the basis of functional studies assessing how the expression of distinct calcium binding proteins might be regulated to compensate for the loss of one of the others.	[Dudczig, Stefanie; Currie, Peter David; Jusuf, Patricia Regina] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Dudczig, Stefanie; Jusuf, Patricia Regina] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia	Australian Regenerative Medicine Institute; Monash University; University of Melbourne	Jusuf, PR (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia.; Jusuf, PR (corresponding author), Univ Melbourne, Sch Biosci, Parkville, Vic, Australia.	patricia.jusuf@unimelb.edu.au	Jusuf, Patricia/V-3476-2019	Jusuf, Patricia/0000-0003-0747-4084; Currie, Peter/0000-0001-8874-8862	ARC Discovery Project grant [DP130102395]; ARC DECRA [DE120101311]; State Government of Victoria; Australian Federal Government	ARC Discovery Project grant(Australian Research Council); ARC DECRA(Australian Research Council); State Government of Victoria; Australian Federal Government(Australian Government)	This project was supported by an ARC Discovery Project grant (DP130102395) and ARC DECRA (DE120101311). The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2012, CELL SIGNAL, V24, P378, DOI 10.1016/j.cellsig.2011.09.028; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; Attems J, 2008, NEUROPATH APPL NEURO, V34, P23, DOI 10.1111/j.1365-2990.2007.00854.x; Attems J, 2007, EXP GERONTOL, V42, P215, DOI 10.1016/j.exger.2006.09.018; Attems J, 2012, P NATL ACAD SCI USA, V109, P6259, DOI 10.1073/pnas.1203843109; Bai YF, 2014, ONCOTARGET, V5, P7760, DOI 10.18632/oncotarget.2305; Bauer MC, 2011, MOL BIOSYST, V7, P2196, DOI 10.1039/c0mb00349b; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-2; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; Cederlund ML, 2011, INVEST OPHTH VIS SCI, V52, P1613, DOI 10.1167/iovs.10-5376; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Chiquet C, 2005, BRAIN RES BULL, V68, P185, DOI 10.1016/j.brainresbull.2005.08.010; Connaughton VP, 2004, J COMP NEUROL, V477, P371, DOI 10.1002/cne.20261; Connaughton VP, 1999, VISUAL NEUROSCI, V16, P483, DOI 10.1017/S0952523899163090; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Di Donato V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053299; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Garas FN, 2016, ELIFE, V5, DOI 10.7554/eLife.16088; Gartner W, 2001, CEREB CORTEX, V11, P1161, DOI 10.1093/cercor/11.12.1161; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Gyengesi E, 2013, BRAIN RES BULL, V94, P1, DOI 10.1016/j.brainresbull.2013.01.009; Hanics J, 2017, P NATL ACAD SCI USA, V114, pE2006, DOI 10.1073/pnas.1700662114; Haverkamp S, 2003, VISUAL NEUROSCI, V20, P589, DOI 10.1017/S0952523803206015; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; HEIZMANN CW, 1992, GEN PHYSIOL BIOPHYS, V11, P411; Hermes M, 2010, J CELL MOL MED, V14, P30, DOI 10.1111/j.1582-4934.2009.00976.x; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Kantor O, 2016, CELL TISSUE RES, V365, P29, DOI 10.1007/s00441-016-2376-z; Kerschensteiner D, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00038; Khandelwal R, 2017, BIOCHEMISTRY-US, V56, P411, DOI 10.1021/acs.biochem.6b00761; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kosaka K, 2013, NEUROSCI RES, V77, P16, DOI 10.1016/j.neures.2013.08.006; Kosaka T, 2017, NEUROSCI RES, V119, P53, DOI 10.1016/j.neures.2017.01.004; Kuscha V, 2012, J COMP NEUROL, V520, P933, DOI 10.1002/cne.22739; Light AC, 2012, J COMP NEUROL, V520, P2864, DOI 10.1002/cne.23068; Maj M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00084; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; Mangrum WI, 2002, VISUAL NEUROSCI, V19, P767, DOI 10.1017/S0952523802196076; Martin ZS, 2012, J NEUROCHEM, V120, P440, DOI 10.1111/j.1471-4159.2011.07576.x; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Matsuda K, 2009, COMP BIOCHEM PHYS A, V153, P3, DOI 10.1016/j.cbpa.2008.10.002; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; Mulder J, 2010, EUR J NEUROSCI, V31, P2166, DOI 10.1111/j.1460-9568.2010.07275.x; Mulder J, 2009, P NATL ACAD SCI USA, V106, P22492, DOI 10.1073/pnas.0912484106; Olsson C, 2008, J COMP NEUROL, V508, P756, DOI 10.1002/cne.21705; PASTEELS B, 1990, VISUAL NEUROSCI, V5, P1, DOI 10.1017/S0952523800000031; Puthussery T, 2011, J COMP NEUROL, V519, P3640, DOI 10.1002/cne.22756; Puthussery T, 2010, J COMP NEUROL, V518, P513, DOI 10.1002/cne.22234; Raju CS, 2017, CEREB CORTEX, P1; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Schwaller B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00003; Shi TJS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-80; Skovhus KV, 2006, SCAND J IMMUNOL, V64, P639, DOI 10.1111/j.1365-3083.2006.01854.x; Song PI, 2008, J COMP NEUROL, V506, P328, DOI 10.1002/cne.21549; Uyttebroek L, 2010, J COMP NEUROL, V518, P4419, DOI 10.1002/cne.22464; Vitorino M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-14; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Wassle H, 1998, CELL TISSUE RES, V292, P211, DOI 10.1007/s004410051052; Weltzien F, 2014, J COMP NEUROL, V522, P435, DOI 10.1002/cne.23420; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Yeo JY, 2009, EXP EYE RES, V88, P553, DOI 10.1016/j.exer.2008.11.014; Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009; Zhang RW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12650	74	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185107	10.1371/journal.pone.0185107	http://dx.doi.org/10.1371/journal.pone.0185107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949993	Green Published, gold			2022-12-26	WOS:000411671000024
J	Bonadonna, LV; Saunders, MJ; Zegarra, R; Evans, C; Alegria-Flores, K; Guio, H				Bonadonna, Lily Victoria; Saunders, Matthew James; Zegarra, Roberto; Evans, Carlton; Alegria-Flores, Kei; Guio, Heinner			Why wait? The social determinants underlying tuberculosis diagnostic delay	PLOS ONE			English	Article							HEALTH SEEKING BEHAVIOR; PULMONARY TUBERCULOSIS; PERUVIAN AMAZON; CARE-SYSTEM; PATIENT; PERCEPTIONS; COMMUNITY; SEARCH; MEXICO	Background Early detection and diagnosis of tuberculosis remain major global priorities for tuberculosis control. Few studies have used a qualitative approach to investigate the social determinants contributing to diagnostic delay and none have compared data collected from individual, community, and health-system levels. We aimed to characterize the social determinants that contribute to diagnostic delay among persons diagnosed with tuberculosis living in resource-constrained settings. Methods/Principle findings Data were collected in public health facilities with high tuberculosis incidence in 19 districts of Lima, Peru. Semi-structured interviews with persons diagnosed with tuberculosis (n = 105) and their family members (n = 63) explored health-seeking behaviours, community perceptions of tuberculosis and socio-demographic circumstances. Focus groups (n = 6) were conducted with health personnel (n = 35) working in the National Tuberculosis Program. All interview data were transcribed and analysed using a grounded theory approach. The median delay between symptom onset and the public health facility visit that led to the first positive diagnostic sample was 57 days (interquartile range 28-126). The great majority of persons diagnosed with tuberculosis distrusted the public health system and sought care at public health facilities only after exhausting other options. It was universally agreed that persons diagnosed with tuberculosis faced discrimination by public and health personnel. Selfmedication with medicines bought at local pharmacies was reported as the most common initial health-seeking behaviour due to the speed and low-cost of treatment in pharmacies. Most persons diagnosed with tuberculosis initially perceived their illness as a simple virus. Conclusions Diagnostic delay was common and prolonged. When individuals reached a threshold of symptom severity, they addressed their health with the least time-consuming, most economically feasible, and well-known healthcare option available to them. In high-burden settings, more human and material resources are required to promote tuberculosis casefinding initiatives, reduce tuberculosis associated stigma and address the social determinants underlying diagnostic delay.	[Bonadonna, Lily Victoria] Univ Michigan, Ann Arbor, MI 48109 USA; [Bonadonna, Lily Victoria; Zegarra, Roberto; Guio, Heinner] Inst Nacl Salud, Lima, Peru; [Bonadonna, Lily Victoria; Saunders, Matthew James; Evans, Carlton] Asociac Benef PRISMA, IPSYD, Lima, Peru; [Bonadonna, Lily Victoria; Saunders, Matthew James; Evans, Carlton] Univ Peruana Cayetano Heredia, Res & Dev Lab, IFHAD, Lima, Peru; [Saunders, Matthew James; Evans, Carlton] Imperial Coll London, Infect Dis & Immun, London, England; [Saunders, Matthew James; Evans, Carlton] Imperial Coll, Wellcome Trust, Ctr Global Hlth Res, London, England; [Alegria-Flores, Kei] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA	University of Michigan System; University of Michigan; Instituto Nacional de Salud - Peru; Universidad Peruana Cayetano Heredia; Imperial College London; Imperial College London; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill	Bonadonna, LV (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.; Bonadonna, LV (corresponding author), Inst Nacl Salud, Lima, Peru.; Bonadonna, LV (corresponding author), Asociac Benef PRISMA, IPSYD, Lima, Peru.; Bonadonna, LV (corresponding author), Univ Peruana Cayetano Heredia, Res & Dev Lab, IFHAD, Lima, Peru.	bonalily@umich.edu	Zegarra, Roberto/GZL-1482-2022; Guio, Heinner/G-9874-2017	Zegarra, Roberto/0000-0002-0471-9413; Evans, Carlton/0000-0002-6873-5447; Guio, Heinner/0000-0003-0078-1188; Saunders, Matthew/0000-0003-3033-2367	Raoul Wallenberg Fellowship, granted through the University of Michigan; Joint Global Health Trials consortium of the Wellcome Trust, UK-MRC and DFID [MR/K007467/1]; Bill and Melinda Gates Foundation award [OPP1118545]; IFHAD: Innovation For Health And Development; Wellcome Trust [201251/Z/16/Z, 105788/Z/14/Z]; Imperial College Biomedical Research Centre; Medical Research Council [MR/K007467/1] Funding Source: researchfish; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1118545] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	Raoul Wallenberg Fellowship, granted through the University of Michigan; Joint Global Health Trials consortium of the Wellcome Trust, UK-MRC and DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation award; IFHAD: Innovation For Health And Development; Wellcome Trust(Wellcome TrustEuropean Commission); Imperial College Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The data collection activities for this research were funded by the 2014 Raoul Wallenberg Fellowship, granted through the University of Michigan. The contributions of LVB, MJS and CAE to this research were funded by: the Joint Global Health Trials consortium of the Wellcome Trust, UK-MRC and DFID (award MR/K007467/1); The Bill and Melinda Gates Foundation award OPP1118545; and IFHAD: Innovation For Health And Development. The contributions of CAE and MJS to this research were also funded by Wellcome Trust (award 201251/Z/16/Z). The contributions of CAE to this research were also funded by the Imperial College Biomedical Research Centre and the Wellcome Trust (award 105788/Z/14/Z).	Alvarez-Gordillo GD, 2000, SALUD PUBLICA MEXICO, V42, P520, DOI 10.1590/S0036-36342000000600008; Baldwin MR, 2004, INT J TUBERC LUNG D, V8, P1484; Baral SC, 2007, CAUSES STIGMA DISCRI, V10, P1; BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Bryman A., 2008, SOCIAL RES METHODS; Bustamante-Montes LP, 2000, INT J TUBERC LUNG D, V4, P208; Chikovore J, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26292; Chimbatata NBW, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0279-1; District N, 2015, PLOS ONE, V1; Dodor EA, 2010, HEALTH POLICY, V98, P195, DOI 10.1016/j.healthpol.2010.06.017; Farmer P, 1991, Semin Respir Infect, V6, P254; Ford CM, 2009, AM J TROP MED HYG, V81, P1097, DOI 10.4269/ajtmh.2009.08-0627; Golub JE, 2005, INT J TUBERC LUNG D, V9, P392; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Hu A, 2012, HEALTH CARE WOMEN IN, V33, P29, DOI 10.1080/07399332.2011.630495; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Liefooghe R, 1997, TROP MED INT HEALTH, V2, P809, DOI 10.1046/j.1365-3156.1997.d01-380.x; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 1999, INT J TUBERC LUNG D, V3, P992; Martinez L, 2013, AM J TROP MED HYG, V89, P507, DOI 10.4269/ajtmh.13-0005; Onifade DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-381; Pan American Health Organization, 2014, TUB AM REG REP 2014; Rios H.C. Graciela, 2004, REV PERU MED EXP SAL, V21, P18; Rocha C, 2011, INT J TUBERC LUNG S2, V15; Rojpibulstit M, 2006, INT J TUBERC LUNG D, V10, P422; RUBEL AJ, 1992, PUBLIC HEALTH REP, V107, P626; Sagbakken M, 2008, QUAL HEALTH RES, V18, P1356, DOI 10.1177/1049732308322596; Saunders MJ, 2016, LANCET INFECT DIS, V16, P395, DOI 10.1016/S1473-3099(15)00434-X; Sekandi JN, 2015, BMC INFECT DIS, P1; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tattevin P, 2012, INT J TUBERC LUNG D, V16, P510, DOI 10.5588/ijtld.11.0420; Ukwaja KN, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-25; Uys PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000757; Verhagen LM, 2010, INFECTION, V38, P433, DOI 10.1007/s15010-010-0051-y; Wang M, 2011, INT J TUBERC LUNG D, V15, P1062, DOI 10.5588/ijtld.10.0734; Westerlund EE, 2015, J INFECTION, V71, P347, DOI 10.1016/j.jinf.2015.05.010; *WHO, 2004, WHO REP 2004 GLOB TU; WILKINSON D, 1994, LANCET, V343, P647, DOI 10.1016/S0140-6736(94)92640-9; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2006, DIAGN TREATM DEL TUB; World Health Organization, 2016, PER COUNTR PROF; 2012, GLOB STRAT TARG TUB, P1	47	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185018	10.1371/journal.pone.0185018	http://dx.doi.org/10.1371/journal.pone.0185018			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945782	Green Published, gold			2022-12-26	WOS:000411645100016
J	Zhang, XW; Han, XZ; Yu, WT; Wang, P; Cheng, WX				Zhang, Xiuwei; Han, Xiaozeng; Yu, Wantai; Wang, Peng; Cheng, Weixin			Priming effects on labile and stable soil organic carbon decomposition: Pulse dynamics over two years	PLOS ONE			English	Article							MICROBIAL BIOMASS; TEMPERATURE SENSITIVITY; MATTER; MECHANISMS; STABILIZATION; NITROGEN; INPUTS; BIODEGRADATION; RESPIRATION; FRACTIONS	Soil organic carbon (SOC) is a major component in the global carbon cycle. Yet how input of plant litter may influence the loss of SOC through a phenomenon called priming effect remains highly uncertain. Most published results about the priming effect came from short-term investigations for a few weeks or at the most for a few months in duration. The priming effect has not been studied at the annual time scale. In this study for 815 days, we investigated the priming effect of added maize leaves on SOC decomposition of two soil types and two treatments (bare fallow for 23 years, and adjacent old-field, represent stable and relatively labile SOC, respectively) of SOC stabilities within each soil type, using a natural C-13-isotope method. Results showed that the variation of the priming effect through time had three distinctive phases for all soils: (1) a strong negative priming phase during the first period (approximate to 0-90 days); (2) a pulse of positive priming phase in the middle (approximate to 70-160 and 140-350 days for soils from Hailun and Shenyang stations, respectively); and (3) a relatively stabilized phase of priming during the last stage of the incubation (>160 days and >350 days for soils from Hailun and Shenyang stations, respectively). Because of major differences in soil properties, the two soil types produced different cumulative priming effects at the end of the experiment, a positive priming effect of 3-7% for the Mollisol and a negative priming effect of 4-8% for the Alfisol. Although soil types and measurement times modulated most of the variability of the priming effect, relative SOC stabilities also influenced the priming effect for a particular soil type and at a particular dynamic phase. The stable SOC from the bare fallow treatment tended to produce a narrower variability during the first phase of negative priming and also during the second phase of positive priming. Averaged over the entire experiment, the stable SOC (i.e., the bare fallow) was at least as responsive to priming as the relatively labile SOC (i.e., the old-field) if not more responsive. The annual time scale of our experiment allowed us to demonstrate the three distinctive phases of the priming effect. Our results highlight the importance of studying the priming effect by investigating the temporal dynamics over longer time scales.	[Zhang, Xiuwei; Yu, Wantai; Wang, Peng; Cheng, Weixin] Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Liaoning, Peoples R China; [Zhang, Xiuwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Han, Xiaozeng] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin, Heilongjiang, Peoples R China; [Cheng, Weixin] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; University of California System; University of California Santa Cruz	Cheng, WX (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Liaoning, Peoples R China.; Han, XZ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin, Heilongjiang, Peoples R China.; Cheng, WX (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	xzhan@iga.ac.cn; wxcheng@ucsc.edu	Cheng, Weixin/F-4968-2011	Cheng, Weixin/0000-0003-2964-2376	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB15030302]; National Basic Research Program of China (973Program) [2015CB150802]; National Natural Science Foundation of China [31200479, 31570620]; US National Science Foundation [DEB-1354098]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation(National Science Foundation (NSF))	This work was supported by Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB15030302), National Basic Research Program of China (973Program) (2015CB150802), National Natural Science Foundation of China (31200479, 31570620), US National Science Foundation (Grant No. DEB-1354098).; This work was supported by the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB15030302), National Basic Research Program of China (973 Program) (2015CB150802), and National Natural Science Foundation of China (31200479, 31570620). A grant from US National Science Foundation (Grant No. DEB-1354098) supported Cheng's work.	Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Blagodatskaya E, 2011, SOIL BIOL BIOCHEM, V43, P159, DOI 10.1016/j.soilbio.2010.09.028; Cardinael R, 2015, BIOGEOCHEMISTRY; Castellano MJ, 2015, GLOBAL CHANGE BIOL, V21, P3200, DOI 10.1111/gcb.12982; Cheng WX, 2014, NEW PHYTOL, V201, P31, DOI 10.1111/nph.12440; Cheng WX, 2003, SOIL SCI SOC AM J, V67, P1418, DOI 10.2136/sssaj2003.1418; Cheng WX, 1996, PLANT SOIL, V183, P263, DOI 10.1007/BF00011441; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Derrien D, 2014, SOIL BIOL BIOCHEM, V76, P149, DOI 10.1016/j.soilbio.2014.04.030; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fontaine S, 2011, SOIL BIOL BIOCHEM, V43, P86, DOI 10.1016/j.soilbio.2010.09.017; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Guenet B, 2012, SOIL BIOL BIOCHEM, V52, P43, DOI 10.1016/j.soilbio.2012.04.001; Guenet B, 2010, APPL SOIL ECOL, V46, P436, DOI 10.1016/j.apsoil.2010.09.006; Hamer U, 2005, SOIL BIOL BIOCHEM, V37, P445, DOI 10.1016/j.soilbio.2004.07.037; Hopkins FM, 2014, SOIL BIOL BIOCHEM, V76, P57, DOI 10.1016/j.soilbio.2014.04.028; HORVATH RS, 1972, BACTERIOL REV, V36, P146, DOI 10.1128/MMBR.36.2.146-155.1972; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Li HB, 2015, COMMUN SOIL SCI PLAN, V46, P405, DOI 10.1080/00103624.2014.956887; Lohnis F, 1926, SOIL SCI, V22, P253, DOI 10.1097/00010694-192610000-00001; Luo ZK, 2016, SOIL BIOL BIOCHEM, V101, P96, DOI 10.1016/j.soilbio.2016.07.011; MARTIN JP, 1980, SOIL SCI SOC AM J, V44, P1250, DOI 10.2136/sssaj1980.03615995004400060024x; Ohm H, 2007, J PLANT NUTR SOIL SC, V170, P551, DOI 10.1002/jpln.200625087; Perelo LW, 2006, SOIL BIOL BIOCHEM, V38, P912, DOI 10.1016/j.soilbio.2005.07.013; Salome C, 2010, GLOBAL CHANGE BIOL, V16, P416, DOI 10.1111/j.1365-2486.2009.01884.x; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Shahbaz M, 2017, BIOL FERT SOILS, V53, P287, DOI 10.1007/s00374-016-1174-9; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; STOTT DE, 1983, PLANT SOIL, V70, P15, DOI 10.1007/BF02374746; Sullivan BW, 2013, SOIL BIOL BIOCHEM, V58, P293, DOI 10.1016/j.soilbio.2012.12.007; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; Tian QX, 2014, SOIL BIOL BIOCHEM, V68, P329, DOI 10.1016/j.soilbio.2013.10.015; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; WU J, 1993, SOIL BIOL BIOCHEM, V25, P1435, DOI 10.1016/0038-0717(93)90058-J; Xiao C, 2015, PRIMING SOIL ORGANIC, P649; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]	42	37	38	13	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184978	10.1371/journal.pone.0184978	http://dx.doi.org/10.1371/journal.pone.0184978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934287	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900070
J	Deckert, A; Neuhann, F; Klose, C; Bruckner, T; Beiersmann, C; Haloka, J; Nsofwa, M; Banda, G; Brune, M; Reutter, H; Rothenbacher, D; Zeier, M				Deckert, Andreas; Neuhann, Florian; Klose, Christina; Bruckner, Thomas; Beiersmann, Claudia; Haloka, John; Nsofwa, Mannie; Banda, Greg; Brune, Maik; Reutter, Helmut; Rothenbacher, Dietrich; Zeier, Martin			Assessment of renal function in routine care of people living with HIV on ART in a resource-limited setting in urban Zambia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; INFECTED ADULTS; SOUTH-AFRICA; FOLLOW-UP; TENOFOVIR; IMPAIRMENT; ASSOCIATION; DYSFUNCTION	Introduction Data on renal impairment in sub-Saharan Africa (SSA) remains scarce, determination of renal function is not part of routine assessments. We evaluated renal function and blood pressure in a cohort of people living with HIV (PLWH) on antiretroviral treatment (ART) in the Renal Care Zambia project (ReCaZa). Methods Using routine data from an HIV outpatient clinic from 2011-2013, we retrospectively estimated the glomerular filtration rate (eGFR, CKD-Epi formula) of PLWH on ART in Lusaka, Zambia. Data were included if adults had had at least one serum creatinine recorded and had been on ART for a minimum of three months. We investigated the differences in eGFR between ART subgroups with and without tenofovir disproxil fumarate (TDF), and applied multivariable linear models to associate ART and eGFR, adjusted for eGFR before ART initiation. Results and discussion Among 1118 PLWH (63,3% female, mean age 41.8 years, 83% ever on TDF; median duration 1461 [range 98 to 4342] days) on ART, 28.3% had an eGFR <90 ml/min, and 5.5% <60 ml/min at their last measurement. Information on other conditions associated with renal impairment was not systematically documented. Fourteen per cent of the PLWH who later switched to TDF-free ART had an initial eGFR lower 60ml/min. Nineteen percent had first-time hypertensive readings at their last visit. The multivariable models suggest that physicians acted according to guidelines and replaced TDF-containing ART if patients developed moderate/severe renal impairment. Conclusions Assessment of renal function in SSA remains a challenge. The vast majority of PLWH benefit from long-term ART, including improved renal function. However, approximately 5% of PLWH on ART may have clinically relevant decreased eGFR, and 27% hypertension. While a routine renal assessment might not be feasible, strategies to identify patients at risk are warranted. Targeted monitoring prior and during ART is recommended, however, should not delay ART access.	[Deckert, Andreas; Neuhann, Florian; Beiersmann, Claudia] Heidelberg Univ Hosp, Inst Publ Hlth, Heidelberg, Germany; [Klose, Christina; Bruckner, Thomas] Heidelberg Univ Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Haloka, John; Nsofwa, Mannie; Banda, Greg; Reutter, Helmut] CHRESO Univ, Lusaka, Zambia; [Brune, Maik] Heidelberg Univ Hosp, Internal Med & Clin Chem 1, Heidelberg, Germany; [Rothenbacher, Dietrich] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Zeier, Martin] Heidelberg Univ Hosp, Div Nephrol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University; Ruprecht Karls University Heidelberg	Deckert, A (corresponding author), Heidelberg Univ Hosp, Inst Publ Hlth, Heidelberg, Germany.	a.deckert@uni-heidelberg.de		Rothenbacher, Dietrich/0000-0002-3563-2791	Else Kroner-Fresenius Stiftung (EKFS) [2013_A84]	Else Kroner-Fresenius Stiftung (EKFS)	The ReCaZa study was enabled by a grant of the Else Kroner-Fresenius Stiftung (EKFS), EKFS project 2013_A84, http://www.ekfs.de/. The funding source was neither involved in design or conduct of the study, nor in the collection, management, analysis, interpretation of the data, or the preparation, review, approval of the manuscript, or the decision to submit the manuscript for publication. The authors declare that they have no other relevant financial interests.	Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Cailhol J, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-40; Chadwick DR, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0192-4; Neto LFDP, 2016, BRAZ J INFECT DIS, V20, P14, DOI 10.1016/j.bjid.2015.09.004; Elias A., 2013, PHARM PHARMACOL-RUSS, V4, P651, DOI [10.4236/pp.2013.49092, DOI 10.4236/PP.2013.49092]; Fabian J, 2009, NAT REV NEPHROL, V5, P591, DOI 10.1038/nrneph.2009.141; Glaser N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130453; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kalayjian RC, 2008, AIDS, V22, P481, DOI 10.1097/QAD.0b013e3282f4706d; Kamkuemah M, 2015, TROP MED INT HEALTH, V20, P518, DOI 10.1111/tmi.12446; Laprise C, 2013, CLIN INFECT DIS, V56, P567, DOI 10.1093/cid/cis937; Lucas GM, 2016, AIDS, V30, P619, DOI [10.1097/QAD.0000000000000949, 10.1097/QAD.0000000000000592]; Milburn J, 2016, NEPHROL DIAL TRANSPL; Ministry of Health, GOV REP ZAMB NAT HLT; Ministry of Health, GOV REP ZAMB NAT HUM; Ministry of Health Government of the Republic of Zambia, 2015, NAT TRAIN OP PLAN 20; Mocroft A, 2016, LANCET HIV, V3, pE23, DOI 10.1016/S2352-3018(15)00211-8; Mocroft A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001809; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mulenga L, 2014, CLIN INFECT DIS, V58, P1473, DOI 10.1093/cid/ciu117; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sauerbrei W, 2008, MULTIVARIABLE MODEL; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2014, WORLD FACTBOOK; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223; World Bank, 2014, WORLD DEV IND ZAMB	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184766	10.1371/journal.pone.0184766	http://dx.doi.org/10.1371/journal.pone.0184766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931037	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700034
J	Muniz, CP; Cavalcante, LTF; Jia, HW; Zheng, HQ; Tang, SH; Augusto, AM; Pissinatti, A; Fedullo, LP; Santos, AF; Soares, MA; Switzer, WM				Muniz, Claudia P.; Cavalcante, Liliane T. F.; Jia, Hongwei; Zheng, HaoQiang; Tang, Shaohua; Augusto, Anderson M.; Pissinatti, Alcides; Fedullo, Luiz P.; Santos, Andre F.; Soares, Marcelo A.; Switzer, William M.			Zoonotic infection of Brazilian primate workers with New World simian foamy virus	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; NONHUMAN-PRIMATES; WIDE DISTRIBUTION; RHESUS MACAQUES; MACACA-MULATTA; CENTRAL-AFRICA; HUMANS; REPLICATION; IDENTIFICATION; RETROVIRUSES	Simian foamy viruses (SFVs) are retroviruses present in nearly all nonhuman primates (NHPs), including Old World primates (OWP) and New World primates (NWP). While all confirmed human infections with SFV are from zoonotic transmissions originating from OWP, little is known about the zoonotic transmission potential of NWP SFV. We conducted a longitudinal, prospective study of 56 workers occupationally exposed to NWP in Brazil. Plasma from these workers was tested using Western blot (WB) assays containing NWP SFV antigens. Genomic DNA from blood and buccal swabs was analyzed for the presence of proviral SFV sequences by three nested PCR tests and a new quantitative PCR assay. Exposure histories were obtained and analyzed for associations with possible SFV infection. Ten persons (18%) tested seropositive and two persons were seroindeterminate (3.6%) for NWP SFV. Six persons had seroreactivity over 2-3 years suggestive of persistent infection. All SFV NWP WB-positive workers reported at least one incident involving NWP, including six reporting NWP bites. NWP SFV viral DNA was not detected in the blood or buccal swabs from all 12 NWP SFV seroreactive workers. We also found evidence of SFV seroreversion in three workers suggestive of possible clearance of infection. Our findings suggest that NWP SFV can be transmitted to occupationally-exposed humans and can elicit specific humoral immune responses but infection remains well-controlled resulting in latent infection and may occasionally clear.	[Muniz, Claudia P.; Cavalcante, Liliane T. F.; Santos, Andre F.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Muniz, Claudia P.; Jia, Hongwei; Zheng, HaoQiang; Tang, Shaohua; Switzer, William M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Lab Branch, Atlanta, GA USA; [Augusto, Anderson M.; Fedullo, Luiz P.] Fundacao Jardim Zool Cidade Rio De Janeiro, Rio De Janeiro, Brazil; [Pissinatti, Alcides] Ctr Primatol Rio De Janeiro, Rio De Janeiro, Brazil; [Soares, Marcelo A.] Inst Nacl Canc, Programa Oncovirol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Centers for Disease Control & Prevention - USA; National Cancer Institute (Inca)	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Lab Branch, Atlanta, GA USA.	bis3@cdc.gov	Soares, Marcelo A/G-5662-2010; Santos, Andre FA/I-5734-2016		Brazilian Science Council (CNPq) grant [480529/2013-2]; Rio de Janeiro State Science Foundation (FAPERJ) grant [E-26/103.059/2011]; CDC intramural funding	Brazilian Science Council (CNPq) grant; Rio de Janeiro State Science Foundation (FAPERJ) grant; CDC intramural funding	This work was funded by the Brazilian Science Council (CNPq) grant 480529/2013-2 awarded to AFS, by the Rio de Janeiro State Science Foundation (FAPERJ) grant # E-26/103.059/2011 awarded to MAS, and by CDC intramural funding.	Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Boneva RS, 2007, AIDS RES HUM RETROV, V23, P1330, DOI 10.1089/aid.2007.0104; Brooks JI, 2007, TRANSFUSION, V47, P162, DOI 10.1111/j.1537-2995.2007.01079.x; Brooks JI, 2002, LANCET, V360, P387, DOI 10.1016/S0140-6736(02)09597-1; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; CARE FOR THE WILD INTERNATIONAL, 2007, GOING POT NEOTR BUSH; Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054; Choudhary A, 2013, VIRUSES-BASEL, V5, P1414, DOI 10.3390/v5061414; Cummins JE, 2005, J VIROL, V79, P13186, DOI 10.1128/JVI.79.20.13186-13189.2005; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Falcone V, 1999, VIROLOGY, V257, P7, DOI 10.1006/viro.1999.9634; Gessain A, 2013, VIROLOGY, V435, P187, DOI 10.1016/j.virol.2012.09.035; Ghersi BM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0214-0; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; Huang F, 2012, AIDS RES HUM RETROV, V28, P591, DOI [10.1089/AID.2011.0305, 10.1089/aid.2011.0305]; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Katzourakis A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-61; Khan AS, 2006, TRANSFUSION, V46, P1352, DOI 10.1111/j.1537-2995.2006.00862.x; Mouinga-Ondeme A, 2013, VIRUSES-BASEL, V5, P1536, DOI 10.3390/v5061536; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Muniz CP, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0217-x; Muniz CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067568; Murray SM, 2008, J VIROL, V82, P5981, DOI 10.1128/JVI.00367-08; Murray SM, 2006, J VIROL, V80, P663, DOI 10.1128/JVI.80.2.663-670.2006; Pacheco B, 2010, J VIROL, V84, P4095, DOI 10.1128/JVI.02631-09; Peeters M, 2014, AIDS REV, V16, P23; Rua R, 2015, CURR OPIN VIROL, V10, P47, DOI 10.1016/j.coviro.2014.12.003; Rua R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077072; Rua R, 2012, J VIROL, V86, P909, DOI 10.1128/JVI.06235-11; Sandstrom PA, 2000, LANCET, V355, P551, DOI 10.1016/S0140-6736(99)05292-7; Soliven K, 2013, J VIROL, V87, P13628, DOI 10.1128/JVI.01989-13; Stenbak CR, 2014, J VIROL, V88, P982, DOI 10.1128/JVI.03154-13; Switzer WM, 2008, J INFECT DIS, V197, P1389, DOI 10.1086/587493; Switzer WM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157709; Switzer WM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-100; Switzer WM, 2004, J VIROL, V78, P2780, DOI 10.1128/JVI.78.6.2780-2789.2004; Switzer WM, 2001, TRANSPLANTATION, V71, P959, DOI 10.1097/00007890-200104150-00022; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Xu FW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-198; Yee JL, 2016, J MED PRIMATOL, V45, P55, DOI 10.1111/jmp.12209	41	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184502	10.1371/journal.pone.0184502	http://dx.doi.org/10.1371/journal.pone.0184502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931021	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700020
J	Gulyas, G; Radvanszki, G; Matuska, R; Balla, A; Hunyady, L; Balla, T; Varnai, P				Gulyas, Gergo; Radvanszki, Gloria; Matuska, Rita; Balla, Andras; Hunyady, Laszlo; Balla, Tamas; Varnai, Peter			Plasma membrane phosphatidylinositol 4-phosphate and 4,5-bisphosphate determine the distribution and function of K-Ras4B but not H-Ras proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); G protein-coupled receptor (GPCR); Golgi; GTPase Kras (KRAS); phosphoinositide	K-RAS; ENDOPLASMIC-RETICULUM; DYNAMIC CHANGES; LOCALIZATION; TRAFFICKING; ACTIVATION; PHOSPHOINOSITIDES; VISUALIZATION; ASSOCIATION; RECEPTOR	Plasma membrane (PM) localization of Ras proteins is crucial for transmitting signals upon mitogen stimulation. Post-translational lipid modification of Ras proteins plays an important role in their recruitment to the PM. Electrostatic interactions between negatively charged PM phospholipids and basic amino acids found in K-Ras4B (K-Ras) but not in H-Ras are important for permanent K-Ras localization to the PM. Here, we investigated how acute depletion of negatively charged PM polyphosphoinositides (PPIns) from the PM alters the intracellular distribution and activity of K- and H-Ras proteins. PPIns depletion from the PM was achieved either by agonist-induced activation of phospholipase C or with a rapamycin-inducible system in which various phosphatidylinositol phosphatases were recruited to the PM. Redistribution of the two Ras proteins was monitored with confocal microscopy or with a recently developed bioluminescence resonance energy transfer-based approach involving fusion of the Ras C-terminal targeting sequences or the entire Ras proteins to Venus fluorescent protein. We found that PM PPIns depletion caused rapid translocation of K-Ras but not H-Ras from the PM to the Golgi. PM depletion of either phosphatidylinositol 4-phosphate (PtdIns4P) or PtdIns(4,5)P-2 but not PtdIns(3,4,5)P-3 was sufficient to evoke K-Ras translocation. This effect was diminished by deltarasin, an inhibitor of the Ras-phosphodiesterase interaction, or by simultaneous depletion of the Golgi PtdIns4P. The PPIns depletion decreased incorporation of [H-3]leucine in K-Ras-expressing cells, suggesting that Golgi-localized K-Ras is not as signaling-competent as its PM-bound form. We conclude that PPIns in the PM are important regulators of K-Ras-mediated signals.	[Gulyas, Gergo; Radvanszki, Gloria; Matuska, Rita; Balla, Andras; Hunyady, Laszlo; Varnai, Peter] Semmelweis Univ, Dept Physiol, Fac Med, H-1094 Budapest, Hungary; [Balla, Andras; Hunyady, Laszlo] Hungarian Acad Sci, MTA SE Lab Mol Physiol, H-1094 Budapest, Hungary; [Balla, Andras; Hunyady, Laszlo] Semmelweis Univ, H-1094 Budapest, Hungary; [Balla, Andras] Eunice Kennedy Shriver NICHD, Sect Mol Signal Transduct, NIH, Bethesda, MD 20892 USA	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Varnai, P (corresponding author), Semmelweis Univ, Dept Physiol, Fac Med, POB 259, H-1444 Budapest, Hungary.	varnai.peter@med.semmelweis-univ.hu	; Gulyas, Gergo/I-8923-2017; Varnai, Peter/F-4902-2019	Balla, Andras/0000-0002-6450-2793; Balla, Tamas/0000-0002-9077-3335; Gulyas, Gergo/0000-0002-5491-8699; Varnai, Peter/0000-0002-7777-806X	Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health; National Research, Development and Innovation Fund [NKFIH K105006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health; National Research, Development and Innovation Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health.; Supported by National Research, Development and Innovation Fund Grant NKFIH K105006. To whom correspondence should be addressed: Dept. of Physiology, Faculty of Medicine, Semmelweis University, Budapest, P. O. Box 259, H-1444 Budapest, Hungary. E-mail: varnai.peter@med.semmelweis-univ.hu.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Balla A, 2011, J BIOL CHEM, V286, P5319, DOI 10.1074/jbc.M110.176933; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Calimeri T, 2017, BRIT J HAEMATOL, V177, P684, DOI 10.1111/bjh.14529; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Carquin M, 2016, PROG LIPID RES, V62, P1, DOI 10.1016/j.plipres.2015.12.004; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Diaz-Rohrer BB, 2014, P NATL ACAD SCI USA, V111, P8500, DOI 10.1073/pnas.1404582111; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gelabert-Baldrich M, 2014, FASEB J, V28, P3023, DOI 10.1096/fj.13-241158; Gentry LR, 2015, J BIOL CHEM, V290, P22851, DOI 10.1074/jbc.M115.656710; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Goldfinger LE, 2017, BIOSCI TRENDS, V11, P23, DOI 10.5582/bst.2016.01220; Gregory MC, 2017, BIOCHEM BIOPH RES CO, V487, P351, DOI 10.1016/j.bbrc.2017.04.063; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Ji C, 2015, J BIOL CHEM, V290, P26978, DOI 10.1074/jbc.M115.663013; Jin T, 2012, CELL RES, V22, P661, DOI 10.1038/cr.2011.161; Johnson CM, 2008, J BIOL CHEM, V283, P29920, DOI 10.1074/jbc.M805921200; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; Koveal D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003289; Levental I, 2016, J MOL BIOL, V428, P4749, DOI 10.1016/j.jmb.2016.08.022; Lorenzo PS, 2001, CANCER RES, V61, P943; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Papke B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11360; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Scheidt HA, 2009, BIOPHYS J, V96, P3663, DOI 10.1016/j.bpj.2009.02.028; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Szakadati G, 2015, MOL PHARMACOL, V87, P972, DOI 10.1124/mol.114.097030; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Toth DJ, 2012, J CELL SCI, V125, P2185, DOI 10.1242/jcs.097279; Toth JT, 2016, BBA-MOL CELL BIOL L, V1861, P177, DOI 10.1016/j.bbalip.2015.12.005; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Varma S, 2007, BBA-GEN SUBJECTS, V1770, P71, DOI 10.1016/j.bbagen.2006.07.016; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Whited AM, 2015, CHEM PHYS LIPIDS, V192, P51, DOI 10.1016/j.chemphyslip.2015.07.015; Woo J, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-23; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	68	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18862	18877		10.1074/jbc.M117.806679	http://dx.doi.org/10.1074/jbc.M117.806679			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939768	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-26	WOS:000415848000012
J	Willmore, J; Marko, TL; Taing, D; Sampasa-Kanyinga, H				Willmore, Jacqueline; Marko, Terry-Lynne; Taing, Darcie; Sampasa-Kanyinga, Hugues			The burden of alcohol-related morbidity and mortality in Ottawa, Canada	PLOS ONE			English	Article							DRINKING PATTERNS; SOCIOECONOMIC-STATUS; GENDER-DIFFERENCES; CONSUMPTION; CONSEQUENCES; OUTLETS; DENSITY	Objectives Alcohol-related morbidity and mortality are significant public health issues. The purpose of this study was to describe the prevalence and trends over time of alcohol consumption and alcohol-related morbidity and mortality; and public attitudes of alcohol use impacts on families and the community in Ottawa, Canada. Methods Prevalence (2013-2014) and trends (2000-2001 to 2013-2014) of alcohol use were obtained from the Canadian Community Health Survey. Data on paramedic responses (2015), emergency department (ED) visits (2013-2015), hospitalizations (2013-2015) and deaths (2007-2011) were used to quantify the acute and chronic health effects of alcohol in Ottawa. Qualitative data were obtained from the "Have Your Say" alcohol survey, an online survey of public attitudes on alcohol conducted in 2016. Results In 2013-2014, an estimated 595,300 (83%) Ottawa adults 19 years and older drank alcohol, 42% reported binge drinking in the past year. Heavy drinking increased from 15% in 2000-2001 to 20% in 2013-2014. In 2015, the Ottawa Paramedic Service responded to 2,060 calls directly attributable to alcohol. Between 2013 and 2015, there were an average of 6,100 ED visits and 1,270 hospitalizations per year due to alcohol. Annually, alcohol use results in at least 140 deaths in Ottawa. Men have higher rates of alcohol-attributable paramedic responses, ED visits, hospitalizations and deaths than women, and young adults have higher rates of alcohol-attributable paramedic responses. Qualitative data of public attitudes indicate that alcohol misuse has greater repercussions not only on those who drink, but also on the family and community. Conclusions Results highlight the need for healthy public policy intended to encourage a culture of drinking in moderation in Ottawa to support lower risk alcohol use, particularly among men and young adults.	[Willmore, Jacqueline; Marko, Terry-Lynne; Taing, Darcie; Sampasa-Kanyinga, Hugues] Ottawa Publ Hlth, Ottawa, ON, Canada		Taing, D (corresponding author), Ottawa Publ Hlth, Ottawa, ON, Canada.	Darcie.Taing@ottawa.ca	Sampasa-Kanyinga, Hugues/ABE-8565-2020	Sampasa-Kanyinga, Hugues/0000-0002-7195-8086				Agic B, 2016, DRUG ALCOHOL REV, V35, P196, DOI 10.1111/dar.12250; Alcohol and Gaming Commission of Ontario, 2013, REG MOD ONT BEV ALC; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Balabanova D, 1999, ALCOHOL ALCOHOLISM, V34, P622, DOI 10.1093/alcalc/34.4.622; Beland Yves, 2002, Health Rep, V13, P9; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI26, DOI 10.1093/alcalc/agl073; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Caldwell TM, 2008, DRUG ALCOHOL DEPEN, V95, P269, DOI 10.1016/j.drugalcdep.2008.01.014; CAMH Health Promotion Resource Centre, 2013, MAK CAS TOOLS SUPP L; Erskine S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-99; Gmel G., 2004, CONTEMP DRUG PROBL, V31, P467, DOI [10.1177/009145090403100304, DOI 10.1177/009145090403100304, DOI 10.1111/J.1360-0443.2005.01224.X]; Hao W, 2004, ALCOHOL ALCOHOLISM, V39, P43, DOI 10.1093/alcalc/agh018; Hart CL, 2010, BMC PUBLIC HEALTH, V10, P1; Helasoja V, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-241; Ialomieanu AR, 2014, CAMH RES DOCUMENT SE, V40; Jones L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1720-7; Laslett A-M, 2010, RANGE MAGNITUDE ALCO, P29; Leslie K, 2008, CAN MED ASSOC J, V178, P149, DOI 10.1503/cmaj.071622; Makela P, 2008, J EPIDEMIOL COMMUN H, V62, P728, DOI 10.1136/jech.2007.065672; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Mulia N, 2012, ALCOHOL ALCOHOLISM, V47, P178, DOI 10.1093/alcalc/agr168; Mulia N, 2011, ALCOHOL CLIN EXP RES, V35, P1557, DOI 10.1111/j.1530-0277.2011.01501.x; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2006, UND DRINK WHY DO AD; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2016, UND DRINK FACT SHEET; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Ottawa Public Health, 2016, CULT ALC MOD; Ottawa Public Health, 2013, SUBST MIS OTT; Patra J, 2007, CAN J PUBLIC HEALTH, V98, P228, DOI 10.1007/BF03403718; Popova S, 2012, DRUG ALCOHOL REV, V31, P4, DOI 10.1111/j.1465-3362.2010.00276.x; Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054; [Public Health Branch Region of Waterloo Public Health York Region Community and Health Services Halton Region Health Department Durham Region Health Department], 2014, CYCL 2 LOC DRIV COL; Rehm J, 2006, ADDICTION, V101, P373, DOI 10.1111/j.1360-0443.2005.01338.x; Rehm J, 2003, ALCOHOL RES HEALTH, V140, pC00; Rehm J, 2006, COSTS SUBSTANCE ABUS, P1; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Shield K. D., 2013, ALCOHOL RES, V85, P2; Stahre M, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130293; Statistics Canada, 2015, SUMM RES 2013 CAN TO; Stockwell T, 2011, ADDICTION, V106, P768, DOI 10.1111/j.1360-0443.2010.03331.x; Stockwell T, 2009, ADDICTION, V104, P1827, DOI 10.1111/j.1360-0443.2009.02658.x; Thomas G., 2012, ALCOHOL PRICE POLICY; Thomas G, 2011, MYTHS FACTS ALCOHOL; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; Wilsnack RW, 2000, ADDICTION, V95, P251, DOI 10.1046/j.1360-0443.2000.95225112.x; World Health Organization, 2009, EV EFF COST EFF INT; Zhao JH, 2015, CAN J PUBLIC HEALTH, V106, pE204, DOI 10.17269/cjph.106.4753	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185457	10.1371/journal.pone.0185457	http://dx.doi.org/10.1371/journal.pone.0185457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957368	Green Submitted, gold, Green Published			2022-12-26	WOS:000411985200061
J	Bai, ZQ; Xia, PG; Wang, RL; Jiao, J; Ru, M; Liu, JL; Liang, ZS				Bai, Zhenqing; Xia, Pengguo; Wang, Ruilin; Jiao, Jie; Ru, Mei; Liu, Jingling; Liang, Zongsuo			Molecular cloning and characterization of five SmGRAS genes associated with tanshinone biosynthesis in Salvia miltiorrhiza hairy roots	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; SCARECROW-LIKE 3; GRAS-GENE; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; FAMILY; ARABIDOPSIS; ACCUMULATION; PHYTOCHROME; EXPRESSION	The gibberellin-responsive element binding factor ( GRAS) family of proteins plays an important role in the transcriptional regulation of plant development and hormone signaling. To date, there are no reports on GRAS family proteins expressed in Salvia miltiorrhiza. In this study, 28 ESTs that contained the GRAS domain were identified from a S. miltiorrhiza cDNA library. Of these, full-length sequences of five genes were cloned and sequence analysis indicated that all five proteins contain only one GRAS domain and therefore, belong to the GRAS family. The five genes were designated S. miltiorrhiza GRAS1-5 (SmGRAS1-5), which belong to groups I (SmGRAS2 and SmGRAS4), II (SmGRAS3), III (SmGRAS1), and VIII (SmGRAS5) respectively. Additionally, SmGRAS1-5 have different expression patterns in the reed head, stems, leaves, flowers, and roots of S. miltiorrhiza. In this study, the expression of SmGRAS1-5 was sensitive to Gibberellin (GA) stress and that of SmGRAS1, SmGRAS4 and SmGRAS5 was sensitive to Ethephon (Eth) stress respectively. Moreover, S. miltiorrhiza copalyl diphosphate synthases 1 (SmCPS1) and S. miltiorrhiza kaurene synthase like 1 (SmKSL1), which are two key enzymes gene in the diterpenoid biosynthesis pathway, were also response to GA and Eth stress. In addition, Dihydrotanshinone (DT-I) and Tanshinone I (T-I) content were enhanced by GA and Eth stress, Tanshinone IIA (T-IIA) content was increased by GA stress, and the accumulation of Cryptotanshinone (CT) was insensitive to both GA and Eth stress. Together, these results provide insights into functional conservation and diversification of SmGRASs and are useful information for further elucidating SmGRAS functions.	[Bai, Zhenqing; Wang, Ruilin; Jiao, Jie; Ru, Mei; Liu, Jingling; Liang, Zongsuo] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Xia, Pengguo; Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Liang, ZS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China.; Liang, ZS (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	liangzs@ms.iswc.ac.cn			National Natural Science Foundation of China [81373908]; National "Twelfth Five-Year" Plan for Science Technology [2015BAC01B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science Technology	These researches were supported by National Natural Science Foundation of China (81373908) and National "Twelfth Five-Year" Plan for Science & Technology Support (2015BAC01B03).	Abarca D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0354-8; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bolle C, 2000, GENE DEV, V14, P1269; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Czikkel BE, 2007, J PLANT PHYSIOL, V164, P1220, DOI 10.1016/j.jplph.2006.07.010; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Du Q., 2015, THESIS; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Fujii H, 2007, PLANT SCI, V173, P340, DOI 10.1016/j.plantsci.2007.06.006; Gao W, 2015, ORGANIC LETT, V11, P5170; Gao Wei, 2015, Zhongguo Zhong Yao Za Zhi, V40, P2486; Guo HJ JY, 2009, CHIN B BOT, V1399, P901; Guoyin Kai AZ, 2012, MOL BIOSYST, V8, P2883; Hao XL, 2015, BIOTECHNOL APPL BIOC, V62, P24, DOI 10.1002/bab.1236; Heo JO, 2011, P NATL ACAD SCI USA, V108, P2166, DOI 10.1073/pnas.1012215108; Hirsch S, 2009, PLANT SIGNAL BEHAV, V4, P698, DOI 10.4161/psb.4.8.9176; Huang W, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0590-6; Kai GY, 2012, ACTA PHYSIOL PLANT, V34, P1421, DOI 10.1007/s11738-012-0940-z; Kai GY, 2011, METAB ENG, V13, P319, DOI 10.1016/j.ymben.2011.02.003; Kim GB, 2013, PLANT GROWTH REGUL, V71, P77, DOI 10.1007/s10725-013-9814-7; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Li G., 2014, J ANHUI AGR SCI, V42, P4207; [李卿 Li Qing], 2015, [中草药, Chinese Traditional and Herbal Drugs], V46, P887; Lijie Cui XN, 2015, SCI REPORTS; Lili Dai, 2015, THESIS; Lim J, 2000, PLANT CELL, V12, P1307, DOI 10.1105/tpc.12.8.1307; Liu W, 2011, PLANT CELL, V23, P3853, DOI 10.1105/tpc.111.089771; Liu XY, 2014, PLANT MOL BIOL REP, V32, P1129, DOI 10.1007/s11105-014-0721-5; Lu JX, 2015, MOL GENET GENOMICS, V290, P303, DOI 10.1007/s00438-014-0918-1; Meng XiangChun, 2011, Scientia Agricultura Sinica, V44, P538; Morohashi K, 2003, J BIOL CHEM, V278, P20865, DOI 10.1074/jbc.M301712200; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shi M, 2016, J AGR FOOD CHEM, V64, P2523, DOI 10.1021/acs.jafc.5b04697; Shi M, 2014, FUNCT INTEGR GENOMIC, V14, P603, DOI 10.1007/s10142-014-0385-0; Song XM, 2014, GENOMICS, V103, P135, DOI 10.1016/j.ygeno.2013.12.004; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Torres-Galea P, 2006, MOL GENET GENOMICS, V276, P13, DOI 10.1007/s00438-006-0123-y; Torres-Galea P, 2013, PLANT PHYSIOL, V161, P291, DOI 10.1104/pp.112.206607; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Xue L, 2015, PLANT PHYSIOL, V167, P854, DOI 10.1104/pp.114.255430; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Yang Deqiang, 2012, THESIS; Yang DF, 2012, PHYSIOL PLANTARUM, V146, P173, DOI 10.1111/j.1399-3054.2012.01603.x; Yoshida H, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29726; Yuan Y, 2016, PLANT CELL REP, V35, P1; Zhang ZL, 2011, P NATL ACAD SCI USA, V108, P2160, DOI 10.1073/pnas.1012232108; Zhou JY, 2010, SCI HORTIC-AMSTERDAM, V126, P229, DOI 10.1016/j.scienta.2010.07.019; Zhou W, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0550-3	55	12	16	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185322	10.1371/journal.pone.0185322	http://dx.doi.org/10.1371/journal.pone.0185322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953930	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300056
J	Lopez, JLB; Estrada, CEE; Mendez, UR; Rodriguez, JJS; Goyenechea, IGM; Ceron, JMC				Becerra Lopez, Jorge Luis; Esparza Estrada, Citlalli Edith; Romero Mendez, Ulises; Sigala Rodriguez, Jose Jesus; Mayer Goyenechea, Irene Goyenechea; Castillo Ceron, Jesus Martin			Evidence of niche shift and invasion potential of Lithobates catesbeianus in the habitat of Mexican endemic frogs	PLOS ONE			English	Article							MODEL COMPLEXITY; CONSERVATISM; ECOLOGY; PREDICTION; RANGE; SPACE; RISK	Invasive alien species are one of most severe threats to biodiversity and natural resources. These biological invasions have been studied from the niche conservatism and niche shifts perspective. Niche differentiation may result from changes in fundamental niche or realized niche or both; in biological invasions, niche differences between native and non-native ranges can appear through niche expansion, niche unfilling and niche stability. The American bullfrog Lithobates catesbeianus is an invasive species that can have negative impacts on native amphibian populations. This research examines the climate niche shifts of this frog, its potential range of expansion in Mexico and the risk of invasion by bullfrog in the habitats of 82 frog species endemic to Mexico, that based on their climatic niche similarity were divided in four ecological groups. The results indicate that species in two ecological groups were the most vulnerable to invasion by bullfrog. However, the climate niche shifts of L. catesbeianus may allow it to adapt to new environmental conditions, so species from the two remaining groups cannot be dismissed as not vulnerable. This information is valuable for decision making in prioritizing areas for conservation of Mexican endemic frogs.	[Becerra Lopez, Jorge Luis] Univ Autonoma Noreste, Ctr Invest Sustentabilidad Energet & Ambiental No, Tamaulipas, Mexico; [Esparza Estrada, Citlalli Edith; Mayer Goyenechea, Irene Goyenechea] Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Lab Sistemat Mol, Hidalgo, Mexico; [Romero Mendez, Ulises] Univ Juarez Estado Durango, Fac Ciencias Biol, Lab Sistemas Informac Geog, Durango, Mexico; [Sigala Rodriguez, Jose Jesus] Univ Autonoma Aguascalientes, Colecc Zool, Aguascalientes, Mexico; [Castillo Ceron, Jesus Martin] Univ Autonoma Estado Hidalgo, Museo Paleontol, Hidalgo, Mexico	Universidad Autonoma del Estado de Hidalgo; Universidad Juarez del Estado de Durango; Universidad Autonoma de Aguascalientes; Universidad Autonoma del Estado de Hidalgo	Estrada, CEE (corresponding author), Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Lab Sistemat Mol, Hidalgo, Mexico.	calli.edithsita@gmail.com	Goyenechea, Irene/AAR-7074-2021; Sigala-Rodriguez, J. Jesus/B-3617-2013	ROMERO MENDEZ, ULISES/0000-0002-6062-8874; Sigala-Rodriguez, J. Jesus/0000-0002-5895-1568	Universidad Autonoma del Estado de Hidalgo IGMG	Universidad Autonoma del Estado de Hidalgo IGMG	This work was supported by the Universidad Autonoma del Estado de Hidalgo IGMG to JMCC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Romero JG, 2008, ANIMALES EXOTICOS ME; [Anonymous], 2007, ANFIBIOS REPTILES ES; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Becerra-Lopez JL, 2016, REV CIENTIFICA BIOL, V5, P1514; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Buckley LB, 2008, ECOLOGY, V89, P48, DOI 10.1890/07-0845.1; Casas-Andreu G, 2001, CIENCIA ERGO SUM, V8, P277; CASPER GS, 2005, AMPHIBIAN DECLINES C, P540; da Mata RA, 2010, BIOL INVASIONS, V12, P1231, DOI 10.1007/s10530-009-9542-0; Dambach J, 2011, AQUAT CONSERV, V21, P92, DOI 10.1002/aqc.1160; Dickerson MC, 1931, THE FROG BOOK; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Estrada-Rodriguez JL, 2004, ANFIBIOS Y REPTILES; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Flores-Villela O., 1993, HERPETOFAUNA MEXICAN; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gervasi SS, 2013, ECOHEALTH, V10, P166, DOI 10.1007/s10393-013-0832-8; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Glennon KL, 2014, ECOL LETT, V17, P574, DOI 10.1111/ele.12259; Govindarajulu P, 2006, J HERPETOL, V40, P249, DOI 10.1670/68-05A.1; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Hernandez-Austria R, 2015, REV MEX BIODIVERS, V86, P269, DOI 10.7550/rmb.45631; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090121; Holt RD, 2005, OIKOS, V108, P18, DOI 10.1111/j.0030-1299.2005.13147.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; INEGI, 2017, COMP INF GEOGR; Iniguez Carlos A., 2012, South American Journal of Herpetology, V7, P85; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Latombe G., 2016, BIOL CONSERV; Laufer G, 2008, BIOL INVASIONS, V10, P1183, DOI 10.1007/s10530-007-9178-x; Lauzeral C, 2011, GLOBAL ECOL BIOGEOGR, V20, P407, DOI 10.1111/j.1466-8238.2010.00611.x; Lever C, 2003, NATURALIZED REPTILES; Levin DA, 2005, SYST BOT, V30, P9, DOI 10.1600/0363644053661869; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moreno-Amat E, 2015, ECOL MODEL, V312, P308, DOI 10.1016/j.ecolmodel.2015.05.035; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nori J, 2011, BIODIVERS CONSERV, V20, P1125, DOI 10.1007/s10531-011-0014-3; Parra-Olea G, 2014, REV MEX BIODIVERS, V85, pS460, DOI 10.7550/rmb.32027; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2013, R LANG ENV STAT COMP; Ramos-Guerra S, 2014, ESPECIES INVASORAS A, P411; Rivas C, 2014, HERPETOL REV, V45, P273; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sanabria E, 2011, REV MEX BIODIVERS, V82, P311; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P476; Soberon J, 2011, REV MEX BIODIVERS, V82, P1348; Stebbins R.C., 1985, FIELD GUIDE W REPTIL, V2nd; Strubbe D, 2015, ECOGRAPHY, V38, P321, DOI 10.1111/ecog.00632; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Urbina-Cardona J. N., 2010, BIODIVERSIDAD CAMBIO, P65; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wright A, 1949, HDB FROGS TOADS US C; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	72	15	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185086	10.1371/journal.pone.0185086	http://dx.doi.org/10.1371/journal.pone.0185086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953907	Green Published, gold			2022-12-26	WOS:000411980300033
J	Kim, J; Montagne, K; Nemoto, H; Ushida, T; Furukawa, KS				Kim, Jeonghyun; Montagne, Kevin; Nemoto, Hidetoshi; Ushida, Takashi; Furukawa, Katsuko S.			Hypergravity down-regulates c-fos gene expression via ROCK/Rho-GTP and the PI3K signaling pathway in murine ATDC5 chondroprogenitor cells	PLOS ONE			English	Article							PARABOLIC FLIGHT MANEUVERS; HYDROSTATIC-PRESSURE; MECHANICAL-PROPERTIES; HUMAN CHONDROCYTES; UP-REGULATION; IN-VITRO; RHO; PROLIFERATION; CYTOSKELETON; INDUCTION	Chondrocytes are known to be physiologically loaded with diverse physical factors such as compressive stress, shear stress and hydrostatic pressure. Although the effects of those mechanical stimuli onto various cell models have been widely studied, those of hypergravity have not yet been revealed clearly. Hereby, we hypothesized that the hypergravity affects relative positions of intracellular elements including nucleus and cytoskeletons due to their density differences, triggering mechanotransduction in the cell. The aim of this study was to investigate the effect of hypergravity on c-fos expression in the murine ATDC5 chondroprogenitor cells, as c-fos is a well known key regulator of cell proliferation and differentiation, including in chondrocytes. We first found that hypergravity down-regulated c-fos expression transiently via ROCK/Rho-GTP and PI3K signaling, and the down-regulation was suppressed by inhibition of actin polymerization.	[Kim, Jeonghyun; Montagne, Kevin; Ushida, Takashi; Furukawa, Katsuko S.] Univ Tokyo, Grad Sch Engn, Dept Mech Engn, Tokyo, Japan; [Nemoto, Hidetoshi] Univ Tokyo, Div Regenerat Med Engn, Ctr Dis Biol & Integrat Med, Sch Med, Tokyo, Japan; [Furukawa, Katsuko S.] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Furukawa, KS (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Mech Engn, Tokyo, Japan.; Furukawa, KS (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo, Japan.	furukawa@mech.t.u-tokyo.ac.jp	, Jeonghyun/GNW-4610-2022	, Jeonghyun/0000-0002-3157-3878	Japanese Ministry of Education, Culture, Sports, Science and Technology; Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Japan Agency for Medical Research and Development (AMED; Development of Manufacturing System for Regenerative Medicinal Cells from Human Mesenchymal Stem Cells), and 5) JSPS KAKENHI [17J07735]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation(Naito Memorial Foundation); Japan Agency for Medical Research and Development (AMED; Development of Manufacturing System for Regenerative Medicinal Cells from Human Mesenchymal Stem Cells), and 5) JSPS KAKENHI(Japan Agency for Medical Research and Development (AMED))	This work was supported by 1) grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, 2) a grant for the Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 3) the Naito Foundation, 4) Japan Agency for Medical Research and Development (AMED; Development of Manufacturing System for Regenerative Medicinal Cells from Human Mesenchymal Stem Cells), and 5) JSPS KAKENHI (Grant Number 17J07735).	Albi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098250; Aleshcheva G, 2015, FASEB J, V29, P2303, DOI 10.1096/fj.14-268151; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764, DOI 10.1152/jappl.1994.76.4.1764; Dreger M, 2003, EUR J BIOCHEM, V270, P589, DOI 10.1046/j.1432-1033.2003.03426.x; Ferraro JT, 2004, AM J PHYSIOL-CELL PH, V286, pC831, DOI 10.1152/ajpcell.00224.2003; Fidelina O V, 2004, J Gravit Physiol, V11, pP35; Govoni M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/918640; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; JANKNECHT R, 1995, CARCINOGENESIS, V16, P443, DOI 10.1093/carcin/16.3.443; JANSSEN YMW, 1995, CANCER RES, V55, P2085; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Kim J, 2015, BIOSCI BIOTECH BIOCH, V79, P239, DOI 10.1080/09168451.2014.975184; Kim JY, 2014, INT IMMUNOPHARMACOL, V20, P213, DOI 10.1016/j.intimp.2014.03.001; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kumahashi N, 2004, CELL TISSUE RES, V317, P117, DOI 10.1007/s00441-004-0893-7; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Montagne K, 2014, J BIOMECH, V47, P354, DOI 10.1016/j.jbiomech.2013.11.027; Nagayama K, 2008, AM J PHYSIOL-CELL PH, V295, pC1569, DOI 10.1152/ajpcell.00098.2008; Newton PT, 2012, INT J MOL MED, V30, P1187, DOI 10.3892/ijmm.2012.1114; O'Conor CJ, 2013, STEM CELL RES THER, V4, P1, DOI DOI 10.1186/SCRT211; Peake MA, 2000, J APPL PHYSIOL, V89, P2498, DOI 10.1152/jappl.2000.89.6.2498; Ranjan V, 1996, BIOTECHNOL BIOENG, V49, P383, DOI 10.1002/(SICI)1097-0290(19960220)49:4<383::AID-BIT4>3.0.CO;2-L; Shiu YT, 2003, BIOCHEM BIOPH RES CO, V303, P548, DOI 10.1016/S0006-291X(03)00388-7; Silberman M, 2009, ANGIOGENESIS, V12, P231, DOI 10.1007/s10456-009-9143-7; Tavakolinejad A, 2015, BIOCHEM BIOPH RES CO, V464, P473, DOI 10.1016/j.bbrc.2015.06.160; Thomas DP, 2000, J CELL SCI, V113, P439; Thomas RS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3536; Ting SYW, 2015, TISSUE ENG PART C-ME, V21, P1005, DOI [10.1089/ten.tec.2014.0428, 10.1089/ten.TEC.2014.0428]; Todd P, 1989, ASGSB Bull, V2, P95; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wehland M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0095-9; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zhou S, 2015, BIOCHEM BIOPH RES CO, V463, P928, DOI 10.1016/j.bbrc.2015.06.037	38	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185394	10.1371/journal.pone.0185394	http://dx.doi.org/10.1371/journal.pone.0185394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953959	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300060
J	Danyuttapolchai, J; Kittimunkong, S; Nateniyom, S; Painujit, S; Klinbuayaem, V; Maipanich, N; Maokamnerd, Y; Pevzner, E; Whitehead, S; Kanphukiew, A; Monkongdee, P; Martin, M				Danyuttapolchai, Junya; Kittimunkong, Somyot; Nateniyom, Sriprapa; Painujit, Sutthapa; Klinbuayaem, Virat; Maipanich, Nuanpun; Maokamnerd, Yongyut; Pevzner, Eric; Whitehead, Sara; Kanphukiew, Apiratee; Monkongdee, Patama; Martin, Michael			Implementing an isoniazid preventive therapy program for people living with HIV in Thailand	PLOS ONE			English	Article							TUBERCULOSIS; ANTIRETROVIRALS; INFECTION; AFRICA	Treatment of people living with HIV (PLHIV) with latent tuberculosis (TB) infection using isoniazid preventive therapy (IPT) can reduce the risk of TB disease, however, the scale-up of IPT among PLHIV in Thailand and worldwide has been slow. To hasten the implementation of IPT in Thailand, we developed IPT implementation training curricula and tools for health care providers and implemented IPT services in seven large government hospitals. Of the 659 PLHIV enrolled, 272 (41.3%) reported symptoms of TB and 39 (14.3% of those with TB symptoms) were diagnosed with TB. A total of 346 (52.4%) participants were eligible for IPT; 318 (91.9%) of these participants opted to have a tuberculin skin test (TST) and 52 (16.3% of those who had a TST) had a positive TST result. Among the 52 participants with a positive TST, 46 (88.5%) initiated and 39 (75.0%) completed 9 months of IPT: physicians instructed three participants to stop IPT, two participants were lost to follow-up, one chose to stop therapy, and one developed TB. IPT can be implemented among PLHIV in Thailand and could reduce the burden of TB in the country.	[Danyuttapolchai, Junya; Whitehead, Sara; Kanphukiew, Apiratee; Monkongdee, Patama; Martin, Michael] Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Bangkok, Nonthaburi Prov, Thailand; [Kittimunkong, Somyot] Thailand Minist Publ Hlth, Bur Vector Borne Dis, Dept Dis Control, Bangkok, Nonthaburi Prov, Thailand; [Nateniyom, Sriprapa] Thailand Minist Publ Hlth, Bur TB, Dept Dis Control, Bangkok, Thailand; [Painujit, Sutthapa] Nakhon Si Thammarat Hosp, Bangkok, Nakhon Si Thamm, Thailand; [Klinbuayaem, Virat] Sanpatong Hosp, Bangkok, Chiang Mai Prov, Thailand; [Maipanich, Nuanpun] Vachira Phuket Hosp, Bangkok, Phuket Province, Thailand; [Maokamnerd, Yongyut] Somdejprajaotaksin Maharaj Hosp, Bangkok, Tak Province, Thailand; [Pevzner, Eric; Martin, Michael] US Ctr Dis Control & Prevent, Atlanta, GA USA	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Danyuttapolchai, J (corresponding author), Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Bangkok, Nonthaburi Prov, Thailand.	hqd2@cdc.gov			President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [5U19GH000004]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work has been supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of grant number 5U19GH000004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 1996, AM FAM PHYSICIAN, V54, P1115; [Anonymous], WHO POL COLL TB HIV; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Briggs MA, 2015, JAIDS-J ACQ IMM DEF, V68, pS297, DOI 10.1097/QAI.0000000000000497; Bureau of AIDS TB and STIs Department of Disease Control Ministry of Public Health Thailand., 2017, THAIL NAT GUID HIV A; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Khongphatthanayothin M, 2012, AIDS RES HUM RETROV, V28, P270, DOI 10.1089/aid.2011.0041; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moolphate Saiyud, 2013, Glob J Health Sci, V5, P60, DOI 10.5539/gjhs.v5n4p60; Ngamvithayapong J, 1997, AIDS, V11, P107, DOI 10.1097/00002030-199701000-00016; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Thailand Ministry of Public Health, 2003, THAIL MIN PUBL HLTH; Thailand Ministry of Public Health, 2013, NAT TUB CONTR PROGR; Thailand Ministry of Public Health, 2009, NAT TB HIV GUID; Thailand Ministry of Public Health, 2008, THAIL MIN PUBL HLTH; UNAIDS, 2015, HIV AIDS EST; WHO, 2016, GLOB TUB REP; World Health Organization, GUID INT TUB CAS FIN	23	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184986	10.1371/journal.pone.0184986	http://dx.doi.org/10.1371/journal.pone.0184986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949995	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000021
J	Soria, I; Quattrocchi, V; Langellotti, C; Gammella, M; Digiacomo, S; de la Torre, BG; Andreu, D; Montoya, M; Sobrino, F; Blanco, E; Zamorano, P				Soria, Ivana; Quattrocchi, Valeria; Langellotti, Cecilia; Gammella, Mariela; Digiacomo, Sebastian; Garcia de la Torre, Beatriz; Andreu, David; Montoya, Maria; Sobrino, Francisco; Blanco, Esther; Zamorano, Patricia			Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle	PLOS ONE			English	Article							B-CELL; RESPIRATORY-TRACT; SOLID PROTECTION; IMMUNE-RESPONSE; ANTIBODIES; VACCINE; EPITOPE; TRANSMISSION; CHALLENGE; VP1	Foot-and-mouth disease virus (FMDV) causes a highly contagious disease in cloven-hoofed animals. A synthetic vaccine candidate consisting of dendrimeric peptides harbouring two copies of a B-epitope [VP1(136-154)] linked to a T-cell epitope [3A(21-35)] of FMDV confers protection to type O FMDV challenge in pigs. Herein we show in cattle that novel dendrimeric peptides bearing a T-cell epitope [VP1(21-40] and two or four copies of a B-cell epitope [VP1(135-160)] from type O1 Campos FMDV (termed B2T and B4T, respectively) elicited FMDV specific immune responses to similar levels to a commercial vaccine. Animals were challenged with FMDV and 100% of vaccinated cattle with B2T or B4T were protected to podal generalization. Moreover, bovines immunized with B4T were completely protected (with no clinical signs) against FMDV challenge after three vaccine doses, which was associated with titers of viral neutralizing antibodies in serum higher than those of B2T group (p< 0.05) and levels of opsonic antibodies similar to those of animals immunized with one dose of FMDV commercial vaccine. Bovines vaccinated with both dendrimeric peptides presented high levels of IgG1 anti FMDV in sera and in mucosa. When IgA in nasal secretions was measured, 20% or 40% of the animals in B2T or B4T groups respectively, showed antiFMDV IgA titers. In addition, B2T and B4T peptides evoked similar consistent T cell responses, being recognized in vitro by lymphocytes from most of the immunized cattle in the proliferation assay, and from all animals in the IFN-. production assay. Taken together, these results support the potential of dendrimers B2T or B4T in cattle as a highly valuable, cost-effective FMDV candidate vaccine with DIVA potential.	[Soria, Ivana; Quattrocchi, Valeria; Langellotti, Cecilia; Gammella, Mariela; Digiacomo, Sebastian; Zamorano, Patricia] Inst Nacl Tecnol Agr INTA Castelar, Inst Virol, Ctr Invest Ciencias Vet, Buenos Aires, DF, Argentina; [Soria, Ivana; Langellotti, Cecilia; Zamorano, Patricia] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Garcia de la Torre, Beatriz; Andreu, David] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Montoya, Maria] Pirbright Inst, Ash Rd, Woking, Surrey, England; [Sobrino, Francisco] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Blanco, Esther] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pompeu Fabra University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Soria, I; Zamorano, P (corresponding author), Inst Nacl Tecnol Agr INTA Castelar, Inst Virol, Ctr Invest Ciencias Vet, Buenos Aires, DF, Argentina.; Soria, I; Zamorano, P (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Sobrino, F (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	soria.ivana@inta.gob.ar; fsobrino@cbm.csic.es; zamorano.patricia@inta.gob.ar	de la Torre, Beatriz G./N-6995-2019; Montoya, Maria/G-3430-2015; Blanco, Esther/C-1245-2013; de la Torre, Beatriz G/AAF-1419-2020	de la Torre, Beatriz G./0000-0001-8521-9172; Montoya, Maria/0000-0002-5703-7360; Blanco, Esther/0000-0001-8413-4222; Sobrino, Francisco/0000-0003-4968-8291	National Institute of Agricultural Technology [PNSA 1115052]; INTA-INIA (Argentina-Spain) [SA 20938]; MINECO, Spain [AGL2014-52395-C2]	National Institute of Agricultural Technology; INTA-INIA (Argentina-Spain); MINECO, Spain	Work at INTA was supported by the National Institute of Agricultural Technology (grant number PNSA 1115052) and cooperation agreement INTA-INIA (Argentina-Spain SA 20938). Evaluation of vaccine immunogenicity and protection in cattle. Work at Universitat Pompeu Fabra and CBMSO was supported by MINECO, Spain (grant number AGL2014-52395-C2). Dendrimeric peptides synthesis and article submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Romera SA, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-8; Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Lavoria MA, 2012, VACCINE, V30, P6845, DOI 10.1016/j.vaccine.2012.09.011; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Barteling SJ, 2004, DEV BIOLOGICALS, V119, P449; BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0; Blanco E, 2016, ANTIVIR RES, V129, P74, DOI 10.1016/j.antiviral.2016.03.005; Blanco E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475960; Bouvet JP, 2002, TRENDS IMMUNOL, V23, P209, DOI 10.1016/S1471-4906(02)02186-5; Brocchi E, 2006, VACCINE, V24, P6966, DOI 10.1016/j.vaccine.2006.04.050; Capozzo AVE, 1997, VACCINE, V15, P624, DOI 10.1016/S0264-410X(96)00284-8; COLLEN T, 1991, J IMMUNOL, V146, P749; Cubillos C, 2008, J VIROL, V82, P7223, DOI 10.1128/JVI.00401-08; Diaz-San Segundo F, 2016, VET MICROBIOL; DIMARCHI R, 1986, SCIENCE, V232, P639, DOI 10.1126/science.3008333; GLASS EJ, 1991, IMMUNOLOGY, V74, P594; Goddeeris B, 1998, HANDBOOK OF INVERTEBRATE IMMUNOLOGY, P439; Heegaard PMH, 2010, BIOCONJUGATE CHEM, V21, P405, DOI 10.1021/bc900290d; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Law M, 2008, CURR OPIN IMMUNOL, V20, P486, DOI 10.1016/j.coi.2008.06.005; Maradei E, 2008, VACCINE, V26, P6577, DOI 10.1016/j.vaccine.2008.09.033; MCCULLOUGH KC, 1992, J VIROL, V66, P1835, DOI 10.1128/JVI.66.4.1835-1840.1992; MCCULLOUGH KC, 1988, IMMUNOLOGY, V65, P187; Monso M, 2013, BIOCONJUGATE CHEM, V24, P578, DOI 10.1021/bc300515t; Moraes MP, 2002, VACCINE, V20, P1631, DOI 10.1016/S0264-410X(01)00483-2; OIE] World Organisation for Animal Health, 2017, MANUAL DIAGNOSTIC TE; Orsel K, 2007, VACCINE, V25, P6381, DOI 10.1016/j.vaccine.2007.06.010; Orsel K, 2005, VACCINE, V23, P4887, DOI 10.1016/j.vaccine.2005.05.014; Orsel K, 2009, CAN VET J, V50, P1059; Pega J, 2015, J VIROL, V89, P9581, DOI 10.1128/JVI.01082-15; Pega J, 2013, J VIROL, V87, P2489, DOI 10.1128/JVI.02879-12; Porta C, 2013, J VIROL METHODS, V187, P406, DOI 10.1016/j.jviromet.2012.11.011; Quattrocchi V, 2014, VACCINE, V32, P2167, DOI 10.1016/j.vaccine.2014.02.061; Quattrocchi V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00037; Rodriguez LL, 2003, VACCINE, V21, P3751, DOI 10.1016/S0264-410X(03)00364-5; Sadler Kristen, 2002, J Biotechnol, V90, P195; SELLERS RF, 1971, LANCET, V1, P1238; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; Taboga O, 1997, J VIROL, V71, P2606, DOI 10.1128/JVI.71.4.2606-2614.1997; Tekleghiorghis T, 2014, CLIN VACCINE IMMUNOL, V21, P674, DOI 10.1128/CVI.00034-14; ZAMORANO P, 1994, VIROLOGY, V201, P383, DOI 10.1006/viro.1994.1305; Zamorano PI, 1998, VACCINE, V16, P558, DOI 10.1016/S0264-410X(97)00244-2; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	43	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185184	10.1371/journal.pone.0185184	http://dx.doi.org/10.1371/journal.pone.0185184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949998	Green Submitted, Green Published, gold			2022-12-26	WOS:000411671000029
J	Hirabayashi, F; Iwanaga, K; Okinaga, T; Takahashi, O; Ariyoshi, W; Suzuki, R; Sugii, M; Maruyama, K; Tominaga, K; Nishihara, T				Hirabayashi, Fumika; Iwanaga, Kenjiro; Okinaga, Toshinori; Takahashi, Osamu; Ariyoshi, Wataru; Suzuki, Ryo; Sugii, Mutsumi; Maruyama, Kazuo; Tominaga, Kazuhiro; Nishihara, Tatsuji			Epidermal growth factor receptor-targeted sonoporation with microbubbles enhances therapeutic efficacy in a squamous cell carcinoma model	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEM; PLASMID DNA; CANCER-CELLS; EGF RECEPTOR; IN-VITRO; ULTRASOUND; LIPOSOMES; BLEOMYCIN; ANTIBODY; GENE	Sonoporation is a drug and gene delivery system using ultrasonication that allows the intracellular delivery of foreign molecules that cannot enter cells under normal conditions. We previously reported that sonoporation with microbubbles (MBs) could achieve effective intracellular drug delivery to human gingival squamous carcinoma Ca9-22 cells. In this study, we developed anti-epidermal growth factor receptor (EGFR) antibody-conjugated MBs (EGFRMBs) and evaluated their capacity to enhance anti-cancer drug toxicity in vitro and in vivo. We first assessed the effect of sonoporation with EGFR-MBs on Ca9-22 cells by the WST-8 assay, flow cytometry and Hoechst's staining in vitro. Sonoporation and EGFR-MB had a strong cytotoxic effect on Ca9-22 cells with low-dose bleomycin. Furthermore, bleomycin delivery using sonoporation with EGFR-MBs remarkably increased the number of apoptotic cells. We next examined the effect of EGFR-MBs in a murine squamous cell carcinoma model. Bleomycin delivery by sonoporation with EGFR-MBs exhibited remarkable antitumor activity. Together, our results show that EGFR-MBs and ultrasound treatment increases the efficacy and specificity of intracellular drug uptake, suggesting this could be a novel drug-targeting modality for oral squamous cell carcinoma chemotherapy treatment.	[Hirabayashi, Fumika; Okinaga, Toshinori; Ariyoshi, Wataru; Nishihara, Tatsuji] Kyushu Dent Univ, Div Infect & Mol Biol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan; [Hirabayashi, Fumika; Iwanaga, Kenjiro; Takahashi, Osamu; Tominaga, Kazuhiro] Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral & Maxillofacial Surg, Kitakyushu, Fukuoka, Japan; [Suzuki, Ryo; Sugii, Mutsumi; Maruyama, Kazuo] Teikyo Univ, Fac Pharma Sci, Lab Drug Delivery Syst, Tokyo, Japan	Kyushu Dental University; Kyushu Dental University; Teikyo University	Iwanaga, K (corresponding author), Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral & Maxillofacial Surg, Kitakyushu, Fukuoka, Japan.	kenjiro.iwanaga.a2@tohoku.ac.jp		Nishihara, Tatsuji/0000-0001-7075-9678; Suzuki, Ryo/0000-0001-6614-4486	JSPS KAKENHI [JP16K11698]; Grants-in-Aid for Scientific Research [17H00864] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP16K11698.	Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739; Bai WK, 2016, ONCOL LETT, V11, P3829, DOI 10.3892/ol.2016.4477; Burger RM, 1998, CHEM REV, V98, P1153, DOI 10.1021/cr960438a; Dewitte H, 2014, J CONTROL RELEASE, V194, P28, DOI 10.1016/j.jconrel.2014.08.011; Endo-Takahashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03883; Fan XZ, 2016, INT J NANOMED, V11, P3585, DOI 10.2147/IJN.S111808; FECHHEIMER M, 1987, P NATL ACAD SCI USA, V84, P8463, DOI 10.1073/pnas.84.23.8463; Garg A, 2011, CURR PHARM BIOTECHNO, V12, P1135, DOI 10.2174/138920111796117328; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Iwanaga K, 2007, CANCER GENE THER, V14, P354, DOI 10.1038/sj.cgt.7701026; Joshi A, 2017, ONCOTARGETS THER, V10, P1859, DOI 10.2147/OTT.S125397; KAMATA N, 1986, CANCER RES, V46, P1648; Lamanauskas N, 2013, J DRUG TARGET, V21, P407, DOI 10.3109/1061186X.2012.761223; Lee EJ, 2005, EXP MOL MED, V37, P379, DOI 10.1038/emm.2005.48; Liang BJ, 2015, CLIN CANCER RES, V21, P1183, DOI 10.1158/1078-0432.CCR-14-1194; Liao AH, 2015, J MED BIOL ENG, V35, P156, DOI 10.1007/s40846-015-0032-9; Maeda H, 2009, J ORAL PATHOL MED, V38, P572, DOI 10.1111/j.1600-0714.2009.00759.x; Napolitano S, 2017, ONCOTARGET; Nejad SM, 2016, THERANOSTICS, V6, P446, DOI 10.7150/thno.13518; Perera RH, 2015, WIRES NANOMED NANOBI, V7, P593, DOI 10.1002/wnan.1326; ROY SN, 1984, CANCER RES, V44, P1541; Sano K, 2014, MOL CANCER THER, V13, P426, DOI 10.1158/1535-7163.MCT-13-0633; Sato T, 2014, ULTRASOUND MED BIOL, V40, P1237, DOI 10.1016/j.ultrasmedbio.2013.12.012; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shen ZP, 2008, GENE THER, V15, P1147, DOI 10.1038/gt.2008.51; Solbach C, 2002, INT J CANCER, V101, P390, DOI 10.1002/ijc.10615; Tachibana K, 1999, JPN J APPL PHYS 1, V38, P3014, DOI 10.1143/JJAP.38.3014; Taniyama Y, 2002, GENE THER, V9, P372, DOI 10.1038/sj.gt.3301678; TOUNEKTI O, 1993, CANCER RES, V53, P5462; VanOsdol J, 2017, J CONTROL RELEASE, V247, P55, DOI 10.1016/j.jconrel.2016.12.033; Wang X, 2014, INT J NANOMED, V9, P4899, DOI 10.2147/IJN.S69845; Yang T, 2014, THERANOSTICS, V4, P1096, DOI 10.7150/thno.9423; Yin TH, 2014, BIOMATERIALS, V35, P5932, DOI 10.1016/j.biomaterials.2014.03.072; Yoon YI, 2014, THERANOSTICS, V4, P1133, DOI 10.7150/thno.9945	35	19	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185293	10.1371/journal.pone.0185293	http://dx.doi.org/10.1371/journal.pone.0185293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938010	Green Submitted, Green Published, gold			2022-12-26	WOS:000411524700025
J	Outten, CE				Outten, Caryn E.			Checks and balances for the iron bank	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SULFUR PROTEINS; HOMEOSTASIS; MATURATION; LIGASE; RNA	The RNA-binding iron regulatory proteins IRP1 and IRP2 are inactivated by either Fe-S cluster insertion or protein degradation mediated by the E3 ligase component FBXL5. However, the mechanisms for coordination between Fe-S cluster assembly, FBXL5, and IRP1/IRP2 activity are poorly defined. A new study reveals that FBXL5 plays a critical role in limiting IRP1 and IRP2 overaccumulation when cytosolic Fe-S cluster assembly is impaired in order to maintain optimal iron levels for cell viability.	[Outten, Caryn E.] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Outten, CE (corresponding author), 631 Sumter St, Columbia, SC 29208 USA.	outten@sc.edu	Outten, Caryn E./I-9433-2019	Outten, Caryn E./0000-0003-0335-6531	National Institutes of Health [GM118164]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM118164.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Johnson NB, 2017, J BIOL CHEM, V292, P15976, DOI 10.1074/jbc.M117.785741; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116	8	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15990	15991		10.1074/jbc.H117.785741	http://dx.doi.org/10.1074/jbc.H117.785741			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28939752	Green Published, hybrid			2022-12-26	WOS:000411512200035
J	Cui, JA; Liu, X; Wang, YL; Liu, HF				Cui, Jianan; Liu, Xin; Wang, Yile; Liu, Huafeng			Deep reconstruction model for dynamic PET images	PLOS ONE			English	Article							EMISSION-TOMOGRAPHY; REGULARIZATION; ALGORITHMS; MAXIMUM	Accurate and robust tomographic reconstruction from dynamic positron emission tomography (PET) acquired data is a difficult problem. Conventional methods, such as the maximum likelihood expectation maximization (MLEM) algorithm for reconstructing the activity distribution-based on individual frames, may lead to inaccurate results due to the checkerboard effect and limitation of photon counts. In this paper, we propose a stacked sparse auto-encoder based reconstruction framework for dynamic PET imaging. The dynamic reconstruction problem is formulated in a deep learning representation, where the encoding layers extract the prototype features, such as edges, so that, in the decoding layers, the reconstructed results are obtained through a combination of those features. The qualitative and quantitative results of the procedure, including the data based on a Monte Carlo simulation and real patient data demonstrates the effectiveness of our method.	[Cui, Jianan; Wang, Yile; Liu, Huafeng] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Zhejiang, Peoples R China; [Liu, Xin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Liu, HF (corresponding author), Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Zhejiang, Peoples R China.	liuhf@zju.edu.cn	Cui, Jianan/Y-9764-2019		National Natural Science Foundation of China [61525106, 61427807]; National Key Technology Research and Development Program of China [2016YFC1300302]; Zhejiang Medical Science and Technology Projects [201128375, 20143675]; Hangzhou Huazheng Medical Equipment Co. Ltd. [491030-121602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Zhejiang Medical Science and Technology Projects; Hangzhou Huazheng Medical Equipment Co. Ltd.	This work is supported in part by the National Natural Science Foundation of China (No: 61525106, 61427807), by National Key Technology Research and Development Program of China (No: 2016YFC1300302), by Zhejiang Medical Science and Technology Projects (201128375, 20143675), and by Hangzhou Huazheng Medical Equipment Co. Ltd. (491030-121602).; This work is supported in part by the National Natural Science Foundation of China (No: 61525106, 61427807), by National Key Technology Research and Development Program of China (No: 2016YFC1300302), by Zhejiang Medical Science and Technology Projects (201128375, 20143675), and by Hangzhou Huazheng Medical Equipment Co. Ltd. (491030-121602).	Cabello J, 2013, IEEE T NUCL SCI, V60, P3364, DOI 10.1109/TNS.2013.2278121; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; FESSLER JA, 1995, IEEE T IMAGE PROCESS, V4, P1417, DOI 10.1109/83.465106; Hecht-Nielsen R., 1989, NEURAL NETWORKS, V1, P445; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; ISHII T, 2013, REVERBERANT SPEECH R; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Kreutz-Delgado K, 2003, NEURAL COMPUT, V15, P349, DOI 10.1162/089976603762552951; LEVITAN E, 1987, IEEE T MED IMAGING, V6, P185, DOI 10.1109/TMI.1987.4307826; Lu X, 2013, SPEECH ENHANCEMENT B; Ollinger JM, 1997, IEEE SIGNAL PROC MAG, V14, P43, DOI 10.1109/79.560323; Rahmim A, 2005, PHYS MED BIOL, V50, P4887, DOI 10.1088/0031-9155/50/20/010; Rahmim A, 2009, MED PHYS, V36, P3654, DOI 10.1118/1.3160108; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; Verhaeghe J, 2008, IEEE T MED IMAGING, V27, P943, DOI 10.1109/TMI.2008.923698; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xu J, 2016, IEEE T MED IMAGING, V35, P119, DOI 10.1109/TMI.2015.2458702; Zubal I, 2003, ZUBAL PHANTOM DATA V	19	25	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184667	10.1371/journal.pone.0184667	http://dx.doi.org/10.1371/journal.pone.0184667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934254	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900038
J	Hu, WS; Rajendran, P; Tzang, BS; Yeh, YL; Shen, CY; Chen, RJ; Ho, TJ; Padma, VV; Chen, YH; Huang, CY				Hu, Wei-Syun; Rajendran, Peramaiyan; Tzang, Bor-Show; Yeh, Yu-Lan; Shen, Chia-Yao; Chen, Ray-Jade; Ho, Tsung-Jung; Padma, Viswanadha Vijaya; Chen, Yi-Hsing; Huang, Chih-Yang			Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARDIOVASCULAR-DISEASE; FAT ACCUMULATION; IMMUNE-RESPONSE; GUT FLORA; REUTERI; METABOLISM; MICROBIOTA; INFLAMMATION; AUTOIMMUNITY	Systemic lupus erythematosus (SLE) is a disease that mostly affects women. Accelerated atherosclerosis is a high-risk factor associated with SLE patients. SLE associated with cardiovascular disease is one of the most important causes of death. In this study, we demonstrated that Lactobacillus paracasei GMNL-32(GMNL-32), a probiotic species, exhibits anti-fibrosis and anti-apoptotic effects on the cardiac tissue of NZB/WF1 mice. Female NZB/W F1 mice, a well-known and commonly used lupus-prone mouse strain, were treated with or without GMNL-32 administration for 12 weeks. Oral administration of GMNL-32 to NZB/WF1 mice significantly increased the ventricular thickness when compared to that of NZB/WF1 mice. Administration of GMNL-32 significantly attenuated the cardiac cell apoptosis that was observed in exacerbate levels in the control NZB/WF1 mice. Further, the cellular morphology that was slightly distorted in the NZB/WF1 was effectively alleviated in the treatment group mice. In addition, GMNL-32 reduced the level of Fas death receptor-related pathway of apoptosis signaling and enhanced anti-apoptotic proteins. These results indicate that GMNL-32 exhibit an effective protective effect on cardiac cells of SLE mice. Thus, GMNL-32 may be a potential therapeutic strategy against SLE associated arthrosclerosis.	[Hu, Wei-Syun] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Hu, Wei-Syun] China Med Univ Hosp, Div Cardiovasc Med, Dept Med, Taichung, Taiwan; [Rajendran, Peramaiyan; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Yeh, Yu-Lan] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Yeh, Yu-Lan] Jen Teh Jr Coll Med Nursing & Management, Miaoli, Taiwan; [Shen, Chia-Yao] Mei Ho Univ, Dept Nursing, Pingtung, Taiwan; [Chen, Ray-Jade] Taipei Med Univ, Dept Surg, Sch Med, Coll Med, Taipei, Taiwan; [Ho, Tsung-Jung; Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Padma, Viswanadha Vijaya] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India; [Chen, Yi-Hsing] GenMt Biotech Inc, Res & Dev Dept, Tainan, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University; Changhua Christian Hospital; Taipei Medical University; China Medical University Taiwan; Bharathiar University; Asia University Taiwan	Huang, CY (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.	cyhuang@mail.cmu.edu.tw	Rajendran, Peramaiyan/I-3877-2012; Rajendran, Peramaiyan/K-3287-2019; Chen, Ray/GRJ-6736-2022	Rajendran, Peramaiyan/0000-0001-6354-4388; Huang, Chih-Yang/0000-0003-2347-0411; Bor-Show, Tzang/0000-0003-0140-9943	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; GenMont Biotech Incorporation, Taiwan [1044EI]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; GenMont Biotech Incorporation, Taiwan	This work is supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019) and GenMont Biotech Incorporation, Taiwan. (1044EI). The funding organization provided support in the form of salaries for Y-H.C. and research materials (L. paracasei GMNL-32), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work is supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019) and GenMont Biotech Incorporation, Taiwan. (1044EI). The funding organization provided support in the form of salaries for authors [Y-H.C] and research materials (L. paracasei GMNL-32), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahi D, 2016, ACTA PHYSL OXF, V217, P300; Andrade S, 2009, J DAIRY RES, V76, P469, DOI 10.1017/S0022029909990173; ANSARI A, 1985, PROG CARDIOVASC DIS, V27, P421, DOI 10.1016/0033-0620(85)90003-9; Aoki-Yoshida A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158643; Ballocca F, 2015, EUR J PREV CARDIOL, V22, P1435, DOI 10.1177/2047487314546826; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Chuang L, 2007, J AGR FOOD CHEM, V55, P11080, DOI 10.1021/jf071786o; Ciou SY, 2014, BIOMEDICINE-TAIWAN, V4, P7, DOI 10.7603/s40681-014-0017-y; Cojocaru Manole, 2011, Maedica (Bucur), V6, P330; Collins FL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153180; Dawood MAO, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/514196; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Ettinger G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168622; Fak F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046837; Gao G, 2015, MBIO, V6; Gao K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28332; Haque S, 2005, NAT CLIN PRACT CARD, V2, P423, DOI 10.1038/ncpcardio0270; He BK, 2017, J EXP MED, V214, P107, DOI 10.1084/jem.20160961; Huang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127440; Huang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170109; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; Jahns R, 2008, AUTOIMMUNITY, V41, P454, DOI 10.1080/08916930802031603; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kosiewicz MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00180; Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002; Lee J, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0686-7; Liao PH, 2016, INT J MED SCI, V13, P569, DOI 10.7150/ijms.15597; MacGregor G, 2002, POSTGRAD MED J, V78, P366, DOI 10.1136/pmj.78.920.366; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; McMahon M, 2011, EXPERT REV CLIN IMMU, V7, P227, DOI [10.1586/eci.10.98, 10.1586/ECI.10.98]; Mortaz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136455; Paiva AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048313; Phatharajaree W, 2007, CAN J CARDIOL, V23, P727, DOI 10.1016/S0828-282X(07)70818-8; Portugal LR, 2006, BRAZ J MED BIOL RES, V39, P629, DOI 10.1590/S0100-879X2006000500010; Sun J, 2016, NUTRITION, V32, P265, DOI 10.1016/j.nut.2015.08.020; Sydora BC, 2010, CLIN EXP IMMUNOL, V161, P187, DOI 10.1111/j.1365-2249.2010.04140.x; Szkaradkiewicz AK, 2014, ARCH IMMUNOL THER EX, V62, P495, DOI 10.1007/s00005-014-0277-y; Takeuchi K, 2006, FEBS J, V273, P3743, DOI 10.1111/j.1742-4658.2006.05377.x; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Tincani A, 2006, RHEUMATOLOGY, V45, P8, DOI 10.1093/rheumatology/kel308; Ting WJ, 2015, INT J MOL SCI, V16, P25881, DOI 10.3390/ijms161025881; Ting WJ, 2015, BRIT J NUTR, V114, P706, DOI 10.1017/S0007114515002469; Toshimitsu T, 2016, J DAIRY SCI, V99, P933, DOI 10.3168/jds.2015-9916; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Tzang BS, 2011, MOL IMMUNOL, V48, P1518, DOI 10.1016/j.molimm.2011.04.013; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Wagner RD, 2000, J FOOD PROTECT, V63, P638, DOI 10.4315/0362-028X-63.5.638; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wegielska I, 2016, ACTA SCI POLON-TECHN, V15, P201, DOI 10.17306/J.AFS.2016.2.20; WINSLOW TM, 1993, AM HEART J, V125, P1117, DOI 10.1016/0002-8703(93)90123-Q; Wutzke KD, 2008, EUR J CLIN NUTR, V62, P197, DOI 10.1038/sj.ejcn.1602716; Xu RY, 2012, J CLIN BIOCHEM NUTR, V50, P72, DOI 10.3164/jcbn.11-38; Zeller CB, 2008, CURR CARDIOL REV, V4, P116, DOI 10.2174/157340308784245775; Zhao P, 2009, FRONT BIOSCI-LANDMRK, V14, P1708, DOI 10.2741/3334	56	10	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185098	10.1371/journal.pone.0185098	http://dx.doi.org/10.1371/journal.pone.0185098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934296	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900087
J	Soldevilla, MM; Hervas, S; Villanueva, H; Lozano, T; Rabal, O; Oyarzabal, J; Lasarte, JJ; Bendandi, M; Inoges, S; de Cerio, ALD; Pastor, F				Martinez Soldevilla, Mario; Hervas, Sandra; Villanueva, Helena; Lozano, Teresa; Rabal, Obdulia; Oyarzabal, Julen; Jose Lasarte, Juan; Bendandi, Maurizio; Inoges, Susana; Lopez-Diaz de Cerio, Ascension; Pastor, Fernando			Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)	PLOS ONE			English	Article							OLIGONUCLEOTIDE APTAMER; MOLECULES; SELECTION; LIGANDS; PROTEIN	LAG3 receptor belongs to a family of immune-checkpoints expressed in T lymphocytes and other cells of the immune system. It plays an important role as a rheostat of the immune response. Focus on this receptor as a potential therapeutic target in cancer immunotherapy has been underscored after the success of other immune-checkpoint blockade strategies in clinical trials. LAG3 showcases the interest in the field of autoimmunity as several studies show that LAG3-targeting antibodies can also be used for the treatment of autoimmune diseases. In this work we describe the identification of a high-affinity LAG3 aptamer by High Throughput Sequencing SELEX in combination with a study of potential conserved binding modes according to sequence conservation by using 2D-structure prediction and 3D-RNA modeling using Rosetta. The aptamer with the highest accumulation of these conserved sequence motifs displays the highest affinity to LAG3 recombinant soluble proteins and binds to LAG3-expressing lymphocytes. The aptamer described herein has the potential to be used as a therapeutic agent, as it enhances the threshold of T-cell activation. Nonetheless, in future applications, it could also be engineered for treatment of autoimmune diseases by target depletion of LAG3-effector T lymphocytes.	[Martinez Soldevilla, Mario; Villanueva, Helena; Pastor, Fernando] Ctr Appl Med Res, Mol Therapeut Program, Aptamer Platform, CIMA, Pamplona, Spain; [Martinez Soldevilla, Mario; Hervas, Sandra; Villanueva, Helena; Lozano, Teresa; Jose Lasarte, Juan; Inoges, Susana; Lopez-Diaz de Cerio, Ascension; Pastor, Fernando] Recinto Complejo Hosp Navarra, Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain; [Hervas, Sandra; Lozano, Teresa; Jose Lasarte, Juan] Univ Navarra, CIMA, Ctr Appl Med Res, Program Immunol & Immunotherapy, Pamplona, Spain; [Rabal, Obdulia; Oyarzabal, Julen] Ctr Appl Med Res CIMA, Mol Therapeut Program, Small Mol Discovery Platform, Pamplona, Spain; [Bendandi, Maurizio] Wake Forest Univ, Baptist Healthcare Ctr, Dept Internal Med, Sect Hematol Oncol,Comprehens Canc Ctr, Winston Salem, NC USA; [Bendandi, Maurizio] WG Hefner VA Med Ctr, Dept Internal Med, Sect Hematol Oncol, Salisbury, NC USA; [Bendandi, Maurizio] WG Hefner VA Med Ctr, Dept Internal Med, Sect Hematol Oncol, Charlotte, NC USA; [Inoges, Susana; Lopez-Diaz de Cerio, Ascension] Univ Clin Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain	University of Navarra; Wake Forest University; University of Navarra	Pastor, F (corresponding author), Ctr Appl Med Res, Mol Therapeut Program, Aptamer Platform, CIMA, Pamplona, Spain.; Pastor, F (corresponding author), Recinto Complejo Hosp Navarra, Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain.	fpasrodri@unav.es	Lasarte, Juan José/AAN-6548-2020; Villanueva, Helena/AAB-7911-2019; Inogés, Susana/AAW-6785-2021; Pastor, Fernando/T-6239-2017; Oyarzabal, Julen/K-7393-2017	Lasarte, Juan José/0000-0003-1641-3881; Pastor, Fernando/0000-0003-0432-3133; Oyarzabal, Julen/0000-0003-1941-7255; Lozano, Teresa/0000-0001-7122-5475	Instituto de Salud Carlos III FIS I+D [PI14/01611, PI11/02854]; Ramon y Cajal [RYC-2012-10699]; Melanoma Research Alliance [509510]	Instituto de Salud Carlos III FIS I+D; Ramon y Cajal(Spanish Government); Melanoma Research Alliance	This research is supported by Instituto de Salud Carlos III FIS I+D [(PI14/01611) and (PI11/02854) (http://www.isciii.es)] and Ramon y Cajal (RYC-2012-10699) (http://www.idi.mineco.gob.es) and Melanoma Research Alliance (509510) (http://www.curemelanoma.org) to FP.	Alam KK, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.4; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Brignone C, 2009, CLIN CANCER RES, V15, P6225, DOI 10.1158/1078-0432.CCR-09-0068; Cheng CY, 2015, METHOD ENZYMOL, V553, P35, DOI 10.1016/bs.mie.2014.10.051; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gefen T, 2017, MOL THER; Gilboa E, 2013, CLIN CANCER RES, V19, P1054, DOI 10.1158/1078-0432.CCR-12-2067; Goldberg MV, 2011, CURR TOP MICROBIOL, V344, P269, DOI 10.1007/82_2010_114; Gutierrez AA, 2015, ANTILAG 3 ANTIBODIES; Hervas-Stubbs S, 2016, ONCOTARGET, V7, P4522, DOI 10.18632/oncotarget.6608; Huang RY, 2015, ONCOTARGET, V6, P27359, DOI 10.18632/oncotarget.4751; HUARD B, 1994, IMMUNOGENETICS, V39, P213; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li B, 2008, CLIN CANCER RES, V14, P3545, DOI 10.1158/1078-0432.CCR-07-5200; Lozano T, 2016, BIOMATERIALS, V91, P73, DOI 10.1016/j.biomaterials.2016.03.007; Soldevilla MM, 2015, BIOMATERIALS, V67, P274, DOI 10.1016/j.biomaterials.2015.07.020; Miyakawa S, 2008, RNA, V14, P1154, DOI 10.1261/rna.1005808; Miyazaki T, 1996, INT IMMUNOL, V8, P725, DOI 10.1093/intimm/8.5.725; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Nozari A, 2017, MOL THER-NUCL ACIDS, V6, P29, DOI 10.1016/j.omtn.2016.12.002; Pastor F, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040064; Pastor F, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.26; Poirier N, 2011, CLIN EXP IMMUNOL, V164, P265, DOI 10.1111/j.1365-2249.2011.04329.x; Rabal Obdulia, 2016, Mol Ther Nucleic Acids, V5, pe376, DOI 10.1038/mtna.2016.84; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Zhang QX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah4569; Zhou J., 2016, NAT REV DRUG DISCOV	31	19	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185169	10.1371/journal.pone.0185169	http://dx.doi.org/10.1371/journal.pone.0185169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934318	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900110
J	Szczygielski, T; Surmik, D; Kapuscinska, A; Rothschild, BM				Szczygielski, Tomasz; Surmik, Dawid; Kapuscinska, Agnieszka; Rothschild, Bruce M.			The oldest record of aquatic amniote congenital scoliosis	PLOS ONE			English	Article							MESOSAURUS-TENUIDENS	We report the first occurrence of congenital scoliosis in an early Permian aquatic parareptile, Stereosternum tumidum from Parana A state, Brazil. The spine malformation is caused by a congenital hemivertebra. These observations give insight into the biomechanical aspects of underwater locomotion in an axial skeleton-compromised aquatic amniote. This is the oldest record of a hemivertebra in an aquatic animal.	[Szczygielski, Tomasz; Kapuscinska, Agnieszka] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Surmik, Dawid] Pk Sci & Human Evolut, Krasiejow, Poland; [Surmik, Dawid] Univ Silesia, Fac Earth Sci, Sosnowiec, Poland; [Rothschild, Bruce M.] Carnegie Museum, Pittsburgh, PA USA; [Rothschild, Bruce M.] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Silesia in Katowice; West Virginia University	Szczygielski, T (corresponding author), Polish Acad Sci, Inst Paleobiol, Warsaw, Poland.	t.szczygielski@twarda.pan.pl	Szczygielski, Tomasz/L-8363-2017; Szczygielski, Tomasz/O-1827-2019	Szczygielski, Tomasz/0000-0001-5108-8493; Kapuscinska, Agnieszka/0000-0002-8050-2582; Surmik, Dawid/0000-0003-0121-9592	National Science Center, Poland [2011/01/N/ST10/06989]	National Science Center, Poland(National Science Centre, Poland)	This research was supported by the National Science Center (Narodowe Centrum Nauki, www.ncn.gov.pl), Poland, project no. 2011/01/N/ST10/06989 granted to D. Surmik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Baur G., 1889, AM J SCI, V37, P310, DOI 10.2475/ajs.s3-37.220.310; Braun J., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P307; Cope ED, 1886, P AM PHILOS SOC, V23, P1; da Silva RC, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00022; DONE SH, 1975, VET REC, V96, P313, DOI 10.1136/vr.96.14.313; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; Garcia ARR, 2015, DIETA MESOSAURIDAE A; Gervais P., 1865, ACAD SCI LETT MONTPE, P169; Holterhoff PF, 2013, US B N M M, V60, P109; Huene F. F.von., 1941, Palaeontographica Stuttgart A, V92, P45; Johnson G. D., 1988, J VERT PALEONTOL S, V8, p19A; Kaplan Kevin M, 2005, Spine J, V5, P564, DOI 10.1016/j.spinee.2004.10.044; Kapuscinska A, 1999, THESIS; Karl Hans-Volker, 2007, Clausthaler Geowissenschaften, V6, P63; Modesto SP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1912; Modesto Sean Patrick, 1999, Palaeontologia Africana, V35, P7; Modesto SP, 2010, J VERTEBR PALEONTOL, V30, P1378, DOI 10.1080/02724634.2010.501443; OELOFSEN BW, 1987, S AFR J SCI, V83, P370; Olson Everett Claire, 1947, FIELDIANA GEOL, V11, P1; Pineiro G, 2016, PEERJ, V4, DOI 10.7717/peerj.2036; Pineiro G, 2012, ACTA PALAEONTOL POL, V57, P299, DOI 10.4202/app.2010.0113; Rossmann Torsten, 2000, Senckenbergiana Lethaea, V80, P13; Rossmann Torsten, 1999, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V39, P69; Rothschild Bruce M., 2012, P1, DOI 10.1007/978-1-4614-0824-6_1; Santos RV, 2006, GONDWANA RES, V9, P456, DOI 10.1016/j.gr.2005.12.001; Schlensker E, 2013, EUR J COMP ANIM PRAC, V23, P119; Seeley H. G., 1892, Quarterly Journal of the Geological Society, Vxlviii, P586; Shawen Scott B, 2002, Spine (Phila Pa 1976), V27, pE539; SHIKAMA TOKIO, 1966, TRANS PROC PALAEONTOL SOC JAP NEW SER, V64, P351; Silva RR, 2017, FRONT EARTH SC-SWITZ, V5, DOI 10.3389/feart.2017.00023; Soares M. B., 2003, Geologica Acta, V1, P349; Song YQ, 2016, TAIWAN J OBSTET GYNE, V55, P112, DOI 10.1016/j.tjog.2015.05.004; Sumida SS, 2001, AM ZOOL, V41, P586, DOI 10.1668/0003-1569(2001)041[0586:APPOLS]2.0.CO;2; Tsuji LA, 2009, FOSS REC, V12, P71, DOI 10.1002/mmng.200800011; Villamil J, 2015, HIST BIOL, V28, P1; Witzmann F, 2014, ANAT HISTOL EMBRYOL, V43, P90, DOI 10.1111/ahe.12050; Woodward AS, 1897, GEOL MAG LONDON, V4, P145	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							E0185338	10.1371/journal.pone.0185338	http://dx.doi.org/10.1371/journal.pone.0185338			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934336	gold, Green Published			2022-12-26	WOS:000411339900148
J	Ekblad, B; Nissen-Meyer, J; Kristensen, T				Ekblad, Bie; Nissen-Meyer, Jon; Kristensen, Tom			Whole-genome sequencing of mutants with increased resistance against the two-peptide bacteriocin plantaricin JK reveals a putative receptor and potential docking site	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; AMINO-ACID TRANSPORTER; CLASS-II BACTERIOCINS; LACTOBACILLUS-PLANTARUM; PROTEIN-STRUCTURE; SENSITIVITY; COMPLEMENTARY; ANTIBIOTICS; RECOGNITION; PREDICTION	By whole-genome sequencing of resistant mutants, a putative receptor for plantaricin JK, a two-peptide bacteriocin produced by some Lactobacillus plantarum strains, was identified in Lactobacillus plantarum NCFB 965 and Weissella viridescens NCFB 1655. The receptors of the two species had 66% identical amino acid sequences and belong to the amino acid-poly-amine-organocation (APC) transporter protein family. The resistant mutants contained point mutations in the protein-encoding gene resulting in either premature stop codons, leading to truncated versions of the protein, or single amino acid substitutions. The secondary structure of the W. viridescens protein was predicted to contain 12 transmembrane (TM) helices, a core structure shared by most members of the APC protein family. The single amino acid substitutions that resulted in resistant strains were located in a confined region of the protein that consists of TM helix 10, which is predicted to be part of an inner membrane pore, and an extracellular loop between TM helix 11 and 12. By use of template-based modeling a 3D structure model of the protein was obtained, which visualizes this mutational hotspot region and further strengthen the hypothesis that it represents a docking site for plantaricin JK.	[Ekblad, Bie; Nissen-Meyer, Jon; Kristensen, Tom] Univ Oslo, Sect Biochem & Mol Biol, Dept Biosci, Oslo, Norway	University of Oslo	Ekblad, B; Kristensen, T (corresponding author), Univ Oslo, Sect Biochem & Mol Biol, Dept Biosci, Oslo, Norway.	bie.ekblad@ibv.uio.no; tom.kristensen@ibv.uio.no	Kristensen, Tom/C-5873-2019; Nissen-Meyer, Jon/Y-8727-2019	Kristensen, Tom/0000-0002-2131-4469	Molecular Life Science initiative at the University of Oslo	Molecular Life Science initiative at the University of Oslo	This work was supported by the Molecular Life Science initiative at the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Arthur TD, 2014, FUTURE MICROBIOL, V9, P235, DOI 10.2217/fmb.13.148; Cavera VL, 2015, INT J ANTIMICROB AG, V46, P494, DOI 10.1016/j.ijantimicag.2015.07.011; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Field D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01363; Gabrielsen C, 2012, ANTIMICROB AGENTS CH, V56, P2908, DOI 10.1128/AAC.00314-12; Galvez A., 2014, FOOD BIOPRESERVATION, P15; Hauge HH, 1999, J BACTERIOL, V181, P740, DOI 10.1128/JB.181.3.740-747.1999; Hechard Y, 2002, BIOCHIMIE, V84, P545, DOI 10.1016/S0300-9084(02)01417-7; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JIMENEZDIAZ R, 1995, APPL ENVIRON MICROB, V61, P4459; Kamboj K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01204; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kjos M, 2011, MICROBIOL-SGM, V157, P3256, DOI 10.1099/mic.0.052571-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Moll GN, 1999, J BACTERIOL, V181, P4848, DOI 10.1128/JB.181.16.4848-4852.1999; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Oppegard C, 2016, MICROBIOLOGYOPEN, V5, P700, DOI 10.1002/mbo3.363; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Ramnath M, 2000, APPL ENVIRON MICROB, V66, P3098, DOI 10.1128/AEM.66.7.3098-3101.2000; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seddik HA, 2017, PROBIOTICS ANTIMICRO, V9, P111, DOI 10.1007/s12602-017-9264-z; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Uzelac G, 2013, J BACTERIOL, V195, P5614, DOI 10.1128/JB.00859-13; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	31	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185279	10.1371/journal.pone.0185279	http://dx.doi.org/10.1371/journal.pone.0185279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931059	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700081
J	Wang, ZQ; Zhang, MY; Deng, ML; Weng, NQ; Wang, HY; Wu, SX				Wang, Zhi-Qiang; Zhang, Mei-Yin; Deng, Mei-Ling; Weng, Nuo-Qing; Wang, Hui-Yun; Wu, Shao-Xiong			Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; EXPRESSION; MICRORNA; CANCER; TUMOR; BIOMARKERS; RADIOTHERAPY; CONCOMITANT	MicroRNAs (miRNAs) are short noncoding RNAs that play critical roles in human malignancies and can be used as biomarkers for cancer. Until now, a number of biomarkers for prognosis of glioblastoma (GBM) have been reported in tumor tissues but only a few biomarkers in circulating fluid. Using a custom microarray, we previously identified 19 differentially expressed miRNAs in serum of patients with GBM. In this study, we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM. We first validated the serum levels of 3 candidate miRNAs in an independent cohort of 24 GBM patients and 12 healthy volunteers by real-time quantitative reverse transcription PCR (qRT-PCR), and then evaluated the prognostic value of these miRNAs in a total of 36 GBM patients. The results show that the serum levels of the 3 miRNAs (miR-451a, miR-485-3p and miR-4298) determined by qRT-PCR are significantly different between 24 GBM patients and 12 healthy volunteers (all P <0.05) and are in concordance with the results of microarray analysis. High serum level of miR-451a is correlated with positive tumor O(6)-methylguanine-DNA methyltransferase (MGMT) expression (P = 0.040). Survival analysis showed that low serum miR-485-3p level is associated with poor progression-free survival (PFS) (P < 0.004) and overall survival (OS) (P < 0.023). Furthermore, univariate and multivariate Cox analyses demonstrated that that serum miR-485-3p expression is a significant independent prognostic factor for PFS and OS in GBM patients. In conclusion, serum miR-485-3p level is reduced and might be a potential prognostic biomarker in GBM patients.	[Wang, Zhi-Qiang; Deng, Mei-Ling; Wu, Shao-Xiong] Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Zhi-Qiang; Zhang, Mei-Yin; Deng, Mei-Ling; Weng, Nuo-Qing; Wang, Hui-Yun; Wu, Shao-Xiong] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Zhi-Qiang; Zhang, Mei-Yin; Deng, Mei-Ling; Weng, Nuo-Qing; Wang, Hui-Yun; Wu, Shao-Xiong] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Wu, SX (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China.; Wang, HY; Wu, SX (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China.; Wang, HY; Wu, SX (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn; wushx@sysucc.org.cn			National Natural Science Foundation of China [81372564]; The Research Fund of the State Key Laboratory of Oncology in South China [010811]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Research Fund of the State Key Laboratory of Oncology in South China	This project is supported by the National Natural Science Foundation of China (Grant No: 81372564 to Hui-Yun Wang) and by The Research Fund of the State Key Laboratory of Oncology in South China (Grant No: 010811 to Hui-Yun Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya-Ruiz M, 2013, ASIAN PAC J CANCER P, V14, P3757, DOI 10.7314/APJCP.2013.14.6.3757; Avet-Loiseau H, 2002, BLOOD, V99, P2185, DOI 10.1182/blood.V99.6.2185; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CF, 2011, MOL PHARMACOL, V79, P735, DOI 10.1124/mol.110.069633; Chen T, 2010, J ENVIRON SCI HEAL C, V28, P89, DOI 10.1080/10590501.2010.481477; De Mattos-Arruda L, 2014, ANN ONCOL, V25, P1729, DOI 10.1093/annonc/mdu239; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; Garcia-Romero N, 2017, ONCOTARGET, V8, P1416, DOI 10.18632/oncotarget.13635; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Karsy M, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14755; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Lou C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.27; Lucotti S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-52; Ma RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038096; Mizoguchi M, 2008, NEUROL SURG TOKYO, V36, P83; Roth P, 2011, J NEUROCHEM, V118, P449, DOI 10.1111/j.1471-4159.2011.07307.x; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; SUZUKI T, 1989, CANCER RES, V49, P1095; Tang HL, 2015, J CANCER RES THER, V11, P630, DOI 10.4103/0973-1482.146121; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang Q, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-97; Wang Z-Q, 2015, PRACT J CANC, V30, P4; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Xiong D, 2016, ONCOTARGET; Yang CH, 2013, INT J CANCER, V132, P116, DOI 10.1002/ijc.27657; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; Yue X, 2016, J NEUROSURG, V124, P122, DOI 10.3171/2015.1.JNS141577; Zhao SG, 2013, NEURO-ONCOLOGY, V15, P707, DOI 10.1093/neuonc/not001	37	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184969	10.1371/journal.pone.0184969	http://dx.doi.org/10.1371/journal.pone.0184969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931080	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700050
J	Cao, ST; Yu, SY; Chen, Y; Wang, XS; Zhou, CH; Liu, YT; Kuang, JQ; Liu, H; Li, DW; Ye, J; Qin, Y; Chu, SL; Wu, LL; Guo, L; Li, YX; Shu, XD; Chen, JK; Liu, J; Pei, DQ				Cao, Shangtao; Yu, Shengyong; Chen, Yan; Wang, Xiaoshan; Zhou, Chunhua; Liu, Yuting; Kuang, Junqi; Liu, He; Li, Dongwei; Ye, Jing; Qin, Yue; Chu, Shilong; Wu, Linlin; Guo, Lin; Li, Yinxiong; Shu, Xiaodong; Chen, Jiekai; Liu, Jing; Pei, Duanqing			Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; chemical biology; hepatocyte; reprogramming; small molecule; MET; endoderm progenitor cells	PLURIPOTENT STEM-CELLS; DIRECT CONVERSION; SOMATIC-CELLS; FUNCTIONAL-NEURONS; GENERATION; INDUCTION; EXPRESSION; SOX17	We report here an approach to redirecting somatic cell fate under chemically defined conditions without transcription factors. We start by converting mouse embryonic fibroblasts to epithelial-like cells with chemicals and growth factors. Subsequent cell fate mapping reveals a robust induction of SOX17 in the resulting epithelial-like cells that can be further reprogrammed to endodermal progenitor cells. Interestingly, these cells can self-renew in vitro and further differentiate into albumin-producing hepatocytes that can rescue mice from acute liver injury. Our results demonstrate a rational approach to convert mouse embryonic fibroblasts to hepatocytes and suggest that this mechanism-driven approach may be generalized for other cells.	[Cao, Shangtao; Yu, Shengyong; Chen, Yan; Wang, Xiaoshan; Zhou, Chunhua; Liu, Yuting; Kuang, Junqi; Liu, He; Li, Dongwei; Ye, Jing; Qin, Yue; Chu, Shilong; Wu, Linlin; Guo, Lin; Li, Yinxiong; Shu, Xiaodong; Chen, Jiekai; Liu, Jing; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Beijing 100049, Peoples R China; [Cao, Shangtao; Yu, Shengyong; Chen, Yan; Wang, Xiaoshan; Zhou, Chunhua; Liu, Yuting; Kuang, Junqi; Liu, He; Li, Dongwei; Ye, Jing; Qin, Yue; Chu, Shilong; Wu, Linlin; Guo, Lin; Li, Yinxiong; Shu, Xiaodong; Chen, Jiekai; Liu, Jing; Pei, Duanqing] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Xiaoshan; Li, Dongwei; Chen, Jiekai; Pei, Duanqing] Chinese Acad Sci, Guangzhou Branch, Supercomp Ctr, Guangzhou 510530, Guangdong, Peoples R China; [Cao, Shangtao; Wang, Xiaoshan; Zhou, Chunhua; Kuang, Junqi; Liu, He; Li, Dongwei; Qin, Yue; Wu, Linlin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, J; Pei, DQ (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Beijing 100049, Peoples R China.; Liu, J; Pei, DQ (corresponding author), Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China.; Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Branch, Supercomp Ctr, Guangzhou 510530, Guangdong, Peoples R China.	liu_jing@gibh.ac.cn; pei_duanqing@gibh.ac.cn	Qin, Yue/GWV-0264-2022		Chinese Academy of Sciences [XDA01020307, XDA01020401]; National Key R&D Program of China [2017YFJC040188, 2016YFA0101800]; National Natural Science Foundation of China [31421004, 31530038, 31522033, 91419310]; National Basic Research Program of China [2014CB965200]; Science and Technology Planning Project of Guangdong Province [2015B020228003, 2014B020225002, 2014B030301058, 2014B05052012]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Planning Project of Guangdong Province	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA01020307 and XDA01020401; National Key R&D Program of China Grants 2017YFJC040188 and 2016YFA0101800; National Natural Science Foundation of China Grants 31421004, 31530038, 31522033, and 91419310; National Basic Research Program of China Grant 2014CB965200; and Science and Technology Planning Project of Guangdong Province Grants 2015B020228003, 2014B020225002, 2014B030301058, and 2014B05052012. The authors declare that they have no conflicts of interest with the contents of this article.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen JN, 2013, KNOWL-BASED SYST, V45, P1, DOI 10.1016/j.knosys.2013.01.031; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Engert S, 2013, DEVELOPMENT, V140, P3128, DOI 10.1242/dev.088765; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hawley RG, 2008, MOL THER, V16, P1354, DOI 10.1038/mt.2008.142; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Li FM, 2011, J CELL BIOCHEM, V112, P1022, DOI 10.1002/jcb.22962; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Long Y, 2015, CELL RES, V25, P1171, DOI 10.1038/cr.2015.96; McDonald ACH, 2014, CELL REP, V9, P780, DOI 10.1016/j.celrep.2014.09.026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nobuhisa I, 2014, MOL CELL BIOL, V34, P1976, DOI 10.1128/MCB.01485-13; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Sakano D, 2014, NAT CHEM BIOL, V10, P141, DOI 10.1038/nchembio.1410; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhao Y, 2015, CELL, V163, P1678, DOI 10.1016/j.cell.2015.11.017	45	16	17	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19122	19132		10.1074/jbc.M117.812537	http://dx.doi.org/10.1074/jbc.M117.812537			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28935668	hybrid, Green Published			2022-12-26	WOS:000415848000035
J	Yoon, JH; Choudhury, JR; Park, J; Prakash, S; Prakash, L				Yoon, Jung-Hoon; Choudhury, Jayati Roy; Park, Jeseong; Prakash, Satya; Prakash, Louise			Translesion synthesis DNA polymerases promote error-free replication through the minor-groove DNA adduct 3-deaza-3-methyladenine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; DNA enzyme; DNA polymerase; DNA repair; N3-methyladenine; translesion synthesis in human cells	HUMAN-CELLS; PROTEIN-TEMPLATE; THYMINE GLYCOL; BYPASS; IOTA; ZETA; YEAST; REV1; REPAIR; KAPPA	N3-Methyladenine (3-MeA) is formed in DNA by reaction with S-adenosylmethionine, the reactive methyl donor, and by reaction with alkylating agents. 3-MeA protrudes into the DNA minor groove and strongly blocks synthesis by replicative DNA polymerases (Pols). However, the mechanisms for replicating through this lesion in human cells remain unidentified. Here we analyzed the roles of translesion synthesis (TLS) Pols in the replication of 3-MeA-damaged DNA in human cells. Because 3-MeA has a short half-life in vitro, we used the stable 3-deaza analog, 3-deaza-3-methyladenine (3-dMeA), which blocks the DNA minor groove similarly to 3-MeA. We found that replication through the 3-dMeA adduct is mediated via three different pathways, dependent upon Pol/Pol, Pol, and Pol. As inferred from biochemical studies, in the Pol/Pol pathway, Pol inserts a nucleotide (nt) opposite 3-dMeA and Pol extends synthesis from the inserted nt. In the Pol pathway, Pol carries out both the insertion and extension steps of TLS opposite 3-dMeA, and in the Pol pathway, Pol extends synthesis following nt insertion by an as yet unidentified Pol. Steady-state kinetic analyses indicated that Pol and Pol insert the correct nt T opposite 3-dMeA with a much reduced catalytic efficiency and that both Pols exhibit a high propensity for inserting a wrong nt opposite this adduct. However, despite their low fidelity of synthesis opposite 3-dMeA, TLS opposite this lesion replicates DNA in a highly error-free manner in human cells. We discuss the implications of these observations for TLS mechanisms in human cells.	[Yoon, Jung-Hoon; Choudhury, Jayati Roy; Park, Jeseong; Prakash, Satya; Prakash, Louise] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	l.prakash@utmb.edu		Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	National Institutes of Health [ES021452, ES022948, ES020833]; National Institutes of Health NIEHS Center Grant [P30 ES06676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021452, P30ES006676, R01ES022948, R01ES020833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIEHS Center Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES021452, ES022948, and ES020833, and in part by National Institutes of Health NIEHS Center Grant P30 ES06676. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Conde J, 2015, J BIOL CHEM, V290, P29794, DOI 10.1074/jbc.M115.693010; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SINGER B, 1981, P NATL ACAD SCI-BIOL, V78, P856, DOI 10.1073/pnas.78.2.856; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Swan MK, 2009, J MOL BIOL, V390, P699, DOI 10.1016/j.jmb.2009.05.026; Yoon JH, 2015, GENE DEV, V29, P2588, DOI 10.1101/gad.272229.115; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	25	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18682	18688		10.1074/jbc.M117.808659	http://dx.doi.org/10.1074/jbc.M117.808659			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939775	Green Published, hybrid			2022-12-26	WOS:000414958100024
J	Ross-Degnan, D; Chalker, J; Liana, J; Kajoka, MD; Valimba, R; Kimatta, S; Dillip, A; Vialle-Valentin, C; Embrey, M; Lieber, R; Johnson, K				Ross-Degnan, Dennis; Chalker, John; Liana, Jafary; Kajoka, Mwikemo Deborah; Valimba, Richard; Kimatta, Suleiman; Dillip, Angel; Vialle-Valentin, Catherine; Embrey, Martha; Lieber, Rachel; Johnson, Keith			A group randomized trial using an appointment system to improve adherence to ART at reproductive and child health clinics implementing Option B plus in Tanzania	PLOS ONE			English	Article							TIME-SERIES ANALYSES; ANTIRETROVIRAL THERAPY; RETENTION; WOMEN; PROGRAM; CARE; CHALLENGES; DESIGN; COHORT	Introduction In October 2013, Tanzania adopted Option B+ under which HIV-positive pregnant women are initiated on antiretroviral therapy in reproductive and child health clinics at diagnosis. Studies have shown that adherence and retention to antiretroviral treatment can be problematic. Methods We implemented a group randomized controlled trial in 24 reproductive and child health clinics in eight districts in Mbeya region. The trial tested the impact of implementing paper-based appointment tracking and community outreach systems on the rate of missed appointments and number of days covered by dispensed antiretroviral medications among women previously established on antiretroviral therapy. We used interrupted time series analysis to assess study outcomes. Clinic staff and patients in intervention clinics were aware of the intervention because of change in clinic procedures; data collectors knew the study group assignment. Results Three months pre-intervention, we identified 1924 and 1226 patients established on antiretroviral therapy for six months or more in intervention and control clinics, respectively, of whom 83.4% and 86.9% had one or more post-intervention visits. The unadjusted rate of missed visits declined from 36.5% to 34.4% in intervention clinics and increased from 38.9% to 45.5% in control clinics following the intervention. Interrupted time series analyses demonstrated a net decrease of 13.7% (95% CI [-15.4,-12.1]) for missed visits at six months post-intervention. Similar differential changes were observed for visits missed by 3, 7, 15, or 60 days. Conclusion Appointment-tracking and community outreach significantly improved appointment-keeping for women on antiretroviral therapy. The facility staff controlled their workload better, identified missing patients rapidly, and worked with existing community organizations. There is now enough evidence to scale up this approach to all antiretroviral therapy and Option B+ reproductive and child health clinics in Tanzania as well as to evaluate the intervention in medical clinics that treat other chronic health conditions.	[Ross-Degnan, Dennis; Vialle-Valentin, Catherine] Harvard Med Sch, Boston, MA USA; [Ross-Degnan, Dennis; Vialle-Valentin, Catherine] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Chalker, John; Embrey, Martha; Lieber, Rachel; Johnson, Keith] Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Arlington, VA 22203 USA; [Liana, Jafary] Apotheker Consultancy Ltd, Dar Es Salaam, Tanzania; [Kajoka, Mwikemo Deborah] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Valimba, Richard; Kimatta, Suleiman] Management Sci Hlth, Dar Es Salaam, Tanzania; [Dillip, Angel] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Ifakara Health Institute	Chalker, J (corresponding author), Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Arlington, VA 22203 USA.	John.chalker@ymail.com			International Initiative for Impact Evaluation (3ie); Apotheker Consultancy (T) Limited	International Initiative for Impact Evaluation (3ie); Apotheker Consultancy (T) Limited	The study was funded by the International Initiative for Impact Evaluation (3ie). The funder provided support in the form of salaries for authors [DRD, JC, JL, RV, SK, AD, CW, ME, RL and KJ]. The funders commented on the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Author JL is employed by Apotheker Consultancy (T) Limited. Apotheker Consultancy (T) Limited provided support in the form of salary for author JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the Author Contributions section.	Atanga PN, 2017, TROP MED INT HEALTH, V22, P161, DOI 10.1111/tmi.12816; Boruett P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-242; Chalker JC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-43; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Fayorsey RN, 2016, JAIDS-J ACQ IMM DEF, V72, pS137, DOI 10.1097/QAI.0000000000001060; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Helova A, 2017, HEALTH POLICY PLANN, V32, P283, DOI 10.1093/heapol/czw122; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kruk ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160764; Linden A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-119; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Mitiku I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20662; Mwatawala S, 2012, INT J PERS CTR MED, V2, P825; Napua M, 2016, JAIDS-J ACQ IMM DEF, V72, pS181, DOI 10.1097/QAI.0000000000001061; Ross-Degnan D, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-42; StataCorp, 2015, STAT STAT SOFTW REL; Woelk GB, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20837; World Health Organization, 2010, NEW GUID PREV MOTH T; Zhang F, 2011, J CLIN EPIDEMIOL, V64, P1252, DOI 10.1016/j.jclinepi.2011.02.007; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184591	10.1371/journal.pone.0184591	http://dx.doi.org/10.1371/journal.pone.0184591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957381	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200015
J	Ahmad, J; Bashir, H; Bagheri, R; Baig, A; Al-Huqail, A; Ibrahim, MM; Qureshi, MI				Ahmad, Javed; Bashir, Humayra; Bagheri, Rita; Baig, Affan; Al-Huqail, Asma; Ibrahim, Mohamed M.; Qureshi, M. Irfan			Drought and salinity induced changes in ecophysiology and proteomic profile of Parthenium hysterophorus	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; RESPONSIVE PROTEINS; HYDROGEN-PEROXIDE; WATER-DEFICIT; ASCORBIC-ACID; STRESS; SALT; GLUTATHIONE; TOLERANCE; PLANT	Parthenium hysterophorus is a plant that tolerates drought and salinity to an extremely high degree. Higher expression of stress-responsive proteome contributes for greater defence against abiotic stresses. Thus, P. hysterophorus could be a rich source of genes that encode stress-imparting mechanisms and systems. The present study utilizes comparative physiological and proteomic approaches for identification of key proteins involved in stress-defence of P. hysterophorus. Thirty-days-old plants were exposed to drought (10% PEG 6000) and salinity (160 mM NaCl) for 10 days duration. Both stresses induced oxidative stress estimated in terms of TBARS and H2O2. Levels of both enzymatic and non-enzymatic antioxidants were elevated, more by drought than salinity. Particularly, SOD, GR, CAT and GST proved to be assisting as very commendable defence under drought, as well as salinity. Levels of ascorbate, glutathione and proline were also increased by both stresses, more in response to drought. Comparative proteomics analysis revealed a significant change in relative abundance of 72 proteins under drought and salinity. Drought and salinity increased abundance of 45 and 41 proteins and decreased abundance of 24 and 26 proteins, respectively. Drought and salinity increased and decreased abundance of 31 and 18 proteins, respectively. The functions of identified proteins included those related to defence response (26%), signal transduction (13%), transcription and translation (10%), growth and development (8.5%), photosynthesis (8.5%), metabolism (7%), terpenoid biosynthesis (5.5%), protein modification and transport (7%), oxido-reductase (4%) and Miscellaneous (11%). Among the defence related proteins, antioxidants and HSPs constituted 26% and 21%, respectively. Present study suggests a potential role of defence proteins. Proteins involved in molecular stabilization, formation of osmolytes and wax and contributing to stress-avoiding anatomical features emerged as key and complex mechanisms for imparting stress tolerance to P. hysterophorus.	[Ahmad, Javed; Bashir, Humayra; Bagheri, Rita; Baig, Affan; Qureshi, M. Irfan] Jamia Millie Islamia Cent Univ, Dept Biotechnol, New Delhi, India; [Al-Huqail, Asma] King Saud Univ, Dept Bot & Microbiol, Sci Coll, Riyadh, Saudi Arabia; [Ibrahim, Mohamed M.] Alexandria Univ, Dept Bot & Microbiol, Fac Sci, Alexandria, Egypt; [Ibrahim, Mohamed M.] Bergen Community Coll, Dept Biol & Hort, Paramus, NJ USA	Jamia Millia Islamia; King Saud University; Egyptian Knowledge Bank (EKB); Alexandria University	Qureshi, MI (corresponding author), Jamia Millie Islamia Cent Univ, Dept Biotechnol, New Delhi, India.	mirfanq@gmail.com	Qureshi, M Irfan/CAF-0824-2022	Qureshi, M Irfan/0000-0001-9625-0036; Baig, Affan/0000-0002-6203-2097	KSU Deanship Funding [RGP-231]; Deanship of scientific research at King Saud University [RGP-231]	KSU Deanship Funding; Deanship of scientific research at King Saud University(King Saud University)	This work was supported by KSU Deanship Funding to RGP-231.; The authors would like to extend their sincere appreciation to the Deanship of scientific research at King Saud University for its funding of research project to group no. RGP-231.	Acevedo RM, 2013, PLANT PHYSIOL BIOCH, V65, P48, DOI 10.1016/j.plaphy.2012.12.016; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al-Huqail AA, 2017, SCI HORTIC-AMSTERDAM, V217, P226, DOI 10.1016/j.scienta.2017.02.007; ANDERSON ME, 1985, ARCH BIOCHEM BIOPHYS, V239, P538, DOI 10.1016/0003-9861(85)90723-4; Arthur CA, 1910, B TORREY BOT CLUB, V37, P569; Bagheri R, 2016, PROTOPLASMA, P1; Bagheri R, 2015, PLANT PHYSIOL BIOCH, V97, P235, DOI 10.1016/j.plaphy.2015.10.012; Bajwa AA, 2017, ENV SCI POLLUT RES; Bajwa AA, 2016, PLANTA, V244, P39, DOI 10.1007/s00425-016-2510-x; Bashir H, 2013, ENVIRON EXP BOT, V94, P19, DOI 10.1016/j.envexpbot.2012.05.004; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhowmik P.C., 2007, ECOPRINT INT J ECOL, V14, P1, DOI [10.3126/eco.v14i0.4824, DOI 10.3126/ECO.V14I0.4824]; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carra S, 2017, CELL STRESS CHAPERON, V22, P601, DOI 10.1007/s12192-017-0787-8; Caverzan A, 2016, GENET MOL BIOL, V39, P1, DOI 10.1590/1678-4685-GMB-2015-0109; Chen ZJ, 2015, PLANT PHYSIOL, V167, P176, DOI 10.1104/pp.114.251017; Cuypers A, 2011, J PLANT PHYSIOL, V168, P309, DOI 10.1016/j.jplph.2010.07.010; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; Das A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6021047; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; EPPO, 2014, PEST RISK AN PARTH H; Eva C, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2118-6; Fasoli E, 2011, J PROTEOMICS, V74, P127, DOI 10.1016/j.jprot.2010.10.009; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Fu Y, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0471-8; Gao F, 2013, PLANT BIOTECHNOL J, V11, P921, DOI 10.1111/pbi.12083; Gazanchian A, 2007, J EXP BOT, V58, P291, DOI 10.1093/jxb/erl226; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hoagland DR, 1950, CIRC CALIF AGR EXPT, V347; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Humbert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039023; Javed Ahmad, 2016, African Journal of Biotechnology, V15, P1035; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Kaur M, 2014, INT SCH RES NOTICES; Kaur Manpreet, 2014, Int Sch Res Notices, V2014, P368647, DOI 10.1155/2014/368647; Kim YH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00510; Krasensky J, 2014, ANTIOXID REDOX SIGN, V21, P1289, DOI 10.1089/ars.2013.5693; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Lane TS, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0277-6; LAW MY, 1983, BIOCHEM J, V210, P899, DOI 10.1042/bj2100899; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Li MY, 2016, SCI REP, V6; Li XN, 2015, PLANT SOIL, V393, P307, DOI 10.1007/s11104-015-2499-0; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep38539; Liu N, 2014, NUCLEIC ACIDS RES, V42, P5556, DOI 10.1093/nar/gku220; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Ma HY, 2012, J PROTEOMICS, V75, P1529, DOI 10.1016/j.jprot.2011.11.026; Manna S, 2015, BIOCHIMIE, V113, P93, DOI 10.1016/j.biochi.2015.04.004; Mulekar JJ, 2014, J EXP BOT, V65, P2883, DOI 10.1093/jxb/ert401; Muneer S, 2013, AUST J CROP SCI, V7; Muneer S, 2012, PLANT GROWTH REGUL, V68, P421, DOI 10.1007/s10725-012-9731-1; Mustroph A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00125; Naik H. K., 2016, American Journal of Plant Sciences, V7, P980, DOI 10.4236/ajps.2016.76093; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Parveen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31218; Patel S, 2004, PLANT CELL, V16, P3260, DOI 10.1105/tpc.104.026740; Per TS, 2017, PLANT PHYSIOL BIOCH, V115, P126, DOI 10.1016/j.plaphy.2017.03.018; Qureshi MH, 2010, J PLANT PHYSIOL, V167, P761, DOI 10.1016/j.jplph.2010.01.017; Qureshi MI, 2007, BIOL PLANTARUM, V51, P121, DOI 10.1007/s10535-007-0024-x; Qureshi MI, 2005, ENVIRON EXP BOT, V53, P185, DOI 10.1016/j.envexpbot.2004.03.014; Reddy PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089125; Ren J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9851095; Salekdeh G. H., 2016, AGR PROTEOMICS; Salma I, ANN BOT, V115, P433; Sampaio BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29265; Schlesier Bernhard, 2006, V323, P381; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shinde VN, 2016, IJAR, V2, P730; Sibert BS, 2012, NUCLEIC ACIDS RES, V40, P2107, DOI 10.1093/nar/gkr1017; Stone SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00135; Sugihara K, 2000, PLANT CELL PHYSIOL, V41, P1279, DOI 10.1093/pcp/pcd061; Sun CX, 2016, AGR WATER MANAGE, V172, P62, DOI 10.1016/j.agwat.2016.04.016; Sun L, 2011, J EXP BOT, V62, P5659, DOI 10.1093/jxb/err252; Suzuki M, 2006, PLANT J, V45, P264, DOI 10.1111/j.1365-313X.2005.02620.x; Tada Y, 2009, PLANT CELL PHYSIOL, V50, P439, DOI 10.1093/pcp/pcp002; Tang D, 2011, NAT COMMUN, V50, P439; Nguyen T, 2017, ENVIRON SCI POLLUT R, V24, P10727, DOI 10.1007/s11356-017-8737-7; Toscano S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00645; Ullah A, 2017, PLANT BIOTECHNOL J, V15, P271, DOI 10.1111/pbi.12688; Upadhyay S.K., 2013, INT J SCIENTIFICAND, V3, P1; Vighi IL, BIOL PLANT; Viotti C, 2005, FEBS J, V272, P5864, DOI 10.1111/j.1742-4658.2005.04985.x; Watson BS, 2003, PLANT PHYSIOL, V131, P1104, DOI 10.1104/pp.102.019034; Wu B, 2017, PLOS ONE, V13; Xu ZR, 2016, ENERGIES, V9, DOI 10.3390/en9050372; Yu CW, 2003, FUNCT PLANT BIOL, V30, P955, DOI 10.1071/FP03091; Zhang HY, 2016, MOL GENET GENOMICS, V291, P1293, DOI 10.1007/s00438-016-1188-x; Zhao PJ, 2015, J EXP BOT, V66, P1477, DOI 10.1093/jxb/eru507	91	30	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185118	10.1371/journal.pone.0185118	http://dx.doi.org/10.1371/journal.pone.0185118			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953916	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300036
J	Thomas, LM; Jorgenson, ZG; Brigham, ME; Choy, SJ; Moore, JN; Banda, JA; Gefell, DJ; Minarik, TA; Schoenfuss, HL				Thomas, Linnea M.; Jorgenson, Zachary G.; Brigham, Mark E.; Choy, Steven J.; Moore, Jeremy N.; Banda, Jo A.; Gefell, Daniel J.; Minarik, Thomas A.; Schoenfuss, Heiko L.			Contaminants of emerging concern in tributaries to the Laurentian Great Lakes: II. Biological consequences of exposure	PLOS ONE			English	Article							WASTE-WATER TREATMENT; TREATMENT-PLANT EFFLUENTS; MEDAKA ORYZIAS-LATIPES; SEWAGE-TREATMENT PLANTS; ZEBRAFISH DANIO-RERIO; CARE PRODUCTS PPCPS; ORGANIC CONTAMINANTS; PIMEPHALES-PROMELAS; SURFACE WATERS; IN-VITRO	The Laurentian Great Lakes contain one fifth of the world's surface freshwater and have been impacted by human activity since the Industrial Revolution. In addition to legacy contaminants, nitrification and invasive species, this aquatic ecosystem is also the recipient of Contaminants of Emerging Concern (CECs) with poorly understood biological consequences. In the current study, we documented the presence, concentrations, and biological effects of CECs across 27 field sites in six Great Lakes tributaries by examining over 2250 resident and caged sunfish (Lepomis ssp.) for a variety of morphological and physiological endpoints and related these results to CEC occurrence. CEC were ubiquitous across studies sites and their presence and concentrations in water and sediment were highest in effluent dominated rivers and downstream of municipal wastewater treatment plant discharges. However, even putative upstream reference sites were not free of CEC presence and fish at these sites exhibited biological effects consistent with CEC exposure. Only the Fox River exhibited consistent adverse biological effects, including increased relative liver size, greater prominence of hepatocyte vacuoles and increased plasma glucose concentrations. Canonical Redundancy Analysis revealed consistent patterns of biological consequences of CEC exposure across all six tributaries. Increasing plasma glucose concentrations, likely as a result of pollutant-induced metabolic stress, were associated with increased relative liver size and greater prominence of hepatocyte vacuoles. These indicators of pollutant exposure were inversely correlated with indicators of reproductive potential including smaller gonad size and less mature gametes. The current study highlights the need for greater integration of chemical and biological studies and suggests that CECs in the Laurentian Great Lakes Basin may adversely affect the reproductive potential of exposed fish populations.	[Thomas, Linnea M.; Jorgenson, Zachary G.; Schoenfuss, Heiko L.] St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA; [Jorgenson, Zachary G.] US Fish & Wildlife Serv, St Cloud, MN USA; [Brigham, Mark E.] US Geol Survey, Mounds View, MN USA; [Choy, Steven J.] US Fish & Wildlife Serv, Madison, WI USA; [Moore, Jeremy N.] US Fish & Wildlife Serv, E Lansing, MI USA; [Banda, Jo A.] US Fish & Wildlife Serv, Columbus, OH USA; [Gefell, Daniel J.] US Fish & Wildlife Serv, Cortland, NY USA; [Minarik, Thomas A.] Metropolitan Water Reclamat Dist Greater Chicago, Cicero, IL USA	Minnesota State Colleges & Universities; Saint Cloud State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Schoenfuss, HL (corresponding author), St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA.	hschoenfuss@stcloudstate.edu		Brigham, Mark/0000-0001-7412-6800; Schoenfuss, Heiko/0000-0001-5464-992X	US Fish & Wildlife Service; Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team; National Science Foundation grant [CBET 1336062]	US Fish & Wildlife Service(US Fish & Wildlife Service); Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team; National Science Foundation grant(National Science Foundation (NSF))	HLS (St Cloud State University) and MEB (U.S. Geological Survey) received funding from the US Fish & Wildlife Service for this project. Funding was provided from the Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team. Additional support for field work in Chicago was provided to HLS by a National Science Foundation grant (CBET 1336062). In-kind support from the Metropolitan Water Reclamation District of Greater Chicago is acknowledged.	Adams SM, 2002, ECOL APPL, V12, P1510, DOI 10.1890/1051-0761(2002)012[1510:ARIASE]2.0.CO;2; AVISE JC, 1984, GENETICS, V108, P237; BAKER DB, 1985, J SOIL WATER CONSERV, V40, P125; Baldwin AK, 2016, SCI TOTAL ENVIRON, V554, P42, DOI 10.1016/j.scitotenv.2016.02.137; Barber LB, 2015, SCI TOTAL ENVIRON, V517, P195, DOI 10.1016/j.scitotenv.2015.02.035; Barber LB, 2011, SCI TOTAL ENVIRON, V409, P4720, DOI 10.1016/j.scitotenv.2011.06.039; Bartelt-Hunt SL, 2012, ENVIRON SCI TECHNOL, V46, P1352, DOI 10.1021/es202680q; Bartlett JA, 2010, J FISH BIOL, V77, P890, DOI 10.1111/j.1095-8649.2010.02724.x; Barucca M, 2006, ENVIRON RES, V101, P68, DOI 10.1016/j.envres.2005.07.002; Bendz D, 2005, J HAZARD MATER, V122, P195, DOI 10.1016/j.jhazmat.2005.03.012; Bevelhimer MS, 2014, ENVIRON TOXICOL CHEM, V33, P1903, DOI 10.1002/etc.2622; Biales AD, 2007, ENVIRON TOXICOL CHEM, V26, P2679, DOI 10.1897/07-101.1; Blazer VS, 2007, J AQUAT ANIM HEALTH, V19, P242, DOI 10.1577/H07-031.1; Bracewell P, 2004, J FISH BIOL, V64, P65, DOI 10.1111/j.1095-8649.2004.00281.x; Brian JV, 2005, ENVIRON HEALTH PERSP, V113, P721, DOI 10.1289/ehp.7598; Burkhardt MR, 2006, BOOK, V5; Burki R, 2006, ENVIRON TOXICOL CHEM, V25, P2077, DOI 10.1897/05-545R.1; Carrara C, 2008, ENVIRON SCI TECHNOL, V42, P2805, DOI 10.1021/es070344q; Carson FL, 1997, HISTOTECHNOLOGY; Cheek AO, 2004, COMP BIOCHEM PHYS C, V137, P249, DOI 10.1016/j.cca.2004.01.005; Cheng MC, 2016, ANIM REPROD SCI, V174, P114, DOI 10.1016/j.anireprosci.2016.09.014; Choy SJ, 2017, BTPR30172013; Crago J, 2011, CHEMOSPHERE, V82, P1669, DOI 10.1016/j.chemosphere.2010.11.011; Dammann AA, 2011, AQUAT TOXICOL, V105, P559, DOI 10.1016/j.aquatox.2011.08.011; Davies R, 2012, PHYSIOL BIOCHEM ZOOL, V85, P321, DOI 10.1086/666058; Deblonde T, 2011, INT J HYG ENVIR HEAL, V214, P442, DOI 10.1016/j.ijheh.2011.08.002; Dougherty JA, OCCURRENCE HERBICIDE; Elliott SM, 2016, CHEM EMERGING WATER; Elliott SM, 2015, CHEM EMERGING WATER; Ellis JB, 2006, ENVIRON POLLUT, V144, P184, DOI 10.1016/j.envpol.2005.12.018; Fanta E, 2003, ECOTOX ENVIRON SAFE, V54, P119, DOI 10.1016/S0147-6513(02)00044-1; Ferrey M., 2017, PHARM CHEM RIVERS OC; Ferrey ML, 2015, ENVIRON TOXICOL CHEM, V34, P2475, DOI 10.1002/etc.3125; Fick J, 2010, ENVIRON SCI TECHNOL, V44, P2661, DOI 10.1021/es903440m; Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003; Fischer J.M., 2015, US GEOLOGICAL SURVEY, V905, P42, DOI DOI 10.3133/DS905; Foreman WT, 2015, BOOK, V5; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Fulton TW, 1904, ANN REPORT, V22, P141; Furlong E.T., 2014, BOOK, V5, DOI DOI 10.3133/TM5B10; Gabe M, 1976, HISTOLOGICAL TECHNIQ; Gerrity D, 2011, WATER RES, V45, P5399, DOI 10.1016/j.watres.2011.07.020; Giebultowicz J, 2014, ECOTOX ENVIRON SAFE, V104, P103, DOI 10.1016/j.ecoenv.2014.02.020; Gravel A, 2007, AQUAT TOXICOL, V85, P87, DOI 10.1016/j.aquatox.2007.07.001; Gros M, 2007, ENVIRON TOXICOL CHEM, V26, P1553, DOI 10.1897/06-495R.1; Gutendorf B, 2001, TOXICOLOGY, V166, P79, DOI 10.1016/S0300-483X(01)00437-1; Han S, 2010, AQUAT TOXICOL, V98, P256, DOI 10.1016/j.aquatox.2010.02.013; Hanson N, 2011, ENVIRON TOXICOL, V26, P315, DOI 10.1002/tox.20559; Harris PM, 2005, COPEIA, P340, DOI 10.1643/CG-04-035R1; Hassanin A, 2002, J VET MED SCI, V64, P921, DOI 10.1292/jvms.64.921; Hemming JM, 2004, ECOTOX ENVIRON SAFE, V57, P303, DOI 10.1016/S0147-6513(03)00025-3; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Huggett DB, 2002, ARCH ENVIRON CON TOX, V43, P229, DOI 10.1007/s00244-002-1182-7; ICES-Institute Franc E ais de Recherche pour l'Exploitation de la Mer, 2004, ICES TECHN MAR ENV S, V38; Jaynes DB, 1999, J ENVIRON QUAL, V28, P45, DOI 10.2134/jeq1999.00472425002800010005x; Joss A, 2004, ENVIRON SCI TECHNOL, V38, P3047, DOI 10.1021/es0351488; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Klaper R., 2011, EMERGING CONTAMINANT; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; LAGLER KARL F., 1957, COPEIA, V1957, P290, DOI 10.2307/1439156; Lee KE, 2012, US GEOLOGICAL SURVEY; Legendre P, 1988, NUMERICAL ECOLOGY, P2; Lei BL, 2013, CHEMOSPHERE, V93, P1104, DOI 10.1016/j.chemosphere.2013.06.025; Leonard JA, 2017, COMP BIOCHEM PHYS C, V191, P14, DOI 10.1016/j.cbpc.2016.09.002; Lin AYC, 2008, CHEMOSPHERE, V74, P131, DOI 10.1016/j.chemosphere.2008.08.027; Lozano N, 2012, SCI TOTAL ENVIRON, V420, P191, DOI 10.1016/j.scitotenv.2011.12.059; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; Macnab V, 2016, AQUAT TOXICOL, V174, P92, DOI 10.1016/j.aquatox.2016.02.010; Martinovic D, 2008, ENVIRON SCI TECHNOL, V42, P3421, DOI 10.1021/es0708013; Martinovic-Weigelt D, 2013, ENVIRON INT, V61, P127, DOI 10.1016/j.envint.2013.07.018; MCMASTER ME, 1991, AQUAT TOXICOL, V21, P199, DOI 10.1016/0166-445X(91)90073-I; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020&lt;0297:EPOCDI&gt;2.0.CO;2, 10.1002/etc.5620200210]; Miller MC, 2001, TOXICOL LETT, V120, P269, DOI 10.1016/S0378-4274(01)00279-X; Minarik TA, 2014, J AM WATER RESOUR AS, V50, P358, DOI 10.1111/jawr.12167; Nakari T, 2004, ENVIRON TOXICOL, V19, P207, DOI 10.1002/tox.20013; Narra MR, 2016, CHEMOSPHERE, V144, P966, DOI 10.1016/j.chemosphere.2015.09.065; Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209; Nassef M, 2010, CHEMOSPHERE, V80, P1095, DOI 10.1016/j.chemosphere.2010.04.073; Newton S, 2014, ENVIRON SCI-PROC IMP, V16, P298, DOI 10.1039/c3em00590a; Oksanen J, 2016, VEGAN INTRO ORDINATI; Olsen KH, 2014, AQUAT TOXICOL, V148, P113, DOI 10.1016/j.aquatox.2013.12.032; Organization for Economic Co-operation and Development (OECD), 2013, PHARM CONS HLTH GLAN; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Palermo FA, 2008, ARCH ENVIRON CON TOX, V55, P295, DOI 10.1007/s00244-007-9113-2; Parks LG, 1999, COMP BIOCHEM PHYS C, V123, P113, DOI 10.1016/S0742-8413(99)00010-9; Paukert CP, 2004, N AM J FISH MANAGE, V24, P154, DOI 10.1577/M03-004; Phillips PJ, 2010, ENVIRON SCI TECHNOL, V44, P4910, DOI 10.1021/es100356f; Reid NM, 2016, SCIENCE, V354, P1305, DOI 10.1126/science.aah4993; Richardson BJ, 2005, MAR POLLUT BULL, V50, P913, DOI 10.1016/j.marpolbul.2005.06.034; Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Schultz MM, 2013, ENVIRON INT, V61, P138, DOI 10.1016/j.envint.2013.08.006; Schultz MM, 2010, ENVIRON SCI TECHNOL, V44, P1918, DOI 10.1021/es9022706; Shala L, 2010, ARCH ENVIRON CON TOX, V58, P551, DOI 10.1007/s00244-009-9463-z; Shappell NW, 2010, AQUAT TOXICOL, V100, P1, DOI 10.1016/j.aquatox.2010.07.005; Smolders R, 2003, ENVIRON TOXICOL CHEM, V22, P890, DOI [10.1897/1551-5028(2003)022&lt;0890:CICEBA&gt;2.0.CO;2, 10.1002/etc.5620220429]; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Soto AM, 2004, ENVIRON HEALTH PERSP, V112, P346, DOI 10.1289/ehp.6590; Stehr CM, 1998, DIS AQUAT ORGAN, V32, P119, DOI 10.3354/dao032119; Swackhamer DL, 2005, J ENVIRON MONITOR, V7, P540, DOI 10.1039/b506709j; Teles M, 2004, CHEMOSPHERE, V57, P147, DOI 10.1016/j.chemosphere.2004.02.023; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; THURMAN EM, 1991, ENVIRON SCI TECHNOL, V25, P1794, DOI 10.1021/es00022a018; USGS (U.S. Geological Survey), 1999, 1225 USGS, P1; Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661; Vajda AM, 2015, ENVIRON TOXICOL CHEM, V34, P1078, DOI 10.1002/etc.2895; Van den Belt K, 2004, AQUAT TOXICOL, V66, P183, DOI 10.1016/j.aquatox.2003.09.004; Walker SL, 2005, WATER QUAL RES J CAN, V40, P251, DOI 10.2166/wqrj.2005.031; WAUCHOPE RD, 1978, J ENVIRON QUAL, V7, P459, DOI 10.2134/jeq1978.00472425000700040001x; Weinberger J, 2014, AQUAT TOXICOL, V151, P77, DOI 10.1016/j.aquatox.2013.10.012; Writer JH, 2013, SCI TOTAL ENVIRON, V461, P519, DOI 10.1016/j.scitotenv.2013.04.099; Writer JH, 2010, SCI TOTAL ENVIRON, V409, P100, DOI 10.1016/j.scitotenv.2010.07.018; Yamauchi R, 2008, AQUAT TOXICOL, V90, P261, DOI 10.1016/j.aquatox.2008.09.007; Zaugg SD, 2006, BOOK, V5	116	17	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184725	10.1371/journal.pone.0184725	http://dx.doi.org/10.1371/journal.pone.0184725			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953953	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300021
J	Hakkila, M; Le Tortorec, E; Brotons, L; Rajasarkka, A; Tornberg, R; Monkkonen, M				Hakkila, Matti; Le Tortorec, Eric; Brotons, Lluis; Rajasarkka, Ari; Tornberg, Risto; Monkkonen, Mikko			Degradation in landscape matrix has diverse impacts on diversity in protected areas	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; PHYLOGENETIC DIVERSITY; FRAGMENTED LANDSCAPES; SPECIES RICHNESS; NORTHERN FINLAND; CLIMATE-CHANGE; BIODIVERSITY; HABITAT; BIRDS; COMMUNITIES	Introduction A main goal of protected areas is to maintain species diversity and the integrity of biological assemblages. Intensifying land use in the matrix surrounding protected areas creates a challenge for biodiversity conservation. Earlier studies have mainly focused on taxonomic diversity within protected areas. However, functional and especially phylogenetic diversities are less studied phenomena, especially with respect to the impacts of the matrix that surrounds protected areas. Phylogenetic diversity refers to the range of evolutionary lineages, the maintenance of which ensures that future evolutionary potential is safeguarded. Functional diversity refers to the range of ecological roles that members of a community perform. For ecosystem functioning and long-term resilience, they are at least as important as taxonomic diversity. Aim We studied how the characteristics of protected areas and land use intensity in the surrounding matrix affect the diversity of bird communities in protected boreal forests. We used line-transect count and land-cover data from 91 forest reserves in Northern Finland, and land-cover data from buffer zones surrounding these reserves. We studied if habitat diversity and productivity inside protected areas, and intensity of forest management in the matrix have consistent effects on taxonomic, functional and phylogenetic diversities, and community specialization. Results We found that habitat diversity and productivity inside protected areas have strong effects on all diversity metrics, but matrix effects were inconsistent. The proportion of old forest in the matrix, reflecting low intensity forest management, had positive effects on community specialization. Interestingly, functional diversity increased with increasing logging intensity in the matrix. Conclusions Our results indicate that boreal forest reserves are not able to maintain their species composition and abundances if embedded in a severely degraded matrix. Our study also highlights the importance of focusing on different aspects of biodiversity.	[Hakkila, Matti; Le Tortorec, Eric; Monkkonen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Brotons, Lluis] InForest JRU, Ctr Tecnol Forestal Catalunya, Ctr Mediterranean Forest Res, Solsona, Spain; [Rajasarkka, Ari] Metsahallitus Pk & Wildlife Finland, Oulu, Finland; [Tornberg, Risto] Univ Oulu, Oulu, Finland	University of Jyvaskyla; Centre Tecnologic Forestal de Catalunya (CTFC); University of Oulu	Hakkila, M (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	matti.i.hakkila@jyu.fi	Brotons, Lluís/D-1570-2009; Le Tortorec, Eric/K-3190-2014	Brotons, Lluís/0000-0002-4826-4457; Le Tortorec, Eric/0000-0003-4051-8691; Monkkonen, Mikko/0000-0001-8897-3314; Hakkila, Matti/0000-0003-0583-332X				Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Brotons L, 2003, LANDSCAPE ECOL, V18, P377, DOI 10.1023/A:1026148825138; Burnham K.P, 2002, PRACTICAL INFORM THE; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Cottee-Jones HEW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123952; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Honkanen M, 2010, GLOBAL ECOL BIOGEOGR, V19, P61, DOI 10.1111/j.1466-8238.2009.00491.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; JARVINEN O, 1976, Ornis Fennica, V53, P115; Jarvinen O., 1981, Studies in Avian Biology, P146; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Laaksonen T, 2013, BIOL CONSERV, V168, P99, DOI 10.1016/j.biocon.2013.09.007; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; LEDERER RJ, 1975, AUK, V92, P385, DOI 10.2307/4084573; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MILES DB, 1984, ECOLOGY, V65, P1629, DOI 10.2307/1939141; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Monkkonen L, 1997, ECOGRAPHY, V20, P634, DOI 10.1111/j.1600-0587.1997.tb00432.x; Monkkonen M, 2014, BIODIVERS CONSERV, V23, P3287, DOI 10.1007/s10531-014-0780-9; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Peltola A., 2014, FINNISH STAT YB FORE, V2014; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tomppo E., 1993, FINNISH FOREST RES I, V444, P53; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Vaisanen R., 1998, MUUTTUVA PESIMALINNU; Watling JI, 2011, GLOBAL ECOL BIOGEOGR, V20, P209, DOI 10.1111/j.1466-8238.2010.00586.x	53	19	19	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184792	10.1371/journal.pone.0184792	http://dx.doi.org/10.1371/journal.pone.0184792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950017	gold, Green Published, Green Submitted			2022-12-26	WOS:000411671000016
J	Raoufi-Rad, N; McRobb, LS; Lee, VS; Bervini, D; Grace, M; Ukath, J; Mchattan, J; Sreenivasan, VKA; Duong, H; Zhao, ZJ; Stoodley, MA				Raoufi-Rad, Newsha; McRobb, Lucinda S.; Lee, Vivienne S.; Bervini, David; Grace, Michael; Ukath, Jaysree; Mchattan, Joshua; Sreenivasan, Varun K. A.; Duong, Hong; Zhao, Zhenjun; Stoodley, Marcus A.			In vivo imaging of endothelial cell adhesion molecule expression after radiosurgery in an animal model of arteriovenous malformation	PLOS ONE			English	Article							IONIZING-RADIATION; ICAM-1 EXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; TISSUE FACTOR; BRAIN; IRRADIATION; NANOCARRIERS; THROMBOSIS; AGENTS	Focussed radiosurgery may provide a means of inducing molecular changes on the luminal surface of diseased endothelium to allow targeted delivery of novel therapeutic compounds. We investigated the potential of ionizing radiation to induce surface expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on endothelial cells (EC) in vitro and in vivo, to assess their suitability as vascular targets in irradiated arteriovenous malformations (AVMs). Cultured brain microvascular EC were irradiated by linear accelerator at single doses of 0, 5, 15 or 25 Gy and expression of ICAM-1 and VCAM-1 measured by qRT-PCR, Western, ELISA and immunocytochemistry. In vivo, near-infrared (NIR) fluorescence optical imaging using Xenolight 750-conjugated ICAM-1 or VCAM-1 antibodies examined luminal biodistribution over 84 days in a rat AVM model after Gamma Knife surgery at a single 15 Gy dose. ICAM-1 and VCAM-1 were minimally expressed on untreated EC in vitro. Doses of 15 and 25 Gy stimulated expression equally; 5 Gy was not different from the unirradiated. In vivo, normal vessels did not bind or retain the fluorescent probes, however binding was significant in AVM vessels. No additive increases in probe binding were found in response to radiosurgery at a dose of 15 Gy. In summary, radiation induces adhesion molecule expression in vitro but elevated baseline levels in AVM vessels precludes further induction in vivo. These molecules may be suitable targets in irradiated vessels without hemodynamic derangement, but not AVMs. These findings demonstrate the importance of using flow-modulated, pre-clinical animal models for validating candidate proteins for vascular targeting in irradiated AVMs.	[Raoufi-Rad, Newsha; McRobb, Lucinda S.; Lee, Vivienne S.; Bervini, David; Sreenivasan, Varun K. A.; Duong, Hong; Zhao, Zhenjun; Stoodley, Marcus A.] Macquarie Univ, Fac Med & Hlth Sci, Dept Clin Med, Sydney, NSW, Australia; [Bervini, David] Univ Bern, Neurosurg Dept, Inselspital, Bern, Switzerland; [Grace, Michael; Ukath, Jaysree] Macquarie Univ Hosp, Genesis Canc Care, Sydney, NSW, Australia; [Mchattan, Joshua] Carestream Mol Imaging, Sydney, NSW, Australia; [Sreenivasan, Varun K. A.] Macquarie Univ, Dept Phys & Astron, Sydney, NSW, Australia	Macquarie University; University of Bern; Macquarie University; Macquarie University	Stoodley, MA (corresponding author), Macquarie Univ, Fac Med & Hlth Sci, Dept Clin Med, Sydney, NSW, Australia.	marcus.stoodley@mq.edu.au		Stoodley, Marcus/0000-0002-4207-8493; Bervini, David/0000-0003-4873-4452; Zhao, Zhenjun/0000-0002-8370-1659; Sreenivasan, Varun/0000-0002-8667-8394; McRobb, Lucinda/0000-0001-5492-1903	National Health and Medical Research Foundation of Australia [APP1047302]; National Heart Foundation of Australia [G10S5202]; Brain Foundation (Australia); John Mitchell Crouch Fellowship (Australia); Macquarie University Research Fellowship (Australia)	National Health and Medical Research Foundation of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Brain Foundation (Australia); John Mitchell Crouch Fellowship (Australia); Macquarie University Research Fellowship (Australia)	This work was supported by the National Health and Medical Research Foundation of Australia (APP1047302) (to MAS), the National Heart Foundation of Australia (#G10S5202) (to MAS), and the Brain Foundation (Australia) (to TTHD, MAS). MAS was supported by a John Mitchell Crouch Fellowship (Australia). VKAS was supported by a Macquarie University Research Fellowship (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang SD, 1997, CLIN NEUROPATHOL, V16, P111; Chang TC, 2004, INT J RADIAT ONCOL, V60, P861, DOI 10.1016/j.ijrobp.2004.04.041; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Epperly MW, 2002, BIOL BLOOD MARROW TR, V8, P175, DOI 10.1053/bbmt.2002.v8.pm12014807; Gaugler MH, 1997, INT J RADIAT BIOL, V72, P201, DOI 10.1080/095530097143428; Gaugler MH, 1998, BRIT J HAEMATOL, V103, P980, DOI 10.1046/j.1365-2141.1998.01119.x; Hallahan DE, 1997, CANCER RES, V57, P2096; Hashimoto T, 2005, NEUROSURGERY, V56, P1058; Haubner F, 2013, CLIN HEMORHEOL MICRO, V54, P371, DOI 10.3233/CH-2012-1626; Heckmann M, 1998, EXP CELL RES, V238, P148, DOI 10.1006/excr.1997.3826; Howard M, 2014, ACS NANO, V8, P4100, DOI 10.1021/nn500136z; Howard MD, 2014, ANNU REV PHARMACOL, V54, P205, DOI 10.1146/annurev-pharmtox-011613-140002; Jabbour MN, 2009, NEUROSURGERY, V64, P139, DOI 10.1227/01.NEU.0000334417.56742.24; Jones Jesse, 2007, Neurosurg Focus, V23, pE7; Kashba SR, 2015, J NEUROSURG, V123, P954, DOI 10.3171/2014.10.JNS1435; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATSUMURA T, 1979, J GERONTOL, V34, P328, DOI 10.1093/geronj/34.3.328; McRobb LS, 2017, AGING-US, V9, P1248, DOI 10.18632/aging.101225; Moftakhar P, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS09317; Molla M, 2003, INT J RADIAT ONCOL, V57, P264, DOI 10.1016/S0360-3016(03)00523-6; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; ONDRA SL, 1990, J NEUROSURG, V73, P387, DOI 10.3171/jns.1990.73.3.0387; Ran S, 1998, CANCER RES, V58, P4646; Reddy R, 2014, J NEUROSURG, V120, P113, DOI 10.3171/2013.9.JNS122056; Sharp CD, 2003, NEUROSURGERY, V53, P154, DOI 10.1227/01.NEU.0000068840.84484.DA; Shenkar R, 2003, NEUROSURGERY, V52, P465, DOI 10.1227/01.NEU.0000044131.03495.22; Storer K, 2007, NEUROSURGERY, V61, P604, DOI 10.1227/01.NEU.0000290909.32600.A8; Storer KP, 2010, NEUROSURGERY, V67, P976, DOI 10.1227/NEU.0b013e3181ee36bc; Storer KR, 2008, J CLIN NEUROSCI, V15, P179, DOI 10.1016/j.jocn.2006.10.013; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Van der Meeren A, 1999, CYTOKINE, V11, P831, DOI 10.1006/cyto.1999.0497; Wang Huan-Chih, 2012, Surg Neurol Int, V3, pS105, DOI 10.4103/2152-7806.95421; Weiser S, 2007, CYTOKINE, V37, P84, DOI 10.1016/j.cyto.2007.02.021; Yassari R, 2004, ACTA NEUROCHIR, V146, P495, DOI 10.1007/s00701-004-0248-x; Zhao ZJ, 2016, J NEUROSURG, V124, P1780, DOI 10.3171/2015.4.JNS142129	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185393	10.1371/journal.pone.0185393	http://dx.doi.org/10.1371/journal.pone.0185393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949989	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000046
J	Zondler, L; Kostka, M; Garidel, P; Heinzelmann, U; Hengerer, B; Mayer, B; Weishaupt, JH; Gillardon, F; Danzer, KM				Zondler, Lisa; Kostka, Marcus; Garidel, Patrick; Heinzelmann, Udo; Hengerer, Bastian; Mayer, Benjamin; Weishaupt, Jochen H.; Gillardon, Frank; Danzer, Karin M.			Proteasome impairment by alpha-synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; PROTEIN; OLIGOMERS; SYSTEM; INCLUSIONS; EXPRESSION; MEMBRANE	Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide and characterized by the loss of dopaminergic neurons in the patients' midbrains. Both the presence of the protein alpha-synuclein in intracellular protein aggregates in surviving neurons and the genetic linking of the alpha-synuclein encoding gene point towards a major role of alpha-synuclein in PD etiology. The exact pathogenic mechanisms of PD development are not entirely described to date, neither is the specific role of alpha-synuclein in this context. Previous studies indicate that one aspect of alpha-synuclein-related cellular toxicity might be direct proteasome impairment. The 20/26S proteasomal machinery is an important instrument of intracellular protein degradation. Thus, direct proteasome impairment by alpha-synuclein might explain or at least contribute to the formation of intracellular protein aggregates. Therefore this study investigates direct proteasomal impairment by alpha-synuclein both in vitro using recombinant alpha-synuclein and isolated proteasomes as well as in living cells. Our experiments demonstrate that the impairment of proteasome activity by alpha-synuclein is highly dependent upon the cellular background and origin. We show that recombinant alpha-synuclein oligomers and fibrils scarcely affect 20S proteasome function in vitro, neither does transient alpha-synuclein expression in U2OS ps 2042 (Ubi(G76V)-GFP) cells. However, stable expression of both wild-type and mutant alpha-synuclein in dopaminergic SH-SY5Y and PC12 cells results in a prominent impairment of the chymotrypsin-like 20S/26S proteasomal protein cleavage. Thus, our results support the idea that alpha-synuclein in a specific cellular environment, potentially present in dopaminergic cells, cannot be processed by the proteasome and thus contributes to a selective vulnerability of dopaminergic cells to alpha-synuclein pathology.	[Zondler, Lisa; Weishaupt, Jochen H.; Danzer, Karin M.] Ulm Univ, Dept Neurol, Ulm, Germany; [Kostka, Marcus; Garidel, Patrick; Heinzelmann, Udo; Hengerer, Bastian; Gillardon, Frank] Boehringer Ingelheim Pharma GmbH Co KG, Biberach, Germany; [Mayer, Benjamin] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany	Ulm University; Boehringer Ingelheim; Ulm University	Danzer, KM (corresponding author), Ulm Univ, Dept Neurol, Ulm, Germany.	karin.danzer@uni-ulm.de		Zondler, Lisa/0000-0001-6760-4499				Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bedford L, 2008, BBA-MOL BASIS DIS, V1782, P683, DOI 10.1016/j.bbadis.2008.10.009; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deger JM, 2015, AGING CELL, V14, P715, DOI 10.1111/acel.12359; Dong J, 2011, J COLLOID INTERF SCI, V362, P33, DOI 10.1016/j.jcis.2011.04.050; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Feng LR, 2010, EUR J NEUROSCI, V32, P10, DOI 10.1111/j.1460-9568.2010.07266.x; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Haasen D, 2006, METHOD ENZYMOL, V414, P121, DOI 10.1016/S0076-6879(06)14008-2; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Lee SS, 2003, NEUROBIOL AGING, V24, P687, DOI 10.1016/S0197-4580(02)00196-3; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mezey E, 1998, MOL PSYCHIATR, V3, P493, DOI 10.1038/sj.mp.4000446; MOOS P, 2004, J BIOL CHEM, V279, P12924; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paleologou Katerina E, 2012, Subcell Biochem, V65, P109, DOI 10.1007/978-94-007-5416-4_6; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stckl MT, 2013, MOL NEUROBIOL, V47, P613, DOI 10.1007/s12035-012-8331-4; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Wales P, 2013, J PARKINSON DIS, V3, P415, DOI 10.3233/JPD-130216	38	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184040	10.1371/journal.pone.0184040	http://dx.doi.org/10.1371/journal.pone.0184040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945746	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100005
J	Khan, WS; Hamadneh, NN; Khan, WA				Khan, Waseem S.; Hamadneh, Nawaf N.; Khan, Waqar A.			Prediction of thermal conductivity of polyvinylpyrrolidone (PVP) electrospun nanocomposite fibers using artificial neural network and prey-predator algorithm	PLOS ONE			English	Article							OPTIMIZATION; ERROR; DYES	In this study, multilayer perception neural network (MLPNN) was employed to predict thermal conductivity of PVP electrospun nanocomposite fibers with multiwalled carbon nanotubes (MWCNTs) and Nickel Zinc ferrites [(Ni0.6Zn0.4) Fe2O4]. This is the second attempt on the application of MLPNN with prey predator algorithm for the prediction of thermal conductivity of PVP electrospun nanocomposite fibers. The prey predator algorithm was used to train the neural networks to find the best models. The best models have the minimal of sum squared error between the experimental testing data and the corresponding models results. The minimal error was found to be 0.0028 for MWCNTs model and 0.00199 for Ni-Zn ferrites model. The predicted artificial neural networks (ANNs) responses were analyzed statistically using z-test, correlation coefficient, and the error functions for both inclusions. The predicted ANN responses for PVP electrospun nanocomposite fibers were compared with the experimental data and were found in good agreement.	[Khan, Waseem S.; Khan, Waqar A.] Majmaah Univ, Coll Engn, Dept Mech & Ind Engn, Majmaah, Saudi Arabia; [Hamadneh, Nawaf N.] Saudi Elect Univ, Coll Sci & Theoret Studies, Dept Basic Sci, Riyadh, Saudi Arabia	Majmaah University; Saudi Electronic University	Khan, WA (corresponding author), Majmaah Univ, Coll Engn, Dept Mech & Ind Engn, Majmaah, Saudi Arabia.	wkhan1956@gmail.com	HAMADNEH, NAWAF N./Y-7759-2019; Khan, Waqar/H-3886-2013; Hamadneh, Nawaf N./AAW-7128-2021	HAMADNEH, NAWAF N./0000-0002-2170-2074; Khan, Waqar/0000-0002-8328-850X; Hamadneh, Nawaf N./0000-0002-2170-2074				AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212; Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; Caizer C, 2001, J OPTOELECTRON ADV M, V3, P919; Chan LS, 2012, CHINESE J CHEM ENG, V20, P535, DOI 10.1016/S1004-9541(11)60216-4; Dev VRG, 2009, J APPL POLYM SCI, V113, P3397, DOI 10.1002/app.30059; Donadio D, 2016, LECT NOTES PHYS, V921, P275, DOI 10.1007/978-3-319-29261-8_7; Flaifel MH, 2013, COMPOS PART B-ENG, V52, P334, DOI 10.1016/j.compositesb.2013.04.021; Gojny FH, 2006, POLYMER, V47, P2036, DOI 10.1016/j.polymer.2006.01.029; Hamadneh Nawaf, 2012, Journal of Applied Sciences, V12, P840, DOI 10.3923/jas.2012.840.847; Hamadneh N, 2013, RES J APPL SCI, V8, P383; HANSEN D, 1965, J POLYM SCI PART A, V3, P659, DOI 10.1002/pol.1965.100030222; Harris PJ, 2004, CARBON NANOTUBES REL; Kapoor A., 1989, GAS SEP PURIF, V3, P187, DOI DOI 10.1016/0950-4214(89)80004-0; Karimzadeh F, 2006, MAT SCI ENG A-STRUCT, V432, P184, DOI 10.1016/j.msea.2006.05.141; Khan W., 2016, POLYM NANOCOMPOSITES; Khan W, 2012, NI J NANOTECHNOLOGY, V2012; Khan WS, 2013, INT J THERM SCI, V71, P74, DOI 10.1016/j.ijthermalsci.2013.03.006; Khan W. S., 2010, Journal of Nanotechnology in Engineering and Medicine, V1, DOI 10.1115/1.4002533; Khanlou HM, 2014, NEURAL COMPUT APPL, V25, P767, DOI 10.1007/s00521-014-1554-8; Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p; Norkhairunnisa M, 2012, J COMPOS MATER, V46, P903, DOI 10.1177/0021998311412985; O'Connell MJ, 2006, CARBON NANOTUBES PRO; Porter JF, 1999, CHEM ENG SCI, V54, P5863, DOI 10.1016/S0009-2509(99)00178-5; Slade P. E., 1970, THERMAL CHARACTERIZA; Tilahun SL, 2017, ADV HOSP TOUR SERV, P400, DOI 10.4018/978-1-5225-1054-3.ch019; Tilahun SL, 2015, INT J INF TECH DECIS, V14, P1331, DOI 10.1142/S021962201450031X; Triola MF, 2014, ELEMENTARY STAT USIN; Yadoji P, 2003, MAT SCI ENG B-SOLID, V98, P269, DOI 10.1016/S0921-5107(03)00063-1; Yeung DS, 2016, IEEE T NEUR NET LEAR, V27, P978, DOI 10.1109/TNNLS.2015.2431251; Zhang D, 2009, POLYMER, V50, P4189, DOI 10.1016/j.polymer.2009.06.062	30	17	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183920	10.1371/journal.pone.0183920	http://dx.doi.org/10.1371/journal.pone.0183920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934220	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900014
J	Pietz, G; De, R; Hedberg, M; Sjoberg, V; Sandstrom, O; Hernell, O; Hammarstrom, S; Hammarstrom, ML				Pietz, Grzegorz; De, Rituparna; Hedberg, Maria; Sjoberg, Veronika; Sandstrom, Olof; Hernell, Olle; Hammarstrom, Sten; Hammarstrom, Marie-Louise			Immunopathology of childhood celiac disease-Key role of intestinal epithelial cells	PLOS ONE			English	Article							T-CELLS; GENE-EXPRESSION; INNATE IMMUNITY; SP NOV.; GLIADIN; IDENTIFICATION; MUCOSA; INTERLEUKIN-18; INFLAMMASOME; LYMPHOCYTES	Background & Aims Celiac disease is a chronic inflammatory disease of the small intestine mucosa due to permanent intolerance to dietary gluten. The aim was to elucidate the role of small intestinal epithelial cells in the immunopathology of celiac disease in particular the influence of celiac disease-associated bacteria. Methods Duodenal biopsies were collected from children with active celiac disease, treated celiac disease, and clinical controls. Intestinal epithelial cells were purified and analyzed for gene expression changes at the mRNA and protein levels. Two in vitro models for human intestinal epithelium, small intestinal enteroids and polarized tight monolayers, were utilized to assess how interferon-gamma, interleukin- 17A, celiac disease-associated bacteria and gluten influence intestinal epithelial cells. Results More than 25 defense-related genes, including IRF1, SPINK4, ITLN1, OAS2, CIITA, HLA-DMB, HLA-DOB, PSMB9, TAP1, BTN3A1, and CX3CL1, were significantly upregulated in intestinal epithelial cells at active celiac disease. Of these genes, 70% were upregulated by interferon-gamma via the IRF1 pathway. Most interestingly, IRF1 was also upregulated by celiac disease-associated bacteria. The NLRP6/8 inflammasome yielding CASP1 and biologically active interleukin-18, which induces interferon-gamma in intraepithelial lymphocytes, was expressed in intestinal epithelial cells. Conclusion A key factor in the epithelial reaction in celiac disease appears to be over-expression of IRF1 that could be inherent and/or due to presence of undesirable microbes that act directly on IRF1. Dual activation of IRF1 and IRF1-regulated genes, both directly and via the interleukin-18 dependent inflammasome would drastically enhance the inflammatory response and lead to the pathological situation seen in active celiac disease.	[Pietz, Grzegorz; De, Rituparna; Hedberg, Maria; Sjoberg, Veronika; Hammarstrom, Sten; Hammarstrom, Marie-Louise] Umea Univ, Dept Clin Microbiol, Immunol, Umea, Sweden; [Sandstrom, Olof; Hernell, Olle] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden	Umea University; Umea University	Hammarstrom, ML (corresponding author), Umea Univ, Dept Clin Microbiol, Immunol, Umea, Sweden.	marie-louise.hammarstrom@umu.se		De, Dr.Rituparna/0000-0002-8573-7276; Hammarstrom, Marie-Louise/0000-0001-6182-4423; Sandstrom, Olof/0000-0003-0899-0531	Swedish Research Council-Natural Sciences and Engineering Sciences [2010-5669, 2013-4522]; Kempe Foundations [SMK-1134]; TORNADO-Project within 7th EU framework program [222720-2]; Fund for Biotechnology-oriented Basic Science at Umea University; Council of the County of Vasterbotten; Swedish Society for Celiac Disease	Swedish Research Council-Natural Sciences and Engineering Sciences(Swedish Research Council); Kempe Foundations; TORNADO-Project within 7th EU framework program; Fund for Biotechnology-oriented Basic Science at Umea University; Council of the County of Vasterbotten; Swedish Society for Celiac Disease	Funding was provided by the Swedish Research Council-Natural Sciences and Engineering Sciences no. 2010-5669 and 2013-4522 (to M-LH and SH); The Kempe Foundations no. SMK-1134 (to M-LH); The TORNADO-Project within the 7th EU framework program theme, grant agreement no. 222720-2 (to M-LH and OH); The Fund for Biotechnology-oriented Basic Science at Umea University (to M-LH); The Council of the County of Vasterbotten (to M-LH and OS); The Swedish Society for Celiac Disease (to M-LH and OS); Donations to the Medical Faculty, Umea University to M-LH, the Medical Faculty, Umea University, grants including PhD-scholarships for GP and VS to M-LH. The funding agencies had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bondar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089068; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Cenit MC, 2015, NUTRIENTS, V7, P6900, DOI 10.3390/nu7085314; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dunne MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076008; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Forsberg G, 2007, INT IMMUNOL, V19, P993, DOI 10.1093/intimm/dxm077; Gianfrani C, 2003, J IMMUNOL, V170, P2719, DOI 10.4049/jimmunol.170.5.2719; Girbovan A, 2017, MED MICROBIOL IMMUN, V206, P83, DOI 10.1007/s00430-017-0496-z; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hedberg ME, 2013, INT J SYST EVOL MICR, V63, P4218, DOI 10.1099/ijs.0.052647-0; Hedberg ME, 2012, INT J SYST EVOL MICR, V62, P2685, DOI 10.1099/ijs.0.033613-0; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Kneepkens CMF, 2012, EUR J PEDIATR, V171, P1011, DOI 10.1007/s00431-012-1714-8; Kondrashova A, 2008, ANN MED, V40, P223, DOI 10.1080/07853890701678689; Leon AJ, 2006, CLIN EXP IMMUNOL, V146, P479, DOI 10.1111/j.1365-2249.2006.03239.x; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; LUNDQVIST C, 1992, J IMMUNOL METHODS, V152, P253, DOI 10.1016/0022-1759(92)90147-L; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Meresse B, 2015, DIGEST DIS, V33, P122, DOI 10.1159/000369521; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Nerdal PT, 2016, J IMMUNOL, V197, P3059, DOI 10.4049/jimmunol.1600913; Oberg ANV, 2004, INT J CANCER, V111, P101, DOI 10.1002/ijc.20231; Olsson C, 2008, PEDIATRICS, V122, P528, DOI 10.1542/peds.2007-2989; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Rhodes DA, 2016, ANNU REV IMMUNOL, V34, P151, DOI 10.1146/annurev-immunol-041015-055435; Salvati VM, 2003, PEDIATR RES, V54, P312, DOI 10.1203/01.PDR.0000079184.70237.9C; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sjoberg V, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.9; Sjoberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053414; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Veeraraghavan G, 2015, EXPERT REV GASTROENT, V9, P913, DOI 10.1586/17474124.2015.1033399; Vitale Serena, 2016, Mol Cell Pediatr, V3, P20, DOI 10.1186/s40348-016-0048-4; Wapenaar MC, 2007, IMMUNOGENETICS, V59, P349, DOI 10.1007/s00251-007-0199-5; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026	50	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185025	10.1371/journal.pone.0185025	http://dx.doi.org/10.1371/journal.pone.0185025			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934294	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900076
J	Zheng, XL; Wang, XM; Teng, D; Mao, RY; Hao, Y; Yang, N; Zong, LF; Wang, JH				Zheng, Xueling; Wang, Xiumin; Teng, Da; Mao, Ruoyu; Hao, Ya; Yang, Na; Zong, Lifen; Wang, Jianhua			Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; SALMONELLA-ENTERITIDIS; STAPHYLOCOCCUS-AUREUS; IN-VITRO; RESISTANCE; EXPRESSION; MECHANISM; MEMBRANE; DEFENSIN; DESIGN	NZ2114 and MP1102 are novel plectasin-derived peptides with potent activity against Gram-positive bacteria. The antibacterial characteristics and mechanism of NZ2114 and MP1102 against gas gangrene-associated Clostridium perfringens were studied for the first time. The minimal inhibitory concentration and minimal bactericidal concentration of NZ2114 and MP1102 against resistant C. perfringens type A strain CVCC 46 were 0.91 mu M. Based on the fractional inhibitory concentration index (FICI) result, an additive or synergic effect was observed between NZ2114 (FICI = 0.5 similar to 0.75) or MP1102 (FICI = 0.375 similar to 1.0) and antibiotics. The flow cytometry, scanning and transmission electron microscopy analysis showed that both NZ2114 and MP1102 induced obviously membrane damage, such as the leakage of cellular materials, partial disappearance of the cell membrane and membrane peeling, as well as retracting cytoplasm and ghost cell. The gel retardation and circular dichroism (CD) detection showed that NZ2114 and MP1102 could bind to C. perfringens genomic DNA and change the DNA conformation. Moreover, NZ2114 also interfered with the double helix and unwind the genomic DNA. The cell cycle analysis showed that C. perfringens CVCC 46 cells exposed to NZ2114 and MP1102 were arrested at the phase I. These data indicated that both NZ2114 and MP1102 have potential as new antimicrobial agents for gas gangrene infection resulting from resistant C. perfringens.	[Zheng, Xueling; Wang, Xiumin; Teng, Da; Mao, Ruoyu; Hao, Ya; Yang, Na; Zong, Lifen; Wang, Jianhua] Minist Agr, Key Lab Feed Biotechnol, Beijing, Peoples R China; [Zheng, Xueling; Wang, Xiumin; Teng, Da; Mao, Ruoyu; Hao, Ya; Yang, Na; Zong, Lifen; Wang, Jianhua] Chinese Acad Agr Sci, Gene Engn Lab, Feed Res Inst, Beijing, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS	Teng, D; Wang, JH (corresponding author), Minist Agr, Key Lab Feed Biotechnol, Beijing, Peoples R China.; Teng, D; Wang, JH (corresponding author), Chinese Acad Agr Sci, Gene Engn Lab, Feed Res Inst, Beijing, Peoples R China.	tengda@caas.cn; wangjianhua@caas.cn	Wang, Xiumin/AAB-3981-2022; Mao, Ruoyu/HDO-7383-2022		National Natural Science Foundation of China [31572445, 31372346, 31572444, 31672456, 31601968]; National Support Program for Science and Technology in China [2013BAD10602]; AMP Direction of National Innovation Program of Agricultural Science and Technology in CAAS [CAAS-ASTIP-2013-FRI-02, 2013-2017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Support Program for Science and Technology in China; AMP Direction of National Innovation Program of Agricultural Science and Technology in CAAS	This study was supported by the National Natural Science Foundation of China (No. 31572445, 31372346, No.31572444, No.31672456, and No.31601968), the Project of the National Support Program for Science and Technology in China (No. 2013BAD10602), and the AMP Direction of National Innovation Program of Agricultural Science and Technology in CAAS (CAAS-ASTIP-2013-FRI-02, 2013-2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 31572445, 31372346, No.31572444, No.31672456, and No.31601968), the Project of the National Support Program for Science and Technology in China (No. 2013BAD10B02), and the AMP Direction of National Innovation Program of Agricultural Science and Technology in CAAS (CAAS-ASTIP-2013-FRI-02, 2013-2017).	Adams V, 2015, PLASMID, V80, P90, DOI 10.1016/j.plasmid.2015.04.004; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P3003, DOI 10.1128/AAC.01584-08; ARANYI C, 1970, APPL MICROBIOL, V20, P633, DOI 10.1128/AEM.20.4.633-637.1970; Brandenburg LO, 2012, POLYMERS-BASEL, V4, P539, DOI 10.3390/polym4010539; Bryant Amy E, 2010, Curr Infect Dis Rep, V12, P383, DOI 10.1007/s11908-010-0127-y; Caly DL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01336; Candido ED, 2014, PEPTIDES, V55, P65, DOI 10.1016/j.peptides.2014.02.003; Cao XT, 2015, APPL MICROBIOL BIOT, V99, P2649, DOI 10.1007/s00253-014-6077-9; Chen Y, 2015, J BIOL CHEM, V280, P12316; Dempsey CE, 2010, PROTEIN PEPTIDE LETT, V17, P1334; Gholamiandehkordi A, 2009, VET RES COMMUN, V33, P1031, DOI 10.1007/s11259-009-9306-4; Giguere S, 2012, VET MICROBIOL, V160, P207, DOI 10.1016/j.vetmic.2012.05.031; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Han XY, 2015, ANTIMICROB AGENTS CH, V59, P6855, DOI 10.1128/AAC.01643-15; Hao Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep44278; Hara S, 2008, BIOCHEM BIOPH RES CO, V374, P709, DOI 10.1016/j.bbrc.2008.07.093; Jiao J, 2015, PROCESS BIOCHEM, V50, P253, DOI 10.1016/j.procbio.2014.12.019; Joshi S, 2010, BBA-BIOMEMBRANES, V1798, P1864, DOI 10.1016/j.bbamem.2010.06.016; Kuwano K, 2005, INT J ANTIMICROB AG, V26, P396, DOI 10.1016/j.ijantimicag.2005.08.010; Lee DG, 2002, BBA-PROTEINS PROTEOM, V1598, P185, DOI 10.1016/S0167-4838(02)00373-4; Lee TH, 2016, CURR TOP MED CHEM, V16, P25, DOI 10.2174/1568026615666150703121700; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; Li L, 2011, CHINESE J STRUC CHEM, V30, P563; Li LR, 2013, APPL MICROBIOL BIOT, V97, P1711, DOI 10.1007/s00253-012-4352-1; Li WY, 2014, AMINO ACIDS, V46, P2287, DOI 10.1007/s00726-014-1820-1; Ma ML, 2014, INFECT IMMUN, V82, P2958, DOI 10.1128/IAI.01848-14; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Millet S, 2011, VET J, V187, P143, DOI 10.1016/j.tvjl.2010.05.001; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Osman KM, 2013, REV SCI TECH OIE, V32, P841; Park M, 2010, ARCH MICROBIOL, V192, P803, DOI 10.1007/s00203-010-0605-5; Saravanan R, 2012, BBA-BIOMEMBRANES, V1818, P1613, DOI 10.1016/j.bbamem.2012.03.015; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Soge OO, 2009, J APPL MICROBIOL, V106, P34, DOI 10.1111/j.1365-2672.2008.03960.x; Songer JG, 1998, SWINE HEALTH PROD, V6, P223; Teng D, 2014, APPL MICROBIOL BIOT, V98, P8313, DOI 10.1007/s00253-014-5898-x; Tsuji BT, 2006, DIAGN MICR INFEC DIS, V54, P73, DOI 10.1016/j.diagmicrobio.2005.08.014; Uzal FA, 2009, INFECT IMMUN, V77, P5291, DOI 10.1128/IAI.00825-09; van Dijk A, 2007, ANTIMICROB AGENTS CH, V51, P912, DOI 10.1128/AAC.00568-06; Wang XM, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01056-16, 10.1128/aac.01056-16]; Xi D, 2013, PROCESS BIOCHEM, V48, P453, DOI 10.1016/j.procbio.2013.01.008; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; Zhang J, 2011, PROTEIN EXPRES PURIF, V78, P189, DOI 10.1016/j.pep.2011.04.014; Zhang Y, 2015, APPL MICROBIOL BIOT, V99, P6255, DOI 10.1007/s00253-015-6394-7; Zhang Y, 2014, APPL MICROBIOL BIOT, V98, P681, DOI 10.1007/s00253-013-4881-2; Zong LF, 2016, APPL MICROBIOL BIOT, V100, P5045, DOI 10.1007/s00253-016-7387-x	46	16	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185215	10.1371/journal.pone.0185215	http://dx.doi.org/10.1371/journal.pone.0185215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934314	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900127
J	Ayyagari, VN; Diaz-Sylvester, PL; Hsieh, THJ; Brard, L				Ayyagari, Vijayalakshmi N.; Diaz-Sylvester, Paula L.; Hsieh, Tsung-han Jeff; Brard, Laurent			Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines	PLOS ONE			English	Article							IN-VITRO; APOPTOSIS; CISPLATIN; EXPRESSION; AUTOTAXIN; P53; DOXORUBICIN; SENSITIVITY; GENERATION; RESISTANCE	Previously, Bithionol (BT) was shown to enhance the chemosensitivity of ovarian cancer cell lines to cisplatin treatment. In the present study, we focused on the anti-tumor potential of the BT-paclitaxel combination when added to a panel of ovarian cancer cell lines. This in vitro study aimed to 1) determine the optimum schedule for combination of BT and paclitaxel and 2) assess the nature and mechanism(s) underlying BT-paclitaxel interactions. The cytotoxic effects of both drugs either alone or in combination were assessed by presto-blue cell viability assay using six human ovarian cancer cell lines. Inhibitory concentrations to achieve 50% cell death (IC50) were determined for BT and paclitaxel in each cell line. Changes in levels of cleaved PARP, XIAP, bcl-2, bcl-xL, p21 and p27 were determined via immunoblot. Luminescent and colorimetric assays were used to determine caspases 3/7 and autotaxin (ATX) activity. Cellular reactive oxygen species (ROS) were measured by flow cytometry. Our results show that the efficacy of the BT-paclitaxel combination depends upon the concentrations and sequence of addition of paclitaxel and BT. Pretreatment with BT followed by paclitaxel resulted in antagonistic interactions whereas synergistic interactions were observed when both drugs were added simultaneously or when cells were pretreated with paclitaxel followed by BT. Synergistic interactions between BT and paclitaxel were attributed to increased ROS generation and enhanced apoptosis. Decreased expression of pro-survival factors (XIAP, bcl-2, bcl-xL) and increased expression of pro-apoptotic factors (caspases 3/7, PARP cleavage) was observed. Additionally, increased expression of key cell cycle regulators p21 and p27 was observed. These results show that BT and paclitaxel interacted synergistically at most drug ratios which, however, was highly dependent on the sequence of the addition of drugs. Our results suggest that BT-paclitaxel combination therapy may be effective in sensitizing ovarian cancer cells to paclitaxel treatment, thus mitigating some of the toxic effects associated with high doses of paclitaxel.	[Ayyagari, Vijayalakshmi N.; Diaz-Sylvester, Paula L.; Hsieh, Tsung-han Jeff; Brard, Laurent] Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA; [Diaz-Sylvester, Paula L.] Southern Illinois Univ, Sch Med, Ctr Clin Res, Springfield, IL USA; [Brard, Laurent] Southern Illinois Univ, Sch Med, Simmons Canc Inst SIU, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Brard, L (corresponding author), Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA.; Brard, L (corresponding author), Southern Illinois Univ, Sch Med, Simmons Canc Inst SIU, Springfield, IL 62702 USA.	lbrard@siumed.edu		Ayyagari, Vijayalakshmi/0000-0003-1001-7044; Diaz-Sylvester, Paula/0000-0002-1531-1958	National Cancer Institute (NCI) of the National Institutes of Health (NIH) [P20CA192987]	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this manuscript was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under award number P20CA192987 (LB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Ayyagari VN, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3034-2; Ayyagari VN, 2016, ANTI-CANCER DRUG, V27, P547, DOI 10.1097/CAD.0000000000000364; Ayyagari VN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-61; BACQ Y, 1991, HEPATOLOGY, V14, P1066, DOI 10.1002/hep.1840140620; Band Horwitz S., TRENDS PHARM SCI, V13, P134; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Braddock D, 2009, Application, Patent No. [WO2009151644 A2, 2009151644]; CHEN HW, 1995, CARCINOGENESIS, V16, P1963, DOI 10.1093/carcin/16.8.1963; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cristea Mihaela, 2010, Ther Adv Med Oncol, V2, P175, DOI 10.1177/1758834010361333; ELIOPOULOS AG, 1995, ONCOGENE, V11, P1217; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Hadzic T, 2010, FREE RADICAL BIO MED, V48, P1024, DOI 10.1016/j.freeradbiomed.2010.01.018; He G, 2006, BRIT J CANCER, V95, P1514, DOI 10.1038/sj.bjc.6603448; Herod JJO, 1996, CANCER RES, V56, P2178; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Kampan NC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/413076; Kasibhatla S., 2006, CSH PROTOC, V2006; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kaufmann SH, 2000, BIOESSAYS, V22, P1007, DOI 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.3.CO;2-W; Kikuchi Y, 2001, Hum Cell, V14, P115; Kim JS, 2008, INT J CANCER, V122, P672, DOI 10.1002/ijc.23158; Kim KK, 2011, GYNECOL ONCOL, V122, P183, DOI 10.1016/j.ygyno.2011.03.035; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; Lambert HE, 2004, INT J GYNECOL CANCER, V14, P772, DOI 10.1111/j.1048-891X.2004.014507.x; Leitao MM, 2003, GYNECOL ONCOL, V91, P123, DOI 10.1016/S0090-8258(03)00464-5; LIPTON RB, 1989, NEUROLOGY, V39, P368, DOI 10.1212/WNL.39.3.368; Mansat-De Mas V, 1999, MOL PHARMACOL, V56, P867, DOI 10.1124/mol.56.5.867; Marx D, 2000, METH MOLEC MED, V39, P687; Meshkini A, 2012, EXP TOXICOL PATHOL, V64, P357, DOI 10.1016/j.etp.2010.09.010; Mitsuuchi Y, 2000, CANCER RES, V60, P5390; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Nam SW, 2001, CANCER RES, V61, P6938; Naumann RW, 2011, DRUGS, V71, P1397, DOI 10.2165/11591720-000000000-00000; Ott I, 2007, ARCH PHARM, V340, P117, DOI 10.1002/ardp.200600151; Pace A, 1997, ITAL J NEUROL SCI, V18, P73, DOI 10.1007/BF01999566; Park YD, 2016, MBIO, V7, DOI 10.1128/mBio.01073-16; Piccart MJ, 2000, J CLIN ONCOL, V18, P1193, DOI 10.1200/JCO.2000.18.6.1193; Pinato DJ, 2013, CANCER TREAT REV, V39, P153, DOI 10.1016/j.ctrv.2012.04.004; Rakovitch E, 1999, INT J RADIAT ONCOL, V44, P1119, DOI 10.1016/S0360-3016(99)00109-1; Rosenberg P, 2002, ACTA ONCOL, V41, P418, DOI 10.1080/028418602320404998; Rowinsky E K, 1993, J Natl Cancer Inst Monogr, P107; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Sevko A, 2012, J IMMUNOTOXICOL, V9, P275, DOI 10.3109/1547691X.2012.655343; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Sui MH, 2006, CANCER BIOL THER, V5, P1015, DOI 10.4161/cbt.5.8.2909; Torchilin VP, 2007, AAPS J, V9, pE128, DOI 10.1208/aapsj0902015; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; Witham J, 2007, CLIN CANCER RES, V13, P7191, DOI 10.1158/1078-0432.CCR-07-0362; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zeng S, 2000, CLIN CANCER RES, V6, P3766; Zhang DS, 2014, DRUG DES DEV THER, V8, P279, DOI 10.2147/DDDT.S56801	60	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185111	10.1371/journal.pone.0185111	http://dx.doi.org/10.1371/journal.pone.0185111			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931042	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700071
J	Kuatsjah, E; Chan, ACK; Kobylarz, MJ; Murphy, MEP; Eltis, LD				Kuatsjah, Eugene; Chan, Anson C. K.; Kobylarz, Marek J.; Murphy, Michael E. P.; Eltis, Lindsay D.			The bacterial meta-cleavage hydrolase LigY belongs to the amidohydrolase superfamily, not to the alpha/beta-hydrolase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; hydrolase; lignin degradation; metalloenzyme; zinc; C-C hydrolase; amidohydrolase superfamily; aromatic compound; meta-cleavage	EPSILON-SEMIALDEHYDE DECARBOXYLASE; LIGNIN-RELATED BIPHENYL; C BOND HYDROLASE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; DEGRADATION; CATABOLISM; ACID; BPHD; GENE	Strain SYK-6 of the bacterium Sphingobium sp. catabolizes lignin-derived biphenyl via a meta-cleavage pathway. In this pathway, LigY is proposed to catalyze the hydrolysis of the meta-cleavage product (MCP) 4,11-dicarboxy-8-hydroxy-9-methoxy-2-hydroxy-6-oxo-6-phenyl-hexa-2,4-dienoate. Here, we validated this reaction by identifying 5-carboxyvanillate and 4-carboxy-2-hydroxypenta-2,4-dienoate as the products and determined the k(cat) and k(cat)/K-m values as 9.3 +/- 0.6 s(-1) and 2.5 +/- 0.2 x 10(7) m(-1) s(-1), respectively. Sequence analyses and a 1.9 resolution crystal structure established that LigY belongs to the amidohydrolase superfamily, unlike previously characterized MCP hydrolases, which are serine-dependent enzymes of the /-hydrolase superfamily. The active-site architecture of LigY resembled that of -amino--carboxymuconic-E-semialdehyde decarboxylase, a class III amidohydrolase, with a single zinc ion coordinated by His-6, His-8, His-179, and Glu-282. Interestingly, we found that LigY lacks the acidic residue proposed to activate water for hydrolysis in other class III amidohydrolases. Moreover, substitution of His-223, a conserved residue proposed to activate water in other amidohydrolases, reduced the k(cat) to a much lesser extent than what has been reported for other amidohydrolases, suggesting that His-223 has a different role in LigY. Substitution of Arg-72, Tyr-190, Arg-234, or Glu-282 reduced LigY activity over 100-fold. On the basis of these results, we propose a catalytic mechanism involving substrate tautomerization, substrate-assisted activation of water for hydrolysis, and formation of a gem-diol intermediate. This last step diverges from what occurs in serine-dependent MCP hydrolases. This study provides insight into C-C-hydrolyzing enzymes and expands the known range of reactions catalyzed by the amidohydrolase superfamily.	[Kuatsjah, Eugene; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Genome Sci & Technol Program, Vancouver, BC V6T 1Z3, Canada; [Chan, Anson C. K.; Kobylarz, Marek J.; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mail.ubc.ca	Kuatsjah, Eugene/GLN-5085-2022; Murphy, Michael/R-6805-2017; Eltis, Lindsay/J-8272-2015	Murphy, Michael/0000-0003-2589-0014; Eltis, Lindsay/0000-0002-6774-8158; Chan, Anson/0000-0001-6625-8942; Kuatsjah, Eugene/0000-0002-8793-2331	Canadian Foundation for Innovation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Canadian Foundation for Innovation(Canada Foundation for Innovation); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Hong-Ming Chen and Prof. Stephen G. Withers synthesized OH-DDVA. Mariko Ikehata assisted with the ICP-MS. We thank the Laboratory of Molecular Biophysics for the use of the spectrofluorometer and CD spectrometer. The Laboratory of Molecular Biophysics is funded by the Canadian Foundation for Innovation. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health, Grant including P41GM103393. Research described in this paper was performed using beamline 08B1-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cooper BF, 1997, PROTEIN SCI, V6, P1031, DOI 10.1002/pro.5560060509; Cornish-Bowden A., 1994, ANAL ENZYME KINETIC; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FOWDEN L, 1955, BIOCHEM J, V59, P228, DOI 10.1042/bj0590228; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Goto M, 2006, J BIOL CHEM, V281, P34365, DOI 10.1074/jbc.M607270200; Hall RS, 2011, BIOCHEMISTRY-US, V50, P5077, DOI 10.1021/bi200483k; Hara H, 2000, J BACTERIOL, V182, P6950, DOI 10.1128/JB.182.24.6950-6957.2000; Henderson IMJ, 1997, BIOCHEMISTRY-US, V36, P12252, DOI 10.1021/bi971116j; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Horsman GP, 2007, J BIOL CHEM, V282, P19894, DOI 10.1074/jbc.M702237200; Horsman GP, 2006, BIOCHEMISTRY-US, V45, P11071, DOI 10.1021/bi0611098; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; Jackson CA, 2017, J APPL MICROBIOL, V122, P940, DOI 10.1111/jam.13401; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuatsjah E, 2017, FEBS LETT, V591, P1001, DOI 10.1002/1873-3468.12611; Lam WWY, 1997, BIOCHEMISTRY-US, V36, P12242, DOI 10.1021/bi971115r; Li JJ, 2006, BIOCHEMISTRY-US, V45, P12461, DOI 10.1021/bi0612519; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Liu XX, 2015, ACTA CRYSTALLOGR E, V71, P272, DOI 10.1107/S2056989015002807; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otani H, 2014, J BACTERIOL, V196, P4293, DOI 10.1128/JB.02247-14; Peng X, 1999, APPL ENVIRON MICROB, V65, P2789; Peng X, 1998, APPL ENVIRON MICROB, V64, P2520; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Ruzzini AC, 2013, BIOCHEMISTRY-US, V52, P7428, DOI 10.1021/bi401156a; Ruzzini AC, 2012, J AM CHEM SOC, V134, P4615, DOI 10.1021/ja208544g; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shiel AE, 2012, GEOCHIM COSMOCHIM AC, V76, P175, DOI 10.1016/j.gca.2011.10.005; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Varman AM, 2016, P NATL ACAD SCI USA, V113, pE5802, DOI 10.1073/pnas.1606043113; Vladimirova A, 2016, J AM CHEM SOC, V138, P826, DOI 10.1021/jacs.5b08251; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu ST, 2013, CELL RES, V23, P1296, DOI 10.1038/cr.2013.107; Yoshikata T, 2014, APPL ENVIRON MICROB, V80, P7142, DOI 10.1128/AEM.02236-14	58	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18290	18302		10.1074/jbc.M117.797696	http://dx.doi.org/10.1074/jbc.M117.797696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28935670	Green Published, hybrid			2022-12-26	WOS:000414458200026
J	White, N; Benton, M; Kennedy, D; Fox, A; Griffiths, L; Lea, R; Mengersen, K				White, Nicole; Benton, Miles; Kennedy, Daniel; Fox, Andrew; Griffiths, Lyn; Lea, Rodney; Mengersen, Kerrie			Accounting for cell lineage and sex effects in the identification of cell-specific DNA methylation using a Bayesian model selection algorithm	PLOS ONE			English	Article							T-CELLS; BLOOD	Cell- and sex-specific differences in DNA methylation are major sources of epigenetic variation in whole blood. Heterogeneity attributable to cell type has motivated the identification of cell-specific methylation at the CpG level, however statistical methods for this purpose have been limited to pairwise comparisons between cell types or between the cell type of interest and whole blood. We developed a Bayesian model selection algorithm for the identification of cell-specific methylation profiles that incorporates knowledge of shared cell lineage and allows for the identification of differential methylation profiles in one or more cell types simultaneously. Under the proposed methodology, sex-specific differences in methylation by cell type are also assessed. Using publicly available, cell-sorted methylation data, we show that 51.3% of female CpG markers and 61.4% of male CpG markers identified were associated with differential methylation in more than one cell type. The impact of cell lineage on differential methylation was also highlighted. An evaluation of sex-specific differences revealed differences in CD56(+) NK methylation, within both single and multi-cell dependent methylation patterns. Our findings demonstrate the need to account for cell lineage in studies of differential methylation and associated sex effects.	[White, Nicole; Kennedy, Daniel; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia; [Benton, Miles; Griffiths, Lyn; Lea, Rodney] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld, Australia; [Fox, Andrew] Florey Dept Neurosci & Mental Hlth, Melbourne, Vic, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Mengersen, K (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia.	ksnengersen@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Mengersen, Kerrie/0000-0001-8625-9168; Benton, Miles/0000-0003-3442-965X; Lea, Rodney/0000-0002-1148-5862; White, Nicole/0000-0002-9292-0773	QUT; Australian Research Council; Australian Government Research Training Program Scholarship; ARC Centre of Excellence for Mathematical and Statistical Frontiers top-up scholarship; Multiple Sclerosis Research Australia; Australian Government Research Training Program (RTP) Scholarship; ARC Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) top-up scholarship	QUT; Australian Research Council(Australian Research Council); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); ARC Centre of Excellence for Mathematical and Statistical Frontiers top-up scholarship(Australian Research Council); Multiple Sclerosis Research Australia; Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); ARC Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) top-up scholarship	MB and NW were supported by a collaborative development grant from QUT. NW was further supported by the Australian Research Council working under a Laureate Fellowship held by KM (http://www.arc.gov.au/). DK is supported by an Australian Government Research Training Program Scholarship (https://www.education.gov.au/research-training-program), and an ARC Centre of Excellence for Mathematical and Statistical Frontiers top-up scholarship (http://acems.org.au/). AF and RL are partially supported by Multiple Sclerosis Research Australia (http://www.msra.org.au/) funding for bioinformatics.; We thank Peter Donnelly for his helpful feedback on the methodology developed in this paper. MB and NW were supported by a collaborative development grant from QUT. NW was further supported by the Australian Research Council (ARC) working under a Laureate Fellowship held by KM. DK is supported by an Australian Government Research Training Program (RTP) Scholarship, and an ARC Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) top-up scholarship. AF and RL are partially supported by Multiple Sclerosis Research Australia funding for bioinformatics.	Abdullah M, 2012, CELL IMMUNOL, V272, P214, DOI 10.1016/j.cellimm.2011.10.009; Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Chen DP, 2016, BRIEF FUNCT GENOMICS, V15, P485, DOI 10.1093/bfgp/elw018; Dedeurwaerder S, 2014, BRIEF BIOINFORM, V15, P929, DOI 10.1093/bib/bbt054; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Fernandez C, 2001, J ECONOMETRICS, V100, P381, DOI 10.1016/S0304-4076(00)00076-2; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Friel N, 2012, STAT NEERL, V66, P288, DOI 10.1111/j.1467-9574.2011.00515.x; Glossop JR, 2013, EPIGENETICS-US, V8, P1188, DOI 10.4161/epi.26265; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Houseman E Andres, 2015, Curr Environ Health Rep, V2, P145, DOI 10.1007/s40572-015-0050-3; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Inoshita M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0029-7; Jeffries MA, 2011, EPIGENETICS-US, V6, P593, DOI 10.4161/epi.6.5.15374; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Koestler DC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0943-7; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; Mamrut S, 2015, EPIGENETICS-US, V10, P943, DOI 10.1080/15592294.2015.1084462; McCarthy NS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-981; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Muers M, 2013, NAT REV GENET, V14, P3535, DOI 10.1038/nrg3535; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Triche Jr T., ILLUMINAHUMANMETHYLA; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Yousefi P, 2015, ENVIRON MOL MUTAGEN, V56, P751, DOI 10.1002/em.21966; Zellner, 1986, BAYESIAN INFERENCE D, P233, DOI DOI 10.4236/OJS.2013.34031	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0182455	10.1371/journal.pone.0182455	http://dx.doi.org/10.1371/journal.pone.0182455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957352	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200004
J	Chung, YJ; Frye, TJ; Aplan, PD				Chung, Yang Jo; Frye, Terry J.; Aplan, Peter D.			Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; MINOR HISTOCOMPATIBILITY BARRIERS; DONOR LYMPHOCYTE INFUSIONS; TERM-FOLLOW-UP; ALLOGENEIC TRANSPLANTATION; SYNDROME MDS; MOUSE MODEL; T-CELLS	Allogeneic hematopoietic stem cell transplantation (A-HSCT) remains the only curative option for patients with myelodysplastic syndrome (MDS). We used the NUP98-HOXD13 (NHD13) murine model for MDS to study HSCT in a pre-clinical setting. NHD13 recipients transplanted with syngeneic bone marrow (S-HSCT) following myeloablative irradiation showed disease remission, with normalization of peripheral blood parameters and marked decrease in circulating leukocytes derived from the MDS clone. Despite the disease remission and improved survival compared to non-transplanted NHD13 controls, all mice eventually relapsed, indicating persistence of a long-lived radio-resistant MDS clone. In an effort to induce a graft versus leukemia (GVL) effect, A-HSCT with donor bone marrow that was mismatched at minor histocompatibility loci was compared to S-HSCT. Although recipients in the A-HSCT showed a lower early relapse rate than in S-HSCT, all mice in both groups eventually relapsed and died by 54 weeks post-transplant. To obtain a more significant GVL effect, donor splenocytes containing reactive T-cells were transplanted with allogeneic bone marrow. Although the relapse rate was only 20% at post-transplantation week 38, suggesting a GVL effect, this was accompanied by a severe graft versus host disease (GVHD) Taken together, these findings indicate that a myeloablative dose of ionizing radiation is insufficient to eradicate the MDS initiating cell, and that transplantation of donor splenocytes leads to decreased relapse rates, at the cost of severe GVHD. We suggest that NHD13 mice represent a feasible pre-clinical model for the study of HSCT for MDS.	[Chung, Yang Jo; Aplan, Peter D.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Frye, Terry J.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Aplan, PD (corresponding author), NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	aplanp@mail.nih.gov			Intramural Research Program of the National Cancer Institute, National Institutes of Health [ZIA SC 010378, BC 010983]; NATIONAL CANCER INSTITUTE [Z01BC010983, ZIASC010378, ZIABC011295] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (grant numbers ZIA SC 010378 and BC 010983). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Michael Kuehl, Crystal Mackall, and current and former members of Aplan lab for insightful discussions. We also thank the NCI Sequencing core for Sanger sequencing, the NCI Transgenic Core for generation of transgenic mice, Bobbi Smith of the NCI Pathohistology Lab for CBC acquisition, and Maria Jorge for excellent animal husbandry. This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (grant numbers ZIA SC 010378 and BC 010983).	Anderson JE, 1996, J CLIN ONCOL, V14, P220, DOI 10.1200/JCO.1996.14.1.220; Atallah E, 2010, AM J HEMATOL, V85, P579, DOI 10.1002/ajh.21761; Balderman SR, 2016, BLOOD, V127, P616, DOI 10.1182/blood-2015-06-653113; Barrett AJ, 2008, SEMIN HEMATOL, V45, P49, DOI 10.1053/j.seminhematol.2007.10.005; Brierley CK, 2016, CURR OPIN HEMATOL, V23, P167, DOI 10.1097/MOH.0000000000000217; Campregher PV, 2007, BONE MARROW TRANSPL, V40, P965, DOI 10.1038/sj.bmt.1705840; Chung YJ, 2008, P NATL ACAD SCI USA, V105, P14088, DOI 10.1073/pnas.0804507105; Clift RA, 1998, BLOOD, V92, P1455, DOI 10.1182/blood.V92.4.1455; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; de Witte T, 2017, BLOOD, V129, P1753, DOI 10.1182/blood-2016-06-724500; Deeg H Joachim, 2015, Am Soc Clin Oncol Educ Book, pe375, DOI 10.14694/EdBook_AM.2015.35.e375; Deeg HJ, 2010, BLOOD, V116, P4762, DOI 10.1182/blood-2010-07-259358; Del Papa B, 2017, BIOL BLOOD MARROW TR; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; FEIG SA, 1993, BONE MARROW TRANSPL, V12, P65; FONTAINE P, 1990, TRANSPLANTATION, V49, P1177, DOI 10.1097/00007890-199006000-00032; Ganan-Gomez I, 2015, LEUKEMIA, V29, P1458, DOI 10.1038/leu.2015.69; Ingram W, 2007, BLOOD REV, V21, P61, DOI 10.1016/j.blre.2006.03.003; Khabori MA, 2011, BONE MARROW TRANSPL, V46, P516, DOI 10.1038/bmt.2010.164; KORNGOLD R, 1987, J EXP MED, V165, P1552, DOI 10.1084/jem.165.6.1552; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Ma XM, 2012, AM J MED, V125, pS2, DOI 10.1016/j.amjmed.2012.04.014; Marin GH, 1999, J EXP CLIN CANC RES, V18, P201; Martelli MF, 2014, BLOOD, V124, P638, DOI 10.1182/blood-2014-03-564401; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Mori S, 2003, BONE MARROW TRANSPL, V31, P865, DOI 10.1038/sj.bmt.1704021; Mukherjee S, 2015, BIOL BLOOD MARROW TR, V21, P412, DOI 10.1016/j.bbmt.2014.07.027; Nimer Stephen D, 2008, Hematology Am Soc Hematol Educ Program, P43, DOI 10.1182/asheducation-2008.1.43; Nishiyama M, 1999, GENE CHROMOSOME CANC, V26, P215, DOI 10.1002/(SICI)1098-2264(199911)26:3<215::AID-GCC5>3.3.CO;2-T; Orti G, 2017, EXP HEMATOL, V48, P1, DOI 10.1016/j.exphem.2016.12.004; Parmar S, 2011, CURR OPIN HEMATOL, V18, P98, DOI 10.1097/MOH.0b013e328343b858; Phillips GL, 2012, LEUKEMIA RES, V36, P1490, DOI 10.1016/j.leukres.2012.08.004; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Riesner K, 2016, BONE MARROW TRANSPL, V51, P410, DOI 10.1038/bmt.2015.279; Ringden O, 2017, BRIT J HAEMATOL, V176, P431, DOI 10.1111/bjh.14428; Sintes J, 2007, TISSUE ANTIGENS, V70, P355, DOI 10.1111/j.1399-0039.2007.00909.x; Tefferi A, 2015, AM J HEMATOL, V90, P831, DOI 10.1002/ajh.24102; van Besien K, 2013, HEMATOL-AM SOC HEMAT, P56, DOI 10.1182/asheducation-2013.1.56; Xu HM, 2012, BLOOD, V120, P3089, DOI 10.1182/blood-2012-01-405332; Zhang P, 2011, IMMUNOL RES, V49, P49, DOI 10.1007/s12026-010-8193-7	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185219	10.1371/journal.pone.0185219	http://dx.doi.org/10.1371/journal.pone.0185219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953912	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300046
J	Trapanese, M; Buglione, M; Maselli, V; Petrelli, S; Aceto, S; Fulgione, D				Trapanese, Martina; Buglione, Maria; Maselli, Valeria; Petrelli, Simona; Aceto, Serena; Fulgione, Domenico			The first transcriptome of Italian wall lizard, a new tool to infer about the Island Syndrome	PLOS ONE			English	Article							LEPTIN GENE-EXPRESSION; RNA-SEQ DATA; ANOLIS-LIZARDS; FREEZE TOLERANCE; EVOLUTION; GENOME; BRAIN; DIVERSIFICATION; POPULATION; GENERATION	Some insular lizards show a high degree of differentiation from their conspecific mainland populations, like Licosa island lizards, which are described as affected by Reversed Island Syndrome (RIS). In previous works, we demonstrated that some traits of RIS, as melanization, depend on a differential expression of gene encoding melanocortin receptors. To better understand the basis of syndrome, and providing raw data for future investigations, we generate the first de novo transcriptome of the Italian wall lizard. Comparing mainland and island transcriptomes, we link differences in life-traits to differential gene expression. Our results, taking together testis and brain sequences, generated 275,310 and 269,885 transcripts, 18,434 and 21,606 proteins in Gene Ontology annotation, for mainland and island respectively. Variant calling analysis identified about the same number of SNPs in island and mainland population. Instead, through a differential gene expression analysis we found some putative genes involved in syndrome more expressed in insular samples like Major Histocompatibility Complex class I, Immunoglobulins, Melanocortin 4 receptor, Neuropeptide Y and Proliferating Cell Nuclear Antigen.	[Trapanese, Martina; Buglione, Maria; Maselli, Valeria; Petrelli, Simona; Aceto, Serena; Fulgione, Domenico] Univ Naples Federico II, Dept Biol, Campus Monte St Angelo, Naples, Italy	University of Naples Federico II	Fulgione, D (corresponding author), Univ Naples Federico II, Dept Biol, Campus Monte St Angelo, Naples, Italy.	fulgione@unina.it	Buglione, Maria/ABH-1103-2021	Aceto, Serena/0000-0003-3906-4872; Maselli, Valeria/0000-0002-1452-8063; FULGIONE, DOMENICO/0000-0002-5121-3298; BUGLIONE, MARIA/0000-0001-6022-707X				Bohme W., 1993, ZOOGEOGRAPHY LACERTI, P17; Bolger A, 2014, TRIMMOMATIC FLEXIBLE; Burke RL, 2002, COPEIA, P836; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chieffi P, 2001, ZYGOTE, V9, P317, DOI 10.1017/S0967199401001368; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; FAITH RE, 1973, IMMUNOLOGY, V25, P151; FELLAH JS, 1993, IMMUNOGENETICS, V38, P311; Flajnik M., 2003, FUNDAMENTAL IMMUNOLO, P519; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulgione D, 2015, J ZOOL, V296, P278, DOI 10.1111/jzo.12242; Fulgione D, 2008, ZOOL SCI, V25, P465, DOI 10.2108/zsj.25.465; Gambon-Deza F, 2008, MOL IMMUNOL, V45, P3470, DOI 10.1016/j.molimm.2008.02.027; Georges A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0085-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jensen J, 2001, COMP BIOCHEM PHYS A, V128, P471, DOI 10.1016/S1095-6433(00)00329-9; Johnson MA, 2010, EVOLUTION, V64, P1151, DOI 10.1111/j.1558-5646.2009.00881.x; Klaczko J, 2015, J ZOOL, V295, P44, DOI 10.1111/jzo.12178; Leng N, 2013, EBSEQ EMPIRICAL BAYE; LESLIE GA, 1972, J IMMUNOL, V108, P1656; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos Jonathan B., 2010, P309; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Marchanolis JJ, 1977, MARCHALONIS IMMUNITY; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Monti DM, 2013, BIOL J LINN SOC, V108, P144, DOI 10.1111/j.1095-8312.2012.02019.x; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Morash B, 2001, MOL CELL ENDOCRINOL, V185, P151, DOI 10.1016/S0303-7207(01)00626-8; MORRIS YA, 1990, BRAIN RES, V530, P339, DOI 10.1016/0006-8993(90)91307-3; O'Grady SP, 2006, MORPHOLOGICAL PHYSIO; Pereira AGT, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0148947, 10.1371/journal.pone.0158165]; Perez-Mellado Valentin, 1993, Bonner Zoologische Beitraege, V44, P193; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sagonas K, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1301-8; Sagonas K, 2014, BIOL J LINN SOC, V112, P469, DOI 10.1111/bij.12290; Sanseverino W, 2015, MOL BIOL EVOL, V32, P2760, DOI 10.1093/molbev/msv152; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; Smit A, 1996, REPEATMASKER OPEN 30; Smith-Unna RD, 2015, TRANSRATE REFERENCE; Storey KB, 2006, CRYOBIOLOGY, V52, P1, DOI 10.1016/j.cryobiol.2005.09.005; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Tzika AC, 2015, GENOME BIOL EVOL, V7, P1827, DOI 10.1093/gbe/evv106; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wegener JE, 2014, BIOL J LINN SOC, V113, P570, DOI 10.1111/bij.12380; Zhang Z, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-44	58	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185227	10.1371/journal.pone.0185227	http://dx.doi.org/10.1371/journal.pone.0185227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953924	Green Published, gold			2022-12-26	WOS:000411980300047
J	Ainelo, H; Lahesaare, A; Teppo, A; Kivisaar, M; Teras, R				Ainelo, Hanna; Lahesaare, Andrio; Teppo, Annika; Kivisaar, Maia; Teras, Riho			The promoter region of lapA and its transcriptional regulation by Fis in Pseudomonas putida	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; GENE-EXPRESSION; PROTEIN FIS; RPOS GENE; DI-GMP; IDENTIFICATION; TRANSPOSITION; AERUGINOSA; ADHESION	LapA is the biggest protein in Pseudomonas putida and a key factor for biofilm formation. Its importance and posttranslational regulation is rather thoroughly studied but less is known about the transcriptional regulation. Here we give evidence that transcription of lapA in LB-grown bacteria is initiated from six promoters, three of which display moderate RpoS-dependence. The global transcription regulator Fis binds to the lapA promoter area at six positions in vitro, and Fis activates the transcription of lapA while overexpressed in cells. Two of the six Fis binding sites, Fis-A7 and Fis-A5, are necessary for the positive effect of Fis on the transcription of lapA in vivo. Our results indicate that Fis binding to the Fis-A7 site increases the level of transcription from the most distal promoter of lapA, whereas Fis binding to the Fis-A5 site could be important for modifying the promoter area topology.	[Ainelo, Hanna; Lahesaare, Andrio; Teppo, Annika; Kivisaar, Maia; Teras, Riho] Univ Tartu, Inst Mol & Cell Biol, Chair Genet, Tartu, Estonia	University of Tartu	Teras, R (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Chair Genet, Tartu, Estonia.	riho.leras@ut.ee	Teras, Riho/ABA-8761-2021	Ainelo, Hanna/0000-0003-3340-9120	Targeted Financing Project [SF0180031s08]; Estonian Research Council [IUT20-19]	Targeted Financing Project; Estonian Research Council	This work was supported by the funding of the Targeted Financing Project SF0180031s08; the Institutional Research Funding IUT20-19 from Estonian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzallag GN, 2004, J THEOR BIOL, V229, P361, DOI 10.1016/j.jtbi.2004.04.001; ANTOINE R, 1992, MOL MICROBIOL, V6, P1785, DOI 10.1111/j.1365-2958.1992.tb01351.x; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; D'Arrigo I, 2016, ENVIRON MICROBIOL, V18, P3466, DOI 10.1111/1462-2920.13326; Duque E, 2013, ENVIRON MICROBIOL, V15, P36, DOI 10.1111/j.1462-2920.2012.02732.x; El-Kirat-Chatel S, 2014, ACS CHEM BIOL, V9, P485, DOI 10.1021/cb400794e; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Fazli M, 2014, ENVIRON MICROBIOL, V16, P1961, DOI 10.1111/1462-2920.12448; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; GonzalezGil G, 1996, MOL MICROBIOL, V22, P21, DOI 10.1111/j.1365-2958.1996.tb02652.x; Gutierrez-Rios RM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-53; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ilves H, 2001, J BACTERIOL, V183, P5445, DOI 10.1128/JB.183.18.5445-5448.2001; Jakovleva J, 2012, MICROBIOL-SGM, V158, P708, DOI 10.1099/mic.0.053355-0; Jimenez-Fernandez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163142; Jovcic B, 2008, J MICROBIOL, V46, P56, DOI 10.1007/s12275-007-0127-2; Jyot J, 2002, J BACTERIOL, V184, P5251, DOI 10.1128/JB.184.19.5251-5260.2002; Kivistik PA, 2006, J BACTERIOL, V188, P8109, DOI 10.1128/JB.01262-06; Kojic M, 2001, J BACTERIOL, V183, P3712, DOI 10.1128/JB.183.12.3712-3720.2001; KUES U, 1989, MICROBIOL REV, V53, P491; Lahesaare A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166078; Lahesaare A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115901; Lenz DH, 2007, MOL MICROBIOL, V63, P859, DOI 10.1111/j.1365-2958.2006.05545.x; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; MENDOZAVARGAS A, 2009, PLOS ONE, V4, P76403, DOI DOI 10.1073/PNAS.0511100103; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moor H, 2014, MICROBIOL-SGM, V160, P2681, DOI 10.1099/mic.0.082503-0; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell P. D., 2011, PLOS BIOL, V9; Prigent-Combaret C, 2012, MOL MICROBIOL, V86, P172, DOI 10.1111/j.1365-2958.2012.08182.x; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; Ramos-Gonzalez MI, 1998, J BACTERIOL, V180, P3421; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shao YP, 2008, J MOL BIOL, V376, P771, DOI 10.1016/j.jmb.2007.11.101; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P8303; Teras R, 2000, J BACTERIOL, V182, P589, DOI 10.1128/JB.182.3.589-598.2000; Teras R, 2009, MICROBIOL-SGM, V155, P1203, DOI 10.1099/mic.0.022830-0; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wolska KI, 2015, J APPL GENET; Wong SM, 2000, P NATL ACAD SCI USA, V97, P10191, DOI 10.1073/pnas.97.18.10191; Xiao YJ, 2016, ENV MICROBIOL REP, V8, P659, DOI 10.1111/1758-2229.12419; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Yousef-Coronado F, 2011, MICROBIOL-SGM, V157, P2257, DOI 10.1099/mic.0.047787-0; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x	61	9	9	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185482	10.1371/journal.pone.0185482	http://dx.doi.org/10.1371/journal.pone.0185482			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945818	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100063
J	Dalton, HA; Wood, BJ; Widowski, TM; Guerin, MT; Torrey, S				Dalton, Hillary A.; Wood, Benjamin J.; Widowski, Tina M.; Guerin, Michele T.; Torrey, Stephanie			An analysis of beak shape variation in two ages of domestic turkeys (Meleagris gallopavo) using landmark-based geometric morphometrics	PLOS ONE			English	Article							INJURIOUS PECKING; BILL SIZE; ENVIRONMENTAL ENRICHMENT; LIGHT-INTENSITY; MARSH SPARROWS; WILD TURKEYS; FLOOR SPACE; DIMORPHISM; BEHAVIOR; GROWTH	The objective of this study was to assess beak shape variation in domestic turkeys (Meleagris gallopavo) and determine the effects of age, sex, and beak size on beak shape variation using geometric morphometrics. Dorsal and right lateral images were taken of 2442 turkeys at 6 and 18.5 weeks of age. Landmarks were digitized in tpsDig in three analyses of the dorsal upper mandible, lateral upper mandible, and lateral lower mandible shape of each turkey at both ages. The coordinate data were then subjected to a principal components analysis (PCA), multivariate regression, and a canonical variates analysis (CVA) with a Procrustes ANOVA in MorphoJ. For the dorsal images, three principal components (PCs) showed beak shape variation ranged from long, narrow, and pointed to short, wide, and blunt upper mandibles at both ages (6 weeks: 95.36%, 18.5 weeks: 92.21%). Three PCs showed the lateral upper mandible shape variation ranged from long, wide beaks with long, curved beak tips to short, narrow beaks with short, pointed beak tips at both ages (6 weeks: 94.91%, 18.5 weeks: 94.33%). Three PCs also explained 97.80% (6 weeks) and 97.11% (18.5 weeks) of the lateral lower mandible shape variation ranging from wide and round to narrow and thin lower mandibles with superior/inferior beak tip shifts. Beak size accounted for varying proportions of the beak shape variation (0.96-54.76%; P < 0.0001) in the three analyses of each age group. For all the analyses, the CVA showed sexual dimorphism in beak shape (P < 0.0001) with female upper mandibles appearing wider and blunter dorsally with long, curved beak tips laterally. Whereas male turkey upper mandibles had a narrow, pointed dorsal appearance and short, pointed beak tips laterally. Future applications of beak shape variability could have a genetic and welfare value by incorporating beak shape variation to select for specific turkey beak phenotypes as an alternative to beak treatment.	[Dalton, Hillary A.; Wood, Benjamin J.; Widowski, Tina M.; Torrey, Stephanie] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada; [Dalton, Hillary A.; Widowski, Tina M.; Torrey, Stephanie] Univ Guelph, Campbell Ctr Study Anim Welf, Guelph, ON, Canada; [Wood, Benjamin J.] Hybrid Turkeys, Kitchener, ON, Canada; [Guerin, Michele T.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Dalton, HA (corresponding author), Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada.; Dalton, HA (corresponding author), Univ Guelph, Campbell Ctr Study Anim Welf, Guelph, ON, Canada.	hdalton@ualberta.ca	Wood, Benjamin/AAN-4266-2020	Wood, Benjamin/0000-0003-4977-3410; Torrey, Stephanie/0000-0002-8157-9207	Campbell Centre for the Study of Animal Welfare [2014-1]; Canadian Poultry Research Council [1154]; Hybrid Turkeys; Ontario Ministry of Agriculture, Food, and Rural Affairs [299278]; Poultry Industry Council [317]	Campbell Centre for the Study of Animal Welfare; Canadian Poultry Research Council; Hybrid Turkeys; Ontario Ministry of Agriculture, Food, and Rural Affairs; Poultry Industry Council	The authors would like to thank the following organizations for financial support: The Campbell Centre for the Study of Animal Welfare (project #2014-1, HAD); Canadian Poultry Research Council (project #1154, ST); Hybrid Turkeys (in-kind support, BJW), Ontario Ministry of Agriculture, Food, and Rural Affairs (HQP project #299278, HAD); and the Poultry Industry Council (project #317, ST). These funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hybrid Turkeys provided support in the form of research materials and author salaries (BJW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Babbitt GA, 2007, WATERBIRDS, V30, P199, DOI 10.1675/1524-4695(2007)30[199:SFSBDI]2.0.CO;2; Berns CM, 2010, AUK, V127, P626, DOI 10.1525/auk.2010.09213; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bright JA, 2016, P NATL ACAD SCI USA, V113, P5352, DOI 10.1073/pnas.1602683113; Buchholz R, 1997, J AVIAN BIOL, V28, P223, DOI 10.2307/3676973; Buchholz R, 1996, AUK, V113, P310, DOI 10.2307/4088897; Buchwalder T, 2004, APPL ANIM BEHAV SCI, V89, P207, DOI 10.1016/j.applanim.2004.07.001; Buchwalder T, 2003, APPL ANIM BEHAV SCI, V84, P75, DOI 10.1016/S0168-1591(03)00149-7; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; Canadian Council on Animal Care, 2009, CCAC GUID CAR US FAR; Carruthers C, 2012, J APPL POULTRY RES, V21, P645, DOI 10.3382/japr.2011-00433; CRAIG JV, 1992, POULTRY SCI, V71, P1830, DOI 10.3382/ps.0711830; Dalton HA, 2013, WORLD POULTRY SCI J, V69, P865, DOI 10.1017/S004393391300086X; Dennis RL, 2009, POULTRY SCI, V88, P38, DOI 10.3382/ps.2008-00227; Dryden IL, 1998, STAT ANAL SHAPE; Duggan G, 2014, J APPL POULTRY RES, V23, P280, DOI 10.3382/japr.2013-00860; DURELL SEALD, 1993, J ANIM ECOL, V62, P205, DOI 10.2307/5495; Fahey AG, 2007, POULTRY SCI, V86, P1312, DOI 10.1093/ps/86.7.1312; Fiks-van Niekerk T.G., 2007, LOHMANN INF, V42, P35; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; FREEMAN BM, 1987, WORLD POULTRY SCI J, V43, P15, DOI 10.1079/WPS19870002; Gentle MJ, 2007, VET REC, V160, P145, DOI 10.1136/vr.160.5.145; GILL DJ, 1984, POULTRY SCI, V63, P1314, DOI 10.3382/ps.0631314; Greenberg R, 2013, ECOL EVOL, V3, P389, DOI 10.1002/ece3.474; Greenberg R, 2012, ECOGRAPHY, V35, P146, DOI 10.1111/j.1600-0587.2011.07002.x; Greenberg R, 2010, ECOLOGY, V91, P2428, DOI 10.1890/09-1136.1; GRIGOR PN, 1995, VET REC, V136, P257, DOI 10.1136/vr.136.11.257; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; HOCKING P, 1993, P 4 EUR S POULTR WEL, P125; Hybrid Turkeys, 2016, COMM MAN GUID; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Kimball RT, 1996, ETHOLOGY, V102, P639; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Krautwald-Junghanns ME, 2011, BERL MUNCH TIERARZTL, V124, P8, DOI 10.2376/0005-9366-124-8; Kulemeyer C, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-2; KUO FL, 1991, POULTRY SCI, V70, P1057, DOI 10.3382/ps.0701057; LEIGHTON AT, 1985, POULTRY SCI, V64, P440, DOI 10.3382/ps.0640440; Lewis PD, 1998, ANIM SCI, V66, P759, DOI 10.1017/S1357729800009358; Marchant-Forde RM, 2008, POULTRY SCI, V87, P1474, DOI 10.3382/ps.2006-00360; Marchant-Forde RM, 2010, POULTRY SCI, V89, P2559, DOI 10.3382/ps.2010-00890; Marcus LF, 1996, NATO ASI SERIES A; Martrenchar A, 2001, BRIT POULTRY SCI, V42, P161, DOI 10.1080/00071660120048393; McKeegan DEF, 2012, ANIM WELFARE, V21, P207, DOI 10.7120/09627286.21.2.207; Moinard C, 2001, ANIM WELFARE, V10, P131; PRICE TD, 1984, AM NAT, V123, P500, DOI 10.1086/284219; Rico-Guevara A, 2015, BEHAV ECOL, V26, P21, DOI 10.1093/beheco/aru182; Rohlf F.J., TPSDIG DIGITIZE LAND; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Shao SM, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0162-0; Sherwin CM, 1999, BRIT POULTRY SCI, V40, P592, DOI 10.1080/00071669986954; Sievwright H, 2011, ORNITHOL SCI, V10, P131, DOI 10.2326/osj.10.131; Tattersall GJ, 2009, SCIENCE, V325, P468, DOI 10.1126/science.1175553; Temeles EJ, 2010, PHILOS T R SOC B, V365, P1053, DOI 10.1098/rstb.2009.0284; WATTS CR, 1971, SCI AM, V224, P112; Willems OW, 2014, BRIT POULTRY SCI, V55, P715, DOI 10.1080/00071668.2014.966058; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	60	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185159	10.1371/journal.pone.0185159	http://dx.doi.org/10.1371/journal.pone.0185159			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934330	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900108
J	Dolka, B; Chrobak-Chmiel, D; Czopowicz, M; Szeleszczuk, P				Dolka, Beata; Chrobak-Chmiel, Dorota; Czopowicz, Michal; Szeleszczuk, Piotr			Characterization of pathogenic Enterococcus cecorum from different poultry groups: Broiler chickens, layers, turkeys, and waterfowl	PLOS ONE			English	Article							VIRULENCE DETERMINANTS; MOLECULAR EPIDEMIOLOGY; STREPTOCOCCAL FLORA; MULTIPLEX PCR; SPONDYLITIS; IDENTIFICATION; OSTEOMYELITIS; INFECTION; STRAINS; INTESTINES	Enterococcus cecorum (EC) is known as a commensal in the intestines of mammals and birds. However, it has been described as an emerging pathogen in poultry industry worldwide. The aim of this study was to analyze and compare EC isolated from clinical material collected from poultry groups with different production purposes. The genetic diversity among pathogenic EC in relation to each specific poultry type was examined. In total, 148 isolates from independent infection outbreaks (2011 - 2016) were used: 76 broiler chickens (CB), 37 broiler breeders (BB), 23 layers (CL), 7 waterfowl (W) and 5 turkey (T) flocks (1 iso-late/1 flock). We provided age ranges at diagnosis of EC-infection for 5 poultry groups. Isolates obtained from CB were significantly more frequently retrieved from bone marrow, joints, spine, and contrary to BB, CL less frequently retrieved from respiratory system. The study showed differences between EC of various poultry types in relation to 10/32 (31.3%) biochemical parameters. EC isolates from CB were significantly more often positive for beta GAL, beta NAG, MLZ, and less often positive for PAL and beta MAN than isolates from other poultry types. However, BB and W isolates showed higher ability to metabolise mannitol than CB, CL, and T. CB isolates showed lower ability to survive at 60 degrees C. Only chicken EC-isolates harbored virulence genes: CB (8.1%) > BB (3.4%) > CL (2%). No specific pulsotype of EC was associated with a specific poultry. One or several various (up to 6) genetic types of EC may be involved in outbreaks in CB flocks within one year in one region. Outbreaks reported in following years in the same region were usually caused by a distinct set of EC-genetic types. PFGE results indicated at the genetic heterogeneity among pathogenic isolates involved in outbreaks in relation to each poultry type. To our best knowledge, this is the first study which provides a comparison between clinical EC from 5 poultry groups. The study provides a new insight into EC as pathogen of different bird species. The obtained data may be useful in further studies on EC-infections more focused on a specific type of poultry.	[Dolka, Beata; Szeleszczuk, Piotr] Warsaw Univ Life Sci, SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Chrobak-Chmiel, Dorota] Warsaw Univ Life Sci, SGGW, Fac Vet Med, Dept Preclin Sci, Warsaw, Poland; [Czopowicz, Michal] Warsaw Univ Life Sci, SGGW, Fac Vet Med, Lab Vet Epidemiol & Econ, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Dolka, B (corresponding author), Warsaw Univ Life Sci, SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland.	beata_dolka@sggw.pl	Czopowicz, Michał/U-5452-2018	Czopowicz, Michał/0000-0002-4238-8360; /0000-0001-8836-5351; Szeleszczuk, Piotr/0000-0003-1830-4232; Chrobak-Chmiel, Dorota/0000-0002-0554-6921	KNOW (Leading National Research Centre) Scientific Consortium [05-1/KNOW2/2015]	KNOW (Leading National Research Centre) Scientific Consortium	The costs of manuscript publication were funded by KNOW (Leading National Research Centre) Scientific Consortium 'Healthy Animal Safe Food,' decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison H, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.1077; Armour N.K., 2011, POULT INF PROF, V117, P1; Aziz T., 2007, World Poultry, V23, P44; Baele M, 2002, J APPL MICROBIOL, V92, P348, DOI 10.1046/j.1365-2672.2002.01537.x; Boerlin P, 2012, VET MICROBIOL, V157, P405, DOI 10.1016/j.vetmic.2012.01.001; Borst LB, 2017, VET PATHOL, V54, P61, DOI 10.1177/0300985816658098; Borst LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121294; Borst LB, 2014, AVIAN DIS, V58, P244, DOI 10.1637/10687-101113-Reg.1; Borst LB, 2012, AVIAN PATHOL, V41, P479, DOI 10.1080/03079457.2012.718070; Brash M, 2011, AHL NEWSLETTER, V15, P5; Daud N.H, 2015, P 2 WORLD VET POULTR, P77; De Herdt P, 2009, VLAAMS DIERGEN TIJDS, V78, P44; DEVRIESE LA, 1991, LETT APPL MICROBIOL, V12, P137, DOI 10.1111/j.1472-765X.1991.tb00524.x; DEVRIESE LA, 1992, J APPL BACTERIOL, V73, P421, DOI 10.1111/j.1365-2672.1992.tb04998.x; DEVRIESE LA, 1991, J APPL BACTERIOL, V71, P46; DEVRIESE LA, 1983, INT J SYST BACTERIOL, V33, P772, DOI 10.1099/00207713-33-4-772; Devriese LA, 2002, VLAAMS DIERGEN TIJDS, V71, P219; Dolka B, 2017, MED WETER, V73, P193; Dolka B, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0761-1; Jackson CR, 2015, LETT APPL MICROBIOL, V60, P111, DOI 10.1111/lam.12374; Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004; Jung A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0949-y; Jung A, 2014, BMC VET RES, V10; Jung A, 2014, AVIAN DIS, V58, P654, DOI 10.1637/10834-040114-Case.1; Jung A, 2013, AVIAN PATHOL, V42, P552, DOI 10.1080/03079457.2013.850151; Kense MJ, 2011, AVIAN PATHOL, V40, P603, DOI 10.1080/03079457.2011.619165; Kizerwetter-Swida M, 2008, J ANIM FEED SCI, V17, P224, DOI 10.22358/jafs/66602/2008; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Makrai L, 2011, ACTA VET HUNG, V59, P11, DOI 10.1556/AVet.59.2011.1.2; Manero A, 1999, APPL ENVIRON MICROB, V65, P4425; Markowski EP, 2009, DECIS SCI-J INNOV ED, V7, P59, DOI 10.1111/j.1540-4609.2008.00202.x; Martin-Platero AM, 2009, INT J FOOD MICROBIOL, V132, P24, DOI 10.1016/j.ijfoodmicro.2009.03.010; Robbins KM, 2012, AVIAN DIS, V56, P768, DOI 10.1637/10253-052412-Case.1; Scupham AJ, 2008, MICROB ECOL, V56, P322, DOI 10.1007/s00248-007-9349-4; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; Stepien-Pysniak D, 2016, ACTA VET HUNG, V64, P148, DOI 10.1556/004.2016.016; Szeleszczuk P, 2013, MED WETER, V69, P298; Talebi A, 2016, VET RES FORUM, V7, P353; van den Braak N, 1998, J CLIN MICROBIOL, V36, P1927, DOI 10.1128/JCM.36.7.1927-1932.1998; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Wijetunge DS, 2012, J VET DIAGN INVEST, V24, P1166, DOI 10.1177/1040638712463563; Wood AM, 2002, VET REC, V150, P27	42	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185199	10.1371/journal.pone.0185199	http://dx.doi.org/10.1371/journal.pone.0185199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934313	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900119
J	Chiang, BJ; Liao, CH; Lin, YH				Chiang, Bing-Juin; Liao, Chun-Hou; Lin, Yu-Hua			The efficacy of extracorporeal shockwave lithotripsy for symptomatic ureteral stones: Predictors of treatment failure without the assistance of computed tomography	PLOS ONE			English	Article							WAVE LITHOTRIPSY; HOUNSFIELD UNITS; STRICTURE FORMATION; URINARY CALCULI; DISTANCE; DISINTEGRATION; DENSITY; SUCCESS	Objectives Non-contrast computed tomography (NCCT) is not always performed clinically if the diagnosis of ureteral calculi has been confirmed using other radiographic imaging modalities. The aim of this study was to identify predictors of successful extracorporeal shockwave lithotripsy (ESWL) without assistance of NCCT. Methods We retrospectively reviewed the medical records of patients with symptomatic solitary ureteral stones who underwent ESWL between November 2015 and January 2016. Abdominal plain radiography or intravenous urography were performed before ESWL for localization. The exclusion criteria were repeated sessions of ESWL for the target stone and congenital genitourinary tract anomalies. The demographic characteristics, clinical history, medical charges, or imaging features of the stones were recorded. Successful treatment was defined as no fragments detected on radiography or ultrasonography in 4 weeks. For radiolucent calculi, successful treatment was regarded as cases without hydronephrosis, symptoms, or hematuria. Patients experiencing intractable pain and undergoing subsequent auxiliary surgeries were regarded as having ESWL treatment failure. Results Age (odds ratio [OR], 1.042; 95% confidence interval [CI], 1.007-1.078), history of ipsilateral renal or ureteral calculi episodes (OR, 2.669; 95% CI, 1.281-5.687), stone burden (OR, 3.499; 95% CI, 1.284-9.530), and radiopaque stone (OR, 2.351; 95% CI, 1.049-5.267) were significant predictors of ESWL failure in all patients. Conclusions For treating symptomatic ureteral stones, those with smaller size, radiolucency, and without a history of ipsilateral renal or ureteral calculi could be considered for first-line therapy with ESWL.	[Chiang, Bing-Juin] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chiang, Bing-Juin; Liao, Chun-Hou; Lin, Yu-Hua] Cardinal Tien Hosp, Dept Surg, Div Urol, New Taipei, Taiwan; [Chiang, Bing-Juin; Liao, Chun-Hou] Fu Jen Catholic Univ, Sch Med, Dept Urol, New Taipei, Taiwan; [Lin, Yu-Hua] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan	National Taiwan Normal University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Lin, YH (corresponding author), Cardinal Tien Hosp, Dept Surg, Div Urol, New Taipei, Taiwan.; Lin, YH (corresponding author), Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan.	jorgesuperowl@gmail.com						AMAR AD, 1981, J UROLOGY, V125, P416, DOI 10.1016/S0022-5347(17)55057-0; [Anonymous], 2007, RAD TRCO AC ONS FLAN; Cho KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144912; Chua ME, 2012, INT UROL NEPHROL, V44, P1349, DOI 10.1007/s11255-012-0189-x; Cimentepe E, 2003, J ENDOUROL, V17, P863, DOI 10.1089/089277903772036154; Delvecchio FC, 2003, UROLOGY, V61, P518, DOI 10.1016/S0090-4295(02)02433-0; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; ERTURK E, 1993, J UROLOGY, V149, P1425, DOI 10.1016/S0022-5347(17)36405-4; Gupta NP, 2005, BJU INT, V95, P1285, DOI 10.1111/j.1464-410X.2005.05520.x; Hall TC, 2015, CLIN RADIOL, V70, P243, DOI 10.1016/j.crad.2014.10.013; Jacobs BL, 2008, J ENDOUROL, V22, P1623, DOI 10.1089/end.2008.0169; Kanao K, 2006, J UROL 1, V176, P6; Kanao K, 2006, J UROLOGY, V176, P1453, DOI 10.1016/j.juro.2006.06.089; Malkawi IM, 2016, J ENDOUROL; Matlaga BR, 2012, J UROLOGY, V188, P130, DOI 10.1016/j.juro.2012.02.2569; Ng CF, 2009, J UROLOGY, V181, P1151, DOI 10.1016/j.juro.2008.10.161; Ouzaid I, 2012, BJU INT, V110, pE438, DOI 10.1111/j.1464-410X.2012.10964.x; Pareek G, 2005, UROLOGY, V66, P941, DOI 10.1016/j.urology.2005.05.011; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; Park BH, 2012, KOREAN J UROL, V53, P40, DOI 10.4111/kju.2012.53.1.40; Roberts WW, 1998, J UROLOGY, V159, P723, DOI 10.1016/S0022-5347(01)63711-X; Schoenfeld EM, 2015, WEST J EMERG MED, V16, P269, DOI 10.5811/westjem.2015.1.23272; Seitz C, 2006, EUR UROL, V49, P1099, DOI 10.1016/j.eururo.2005.12.003; Smith-Bindman R, 2014, NEW ENGL J MED, V371, P1100, DOI 10.1056/NEJMoa1404446; STEIN J, 1962, J UROLOGY, V87, P33, DOI 10.1016/S0022-5347(17)64902-4; Tamm EP, 2003, RADIOLOGY, V228, P319, DOI 10.1148/radiol.2282011726; Thomson J M, 2001, Australas Radiol, V45, P291, DOI 10.1046/j.1440-1673.2001.00923.x; Wiesenthal JD, 2011, J UROLOGY, V186, P556, DOI 10.1016/j.juro.2011.03.109; Wiesenthal JD, 2010, UROL RES, V38, P307, DOI 10.1007/s00240-010-0295-0; Yang TK, 2013, J FORMOS MED ASSOC, V112, P421, DOI 10.1016/j.jfma.2012.02.004; Yoshida S, 2006, UROLOGY, V68, P33, DOI 10.1016/j.urology.2006.01.052	31	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184855	10.1371/journal.pone.0184855	http://dx.doi.org/10.1371/journal.pone.0184855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931028	Green Submitted, gold, Green Published			2022-12-26	WOS:000411314700039
J	Vander Roost, J; Thorseth, IH; Dahle, H				Vander Roost, Jan; Thorseth, Ingunn Hindenes; Dahle, Hakon			Microbial analysis of Zetaproteobacteria and co-colonizers of iron mats in the Troll Wall Vent Field, Arctic Mid-Ocean Ridge	PLOS ONE			English	Article							LOIHI SEAMOUNT; HYDROTHERMAL FIELDS; OXIDIZING BACTERIA; FRESH-WATER; SEA; DIVERSITY; COMMUNITIES; FE; DEPOSITS; PHYSIOLOGY	Over the last decade it has become increasingly clear that Zetaproteobacteria are widespread in hydrothermal systems and that they contribute to the biogeochemical cycling of iron in these environments. However, how chemical factors control the distribution of Zetaproteobacteria and their co-occurring taxa remains elusive. Here we analysed iron mats from the Troll Wall Vent Field (TWVF) located at the Arctic Mid-Ocean Ridge (AMOR) in the Norwegian-Greenland Sea. The samples were taken at increasing distances from high-temperature venting chimneys towards areas with ultraslow low-temperature venting, encompassing a large variety in geochemical settings. Electron microscopy revealed the presence of biogenic iron stalks in all samples. Using 16S rRNA gene sequence profiling we found that relative abundances of Zetaproteobacteria in the iron mats varied from 0.2 to 37.9%. Biogeographic analyses of Zetaproteobacteria, using the ZetaHunter software, revealed the presence of ZetaOtus 1, 2 and 9, supporting the view that they are cosmopolitan. Relative abundances of co-occurring taxa, including Thaumarchaeota, Euryarchaeota and Proteobacteria, also varied substantially. From our results, combined with results from previous microbiological and geochemical analyses of the TWVF, we infer that the distribution of Zetaproteobacteria is connected to fluid-flow patterns and, ultimately, variations in chemical energy landscapes. Moreover, we provide evidence for iron-oxidizing members of Gallionellaceae being widespread in TWVF iron mats, albeit at low relative abundances.	[Vander Roost, Jan; Thorseth, Ingunn Hindenes; Dahle, Hakon] Univ Bergen, Ctr Geobiol, Bergen, Norway; [Vander Roost, Jan; Dahle, Hakon] Univ Bergen, Dept Biol, Bergen, Norway; [Thorseth, Ingunn Hindenes] Univ Bergen, Dept Earth Sci, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Dahle, H (corresponding author), Univ Bergen, Ctr Geobiol, Bergen, Norway.; Dahle, H (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	Hakon.Dahle@uib.no			Reseach Council of Norway [179560]	Reseach Council of Norway	This project was funded by The Reseach Council of Norway (http://www.forskningsradet.no/ en/Home_page/1177315753906) through Grant Number: 179560. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT JC, 1988, MAR GEOL, V81, P227, DOI 10.1016/0025-3227(88)90029-1; Amend JP, 2011, GEOCHIM COSMOCHIM AC, V75, P5736, DOI 10.1016/j.gca.2011.07.041; Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; Baumberger T., 2012, THESIS; Chan CS, 2004, SCIENCE, V303, P1656, DOI 10.1126/science.1092098; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dahle H, 2015, ISME J, V9, P1593, DOI 10.1038/ismej.2014.247; Davis RE, 2009, GEOMICROBIOL J, V26, P570, DOI 10.1080/01490450902889080; Davis RE, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005413; Dekov VM, 2010, CHEM GEOL, V278, P186, DOI 10.1016/j.chemgeo.2010.09.012; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Edgar R.C., 2011, BIOINFORMATICS; Edwards KJ, 2011, ISME J, V5, P1748, DOI 10.1038/ismej.2011.48; Emerson D, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01502; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Field EK, 2015, ISME J, V9, P857, DOI 10.1038/ismej.2014.183; Fleming EJ, 2013, FEMS MICROBIOL ECOL, V85, P116, DOI 10.1111/1574-6941.12104; Fullerton H, 2017, ISME J, V11, P1900, DOI 10.1038/ismej.2017.40; German CR, 2015, EARTH PLANET SC LETT, V419, P143, DOI 10.1016/j.epsl.2015.03.012; Hodges TW, 2009, APPL ENVIRON MICROB, V75, P1650, DOI 10.1128/AEM.01835-08; Hoshino T, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01554; Ishibashi J. I, 2015, SUBSEAFLOOR BIOSPHER, P301, DOI [10.1007/978-4-431-54865-2, DOI 10.1007/978-4-431-54865-2]; Jesser KJ, 2015, APPL ENVIRON MICROB, V81, P2976, DOI 10.1128/AEM.03608-14; Johannessen KC, 2017, GEOCHIM COSMOCHIM AC, V202, P101, DOI 10.1016/j.gca.2016.12.016; JUNIPER SK, 1988, CAN MINERAL, V26, P859; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; Kato S, 2009, ENVIRON MICROBIOL, V11, P2094, DOI 10.1111/j.1462-2920.2009.01930.x; Kennedy CB, 2003, GEOMICROBIOL J, V20, P199, DOI 10.1080/01490450303873; Kopylova E, 2012, BIOINFORMATICS; Li JT, 2012, FEMS MICROBIOL ECOL, V81, P205, DOI 10.1111/j.1574-6941.2012.01367.x; Li JW, 2013, J GEOPHYS RES-BIOGEO, V118, P665, DOI 10.1002/jgrg.20057; Makita H, 2017, ARCH MICROBIOL, V199, P335, DOI 10.1007/s00203-016-1307-4; McAllister SM, 2011, APPL ENVIRON MICROB, V77, P5445, DOI 10.1128/AEM.00533-11; McBeth JM, 2013, ENV MICROBIOL REP, V5, P453, DOI 10.1111/1758-2229.12033; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; Moeller K, 2014, GEOCHIM COSMOCHIM AC, V126, P422, DOI 10.1016/j.gca.2013.11.018; Moyer CL, 1998, DEEP-SEA RES PT II, V45, P303, DOI 10.1016/S0967-0645(97)00081-7; MOYER CL, 1995, APPL ENVIRON MICROB, V61, P1555, DOI 10.1128/AEM.61.4.1555-1562.1995; Pedersen RB, 2010, GEOPHYS MONOGR SER, V188, P67, DOI 10.1029/2008GM000783; Peng XT, 2015, GEOCHIM COSMOCHIM AC, V169, P200, DOI 10.1016/j.gca.2015.09.011; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raiswell R, 2012, GEOCHEM PERSPECT, V1, P1, DOI 10.7185/geochempersp.1.1; Ramirez Gustavo A, 2016, Front Microbiol, V7, P1679; Resing JA, 2015, NATURE, V523, P200, DOI 10.1038/nature14577; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rubin-Blum M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091456; Schander C, 2010, MAR BIOL RES, V6, P155, DOI 10.1080/17451000903147450; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott JJ, 2017, ENVIRON MICROBIOL, V19, P301, DOI 10.1111/1462-2920.13607; Scott JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119284; Singer E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01409; Singer E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00052; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Sylvan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00279-11; Tischler JS, 2013, J MICROBIOL METH, V95, P138, DOI 10.1016/j.mimet.2013.07.027; Toner BM, 2009, GEOCHIM COSMOCHIM AC, V73, P388, DOI 10.1016/j.gca.2008.09.035; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Urich T, 2014, ENVIRON MICROBIOL, V16, P2699, DOI 10.1111/1462-2920.12283; Warnes GR, 2013, GPLOTS VARIOUS R PRO	63	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185008	10.1371/journal.pone.0185008	http://dx.doi.org/10.1371/journal.pone.0185008			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931087	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700057
J	Yi, L; Hu, N; Yin, J; Sun, J; Mu, HX; Dai, KR; Ding, DX				Yi, Lan; Hu, Nan; Yin, Jie; Sun, Jing; Mu, Hongxiang; Dai, Keren; Ding, Dexin			Up-regulation of calreticulin in mouse liver tissues after long-term irradiation with low-dose-rate gamma rays	PLOS ONE			English	Article							IONIZING-RADIATION; PROTEOMIC ANALYSIS; BLADDER-CANCER; IN-VIVO; MICE; EXPOSURE; GROWTH; RISK	The biological effects of low-dose or low-dose-rate ionizing radiation on normal tissues has attracted attention. Based on previous research, we observed the morphology of liver tissues of C57BL/6J mice that received <50, 50-500, and 500-1000 mu Gy/h of Cs-137 radiation for 180 d. We found that the pathological changes in liver tissues were more obvious as the irradiation dose rates increased. Additionally, differential protein expression in liver tissues was analyzed using a proteomics approach. Compared with the matched group in the 2D gel analysis of the irradiated groups, 69 proteins had >= 1.5-fold changes in expression. Twenty-three proteins were selected based on >= 2.5-fold change in expression, and 22 of them were meaningful for bioinformatics and protein fingerprinting analysis. These molecules were relevant to cytoskeleton processes, cell metabolism, biological defense, mitochondrial damage, detoxification and tumorigenesis. The results from real-time PCR and western blot (WB) analyses showed that calreticulin (CRT) was up-regulated in the irradiated groups, which indicates that CRT may be relevant to stress reactions when mouse livers are exposed to low-dose irradiation and that low-dose-rate ionizing radiation may pose a cancer risk. The CRT protein can be a potential candidate for low-dose or low-dose-rate ionizing radiation early-warning biomarkers. However, the underlying mechanism requires further investigation.	[Yi, Lan; Hu, Nan; Yin, Jie; Ding, Dexin] Univ South China, Key Discipline Lab Natl Def Biotechnol Uranium Mi, Hengyang, Hunan, Peoples R China; [Yi, Lan; Yin, Jie; Sun, Jing; Mu, Hongxiang; Dai, Keren] Univ South China, Coll Pharm & Biol Sci, Hengyang, Hunan, Peoples R China	University of South China; University of South China	Ding, DX (corresponding author), Univ South China, Key Discipline Lab Natl Def Biotechnol Uranium Mi, Hengyang, Hunan, Peoples R China.	dingdxzzz@163.com			Defense Industrial Technology Development Program [JCKY2016403C001]; Key Project of National Defense Basic Research [B3720132001]; National Natural Science Foundation of China [U1401231]; China Postdoctoral Science Foundation [2014M562115]; National Natural Scientific Foundation of China [81400117]; Hunan Provincial Postgraduate Students Scientific Research Innovation Project [CX2016B473]; University of South China [2014XQD46]	Defense Industrial Technology Development Program; Key Project of National Defense Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Postgraduate Students Scientific Research Innovation Project; University of South China	This project was sponsored by the following: Defense Industrial Technology Development Program (No. JCKY2016403C001) (Dr Dexin Ding) had a role in study design and decision to publish. Key Project of National Defense Basic Research (B3720132001) (Dr Dexin Ding) had a role in data collection and analysis. National Natural Science Foundation of China (U1401231) (Dr Lan Yi) had a role in study design and preparation of the manuscript. China Postdoctoral Science Foundation (2014M562115) (Dr Lan Yi) had a role in preparation of the manuscript. National Natural Scientific Foundation of China (81400117) (Dr Lan Yi) had a role in data collection and analysis. Hunan Provincial Postgraduate Students Scientific Research Innovation Project (CX2016B473) (Miss Jing Sun) had a role in data collection and analysis. Research Initiation Funding of University of South China for the Returned Scholars from Abroad (2014XQD46) (Dr Lan Yi) had a role in preparation of the manuscript.	Alfonso P, 2005, PROTEOMICS, V5, P2602, DOI 10.1002/pmic.200401196; Chen QF, 2015, BIOMED PHARMACOTHER, V73, P109, DOI 10.1016/j.biopha.2015.05.017; Chiang WF, 2013, ORAL ONCOL, V49, P534, DOI 10.1016/j.oraloncology.2013.01.003; Ciplys E, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0356-8; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Fuller N, 2015, AQUAT TOXICOL, V167, P55, DOI 10.1016/j.aquatox.2015.07.013; Kageyama S, 2004, CLIN CHEM, V50, P857, DOI 10.1373/clinchem.2003.027425; Khong P-L., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.10.001; Kron T, 2016, PHYS MED BIOL, V61, pR167, DOI 10.1088/0031-9155/61/14/R167; Lian YL, 2015, OCCUP ENVIRON MED, V72, P640, DOI 10.1136/oemed-2014-102772; Lu YC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/526524; Lu YC, 2011, AM J PATHOL, V179, P1425, DOI 10.1016/j.ajpath.2011.05.015; Mancuso M, 2015, ONCOTARGET, V6, P31263, DOI 10.18632/oncotarget.5075; Mitchel R. E. J., 2006, Dose-Response, V4, P75, DOI 10.2203/dose-response.04-002.Mitchel; Nenoi M, 2015, HUM EXP TOXICOL, V34, P272, DOI 10.1177/0960327114537537; Oujifard A, 2015, AQUAT TOXICOL, V165, P259, DOI 10.1016/j.aquatox.2015.06.010; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Pernemalm M, 2013, J PROTEOME RES, V12, P3934, DOI 10.1021/pr4002096; Rednam S, 2013, PEDIATR BLOOD CANCER, V60, P593, DOI 10.1002/pbc.24366; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Rosenstierne MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100813; Rybkina V. L., 2016, Radiatsionnaya Biologiya Radioekologiya, V56, P44, DOI 10.7868/S0869803116010136; Sasaki MS, 2014, J RADIAT RES, V55, P391, DOI 10.1093/jrr/rrt133; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; Sheng WW, 2014, J CELL PHYSIOL, V229, P887, DOI 10.1002/jcp.24519; Sun C, 2015, LEUKEMIA LYMPHOMA, V56, P1593, DOI 10.3109/10428194.2014.953153; Taki K, 2009, J RADIAT RES, V50, P241, DOI 10.1269/jrr.09011; Tatsukawa Y, 2013, INT J OBESITY, V37, P1123, DOI 10.1038/ijo.2012.193; Tatsukawa Y, 2013, J RADIOL PROT, V33, P281, DOI 10.1088/0952-4746/33/2/281; Uehara Y, 2010, RADIAT RES, V174, P611, DOI 10.1667/RR2195.1; UNSCEAR Publication, 2013, BIOL MECH RAD ACT LO; Xiao X, 2015, STEM CELLS DEV, V24, P1342, DOI 10.1089/scd.2014.0402; Yamashita S, 2016, RADIAT PROT DOSIM, V171, P41, DOI 10.1093/rpd/ncw189; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Yi L, 2016, ONCOL LETT, V12, P1861, DOI 10.3892/ol.2016.4850; Yi L, 2016, ENVIRON SCI POLLUT R, V23, P2549, DOI 10.1007/s11356-015-5494-3; Zamanian M, 2013, PATHOL ONCOL RES, V19, P149, DOI 10.1007/s12253-012-9600-2	37	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0182671	10.1371/journal.pone.0182671	http://dx.doi.org/10.1371/journal.pone.0182671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931006	Green Submitted, gold, Green Published			2022-12-26	WOS:000411314700005
J	Shi, C; Uda, Y; Dedic, C; Azab, E; Sun, NY; Hussein, AI; Petty, CA; Fulzele, K; Mitterberger-Vogt, MC; Zwerschke, W; Pereira, R; Wang, KZ; Pajevic, PD				Shi, Chao; Uda, Yuhei; Dedic, Christopher; Azab, Ehab; Sun, Ningyuan; Hussein, Amira I.; Petty, Christopher A.; Fulzele, Keertik; Mitterberger-Vogt, Maria C.; Zwerschke, Werner; Pereira, Renata; Wang, Kunzheng; Pajevic, Paola Divieti			Carbonic anhydrase III protects osteocytes from oxidative stress	FASEB JOURNAL			English	Article						bone homeostasis; sclerostin; PTH	VAN-BUCHEM-DISEASE; PHOSPHATASE-ACTIVITY; SOST GENE; IN-VIVO; OSTEOCLAST DIFFERENTIATION; INHIBITOR SCLEROSTIN; PARATHYROID-HORMONE; BONE-FORMATION; EXPRESSION; ACTIVATION	Osteocytes are master orchestrators of bone remodeling; they control osteoblast and osteoclast activities both directly via cell-to-cell communication and indirectly via secreted factors, and they are the main postnatal source of sclerostin and RANKL(receptor activator of NF-kB ligand), two regulators of osteoblast and osteoclast function. Despite progress in understanding osteocyte biology and function, much remains to be elucidated. Recently developed osteocytic cell lines-together with new genome editing tools-has allowed a closer look at the biology and molecular makeup of these cells. By using single-cell cloning, we identified genes that are associated with high Sost/sclerostin expression and analyzed their regulation and function. Unbiased transcriptome analysis of high-vs. low-Sost/sclerostin-expressing cells identified known and novel genes. Dmp1 (dentin matrix protein 1), Dkk1 (Dickkopf WNT signaling pathway inhibitor 1), and Phex were among the most up-regulated known genes, whereas Srpx2, Cd200, and carbonic anhydrase III (CAIII) were identified as novel markers of differentiated osteocytes. Aspn, Enpp2, Robo2, Nov, and Serpina3g were among the transcripts that were most significantly suppressed in high-Sost cells. Considering that CAII was recently identified as being regulated by Sost/sclerostin and capable of controlling mineral homeostasis, we focused our attention on CAIII. Here, we report that CAIII is highly expressed in osteocytes, is regulated by parathyroid hormone both in vitro and in vivo, and protects osteocytes from oxidative stress.	[Shi, Chao; Wang, Kunzheng] Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Shi, Chao; Uda, Yuhei; Dedic, Christopher; Azab, Ehab; Sun, Ningyuan; Petty, Christopher A.; Fulzele, Keertik; Pajevic, Paola Divieti] Boston Univ, Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Hussein, Amira I.] Boston Univ, Sch Med, Dept Orthoped, Boston, MA 02118 USA; [Hussein, Amira I.] Univ Innsbruck, Cell Metab & Differentiat Res Grp, Innsbruck, Austria; [Pereira, Renata] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Xi'an Jiaotong University; Boston University; Boston University; University of Innsbruck; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, KZ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China.; Pajevic, PD (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, 700 Albany St,W201C, Boston, MA 02118 USA.	wangkunzheng66@163.com; pdivieti@bu.edu	Azab, Ehab/GQH-9122-2022; Uda, Yuhei/AAZ-4978-2021; Azab, Ehab/F-5269-2019; Pajevic, Paola Divieti/M-3236-2019	Uda, Yuhei/0000-0003-4705-6215; Azab, Ehab/0000-0002-1122-3942; Zwerschke, Werner/0000-0003-1137-2953; Petty, Christopher/0000-0001-5219-5776	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR060221, AR059655]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK079161]; Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P30-AR066261]; Boston University Flow Cytometry Core Facility; Boston University Microarray Core Facility [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR059655, P30AR066261, R01AR060221, UH3AR059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079161, R56DK079161] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases); Boston University Flow Cytometry Core Facility; Boston University Microarray Core Facility; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR060221, AR059655, and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK079161 (to P.D.P.). The Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant P30-AR066261) provided primary calvaria osteoblasts and hypoxic chambers and conducted radioimmunoassays for cAMP. This work was also supported by the Boston University Flow Cytometry Core Facility and the Boston University Microarray Core Facility (Clinical & Translational Science Institute Grant U54-TR001012). The authors declare no conflicts of interest.	Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cabiscol E, 1996, P NATL ACAD SCI USA, V93, P4170, DOI 10.1073/pnas.93.9.4170; CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742; Frikha-Benayed D, 2016, BONE, V90, P15, DOI 10.1016/j.bone.2016.05.011; Fulzele K, 2017, J BONE MINER RES, V32, P373, DOI 10.1002/jbmr.3001; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Gailly P, 2008, KIDNEY INT, V74, P52, DOI 10.1038/sj.ki.5002794; Guo DY, 2009, THER ADV MUSCULOSKEL, V1, P87, DOI 10.1177/1759720X09341484; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang H, 2014, MOL MED REP, V10, P1887, DOI 10.3892/mmr.2014.2439; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kato K, 2012, ACTA CRYSTALLOGR F, V68, P778, DOI 10.1107/S1744309112019306; Kim CA, 2008, GENET TEST, V12, P475, DOI 10.1089/gte.2008.0036; Kim G, 2004, MOL CELL BIOL, V24, P9942, DOI 10.1128/MCB.24.22.9942-9947.2004; Kogawa M, 2013, J BONE MINER RES, V28, P2436, DOI 10.1002/jbmr.2003; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Mitterberger MC, 2012, EXP CELL RES, V318, P877, DOI 10.1016/j.yexcr.2012.02.011; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Roy P, 2010, FEBS J, V277, P441, DOI 10.1111/j.1742-4658.2009.07496.x; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Shang XL, 2012, ARCH MED SCI, V8, P711, DOI 10.5114/aoms.2012.30295; Shang XL, 2009, MED HYPOTHESES, V72, P427, DOI 10.1016/j.mehy.2008.10.027; Spatz JM, 2012, J CLIN ENDOCR METAB, V97, pE1736, DOI 10.1210/jc.2012-1579; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun HL, 2009, CELLS TISSUES ORGANS, V190, P69, DOI 10.1159/000178020; Tang HT, 2016, CELL MOL NEUROBIOL, V36, P1067, DOI 10.1007/s10571-015-0300-9; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang WC, 2009, BONE, V44, P32, DOI 10.1016/j.bone.2008.08.133; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	45	18	19	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					440	452		10.1096/fj.201700485RR	http://dx.doi.org/10.1096/fj.201700485RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928248	Green Published			2022-12-26	WOS:000419172700039
J	Meisterernst, J; Klinger-Gratz, PP; Leidolt, L; Lang, MF; Schroth, G; Mordasini, P; Heldner, MR; Mono, ML; Kurmann, R; Buehlmann, M; Fischer, U; Arnold, M; Gralla, J; Mettle, HP; El-Koussy, M; Jung, SM				Meisterernst, Julia; Klinger-Gratz, Pascal P.; Leidolt, Lars; Lang, Matthias F.; Schroth, Gerhard; Mordasini, Pasquale; Heldner, Mirjam R.; Mono, Marie-Luise; Kurmann, Rebekka; Buehlmann, Monika; Fischer, Urs; Arnold, Marcel; Gralla, Jan; Mettle, Heinrich P.; El-Koussy, Marwan; Jung, Simon			Focal T2 and FLAIR hyperintensities within the infarcted area: A suitable marker for patient selection for treatment?	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INVERSION-RECOVERY HYPERINTENSITY; WEIGHTED IMAGING LESIONS; HEMORRHAGIC TRANSFORMATION; INTRAARTERIAL THROMBOLYSIS; INTRACEREBRAL HEMORRHAGE; MULTICENTER; MISMATCH; THERAPY; PREDICT	Background and purpose Some authors use FLAIR imaging to select patients for stroke treatment. However, the effect of hyperintensity on FLAIR images on outcome and bleeding has been addressed in only few studies with conflicting results. Methods 466 patients with anterior circulation strokes were included in this study. They all were examined with MRI before intravenous or endovascular treatment. Baseline data and 3 months outcome were recorded prospectively. Focal T2 and FLAIR hyperintensities within the ischemic lesion were evaluated by two raters, and the PROACT II classification was applied to assess bleeding complications on follow up imaging. Logistic regression analysis was used to determine predictors of bleeding complications and outcome and to analyze the influence of T2 or FLAIR hyperintensity on outcome. Results Focal hyperintensities were found in 142 of 307 (46.3%) patients with T2 weighted imaging and in 89 of 159 (56%) patients with FLAIR imaging. Hyperintensity in the basal ganglia, especially in the lentiform nucleus, on T2 weighted imaging was the only independent predictor of any bleeding after reperfusion treatment (33.8% in patients with vs. 18.2% in those without; p = 0.003) and there was a non-significant trend for more bleedings in patients with FLAIR hyperintensity within the basal ganglia (p = 0.069). However, there was no association of hyperintensity on T2 weighted or FLAIR images and symptomatic bleeding or worse outcome. Conclusion Our results question the assumption that T2 or FLAIR hyperintensities within the ischemic lesion should be used to exclude patients from reperfusion therapy, especially not from endovascular treatment.	[Meisterernst, Julia; Heldner, Mirjam R.; Mono, Marie-Luise; Kurmann, Rebekka; Buehlmann, Monika; Fischer, Urs; Arnold, Marcel; Mettle, Heinrich P.; Jung, Simon] Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland; [Meisterernst, Julia; Klinger-Gratz, Pascal P.; Leidolt, Lars; Lang, Matthias F.; Schroth, Gerhard; Mordasini, Pasquale; Heldner, Mirjam R.; Mono, Marie-Luise; Kurmann, Rebekka; Buehlmann, Monika; Fischer, Urs; Arnold, Marcel; Gralla, Jan; Mettle, Heinrich P.; El-Koussy, Marwan; Jung, Simon] Univ Bern, Bern, Switzerland; [Klinger-Gratz, Pascal P.; Leidolt, Lars; Lang, Matthias F.; Schroth, Gerhard; Mordasini, Pasquale; Gralla, Jan; El-Koussy, Marwan] Univ Hosp Bern, Inselspital, Dept Diagnost & Intervent Neuroradiol, Bern, Switzerland; [Klinger-Gratz, Pascal P.] Univ Basel, Univ Basel Hosp, Dept Radiol, Basel, Switzerland; [Lang, Matthias F.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Basel; University of Bern; University Hospital of Bern	Jung, SM (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland.	simon.jung@insel.ch	Mordasini, Pasquale/H-8321-2015	Fischer, Urs/0000-0003-0521-4051; Heldner, Mirjam R/0000-0002-3594-2159	Swiss Heart Foundation	Swiss Heart Foundation	This work was supported by the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2011, CEREBROVASC DIS, V31, P435, DOI 10.1159/000323850; Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011; Campbell BCV, 2011, CEREBROVASC DIS, V32, P401, DOI 10.1159/000331467; Cho AH, 2008, STROKE, V39, P3424, DOI 10.1161/STROKEAHA.108.516740; Chung JW, 2013, CEREBROVASC DIS, V35, P461, DOI 10.1159/000350201; Dzialowski I, 2007, STROKE, V38, P75, DOI 10.1161/01.STR.0000251644.76546.62; Ebinger M, 2012, STROKE, V43, P539, DOI 10.1161/STROKEAHA.111.632026; Ebinger M, 2010, STROKE, V41, P1823, DOI 10.1161/STROKEAHA.110.583971; Emeriau S, 2015, J NEURORADIOLOGY, V42, P269, DOI 10.1016/j.neurad.2015.04.008; Gilgen MD, 2015, STROKE, V46, P2510, DOI 10.1161/STROKEAHA.115.010250; Gratz PP, 2014, STROKE, V45, P1684, DOI 10.1161/STROKEAHA.114.004796; Hobohm C, 2014, ACTA NEUROL SCAND, V130, P338, DOI 10.1111/ane.12272; Jha R, 2014, STROKE, V45, P1040, DOI 10.1161/STROKEAHA.113.004627; Jung S, 2013, BRAIN, V136, P3554, DOI 10.1093/brain/awt246; Jung S, 2012, STROKE, V43, P1584, DOI 10.1161/STROKEAHA.111.645358; Jung S, 2011, STROKE, V42, P1946, DOI 10.1161/STROKEAHA.110.606038; Kang DW, 2012, STROKE, V43, P3278, DOI 10.1161/STROKEAHA.112.675926; Kase CS, 2001, NEUROLOGY, V57, P1603, DOI 10.1212/WNL.57.9.1603; Kufner A, 2013, EUR J NEUROL, V20, P281, DOI 10.1111/j.1468-1331.2012.03841.x; Luedi R, 2014, J NEUROL, V261, P1622, DOI 10.1007/s00415-014-7401-0; Park JH, 2012, NEUROLOGY, V78, P421, DOI 10.1212/WNL.0b013e318245d22c; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651; Witkowski G, 2014, NEURORADIOLOGY, V56, P825, DOI 10.1007/s00234-014-1407-2; Wouters A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00153	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185158	10.1371/journal.pone.0185158	http://dx.doi.org/10.1371/journal.pone.0185158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957339	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200031
J	Garcia, M; Harris, AL				Garcia, Moctezuma; Harris, Allyssa L.			PrEP awareness and decision-making for Latino MSM in San Antonio, Texas	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV; POSTEXPOSURE	Pre-Exposure Prophylaxis (PrEP) has been promoted among high-risk populations as an effective HIV biomedical intervention. However, limited research is available on the significance of culturally informed biomedical interventions for Latino MSM. A total of 159 selfadministered Internet surveys were completed by Latino MSM ages 21 - 30 in San Antonio, Texas. The purpose of this research was to develop an instrument that measured Latino MSM attitudes and beliefs towards PrEP, identify associations between demographic factors and PrEP related factors and to suggest culturally appropriate strategies for the promotion of PrEP among the Latino MSM population. Research findings revealed implications for PrEP at the structural and individual level for Latino MSM. Structural level indicators emphasized the importance for raising PrEP awareness among Latino MSM in regards to PrEP related expenses, ameliorating stigmatization of high-risk populations, enhancing access to PrEP informed medical providers, and address mistrust of the government and medical providers role on addressing health disparities among Latino MSM. Overall, the findings for individual factors emphasize the need for patient-centered interventions for Latino MSM. Latino MSM currently on PrEP require supplemental resources to enhance PrEP adherence. Latino MSM not on PrEP require alternate options for PrEP delivery and/or cognitive behavioral approaches minimizing HIV risk behavior for Latino MSM concerned with PrEP toxicity, which may require non-biomedical interventions. Integration of Latino MSM currently on PrEP as peer educators provides a valuable resource for developing culturally informed PrEP interventions for Latino MSM. Peer educators are able to share their experiential knowledge of PrEP contextualized through cultural norms, beliefs, and values.	[Garcia, Moctezuma] Texas State Univ, Sch Social Work, San Marcos, TX 78666 USA; [Harris, Allyssa L.] Boston Coll, Connell Sch Nursing, Chestnut Hill, MA 02167 USA	Texas State University System; Texas State University San Marcos; Boston College	Garcia, M (corresponding author), Texas State Univ, Sch Social Work, San Marcos, TX 78666 USA.	m_g558@txstate.edu	Garcia, Moctezuma/I-9860-2019	Garcia, Moctezuma/0000-0002-8703-4929; Harris, Allyssa/0000-0002-5001-1483	Texas State University	Texas State University	Research funding was provided through an internal grant at Texas State University.	Adams J., 1995, RISK, V1st ed.; Arnold T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172354; Ayala George, 2013, J Sex Transm Dis, V2013, P953123, DOI 10.1155/2013/953123; Bauermeister J, 2013, CURRENT HIV RES, V11; Blumenthal J, 2015, AIDS BEHAV, V19, P802, DOI 10.1007/s10461-015-0996-z; Calabrese SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157324; Calabrese SK, 2014, AIDS BEHAV, V18, P226, DOI 10.1007/s10461-013-0675-x; Calabrese SK, 2016, AIDS BEHAV, V20; CDC, 2014, CDCS NEW HIGH IMP AP; CDC, 2016, PREEXP PROPH PREP; Chen Y, 2016, AIDS BEHAV, V20; Collins S, 2016, INT J SEXUAL HLTH, V29; Dolezal C, 2015, AIDS ED PREVENTION, V27; Drabo EF, 2016, CLIN INFECT DIS, V63, P1495, DOI 10.1093/cid/ciw578; Eaton LA, 2015, AIDS PATIENT CARE ST, V29, P423, DOI 10.1089/apc.2014.0303; Elopre L, 2017, JAIDS J ACQUIRED IMM, V74; Elsesser SA, 2016, AIDS BEHAV, V20, P1400, DOI 10.1007/s10461-015-1238-0; Galvan FH, 2017, J BEHAV MED, P1; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; Gersh JK, 2014, J AIDS CLIN RES, V5; Goedel WC, 2016, AIDS BEHAV, V20, P1435, DOI 10.1007/s10461-016-1353-6; Golub SA, 2013, AIDS PATIENT CARE ST, V27; Gomez GB, 2013, PLOS ONE, V10; Graham J., 1998, INJURY PREVENTION, V4; Greene GJ, 2016, AIDS BEHAV, V21; Grov C, 2015, AIDS BEHAV, V19, P2234, DOI 10.1007/s10461-015-1030-1; Heller J, 2015, AM J PUBLIC HEALTH, V105, pE43, DOI 10.2105/AJPH.2014.302284; Hojilla JC, 2016, AIDS BEHAV, V20, P1461, DOI 10.1007/s10461-015-1055-5; Jacobs RJ, 2015, J HIV AIDS SOCIAL SE, V14; Jayakumaran JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145670; Joint Economic Committee, 2015, EC STAT LAT COMM AM; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Kubicek K, 2015, ARCH SEXUAL BEHAV, V44; Lelutiu-Weinberger C, 2016, J ACQUIRED IMMUNE DE, V73; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Marcus JL, 2016, J ACQUIRED IMMUNE DE, V73; Mayer KH, 2017, AIDS BEHAV, V21, P1350, DOI 10.1007/s10461-016-1606-4; McLaughlin ML, 2016, HEALTH COMMUN, V31, P998, DOI 10.1080/10410236.2015.1027033; Merchant RC, 2016, J GAY LESBIAN MENTAL, V20; Mimiaga MJ, 1999, J ACQUIRED IMMUNE DE, V50; Molina JM, C RETR OPP INF; Oldenburg C, 2014, AIDS RES HUM RETROV, V30, pA22, DOI 10.1089/aid.2014.5031.abstract; Parsons J, 2016, AIDS BEHAV, V20; Pines HA, 1999, J ACQUIRED IMMUNE DE, V65; Pritchard A, 2000, LEISURE STUDIES, V19; Raifman JR, 2016, AM J PREVENTIVE MED, V52; Ryan CL, 2016, ED ATTAINMENT US 201; Smith DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156592; Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2; Taylor SW, 2014, AIDS BEHAV, V18, P871, DOI 10.1007/s10461-013-0617-7; Taylor SW, 2017, COGNITIVE BEHAV PRAC, V24; Underhill K, 2016, AIDS BEHAV, V20; Westergaard RP, 2014, J GEN INTERN MED, V29, P140, DOI 10.1007/s11606-013-2554-6	54	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184014	10.1371/journal.pone.0184014	http://dx.doi.org/10.1371/journal.pone.0184014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953905	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300009
J	Herath, TK; Ashby, AJ; Jayasuriya, NS; Bron, JE; Taylor, JF; Adams, A; Richards, RH; Weidmann, M; Ferguson, HW; Taggart, JB; Migaud, H; Fordyce, MJ; Thompson, KD				Herath, Tharangani K.; Ashby, Angela J.; Jayasuriya, Nilantha S.; Bron, James E.; Taylor, John F.; Adams, Alexandra; Richards, Randolph H.; Weidmann, Manfred; Ferguson, Hugh W.; Taggart, John B.; Migaud, Herve; Fordyce, Mark J.; Thompson, Kim D.			Impact of Salmonid alphavirus infection in diploid and triploid Atlantic salmon (Salmo salar L.) fry	PLOS ONE			English	Article							PANCREAS DISEASE PD; POST-SMOLTS; RAINBOW-TROUT; HOST RESPONSE; FRESH-WATER; CHALLENGE; VIRUS; HEART; SUSCEPTIBILITY; PREVALENCE	With increasing interest in the use of triploid salmon in commercial aquaculture, gaining an understanding of how economically important pathogens affect triploid stocks is important. To compare the susceptibility of diploid and triploid Atlantic salmon (Salmo salar L.) to viral pathogens, fry were experimentally infected with Salmonid alphavirus sub-type 1 (SAV1), the aetiological agent of pancreas disease (PD) affecting Atlantic salmon aquaculture in Europe. Three groups of fry were exposed to the virus via different routes of infection: intraperitoneal injection (IP), bath immersion, or cohabitation (co-hab) and untreated fry were used as a control group. Mortalities commenced in the co-hab challenged diploid and triploid fish from 11 days post infection (dpi), and the experiment was terminated at 17 dpi. Both diploid and triploid IP challenged groups had similar levels of cumulative mortality at the end of the experimental period (41.1% and 38.9% respectively), and these were significantly higher (p < 0.01) than for the other challenge routes. A TaqMan-based quantitative PCR was used to assess SAV load in the heart, a main target organ of the virus, and also liver, which does not normally display any pathological changes during clinical infections, but exhibited severe degenerative lesions in the present study. The median viral RNA copy number was higher in diploid fish compared to triploid fish in both the heart and the liver of all three challenged groups. However, a significant statistical difference (p < 0.05) was only apparent in the liver of the co-hab groups. Diploid fry also displayed significantly higher levels of pancreatic and myocardial degeneration than triploids. This study showed that both diploid and triploid fry are susceptible to experimental SAV1 infection. The lower virus load seen in the triploids compared to the diploids may possibly be related to differences in cell metabolism between the two groups, however, further investigation is necessary to confirm this and also to assess the outcome of PD outbreaks in other developmental stages of the fish when maintained in commercial production systems.	[Herath, Tharangani K.; Ashby, Angela J.; Jayasuriya, Nilantha S.; Bron, James E.; Taylor, John F.; Adams, Alexandra; Richards, Randolph H.; Weidmann, Manfred; Taggart, John B.; Migaud, Herve; Thompson, Kim D.] Univ Stirling, Inst Aquaculture, Stirling, Scotland; [Herath, Tharangani K.] Harper Adams Univ, Dept Anim Prod Welf & Vet Sci, Newport, Shrops, England; [Ashby, Angela J.] Fish Vet Grp, Inverness, Scotland; [Ferguson, Hugh W.] St Georges Univ, Sch Vet Med, Marine Med Programme, True Blue, Grenada; [Fordyce, Mark J.] Marine Scotland Sci, Aberdeen, Scotland; [Thompson, Kim D.] Moredun Res Inst, Edinburgh, Midlothian, Scotland	University of Stirling; Marine Scotland Science (MSS); Moredun Research Institute	Herath, TK (corresponding author), Univ Stirling, Inst Aquaculture, Stirling, Scotland.; Herath, TK (corresponding author), Harper Adams Univ, Dept Anim Prod Welf & Vet Sci, Newport, Shrops, England.	therath@harper-adams.ac.uk	Thompson, Kim/GLU-8547-2022; Weidmann, Manfred/G-1817-2015; Bron, James E/B-6231-2018; Migaud, Herve/C-5647-2009; Thompson, Kim/O-7707-2015	Weidmann, Manfred/0000-0002-7063-7491; Bron, James E/0000-0003-3544-0519; Migaud, Herve/0000-0002-5404-7512; Thompson, Kim/0000-0003-3550-4842; Taggart, John/0000-0002-3843-9663; Fordyce, Mark/0000-0002-7899-5445; Adams, Alexandra/0000-0002-2469-3310	Scottish Government, Strategic Partnership for Animal Science Excellence (SPASE) consortium; Innovate UK (AgriTech/0 [101908]; Biotechnology and Biological Sciences Research Council [BB/M013049/1] Funding Source: researchfish; BBSRC [BB/M013049/1] Funding Source: UKRI	Scottish Government, Strategic Partnership for Animal Science Excellence (SPASE) consortium; Innovate UK (AgriTech/0; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Scottish Government, Strategic Partnership for Animal Science Excellence (SPASE) consortium, http://spasepartnership.org/index.html, Received funding RR (PI), KT, AA, JB, JBT, and the Innovate UK (AgriTech; 101908) project on triploid salmon, https://connect.innovateuk.org/web/biosciencesktn/agri-tech-catalyst, Received funding- HM and JFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, DIS AQUAT ORGAN, V59, P217; Benfey T. J., 2015, REV AQUAC; Biacchesi S, 2016, VET RES, V47, DOI 10.1186/s13567-015-0301-1; Braceland M, 2013, J PROTEOMICS, V94, P423, DOI 10.1016/j.jprot.2013.10.016; Cano I, 2015, J FISH DIS, V38, P271, DOI 10.1111/jfd.12310; Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169; Ching B, 2010, HEREDITY, V104, P224, DOI 10.1038/hdy.2009.108; Christie KE, 2007, DIS AQUAT ORGAN, V75, P13, DOI 10.3354/dao075013; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; Falk T, 2000, J SMALL ANIM PRACT, V41, P97, DOI 10.1111/j.1748-5827.2000.tb03173.x; FERGUSON HW, 1986, J FISH DIS, V9, P95, DOI 10.1111/j.1365-2761.1986.tb00987.x; Frenzl B, 2014, PEST MANAG SCI, V70, P982, DOI 10.1002/ps.3639; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Graham DA, 2011, J FISH DIS, V34, P273, DOI 10.1111/j.1365-2761.2010.01234.x; Herath T, 2009, ICELAND AGR SCI, V22, P19; Herath TK, 2013, VET IMMUNOL IMMUNOP, V155, P9, DOI 10.1016/j.vetimm.2013.05.011; Herath TK, 2012, FISH SHELLFISH IMMUN, V32, P796, DOI 10.1016/j.fsi.2012.02.001; Hodneland K, 2006, J VIROL METHODS, V131, P184, DOI 10.1016/j.jviromet.2005.08.012; Jansen MD, 2010, J FISH DIS, V33, P391, DOI 10.1111/j.1365-2761.2009.01131.x; Kawa S, 2007, HEPATOL RES, V37, pS487, DOI 10.1111/j.1872-034X.2007.00235.x; Kilburn R, 2012, AQUACULTURE, V368, P89, DOI 10.1016/j.aquaculture.2012.09.004; Larsson T, 2012, AQUACULTURE, V330, P82, DOI 10.1016/j.aquaculture.2011.12.016; Leclercq E, 2011, COMP BIOCHEM PHYS A, V158, P116, DOI 10.1016/j.cbpa.2010.09.018; McCleary S, 2014, DIS AQUAT ORGAN, V109, P1, DOI 10.3354/dao02719; McLoughlin MF, 2006, DIS AQUAT ORGAN, V72, P125, DOI 10.3354/dao072125; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; McLoughlin M. F., 1995, Journal of Aquatic Animal Health, V7, P104, DOI 10.1577/1548-8667(1995)007&lt;0104:POEPDI&gt;2.3.CO;2; McLoughlin MF, 1996, DIS AQUAT ORGAN, V26, P117, DOI 10.3354/dao026117; McLoughlin MF, 2002, J FISH DIS, V25, P33, DOI 10.1046/j.1365-2761.2002.00334.x; NELSON RT, 1995, DIS AQUAT ORGAN, V22, P25, DOI 10.3354/dao022025; Nichols Krista M., 2009, P195, DOI 10.1002/9780813807379.ch8; Noguera PA, 2010, J FISH DIS, V33, P819, DOI 10.1111/j.1365-2761.2010.01193.x; Norris A, 2008, J FISH DIS, V31, P913, DOI 10.1111/j.1365-2761.2008.00982.x; Ozerov MY, 2010, DIS AQUAT ORGAN, V91, P129, DOI 10.3354/dao02242; Phillips AT, 2014, J VIROL, V88, P1771, DOI 10.1128/JVI.02297-13; Rimstad E, 2011, AQUAC RES, V42, P86, DOI 10.1111/j.1365-2109.2010.02670.x; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Sadler J, 2000, AQUACULTURE, V184, P349, DOI 10.1016/S0044-8486(99)00321-X; Taksdal T, 2007, J FISH DIS, V30, P545, DOI 10.1111/j.1365-2761.2007.00845.x; Taylor JF, 2013, AQUACULTURE, V410, P41, DOI 10.1016/j.aquaculture.2013.06.004; Watson PJ, 2010, J SMALL ANIM PRACT, V51, P566, DOI 10.1111/j.1748-5827.2010.00996.x; Weber GM, 2013, AQUACULTURE, V410, P66, DOI 10.1016/j.aquaculture.2013.06.014; Yousaf MN, 2013, VET IMMUNOL IMMUNOP, V151, P49, DOI 10.1016/j.vetimm.2012.10.004	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0179192	10.1371/journal.pone.0179192	http://dx.doi.org/10.1371/journal.pone.0179192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949966	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000411671000001
J	Labiran, C; Rowen, D; Clarke, IN; Marsh, P				Labiran, Clare; Rowen, David; Clarke, Ian Nicholas; Marsh, Peter			Detailed molecular epidemiology of Chlamydia trachomatis in the population of Southampton attending the genitourinary medicine clinic in 2012-13 reveals the presence of long established genotypes and transitory sexual networks	PLOS ONE			English	Article							STRAINS; CLUSTERS; MEN	Chlamydia trachomatis is the most common sexually transmitted infection (STI) in England. Our objective was to perform a detailed survey of the molecular epidemiology of C. trachomatis in the population of Southampton UK attending the genitourinary medicine clinic (GUM) to seek evidence of sexual network activity. Our hypothesis was that certain genotypes can be associated with specific demographic determinants. 380 positive samples were collected from 375 C. trachomatis positive GUM attendees out of the 3118 who consented to be part of the survey. 302 of the positive samples were fully genotyped. All six of the predominant genotypes possessed ompA locus type E. One ward of Southampton known to contain a large proportion of students had a different profile of genotypes compared to other areas of the city. Some genotypes appeared embedded in the city population whilst others appeared transient. Predominant circulating genotypes remain stable within a city population whereas others are sporadic. Sexual networks could be inferred but not conclusively identified using the data from this survey.	[Labiran, Clare; Clarke, Ian Nicholas] Univ Southampton, Fac Med, Mol Microbiol, Clin & Expt Sci, Southampton, Hants, England; [Rowen, David] Royal South Hants Hosp, Dept GU Med, Southampton, Hants, England; [Marsh, Peter] Southampton Gen Hosp, Publ Hlth England, Publ Hlth Lab Southampton, Southampton, Hants, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital; Public Health England; University of Southampton	Marsh, P (corresponding author), Southampton Gen Hosp, Publ Hlth England, Publ Hlth Lab Southampton, Southampton, Hants, England.	Peter.Marsh@suht.swest.nhs.uk		Marsh, Peter/0000-0001-7073-7268; Clarke, Ian/0000-0002-4938-1620	Health Protection Agency PhD fund [2010/001]	Health Protection Agency PhD fund	This work was funded by the Health Protection Agency PhD fund in 2010, reference number 2010/001.	Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Christerson L, 2012, J CLIN MICROBIOL, V50, P3548, DOI 10.1128/JCM.01713-12; de Vries HJC, 2015, CURR OPIN INFECT DIS, V28, P61, DOI 10.1097/QCO.0000000000000129; DEAN D, 1995, J INFECT DIS, V172, P1013, DOI 10.1093/infdis/172.4.1013; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Vaulet LG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153511; Geisler WM, 2006, SEX TRANSM DIS, V33, P621, DOI 10.1097/01.olq.0000216027.71144.74; Gharsallah H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-333; Harris SR, 2012, NATURE GENETICS; Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jurstrand M, 2001, J CLIN MICROBIOL, V39, P3915, DOI 10.1128/JCM.39.11.3915-3919.2001; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Labiran C, 2016, SEX TRANSM INFECT, V92, P299, DOI 10.1136/sextrans-2015-052261; Labiran C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00068; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; Moslonka-Lefebvre M, 2012, J THEOR BIOL, V311, P46, DOI 10.1016/j.jtbi.2012.06.031; OfNSd, 2001, PORTSW WARD NAT STAT; ONS, 2014, CONC STAT ENG WAL; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Peuchant O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031538; PHE, 2016, HLTH PROTECTION REPO, V10; Qin X, 2016, PLOS ONE, V11; Ripa T, 2007, SEX TRANSM DIS, V34, P255, DOI 10.1097/OLQ.0b013e31805ce2b9; Satoh M, 2014, J INFECT CHEMOTHER, V20, P656, DOI 10.1016/j.jiac.2014.06.010; UCdd, 2011, UK CENS DAT PORTSW 2; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016971	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9								10.1371/journal.pone.0185059	http://dx.doi.org/10.1371/journal.pone.0185059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945766	Green Published, Green Accepted, gold			2022-12-26	WOS:000411645100018
J	Sarabdjitsingh, RA; Loi, M; Joels, M; Dijkhuizen, RM; van der Toorn, A				Sarabdjitsingh, R. Angela; Loi, Manila; Joels, Marian; Dijkhuizen, Rick M.; van der Toorn, Annette			Early life stress-induced alterations in rat brain structures measured with high resolution MRI	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; HIPPOCAMPAL VOLUME; MATTER VOLUME; WHITE-MATTER; MAJOR DEPRESSION; CHILDHOOD TRAUMA; SEXUAL-ABUSE; DISORDER; MALTREATMENT; BEHAVIOR	Adverse experiences early in life impair cognitive function both in rodents and humans. In humans this increases the vulnerability to develop mental illnesses while in the rodent brain early life stress (ELS) abnormalities are associated with changes in synaptic plasticity, excitability and microstructure. Detailed information on the effects of ELS on rodent brain structural integrity at large and connectivity within the brain is currently lacking; this information is highly relevant for understanding the mechanism by which early life stress predisposes to mental illnesses. Here, we exposed rats to 24 hours of maternal deprivation (MD) at postnatal day 3, a paradigm known to increase corticosterone levels and thereby activate glucocorticoid receptors in the brain. Using structural magnetic resonance imaging we examined: i) volumetric changes and white/grey matter properties of the whole cerebrum and of specific brain areas; and ii) whether potential alterations could be normalized by blocking glucocorticoid receptors with mifepristone during the critical developmental window of early adolescence, i.e. between postnatal days 26 and 28. The results show that MD caused a volumetric reduction of the prefrontal cortex, particularly the ventromedial part, and the orbitofrontal cortex. Within the whole cerebrum, white (relative to grey) matter volume was decreased and region-specifically in prefrontal cortex and dorsomedial striatum following MD. A trend was found for the hippocampus. Grey matter fractions were not affected. Treatment with mifepristone did not normalize these changes. This study indicates that early life stress in rodents has long lasting consequences for the volume and structural integrity of the brain. However, changes were relatively modest and-unlike behavior-not mitigated by blockade of glucocorticoid receptors during a critical developmental period.	[Sarabdjitsingh, R. Angela; Loi, Manila; Joels, Marian] Univ Utrecht, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Joels, Marian] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Dijkhuizen, Rick M.; van der Toorn, Annette] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Images Sci, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; Utrecht University; Utrecht University Medical Center	Sarabdjitsingh, RA (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	r.a.sarabdjitsingh@umcutrecht.nl	Joëls, Marian/P-6415-2016	Joels, Marian/0000-0002-4826-6209; Dijkhuizen, Rick/0000-0002-4623-4078	Netherlands Organization for Scientific Research with Veni [863.13.021, 024.001.003]	Netherlands Organization for Scientific Research with Veni	This work was supported by the Netherlands Organization for Scientific Research with Veni grant 863.13.021 to RAS, Gravitation grant 024.001.003 to MJ (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Arp JM, 2016, NEUROBIOL LEARN MEM, V133, P30, DOI 10.1016/j.nlm.2016.05.009; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; Cirulli F, 2003, NEUROSCI BIOBEHAV R, V27, P73, DOI 10.1016/S0149-7634(03)00010-1; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; Palacios RDY, 2011, BIOL PSYCHIAT, V70, P449, DOI 10.1016/j.biopsych.2011.05.014; Fan Y, 2015, NEUROPSYCHOPHARMACOL, V40, P2736, DOI 10.1038/npp.2015.123; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; Gorka AX, 2014, BIOL MOOD ANXIETY DI, V4, DOI 10.1186/2045-5380-4-12; Halligan SL, 2007, BIOL PSYCHIAT, V62, P40, DOI 10.1016/j.biopsych.2006.09.011; Hanson JL, 2015, BIOL PSYCHIAT, V77, P314, DOI 10.1016/j.biopsych.2014.04.020; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; Hedges DW, 2011, PSYCHOPHARMACOLOGY, V214, P121, DOI 10.1007/s00213-010-2090-6; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Henckens MJAG, 2015, NEUROIMAGE, V105, P312, DOI 10.1016/j.neuroimage.2014.10.037; Herpfer I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046004; Martinez-Tellez RI, 2009, SYNAPSE, V63, P794, DOI 10.1002/syn.20664; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Koolschijn PCMP, 2013, EUR NEUROPSYCHOPHARM, V23, P622, DOI 10.1016/j.euroneuro.2012.07.001; Leao P, 2007, SYNAPSE, V61, P40, DOI 10.1002/syn.20341; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; Molet J, 2016, HIPPOCAMPUS, V26, P1618, DOI 10.1002/hipo.22661; Naninck EFG, 2015, HIPPOCAMPUS, V25, P309, DOI 10.1002/hipo.22374; Nishi M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00166; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2011, PSYCHOPHARMACOLOGY, V214, P249, DOI 10.1007/s00213-010-1922-8; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Tse YC, 2014, HIPPOCAMPUS, V24, P1120, DOI 10.1002/hipo.22296; Tsoory M, 2006, INT J NEUROPSYCHOPH, V9, P713, DOI 10.1017/S1461145705006255; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Walsh ND, 2014, NEUROIMAGE-CLIN, V4, P308, DOI 10.1016/j.nicl.2014.01.001; Weinberg MS, 2010, NEUROSCIENCE, V168, P744, DOI 10.1016/j.neuroscience.2010.04.006; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Whittle S, 2011, DEV PSYCHOPATHOL, V23, P115, DOI 10.1017/S0954579410000684; Yan CG, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.276; Young AH, 2004, NEUROPSYCHOPHARMACOL, V29, P1538, DOI 10.1038/sj.npp.1300471; Zhang LX, 2002, DEV BRAIN RES, V133, P1, DOI 10.1016/S0926-6410(01)00118-5	61	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185061	10.1371/journal.pone.0185061	http://dx.doi.org/10.1371/journal.pone.0185061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945761	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100019
J	Prajzlerova, K; Grobelna, K; Husakova, M; Forejtova, S; Jungel, A; Gay, S; Vencovsky, J; Pavelka, K; Senolt, L; Filkova, M				Prajzlerova, Klara; Grobelna, Kristyna; Husakova, Marketa; Forejtova, Sarka; Juengel, Astrid; Gay, Steffen; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav; Filkova, Maria			Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis	PLOS ONE			English	Article							SOCIETY CLASSIFICATION CRITERIA; DISEASE-ACTIVITY; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; ANKYLOSING-SPONDYLITIS; BONE-FORMATION; EXPRESSION; MICRORNAS; BIOMARKERS; ARTHRITIS	Objectives Dysregulation of miRNAs and their target genes contributes to the pathophysiology of autoimmune diseases. Circulating miRNAs may serve as diagnostic/prognostic biomarkers. We aimed to investigate the association between circulating miRNAs, disease activity and spinal involvement in patients with axial spondyloarthritis (AxSpA). Methods Total RNA was isolated from the plasma of patients with non-radiographic (nr) AxSpA, patients with ankylosing spondylitis (AS) and healthy controls (HC) via phenol-chloroform extraction. A total of 760 miRNAs were analysed with TaqMan (R) Low Density Arrays, and the expression of 21 miRNAs was assessed using single assays. Results Comprehensive analysis demonstrated the differential expression of miRNAs among patients with progressive spinal disease. Of the 21 miRNAs selected according to their expression patterns, the levels of miR-625-3p were significantly different between nr-AxSpA patients and HCs. We found no correlation between miRNA levels and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in nr-AxSpA patients. Selected miRNAs, such as miR-29a-3p, miR-146a-5p or miR-222-3p with an established role in extracellular matrix formation and inflammation were associated with spinal changes and/or disease activity assessed by BASDAI in AS patients, including miR-625-3p reflecting disease activity in AS with spinal involvement. Conclusions Our data indicate that circulating miRNAs play a role in the pathogenesis of AxSpA and are also suggestive of their potential as biomarkers of disease progression. We hypothesize that differential systemic levels of miRNA expression reflect miRNA dysregulation at sites of spinal inflammation or bone formation where these molecules contribute to the development of pathophysiological features typical of AxSpA.	[Prajzlerova, Klara; Grobelna, Kristyna; Husakova, Marketa; Forejtova, Sarka; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav; Filkova, Maria] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic; [Prajzlerova, Klara; Grobelna, Kristyna; Husakova, Marketa; Forejtova, Sarka; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav; Filkova, Maria] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic; [Juengel, Astrid; Gay, Steffen] Univ Hosp Zurich, Ctr Expt Rheumatol, Zurich, Switzerland	Charles University Prague; Institute of Rheumatology; Charles University Prague; University of Zurich; University Zurich Hospital	Prajzlerova, K (corresponding author), Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic.; Prajzlerova, K (corresponding author), Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic.	prajzierova@revma.cz	Pavelka, Karel/E-6578-2017; Bubova, Kristyna/AAD-2275-2019; Vencovsky, Jiri/G-6094-2017; Husakova, Marketa/C-6687-2019; Filkova, Maria/M-9307-2017	Pavelka, Karel/0000-0003-1952-8422; Bubova, Kristyna/0000-0002-4903-1022; Vencovsky, Jiri/0000-0002-0851-0713; Husakova, Marketa/0000-0002-6867-4373; Filkova, Maria/0000-0002-8488-9227	Ministry of Health of the Czech Republic for conceptual research development [023728, 17-33127A]	Ministry of Health of the Czech Republic for conceptual research development	This work was financially supported by a project of the Ministry of Health of the Czech Republic for conceptual research development number 023728 and grant project 17-33127A. There is no financial support or other benefits from commercial sources for the work reported on in the manuscript.	Azevedo VF, 2013, RHEUMATOL INT, V33, P1779, DOI 10.1007/s00296-012-2631-x; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Braun J, 2002, ANN RHEUM DIS     S3, V61, piii9; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Carlsen AL, 2013, ARTHRITIS RHEUM-US, V65, P1324, DOI 10.1002/art.37890; Castro-Villegas C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0555-z; de la Rica L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0561-5; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Filkova M, 2014, ANN RHEUM DIS, V73, P1898, DOI 10.1136/annrheumdis-2012-202815; Filkova M, 2012, BIODRUGS, V26, P131, DOI 10.2165/11631480-000000000-00000; Fukuda T, 2015, FEBS LETT, V589, P3302, DOI 10.1016/j.febslet.2015.09.024; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hong Z, 2015, MEDIAT INFLAMM, V2015; Huang JX, 2014, MOD RHEUMATOL, V24, P331, DOI 10.3109/14397595.2013.854077; Landskroner-Eiger S, 2015, P NATL ACAD SCI USA, V112, P12812, DOI 10.1073/pnas.1507094112; Le LT, 2015, J MOL MED; Li HL, 2013, STEM CELL RES, V10, P313, DOI 10.1016/j.scr.2012.11.007; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; Lv Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504208; M'Baya-Moutoula E, 2015, BBA-MOL BASIS DIS, V1852, P2202, DOI 10.1016/j.bbadis.2015.08.003; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991; Peng JS, 2016, ARTHRITIS RHEUMATOL, V68, P370, DOI 10.1002/art.39446; Prajzlerova K, 2016, AUTOIMMUN REV, V15, P501, DOI 10.1016/j.autrev.2016.02.002; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P770, DOI 10.1136/ard.2009.108217; Sieper J, 2008, ARTHRITIS RHEUM-US, V58, P649, DOI 10.1002/art.23260; Sieper J, 2013, ANN RHEUM DIS, V72, P815, DOI 10.1136/annrheumdis-2012-201766; Song J, 2015, BBA CLIN, V3, P79, DOI 10.1016/j.bbacli.2014.11.009; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Xie Y, 2015, MOLECULES, V20, P19433, DOI 10.3390/molecules201019433; Xu HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124425; Yu FC, 2011, BIOSCI TRENDS, V5, P46, DOI 10.5582/bst.2011.v5.2.46; Zhao WG, 2015, INT J MOL SCI, V16, P11699, DOI 10.3390/ijms160511699	38	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185323	10.1371/journal.pone.0185323	http://dx.doi.org/10.1371/journal.pone.0185323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938006	gold, Green Published, Green Accepted			2022-12-26	WOS:000411524700026
J	Rocheleau, G; Franco-Villalobos, C; Oliveira, N; Brumme, ZL; Rusch, M; Shoveller, J; Brumme, CJ; Harrigan, PR				Rocheleau, Genevieve; Franco-Villalobos, Conrado; Oliveira, Natalia; Brumme, Zabrina L.; Rusch, Melanie; Shoveller, Jeannie; Brumme, Chanson J.; Harrigan, P. Richard			Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; RISK-FACTORS; ADHERENCE; HEALTH; TUBERCULOSIS; CARE; PREDICTORS; MUTATIONS; RESPONSES	Sociodemographic correlates of engagement in human immunodeficiency virus (HIV) care are well studied, however the association with accessing drug resistance testing (DRT) and the development of drug resistance have not been characterized. Between 1996 - 2014, 11 801 HIV patients accessing therapy in British Columbia were observed longitudinally. A subset of 9456 patients had testable viral load; of these 8398 were linked to census data. Sociodemographic (census tract-level) and clinical (individual-level) correlates of DRT were assessed using multivariable General Estimating Equation logistic regression adjusted odds ratios (aOR). The mean number of tests per patient was 2.1 (Q1-Q3; 0-3). Separately, any drug resistance was determined using IAS-USA (2013) list for 5703 initially treatment naive patients without baseline resistance; 5175 were census-linked (mean of 1.5 protease-reverse transcriptase sequences/patient, Q1-Q3; 0-2). Correlates of detecting drug resistance in this subset were analyzed using Cox PH regression adjusted hazard ratios (aHR). Our results indicate baseline CD4 < 200 cells/L (aOR: 1.5, 1.3-1.6), nRTIonly baseline regimens (aOR: 1.4, 1.3 -1.6), and unknown (therapy initiation before routine pVL in BC) baseline pVL (aOR: 1.8, 1.5 - 2.1) were among individual-level clinical covariates strongly associated with having accessed DRT; while imperfect adherence (aHR: 2.2, 1.9- 2.5), low baseline CD4 count (aHR: 1.9, 1.6 -2.3), and high baseline pVL (aHR: 2.0, 1.6 - 2.6) were associated with a higher likelihood of developing drug resistance. A higher median income (aOR: 0.83, 0.77 - 0.89) and higher percentage of those with aboriginal ancestry (aOR: 0.85, 0.76 - 0.95) were census tract-level sociodemographic covariates associated with decreased access to DRT. Similarly, aboriginal ancestry (aHR: 1.2, 1.1 - 1.5) was associated with development of drug resistance. In conclusion, clinical covariates continue to be the strongest correlates of development of drug resistance and access to DRT for individuals. Regions of high median income and high aboriginal ancestry were weak census-level sociodemographic indicators of reduced DRT uptake, however high aboriginal ancestry was the only sociodemographic indicator for development of drug resistance.	[Rocheleau, Genevieve; Harrigan, P. Richard] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Rocheleau, Genevieve; Franco-Villalobos, Conrado; Oliveira, Natalia; Brumme, Zabrina L.; Shoveller, Jeannie; Brumme, Chanson J.; Harrigan, P. Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Rusch, Melanie] Vancouver Isl Hlth Author, Victoria, BC, Canada; [Shoveller, Jeannie] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Vancouver Island Health Authority; University of British Columbia	Harrigan, PR (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.; Harrigan, PR (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	prharrigan@cfenet.ubc.ca		Brumme, Chanson/0000-0003-2722-5288; Rocheleau, Genevieve/0000-0003-4347-8015; Brumme, Zabrina/0000-0002-8157-1037	Providence Health Care; Genome BC; Genome Canada; Genome Quebec; Canadian Institutes of Health Research; Partnership in Genomics and Personalized Health [HIV142]; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research Postdoctoral Fellowship [MFE-146750]	Providence Health Care; Genome BC; Genome Canada(Genome Canada); Genome Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Partnership in Genomics and Personalized Health; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR))	This work received support from Providence Health Care (http://www.providencehealthcare.org/) for providing operational funding; Genome BC (https://www.genomebc.ca/), Genome Canada (https://www.genomecanada.ca/), Genome Quebec (http://www.genomequebec.com/en/home.html), and Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) Partnership in Genomics and Personalized Health provided a Large-Scale Applied Research Project HIV142 contract to RH; the Scholar Award from Michael Smith Foundation for Health Research (http://www.msfhr.org/our-work/activities/scholar-awards) for salary support provided to ZB; and the Canadian Institutes of Health Research Postdoctoral Fellowship (http://www.cihr-irsc.gc.ca/e/44244.html) for stipend support provided to CB (MFE-146750).	Alexander CS, 2001, AIDS, V15, P601, DOI 10.1097/00002030-200103300-00009; Barroso Elizabeth Clara, 2003, J. Pneumologia, V29, P89, DOI 10.1590/S0102-35862003000200008; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bolsewicz K, 2015, AIDS CARE, V27, P570, DOI 10.1080/09540121.2014.986050; British Columbia Center for Excellence in HIV/AIDS, 2015, PRIM CAR GUID MAN HI; British Columbia Centre for Excellence in HIV/AIDS, 2006, THER GUID ANT THER H; British Columbia Centre for Excellence in HIV/AIDS, 1999, THER GUID TREATM HIV; Brumme C, 2017, CLIN MICROBIOL INFEC; Chambers LA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2197-0; Cunningham CO, 2007, AIDS PATIENT CARE ST, V21, P177, DOI 10.1089/apc.2006.103; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents Office of AIDS Research Advisory Council (OARAC), 2016, GUID US ANT AG HIV 1; DiNenno E., 2015, COMMUNITIES CRISIS I; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; *GEN COD CORP, SEQ VERS 5 4 6 DNA S; Giordano TP, 2010, TOP ANTIVIR MED, V19, P12; Godin G, 2005, AIDS CARE, V17, P493, DOI 10.1080/09540120412331291715; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Gwadz M, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00062; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Harrigan PR, 1999, AIDS, V13, P1863, DOI 10.1097/00002030-199910010-00008; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Kinsler JJ, 2007, AIDS PATIENT CARE ST, V21, P584, DOI 10.1089/apc.2006.0202; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Long C, 2014, INT J DRUG POLICY, V25, P458, DOI 10.1016/j.drugpo.2013.11.011; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012; Montaner JSG, 2000, J INFECT DIS, V181, P729, DOI 10.1086/315243; Montaner JSG, 2001, AIDS, V15, P61, DOI 10.1097/00002030-200101050-00010; NIH, 2014, GUID US ANT AG HIV 1; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Pande JN, 2005, CHEST, V128, p404S, DOI 10.1378/chest.128.4_MeetingAbstracts.404S-a; R Core Team, 2018, R LANG ENV STAT COMP; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; SAS Institute Inc, 2013, SAS 9 4 SOFTW; Smith WR, 2015, STATCAN BLOG; Statistics Canada, 2011, 2011 CENS AB PEOPL C; Suarez-Garcia I, 2009, EUR J CLIN MICROBIOL, V28, P325, DOI 10.1007/s10096-008-0627-y; Vandenbroucke J.P., 2007, STRENGTHENING REPORT; Walmsley SL, 2001, ANTIVIR THER, V6, P47; Wood E, 2003, CAN MED ASSOC J, V169, P656; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							0184848	10.1371/journal.pone.0184848	http://dx.doi.org/10.1371/journal.pone.0184848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937991	Green Published, Green Submitted, gold			2022-12-26	WOS:000411524700011
J	Affram, K; Udofot, O; Singh, M; Krishnan, S; Reams, R; Rosenberg, J; Agyare, E				Affram, Kevin; Udofot, Ofonime; Singh, Mandip; Krishnan, Sunil; Reams, Renee; Rosenberg, Jens; Agyare, Edward			Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging	PLOS ONE			English	Article							TEMPERATURE-SENSITIVE LIPOSOME; PANCREATIC-CANCER; CONTRAST AGENTS; DRUG-DELIVERY; GEMCITABINE; EFFICACY; PHARMACOKINETICS; HYPERTHERMIA; RELEASE; MODEL	In numerous studies, liposomes have been used to deliver anticancer drugs such as doxorubicin to local heat-triggered tumor. Here, we investigate: (i) the ability of thermosensitive liposomal nanoparticle (TSLnp) as a delivery system to deliver poorly membrane-permeable anticancer drug, gemcitabine (Gem) to solid pancreatic tumor with the aid of local mild hyperthermia and, (ii) the possibility of using gadolinium (Magnevist (R)) loaded-TSLnps (Gd-TSLnps) to increase magnetic resonance imaging (MRI) contrast in solid tumor. In this study, we developed and tested gemcitabine-loaded thermosensitive liposomal nanoparticles (Gem-TSLnps) and gadolinium-loaded thermosensitive liposomal nanoparticles (Gd-TSLnps) both in in-vitro and in-vivo. The TSLnps exhibited temperature-dependent release of Gem, at 40-42 degrees C, 65% of Gem was released within 10 min, whereas <23% Gem leakage occurred at 37 degrees C after a period of 2 h. The pharmacokinetic parameters and tissue distribution of both Gem-TSLnps and Gd-TSLnps were significantly greater compared with free Gem and Gd, while Gem-TSLnps plasma clearance was reduced by 17-fold and that of Gd-TSLpns was decreased by 2-fold. Area under the plasma concentration time curve (AUC) of Gem-TSLnps (35.17 +/- 0.04 mu ghr/mL) was significantly higher than that of free Gem (2.09 +/- 0.01 mu ghr/mL) whereas, AUC of Gd-TSLnps was higher than free Gd by 3.9 fold high. TSLnps showed significant Gem accumulation in heated tumor relative to free Gem. Similar trend of increased Gd-TSLnps accumulation was observed in non-heated tumor compared to that of free Gd; however, no significant difference in MRI contrast enhancement between free Gd and Gd-TSLnps ex-vivo tumor images was observed. Despite Gem-TSLnps dose being half of free Gem dose, antitumor efficacy of Gem-TSLnps was comparable to that of free Gem(Gem-TSLnps 10 mg Gem/kg compared with free Gem 20 mg/kg). Overall, the findings suggest that TSLnps may be used to improve Gem delivery and enhance its antitumor activity. However, the formulation of Gd-TSLnp needs to be fully optimized to significantly enhance MRI contrast in tumor.	[Affram, Kevin; Udofot, Ofonime; Singh, Mandip; Reams, Renee; Agyare, Edward] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Krishnan, Sunil] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Rosenberg, Jens] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Udofot, Ofonime] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	State University System of Florida; Florida A&M University; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; Florida State University; University of Iowa	Agyare, E (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	edward.agyare@famu.edu		Sachdeva, Mandip/0000-0001-9192-8143; Agyare, Edward/0000-0002-6905-5136	NIH/RCMI [5G12MD007582-32]; NIH/NCI [5P20CA192990-03]; NATIONAL CANCER INSTITUTE [P20CA192990] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582] Funding Source: NIH RePORTER	NIH/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH/RCMI #5G12MD007582-32 and NIH/NCI #5P20CA192990-03.; The authors acknowledge the financial assistance provided by the NIH/RCMI #5G12MD00758232 and NIH/NCI #5P20CA192990-03. The authors would like to thank Anna Cat for her assistance in designing the graphical abstract.	Affram Kevin, 2015, Integr Cancer Sci Ther, V2, P133; Agyare EK, 2014, J CONTROL RELEASE, V185, P121, DOI 10.1016/j.jconrel.2014.04.010; Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102; Allen Y DaC, 2015, THERMOSENSITIVE LIPO; Apparaju SK, 2008, CANCER CHEMOTH PHARM, V61, P223, DOI 10.1007/s00280-007-0464-1; Arpicco S, 2013, EUR J PHARM BIOPHARM, V85, P373, DOI 10.1016/j.ejpb.2013.06.003; Aydin RST, 2012, J NANOMATER, V2012, DOI 10.1155/2012/313961; Brusa P, 2007, ANTICANCER RES, V27, P195; Ciccolini J, 2016, CANCER CHEMOTH PHARM, V78, P1, DOI 10.1007/s00280-016-3003-0; Cosco D, 2012, INT J NANOMED, V7, P2535, DOI [10.2147/IJN.S28114, 10.2147/IJN.S34025]; Dash S, 2010, ACTA POL PHARM, V67, P217; de Smet M, 2013, INVEST RADIOL, V48, P395, DOI 10.1097/RLI.0b013e3182806940; de Smet M, 2010, J CONTROL RELEASE, V143, P120, DOI 10.1016/j.jconrel.2009.12.002; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dumstrei K, 2016, ONCOTARGET, V7, P11151, DOI 10.18632/oncotarget.7098; Ernsting MJ, 2013, J CONTROL RELEASE, V172, P782, DOI 10.1016/j.jconrel.2013.09.013; Fox RG, 2016, NATURE, V534, P407, DOI 10.1038/nature17988; Fu R, 2005, J MAGN RESON, V177, P1, DOI 10.1016/j.jmr.2005.07.013; Ghaghada K, 2008, ACAD RADIOL, V15, P1259, DOI 10.1016/j.acra.2008.04.018; Ghaghada KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007628; Hanada K, 2015, J GASTROENTEROL, V50, P147, DOI 10.1007/s00535-014-1026-z; Humbert M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009430; Hylander BL, 2015, J CONTROL RELEASE, V217, P160, DOI 10.1016/j.jconrel.2015.08.047; Immordino ML, 2004, J CONTROL RELEASE, V100, P331, DOI 10.1016/j.jconrel.2004.09.001; Ji TJ, 2016, ACS APPL MATER INTER, V8, P3438, DOI 10.1021/acsami.5b11619; Kaasgaard T, 2003, BIOPHYS J, V85, P350, DOI 10.1016/S0006-3495(03)74479-8; Ketan B, 2009, PLOS ONE, V4, P1; Kong G, 2000, CANCER RES, V60, P6950; Lanz C, 2007, J SEP SCI, V30, P1811, DOI 10.1002/jssc.200600534; Li L, 2013, J CONTROL RELEASE, V167, P130, DOI 10.1016/j.jconrel.2013.01.026; Liu XS, 2016, ACS NANO, V10, P2702, DOI 10.1021/acsnano.5b07781; Liu YJ, 2015, FOOD RES INT, V74, P97, DOI 10.1016/j.foodres.2015.04.024; Lokling KE, 2001, MAGN RESON IMAGING, V19, P731, DOI 10.1016/S0730-725X(01)00380-0; Luedke E, 2012, J IMMUNOTHER, V35, P367, DOI 10.1097/CJI.0b013e3182562d76; Luo H, 2016, CLIN CANC RES OFFICI; Mondal G, 2016, BIOMACROMOLECULES, V17, P301, DOI 10.1021/acs.biomac.5b01419; Nakamura H, 2015, J CONTROL RELEASE, V220, P406, DOI 10.1016/j.jconrel.2015.11.002; Needham D, 2000, CANCER RES, V60, P1197; Needham D, 2013, FARADAY DISCUSS, V161, P515, DOI 10.1039/c2fd20111a; Paolino D, 2010, J CONTROL RELEASE, V144, P144, DOI 10.1016/j.jconrel.2010.02.021; Qi H, 2016, J PHARM SCI; Rao M. A., 2014, FLOW FUNCTIONAL MODE, P27, DOI DOI 10.1007/978-1-4614-9230-6_2; Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051; SONG CW, 1984, CANCER RES, V44, P4721; Steffe JF, 1996, BIOPROCESSING PIPELI; Ta T, 2013, J CONTROL RELEASE, V169, P112, DOI 10.1016/j.jconrel.2013.03.036; Tagami T, 2011, BIOMATERIALS, V32, P6570, DOI 10.1016/j.biomaterials.2011.05.029; Tangutoori S, 2016, NANOMED-NANOTECHNOL, V12, P223, DOI 10.1016/j.nano.2015.08.007; Wang THM, 2010, IFMBE P, V25, P3; Xu HT, 2015, PHARM RES-DORDR, V32, P2428, DOI 10.1007/s11095-015-1635-0	50	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185116	10.1371/journal.pone.0185116	http://dx.doi.org/10.1371/journal.pone.0185116			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934281	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900094
J	Ellsworth, SG; Rabatic, BM; Chen, J; Zhao, J; Campbell, J; Wang, WL; Pi, WH; Stanton, P; Matuszak, M; Jolly, S; Miller, A; Kong, FM				Ellsworth, Susannah G.; Rabatic, Bryan M.; Chen, Jie; Zhao, Jing; Campbell, Jeffrey; Wang, Weili; Pi, Wenhu; Stanton, Paul; Matuszak, Martha; Jolly, Shruti; Miller, Amy; Kong, Feng-Ming			Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapy	PLOS ONE			English	Article							SOLUBLE CD40 LIGAND; DISEASES	Background/Purpose Radiation treatment (RT) stimulates the release of many immunohumoral factors, complicating the identification of clinically significant cytokine expression patterns. This study used principal component analysis (PCA) to analyze cytokines in non-small cell lung cancer (NSCLC) patients undergoing RT and explore differences in changes after hypofractionated stereotactic body radiation therapy (SBRT) and conventionally fractionated RT (CFRT) without or with chemotherapy. Methods The dataset included 141 NSCLC patients treated on prospective clinical protocols; PCA was based on the 128 patients who had complete CK values at baseline and during treatment. Patients underwent SBRT (n = 16), CFRT (n = 18), or CFRT (n = 107) with concurrent chemotherapy (ChRT). Levels of 30 cytokines were measured from prospectively collected platelet-poor plasma samples at baseline, during RT, and after RT. PCA was used to study variations in cytokine levels in patients at each time point. Results Median patient age was 66, and 22.7% of patients were female. PCA showed that sCD40l, fractalkine/C3, IP10, VEGF, IL-1a, IL-10, and GMCSF were responsible for most variability in baseline cytokine levels. During treatment, sCD40l, IP10, MIP-1b, fractalkine, IFN-r, and VEGF accounted for most changes in cytokine levels. In SBRT patients, the most important players were sCD40l, IP10, and MIP-1b, whereas fractalkine exhibited greater variability in CFRT alone patients. ChRT patients exhibited variability in IFN-gamma and VEGF in addition to IP10, MIP-1b, and sCD40l. Conclusions PCA can identify potentially significant patterns of cytokine expression after fractionated RT. Our PCA showed that inflammatory cytokines dominate post-treatment cytokine profiles, and the changes differ after SBRT versus CFRT, with vs without chemotherapy. Further studies are planned to validate these findings and determine the clinical significance of the cytokine profiles identified by PCA.	[Ellsworth, Susannah G.; Wang, Weili; Pi, Wenhu; Miller, Amy; Kong, Feng-Ming] Indiana Univ Sch Med, Dept Radiat Oncol, Indianapolis, IN 46202 USA; [Rabatic, Bryan M.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA; [Chen, Jie] Augusta Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Zhao, Jing; Campbell, Jeffrey; Stanton, Paul] Augusta Univ, Dept Radiat Oncol, Augusta, GA USA; [Matuszak, Martha; Jolly, Shruti] Univ Michigan, Dept Radiat Oncol, Sch Med, Ann Arbor, MI 48109 USA	Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Michigan System; University of Michigan	Kong, FM (corresponding author), Indiana Univ Sch Med, Dept Radiat Oncol, Indianapolis, IN 46202 USA.	fskong@iupui.edu	Chen, Jie/S-1161-2019; Kong, Feng-Ming/Y-2825-2019; Wang, Weili/A-5336-2013	Chen, Jie/0000-0003-2151-5276; Kong, Feng-Ming/0000-0003-2652-098X; Wang, Weili/0000-0002-1627-3025	National Cancer Institute, National Institutes of Health [R01CM 42840]; NATIONAL CANCER INSTITUTE [P01CA059827, R01CA142840] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health, no. R01CM 42840, https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci. The funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloui C, 2014, INT J MOL SCI, V15, P22342, DOI 10.3390/ijms151222342; Anscher MS, 1998, LUNG CANCER-J IASLC, V19, P109, DOI 10.1016/S0169-5002(97)00076-7; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; Caggiari Laura, 2007, Infect Agent Cancer, V2, P5, DOI 10.1186/1750-9378-2-5; Easton R, 2014, INJURY, V45, P934, DOI 10.1016/j.injury.2013.12.002; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Ferroni P, 2007, CURR MED CHEM, V14, P2170; Huang JP, 2012, BLOOD, V120, P3030, DOI 10.1182/blood-2012-05-427799; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Kong FM, 2015, SEMIN RADIAT ONCOL, V25, P100, DOI 10.1016/j.semradonc.2014.12.003; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Mauri FA, 2012, ONCOL REP, V28, P647, DOI 10.3892/or.2012.1818; Roselli M, 2004, CLIN CANCER RES, V10, P610, DOI 10.1158/1078-0432.CCR-0348-03; Sainani KL, 2014, PM&R, V6, P275, DOI 10.1016/j.pmrj.2014.02.001; Siebert JC, 2014, BIOANALYSIS, V6, P209, DOI [10.4155/BIO.13.309, 10.4155/bio.13.309]; Siva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109560; Wang SL, 2015, INT J RADIAT ONCOL, V93, pS153, DOI 10.1016/j.ijrobp.2015.07.363	18	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183239	10.1371/journal.pone.0183239	http://dx.doi.org/10.1371/journal.pone.0183239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934231	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900009
J	Kawano, T; Imada, M; Chamavit, P; Kobayashi, S; Hashimoto, T; Nozaki, T				Kawano, Tetsuro; Imada, Mihoko; Chamavit, Pennapa; Kobayashi, Seiki; Hashimoto, Tetsuo; Nozaki, Tomoyoshi			Genetic diversity of Entamoeba: Novel ribosomal lineages from cockroaches	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; HISTOLYTICA; PATTERNS; REVEALS; TOOL	Our current taxonomic perspective on Entamoeba is largely based on small-subunit ribosomal RNA genes (SSU rDNA) from Entamoeba species identified in vertebrate hosts with minor exceptions such as E. moshkovskii from sewage water and E. marina from marine sediment. Other Entamoeba species have also been morphologically identified and described from non-vertebrate species such as insects; however, their genetic diversity remains unknown. In order to further disclose the diversity of the genus, we investigated Entamoeba spp. in the intestines of three cockroach species: Periplaneta americana, Blaptica dubia, and Gromphadorhina oblongonota. We obtained 134 Entamoeba SSU rDNA sequences from 186 cockroaches by direct nested PCR using the DNA extracts of intestines from cockroaches, followed by scrutinized BLASTn screening and phylogenetic analyses. All the sequences identified in this study were distinct from those reported from known Entamoeba species, and considered as novel Entamoeba ribosomal lineages. Furthermore, they were positioned at the base of the clade of known Entamoeba species and displayed remarkable degree of genetic diversity comprising nine major groups in the three cockroach species. This is the first report of the diversity of SSU rDNA sequences from Entamoeba in non-vertebrate host species, and should help to understand the genetic diversity of the genus Entamoeba.	[Kawano, Tetsuro; Hashimoto, Tetsuo; Nozaki, Tomoyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kawano, Tetsuro; Imada, Mihoko; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo, Japan; [Kawano, Tetsuro; Nozaki, Tomoyoshi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Imada, Mihoko; Kobayashi, Seiki] Keio Univ, Sch Med, Dept Infect Dis, Shinjuku Ku, Tokyo, Japan; [Chamavit, Pennapa] Hauchiew Univ, Fac Med Technol, Bangplee, Samutprakarn, Thailand; [Hashimoto, Tetsuo] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Institute of Infectious Diseases (NIID); University of Tokyo; Keio University; University of Tsukuba	Nozaki, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo, Japan.; Nozaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan.	nozaki@m.u-tokyo.ac.jp		Kawano-Sugaya, Tetsuro/0000-0001-5401-4414	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23117001, 23117005, 23390099, 26111524]; Japan Agency for Medical Research and Development (AMED); AMED; Japan International Cooperation Agency (JICA);  [15H05231]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED; Japan International Cooperation Agency (JICA); 	This work was supported in part by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (23117001, 23117005, 23390099, 26111524) to T.N. and 15H05231 to T.H., a grant for research on emerging and re-emerging infectious diseases from Japan Agency for Medical Research and Development (AMED) to T.N., and a grant for Science and Technology Research Partnership for Sustainable Development (SATREPS) from AMED and Japan International Cooperation Agency (JICA) to T.N.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali IKM, 2005, J CLIN MICROBIOL, V43, P5842, DOI 10.1128/JCM.43.12.5842-5847.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BISHOP ANN, 1932, PARASITOLOGY, V24, P225; CARINI A., 1933, ANN PARASITOL HUMAINE ET COMP, V11, P297; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clark CG, 2006, MOL BIOCHEM PARASIT, V146, P24, DOI 10.1016/j.molbiopara.2005.10.013; Das K, 2014, PARASITOL INT, V63, P308, DOI 10.1016/j.parint.2013.11.014; Escueta-de Cadiz A, 2010, PARASITOL INT, V59, P75, DOI 10.1016/j.parint.2009.10.010; Fantham H, 1911, P ZOOL SOC LOND, P625; Global Health Estimates, 2016, GLOB HLTH EST 2015 B; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kay MW, 1940, SAY AM MIDL NAT, P724; KIDDER GEORGE W., 1937, PARASITOLOGY, V29, P163; Marsh TL, 1998, WATER SCI TECHNOL, V37, P455, DOI 10.2166/wst.1998.0693; Shiratori T, 2016, J EUKARYOT MICROBIOL, V63, P280, DOI 10.1111/jeu.12276; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stensvold CR, 2011, PROTIST, V162, P525, DOI 10.1016/j.protis.2010.11.002; Tawari B, 2008, MOL BIOL EVOL, V25, P187, DOI 10.1093/molbev/msm238; Zaki M, 2002, J CLIN MICROBIOL, V40, P1271, DOI 10.1128/JCM.40.4.1271-1276.2002; Zaki M, 2001, J CLIN MICROBIOL, V39, P897, DOI 10.1128/JCM.39.3.897-905.2001	21	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185233	10.1371/journal.pone.0185233	http://dx.doi.org/10.1371/journal.pone.0185233			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934335	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900129
J	Luque, MA; Beltran-Matas, P; Marin, MC; Torres, B; Herrero, L				Angeles Luque, M.; Beltran-Matas, Pablo; Carmen Marin, M.; Torres, Blas; Herrero, Luis			Excitability is increased in hippocampal CA1 pyramidal cells of Fmr1 knockout mice	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MOUSE MODEL; NEURONAL EXCITABILITY; AFTER-HYPERPOLARIZATION; SYNAPTIC PLASTICITY; POTASSIUM CHANNELS; FMR1(-/Y) MOUSE; MESSENGER-RNAS; I-H	Fragile X syndrome (FXS) is caused by a failure of neuronal cells to express the gene encoding the fragile mental retardation protein (FMRP). Clinical features of the syndrome include intellectual disability, learning impairment, hyperactivity, seizures and anxiety. Fmr1 knockout (KO) mice do not express FMRP and, as a result, reproduce some FXS behavioral abnormalities. While intrinsic and synaptic properties of excitatory cells in various part of the brain have been studied in Fmr1 KO mice, a thorough analysis of action potential characteristics and input-output function of CA1 pyramidal cells in this model is lacking. With a view to determining the effects of the absence of FMRP on cell excitability, we studied rheobase, action potential duration, firing frequency-current intensity relationship and action potential after-hyperpolarization (AHP) in CA1 pyramidal cells of the hippocampus of wild type (WT) and Fmr1 KO male mice. Brain slices were prepared from 8-to 12-week-old mice and the electrophysiological properties of cells recorded. Cells from both groups had similar resting membrane potentials. In the absence of FMRP expression, cells had a significantly higher input resistance, while voltage threshold and depolarization voltage were similar in WT and Fmr1 KO cell groups. No changes were observed in rheobase. The action potential duration was longer in the Fmr1 KO cell group, and the action potential firing frequency evoked by current steps of the same intensity was higher. Moreover, the gain (slope) of the relationship between firing frequency and injected current was 1.25-fold higher in the Fmr1 KO cell group. Finally, AHP amplitude was significantly reduced in the Fmr1 KO cell group. According to these data, FMRP absence increases excitability in hippocampal CA1 pyramidal cells.	[Angeles Luque, M.; Beltran-Matas, Pablo; Carmen Marin, M.; Torres, Blas; Herrero, Luis] Univ Seville, Dept Physiol, Seville, Spain	University of Sevilla	Herrero, L (corresponding author), Univ Seville, Dept Physiol, Seville, Spain.	lherrero@us.es	Herrero, Luis/B-9959-2015	Herrero, Luis/0000-0002-4311-8792; Beltran Matas, Pablo/0000-0003-3817-5095				Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Bianchi R, 2009, J NEUROSCI, V29, P3497, DOI 10.1523/JNEUROSCI.5447-08.2009; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brager DH, 2014, BRAIN RES BULL, V103, P11, DOI 10.1016/j.brainresbull.2014.01.002; Brager DH, 2012, CELL REP, V1, P225, DOI 10.1016/j.celrep.2012.02.002; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Chen S, 2014, J NEUROSCI, V34, P8219, DOI 10.1523/JNEUROSCI.0936-14.2014; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Contractor A, 2015, NEURON, V87, P699, DOI 10.1016/j.neuron.2015.06.017; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng PY, 2016, CELL REP, V16, P3157, DOI 10.1016/j.celrep.2016.08.046; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Ferron L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4628; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Gu N, 2008, J NEUROPHYSIOL, V100, P2589, DOI 10.1152/jn.90433.2008; Honigsperger C, 2015, J PHYSIOL-LONDON, V593, DOI 10.1113/jphysiol.2014.280826; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kalmbach BE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0114-15.2015; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Myrick LK, 2015, P NATL ACAD SCI USA, V112, P949, DOI 10.1073/pnas.1423094112; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Paxinos G. F, MOUSE BRAIN STEREOTA; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Routh BN, 2017, J PHYSIOL-LONDON, V595, P4431, DOI 10.1113/JP274258; Santos AR, 2014, LEARN MEMORY, V21, P543, DOI 10.1101/lm.035956.114; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Tang AH, 2015, J NEUROSCI, V35, P3938, DOI 10.1523/JNEUROSCI.4499-14.2015; Wahlstrom-Helgren S, 2015, J PHYSIOL-LONDON, V593, P5009, DOI 10.1113/JP271190; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Zhang LM, 2016, EXP NEUROL, V280, P60, DOI 10.1016/j.expneurol.2016.03.025; Zhang LH, 2010, J NEUROSCI, V30, P5724, DOI 10.1523/JNEUROSCI.0795-10.2010; Zhang YL, 2012, J NEUROSCI, V32, P15318, DOI 10.1523/JNEUROSCI.2162-12.2012; Zhang Y, 2014, NAT NEUROSCI, V17, P1701, DOI 10.1038/nn.3864; Zhao WF, 2011, J NEUROSCI, V31, P725, DOI 10.1523/JNEUROSCI.2915-10.2011	48	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185067	10.1371/journal.pone.0185067	http://dx.doi.org/10.1371/journal.pone.0185067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931075	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700067
J	Gehle, P; Goergen, B; Pilger, D; Ruokonen, P; Robinson, PN; Salchow, DJ				Gehle, Petra; Goergen, Barbara; Pilger, Daniel; Ruokonen, Peter; Robinson, Peter N.; Salchow, Daniel J.			Biometric and structural ocular manifestations of Marfan syndrome	PLOS ONE			English	Article							REVISED GHENT NOSOLOGY; RETINAL-DETACHMENT; ECTOPIA LENTIS; FIBRILLIN GENE; MUTATIONS; PREVALENCE; ADULTS	Background To study biometric and structural ocular manifestations of Marfan syndrome (MFS). Methods Observational, retrospective, comparative cohort study in a tertiary referral center on 285 MFS patients and 267 controls. Structural and biometric ocular characteristic were compared. Results MFS eyes were longer (axial length 24.25 +/- 1.74 mm versus 23.89 +/- 1.31 mm, p < 0.001) and had a flatter cornea than control eyes (mean keratometry 41.78 +/- 1.80 diopters (D) versus 43.05 +/- 1.51 D, p < 0.001). Corneal astigmatism was greater and the central cornea was thinner in MFS eyes (530.14 +/- 41.31 mu m versus 547.02 +/- 39.18 mu m, p < 0.001). MFS eyes were more myopic than control eyes (spherical equivalent -2.16 +/- 3.75 D versus -1.17 +/- 2.58 D, p < 0.001). Visual acuity was reduced (0.13 +/- 0.25 logMAR versus 0.05 +/- 0.18 logMAR, p < 0.001) and intraocular pressure was lower in MFS eyes (14.6 +/- 3.4 mmHg versus 15.1 +/- 3.2 mmHg, p = 0.01). Iris transillumination defects (ITD) were significantly more common in MFS eyes (odds ratio for MFS in the presence of ITD, 3.7). Ectopia lentis (EL) was only present in MFS eyes (33.4%). History of retinal detachment was significantly more common in MFS eyes. Glaucoma was equally common in both groups. Conclusions ITD and EL are most characteristic findings in MFS. ITD and corneal curvature should be studied as diagnostic criteria for MFS. Visual acuity is reduced in MFS. MFS patients need regular eye exams to identify serious ocular complications.	[Gehle, Petra] Charite Univ Med Berlin, Dept Cardiol, Augustenburger Pl 1, Berlin, Germany; [Goergen, Barbara; Pilger, Daniel; Salchow, Daniel J.] Charite Univ Med Berlin, Dept Ophthalmol, Augustenburger Pl 1, Berlin, Germany; [Ruokonen, Peter] Private Practice Zehlendorf, Berlin, Germany; [Robinson, Peter N.] Jackson Lab Genom Med, Farmington, CT USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jackson Laboratory	Salchow, DJ (corresponding author), Charite Univ Med Berlin, Dept Ophthalmol, Augustenburger Pl 1, Berlin, Germany.	daniel.salchow@charite.de		Salchow, Daniel/0000-0003-3678-6183; Gehle, Petra/0000-0002-0652-8098				Chandra A, 2015, CLIN GENET, V87, P284, DOI 10.1111/cge.12358; Chandra A, 2014, ACTA OPHTHALMOL, V92, pE82, DOI 10.1111/aos.12175; CROSS HE, 1973, AM J OPHTHALMOL, V75, P405, DOI 10.1016/0002-9394(73)91149-5; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dotrelova D, 1997, RETINA-J RET VIT DIS, V17, P390; Drolsum L, 2015, ACTA OPHTHALMOL, V93, P46, DOI 10.1111/aos.12448; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Foster PJ, 2014, EYE, V28, P202, DOI 10.1038/eye.2013.280; Fotedar R, 2010, OPHTHALMOLOGY, V117, P417, DOI 10.1016/j.ophtha.2009.07.028; Fuchs J, 1997, ACTA PAEDIATR, V86, P947, DOI 10.1111/j.1651-2227.1997.tb15176.x; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785; Hashemi H, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-50; Hayward C, 1997, HUM MUTAT, V10, P415, DOI 10.1002/(SICI)1098-1004(1997)10:6<415::AID-HUMU1>3.3.CO;2-2; Heur M, 2008, AM J OPHTHALMOL, V145, P997, DOI 10.1016/j.ajo.2008.01.028; Izquierdo N J, 1992, Trans Am Ophthalmol Soc, V90, P111; Jobke S, 2008, CLIN OPHTHALMOL, V2, P601; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; Kara N, 2012, J CATARACT REFR SURG, V38, P309, DOI 10.1016/j.jcrs.2011.08.036; Kinori M, 2017, AM J OPHTHALMOL; Konradsen TR, 2013, ACTA OPHTHALMOL, V91, P751, DOI 10.1111/aos.12068; Konradsen TR, 2012, ACTA OPHTHALMOL, V90, P375, DOI 10.1111/j.1755-3768.2010.01996.x; Konradsen TR, 2009, OPHTHALMOLOGY, V116, P1343, DOI 10.1016/j.ophtha.2009.01.023; Lee SY, 2003, RETINA-J RET VIT DIS, V23, P24, DOI 10.1097/00006982-200302000-00004; Loewenstein A, 2000, RETINA-J RET VIT DIS, V20, P358, DOI 10.1097/00006982-200007000-00006; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Maumenee I H, 1981, Trans Am Ophthalmol Soc, V79, P684; Remulla JF, 2001, INT OPHTHALMOL CLIN, V41, P235, DOI 10.1097/00004397-200110000-00021; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SETALA K, 1988, ACTA OPHTHALMOL, V66, P334; Sharma T, 2002, RETINA-J RET VIT DIS, V22, P423, DOI 10.1097/00006982-200208000-00005; Sultan G, 2002, INVEST OPHTH VIS SCI, V43, P1757; Traboulsi E I, 2000, Ophthalmic Genet, V21, P9, DOI 10.1076/1381-6810(200003)21:1;1-I;FT009; WHEATLEY HM, 1995, ARCH OPHTHALMOL-CHIC, V113, P103, DOI 10.1001/archopht.1995.01100010105028	35	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0183370	10.1371/journal.pone.0183370	http://dx.doi.org/10.1371/journal.pone.0183370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931008	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700009
J	Igawa, M; Kato, M				Igawa, Momoko; Kato, Makoto			A new species of hermit crab, Diogenes heteropsammicola (Crustacea, Decapoda, Anomura, Diogenidae), replaces a mutualistic sipunculan in a walking coral symbiosis	PLOS ONE			English	Article							OBLIGATE POLLINATION MUTUALISM; EUPHORBIACEAE; PAGUROIDEA; CHINA	Symbiont shift is rare in obligate mutualisms because both the partners are reciprocally dependent on and specialized to each other. In the obligate accommodation-transportation mutualism between walking corals and sipunculans, however, an unusual saltatory symbiont shift was discovered. In shallow waters of southern Japan, an undescribed hermit crab species was found living in corallums of solitary scleractinian corals of the genera Heterocyathus and Heteropsammia, replacing the usual sipunculan symbiont. We described the hermit crab as a new species Diogenes heteropsammicola (Decapoda, Anomura, Diogenidae), and explored its association with the walking corals. This hermit crab species obligately inhabits the coiled cavity of the corals, and was easily distinguished from other congeneric species by the exceedingly slender chelipeds and ambulatory legs, and the symmetrical telson. Observations of behavior in aquaria showed that the new hermit crab, like the sipunculan, carries the host coral and prevents the coral from being buried. This is an interesting case in which an organism phylogenetically distant from Sipuncula takes over the symbiotic role in association with a walking coral. The hermit crab species is unique in that its lodging is a living solitary coral that grows with the hermit crab in an accommodation-transportation mutualism.	[Igawa, Momoko; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Kyoto University	Igawa, M (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan.	momoko.igawa.43e@gmail.com			Ministry of Education, Culture, Sports, Science and Technology [22247003, 15H02420]; Grants-in-Aid for Scientific Research [15H02420] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/) given to MK (22247003, 15H02420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura Akira, 2010, V14, P133; Bouvier E. L., 1895, ANN SCI NAT ZOOL, V20, P1; Bouvier EL, 1894, ANN MAG NAT HIST SER, V14, P312; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Dana J. D., 1851, P ACAD NAT SCI PHILA, V5, P267, DOI DOI 10.2307/20021092; Fujii T., 2016, HETEROPSAMMIA COCHLE, P1; GILL GA, 1977, LETHAIA, V10, P119, DOI 10.1111/j.1502-3931.1977.tb00601.x; GOREAU TF, 1968, NATURE, V217, P421, DOI 10.1038/217421a0; HICKSON SJ, 1924, INTRO STUDY RECENT C; HOEKSEMA B W, 1991, Zoologische Mededelingen (Leiden), V65, P221; Igawa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169825; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kawakita A, 2004, EVOLUTION, V58, P2201; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Komai T, 2013, ZOOTAXA, V3613, P380, DOI 10.11646/zootaxa.3613.4.5; Komai T, 2012, J NAT HIST, V46, P1219, DOI 10.1080/00222933.2011.654279; Macdonald JD, 1862, NAT HIST REV LOND, V1862, P78; McLaughlin PA, 2005, J CRUSTACEAN BIOL, V25, P598, DOI 10.1651/C-2598.1; McLaughlin PA, 2007, CATALOG HERMIT CRABS; McLaughlin PA, 2010, RAFFLES B ZOOL, P5; Neelakantan B, 1985, THE INDIAN ZOOLOGIST, V9, P15; Rahayu D.L., 2012, CRUSTACEANA MONOGRAP, P263, DOI DOI 10.1163/9789004202894_022; Rahayu DL, 2015, RAFFLES B ZOOL, P182; RICE M E, 1976, Micronesica, V12, P119; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Schindewolf OH, AKAD WISSENSCHAFTEN; Sluiter GP, 1902, MONOGRAPH, V25, P1; Stolarski J, 2001, ACTA PALAEONTOL POL, V46, P309; Trivedi JN, 2016, ZOOTAXA, V509, P4208; Xiao LC, 2015, CRUSTACEANA, V88, P1439, DOI 10.1163/15685403-00003497; Yonge C.M., 1975, P305	31	10	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184311	10.1371/journal.pone.0184311	http://dx.doi.org/10.1371/journal.pone.0184311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931020	Green Published, Green Submitted, gold			2022-12-26	WOS:000411314700019
J	Wiese, AV; Ender, F; Quell, KM; Antoniou, K; Vollbrandt, T; Konig, P; Kohl, J; Laumonnier, Y				Wiese, Anna V.; Ender, Fanny; Quell, Katharina M.; Antoniou, Konstantina; Vollbrandt, Tillman; Koenig, Peter; Koehl, Joerg; Laumonnier, Yves			The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells	PLOS ONE			English	Article							COMPLEMENT FACTORS C3A; DENDRITIC CELLS; EFFECTOR FUNCTIONS; HUMAN EOSINOPHILS; C5A; MACROPHAGES; ANAPHYLATOXINS; INDUCTION; DISEASE; GENE	C5a regulates the development of maladaptive immune responses in allergic asthma mainly through the activation of C5a receptor 1 (C5aR1). Yet, the cell types and the mechanisms underlying this regulation are ill-defined. Recently, we described increased C5aR1 expression in lung tissue eosinophils but decreased expression in airway and pulmonary macrophages as well as in pulmonary CD11b(+) conventional dendritic cells (cDCs) and monocyte-derived DCs (moDCs) during the allergic effector phase using a floxed green fluorescent protein (GFP)-C5aR1 knock-in mouse. Here, we determined the role of C5aR1 signaling in neutrophils, moDCs and macrophages for the pulmonary recruitment of such cells and the importance of C5aR1-mediated activation of LysM-expressing cells for the development of allergic asthma. We used LysM-C5aR1 KO mice with a specific deletion of C5aR1 in LysMCre-expressing cells and confirmed the specific deletion of C5aR1 in neutrophils, macrophages and moDCs in the airways and/or the lung tissue. We found that alveolar macrophage numbers were significantly increased in LysM-C5aR1 KO mice. Induction of ovalbumin (OVA)-driven experimental allergic asthma in GFP-C5aR1(fl/fl) and LysM-C5aR1 KO mice resulted in strong but similar airway resistance, mucus production and Th2/Th17 cytokine production. In contrast, the number of airway but not of pulmonary neutrophils was lower in LysM-C5aR1 KO as compared with GFP-C5aR1(fl/fl) mice. The recruitment of macrophages, cDCs, moDCs, T cells and type 2 innate lymphoid cells was not altered in LysM-C5aR1 KO mice. Our findings demonstrate that C5aR1 is critical for steady state control of alveolar macrophage numbers and the transition of neutrophils from the lung into the airways in OVA-driven allergic asthma. However, C5aR1 activation of LysM-expressing cells plays a surprisingly minor role in the recruitment and activation of such cells and the development of the allergic phenotype in OVA-driven experimental allergic asthma.	[Wiese, Anna V.; Ender, Fanny; Quell, Katharina M.; Antoniou, Konstantina; Koehl, Joerg; Laumonnier, Yves] Univ Lubeck, Inst System Inflammat Res, Lubeck, Germany; [Vollbrandt, Tillman] Univ Lubeck, Cell Anal Core, Lubeck, Germany; [Koenig, Peter] Univ Lubeck, Inst Anat, Lubeck, Germany; [Koehl, Joerg] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Koehl, Joerg] Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA	University of Lubeck; University of Lubeck; University of Lubeck; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Kohl, J; Laumonnier, Y (corresponding author), Univ Lubeck, Inst System Inflammat Res, Lubeck, Germany.; Kohl, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Kohl, J (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA.	joerg.koehl@uksh.de; yves.laumonnier@uksh.de	Laumonnier, yves/F-6348-2018; König, Peter/AAK-2021-2020; Koehl, Joerg/C-8531-2011	Koehl, Joerg/0000-0003-1121-3178	Deutsch Forschungsgemeinschaft [IRTG1911A1, IRTG1911A2, KO 1245/3-1]	Deutsch Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsch Forschungsgemeinschaft Grants IRTG1911A1 to Y.L and J.K, IRTG1911A2 to P.K., KO 1245/3-1 to J.K. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Doyle AD, 2013, J LEUKOCYTE BIOL, V94, P17, DOI 10.1189/jlb.0213089; Elsner J, 1996, EUR J IMMUNOL, V26, P1560, DOI 10.1002/eji.1830260723; Ender F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172446; Engelke C, 2014, J IMMUNOL, V193, P5387, DOI 10.4049/jimmunol.1400080; Fujiu T, 2002, ANN ALLERG ASTHMA IM, V89, P90, DOI 10.1016/S1081-1206(10)61917-5; GOETZL EJ, 1976, AM J PATHOL, V85, P419; Haggadone MD, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1340156; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.274; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Krug N, 2001, AM J RESP CRIT CARE, V164, P1841, DOI 10.1164/ajrccm.164.10.2010096; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Marc MM, 2004, AM J RESP CELL MOL, V31, P216, DOI 10.1165/rcmb.2003-0394OC; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Nieuwenhuizen NE, 2012, J ALLERGY CLIN IMMUN, V130, P743, DOI 10.1016/j.jaci.2012.03.011; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Quell KM, 2017, J IMMUNOL, V199, P688, DOI 10.4049/jimmunol.1700318; Schmudde I, 2013, MUCOSAL IMMUNOL, V6, P807, DOI 10.1038/mi.2012.119; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Staab EB, 2014, INT IMMUNOPHARMACOL, V21, P293, DOI 10.1016/j.intimp.2014.05.008; Stiehm M, 2013, CLIN EXP ALLERGY, V43, P785, DOI 10.1111/cea.12116; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Verschoor A, 2016, IMMUNOL REV, V274, P112, DOI 10.1111/imr.12473; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Yves L, 2017, MOL IMMUNOL, V84, P51, DOI 10.1016/j.molimm.2016.11.013; Zhang X, 2010, J IMMUNOL, V185, P6741, DOI 10.4049/jimmunol.1000892; Zhang X, 2009, J IMMUNOL, V182, P5123, DOI 10.4049/jimmunol.0804276	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184956	10.1371/journal.pone.0184956	http://dx.doi.org/10.1371/journal.pone.0184956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931049	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700046
J	Cai, XC; Yuan, YX; Liao, ZR; Xing, KP; Zhu, CJ; Xu, YQ; Yu, LL; Wang, LN; Wang, SB; Zhu, XT; Gao, P; Zhang, YL; Jiang, QY; Xu, PW; Shu, G				Cai, Xingcai; Yuan, Yexian; Liao, Zhengrui; Xing, Kongping; Zhu, Canjun; Xu, Yaqiong; Yu, Lulu; Wang, Lina; Wang, Songbo; Zhu, Xiaotong; Gao, Ping; Zhang, Yongliang; Jiang, Qingyan; Xu, Pingwen; Shu, Gang			alpha-Ketoglutarate prevents skeletal muscle protein degradation and muscle atrophy through PHD3/ADRB2 pathway	FASEB JOURNAL			English	Article						tricarboxylic acid cycle; metabolite; Duchenne muscular dystrophy; metabolism	UBIQUITIN LIGASES; CANCER CACHEXIA; EXPRESSION; HYPERTROPHY; PROTEOLYSIS; CAMP; SUPPRESSES; MECHANISMS; INHIBITION; KINASE	Skeletalmuscle atrophy due to excessive protein degradation is the main cause for muscle dysfunction, fatigue, and weakening of athletic ability. Endurance exercise is effective to attenuate muscle atrophy, but the underlying mechanismhas not been fully investigated. alpha-Ketoglutarate (AKG) is akey intermediate of tricarboxylic acid cycle, which is generated during endurance exercise. Here, we demonstrated that AKG effectively attenuated corticosterone-induced protein degradation and rescued the muscle atrophy and dysfunction in a Duchenne muscular dystrophy mouse model. Interestingly, AKG also inhibited the expression of proline hydroxylase 3 (PHD3), one of the important oxidoreductases expressed under hypoxic conditions. Subsequently, we identified the beta(2) adrenergic receptor (ADRB2) as a downstreamtarget for PHD3. We found AKG inhibited PHD3/ADRB2 interaction and therefore increased the stability of ADRB2. In addition, combining pharmacologic and genetic approaches, we showed that AKG rescues skeletal muscle atrophy and protein degradation through a PHD3/ADRB2 mediated mechanism. Taken together, these data reveal a mechanism for inhibitory effects of AKG on muscle atrophy and protein degradation. These findings not only provide a molecular basis for the potential use of exercise-generated metabolite AKG in muscle atrophy treatment, but also identify PHD3 as a potential target for the development of therapies formusclewasting.	[Cai, Xingcai; Yuan, Yexian; Liao, Zhengrui; Xing, Kongping; Zhu, Canjun; Xu, Yaqiong; Yu, Lulu; Wang, Lina; Wang, Songbo; Zhu, Xiaotong; Gao, Ping; Zhang, Yongliang; Jiang, Qingyan; Shu, Gang] South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Control, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Jiang, Qingyan; Shu, Gang] South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Pingwen] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	South China Agricultural University; South China Agricultural University; Baylor College of Medicine	Shu, G (corresponding author), South China Agr Univ, Guangzhou 510640, Guangdong, Peoples R China.	shugang@scau.edu.cn	Xu, Pingwen/GRR-9137-2022		National Basic Research Program of China [2013CB127306]; National Key Point Research and Invention Program [2016YFD0501205]; Training Program for Outstanding Young Teachers in the Universities of Guangdong Province; National Natural Science Foundation of China [31572480, 31472105]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K99DK107008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK107008] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Key Point Research and Invention Program; Training Program for Outstanding Young Teachers in the Universities of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Basic Research Program of China (Grant 2013CB127306 to G.S.), National Key Point Research and Invention Program (Grant 2016YFD0501205 to G.S.), Training Program for Outstanding Young Teachers in the Universities of Guangdong Province (G.S.), National Natural Science Foundation of China (Grants 31572480 to G.S. and 31472105 to Q.J.), and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grant K99DK107008 to P.X.). The authors declare no conflicts of interest.	Anthony TG, 2016, DOMEST ANIM ENDOCRIN, V56, pS23, DOI 10.1016/j.domaniend.2016.02.012; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE594, DOI 10.1152/ajpendo.00257.2016; Bamman MM, 2017, COLD SPRING HARB PER; Barbe C, 2015, AM J PHYSIOL-ENDOC M, V309, pE557, DOI 10.1152/ajpendo.00098.2015; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bonifacio A, 2015, BBA-MOL CELL RES, V1853, P1841, DOI 10.1016/j.bbamcr.2015.04.010; Bowman SL, 2016, J CELL BIOL, V214, P797, DOI 10.1083/jcb.201512068; Cai XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26802; Carbo N, 1997, CANCER LETT, V115, P113, DOI 10.1016/S0304-3835(97)04718-6; Chung YW, 2011, J BIOL CHEM, V286, P29681, DOI 10.1074/jbc.M111.264945; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Diehl J, 2016, CELL TISSUE RES, V364, P245, DOI 10.1007/s00441-015-2318-1; Duran RV, 2013, ONCOGENE, V32, P4549, DOI 10.1038/onc.2012.465; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Escobar RG, 2017, REV CHIL PEDIATR-CHI, V88, P100, DOI 10.1016/j.rchipe.2016.07.003; Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fuster G, 2007, CANCER RES, V67, P6512, DOI 10.1158/0008-5472.CAN-07-0231; Garvalov BK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6577; German NJ, 2016, MOL CELL, V63, P1006, DOI 10.1016/j.molcel.2016.08.014; Gianelo MCS, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20154118; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Goncalves DAP, 2012, AM J PHYSIOL-ENDOC M, V302, pE123, DOI 10.1152/ajpendo.00188.2011; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Hinkle RT, 2005, MUSCLE NERVE, V32, P775, DOI 10.1002/mus.20416; Hou YQ, 2011, FRONT BIOSCI-LANDMRK, V16, P1186, DOI 10.2741/3783; Kang SH, 2017, AM J PHYSIOL-ENDOC M, V312, pE495, DOI 10.1152/ajpendo.00389.2016; Kornegay JN, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0124-z; Kristensen NB, 2002, J ANIM PHYSIOL AN N, V86, P239, DOI 10.1046/j.1439-0396.2002.00380.x; Lee DE, 2017, PHYSIOL GENOMICS, V49, P253, DOI 10.1152/physiolgenomics.00006.2017; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Leibowitz A, 2012, ACTA NEUROBIOL EXP, V72, P385; LEPEUCH CJ, 1979, BIOCHEMISTRY-US, V18, P5267, DOI 10.1021/bi00591a001; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Lim JY, 2016, INTEGR MED RES, V5, P176, DOI 10.1016/j.imr.2016.06.003; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Navegantes LCC, 2000, AM J PHYSIOL-ENDOC M, V279, pE663, DOI 10.1152/ajpendo.2000.279.3.E663; Ng R, 2012, PROG MOL BIOL TRANSL, V105, P83, DOI 10.1016/B978-0-12-394596-9.00004-4; OHTSUKA A, 1992, J NUTR SCI VITAMINOL, V38, P83, DOI 10.3177/jnsv.38.83; Percival Justin M, 2011, Biophys Rev, V3, P209, DOI 10.1007/s12551-011-0060-9; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; ROGERS JE, 1985, J BIOL CHEM, V260, P8002; Rossetti ML, 2017, MOL CELL ENDOCRINOL, V447, P35, DOI 10.1016/j.mce.2017.02.031; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sato T, 2014, MOL CELL BIOCHEM, V391, P37, DOI 10.1007/s11010-014-1984-8; Schoepflin Z. R., 2017, FASEB J; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Silveira WA, 2014, J APPL PHYSIOL, V117, P11, DOI 10.1152/japplphysiol.01055.2013; Singh Y, 2016, MOL IMMUNOL, V76, P7, DOI 10.1016/j.molimm.2016.06.003; Stephens NA, 2010, GENOME MED, V2, DOI 10.1186/gm122; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; van der Heide LP, 2005, TRENDS BIOCHEM SCI, V30, P81, DOI 10.1016/j.tibs.2004.12.002; Verdijk LB, 2012, MED SCI SPORT EXER, V44, P2322, DOI 10.1249/MSS.0b013e3182667c2e; Voltarelli VA, 2014, J CELL MOL MED, V18, P1087, DOI 10.1111/jcmm.12253; Wannenes F, 2012, WORLD ALLERGY ORGAN, V5, P66, DOI 10.1097/WOX.0b013e31825eff8b; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Xie L, 2015, J CLIN INVEST, V125, P2759, DOI 10.1172/JCI80369; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yao K, 2012, AMINO ACIDS, V42, P2491, DOI 10.1007/s00726-011-1060-6; YOUNG VR, 1978, FED PROC, V37, P2291; ZALIN RJ, 1974, CELL, V2, P103, DOI 10.1016/0092-8674(74)90098-1; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	70	25	28	3	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					488	499		10.1096/fj.201700670R	http://dx.doi.org/10.1096/fj.201700670R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28939592	Green Published			2022-12-26	WOS:000419172700043
J	von Volkmann, HL; Bronstad, I; Gilja, OH; Tronstad, RR; Sangnes, DA; Nortvedt, R; Hausken, T; Dimcevski, G; Fiskerstrand, T; Nylund, K				von Volkmann, Hilde L.; Bronstad, Ingeborg; Gilja, Odd Helge; Tronstad, Rune R.; Sangnes, Dag Andre; Nortvedt, Ragnar; Hausken, Trygve; Dimcevski, Georg; Fiskerstrand, Torunn; Nylund, Kim			Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUANYLATE-CYCLASE-C; COLONIC TRANSIT; GASTROINTESTINAL MOTILITY; CONSTIPATION; PH; CAPSULE; PAIN; TIME; LINACLOTIDE	Introduction Increased intestinal hydration by activation of the epithelial enzyme linked receptor guanylate cyclase C (GC-C) is a pharmacological principle for treating constipation. Activating mutations in the GUCY2C gene encoding GC-C cause Familial GUCY2C diarrhea syndrome (FGDS) which has been diagnosed with severe dysmotility. Aim To investigate gut motility and hormones before and after a meal in FGDS patients and compare with healthy controls (HC). Subjects and methods Bristol stool chart and stool frequency was assessed. Before and after a meal occlusive and non-occlusive contractions were obtained using ultrasound. A wireless motility capsule (WMC) recorded gut transit time, pH, contractions and pressure. Plasma levels of selected gut hormones were measured at different time points. Results The FGDS patients had 4 (range 1-10) loose stools/day and prolonged total gut transit time compared to HC, 55.5 h vs 28.5 h, respectively, with significantly increased colon transit time. In FGDS patients, pH in duodenum, small bowel and colon was increased and the number of contractions and the intraluminal pressure were significantly decreased, measured by WMC. Ultrasound showed in small bowel increased number of non-occlusive contractions in the FGDS patients. Serotonin (5-HT) plasma levels in the HC peaked 30 min after the meal, while the FGDS patients had no response. Conclusion Despite having diarrhea, the FGDS patients have prolonged transit time through the gut compared to HC, particularly in colon. The reduced number of intestinal contractions and lack of 5-HT release after a meal in FGDS patients surprisingly resemble colonic motility disturbances seen in patients with constipation.	[von Volkmann, Hilde L.; Bronstad, Ingeborg; Gilja, Odd Helge; Sangnes, Dag Andre; Nortvedt, Ragnar; Hausken, Trygve; Dimcevski, Georg; Nylund, Kim] Haukeland Hosp, Natl Ctr Ultrasound Gastroenterol, Bergen, Norway; [von Volkmann, Hilde L.; Bronstad, Ingeborg; Gilja, Odd Helge; Hausken, Trygve; Dimcevski, Georg] Univ Bergen, Dept Clin Med, Bergen, Norway; [Tronstad, Rune R.] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Tronstad, Rune R.; Fiskerstrand, Torunn] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Fiskerstrand, Torunn] Haukeland Hosp, Ctr Med Genet, Bergen, Norway; [Fiskerstrand, Torunn] Haukeland Hosp, Ctr Mol Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	von Volkmann, HL (corresponding author), Haukeland Hosp, Natl Ctr Ultrasound Gastroenterol, Bergen, Norway.; von Volkmann, HL (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	Hilda.loland.von.volkmann@helse-bergen.no	Dimcevski, Georg/F-2860-2018; Nylund, Kim/AAB-7785-2019	Dimcevski, Georg/0000-0003-2864-5129; 	Norsk Gastroenterologisk forening; Norsk forening for Ultralyd-diagnostikk; Karla og Arne Oddmars medisinske fond; Inclino AS	Norsk Gastroenterologisk forening; Norsk forening for Ultralyd-diagnostikk; Karla og Arne Oddmars medisinske fond; Inclino AS	The stipendium for HLvV was provided by Helse Vest, the Regional Health Autority. The research was supported with funding from: Norsk Gastroenterologisk forening (www.Legeforeningen. no/NGF); Norsk forening for Ultralyd-diagnostikk (www.Nfud.no); Karla og Arne Oddmars medisinske fond. Inclino AS (www.Incline.no) has supported this study with WMC recorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson W, 2006, GASTROENTEROLOGY, V130, P34, DOI 10.1053/j.gastro.2005.09.031; Barreto SG, 2016, DIG DIS SCI; Basu N, 2014, J BIOL CHEM, V289, P581, DOI 10.1074/jbc.M113.511311; Basu N, 2010, MOL CELL BIOCHEM, V334, P67, DOI 10.1007/s11010-009-0324-x; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brierley SM, 2012, CURR OPIN PHARMACOL, V12, P632, DOI 10.1016/j.coph.2012.10.005; Bryant AP, 2010, LIFE SCI, V86, P760, DOI 10.1016/j.lfs.2010.03.015; Cabrera-Pastor A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33124; Camilleri M, 2010, NEUROGASTROENT MOTIL, V22, P874, DOI 10.1111/j.1365-2982.2010.01517.x; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; Degen LP, 1996, GUT, V39, P109, DOI 10.1136/gut.39.1.109; Drossman DA, 2011, AM J GASTROENTEROL, V106, P1749, DOI 10.1038/ajg.2011.201; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; DuPont AW, 2014, DIGESTION, V89, P119, DOI 10.1159/000356314; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Feng B, 2013, J NEUROSCI, V33, P9831, DOI 10.1523/JNEUROSCI.5114-12.2013; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Gilja Odd Helge, 2008, Expert Rev Gastroenterol Hepatol, V2, P5, DOI 10.1586/17474124.2.1.5; Hannig G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00031; Hasler WL, 2009, AM J PHYSIOL-GASTR L, V297, pG1107, DOI 10.1152/ajpgi.00136.2009; HVEEM K, 1994, SCAND J GASTROENTERO, V29, P786, DOI 10.3109/00365529409092511; Kuhn M, 2016, PHYSIOL REV, V96, P751, DOI 10.1152/physrev.00022.2015; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lies B, 2014, NEUROGASTROENT MOTIL, V26, P901, DOI 10.1111/nmo.12367; Malagelada Carolina, 2017, Curr Gastroenterol Rep, V19, P26, DOI 10.1007/s11894-017-0565-x; Nylund K, 2012, Ultraschall Med, V33, pE225, DOI 10.1055/s-0031-1299329; Nylund K, 2017, ULTRASCHALL MED, V38, pE1, DOI 10.1055/s-0042-115853; Nylund Kim, 2010, Ultraschall Med, V31, P438, DOI 10.1055/s-0030-1263234; Odegaard S, 2015, SCAND J GASTROENTERO, V50, P698, DOI 10.3109/00365521.2015.1028436; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Pattison AM, 2016, WORLD J GASTROENTERO, V22, P8070, DOI 10.3748/wjg.v22.i36.8070; Ringel-Kulka T, 2015, AM J GASTROENTEROL, V110, P1339, DOI 10.1038/ajg.2015.220; Rodriguez A, 2016, INT J OBESITY, V40, P1405, DOI 10.1038/ijo.2016.66; Roland BC, 2014, JCLINGASTROENTEROL; Saad Richard J, 2016, Curr Gastroenterol Rep, V18, P14, DOI 10.1007/s11894-016-0489-x; Saad Richard J, 2011, Gastroenterol Hepatol (N Y), V7, P795; Saad RJ, 2010, AM J GASTROENTEROL, V105, P403, DOI 10.1038/ajg.2009.612; Silos-Santiago I, 2013, PAIN, V154, P1820, DOI 10.1016/j.pain.2013.05.044; Sindic Aleksandra, 2013, ISRN Nephrol, V2013, P813648, DOI 10.5402/2013/813648; Spencer NJ, 2016, ADV EXP MED BIOL, V891, P113, DOI 10.1007/978-3-319-27592-5_11; Tillou J, 2017, CLIN COLON RECT SURG, V30, P76, DOI 10.1055/s-0036-1593436; Tornblom H, 2012, AM J GASTROENTEROL, V107, P754, DOI 10.1038/ajg.2012.5; Tronstad RR., 2016, SCAND J GASTROENTERO, P1; Valentin N, 2015, EXPERT OPIN INV DRUG, V24, P769, DOI 10.1517/13543784.2015.1025132; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Wang YT, 2015, ALIMENT PHARM THER, V42, P761, DOI 10.1111/apt.13329; Zietek T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00154	49	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185496	10.1371/journal.pone.0185496	http://dx.doi.org/10.1371/journal.pone.0185496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957388	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200070
J	Guan, RH; Zhou, H; Li, JW; Xiao, SY; Pang, CL; Chen, YF; Du, XR; Ke, SX; Tang, QY; Su, JG; Zhan, Y; An, HL				Guan, Ronghua; Zhou, Hui; Li, Junwei; Xiao, Shaoying; Pang, Chunli; Chen, Yafei; Du, Xiangrong; Ke, Shaoxi; Tang, Qiongyao; Su, Jiguo; Zhan, Yong; An, Hailong			Allosteric-activation mechanism of BK channel gating ring triggered by calcium ions	PLOS ONE			English	Article							PLANAR LIPID BILAYERS; LARGE-CONDUCTANCE; MOLECULAR-DYNAMICS; CA2+; IDENTIFICATION; QUALITY; MUSCLE; PRODY	Calcium ions bind at the gating ring which triggers the gating of BK channels. However, the allosteric mechanism by which Ca2+ regulates the gating of BK channels remains obscure. Here, we applied Molecular Dynamics ( MD) and Targeted MD to the integrated gating ring of BK channels, and achieved the transition from the closed state to a half-open state. Our date show that the distances of the diagonal subunits increase from 41.0 angstrom at closed state to 45.7 angstrom or 46.4 angstrom at a half-open state. It is the rotatory motion and flower-opening like motion of the gating rings which are thought to pull the bundle crossing gate to open ultimately. Compared with the 'Ca2+ bowl' at RCK2, the RCK1 Ca2+ sites make more contribution to opening the channel. The allosteric motions of the gating ring are regulated by three group of interactions. The first weakened group is thought to stabilize the close state; the second strengthened group is thought to stabilize the open state; the third group thought to lead AC region forming the CTD pore to coordinated motion, which exquisitely regulates the conformational changes during the opening of BK channels by Ca2+.	[Guan, Ronghua; Zhou, Hui] North China Elect Power Univ, Sch Math & Phys Sci, Baoding, Peoples R China; [Li, Junwei; Pang, Chunli; Chen, Yafei; Zhan, Yong; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Hebei, Peoples R China; [Xiao, Shaoying] Hebei Univ Technol, Sch Architecture & Art Design, Tianjin, Peoples R China; [Du, Xiangrong; Ke, Shaoxi; Tang, Qiongyao] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Su, Jiguo] Yanshan Univ, Coll Sci, Qinhuangdao, Peoples R China	North China Electric Power University; Hebei University of Technology; Hebei University of Technology; Xuzhou Medical University; Yanshan University	Zhan, Y; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Hebei, Peoples R China.	zhany@hebut.edu.cn; hailong_an@hebut.edu.cn	Li, Junwei/B-6936-2019	Li, Junwei/0000-0002-1724-4752; Zhou, Hui/0000-0002-0916-8200	National Natural Science Fund of China [11647121, 31600594, 31400711, 81450064, 31671212, 11247010, 11475053]; Natural Science Fund for Distinguished Young Scholars of Hebei Province of China [C2015202340]; Fund for Outstanding Talents of Hebei Province of China [C201400305]; Natural Science Foundation of Hebei Province [C2017202208]; Fund for the Science and Technology Program of Higher Education Institutions of Hebei Province [QN2016113]; Scientific Innovation Grant for Excellent Young Scientists of Hebei University of Technology [2015010]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund for Distinguished Young Scholars of Hebei Province of China; Fund for Outstanding Talents of Hebei Province of China; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Fund for the Science and Technology Program of Higher Education Institutions of Hebei Province; Scientific Innovation Grant for Excellent Young Scientists of Hebei University of Technology	This work was supported by the National Natural Science Fund of China (11647121, 31600594, 31400711, 81450064, 31671212, 11247010 and 11475053), Natural Science Fund for Distinguished Young Scholars of Hebei Province of China (C2015202340), Fund for Outstanding Talents of Hebei Province of China (C201400305), Natural Science Foundation of Hebei Province (C2017202208), Fund for the Science and Technology Program of Higher Education Institutions of Hebei Province (QN2016113), Scientific Innovation Grant for Excellent Young Scientists of Hebei University of Technology (2015010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bakan A, 2014, BIOINFORMATICS, V30, P2681, DOI 10.1093/bioinformatics/btu336; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Barzegar A, 2008, J PEPT SCI, V14, P1173, DOI 10.1002/psc.1055; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fodor AA, 2006, J GEN PHYSIOL, V127, P755, DOI 10.1085/jgp.200509419; Hong J, 2011, BMC MED GENOMICS, V4, P1; Hou SW, 2009, CHANNELS, V3, P249; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kursula P, 2014, AMINO ACIDS, V46, P2295, DOI 10.1007/s00726-014-1795-y; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Li JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11289; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Seibold MA, 2008, HUM MOL GENET, V17, P2681, DOI 10.1093/hmg/ddn168; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Surhone L. M., 2010, SELECTIVE CATALYTIC; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HG, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00029; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	44	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0182067	10.1371/journal.pone.0182067	http://dx.doi.org/10.1371/journal.pone.0182067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953901	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300003
J	Budge, GE; Hodgetts, J; Jones, EP; Ostoja-Starzewski, JC; Hall, J; Tomkies, V; Semmence, N; Brown, M; Wakefield, M; Stainton, K				Budge, Giles E.; Hodgetts, Jennifer; Jones, Eleanor P.; Ostoja-Starzewski, Jozef C.; Hall, Jayne; Tomkies, Victoria; Semmence, Nigel; Brown, Mike; Wakefield, Maureen; Stainton, Kirsty			The invasion, provenance and diversity of Vespa velutina Lepeletier (Hymenoptera: Vespidae) in Great Britain	PLOS ONE			English	Article							SPREAD	The yellow-legged or Asian hornet (Vespa velutina colour form nigrithorax) was introduced into France from China over a decade ago. Vespa velutina has since spread rapidly across Europe, facilitated by suitable climatic conditions and the ability of a single nest to disperse many mated queens over a large area. Yellow-legged hornets are a major concern because of the potential impact they have on populations of many beneficial pollinators, most notably the western honey bee (Apis mellifera), which shows no effective defensive behaviours against this exotic predator. Here, we present the first report of this species in Great Britain. Actively foraging hornets were detected at two locations, the first around a single nest in Gloucestershire, and the second a single hornet trapped 54 km away in Somerset. The foraging activity observed in Gloucestershire was largely restricted to within 700 m of a single nest, suggesting highly localised movements. Genetic analyses of individuals from the Gloucestershire nest and the single hornet from Somerset suggest that these incursions represent an expansion of the European population, rather than a second incursion from Asia. The founding queen of the Gloucestershire nest mated with a single male, suggesting that sexual reproduction may have occurred in an area of low nest density. Whilst the nest contained diploid adult males, haploid 'true' males were only present at the egg stage, indicating that the nest was detected and removed before the production of queens. Members of the public reported additional dead hornets associated with camping equipment recently returned from France and imported timber products, highlighting possible pathways of incursion. The utility of microsatellites to inform surveillance during an incursion and the challenge of achieving eradication of this damaging pest are discussed.	[Budge, Giles E.; Hodgetts, Jennifer; Jones, Eleanor P.; Ostoja-Starzewski, Jozef C.; Hall, Jayne; Tomkies, Victoria; Wakefield, Maureen; Stainton, Kirsty] Fera, Natl Agrifood Innovat Campus, York, N Yorkshire, England; [Budge, Giles E.] Newcastle Univ, Inst Agri Food Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England; [Semmence, Nigel; Brown, Mike] Anim & Plant Hlth Agcy, Natl Bee Unit, Natl Agrifood Innovat Campus, York, N Yorkshire, England	Food & Environment Research Agency; Newcastle University - UK; Animal & Plant Health Agency UK	Budge, GE (corresponding author), Fera, Natl Agrifood Innovat Campus, York, N Yorkshire, England.; Budge, GE (corresponding author), Newcastle Univ, Inst Agri Food Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England.	giles.budge@ncl.ac.uk		Wakefield, Maureen/0000-0003-0127-0988; stainton, kirsty/0000-0002-2024-2010	Department for Environment, Food & Rural Affairs (Defra) [PH0533]; Welsh Government	Department for Environment, Food & Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Welsh Government	This work was funded with the support of the Department for Environment, Food & Rural Affairs (Defra; project number PH0533) and the Welsh Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca M, 2015, BIOL INVASIONS, V17, P2357, DOI 10.1007/s10530-015-0880-9; Archer ME, 1989, KEY WORLD SPECIES 1; Archer Michael E., 1994, Entomologist's Monthly Magazine, V130, P149; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; CABI, 2013, INV SPEC COMP VESP V; Chauzat MP, 2009, BIOLOGIST, V56, P6; Darrouzet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136680; Dong DZ, 1989, ZOOL RES, V10, P8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faria LRR, 2016, THEOR BIOSCI, V135, P111, DOI 10.1007/s12064-016-0226-x; Folmer O, 1994, MOL MARINE BIOL BIOT, V3, P6; Franklin DN, 2017, APPL ENTOMOL ZOOL, V52, P8; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grosso-Silva JM, 2012, ARQUIVOS ENTOMOLOXIC, P53; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim J, 2006, ENTOMOLOGY RES, V36, P4; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kovacs JL, 2010, INSECT SOC, V57, P53, DOI 10.1007/s00040-009-0050-0; Lopez S., 2011, Bulletin OEPP, V41, P439, DOI 10.1111/j.1365-2338.2011.02513.x; Marris G, 2011, GB NONNATIVE ORGNISM; Moilanen A, 2004, MOL ECOL NOTES, V4, P795, DOI 10.1111/j.1471-8286.2004.00779.x; Monceau K, 2014, INSECT SCI, V21, P765, DOI 10.1111/1744-7917.12090; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Orlov M., 2014, VESPA VELUTINA HAS A; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Pritchard JK, 2000, GENETICS, V155, P945; Robinet C., 2016, J APPL ECOLOGY; Rome Q, 2015, J APPL ENTOMOL, V139, P771, DOI 10.1111/jen.12210; Rome Quentin, 2013, Bulletin de la Societe Entomologique de France, V118, P21; Ueno T, 2014, INT J CHEM ENV BIOL, V2, P3; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Villemant C, 2006, INSECTES, V143, P5; Villemant Claire, 2006, Bulletin de la Societe Entomologique de France, V111, P535; Williams F., 2010, EC COST INVASIVE NON	36	55	58	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185172	10.1371/journal.pone.0185172	http://dx.doi.org/10.1371/journal.pone.0185172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950004	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000028
J	Engelbrecht, T; Kock, A; Waries, S; O'Riain, MJ				Engelbrecht, Tamlyn; Kock, Alison; Waries, Sarah; O'Riain, M. Justin			Shark Spotters: Successfully reducing spatial overlap between white sharks (Carcharodon carcharias) and recreational water users in False Bay, South Africa	PLOS ONE			English	Article							ARCTOCEPHALUS-PUSILLUS-PUSILLUS; CONTROL PROGRAMS; PREDATION RISK; BEHAVIOR; AUSTRALIA; MESOPREDATOR; QUEENSLAND; WALES	White sharks (Carcharodon carcharias) are apex predators that play an important role in the structure and stability of marine ecosystems. Despite their ecological importance and protected status, white sharks are still subject to lethal control to reduce the risk of shark bites for recreational water users. The Shark Spotters program, pioneered in Cape Town, South Africa, provides a non-lethal alternative for reducing the risk of human-shark conflict. In this study we assessed the efficacy of the Shark Spotters program in reducing overlap between water users and white sharks at two popular beaches in False Bay, South Africa. We investigated seasonal and diel patterns in water use and shark presence at each beach, and thereafter quantified the impact of different shark warnings from shark spotters on water user abundance. We also assessed the impact of a fatal shark incident on patterns of water use. Our results revealed striking diel and seasonal overlap between white sharks and water users at both beaches. Despite this, there was a low rate of shark-human incidents (0.5/annum) which we attribute partly to the success of the Shark Spotters program. Shark spotters use visual (coloured flags) and auditory (siren) cues to inform water users of risk associated with white shark presence in the surf zone. Our results showed that the highest risk category (denoted by a white flag and accompanying siren) caused a significant reduction in water user abundance; however the secondary risk category (denoted by a red flag with no siren) had no significant effect on water users. A fatal shark incident was shown to negatively impact the number of water users present for at least three months following the incident. Our results indicate that the Shark Spotters program effectively reduces spatial overlap between white sharks and water users when the risk of conflict is highest.	[Engelbrecht, Tamlyn; Kock, Alison; O'Riain, M. Justin] Univ Cape Town, Inst Communities & Wildlife Africa, Dept Biol Sci, Cape Town, South Africa; [Engelbrecht, Tamlyn; Waries, Sarah] Shark Spotters, Cape Town, South Africa; [Kock, Alison] Cape Res Ctr, South African Natl Pk, Cape Town, South Africa; [Kock, Alison] SAIAB, Grahamstown, South Africa	University of Cape Town; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Engelbrecht, T (corresponding author), Univ Cape Town, Inst Communities & Wildlife Africa, Dept Biol Sci, Cape Town, South Africa.; Engelbrecht, T (corresponding author), Shark Spotters, Cape Town, South Africa.	engelbrecht.tamlyn@gmail.com		O'Riain, M. Justin/0000-0001-5233-8327; Kock, Alison/0000-0001-9981-1652	National Research Foundation of South Africa; City of Cape Town; Save Our Seas Foundation	National Research Foundation of South Africa(National Research Foundation - South Africa); City of Cape Town; Save Our Seas Foundation	Funding was provided to TE for her BSc (Hons) research by the National Research Foundation of South Africa (www.nrf.ac.za). The primary sponsors of the Shark Spotters Program are the City of Cape Town (www.capetown.gov.za) and Save Our Seas Foundation (www.saveourseas. corn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, RESOLVING HUMAN WILD; Burgess GH, 2017, ISAF 2016 WORLDWIDE; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Cliff G., 2006, WWF S AFRICA REPORT, V1; Cliff G, 2011, MAR FRESHWATER RES, V62, P700, DOI 10.1071/MF10182; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Curtis T, 2012, GLOBAL PERSPECTIVES, VFirst, P477; De Vos A, 2015, MAR MAMMAL SCI, V31, P1118, DOI 10.1111/mms.12208; De Vos A, 2015, MAR MAMMAL SCI, V31, P1234, DOI 10.1111/mms.12215; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dudley SFJ, 1997, OCEAN COAST MANAGE, V34, P1, DOI 10.1016/S0964-5691(96)00061-0; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Green M, 2009, REPORT NSW SHARK MES; Hammerschlag N, 2017, B MAR SCI, V93, P355, DOI 10.5343/bms.2016.1046; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Jacobs Herbert A., 1967, COLUMBIA JOURNALISM, V6, P37; Kock AA, 2012, GLOBAL PERSPECTIVES, P447; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; Krogh M, 1996, BIOL CONSERV, V77, P219, DOI 10.1016/0006-3207(95)00141-7; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; McComas KA, 2006, J HEALTH COMMUN, V11, P75, DOI 10.1080/10810730500461091; Neff C, 2012, COAST MANAGE, V40, P88, DOI 10.1080/08920753.2011.639867; Neff CL, 2013, MAR POLICY, V38, P545, DOI 10.1016/j.marpol.2012.06.017; PATERSON RA, 1990, BIOL CONSERV, V52, P147, DOI 10.1016/0006-3207(90)90123-7; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Redpath S.M., 2015, CONFLICTS CONSERVATI; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Wetherbee Bradley M., 1994, Pacific Science, V48, P95; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1	35	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185335	10.1371/journal.pone.0185335	http://dx.doi.org/10.1371/journal.pone.0185335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945806	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100048
J	Taniguchi, D; LoGerfo, J; van Pelt, M; Mielcarek, B; Huster, K; Haider, M; Thomas, B				Taniguchi, Dawn; LoGerfo, James; van Pelt, Maurits; Mielcarek, Bessie; Huster, Karin; Haider, Mahri; Thomas, Bernadette			Evaluation of a multi-faceted diabetes care program including community-based peer educators in Takeo province, Cambodia, 2007-2013	PLOS ONE			English	Article							SELF-MANAGEMENT; SUPPORT; PREVENTION; OUTCOMES; INDIA	Introduction Early detection and treatment for diabetes are essential for reducing disability and death from the disease. Finding effective screening and treatment for individuals living with diabetes in resource-limited countries is a challenge. MoPoTsyo, a Cambodian non-governmental organization, addressed this gap by utilizing a multi-pronged approach with community-based peer educators, access to laboratory procedures, local outpatient medical consultation, and a revolving drug fund. This study evaluated outcomes of MoPoTsyo's diabetes program in Takeo Province by assessing glycemic and blood pressure outcomes for individuals diagnosed with diabetes over a 24-month follow-up period between 2007-2013. Methods This is a retrospective cohort analysis of records without a comparison group. We calculated the mean fasting blood glucose (FBG) and blood pressure (BP) at regular intervals of followup. The proportion of patients reaching recommended treatment targets for FBG and BP was assessed. Results Of the 3411 patients enrolled in the program, 2230 were included in the study. The cohort was predominantly female (68.9%) with a median age of 54 years. Median follow-up time in the program was 16 months (4.9-38.4 months). Mean FBG decreased 63.9 mg/dl in mean FBG (95% CI 58.5 to 69.3) at one year of follow-up (p< 0.001). After one year, 45% (321/708) of patients achieved goal FBG < 126. Of the 41.6% (927/2230) with elevated BP at enrollment, systolic and diastolic BP levels significantly decreased (p< 0.001) by 16.9 mmHg (95% CI 1.2 to 22.9) and 10 mm Hg (95% CI 0.7 to 12.9) respectively between enrollment and one year of follow-up. At one year of follow-up, 51.1%% (183/355) of these patients reached the BP goal < 140/90. Conclusion The improved outcome indicators of diabetes care for MoPoTsyo's Takeo program evaluation showed promise. The program demonstrated a reasonable and practical approach to delivering effective diabetes care in a rural area and may serve as a model for other lowincome communities. Future prospective evaluations with more complete data are necessary for longer-term outcomes.	[Taniguchi, Dawn; LoGerfo, James; Haider, Mahri] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA; [LoGerfo, James; Huster, Karin; Thomas, Bernadette] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [van Pelt, Maurits] MoPoTsyo Patient Informat Ctr, Phnom Penh, Cambodia; [Mielcarek, Bessie] Univ Washington, Dept Publ Hlth, Div Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Taniguchi, D (corresponding author), Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA.	dawntani@uw.edu			MoPoTsyo Information Centre	MoPoTsyo Information Centre	Maurits van Pelt is the Director of MoPoTsyo Patient Information Centre, a nonprofit organization. MoPoTsyo Information Centre provided support in the form of salaries for author MVP and played a role in data collection. The organization did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Assah FK, 2015, DIABETIC MED, V32, P886, DOI 10.1111/dme.12720; Balagopal P, 2008, DIABETES CARE, V31, P1097, DOI 10.2337/dc07-1680; Balagopal P, 2012, DIABETES EDUCATOR, V38, P822, DOI 10.1177/0145721712459890; Baumann LC, 2015, INT J BEHAV MED, V22, P374, DOI 10.1007/s12529-014-9412-8; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Chalermsri Chalobol, 2014, Journal of the Medical Association of Thailand, V97, pS197; Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914; Funnell MM, 2010, FAM PRACT, V27, pI17, DOI 10.1093/fampra/cmp027; International Diabetes Federation, 2014, IDF DIAB ATLS 6 ED; International Diabetes Federation, 2013, IDF DIABETES ATLAS; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jayawardena MHDS, 2007, DIABETES RES CLIN PR, V75, P249, DOI 10.1016/j.diabres.2006.06.030; Jung CH, 2014, DIABETES RES CLIN PR, V104, pE34, DOI 10.1016/j.diabres.2014.02.008; Mafauzy M., 2011, MED J MALAYSIA, V66, P175; Men C, 2012, QUALITATIVE STUDY AC, P1; Otgontuya D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-254; Oum S, 2010, PREVALENCE NONCOMMUN; Raguenaud ME, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-33; Shivashankar R, 2015, DIABETES RES CLIN PR, V107, P203, DOI 10.1016/j.diabres.2014.11.004; Thomas B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086123; van Olmen Josefien, 2016, J Pharm Policy Pract, V9, P1, DOI 10.1186/s40545-016-0050-1; Van Olmen J, 2015, PRIM CARE DIABETES, V9, P196, DOI 10.1016/j.pcd.2014.09.001; Van Pelt M., 2009, DIABETES VOICE, V54, P15; Wei N, 2014, DIABETES CARE, V37, P1048, DOI 10.2337/dc13-2173; World Health Organization, 2008, PEER SUPP PROGR DIAB; World Health Organization, 2013, NONC DIS FACT SHEET; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0181582	10.1371/journal.pone.0181582	http://dx.doi.org/10.1371/journal.pone.0181582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945753	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100002
J	Holterman, M; Karegar, A; Mooijman, P; van Megen, H; van den Elsen, S; Vervoort, MTW; Quist, CW; Karssen, G; Decraemer, W; Opperman, CH; Bird, DM; Kammenga, J; Goverse, A; Smant, G; Helder, J				Holterman, Martijn; Karegar, Akbar; Mooijman, Paul; van Megen, Hanny; van den Elsen, Sven; Vervoort, Mariette T. W.; Quist, Casper W.; Karssen, Gerrit; Decraemer, Wilfrida; Opperman, Charles H.; Bird, David M.; Kammenga, Jan; Goverse, Aska; Smant, Geert; Helder, Johannes			Disparate gain and loss of parasitic abilities among nematode lineages	PLOS ONE			English	Article							TOBACCO RATTLE VIRUS; LONGIDORIDAE NEMATODA; PHYLOGENETIC APPROACH; N. SP; EVOLUTION; DIPHTHEROPHORINA; TYLENCHOMORPHA; IDENTIFICATION; TRANSMISSION; COEVOLUTION	Plant parasitism has arisen time and again in multiple phyla, including bacteria, fungi, insects and nematodes. In most of these organismal groups, the overwhelming diversity hampers a robust reconstruction of the origins and diversification patterns of this trophic lifestyle. Being a moderately diversified phylum with approximate to 4,100 plant parasites (15% of total biodiversity) subdivided over four independent lineages, nematodes constitute a major organismal group for which the genesis of plant parasitism could be mapped. Since substantial crop losses worldwide have been attributed to less than 1% of these plant parasites, research efforts are severely biased towards this minority. With the first molecular characterisation of numerous basal and supposedly harmless plant parasites as well as their non-parasitic relatives, we were able to generate a comprehensive molecular framework that allows for the reconstruction of trophic diversification for a complete phylum. In each lineage plant parasites reside in a single taxonomic grouping (family or order), and by taking the coverage of the next lower taxonomic level as a measure for representation, 50, 67, 100 and 85% of the known diversity was included. We revealed distinct gain and loss patterns with regard to plant parasitism per se as well as host exploitation strategies between these lineages. Our map of parasitic nematode biodiversity also revealed an unanticipated time reversal in which the two most ancient lineages showed the lowest level of ecological diversification and vice versa.	[Holterman, Martijn; Mooijman, Paul; van Megen, Hanny; van den Elsen, Sven; Vervoort, Mariette T. W.; Quist, Casper W.; Kammenga, Jan; Goverse, Aska; Smant, Geert; Helder, Johannes] Wageningen Univ, Dept Plant Sci, Lab Nematol, Wageningen, Netherlands; [Karegar, Akbar] Shiraz Univ, Sch Agr, Dept Plant Protect, Shiraz, Iran; [Karssen, Gerrit] Wageningen Nematode Collect, Natl Plant Protect Org, Wageningen, Netherlands; [Decraemer, Wilfrida] Univ Ghent, Dept Biol, Nematol Res Unit, Ghent, Belgium; [Opperman, Charles H.; Bird, David M.] North Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA	Wageningen University & Research; Shiraz University; Ghent University; University of North Carolina; North Carolina State University	Helder, J (corresponding author), Wageningen Univ, Dept Plant Sci, Lab Nematol, Wageningen, Netherlands.	Hans.Helder@wur.nl	Karegar, Akbar/V-1579-2018; Holterman, Martijn/GYQ-8578-2022; Karegar, Akbar/W-8047-2018; Decraemer, Wilfrida/AAD-2639-2020	Karegar, Akbar/0000-0002-2041-816X; Karegar, Akbar/0000-0002-2041-816X; Bird, David/0000-0002-1041-6769	Technology Foundation STVV; WBI [4725]	Technology Foundation STVV; WBI	Funding provided by the Technology Foundation STVV, WBI 4725.	[Anonymous], 2010, P GATEWAY COMPUTING; AYALA A, 1966, NEMATOLOGICA, V12, P87; B'CHIR M M, 1988, Revue de Nematologie, V11, P213; Blaxter M, 2015, PARASITOLOGY, V142, pS26, DOI 10.1017/S0031182014000791; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bragard C, 2013, ANNU REV PHYTOPATHOL, V51, P177, DOI 10.1146/annurev-phyto-082712-102346; COOMANS A, 1985, AGR ECOSYST ENVIRON, V12, P335, DOI 10.1016/0167-8809(85)90006-4; Danchin EGJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003745; Davies KA, 2015, NEMATOLOGY, V17, P761, DOI 10.1163/15685411-00002907; de Almeida MTM, 2005, NEMATOLOGY, V7, P343, DOI 10.1163/156854105774355572; Decraemer W., 2013, Plant nematology, P179, DOI 10.1079/9781780641515.0179; Decraemer W, 2006, PLANT NEMATOLOGY, P3, DOI [10.1079/9781845930561.0003, 10.1079/9781780641515.0003]; Decraemer W, 2012, NEMATOLOGY, V14, P151, DOI 10.1163/138855411X581703; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Forge T, 2012, CAN J PLANT PATHOL, V34, P277, DOI 10.1080/07060661.2012.689261; Giblin-Davis RM, 2001, J NEMATOL, V33, P239; GIBLINDAVIS RM, 1995, J NEMATOL, V27, P1; de Oliveira CMG, 2011, TROP PLANT PATHOL, V36, P65, DOI 10.1590/S1982-56762011000200001; He Y, 2005, NEMATOLOGY, V7, P111, DOI 10.1163/1568541054192108; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Huang RE, 2012, NEMATOLOGY, V14, P93, DOI 10.1163/138855411X579418; Hunt D. J., 2007, Journal of Nematode Morphology and Systematics, V10, P99; Hunt DJ, 1993, APHELENCHIDA LONGIDO; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kanzaki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099241; Kanzaki N, 2010, NEMATOLOGY, V12, P803, DOI 10.1163/138855410X499067; Karanastasi E, 2001, NEMATOLOGY, V3, P525, DOI 10.1163/156854101753389130; Kenrick P, 2012, PHILOS T R SOC B, V367, P519, DOI 10.1098/rstb.2011.0271; Knogge W, 1996, PLANT CELL, V8, P1711, DOI 10.1105/tpc.8.10.1711; Martinson EO, 2012, MICROB ECOL, V64, P1073, DOI 10.1007/s00248-012-0079-x; Nelson LA, 2014, BIOL J LINN SOC, V111, P699, DOI 10.1111/bij.12237; Oehlschlager AC, 2002, FLA ENTOMOL, V85, P507, DOI 10.1653/0015-4040(2002)085[0507:CORRDB]2.0.CO;2; Palomares-Rius JE, 2010, NEMATOLOGY, V12, P649, DOI 10.1163/138855410X489338; Paton AJ, 2008, TAXON, V57, P602, DOI 10.2307/25066027; Ragsdale EJ, 2011, ZOOL J LINN SOC-LOND, V161, P1, DOI 10.1111/j.1096-3642.2009.00632.x; Replogle A, 2013, MOL PLANT MICROBE IN, V26, P87, DOI 10.1094/MPMI-05-12-0118-FI; ROBBINS R T, 1985, Revue de Nematologie, V8, P215; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; Schellenberger P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002034; Shahina F., 1996, PAKISTAN J NEMATOL, V14, P1; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; Simon JC, 2015, BRIEF FUNCT GENOMICS, V14, P413, DOI 10.1093/bfgp/elv015; Sturhan D, 2005, NEMATOLOGY, V7, P249, DOI 10.1163/1568541054879593; Taylor C.E., 1997, NEMATODE VECTORS PLA; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vellios E, 2002, VIROLOGY, V300, P118, DOI 10.1006/viro.2002.1511; Wubben MJ, 2010, J NEMATOL, V42, P342; YEATES GW, 1993, J NEMATOL, V25, P315; Zhang YC, 2001, CAN J ZOOL, V79, P16, DOI 10.1139/cjz-79-1-16	50	23	23	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185445	10.1371/journal.pone.0185445	http://dx.doi.org/10.1371/journal.pone.0185445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934343	gold, Green Submitted, Green Published			2022-12-26	WOS:000411339900153
J	Ruff, CA; Faulkner, SD; Rumajogee, P; Beldick, S; Foltz, W; Corrigan, J; Basilious, A; Jiang, SJ; Thiyagalingam, S; Yager, JY; Fehlings, MG				Ruff, Crystal A.; Faulkner, Stuart D.; Rumajogee, Prakasham; Beldick, Stephanie; Foltz, Warren; Corrigan, Jennifer; Basilious, Alfred; Jiang, Shangjun; Thiyagalingam, Shanojan; Yager, Jerome Y.; Fehlings, Michael G.			The extent of intrauterine growth restriction determines the severity of cerebral injury and neurobehavioural deficits in rodents	PLOS ONE			English	Article							WHITE-MATTER INJURY; LATE OLIGODENDROCYTE PROGENITORS; BRAIN-INJURY; SPINAL-CORD; MAGNETIZATION-TRANSFER; PRENATAL ISCHEMIA; PREMATURE-INFANTS; HYPOXIA-ISCHEMIA; MOTOR IMPAIRMENT; CORPUS-CALLOSUM	Background Cerebral Palsy (CP) is the most common physical pediatric neurodevelopmental disorder and spastic diplegic injury is its most frequent subtype. CP results in substantial neuromotor and cognitive impairments that have significant socioeconomic impact. Despite this, its underlying pathophysiological mechanisms and etiology remain incompletely understood. Furthermore, there is a need for clinically relevant injury models, which a) reflect the heterogeneity of the condition and b) can be used to evaluate new translational therapies. To address these key knowledge gaps, we characterized a chronic placental insufficiency (PI) model, using bilateral uterine artery ligation (BUAL) of dams. This injury model results in intrauterine growth restriction (IUGR) in pups, and animals recapitulate the human phenotype both in terms of neurobehavioural and anatomical deficits. Methods Effects of BUAL were studied using luxol fast blue (LFB)/hematoxylin & eosin (H&E) staining, immunohistochemistry, quantitative Magnetic Resonance Imaging (MRI), and Catwalk neurobehavioural tests. Results Neuroanatomical analysis revealed regional ventricular enlargement and corpus callosum thinning in IUGR animals, which was correlated with the extent of growth restriction. Olig2 staining revealed reductions in oligodendrocyte density in white and grey matter structures, including the corpus callosum, optic chiasm, and nucleus accumbens. The caudate nucleus, along with other brain structures such as the optic chiasm, internal capsule, septofimbrial and lateral septal nuclei, exhibited reduced size in animals with IUGR. The size of the pretectal nucleus was reduced only in moderately injured animals. MAG/NF200 staining demonstrated reduced myelination and axonal counts in the corpus callosum of IUGR animals. NeuN staining revealed changes in neuronal density in the hippocampus and in the thickness of hippocampal CA2 and CA3 regions. Diffusion weighted imaging (DWI) revealed regional white and grey matter changes at 3 weeks of age. Furthermore, neurobehavioural testing demonstrated neuromotor impairments in animals with IUGR in paw intensities, swing speed, relative print positions, and phase dispersions. Conclusions We have characterized a rodent model of IUGR and have demonstrated that the neuroanatomical and neurobehavioural deficits mirror the severity of the IUGR injury. This model has the potential to be applied to examine the pathobiology of and potential therapeutic strategies for IUGR-related brain injury. Thus, this work has potential translational relevance for the study of CP.	[Ruff, Crystal A.; Faulkner, Stuart D.; Rumajogee, Prakasham; Beldick, Stephanie; Basilious, Alfred; Jiang, Shangjun; Thiyagalingam, Shanojan; Fehlings, Michael G.] Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Ruff, Crystal A.; Faulkner, Stuart D.; Rumajogee, Prakasham; Beldick, Stephanie; Basilious, Alfred; Jiang, Shangjun; Thiyagalingam, Shanojan; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Ruff, Crystal A.; Faulkner, Stuart D.; Rumajogee, Prakasham; Beldick, Stephanie; Basilious, Alfred; Jiang, Shangjun; Thiyagalingam, Shanojan; Fehlings, Michael G.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Foltz, Warren] STARR facil, Toronto Med Discovery Tower, Toronto, ON, Canada; [Corrigan, Jennifer; Yager, Jerome Y.] Univ Alberta, Sect Pediat Neurosci, Dept Pediat, Edmonton, AB, Canada; [Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Alberta; University of Toronto	Fehlings, MG (corresponding author), Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Div Neurosurg, Toronto, ON, Canada.	michael.fehlings@uhn.on.ca		Beldick, Stephanie/0000-0002-5349-0352; Fehlings, Michael/0000-0002-5722-6364	Kids Brain Health Network; Ontario Brain Institute; Jeremy and Judith Freedman Family Foundation; Ontario Stem Cell Initiative; Halbert Chair in Neural Repair and Regeneration	Kids Brain Health Network; Ontario Brain Institute; Jeremy and Judith Freedman Family Foundation; Ontario Stem Cell Initiative; Halbert Chair in Neural Repair and Regeneration	This project received financial support from the Kids Brain Health Network as well as the Ontario Brain Institute. C.A.R. was supported by postdoctoral research grants from the Jeremy and Judith Freedman Family Foundation and the Ontario Stem Cell Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Kids Brain Health Network as well as the Ontario Brain Institute for project support. C.A.R. was supported by postdoctoral research grants from the Jeremy and Judith Freedman Family Foundation and the Ontario Stem Cell Initiative. The authors wish to also thank Mr. E. Armstrong, Ms. X. Y. S. Fan, Ms. S. Altamentova for technical support and collaboration, as well as Dr. M. O'Higgins for editorial support. Dr. M. G. Fehlings acknowledges support from the Halbert Chair in Neural Repair and Regeneration.	Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 2014, ANN NEUROL, V75, P469, DOI 10.1002/ana.24132; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Basilious A, 2015, DEV MED CHILD NEUROL, V57, P420, DOI 10.1111/dmcn.12599; Bihel E, 2011, STROKE, V42, P1412, DOI 10.1161/STROKEAHA.110.596650; Black AM, 2015, BEHAV BRAIN RES, V291, P289, DOI 10.1016/j.bbr.2015.05.033; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Cao Y, 2017, NEUROCHEM INT, V107, P198, DOI 10.1016/j.neuint.2016.10.014; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Constantinou Janet C, 2005, J Perinatol, V25, P788, DOI 10.1038/sj.jp.7211403; Coq JO, 2016, DEV MED CHILD NEUROL, V58, P7, DOI 10.1111/dmcn.13040; Dahlseng MO, 2014, DEV MED CHILD NEUROL, V56, P53, DOI 10.1111/dmcn.12293; Delcour M, 2012, BEHAV BRAIN RES, V232, P233, DOI 10.1016/j.bbr.2012.03.029; Delcour M, 2012, BRAIN PATHOL, V22, P1, DOI 10.1111/j.1750-3639.2011.00504.x; Drobyshevsky A, 2007, ANN NEUROL, V61, P307, DOI 10.1002/ana.21095; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Faulkner SD, 2013, SEMIN PEDIATR NEUROL, V20, P146, DOI 10.1016/j.spen.2013.06.002; French HM, 2009, J NEUROSCI RES, V87, P3076, DOI 10.1002/jnr.22139; Fung C, 2012, PEDIATR RES, V72, P2, DOI 10.1038/pr.2012.32; Graham HK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.82; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Jantzie LL, 2015, DEV NEUROSCI-BASEL, V37, P277, DOI 10.1159/000371721; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Koman L Andrew, 2003, Paediatr Drugs, V5, P11, DOI 10.2165/00128072-200305010-00002; Kruse M, 2009, DEV MED CHILD NEUROL, V51, P622, DOI 10.1111/j.1469-8749.2008.03190.x; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Levesque IR, 2010, MAGN RESON MED, V63, P633, DOI 10.1002/mrm.22244; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Logitharajah P, 2009, PEDIATR RES, V66, P222, DOI 10.1203/PDR.0b013e3181a9ef34; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mallard EC, 1999, SCHIZOPHR RES, V40, P11, DOI 10.1016/S0920-9964(99)00041-9; Mukhopadhyay K, 2010, INDIAN J PEDIATR, V77, P963, DOI 10.1007/s12098-010-0149-3; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; NITSOS I, 1990, INT J DEV NEUROSCI, V8, P233, DOI 10.1016/0736-5748(90)90029-2; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Ohshima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39377; Olivier P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007128; Padilla N, 2014, BRAIN RES, V1545, P1, DOI 10.1016/j.brainres.2013.12.007; Panigrahy A, 2005, PEDIATR RADIOL, V35, P1199, DOI 10.1007/s00247-005-1577-5; Reid MV, 2012, J NEUROPATH EXP NEUR, V71, P640, DOI 10.1097/NEN.0b013e31825cfa81; Ruff CA, 2013, J NEUROSCI, V33, P11899, DOI 10.1523/JNEUROSCI.1131-13.2013; Ruff CA, 2013, DEV MED CHILD NEUROL, V55, P689, DOI 10.1111/dmcn.12166; Rumajogee P, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00057; Salewski RP, 2015, STEM CELL TRANSL MED, V4, P743, DOI 10.5966/sctm.2014-0236; Schober ME, 2009, AM J PHYSIOL-REG I, V296, pR681, DOI 10.1152/ajpregu.90396.2008; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shevell MI, 2009, DEV MED CHILD NEUROL, V51, P872, DOI 10.1111/j.1469-8749.2009.03269.x; Stoinska B, 2011, J PERINATOL, V31, P137, DOI 10.1038/jp.2010.75; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Surman G, 2009, PAEDIATR PERINAT EP, V23, P513, DOI 10.1111/j.1365-3016.2009.01060.x; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tolcos M, 2017, PROG NEUROBIOL, V154, P62, DOI 10.1016/j.pneurobio.2017.03.009; Tolcos M, 2011, EXP NEUROL, V232, P53, DOI 10.1016/j.expneurol.2011.08.002; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Towsley K, 2011, EUR J PAEDIATR NEURO, V15, P29, DOI 10.1016/j.ejpn.2010.07.005; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wren TAL, 2005, J PEDIATR ORTHOPED, V25, P79, DOI 10.1097/00004694-200501000-00018; Xie M, 2011, NEUROSCIENCE, V197, P339, DOI 10.1016/j.neuroscience.2011.09.042; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3	68	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184653	10.1371/journal.pone.0184653	http://dx.doi.org/10.1371/journal.pone.0184653			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934247	gold, Green Submitted, Green Published			2022-12-26	WOS:000411339900037
J	Schmoll, M; Unger, E; Bijak, M; Stoiber, M; Lanmuller, H; Jarvis, JC				Schmoll, Martin; Unger, Ewald; Bijak, Manfred; Stoiber, Martin; Lanmueller, Hermann; Jarvis, Jonathan Charles			A novel miniature in-line load-cell to measure in-situ tensile forces in the tibialis anterior tendon of rats	PLOS ONE			English	Article							VIVO MUSCLE FORCE; SKELETAL-MUSCLE; CONTRACTILE PROPERTIES; OPTIC FIBER; LOCOMOTION; GASTROCNEMIUS; TRANSDUCER; EXERCISE; BEHAVIOR	Direct measurements of muscular forces usually require a substantial rearrangement of the biomechanical system. To circumvent this problem, various indirect techniques have been used in the past. We introduce a novel direct method, using a lightweight (similar to 0.5 g) miniature (3 x 3 x 7 mm) in-line load-cell to measure tension in the tibialis anterior tendon of rats. A linear motor was used to produce force-profiles to assess linearity, step-response, hysteresis and frequency behavior under controlled conditions. Sensor responses to a series of rectangular force-pulses correlated linearly (R-2 = 0.999) within the range of 0-20 N. The maximal relative error at full scale (20 N) was 0.07% of the average measured signal. The standard deviation of the mean response to repeated 20 N force pulses was +/- 0.04% of the mean response. The step-response of the load-cell showed the behavior of a PD2T2-element in control-engineering terminology. The maximal hysteretic error was 5.4% of the full-scale signal. Sinusoidal signals were attenuated maximally (-4 dB) at 200 Hz, within a measured range of 0.01-200 Hz. When measuring muscular forces this should be of minor concern as the fusion-frequency of muscles is generally much lower. The newly developed load-cell measured tensile forces of up to 20 N, without inelastic deformation of the sensor. It qualifies for various applications in which it is of interest directly to measure forces within a particular tendon causing only minimal disturbance to the biomechanical system.	[Schmoll, Martin; Unger, Ewald; Bijak, Manfred; Stoiber, Martin; Lanmueller, Hermann] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Waehringer Guertel, Vienna, Austria; [Schmoll, Martin; Jarvis, Jonathan Charles] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England	Medical University of Vienna; Liverpool John Moores University	Schmoll, M (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Waehringer Guertel, Vienna, Austria.; Schmoll, M; Jarvis, JC (corresponding author), Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England.	martin.schmoll@meduniwien.ac.at; J.C.Jarvis@ljmu.ac.uk	Bijak, Manfred/I-4448-2019	Stoiber, Martin/0000-0003-1174-987X; Unger, Ewald/0000-0003-0275-9988; Schmoll, Martin/0000-0001-6354-3879	MED-EL GmbH (Innsbruck, Austria)	MED-EL GmbH (Innsbruck, Austria)	This work is the outcome of a collaboration between the Medical University of Vienna and Liverpool John Moores University. This project was supported by MED-EL GmbH (Innsbruck, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is the outcome of a collaboration between the Medical University of Vienna and Liverpool John Moores University. This project was supported by MED-EL GmbH (Innsbruck, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding does not alter our adherence to PLOS ONE policies on sharing data and materials.	Arndt AN, 1998, CLIN BIOMECH, V13, P532, DOI 10.1016/S0268-0033(98)00032-1; BIEWENER AA, 1988, J EXP BIOL, V137, P191; Biewener AA, 1998, J EXP BIOL, V201, P1681; BIEWENER AA, 1995, J EXP BIOL, V198, P1829; Biewener AA, 1998, AM ZOOL, V38, P703; Daley MA, 2003, J EXP BIOL, V206, P2941, DOI 10.1242/jeb.00503; DEKONING JJ, 1987, J MORPHOL, V194, P75, DOI 10.1002/jmor.1051940107; Duncan ND, 1998, EUR J APPL PHYSIOL O, V77, P372, DOI 10.1007/s004210050347; Finni T, 1998, EUR J APPL PHYSIOL O, V77, P289, DOI 10.1007/s004210050335; Genovese A, 2007, MACROMOL MATER ENG, V292, P184, DOI 10.1002/mame.200600346; GLOS DL, 1993, J BIOMECH ENG-T ASME, V115, P335, DOI 10.1115/1.2895495; GONYEA W, 1978, EXP NEUROL, V59, P75, DOI 10.1016/0014-4886(78)90202-9; JARVIS JC, 1991, J APPL PHYSIOL, V70, P938, DOI 10.1152/jappl.1991.70.2.938; Komi PV, 1996, EUR J APPL PHYSIOL, V72, P278, DOI 10.1007/BF00838652; Ling X, 2007, INT J PRES VES PIP, V84, P304, DOI 10.1016/j.ijpvp.2006.11.003; Marsh DR, 1998, MUSCLE NERVE, V21, P1265, DOI 10.1002/(SICI)1097-4598(199810)21:10<1265::AID-MUS4>3.0.CO;2-9; Plaut Ronald Lesley, 2007, Mat. Res., V10, P453; Ramirez A, 2010, J THEOR BIOL, V267, P546, DOI 10.1016/j.jtbi.2010.09.018; Schmoll M, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13245; Shin RH, 2008, MICROSURG, V28, P452, DOI 10.1002/micr.20520; SIMARD CP, 1982, EXP NEUROL, V77, P467, DOI 10.1016/0014-4886(82)90221-7; SPYROPOULOS BP, 1994, J NEUROSCI METH, V53, P95, DOI 10.1016/0165-0270(94)90149-X; Sutherland H, 2003, NEUROMODULATION, V6, P176, DOI 10.1046/j.1525-1403.2003.03025.x; van Bolhuis AI, 2001, J NEUROSCI METH, V107, P87, DOI 10.1016/S0165-0270(01)00355-7; Vickerton P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0786; WALMSLEY B, 1978, J NEUROPHYSIOL, V41, P1203, DOI 10.1152/jn.1978.41.5.1203; Weinmann A., 2013, REGELUNGEN ANAL TECH, V1; WINIARSKI AM, 1987, EXP NEUROL, V96, P650, DOI 10.1016/0014-4886(87)90226-3	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185209	10.1371/journal.pone.0185209	http://dx.doi.org/10.1371/journal.pone.0185209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934327	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000411339900124
J	Wu, XR; Jin, L; Zhang, H; Tong, RN; Ma, M; Chen, YJ				Wu, Xuri; Jin, Liang; Zhang, Hong; Tong, Ruinian; Ma, Min; Chen, Yijun			Identification of truncated form of NosP as a transcription factor to regulate the biosynthesis of nosiheptide	FASEB JOURNAL			English	Article						Streptomyces; antibiotics; SARP family; transcription regulation; secondary metabolism	STREPTOMYCES-COELICOLOR A3(2); GENE-CLUSTER; FAMILY; ANTIBIOTICS; MATURATION; MECHANISM; ACTIVATOR; PROMOTER; SYNTHASE; PEPTIDE	Nosiheptide (NOS), a typical member of the thiopeptides, possesses strong activities against multidrug-resistant, gram-positive bacterial pathogens. Similar to other thiopeptides, the biosynthetic pathway of NOS belongs to a ribosomally synthesized and posttranslationally modified peptide system. Bioinformatics analysis of the NOS gene cluster suggests that nosP gene encodes a homologous protein of the Streptomyces antibiotic regulatory protein (SARP) family. In the present study, the actual initiation codon of nosP was identified by comparison of potential initiation codons GUG and AUG. In contrast to previous predictions of starting with GUG, AUG, corresponding to methionine residue as the 53rd residue in the original sequence, is actually the initiation codon of nosP, indicating that a truncated form of NosP (NosP(53-323)) is a functional protein. For better understanding of the transcriptional regulation for NOS biosynthesis, the binding region was subsequently investigated with NosP(53-323), demonstrating that NosP(53-323) specifically binds the bidirectional nosL-nosM promoter region. Additionally, NosP(53-323) was confirmed to serve as a transcription factor to activate the transcription of all 15 structural genes in the gene cluster. The present study provides new insights into pathway-specific regulation of the biosynthesis of NOS, which would be beneficial to the investigation of the regulatory function of similar SARP proteins in the gene clusters of other thiopeptides.	[Chen, Yijun] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China; [Chen, Yijun] China Pharmaceut Univ, Lab Biol Chem, 24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Chen, YJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China.; Chen, YJ (corresponding author), China Pharmaceut Univ, Lab Biol Chem, 24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China.	yjchen@cpu.edu.cn	Chen, Yijun/H-3209-2019	Chen, Yijun/0000-0002-4920-152X; Wu, Xuri/0000-0002-0933-5902	Ministry of Education of the People's Republic of China 111 Project; State Administration of Foreign Exports Affairs of China [111-2-07]; National Natural Science Foundation of China [81502961]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Ministry of Education of the People's Republic of China 111 Project; State Administration of Foreign Exports Affairs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Ministry of Education of the People's Republic of China 111 Project, the State Administration of Foreign Exports Affairs of China (Grant 111-2-07), the National Natural Science Foundation of China (Grant 81502961), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Aigle B, 2005, J BACTERIOL, V187, P2491, DOI 10.1128/JB.187.7.2491-2500.2005; Badding ED, 2017, J AM CHEM SOC, V139, P5896, DOI 10.1021/jacs.7b01497; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; BENAZET F, 1980, EXPERIENTIA, V36, P414, DOI 10.1007/BF01975121; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; Colombo V, 2001, MICROBIOL-SGM, V147, P3083, DOI 10.1099/00221287-147-11-3083; Procopio RED, 2012, BRAZ J INFECT DIS, V16, P466, DOI 10.1016/j.bjid.2012.08.014; Ding W, 2017, ANGEW CHEM INT EDIT, V56, P3857, DOI 10.1002/anie.201609948; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; GRAMAJO HC, 1993, MOL MICROBIOL, V7, P837, DOI 10.1111/j.1365-2958.1993.tb01174.x; Guthrie EP, 1998, MICROBIOL-SGM, V144, P727, DOI 10.1099/00221287-144-3-727; Hughes RA, 2007, ANGEW CHEM INT EDIT, V46, P7930, DOI 10.1002/anie.200700728; Ji XJ, 2015, ANGEW CHEM INT EDIT, V54, P9021, DOI 10.1002/anie.201503976; Jiang Lei, 2015, Chin J Nat Med, V13, P854, DOI 10.1016/S1875-5364(15)30089-3; Jin L, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02880-16; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kurniawan YN, 2014, APPL MICROBIOL BIOT, V98, P9713, DOI 10.1007/s00253-014-5988-9; Lee PC, 2002, MOL MICROBIOL, V43, P1413, DOI 10.1046/j.1365-2958.2002.02840.x; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Liu SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12744; Liu WY, 2013, CHEMBIOCHEM, V14, P1544, DOI 10.1002/cbic.201300427; Liu WY, 2013, CHEMBIOCHEM, V14, P573, DOI 10.1002/cbic.201200681; Ma M, 2014, CHEM COMMUN, V50, P10430, DOI 10.1039/c4cc04974h; MADDURI K, 1995, J BACTERIOL, V177, P3879, DOI 10.1128/jb.177.13.3879-3884.1995; Matsuno K, 2004, ARCH MICROBIOL, V181, P52, DOI 10.1007/s00203-003-0625-5; Nicolet Y, 2014, ANGEW CHEM INT EDIT, V53, P11840, DOI 10.1002/anie.201407320; Romero-Rodriguez A, 2015, BBA-GENE REGUL MECH, V1849, P1017, DOI 10.1016/j.bbagrm.2015.06.007; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Stratigopoulos G, 2002, CHEM BIOL, V9, P71, DOI 10.1016/S1074-5521(01)00095-3; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Suzuki T, 2010, BIOSCI BIOTECH BIOCH, V74, P819, DOI 10.1271/bbb.90927; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Takano E, 2003, MOL MICROBIOL, V50, P475, DOI 10.1046/j.1365-2958.2003.03728.x; TAKANO E, 1992, MOL MICROBIOL, V6, P2797, DOI 10.1111/j.1365-2958.1992.tb01459.x; Vior NM, 2014, MICROBIOL-SGM, V160, P467, DOI 10.1099/mic.0.075218-0; Wang SF, 2013, CURR OPIN CHEM BIOL, V17, P626, DOI 10.1016/j.cbpa.2013.06.021; Wang SZ, 2016, RSC ADV, V6, P94643, DOI 10.1039/c6ra20302g; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Yu Y, 2010, J AM CHEM SOC, V132, P16324, DOI 10.1021/ja106571g; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	43	7	9	3	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					453	+		10.1096/fj.201700556R	http://dx.doi.org/10.1096/fj.201700556R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28935819				2022-12-26	WOS:000419172700040
J	Mulero, MC; Huang, DB; Nguyen, HT; Wang, VYF; Li, YD; Biswas, T; Ghosh, G				Mulero, Maria Carmen; Huang, De-Bin; Thien Nguyen, H.; Wang, Vivien Ya-Fan; Li, Yidan; Biswas, Tapan; Ghosh, Gourisankar			DNA-binding affinity and transcriptional activity of the RelA homodimer of nuclear factor B are not correlated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cooperativity; crystal structure; dimerization; DNA transcription; NF-kB transcription factor; E-selectin; RelA; kB site	NF-KAPPA-B; ACTIVATION; COMPLEXES; DIMERS; SITES; CRYSTALLIZATION; SUBUNIT	The nuclear factor B (NF-B) transcription factor family regulates genes involved in cell proliferation and inflammation. The promoters of these genes often contain NF-B-binding sites (B sites) arranged in tandem. How NF-B activates transcription through these multiple sites is incompletely understood. We report here an X-ray crystal structure of homodimers comprising the RelA DNA-binding domain containing the Rel homology region (RHR) in NF-B bound to an E-selectin promoter fragment with tandem B sites. This structure revealed that two dimers bind asymmetrically to the symmetrically arranged B sites at which multiple cognate contacts between one dimer to the corresponding DNA are broken. Because simultaneous RelA-RHR dimer binding to tandem sites in solution was anti-cooperative, we inferred that asymmetric RelA-RHR binding with fewer contacts likely indicates a dissociative binding mode. We found that both B sites are essential for reporter gene activation by full-length RelA homodimer, suggesting that dimers facilitate DNA binding to each other even though their stable co-occupation is not promoted. Promoter variants with altered spacing and orientation of tandem B sites displayed unexpected reporter activities that were not explained by the solution-binding pattern of RelA-RHR. Remarkably, full-length RelA bound all DNAs with a weaker affinity and specificity. Moreover, the transactivation domain played a negative role in DNA binding. These observations suggest that other nuclear factors influence full-length RelA binding to DNA by neutralizing the transactivation domain negative effect. We propose that DNA binding by NF-B dimers is highly complex and modulated by facilitated association-dissociation processes.	[Mulero, Maria Carmen; Huang, De-Bin; Thien Nguyen, H.; Wang, Vivien Ya-Fan; Li, Yidan; Biswas, Tapan; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Wang, Vivien Ya-Fan] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	University of California System; University of California San Diego; University of Macau	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gghosh@ucsd.edu			National Institutes of Health [GM085490]; University of Macau [SRG2016-00084-FHS]; Biochemistry of Growth Regulation and Oncogenesis T32 Training Grant from the NCI, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Macau; Biochemistry of Growth Regulation and Oncogenesis T32 Training Grant from the NCI, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM085490 (to G. G.) and Start-up Research Grant SRG2016-00084-FHS from the University of Macau (to V. Y. F. W). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Biochemistry of Growth Regulation and Oncogenesis T32 Training Grant from the NCI, National Institutes of Health.	Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Choy MK, 2010, GENOME MED, V2, DOI 10.1186/gm158; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Huxford T, 2000, J BIOL CHEM, V275, P32800, DOI 10.1074/jbc.M006037200; JOACHIMIAK A, 1991, METHOD ENZYMOL, V208, P82; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Moorthy AK, 2007, J MOL BIOL, V373, P723, DOI 10.1016/j.jmb.2007.08.039; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Pober JS, 1999, IMMUNOL RES, V19, P225, DOI 10.1007/BF02786490; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Xing YJ, 2013, GENE, V526, P142, DOI 10.1016/j.gene.2013.05.001	26	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18821	18830		10.1074/jbc.M117.813980	http://dx.doi.org/10.1074/jbc.M117.813980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28935669	hybrid, Green Published			2022-12-26	WOS:000415848000008
J	Hall, SS; Wright, HF; Mills, DS				Hall, Sophie S.; Wright, Hannah F.; Mills, Daniel S.			Parent perceptions of the quality of life of pet dogs living with neuro-typically developing and neuro-atypically developing children: An exploratory study	PLOS ONE			English	Article							SEPARATION ANXIETY; HEALTH-BENEFITS; DOMESTIC DOGS; RISK-FACTORS; BEHAVIOR; STRESS; AUTISM; OWNERSHIP; DIRECTIONS; STRENGTHS	There is growing scientific and societal recognition of the role that pet dogs can play in healthy development of children; both those who are neuro-typically developing and those who live with a neuro-developmental disorder, such as autism or attention deficit hyperactivity disorder. However, little attention has been paid to how living with children positively and negatively affects quality of life of a pet dog. In this exploratory study we conducted semi-structured interviews with parents of neuro-typically developing children (n = 18) and those with a neuro-developmental disorder (n = 18) who owned a pet dog, until no new factors were identified. Living with children brought potentially positive benefits to the dog's life including: imposition of a routine, participation in recreational activities and the development of a strong bond between the child and the dog. The importance of maintaining a routine was particularly prevalent in families with children with neuro-developmental disorders. Potential negative factors included having to cope with child meltdowns and tantrums, over stimulation from child visitors, harsh contact and rough and tumble play with the child. The regularity and intensity of meltdowns and tantrums was particularly evident in responses from parents with children with a neuro-developmental disorder. However, child visitors and rough play and contact were mentioned similarly across the groups. Protective factors included having a safe haven for the dog to escape to, parent's awareness of stress signs and child education in dog-interaction. Parents were also asked to complete a stress response scale to provide an initial quantitative comparison of stress responses between dogs living with the two family-types. Parents with neuro-typically developing children more frequently observed their dog rapidly running away from a situation and less frequently observed their dog widening their eyes, than parents with children with a neuro-developmental disorder. We propose the development of a stress audit based on the findings reported here, to prevent potential dangerous situations, which may lead to dog bites and dog relinquishment and allow owners to maximise the benefits of dog ownership.	[Hall, Sophie S.; Wright, Hannah F.; Mills, Daniel S.] Univ Lincoln, Sch Life Sci, Lincoln, England	University of Lincoln	Hall, SS (corresponding author), Univ Lincoln, Sch Life Sci, Lincoln, England.	shall@lincoln.ac.uk		Hall, Sophie/0000-0002-9847-8269	Dogs Trust Canine Welfare Grant	Dogs Trust Canine Welfare Grant	This project was funded by a Dogs Trust Canine Welfare Grant, awarded to SH and DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by a Dogs Trust Canine Welfare grant.	Ainsworth MD., 1964, MERRILL PALMER QUART, V10, P51, DOI DOI 10.2307/23082925; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; ANDERSON WP, 1992, MED J AUSTRALIA, V157, P298, DOI 10.5694/j.1326-5377.1992.tb137178.x; [Anonymous], 2012, QUALITATIVE RES METH; Arhant C, 2016, J VET BEHAV, V14, P10, DOI 10.1016/j.jveb.2016.06.007; Beck AM, 2003, AM BEHAV SCI, V47, P79, DOI 10.1177/0002764203255214; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Beerda B, 2000, ANIM WELFARE, V9, P49; Beetz A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00352; Beetz A, 2011, ANTHROZOOS, V24, P349, DOI 10.2752/175303711X13159027359746; Belshaw Z, 2015, VET J, V206, P203, DOI 10.1016/j.tvjl.2015.07.016; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burgoyne L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004786; Burrows KE, 2008, J APPL ANIM WELF SCI, V11, P42, DOI 10.1080/10888700701555550; Cooper JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102722; CORSON SA, 1976, PSYCHOPATHOLOGY HUMA, P77; Custance D, 2012, ANIM COGN, V15, P851, DOI 10.1007/s10071-012-0510-1; Endenburg N, 2011, VET J, V190, P208, DOI 10.1016/j.tvjl.2010.11.020; Esposito L, 2011, CHILD DEV PERSPECT, V5, P205, DOI 10.1111/j.1750-8606.2011.00175.x; FRIEDMANN E, 1980, PUBLIC HEALTH REP, V95, P307; Golinko MS, 2016, CLIN PEDIATR; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Grandgeorge M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041739; Guy NC, 2001, APPL ANIM BEHAV SCI, V74, P29, DOI 10.1016/S0168-1591(01)00154-X; Hall SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149759; Headey B, 1999, SOC INDIC RES, V47, P233, DOI 10.1023/A:1006892908532; HUBRECHT RC, 1992, APPL ANIM BEHAV SCI, V34, P365, DOI 10.1016/S0168-1591(05)80096-6; Kerswell KJ, 2009, ANTHROZOOS, V22, P183, DOI 10.2752/175303709X434202; Kertes DA, 2016, SOC DEV; Kiddie JL, 2014, APPL ANIM BEHAV SCI, V158, P57, DOI 10.1016/j.applanim.2014.05.008; Landsberg GM., 2003, HDB BEHAV PROBLEMS C, P227; Le Roux MC, 2009, PSYCHOGERIATRICS, V9, P23, DOI 10.1111/j.1479-8301.2009.00268.x; Levine GN, 2013, CIRCULATION, V127, P2353, DOI 10.1161/CIR.0b013e31829201e1; Mariti C, 2012, J VET BEHAV, V7, P213, DOI 10.1016/j.jveb.2011.09.004; MATHEWS JR, 1994, J DEV BEHAV PEDIATR, V15, P44, DOI 10.1097/00004703-199402000-00008; Mills D.S., 2012, STRESS PHEROMONATHER; Mills D, 2014, VET CLIN N AM-SMALL, V44, P525, DOI 10.1016/j.cvsm.2014.01.005; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Myers SM, 2007, PEDIATRICS, V120, P1162, DOI 10.1542/peds.2007-2362; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; Overall KL, 2001, J AM VET MED ASSOC, V219, P467, DOI 10.2460/javma.2001.219.467; Pirrone F, 2015, J VET BEHAV, V10, P295, DOI 10.1016/j.jveb.2015.03.004; Purewal R, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030234; Reisner IR, 2007, INJURY PREV, V13, P348, DOI 10.1136/ip.2007.015396; Reisner IR, 2011, INJ PREV; Rhoades H, 2015, CHILD PSYCHIAT HUM D, V46, P237, DOI 10.1007/s10578-014-0463-5; Russell G, 2014, J AUTISM DEV DISORD, V44, P31, DOI 10.1007/s10803-013-1849-0; Sacks J J, 1996, Inj Prev, V2, P52, DOI 10.1136/ip.2.1.52; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sheppard G, 2003, VET REC, V152, P432, DOI 10.1136/vr.152.14.432; Sherman BL, 2008, VET CLIN N AM-SMALL, V38, P1081, DOI 10.1016/j.cvsm.2008.04.012; Smyth C., 2010, LEARNING DISABILITY, V13, P12, DOI [https://doi.org/10.7748/ldp2010.05.13.4.12.c7758, DOI 10.7748/LDP2010.05.13.4.12.C7758, DOI 10.7748/LDP2010.05.13.4]; Solomon O, 2010, ETHOS, V38, P143, DOI 10.1111/j.1548-1352.2010.01085.x; Solomon RL, 1953, PSYCHOL MONOGR-GEN A, V67, P1, DOI 10.1037/h0093649; Viau R, 2010, PSYCHONEUROENDOCRINO, V35, P1187, DOI 10.1016/j.psyneuen.2010.02.004; Wells DL, 2002, ANIM WELFARE, V11, P385; Wright H, 2016, HUM ANIM INTERACT B, V1, P38; Wright HF, 2015, J AUTISM DEV DISORD, V45, P2531, DOI 10.1007/s10803-015-2418-5; Wright H, 2015, ANTHROZOOS, V28, P611, DOI 10.1080/08927936.2015.1070003	61	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185300	10.1371/journal.pone.0185300	http://dx.doi.org/10.1371/journal.pone.0185300			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953961	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300054
J	Kammerle, JL; Brieger, F; Kroschel, M; Hagen, R; Storch, I; Suchant, R				Kammerle, Jim-Lino; Brieger, Falko; Kroeschel, Max; Hagen, Robert; Storch, Ilse; Suchant, Rudi			Temporal patterns in road crossing behaviour in roe deer (Capreolus capreolus) at sites with wildlife warning reflectors	PLOS ONE			English	Article							VEHICLE COLLISIONS; HABITAT SELECTION; HOME-RANGE; LANDSCAPE; MIGRATION; AVOIDANCE; GRADIENT; SPACE; BOAR	Every year, there are millions of documented vehicle collisions involving cervids across Europe and North America. While temporal patterns in collision occurrence are relatively well described, few studies have targeted deer behaviour as a critical component of collision prevention. In this study, we investigated weekly and daily patterns in road crossing behaviour in roe deer. Using road crossing events and movement data obtained from GPS telemetry, we employed mixed-effect models to explain frequency and timing of crossings at five road segments by a number of predictors including traffic volume, deer movement activity and the presence of wildlife warning reflectors. We analysed 13,689 road crossing events by 32 study animals. Individual variation in crossing frequency was high but daily patterns in crossing events were highly consistent among animals. Variation in the intensity of movement activity on a daily and seasonal scale was the main driver of road crossing behaviour. The seasonal variation in crossing frequency reflected differences in movement activity throughout the reproductive cycle, while daily variation in the probability to cross exhibited a clear nocturnal emphasis and reflected crepuscular activity peaks. The frequency of road crossings increased as a function of road density in the home-range, while traffic volume only exerted marginal effects. Movement activity of roe deer in our study coincided with commuter traffic mainly in the early morning and late afternoon during winter and during periods of high spatial activity such as the rut. Both timing and frequency of crossing events remained unchanged in the presence of reflectors. Our results emphasise the importance of behavioural studies for understanding roe deer vehicle-collision patterns and thus provide important information for collision prevention. We suggest that mitigation of collision risk should focus on strategic seasonal measures and animal warning systems targeting drivers.	[Kammerle, Jim-Lino; Brieger, Falko; Kroeschel, Max; Storch, Ilse] Univ Freiburg, Chair Wildlife Ecol & Wildlife Management, Freiburg, Germany; [Kammerle, Jim-Lino; Brieger, Falko; Kroeschel, Max; Hagen, Robert; Suchant, Rudi] Forest Res Inst Baden Wurttemberg, Div Wildlife Ecol, Freiburg, Germany	University of Freiburg	Brieger, F (corresponding author), Univ Freiburg, Chair Wildlife Ecol & Wildlife Management, Freiburg, Germany.; Brieger, F (corresponding author), Forest Res Inst Baden Wurttemberg, Div Wildlife Ecol, Freiburg, Germany.	falko.brieger@forst.bwl.d	Storch, Ilse/N-7478-2019; Storch, Ilse/P-6806-2019	Storch, Ilse/0000-0002-3252-2036	federal state of Baden-Wurttemberg; foundation Dr. Joachim und Hanna Schmidt Stiftung fur Umwelt und Verkehr; German Research Foundation (DFG); University of Freiburg	federal state of Baden-Wurttemberg; foundation Dr. Joachim und Hanna Schmidt Stiftung fur Umwelt und Verkehr; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This study was funded by the federal state of Baden-Wurttemberg (Landesjagdabgabe). FB was supported with a PhD Scholarship by the foundation Dr. Joachim und Hanna Schmidt Stiftung fur Umwelt und Verkehr (http://www.dr-schmidt-stiftung.de). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Angelo GD, 2015, HANDBOOK OF ROAD ECOLOGY, P213; Barton K., 2015, MULTIMODEL INFERENCE; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bivand R., 2016, MAPTOOLS TOOLS READI; Blackwell BF, 2009, J WILDLIFE MANAGE, V73, P128, DOI 10.2193/2008-014; Bongi P, 2008, J ZOOL, V276, P242, DOI 10.1111/j.1469-7998.2008.00481.x; Brieger F, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1130-5; Brieger F, 2016, ACCIDENT ANAL PREV, V97, P242, DOI 10.1016/j.aap.2016.08.030; Brown DD, 2012, WILDLIFE SOC B, V36, P139, DOI 10.1002/wsb.111; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Clair CCS, 2009, BEHAVIOUR, V146, P393, DOI 10.1163/156853909X410973; Coe PK, 2015, WILDLIFE SOC B, V39, P256, DOI 10.1002/wsb.544; CONOVER MR, 1995, WILDLIFE SOC B, V23, P407; D'Angelo GJ, 2006, WILDLIFE SOC B, V34, P1175, DOI 10.2193/0091-7648(2006)34[1175:EOWWRF]2.0.CO;2; Dal Compare L, 2007, ITAL J ANIM SCI, V6, P848, DOI 10.4081/ijas.2007.1s.848; Danks ZD, 2010, J WILDLIFE MANAGE, V74, P1229, DOI 10.2193/2008-358; Dodd NL, 2005, P 2005 INT C EC TRAN, P461; Dussault C, 2007, J WILDLIFE MANAGE, V71, P2338, DOI 10.2193/2006-499; Fahrig L, 2009, ECOL SOC, V14; Found R, 2011, J ENVIRON MANAGE, V92, P2486, DOI 10.1016/j.jenvman.2011.05.010; Gagnon JW, 2007, J WILDLIFE MANAGE, V71, P2324, DOI 10.2193/2006-445; Gladfelter L., 1984, EFFECT WILDLIFE HIGH; Hothorn T, 2015, ACCIDENT ANAL PREV, V81, P143, DOI 10.1016/j.aap.2015.04.037; Hothorn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029510; Huijser MP, 2009, ECOL SOC, V14; Iuell B, 2003, COST 341 HABITAT FRA; Jacobson SL, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1345; Jepsen JU, 2004, CAN J ZOOL, V82, P1528, DOI 10.1139/Z04-131; Krop-Benesch A, 2013, ITAL J ZOOL, V80, P69, DOI 10.1080/11250003.2012.725777; Lagos L, 2012, EUR J WILDLIFE RES, V58, P661, DOI 10.1007/s10344-012-0614-6; Lamberti P, 2006, J ETHOL, V24, P181, DOI 10.1007/s10164-005-0179-x; Langbein Jochen, 2011, P215; Leblond M, 2013, J ZOOL, V289, P32, DOI 10.1111/j.1469-7998.2012.00959.x; Lima SL, 2015, BIOL REV, V90, P60, DOI 10.1111/brv.12093; Maublanc ML, 2012, CR BIOL, V335, P735, DOI 10.1016/j.crvi.2012.11.003; Meisingset EL, 2014, J WILDLIFE MANAGE, V78, P679, DOI 10.1002/jwmg.712; Meisingset EL, 2013, J WILDLIFE MANAGE, V77, P181, DOI 10.1002/jwmg.469; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neumann W, 2012, BIOL CONSERV, V145, P70, DOI 10.1016/j.biocon.2011.10.011; Ng Janet W., 2008, Human-Wildlife Conflicts, V2, P34; Pagon N, 2013, CHRONOBIOL INT, V30, P772, DOI 10.3109/07420528.2013.765887; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pokorny Bostjan, 2006, Veterinarski Arhiv, V76, pS177; Proppe DS, 2016, ANIM COGN, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Ramanzin M, 2007, CAN J ZOOL, V85, P280, DOI 10.1139/Z06-210; Rodriguez-Morales B, 2013, ACCIDENT ANAL PREV, V60, P121, DOI 10.1016/j.aap.2013.07.032; Romin LA, 1996, WILDLIFE SOC B, V24, P276; SCHAFER JA, 1985, J WILDLIFE MANAGE, V49, P774, DOI 10.2307/3801710; Schwabe KA, 1999, USDA NAT RESC S HUM, V10, P14; Sivic A., 2001, WILDLIFE WARNING REF; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; Steiner W, 2014, ACCIDENT ANAL PREV, V66, P168, DOI 10.1016/j.aap.2014.01.020; Thurfjell H, 2015, LANDSCAPE URBAN PLAN, V133, P98, DOI 10.1016/j.landurbplan.2014.09.015; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; Ujvari M, 1998, J WILDLIFE MANAGE, V62, P1094, DOI 10.2307/3802562; Ware HE, 2015, P NATL ACAD SCI USA, V112, P12105, DOI 10.1073/pnas.1504710112; WARING GH, 1991, APPL ANIM BEHAV SCI, V29, P215, DOI 10.1016/0168-1591(91)90249-W; Zacks JL, 1986, 1075 TRB NAT RES COU; Zuberogoitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107713	63	23	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184761	10.1371/journal.pone.0184761	http://dx.doi.org/10.1371/journal.pone.0184761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953951	gold, Green Submitted, Green Published			2022-12-26	WOS:000411980300022
J	Song, Y; Kim, JG; Cho, HJ; Kim, JK; Suh, DC				Song, Yunsun; Kim, Joong-goo; Cho, Hong-Jun; Kim, Jae Kyun; Suh, Dae Chul			Evaluation of cerebral blood flow change after cigarette smoking using quantitative MRA	PLOS ONE			English	Article							CAROTID-ARTERY; HEART-DISEASE; RISK-FACTORS; NICOTINE; STROKE; AGE; CESSATION; ANGIOGRAPHY; PRESSURE; EXPOSURE	Background and objective Changes in cerebral blood flow (CBF) immediately after cigarette smoking (CS) are still unclear. Our purpose was to evaluate the hemodynamic changes in each intracranial vessel after CS by using quantitative magnetic resonance angiography (MRA). Material and methods Fifteen healthy male smokers less than 45 years old with more than 3 pack-year smoking history were enrolled in this study. The hemodynamic change in the vessels, represented by cerebral flow rate (CFR, ml/s) and flow velocity (FV, cm/s), was quantitatively measured in eleven vascular segments of the brain using phase-contrast MRA. Two sets of data at each vessel before and after CS were statistically analyzed by paired t-test. Three of 15 participants, as a control group, followed all the procedures but did not smoke. Results Total CFR of the distal intracranial vessels (anterior, middle, and posterior cerebral arteries; ACA, MCA, and PCA) was significantly reduced after CS by 7.3% (847 vs. 785 ml/s, p = 0.024). Such flow changes were statistically more significant in the anterior circulation (ACA and MCA) compared to the posterior circulation (PCA). All distal intracranial vessels did not have significant FV change while peak systolic velocity and mean velocity dropped 7.4 and 4.3% and pulsatility index decreased 10.9% in the internal carotid artery. Regarding cross-sectional areas, all distal intracranial vessels showed diminished, and only MCA had a statistical significance (9.9 vs. 9.3 mm(2), p = 0.016). Conclusions There was a significant decrease of CFR after CS especially in the anterior circulation of twelve young male smokers. Considering the changes of FV and cross-sectional area all together, it can be suggested that cerebrovascular impedance increased after CS especially at the main trunk level of the distal intracranial vessels (ACA, MCA, and PCA).	[Song, Yunsun; Kim, Joong-goo; Suh, Dae Chul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol,Inst Radiol, Seoul, South Korea; [Song, Yunsun; Kim, Joong-goo; Suh, Dae Chul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Res,Inst Radiol, Seoul, South Korea; [Cho, Hong-Jun] Univ Ulsan, Dept Family Med, Coll Med, Asan Med Ctr, Seoul, South Korea; [Kim, Jae Kyun] Chung Ang Univ, Dept Radiol, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Chung Ang University; Chung Ang University Hospital	Suh, DC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol,Inst Radiol, Seoul, South Korea.; Suh, DC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Res,Inst Radiol, Seoul, South Korea.	desuh@amc.seoul.kr	Suh, Dae Chul/F-5949-2014	Suh, Dae Chul/0000-0003-1561-5596; Kim, Joong-Goo/0000-0002-4166-6023	Soelim, Inc. of Korea [2015-0735]; Korean Society of Ginseng	Soelim, Inc. of Korea; Korean Society of Ginseng	This work was supported by the Soelim, Inc. of Korea (project number 2015-0735) to DCS and was partly supported by the 2016 research project of the Korean Society of Ginseng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by 2016 research project of the Korean Society of Ginseng.	Amin-Hanjani S, 2005, STROKE, V36, P1140, DOI 10.1161/01.STR.0000166195.63276.7c; Babizhayev MA, 2011, AM J THER, V18, pE209, DOI 10.1097/MJT.0b013e3181cf8ebb; Barutcu I, 2004, CIRC J, V68, P1127, DOI 10.1253/circj.68.1127; Boyajian RA, 2000, J NEUROIMAGING, V10, P204, DOI 10.1111/jon2000104204; Buijs PC, 1998, RADIOLOGY, V209, P667, DOI 10.1148/radiology.209.3.9844657; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Choi JW, 2010, CEREBROVASC DIS, V29, P297, DOI 10.1159/000275508; CRUICKSHANK JM, 1989, J HUM HYPERTENS, V3, P443; Csordas A, 2013, NAT REV CARDIOL, V10, P219, DOI 10.1038/nrcardio.2013.8; D'Armiento FP, 2001, STROKE, V32, P2472, DOI 10.1161/hs1101.098520; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Domino EF, 2000, SYNAPSE, V38, P313, DOI 10.1002/1098-2396(20001201)38:3<313::AID-SYN10>3.0.CO;2-6; Domino EF, 2004, PROG NEURO-PSYCHOPH, V28, P319, DOI 10.1016/j.pnpbp.2003.10.011; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Kim S, 2010, NICOTINE TOB RES, V12, P1246, DOI 10.1093/ntr/ntq189; Kochanowicz J, 2015, BIOL RES NURS, V17, P8, DOI 10.1177/1099800413512175; Kodaira K, 1993, Yakubutsu Seishin Kodo, V13, P157; Krejza J, 2005, RADIOLOGY, V236, P621, DOI 10.1148/radiol.2362031662; Kweon SS, 2012, CIRC J, V76, P2041, DOI 10.1253/circj.CJ-11-1353; Lapenna D, 2015, ATHEROSCLEROSIS, V238, P190, DOI 10.1016/j.atherosclerosis.2014.11.028; Liu Hairi, 2014, Neurointervention, V9, P89, DOI 10.5469/neuroint.2014.9.2.89; Lu PH, 2011, STROKE, V42, P3470, DOI 10.1161/STROKEAHA.111.622282; Morioka C, 1997, PSYCHOPHARMACOLOGY, V131, P220, DOI 10.1007/s002130050287; Organisation for Economic Co-operation and Development (OECD), 2014, SOURC SYMB STAT; Powell J T, 1998, Vasc Med, V3, P21, DOI 10.1191/135886398670269973; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Redgrave JNE, 2010, STROKE, V41, P2288, DOI 10.1161/STROKEAHA.110.587006; RODRIGUEZ BL, 1994, HYPERTENSION, V24, P779, DOI 10.1161/01.HYP.24.6.779; ROGERS RL, 1983, JAMA-J AM MED ASSOC, V250, P2796, DOI 10.1001/jama.250.20.2796; Rose JE, 2003, AM J PSYCHIAT, V160, P323, DOI 10.1176/appi.ajp.160.2.323; Silvestrini M, 1996, J CEREBR BLOOD F MET, V16, P746, DOI 10.1097/00004647-199607000-00027; Suh DC, 2003, AM J NEURORADIOL, V24, P239; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; Vafaee MS, 2015, J CEREBR BLOOD F MET, V35, P699, DOI 10.1038/jcbfm.2014.246; Yamamoto Y, 2003, EUR J NUCL MED MOL I, V30, P612, DOI 10.1007/s00259-003-1119-z; Yamashita K, 2000, INTERNAL MED, V39, P891, DOI 10.2169/internalmedicine.39.891; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567; Zubieta JK, 2001, BIOL PSYCHIAT, V49, P906, DOI 10.1016/S0006-3223(00)01070-2	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184551	10.1371/journal.pone.0184551	http://dx.doi.org/10.1371/journal.pone.0184551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953897	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300015
J	Cherry, JD; Stein, TD; Tripodis, Y; Alvarez, VE; Huber, BR; Au, R; Kiernan, PT; Daneshvar, DH; Mez, J; Solomon, TM; Alosco, ML; McKee, AC				Cherry, Jonathan D.; Stein, Thor D.; Tripodis, Yorghos; Alvarez, Victor E.; Huber, Bertrand R.; Au, Rhoda; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.			CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease	PLOS ONE			English	Article							NATIONAL INSTITUTE; NEUROPATHOLOGIC ASSESSMENT; ASSOCIATION GUIDELINES; BRAIN-INJURY; TAU; CRITERIA; RELIABILITY; MICROGLIA; DIAGNOSIS; CONSENSUS	CCL11, a protein previously associated with age-associated cognitive decline, is observed to be increased in the brain and cerebrospinal fluid (CSF) in chronic traumatic encephalopathy (CTE) compared to Alzheimer's disease (AD). Using a cohort of 23 deceased American football players with neuropathologically verified CTE, 50 subjects with neuropathologically diagnosed AD, and 18 non-athlete controls, CCL11 was measured with ELISA in the dorsolateral frontal cortex (DLFC) and CSF. CCL11 levels were significantly increased in the DLFC in subjects with CTE (fold change = 1.234, p < 0.050) compared to non-athlete controls and AD subjects with out a history of head trauma. This increase was also seen to correlate with years of exposure to American football (beta = 0.426, p = 0.048) independent of age (beta = -0.046, p = 0.824). Preliminary analyses of a subset of subjects with available post-mortem CSF showed a trend for increased CCL11 among individuals with CTE (p = 0.069) mirroring the increase in the DLFC. Furthermore, an association between CSF CCL11 levels and the number of years exposed to football (beta = 0.685, p = 0.040) was observed independent of age (beta = -0.103, p = 0.716). Finally, a receiver operating characteristic (ROC) curve analysis demonstrated CSF CCL11 accurately distinguished CTE subjects from non-athlete controls and AD subjects (AUC = 0.839, 95% CI 0.62 - 1.058, p = 0.028). Overall, the current findings provide preliminary evidence that CCL11 may be a novel target for future CTE biomarker studies.	[Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, Boston Univ Alzheimers Dis, Boston, MA 02118 USA; [Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Au, Rhoda; Mez, Jesse; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Au, Rhoda] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Boston University; Framingham Heart Study; Boston University	Cherry, JD (corresponding author), Boston Univ, Sch Med, Boston Univ Alzheimers Dis, Boston, MA 02118 USA.; Cherry, JD (corresponding author), Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA.; Cherry, JD (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.; Cherry, JD (corresponding author), VA Boston Healthcare Syst, Boston, MA 02130 USA.	Jdcherry@bu.edu	Tripodis, Yorghos/GRY-0583-2022	Tripodis, Yorghos/0000-0003-2190-7608; Stein, Thor/0000-0001-6954-4477; Daneshvar, Daniel/0000-0003-3691-9513	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development [I01-CX001038]; Alzheimer's Association [NIRG-305779]; Veterans Affairs Biorepository [CSP 501]; National Institute of Aging [1RF1AG054156-01]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program [DoD-PRARP 13267017]; National Heart, Lung, and Blood Institute, Framingham Heart Study, (NHLBI/NIH) [N01-HC-25195, R01AG08122]; NINDS [1F32NS096803-01]; Concussion Legacy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG057902, RF1AG054156, K23AG046377, P30AG013846] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development(US Department of Veterans Affairs); Alzheimer's Association(Alzheimer's Association); Veterans Affairs Biorepository; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Aging Boston University AD Center; Department of Defense Peer Reviewed Alzheimer's Research Program; National Heart, Lung, and Blood Institute, Framingham Heart Study, (NHLBI/NIH); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Concussion Legacy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038 to TDS); Alzheimer's Association (NIRG-305779 to TDS); Veterans Affairs Biorepository (CSP 501 to ACM); National Institute of Aging (1RF1AG054156-01); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5 to ACM); Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP #13267017 to ACM); National Heart, Lung, and Blood Institute, Framingham Heart Study, (NHLBI/NIH #N01-HC-25195 and R01AG08122 to RA); NINDS (1F32NS096803-01 to MLA); Concussion Legacy Foundation to ACM. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE to ACM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS CURR; Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Belkhelfa M, 2014, J INTERFERON CYTOKIN; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Castellano JM, 2015, JAMA NEUROL, V72, P1191, DOI 10.1001/jamaneurol.2015.1616; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Furukawa T, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000138; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Huber A. K., 2016, CLIN IMMUNOL; Huber AK, 2014, NEUROLOGY, V83, P1500, DOI 10.1212/WNL.0000000000000908; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Leung R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064971; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Love S, 2008, GREENFIELDS NEUROPAT, DOI 10.1201/b22602; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Okamura N, 2016, AGEING RES REV, V30, P107, DOI 10.1016/j.arr.2015.12.010; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Parajuli B, 2015, GLIA, V63, P2274, DOI 10.1002/glia.22892; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Shahim P, 2017, JAMA NEUROL; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Yang LP, 2007, MOL VIS, V13, P1083; Zhu C, 2016, MOL NEUROBIOL	63	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185541	10.1371/journal.pone.0185541	http://dx.doi.org/10.1371/journal.pone.0185541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950005	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000062
J	Olivera, MJ; Cucunuba, ZM; Valencia-Hernandez, CA; Herazo, R; Agreda-Rudenko, D; Florez, C; Duque, S; Nicholls, RS				Olivera, Mario J.; Cucunuba, Zulma M.; Valencia-Hernandez, Carlos A.; Herazo, Rafael; Agreda-Rudenko, Diana; Florez, Carolina; Duque, Sofia; Nicholls, Ruben S.			Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease	PLOS ONE			English	Article							TOLERANCE; SAFETY; NIFURTIMOX; TRIAL; MODEL	Background Etiological treatment of Chagas disease in chronic asymptomatic patients is still in debate and the adverse effects of traditional drugs are one of the main concerns in clinical practice. This study evaluated retrospectively the safety profile of benznidazole (BZN) and identified predictive factors for definite treatment interruption and development of severe reactions in adult patients treated with BZN in Colombia. Methods Retrospective follow-up study conducted by review of medical records of adults with chronic Chagas disease treated with BZN in Colombia. A parametric survival analysis based on a generalized gamma distribution was used for assessing risk factors for treatment interruption. A multinomial logistic regression model was used to estimate the probability of severe adverse drug reactions (ADRs). Statistical associations were expressed as time ratios (TR) and adjusted odds ratios (aOR) respectively. Results In total 224 adults patients treated with BZN were included; 172 (76.8%) completed the standard therapy (60 days of treatment), 205 (91.5%) presented ADRs and 52 cases (23.2%) required treatment interruption. The predominant symptoms were: rash (37.9%), itching (33.7%), epigastric pain (26.4%), abdominal bloating (24.2%) and nausea (22.1%). ADRs were mild (57.4%), moderate (35.5%) and severe (7.3%). Time to treatment interruption was significantly shorter when using doses of BZN >= 6 mg/ kg/ day (TR 0.55; 95% CI 0.39-0.76), presenting severe ADRs (TR 0.12; 95% CI: 0.07-0.19) and eosinophilia (TR 0.68; 95% CI: 0.49-0.94). Female sex (aOR 3.98; 95% CI 1.56-10.16), dose of BZN >= 6 mg/ kg/ day (aOR 1.41; 95% CI 1.17-1.70) and presence of > 3 ADRs (aOR 6.47; 95% CI 1.24-34.34) were considered as risk factors for developing severe ADRs. Conclusions Dose, severity of ADRs, eosinophilia and female sex were the main predictors for treatment interruption or severe ADRs. The potential implications of these findings are discussed.	[Olivera, Mario J.; Cucunuba, Zulma M.; Valencia-Hernandez, Carlos A.; Herazo, Rafael; Agreda-Rudenko, Diana] Red Chagas Colombia, Bogota, Colombia; [Olivera, Mario J.; Cucunuba, Zulma M.; Valencia-Hernandez, Carlos A.; Herazo, Rafael; Agreda-Rudenko, Diana; Florez, Carolina; Duque, Sofia; Nicholls, Ruben S.] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia	Instituto Nacional de Salud (Colombia)	Olivera, MJ (corresponding author), Red Chagas Colombia, Bogota, Colombia.; Olivera, MJ (corresponding author), Inst Nacl Salud, Grp Parasitol, Bogota, Colombia.	moliverajr@gmail.com	Cucunuba, Zulma M/X-5670-2019; Olivera, Mario/T-5486-2018	Cucunuba, Zulma M/0000-0002-8165-3198; Olivera, Mario/0000-0002-6885-6353				Altcheh J, 2011, PEDIATRICS, V127, pE212, DOI 10.1542/peds.2010-1172; Anderson GD, 2008, INT REV NEUROBIOL, V83, P1, DOI 10.1016/S0074-7742(08)00001-9; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2010, GUIA AT CLIN INT PAC; Antinori S, 2015, CLIN INFECT DIS, V60, P1873, DOI 10.1093/cid/civ230; CANÇADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006; Villar JC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003463.pub2; Carrilero B, REV ESPANOLA QUIMIOT; Coelho H L, 1999, Cad Saude Publica, V15, P631, DOI 10.1590/S0102-311X1999000300021; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; de Graauw E, 2015, IMMUNOL ALLERGY CLIN, V35, P545, DOI 10.1016/j.iac.2015.05.005; Fabbro de Suasnabar Diana, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P99; Alvarez MG, 2016, ANTIMICROB AGENTS CH, V60, P833, DOI 10.1128/AAC.00745-15; Hasslocher-Moreno AM, 2012, J ANTIMICROB CHEMOTH, V67, P1261, DOI 10.1093/jac/dks027; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jackson Y, 2010, CLIN INFECT DIS, V51, pE69, DOI 10.1086/656917; Olivera MJ, 2015, AM J TROP MED HYG, V93, P1224, DOI 10.4269/ajtmh.15-0256; Olivera MJ, 2015, REV SOC BRAS MED TRO, V48, P343, DOI 10.1590/0037-8682-0251-2014; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1; Lee EW, 2003, STAT METHODS SURVIVA, Vthird, DOI DOI 10.1002/0471458546; Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002; Miller DA, 2015, CLIN INFECT DIS, V60, P1237, DOI 10.1093/cid/civ005; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Ng ES-W, 2015, PHARM STAT; de Pontes VMO, 2010, REV SOC BRAS MED TRO, V43, P182, DOI 10.1590/S0037-86822010000200015; Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10; R Development Core Team, 2013, LANG ENV STAT COMP; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Silva G. M. S. da, 2014, Antimicrobial Agents and Chemotherapy, V58, P6371, DOI 10.1128/AAC.02842-14; Sosa-Estani S, 2004, MEDICINA-BUENOS AIRE, V64, P1; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; White KD, 2015, J ALLERGY CLIN IMMUN, V136, P219, DOI 10.1016/j.jaci.2015.05.050	36	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185033	10.1371/journal.pone.0185033	http://dx.doi.org/10.1371/journal.pone.0185033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949997	gold, Green Published, Green Submitted			2022-12-26	WOS:000411671000022
J	Cherry, JJ; DiDonato, CJ; Androphy, EJ; Calo, A; Potter, K; Custer, SK; Du, S; Foley, TL; Gopalsamy, A; Reedich, EJ; Gordo, SM; Gordon, W; Hosea, N; Jones, LH; Krizay, DK; LaRosa, G; Li, HX; Mathur, S; Menard, CA; Patel, P; Ramos-Zayas, R; Rietz, A; Rong, HJ; Zhang, BH; Tones, MA				Cherry, Jonathan J.; DiDonato, Christine J.; Androphy, Elliot J.; Calo, Alessandro; Potter, Kyle; Custer, Sara K.; Du, Sarah; Foley, Timothy L.; Gopalsamy, Ariamala; Reedich, Emily J.; Gordo, Susana M.; Gordon, William; Hosea, Natalie; Jones, Lyn H.; Krizay, Daniel K.; LaRosa, Gregory; Li, Hongxia; Mathur, Sachin; Menard, Carol A.; Patel, Paraj; Ramos-Zayas, Rebeca; Rietz, Anne; Rong, Haojing; Zhang, Baohong; Tones, Michael A.			In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levels	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON GENE; MOUSE MODEL; 2,4-DIAMINOQUINAZOLINE DERIVATIVES; LYSOSOMOTROPIC AGENTS; PROTEIN-LEVELS; SURVIVAL; EXPRESSION; MICE; RNA	`C5-substituted 2,4-diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS (DAQ-DcpSi) have been developed for the treatment of spinal muscular atrophy (SMA), which is caused by genetic deficiency in the Survival Motor Neuron (SMN) protein. These compounds are claimed to act as SMN2 transcriptional activators but data underlying that claim are equivocal. In addition it is unclear whether the claimed effects on SMN2 are a direct consequence of DcpS inhibitor or might be a consequence of lysosomotropism, which is known to be neuroprotective. DAQ-DcpSi effects were characterized in cells in vitro utilizing DcpS knockdown and 7-methyl analogues as probes for DcpS vs non-DcpS-mediated effects. We also performed analysis of Smn transcript levels, RNA-Seq analysis of the transcriptome and SMN protein in order to identify affected pathways underlying the therapeutic effect, and studied lysosomotropic and non-lysosomotropic DAQ-DCpSi effects in 2B/-SMA mice. Treatment of cells caused modest and transient SMN2 mRNA increases with either no change or a decrease in SMN.7 and no change in SMN1 transcripts or SMN protein. RNA-Seq analysis of DAQ-DcpSi-treated N2a cells revealed significant changes in expression (both up and down) of approximately 2,000 genes across a broad range of pathways. Treatment of 2B/-SMA mice with both lysomotropic and non-lysosomotropic DAQ-DcpSi compounds had similar effects on disease phenotype indicating that the therapeutic mechanism of action is not a consequence of lysosomotropism. In striking contrast to the findings in vitro, Smn transcripts were robustly changed in tissues but there was no increase in SMN protein levels in spinal cord. We conclude that DAQ-DcpSi have reproducible benefit in SMA mice and a broad spectrum of biological effects in vitro and in vivo, but these are complex, context specific, and not the result of simple SMN2 transcriptional activation.	[Cherry, Jonathan J.; Calo, Alessandro; Gordo, Susana M.; Krizay, Daniel K.; LaRosa, Gregory; Patel, Paraj; Ramos-Zayas, Rebeca; Tones, Michael A.] Pfizer Worldwide Res & Dev, Rare Dis Res Unit, Cambridge, MA USA; [DiDonato, Christine J.; Potter, Kyle; Reedich, Emily J.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60208 USA; [DiDonato, Christine J.; Potter, Kyle; Reedich, Emily J.] Ann & Robert Lurie Childrens Hosp, Stanley Manne Res Inst, Human Mol Genet Program, Chicago, IL 60640 USA; [Androphy, Elliot J.; Custer, Sara K.; Li, Hongxia; Rietz, Anne] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Du, Sarah; Gordon, William] Pfizer Worldwide Res & Dev, Precis Med, Cambridge, MA 02139 USA; [Foley, Timothy L.; Menard, Carol A.] Pfizer Worldwide Res & Dev, Pharmaceut Sci, Groton, CT USA; [Foley, Timothy L.; Menard, Carol A.] Pfizer Worldwide Res & Dev, Primary Pharmacol Grp, Groton, CT USA; [Gopalsamy, Ariamala; Jones, Lyn H.] Pfizer Worldwide Res & Dev, Med Design, Cambridge, MA USA; [Hosea, Natalie; Rong, Haojing] Pfizer Worldwide Res & Dev, Pharmacokinet & Drug Metab, Cambridge, MA USA; [Mathur, Sachin] Pfizer Worldwide Res & Dev, Business Technol, Cambridge, MA USA; [Zhang, Baohong] Pfizer Worldwide Res & Dev, Clin Genet, Cambridge, MA USA; [Cherry, Jonathan J.; Gordo, Susana M.] RaNA Therapeut Inc, Cambridge, MA USA; [Hosea, Natalie] Takeda Calif, Global DMPK, San Diego, CA USA	Pfizer; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Indiana University System; Indiana University Bloomington; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc	DiDonato, CJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60208 USA.; DiDonato, CJ (corresponding author), Ann & Robert Lurie Childrens Hosp, Stanley Manne Res Inst, Human Mol Genet Program, Chicago, IL 60640 USA.; Gordon, W (corresponding author), Pfizer Worldwide Res & Dev, Precis Med, Cambridge, MA 02139 USA.	c-didonato@northwestern.edu; william.gordon@pfizer.com	Foley, Timothy/O-7281-2018	Foley, Timothy/0000-0002-5987-5253; Jones, Lyn/0000-0002-8388-5865	Pfizer Inc. EJR is a Dr. Virginia Mullins Investigator; Ann & Robert H. Lurie Children's Hospital of Chicago Foundation; National Institutes of Health [5T32NS041234-15, 1ROIN5060926]; Muscular Dystrophy Association [255785]; Cure SMA [DiD1214]; Lurie Children's Hospital; Pfizer; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041234] Funding Source: NIH RePORTER	Pfizer Inc. EJR is a Dr. Virginia Mullins Investigator; Ann & Robert H. Lurie Children's Hospital of Chicago Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Cure SMA; Lurie Children's Hospital; Pfizer(Pfizer); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Pfizer Inc. EJR is a Dr. Virginia Mullins Investigator, Ann & Robert H. Lurie Children's Hospital of Chicago Foundation and was supported by a National Institutes of Health training grant [#5T32NS041234-15] with additional support provided by National Institutes of Health [#1ROIN5060926], Muscular Dystrophy Association [255785], Cure SMA [DiD1214] and Lurie Childrens Hospital to CJD. Employees of Pfizer who are named in this manuscript participated in all or portions of this research. Pfizer provided support in the form of salaries for authors (JJC, AC, SD,TLF, AG, SMG, WG, NH, LHJ, DKK, GL, HL, SM, CAM,PP, RR-Z, HR, BZ, and MAT), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond the contributions of the individual authors who were Pfizer employees at the time the work was performed, as detailed in the 'authors contributions' section.	Ahmad S, 2012, HUM MOL GENET, V21, P2745, DOI 10.1093/hmg/dds102; Bosse GD, 2013, MOL CELL, V50, P281, DOI 10.1016/j.molcel.2013.02.023; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Cherry JJ, 2013, EMBO MOL MED, V5, P1103, DOI 10.1002/emmm.201202305; Cherry JJ, 2012, J BIOMOL SCREEN, V17, P481, DOI 10.1177/1087057111431605; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Gogliotti RG, 2013, HUM MOL GENET, V22, P4084, DOI 10.1093/hmg/ddt258; Gopalsamy A, 2017, J MED CHEM, V60, P3094, DOI 10.1021/acs.jmedchem.7b00124; Hett EC, 2016, ACS COMB SCI; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Meziane O, 2015, SCI REP-UK, V5, DOI 10.1038/srep16688; Murray LM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0231-1; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rochette CF, 2001, HUM GENET, V108, P255, DOI 10.1007/s004390100473; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Singh J, 2008, ACS CHEM BIOL, V3, P711, DOI 10.1021/cb800120t; Sinturel F, 2012, P NATL ACAD SCI USA, V109, P8264, DOI 10.1073/pnas.1120090109; Thurmond J, 2008, J MED CHEM, V51, P449, DOI 10.1021/jm061475p; Van Meerbeke JP, 2013, HUM MOL GENET, V22, P4074, DOI 10.1093/hmg/ddt257; Wang Y, 2015, MOL NEUROBIOL, V52, P64, DOI 10.1007/s12035-014-8846-y; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Xu H, 2016, ORG BIOMOL CHEM, V14, P6179, DOI 10.1039/c6ob01078d; Zhou M, 2015, RNA, V21, P1306, DOI 10.1261/rna.051573.115	33	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9								10.1371/journal.pone.0185079	http://dx.doi.org/10.1371/journal.pone.0185079			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945765	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100021
J	Koyama, D; Murata, M; Hanajiri, R; Okuno, S; Kamoshita, S; Julamanee, J; Takagi, E; Hirano, D; Miyao, K; Sakemura, R; Goto, T; Hayakawa, F; Seto, A; Ozawa, Y; Miyamura, K; Terakura, S; Nishida, T; Kiyoi, H				Koyama, Daisuke; Murata, Makoto; Hanajiri, Ryo; Okuno, Shingo; Kamoshita, Sonoko; Julamanee, Jakrawadee; Takagi, Erina; Hirano, Daiki; Miyao, Kotaro; Sakemura, Reona; Goto, Tatsunori; Hayakawa, Fumihiko; Seto, Aika; Ozawa, Yukiyasu; Miyamura, Koichi; Terakura, Seitaro; Nishida, Tetsuya; Kiyoi, Hitoshi			High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; INTESTINAL MICROBIOTA; METABOLITE BUTYRATE; COMPETING RISK; T-CELLS; GUT; INTERLEUKIN-22; INFLAMMATION; EXPRESSION; BIOMARKERS	Regenerating islet-derived protein 3 alpha (REG3A) is a biomarker of lower gastrointestinal graft-versus-host disease (GVHD); however, the biological role of REG3A in the pathophysiology of GVHD is not understood. Here, we examined the association between a single nucleotide polymorphism in the REG3A gene, rs7588571, which is located upstream and within 2 kb of the REG3A gene, and transplant outcomes including the incidence of GVHD. The study population consisted of 126 adult Japanese patients who had undergone bone marrow transplantation from a HLA-matched sibling. There was no association between rs7588571 polymorphism and the incidence of acute GVHD. However, a significantly higher incidence of extensive chronic GVHD was observed in patients with the rs7588571 non-GG genotype than in those with the GG genotype (Odds ratio 2.6; 95% confidence interval, 1.1-6.0; P = 0.029). Semi-quantitative reverse transcription PCR demonstrated that the rs7588571 non-GG genotype exhibited a significantly lower REG3A mRNA expression level than the GG genotype (P = 0.032), and Western blot analysis demonstrated that the rs7588571 non-GG genotype exhibited a trend toward lower REG3A protein expression level than the GG genotype (P = 0.053). Since REG proteins have several activities that function to control intestinal microbiota, and since intestinal dysbiosis is in part responsible for the development of GVHD, our findings lead to the novel concept that REG3A could have some protective effect in the pathogenesis of GVHD through the regulation of gut microbiota.	[Koyama, Daisuke; Murata, Makoto; Hanajiri, Ryo; Okuno, Shingo; Kamoshita, Sonoko; Julamanee, Jakrawadee; Takagi, Erina; Hirano, Daiki; Miyao, Kotaro; Sakemura, Reona; Goto, Tatsunori; Hayakawa, Fumihiko; Terakura, Seitaro; Nishida, Tetsuya; Kiyoi, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Seto, Aika; Ozawa, Yukiyasu; Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan	Nagoya University; Red Cross Nagoya Daiichi Hospital	Murata, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan.	mmurata@med.nagoya-u.ac.jp	Julamanee, Jakrawadee/AAQ-5827-2021; Julamanee, Jakrawadee/AAQ-7762-2021; Terakura, Seitaro/A-6188-2011	Julamanee, Jakrawadee/0000-0002-6526-9479; 	Japan Agency for Medical Research and Development (AMED) [17ek0510022h0001 to M. Murata) from the]; Japan Society for the Promotion of Science (JSPS) [15K09498]; Grants-in-Aid for Scientific Research [17K09921, 16H06868] Funding Source: KAKEN	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Practical Research Project for Allergic Diseases and Immunology (17ek0510022h0001 to M. Murata) from the Japan Agency for Medical Research and Development (AMED; http://www.amed.go.jp/en/) and a Grant-in-Aid for Scientific Research (KAKENHI) (15K09498 to M. Murata) from the Japan Society for the Promotion of Science (JSPS; https://www.jsps.go.jp/english/index.html).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Beilhack A, 2008, BLOOD, V111, P2919, DOI 10.1182/blood-2007-09-112789; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Byun JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163998; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; COX DR, 1958, J R STAT SOC B, V20, P215; Docampo MD, 2015, BIOL BLOOD MARROW TR, V21, P1360, DOI 10.1016/j.bbmt.2015.02.016; Eriguchi Y, 2013, BIOL BLOOD MARROW TR, V19, P1525, DOI 10.1016/j.bbmt.2013.07.027; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; Inamoto Y, 2010, BONE MARROW TRANSPL, V45, P363, DOI 10.1038/bmt.2009.131; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein JP, 2001, BONE MARROW TRANSPL, V28, P1001, DOI 10.1038/sj.bmt.1703271; Koenecke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038252; Kojima Y, 2017, PHARMACOL RES, V120, P242, DOI 10.1016/j.phrs.2017.04.006; Levine JE, 2015, LANCET HAEMATOL, V2, pE21, DOI 10.1016/S2352-3026(14)00035-0; Levine JE, 2012, BLOOD, V119, P3854, DOI 10.1182/blood-2012-01-403063; Martin PJ, 2016, BLOOD, V128, P2450, DOI 10.1182/blood-2016-07-728063; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Shono Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2311; Shono Y, 2015, INT J HEMATOL, V101, P428, DOI 10.1007/s12185-015-1781-5; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sugimoto K, 2009, J IMMUNOL, V183, P5991, DOI 10.4049/jimmunol.0804310; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Tumino M, 2015, BRIT J HAEMATOL, V168, P142, DOI 10.1111/bjh.13068; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zama D, 2017, BONE MARROW TRANSPL, V52, P7, DOI 10.1038/bmt.2016.173	42	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185213	10.1371/journal.pone.0185213	http://dx.doi.org/10.1371/journal.pone.0185213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945764	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100029
J	Puozaa, DK; Jaiswal, SK; Dakora, FD				Puozaa, Doris K.; Jaiswal, Sanjay K.; Dakora, Felix D.			African origin of Bradyrhizobium populations nodulating Bambara groundnut (Vigna subterranea L. Verdc) in Ghanaian and South African soils	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; NITROGEN-FIXING BACTERIUM; SP NOV.; RHIZOBIUM-MELILOTI; ROOT-NODULES; NOD GENES; FLAVONOIDS; SEEDS; PLANT; DIVERSITY	Flavonoids secreted by legumes play a major role as signal molecules for attracting compatible rhizobia. The aim of this study was to assess and understand the diversity of micro-symbionts nodulating Bambara groundnut (Vigna subterranea L. Verdc.) landraces of different seedcoat colours using restriction fragment length polymorphism and phylogenetic analysis. Seedcoat pigmentation of landraces had effect on the diversity of microsymbionts of Bambara groundnut. Even when planted together in one hole, nodulating bradyrhizobia clustered differently. For example, 16S rDNA-RFLP typing of rhizobial samples TUTVSBLM. I, TUTVSCRM. I and TUTVSRDM. I originating respectively from Black, Cream and Red landraces that were co-planted in the same hole at Manga in the Sudano-sahelian savanna, as well as TUTVSCRK. I and TUTVSRDK. I respectively from Cream and Red landraces co-planted at Kpalisogu in the Guinea savanna, revealed different 16S rDNA-RFLP types. Phylogenetic analysis of 16S rDNA, glnII, recA and atpD sequences showed that Vigna subterranea was nodulated specifically by a diverse group of Bradyrhizobium species (e.g. Bradyrhizobium vignae, and a novel group of Bradyrhizobium spp.) in soils from Ghana and South Africa. The recA gene phylogeny showed incongruency with the other housekeeping genes, indicating the possibility of lateral gene transfer and/or recombination events. The grouping of isolates according to symbiotic gene (nifH and nodD) phylogenies revealed inter-and intra-specific symbiotic plasmid transfer and different evolutionary history. The results also showed that a cropping history and physico-chemical environment of soils increased bradyrhizobial diversity in Ghana and South Africa.	[Puozaa, Doris K.] Univ Technol, Dept Crop Sci, Pretoria, South Africa; [Jaiswal, Sanjay K.; Dakora, Felix D.] Univ Technol, Dept Chem, Arcadia Campus, Pretoria, South Africa		Jaiswal, SK; Dakora, FD (corresponding author), Univ Technol, Dept Chem, Arcadia Campus, Pretoria, South Africa.	sanjaysiswa@gmail.com; dakorafd@tut.ac.za	JAISWAL, SANJAY/AAI-8262-2021; Dakora, Felix/AAI-4090-2020; Jaiswal, Sanjay K/AAB-6076-2022	JAISWAL, SANJAY/0000-0003-2745-9949; Dakora, Felix/0000-0002-9070-6896; 	Bill and Melinda Gates Foundation in Africa; South African Department of Science and Technology; Tshwane University of Technology; National Research Foundation in Pretoria; South African Research Chair in Agrochemurgy and Plant Symbioses	Bill and Melinda Gates Foundation in Africa; South African Department of Science and Technology; Tshwane University of Technology; National Research Foundation in Pretoria; South African Research Chair in Agrochemurgy and Plant Symbioses	This work was supported with grants from the Bill and Melinda Gates Foundation Project on Capacity Building in Legume Sciences in Africa, the South African Department of Science and Technology, the Tshwane University of Technology, the National Research Foundation in Pretoria, and the South African Research Chair in Agrochemurgy and Plant Symbioses	AGUILAR JMM, 1988, J GEN MICROBIOL, V134, P2741; Begum AA, 2001, J EXP BOT, V52, P1537, DOI 10.1093/jexbot/52.360.1537; Benoit LF, 1997, PHYSIOL PLANTARUM, V99, P588, DOI 10.1034/j.1399-3054.1997.990410.x; Dakora FD, 2003, NEW PHYTOL, V158, P39, DOI 10.1046/j.1469-8137.2003.00725.x; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Degefu T, 2012, INT J SYST EVOL MICR, V62, P2286, DOI 10.1099/ijs.0.039230-0; Depret G, 2004, FEMS MICROBIOL ECOL, V51, P87, DOI 10.1016/j.femsec.2004.07.009; Desbrosses GJ, 2011, CELL HOST MICROBE, V10, P348, DOI 10.1016/j.chom.2011.09.005; Doku EV, 1995, CONSERVATION IMPROVE, P72; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gronemeyer JL, 2014, APPL ENVIRON MICROB, V80, P7244, DOI 10.1128/AEM.02417-14; Gronemeyer JL, 2015, INT J SYST EVOL MICR, V65, P4886, DOI 10.1099/ijsem.0.000666; Gronemeyer JL, 2015, INT J SYST EVOL MICR, V65, P3241, DOI 10.1099/ijsem.0.000403; Gronemeyer JL, 2016, INT J SYST EVOL MICR, V66, P62, DOI 10.1099/ijsem.0.000674; GUEYE M, 1988, MIRCEN Journal of Applied Microbiology and Biotechnology, V4, P365, DOI 10.1007/BF01096142; Hall T., 2005, BIOEDIT VERSION 7 0; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; HARTWIG UA, 1991, PLANT PHYSIOL, V95, P797, DOI 10.1104/pp.95.3.797; HARTWIG UA, 1990, PLANT PHYSIOL, V92, P116, DOI 10.1104/pp.92.1.116; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; HUNGRIA M, 1993, MOL PLANT MICROBE IN, V6, P418, DOI 10.1094/MPMI-6-418; HUNGRIA M, 1991, PLANT PHYSIOL, V97, P751, DOI 10.1104/pp.97.2.751; Kishinevsky BD, 1996, FIELD CROP RES, V48, P57, DOI 10.1016/0378-4290(96)00037-8; KUMAGA F, 1994, BIOL FERT SOILS, V18, P231, DOI 10.1007/BF00647672; Kuykendall LD, 1982, CAN J MICROBIOL, V1992, P501; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Delamuta JRM, 2012, BRAZ J MICROBIOL, V43, P698, DOI 10.1590/S1517-83822012000200035; MartinezRomero E, 1996, CRIT REV PLANT SCI, V15, P113, DOI 10.1080/713608131; Mazahib A. M., 2013, International Food Research Journal, V20, P1165; Mohale KC, 2014, BIOL FERT SOILS, V50, P307, DOI 10.1007/s00374-013-0841-3; Moise JA, 2005, IN VITRO CELL DEV-PL, V41, P620, DOI 10.1079/IVP2005686; Naamala J, 2016, SYST APPL MICROBIOL, V39, P336, DOI 10.1016/j.syapm.2016.05.009; Ndakidemi PA, 2003, FUNCT PLANT BIOL, V30, P729, DOI 10.1071/FP03042; Nkot LN, 2008, APPL SOIL ECOL, V40, P411, DOI 10.1016/j.apsoil.2008.06.007; Nyemba RC, 2010, BIOL FERT SOILS, V46, P461, DOI 10.1007/s00374-010-0451-2; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Pueppke SG, 1998, PLANT PHYSIOL, V117, P599, DOI 10.1104/pp.117.2.599; Pueppke SG, 1996, CRIT REV BIOTECHNOL, V16, P1, DOI 10.3109/07388559609146599; Redmond J. W., 1986, RECOGNITION MICROBE, P115, DOI 10.1007/978-3-642-71652-2_11; Rivas R, 2009, SYST APPL MICROBIOL, V32, P101, DOI 10.1016/j.syapm.2008.12.005; ROHLF F. J., 2009, NTSYSPC NUMERICAL TA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shirley BW, 1998, SEED SCI RES, V8, P415, DOI 10.1017/S0960258500004372; Somasegaran P., 1994, HDB RHIZOBIA, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8]; Steenkamp ET, 2008, MOL PHYLOGENET EVOL, V48, P1131, DOI 10.1016/j.ympev.2008.04.032; Subramanian S, 2007, TRENDS PLANT SCI, V12, P282, DOI 10.1016/j.tplants.2007.06.006; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THIES JE, 1995, SOIL BIOL BIOCHEM, V27, P633, DOI 10.1016/0038-0717(95)98643-3; van Berkum P, 2012, MOL PLANT MICROBE IN, V25, P321, DOI 10.1094/MPMI-09-11-0241; Venkateswarlu B, 1997, APPL SOIL ECOL, V7, P1, DOI 10.1016/S0929-1393(97)00030-9; Vinuesa P, 2005, SYST APPL MICROBIOL, V28, P702, DOI 10.1016/j.syapm.2005.05.007; Wang M. L., 2008, Plant Genetic Resources Characterization and Utilization, V6, P62, DOI 10.1017/S1479262108923807; YOUNG JPW, 2006, GENOME BIOL, V7, P234, DOI DOI 10.1016/J.SYAPM.2005.05.007	54	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184943	10.1371/journal.pone.0184943	http://dx.doi.org/10.1371/journal.pone.0184943			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945783	Green Submitted, gold, Green Published			2022-12-26	WOS:000411645100014
J	Wang, J; Ramette, A; Jurca, M; Goutaki, M; Beardsmore, CS; Kuehni, CE				Wang, Jingying; Ramette, Alban; Jurca, Maja; Goutaki, Myrofora; Beardsmore, Caroline S.; Kuehni, Claudia E.			Association between breastfeeding and eczema during childhood and adolescence: A cohort study	PLOS ONE			English	Article							ATOPIC-DERMATITIS; RISK-FACTOR; CHILDREN; DISEASE; METAANALYSIS; PROPHYLAXIS; MODELS; ASTHMA	Background Breastfeeding is said to protect children from eczema (atopic dermatitis), but the available evidence is conflicting and subject to the influences of parental atopy and reverse causation (when mothers extended duration of breastfeeding because their children had eczema). Methods In the prospective, population-based Leicester Respiratory Cohort study, we assessed duration of breastfeeding in children aged 1-4 years. Prevalence of eczema was determined by questionnaire surveys that were repeated until the children were 17 years old. We investigated the association between having been breastfed and current eczema using generalized estimating equations, adjusting for potential confounders, and tested for effect modification by parental atopy. We also assessed the association between having been breastfed and incident eczema at ages 2, 4, and 6 years using multivariable logistic regression. Results Among the 5,676 children in the study, 2,284 (40%) had never been breastfed, while 1,610 (28%), 705 (12%), and 1,077 (19%) had been breastfed for 0-3, 4-6, and > 6 months, respectively. Prevalence of current eczema decreased from 36% in 1-year-olds to 18% in children aged 10-17 years. Breastfeeding was not associated with current eczema. Compared with children who had never been breastfed, the adjusted odds ratios for current eczema at any age were 1.02 (95% confidence interval 0.90-1.15) for children who had been breastfed for 0-3 months, 0.97 (0.82-1.13) for children breastfed for 4-6 months, and 0.98 (0.85-1.14) for children breastfed for > 6 months. There was no strong evidence for an effect modification by parental atopy (p-value for interaction term was 0.061) and no association between having been breastfed and incident eczema later in childhood. Conclusions This population-based cohort study found no evidence for protection of breastfeeding against childhood eczema at any age, from infancy through adolescence.	[Wang, Jingying; Ramette, Alban; Jurca, Maja; Goutaki, Myrofora; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Goutaki, Myrofora; Kuehni, Claudia E.] Childrens Univ Hosp Bern, Paediat Resp Med, Bern, Switzerland; [Beardsmore, Caroline S.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Beardsmore, Caroline S.] Univ Leicester, Leicester Resp Biomed Res Unit, Leicester, Leics, England	University of Bern; University of Bern; University Hospital of Bern; University of Leicester; University of Leicester	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Kuehni, CE (corresponding author), Childrens Univ Hosp Bern, Paediat Resp Med, Bern, Switzerland.	claudia.kuehni@ispm.unibe.ch	Ramette, Alban/E-9197-2016; Goutaki, Myrofora/J-2869-2019	Ramette, Alban/0000-0002-3437-4639; Goutaki, Myrofora/0000-0001-8036-2092; /0000-0002-0231-5036	Swiss National Science Foundation [32003B-144068, 32003B_162820, PDFMP3 137033]; China Scholarship Council [CSC201308340039]; Bern Lung League; Asthma UK [07/048]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); China Scholarship Council(China Scholarship Council); Bern Lung League; Asthma UK	C. E. Kuehni has received research support from the Swiss National Science Foundation (grant nos. 32003B-144068; 32003B_162820; PDFMP3 137033; www.snf.ch). J. Wang has received support from China Scholarship Council (CSC201308340039; http://en.csc.edu.cn/). M. Goutaki has received research support from Bern Lung League. C.S. Beardsmore was in the receipt of grant 07/048 from Asthma UK (www.asthma.org.uk). The remaining authors have no financial relationship relevant to this article to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Barnetson RS, 2002, BRIT MED J, V324, P1376, DOI 10.1136/bmj.324.7350.1376; Benn CS, 2004, AM J EPIDEMIOL, V160, P217, DOI 10.1093/aje/kwh208; Bergmann RL, 2002, CLIN EXP ALLERGY, V32, P205, DOI 10.1046/j.1365-2222.2002.01274.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Carroll CL, 2005, PEDIATR DERMATOL, V22, P192, DOI 10.1111/j.1525-1470.2005.22303.x; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Dharmage SC, 2014, ALLERGY, V69, P17, DOI 10.1111/all.12268; Fitzmaurice GM., 2004, APPL LONGITUDINAL DA; Flohr C, 2014, ALLERGY, V69, P3, DOI 10.1111/all.12270; Flohr C, 2011, BRIT J DERMATOL, V165, P1280, DOI 10.1111/j.1365-2133.2011.10588.x; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; Grulee CG, 1936, J PEDIATR-US, V9, P223, DOI 10.1016/S0022-3476(36)80058-4; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Horta B. L., 2013, SHORT TERM EFFECTS B; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Jelding-Dannemand E, 2015, J ALLERGY CLIN IMMUN, V136, P1302, DOI 10.1016/j.jaci.2015.02.023; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; Madhok V, 2015, CLIN EXP DERMATOL, V40, P349, DOI 10.1111/ced.12591; Matheson MC, 2012, CLIN EXP ALLERGY, V42, P827, DOI 10.1111/j.1365-2222.2011.03925.x; Matheson MC, 2007, J ALLERGY CLIN IMMUN, V120, P1051, DOI 10.1016/j.jaci.2007.06.030; Purvis DJ, 2005, BRIT J DERMATOL, V152, P742, DOI 10.1111/j.1365-2133.2005.06540.x; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; SAARINEN UM, 1979, LANCET, V2, P163; Santorelli G, 2014, BRIT J NUTR, V111, P1891, DOI 10.1017/S0007114514000099; Sariachvili M, 2007, PEDIATR ALLERGY IMMU, V18, P410, DOI 10.1111/j.1399-3038.2007.00543.x; Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Siltanen M, 2003, ALLERGY, V58, P524, DOI 10.1034/j.1398-9995.2003.00150.x; Silverberg IT, 2013, J INVEST DERMATOL, V133, pS179; Strippoli MPF, 2007, ARCH DIS CHILD, V92, P861, DOI 10.1136/adc.2007.117978; Taylor-Robinson DC, 2016, BRIT J DERMATOL, V174, P569, DOI 10.1111/bjd.14310; Townsend PP., 1988, HLTH DEPRIVATION INE; Yang YW, 2009, BRIT J DERMATOL, V161, P373, DOI 10.1111/j.1365-2133.2009.09049.x; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	36	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185066	10.1371/journal.pone.0185066	http://dx.doi.org/10.1371/journal.pone.0185066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945812	Green Published, Green Submitted, gold			2022-12-26	WOS:000411645100020
J	Zainabadi, K; Liu, CJ; Caldwell, ALM; Guarente, L				Zainabadi, Kayvan; Liu, Cassie J.; Caldwell, Alison L. M.; Guarente, Leonard			SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CALORIE RESTRICTION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HISTONE DEACETYLASE; IMPROVES HEALTH; STANDARD DIET; BETA-CATENIN; MALE RATS; MICE; EXPRESSION	Overexpression or pharmacological activation of SIRT1 has been shown to extend the lifespan of mice and protect against aging-related diseases. Here we show that pharmacological activation of SIRT1 protects in two models of osteoporosis. Ovariectomized female mice and aged male mice, models for post-menopausal and aging-related osteoporosis, respectively, show significant improvements in bone mass upon treatment with SIRT1 agonist, SRT1720. Further, we find that calorie restriction (CR) results in a two-fold upregulation of sirt1 mRNA expression in bone tissue that is associated with increased bone mass in CR mice. Reciprocally, SIRT1 whole-body knockout (KO) mice, as well as osteoblast and osteoclast specific KOs, show a low bone mass phenotype; though double knockout mice (containing SIRT1 deleted in both osteoblasts and osteoclasts) do not show a more severe phenotype. Altogether, these findings provide strong evidence that SIRT1 is a positive regulator of bone mass and a promising target for the development of novel therapeutics for osteoporosis.	[Zainabadi, Kayvan; Liu, Cassie J.; Caldwell, Alison L. M.; Guarente, Leonard] MIT, Dept Biol, Koch Inst, Glenn Ctr Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zainabadi, K (corresponding author), MIT, Dept Biol, Koch Inst, Glenn Ctr Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kayvan@alum.mit.edu			NIH; Glenn Foundation for Medical Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research	This work was supported by grants from the NIH and The Glenn Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artsi H, 2014, ENDOCRINOLOGY, V155, P3508, DOI 10.1210/en.2014-1334; Baksi A, 2014, BRIT J CLIN PHARMACO, V78, P69, DOI 10.1111/bcp.12327; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Gong H, 2014, MOL MED REP, V10, P3296, DOI 10.3892/mmr.2014.2648; Graff J, 2013, J NEUROSCI, V33, P8951, DOI 10.1523/JNEUROSCI.5657-12.2013; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gurt I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134391; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Iyer S, 2014, J BIOL CHEM, V289, P24069, DOI 10.1074/jbc.M114.561803; KALU DN, 1984, MECH AGEING DEV, V26, P103, DOI 10.1016/0047-6374(84)90169-6; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim HN, 2015, MOL ENDOCRINOL, V29, P1498, DOI 10.1210/me.2015-1133; Kolthur-Seetharam U, 2009, BIOL REPROD, V80, P384, DOI 10.1095/biolreprod.108.070193; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Krueger JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142081; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lowe DA, 2000, J GERONTOL A-BIOL, V55, pB160, DOI 10.1093/gerona/55.3.B160; Maran A, 2004, CALCIFIED TISSUE INT, V74, P204, DOI 10.1007/s00223-002-1098-2; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mohelnikova-Duchonova B, 2012, DIS MARKERS, V32, P203, DOI [10.1155/2012/582107, 10.3233/DMA-2011-0875]; Mozdziak PE, 2003, NUTRITION, V19, P438, DOI 10.1016/S0899-9007(02)01006-7; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ornstrup MJ, 2014, J CLIN ENDOCR METAB, V99, P4720, DOI 10.1210/jc.2014-2799; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Redman LM, 2008, ARCH INTERN MED, V168, P1859, DOI 10.1001/archinte.168.17.1859; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sanderson JP, 1997, J GERONTOL A-BIOL, V52, pB20, DOI 10.1093/gerona/52A.1.B20; Sands BE, 2016, INFLAMM BOWEL DIS, V22, P607, DOI 10.1097/MIB.0000000000000597; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Tatsumi S, 2008, ENDOCRINOLOGY, V149, P634, DOI 10.1210/en.2007-1089; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toorie AM, 2016, J BIOL CHEM, V291, P5844, DOI 10.1074/jbc.M115.675264; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zainabadi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178520; Zhou LH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-75	59	37	44	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185236	10.1371/journal.pone.0185236	http://dx.doi.org/10.1371/journal.pone.0185236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937996	Green Published, gold, Green Submitted			2022-12-26	WOS:000411524700024
J	Dong, JJ; Zhai, B; Sun, WH; Hu, FL; Cheng, H; Xu, J				Dong, Jiejie; Zhai, Bo; Sun, Weihua; Hu, Fengli; Cheng, Hao; Xu, Jun			Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-RESISTANCE; EXPRESSION; SNAIL; INVASION; CHEMORESISTANCE; INHIBITION; INDUCTION; AUTOPHAGY; REVERSES	Sorafenib, an orally available kinase inhibitor, is the standard first-line systemic drug for advanced hepatocellular carcinoma (HCC), and it exerts potent inhibitory activity against epithelial-mesenchymal transition (EMT) and multidrug resistance (MDR) by inhibiting mitogen-activated protein kinase (MAPK) signaling in HCC. However, after long-term exposure to sorafenib, HCC cells exhibit EMT and resistance to sorafenib. The activation of AKT by sorafenib is thought to be responsible for the development of these characteristics. The present study aims to examine the underlying mechanism and seek potential strategies to reverse this resistance and the progression to EMT. Sorafenib-resistant cells showed increased metastatic and invasive ability, with a higher expression of P-glycoprotein (P-gp), compared with the parental cells. This phenomenon was at least partially due to EMT and the appearance of MDR in sorafenib-resistant HCC cells. Moreover, MDR was a downstream molecular event of EMT. Silencing Snail with siRNA blocked EMT and partially reversed the MDR, thereby markedly abolishing invasion and metastasis in sorafenib-resistant HCC cells, but silencing of MDR1 had no effect on the EMT phenotype. Additionally, HCC parental cells that were stably transfected with pCDNA3.1-Snail exhibited EMT and MDR. Two sorafenib-resistant HCC cell lines, established from human HCC HepG2 and Huh7 cells, were refractory to sorafenib-induced growth inhibition but were sensitive to MK-2206, a novel allosteric AKT inhibitor. Thus, the combination of sorafenib and MK-2206 led to significant reversion of the EMT phenotype and P-gp-mediated MDR by downregulating phosphorylated AKT. These findings underscore the significance of EMT, MDR and enhanced PI3K/AKT signaling in sorafenib-resistant HCC cells.	[Dong, Jiejie; Cheng, Hao; Xu, Jun] Harbin Med Univ, Dept Gen Surg, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China; [Dong, Jiejie] Yuncheng Cent Hosp, Dept Hepatobiliary Surg, Yuncheng, Shanxi, Peoples R China; [Zhai, Bo; Hu, Fengli] Harbin Med Univ, Dept Gen Surg, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China; [Zhai, Bo; Hu, Fengli; Xu, Jun] Heilongjiang Med Sci Inst, Harbin, Heilongjiang, Peoples R China; [Sun, Weihua] Jinzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Jinzhou, Liaoning, Peoples R China	Harbin Medical University; Shanxi Medical University; Harbin Medical University; Jinzhou Medical University	Xu, J (corresponding author), Harbin Med Univ, Dept Gen Surg, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China.; Xu, J (corresponding author), Heilongjiang Med Sci Inst, Harbin, Heilongjiang, Peoples R China.	medxujun@163.com			National Natural Science Foundation of China [81401975]; Heilongjiang Medical Science Institute [201502, 201504]; China Postdoctoral Science Foundation [2016M591564]; Heilongjiang Postdoctoral Fund [LBH-Z14219, LBH-Z16191]; Heilongjiang Province Health Bureau, China [2014-399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Medical Science Institute; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Fund; Heilongjiang Province Health Bureau, China	This work was supported in part by grants from the National Natural Science Foundation of China (81401975), Scientific Research Project of Heilongjiang Medical Science Institute (201502, 201504), China Postdoctoral Science Foundation (2016M591564), Heilongjiang Postdoctoral Fund (LBH-Z14219, LBH-Z16191), and Heilongjiang Province Health Bureau (2014-399), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Borght SV, 2008, LIVER INT, V28, P1370, DOI 10.1111/j.1478-3231.2008.01889.x; Chen J, 2015, CANCER LETT, V367, P1, DOI 10.1016/j.canlet.2015.06.019; Chen JS, 2014, MOL CELL BIOCHEM, V393, P283, DOI 10.1007/s11010-014-2071-x; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Chen SY, 2014, ONCOL LETT, V8, P2333, DOI 10.3892/ol.2014.2521; Chen XL, 2011, J HEPATOL, V55, P838, DOI 10.1016/j.jhep.2010.12.043; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheng L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.450; Chow AKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078675; Gedaly R, 2010, ANTICANCER RES, V30, P4951; He CJ, 2015, ONCOTARGET, V6, P28867, DOI 10.18632/oncotarget.4814; Jiao M, 2012, INT J ONCOL, V40, P461, DOI 10.3892/ijo.2011.1197; Jin X, 2016, TUMOR BIOL, V37, P2683, DOI 10.1007/s13277-015-4068-9; Jou J, 2010, J CLIN INVEST, V120, P1031, DOI 10.1172/JCI42615; Kong LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11747; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Li WT, 2011, ASIAN PAC J CANCER P, V12, P2575; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma JL, 2016, TUMOR BIOL, V37, P6177, DOI 10.1007/s13277-015-4458-z; Mallini P, 2014, CANCER TREAT REV, V40, P341, DOI 10.1016/j.ctrv.2013.09.008; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meng FD, 2015, INT J CLIN EXP PATHO, V8, P6157; Miyoshi A, 2005, BRIT J CANCER, V92, P252, DOI 10.1038/sj.bjc.6602266; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Smith BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104987; Tabrizi M, 2015, ARCH IRAN MED, V18, P173, DOI 0151803/AIM.007; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsou SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116747; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Wang HB, 2015, MOL MED REP, V12, P3902, DOI 10.3892/mmr.2015.3871; Wang L, 2014, TUMOR BIOL, V35, P9, DOI 10.1007/s13277-013-1141-0; Wu Q, 2014, CANCER LETT, V347, P159, DOI 10.1016/j.canlet.2014.03.013; Yamada S, 2014, ANN SURG ONCOL, V21, P3882, DOI 10.1245/s10434-014-3779-2; Zhai B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138485; Zhai B, 2015, TUMOR BIOL, V36, P2323, DOI 10.1007/s13277-014-2839-3; Zhai B, 2014, MOL CANCER THER, V13, P1589, DOI 10.1158/1535-7163.MCT-13-1043; Zhao DL, 2014, CELL SIGNAL, V26, P1030, DOI 10.1016/j.cellsig.2014.01.026; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhou SL, 2015, CANCER LETT, V358, P124, DOI 10.1016/j.canlet.2014.11.044; Zucchini-Pascal N, 2013, INT J MOL SCI, V14, P20768, DOI 10.3390/ijms141020768	43	75	83	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185088	10.1371/journal.pone.0185088	http://dx.doi.org/10.1371/journal.pone.0185088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934275	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900085
J	Johnston, CD; Skeete, CA; Fomenkov, A; Roberts, RJ; Rittling, SR				Johnston, Christopher D.; Skeete, Chelsey A.; Fomenkov, Alexey; Roberts, Richard J.; Rittling, Susan R.			Restriction-modification mediated barriers to exogenous DNA uptake and incorporation employed by Prevotella intermedia	PLOS ONE			English	Article							MODIFICATION SYSTEMS; SINGLE-MOLECULE; S-MODIFICATION; CRISPR RNA; WEB TOOL; METHYLTRANSFERASES; INTERFERENCE; PHAGE; CLASSIFICATION; ENDONUCLEASES	Prevotella intermedia, a major periodontal pathogen, is increasingly implicated in human respiratory tract and cystic fibrosis lung infections. Nevertheless, the specific mechanisms employed by this pathogen remain only partially characterized and poorly understood, largely due to its total lack of genetic accessibility. Here, using Single Molecule, Real-Time ( SMRT) genome and methylome sequencing, bisulfite sequencing, in addition to cloning and restriction analysis, we define the specific genetic barriers to exogenous DNA present in two of the most widespread laboratory strains, P. intermedia ATCC 25611 and P. intermedia Strain 17. We identified and characterized multiple restriction-modification (R-M) systems, some of which are considerably divergent between the two strains. We propose that these R-M systems are the root cause of the P. intermedia transformation barrier. Additionally, we note the presence of conserved Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) systems in both strains, which could provide a further barrier to exogenous DNA uptake and incorporation. This work will provide a valuable resource during the development of a genetic system for P. intermedia, which will be required for fundamental investigation of this organism's physiology, metabolism, and pathogenesis in human disease.	[Johnston, Christopher D.; Skeete, Chelsey A.; Rittling, Susan R.] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA; [Johnston, Christopher D.; Rittling, Susan R.] Harvard Sch Dent Med, Boston, MA 02115 USA; [Fomenkov, Alexey; Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; New England Biolabs	Johnston, CD (corresponding author), Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA.; Johnston, CD (corresponding author), Harvard Sch Dent Med, Boston, MA 02115 USA.	cjohnston@forsyth.org		Johnston, Christopher D/0000-0002-6765-2383	Forsyth Institute Pilot Grant Program; National Institute of Dental and Craniofacial Research of the National Institutes of Health [R01-DE22380]; New England Biolabs, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022380] Funding Source: NIH RePORTER	Forsyth Institute Pilot Grant Program; National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); New England Biolabs, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was carried out with internal financial support from The Forsyth Institute Pilot Grant Program and by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number #R01-DE22380, www.nidcr.nih.gov. The funder provided support in the form of salaries for authors (CDJ and SRR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AF and RJR also acknowledge and New England Biolabs, Inc. for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetto T, 2005, FEMS MICROBIOL LETT, V247, P177, DOI 10.1016/j.femsle.2005.05.016; Alkhnbashi OS, 2016, BIOINFORMATICS, V32, P576, DOI 10.1093/bioinformatics/btw454; Anton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127446; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R., 2009, MICROBE, V4, P224, DOI [10.1128/microbe.4.224.1, DOI 10.1128/microbe.4.224.1, DOI 10.1128/MICROBE.4.224.1]; Beaulaurier J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8438; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Blumenthal RM, 1988, GENE, V74, P269; Brook I, 2003, CHEST, V124, P832, DOI 10.1378/chest.124.3.832; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Clark TA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-4; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Croucher NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6471; Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dorn BR, 1998, INFECT IMMUN, V66, P6054, DOI 10.1128/IAI.66.12.6054-6057.1998; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Froger A., 2007, J VISUALIZED EXPT JO; Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; He W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12368; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; Ibrahim M, 2017, FUNCT INTEGR GENOMIC, V17, P513, DOI 10.1007/s10142-017-0550-3; Iyer D, 2010, INFECT IMMUN, V78, P2385, DOI 10.1128/IAI.00510-09; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Lees J, 2015, NAT REV MICROBIOL, V13, DOI 10.1038/nrmicro3435; Leung KP, 2002, PLASMID, V48, P64, DOI 10.1016/S0147-619X(02)00011-2; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Loenen WA, 2013, NUCLEIC ACIDS RES; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Makarova KS, 2017, CELL, V168, P946, DOI [10.1016/j.cell.2016.12.038, 10.1016/j.cell.2017.02.018]; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Matsui A, 2014, INFECT IMMUN, V82, P4068, DOI 10.1128/IAI.02256-14; Murphy J, 2013, APPL ENVIRON MICROB, V79, P7547, DOI 10.1128/AEM.02229-13; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Nagaoka K, 2014, INFECT IMMUN, V82, P587, DOI 10.1128/IAI.00943-13; Naito M, 2016, DNA RES, V23, P11, DOI 10.1093/dnares/dsv032; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Piknova M, 2004, LETT APPL MICROBIOL, V38, P311, DOI 10.1111/j.1472-765X.2004.01483.x; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Price VJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00064-16; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3944; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Seshasayee ASN, 2012, NUCLEIC ACIDS RES, V40, P7066, DOI 10.1093/nar/gks390; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; Suzuki H, 2012, HOST MIMICKING STRAT; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Vasu K, 2012, P NATL ACAD SCI USA, V109, pE1287, DOI 10.1073/pnas.1119226109; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Yoshimoto H, 1997, FEMS MICROBIOL LETT, V152, P175, DOI 10.1111/j.1574-6968.1997.tb10425.x; Zhang GQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002987; Zhang Q, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1512-4; Zhu DK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3040-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	12	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185234	10.1371/journal.pone.0185234	http://dx.doi.org/10.1371/journal.pone.0185234			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934361	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900130
J	Mashima, I; Theodorea, CF; Thaweboon, B; Thaweboon, S; Scannapieco, FA; Nakazawa, F				Mashima, Izumi; Theodorea, Citra F.; Thaweboon, Boonyanit; Thaweboon, Sroisiri; Scannapieco, Frank A.; Nakazawa, Futoshi			Exploring the salivary microbiome of children stratified by the oral hygiene index	PLOS ONE			English	Article							GUT MICROBIOME; POPULATION; DIVERSITY; BIOFILMS; BACTERIA; HEALTH	Poor oral hygiene often leads to chronic diseases such as periodontitis and dental caries resulting in substantial economic costs and diminished quality of life in not only adults but also in children. In this study, the salivary microbiome was characterized in a group of children stratified by the Simplified Oral Hygiene Index (OHI-S). Illumina MiSeq high-throughput sequencing based on the 16S rRNA was utilized to analyze 90 salivary samples (24 Good, 31 Moderate and 35 Poor oral hygiene) from a cohort of Thai children. A total of 38,521 OTUs (Operational Taxonomic Units) with a 97% similarity were characterized in all of the salivary samples. Twenty taxonomic groups (Seventeen genera, two families and one class; Streptococcus, Veillonella, Gemellaceae, Prevotella, Rothia, Porphyromonas, Granulicatella, Actinomyces, TM-7-3, Leptotrichia, Haemophilus, Selenomonas, Neisseria, Megasphaera, Capnocytophaga, Oribacterium, Abiotrophia, Lachnospiraceae, Peptostreptococcus, and Atopobium) were found in all subjects and constituted 94.5-96.5% of the microbiome. Of these twenty genera, the proportion of Streptococcus decreased while Veillonella increased with poor oral hygiene status (P < 0.05). Furthermore, an unassigned species of Veillonella, Veillonella dispar and Veillonella parvula tended to be elevated in the Poor oral hygiene group. This is the first study demonstrating an important association between increase of Veillonella and poor oral hygiene status in children. However, further studies are required to identify the majority of Veillonella at species level in salivary microbiome of the Poor oral hygiene group.	[Mashima, Izumi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Mashima, Izumi; Nakazawa, Futoshi] SUNY Buffalo, Dept Oral Biol, Sch Dent Med, Buffalo, NY USA; [Mashima, Izumi; Theodorea, Citra F.; Nakazawa, Futoshi] Hlth Sci Univ Hokkaido, Sch Dent, Dept Microbiol, Ishikari, Hokkaido, Japan; [Theodorea, Citra F.] Univ Indonesia, Fac Dent, Dept Oral Biol, Jakarta, Indonesia; [Thaweboon, Boonyanit; Thaweboon, Sroisiri] Mahidol Univ, Fac Dent, Dept Oral Microbiol, Bangkok, Thailand	Japan Society for the Promotion of Science; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Health Sciences University of Hokkaido; University of Indonesia; Mahidol University	Nakazawa, F (corresponding author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Microbiol, Ishikari, Hokkaido, Japan.	nakazawa@hoku-iryo-u.ac.jp	Theodorea, Citra Fragrantia/AAD-4106-2021; Scannapieco, Frank A./AAE-1584-2020	Scannapieco, Frank A./0000-0002-8804-6593; Theodorea, Citra Fragrantia/0000-0002-9310-9659; Mashima, Izumi/0000-0001-6436-1268	Japan Society for the Promotion of Science [15J30007, 26462793]; Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido [2014-200-3, 2016-200-4]; Institute for Fermentation, Osaka; Mahidol University Faculty of Dentistry [0517.033/62]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido; Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Mahidol University Faculty of Dentistry	This study was supported by the Japan Society for the Promotion of Science (15J30007 to I M, 26462793 to FN; https://www.jsps.go.jp/j-grantsinaid/), Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido (2014-200-3, 2016-200-4 to FN; http://www.hoku-iryo-u.acjp/similar to kotaisa/index.html), The Institute for Fermentation, Osaka (Research grant 2016 and 2017 to IM; http://www.ifo.or.jp/ research/re_02.html), and the Mahidol University Faculty of Dentistry (0517.033/62 to BT; www.dt. mahidal.ac.th/eng/). The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ahn J., 2015, PLOS ONE, V6; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Belstrom D, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23609; Bo T, 2017, MICROBIOLOG IN PRESS; Byun R, 2007, INT J SYST EVOL MICR, V57, P2844, DOI 10.1099/ijs.0.65096-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; DELWICHE EA, 1985, ANNU REV MICROBIOL, V39, P175, DOI 10.1146/annurev.mi.39.100185.001135; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Furquim CP, 2017, J DENT RES, V96, P292, DOI 10.1177/0022034516678169; Gao R, 2017, EUR J CLIN IN PRESS; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Jahangir GZ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3158-5; Jiang S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121978; Jo JH, 2016, VIRULENCE IN PRESS; Johansson I, 2016, J DENT RES, V95, P80, DOI 10.1177/0022034515609554; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lazarevic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067699; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Marchandin H, 2005, RES MICROBIOL, V156, P603, DOI 10.1016/j.resmic.2005.01.013; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Mashima I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157516; Mashima I, 2014, ANAEROBE, V28, P54, DOI 10.1016/j.anaerobe.2014.05.003; McCune, 2002, MJM SOFTWARE DESIGN, V289, P448; Mielke PW, 2010, SANKHYA, V3, P350; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nieto-Pelegrin E, 2015, TRANSBOUND EMERG DIS, V62, P594, DOI 10.1111/tbed.12429; Nishiwaki M, 2017, NIPPON SAIKINGAKU ZA, V72, P57; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Pereira Juliana Vianna, 2012, Braz. Dent. J., V23, P409, DOI 10.1590/S0103-64402012000400017; Prabhu S, 2015, IOSR J DENT MED SCI, V14, P101; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; RITZ HL, 1967, ARCH ORAL BIOL, V12, P1561, DOI 10.1016/0003-9969(67)90190-2; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saravanan P, 2010, J BACTERIOL, V192, P2965; Seirawan H, 2012, AM J PUBLIC HEALTH, V102, P1729, DOI 10.2105/AJPH.2011.300478; Shanahan F, 2017, GUT IN PRESS; Takeshita T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06990; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Vesty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169877; Yu GQ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0226-6; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141310; Zhou JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147039	56	39	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185274	10.1371/journal.pone.0185274	http://dx.doi.org/10.1371/journal.pone.0185274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934367	gold, Green Submitted, Green Published			2022-12-26	WOS:000411339900137
J	Zajenkowski, M				Zajenkowski, Marcin			Hostile and energetic: Anger is predicted by low agreeableness and high energetic arousal	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PERSONALITY; AGGRESSION; PERFORMANCE; EMOTION; STATE; TRAIT	A hypothesis that anger is related to high energetic arousal (EA), but only at a low level of agreeableness was tested. In the first two studies, the association between trait anger, agreeableness, and EA was explored. In the next two studies, the interactions of agreeableness with constructs conceptually and empirically close to EA, in predicting anger were tested. Study 3 revealed that anger was predicted by a low level of agreeableness and a high level of positive affect. In study 4 task engagement (construct containing an energetic component) was included in the context of cognitive performance. At a high level of agreeableness the association between anger and task engagement was negative, whereas among individuals with low agreeableness this relation was not significant.	[Zajenkowski, Marcin] Univ Warsaw, Fac Psychol, Warsaw, Poland	University of Warsaw	Zajenkowski, M (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	zajenkowski@psych.uw.edu.pl		Zajenkowski, Marcin/0000-0001-8669-4231	National Science Centre in Poland [2014/13/B/HS6/04083]	National Science Centre in Poland(National Science Centre, Poland)	The work was supported by a grant 2014/13/B/HS6/04083 funded by the National Science Centre in Poland.	[Anonymous], 2016, POLSKIE FORUM PSYCHO, V21, P93; [Anonymous], 1983, MANUAL RAVENS PROGR; [Anonymous], 2014, ROCZNIKI PSYCHOL, V17, P327; Austin EJ, 2002, PERS INDIV DIFFER, V32, P1391, DOI 10.1016/S0191-8869(01)00129-5; Berkowitz L., 1993, AGGRESSION ITS CAUSE, DOI 3.0.CO;2-9; Bettencourt BA, 2006, PSYCHOL BULL, V132, P751, DOI 10.1037/0033-2909.132.5.751; Bresin K, 2012, J RES PERS, V46, P79, DOI 10.1016/j.jrp.2011.12.007; Brzozowski P, 2010, SKALA UCZUC POZYTYWN; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Costa PT, 2007, REVISED NEO PERSONAL; DEFFENBACHER JL, 1992, ADV PERS AS, V9, P177; Finley A, 2016, J PERS; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Harmon-Jones E, 2010, J RES PERS, V44, P120, DOI 10.1016/j.jrp.2009.09.001; Harmon-Jones E, 2009, EMOTION, V9, P183, DOI 10.1037/a0014959; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Hindmarch I., 1988, PSYCHOPHARMACOLOGY R; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; MATTHEWS G, 1990, BRIT J PSYCHOL, V81, P17, DOI 10.1111/j.2044-8295.1990.tb02343.x; Matthews G., 2009, PERSONALITY TRAITS; Matthews G., 2000, HDB SELF REGULATION, P171, DOI [10.1016/B978-012109890-2/50035-4, DOI 10.1016/B978-012109890-2/50035-4]; Matthews G, 2012, PERS INDIV DIFFER, V53, P574, DOI 10.1016/j.paid.2012.04.034; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; Matthews G, 2010, SPRINGER SER HUM EXC, P205, DOI 10.1007/978-1-4419-1210-7_13; Meier BP, 2004, PERS SOC PSYCHOL B, V30, P856, DOI 10.1177/0146167204264764; Meier BP, 2006, PSYCHOL SCI, V17, P136, DOI 10.1111/j.1467-9280.2006.01676.x; Ode S, 2008, J RES PERS, V42, P295, DOI 10.1016/j.jrp.2007.05.007; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Smith TW, 2004, J PERS, V72, P1217, DOI 10.1111/j.1467-6494.2004.00296.x; Spielberger C.D., 1999, STAXI 2 STATE TRAIT; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; Tobin RM, 2000, J PERS SOC PSYCHOL, V79, P656, DOI 10.1037//0022-3514.79.4.656; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 2000, MOOD TEMPERAMENT; Wilkowski BM, 2010, J PERS, V78, P9, DOI 10.1111/j.1467-6494.2009.00607.x; Zajenkowski M, 2016, INTELLIGENCE, V58, P1, DOI 10.1016/j.intell.2016.06.002; Zajenkowski M, 2015, PERS INDIV DIFFER, V81, P23, DOI 10.1016/j.paid.2014.12.062; Zajenkowski M, 2012, PERS INDIV DIFFER, V52, P858, DOI 10.1016/j.paid.2012.01.007; Zawadzki B, INWENTARZ NEO FFI CO	40	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184919	10.1371/journal.pone.0184919	http://dx.doi.org/10.1371/journal.pone.0184919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931038	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700043
J	Araujo, DFS; Guerra, GCB; Pintado, MME; Sousa, YRF; Algieri, F; Rodriguez-Nogales, A; Araujo, RF; Galvez, J; Queiroga, RDRE; Rodriguez-Cabezas, ME				Araujo, Daline F. S.; Guerra, Gerlane C. B.; Pintado, Maria Manuela E.; Sousa, Yasmim R. F.; Algieri, Francesca; Rodriguez-Nogales, Alba; Araujo, Raimundo F., Jr.; Galvez, Julio; Queiroga, Rita de Cassia R. E.; Rodriguez-Cabezas, Maria Elena			Intestinal anti-inflammatory effects of goat whey on DNBS-induced colitis in mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MILK OLIGOSACCHARIDES; CHRONIC INFLAMMATION; RAT MODEL; CYTOKINES; EXPRESSION; MANAGEMENT; DISEASE; IL-6	This study evaluated the intestinal anti-inflammatory effects of goat whey in a mouse model of colitis induced by 2,4-dinitrobenzenesulfonic acid that resembles human IBD. At a concentration of 4 g/kg/day, the goat whey improved the symptoms of intestinal inflammation, namely by decreasing the disease activity index, colonic weight/length, and leukocyte infiltration. Moreover, goat whey inhibited NF-kappa B p65 and p38 MAPK signaling pathways and consequently down-regulated the gene expression of various proinflammatory markers such as IL-1 beta, IL-6, IL-17, TNF-alpha, iNOS, MMP-9, ICAM-1. Also, goat whey increased the expression of proteins such as mucins, occludin proteins and cytokine signalling suppressors. The immunomodulatory properties of goat whey were also evaluated in vitro using the murine macrophage cell line Raw 264 and CMT-93 cells derived from mouse rectum carcinomas. The results revealed the ability of goat whey to inhibit the production of NO and reduce IL-6 production in LPS-stimulated cells. In conclusion, goat whey exhibited antiinflammatory effects in the DNBS model of intestinal inflammation, and these observations were confirmed by its immunomodulatory properties in vitro. Together, our results indicate that goat whey could have applications for the treatment of IBD.	[Araujo, Daline F. S.] Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi, Santa Cruz, Brazil; [Guerra, Gerlane C. B.] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Biosci Ctr, Natal, RN, Brazil; [Pintado, Maria Manuela E.] Catholic Univ Portugal, Sch Biotechnol, Porto, Portugal; [Sousa, Yasmim R. F.] Univ Fed Paraiba, Technol Ctr, Joao Pessoa, Paraiba, Brazil; [Algieri, Francesca; Rodriguez-Nogales, Alba; Galvez, Julio; Rodriguez-Cabezas, Maria Elena] Univ Granada, Dept Pharmacol, Ctr Biomed Res CIBM, Ibs GRANADA,CIBER EHD, Granada, Spain; [Araujo, Raimundo F., Jr.] Univ Fed Rio Grande do Norte, Dept Morphol, Histol & Basic Pathol Biosci Ctr, Natal, RN, Brazil; [Queiroga, Rita de Cassia R. E.] Univ Fed Paraiba, Dept Nutr, Hlth Sci Ctr, Joao Pessoa, Paraiba, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Catolica Portuguesa; Universidade Federal da Paraiba; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Universidade Federal do Rio Grande do Norte; Universidade Federal da Paraiba	Guerra, GCB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Biosci Ctr, Natal, RN, Brazil.	gerlaneguerra@hotmail.com	Rodríguez-Nogales, Alba/J-2782-2017; rodriguez-cabezas, maria elena/L-3086-2014; Araújo Júnior, Raimundo Fernandes/D-2354-2014; Pintado, Maria Manuela/AAW-6709-2021; Algieri, Francesca F/J-4281-2017; Pintado, Maria Manuela/ABE-2085-2021; Gálvez, Julio/K-6875-2014	Rodríguez-Nogales, Alba/0000-0003-1927-0628; rodriguez-cabezas, maria elena/0000-0001-9085-8147; Araújo Júnior, Raimundo Fernandes/0000-0003-2349-2354; Pintado, Maria Manuela/0000-0002-0760-3184; Gálvez, Julio/0000-0001-6876-3782	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; European Union [AGL2015-67995-C3-3-R, CTS 164]; Institute de Salud Carlos III	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Union(European Commission); Institute de Salud Carlos III(Instituto de Salud Carlos III)	The authors are grateful to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq for funding the research, the Laboratory Food Chemistry-UFPB, Brazil, for drying the goat whey, the Federal University of Rio Grande do Norte for technical-scientific support, the Junta de Andalucia (CTS 164) and the Spanish Ministry of Economy and Competitiveness (AGL2015-67995-C3-3-R) with funds from the European Union. A. Rodriguez-Nogales and F. Algieri are postdoctoral fellows at the University of Granada; M.E. Rodriguez-Cabezas is a postdoctoral fellow at the CIBER-EHD. The CIBER-EHD is funded by the Institute de Salud Carlos III.	Acosta MB, 2016, REV ED SUPER, V12, P227; Ahmed AS, 2015, FOOD RES INT, V74, P80, DOI 10.1016/j.foodres.2015.04.032; Ala A, 2003, INT J EXP PATHOL, V84, P1, DOI 10.1046/j.1365-2613.2003.00235.x; de Assis POA, 2016, INT DAIRY J, V56, P45, DOI 10.1016/j.idairyj.2015.11.002; Araujo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092177; Ardizzone S, 2005, DRUGS, V65, P2253, DOI 10.2165/00003495-200565160-00002; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; Bassaganya-Riera J, 2012, CLIN NUTR, V31, P721, DOI 10.1016/j.clnu.2012.03.002; Beringer A, 2016, TRENDS MOL MED, V22, P230, DOI 10.1016/j.molmed.2016.01.001; Bressler B, 2015, GASTROENTEROLOGY, V148, P1035, DOI 10.1053/j.gastro.2015.03.001; Broom OJ, 2009, CLIN EXP IMMUNOL, V158, P272, DOI 10.1111/j.1365-2249.2009.04033.x; Chaturvedi P, 2001, ADV EXP MED BIOL, V501, P315; Daddaoua A, 2006, J NUTR, V136, P672, DOI 10.1093/jn/136.3.672; Folch J., 1957, J BIOL CHEM, V55, P999, DOI DOI 10.1016/J.ULTRASMEDBIO.2011.03.005; de Sousa YRF, 2015, LIVEST SCI, V177, P175, DOI 10.1016/j.livsci.2015.04.005; de Oliveira MEG, 2012, SCI AGR, V69, P370, DOI 10.1590/S0103-90162012000600005; Granger DL, 1999, METHOD ENZYMOL, V301, P49; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Greicius G, 2004, GASTROENTEROLOGY, V127, P994, DOI 10.1053/j.gastro.2004.07.038; Guerra GCB, 2015, PHARMACOL REP, V67, P520, DOI 10.1016/j.pharep.2014.12.011; Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470; Hontecillas R, 2002, J NUTR, V132, P2019, DOI 10.1093/jn/132.7.2019; Kanwar JR, 2016, J DAIRY SCI, V99, P2488, DOI 10.3168/jds.2015-10122; Kelly G S, 2001, Altern Med Rev, V6, P367; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Koelink PJ, 2014, GUT, V63, P578, DOI 10.1136/gutjnl-2012-303252; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kunz C, 2006, INT DAIRY J, V16, P1341, DOI 10.1016/j.idairyj.2006.06.020; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; KUO PC, 1995, ANN SURG, V221, P220, DOI 10.1097/00000658-199503000-00003; Lara-Villostada F, 2006, CLIN NUTR, V25, P477, DOI 10.1016/j.clnu.2005.11.004; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Martinez-Ferez A, 2006, INT DAIRY J, V16, P173, DOI 10.1016/j.idairyj.2005.02.003; Matsumoto S, 2004, CLIN EXP IMMUNOL, V136, P432, DOI 10.1111/j.1365-2249.2004.02462.x; Meyrand M, 2013, SMALL RUMINANT RES, V113, P411, DOI 10.1016/j.smallrumres.2013.03.014; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P935, DOI 10.1002/ibd.20797; Nicola NA, 2000, EXP HEMATOL, V28, P1105, DOI 10.1016/S0301-472X(00)00525-7; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Palatka K, 2005, SCAND J GASTROENTERO, V40, P670, DOI 10.1080/00365520510015539; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RACHMILEWITZ D, 1995, GUT, V37, P247, DOI 10.1136/gut.37.2.247; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Reddy JG, 2006, GASTROENTEROL CLIN N, V35, P837, DOI 10.1016/j.gtc.2006.09.008; Ren TH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09047; Safdari BK, 2016, CYTOKINE, V83, P231, DOI 10.1016/j.cyto.2016.04.017; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Spichtig V, 2010, ANAL BIOCHEM, V405, P28, DOI 10.1016/j.ab.2010.06.010; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Thum C, 2015, J FOOD COMPOS ANAL, V42, P30, DOI 10.1016/j.jfca.2015.01.022; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; ZeaIriarte WL, 1996, SCAND J GASTROENTERO, V31, P985, DOI 10.3109/00365529609003118	58	16	18	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185382	10.1371/journal.pone.0185382	http://dx.doi.org/10.1371/journal.pone.0185382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957373	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200052
J	Li, ZW; Xin, YZ; Cui, XR; Liu, X; Wang, LQ; Zhang, WS; Lu, QH; Zhu, H				Li, Zhongwei; Xin, Yuezhen; Cui, Xuerong; Liu, Xin; Wang, Leiquan; Zhang, Weishan; Lu, Qinghua; Zhu, Hu			Optimization to the Phellinus experimental environment based on classification forecasting method	PLOS ONE			English	Article							NEURAL P SYSTEMS; IMBALANCED DATA; ALGORITHM; DESIGN; SMOTE	Phellinus is a kind of fungus and known as one of the elemental components in drugs to avoid cancer. With the purpose of finding optimized culture conditions for Phellinus production in the lab, plenty of experiments focusing on single factor were operated and large scale of experimental data was generated. In previous work, we used regression analysis and GA Gene-set based Genetic Algorithm (GA) to predict the production, but the data we used depended on experimental experience and only little part of the data was used. In this work we use the values of parameters involved in culture conditions, including inoculum size, PH value, initial liquid volume, temperature, seed age, fermentation time and rotation speed, to establish a high yield and a low yield classification model. Subsequently, a prediction model of BP neural network is established for high yield data set. GA is used to find the best culture conditions. The forecast accuracy rate more than 90% and the yield we got have a slight increase than the real yield.	[Li, Zhongwei; Xin, Yuezhen; Cui, Xuerong; Liu, Xin; Wang, Leiquan; Zhang, Weishan; Lu, Qinghua] China Univ Petr, Coll Comp & Commun Engn, Qingdao 266580, Shandong, Peoples R China; [Zhu, Hu] Fujian Normal Univ, Coll Chem & Mat, Fuzhou 350007, Fujian, Peoples R China	China University of Petroleum; Fujian Normal University	Zhu, H (corresponding author), Fujian Normal Univ, Coll Chem & Mat, Fuzhou 350007, Fujian, Peoples R China.	zhuhu@fjnu.edu.cn	zhu, hu/GQQ-8365-2022	Wang, Leiquan/0000-0003-4314-0030	863 program [2015AA020925]; National Natural Science Foundation of China [61402187, 61502535, 61572522, 61572523, 61672033, 61672248]; China Postdoctoral Science Foundation funded project [2016M592267]; PetroChina Innovation Foundation [2016D-5007-0305]; Fundamental Research Funds for the Central Universities [R1607005A, 16CX02006A]; Key Research and Development Program of Shandong Province [2017GGX10147]	863 program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); PetroChina Innovation Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Research and Development Program of Shandong Province	This work was supported by 863 program (2015AA020925 to HZ), National Natural Science Foundation of China (61402187, 61502535, 61572522, 61572523, 61672033 and 61672248 to HZ), China Postdoctoral Science Foundation funded project (2016M592267 to HZ), PetroChina Innovation Foundation (2016D-5007-0305 to ZL), Fundamental Research Funds for the Central Universities (R1607005A and 16CX02006A to HZ), Key Research and Development Program of Shandong Province (No. 2017GGX10147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation of China (61402187, 61502535, 61572522, 61572523, 61672033 and 61672248), China Postdoctoral Science Foundation funded project (2016M592267), PetroChina Innovation Foundation (2016D-5007-0305), Fundamental Research Funds for the Central Universities (R1607005A), Key Research and Development Program of Shandong Province (No. 2017GGX10147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzan ALC, 2009, LECT NOTES COMPUT SC, V5680, P3, DOI 10.1007/978-3-642-03603-3_1; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen BJ, 2017, NEUROCOMPUTING, V266, P293, DOI 10.1016/j.neucom.2017.05.047; Cohen G, 2006, ARTIF INTELL MED, V37, P7, DOI 10.1016/j.artmed.2005.03.002; David S.K., 2013, COMPUT ENG INTELL SY, V4, P28; Davis L., 1991, HDB GENETIC ALGORITH, DOI DOI 10.1.1.87.3586; Ding SF, 2011, ARTIF INTELL REV, V36, P153, DOI 10.1007/s10462-011-9208-z; Dogan HH, 2009, TURK J BOT, V33, P239, DOI 10.3906/bot-0808-9; Fu ZJ, 2017, IEEE T INF FOREN SEC, V12, P1874, DOI 10.1109/TIFS.2017.2692728; GALLETLY JE, 1992, KYBERNETES, V21, P26, DOI 10.1108/eb005943; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Han H, 2005, LECT NOTES COMPUT SC, V3644, P878, DOI 10.1007/11538059_91; Hong TP, 2007, IEEE SYS MAN CYBERN, P2628; Ju Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33870; Kang J, 2015, INT J RADIAT ONCOL, V93, P1127, DOI 10.1016/j.ijrobp.2015.07.2286; Khaouane L, 2012, BIOTECHNOL BIOPROC E, V17, P1048, DOI 10.1007/s12257-012-0254-4; Lavecchia A, 2015, DRUG DISCOV TODAY, V20, P318, DOI 10.1016/j.drudis.2014.10.012; [李朔 LI Shuo], 2006, [食品科学, Food Science], V27, P236; Li Z, 2016, BIOMED RES INT, V2016; Li Z, 2016, BIOMED RES INT, V2016, P6; Liu Q, 2016, SECUR COMMUN NETW, V9, P4002, DOI 10.1002/sec.1582; Liu S Q., 2003, COMPUTER ENG DESIGN; Liu W, 2012, STUDY METABOLIC REGU; Ma TH, 2015, COMPUTING, V97, P1165, DOI 10.1007/s00607-015-0453-x; Man K.F., 1989, PERSPECT NEURAL COMP, V83, P55; [邵杰 Shao Jie], 2012, [食品科学, Food Science], V33, P121; Shen J, 2017, IEEE T INF FOREN SEC, V12, P2402, DOI 10.1109/TIFS.2017.2705620; Sliva D, 2008, BRIT J CANCER, V98, P1348, DOI 10.1038/sj.bjc.6604319; Song T, 2014, NEURAL COMPUT APPL, P24; Song T, 2016, IEEE T NANOBIOSCI, V15, P666, DOI 10.1109/TNB.2016.2598879; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2015, IEEE T NANOBIOSCI, V14, P960, DOI 10.1109/TNB.2015.2503603; Tsai MF, 2015, J MED BIOL ENG, V35, P775, DOI 10.1007/s40846-015-0094-8; Wang R, 2015, IEEE T CYBERNETICS, V45, P1262, DOI 10.1109/TCYB.2014.2348012; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep27624; Wang Y, 2012, FOOD CHEM, V131, P206, DOI 10.1016/j.foodchem.2011.08.061; Xia GuoHua, 2010, Journal of Jiangsu University - Medicine Edition, V20, P40; Xia ZH, 2016, IEEE T INF FOREN SEC, V11, P2594, DOI 10.1109/TIFS.2016.2590944; Xia ZH, 2016, IEEE T PARALL DISTR, V27, P340, DOI 10.1109/TPDS.2015.2401003; Xue Y, 2018, SOFT COMPUT, V22, P2935, DOI 10.1007/s00500-017-2547-1; Zeng XX, 2015, FRONT COMPUT SCI-CHI, V9, P643, DOI 10.1007/s11704-014-4089-3; Zhang L, 2017, IEEE T CYBERNETICS, V47, P2703, DOI 10.1109/TCYB.2017.2711038; Zhang X, PATTERN RECOMMENDATI; Zhang X, 2016, IEEE T EVOLUTIONARY; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P761, DOI 10.1109/TEVC.2014.2378512; Zhu T, 2007, BRIT J CANCER, V96, P583, DOI 10.1038/sj.bjc.6603595	47	1	1	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185444	10.1371/journal.pone.0185444	http://dx.doi.org/10.1371/journal.pone.0185444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957375	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200058
J	Zuliani, G; Volpato, S; Dugo, M; Vigna, GB; Morieri, ML; Maggio, M; Cherubini, A; Bandinelli, S; Gurainik, JM; Ferrucci, L				Zuliani, Giovanni; Volpato, Stefano; Dugo, Marco; Vigna, Giovanni B.; Morieri, Mario Luca; Maggio, Marcello; Cherubini, Antonio; Bandinelli, Stefania; Gurainik, Jack M.; Ferrucci, Luigi			Combining LDL-C and HDL-C to predict survival in late life: The InChianti study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL; CANCER INCIDENCE; MORTALITY RISK; OLDER-ADULTS; FOLLOW-UP; APOLIPOPROTEINS; LIPIDS	Background While the relationship between total cholesterol (TC) and cardiovascular disease (CVD) progressively weakens with aging, several studies have shown that low TC is associated with increased mortality in older individuals. However, the possible additive/synergic contribution of the two most important cholesterol rich fractions (LDL-C and HDL-C) to mortality risk has not been previously investigated. Our study aimed to investigate the relationship between baseline LDL-C and HDL-C, both separately and combined, and 9-years mortality in a sample of community dwelling older individuals from the InCHIANTI study. Methods and findings 1044 individuals over 64 years were included. CVD and cancer mortality were defined by ICD-9 codes 390-459 and 140-239, respectively. LDL-C <130 mg/dL (3.36 mmol/L) was defined as "optimal/near optimal". Low HDL-C was defined as <40/50 mg/dL (1.03/1.29 mmol/L) in males/females, respectively. Nine-years mortality risk was calculated by multivariate Cox proportional hazards model. We found that, compared to subjects with high LDL-C and normal HDL-C (reference group), total mortality was significantly increased in subjects with optimal/near optimal LDL-C and low HDL-C (H.R.:1.58; 95% CI:1.11-2.25). As regards the specific cause of death, CVD mortality was not affected by LDL-C/HDL-C levels, while cancer mortality was significantly increased in all subjects with optimal/near optimal LDL-C (with normal HDL-C: H.R.:2.49; with low HDL-C: H.R.:4.52). Results were unchanged after exclusion of the first three years of follow-up, and of subjects with low TC (<160 g/dL-4.13 mmol/L). Conclusions Our findings suggest that, in community dwelling older individuals, the combined presence of optimal/near optimal LDL-C and low HDL-C represents a marker of increased future mortality.	[Zuliani, Giovanni; Volpato, Stefano; Dugo, Marco; Vigna, Giovanni B.; Morieri, Mario Luca] Univ Ferrara, Sect Internal & Cardiopulm Med, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Maggio, Marcello] Univ Parma, Sect Geriatr, Dept Clin & Expt Med, Parma, Italy; [Cherubini, Antonio] INNRCA, Inst Gerontol & Geriatr, Ancona, Italy; [Bandinelli, Stefania] Azienda Sanit Firenze, Florence, Italy; [Gurainik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA	University of Ferrara; University of Parma; University Hospital of Parma; Azienda Sanitaria di Firenze; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Zuliani, G (corresponding author), Univ Ferrara, Sect Internal & Cardiopulm Med, Dept Morphol Surg & Expt Med, Ferrara, Italy.	giovanni.zuliani@unife.it	Morieri, Mario Luca/K-3238-2018; bandinelli, stefania/AAL-4570-2020; Cherubini, Antonio/AAL-4632-2020; Vigna, Giovanni/H-2826-2015	Morieri, Mario Luca/0000-0001-6864-0547; Vigna, Giovanni/0000-0001-8640-7052; dugo, Marco/0000-0002-7822-4587; Bandinelli, Stefania/0000-0002-6491-0850; Zuliani, Giovanni/0000-0003-0969-3184	Italian Ministry of Health [ICS110.1/RF97.71]; U.S. National Institute on Aging [263 MD 9164, 263 MD 821336, N.1-AG-1-1, N.1-AG-1-2111, N01-AG-5-0002]; National Institute on Aging, National Institutes of Health, Baltimore, Maryland	Italian Ministry of Health(Ministry of Health, Italy); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging, National Institutes of Health, Baltimore, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The InCHIANTI study baseline (19982000) was supported as a "targeted project" (ICS110.1/RF97.71) by the Italian Ministry of Health, and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336). The Follow-up 1 (2001-2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1-1 and N.1-AG-1-2111); the Follow-up 2 and 3 studies (2004-2010) were financed by the U.S. National Institute on Aging (Contract: N01-AG-5-0002). Supported in part by the Intramural research program of the National Institute on Aging, National Institutes of Health, Baltimore, Maryland.	Ahn J, 2009, CANCER EPIDEM BIOMAR, V18, P2814, DOI 10.1158/1055-9965.EPI-08-1248; Assmann G, 1998, EUR HEART J, V19, pA2; Barzilai N, 2001, J AM GERIATR SOC, V49, P76, DOI 10.1046/j.1532-5415.2001.49013.x; Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Brescianini S, 2003, J AM GERIATR SOC, V51, P991, DOI 10.1046/j.1365-2389.2003.51313.x; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; GLUECK CJ, 1977, ATHEROSCLEROSIS, V27, P387, DOI 10.1016/0021-9150(77)90159-9; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; ISLES CG, 1989, BMJ-BRIT MED J, V298, P920, DOI 10.1136/bmj.298.6678.920; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karlamangla AS, 2004, J AM GERIATR SOC, V52, P487, DOI 10.1111/j.1532-5415.2004.52152.x; KREGER BE, 1992, CANCER-AM CANCER SOC, V70, P1038, DOI 10.1002/1097-0142(19920901)70:5<1038::AID-CNCR2820700505>3.0.CO;2-M; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; Nofer JR, 2001, THROMB HAEMOSTASIS, V85, P730; Raiha I, 1997, ARTERIOSCL THROM VAS, V17, P1224, DOI 10.1161/01.ATV.17.7.1224; Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401; SALMOND CE, 1985, BMJ-BRIT MED J, V290, P422, DOI 10.1136/bmj.290.6466.422; Cabrera MAS, 2012, SCI WORLD J, DOI 10.1100/2012/930139; SCHAEFER EJ, 1989, METABOLISM, V38, P293, DOI 10.1016/0026-0495(89)90113-3; SCHATZKIN A, 1987, LANCET, V2, P298; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; SIMONS LA, 1986, AM J CARDIOL, V57, pG5, DOI 10.1016/0002-9149(86)90659-4; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; TORNBERG SA, 1989, JNCI-J NATL CANCER I, V81, P1917, DOI 10.1093/jnci/81.24.1917; Volpato S, 2001, J AM GERIATR SOC, V49, P1142, DOI 10.1046/j.1532-5415.2001.49229.x; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Weverling-Rijnsburger AWE, 2003, ARCH INTERN MED, V163, P1549, DOI 10.1001/archinte.163.13.1549; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; WILLIAMS RR, 1981, JAMA-J AM MED ASSOC, V245, P247, DOI 10.1001/jama.245.3.247; Yang XL, 2008, CAN MED ASSOC J, V179, P427, DOI 10.1503/cmaj.071474; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967; Zuliani G, 1999, GERONTOLOGY, V45, P317, DOI 10.1159/000022112; Zuliani G, 2007, ATHEROSCLEROSIS, V192, P384, DOI 10.1016/j.atherosclerosis.2006.05.024	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185307	10.1371/journal.pone.0185307	http://dx.doi.org/10.1371/journal.pone.0185307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957382	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200043
J	Grimaldi, G; Teva, A; dos-Santos, CB; Santos, FN; Pinto, ID; Fux, B; Leite, GR; Falqueto, A				Grimaldi, Gabriel, Jr.; Teva, Antonio; dos-Santos, Claudiney B.; Santos, Fernanda Nunes; Pinto, Israel de-Souza; Fux, Blima; Leite, Gustavo Rocha; Falqueto, Aloisio			Field trial of efficacy of the Leish-tec((R)) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; LONG-LASTING PROTECTION; IMPREGNATED DOG COLLARS; VISCERAL LEISHMANIASIS; BRAZILIAN DOGS; INFECTIONS; CHAGASI; A2; SERODIAGNOSIS; EPIDEMIOLOGY	Background Because domestic dogs are reservoir hosts for visceral leishmaniasis (VL) in Brazil, one of the approaches used to reduce human disease incidence is to cull infected dogs. However, the results of controlled intervention trials based on serological screening of dogs and killing of seropositive animals are equivocal. A prophylactic vaccine to protect dogs from being infectious to the sand fly vector could be an effective strategy to provide sustained control. Here, we investigated whether a currently licensed commercial subunit rA2 protein-saponin vaccine (Leish-tec((R))) had an additional effect to dog culling on reducing the canine infectious populations. Methodology/Principal findings This prospective study was conducted in an L. infantum highly endemic area of southeast Brazil. At the onset of the intervention, all of the eligible dogs received through subcutaneous route a three-dose vaccine course at 21-day intervals and a booster on month 12. For the purpose of comparison, newly recruited healthy dogs were included as the exposed control group. To ascertain vaccine-induced protection, dogs were screened on clinical and serological criteria every 6 months for a 2-year follow-up period. Antibody-based tests and histopathological examination of post-mortem tissue specimens from euthanized animals were used as a marker of infection. The standardized vaccine regime, apart from being safe, was immunogenic as immunized animals responded with a pronounced production of anti-A2-specific IgG antibodies. It should be noted the mean seroconversion time for infection obtained among immunized exposed dogs (similar to 18 months), which was twice as high as that for unvaccinated ones (similar to 9 months). After two transmission cycles completed, the cumulative incidence of infection did differ significantly (P = 0.016) between the vaccinated ( 27%) and unvaccinated ( 42%) dogs. However, the expected efficacy for the vaccine in inducing clinical protection was not evident since 43% of vaccine recipients developed disease over time. Our estimates also indicated that immunoprophylaxis by Leish- tec r vaccine in addition to dog culling might not have an impact on bringing down the incidence of canine infection with L. infantum in areas of high transmission rates. Conclusions/Significance Leish-tec((R)) as a prophylactic vaccine showed promise but needs to be further optimized to be effective in dogs under field conditions, and thereby positively impacts human incidence.	[Grimaldi, Gabriel, Jr.] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil; [Teva, Antonio; Santos, Fernanda Nunes] Fiocruz MS, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil; [dos-Santos, Claudiney B.; Pinto, Israel de-Souza; Fux, Blima; Leite, Gustavo Rocha; Falqueto, Aloisio] Univ Fed Espirito Santos, Ctr Ciencias Saude, Vitoria, ES, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Espirito Santo	Grimaldi, G (corresponding author), Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.	grimaldi@bahia.fiocruz.br	Fux, Blima/AAO-2941-2020	Fux, Blima/0000-0002-5038-3551; de Souza Pinto, Israel/0000-0001-8924-640X; Grimaldi Jr, Gabriel/0000-0001-5189-9763				ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrade HM, 2002, VET PARASITOL, V103, P71, DOI 10.1016/S0304-4017(01)00552-0; Baneth G, 2002, VET PARASITOL, V106, P315, DOI 10.1016/S0304-4017(02)00115-2; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Berrahal F, 1996, AM J TROP MED HYG, V55, P273, DOI 10.4269/ajtmh.1996.55.273; Borj-Cabrera GP, 2002, VACCINE, V20, P3277, DOI 10.1016/S0264-410X(02)00294-3; Carrillo E, 2009, VET IMMUNOL IMMUNOP, V128, P67, DOI 10.1016/j.vetimm.2008.10.310; Ciaramella P, 1997, VET REC, V141, P539, DOI 10.1136/vr.141.21.539; CORREDOR A, 1989, AM J TROP MED HYG, V40, P480, DOI 10.4269/ajtmh.1989.40.480; Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; de Amorim IFG, 2010, VET PARASITOL, V173, P55, DOI 10.1016/j.vetpar.2010.06.021; Testasicca MCDS, 2014, VET PARASITOL, V204, P169, DOI 10.1016/j.vetpar.2014.04.025; DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198; Duthie MS, 2012, VACCINE, V30, P134, DOI 10.1016/j.vaccine.2011.11.005; Evans KJ, 2011, J TROP MED, V2012, P1; Falqueto A, 2009, AM J TROP MED HYG, V80, P559, DOI 10.4269/ajtmh.2009.80.559; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Fernandes CB, 2014, VACCINE, V32, P1287, DOI 10.1016/j.vaccine.2013.12.046; Ghosh A, 2001, VACCINE, V20, P59, DOI 10.1016/S0264-410X(01)00322-X; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Gradoni L, 2005, VACCINE, V23, P5245, DOI 10.1016/j.vaccine.2005.07.001; Grimaldi G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002853; Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; LACERDA MM, 1994, MEM I OSWALDO CRUZ, V89, P489, DOI 10.1590/S0074-02761994000300036; LAINSON R, 1969, T ROY SOC TROP MED H, V63, P741, DOI 10.1016/0035-9203(69)90118-7; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Leontides LS, 2002, VET PARASITOL, V109, P19, DOI 10.1016/S0304-4017(02)00201-7; Mackinnon MJ, 2008, VACCINE, V26, pC42, DOI 10.1016/j.vaccine.2008.04.012; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Palatnik-De-Sousa CB, 2009, VACCINE, V27, P3505, DOI 10.1016/j.vaccine.2009.03.045; Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; Reguera RM, 2016, VET PARASITOL, V227, P98, DOI 10.1016/j.vetpar.2016.07.011; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Rosypal AC, 2005, J PARASITOL, V91, P970, DOI 10.1645/GE-483R.1; Sherlock I.A., 1984, Memorias do Instituto Oswaldo Cruz, V79, P511, DOI 10.1590/S0074-02761984000400020; SILVA V. O, 2001, VACCINE, P1082; Ward R. D., 1985, Leishmaniasis. (Human Parasitic Diseases Vol.1.), P199; Werneck GL, 2007, EPIDEMIOL INFECT, V135, P195, DOI 10.1017/S0950268806006881; WHO, 2010, WHO TECH REP SER, V949, P1; Zanin FHC, 2007, MICROBES INFECT, V9, P1070, DOI 10.1016/j.micinf.2007.05.012	51	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185438	10.1371/journal.pone.0185438	http://dx.doi.org/10.1371/journal.pone.0185438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953944	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300068
J	Long, K; Prothero, D; Madan, M; Syverson, VJP				Long, Katherine; Prothero, Donald; Madan, Meena; Syverson, Valerie J. P.			Did saber-tooth kittens grow up musclebound? A study of postnatal limb bone allometry in felids from the Pleistocene of Rancho La Brea	PLOS ONE			English	Article							MAMMALS; BEHAVIOR	Previous studies have demonstrated that the Pleistocene saber-toothed cat Smilodon fatalis had many forelimb adaptations for increased strength, presumably to grapple with and subdue prey. The Rancho La Brea tar pits yield large samples of juvenile limb bones forming a growth series that allow us to examine how Smilodon kittens grew up. Almost all available juvenile limb bones were measured, and reduced major axis fits were calculated to determine the allometric growth trends. Contrary to expectations based on their robust limbs, Smilodon kittens show the typical pattern of growth found in other large felids (such as the Ice Age lion, Panthera atrox, as well as living tigers, cougars, servals, and wildcats) where the limb grows longer and more slender faster than they grow thick. This adaptation is thought to give felids greater running speed. Smilodon kittens do not grow increasingly more robust with age. Instead, they start out robust and follow the ancestral felid growth pattern, while maintaining their robustness compared to other felids. Apparently, the growth of felid forelimbs is highly canalized and their ontogeny is tightly constrained.	[Long, Katherine; Prothero, Donald] Calif State Polytech Univ Pomona, Dept Geol Sci, Pomona, CA 91768 USA; [Prothero, Donald] Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; [Madan, Meena] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Syverson, Valerie J. P.] Univ Wisconsin, Dept Geol Sci, Madison, WI USA	California State University System; California State Polytechnic University Pomona; University of Bristol; University of Wisconsin System; University of Wisconsin Madison	Prothero, D (corresponding author), Calif State Polytech Univ Pomona, Dept Geol Sci, Pomona, CA 91768 USA.; Prothero, D (corresponding author), Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA.	donaldprothero@att.net	Syverson, Val/GOK-1758-2022	Syverson, Val/0000-0002-6076-5326				AKERSTEN W A, 1985, Contributions in Science (Los Angeles), P1; Ant?n M., 2013, SABERTOOTH; Anyonge W, 1996, J ZOOL, V238, P395, DOI 10.1111/j.1469-7998.1996.tb05402.x; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; GONYEA W J, 1976, Paleobiology, V2, P332; Kilbourne BM, 2012, J MORPHOL, V273, P1111, DOI 10.1002/jmor.20048; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Merriam J.C., 1932, CARNEGIE I WASHINGTO, V442, P1; SCHULTZ C B, 1970, Bulletin of the University of Nebraska State Museum, V9, P33; Turner A., 1997, BIG CATS THEIR FOSSI; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008	13	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0183175	10.1371/journal.pone.0183175	http://dx.doi.org/10.1371/journal.pone.0183175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953899	Green Submitted, Green Published, gold			2022-12-26	WOS:000411980300006
J	Roure, S; Valerio, L; Perez-Quilez, O; Fernandez-Rivas, G; Martinez-Cuevas, O; Alcantara-Roman, A; Viasus, D; Pedro-Botet, ML; Sabria, M; Clotet, B				Roure, Silvia; Valerio, Lluis; Perez-Quilez, Olga; Fernandez-Rivas, Gema; Martinez-Cuevas, Octavio; Alcantara-Roman, Albert; Viasus, Diego; Pedro-Botet, M. Luisa; Sabria, Miguel; Clotet, Bonaventura			Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a nonendemic country (North Metropolitan area of Barcelona, 2002-2016)	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; UROGENITAL SCHISTOSOMIASIS; HAEMATOBIUM; TRAVELERS; DISEASES; MANSONI; AFRICA	Background Schistosomiasis, one of the neglected tropical diseases (NTD) listed by the WHO, is an acute and chronic parasitic disease caused by blood flukes (trematode worms) of the genus Schistosoma. Complications of long-term infestation include liver cirrhosis, bladder tumors and kidney failure. The objective of this study was to carry out a clinical and epidemiological characterization of a schistosomiasis-diagnosed immigrant population with long-term residencein the EU as well as to evaluate the diagnostic methods available to date. Methods and results A total of 61 individuals with Schistosoma infection who received medical attention between June 2002 and June 2016 at the North Metropolitan International Health Unit in Barcelona (Catalonia, Spain), were included in the study. All patients were sub-Saharan African immigrants. The majority were male (91.8%) with a median age of 34 years. Symptoms attributable to infection such as haematuria, abdominal pain and dysuria were recorded in up to 90% of patients. The percentage of eosinophils decreased amongst older patients (p = 0.002) and those with symptoms associated with urinary tract infections (p = 0.017). Serology was used for diagnosis in 80.3% of the cases, with microscopic examination showing the remaining 9.8% positive for parasite eggs. Direct microbiological diagnosis was more useful in patients with less than 5 years of residence in the EU (p = 0.05). Chronic complications were present in 22 (36%) of the patients, with renal failure affecting 20 (33%). Of these 20, 6(10%) developed terminal renal failure and required hemodialysis, while 3 (5%) received a renal transplantation. Conclusion Morbidity associated with chronic long-term schistosomiasis is frequent among African immigrants in non-endemic countries. Better diagnostic tools and appropriate early treatment would prevent the development of visceral damage. Thorough screening in selected patients would also be useful to avoid chronic complications.	[Roure, Silvia] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, North Metropolitan Int Hlth Unit PROSICS, Barcelona, Spain; [Roure, Silvia; Pedro-Botet, M. Luisa; Sabria, Miguel; Clotet, Bonaventura] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Internal Med, Infect Dis Unit, Barcelona, Spain; [Valerio, Lluis; Perez-Quilez, Olga; Martinez-Cuevas, Octavio; Alcantara-Roman, Albert] Serv Atencio Primaria, North Metropolitan Int Hlth Unit PROSICS, Barcelona, Spain; [Fernandez-Rivas, Gema] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Microbiol, Barcelona, Spain; [Viasus, Diego] Hosp Univ Norte, Fac Med, Div Hlth Sci, Barranquilla, Colombia; [Viasus, Diego] Univ Norte, Barranquilla, Colombia; [Clotet, Bonaventura] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universidad del Norte; Universidad del Norte; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Roure, S (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, North Metropolitan Int Hlth Unit PROSICS, Barcelona, Spain.; Roure, S (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Internal Med, Infect Dis Unit, Barcelona, Spain.	sroura.mn.ics@gencat.cat	Rivas, Gema Fernández G Fernandez/C-6022-2018; Viasus, Diego/HDN-6634-2022	Roure, Silvia/0000-0002-7982-0890				Agbessi CA, 2006, REV MED INTERNE, V27, P595, DOI 10.1016/j.revmed.2006.05.006; Andrade JR, 2014, T ROY SOC TROP MED H, V108, P159, DOI 10.1093/trstmh/tru010; AZEVEDO LS, 1987, TRANSPLANTATION, V44, P795, DOI 10.1097/00007890-198712000-00015; Barrou B, 1997, J UROLOGY, V157, P1232, DOI 10.1016/S0022-5347(01)64932-2; Becker S L, 2015, Euro Surveill, V20; Boissier J, 2016, LANCET INFECT DIS, V16, P971, DOI 10.1016/S1473-3099(16)00175-4; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Coltart C, 2015, CLIN MED, V15, P67, DOI 10.7861/clinmedicine.15-1-67; Coltart CEM, 2015, T ROY SOC TROP MED H, V109, P214, DOI 10.1093/trstmh/tru195; Deniaud F, 2006, Bull Soc Pathol Exot, V99, P110; Deniaud Francois, 2010, Sante, V20, P201; Gandasegui J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003963; Gray Darren J, 2011, BMJ, V342, pd2651, DOI 10.1136/bmj.d2651; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Inobaya MT, 2014, RES REP TROP MED, V5, P65, DOI 10.2147/RRTM.S44274; Khyatti M, 2014, EUR J PUBLIC HEALTH, V24, P47, DOI 10.1093/eurpub/cku109; Kinkel HF, 2012, CLIN VACCINE IMMUNOL, V19, P948, DOI 10.1128/CVI.05680-11; Kjetland EF, 2008, TROP MED INT HEALTH, V13, P1509, DOI 10.1111/j.1365-3156.2008.02161.x; Knopp S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003752; Meurs L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003959; Onile OS, 2016, J TROP MED-US, V2016, DOI 10.1155/2016/5405207; Rambau PF, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-19; Roca C, 2002, EUR J CLIN MICROBIOL, V21, P219, DOI 10.1007/s10096-001-0683-z; Sady H, 2015, INT J MOL SCI, V16, P16085, DOI 10.3390/ijms160716085; Salas-Coronas J, 2013, ENFERM INFEC MICR CL, V31, P205, DOI 10.1016/j.eimc.2012.04.003; Salawu OT, 2014, J PEDIATR UROL, V10, P88, DOI 10.1016/j.jpurol.2013.06.010; Shokeir AA, 2001, BJU INT, V88, P915, DOI 10.1046/j.1464-4096.2001.01549.x; Tukahebwa EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002268; Utzinger J, CLIN MICROBIOLOGY IN; Valerio L, CAMFIC GUIA ATENCION; Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4; Yirenya-Tawiah D, 2011, Ghana Med J, V45, P16	32	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185245	10.1371/journal.pone.0185245	http://dx.doi.org/10.1371/journal.pone.0185245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953954	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300049
J	Shin, DH; Lee, YK; Oh, J; Yoon, JW; Rhee, SY; Kim, EJ; Ryu, J; Cho, A; Jeon, HJ; Choi, MJ; Noh, JW				Shin, Dong Ho; Lee, Young-Ki; Oh, Jieun; Yoon, Jong-Woo; Rhee, So Yon; Kim, Eun-Jung; Ryu, Jiwon; Cho, Ajin; Jeon, Hee Jung; Choi, Myung-Jin; Noh, Jung-Woo			Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PERITONEAL-DIALYSIS PATIENTS; PROTEIN-BOUND SOLUTES; PULSE-WAVE VELOCITY; CARDIOVASCULAR-DISEASE; PHOSPHATE CONTROL; AORTIC STIFFNESS; BLOOD-PRESSURE; BETA-2-MICROGLOBULIN; MORTALITY	Background Vascular calcification is common and may affect cardiac function in patients with end-stage renal disease (ESRD). However, little is known about the effect of residual renal function on vascular calcification and cardiac function in patients on hemodialysis. Methods This study was conducted between January 2014 and January 2017. One hundred six patients with residual renal function on maintenance hemodialysis for 3 months were recruited. We used residual renal urea clearance (KRU) to measure residual renal function. First, abdominal aortic calcification score (AACS) and brachial-ankle pulse wave velocity (baPWV) were measured in patients on hemodialysis. Second, we performed echocardiography and investigated new cardiovascular events after study enrollment. Results The median KRU was 0.9 (0.3-2.5) mL/min/1.73m(2). AACS (4.0 [1.0-10.0] vs. 3.0 [0.0-8.0], p = 0.05) and baPWV (1836.1 +/- 250.4 vs. 1676.8 +/- 311.0 cm/s, p = 0.01) were significantly higher in patients with a KRU < 0.9 mL/min/1.73m(2) than a KRU >= 0.9 mL/min/1.73m(2). Log-KRU significantly negatively correlated with log-AACS (beta = -0.29, p = 0.002) and baPWV (beta = -0.19, P = 0.05) after factor adjustment. The proportion of left ventricular diastolic dysfunction was significantly higher in patients with a KRU < 0.9 mL/min/1.73m(2) than with a KRU < 0.9 mL/min/1.73m(2) (67.9% vs. 49.1%, p = 0.05). Patients with a KRU < 0.9 mL/min/1.73m(2) showed a higher tendency of cumulative cardiovascular events compared to those with a KRU >= 0.9 ml/min/1.73m(2) (P = 0.08). Conclusions Residual renal function was significantly associated with vascular calcification and left ventricular diastolic dysfunction in patients on hemodialysis.	[Shin, Dong Ho; Oh, Jieun; Rhee, So Yon; Kim, Eun-Jung; Jeon, Hee Jung] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Young-Ki; Cho, Ajin; Noh, Jung-Woo] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Yoon, Jong-Woo; Ryu, Jiwon; Choi, Myung-Jin] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Internal Med, Chunchon, Gangwon Do, South Korea	Hallym University; Hallym University; Hallym University	Oh, J (corresponding author), Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea.; Lee, YK (corresponding author), Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea.; Yoon, JW (corresponding author), Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Internal Med, Chunchon, Gangwon Do, South Korea.	km2071@naver.com; jieunmd@gmail.com; yoonjw@hallym.or.kr	Oh, Jieun/ABA-4669-2020	Oh, Jieun/0000-0001-9429-9602; CHOI, MYUNG JIN/0000-0002-2761-7161	Hallym Research Fund [HURF-2014-09]	Hallym Research Fund	This study was supported by Hallym Research Fund 2014 (HURF-2014-09).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bammens B, 2003, KIDNEY INT, V64, P2238, DOI 10.1046/j.1523-1755.2003.00310.x; BARENBROCK M, 1994, KIDNEY INT, V45, P1397, DOI 10.1038/ki.1994.182; Birkenhager AM, 2007, NETH J MED, V65, P127; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Bragg-Gresham JL, 2007, AM J KIDNEY DIS, V49, P426, DOI 10.1053/j.ajkd.2006.12.012; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Daugirdas J.T., 2012, HDB DIALYSIS; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fry AC, 2007, BLOOD PURIFICAT, V25, P295, DOI 10.1159/000104870; Goodman WG, 2004, AM J KIDNEY DIS, V43, P572, DOI 10.1053/j.ajkd.2003.12.005; Honkanen E, 2008, NEPHROL DIAL TRANSPL, V23, P4009, DOI 10.1093/ndt/gfn403; Hruska KA, 2009, SEMIN NEPHROL, V29, P156, DOI 10.1016/j.semnephrol.2009.01.008; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Levin A, 2003, SEMIN DIALYSIS, V16, P101, DOI 10.1046/j.1525-139X.2003.16025.x; Liabeuf S, 2012, KIDNEY INT, V82, P1297, DOI 10.1038/ki.2012.301; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Marquez IO, 2011, CLIN J AM SOC NEPHRO, V6, P290, DOI 10.2215/CJN.06100710; Neven E, 2011, NEPHROL DIAL TRANSPL, V26, P1137, DOI 10.1093/ndt/gfq858; Oh JK, 1997, J AM SOC ECHOCARDIOG, V10, P246, DOI 10.1016/S0894-7317(97)70062-2; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6; Penne EL, 2011, CLIN J AM SOC NEPHRO, V6, P281, DOI 10.2215/CJN.04480510; Rroji M, 2014, INT UROL NEPHROL, V46, P175, DOI 10.1007/s11255-013-0438-7; Shafi T, 2010, AM J KIDNEY DIS, V56, P348, DOI 10.1053/j.ajkd.2010.03.020; Shemin D, 2001, AM J KIDNEY DIS, V38, P85, DOI 10.1053/ajkd.2001.25198; Stompor T, 2006, INT J ARTIF ORGANS, V29, P736, DOI 10.1177/039139880602900802; Stompor T, 2002, PERITON DIALYSIS INT, V22, P670; Suda T, 2000, NEPHROL DIAL TRANSPL, V15, P396, DOI 10.1093/ndt/15.3.396; Velasquez MT, 2016, KIDNEY INT REP, V1, P94, DOI 10.1016/j.ekir.2016.05.001; Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382; Wang AYM, 2002, KIDNEY INT, V62, P639, DOI 10.1046/j.1523-1755.2002.00471.x; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P396, DOI 10.1093/ndt/gfh331; Wang AYM, 2004, AM J KIDNEY DIS, V43, P712, DOI 10.1053/j.ajkd.2003.12.032; Wang X, 2009, CHINESE MED J-PEKING, V122, P2103, DOI 10.3760/cma.j.issn.0366-6999.2009.18.005; Wheeler DC, 1996, LANCET, V348, P1673, DOI 10.1016/S0140-6736(05)65816-3; Won HS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731296; Wong J, 2016, KIDNEY INT, V89, P1090, DOI 10.1016/j.kint.2015.12.042; Zhang MM, 2014, AM J NEPHROL, V40, P140, DOI 10.1159/000365819	41	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185296	10.1371/journal.pone.0185296	http://dx.doi.org/10.1371/journal.pone.0185296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953969	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300053
J	Circu, M; Cardelli, J; Barr, M; O'Byrne, K; Mills, G; El-Osta, H				Circu, Magdalena; Cardelli, James; Barr, Martin; O'Byrne, Kenneth; Mills, Glenn; El-Osta, Hazem			Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells	PLOS ONE			English	Article							TARGETING AUTOPHAGY; INDUCED APOPTOSIS; CARCINOMA-CELLS; WILD-TYPE; RESISTANCE; CHEMOTHERAPY; INHIBITION; INDUCTION; DEATH; P53	Lung cancer is the leading cause of cancer-related deaths. Most patients develop resistance to platinum within several months of treatment. We investigated whether triggering lysosomal membrane permeabilization (LMP) or suppressing autophagy can restore cisplatin susceptibility in lung cancer with acquired chemoresistance. Cisplatin IC50 in A549Pt (parental) and A549cisR (cisplatin resistant) cells was 13 mu M and 47 mu M, respectively. Following cisplatin exposure, A549cisR cells failed to elicit an apoptotic response. This was manifested by diminished Annexin-V staining, caspase 3 and 9, BAX and BAK activation in resistant but not in parental cells. Chloroquine preferentially promoted LMP in A549cisR cells, revealed by leakage of FITC-dextran into the cytosol as detected by immunofluorescence microscopy. This was confirmed by increased cytosolic cathepsin D signal on Immunoblot. Cell viability of cisplatin-treated A549cisR cells was decreased when co-treated with chloroquine, corresponding to a combination index below 0.8, suggesting synergism between the two drugs. Notably, chloroquine activated the mitochondrial cell death pathway as indicated by increase in caspase 9 activity. Interestingly, inhibition of lysosomal proteases using E64 conferred cytoprotection against cisplatin and chloroquine co-treatment, suggesting that chloroquine-induced cell death occurred in a cathepsin-mediated mechanism. Likewise, blockage of caspases partially rescued A549cisR cells against the cytotoxicity of cisplatin and chloroquine combination. Cisplatin promoted a dose-dependent autophagic flux induction preferentially in A549cisR cells, as evidenced by a surge in LC3-II/alpha-tubulin following pre-treatment with E64 and increase in p62 degradation. Compared to untreated cells, cisplatin induced an increase in cyto-ID-loaded autophagosomes in A549cisR cells that was further amplified by chloroquine, pointing toward autophagic flux activation by cisplatin. Interestingly, this effect was less pronounced in A549Pt cells. Blocking autophagy by ATG5 depletion using siRNA markedly enhances susceptibility to cisplatin in A549cisR cells. Taken together, our results underscore the utility of targeting lysosomal function in overcoming acquired cisplatin refractoriness in lung cancer.	[Circu, Magdalena; Mills, Glenn; El-Osta, Hazem] Louisiana State Univ, Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Cardelli, James] Segue Therapeut LLC, Shreveport, LA USA; [Barr, Martin] St James Hosp, Trinity Ctr Hlth Sci, Trinity Translat Med Inst, Thorac Oncol Res Grp, Dublin, Ireland; [Barr, Martin] Trinity Coll Dublin, Dublin, Ireland; [O'Byrne, Kenneth] Queensland Univ Technol, Canc & Ageing Res Program, Brisbane, Qld, Australia; [El-Osta, Hazem] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Trinity College Dublin; Trinity College Dublin; Queensland University of Technology (QUT); University of Texas System; University of Texas Health Science Center Houston	El-Osta, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA.; El-Osta, H (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.	hazemelosta@yahoo.com		Barr, Martin/0000-0001-5202-9655; O'Byrne, Kenneth/0000-0002-6754-5633	Feist-Weiller Cancer Center	Feist-Weiller Cancer Center	This research was funded by Feist-Weiller Cancer Center. It provided support in the form of buying equipment and materials necessary for the conduction of the project, and salary to MC (coauthor), but didn't have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Cervia D, 2016, ONCOTARGET, V7, P24995, DOI 10.18632/oncotarget.8735; Cetintas VB, 2012, CELL BIOL INT, V36, P261, DOI 10.1042/CBI20110329; Chee JLY, 2013, CELL CYCLE, V12, P278, DOI 10.4161/cc.23054; Chen QY, 2012, MOL CELL BIOCHEM, V359, P389, DOI 10.1007/s11010-011-1033-9; Circu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146931; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; DeFeudis P, 1997, BRIT J CANCER, V76, P474, DOI 10.1038/bjc.1997.412; Dong XQ, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.87; Enzenmuller S, 2013, ANTI-CANCER DRUG, V24, P14, DOI 10.1097/CAD.0b013e32835a36db; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Fukuda T, 2015, GYNECOL ONCOL, V137, P538, DOI 10.1016/j.ygyno.2015.03.053; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Garcia-Cano J, 2015, ONCOTARGET, V6, P15551, DOI 10.18632/oncotarget.3902; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Groth-Pedersen L, 2013, CANCER LETT, V332, P265, DOI 10.1016/j.canlet.2010.05.021; Hsin IL, 2016, PHYTOMEDICINE, V23, P1566, DOI 10.1016/j.phymed.2016.09.003; Jaattela Marja, 2015, Cold Spring Harb Protoc, V2015, P975, DOI 10.1101/pdb.top070367; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Liu FF, 2013, ONCOL LETT, V5, P1261, DOI 10.3892/ol.2013.1154; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Matsumoto M, 2016, BIOCHEM BIOPH RES CO, V473, P490, DOI 10.1016/j.bbrc.2016.03.053; Mijatovic T, 2006, NEOPLASIA, V8, P402, DOI 10.1593/neo.05850; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pan YZ, 2011, CLIN CANCER RES, V17, P3248, DOI 10.1158/1078-0432.CCR-10-0890; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Park Deokbae, 2014, Dev Reprod, V18, P225, DOI 10.12717/devrep.2014.18.4.225; Qin L, 2016, DRUG DES DEV THER, V10, P1035, DOI 10.2147/DDDT.S101701; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Seitz C, 2013, INT J CANCER, V132, P2682, DOI 10.1002/ijc.27935; Sharma N, 2012, CANCER LETT, V326, P143, DOI 10.1016/j.canlet.2012.07.029; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Sukhai MA, 2013, J CLIN INVEST, V123, P315, DOI 10.1172/JCI64180; Verrier F, 2001, J VIROL, V75, P9177, DOI 10.1128/JVI.75.19.9177-9186.2001; White E, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-14; Wu HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12291; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yao WL, 2015, CANCER LETT, V364, P70, DOI 10.1016/j.canlet.2015.04.028; Yu L, 2014, CANCER LETT, V355, P34, DOI 10.1016/j.canlet.2014.09.020; Zhao XG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126147	59	37	39	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184922	10.1371/journal.pone.0184922	http://dx.doi.org/10.1371/journal.pone.0184922			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945807	Green Published, gold			2022-12-26	WOS:000411645100012
J	Ferron, HG				Ferron, Humberto G.			Regional endothermy as a trigger for gigantism in some extinct macropredatory sharks	PLOS ONE			English	Article							CRETACEOUS LAMNIFORM SHARK; TUNA SWIMMING PERFORMANCE; BONITO SARDA-CHILIENSIS; STABLE OXYGEN ISOTOPES; TOOTHED WHITE SHARKS; LARGE WATER TUNNEL; CRETOXYRHINA-MANTELLI; NIOBRARA CHALK; CARCHARODON LAMNIFORMES; ECOLOGICAL IMPLICATIONS	Otodontids include some of the largest macropredatory sharks that ever lived, the most extreme case being Otodus (Megaselachus) megalodon. The reasons underlying their gigantism, distribution patterns and extinction have been classically linked with climatic factors and the evolution, radiation and migrations of cetaceans during the Paleogene. However, most of these previous proposals are based on the idea of otodontids as ectothermic sharks regardless of the ecological, energetic and body size constraints that this implies. Interestingly, a few recent studies have suggested the possible existence of endothermy in these sharks thus opening the door to a series of new interpretations. Accordingly, this work proposes that regional endothermy was present in otodontids and some closely related taxa (cretoxyrhinids), playing an important role in the evolution of gigantism and in allowing an active mode of live. The existence of regional endothermy in these groups is supported here by three different approaches including isotopic-based approximations, swimming speed inferences and the application of a novel methodology for assessing energetic budget and cost of swimming in extinct taxa. In addition, this finding has wider implications. It calls into question some previous paleotemperature estimates based partially on these taxa, suggests that the existing hypothesis about the evolution of regional endothermy in fishes requires modification, and provides key evidence for understanding the evolution of gigantism in active macropredators.	[Ferron, Humberto G.] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Burjassot, Spain	University of Valencia	Ferron, HG (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Burjassot, Spain.	Humberto.Ferron@uv.es	Ferron, Humberto/ABH-9895-2020	Ferron, Humberto/0000-0003-2254-8424	Spanish Ministry of Economy and Competitiveness [CGL2014-52662-P]; Valencian Generality [GV/2016/102]; FPU Spanish Research Programme [FPU13/02660]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Valencian Generality; FPU Spanish Research Programme	This work has been funded by the Spanish Ministry of Economy and Competitiveness http://www.mineco.gob.es/portal/site/mineco/ (CGL2014-52662-P) and the Valencian Generality littp://www.ceice.gva.es/web/ciencia/becas-ayudas-y-subvencionescientificas (GV/2016/102). HGF is a recipient of a Fellowship from the FPU Spanish Research Programme (FPU13/02660) http://www.mecd.gob.es/mecd/servicios-alciudadanomecd/catalogo/general/educacion/998758/ficha.html.	Aguilera O, 2004, CARIBB J SCI, V40, P368; Aguilera OA, 2008, PALAEONTOL Z, V82, P204, DOI 10.1007/BF02988410; Alexander RL, 1996, ZOOL J LINN SOC-LOND, V118, P151, DOI 10.1111/j.1096-3642.1996.tb00224.x; ALEXANDER RL, 1995, J ZOOL, V237, P377, DOI 10.1111/j.1469-7998.1995.tb02768.x; Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; ALTRINGHAM JD, 1990, J EXP BIOL, V151, P453; ALTRINGHAM JD, 1991, J EXP BIOL, V157, P381; Amiot R, 2008, PALAEOGEOGR PALAEOCL, V264, P85, DOI 10.1016/j.palaeo.2008.04.001; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Anderson SD, 2001, COPEIA, P794; Aoki K, 2012, MAR ECOL PROG SER, V444, P289, DOI 10.3354/meps09371; Applegate RW, 1996, GREAT WHITE SHARKS B, P19; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Balter V, 2004, GEOCHIM COSMOCHIM AC, V68, P423, DOI 10.1016/S0016-7037(03)00453-8; BARRICK RE, 1994, SCIENCE, V265, P222, DOI 10.1126/science.265.5169.222; Barrick RE, 1995, PALEOBIOLOGY, V21, P552, DOI 10.1017/S0094837300013531; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BEAMISH FWH, 1990, ENVIRON BIOL FISH, V27, P309; BENDIX-ALMGREEN S E, 1983, Bulletin of the Geological Society of Denmark, V32, P1; Bernal D, 2005, NATURE, V437, P1349, DOI 10.1038/nature04007; Bernal D, 2005, COPEIA, P146; Bernal D, 2003, J EXP BIOL, V206, P2845, DOI 10.1242/jeb.00504; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Biology Siversson M., 1992, PALAEONTOLOGY, V35, P519; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; BLOCK BA, 1994, ENVIRON BIOL FISH, V40, P283, DOI 10.1007/BF00002518; Bowden DL, 2016, MITOCHONDRIAL DNA A, V27, P4328, DOI 10.3109/19401736.2015.1089486; BRILL RW, 1979, ENVIRON BIOL FISH, V4, P199, DOI 10.1007/BF00005478; Buckley LB, 2012, GLOBAL ECOL BIOGEOGR, V21, P873, DOI 10.1111/j.1466-8238.2011.00737.x; BUSHNELL PG, 1989, EXP BIOL, V48, P279; Cairns DK, 2008, MAR ECOL PROG SER, V356, P239, DOI 10.3354/meps07286; Capetta H., 1987, CHONDRICHTHYES, V2; Capetta H., 2012, HDB PALEOICHTHYOLO E, V3E; CAREY FG, 1971, AM ZOOL, V11, P137; CAREY FG, 1982, COPEIA, P254; Carlson JK, 1999, COPEIA, P34; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Collareta A, 2017, PALAEOGEOGR PALAEOCL, V469, P84, DOI 10.1016/j.palaeo.2017.01.001; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Cook TD, 2008, CAN J EARTH SCI, V45, P1185, DOI 10.1139/E08-064; Cumbaa SL, 2010, PALAEOGEOGR PALAEOCL, V295, P199, DOI 10.1016/j.palaeo.2010.05.038; Dera G, 2009, EARTH PLANET SC LETT, V286, P198, DOI 10.1016/j.epsl.2009.06.027; DEWAR H, 1994, J EXP BIOL, V192, P13; DEWAR H, 1994, J EXP BIOL, V192, P45; Dickson KA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P998, DOI 10.1086/423743; DICKSON KA, 1994, J EXP BIOL, V190, P79; Dickson KA, 2000, J EXP BIOL, V203, P3077; Diedrich C. G., 2013, NAT SCI, V5, P1203; Diedrich CG, 2014, PALEONTOLOGY J, P93423; Diedrich CG, 2012, VERTEBRATE COPROLITE, V57, P301; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; Domenici P, 1997, J EXP BIOL, V200, P1165; Dowd WW, 2003, METABOLIC RATES BIOE; Dowis HJ, 2003, J EXP BIOL, V206, P2749, DOI 10.1242/jeb.00496; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Ebert DA, 2013, SHARKS WORLD, P256; Ehret DJ, 2012, PALAEONTOLOGY, V55, P1139, DOI 10.1111/j.1475-4983.2012.01201.x; Ehret DJ, 2009, J VERTEBR PALEONTOL, V29, P1; Ehret DJ, 2010, THESIS; Everhart M. J., 1999, Journal of Vertebrate Paleontology, V19, p43A; Everhart M. J., 2005, OCEANS KANSAS NATURA; Everhart M.J., 2005, PALARCH, V2, P14; Everhart M.J., 2005, TATE 2005 11 ANN S P, P16; Ezcurra Juan M., 2012, P17; Ferron H, 2014, J IBER GEOL, V40, P87, DOI 10.5209/rev_JIGE.2014.v40.n1.44089; Ferron HG, 2017, HIST BIOL; Ferron HG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172781; Fischer J, 2013, CHEM GEOL, V342, P44, DOI 10.1016/j.chemgeo.2013.01.022; Fischer J, 2012, PALAEOGEOGR PALAEOCL, V353, P60, DOI 10.1016/j.palaeo.2012.07.002; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Fricke HC, 2000, GEOLOGY, V28, P799, DOI 10.1130/0091-7613(2000)028<0799:MTMLAT>2.3.CO;2; Gerstein ER, 2002, AM SCI, V90, P154, DOI 10.1511/2002.2.154; Giorgioni M, 2015, GLOBAL PLANET CHANGE, V126, P46, DOI 10.1016/j.gloplacha.2015.01.005; Godfrey Stephen J., 2005, Jeffersoniana, V16, P1; Goldman KJ, 2004, ENVIRON BIOL FISH, V71, P403, DOI 10.1007/s10641-004-6588-9; Gottfried MD, 1996, GREAT WHITE SHARKS, P55, DOI 10.1016/B978-012415031-7/50008-2; Gottfried MD, 2001, J VERTEBR PALEONTOL, V21, P730, DOI 10.1671/0272-4634(2001)021[0730:AASOCA]2.0.CO;2; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; HALL CAS, 1992, OIKOS, V65, P377, DOI 10.2307/3545553; Harrell TL, 2016, PALAEONTOLOGY, V59, P351, DOI 10.1111/pala.12240; HUBER BT, 1995, GEOL SOC AM BULL, V107, P1164, DOI 10.1130/0016-7606(1995)107<1164:MLCCOT>2.3.CO;2; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Iosilevskii G, 2008, J R SOC INTERFACE, V5, P329, DOI 10.1098/rsif.2007.1073; Jacoby DM, 2016, BIOL LETT, P12; Jefferson T.A., 2015, MARINE MAMMALS WORLD; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Kallal RJ, 2012, INT J OSTEOARCHAEOL, V22, P253, DOI 10.1002/oa.1199; Kent Bretton W., 1999, Mosasaur, V6, P11; Kim SH, 2013, ANAT REC, V296, P433, DOI 10.1002/ar.22647; Knower T, 1999, J EXP BIOL, V202, P2127; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Kocsis L, 2012, AGU FALL M, V1, P2116; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; KOLODNY Y, 1988, PALAEOGEOGR PALAEOCL, V64, P59, DOI 10.1016/0031-0182(88)90142-3; Kolodny Y, 1991, GEOCHEM SOC SPEC PUB, V3, P105; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Lecuyer C, 1996, PALAEOGEOGR PALAEOCL, V126, P61, DOI 10.1016/S0031-0182(96)00070-3; LECUYER C, 1993, PALAEOGEOGR PALAEOCL, V105, P235, DOI 10.1016/0031-0182(93)90085-W; Lecuyer C, 2004, CHEM GEOL, V204, P63, DOI 10.1016/j.chemgeo.2003.11.003; LERICHE MAURICE, 1926, MEM MUS ROY HIST NAT BELGIQUE, V32, P365; Lowe CG, 2001, ENVIRON BIOL FISH, V60, P251, DOI 10.1023/A:1007650502269; Lowe CG, 2001, MAR BIOL, V139, P447, DOI 10.1007/s002270100585; MacFadden BJ, 2015, J GEOL, V123, P491, DOI 10.1086/684006; Magnuson JJ, 1979, FISH PHYSIOL, V7, P240; Maisey JG, 2012, J FISH BIOL, V80, P918, DOI 10.1111/j.1095-8649.2012.03245.x; Maisey JG, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1325369; Martin AP, 1996, GREAT WHITE SHARKS, P49, DOI 10.1016/B978-012415031-7/50007-0; Martin JE, 2015, CHEM GEOL, V415, P118, DOI 10.1016/j.chemgeo.2015.09.011; Martin RA, 2012, MAR BIOL RES, V8, P90, DOI 10.1080/17451000.2011.614255; Mas Guillem, 2003, Bolleti de la Societat d'Historia Natural de les Balears, V46, P85; McClain CR, 2015, PEERJ, V2, DOI 10.7717/peerj.715; Mollet HF, 1996, GREAT WHITE SHARKS, P81, DOI 10.1016/B978-012415031-7/50010-0; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Myers CE, 2010, P ROY SOC LOND B BIO, V278; Nyberg KG, 2006, J VERTEBR PALEONTOL, V26, P806, DOI 10.1671/0272-4634(2006)26[806:TTAOTG]2.0.CO;2; Ohlberger J, 2007, J COMP PHYSIOL B, V177, P905, DOI 10.1007/s00360-007-0189-9; Pelc A., 2011, MINERALOGIA, V42, P53, DOI DOI 10.2478/V10002-011-0006-7; PETERSON CC, 1990, P NATL ACAD SCI USA, V87, P2324, DOI 10.1073/pnas.87.6.2324; Picard S, 1998, GEOLOGY, V26, P975, DOI 10.1130/0091-7613(1998)026<0975:OVOCBA>2.3.CO;2; Pimiento C, 2017, NATURE ECOLOGY EVOLU; Pimiento C, 2016, J BIOGEOGR, V43, P1645, DOI 10.1111/jbi.12754; Pimiento C, 2015, PALEOBIOLOGY, V41, P479, DOI 10.1017/pab.2015.16; Pimiento C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111086; Pimiento C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010552; PONGANIS PJ, 1990, CAN J ZOOL, V68, P2105, DOI 10.1139/z90-293; Pontzer H, 2009, PLOS ONE, V4, pA127, DOI 10.1371/journal.pone.0007783; Puceat E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000823; Puceat E, 2007, GEOLOGY, V35, P107, DOI 10.1130/G23103A.1; Purdy RW, 1996, GREAT WHITE SHARKS, P67, DOI 10.1016/B978-012415031-7/50009-4; Purdy RW, 2001, SM C PALEOB, V90, P71; RADTKE RL, 1987, COMP BIOCHEM PHYS A, V87, P797, DOI 10.1016/0300-9629(87)90403-8; RANDALL JE, 1973, SCIENCE, V181, P169, DOI 10.1126/science.181.4095.169; RASCHI W, 1992, AUST J MAR FRESH RES, V43, P123, DOI 10.1071/MF9920123; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P172; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P184; Reif WE., 1985, COURIER FORSCHUNGSIN; Roelofs B, 2017, PALAEOGEOGR PALAEOCL, V465, P79, DOI 10.1016/j.palaeo.2016.10.018; Rohr JJ, 2002, MAR MAMMAL SCI, V18, P1, DOI 10.1111/j.1748-7692.2002.tb01014.x; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Sambilay V.C.J., 1990, FISHBYTE, V8, P16; Semmens JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01471; Sepulveda C, 2000, J EXP BIOL, V203, P3089; Sepulveda CA, 2007, MAR BIOL, V152, P1087, DOI 10.1007/s00227-007-0757-2; Sepulveda CA, 2007, J FISH BIOL, V70, P1720, DOI 10.1111/j.1095-8649.2007.01446.x; Sepulveda CA, 2005, J EXP BIOL, V208, P4255, DOI 10.1242/jeb.01898; Sepulveda CA, 2003, J EXP BIOL, V206, P2739, DOI 10.1242/jeb.00497; Shimada K, 2004, J PALEONTOL, V78, P205, DOI 10.1666/0022-3360(2004)078<0205:SPTFTU>2.0.CO;2; Shimada K, 1997, J VERTEBR PALEONTOL, V17, P642, DOI 10.1080/02724634.1997.10011014; Shimada K, 1997, J PALEONTOL, V71, P926, DOI 10.1017/S002233600003585X; Shimada K., 2002, J FOSSIL RES, V35, P28, DOI DOI 10.3390/GEOSCIENCES2020109; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P584, DOI 10.1671/0272-4634(2007)27[584:SADAOL]2.0.CO;2; Shimada Kenshu, 2005, Paleontological Research, V9, P55, DOI 10.2517/prpsj.9.55; Shimada Kenshu, 2004, Mosasaur, V7, P35; Shimada K, 2017, HIST BIOL, V29, P704, DOI 10.1080/08912963.2016.1236795; Shimada Kenshu, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P185; Siverson M, 2005, ACTA PALAEONTOL POL, V50, P301; Siverson M, 1999, T ROY SOC EDIN-EARTH, V90, P49, DOI 10.1017/S0263593300002509; Siversson M, 2015, ACTA PALAEONTOL POL, V60, P339, DOI 10.4202/app.2012.0137; Sundstrom LF, 1998, HYDROBIOLOGIA, V372, P241; Tabor CR, 2016, GEOLOGY, V44, P963, DOI 10.1130/G38363.1; THOMSON KS, 1977, AM ZOOL, V17, P343; Tubbesing VA, 2000, ACTA ZOOL-STOCKHOLM, V81, P49, DOI 10.1046/j.1463-6395.2000.00037.x; UYENO T, 1989, B SAITAMA MUSEUM NAT, V7, P73; Van Damme R, 1999, ANIM BEHAV, V57, P347, DOI 10.1006/anbe.1998.0980; Vennemann TW, 2001, GEOCHIM COSMOCHIM AC, V65, P1583, DOI 10.1016/S0016-7037(00)00629-3; Videler J. J, 1993, FISH SWIMMING, V10; Ward David J., 2001, Central Mediterranean Naturalist, V3, P131; Ward DJ, 2009, FOSSILS GAULT CLAY, P275; Wardle C.S., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V35, P519; WARDLE CS, 1975, NATURE, V255, P725, DOI 10.1038/255725a0; Watanabe YY, 2015, P NATL ACAD SCI USA, V112, P6104, DOI 10.1073/pnas.1500316112; Watanabe YY, 2012, J EXP MAR BIOL ECOL, V426, P5, DOI 10.1016/j.jembe.2012.04.021; WEBB PW, 1984, J EXP BIOL, V109, P77; WEBB PW, 1976, J EXP BIOL, V65, P157; Webb PW, 1979, FISH PHYSIOL, V7, P190; Wegner NC, 2015, SCIENCE, V348, P786, DOI 10.1126/science.aaa8902; Welsh JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033187; Weng KC, 2004, FISH B-NOAA, V102, P221; Willmer P., 2009, ENV PHYSL ANIMALS; Zacke A, 2009, J GEOL SOC LONDON, V166, P969, DOI 10.1144/0016-76492008-068; Zhelezko V., 2000, MAT STRATIGRAPHY PAL, V4, P136; Zhelezko VI, 1999, MAT STRATIGRAPHY PAL, V3, P403; Zigaite Z, 2014, GFF, V136, P337, DOI 10.1080/11035897.2013.878747	185	21	21	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185185	10.1371/journal.pone.0185185	http://dx.doi.org/10.1371/journal.pone.0185185			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938002	gold, Green Published, Green Submitted			2022-12-26	WOS:000411524700022
J	Hakobyan, D; Gerke, V; Heuer, A				Hakobyan, Davit; Gerke, Volker; Heuer, Andreas			Modeling of annexin A2-Membrane interactions by molecular dynamics simulations	PLOS ONE			English	Article							CA2+-INDUCED CONFORMATIONAL-CHANGES; MEMBRANE-BINDING; PHOSPHOLIPID-BINDING; TYROSINE KINASE; FORCE-FIELD; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; CALCIUM-BINDING; LIPID-MEMBRANES; CALPACTIN-I	The annexins are a family of Ca2+-regulated phospholipid binding proteins that are involved in membrane domain organization and membrane trafficking. Although they are widely studied and crystal structures are available for several soluble annexins their mode of membrane association has never been studied at the molecular level. Here we obtained molecular information on the annexin-membrane interaction that could serve as paradigm for the peripheral membrane association of cytosolic proteins by Molecular Dynamics simulations. We analyzed systems containing the monomeric annexin A2 (AnxA2), a membrane with negatively charged phosphatidylserine ( POPS) lipids as well as Ca2+ ions. On the atomic level we identify the AnxA2 orientations and the respective residues which display the strongest interaction with Ca2+ ions and the membrane. The simulation results fully agree with earlier experimental findings concerning the positioning of bound Ca2+ ions. Furthermore, we identify for the first time a significant interaction between lysine residues of the protein and POPS lipids that occurs independently of Ca2+ suggesting that AnxA2-membrane interactions can also occur in a low Ca2+ environment. Finally, by varying Ca2+ concentrations and lipid composition in our simulations we observe a calcium-induced negative curvature of the membrane as well as an AnxA2-induced lipid ordering.	[Hakobyan, Davit; Heuer, Andreas] Univ Munster, Inst Phys Chem, Munster, Germany; [Hakobyan, Davit; Heuer, Andreas] Univ Munster, CMTC, Munster, Germany; [Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat ZMBE, Munster, Germany	University of Munster; University of Munster; University of Munster	Hakobyan, D (corresponding author), Univ Munster, Inst Phys Chem, Munster, Germany.; Hakobyan, D (corresponding author), Univ Munster, CMTC, Munster, Germany.	dhako_01@uni-muenster.de			German Research foundation (DFG) [SFB 858]	German Research foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research foundation (DFG) via SFB 858 ("Synergetic Effects in Chemistry - From Additivity towards Cooperativity"). https://www.unimuenster.de/SFB858/research.htrnl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PF, 2011, BIOPHYS J, V101, P1930, DOI 10.1016/j.bpj.2011.09.015; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15179, DOI 10.1021/bi000501x; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; BLACKWOOD RA, 1990, BIOCHEM J, V266, P195, DOI 10.1042/bj2660195; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Chen ZX, 2014, PROTEINS, V82, P312, DOI 10.1002/prot.24389; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; Donohue MP, 2014, PROTEINS, V82, P2936, DOI 10.1002/prot.24623; Drucker P, 2013, J BIOL CHEM, V288, P24764, DOI 10.1074/jbc.M113.474023; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fisette O, 2016, J AM CHEM SOC, V138, P11526, DOI 10.1021/jacs.6b07005; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GERKE V, 1985, J BIOL CHEM, V260, P1688; Gerke V, 2016, BIOL CHEM, V397, P995, DOI 10.1515/hsz-2016-0207; GLENNEY J, 1986, J BIOL CHEM, V261, P7247; GLENNEY JR, 1987, J CELL BIOL, V104, P503, DOI 10.1083/jcb.104.3.503; Graber ZT, 2017, PHYS CHEM CHEM PHYS, V19, P15285, DOI 10.1039/c7cp00718c; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JOHNSSON N, 1986, FEBS LETT, V198, P361, DOI 10.1016/0014-5793(86)80437-9; Jost M, 1997, J CELL SCI, V110, P221; JOST M, 1994, BIOCHEM J, V298, P553, DOI 10.1042/bj2980553; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koerdt SN, 2017, BBA-MOL CELL RES, V1864, P1046, DOI 10.1016/j.bbamcr.2016.12.007; Kucerka N, 2017, LANGMUIR, V33, P3134, DOI 10.1021/acs.langmuir.6b03228; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Magarkar A, 2017, J PHYS CHEM LETT, V8, P518, DOI 10.1021/acs.jpclett.6b02818; MEERS P, 1990, BIOCHEMISTRY-US, V29, P3325, DOI 10.1021/bi00465a025; Melcrova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38035; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Merzel F, 2006, J COMPUT CHEM, V27, P446, DOI 10.1002/jcc.20340; Miyagi A, 2016, NAT NANOTECHNOL, V11, P783, DOI [10.1038/nnano.2016.89, 10.1038/NNANO.2016.89]; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; PIGAULT C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P106, DOI 10.1016/0167-4838(90)90108-R; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Roberts VA, 2013, J COMPUT CHEM, V34, P1743, DOI 10.1002/jcc.23304; Rosengarth A., 2004, ANNEXINS, V1, P129; Shesham RD, 2008, PROTEIN ENG DES SEL, V21, P115, DOI 10.1093/protein/gzm094; Simpkins B, 2014, PROTEINS, V82, P3327, DOI 10.1002/prot.24684; Singharoy A, 2016, J AM CHEM SOC, V138, P12077, DOI 10.1021/jacs.6b01193; SOPKOVA J, 1994, BIOCHEMISTRY-US, V33, P4490, DOI 10.1021/bi00181a008; Sopkova J, 1998, BIOCHEMISTRY-US, V37, P11962, DOI 10.1021/bi980773o; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; THIEL C, 1992, J CELL SCI, V103, P733; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; ZOKAS L, 1987, J CELL BIOL, V105, P2111, DOI 10.1083/jcb.105.5.2111	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185440	10.1371/journal.pone.0185440	http://dx.doi.org/10.1371/journal.pone.0185440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937994	Green Submitted, Green Published, gold			2022-12-26	WOS:000411524700035
J	Ohno, T; Yamamoto, G; Hayashi, J; Nishida, E; Goto, H; Sasaki, Y; Kikuchi, T; Fukuda, M; Hasegawa, Y; Mogi, M; Mitani, A				Ohno, Tasuku; Yamamoto, Genta; Hayashi, Jun-ichiro; Nishida, Eisaku; Goto, Hisashi; Sasaki, Yasuyuki; Kikuchi, Takeshi; Fukuda, Mitsuo; Hasegawa, Yoshiaki; Mogi, Makio; Mitani, Akio			Angiopoietin-like protein 2 regulates Porphyromonas gingivalis lipopolysaccharide-induced inflammatory response in human gingival epithelial cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; PERIODONTAL-DISEASE; CREVICULAR FLUID; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; FACTOR-ALPHA; EXPRESSION; ASSOCIATION; ANGPTL2; RISK	Angiopoietin-like protein 2 (ANGPTL2) maintains tissue homeostasis by inducing inflammation and angiogenesis. It is produced in infiltrating immune cells or resident cells, such as adipocytes, vascular endothelial cells, and tumor cells. We hypothesized that ANGPTL2 might play an important role as a unique mediator in both systemic and periodontal disease. We demonstrated an increased ANGPTL2 concentration in gingival crevicular fluid from chronic periodontitis patients. Porphyromonas gingivalis lipopolysaccharide (LPS) treatment strongly induced ANGPTL2 mRNA and protein levels in Ca9-22 human gingival epithelial cells. Recombinant human ANGPTL2 increased interleukin 1 beta (IL-1 beta), IL-8, and tumor necrosis factor-a (TNF-alpha) mRNA and protein levels in Ca9-22 cells. Small-interfering (si) RNA-mediated ANGPTL2 knockdown in Ca9-22 cells reduced IL-1 beta, IL-8 and TNF-a mRNA and protein levels compared with control siRNA (p<0.01) in P. gingivalis LPS-stimulated Ca9-22 cells. Antibodies against integrin alpha 5 beta 1, an ANGPTL receptor, blocked induction of these inflammatory cytokines in P. gingivalis LPS-treated Ca9-22 cells, suggesting that secreted ANGPTL induces inflammatory cytokines in gingival epithelial cells via an autocrine loop. The classic sequential cascade of P. gingivalis LPS! inflammatory cytokine induction is well established. However, in the current study, we reveal a novel cascade comprising sequential P. gingivalis LPS! ANGPTL2! integrin alpha 5 beta inflammatory cytokine induction, which might be responsible for inducing potent periodontal disorganization activity in gingival epithelial cells. Via this pathway, ANGPTL2 functions in the pathogenesis of periodontitis and contributes to prolonging chronic inflammation in patients with systemic disease.	[Ohno, Tasuku; Yamamoto, Genta; Hayashi, Jun-ichiro; Nishida, Eisaku; Goto, Hisashi; Sasaki, Yasuyuki; Kikuchi, Takeshi; Fukuda, Mitsuo; Mitani, Akio] Aichi Gakuin Univ, Dept Periodontol, Sch Dent, Chikusa Ku, Nagoya, Aichi, Japan; [Hasegawa, Yoshiaki] Aichi Gakuin Univ, Dept Microbiol, Sch Dent, Chikusa Ku, Nagoya, Aichi, Japan; [Mogi, Makio] Aichi Gakuin Univ, Dept Integrat Educ Pharm, Sch Pharm, Chikusa Ku, Nagoya, Aichi, Japan	Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University	Yamamoto, G (corresponding author), Aichi Gakuin Univ, Dept Periodontol, Sch Dent, Chikusa Ku, Nagoya, Aichi, Japan.	genta@dpc.agu.ac.jp		Kikuchi, Takeshi/0000-0003-0310-5302; OHNO, TASUKU/0000-0003-4718-5340	Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan) [24593134, 16K11571]; Grants-in-Aid for Scientific Research [26463149] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan) grant no. 24593134 (A.M.) grant no. 16K11571 (M.M.) https://www.jsps.go.jp/j-grantsinaid/.; This work was supported by a Grant-in-Aid for Scientific Research (C) (grant no. 24593134 and 16K11571) from the Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan). The authors report no conflicts of interest related to this study.	Arbes SJ, 1999, J DENT RES, V78, P1777, DOI 10.1177/00220345990780120301; Armitage GC, 2004, PERIODONTOL 2000, V34, P109, DOI 10.1046/j.0906-6713.2002.003427.x; Champagne CME, 2003, PERIODONTOL 2000, V31, P167, DOI 10.1034/j.1600-0757.2003.03110.x; Chapple ILC, 2013, J CLIN PERIODONTOL, V40, pS106, DOI [10.1111/jcpe.12077, 10.1902/jop.2013.1340011]; Chaves ES, 2000, J CLIN PERIODONTOL, V27, P897, DOI 10.1034/j.1600-051x.2000.027012897.x; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Deng M, 2014, BLOOD, V124, P924, DOI 10.1182/blood-2014-01-549162; Dutzan N, 2009, J CLIN PERIODONTOL, V36, P396, DOI 10.1111/j.1600-051X.2009.01390.x; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Erdemir Ebru Olgun, 2008, Eur J Dent, V2, P102; Fujimura T, 2014, LASER MED SCI, V29, P987, DOI 10.1007/s10103-013-1439-6; Goto H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140942; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; GRENIER D, 1995, ORAL MICROBIOL IMMUN, V10, P319, DOI 10.1111/j.1399-302X.1995.tb00161.x; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Iwata T, 2005, CLIN EXP IMMUNOL, V141, P261, DOI 10.1111/j.1365-2249.2005.02836.x; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kanda A, 2012, LAB INVEST, V92, P1553, DOI 10.1038/labinvest.2012.111; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Knight ET, 2016, PERIODONTOL 2000, V71, P22, DOI 10.1111/prd.12110; Kubota Y, 2005, P NATL ACAD SCI USA, V102, P13502, DOI 10.1073/pnas.0501902102; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Mitani A, 2015, J PERIODONTOL, V86, P301, DOI 10.1902/jop.2014.140293; Mogi M, 1999, ARCH ORAL BIOL, V44, P535, DOI 10.1016/S0003-9969(99)00020-5; Mogi M, 2004, J DENT RES, V83, P166, DOI 10.1177/154405910408300216; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Sato R, 2015, ONCOL REP, V33, P58, DOI 10.3892/or.2014.3586; Singhal S, 2016, J ORAL SCI, V58, P547, DOI 10.2334/josnusd.16-0017; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Uehara A, 2002, J MED MICROBIOL, V51, P626, DOI 10.1099/0022-1317-51-8-626; Umikawa M, 2015, BIOCHEM BIOPH RES CO, V467, P235, DOI 10.1016/j.bbrc.2015.09.183	41	20	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184825	10.1371/journal.pone.0184825	http://dx.doi.org/10.1371/journal.pone.0184825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934245	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900048
J	Saghapour, E; Kermani, S; Sehhati, M				Saghapour, Ehsan; Kermani, Saeed; Sehhati, Mohammadreza			A novel feature ranking method for prediction of cancer stages using proteomics data	PLOS ONE			English	Article							MULTI-LABEL CLASSIFIER; FEATURE-SELECTION; PROGNOSTIC-FACTOR; PROTEINS; IDENTIFICATION; EXPRESSION; SITES; ATTRIBUTES; RECURRENCE; DIAGNOSIS	Proteomic analysis of cancers' stages has provided new opportunities for the development of novel, highly sensitive diagnostic tools which helps early detection of cancer. This paper introduces a new feature ranking approach called FRMT. FRMT is based on the Technique for Order of Preference by Similarity to Ideal Solution method (TOPSIS) which select the most discriminative proteins from proteomics data for cancer staging. In this approach, outcomes of 10 feature selection techniques were combined by TOPSIS method, to select the final discriminative proteins from seven different proteomic databases of protein expression profiles. In the proposed workflow, feature selection methods and protein expressions have been considered as criteria and alternatives in TOPSIS, respectively. The proposed method is tested on seven various classifier models in a 10-fold cross validation procedure that repeated 30 times on the seven cancer datasets. The obtained results proved the higher stability and superior classification performance of method in comparison with other methods, and it is less sensitive to the applied classifier. Moreover, the final introduced proteins are informative and have the potential for application in the real medical practice.	[Saghapour, Ehsan; Kermani, Saeed; Sehhati, Mohammadreza] Isfahan Univ Med Sci, Sch Adv Technol Med, Dept Biomed Engn, Esfahan, Iran	Isfahan University Medical Science	Kermani, S (corresponding author), Isfahan Univ Med Sci, Sch Adv Technol Med, Dept Biomed Engn, Esfahan, Iran.	kermani@med.mui.ac.ir	Sehhati, Mohammadreza/U-6753-2017; Kermani, Saeed/V-3925-2017	Sehhati, Mohammadreza/0000-0002-7316-5645; Kermani, Saeed/0000-0003-3339-9532	Isfahan University of Medical Sciences, Isfahan, Iran [395775]	Isfahan University of Medical Sciences, Isfahan, Iran	This research was financially supported by the Isfahan University of Medical Sciences, Isfahan, Iran (Grant no.395775).r This research was financially supported by the Isfahan University of Medical Sciences, Isfahan, Iran (Grant no.395775). The authors would like to acknowledge the products and services provided by Isfahan University of Medical Sciences. The results published here are in whole or part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/; for this reason, the authors would like to greatly acknowledge the TCGA Research Network. Also, we wish to acknowledge MS Solutions LLC members for supplying us with editing, proofreading, and high-quality research publication support services.	ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Azodi MZ, 2012, J PARAMEDICAL SCI, V4; Behbahani M, 2016, J THEOR BIOL, V411, P1, DOI 10.1016/j.jtbi.2016.09.001; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown G, 2012, J MACH LEARN RES, V13, P27; Cai YD, 2005, J THEOR BIOL, V234, P145, DOI 10.1016/j.jtbi.2004.11.017; Chen XX, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1654623; Cheng X, 2017, ONCOTARGET; Cheng X, 2017, BIOINFORMATICS, V33, P341, DOI 10.1093/bioinformatics/btw644; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Ding CB, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-015-0280-0; Ding CB, 2015, INT J CLIN EXP PATHO, V8, P2779; Ding H, 2016, VIROL SIN, V31, P350, DOI 10.1007/s12250-016-3740-6; Ding H, 2016, COMPUT BIOL MED, V71, P156, DOI 10.1016/j.compbiomed.2016.02.012; Ding H, 2015, AMINO ACIDS, V47, P329, DOI 10.1007/s00726-014-1862-4; Ding H, 2014, INTERDISCIP SCI, V6, P235, DOI 10.1007/s12539-013-0205-6; Ding H, 2014, MOL BIOSYST, V10, P2229, DOI 10.1039/c4mb00316k; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Duckworth C, 2015, ONCOGENE; Duda R.O., 2000, PATTERN CLASSIFICATI; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Fleuren EDG, 2010, INT J CANCER, V127, P1486, DOI 10.1002/ijc.25172; Garcia-Carracedo D, 2016, ONCOTARGET, V7, P29780, DOI 10.18632/oncotarget.8957; Han J, 2012, MOR KAUF D, P1; Hanash S, 2010, NAT REV CANCER, V10, P652, DOI 10.1038/nrc2918; Hanyuda A, 2016, ANN SURG ONCOL, V23, P908, DOI 10.1245/s10434-015-4967-4; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Ho TK, 1995, P 3 INT C DOC AN REC; Honda K, 2012, JAPANESE J CLIN ONCO; Jia JH, 2016, ONCOTARGET, V7, P34558, DOI 10.18632/oncotarget.9148; Jia JH, 2016, J THEOR BIOL, V394, P223, DOI 10.1016/j.jtbi.2016.01.020; Kaddi C, 2015, MODELS PREDICTING ST; Karnik NN, 1999, IEEE T FUZZY SYST, V7, P643, DOI 10.1109/91.811231; Khatib H, 2013, IRAN J CANCER PREV, V6, P30; Klir G.J., 1995, FUZZY SETS FUZZY LOG, DOI 10.1109/9780470544341.ch11; Lai HY, 2017, ONCOTARGET, V8, P28169, DOI 10.18632/oncotarget.15963; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019; Lin H, 2012, J BIOMOL STRUCT DYN, V29, P643, DOI 10.1080/07391102.2011.672628; Lin H, 2011, THEOR BIOSCI, V130, P91, DOI 10.1007/s12064-010-0114-8; Lin H, 2010, MOL DIVERS, V14, P667, DOI 10.1007/s11030-009-9205-1; Lin H, 2011, J MICROBIOL METH, V84, P67, DOI 10.1016/j.mimet.2010.10.013; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu L, 2017, MED CHEM SHARIQAH UN; Lu J-W, 2016, CANC METASTASIS; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mazumder A, 2008, EXPERT REV MOL DIAGN, V8, P125, DOI 10.1586/14737159.8.2.125; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Meher PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep42362; Nanni L, 2016, PATTERN RECOGN LETT, V84, P259, DOI 10.1016/j.patrec.2016.10.010; Nanni L, 2014, J THEOR BIOL, V360, P109, DOI 10.1016/j.jtbi.2014.07.003; Pelletier F.J., 2020, B SYMB LOG, V63, P342, DOI [10.28933/rjcms-2018-04-0501, DOI 10.28933/RJCMS-2018-04-0501]; Poincloux L, 2009, SURG ONCOL, V18, P357, DOI 10.1016/j.suronc.2008.09.003; Qiu W.R., 2017, ONCOTARGET; Qiu WR, 2016, BIOINFORMATICS, V32, P3116, DOI 10.1093/bioinformatics/btw380; QUINLAN JR, 1987, INT J MAN MACH STUD, V27, P221, DOI 10.1016/S0020-7373(87)80053-6; Rezaie-Tavirani M, 2013, GASTROENTEROLOGY HEP, V6; Saghapour E, 2017, J THEORETICAL BIOL; Scholkopft B., 1999, NEURAL NETW SIGNAL P, V1, P1; Sehhati M, 2015, IEEE ACM T COMPUT BI, V12, P1440, DOI 10.1109/TCBB.2015.2407407; Sonntag J., 2014, TRANSL PROTEOMICS, V2, P52, DOI DOI 10.1016/j.trprot.2014.02.001; Stafford P, 2014, P NATL ACAD SCI USA, V111, pE3072, DOI 10.1073/pnas.1409432111; Tang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30529; Tang H, 2016, BIOCHEM BIOPH RES CO, V477, P150, DOI 10.1016/j.bbrc.2016.06.035; Nguyen T, 2016, IEEE T FUZZY SYST, V24, P273, DOI 10.1109/TFUZZ.2015.2453153; Nguyen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120364; Tripathi P, 2017, J THEOR BIOL, V424, P49, DOI 10.1016/j.jtbi.2017.04.027; Tzeng GH, 2011, MULTIPLE ATTRIBUTE DECISION MAKING: METHODS AND APPLICATIONS, P1; Wei LY, 2019, IEEE ACM T COMPUT BI, V16, P1264, DOI 10.1109/TCBB.2017.2670558; Xiao X, 2013, ANAL BIOCHEM, V436, P168, DOI 10.1016/j.ab.2013.01.019; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xiao X, 2009, J APPL CRYSTALLOGR, V42, P169, DOI 10.1107/S0021889809002751; Xu Y, 2017, MED CHEM SHARIQAH UN; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105018; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yang H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5413903; Yuan LF, 2013, TOXICOL IN VITRO, V27, P852, DOI 10.1016/j.tiv.2012.12.024; Zali H, 2011, GASTROENTEROLOGY HEP, V4; Zhang P., 2015, J SENSORS, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0133137; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890	90	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184203	10.1371/journal.pone.0184203	http://dx.doi.org/10.1371/journal.pone.0184203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934234	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900023
J	Reis, ZSN; Vitral, GLN; de Souza, IMF; Rego, MAS; Guimaraes, RN				Nogueira Reis, Zilma Silveira; Nogueira Vitral, Gabriela Luiza; Fonseca de Souza, Ingrid Michelle; Santiago Rego, Maria Albertina; Guimaraes, Rodney Nascimento			Newborn skin reflection: Proof of concept for a new approach for predicting gestational age at birth. A cross-sectional study	PLOS ONE			English	Article							FETAL SKIN; THICKNESS; INFANTS; NM	Background Current methods to assess the gestational age during prenatal care or at birth are a global challenge. Disadvantages, such as low accessibility, high costs, and imprecision of clinical tests and ultrasonography measurements, may compromise health decisions at birth, based on the gestational age. Newborns' organs and tissues can indirectly indicate their physical maturity, and we hypothesized that evolutionary changes in their skin, detected using an optoelectronic device meter, may aid in estimating the gestational age. This study analyzed the feasibility of using newborn skin reflectance to estimate the gestational age at birth noninvasively. Methods and findings A cross-sectional study evaluated the skin reflectance of selected infants, preferably premature, at birth. The first-trimester ultrasound was the reference for gestational age. A prototype of a new noninvasive optoelectronic device measured the backscattering of light from the skin, using a light emitting diode at wavelengths of 470 nm, 575 nm, and 630 nm. Univariate and multivariate regression analysis models were employed to predict gestational age, combining skin reflectance with clinical variables for gestational age estimation. The gestational age at birth of 115 newborns from 24.1 to 41.8 weeks of gestation correlated with the light at 630 nm wavelength reflectance 3.3 mm/6.5 mm ratio distant of the sensor, at the forearm and sole (Pearson's correlation = 0.505, P < 0.001 and 0.710, P < 0.001, respectively). The best-combined variables to predict the gold standard gestational age at birth was the skin reflectance at wavelengths of 630 nm and 470 nm in combination with birth weight, phototherapy, and adjusted to include incubator stay, and sex (R-2 = 0.828, P < 0.001). The main limitation of the study is that it was very specific to the premature population we studied and needs to be studied in a broader spectrum of newborns. Conclusions A novel automated skin reflectometer device, in combination with clinical variables, was able to predict the gestational age and could be useful when the information is in doubt or is unknown. Multivariable predictive models associated the skin reflectance with easy to obtain clinical parameters, at the birth scenario. External validation needs to be proven in an actual population with the real incidence of premature infants.	[Nogueira Reis, Zilma Silveira; Fonseca de Souza, Ingrid Michelle] Univ Fed Minas Gerais, Fac Med, Ctr Hlth Informat, Belo Horizonte, MG, Brazil; [Nogueira Reis, Zilma Silveira; Nogueira Vitral, Gabriela Luiza; Guimaraes, Rodney Nascimento] Univ Fed Minas Gerais, Fac Med, Postgrad Program Womens Hlth, Belo Horizonte, MG, Brazil; [Nogueira Reis, Zilma Silveira] Univ Fed Minas Gerais, Fac Med, Dept Gynecol & Obstet, Belo Horizonte, MG, Brazil; [Santiago Rego, Maria Albertina] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Nogueira Reis, Zilma Silveira; Nogueira Vitral, Gabriela Luiza; Fonseca de Souza, Ingrid Michelle; Santiago Rego, Maria Albertina; Guimaraes, Rodney Nascimento] Univ Fed Minas Gerais, Fac Med, Ave Prof Alfredo Balena, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Ctr Hlth Informat, Belo Horizonte, MG, Brazil.; Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Postgrad Program Womens Hlth, Belo Horizonte, MG, Brazil.; Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Gynecol & Obstet, Belo Horizonte, MG, Brazil.; Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Ave Prof Alfredo Balena, Belo Horizonte, MG, Brazil.	zilma@medicina.ufmg.br	Reis, Zilma/H-8105-2013	Reis, Zilma/0000-0001-6374-9295	Bill & Melinda Gates Foundation [OPP1128907]; Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1128907] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative	This research was supported by the Grand Challenges Exploration from the Bill & Melinda Gates Foundation (Grant number OPP1128907, Contract), http://www.gatesfoundation.org/, and Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil, http://www.fapemig.br/en/. Revision in manuscript written in English was supported by Pro-Reitoria de Pesquisa of Universidade Federal de Minas Gerais, Brazil PRPq Call number 02/2017, http://www.ufmg.br/prpq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Beydoun H, 2011, REPROD BIOMED ONLINE, V22, P321, DOI 10.1016/j.rbmo.2010.12.003; Coolen NA, 2010, ARCH DERMATOL RES, V302, P47, DOI 10.1007/s00403-009-0989-8; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Ersch J, 1999, OBSTET GYNECOL, V94, P753, DOI 10.1016/S0029-7844(99)00379-8; Fenton TR, 2013, BMC PEDIATR, V13, P1, DOI DOI 10.1186/1471-2431-13-1; FRIEHE CA, 1975, J OPT SOC AM, V65, P1502, DOI 10.1364/JOSA.65.001502; HALL MH, 1985, BRIT J OBSTET GYNAEC, V92, P445, DOI 10.1111/j.1471-0528.1985.tb01347.x; Hardman MJ, 1999, J INVEST DERMATOL, V113, P1106, DOI 10.1046/j.1523-1747.1999.00800.x; Ho DS, 2007, J KOREAN PHYS SOC, V51, P1663, DOI 10.3938/jkps.51.1663; Karl S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124286; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lister T., 2012, J BIOMEDICAL OPTICS, V17; LYNN CJ, 1993, BIOL NEONATE, V64, P69; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; MOLL I, 1986, J INVEST DERMATOL, V87, P779, DOI 10.1111/1523-1747.ep12458993; Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60; POST PW, 1976, HUM BIOL, V48, P541; Reis ZSN, 2016, INVENTORSDISPOSITIVO; Robertson K, 2010, ACTA DERM-VENEREOL, V90, P368, DOI 10.2340/00015555-0875; SAIDI IS, 1995, APPL OPTICS, V34, P7410, DOI 10.1364/AO.34.007410; Telofski LS, 2012, DERMATOLOGY RES PRAC, V2012; Wingate MS, 2007, ANN EPIDEMIOL, V17, P425, DOI 10.1016/j.annepidem.2007.01.035; Yudovsky D, 2010, APPL OPTICS, V49, P1707, DOI 10.1364/AO.49.001707; 2003, INT J GYNAECOL OBSTE, V82, P127	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184734	10.1371/journal.pone.0184734	http://dx.doi.org/10.1371/journal.pone.0184734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931040	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700031
J	Rao, MV; Williams, DR; Cocklin, S; Loll, PJ				Rao, Maya V.; Williams, Dewight R.; Cocklin, Simon; Loll, Patrick J.			Interaction between the AAA(+) ATPase p97 and its cofactor ataxin3 in health and disease: Nucleotide-induced conformational changes regulate cofactor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); conformational change; electron microscopy (EM); proteostasis; surface plasmon resonance (SPR); ataxin3; cofactor binding; multisystem proteinopathy 1 (MSP1); nucleotide regulation; p97; VCP	MACHADO-JOSEPH-DISEASE; VALOSIN-CONTAINING PROTEIN; CRYO-EM STRUCTURE; ENDOPLASMIC-RETICULUM STRESS; STRUCTURAL BASIS; PAGET-DISEASE; MOUSE MODEL; POLYGLUTAMINE DISEASE; UBIQUITIN CHAINS; VCP/P97	p97 is an essential ATPase associated with various cellular activities (AAA(+)) that functions as a segregase in diverse cellular processes, including the maintenance of proteostasis. p97 interacts with different cofactors that target it to distinct pathways; an important example is the deubiquitinase ataxin3, which collaborates with p97 in endoplasmic reticulum-associated degradation. However, the molecular details of this interaction have been unclear. Here, we characterized the binding of ataxin3 to p97, showing that ataxin3 binds with low-micromolar affinity to both wild-type p97 and mutants linked to degenerative disorders known as multisystem proteinopathy 1 (MSP1); we further showed that the stoichiometry of binding is one ataxin3 molecule per p97 hexamer. We mapped the binding determinants on each protein, demonstrating that ataxin3's p97/VCP-binding motif interacts with the inter-lobe cleft in the N-domain of p97. We also probed the nucleotide dependence of this interaction, confirming that ataxin3 and p97 associate in the presence of ATP and in the absence of nucleotide, but not in the presence of ADP. Our experiments suggest that an ADP-driven downward movement of the p97 N-terminal domain dislodges ataxin3 by inducing a steric clash between the D1-domain and ataxin3's C terminus. In contrast, MSP1 mutants of p97 bind ataxin3 irrespective of their nucleotide state, indicating a failure by these mutants to translate ADP binding into a movement of the N-terminal domain. Our model provides a mechanistic explanation for how nucleotides regulate the p97-ataxin3 interaction and why atypical cofactor binding is observed with MSP1 mutants.	[Rao, Maya V.; Cocklin, Simon; Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 North 15th St, Philadelphia, PA 19102 USA; [Williams, Dewight R.] Arizona State Univ, LeRoy Eyring Ctr Solid State Sci, Tempe, AZ 85287 USA	Drexel University; Arizona State University; Arizona State University-Tempe	Loll, PJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 North 15th St, Philadelphia, PA 19102 USA.	pjl28@drexel.edu			National Institutes of Health [R01 NS065140]; NCI Cancer Center Support Grant [P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant R01 NS065140. Research in this publication includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility at Thomas Jefferson University, which is supported in part by NCI Cancer Center Support Grant P30 CA56036. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann L, 2016, NAT STRUCT MOL BIOL, V23, P995, DOI 10.1038/nsmb.3296; Almeida B, 2015, BBA-MOL BASIS DIS, V1852, P1950, DOI 10.1016/j.bbadis.2015.06.010; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Boy J, 2010, NEUROBIOL DIS, V37, P284, DOI 10.1016/j.nbd.2009.08.002; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buchberger A, 2015, FEBS LETT, V589, P2578, DOI 10.1016/j.febslet.2015.08.028; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Bulfer SL, 2016, ACS CHEM BIOL, V11, P2112, DOI 10.1021/acschembio.6b00350; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Dargemont C, 2012, BBA-MOL CELL RES, V1823, P138, DOI 10.1016/j.bbamcr.2011.07.011; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Erzurumlu Y, 2013, INT J BIOCHEM CELL B, V45, P773, DOI 10.1016/j.biocel.2013.01.006; Ewens CA, 2010, BIOCHEM CELL BIOL, V88, P41, DOI [10.1139/O09-128, 10.1139/o09-128]; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Franz A, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00073; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Hanzelmann P, 2016, STRUCTURE, V24, P140, DOI 10.1016/j.str.2015.10.027; Hanzelmann P, 2016, STRUCTURE, V24, P127, DOI 10.1016/j.str.2015.10.026; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hubener J, 2011, BRAIN, V134, P1925, DOI 10.1093/brain/awr118; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim SJ, 2014, J BIOL CHEM, V289, P12264, DOI 10.1074/jbc.M113.523936; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kuhlbrodt K, 2011, NAT CELL BIOL, V13, P273, DOI 10.1038/ncb2200; Li XL, 2015, PROG NEUROBIOL, V132, P34, DOI 10.1016/j.pneurobio.2015.06.004; Liebl MP, 2016, AM J PHYSIOL-CELL PH, V311, pC166, DOI 10.1152/ajpcell.00074.2016; Lim JJ, 2016, BIOCHEM J, V473, P2863, DOI 10.1042/BCJ20160237; Liu S, 2013, BBA-PROTEINS PROTEOM, V1834, P2672, DOI 10.1016/j.bbapap.2013.09.021; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Locatelli-Hoops SC, 2013, BBA-PROTEINS PROTEOM, V1834, P2045, DOI 10.1016/j.bbapap.2013.06.003; Locke M, 2014, BIOCHEM J, V459, P205, DOI 10.1042/BJ20120662; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macedo-Ribeiro S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005834; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Molday LL, 2014, METHODS MOL BIOL, V1177, P1, DOI 10.1007/978-1-4939-1034-2_1; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Nishikori S, 2008, GENES CELLS, V13, P827, DOI 10.1111/j.1365-2443.2008.01214.x; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Onofre I, 2016, SCI REP-UK, V6, DOI 10.1038/srep28220; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Ramani B, 2015, HUM MOL GENET, V24, P1211, DOI 10.1093/hmg/ddu532; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigues AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018512; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Song C, 2007, BIOCHEMISTRY-US, V46, P14889, DOI 10.1021/bi700499j; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Sutton JR, 2017, HUM MOL GENET, V26, P1419, DOI 10.1093/hmg/ddx039; Tang WK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00079; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tang WK, 2012, J STRUCT BIOL, V179, P83, DOI 10.1016/j.jsb.2012.04.024; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsou WL, 2015, NEUROBIOL DIS, V82, P12, DOI 10.1016/j.nbd.2015.05.010; van den Boom J, 2016, MOL CELL, V64, P189, DOI 10.1016/j.molcel.2016.08.037; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Weeks SD, 2011, J BIOL CHEM, V286, P4555, DOI 10.1074/jbc.M110.177360; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C., 2011, MUSCLE AGING INCLUSI, P206; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06410; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang XH, 2015, PROCEEDINGS OF THE 2015 IEEE INTERNATIONAL CONFERENCE ON NETWORKING, ARCHITECTURE AND STORAGE (NAS), P112, DOI 10.1109/NAS.2015.7255213; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	103	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18392	18407		10.1074/jbc.M117.806281	http://dx.doi.org/10.1074/jbc.M117.806281			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939772	hybrid, Green Published			2022-12-26	WOS:000414958100002
J	Freedman, S; Nikpay, S; Carroll, A; Simon, K				Freedman, Seth; Nikpay, Sayeh; Carroll, Aaron; Simon, Kosali			Changes in inpatient payer-mix and hospitalizations following Medicaid expansion: Evidence from all-capture hospital discharge data	PLOS ONE			English	Article							COVERAGE	Context The Affordable Care Act resulted in unprecedented reductions in the uninsured population through subsidized private insurance and an expansion of Medicaid. Early estimates from the beginning of 2014 showed that the Medicaid expansion decreased uninsured discharges and increased Medicaid discharges with no change in total discharges. Objective To provide new estimates of the effect of the ACA on discharges for specific conditions. Design, setting, and participants We compared outcomes between states that did and did not expand Medicaid using statelevel all-capture discharge data from 2009-2014 for 42 states from the Healthcare Costs and Utilization Project's FastStats database; for a subset of states we used data through 2015. We stratified the analysis by baseline uninsured rates and used difference-in-differences and synthetic control methods to select comparison states with similar baseline characteristics that did not expand Medicaid. Main outcome Our main outcomes were total and condition-specific hospital discharges per 1,000 population and the share of total discharges by payer. Conditions reported separately in FastStats included maternal, surgical, mental health, injury, and diabetes. Results The share of uninsured discharges fell in Medicaid expansion states with below (-4.39 percentage points (p. p.), -6.04--2.73) or above (-7.66 p. p., -9.07--6.24) median baseline uninsured rates. The share of Medicaid discharges increased in both small (6.42 p. p. 4.22-6.62) and large (10.5 p. p., 8.48-12.5) expansion states. Total and most condition-specific discharges per 1,000 residents did not change in Medicaid expansion states with high or low baseline uninsured rates relative to non-expansion states (0.418, p = 0.225), with one exception: diabetes. Discharges for that condition per 1,000 fell in states with high baseline uninsured rates relative to non-expansion states (-0.038 95% p = 0.027). Conclusions Early changes in payer mix identified in the first two quarters of 2014 continued through the Medicaid expansion's first year and are distributed across all condition types studied. We found no change in total discharges between Medicaid expansion and non-expansion states, however residents of states that should have been most affected by the Medicaid expansion were less likely to be hospitalized for diabetes.	[Freedman, Seth; Simon, Kosali] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Nikpay, Sayeh] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA; [Carroll, Aaron] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Vanderbilt University; Indiana University System; Indiana University-Purdue University Indianapolis	Simon, K (corresponding author), Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.	simonkos@indiana.edu						Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Agency for Healthcare Research and Quality, 2017, HLTH COST UT PROJ FA, V7; Cameron A.C., 2013, J HUM RESOU IN PRESS, P221; Casagrande SS, 2012, DIABETES CARE, V35, P2243, DOI 10.2337/dc12-0257; Center for Medicare and Medicaid Services, 2016, ACT REP FIN OUTL MED; Fisher RA, 1935, DESIGN EXPT; Frean M, 2016, PREMIUM SUBSIDIES MA; Ghosh A, 2017, EFFECT STATE MEDICAI; Hempstead K, 2016, NEW ENGL J MED, V374, P196, DOI 10.1056/NEJMc1507366; Hu L., 2016, EFFECT PATIENT PROTE; Kaestner R., 2015, EFFECTS ACA MEDICAID; Kaiser Family Foundation, 2017, STAT STAT ACT MED EX, V1, P1; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Muhlstein D, 2016, 2016 PRIVATE PUBLIC; Myerson R, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0712-z; Nikpay S, 2016, HEALTH AFFAIR, V35, P106, DOI 10.1377/hlthaff.2015.1144; Wherry LR, 2016, ANN INTERN MED, V164, P795, DOI 10.7326/M15-2234	17	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0183616	10.1371/journal.pone.0183616	http://dx.doi.org/10.1371/journal.pone.0183616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957347	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200010
J	Eseberri, I; Lasa, A; Miranda, J; Gracia, A; Portillo, MP				Eseberri, Itziar; Lasa, Arrate; Miranda, Jonatan; Gracia, Ana; Portillo, Maria P.			Potential miRNA involvement in the anti-adipogenic effect of resveratrol and its metabolites	PLOS ONE			English	Article							3T3-L1 PREADIPOCYTE DIFFERENTIATION; ACTIVATED-RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; INHIBITS ADIPOGENESIS; TRANSCRIPTIONAL CONTROL; REGULATED EXPRESSION; ADIPOSE-TISSUE; MICRORNAS; GENE	Objective Scientific research is constantly striving to find molecules which are effective against excessive body fat and its associated complications. Taking into account the beneficial effects that resveratrol exerts on other pathologies through miRNA, the aim of the present work was to analyze the possible involvement of miRNAs in the regulation of adipogenic transcription factors peroxisome proliferator-activated receptor y (ppar gamma), CCAAT enhancer-binding proteins a and beta (cebp beta and cebpa) induced by resveratrol and its metabolites. Methods 3T3-L1 maturing pre-adipocytes were treated during differentiation with 25 mu M of trans-resveratrol (RSV), trans-resveratrol-3-O-sulfate (3S), trans-resveratrol-3'-O-glucuronide (3G) and trans-resveratrol-4'-O-glucuronide (4G). After computational prediction and bibliographic search of miRNAs targeting ppar gamma, cebp beta and cebpa, the expression of microRNA-130b-3p (miR-130b-3p), microRNA-155-5p (miR-155-5p), microRNA-27b-3p (miR-27b-3p), microRNA-31-5p (miR-31-5p), microRNA-326-3p (miR-326-3p), microRNA-27a-3p (miR27a-3p), microRNA-144-3p (miR-144-3p), microRNA-205-5p (miR-205-5p) and microRNA224-3p (miR-224-3p) was analyzed. Moreover, other adipogenic mediators such as sterol regulatory element binding transcription factor 1 (srebfl), kriippel-like factor 5 (k1f5), liver x receptor a (lxra) and cAMP responding element binding protein 1 (crebl), were measured by Real Time RT-PCR. As a confirmatory assay, cells treated with RSV were transfected with anti-miR-155 in order to measure cebp beta gene and protein expressions. Results Of the miRNAs analyzed only miR-155 was modified after resveratrol and glucuronide metabolite treatment. In transfected cells with anti-miR-155, RSV did not reduce cebp beta gene and protein expression. 3S decreased gene expression of crebl, klf5, srebfl and lxra. Conclusions While RSV and glucuronide metabolites exert their inhibitory effect on adipogenesis through miR-155 up-regulation, the anti-adipogenic effect of 3S is not mediated via miRNAs.	[Eseberri, Itziar; Lasa, Arrate; Miranda, Jonatan; Gracia, Ana; Portillo, Maria P.] Univ Basque Country, UPV EHU, Dept Nutr & Food Sci, Nutr & Obes Grp, Vitoria, Spain; [Eseberri, Itziar; Lasa, Arrate; Miranda, Jonatan; Gracia, Ana; Portillo, Maria P.] Lucio Lascaray Res Ctr, Vitoria, Spain; [Eseberri, Itziar; Lasa, Arrate; Miranda, Jonatan; Gracia, Ana; Portillo, Maria P.] Inst Salud Carlos III, Ctr Invest Biomed Fisiopatol Obesidad & Nutr CIBE, Madrid, Spain	University of Basque Country; Instituto de Salud Carlos III	Lasa, A (corresponding author), Univ Basque Country, UPV EHU, Dept Nutr & Food Sci, Nutr & Obes Grp, Vitoria, Spain.; Lasa, A (corresponding author), Lucio Lascaray Res Ctr, Vitoria, Spain.; Lasa, A (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Fisiopatol Obesidad & Nutr CIBE, Madrid, Spain.	arrate.lasa@ehu.eus	Portillo, Maria Puy/ABH-2374-2020; Miranda, Jonatan/F-3289-2011; Eseberri, Itziar/ABE-7228-2020; Miranda, Jonatan/L-4511-2014; Eseberri, Itziar/AAA-8168-2021	Portillo, Maria Puy/0000-0003-0210-6549; Miranda, Jonatan/0000-0002-5484-2671; Eseberri, Itziar/0000-0001-5036-963X; LASA ELGUEZUA, ARRATE/0000-0002-8309-8212; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X	Ministerio de Economia y Competitividad [AGL2011-27406-ALI]; Institute de Salud Carlos III (CIBERObn), Government of the Basque Country [IT-572-13]; University of the Basque Country (UPV/EHU) [ELDUNANOTEK UFI11/32]; University of the Basque Country	Ministerio de Economia y Competitividad(Spanish Government); Institute de Salud Carlos III (CIBERObn), Government of the Basque Country; University of the Basque Country (UPV/EHU); University of the Basque Country	This study was supported by grants from the Ministerio de Economia y Competitividad (AGL2011-27406-ALI), Institute de Salud Carlos III (CIBERObn), Government of the Basque Country (IT-572-13) and University of the Basque Country (UPV/EHU) (ELDUNANOTEK UFI11/32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. I. Eseberri is a recipient of a doctoral fellowship from the University of the Basque Country.	Aguirre L, 2014, MOLECULES, V19, P18632, DOI 10.3390/molecules191118632; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andres-Lacueva C, 2009, PLANT PHENOLICS HUMA; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Azorin-Ortuno M, 2011, MOL NUTR FOOD RES, V55, P1154, DOI 10.1002/mnfr.201100140; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chan LS, 2012, HORM METAB RES, V44, P819, DOI 10.1055/s-0032-1321909; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Chen Z., 2015, SHOCK VIB, V2015, P1, DOI DOI 10.1155/2015/390134; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Dweep H, 2015, MIRWALK2 0 COMPREHEN; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Eseberri I, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/480943; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gan CC, 2017, EUR J PHARMACOL, V797, P45, DOI 10.1016/j.ejphar.2017.01.009; Gaudet AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22862; Hilton C, 2013, INT J OBESITY, V37, P325, DOI 10.1038/ijo.2012.59; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; Kawai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P609, DOI 10.1271/bbb.100785; Kim MA, 2014, LIFE SCI, V101, P64, DOI 10.1016/j.lfs.2014.02.012; Kim M, 2015, NUTRIENTS, V7, P277, DOI 10.3390/nu7010277; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lancon A, 2013, J SCI FOOD AGR, V93, P3155, DOI 10.1002/jsfa.6228; Lasa A, 2012, MOL NUTR FOOD RES, V56, P1559, DOI 10.1002/mnfr.201100772; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Lindroos J, 2013, CELL METAB, V18, P62, DOI 10.1016/j.cmet.2013.05.020; Liu LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01294-2; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CF, 2017, INT J MOL MED, V39, P231, DOI 10.3892/ijmm.2016.2802; Marques AP, 2017, BBA-GEN SUBJECTS, V1861, P673, DOI 10.1016/j.bbagen.2016.12.005; Martin PJ, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0057-5; Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pan SF, 2014, J CELL PHYSIOL, V229, P631, DOI 10.1002/jcp.24486; Pang WJ, 2013, J CELL BIOCHEM, V114, P2500, DOI 10.1002/jcb.24595; Peng YD, 2013, INT J BIOCHEM CELL B, V45, P1585, DOI 10.1016/j.biocel.2013.04.029; Phuah NH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/804510; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Rohm B, 2015, J CELL BIOCHEM, V116, P1153, DOI 10.1002/jcb.25052; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Son YH, 2014, ENDOCRINOL METAB, V29, P122, DOI 10.3803/EnM.2014.29.2.122; Sonkoly E, 2009, INT REV IMMUNOL, V28, P535, DOI 10.3109/08830180903208303; Stefanon B, 2015, EXP BIOL MED, V240, P884, DOI 10.1177/1535370214562341; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Tang YF, 2009, OMICS, V13, P331, DOI 10.1089/omi.2009.0017; Tao C, 2015, BIOCHEM BIOPH RES CO, V463, P193, DOI 10.1016/j.bbrc.2015.05.014; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang T, 2011, INT J MOL SCI, V12, P7950, DOI 10.3390/ijms12117950; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Yu JW, 2014, BIOTECHNOL LETT, V36, P1233, DOI 10.1007/s10529-014-1491-8; Zhang J, 2016, BIOMED PHARMACOTHER, V86, P292; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang T, 2014, ARCH BIOCHEM BIOPHYS, V554, P44, DOI 10.1016/j.abb.2014.05.008; Zhu JG, 2012, CELL BIOCHEM BIOPHYS, V63, P1, DOI 10.1007/s12013-012-9336-3; Zhu W, 2015, J NUTR BIOCHEM, V26, P1124, DOI 10.1016/j.jnutbio.2015.05.006; Zou B, 2015, EUR J NUTR, V54, P1333, DOI 10.1007/s00394-014-0814-9	77	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184875	10.1371/journal.pone.0184875	http://dx.doi.org/10.1371/journal.pone.0184875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953910	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300024
J	Ko, BJ; Chang, Y; Ryu, S; Kim, EM; Lee, MY; Hyun, YY; Lee, KB				Ko, Byung-Joon; Chang, Yoosoo; Ryu, Seungho; Kim, Eun Mi; Lee, Mi Yeon; Hyun, Young Youl; Lee, Kyu-Beck			Dietary acid load and chronic kidney disease in elderly adults: Protein and potassium intake	PLOS ONE			English	Article							METABOLIC-ACIDOSIS; SODIUM; RISK; CKD; CONSUMPTION; EXCRETION; EQUATION; FRUIT	Background Dietary net endogenous acid production (NEAP), which represents total dietary load of nonvolatile acid, may affect kidney function. Estimated NEAP (eNEAP) is calculated indirectly by the ratio of protein and potassium intake. A few studies are available assessing the association between eNEAP and chronic kidney disease (CKD), and its relation to dietary protein and potassium intake in the elderly. Methods A total 1,369 community-dwelling elderly Koreans in the Kangbuk Samsung Cohort Study (KSCS) were evaluated using a food frequency questionnaire (FFQ) and comprehensive health examination. We evaluated the association between eNEAP and the CKD. We also examined their relation to protein and potassium intake. Results eNEAP was correlated with potassium intake (r = -0.410, P < 0.001), but was not correlated with protein intake (r = -0.004, P = 0.879). In a full multivariate adjustment for sociodemographic factors, dietary factors, and comorbidities, the participants with higher eNEAP quartiles (Q2, Q3, Q4) had higher odds of CKD compared to the lowest eNEAP quartile (Q1); OR (95% CI) were 1.47 (0.78-2.72), 1.66 (0.85-3.23), and 2.30 (1.16-4.60) respectively (P for trend = 0.019). The odds of CKD decreased for participants with higher potassium intake quartiles (Q2, Q3, Q4) compared to the lowest potassium intake quartile (Q1); OR (95% CI) were 0.52 (0.28-0.95), 0.50 (0.26-0.96), and 0.50 (0.21-0.99) respectively (P for trend = 0.050). Protein intake was not associated with CKD. The association between eNEAP and CKD was similar in subgroup analysis. Conclusion Dietary acid load was associated with CKD. Among the nutrients related to dietary acid load, potassium intake was negatively associated with CKD, but protein intake was not associated with CKD in elderly adults.	[Ko, Byung-Joon; Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Occupat & Environm Med, Seoul, South Korea; [Ko, Byung-Joon; Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Kim, Eun Mi] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Dietet, Seoul, South Korea; [Lee, Mi Yeon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Biostat, Sch Med, Seoul, South Korea; [Hyun, Young Youl; Lee, Kyu-Beck] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med,Div Nephrol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, KB (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med,Div Nephrol, Seoul, South Korea.	kyubeck.lee@samsung.com		Chang, Yoosoo/0000-0002-6945-9050; Lee, kyu-Beck/0000-0002-3904-5404				Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Banerjee T, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-137; Blanch N, 2015, NUTR METAB CARDIOVAS, V25, P253, DOI 10.1016/j.numecd.2014.10.001; Chiavaroli L, 2015, EUR J CLIN NUTR, V69, P761, DOI 10.1038/ejcn.2014.237; Choi Y, 2015, ATHEROSCLEROSIS, V241, P305, DOI 10.1016/j.atherosclerosis.2015.05.036; Choi Y, 2015, HEART, V101, P686, DOI 10.1136/heartjnl-2014-306663; Fagherazzi G, 2014, DIABETOLOGIA, V57, P313, DOI 10.1007/s00125-013-3100-0; Fenton TR, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-41; Frassetto LA, 1998, AM J CLIN NUTR, V68, P576, DOI 10.1093/ajcn/68.3.576; Hariharan D, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0529-6; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Ji E, 2016, KOREAN J INTERN MED, V31, P1120, DOI 10.3904/kjim.2015.193; Kieneker LM, 2016, KIDNEY INT, V90, P888, DOI 10.1016/j.kint.2016.07.012; Korean Nutrition Society, 2006, FOOD VAL NUTR COMP T; Kraut JA, 2016, AM J KIDNEY DIS, V67, P307, DOI 10.1053/j.ajkd.2015.08.028; Leonberg-Yoo AK, 2016, AM J KIDNEY DIS; Levey AS, 2006, AM J KIDNEY DIS, V48, P879, DOI 10.1053/j.ajkd.2006.08.023; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lew QLJ, 2017, J AM SOC NEPHROL, V28, P304, DOI [10.1681/ASN.2016030248, 10.1681/asn.2016030248]; Lim H, 2014, NUTR RES, V34, P760, DOI 10.1016/j.nutres.2014.08.002; Millen BE, 2016, ADV NUTR, V7, P438, DOI 10.3945/an.116.012120; Rebholz CM, 2015, AM J NEPHROL, V42, P427, DOI 10.1159/000443746; Scialla JJ, 2013, ADV CHRONIC KIDNEY D, V20, P141, DOI 10.1053/j.ackd.2012.11.001; Sharma S, 2013, AM J NEPHROL, V37, P526, DOI 10.1159/000351178; Smyth A, 2014, KIDNEY INT, V86, P1205, DOI 10.1038/ki.2014.214; Tonelli M, 2014, AM J KIDNEY DIS, V63, P349, DOI 10.1053/j.ajkd.2014.01.003; Weaver CM, 2013, ADV NUTR, V4, p368S, DOI 10.3945/an.112.003533; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Wesson DE, 2012, KIDNEY INT, V82, P1184, DOI 10.1038/ki.2012.267; Wesson DE, 2009, KIDNEY INT, V75, P929, DOI 10.1038/ki.2009.6; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Williams RS, 2016, BIOCHIMIE, V124, P171, DOI 10.1016/j.biochi.2015.09.012	34	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185069	10.1371/journal.pone.0185069	http://dx.doi.org/10.1371/journal.pone.0185069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953915	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300031
J	Saak, CC; Zepeda-Rivera, MA; Gibbs, KA				Saak, Christina C.; Zepeda-Rivera, Martha A.; Gibbs, Karine A.			A single point mutation in a TssB/VipA homolog disrupts sheath formation in the type VI secretion system of Proteus mirabilis	PLOS ONE			English	Article							SWISS-MODEL; DIENES PHENOMENON; SELF-IDENTITY; IDENTIFICATION; WEB; DETERMINANTS; MUTAGENESIS; COMPETITION; EFFECTORS; REQUIRES	The type VI secretion (T6S) system is a molecular device for the delivery of proteins from one cell into another. T6S function depends on the contractile sheath comprised of TssB/VipA and TssC/VipB proteins. We previously reported on a mutant variant of TssB that disrupts T6S-dependent export of the self-identity protein, IdsD, in the bacterium Proteus mirabilis. Here we determined the mechanism underlying that initial observation. We show that T6S-dependent export of multiple self-recognition proteins is abrogated in this mutant strain. We have mapped the mutation, which is a single amino acid change, to a region predicted to be involved in the formation of the TssB-TssC sheath. We have demonstrated that this mutation does indeed inhibit sheath formation, thereby explaining the global disruption of T6S activity. We propose that this mutation could be utilized as an important tool for studying functions and behaviors associated with T6S systems.	[Saak, Christina C.; Zepeda-Rivera, Martha A.; Gibbs, Karine A.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Gibbs, KA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kagibbs@mcb.harvard.edu	Zepeda Rivera, Martha/AAE-2524-2022	Zepeda Rivera, Martha/0000-0002-2408-8719; Saak, Christina Caroline/0000-0001-7041-8531; Gibbs, Karine/0000-0002-1246-6401				Alteri CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003608; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BELAS R, 1991, J BACTERIOL, V173, P6289, DOI 10.1128/jb.173.19.6289-6293.1991; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brooks TM, 2013, J BIOL CHEM, V288, P7618, DOI 10.1074/jbc.M112.436725; Brunet YR, 2015, INFECT IMMUN, V83, P2738, DOI 10.1128/IAI.00198-15; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Budding AE, 2009, J BACTERIOL, V191, P3892, DOI 10.1128/JB.00975-08; Cardarelli L, 2015, MBIO, V6, DOI 10.1128/mBio.00251-15; Clemens DL, 2015, CELL, V160, P940, DOI 10.1016/j.cell.2015.02.005; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; DIENES L, 1947, P SOC EXP BIOL MED, V66, P97; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Durand E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.390153; Gerc AJ, 2015, CELL REP, V12, P2131, DOI 10.1016/j.celrep.2015.08.053; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hachani A, 2014, J BIOL CHEM, V289, P17872, DOI 10.1074/jbc.M114.563429; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HOENIGER JF, 1965, J GEN MICROBIOL, V40, P29, DOI 10.1099/00221287-40-1-29; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Kube S, 2014, CELL REP, V8, P20, DOI 10.1016/j.celrep.2014.05.034; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Ma LS, 2014, CELL HOST MICROBE, V16, P94, DOI 10.1016/j.chom.2014.06.002; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rauprich O, 1996, J BACTERIOL, V178, P6525, DOI 10.1128/jb.178.22.6525-6538.1996; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Saak CC, 2016, J BACTERIOL, V198, P3278, DOI 10.1128/JB.00402-16; Schrodinger L.L.C., 2015, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S13398-014-0173-7.2; Sei E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004652; SENIOR BW, 1977, J GEN MICROBIOL, V102, P235, DOI 10.1099/00221287-102-2-235; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sturgill GM, 2002, FEMS MICROBIOL LETT, V217, P43, DOI 10.1016/S0378-1097(02)01043-1; Sullivan NL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00024-13; Unterweger D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4549; Vallejo AN, 2008, CSH PROTOC 2008; WARREN JW, 1982, J INFECT DIS, V146, P719, DOI 10.1093/infdis/146.6.719; Wenren LM, 2013, MBIO, V4, DOI 10.1128/mBio.00374-13; Whitney JC, 2013, J BIOL CHEM, V288, P26616, DOI 10.1074/jbc.M113.488320; WU Q-R, 1991, Zhonghua Jiehe He Huxi Zazhi, V14, P173; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081074; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	65	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184797	10.1371/journal.pone.0184797	http://dx.doi.org/10.1371/journal.pone.0184797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949977	Green Submitted, Green Published, gold			2022-12-26	WOS:000411671000017
J	Gayda, M; Gremeaux, V; Bherer, L; Juneau, M; Drigny, J; Dupuy, O; Lapierre, G; Labelle, V; Fortier, A; Nigam, A				Gayda, Mathieu; Gremeaux, Vincent; Bherer, Louis; Juneau, Martin; Drigny, Joffrey; Dupuy, Olivier; Lapierre, Gabriel; Labelle, Veronique; Fortier, Annik; Nigam, Anil			Cognitive function in patients with stable coronary heart disease: Related cerebrovascular and cardiovascular responses	PLOS ONE			English	Article							CARDIAC-OUTPUT; CARDIORESPIRATORY FITNESS; CEREBRAL OXYGENATION; ARTERY-DISEASE; OLDER-ADULTS; IMPEDANCE CARDIOGRAPHY; METABOLIC SYNDROME; EXERCISE; PERFORMANCE; DECLINE	Chronic exercise has been shown to prevent or slow age-related decline in cognitive functions in otherwise healthy, asymptomatic individuals. We sought to assess cognitive function in a stable coronary heart disease (CHD) sample and its relationship to cerebral oxygenation-perfusion, cardiac hemodynamic responses, and VO2 peak compared to age-matched and young healthy control subjects. Twenty-two young healthy controls (YHC), 20 age-matched old healthy controls (OHC) and 25 patients with stable CHD were recruited. Cognitive function assessment included short term- working memory, perceptual abilities, processing speed, cognitive inhibition and flexibility and long-term verbal memory. Maximal cardiopulmonary function (gas exchange analysis), cardiac hemodynamic (impedance cardiography) and left frontal cerebral oxygenation-perfusion (near-infra red spectroscopy) were measured during and after a maximal incremental ergocycle test. Compared to OHC and CHD, YHC had higher VO2 peak, maximal cardiac index (CI max), cerebral oxygenation-perfusion (Delta O-2 Hb, Delta tHb: exercise and recovery) and cognitive function (for all items) (P< 0.05). Compared to OHC, CHD patients had lower VO2 peak, CI max, cerebral oxygenation- perfusion (during recovery) and short term-working memory, processing speed, cognitive inhibition and flexibility and long-term verbal memory (P< 0.05). VO2 peak and CI max were related to exercise cerebral oxygenation-perfusion and cognitive function (P< 0.005). Cerebral oxygenation-perfusion (exercise) was related to cognitive function (P< 0.005). Stable CHD patients have a worse cognitive function, a similar cerebral oxygenation/ perfusion during exercise but reduced one during recovery vs. their aged-matched healthy counterparts. In the all sample, cognitive functions correlated with VO2 peak, CI max and cerebral oxygenation-perfusion.	[Gayda, Mathieu; Bherer, Louis; Juneau, Martin; Drigny, Joffrey; Dupuy, Olivier; Lapierre, Gabriel; Nigam, Anil] Montreal Heart Inst, Cardiovasc Prevent & Rehabil Ctr EPIC, Montreal, PQ, Canada; [Gayda, Mathieu; Bherer, Louis; Juneau, Martin; Drigny, Joffrey; Dupuy, Olivier; Lapierre, Gabriel; Nigam, Anil] Univ Montreal, Montreal, PQ, Canada; [Gayda, Mathieu; Bherer, Louis; Juneau, Martin; Lapierre, Gabriel; Nigam, Anil] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Gayda, Mathieu; Bherer, Louis; Juneau, Martin; Lapierre, Gabriel; Nigam, Anil] Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada; [Gremeaux, Vincent] INSERM, Cognit Act & Plast Sensorimotrice U1093, Dijon, France; [Dupuy, Olivier] Concordia Univ, PERFORM Ctr, Dept Psychol, Montreal, PQ, Canada; [Dupuy, Olivier; Labelle, Veronique] Inst Univ Geriatr Montreal, Res Ctr, Montreal, PQ, Canada; [Dupuy, Olivier] Univ Poitiers, Fac Sport Sci, Lab, MOVE EA6314, Poitiers, France; [Fortier, Annik] Montreal Heart Inst, Montreal Hlth Innovat Coordinating Ctr, Div A, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Concordia University - Canada; Universite de Montreal; Universite de Poitiers; Universite de Montreal	Nigam, A (corresponding author), Montreal Heart Inst, Cardiovasc Prevent & Rehabil Ctr EPIC, Montreal, PQ, Canada.; Nigam, A (corresponding author), Univ Montreal, Montreal, PQ, Canada.; Nigam, A (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada.; Nigam, A (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada.	anil.nigam@icm-mhi.org	drigny, joffrey/AAD-4046-2020; Dupuy, Olivier/AAT-4275-2020; Gayda, Mathieu/U-8520-2019	Gayda, Mathieu/0000-0003-1721-2299; Drigny, Joffrey/0000-0001-7670-8791; Dupuy, Olivier/0000-0001-7273-8272	Cardiovascular Prevention and Rehabilitation Centre Foundation; Montreal Heart Institute Foundation; Reseau Quebecois de Recherche sur le Vieillissement	Cardiovascular Prevention and Rehabilitation Centre Foundation; Montreal Heart Institute Foundation; Reseau Quebecois de Recherche sur le Vieillissement	This work was supported by Cardiovascular Prevention and Rehabilitation Centre Foundation (MG, VG, MJ, GL, AN), Montreal Heart Institute Foundation (MG, VG, MJ, GL, AN) and Reseau Quebecois de Recherche sur le Vieillissement (LB, VL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Alosco ML, 2013, BRAIN BEHAV, V3, P626, DOI 10.1002/brb3.171; Alosco ML, 2012, CEREBROVASC DIS EXTR, V2, P88, DOI 10.1159/000343222; Avadhani R, 2015, AM J MED, V128, P46, DOI 10.1016/j.amjmed.2014.08.025; Barekatain M, 2014, J RES MED SCI, V19, P739; Belardinelli R, 1996, AM J CARDIOL, V77, P1293, DOI 10.1016/S0002-9149(97)89153-9; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, pH620, DOI 10.1152/ajpheart.00624.2012; Boots EA, 2014, BRAIN IMAGING BEHAV; Charloux A, 2000, EUR J APPL PHYSIOL, V82, P313, DOI 10.1007/s004210000226; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Davenport MH, 2012, EXERC SPORT SCI REV, V40, P153, DOI 10.1097/JES.0b013e3182553430; Drigny J, 2014, J REHABIL MED, V46, P1050, DOI 10.2340/16501977-1905; Fisher JP, 2013, J PHYSIOL-LONDON, V591, P1859, DOI 10.1113/jphysiol.2012.244905; Fu TC, 2013, INT J CARDIOL, V167, P41, DOI 10.1016/j.ijcard.2011.11.086; Fu TC, 2011, AM J PHYSIOL-HEART C, V300, pH1545, DOI 10.1152/ajpheart.00867.2010; Galioto RM, 2013, AGING NEUROPSYCHOL C, V20, P684, DOI 10.1080/13825585.2012.762972; Gayda M, 2015, CAN J CARDIOL; Gayda M, 2008, NUTR METAB CARDIOVAS, V18, P142, DOI 10.1016/j.numecd.2006.07.003; Gayda M, 2016, CAN J CARDIOL, V32, P539, DOI 10.1016/j.cjca.2015.07.011; Gayda M, 2012, APPL PHYSIOL NUTR ME, V37, P1171, DOI 10.1139/h2012-109; Gayda M, 2010, EUR J APPL PHYSIOL, V109, P191, DOI 10.1007/s00421-009-1312-2; Gremeaux V, 2012, CAN J CARDIOL, V28, pS386, DOI 10.1016/j.cjca.2012.07.676; Guiraud T, 2011, MED SCI SPORT EXER, V43, P211, DOI 10.1249/MSS.0b013e3181ebc5de; Hutter I, 2014, INT ANGIOL; Jefferson AL, 2007, NEUROBIOL AGING, V28, P477, DOI 10.1016/j.neurobiolaging.2006.01.001; Koike A, 2004, AM J CARDIOL, V94, P821, DOI 10.1016/j.amjcard.2004.06.013; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Langlois F, 2013, J GERONTOL B-PSYCHOL, V68, P400, DOI 10.1093/geronb/gbs069; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Lucas SJE, 2012, EXP GERONTOL, V47, P541, DOI 10.1016/j.exger.2011.12.002; Moser D J, 1999, J Cardiopulm Rehabil, V19, P91, DOI 10.1097/00008483-199903000-00002; NORTHRIDGE DB, 1990, BRIT HEART J, V63, P93; Perez-Belmonte LM, 2014, MED CLIN-BARCELONA, V143, P109, DOI 10.1016/j.medcli.2013.06.031; Prakash RS, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00229; Reis JP, 2013, ATHEROSCLEROSIS, V231, P72, DOI 10.1016/j.atherosclerosis.2013.08.038; Richard R, 2001, EUR J APPL PHYSIOL, V85, P202, DOI 10.1007/s004210100458; Scherhag A, 2005, KIDNEY BLOOD PRESS R, V28, P77, DOI 10.1159/000083695; Selnes OA, 2009, ANN THORAC SURG, V88, P445, DOI 10.1016/j.athoracsur.2009.04.061; Singh-Manoux A, 2003, J AM GERIATR SOC, V51, P1445, DOI 10.1046/j.1532-5415.2003.51464.x; Swardfager W, 2010, J AM GERIATR SOC, V58, P1519, DOI 10.1111/j.1532-5415.2010.02966.x; Tseng BY, 2013, J MAGN RESON IMAGING, V38, P1169, DOI 10.1002/jmri.24085; van der Veen PH, 2013, J NEUROL SCI; Vinkers DJ, 2005, NEUROLOGY, V65, P107, DOI 10.1212/01.wnl.0000167544.54228.95; Weinstein G, 2014, INT J STROKE, V9, P48, DOI 10.1111/ijs.12275; Welsman J, 2005, EUR J APPL PHYSIOL, V94, P228, DOI 10.1007/s00421-004-1300-5; Wendell CR, 2014, J GERONTOL A-BIOL, V69, P455, DOI 10.1093/gerona/glt144; Zheng L, 2012, J AM GERIATR SOC, V60, P499, DOI 10.1111/j.1532-5415.2011.03839.x; Zhu N, 2014, NEUROLOGY, V82, P1339, DOI 10.1212/WNL.0000000000000310	48	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0183791	10.1371/journal.pone.0183791	http://dx.doi.org/10.1371/journal.pone.0183791			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937981	gold, Green Submitted, Green Published			2022-12-26	WOS:000411524700003
J	Rahman, MM; Hussain, MM; Asiri, AM				Rahman, Mohammed M.; Hussain, Mohammad Musarraf; Asiri, Abdullah M.			Fabrication of 3-methoxyphenol sensor based on Fe3O4 decorated carbon nanotube nanocomposites for environmental safety: Real sample analyses	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; CHEMICAL SENSOR; ELECTROCHEMICAL DETECTION; MAGNETIC NANOCOMPOSITES; FACILE SYNTHESIS; ELECTRODE; AEROGRAPHITE; 4-AMINOPHENOL; NANOSHEETS; REDUCTION	Iron oxide ornamented carbon nanotube nanocomposites (Fe3O4. CNT NCs) were prepared by a wet-chemical process in basic means. The optical, morphological, and structural characterizations of Fe3O4. CNT NCs were performed using FTIR, UV/Vis., FESEM, TEM; XEDS, XPS, and XRD respectively. Flat GCE had been fabricated with a thin-layer of NCs using a coating binding agent. It was performed for the chemical sensor development by a dependable I-V technique. Among all interfering analytes, 3-methoxyphenol (3-MP) was selective towards the fabricated sensor. Increased electrochemical performances for example elevated sensitivity, linear dynamic range (LDR) and continuing steadiness towards selective 3-MP had been observed with chemical sensor. The calibration graph found linear (R R-2 = 0.9340) in a wide range of 3-MP concentration (90.0 pM similar to 90.0 mM). The limit of detection and sensitivity were considered as 1.0 pM and 9x10(-4) mu A mu M-1 cm(-2) respectively. The prepared of Fe3O4. CNT NCs by a wet-chemical progression is an interesting route for the development of hazardous phenolic sensor based on nanocomposite materials. It is also recommended that 3-MP sensor is exhibited a promising performances based on Fe3O4. CNT NCs by a facile I-V method for the significant applications of toxic chemicals for the safety of environmental and health-care fields.	[Rahman, Mohammed M.; Hussain, Mohammad Musarraf; Asiri, Abdullah M.] King Abdulaziz Univ, Chem Dept, Jeddah, Saudi Arabia; [Rahman, Mohammed M.; Hussain, Mohammad Musarraf; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Chem Dept, Jeddah, Saudi Arabia.; Rahman, MM (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah, Saudi Arabia.	mmrahman@kau.edu.sa	Asiri, Abdullah M./C-3458-2009; Rahman, Mohammed M./H-5823-2012; Hussain, Mohammad Musarraf/P-9590-2016	Asiri, Abdullah M./0000-0001-7905-3209; Rahman, Mohammed M./0000-0003-2773-1244; Hussain, Mohammad Musarraf/0000-0001-9270-0474				Alam MK, 2017, J ELECTROANAL CHEM, V788, P66, DOI 10.1016/j.jelechem.2017.02.004; Amstad E, 2011, NANOSCALE, V3, P2819, DOI 10.1039/c1nr10173k; Anju M, 2015, RSC ADV, V5, P78648, DOI 10.1039/c5ra16954b; Balkhoyor HB, 2016, RSC ADV, V6, P58236, DOI 10.1039/c6ra10863f; Balkhoyor HB, 2017, CHEM SENSORS BASED N, P1; Chen SL, 2009, J MATER CHEM, V19, P6387, DOI 10.1039/b902170a; Easterday R, 2015, CATAL SCI TECHNOL, V5, P1902, DOI 10.1039/c4cy01277a; Faisal M, 2011, APPL SURF SCI, V258, P672, DOI 10.1016/j.apsusc.2011.07.067; Fan Y, 2011, SENSOR ACTUAT B-CHEM, V157, P669, DOI 10.1016/j.snb.2011.05.053; Garlof S, 2017, CARBON, V111, P103, DOI 10.1016/j.carbon.2016.09.046; Garlof S, 2016, COMPOS SCI TECHNOL, V134, P226, DOI 10.1016/j.compscitech.2016.08.019; Ge JW, 2013, GREEN CHEM, V15, P2064, DOI 10.1039/c3gc40712h; Herman DAJ, 2011, CHEM COMMUN, V47, P9221, DOI 10.1039/c1cc13416g; Hussain MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166265; Hussain MM, 2017, J ENVIRON SCI, V53, P27, DOI 10.1016/j.jes.2016.03.028; Hussain MM, 2016, MICROCHIM ACTA, V183, P3265, DOI 10.1007/s00604-016-1983-4; Hussain MM, 2016, RSC ADV, V6, P80511, DOI 10.1039/c6ra12256f; Jang B, 2013, J MATER CHEM A, V1, P15442, DOI 10.1039/c3ta13717a; Jianying Qu, 2015, Sensing and Bio-Sensing Research, V3, P74, DOI 10.1016/j.sbsr.2014.10.009; Khan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085290; Khayatian G, 2013, J BRAZIL CHEM SOC, V24, P1808, DOI 10.5935/0103-5053.20130226; Lin CY, 2015, SENSOR ACTUAT B-CHEM, V220, P695, DOI 10.1016/j.snb.2015.06.022; Lin TY, 2014, RSC ADV, V4, P29357, DOI 10.1039/c4ra03505d; Liu CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09498; Liu JX, 2010, ANAL CHEM, V82, P7380, DOI 10.1021/ac101510b; Lupan O, 2017, SMALL, V13, DOI 10.1002/smll.201602868; Mitchell E, 2014, NEW J CHEM, V38, P4344, DOI 10.1039/c4nj00741g; Nallathamby PD, 2015, NANOSCALE, V7, P6545, DOI 10.1039/c4nr06441k; Nissim R, 2014, ANALYST, V139, P5911, DOI 10.1039/c4an01417k; Nolan M, 2011, PHYS CHEM CHEM PHYS, V13, P18194, DOI 10.1039/c1cp21418g; Oliveira HS, 2015, NEW J CHEM, V39, P3051, DOI 10.1039/c4nj02063d; Prakash R, 2013, BEILSTEIN J NANOTECH, V4, P699, DOI 10.3762/bjnano.4.79; Qiao RR, 2009, J MATER CHEM, V19, P6274, DOI 10.1039/b902394a; Rahman MM, 2011, NANOMATERIALS, P1, DOI 10.5772/1371; Rahman MM, 2017, ELECTROCHEMICAL SENS; Rahman MM, 2017, TALANTA, V170, P215, DOI 10.1016/j.talanta.2017.04.017; Rahman MM, 2017, SENSOR ACTUAT B-CHEM, V242, P167, DOI 10.1016/j.snb.2016.11.053; Rahman MM, 2017, J ENVIRON MANAGE, V188, P228, DOI 10.1016/j.jenvman.2016.12.008; Rahman MM, 2016, MICROCHIM ACTA, V183, P3255, DOI 10.1007/s00604-016-1987-0; Rahman MM, 2016, RSC ADV, V6, P65338, DOI 10.1039/c6ra11582a; Rahman MM, 2016, J TAIWAN INST CHEM E, V64, P157, DOI 10.1016/j.jtice.2016.04.009; Rahman MM, 2016, RSC ADV, V6, P48435, DOI 10.1039/c6ra04124h; Rahman MM, 2015, RSC ADV, V5, P71370, DOI 10.1039/c5ra10793h; Rahman MM, 2015, RSC ADV, V5, P63252, DOI 10.1039/c5ra08224b; Rahman MM, 2015, MICROCHIM ACTA, V182, P487, DOI 10.1007/s00604-014-1345-z; Rahman MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085036; Rahman MM, 2013, ELECTROCHIM ACTA, V112, P422, DOI 10.1016/j.electacta.2013.08.164; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Saber O, 2015, RSC ADV, V5, P72863, DOI 10.1039/c5ra13051d; Schuchardt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08839; Snure M, 2007, J NANOSCI NANOTECHNO, V7, P481, DOI 10.1166/jnn.2007.139; Snure M, 2008, J APPL PHYS, V104, DOI 10.1063/1.2988131; Su YX, 2015, FUEL, V160, P80, DOI 10.1016/j.fuel.2015.07.077; Sundar S, 2015, RSC ADV, V5, P74408, DOI 10.1039/c5ra15166j; Tian K, 2015, MAT SCI ENG C-MATER, V46, P548, DOI 10.1016/j.msec.2014.10.064; Tiginyanu I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32913; Vilian ATE, 2015, ANAL METHODS-UK, V7, P5627, DOI [10.1039/C5AY01005E, 10.1039/c5ay01005e]; Wawrzynczak A, 2016, DYES PIGMENTS, V124, P27, DOI 10.1016/j.dyepig.2015.08.025; Xiong R, 2014, RSC ADV, V4, P22632, DOI 10.1039/c4ra01397b; Xu JQ, 2008, SENSOR ACTUAT B-CHEM, V132, P334, DOI 10.1016/j.snb.2008.01.062; Xu JJ, 2010, ACS NANO, V4, P5019, DOI 10.1021/nn1006539; Xu YL, 2014, J MATER CHEM B, V2, P6198, DOI 10.1039/c4tb00840e; Yang X, 2012, RSC ADV, V2, P8821, DOI 10.1039/c2ra20885g; Zhang C, 2016, CHEM ENG J, V284, P247, DOI 10.1016/j.cej.2015.08.096; Zhang Y, 2015, PHYS CHEM CHEM PHYS, V17, P14656, DOI 10.1039/c5cp00373c	65	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0177817	10.1371/journal.pone.0177817	http://dx.doi.org/10.1371/journal.pone.0177817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938019	Green Published, Green Submitted, gold			2022-12-26	WOS:000411524700001
J	Arfken, A; Song, B; Bowman, JS; Piehler, M				Arfken, Ann; Song, Bongkeun; Bowman, Jeff S.; Piehler, Michael			Denitrification potential of the eastern oyster microbiome using a 16S rRNA gene based metabolic inference approach	PLOS ONE			English	Article							NITROUS-OXIDE REDUCTASE; BACTERIAL COMMUNITIES; CRASSOSTREA-GIGAS; PACIFIC OYSTER; SEDIMENT; DIVERSITY; NITRIFICATION; EMISSION; GUT; BAY	The eastern oyster (Crassostrea virginica) is a foundation species providing significant ecosystem services. However, the roles of oyster microbiomes have not been integrated into any of the services, particularly nitrogen removal through denitrification. We investigated the composition and denitrification potential of oyster microbiomes with an approach that combined 16S rRNA gene analysis, metabolic inference, qPCR of the nitrous oxide reductase gene (nosZ), and N-2 flux measurements. Microbiomes of the oyster digestive gland, the oyster shell, and sediments adjacent to the oyster reef were examined based on next generation sequencing (NGS) of 16S rRNA gene amplicons. Denitrification potentials of the microbiomes were determined by metabolic inferences using a customized denitrification gene and genome database with the paprica (PAthway PRediction by phylogenetIC plAcement) bioinformatics pipeline. Denitrification genes examined included nitrite reductase (nirS and nirK) and nitrous oxide reductase (nosZ), which was further subdivided by genotype into clade I (nosZI) or clade II (nosZII). Continuous flow through experiments measuring N-2 fluxes were conducted with the oysters, shells, and sediments to compare denitrification activities. Paprica properly classified the composition of microbiomes, showing similar classification results from Silva, Greengenes and RDP databases. Microbiomes of the oyster digestive glands and shells were quite different from each other and from the sediments. The relative abundance of denitrifying bacteria inferred by paprica was higher in oysters and shells than in sediments suggesting that oysters act as hotspots for denitrification in the marine environment. Similarly, the inferred nosZI gene abundances were also higher in the oyster and shell microbiomes than in the sediment microbiome. Gene abundances for nosZI were verified with qPCR of nosZI genes, which showed a significant positive correlation (F-1,F-7 = 14.7, p = 6.0x10(-3), R-2 = 0.68). N-2 flux rates were significantly higher in the oyster (364.4 +/- 23.5 mu mol N-N-2 m(-2) h(-1)) and oyster shell (355.3 +/- 6.4 mu mol N-N-2 m(-2) h(-1)) compared to the sediment (270.5 +/- 20.1 mu mol N-N-2 m(-2) h(-1)). Thus, bacteria carrying nosZI genes were found to be an important denitrifier, facilitating nitrogen removal in oyster reefs. In addition, this is the first study to validate the use of 16S gene based metabolic inference as a method for determining microbiome function, such as denitrification, by comparing inference results with qPCR gene quantification and rate measurements.	[Arfken, Ann; Song, Bongkeun] Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA; [Bowman, Jeff S.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, San Diego, CA 92103 USA; [Piehler, Michael] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA	William & Mary; Virginia Institute of Marine Science; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of North Carolina; University of North Carolina Chapel Hill	Arfken, A (corresponding author), Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA.	amarfken@vims.edu		Piehler, Michael/0000-0003-3881-4862; Bowman, Jeff/0000-0002-8811-6280	National Science Foundation Division of Biological Oceanography [1321373, 11696, 1233327]; National Science Foundation Division of Polar Programs [1641019]; National Science Foundation; Commonwealth of Virginia Equipment Trust Fund; Office of Naval Research	National Science Foundation Division of Biological Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); National Science Foundation Division of Polar Programs(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Commonwealth of Virginia Equipment Trust Fund; Office of Naval Research(Office of Naval Research)	Funding was provided by the National Science Foundation Division of Biological Oceanography, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=11696, grant number 1321373 to BS; National Science Foundation Division of Biological Oceanography, https://www.nstgovifunding/pgm_summ.jsp?pims_id=11696, grant number 1233327 to MP; National Science Foundation Division of Polar Programs, https://www.nsf.gov/div/index.jsp?div=PLR, grant number 1641019 to JSB; as well as contributions from the National Science Foundation, the Commonwealth of Virginia Equipment Trust Fund and the Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bowman JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135868; Caffrey JM, 2016, MAR POLLUT BULL, V112, P86, DOI 10.1016/j.marpolbul.2016.08.038; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Cleary DFR, 2015, MICROB ECOL, V70, P889, DOI 10.1007/s00248-015-0632-5; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Depkat-Jakob PS, 2010, APPL ENVIRON MICROB, V76, P6205, DOI 10.1128/AEM.01373-10; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desnues C, 2007, WATER RES, V41, P3407, DOI 10.1016/j.watres.2007.04.018; Domeignoz-Horta LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00971; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ensign SH, 2008, BIOGEOCHEMISTRY, V91, P133, DOI 10.1007/s10533-008-9265-9; Fernandez-Piquer J, 2012, J APPL MICROBIOL, V112, P1134, DOI 10.1111/j.1365-2672.2012.05287.x; Giles H, 2006, AQUACULTURE, V261, P125, DOI 10.1016/j.aquaculture.2006.06.048; Glibert PM, 2014, ESTUAR COAST, V37, pS128, DOI 10.1007/s12237-013-9630-3; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Green TJ, 2010, J APPL MICROBIOL, V109, P613, DOI 10.1111/j.1365-2672.2010.04687.x; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Hernandez-Zarate G, 2006, J APPL MICROBIOL, V100, P664, DOI 10.1111/j.1365-2672.2005.02800.x; Hoellein TJ, 2015, BIOGEOCHEMISTRY, V122, P113, DOI 10.1007/s10533-014-0034-7; Humphries AT, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00074; JENKINS MC, 1984, LIMNOL OCEANOGR, V29, P609, DOI 10.4319/lo.1984.29.3.0609; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Kellogg ML, 2014, ESTUAR COAST SHELF S, V151, P156, DOI 10.1016/j.ecss.2014.09.025; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; King GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051475; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lokmer A, 2016, ENVIRON MICROBIOL, V18, P970, DOI 10.1111/1462-2920.13163; Lokmer A, 2015, ISME J, V9, P670, DOI 10.1038/ismej.2014.160; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mosier AC, 2010, ENV MICROBIOL REP, V2, P667, DOI 10.1111/j.1758-2229.2010.00156.x; Newell RIE, 2005, NATO SCI S SS IV EAR, V47, P93; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Ngugi DK, 2012, ENVIRON MICROBIOL, V14, P860, DOI 10.1111/j.1462-2920.2011.02648.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orellana LH, 2014, MBIO, V5, DOI 10.1128/mBio.01193-14; Pfister CA, 2014, PEERJ, V2, DOI 10.7717/peerj.631; Piehler MF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00082.1; Polymenakou PN, 2005, MICROB ECOL, V49, P367, DOI 10.1007/s00248-004-0274-5; Rothig T, 2016, MOL ECOL, V25, P1308, DOI 10.1111/mec.13567; Romero J, 2002, MICROBIAL ECOL, V44, P365, DOI 10.1007/s00248-002-1063-7; Rubin BER, 2014, MICROBIOLOGYOPEN, V3, P910, DOI 10.1002/mbo3.216; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Smith CJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00542; Smyth AR, 2016, MAR ECOL PROG SER, V560, P173, DOI 10.3354/meps11922; Smyth AR, 2013, MAR ECOL PROG SER, V493, P23, DOI 10.3354/meps10516; Stief P, 2009, P NATL ACAD SCI USA, V106, P4296, DOI 10.1073/pnas.0808228106; Sun MY, 2013, ENVIRON MICROBIOL, V15, P2517, DOI 10.1111/1462-2920.12133; Svenningsen NB, 2012, APPL ENVIRON MICROB, V78, P4505, DOI 10.1128/AEM.00401-12; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Fernandez NT, 2014, FEMS MICROBIOL ECOL, V88, P69, DOI 10.1111/1574-6941.12270; Trabal N, 2012, MICROB ECOL, V64, P555, DOI 10.1007/s00248-012-0039-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wegner KM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-252; Wust PK, 2009, APPL ENVIRON MICROB, V75, P3430, DOI 10.1128/AEM.00304-09; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zurel D, 2011, ENVIRON MICROBIOL, V13, P1467, DOI 10.1111/j.1462-2920.2011.02448.x	66	48	49	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185071	10.1371/journal.pone.0185071	http://dx.doi.org/10.1371/journal.pone.0185071			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934286	Green Published, gold			2022-12-26	WOS:000411339900083
J	Cabanas, M; Bassil, F; Mons, N; Garret, M; Cho, YH				Cabanas, Magali; Bassil, Fares; Mons, Nicole; Garret, Maurice; Cho, Yoon H.			Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; IMMEDIATE-EARLY GENES; TRANSGENIC MICE; SYNAPTIC PLASTICITY; PROJECTION NEURONS; INDIRECT PATHWAYS; PREFERENTIAL LOSS; SPINY NEURONS; ABNORMALITIES; ACTIVATION	Hereditary Huntington's disease (HD) is associated with progressive motor, cognitive and psychiatric symptoms. A primary consequence of the HD mutation is the preferential loss of medium spiny projection cells with relative sparing of local interneurons in the striatum. In addition, among GABAergic striatal projection cells, indirect pathway cells expressing D2 dopamine receptors are lost earlier than direct pathway cells expressing D1 receptors. To test in vivo the functional integrity of direct and indirect pathways as well as interneurons in the striatum of male R6/1 transgenic mice, we assessed their c-Fos expression levels induced by a striatal-dependent cognitive task and compared them with age-matched wildtype littermates. We found a significant increase of c-Fos+ nuclei in the dorsomedial striatum, and this only at 2 months, when our HD mouse model is still pre-motor symptomatic, the increase disappearing with symptom manifestation. Contrary to our expectation, the indirect pathway projection neurons did not undergo any severer changes of c-Fos expression regardless of age in R6/1 mice. We also found a decreased activation of interneurons that express parvalbumin in the dorsomedial striatum at both presymptomatic and symptomatic ages. Finally, analysis of c-Fos expression in extended brain regions involved in the cognitive learning used in our study, demonstrates, throughout ages studied, changes in the functional connectivity between regions in the transgenic mice. Further analysis of the cellular and molecular changes underlying the transient striatal hyperactivity in the HD mice may help to understand the mechanisms involved in the disease onset.	[Cabanas, Magali; Bassil, Fares; Mons, Nicole; Garret, Maurice; Cho, Yoon H.] CNRS, UMR 5287, Inst Neurosci Cognit & Integrat Aquitaine, Pessac, France; [Cabanas, Magali; Bassil, Fares; Mons, Nicole; Garret, Maurice; Cho, Yoon H.] Univ Bordeaux, Bordeaux, France; [Bassil, Fares] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Pennsylvania; Pennsylvania Medicine	Garret, M; Cho, YH (corresponding author), CNRS, UMR 5287, Inst Neurosci Cognit & Integrat Aquitaine, Pessac, France.; Garret, M; Cho, YH (corresponding author), Univ Bordeaux, Bordeaux, France.	maurice.garret@u-bordeaux.fr; yoon.cho@u-bordeaux.fr	Bassil, Fares/H-7073-2018; Mons, Nicole/AAD-5541-2019; Bassil, Fares/F-4227-2018		University of Bordeaux, France; Hereditary Disease Foundation, USA	University of Bordeaux, France; Hereditary Disease Foundation, USA	Our work was funded by the University of Bordeaux, France (to MC) and the Hereditary Disease Foundation, USA (to YHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Cayzac S, 2011, P NATL ACAD SCI USA, V108, P9280, DOI 10.1073/pnas.1016190108; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cepeda C, 2013, J NEUROSCI, V33, P7393, DOI 10.1523/JNEUROSCI.2137-12.2013; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Cicchetti F, 1996, MOVEMENT DISORD, V11, P619, DOI 10.1002/mds.870110605; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Cummings DM, 2007, BRAIN RES BULL, V72, P103, DOI 10.1016/j.brainresbull.2006.10.016; Deng YP, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00198; Du ZW, 2016, NEUROSCIENCE, V329, P363, DOI 10.1016/j.neuroscience.2016.05.027; FERRANTE RJ, 1987, BRAIN RES, V411, P162, DOI 10.1016/0006-8993(87)90694-9; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00124; Giampa C, 2009, EUR J NEUROSCI, V29, P902, DOI 10.1111/j.1460-9568.2009.06649.x; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Harrington DL, 2015, BRAIN, V138, P2332, DOI 10.1093/brain/awv145; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hohn S, 2011, J NEUROSCI, V31, P8986, DOI 10.1523/JNEUROSCI.1238-11.2011; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Kloppel S, 2015, EBIOMEDICINE, V2, P1420, DOI 10.1016/j.ebiom.2015.08.002; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Lebreton F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126972; Li JY, 2003, TRENDS MOL MED, V9, P414, DOI 10.1016/j.molmed.2003.08.006; Lobo MK, 2013, J NEUROSCI, V33, P18381, DOI 10.1523/JNEUROSCI.1875-13.2013; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Moratalla R, 1996, NEUROREPORT, V8, P1, DOI 10.1097/00001756-199612200-00001; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Murphy KP, 2000, J NEUROSCIENCE OFFIC, P20; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Nithianantharajah J, 2013, NEUROSCIENCE, V251, P66, DOI 10.1016/j.neuroscience.2012.05.043; Petersen A, 2002, NEUROBIOL DIS, V11, P134, DOI 10.1006/nbdi.2002.0534; Picconi B, 2006, NEUROBIOL DIS, V22, P143, DOI 10.1016/j.nbd.2005.10.009; Pietropaolo S, 2015, NEUROPHARMACOLOGY, V89, P368, DOI 10.1016/j.neuropharm.2014.07.021; Pignatelli M, 2012, NEUROBIOL DIS, V48, P409, DOI 10.1016/j.nbd.2012.07.015; Poudel GR, 2015, BRAIN STRUCT FUNCT, V220, P501, DOI 10.1007/s00429-013-0670-z; Quarantelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072159; Rebec GV, 2006, NEUROSCIENCE, V137, P327, DOI 10.1016/j.neuroscience.2005.08.062; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Reiner A, 2013, MOVEMENT DISORD, V28, P1691, DOI 10.1002/mds.25624; Richfield EK, 1995, ANN NEUROL, V38, P852, DOI 10.1002/ana.410380605; Spektor BS, 2002, MOL BRAIN RES, V102, P118, DOI 10.1016/S0169-328X(02)00216-4; Stalnaker TA, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00012; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Werme M, 2002, J NEUROSCI, V22, P8133; Werner CJ, 2014, HUM BRAIN MAPP, V35, P2582, DOI 10.1002/hbm.22351; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184580	10.1371/journal.pone.0184580	http://dx.doi.org/10.1371/journal.pone.0184580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934250	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900032
J	Rodionova, NN; Allakhverdiev, ES; Maksimov, GV				Rodionova, Natalia N.; Allakhverdiev, Elvin S.; Maksimov, Georgy V.			Study of myelin structure changes during the nerve fibers demyelination	PLOS ONE			English	Article							SODIUM CONDUCTANCE INACTIVATION; POTASSIUM CHANNELS; PRONASE; AXONS; DESTRUCTION; CAROTENOIDS; MEMBRANES	Raman, NMR and EPR spectroscopy and electrophysiology methods were used to investigate the excitability and the packaging of myelin lipid layers and its viscosity during nerve exposure to pronase E. It was established that during exposure of nerve to pronase E the action potential (AP) conduction velocity and the Schwann cell (SC) (or myelin) water ordering increases, but the nerve myelin refractive index and internode incisions numbers decrease. This effect included two periods-short-and long-time period, probably, because the first one depends on SC protein changes and the second one-on the nerve fiber internode demyelination. It was concluded that high electrical resistance of myelin, which is important for a series of AP conduction velocity, not only depends on nerve fiber diameter and the myelin lipid composition, but also on the regularity of myelin lipid fatty acids and myelin lipid layer packing during the axoglial interaction.	[Rodionova, Natalia N.; Maksimov, Georgy V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Allakhverdiev, Elvin S.] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University	Maksimov, GV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	gmaksimov@mail.ru						ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; BENOIT E, 1986, BRAIN RES, V377, P374, DOI 10.1016/0006-8993(86)90884-X; Brazhe NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041990; CAHALAN MD, 1978, BIOPHYS J, V23, P285, DOI 10.1016/S0006-3495(78)85449-6; CHIU SY, 1994, GLIA, V11, P191, DOI 10.1002/glia.440110213; DUBOIS JM, 1981, J PHYSIOL-LONDON, V318, P297; Hermann PM, 1997, EUR J NEUROSCI, V9, P2624, DOI 10.1111/j.1460-9568.1997.tb01692.x; Kutuzov N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142084; Kutuzov NP, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.050501; Kutuzov NP, 2014, BIOPHYS J, V107, P891, DOI 10.1016/j.bpj.2014.07.002; LAMOTTE CC, 1989, J COMP NEUROL, V288, P311, DOI 10.1002/cne.902880209; Maksimov G. V., 2014, Biophysics, V59, P81, DOI 10.1134/S0006350914010072; MAKSIMOV GV, 1986, BIOFIZIKA+, V31, P456; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Rodionova N. N., 2014, Biofizika, V59, P108, DOI 10.1134/S0006350914010163; ROJAS E, 1976, J PHYSIOL-LONDON, V262, P501, DOI 10.1113/jphysiol.1976.sp011608; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; SCHREIERMUCCILLO S, 1976, ARCH BIOCHEM BIOPHYS, V172, P1, DOI 10.1016/0003-9861(76)90041-2; Sezginer A, 1969, J MAGN RESON, V92, P504; SMITH KJ, 1982, J NEUROL SCI, V54, P13, DOI 10.1016/0022-510X(82)90215-5; Verdiyan EE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158083; Waxman SG, 1995, AXON STRUCTURE FUNCT, P325; Yusipovich AI, 2008, B EXP BIOL MED+, V145, P382, DOI 10.1007/s10517-008-0097-3	24	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185170	10.1371/journal.pone.0185170	http://dx.doi.org/10.1371/journal.pone.0185170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934355	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900111
J	Simic, M; Stephansson, O; Petersson, G; Cnattingius, S; Wikstrom, AK				Simic, Marija; Stephansson, Olof; Petersson, Gunnar; Cnattingius, Sven; Wikstrom, Anna-Karin			Slow fetal growth between first and early second trimester ultrasound scans and risk of small for gestational age (SGA) birth	PLOS ONE			English	Article							LAST MENSTRUAL PERIOD; BIPARIETAL DIAMETER; PREDICTION; RESTRICTION; 1ST-TRIMESTER; PREGNANCY; PREECLAMPSIA; DELIVERY; DOPPLER; INSULIN	Objectives To investigate the association between fetal growth between first and early second trimester ultrasound scan and the risk of severe small for gestational age (SGA) birth. Methods This cohort study included 69 550 singleton pregnancies with first trimester dating and an early second trimester growth scan in Stockholm and Gotland Counties, Sweden between 2008 and 2014. Exposure was difference in biparietal diameter growth between observed and expected at the second trimester scan, calculated by z-scores. Risk of birth of a severe SGA infant (birth weight for gestational age by fetal sex less than the 3 rd centile) was calculated using multivariable logistic regression analysis and presented as adjusted odds ratio (aOR). Results Parietal growth less than 2.5 percentile between first and second trimester ultrasound examination was associated with elevated risk of being born severe SGA. (aOR 1.67; 95% Confidence Interval 1.28-2.18). The risks of preterm severe SGA (birth before 37 weeks) and term severe SGA (birth 37 weeks or later) were at similar levels, and risk of severe SGA were also elevated in the absence of preeclampsia, hypertensive diseases or gestational diabetes. Conclusions Fetuses with slow growth of biparietal diameter at ultrasound examination in early second trimester exhibit increased risk of being born SGA independent of gestational age at birth and presence of maternal hypertensive diseases or diabetes mellitus.	[Simic, Marija; Stephansson, Olof; Petersson, Gunnar; Cnattingius, Sven; Wikstrom, Anna-Karin] Karolinska Univ Hosp & Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Stephansson, Olof] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Simic, Marija] Karolinska Univ Hosp Solna, Clin Epidemiol Unit, T2, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; University of California System; University of California Berkeley; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Simic, M (corresponding author), Karolinska Univ Hosp & Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden.; Simic, M (corresponding author), Karolinska Univ Hosp Solna, Clin Epidemiol Unit, T2, Stockholm, Sweden.	marija.simic@ki.se		Simic, Marija/0000-0002-1804-4015; Stephansson, Olof/0000-0003-1528-4563	Swedish research council [2013-2429, 2014-3561]	Swedish research council(Swedish Research CouncilEuropean Commission)	This study was supported by grant from the Swedish research council, project No. 2013-2429 (OS) and 2014-3561(to AKW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2008, ULTRASOUND OBST GYN, V32, P732, DOI 10.1002/uog.6244; ALFIREVIC Z, 1995, AM J OBSTET GYNECOL, V172, P1379, DOI 10.1016/0002-9378(95)90466-2; Baschat AA, 2010, J PERINAT MED, V38, P239, DOI [10.1515/JPM.2010.041, 10.1515/jpm.2010.041]; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Bukowski R, 2007, BMJ-BRIT MED J, V334, P836, DOI 10.1136/bmj.39129.637917.AE; Hiden U, 2012, J CLIN ENDOCR METAB, V97, P3613, DOI 10.1210/jc.2012-1212; Hiden U, 2009, CURR VASC PHARMACOL, V7, P460, DOI 10.2174/157016109789043973; Kady SM, 2004, BEST PRACT RES CL OB, V18, P397, DOI 10.1016/j.bpobgyn.2004.02.009; Kallen K, 2004, ULTRASOUND OBST GYN, V24, P30, DOI 10.1002/uog.1085; Kovo M, 2015, REPROD SCI, V22, P316, DOI 10.1177/1933719114542024; Larsen T, 2000, BRIT J OBSTET GYNAEC, V107, P238, DOI 10.1111/j.1471-0528.2000.tb11695.x; Lesmes C, 2015, ULTRASOUND OBST GYN, V46, P341, DOI 10.1002/uog.14899; Lesmes C, 2015, ULTRASOUND OBST GYN, V46, P198, DOI 10.1002/uog.14826; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Nakling J, 2002, ACTA OBSTET GYN SCAN, V81, P846, DOI 10.1034/j.1600-0412.2002.810908.x; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Pedersen NG, 2008, ULTRASOUND OBST GYN, V32, P147, DOI 10.1002/uog.6109; Pedersen NG, 2013, EUR J OBSTET GYN R B, V168, P20, DOI 10.1016/j.ejogrb.2012.12.006; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Schwartz N, 2011, J ULTRAS MED, V30, P55, DOI 10.7863/jum.2011.30.1.55; SELBING A, 1985, ACTA OBSTET GYN SCAN, V64, P593, DOI 10.3109/00016348509156368; Simic M, 2014, J PERINAT MED, V42, P247, DOI 10.1515/jpm-2013-0061; Smith GCS, 2004, JAMA-J AM MED ASSOC, V292, P2249, DOI 10.1001/jama.292.18.2249; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Smith-Bindman R, 2002, RADIOLOGY, V223, P153, DOI 10.1148/radiol.2231010876; Thorsell M, 2008, BJOG-INT J OBSTET GY, V115, P585, DOI 10.1111/j.1471-0528.2008.01678.x; Tunon K, 1999, ULTRASOUND OBST GYN, V14, P17, DOI 10.1046/j.1469-0705.1999.14010017.x; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Vintzileos AM, 2014, SEMIN PERINATOL, V38, P159, DOI 10.1053/j.semperi.2014.03.006; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]	35	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184853	10.1371/journal.pone.0184853	http://dx.doi.org/10.1371/journal.pone.0184853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934257	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900051
J	Smith, JA; Bar-Peled, M				Smith, James Amor; Bar-Peled, Maor			Synthesis of UDP-apiose in Bacteria: The marine phototroph Geminicoccus roseus and the plant pathogen Xanthomonas pisi	PLOS ONE			English	Article							D-XYLOSE SYNTHASE; BETA-D-XYLOSYLTRANSFERASE; ESCHERICHIA-COLI; GLUCURONIC ACID; PSEUDOMONAS-AERUGINOSA; RHAMNOSE BIOSYNTHESIS; EMBL-EBI; IDENTIFICATION; CLONING; POLYSACCHARIDE	The branched-chain sugar apiose was widely assumed to be synthesized only by plant species. In plants, apiose-containing polysaccharides are found in vascularized plant cell walls as the pectic polymers rhamnogalacturonan II and apiogalacturonan. Apiosylated secondary metabolites are also common in many plant species including ancestral avascular bryophytes and green algae. Apiosyl-residues have not been documented in bacteria. In a screen for new bacterial glycan structures, we detected small amounts of apiose in methanolic extracts of the aerobic phototroph Geminicoccus roseus and the pathogenic soil-dwelling bacteria Xanthomonas pisi. Apiose was also present in the cell pellet of X. pisi. Examination of these bacterial genomes uncovered genes with relatively low protein homology to plant UDP-apiose/UDP-xylose synthase (UAS). Phylogenetic analysis revealed that these bacterial UAS-like homologs belong in a clade distinct to UAS and separated from other nucleotide sugar biosynthetic enzymes. Recombinant expression of three bacterial UAS-like proteins demonstrates that they actively convert UDP-glucuronic acid to UDP-apiose and UDP-xylose. Both UDP-apiose and UDP-xylose were detectable in cell cultures of G. roseus and X. pisi. We could not, however, definitively identify the apiosides made by these bacteria, but the detection of apiosides coupled with the in vivo transcription of bUAS and production of UDP-apiose clearly demonstrate that these microbes have evolved the ability to incorporate apiose into glycans during their life-cycles. While this is the first report to describe enzymes for the formation of activated apiose in bacteria, the advantage of synthesizing apiose-containing glycans in bacteria remains unknown. The characteristics of bUAS and its products are discussed.	[Smith, James Amor; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Smith, James Amor; Bar-Peled, Maor] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Bar-Peled, M (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Bar-Peled, M (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	peled@ccrc.uga.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-12ER16324]; U.S. Department of Energy [DE-FG02-93ER20097]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	The authors acknowledge the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-FG02-12ER16324 (M.A.O and M.B-P.) for funding studies of Apiose synthesis. We also acknowledge the U.S. Department of Energy-funded Center for Plant and Microbial Complex Carbohydrates (Grant DE-FG02-93ER20097) for equipment support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beck E., 1990, Methods in Plant Biochemistry, Vol. 2: Carbohydrates., P235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Broach B, 2012, FEBS J, V279, P100, DOI 10.1111/j.1742-4658.2011.08402.x; Bystrova OV, 2006, FEMS IMMUNOL MED MIC, V46, P85, DOI 10.1111/j.1574-695X.2005.00004.x; Choi SH, 2012, J AM CHEM SOC, V134, P13946, DOI 10.1021/ja305322x; Coyne MJ, 2011, J BACTERIOL, V193, P5252, DOI 10.1128/JB.05337-11; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; Fletcher CM, 2007, P NATL ACAD SCI USA, V104, P2413, DOI 10.1073/pnas.0608797104; Foesel BU, 2007, SYST APPL MICROBIOL, V30, P581, DOI 10.1016/j.syapm.2007.05.005; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; GRISEBACH H, 1964, BIOCHEM BIOPH RES CO, V17, P737, DOI 10.1016/0006-291X(64)90423-1; Gu XG, 2011, MICROBIOL-SGM, V157, P260, DOI 10.1099/mic.0.040758-0; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; ISOGAI E, 1986, ZBL BAKT-INT J MED M, V261, P53, DOI 10.1016/S0176-6724(86)80062-1; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KNIREL YA, 1990, CRIT REV MICROBIOL, V17, P273, DOI 10.3109/10408419009105729; Kobayashi M, 2002, PLANT CELL PHYSIOL, V43, P1259, DOI 10.1093/pcp/pcf157; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li Z, 2016, J BIOL CHEM, V291, P19051, DOI 10.1074/jbc.M116.724708; MACPHERSON DF, 1994, MOL MICROBIOL, V11, P281, DOI 10.1111/j.1365-2958.1994.tb00308.x; MAROLDA CL, 1995, J BACTERIOL, V177, P5539, DOI 10.1128/jb.177.19.5539-5546.1995; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; ORTMANN R, 1972, BIOCHIM BIOPHYS ACTA, V289, P293, DOI 10.1016/0005-2744(72)90080-0; Picmanova M, 2016, GLYCOBIOLOGY, V26, P430, DOI 10.1093/glycob/cww012; Polizzi SJ, 2012, BIOCHEMISTRY-US, V51, P8844, DOI 10.1021/bi301135b; Rezanka T, 2000, PHYTOCHEMISTRY, V54, P635, DOI 10.1016/S0031-9422(00)00147-3; Rezanka T, 2013, PHYTOCHEMISTRY, V88, P34, DOI 10.1016/j.phytochem.2013.01.003; ROBERTSON BD, 1994, J BACTERIOL, V176, P6915, DOI 10.1128/JB.176.22.6915-6920.1994; SANDERMA.H, 1968, BIOCHIM BIOPHYS ACTA, V165, P552, DOI 10.1016/0304-4165(68)90239-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Smith J, 2016, J BIOL CHEM, V291, P21434, DOI 10.1074/jbc.M116.749069; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Watson R R, 1975, Adv Carbohydr Chem Biochem, V31, P135; Yang T, 2012, ANAL BIOCHEM, V421, P691, DOI 10.1016/j.ab.2011.12.028; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; Yin S, 2016, PLANT CELL REP, V35, P2403, DOI 10.1007/s00299-016-2044-5; Yin YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027995; Zheng SZ, 1998, INDIAN J CHEM B, V37, P825	47	5	5	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184953	10.1371/journal.pone.0184953	http://dx.doi.org/10.1371/journal.pone.0184953			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931093	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700045
J	Elam, WA; Cao, WX; Kang, H; Huehn, A; Hocky, GM; Prochniewicz, E; Schramm, AC; Negron, K; Garcia, J; Bonello, TT; Gunning, PW; Thomas, DD; Voth, GA; Sindelar, CV; De La Cruz, EM				Elam, W. Austin; Cao, Wenxiang; Kang, Hyeran; Huehn, Andrew; Hocky, Glen M.; Prochniewicz, Ewa; Schramm, Anthony C.; Negron, Karina; Garcia, Jean; Bonello, Teresa T.; Gunning, Peter W.; Thomas, David D.; Voth, Gregory A.; Sindelar, Charles V.; De La Cruz, Enrique M.			Phosphomimetic S3D cofilin binds but only weakly severs actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cofilin; cooperativity; molecular dynamics; spectroscopy	F-ACTIN; DEPOLYMERIZING FACTOR; MOLECULAR-DYNAMICS; KINETIC-ANALYSIS; NONCOOPERATIVE BINDING; ADF/COFILIN FAMILY; CIRCULAR-DICHROISM; PHALLOIDIN BINDING; PH SENSITIVITY; LINKED CHANGES	Many biological processes, including cell division, growth, and motility, rely on rapid remodeling of the actin cytoskeleton and on actin filament severing by the regulatory protein cofilin. Phosphorylation of vertebrate cofilin at Ser-3 regulates both actin binding and severing. Substitution of serine with aspartate at position 3 (S3D) is widely used to mimic cofilin phosphorylation in cells and in vitro. The S3D substitution weakens cofilin binding to filaments, and it is presumed that subsequent reduction in cofilin occupancy inhibits filament severing, but this hypothesis has remained untested. Here, using time-resolved phosphorescence anisotropy, electron cryomicroscopy, and all-atom molecular dynamics simulations, we show that S3D cofilin indeed binds filaments with lower affinity, but also with a higher cooperativity than wild-type cofilin, and severs actin weakly across a broad range of occupancies. We found that three factors contribute to the severing deficiency of S3D cofilin. First, the high cooperativity of S3D cofilin generates fewer boundaries between bare and decorated actin segments where severing occurs preferentially. Second, S3D cofilin only weakly alters filament bending and twisting dynamics and therefore does not introduce the mechanical discontinuities required for efficient filament severing at boundaries. Third, Ser-3 modification (i.e. substitution with Asp or phosphorylation) undocks and repositions the cofilin N terminus away from the filament axis, which compromises S3D cofilin's ability to weaken longitudinal filament subunit interactions. Collectively, our results demonstrate that, in addition to inhibiting actin binding, Ser-3 modification favors formation of a cofilin-binding mode that is unable to sufficiently alter filament mechanical properties and promote severing.	[Elam, W. Austin; Cao, Wenxiang; Kang, Hyeran; Huehn, Andrew; Schramm, Anthony C.; Negron, Karina; Garcia, Jean; Sindelar, Charles V.; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hocky, Glen M.; Voth, Gregory A.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Prochniewicz, Ewa; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Bonello, Teresa T.; Gunning, Peter W.] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Elam, W. Austin] C4 Therapeut, 675 W Kendall St, Cambridge, MA 02142 USA; [Kang, Hyeran] Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32826 USA; [Negron, Karina] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Garcia, Jean] Johns Hopkins Univ, Sch Med, Cellular & Mol Med Program, Baltimore, MD 21205 USA	Yale University; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of New South Wales Sydney; State University System of Florida; University of Central Florida; Johns Hopkins University; Johns Hopkins University	De La Cruz, EM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	enrique.delacruz@yale.edu	Gunning, Peter W/E-9058-2010; Hocky, Glen/E-9412-2012	Gunning, Peter/0000-0003-0833-3128; Thomas, David D./0000-0002-8822-2040; Negron, Karina/0000-0002-5376-7657; Hocky, Glen/0000-0002-5637-0698; Kang, Ellen/0000-0003-2785-3479	National Institutes of Health R01 Grants [GM097348, GM110533001, AR032961]; American Cancer Society [IRG5801255]; Department of Defense Army Research Office through MURI Grant [W911NF1410403]; American Heart Association Postdoctoral Fellowship; Ruth L. Kirschstein National Research Service Award (NIGMS, National Institutes of Health) [F32 GM11345-01]; National Science Foundation [DBI-1156585]; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences; NHMRC [APP1004188]; Kids Cancer Network; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032961, R37AR032961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097348, T32GM008283, R01GM110530, F32GM113415] Funding Source: NIH RePORTER	National Institutes of Health R01 Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense Army Research Office through MURI Grant; American Heart Association Postdoctoral Fellowship(American Heart Association); Ruth L. Kirschstein National Research Service Award (NIGMS, National Institutes of Health); National Science Foundation(National Science Foundation (NSF)); Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Kids Cancer Network; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 Grants GM097348 (to E. M. D. L. C.), GM110533001 (to C. V. S.), and AR032961 (to D. D. T.); American Cancer Society Grant IRG5801255 (to C. V. S.); and the Department of Defense Army Research Office through MURI Grant W911NF1410403 (on which G. A. V. and E. M. D. L. C. are co-investigators). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an American Heart Association Postdoctoral Fellowship. Present address: C4 Therapeutics, 675 W. Kendall St., Cambridge, MA 02142.; Supported by a Ruth L. Kirschstein National Research Service Award (NIGMS, National Institutes of Health, Grant F32 GM11345-01).; Supported by the National Science Foundation, Grant DBI-1156585, and by the Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences.; Supported by NHMRC Grant APP1004188 and the Kids Cancer Network.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; ALLISON SA, 1979, CHEM PHYS, V41, P35, DOI 10.1016/0301-0104(79)80131-7; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Bonello TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep19816; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Clark MG, 2006, MOL BIOL CELL, V17, P1971, DOI 10.1091/mbc.E05-10-0956; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; De la Cruz EM, 2015, BIOPHYS J, V108, P2270, DOI 10.1016/j.bpj.2015.03.058; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Gateva G, 2017, CURR BIOL, V27, P705, DOI 10.1016/j.cub.2017.01.018; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Graham JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094766; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gressin L, 2015, CURR BIOL, V25, P1437, DOI 10.1016/j.cub.2015.04.011; Hayakawa K, 2014, P NATL ACAD SCI USA, V111, P9810, DOI 10.1073/pnas.1321451111; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Hocky GM, 2016, J PHYS CHEM B, V120, P4558, DOI 10.1021/acs.jpcb.6b02741; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jansen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8202; Kanellos G, 2016, J CELL SCI, V129, P3211, DOI 10.1242/jcs.187849; Kang HR, 2014, P NATL ACAD SCI USA, V111, P17821, DOI 10.1073/pnas.1413397111; Kang H, 2013, BIOPHYS J, V105, P2621, DOI 10.1016/j.bpj.2013.10.032; Kang HR, 2012, P NATL ACAD SCI USA, V109, P16923, DOI 10.1073/pnas.1211078109; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P1226, DOI 10.1021/bi00354a006; Lakowicz J., 1983, PRINCIPLES FLUORESCE, p[98, 353]; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Maciver SK, 1998, EUR J BIOCHEM, V256, P388, DOI 10.1046/j.1432-1327.1998.2560388.x; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mayhood TW, 2005, ANAL BIOCHEM, V345, P187, DOI 10.1016/j.ab.2005.07.032; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pope BJ, 2000, J MOL BIOL, V298, P649, DOI 10.1006/jmbi.2000.3688; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Prochniewicz E, 1999, BIOCHEMISTRY-US, V38, P14860, DOI 10.1021/bi991343g; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schramm AC, 2017, BIOPHYS J, V112, P2624, DOI 10.1016/j.bpj.2017.05.016; SCHURR JM, 1984, CHEM PHYS, V84, P71, DOI 10.1016/0301-0104(84)80007-5; Shukla VK, 2015, BIOCHEM J, V465, P63, DOI 10.1042/BJ20140923; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Vitriol EA, 2013, MOL BIOL CELL, V24, P2238, DOI 10.1091/mbc.E13-03-0156; Wioland H, 2017, CURR BIOL, V27, P1956, DOI 10.1016/j.cub.2017.05.048; Yehl J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44506; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	76	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19565	19579		10.1074/jbc.M117.808378	http://dx.doi.org/10.1074/jbc.M117.808378			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28939776	hybrid, Green Published			2022-12-26	WOS:000416911300003
J	Malmlov, A; Seetahal, J; Carrington, C; Ramkisson, V; Foster, J; Miazgowicz, KL; Quackenbush, S; Rovnak, J; Negrete, O; Munster, V; Schountz, T				Malmlov, Ashley; Seetahal, Janine; Carrington, Christine; Ramkisson, Vernie; Foster, Jerome; Miazgowicz, Kerri L.; Quackenbush, Sandra; Rovnak, Joel; Negrete, Oscar; Munster, Vincent; Schountz, Tony			Serological evidence of arenavirus circulation among fruit bats in Trinidad	PLOS ONE			English	Article							GUANARITO VIRUS ARENAVIRIDAE; TACARIBE VIRUS; EXPERIMENTAL-INFECTION; HOST ASSOCIATIONS; ETIOLOGIC AGENT; IMMUNOLOGY; MURIDAE	Tacaribe virus (TCRV) was isolated in the 1950s from artibeus bats captured on the island of Trinidad. The initial characterization of TCRV suggested that artibeus bats were natural reservoir hosts. However, nearly 60 years later experimental infections of Jamaican fruit bats (Artibeus jamaicensis) resulted in fatal disease or clearance, suggesting artibeus bats may not be a reservoir host. To further evaluate the TCRV reservoir host status of artibeus bats, we captured bats of six species in Trinidad for evidence of infection. Bats of all four fruigivorous species captured had antibodies to TCRV nucleocapsid, whereas none of the insectivore or nectarivore species did. Many flat-faced fruit-eating bats (A. planirostris) and great fruit-eating bats (A. literatus) were seropositive by ELISA and western blot to TCRV nucleocapsid antigen, as were two of four Seba's fruit bats (Carollia perspicillata) and two of three yellow-shouldered fruit bats (Sturnira lilium). Serum neutralization tests failed to detect neutralizing antibodies to TCRV from these bats. TCRV RNA was not detected in lung tissues or lung homogenates inoculated onto Vero cells. These data indicate that TCRV or a similar arenavirus continues to circulate among fruit bats of Trinidad but there was no evidence of persistent infection, suggesting artibeus bats are not reservoir hosts.	[Malmlov, Ashley; Schountz, Tony] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA; [Malmlov, Ashley; Quackenbush, Sandra; Rovnak, Joel; Schountz, Tony] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Seetahal, Janine; Carrington, Christine; Ramkisson, Vernie; Foster, Jerome] Univ West Indies, Fac Med Sci, Dept Preclin Sci, St Augustine, Trinidad Tobago; [Miazgowicz, Kerri L.; Negrete, Oscar] Sandia Natl Labs, Biotechnol & Bioengn, Livermore, CA USA; [Munster, Vincent] NIAID, Virus Ecol Unit, Virol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	Colorado State University; Colorado State University; University West Indies Mona Jamaica; University West Indies Saint Augustine; United States Department of Energy (DOE); Sandia National Laboratories; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schountz, T (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.; Schountz, T (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	tony.schountz@colostat.edu	Munster, Vincent/I-7607-2018	Munster, Vincent/0000-0002-2288-3196; Foster, Jerome/0000-0001-5699-3791; Carrington, Christine/0000-0001-6533-9302	NIH [AI089419]; NIH Emerging Virus Diseases Unit [AI25489]; University of Northern Colorado Provost Fund; Colorado State University; NIAID intramural research program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089419, N01AI025489, ZIAAI001179, ZIAAI001190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Emerging Virus Diseases Unit; University of Northern Colorado Provost Fund; Colorado State University; NIAID intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by NIH grant AI089419 (TS), NIH Emerging Virus Diseases Unit contract AI25489 (TS), and the University of Northern Colorado Provost Fund (TS), Colorado State University, NIAID intramural research program (VM).; This work was supported by NIH grant AI089419 (TS), NIH Emerging Virus Diseases Unit contract AI25489 (TS), and the University of Northern Colorado Provost Fund (TS), Colorado State University, NIAID intramural research program (VM). We also thank Partap Seenath and Kirk Amour of the Anti-Rabies Unit of the Ministry of Agriculture, Trinidad and Tobago.	ALLISON LMC, 1991, J GEN VIROL, V72, P2025, DOI 10.1099/0022-1317-72-8-2025; Amman BR, 2015, J WILDLIFE DIS, V51, P113, DOI 10.7589/2014-08-198; Basu Asoke K., 2017, pXIII; Bowen MD, 1996, VIROLOGY, V219, P285, DOI 10.1006/viro.1996.0248; Bratsch S, 2011, DEV COMP IMMUNOL, V35, P421, DOI 10.1016/j.dci.2010.06.004; Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12; DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Easterbrook JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000172; Fulhorst CF, 1997, AM J TROP MED HYG, V56, P548; Fulhorst CF, 2001, AM J TROP MED HYG, V65, P147, DOI 10.4269/ajtmh.2001.65.147; Fulhorst CF, 1999, J INFECT DIS, V180, P966, DOI 10.1086/315029; Fulhorst CF, 1999, AM J TROP MED HYG, V61, P325, DOI 10.4269/ajtmh.1999.61.325; Gard G., 2009, COMMUNICATION; Gomes G.A., 2015, BATS TRINIDAD TOBAGO; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Harmon B, 2013, J BIOL CHEM, V288, P8702, DOI 10.1074/jbc.M112.444760; JUSTINES G, 1969, NATURE, V222, P1090, DOI 10.1038/2221090a0; Kollars TM, 2000, J PARASITOL, V86, P1156, DOI 10.1645/0022-3395(2000)086[1156:HAASAO]2.0.CO;2; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; McGuire A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100286; MORRISON DW, 1980, J MAMMAL, V61, P20, DOI 10.2307/1379953; Paweska JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045479; PRICE JL, 1978, AM J TROP MED HYG, V27, P162, DOI 10.4269/ajtmh.1978.27.162; Sayler KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115769; Schountz T, 2007, EMERG INFECT DIS, V13, P1604, DOI 10.3201/eid1310.070383; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Schountz T, 2014, VIRUSES-BASEL, V6, P4880, DOI 10.3390/v6124880; Schountz T, 2014, VIRUSES-BASEL, V6, P1317, DOI 10.3390/v6031317; Spengler JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055310; TESH RB, 1994, AM J TROP MED HYG, V50, P452, DOI 10.4269/ajtmh.1994.50.452	31	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185308	10.1371/journal.pone.0185308	http://dx.doi.org/10.1371/journal.pone.0185308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953976	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300055
J	Brooks, HM; Paul, MKJ; Claude, KM; Mocanu, V; Hawkes, MT				Brooks, Hannah Myfanwy; Paul, Makelele Katsuva Jean; Claude, Kasereka Masumbuko; Mocanu, Victor; Hawkes, Michael T.			Use and disuse of malaria bed nets in an internally displaced persons camp in the Democratic Republic of the Congo: A mixed methods study	PLOS ONE			English	Article							REFUGEE CAMPS; INSECTICIDE; MORTALITY	Introduction Malaria is a major cause of morbidity and mortality among displaced populations in tropical zones. Bed nets are widely used to prevent malaria; however, few data are available on bed net distribution within displaced populations. Methods Mixed methods study in a single internally displaced persons (IDP) camp and neighboring community in Eastern Democratic Republic of the Congo (DRC). Qualitative data (focus group discussions, FGDs) and quantitative data (door-to-door survey and individual testing using malaria rapid diagnostic test, RDT) were collected. Results Ten FGDs were conducted with 55 individuals. Although malaria was widely recognized as a significant threat and bed nets were freely distributed in the camp, many households did not own or use them. IDPs converged on the following reasons for low bed net ownership and use: inconvenience of net installation and sale of nets to meet immediate needs such as food. One hundred households, comprised of 411 individuals, were surveyed in Birambizo. The burden of malaria was high (45/78 (58%) of children < 5 were positive for malaria by RDT) and bed net utilization was low (29/100 (29%) households owned a bed net, and 85/411 (20%) individuals slept under a bed net the previous night). Children < 5 were more likely to use a bed net than older children or adults (OR 3.4 (95% CI 2.0-5.8), p< 0.0001). Compared to 29 bed nets currently in use by study participants, 146 bed nets had been sold (82%) or exchanged (18%) either in the camp (27%) or in the neighbouring village market (73%). Conclusions Qualitative descriptions and quantitative analysis revealed pragmatic barriers to bed net usage and widespread sale of freely distributed bed nets within IDP camps, despite a high burden of malaria. Additional strategies, beyond bed net distribution, are warranted to combat malaria in vulnerable and hard-to-reach population.	[Brooks, Hannah Myfanwy; Hawkes, Michael T.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Paul, Makelele Katsuva Jean] Med Sans Frontieres, Goma, DEM REP CONGO; [Claude, Kasereka Masumbuko] Univ Catholique Graben, Butembo, DEM REP CONGO; [Mocanu, Victor] Univ Alberta, Dept Sci, Edmonton, AB, Canada; [Hawkes, Michael T.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Hawkes, MT (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	mthawkes@ualberta.ca	, Michael/AAP-3049-2020	Hawkes, Michael/0000-0002-4122-0937; Kasereka, Masumbuko/0000-0003-1367-3426				[Anonymous], 1998, COCHRANE DB SYST REV; [Anonymous], 2010, GUID TREATM MAL; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Birganie AB, 2010, HUM RIGHTS LAW REV, V10, P179, DOI 10.1093/hrlr/ngp042; Brooks HMJP, 2017, MALARIA INTERNALLY D; Burns M, 2012, AM J TROP MED HYG, V87, P242, DOI 10.4269/ajtmh.2012.11-0744; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Charchuk R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1479-z; CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377; CIA, 2016, REF INT DISPL PERS; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Coghlan B, 2009, DISASTER MED PUBLIC, V3, P88, DOI 10.1097/DMP.0b013e3181a6e952; Democratic Republic of the Congo, 2015, WORLD FACTBOOK; Eijk AM, 2015, LANCET GLOB HLTH, V3; Filmer D., 1998, ESTIMATING WEALTH EF; Gobena T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-914; Graham K, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-25; Graham K, 2002, MED VET ENTOMOL, V16, P404, DOI 10.1046/j.1365-2915.2002.00395.x; Hamze H, 2016, PATHOGENS GLOBAL HLT; Hawkes M, 2009, MALAR J, V8; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; IDMC, 2016, GLOB INT DISPL DAT; INTERNAL DISPLACEMENT MONITORING CENTRE (IDMC), 2015, INF GLOB 2015 DESPL; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Koenker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097496; Malaria RB, 2013, MIS PACKAGE HOUSEHOL; Martin AIC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003181; Mattern C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151068; Messenger LA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1867-z; Njau JD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-245; Obembe A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-514; Obol JH, 2013, AFR HEALTH SCI, V13, P962, DOI 10.4314/ahs.v13i4.15; Olack B, 2015, RISK FACTORS HYPERTE; Ordinioha B, 2012, ANN AFR MED, V11, P163, DOI 10.4103/1596-3519.96879; Pluess B, 2010, INDOOR RESIDUAL SPRA; Rowland M, 2001, ANN TROP MED PARASIT, V95, P741, DOI 10.1080/00034980120103405; Sadasivaiah S, 2007, AM J TROP MED HYG, V77, P249, DOI 10.4269/ajtmh.2007.77.249; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sexton AR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-157; Sharifi-Mood B, 2015, INT J INFECT, V2; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Spencer S, 2004, T ROY SOC TROP MED H, V98, P719, DOI 10.1016/j.trstmh.2004.01.012; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Tiono AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-30; UNHCR, 2016, REF FLOW BORD; UNHCR, 2016, OFF UN HIGH COMM REF; United Nations High Commissioner for Refugees (UNHCR), 2014, WORLD WAR; World Health Organization (WHO), 2016, WORLD MAL REP 2016, P186, DOI DOI 10.4135/9781452276151.N221; Zhou GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1512-2	49	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185290	10.1371/journal.pone.0185290	http://dx.doi.org/10.1371/journal.pone.0185290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950001	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000035
J	Ermakov, EA; Smirnova, LP; Bokhan, NA; Semke, AV; Ivanova, SA; Buneva, VN; Nevinsky, GA				Ermakov, Evgeny A.; Smirnova, Ludmila P.; Bokhan, Nikolay A.; Semke, Arkadiy V.; Ivanova, Svetlana A.; Buneva, Valentina N.; Nevinsky, Georgy A.			Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia	PLOS ONE			English	Article							ERYTHEMATOSUS MOLECULAR-CLONING; MYELIN BASIC-PROTEIN; KAPPA LIGHT-CHAINS; CATALYTIC ANTIBODIES; OXIDOREDUCTASE ACTIVITIES; MULTIPLE-SCLEROSIS; LIPID-PEROXIDATION; SYNAPTIC PROTEINS; IMMUNE-SYSTEM; AUTOIMMUNITY	We present first evidence showing that some electrophoretically homogeneous IgGs from the sera of patients with schizophrenia (36.4%) and their Fab and F(ab)(2) fragments as well as from healthy donors (33.3%) possess catalase activity. The relative catalase activity of IgGs from the sera of individual schizophrenia patients (and healthy donors) significantly varied from patient to patient, but the activity of IgGs from healthy donors is on average 15.8-fold lower than that for schizophrenia patients. After extensive dialysis of purified IgGs against EDTA chelating metal ions, the relative catalase activity of IgGs decreases on average approximately 2.5-3.7-fold; all IgGs possess metal-dependent and independent catalase activity. The addition of external Me2+ ions to dialyzed and non-dialyzed IgGs leads to a significant increase in their activity. The best activator of dialyzed and non-dialyzed IgGs is Co2+, the activation by Cu2+, Mn2+, and Ni2+ ions were rare and always lower than by Co2+. Every IgG preparation demonstrates several individual sets of very well expressed pH optima in the pH range from 4.0 to 9.5. These data speak for the individual repertoire of catalase IgGs in every person and an extreme diversity of abzymes in their pH optima and activation by different metal ions. It is known that antioxidant enzymes such as superoxide dismutases, catalases, and glutathione peroxidases represent critical defense mechanisms preventing oxidative modifications of DNA, proteins, and lipids. Catalase activity of human IgGs could probably also play a major role in the protection of organisms from oxidative stress and toxic compounds.	[Ermakov, Evgeny A.; Buneva, Valentina N.; Nevinsky, Georgy A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia; [Ermakov, Evgeny A.; Buneva, Valentina N.; Nevinsky, Georgy A.] Novosibirsk State Univ, Novosibirsk, Russia; [Smirnova, Ludmila P.; Bokhan, Nikolay A.; Semke, Arkadiy V.; Ivanova, Svetlana A.] Russian Acad Sci, Mental Hlth Res Inst, Tomsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Tomsk National Research Medical Center; Mental Health Research Institute, Tomsk	Nevinsky, GA (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia.; Nevinsky, GA (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	nevinsky@niboch.nsc.ru	Semke, Arkady/GPS-6258-2022; Nevinsky, Georgy/E-6053-2012; Ivanova, Svetlana/C-5333-2012; Buneva, Valentina Nikolaevna/I-6329-2012; Semke, Arkady V./B-1714-2016; Smirnova, Liudmila Pavlovna/C-9026-2012; Bokhan, Nikolai/P-1720-2014; Ermakov, Evgeny E.A./D-8982-2015	Ivanova, Svetlana/0000-0001-7078-323X; Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Smirnova, Liudmila Pavlovna/0000-0003-0083-9124; Bokhan, Nikolai/0000-0002-1052-855X; Ermakov, Evgeny E.A./0000-0002-1084-6419; Semke, Arkady V./0000-0002-8698-0251	SB RAS omplex Scientific Program [II.2Pi/VI.57-5 (0309-2015-0022)]; Russian Foundation for Basic Research [16-04-00603]; RSF [14-15-00480]	SB RAS omplex Scientific Program; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RSF(Russian Science Foundation (RSF))	This research was made possible in part by grants from partially under SB RAS omplex Scientific Program, II.2 Pi/VI.57-5 (0309-2015-0022), Russian Foundation for Basic Research (16-04-00603), Grant of RSF (14-15-00480: a part of work corresponding to collection of the sera of schizophrenia patients, purification of antibodies and their partial characterization was done). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was made possible in part by grants from partially under SB RAS Complex scientific program, II.2 Pi/VI.57-5 (0309-2015-0022), Russian Foundation for Basic Research (16-04-00603), Grant of RSF (14-15-00480: a part of work corresponding to collection of the sera of schizophrenia patients, purification of antibodies and their partial characterization was done).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Andrievskaya O A, 2000, Med Sci Monit, V6, P460; Andrievskaya OA, 2002, IMMUNOL LETT, V81, P191, DOI 10.1016/S0165-2478(02)00006-8; Andryushkova AA, 2007, J CELL MOL MED, V11, P531, DOI 10.1111/j.1582-4934.2007.00048.x; [Anonymous], 2000, DIAGN STAT MAN MENT, P299; Baranovskii AG, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1239; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Bezuglova AM, 2012, INT IMMUNOL, V24, P759, DOI 10.1093/intimm/dxs071; Bezuglova AM, 2011, J MOL RECOGNIT, V24, P960, DOI 10.1002/jmr.1143; Boksha I, 2012, SPECIFIC METABOLISM, P1; Burbaeva GS, 2002, PROG NEURO-PSYCHOPH, V26, P427, DOI 10.1016/S0278-5846(01)00273-1; Carson VB, 1995, MENTAL HLTH NURSING, P368; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S; Deakin J, 2014, BIOL PSYCHIAT, V75, P284, DOI 10.1016/j.biopsych.2013.07.018; Drexhage RC, 2011, INT J NEUROPSYCHOPH, V14, P746, DOI 10.1017/S1461145710001653; Ermakov EA, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150064; Eschenko ND, 2004, BIOCH PSYCHIAT NEURO, P1; Fedorenko O, 2009, PSYCHOPHARMACOLOGY, V206, P429, DOI 10.1007/s00213-009-1621-5; Fersht A., 1985, ENZYME STRUCTURE MEC; FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Generalov II, 1999, SERYYA BIYALAGICHNYK, V1, P90; Ghadermarzi M, 1996, J ENZYM INHIB, V10, P167, DOI 10.3109/14756369609030310; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Goldner EM, 2002, CAN J PSYCHIAT, V47, P833, DOI 10.1177/070674370204700904; Harlow T, 1988, ANTIBODIES ALABORATO, P630; Harris D.C., 2002, QUANTITATIVE CHEM AN, V6th ed.; Hifumi E, 2017, FASEB J, V31, P1668, DOI 10.1096/fj.201600819R; Hifumi E, 2016, FASEB J, V30, P895, DOI 10.1096/fj.15-276394; Ikhmyangan EN, 2005, FEBS LETT, V579, P3960, DOI 10.1016/j.febslet.2005.06.020; Ikhmyangan EN, 2006, IMMUNOPATHOLOGY ALLE, V2, P32; Ikhmyangan EN, 2006, J MOL RECOGNIT, V19, P432, DOI 10.1002/jmr.787; Ivanova SA, 2014, PROCEDIA CHEM, V10, P80, DOI 10.1016/j.proche.2014.10.015; Ivanova SA, 2014, NEUROCHEM J+, V8, P66, DOI 10.1134/S1819712414010061; Jenkins TA, 2009, BEHAV BRAIN RES, V205, P355, DOI 10.1016/j.bbr.2009.07.014; KALAGA R, 1995, J IMMUNOL, V155, P2695; Keinan E, 2021, ASIACHEM, V2, P96; KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343; Kliushnik TP, 2007, ZH NEVROL PSIKHIATR, V108, P61; Kneisl C, 2009, CONT PSYCHIAT MENTAL; Koch M, 2007, EUR J NEUROL, V14, P529, DOI 10.1111/j.1468-1331.2007.01739.x; Kohda K, 1997, FEBS LETT, V407, P280, DOI 10.1016/S0014-5793(97)00338-4; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Kostrikina IA, 2014, BBA-GEN SUBJECTS, V1840, P1725, DOI 10.1016/j.bbagen.2014.01.027; Krotenko NV, 2007, ACTUAL PROBLEMS PSYC, V13, P108; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; LIEBERMAN JA, 1990, SCHIZOPHRENIA BULL, V16, P97, DOI 10.1093/schbul/16.1.97; Mates J M, 1999, Front Biosci, V4, pD339; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Morkovkin VM, 1988, PATHOCHEMISTRY SCHIZ, P1; Nevinsky GA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P945, DOI 10.1134/S0006297909090028; Nevinsky G.A., 2017, LUPUS; Nevinsky G.A., 2010, AUTOIMMUNE DIS SYMPT, P1; Nevinsky G.A., 2011, UNDERSTANDING HIVAID, P151, DOI DOI 10.5772/22294; Nevinsky G.A., 2005, CATALYTIC ANTIBODIES, P503; Nevinsky GA, 2003, J CELL MOL MED, V7, P265, DOI 10.1111/j.1582-4934.2003.tb00227.x; Nevinsky GA, 2016, MULT SCLER, P151; Nevinsky GA, 2012, ADV NEUROIMMUNE BIOL, V3, P157, DOI 10.3233/NIB-2012-012042; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Planque SA, 2014, J BIOL CHEM, V289, P13243, DOI 10.1074/jbc.M114.557231; Polosukhina DI, 2005, MED SCI MONITOR, V11, pBR266; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; PRILIPKO LL, 1982, VESTN AKAD MED NAUK+, P33; Reynolds LM, 2011, J PSYCHIATR RES, V45, P54, DOI 10.1016/j.jpsychires.2010.05.001; Ryazantseva NV, 2004, PATHOLOGY CELL MEMBR, P1; Savel'ev AN, 1999, PROTEIN PEPTIDE LETT, V6, P179; [Щеглова Т.В. Shcheglova T.V.], 2011, [Российский иммунологический журнал, Russian Journal of Immunology, Rossiiskii immunologicheskii zhurnal], V5, P11; Sies H., 1991, OXIDATIVE STRESS OXI; Smirnova LP, 2011, BIOCHEM MOSC-SUPPL S, V5, P76, DOI 10.1134/S1990750811010136; Smirnova LP, 2008, SIBERIAN HERALD PSYC, V1, P133; Steiner J, 2015, CNS DRUGS, V29, P197, DOI 10.1007/s40263-015-0233-3; Strous RD, 2006, AUTOIMMUN REV, V6, P54, DOI 10.1016/j.autrev.2006.07.002; Strous RD, 2006, J AUTOIMMUN, V27, P71, DOI 10.1016/j.jaut.2006.07.006; Timofeeva AM, 2016, MOL BIOSYST, V12, P3556, DOI 10.1039/c6mb00573j; Timofeeva AM, 2015, INT IMMUNOL, V27, P633, DOI 10.1093/intimm/dxv042; Timofeeva AM, 2015, J MOL RECOGNIT, V28, P614, DOI 10.1002/jmr.2476; Tolmacheva AS, 2015, J MOL RECOGNIT, V28, P565, DOI 10.1002/jmr.2474; Tolmacheva AS, 2009, J MOL RECOGNIT, V22, P26, DOI 10.1002/jmr.923; Velligan DI, 2008, PSYCHIAT TIMES, V25, P3; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Waziri R, 1999, SCHIZOPHR RES, V37, P205, DOI 10.1016/S0920-9964(98)00169-8; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wood SJ, 2009, ANN ACAD MED SINGAP, V38, P396; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P1999, DOI 10.1089/ars.2010.3646; YUDELEVICH IG, 1984, SPECTROCHIM ACTA B, V39, P777, DOI 10.1016/0584-8547(84)80086-5; Zenkov N.K., 2001, OXIDATIVE STRESS BIO, P3; Zhil'tsov I V, 1998, Zh Mikrobiol Epidemiol Immunobiol, P73	96	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0183867	10.1371/journal.pone.0183867	http://dx.doi.org/10.1371/journal.pone.0183867			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945759	Green Published, gold, Green Submitted			2022-12-26	WOS:000411645100004
J	Kepchia, D; Sherman, B; Haddad, R; Luetje, CW				Kepchia, Devin; Sherman, Benjamin; Haddad, Rafi; Luetje, Charles W.			Mammalian odorant receptor tuning breadth persists across distinct odorant panels	PLOS ONE			English	Article							MOUSE OLFACTORY RECEPTOR; KEY FOOD ODORANT; FUNCTIONAL EXPRESSION; RANGE; BROAD; IDENTIFICATION; CONDUCTANCE; MOR256-17; SYSTEM	The molecular receptive range (MRR) of a mammalian odorant receptor (OR) is the set of odorant structures that activate the OR, while the distribution of these odorant structures across odor space is the tuning breadth of the OR. Variation in tuning breadth is thought to be an important property of ORs, with the MRRs of these receptors varying from narrowly to broadly tuned. However, defining the tuning breadth of an OR is a technical challenge. For practical reasons, a screening panel that broadly covers odor space must be limited to sparse coverage of the many potential structures in that space. When screened with such a panel, ORs with different odorant specificities, but equal tuning breadths, might appear to have different tuning breadths due to chance. We hypothesized that ORs would maintain their tuning breadths across distinct odorant panels. We constructed a new screening panel that was broadly distributed across an estimated odor space and contained compounds distinct from previous panels. We used this new screening panel to test several murine ORs that were previously characterized as having different tuning breadths. ORs were expressed in Xenopus laevis oocytes and assayed by two-electrode voltage clamp electrophysiology. MOR256-17, an OR previously characterized as broadly tuned, responded to nine novel compounds from our new screening panel that were structurally diverse and broadly dispersed across an estimated odor space. MOR256-22, an OR previously characterized as narrowly tuned, responded to a single novel compound that was structurally similar to a previously known ligand for this receptor. MOR174-9, a well-characterized receptor with a narrowly tuned MRR, did not respond to any novel compounds in our new panel. These results support the idea that variation in tuning breadth among these three ORs is not an artifact of the screening protocol, but is an intrinsic property of the receptors.	[Kepchia, Devin; Sherman, Benjamin; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Haddad, Rafi] Bar Ilan Univ, Leslie & Susan Goldschmied Gonda Multidisciplinar, Ramat Gan, Israel	University of Miami; Bar Ilan University	Luetje, CW (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu			National Institutes of Health [R01 DC008119]; Israel Science Foundation as part of the ISF-UGC joint program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation as part of the ISF-UGC joint program	This work was supported by a grant from the National Institutes of Health [R01 DC008119 to CWL] and by the Israel Science Foundation as part of the ISF-UGC joint program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; Bavan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092064; Bohbot JD, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00039; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Dahoun T, 2011, BIOCHEMISTRY-US, V50, P7228, DOI 10.1021/bi2008596; Dunkel A, 2014, ANGEW CHEM INT EDIT, V53, P7124, DOI 10.1002/anie.201309508; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Geithe C, 2017, CHEM SENSES, V42, P181, DOI 10.1093/chemse/bjw117; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Haddad R, 2010, J NEUROSCI, V30, P9017, DOI 10.1523/JNEUROSCI.0398-10.2010; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Li JY, 2015, J NEUROCHEM, V134, P47, DOI 10.1111/jnc.13095; Li JY, 2012, J NEUROCHEM, V121, P881, DOI 10.1111/j.1471-4159.2012.07740.x; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Noe F, 2017, CHEM SENSES, V42, P195, DOI 10.1093/chemse/bjw118; Repicky SE, 2009, J NEUROCHEM, V109, P193, DOI 10.1111/j.1471-4159.2009.05925.x; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Tazir B, 2016, EUR J NEUROSCI, V43, P608, DOI 10.1111/ejn.13153; Trimmer C, 2017, CHEM SENSES, V42, P177, DOI 10.1093/chemse/bjx002; UEZONO Y, 1993, RECEPTOR CHANNEL, V1, P233; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185329	10.1371/journal.pone.0185329	http://dx.doi.org/10.1371/journal.pone.0185329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945824	gold, Green Submitted, Green Published			2022-12-26	WOS:000411645100047
J	Arca-Suarez, J; Galan-Sanchez, F; Marin-Casanova, P; Rodriguez-Iglesias, MA				Arca-Suarez, Jorge; Galan-Sanchez, Fatima; Marin-Casanova, Pilar; Rodriguez-Iglesias, Manuel A.			Direct identification of microorganisms from thioglycolate broth by MALDI-TOF MS	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION IONIZATION-TIME; POSITIVE BLOOD CULTURES; MICROBIOLOGY; PERFORMANCE; INFECTIONS; BACTERIA; PATHOGEN	We developed an easy MALDI-TOF MS-based assay to identify microorganisms directly from thioglycolate broth. A total of 101 positive thioglycolate broths inoculated with 15 different kinds of samples were evaluated. In 91 samples (90.1%), direct MALDI-TOF MS identifications were the same as those obtained after conventional laboratory procedures including subcultures. In 10 samples misidentified by direct processing, yeasts or mixed cultures grew in the thioglycolate subcultures, or high cellular debris hampered a correct analysis. This rapid method can provide a fast, clinically-relevant species-level identification without disturbing the daily workflow in clinical microbiology laboratories.	[Arca-Suarez, Jorge; Galan-Sanchez, Fatima; Marin-Casanova, Pilar; Rodriguez-Iglesias, Manuel A.] Hosp Univ Puerta Mar, Lab Microbiol, Cadiz, Spain; [Galan-Sanchez, Fatima; Rodriguez-Iglesias, Manuel A.] Univ Cadiz, Area Microbiol, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz	Galan-Sanchez, F (corresponding author), Hosp Univ Puerta Mar, Lab Microbiol, Cadiz, Spain.; Galan-Sanchez, F (corresponding author), Univ Cadiz, Area Microbiol, Cadiz, Spain.	fatima.galan@uca.es	Arca-Suárez, Jorge/ABG-5575-2021; Galán-Sánchez, Fátima/AAT-1475-2021	Galán-Sánchez, Fátima/0000-0003-0101-6701; Arca-Suarez, Jorge/0000-0002-4248-503X				Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Barlam TF, 2016, CLIN INFECT DIS, V62, P1197, DOI 10.1093/cid/ciw217; Buchan BW, 2013, J CLIN MICROBIOL, V51, P1359, DOI 10.1128/JCM.03105-12; Chen JHK, 2013, J CLIN MICROBIOL, V51, P1733, DOI 10.1128/JCM.03259-12; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; CLAROS MC, 1995, J CLIN MICROBIOL, V33, P2505, DOI 10.1128/JCM.33.9.2505-2507.1995; Dhiman N, 2011, J CLIN MICROBIOL, V49, P1614, DOI 10.1128/JCM.02381-10; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P546, DOI 10.1111/j.1469-0691.2010.03257.x; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Lagace-Wiens PRS, 2012, J CLIN MICROBIOL, V50, P3324, DOI 10.1128/JCM.01479-12; Lallemand E, 2016, EUR J CLIN MICROBIOL, V35, P857, DOI 10.1007/s10096-016-2608-x; Martinez RM, 2014, J CLIN MICROBIOL, V52, P2521, DOI 10.1128/JCM.00529-14; Moussaoui W, 2010, CLIN MICROBIOL INFEC, V16, P1631, DOI 10.1111/j.1469-0691.2010.03356.x; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Segawa S, 2014, CLIN CHIM ACTA, V435, P59, DOI 10.1016/j.cca.2014.04.024; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589	19	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185229	10.1371/journal.pone.0185229	http://dx.doi.org/10.1371/journal.pone.0185229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934331	gold, Green Submitted, Green Published			2022-12-26	WOS:000411339900128
J	Khayer, N; Marashi, SA; Mirzaie, M; Goshadrou, F				Khayer, Nasibeh; Marashi, Sayed-Amir; Mirzaie, Mehdi; Goshadrou, Fatemeh			Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; COLONY-STIMULATING FACTOR; AMYLOID-BETA-PEPTIDE; MAST-CELLS; MICROARRAY DATA; UP-REGULATION; COEXPRESSION ANALYSIS; COGNITIVE IMPAIRMENT; RHEUMATOID-ARTHRITIS; REGULATORY NETWORKS	Alzheimer's disease (AD) is the most common cause for dementia in human. Currently, more than 46 million people in the world suffer from AD and it is estimated that by 2050 this number increases to more than 131 million. AD is considered as a complex disease. Therefore, understanding the mechanism of AD is a universal challenge. Nowadays, a huge number of disease-related high-throughput "omics" datasets are freely available. Such datasets contain valuable information about disease-related pathways and their corresponding gene interactions. In the present work, a three-way interaction model is used as a novel approach to understand AD-related mechanisms. This model can trace the dynamic nature of co-expression relationship between two genes by introducing their link to a third gene. Apparently, such relationships cannot be traced by the classical two-way interaction model. Liquid association method was applied to capture the statistically significant triplets which are involved in three-way interaction. Subsequently, gene set enrichment analysis (GSEA) and gene regulatory network (GRN) inference were applied to analyze the biological relevance of the statistically significant triplets. The results of this study suggest that the innate immunity processes are important in AD. Specifically, our results suggest that H2-Ob as the switching gene and the gene pair {Csf1r, Milr1} form a statistically significant and biologically relevant triplet, which may play an important role in AD. We propose that the homeostasis-related link between mast cells and microglia is presumably controlled with H2-Ob expression levels as a switching gene.	[Khayer, Nasibeh; Goshadrou, Fatemeh] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Dept Basic Sci, Tehran, Iran; [Marashi, Sayed-Amir] Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran; [Marashi, Sayed-Amir] Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran; [Mirzaie, Mehdi] Tarbiat Modares Univ, Fac Math Sci, Dept Appl Math, Tehran, Iran	Shahid Beheshti University Medical Sciences; University of Tehran; Tarbiat Modares University	Marashi, SA (corresponding author), Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran.; Marashi, SA (corresponding author), Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran.	marashi@ut.ac.ir	Marashi, Sayed-Amir/A-5384-2008; Goshadrou, Fatemeh/AAU-1568-2021	Marashi, Sayed-Amir/0000-0001-9801-7449; Mirzaie, Mehdi/0000-0003-4434-5118; Khayer, Nasibeh/0000-0002-3524-8589				Adamec E, 2000, NEUROSCIENCE, V100, P663, DOI 10.1016/S0306-4522(00)00281-5; AKIYAMA H, 1994, BRAIN RES, V639, P171, DOI 10.1016/0006-8993(94)91779-5; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alcolea D, 2015, NEUROLOGY, V85, P626, DOI 10.1212/WNL.0000000000001859; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Cerrato S, 2010, VET IMMUNOL IMMUNOP, V133, P9, DOI 10.1016/j.vetimm.2009.06.011; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Dong HQ, 2014, MOL NEUROBIOL, V49, P1487, DOI 10.1007/s12035-014-8697-6; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; Fernandez-Botran R, 2011, PARKINSONISM RELAT D, V17, P683, DOI 10.1016/j.parkreldis.2011.06.007; Fernandez-Flores A, 2016, J AM ACAD DERMATOL, V74, P536, DOI 10.1016/j.jaad.2015.09.038; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Garcia I, 2011, MOL DIVERS, V15, P561, DOI 10.1007/s11030-010-9280-3; Gentleman R., 2015, GENEFILTER METHODS F; GEULA C, 1995, ALZ DIS ASSOC DIS, V9, P23, DOI 10.1097/00002093-199501002-00005; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gunderson T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0371-5; Harcha PA, 2015, J NEUROSCI, V35, P9526, DOI 10.1523/JNEUROSCI.3686-14.2015; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hilla AM, 2017, J NEUROSCI, V37, P6113, DOI 10.1523/JNEUROSCI.0584-17.2017; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Ho YY, 2011, BIOMETRICS, V67, P133, DOI 10.1111/j.1541-0420.2010.01440.x; Jiang X, 2016, RHEUMATOLOGY, V55, P149, DOI 10.1093/rheumatology/kev285; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang YJ, 2013, BRIT J HAEMATOL, V163, P343, DOI 10.1111/bjh.12544; Kayano M, 2009, BIOINFORMATICS, V25, P2735, DOI 10.1093/bioinformatics/btp531; Korolainen MA, 2010, J NEUROCHEM, V112, P1386, DOI 10.1111/j.1471-4159.2009.06558.x; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li KC, 2002, P NATL ACAD SCI USA, V99, P16875, DOI 10.1073/pnas.252466999; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Lopez-Gonzalez I, 2015, J NEUROPATH EXP NEUR, V74, P319, DOI 10.1097/NEN.0000000000000176; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Mirza Z, 2014, CNS NEUROL DISORD-DR, V13, P501, DOI 10.2174/18715273113126660154; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Murphy GM, 2000, AM J PATHOL, V157, P895, DOI 10.1016/S0002-9440(10)64603-2; MYLLYKANGASLUOSUJARVI R, 1994, BRIT J RHEUMATOL, V33, P501; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076160; Niederhoffer N, 2009, INT J IMMUNOPATH PH, V22, P473, DOI 10.1177/039463200902200224; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Qiu YH, 2015, HUM IMMUNOL, V76, P753, DOI 10.1016/j.humimm.2015.09.033; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Ray M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r148; Ray M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-136; Remo A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0492-2; Rentzos M, 2012, ACTA NEUROL SCAND, V125, P77, DOI 10.1111/j.1600-0404.2011.01524.x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Sanmartin C, 2011, CURR MED CHEM, V18, P4635, DOI 10.2174/092986711797379249; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shendre A, 2014, GENES IMMUN, V15, P534, DOI 10.1038/gene.2014.47; Souwer Y, 2009, BRIT J HAEMATOL, V145, P334, DOI 10.1111/j.1365-2141.2009.07625.x; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Wes PD, 2016, GLIA, V64, P1710, DOI 10.1002/glia.22988; Willse JT, 2014, PACKAGE CTT; Wirz KTS, 2014, J ALZHEIMERS DIS, V38, P719, DOI 10.3233/JAD-130920; Xu ZP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03766; Yuan HB, 2010, J NEUROSCI RES, V88, P1348, DOI 10.1002/jnr.22304; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang JX, 2007, BIOINFORMATICS, V23, P2903, DOI 10.1093/bioinformatics/btm482; Zhang S, 2012, CELL PHYSIOL BIOCHEM, V29, P931, DOI 10.1159/000171029; Zhang X, 2016, CELL PHYSIOL BIOCHEM, V38, P1520, DOI 10.1159/000443093; Zhang ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122851; Zhou XHJ, 2005, NAT BIOTECHNOL, V23, P238, DOI 10.1038/nbt1058	88	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184697	10.1371/journal.pone.0184697	http://dx.doi.org/10.1371/journal.pone.0184697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934252	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900039
J	Lundgren, H; Martinsson, K; Cederbrant, K; Jirholt, J; Mucs, D; Madeyski-Bengtson, K; Havarinasab, S; Hultman, P				Lundgren, Hanna; Martinsson, Klara; Cederbrant, Karin; Jirholt, Johan; Mucs, Daniel; Madeyski-Bengtson, Katja; Havarinasab, Said; Hultman, Per			HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity	PLOS ONE			English	Article							INDUCED LIVER-INJURY; HLA CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; NONVALVULAR ATRIAL-FIBRILLATION; DIRECT THROMBIN INHIBITOR; DRUG HYPERSENSITIVITY; STROKE PREVENTION; PEPTIDE REPERTOIRE; RISK-FACTORS; GENOME-WIDE	The oral thrombin inhibitor ximelagatran was withdrawn in the late clinical trial phase because it adversely affected the liver. In approximately 8% of treated patients, drug-induced liver injury (DILI) was expressed as transient alanine transaminase (ALT) elevations. No evidence of DILI had been revealed in the pre-clinical in vivo studies. A whole genome scan study performed on the clinical study material identified a strong genetic association between the major histocompatibility complex alleles for human leucocyte antigens (HLA) (HLA-DR7 and HLA-DQ2) and elevated ALT levels in treated patients. An immunemediated pathogenesis was suggested. Here, we evaluated whether HLA transgenic mice models could be used to investigate whether the expression of relevant HLA molecules was enough to reproduce the DILI effects in humans. In silico modelling performed in this study revealed association of both ximelagatran (pro-drug) and melagatran (active drug) to the antigen-presenting groove of the homology modelled HLA-DR7 molecule suggesting "altered repertoire" as a key initiating event driving development of DILI in humans. Transgenic mouse strains (tgms) expressing HLA of serotype HLA-DR7 (HLA-DRB1*0701, -DRA*0102), and HLA-DQ2 (HLA-DQB1*0202, -DQA1*0201) were created. These two lines were crossed with a human (h) CD4 transgenic line, generating the two tgms DR7xhCD4 and DQ2xhCD4. To investigate whether the DILI effects observed in humans could be reproduced in tgms, the mice were treated for 28 days with ximelagatran. Results revealed no signs of DILI when biomarkers for liver toxicity were measured and histopathology was evaluated. In the ximelagatran case, presence of relevant HLA-expression in a preclinical model did not fulfil the prerequisite for reproducing DILI observed in patients. Nonetheless, for the first time an HLA-transgenic mouse model has been investigated for use in HLA-associated DILI induced by a low molecular weight compound. This study shows that mimicking of genetic susceptibility, expressed as DILI-associated HLA-types in mice, is not sufficient for reproducing the complex pathogenesis leading to DILI in man.	[Lundgren, Hanna; Cederbrant, Karin; Havarinasab, Said; Hultman, Per] Linkoping Univ, Div Mol & Immunol Pathol, Dept Clin & Expt Med, Fac Hlth Sci,Ostergotland Cty Council, Linkoping, Sweden; [Martinsson, Klara] Linkoping Univ, AIR Rheumatol Unit, Dept Clin & Expt Med, Fac Hlth Sci,Ostergotland Cty Council, Linkoping, Sweden; [Cederbrant, Karin; Mucs, Daniel] Karolinska Inst, Swetox, Unit Toxicol Sci, Sodertalje, Sweden; [Jirholt, Johan; Madeyski-Bengtson, Katja] AstraZeneca R&D, Transgen Ctr, Molndal, Sweden	City Council Ostergotland; Linkoping University; City Council Ostergotland; Linkoping University; Karolinska Institutet; AstraZeneca	Cederbrant, K (corresponding author), Linkoping Univ, Div Mol & Immunol Pathol, Dept Clin & Expt Med, Fac Hlth Sci,Ostergotland Cty Council, Linkoping, Sweden.; Cederbrant, K (corresponding author), Karolinska Inst, Swetox, Unit Toxicol Sci, Sodertalje, Sweden.	Karin.Cederbrant@swetox.se		Mucs, Daniel/0000-0002-7370-926X	AstraZeneca; AstraZeneca R&D as part of safety problem-solving activities initiated for ximelagatran (Exanta(R))	AstraZeneca(AstraZeneca); AstraZeneca R&D as part of safety problem-solving activities initiated for ximelagatran (Exanta(R))(AstraZeneca)	The funder of this study AstraZeneca provided support in the form of salaries for authors (HL, KC, KM, JJ, KMB) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This work was financed by AstraZeneca R&D as part of the safety problem-solving activities initiated for ximelagatran (Exanta (R)). The plasmid Pdoi5 was a kind gift from Dr C. Benoist. The pathology readings were kindly carried out by pathologist Frank Seeliger at AstraZeneca Safety Assessment (Sweden) and all the blood and tissue samplings were carried out by the staff from the AstraZeneca animal department (Sodertalje, Sweden).	Agnelli G, 2009, THROMB RES, V123, P488, DOI 10.1016/j.thromres.2008.02.017; Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Alfirevic A, 2012, GENOME MED, V4, DOI 10.1186/gm350; ALTMANN DM, 1995, J EXP MED, V181, P867, DOI 10.1084/jem.181.3.867; Andersson U, 2009, BIOMARKERS, V14, P572, DOI 10.3109/13547500903261354; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bharadwaj M, 2012, ANNU REV PHARMACOL, V52, P401, DOI 10.1146/annurev-pharmtox-010611-134701; Chakraborty M, 2015, HEPATOLOGY, V62, P546, DOI 10.1002/hep.27764; Chen Z, 2006, TISSUE ANTIGENS, V68, P210, DOI 10.1111/j.1399-0039.2006.00656.x; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Cullberg M, 2005, CLIN PHARMACOL THER, V77, P279, DOI 10.1016/j.clpt.2004.11.001; Daly AK, 2009, SEMIN LIVER DIS, V29, P400, DOI 10.1055/s-0029-1240009; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Eriksson BI, 2003, J THROMB HAEMOST, V1, P2490, DOI 10.1111/j.1538-7836.2003.00494.x; Eriksson UG, 2003, DRUG METAB DISPOS, V31, P294, DOI 10.1124/dmd.31.3.294; Ford GA, 2007, STROKE, V38, P2965, DOI 10.1161/STROKEAHA.107.488007; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Harper AR, 2012, NAT BIOTECHNOL, V30, P1117, DOI 10.1038/nbt.2424; Hughes CA, 2008, ANN PHARMACOTHER, V42, P387, DOI 10.1345/aph.1K522; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Karlin E, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0418-0; Keisu M, 2010, Handb Exp Pharmacol, P407, DOI 10.1007/978-3-642-00663-0_13; Kenne K, 2008, TOXICOL IN VITRO, V22, P730, DOI 10.1016/j.tiv.2007.11.014; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Klitz W, 2003, TISSUE ANTIGENS, V62, P296, DOI 10.1034/j.1399-0039.2003.00103.x; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Lee WM, 2005, DRUG SAFETY, V28, P351, DOI 10.2165/00002018-200528040-00006; Luckey D, 2011, J AUTOIMMUN, V37, P122, DOI 10.1016/j.jaut.2011.05.001; MADDON PJ, 1987, P NATL ACAD SCI USA, V84, P9155, DOI 10.1073/pnas.84.24.9155; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mangalam AK, 2008, ADV IMMUNOL, V97, P65, DOI 10.1016/S0065-2776(08)00002-3; Martin-Murphy BV, 2010, TOXICOL LETT, V192, P387, DOI 10.1016/j.toxlet.2009.11.016; Metushi IG, 2015, HEPATOLOGY, V61, P1332, DOI 10.1002/hep.27549; Monshi MM, 2013, HEPATOLOGY, V57, P727, DOI 10.1002/hep.26077; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; PANINABORDIGNON P, 1992, J EXP MED, V176, P1779, DOI 10.1084/jem.176.6.1779; Pavlos R, 2012, PHARMACOGENOMICS, V13, P1285, DOI [10.2217/PGS.12.108, 10.2217/pgs.12.108]; Petersen P, 2003, J AM COLL CARDIOL, V41, P1445, DOI 10.1016/S0735-1097(03)00255-9; Robles-Diaz M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00267; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Sonderstrup G, 1999, IMMUNOL REV, V172, P335, DOI 10.1111/j.1600-065X.1999.tb01377.x; Southworth H, 2014, STAT MED, V33, P2914, DOI 10.1002/sim.6142; Spraggs CF, 2012, CLIN PHARMACOL THER, V91, P647, DOI 10.1038/clpt.2011.277; Taneja V, 2010, IMMUNOL REV, V233, P62, DOI 10.1111/j.0105-2896.2009.00858.x; Ulrich RG, 2007, ANNU REV MED, V58, P17, DOI 10.1146/annurev.med.58.072905.160823; YAMAMOTO K, 1994, J EXP MED, V180, P165, DOI 10.1084/jem.180.1.165; YEUNG RSM, 1994, J EXP MED, V180, P1911, DOI 10.1084/jem.180.5.1911; Yip VLM, 2015, CLIN REV ALLERG IMMU, V48, P165, DOI 10.1007/s12016-014-8418-y; Zhou RR, 2012, EXP MOL PATHOL, V93, P213, DOI 10.1016/j.yexmp.2012.05.006	56	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184744	10.1371/journal.pone.0184744	http://dx.doi.org/10.1371/journal.pone.0184744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934241	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900042
J	Ortega, A; Tarazon, E; Gil-Cayuela, C; Garcia-Manzanares, M; Martinez-Dolz, L; Lago, F; Gonzalez-Juanatey, JR; Cinca, J; Jorge, E; Portoles, M; Rosello-Lleti, E; Rivera, M				Ortega, Ana; Tarazon, Estefania; Gil-Cayuela, Carolina; Garcia-Manzanares, Maria; Martinez-Dolz, Luis; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Cinca, Juan; Jorge, Esther; Portoles, Manuel; Rosello-Lleti, Esther; Rivera, Miguel			Intercalated disc in failing hearts from patients with dilated cardiomyopathy: Its role in the depressed left ventricular function	PLOS ONE			English	Article							ALPHA-T-CATENIN; GENE-EXPRESSION DATA; ELECTRON-MICROSCOPY; GAP-JUNCTIONS; FAILURE; CONDUCTION; MUTATIONS; QUANTIFICATION; HYPERTROPHY; GUIDELINES	Alterations in myocardial structure and reduced cardiomyocyte adhesions have been previously described in dilated cardiomyopathy (DCM). We studied the transcriptome of cell adhesion molecules in these patients and their relationships with left ventricular (LV) function decay. We also visualized the intercalated disc (ID) structure and organization. The transcriptomic profile of 23 explanted LV samples was analyzed using RNA-sequencing (13 DCM, 10 control [CNT]), focusing on cell adhesion genes. Electron microscopy analysis to visualize ID structural differences and immunohistochemistry experiments of ID proteins was also performed. RT-qPCR and western blot experiments were carried out on ID components. We found 29 differentially expressed genes, most of all, constituents of the ID structure. We found that the expression of GJA3, DSP and CTNNA3 was directly associated with LV ejection fraction (r = 0.741, P = 0.004; r = 0.674, P = 0.011 and r = 0.565, P = 0.044, respectively), LV systolic (P = 0.003, P = 0.003, P = 0.028, respectively) and diastolic dimensions (P = 0.006, P = 0.001, P = 0.025, respectively). Electron microscopy micrographs showed a reduced ID convolution index and immunogold labeling of connexin 46 (GJA gene), desmoplakin (DSP gene) and catenin alpha-3 (CTNNA3 gene) proteins in DCM patients. Moreover, we observed that protein and mRNA levels analyzed by RT-qPCR of these ID components were diminished in DCM group. In conclusion, we report significant gene and protein expression changes and found that the ID components GJA3, DSP and CTNNA3 were highly related to LV function. Microscopic observations indicated that ID is structurally compromised in these patients. These findings give new data for understanding the ventricular depression that characterizes DCM, opening new therapeutic perspectives for these critically diseased patients.	[Ortega, Ana; Tarazon, Estefania; Gil-Cayuela, Carolina; Garcia-Manzanares, Maria; Portoles, Manuel; Rosello-Lleti, Esther; Rivera, Miguel] Hlth Res Inst La Fe, Cardiocirculatory Unit, Valencia, Spain; [Ortega, Ana; Tarazon, Estefania; Gil-Cayuela, Carolina; Garcia-Manzanares, Maria; Martinez-Dolz, Luis; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Cinca, Juan; Jorge, Esther; Portoles, Manuel; Rosello-Lleti, Esther; Rivera, Miguel] Ctr Biomed Res Network Cardiovasc Dis CIBERCV, Madrid, Spain; [Martinez-Dolz, Luis] Univ & Polytech La Fe Hosp, Heart Failure & Transplantat Unit, Cardiol Dept, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Cellular & Mol Cardiol Res Unit, Dept Cardiol, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Cinca, Juan; Jorge, Esther] Santa Creu & St Pau Hosp, Cardiol Serv, Barcelona, Spain	Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Rivera, M (corresponding author), Hlth Res Inst La Fe, Cardiocirculatory Unit, Valencia, Spain.; Rivera, M (corresponding author), Ctr Biomed Res Network Cardiovasc Dis CIBERCV, Madrid, Spain.	miguelrivera492@gmail.com	Ortega, Ana AO/D-3027-2017; Ortega, Ana/AAG-5941-2020; Dolz, Luis Martinez/X-4627-2018; PORTOLES, MANUEL/B-4789-2009; Tarazón, Estefanía/D-6950-2017; Roselló Lletí, Esther/ABG-8503-2020; jorge, esther/D-4206-2014	Ortega, Ana AO/0000-0002-9763-0505; Ortega, Ana/0000-0002-9763-0505; Dolz, Luis Martinez/0000-0001-5145-8191; PORTOLES, MANUEL/0000-0002-4415-7160; Tarazón, Estefanía/0000-0003-3466-2558; Roselló Lletí, Esther/0000-0003-2627-6104; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; jorge, esther/0000-0002-2777-0000	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" [PI13/00100, PI14/01506]; CIBERCV [CB16/11/00261]; European Regional Development Fund (FEDER); RETICS [12/0042/0003]	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III"; CIBERCV; European Regional Development Fund (FEDER)(European Commission); RETICS	This work was supported by the National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" [PI13/00100; PI14/01506], CIBERCV [CB16/11/00261], the European Regional Development Fund (FEDER), and RETICS [12/0042/0003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Basso C, 2006, EUR HEART J, V27, P1847, DOI 10.1093/eurheartj/ehl095; Bauce B, 2005, EUR HEART J, V26, P1666, DOI 10.1093/eurheartj/ehi341; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chi NC, 2010, P NATL ACAD SCI USA, V107, P14662, DOI 10.1073/pnas.0909432107; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fry CH, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1198, DOI 10.1161/CIRCEP.114.001471; Garcia-Pavia P, 2011, HEART, V97, P1744, DOI 10.1136/hrt.2011.227967; Goossens S, 2007, J CELL SCI, V120, P2126, DOI 10.1242/jcs.004713; Herrer I, 2014, LAB INVEST, V94, P645, DOI 10.1038/labinvest.2014.54; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; Janssens B, 2003, HUM GENET, V112, P227, DOI 10.1007/s00439-002-0857-5; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kanno S, 2001, CARDIOVASC PATHOL, V10, P169, DOI 10.1016/S1054-8807(01)00078-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucocq J, 2008, METHOD CELL BIOL, V88, P59, DOI 10.1016/S0091-679X(08)00404-4; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Ortega A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160168; Ortega A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107635; Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosello-Lleti E, 2015, J CELL MOL MED, V19, P442, DOI 10.1111/jcmm.12477; Severs NJ, 2002, J CARD FAIL, V8, pS293, DOI 10.1054/jcaf.2002.129255; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Tomas M, 2002, J NEUROCHEM, V83, P601, DOI 10.1046/j.1471-4159.2002.01167.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vermij SH, 2017, CARDIOVASC RES, V113, P259, DOI 10.1093/cvr/cvw259; Wang XJ, 1999, J MOL CELL CARDIOL, V31, P333, DOI 10.1006/jmcc.1998.0886; Wilson A, 2014, CELL MOL LIFE SCI, V71, P165, DOI 10.1007/s00018-013-1374-5; Yamada KA, 2003, J CARDIOVASC ELECTR, V14, P1205, DOI 10.1046/j.1540-8167.2003.03276.x; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6	39	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185062	10.1371/journal.pone.0185062	http://dx.doi.org/10.1371/journal.pone.0185062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934278	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900082
J	Sabry, AH; Hasan, WZW; Kadir, MZAA; Radzi, MAM; Shafie, S				Sabry, Ahmad H.; Hasan, W. Z. W.; Kadir, M. Z. A. Ab.; Radzi, M. A. M.; Shafie, S.			DC-based smart PV-powered home energy management system based on voltage matching and RF module	PLOS ONE			English	Article							BIDIRECTIONAL INVERTER; APPLIANCES	The main tool for measuring system efficiency in homes and offices is the energy monitoring of the household appliances' consumption. With the help of GUI through a PC or smart phone, there are various applications that can be developed for energy saving. This work describes the design and prototype implementation of a wireless PV-powered home energy management system under a DC-distribution environment, which allows remote monitoring of appliances' energy consumptions and power rate quality. The system can be managed by a central computer, which obtains the energy data based on XBee RF modules that access the sensor measurements of system components. The proposed integrated prototype framework is characterized by low power consumption due to the lack of components and consists of three layers: XBee-based circuit for processing and communication architecture, solar charge controller, and solar-battery-load matching layers. Six precise analogue channels for data monitoring are considered to cover the energy measurements. Voltage, current and temperature analogue signals were accessed directly from the remote XBee node to be sent in real time with a sampling frequency of 11-123 Hz to capture the possible surge power. The performance shows that the developed prototype proves the DC voltage matching concept and is able to provide accurate and precise results.	[Sabry, Ahmad H.] Univ Putra Malaysia, Fac Engn, Control & Automat, Serdang, Malaysia; [Hasan, W. Z. W.; Kadir, M. Z. A. Ab.; Radzi, M. A. M.; Shafie, S.] Univ Putra Malaysia, Fac Engn, Serdang, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Sabry, AH (corresponding author), Univ Putra Malaysia, Fac Engn, Control & Automat, Serdang, Malaysia.; Hasan, WZW (corresponding author), Univ Putra Malaysia, Fac Engn, Serdang, Malaysia.	ahs4771384@gmail.com; wanzuha@upm.edu.my	Hassan, Wan Zuha Wan/AAD-8694-2020; Kadir, Zainal/B-6629-2009; Radzi, Mohd Amran Mohd/I-7637-2013; Sabry, Ahmad H./ACN-4519-2022	Hassan, Wan Zuha Wan/0000-0003-4691-066X; Kadir, Zainal/0000-0001-7263-2953; Radzi, Mohd Amran Mohd/0000-0003-3785-1573; Sabry, Ahmad H./0000-0002-2736-5582; Shafie, Suhaidi/0000-0002-8867-2754	GERAN PUTRA University Putra Malaysia [9399822/ 12000RM]	GERAN PUTRA University Putra Malaysia	This work was supported by the GERAN PUTRA University Putra Malaysia [grant number 9399822/ 12000RM]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MA, 2015, ENERGIES, V8, P8716, DOI 10.3390/en8088716; Bai YW, 2008, P INT S CONS EL; Bian D, 2014, 2014 IEEE PES INNOVATIVE SMART GRID TECHNOLOGIES CONFERENCE (ISGT); Chobot E., 2013, IJESA, V3, P1; Ciabattoni L, 2015, NEUROCOMPUTING, V170, P296, DOI 10.1016/j.neucom.2015.01.086; Erol-Kantarci M, 2011, IEEE T SMART GRID, V2, P314, DOI 10.1109/TSG.2011.2114678; Gholase V, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P696, DOI 10.1109/ICIT.2015.7125179; Gudi N, 2012, INT J ELEC POWER, V43, P185, DOI 10.1016/j.ijepes.2012.05.023; Han J, 2009, IEEE INT C CONS EL; Jiang BN, 2015, IEEE T SMART GRID, V6, P3, DOI 10.1109/TSG.2014.2347043; Lien CH, 2007, IEEE T CONSUM ELECTR, V53, P1634, DOI 10.1109/TCE.2007.4429263; Lien CH, 2008, IEEE IMTC P, P2179, DOI 10.1109/IMTC.2008.4547409; Lobaccaro G, 2016, ENERGIES, V9, DOI 10.3390/en9050348; Lucia O, 2013, IEEE J EM SEL TOP P, V1, P315, DOI 10.1109/JESTPE.2013.2283224; Nazabal JA, 2013, C EXH 2013 INT C NEW; OEM RF Modules, 2005, MAXSTREAM, P1; Sabry Ahmad H., 2015, Applied Mechanics and Materials, V785, P225, DOI 10.4028/www.scientific.net/AMM.785.225; Sabry A. H., 2015, J APPL MECH MAT, V785, P156; Sabry AH, 2015, ARPN J ENG APPL SCI, V10, P6424; Serra H, 2005, 2005 IEEE International Workshop on Intelligent Signal Processing (WISP), P128; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Whaite S, 2015, ENERGIES, V8, P4378, DOI 10.3390/en8054378; Wu TF, 2013, IEEE T POWER ELECTR, V28, P5098, DOI 10.1109/TPEL.2013.2245681; Wu TF, 2013, IEEE T POWER ELECTR, V28, P1890, DOI 10.1109/TPEL.2012.2206057; Wu TF, 2010, IEEE T POWER ELECTR, V25, P1915, DOI 10.1109/TPEL.2010.2043542; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157	26	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185012	10.1371/journal.pone.0185012	http://dx.doi.org/10.1371/journal.pone.0185012			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934271	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000411339900075
J	Sim, WJ; Ang, AS; Tan, MC; Xiang, WW; Foo, D; Loh, KK; Jafary, FH; Watson, TJ; Ong, PJL; Ho, HH				Sim, Wen Jun; Ang, An Shing; Tan, Mae Chyi; Xiang, Wen Wei; Foo, David; Loh, Kwok Kong; Jafary, Fahim Haider; Watson, Timothy James; Ong, Paul Jau Lueng; Ho, Hee Hwa			Causes of delay in door-to-balloon time in south-east Asian patients undergoing primary percutaneous coronary intervention	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; PRIMARY PCI; MORTALITY; ANGIOPLASTY; STRATEGIES	Objective To evaluate causes and impact of delay in the door-to-balloon (D2B) time for patients undergoing primary percutaneous coronary intervention (PPCI). Subjects and methods From January 2009 to December 2012, 1268 patients (86% male, mean age of 58 +/- 12 years) presented to our hospital for ST-elevation myocardial infarction (STEMI) and underwent PPCI. They were divided into two groups: Non-delay defined as D2B time <= 90 mins and delay group defined as D2B time > 90 mins. Data were collected retrospectively on baseline clinical characteristics, mode of presentation, angiographic findings, therapeutic modality and inhospital outcome. Results 202 patients had delay in D2B time. There were more female patients in the delay group. They were older and tend to self-present to hospital. They were less likely to be smokers and have a higher prevalence of prior MI. The incidence of posterior MI was higher in the delay group. They also had a higher incidence of triple vessel disease. The 3 most common reasons for D2B delay was delay in the emergency department (39%), atypical clinical presentation (37.6%) and unstable medical condition requiring stabilisation/ computed tomographic imaging (26.7%). The inhospital mortality was numerically higher in the delay group (7.4% versus 4.8%, p = 0.12). Conclusions Delay in D2B occurred in 16% of our patients undergoing PPCI. Several key factors for delay were identified and warrant further intervention.	[Sim, Wen Jun; Ang, An Shing; Tan, Mae Chyi; Foo, David; Loh, Kwok Kong; Jafary, Fahim Haider; Watson, Timothy James; Ong, Paul Jau Lueng; Ho, Hee Hwa] Tan Tock Seng Hosp, Dept Cardiol, Singapore, Singapore; [Xiang, Wen Wei] Tan Tock Seng Hosp, Clin Res & Innovat Off, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital	Ho, HH (corresponding author), Tan Tock Seng Hosp, Dept Cardiol, Singapore, Singapore.	hokai_wah@yahoo.com						Angeja BG, 2002, AM J CARDIOL, V89, P1156, DOI 10.1016/S0002-9149(02)02296-8; Bates ER, 2013, NEW ENGL J MED, V369, P889, DOI 10.1056/NEJMp1308772; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Bhatia Lovleen C, 2013, J Cardiovasc Dis Res, V4, P107, DOI 10.1016/j.jcdr.2012.07.003; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Gregoratos G, 2001, Am J Geriatr Cardiol, V10, P345, DOI 10.1111/j.1076-7460.2001.00641.x; Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503; Levine GN, 2016, J AM COLL CARDIOL, V67, P1235, DOI 10.1016/j.jacc.2015.10.005; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Miedema MD, 2011, CIRCULATION, V124, P1636, DOI 10.1161/CIRCULATIONAHA.111.033118; Parikh SV, 2008, AM HEART J, V155, P290, DOI 10.1016/j.ahj.2007.10.021; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Ricci B, 2016, CURR PHARM DESIGN, V22, P3877, DOI 10.2174/1381612822666160309115125; RICH MW, 1989, CHEST, V96, P489, DOI 10.1378/chest.96.3.489; Swaminathan RV, 2013, J AM COLL CARDIOL, V61, P1688, DOI 10.1016/j.jacc.2012.11.073; Wu EB, 2008, CATHETER CARDIO INTE, V71, P152, DOI 10.1002/ccd.21315	19	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185186	10.1371/journal.pone.0185186	http://dx.doi.org/10.1371/journal.pone.0185186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934306	gold, Green Submitted, Green Published			2022-12-26	WOS:000411339900114
J	Xu, QH; Shi, WZ; Xie, YH; Wang, ZF; Li, XS; Tong, CX				Xu, Qinghai; Shi, Wanzhong; Xie, Yuhong; Wang, Zhenfeng; Li, Xusheng; Tong, Chuanxin			Identification of low-overpressure interval and its implication to hydrocarbon migration: Case study in the Yanan sag of the Qiongdongnan Basin, South China Sea	PLOS ONE			English	Article							KRISHNA-GODAVARI BASIN; ORGANIC-MATTER MATURATION; PORE-PRESSURE PREDICTION; GEOPRESSURE PREDICTION; SEISMIC DATA; WELL LOGS; INDIA; YINGGEHAI; GENERATION; SYSTEMS	The Qiongdongnan Basin is a strongly overpressured basin with the maximum pressure coefficient (the ratio of the actual pore pressure versus hydrostatic pressure at the same depth) over 2.27. However, there exists a widespread low-overpressure interval between the strong overpressure intervals in the Yanan Sag of western basin. The mechanisms of the low-overpressure interval are not well understood. Three main approaches, pore pressure test data and well-log analysis, pressure prediction based on the relationship between the deviation of the velocity and the pressure coefficients, and numerical modeling, were employed to illustrate the distribution and evolution of the low-overpressure interval. And we analyzed and explained the phenomenon of the low-overpressure interval that is both underlain and overlain by high overpressure internal. The low-overpressure interval between the strong overpressure intervals can be identified and modelled by drilling data of P-wave sonic and the mud weight, and the numerical modeling using the PetroMod software. Results show that the low-overpressure interval is mainly composed of sandstone sediments. The porosities of sandstone in the low-overpressure interval primarily range from 15%-20%, and the permeabilities range from 10-100 md. Analysis of the geochemical parameters of C1, iC4/nC4, Delta R3, and numerical modeling shows that oil and gas migrated upward into the sandstone in the low-overpressure interval, and then migrated along the sandstone of low-overpressure interval into the Yacheng uplift. The low-overpressure both underlain and overlain by overpressure resulted from the fluids migrating along the sand-stones in the low-overpressure interval into the Yacheng uplift since 1.9Ma. The mudstone in the strong overpressure interval is good cap overlain the sandstone of low-overpressure interval, therefore up-dip pinchouts or isolated sandstone in the low-overpressure interval locating the migration path of oil and gas are good plays for hydrocarbon exploration.	[Xu, Qinghai; Shi, Wanzhong] China Univ Geosci, Minist Educ, Key Lab Tecton & Petr Resources, Wuhan, Hubei, Peoples R China; [Xu, Qinghai; Shi, Wanzhong] China Univ Geosci, Fac Earth Resources, Wuhan, Hubei, Peoples R China; [Xie, Yuhong; Wang, Zhenfeng; Li, Xusheng; Tong, Chuanxin] CNOOC, Zhanjiang Co, Beijing, Peoples R China	China University of Geosciences; China University of Geosciences; China National Offshore Oil Corporation (CNOOC)	Shi, WZ (corresponding author), China Univ Geosci, Minist Educ, Key Lab Tecton & Petr Resources, Wuhan, Hubei, Peoples R China.; Shi, WZ (corresponding author), China Univ Geosci, Fac Earth Resources, Wuhan, Hubei, Peoples R China.	shiwz@cug.edu.cn			Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan); Ministry of Science and Technology of China [2011ZX05023-004-010]	Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan)(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was jointly supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan), and the 12th "five-year" plan of the Ministry of Science and Technology of China (2011ZX05023-004-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was jointly supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan), and the 12th "five-year" plan of the Ministry of Science and Technology of China (2011ZX05023-004-010). The authors would like to express their sincere appreciations to Keyu Liu of Commonwealth Scientific and Industrial Research Organization (CSIRO) Australia for his valuable suggestions. We also thank the Editor Iratxe Puebla and two reviewers who give helpful comments and suggestions.	Belotti P., 1978, J OIL GAS, V21, P76; Carcione JM, 2003, GEOPHYSICS, V68, P1569, DOI 10.1190/1.1620631; Chatterjee R, 2011, NAT HAZARDS, V57, P121, DOI 10.1007/s11069-010-9659-6; Chen HH, 1998, AAPG BULL, V82, P757; Chen HH, 2003, GEOFLUIDS, V3, P177, DOI 10.1046/j.1468-8123.2003.00061.x; Das B, 2017, INT J ROCK MECH MIN, V93, P30, DOI 10.1016/j.ijrmms.2016.12.018; Dasgupta S, 2016, AAPG BULL, V100, P1833, DOI 10.1306/05131615170; Dasgupta S, 2016, MAR PETROL GEOL, V78, P493, DOI 10.1016/j.marpetgeo.2016.10.004; [杜学斌 Du Xuebin], 2010, [大地构造与成矿学, Geotectonica et Metallogenia], V34, P554; Dutta NC, 2002, GEOPHYSICS, V67, P2012, DOI 10.1190/1.1527101; Eaton B. A, 1972, WORLD OIL, V185, P51; Fu N., 2005, PETROLEUM EXPLORATIO, V32, P34; Guo XW, 2010, AAPG BULL, V94, P1859, DOI 10.1306/05191009179; HAO F, 1995, AAPG BULL, V79, P551; Hao F, 1998, J PETROL GEOL, V21, P427, DOI 10.1111/j.1747-5457.1998.tb00794.x; Hao F., 2001, SCI CHINA SER D, V31, P471; Hermanrud C, 1998, AAPG MEMOIR, V70, P65; Kan TK, 2001, GEOPHYSICS, V66, P1937, DOI 10.1190/1.1487135; [李纯泉 Li Chunquan], 2002, [新疆石油地质, Xinjiang Petroleum Geology], V23, P389; [李绪深 Li Xushen], 2005, [地质科技情报, Geological Science and Techology Information], V24, P70; [李宗亮 LI Zongliang], 2008, [新疆石油地质, Xinjiang Petroleum Geology], V29, P753; Muggeridge A, 2005, AAPG BULL, V89, P61, DOI 10.1306/07300403002; Pennebaker E. S, 1968, WORLD OIL, V166, P73; Sayers CM, 2002, GEOPHYSICS, V67, P1286, DOI 10.1190/1.1500391; Shi WZ, 2013, J ASIAN EARTH SCI, V66, P150, DOI 10.1016/j.jseaes.2012.12.037; Singha DK, 2014, GEOCHEM GEOPHY GEOSY, V15, P1009, DOI 10.1002/2013GC005162; Tingay MRP, 2009, AAPG BULL, V93, P51, DOI 10.1306/08080808016; Wilkinson M, 2006, AAPG BULL, V90, P1945, DOI 10.1306/06270605178; Xiao J., 2007, J OIL GAS TECHNOLOGY, V29, P7; Xiao XM, 2006, ORG GEOCHEM, V37, P990, DOI 10.1016/j.orggeochem.2006.06.001; Xie X. N., 1999, SCI CHINA SER D, V29, P247; [谢玉洪 Xie Yuhong], 2011, [天然气工业, Natural Gas Industry], V31, P21; Yuan Y, 2009, MAR PETROL GEOL, V26, P1152, DOI 10.1016/j.marpetgeo.2008.08.008; Zhang T., 1999, ACTA SEDIMENTOL SINI, V17, P627; Zhu G. H., 2000, CHINA OFFSHORE OIL G, V14, P29; [祝建军 ZHU Jianjun], 2011, [天然气地球科学, Natural Gas Geoscience], V22, P324; Zhu W. L, 2007, PETROLEUM PRINT, P145; 杨计海, 1999, [天然气工业, Natural Gas Industry], V19, P39	38	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183676	10.1371/journal.pone.0183676	http://dx.doi.org/10.1371/journal.pone.0183676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934237	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900013
J	Barington, M; Brorson, MM; Hofman-Bang, J; Rasmussen, SK; Holst, B; Feldt-Rasmussen, U				Barington, Maria; Brorson, Marianne Moller; Hofman-Bang, Jacob; Rasmussen, Se Krogh; Holst, Birgitte; Feldt-Rasmussen, Ulla			Ghrelin-mediated inhibition of the TSH-stimulated function of differentiated human thyrocytes ex vivo	PLOS ONE			English	Article							PITUITARY-THYROID AXIS; AGOUTI-RELATED PROTEIN; BODY-MASS INDEX; METABOLIC PARAMETERS; CIRCULATING GHRELIN; PLASMA GHRELIN; NEUROPEPTIDE-Y; MESSENGER-RNA; FOOD-INTAKE; ENERGY HOMEOSTASIS	Ghrelin is a peptide hormone produced mainly in the gastrointestinal tract known to regulate several physiological functions including gut motility, adipose tissue accumulation and hunger sensation leading to increased bodyweight. Studies have found a correlation between the plasma levels of thyroid hormones and ghrelin, but an effect of ghrelin on the human thyroid has never been investigated even though ghrelin receptors are present in the thyroid. The present study shows a ghrelin-induced decrease in the thyroid-stimulating hormone (TSH)-induced production of thyroglobulin and mRNA expression of thyroperoxidase in a primary culture of human thyroid cells obtained from paranodular tissue. Accordingly, a trend was noted for an inhibition of TSH-stimulated expression of the sodium-iodine symporter and the TSH-receptor. Thus, this study suggests an effect of ghrelin on human thyrocytes and thereby emphasizes the relevance of examining whether ghrelin also influences the metabolic homeostasis through altered thyroid hormone production.	[Barington, Maria; Brorson, Marianne Moller; Hofman-Bang, Jacob; Rasmussen, Se Krogh; Feldt-Rasmussen, Ulla] Univ Copenhagen Hosp, Dept Med Endocrinol, Rigshosp, Copenhagen, Denmark; [Holst, Birgitte] Univ Copenhagen, Inst Pharmacol, Dept Neurosci & Pharmacol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Feldt-Rasmussen, U (corresponding author), Univ Copenhagen Hosp, Dept Med Endocrinol, Rigshosp, Copenhagen, Denmark.	ufeldt@rh.dk	Feldt-Rasmussen, Ulla/AAB-9218-2021	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Holst, Birgitte/0000-0001-7432-097X				Abd El Gawad SS, 2012, ENDOCR PRACT, V18, P376, DOI 10.4158/EP11130.OR; Altinova AE, 2006, THYROID, V16, P1259, DOI 10.1089/thy.2006.16.1259; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; BELLUR S, 1990, ENDOCRINOLOGY, V127, P1526, DOI 10.1210/endo-127-3-1526; Biyikli HH, 2014, ENDOCR PRACT, V20, P818, DOI 10.4158/EP13469.OR; Braclik M, 2008, THYROID, V18, P545, DOI 10.1089/thy.2007.0300; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Cassoni P, 2000, J ENDOCRINOL, V165, P139, DOI 10.1677/joe.0.1650139; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Emami A, 2014, REGUL PEPTIDES, V189, P17, DOI 10.1016/j.regpep.2014.01.001; Fekete C, 2006, ENDOCRINOLOGY, V147, P520, DOI 10.1210/en.2005-0956; Fekete C, 2004, ENDOCRINOLOGY, V145, P4816, DOI 10.1210/en.2004-0476; Fekete C, 2002, ENDOCRINOLOGY, V143, P3846, DOI 10.1210/en.2002-220338; Fekete C, 2001, ENDOCRINOLOGY, V142, P2606, DOI 10.1210/en.142.6.2606; Fusco A, 2007, J ENDOCRINOL INVEST, V30, P948, DOI 10.1007/BF03349243; Gimenez-Palop O, 2005, EUR J ENDOCRINOL, V153, P73, DOI 10.1530/eje.1.01934; Gjedde S, 2008, J CLIN ENDOCR METAB, V93, P2277, DOI 10.1210/jc.2007-2619; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gurgul E, 2012, ENDOKRYNOL POL, V63, P456; Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P174, DOI 10.1210/jc.2002-021052; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kluge M, 2013, J PSYCHIATR RES, V47, P1236, DOI 10.1016/j.jpsychires.2013.05.010; Kluge M, 2010, EUR J ENDOCRINOL, V162, P1059, DOI 10.1530/EJE-10-0094; Kokkinos A, 2007, ENDOCRINE, V32, P30, DOI 10.1007/s12020-007-9002-5; Konturek PC, 2004, J PHYSIOL PHARMACOL, V55, P325; Kordi F, 2015, INT J ENDOCRINOL MET, V13, DOI 10.5812/ijem.17988; Kosowicz J, 2011, HORM METAB RES, V43, P121, DOI 10.1055/s-0030-1269853; Kronborg TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179858; Kuroda K, 2015, ENDOCRINOLOGY, V156, P4437, DOI 10.1210/en.2015-1561; MADSEN SN, 1976, ACTA ENDOCRINOL-COP, V81, P208, DOI 10.1530/acta.0.0810208; Mahmoudi F, 2011, IRAN J PHARM RES, V10, P627; Malandrino N, 2014, EXP CLIN ENDOCR DIAB, V122, P540, DOI 10.1055/s-0034-1376965; Marzullo P, 2004, J CLIN ENDOCR METAB, V89, P936, DOI 10.1210/jc.2003-031328; Morillo-Bernal J, 2011, PEPTIDES, V32, P2333, DOI 10.1016/j.peptides.2011.09.013; Otto B, 2001, EUR J ENDOCRINOL, V145, pR5; Park YJ, 2008, MOL CELL ENDOCRINOL, V285, P19, DOI 10.1016/j.mce.2008.01.003; Pazos Y, 2008, VITAM HORM, V77, P89, DOI 10.1016/S0083-6729(06)77005-4; Pekary AE, 2012, PEPTIDES, V36, P157, DOI 10.1016/j.peptides.2012.04.021; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P173, DOI 10.1016/0303-7207(95)03712-8; Reichenbach A, 2012, ENDOCRINOLOGY, V153, P5452, DOI 10.1210/en.2012-1622; Riis ALD, 2003, J CLIN ENDOCR METAB, V88, P853, DOI 10.1210/jc.2002-021302; ROGER P, 1988, J CLIN ENDOCR METAB, V66, P1158, DOI 10.1210/jcem-66-6-1158; Ruchala M, 2014, PEPTIDES, V51, P31, DOI 10.1016/j.peptides.2013.10.018; Sawicka B, 2010, J PEDIATR ENDOCR MET, V23, P345, DOI 10.1515/jpem.2010.055; Sawicka Beata, 2009, Pediatr Endocrinol Diabetes Metab, V15, P20; Schussler P, 2012, OBESITY, V20, P1212, DOI 10.1038/oby.2011.385; Sivertsen B, 2013, BRIT J PHARMACOL, V170, P1349, DOI 10.1111/bph.12361; Sosic-Jurjevic B, 2009, NEUROENDOCRINOLOGY, V89, P327, DOI 10.1159/000188603; Tanda ML, 2009, J ENDOCRINOL INVEST, V32, P74, DOI 10.1007/BF03345683; Tang-Christensen M, 2004, ENDOCRINOLOGY, V145, P4645, DOI 10.1210/en.2004-0529; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Yu HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143001; Zhu Y, 2014, PHYSIOL BEHAV, V135, P135, DOI 10.1016/j.physbeh.2014.06.009; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zimmermann-Belsing T, 1998, SCAND J CLIN LAB INV, V58, P529, DOI 10.1080/00365519850186148	61	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184992	10.1371/journal.pone.0184992	http://dx.doi.org/10.1371/journal.pone.0184992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931076	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700052
J	Rosinska, M; Parda, N; Kolakowska, A; Godzik, P; Zakrzewska, K; Madalinski, K; Zielinski, A; Boguradzka, A; Gierczynski, R; Stepien, M				Rosinska, Magdalena; Parda, Natalia; Kolakowska, Agnieszka; Godzik, Paulina; Zakrzewska, Karolina; Madalinski, Kazimierz; Zielinski, Andrzej; Boguradzka, Anna; Gierczynski, Rafal; Stepien, Malgorzata			Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general population in Poland, 2012-2016	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; VIRUS-INFECTION; DISEASE BURDEN; HIV-INFECTION; UNITED-STATES; RISK-FACTORS; B-VIRUS; HCV; CIRRHOSIS; TRANSMISSION	Background & aims There is a considerable burden of hepatitis C in Europe related to the lack of prompt diagnosis. We aimed to estimate the prevalence and related risk factors of HCV infections by the stages of liver fibrosis, using non-invasive methods, to understand testing needs in Poland. Methods A cross-sectional study was conducted in 2012-2016 adopting a stratified random sampling of primary health care units followed by systematic sampling of patients within each unit. Study participants filled a questionnaire and donated blood for laboratory HCV testing. Additionally, the results of liver function tests and platelet count were collected to calculate APRI and FIB-4 scores. Cases were classified according to the level of fibrosis: 'significant fibrosis' (APRI >= 0.7 or FIB4 >= 1.45) and 'no significant fibrosis' (APRI< 0.7 and FIB4< 1.45). Results Of 21 875 study participants, 102 were HCV-RNA positive. Prevalence of HCV infections and significant fibrosis was estimated at 0.47% (95% CI 0.38% -0.57%) and 0.12% (0.08% -0.17%), respectively. Cases with significant fibrosis accounted for 51.6% (33.4%-69.9%) in men and 34.4% (17.3%-51.4%) in women. There was no correlation between the HCV prevalence and age. Blood transfusion prior to 1992 strongly predicted significant fibrosis as did the history of injecting drug use (IDU) and ever having an HCV-infected sexual partner in men and caesarean sections in women. Factors associated with HCV infection without significant fibrosis were tattooing in men and younger age in women. We acknowledge limited possibility to study the associations between IDU and ever having HCV-infected sexual partner, given small sample sizes for these exposures. Conclusions As no clear birth cohort affected by HCV could be identified, risk factor-based screening in the general population should be considered, taking into account the association between the increased risk of liver fibrosis and the history of transfusion prior to 1992 and caesarean sections.	[Rosinska, Magdalena; Parda, Natalia; Zakrzewska, Karolina; Zielinski, Andrzej; Stepien, Malgorzata] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Epidemiol, Warsaw, Poland; [Kolakowska, Agnieszka; Godzik, Paulina; Zakrzewska, Karolina; Madalinski, Kazimierz] Natl Inst Hyg, Dept Virol, Natl Inst Publ Hlth, Warsaw, Poland; [Boguradzka, Anna] Ctr Postgrad Med Educ, Dept Family Practice, Warsaw, Poland; [Gierczynski, Rafal] Natl Inst Hyg, Dept Bacteriol, Natl Inst Publ Hlth, Warsaw, Poland	National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); Centre of Postgraduate Medical Education - Poland; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH)	Rosinska, M (corresponding author), Natl Inst Hyg, Natl Inst Publ Hlth, Dept Epidemiol, Warsaw, Poland.	mrosinska@pzh.gov.pl	Stępień, Małgorzata/AAV-4282-2020; Zielinski, Andrzej/ABA-2921-2020; Rosińska, Magdalena/K-5857-2019; Rosińska, Magdalena/Q-2068-2018	Stępień, Małgorzata/0000-0002-4640-7290; Rosińska, Magdalena/0000-0002-6256-7809; Rosińska, Magdalena/0000-0002-6256-7809; Zakrzewska, Karolina/0000-0003-4131-4738	Switzerland through the Swiss Contribution to the enlarged European Union [KIK 35]; Minister of Health of the Republic of Poland	Switzerland through the Swiss Contribution to the enlarged European Union; Minister of Health of the Republic of Poland	This study was supported by a grant number KIK 35 Prevention of HCV infections from Switzerland through the Swiss Contribution to the enlarged European Union (https://www.programszwajcarski.gov.pl/) and the Minister of Health of the Republic of Poland (http://www.mz.gov.pl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspinall EJ, 2015, EUR J EPIDEMIOL, V30, P115, DOI 10.1007/s10654-014-9958-4; Bailey H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2089-7; Brouard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126920; Carney K, 2013, HEPATOLOGY, V57, P2117, DOI 10.1002/hep.26245; Coward S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011821; Cullen BL, 2012, J PUBLIC HEALTH-UK, V34, P14, DOI 10.1093/pubmed/fdr097; European Association for the Study of the Liver, 2016, J HEPATOL; Fierer DS, 2016, J INFECT DIS, V214, P1134, DOI 10.1093/infdis/jiw336; Flisiak R, 2011, EUR J GASTROEN HEPAT, V23, P1213, DOI 10.1097/MEG.0b013e32834d173c; Foster GR, 2016, J HEPATOL, V64, P1224, DOI 10.1016/j.jhep.2016.01.029; Godzik Paulina, 2012, Przegl Epidemiol, V66, P575; Green L, 2016, BJOG-INT J OBSTET GY, V123, P2164, DOI 10.1111/1471-0528.13831; Hager RME, 2004, AM J OBSTET GYNECOL, V190, P428, DOI 10.1016/j.ajog.2003.08.037; Hahne A SJ, 2013, BMC INFECT DIS, P13; Hartleb M, 2012, EUR J GASTROEN HEPAT, V24, P1288, DOI 10.1097/MEG.0b013e328357632a; Hatzakis A, 2015, J VIRAL HEPATITIS, V22, P26, DOI 10.1111/jvh.12351; Hope VD, 2014, EPIDEMIOL INFECT, V142, P270, DOI 10.1017/S0950268813000940; Indolfi G, 2013, J MED VIROL, V85, P608, DOI 10.1002/jmv.23522; Jewett A, 2015, HEALTH PROMOT PRACT, V16, P256, DOI 10.1177/1524839914532291; Klevens RM, 2016, CLIN INFECT DIS, V63, P1049, DOI 10.1093/cid/ciw468; Leznicka M, 2014, MED PR, V65, P633, DOI 10.13075/mp.5893.00083; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Little R.J.A., 2002, STAT ANAL MISSING DA; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; Parda N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013359; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Rosinska M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0828-9; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sulkowski MS, 2016, GASTROENTEROLOGY, V150, P419, DOI 10.1053/j.gastro.2015.10.013; Tohme RA, 2012, CLIN INFECT DIS, V54, P1167, DOI 10.1093/cid/cir991; Udompap P, 2016, J HEPATOL, V64, P1027, DOI 10.1016/j.jhep.2016.01.009; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249; Xu FJ, 2016, CLIN INFECT DIS, V62, P289, DOI 10.1093/cid/civ860; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566; Zuure FR, 2014, BMC PUBLIC HEALTH, P14	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185055	10.1371/journal.pone.0185055	http://dx.doi.org/10.1371/journal.pone.0185055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931062	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700064
J	Kim, S; Yang, XK; Li, QJ; Wu, M; Costyn, L; Beharry, Z; Bartlett, MG; Cai, HJ				Kim, Sungjin; Yang, Xiangkun; Li, Qianjin; Wu, Meng; Costyn, Leah; Beharry, Zanna; Bartlett, Michael G.; Cai, Houjian			Myristoylation of Src kinase mediates Src-induced and high-fat diet-accelerated prostate tumor progression in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diet; fatty acid; prostate cancer; protein myristoylation; Src	PROTEIN N-MYRISTOYLATION; FAMILY KINASES; CANCER; METABOLISM; ACTIVATION; ACIDS; N-MYRISTOYLTRANSFERASE-1; MYRISTYLATION; MEN	Exogenous fatty acids provide substrates for energy production and biogenesis of the cytoplasmic membrane, but they also enhance cellular signaling during cancer cell proliferation. However, it remains controversial whether dietary fatty acids are correlated with tumor progression. In this study, we demonstrate that increased Src kinase activity is associated with high-fat diet-accelerated progression of prostate tumors and that Src kinases mediate this pathological process. Moreover, in the in vivo prostate regeneration assay, host SCID mice carrying Src(Y529F)-transduced regeneration tissues were fed a low-fat diet or a high-fat diet and treated with vehicle or dasatinib. The high-fat diet not only accelerated Src-induced prostate tumorigenesis in mice but also compromised the inhibitory effect of the anticancer drug dasatinib on Src kinase oncogenic potential in vivo. We further show that myristoylation of Src kinase is essential to facilitate Src-induced and high-fat diet-accelerated tumor progression. Mechanistically, metabolism of exogenous myristic acid increased the biosynthesis of myristoyl CoA and myristoylated Src and promoted Src kinase-mediated oncogenic signaling in human cells. Of the fatty acids tested, only exogenous myristic acid contributed to increased intracellular myristoyl CoA levels. Our results suggest that targeting Src kinase myristoylation, which is required for Src kinase association at the cellular membrane, blocks dietary fat-accelerated tumorigenesis in vivo. Our findings uncover the molecular basis of how the metabolism of myristic acid stimulates high-fat diet-mediated prostate tumor progression.	[Kim, Sungjin; Yang, Xiangkun; Li, Qianjin; Wu, Meng; Costyn, Leah; Bartlett, Michael G.; Cai, Houjian] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Beharry, Zanna] Florida Gulf Coast Univ, Dept Chem & Phys, Ft Myers, FL 33965 USA	University System of Georgia; University of Georgia; State University System of Florida; Florida Gulf Coast University	Cai, HJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	caihj@uga.edu	Cai, Houjian/AAJ-1290-2020; Yang, Xiangkun/I-6141-2019; Wu, Meng/N-9345-2014	Wu, Meng/0000-0001-8436-2209; Bartlett, Michael/0000-0003-0626-3234	National Institutes of Health Grant [R01CA172495]; Department of Defense [W81XWH-15-1-0507]; NATIONAL CANCER INSTITUTE [R01CA172495] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA172495 and Department of Defense Grant W81XWH-15-1-0507 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Araujo JC, 2013, LANCET ONCOL, V14, P1307, DOI 10.1016/S1470-2045(13)70479-0; BAGRODIA S, 1993, MOL CELL BIOL, V13, P1464, DOI 10.1128/MCB.13.3.1464; Bullen JW, 2004, AM J PHYSIOL-ENDOC M, V287, pE662, DOI 10.1152/ajpendo.00114.2004; Cai HJ, 2011, P NATL ACAD SCI USA, V108, P6579, DOI 10.1073/pnas.1103904108; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; Crowe FL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju240; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Epstein MM, 2012, AM J EPIDEMIOL, V176, P240, DOI 10.1093/aje/kwr520; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; FELSTED RL, 1995, J NATL CANCER I, V87, P1571, DOI 10.1093/jnci/87.21.1571; French KJ, 2004, J PHARMACOL EXP THER, V309, P340, DOI 10.1124/jpet.103.061572; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Higuchi T, 2012, J PHYSIOL SCI, V62, P45, DOI 10.1007/s12576-011-0184-5; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Kovacs M, 2014, J EXP MED, V211, P1993, DOI 10.1084/jem.20132496; Le TT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-42; Liu ST, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00416; Mollinedo Faustino, 2015, Adv Biol Regul, V57, P130, DOI 10.1016/j.jbior.2014.10.003; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Shrivastav A, 2008, J IMMUNOL, V180, P1019, DOI 10.4049/jimmunol.180.2.1019; Strom SS, 2008, INT J CANCER, V122, P2581, DOI 10.1002/ijc.23414; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; Tholstrup T, 2001, AM J CLIN NUTR, V73, P198; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WHITTEMORE AS, 1995, JNCI-J NATL CANCER I, V87, P652, DOI 10.1093/jnci/87.9.652; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Yang XK, 2017, ANAL CHEM, V89, P813, DOI 10.1021/acs.analchem.6b03623; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	38	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18422	18433		10.1074/jbc.M117.798827	http://dx.doi.org/10.1074/jbc.M117.798827			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939770	Green Published, hybrid			2022-12-26	WOS:000414958100004
J	Yeh, ML; Huang, CI; Huang, CF; Hsieh, MY; Lin, ZY; Huang, JF; Dai, CY; Yu, ML; Chen, SC; Chuang, WL				Yeh, Ming-Lun; Huang, Ching-I; Huang, Chung-Feng; Hsieh, Ming-Yen; Lin, Zu-Yau; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chen, Shinn-Cherng; Chuang, Wan-Long			The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma	PLOS ONE			English	Article							CANCER	Background The impact of additional extra-hepatic primary cancer (EHPC) on the outcomes of patients with hepatocellular carcinoma (HCC) remains uncertain. Methods We retrospectively analyzed the cancer registration database from a tertiary hospital in Southern Taiwan. Patients who were diagnosed with HCC from 2008 to 2012 were enrolled. Overall survival (OS), HCC-specific survival and recurrence after curative therapy were analyzed and compared between the patients with and the patients without EHPC. Results EHPC was found in 121/1506 (8.0%) patients. HCC patients with EHPC were older, more likely to be classified as Child-Pugh A, less likely to have viral hepatitis B or C, more likely to be single, had early stage HCC and received curative therapy for HCC. The OS did not significantly differ between the patients with and without EHPC(p = 0.061). However, significantly higher HCC-specific survival was observed in patients with EHPC (p< 0.001), and a higher rate of non-HCC mortality was demonstrated in patients with EHPC (54.4% vs 9.3%). The subgroup analysis revealed better OS in patients with EHPC who were older than 65, had viral hepatitis B or C, had non-stage 1 HCC, had non-early stage BCLC and received non-curative therapy. Conversely, patients with HCC stage 1 who received curative therapy exhibited worse OS if they also had EHPC. The analysis of recurrence after curative therapy showed no difference between the two groups. Conclusions Our results implied that EHPC did not affect OS, but HCC-related survival was better in patients with EHPC. Based on these findings, the management of additional primary cancer is warranted.	[Yeh, Ming-Lun; Huang, Ching-I; Huang, Chung-Feng; Hsieh, Ming-Yen; Lin, Zu-Yau; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chen, Shinn-Cherng; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatitis Ctr, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Ching-I; Huang, Chung-Feng; Hsieh, Ming-Yen; Lin, Zu-Yau; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chen, Shinn-Cherng; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Chung-Feng; Lin, Zu-Yau; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chen, Shinn-Cherng; Chuang, Wan-Long] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Dai, Chia-Yen] Kaohsiung Med Univ Hosp, Hlth Management Ctr, Kaohsiung, Taiwan; [Chen, Shinn-Cherng] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, SC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatitis Ctr, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan.	chshch@cc.kmu.edu.tw	Yu, Ming-Lung/AAZ-4306-2020; Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020	Yu, Ming-Lung/0000-0001-8145-1900; Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051; Yeh, Ming-Lun/0000-0003-3728-7618				BARBARA L, 1992, HEPATOLOGY, V16, P132, DOI 10.1002/hep.1840160122; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang YS, HEPATOGASTROENTEROLO, V62, P1011; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; El-Serag HB, N ENGL J MED, V365, P1118; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Ruiz M, 2009, J GASTROEN HEPATOL, V24, P1424, DOI 10.1111/j.1440-1746.2009.05793.x; Hong S, BMC CANC, V15, P146; Huang CF, MEDICINE BALTIMORE, V95; Huang CF, 2014, J HEPATOL, V61, P67, DOI 10.1016/j.jhep.2014.02.022; Huang JF, J GASTROENTEROL HEPA, V30, P1768; Jembere N, PLOS ONE, V7; Nanashima A, 2015, ANTICANCER RES, V35, P1073; NZEAKO UC, 1994, CANCER, V74, P2765, DOI 10.1002/1097-0142(19941115)74:10<2765::AID-CNCR2820741005>3.0.CO;2-Q; ONITSUKA A, 1995, INT SURG, V80, P128; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Shimada M, 1996, AM J GASTROENTEROL, V91, P754; TAKAYASU K, 1992, CANCER, V69, P45, DOI 10.1002/1097-0142(19920101)69:1<45::AID-CNCR2820690110>3.0.CO;2-G; Yeh ML, 2015, KAOHSIUNG J MED SCI, V31, P77, DOI 10.1016/j.kjms.2014.11.003; Zeng QA, BMC CANC, V12, P148	21	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184878	10.1371/journal.pone.0184878	http://dx.doi.org/10.1371/journal.pone.0184878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957337	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200021
J	Dong, XL; Al Awak, M; Tomlinson, N; Tang, YG; Sun, YP; Yang, LJ				Dong, Xiuli; Al Awak, Mohamad; Tomlinson, Nicholas; Tang, Yongan; Sun, Ya-Ping; Yang, Liju			Antibacterial effects of carbon dots in combination with other antimicrobial reagents	PLOS ONE			English	Article							QUANTUM DOTS; LISTERIA-MONOCYTOGENES; CELLS; NANOPARTICLES; MECHANISM; PATHOGENS; GRAPHENE; BIOFILM; NISIN; ACID	This study was designed to investigate the antimicrobial effects of CDots in combination with other antimicrobial reagents, including H2O2, Na2CO3, and AcOH (acetic acid). CDots were synthesized and passivated with 2,2'-(ethylenedioxy) bis(ethylamine) (EDA). The minimal inhibitory concentration (MIC) of CDots was 64 mu g/mL on both Gram negative bacteria E. coli cells and Gram positive bacteria Bacillus subtilis cells. When CDots were combined with H2O2, antibacterial synergistic effects were observed based on the fractional inhibitory concentration (FIC) index, and further confirmed by an isobologram analysis and viable cell number counting methods. With the combination treatment of 10 mu g/mL CDots with 8.82 mM H2O2, the viable E. coli cell numbers decreased 2.46 log, which was significant lower than the log reduction from 8.82 mM H2O2 (1.57 log) or 10 mu g/mL CDots (0.14 log) treatment alone. However, the combination of CDots with Na2CO3 or AcOH did not show synergistic effects, instead, exhibiting indifference effects according to the FIC index. This study indicated that the combination of CDots with their synergistic antimicrobial reagents, such as H2O2, could reach the goal of inhibiting bacteria growth by using lower concentration of each individual chemical in the combination than using one chemical treatment alone, reduce the risks imposed on environmental health and the possibilities of the development of microbial resistances.	[Dong, Xiuli; Al Awak, Mohamad; Yang, Liju] North Carolina Cent Univ, BRITE, Durham, NC 27707 USA; [Tomlinson, Nicholas; Sun, Ya-Ping] Clemson Univ, Dept Chem, Clemson, SC 29634 USA; [Tomlinson, Nicholas; Sun, Ya-Ping] Clemson Univ, Lab Emerging Mat & Technol, Clemson, SC 29634 USA; [Tang, Yongan] North Carolina Cent Univ, Dept Math & Phys, Durham, NC USA	University of North Carolina; North Carolina Central University; Clemson University; Clemson University; University of North Carolina; North Carolina Central University	Yang, LJ (corresponding author), North Carolina Cent Univ, BRITE, Durham, NC 27707 USA.; Sun, YP (corresponding author), Clemson Univ, Dept Chem, Clemson, SC 29634 USA.; Sun, YP (corresponding author), Clemson Univ, Lab Emerging Mat & Technol, Clemson, SC 29634 USA.	syaping@clemson.edu; lyang@nccu.edu			NIH [R15GM114752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH grant R15GM114752.	Arias LR, 2009, LANGMUIR, V25, P3003, DOI 10.1021/la802769m; Baldeck JD, 2008, CAN J MICROBIOL, V54, P868, DOI 10.1139/w08-078; BRANDI G, 1989, MICROBIOL IMMUNOL, V33, P991, DOI 10.1111/j.1348-0421.1989.tb03157.x; Cai Y, 2007, J ANTIBIOT, V60, P335, DOI 10.1038/ja.2007.45; Cao L, 2013, ACCOUNTS CHEM RES, V46, P171, DOI 10.1021/ar300128j; Cao L, 2011, J AM CHEM SOC, V133, P4754, DOI 10.1021/ja200804h; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Dong XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00675-x; Fernando KAS, 2015, ACS APPL MATER INTER, V7, P8363, DOI 10.1021/acsami.5b00448; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GEORGE M, 1996, ANTIMICROBIAL COMBIN; Jarvis GN, 2001, LETT APPL MICROBIOL, V33, P196, DOI 10.1046/j.1472-765x.2001.00976.x; Joller N, 2010, P NATL ACAD SCI USA, V107, P20441, DOI 10.1073/pnas.1013827107; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Ko KY, 2008, POULTRY SCI, V87, P2660, DOI 10.3382/ps.2007-00503; Kumar KA, 2004, BIOL PHARM BULL, V27, P1116, DOI 10.1248/bpb.27.1116; Lapenna D, 1996, GEN PHARMACOL, V27, P1145, DOI 10.1016/S0306-3623(96)00063-8; LeCroy GE, 2016, COORDIN CHEM REV, V320, P66, DOI 10.1016/j.ccr.2016.02.017; LeCroy GE, 2014, ACS NANO, V8, P4522, DOI 10.1021/nn406628s; Li JX, 2014, ACS NANO, V8, P11118, DOI 10.1021/nn505029k; Lim SY, 2015, CHEM SOC REV, V44, P362, DOI 10.1039/c4cs00269e; Luo PJG, 2014, RSC ADV, V4, P10791, DOI 10.1039/c3ra47683a; Luo PJG, 2013, J MATER CHEM B, V1, P2116, DOI 10.1039/c3tb00018d; Meziani MJ, 2016, ACS APPL MATER INTER, V8, P10761, DOI 10.1021/acsami.6b01765; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Mu HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep18877; Murdock CA, 2007, LETT APPL MICROBIOL, V44, P255, DOI 10.1111/j.1472-765X.2006.02076.x; Najjar MB, 2007, LETT APPL MICROBIOL, V45, P13, DOI 10.1111/j.1472-765X.2007.02157.x; Narband N, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445102; Roks G, 1999, J PHARMACOL EXP THER, V288, P472; Samia ACS, 2003, J AM CHEM SOC, V125, P15736, DOI 10.1021/ja0386905; Singh VV, 2015, ADV FUNCT MATER, V25, P2147, DOI 10.1002/adfm.201500033; Sun C, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1326-8; Sun HJ, 2014, ACS NANO, V8, P6202, DOI 10.1021/nn501640q; Sun YP, 2006, J AM CHEM SOC, V128, P7756, DOI 10.1021/ja062677d; Swathy JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07161; Wang YF, 2014, J MATER CHEM C, V2, P6921, DOI 10.1039/c4tc00988f; Xiuli Dong, 2015, J NANOMEDICINE NANOT, V6, P1; Yuan H, 2016, RSC ADV, V6, P15192, DOI 10.1039/c5ra26870b	39	46	46	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185324	10.1371/journal.pone.0185324	http://dx.doi.org/10.1371/journal.pone.0185324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934346	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900146
J	Huggins, LG; Michaels, CJ; Cruickshank, SM; Preziosi, RF; Else, KJ				Huggins, Lucas G.; Michaels, Christopher J.; Cruickshank, Sheena M.; Preziosi, Richard F.; Else, Kathryn J.			A novel copro-diagnostic molecular method for qualitative detection and identification of parasitic nematodes in amphibians and reptiles	PLOS ONE			English	Article							6TH MASS EXTINCTION; N. SP; ASPICULURIS-TETRAPTERA; PCR PRIMERS; DNA; TOOLS; PHARYNGODONIDAE; COMMUNITIES; INFECTIONS; DIVERSITY	Anthropogenic disturbance via resource acquisition, habitat fragmentation and climate change, amongst other factors, has led to catastrophic global biodiversity losses and species extinctions at an accelerating rate. Amphibians are currently one of the worst affected classes with at least a third of species categorised as being threatened with extinction. At the same time, they are also critically important for many habitats and provide man with a powerful proxy for ecosystem health by acting as a bioindicator group. Whilst the causes of synchronised amphibian losses are varied recent research has begun to highlight a growing role that macroparasites are playing in amphibian declines. However, diagnosing parasite infection in the field can be problematic, principally relying on collection and euthanasia of hosts, followed by necropsy and morphological identification of parasites in situ. The current study developed a non-invasive PCR-based methodology for sensitive detection and identification of parasitic nematode DNA released in the faeces of infected amphibians as egg or tissue fragments (environmental DNA). A DNA extraction protocol optimised for liberation of DNA from resilient parasite eggs was developed alongside the design of a novel, nematode universal, degenerate primer pair, thus avoiding the difficulties of using species specific primers in situations where common parasite species are unknown. Used in conjunction this protocol and primer pair was tested on a wide range of faecal samples from captive and wild amphibians. The primers and protocol were validated and detected infections, including a Railletnema nematode infection in poison dart frogs from ZSL London Zoo and Mantella cowani frogs in the wild. Furthermore, we demonstrate the efficacy of our PCR-based protocol for detecting nematode infection in other hosts, such as the presence of pinworm (Aspiculuris) in two tortoise species and whipworm (Trichuris muris) in mice. Our environmental DNA approach mitigates problems associated with microscopic identification and can be applied to detect nematode parasitoses in wild and captive hosts for infection surveillance and maintenance of healthy populations.	[Huggins, Lucas G.; Cruickshank, Sheena M.; Else, Kathryn J.] Univ Manchester, MAHSC, Fac Biol Med & Hlth, Manchester, Lancs, England; [Michaels, Christopher J.] ZSL London Zoo, Herpetol Sect, London, England; [Preziosi, Richard F.] Manchester Metropolitan Univ, Fac Sci & Engn, Manchester, Lancs, England	University of Manchester; Manchester Metropolitan University	Huggins, LG (corresponding author), Univ Manchester, MAHSC, Fac Biol Med & Hlth, Manchester, Lancs, England.	lucas-g-h@hotmail.com	Huggins, Lucas/AAJ-7346-2021; Preziosi, Richard F/A-8626-2010	Huggins, Lucas/0000-0002-1384-2886; Preziosi, Richard F/0000-0003-0468-6655; Cruickshank, Sheena/0000-0002-3047-5475				Baille D, 2008, MOL ECOL, V17, P1523, DOI 10.1111/j.1365-294X.2008.03697.x; BAKER MR, 1985, P HELM SOC WASH, V52, P76; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Bhadury P, 2006, AQUAT MICROB ECOL, V44, P97, DOI 10.3354/ame044097; Bhadury P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026445; Bhadury P, 2010, HYDROBIOLOGIA, V641, P245, DOI 10.1007/s10750-009-0088-z; Blackwood CB, 2005, APPL ENVIRON MICROB, V71, P6193, DOI 10.1128/AEM.71.10.6193-6198.2005; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Bouamer S, 2005, ZOOSYSTEMA, V27, P193; Bouamer S, 2003, CAN J ZOOL, V81, P1885, DOI [10.1139/z03-166, 10.1139/Z03-166]; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Budischak SA, 2015, MOL ECOL RESOUR, V15, P1112, DOI 10.1111/1755-0998.12382; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Bursey CR, 2006, COMP PARASITOL, V73, P193, DOI 10.1654/4181.1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Costa FO, 2010, THEOR BIOSCI, V129, P149, DOI 10.1007/s12064-010-0091-y; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Cutillas C, 2002, PARASITOL RES, V88, P574, DOI 10.1007/s00436-002-0596-5; Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061285; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; Eckert J, 2003, ACTA TROP, V85, P157, DOI 10.1016/S0001-706X(02)00216-4; Eisenberg Tobias, 2009, Salamandra, V45, P91; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Giangaspero A, 2004, IPPOLOGIA, V15, P11; Gobert GN, 2005, MOL CELL PROBE, V19, P250, DOI 10.1016/j.mcp.2005.01.006; Golab E, 2009, J MICROBIOL METH, V78, P213, DOI 10.1016/j.mimet.2009.05.019; Gomez Andres, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P222, DOI 10.1016/j.ijppaw.2013.07.002; Goswami U, 2015, ACTA PARASITOL, V60, P553, DOI 10.1515/ap-2015-0079; Hong RL, 2005, J EXP ZOOL PART A, V303A, P742, DOI 10.1002/jez.a.200; Hunt DJ, 2002, NEMATOLOGY, V4, P803, DOI 10.1163/156854102760402595; Huver JR, 2015, ECOL APPL, V25, P991, DOI 10.1890/14-1530.1; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Johnson PTJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P124; Johnson Pieter T. J., 2009, P249, DOI 10.1007/978-0-387-09577-6_11; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Kenney SJ, 2006, INT J FOOD MICROBIOL, V106, P61, DOI 10.1016/j.ijfoodmicro.2005.05.011; Koprivnikar J, 2012, ECOHEALTH, V9, P342, DOI 10.1007/s10393-012-0785-3; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Malysheva SV, 2016, J HELMINTHOL, V90, P186, DOI 10.1017/S0022149X15000061; Malysheva SV, 2015, ZOOTAXA, V3926, P100, DOI 10.11646/zootaxa.3926.1.4; McNally J, 2013, VET PARASITOL, V198, P325, DOI 10.1016/j.vetpar.2013.09.014; Nilsson RH, 2016, FUNG BIOL-US, P47, DOI 10.1007/978-3-319-29137-6_4; Oldekop JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038922; Pan F, 2015, J SOIL SCI PLANT NUT, V15, P129, DOI 10.4067/S0718-95162015005000011; Pessier AP, 2014, ZOO BIOL, V33, P516, DOI 10.1002/zoo.21166; Rahman L, 2014, SOIL RES, V52, P604, DOI 10.1071/SR14041; Renco M, 2012, J NEMATOL, V44, P329; da Silva NRR, 2010, NEMATOLOGY, V12, P661, DOI 10.1163/138855410X500073; Roedder Dennis, 2009, Diversity, V1, P52; Romansic JM, 2011, OECOLOGIA, V166, P1029, DOI 10.1007/s00442-011-1932-1; Schar F, 2014, PARASITOL INT, V63, P597, DOI 10.1016/j.parint.2014.03.007; Shah AA, 2015, J NEMATOL, V47, P153; Shen YY, 2013, PLOS ONE, V8, P5; Steel H, 2012, APPL SOIL ECOL, V61, P100, DOI 10.1016/j.apsoil.2012.05.004; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taniuchi M, 2011, AM J TROP MED HYG, V84, P332, DOI 10.4269/ajtmh.2011.10-0461; Tinsley RC, 1995, PARASITOLOGY, V111, pS153, DOI 10.1017/S0031182000075879; Tkach V. V., 2010, Vestnik Zoologii, V44, P3, DOI 10.2478/v10058-010-0001-2; Traub RJ, 2008, VET PARASITOL, V155, P67, DOI 10.1016/j.vetpar.2008.05.001; Van Steenkiste N, 2015, MOL ECOL RESOUR, V15, P945, DOI 10.1111/1755-0998.12358; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; WAKELIN D, 1976, PARASITOLOGY, V72, P173, DOI 10.1017/S0031182000048472; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Wang CR, 2016, GENE, V585, P71, DOI 10.1016/j.gene.2016.03.037; Wright K, 2001, AMPHIBIANS MED CAPTI, P193	68	3	4	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185151	10.1371/journal.pone.0185151	http://dx.doi.org/10.1371/journal.pone.0185151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934299	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900106
J	Weber, D; Frauenschlager, K; Ghimire, S; Peter, K; Panzer, I; Hiergeist, A; Weber, M; Kutny, D; Wolff, D; Grube, M; Huber, E; Oefner, P; Gessner, A; Hehlgans, T; Herr, W; Holler, E				Weber, Daniela; Frauenschlaeger, Katrin; Ghimire, Sakhila; Peter, Katrin; Panzer, Isabella; Hiergeist, Andreas; Weber, Markus; Kutny, Daniel; Wolff, Daniel; Grube, Matthias; Huber, Elisabeth; Oefner, Peter; Gessner, Andre; Hehlgans, Thomas; Herr, Wolfgang; Holler, Ernst			The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation	PLOS ONE			English	Article							ALPHA-DEFENSINS; GVHD; MORTALITY; INTERLEUKIN-22	Intestinal microbiota disruption is associated with acute gastrointestinal (GI) Graft-versus-Host Disease (GvHD) and poor outcome after allogeneic stem cell transplantation (ASCT). Here, in a retrospective analysis of 200 patients undergoing ASCT at the Regensburg University Medical Center, we assessed the relative expression of Paneth cell antimicrobial peptides (AMPs), Human Defensins (HD) 5 and 6 and regenerating islet-derived 3 alpha (Reg3 alpha), in 292 human intestinal biopsies as well as Reg3a serum levels in relation to acute GI GvHD. In the absence of GI GvHD, the relative expression of Paneth cell AMPs was significantly higher in the small intestine (duodenum to ileum) than in the stomach and large intestine (cecum to rectum) for Reg3a (p <= 0.001), HD5 (p <= 0.002) and HD6 (p <= 0.02). Acute stage 2-4 GI GvHD was associated with reduced expression of AMPs in the small intestine (p <= 0.01) in comparison to stage 0-1 disease, accompanied by a decrease in Paneth cell count in case of severe acute GI GvHD (p<0.001). The opposite held true for the large intestine as we found stage 2-4 GI GvHD correlated with significantly higher expression of HD5, HD6, and Reg3a compared to mild or no acute GI GvHD (p <= 0.002). Severe GI GvHD in both the lower and the upper GI tract also correlated with higher serum concentrations of Reg3a (p = 0.002). As indirect markers of intestinal microbiome diversity low levels of urinary 3-indoxyl sulfate levels were associated with severe stages of acute GI GvHD compared to mild stage or no acute GI GvHD (p = 0.05). In conclusion, acute GI GvHD correlates with intestinal expression of HD5, HD6 and Reg3a as well as Reg3a serum levels and is associated with intestinal dysbiosis.	[Weber, Daniela; Ghimire, Sakhila; Peter, Katrin; Panzer, Isabella; Kutny, Daniel; Wolff, Daniel; Grube, Matthias; Herr, Wolfgang; Holler, Ernst] Univ Med Ctr, Dept Hematol & Oncol, Internal Med 3, Regensburg, Germany; [Frauenschlaeger, Katrin; Huber, Elisabeth] Univ Regensburg, Dept Pathol, Regensburg, Germany; [Hiergeist, Andreas; Gessner, Andre] Univ Med Ctr, Inst Clin Microbiol & Hyg, Regensburg, Germany; [Weber, Markus] Univ Med Ctr, Dept Orthoped Surg, Regensburg, Germany; [Oefner, Peter] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Hehlgans, Thomas] Regensburg Ctr Intervent Immunol RCI, Inst Immunol, Regensburg, Germany; [Hehlgans, Thomas] Univ Med Ctr Regensburg, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Weber, D (corresponding author), Univ Med Ctr, Dept Hematol & Oncol, Internal Med 3, Regensburg, Germany.	daniela.weber@ukr.de	Hiergeist, Andreas/P-5408-2019	Hiergeist, Andreas/0000-0002-3154-0638	DFG [SFB 1066, KF0262, 315963, KFO 243, HE 3116/7-2]; German Jose Carreras Foundation project "GVHD Competence center Regensburg"; German Research Foundation [DFG GE 671/14-1]	DFG(German Research Foundation (DFG)); German Jose Carreras Foundation project "GVHD Competence center Regensburg"; German Research Foundation(German Research Foundation (DFG))	This work was supported DFG SFB 1066, Project B9: Transfection of tumor-reactive T cells with RNA -loaded nanoparticles; DFG KF0262, Project P9: IDH mutations in the interplay of metabolism and antileukemic immune response; DFG KF0262, Project P12: Impact of drugs targeting tumor metabolism on human CD8 T cell effector functions europenan comission: Project Number 315963; DFG KFO 243 (HE 3116/7-2); German Jose Carreras Foundation project "GVHD Competence center Regensburg" and the German Research Foundation (DFG GE 671/14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bevins CL, 2013, DIGEST DIS, V31, P299, DOI 10.1159/000354681; Cahn JY, 2005, BLOOD, V106, P1495, DOI 10.1182/blood-2004-11-4557; Courth LF, 2015, P NATL ACAD SCI USA, V112, P14000, DOI 10.1073/pnas.1510084112; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; Eriguchi Y, 2015, TRANSPL INFECT DIS, V17, P702, DOI 10.1111/tid.12423; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Holler E, 2014, BIOL BLOOD MARROW TR; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Landfried K, 2011, BLOOD, V118, P6971, DOI 10.1182/blood-2011-06-357814; Levine JE, 2013, BLOOD, V122, P1505, DOI 10.1182/blood-2013-02-485813; Li M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00692; Masuda K, 2011, J INNATE IMMUN, V3, P315, DOI 10.1159/000322037; Miles DR, 2016, J INFLAMM BOWEL DIS, V1; Nakamura K, 2016, BIOSCI MICROB FOOD H, V35, P57, DOI 10.12938/bmfh.2015-019; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Tan G, 2015, EUR J CELL BIOL, V94, P60, DOI 10.1016/j.ejcb.2014.10.007; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Vigorito AC, 2009, BLOOD, V114, P702, DOI 10.1182/blood-2009-03-208983; Weber D, 2015, BLOOD; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	26	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185265	10.1371/journal.pone.0185265	http://dx.doi.org/10.1371/journal.pone.0185265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934349	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900135
J	Wu, JH; Liu, X; Nayak, SG; Pitarresi, JR; Cuitino, MC; Yu, LB; Hildreth, BE; Thies, KA; Schilling, DJ; Fernandez, SA; Leone, G; Ostrowski, MC				Wu, Jinghai; Liu, Xin; Nayak, Sunayana G.; Pitarresi, Jason R.; Cuitino, Maria C.; Yu, Lianbo; Hildreth, Blake E., III; Thies, Katie A.; Schilling, Daniel J.; Fernandez, Soledad A.; Leone, Gustavo; Ostrowski, Michael C.			Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele	PLOS ONE			English	Article							MOUSE MODELS; DUCTAL ADENOCARCINOMA; GENE; SYSTEM; MICE	The contribution of the tumor microenvironment to the development of pancreatic adenocarcinoma ( PDAC) is unclear. The LSL-Kras(G12D/+); LSL-p53(R172H/+); Pdx-1-Cre(KPC) tumor model, which is widely utilized to faithfully recapitulate human pancreatic cancer, depends on Cre-mediated recombination in the epithelial lineage to drive tumorigenesis. Therefore, specific Cre-loxP recombination in stromal cells cannot be applied in this model, limiting the in vivo investigation of stromal genetics in tumor initiation and progression. To address this issue, we generated a new Pdx1FlpO knock-in mouse line, which represents the first mouse model to physiologically express FlpO recombinase in pancreatic epithelial cells. This mouse specifically recombines Frt loci in pancreatic epithelial cells, including acinar, ductal, and islet cells. When combined with the Frt-STOP-Frt Kras(G12D) and p53(Frt) mouse lines, simultaneous Pdx1FlpO activation of mutant Kras and deletion of p53 results in the spectrum of pathologic changes seen in PDAC, including PanIN lesions and ductal carcinoma. Combination of this KPF mouse model with any stroma-specific Cre can be used to conditionally modify target genes of interest. This will provide an excellent in vivo tool to study the roles of genes in different cell types and multiple cell compartments within the pancreatic tumor microenvironment.	[Wu, Jinghai; Liu, Xin; Nayak, Sunayana G.; Pitarresi, Jason R.; Cuitino, Maria C.; Schilling, Daniel J.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Wu, Jinghai; Liu, Xin; Nayak, Sunayana G.; Pitarresi, Jason R.; Cuitino, Maria C.; Schilling, Daniel J.] Ohio State Univ, Canc Biol & Genet Dept, Columbus, OH 43210 USA; [Yu, Lianbo; Fernandez, Soledad A.] Ohio State Univ, Ctr Biostat, Dept Biomed Informat, Columbus, OH 43210 USA; [Hildreth, Blake E., III; Thies, Katie A.; Leone, Gustavo; Ostrowski, Michael C.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Hildreth, Blake E., III; Thies, Katie A.; Leone, Gustavo; Ostrowski, Michael C.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Medical University of South Carolina; Medical University of South Carolina	Wu, JH (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.; Wu, JH (corresponding author), Ohio State Univ, Canc Biol & Genet Dept, Columbus, OH 43210 USA.; Ostrowski, MC (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.; Ostrowski, MC (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	Jinghai.Wu@osumc.edu; ostrowsk@musc.edu	Ostrowski, Michael C/H-3108-2011; yu, lianbo/B-3472-2010; Hildreth, Eason/W-8186-2019	Hildreth, Eason/0000-0002-4631-1117; Nayak, Sunayana/0000-0003-3935-7501	NIH [PO1CA097189]; NATIONAL CANCER INSTITUTE [P01CA097189, P30CA138313] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (PO1CA097189, MCO and GL); https://www.nih.gov/. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; The authors thank Dr. Tyler Jacks (Massachusetts Institute of Technology), Dr. David Kirsch (Duke University) for providing transgenic animals; Dr. Mark Magnuson (Vanderbilt University) for providing Pdx1CFP vector [10]; Dr. A. Francis Stewart for providing pCAGGs-FlpO vector [2]; Dr. V. Coppola (Genetically Engineered Mouse Modeling facility of The Ohio State University James Comprehensive Cancer Center) for helping mouse targeting; Shannon K. Halloran, and Maokun Li for helping mouse housing and genotyping. This study was supported by NIH PO1 CA097189 (M.C.O. and G.L.).	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; CASEY G, 1993, CANCER LETT, V69, P151, DOI 10.1016/0304-3835(93)90168-9; Doyle A, 2012, TRANSGENIC RES, V21, P327, DOI 10.1007/s11248-011-9537-3; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Howlader N, 2013, SEER CANC STAT REV 1; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Mazur PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013578; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ostapoff, 2013, EXPT METASTASIS MODE, P57; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Potter LA, 2012, GENESIS, V50, P384, DOI 10.1002/dvg.20804; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184984	10.1371/journal.pone.0184984	http://dx.doi.org/10.1371/journal.pone.0184984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934293	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900072
J	Yao, PC; Gao, HY; Wei, YN; Zhang, JH; Chen, XY; Li, HQ				Yao, Peng-Cheng; Gao, Hai-Yan; Wei, Ya-Nan; Zhang, Jian-Hang; Chen, Xiao-Yong; Li, Hong-Qing			Evaluating sampling strategy for DNA barcoding study of coastal and inland halotolerant Poaceae and Chenopodiaceae: A case study for increased sample size	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SPECIES IDENTIFICATION; BIOGEOGRAPHY; PLANT; DIVERSITY; EVOLUTION; DISTANCE; MORACEAE; GENOME; FLOWER	Environmental conditions in coastal salt marsh habitats have led to the development of specialist genetic adaptations. We evaluated six DNA barcode loci of the 53 species of Poaceae and 15 species of Chenopodiaceae from China's coastal salt marsh area and inland area. Our results indicate that the optimum DNA barcode was ITS for coastal salt-tolerant Poaceae and matK for the Chenopodiaceae. Sampling strategies for ten common species of Poaceae and Chenopodiaceae were analyzed according to optimum barcode. We found that by increasing the number of samples collected from the coastal salt marsh area on the basis of inland samples, the number of haplotypes of Arundinella hirta, Digitaria ciliaris, Eleusine indica, Imperata cylindrica, Setaria viridis, and Chenopodium glaucum increased, with a principal coordinate plot clearly showing increased distribution points. The results of a Mann- Whitney test showed that for Digitaria ciliaris, Eleusine indica, Imperata cylindrica, and Setaria viridis, the distribution of intraspecific genetic distances was significantly different when samples from the coastal salt marsh area were included (P < 0.01). These results suggest that increasing the sample size in specialist habitats can improve measurements of intraspecific genetic diversity, and will have a positive effect on the application of the DNA barcodes in widely distributed species. The results of random sampling showed that when sample size reached 11 for Chloris virgata, Chenopodium glaucum, and Dysphania ambrosioides, 13 for Setaria viridis, and 15 for Eleusine indica, Imperata cylindrica and Chenopodium album, average intraspecific distance tended to reach stability. These results indicate that the sample size for DNA barcode of globally distributed species should be increased to 11-15.	[Yao, Peng-Cheng; Gao, Hai-Yan; Wei, Ya-Nan; Zhang, Jian-Hang; Li, Hong-Qing] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Chen, Xiao-Yong] East China Normal Univ, Sch Ecol & Environm Sci, Tiantong Natl Stn Forest Ecosyst, Shanghai, Peoples R China	East China Normal University; East China Normal University	Li, HQ (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.; Chen, XY (corresponding author), East China Normal Univ, Sch Ecol & Environm Sci, Tiantong Natl Stn Forest Ecosyst, Shanghai, Peoples R China.	xychen@des.ecnu.edu.cn; hqli@bio.ecnu.edu.cn	Chen, Xiao-Yong/B-1467-2009	Chen, Xiao-Yong/0000-0002-4795-8940	Foundation of Science and Technology Ministry, National Science and Technology Works Special [2014FY130300]	Foundation of Science and Technology Ministry, National Science and Technology Works Special	This study was funded by the Foundation of Science and Technology Ministry, National Science and Technology Works Special (Grant No. 2014FY130300). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Avise JC, 2000, PHYLOGEOGRAPHY, P47; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bafeel S.O., 2012, INT J BIOL, V4, P66, DOI [10.5539/ijb.v4n4p66, DOI 10.5539/ijb.v4n4p66]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blyton M, 2006, COMPREHENSIVE GUIDE; BOKHARI UG, 1990, J RANGE MANAGE, V43, P202, DOI 10.2307/3898672; Brandt R, 2015, PLANT SYST EVOL, V301, P2351, DOI 10.1007/s00606-015-1233-y; Burland T G, 2000, Methods Mol Biol, V132, P71; Cai ZM, 2012, J SYST EVOL, V50, P527, DOI 10.1111/j.1759-6831.2012.00216.x; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Costion CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155118; De la Fuente V, 2016, PLANT BIOSYST, V150, P343, DOI 10.1080/11263504.2015.1022239; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Elizabeth A. K., 2015, FAMILIES GENERA VASC, P1; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Fuentes-Bazan S, 2012, MOL PHYLOGENET EVOL, V62, P359, DOI 10.1016/j.ympev.2011.10.006; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Gao LM, 2017, J SYST EVOL, V55, P16, DOI 10.1111/jse.12207; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; IBM Corp, 2011, IBM SPSS STAT WIND V; Ito Y, 2010, AM J BOT, V97, P1156, DOI 10.3732/ajb.0900168; Kadereit G, 2006, TAXON, V55, P617, DOI 10.2307/25065639; Kadereit G, 2010, AM J BOT, V97, P1664, DOI 10.3732/ajb.1000169; Kamal AHM, 2010, AUST J CROP SCI, V4, P196; Kapralov MV, 2006, SYST BOT, V31, P571, DOI 10.1600/036364406778388674; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuhn U, 1993, FAMILIES GENERA VASC, P253, DOI DOI 10.1007/978-3-662-02899-5_26; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lee JeongRan, 2014, Journal of Agricultural Science and Technology B, V4, P533; Lee SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154631; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Little DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081008; Lopez-Alvarez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051058; Lu J, 2016, PHYTOTAXA, V261, P121, DOI 10.11646/phytotaxa.261.2.2; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Murakeozy EP, 2007, PLANT SYST EVOL, V264, P217, DOI 10.1007/s00606-006-0511-0; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parveen I, 2012, MOL ECOL RESOUR, V12, P82, DOI 10.1111/j.1755-0998.2011.03071.x; Peterson Paul M., 2014, Webbia, V69, P1, DOI 10.1080/00837792.2014.927555; Peterson PM, 2010, MOL PHYLOGENET EVOL, V55, P580, DOI 10.1016/j.ympev.2010.01.018; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousseau-Gueutin M, 2015, MOL PHYLOGENET EVOL, V93, P5, DOI 10.1016/j.ympev.2015.06.013; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Schutze P, 2003, PLANT SYST EVOL, V239, P257, DOI 10.1007/s00606-003-0013-2; Spangler R, 1999, SYST BOT, V24, P267, DOI 10.2307/2419552; Spangler R. E., 2000, Grasses: systematics and evolution., P167; Su XF, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7279361; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Triest L, 2010, AQUAT BOT, V93, P68, DOI 10.1016/j.aquabot.2010.03.007; Wang M, 2013, GENE, V528, P206, DOI 10.1016/j.gene.2013.07.009; Wright S, 1943, GENETICS, V28, P114; Xu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115168; Yan HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122903; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yang ZH, 2017, MOL ECOL, V26, P3028, DOI 10.1111/mec.14093; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055927; Zhao KF, 1998, TYPES CHINESE HALOPH, P76	71	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185311	10.1371/journal.pone.0185311	http://dx.doi.org/10.1371/journal.pone.0185311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934362	Green Submitted, gold, Green Published			2022-12-26	WOS:000411339900143
J	Ahmad, MS; Kimhofer, T; Ahmad, S; AlAma, MN; Mosli, HH; Hindawi, SI; Mook-Kanamori, DO; Sebekova, K; Damanhouri, ZA; Holmes, E				Ahmad, Muhammad Saeed; Kimhofer, Torben; Ahmad, Sultan; AlAma, Mohammed Nabil; Mosli, Hala Hisham; Hindawi, Salwa Ibrahim; Mook-Kanamori, Dennis O.; Sebekova, Katarina; Damanhouri, Zoheir Abdullah; Holmes, Elaine			Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA MEDIA THICKNESS; HEMODIALYSIS-PATIENTS; REFERENCE VALUES; FLUORESCENCE; ACCUMULATION; POPULATION; MORTALITY; STRESS; FOOD	Skin auto fluorescence (SAF) is used as a proxy for the accumulation of advanced glycation end products (AGEs) and has been proposed to stratify patients into cardiovascular disease (CVD) and diabetes mellitus (DM) risk groups. This study evaluates the effects of seven different ethnicities (Arab, Central-East African, Eastern Mediterranean, European, North African, South Asian and Southeast Asian) and gender on SAF as well as validating SAF assessment as a risk estimation tool for CVD and DM in an Arabian cohort. SAF data from self-reported healthy 2,780 individuals, collated from three independent studies, has been linear modelled using age and gender as a covariate. A cross-study harmonized effect size (Cohens'd) is provided for each ethnicity. Furthermore, new data has been collected from a clinically well-defined patient group of 235 individuals, to evaluate SAF as a clinical tool for DM and CVD-risk estimation in an Arab cohort. In an Arab population, SAF-based CVD and/or DM risk-estimation can be improved by referencing to ethnicity and gender-specific SAF values. Highest SAF values were observed for the North African population, followed by East Mediterranean, Arab, South Asian and European populations. The South Asian population had a slightly steeper slope in SAF values with age compared to other ethnic groups. All ethnic groups except Europeans showed a significant gender effect. When compared with a European group, effect size was highest for Eastern Mediterranean group and lowest for South Asian group. The Central-East African and Southeast Asian ethnicity matched closest to the Arab and Eastern Mediterranean ethnicities, respectively. Ethnic and gender-specific data improves performance in SAF-based CVD and DM risk estimation. The provided harmonized effect size allows a direct comparison of SAF in different ethnicities. For the first time, gender differences in SAF are described for North African and East Mediterranean populations.	[Ahmad, Muhammad Saeed; Ahmad, Sultan; Damanhouri, Zoheir Abdullah; Holmes, Elaine] King Abdulaziz Univ, King Fahad Med Res Ctr, Drug Metab Unit, Jeddah, Saudi Arabia; [Ahmad, Muhammad Saeed; Kimhofer, Torben; Holmes, Elaine] Imperial Coll London, Fac Med, Dept Surg & Canc, Biomol Med, London, England; [AlAma, Mohammed Nabil] King Abdulaziz Univ Hosp, Dept Med, Cardiol Unit, Jeddah, Saudi Arabia; [Mosli, Hala Hisham] King Abdulaziz Univ, Fac Med, Dept Med, Jeddah, Saudi Arabia; [Hindawi, Salwa Ibrahim] King Abdulaziz Univ, Fac Med, Dept Haematol, Jeddah, Saudi Arabia; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Primary Care Publ Hlth & Clin Epidemiol, Leiden, Netherlands; [Sebekova, Katarina] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia; [Damanhouri, Zoheir Abdullah] King Abdulaziz Univ, Fac Med, Dept Pharmacol, Jeddah, Saudi Arabia	King Abdulaziz University; Imperial College London; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Abdulaziz University; King Abdulaziz University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Comenius University Bratislava; King Abdulaziz University	Ahmad, MS (corresponding author), King Abdulaziz Univ, King Fahad Med Res Ctr, Drug Metab Unit, Jeddah, Saudi Arabia.; Ahmad, MS; Kimhofer, T (corresponding author), Imperial Coll London, Fac Med, Dept Surg & Canc, Biomol Med, London, England.	maahmad2@kau.edu.sa; t.kimhofer12@imperial.ac.uk	Ahmad, Muhammad S/L-5322-2013; Damanhouri, Zoheir/ABI-6203-2020; Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020; Sebekova, Katarina/GSD-7056-2022; Sebekova, Katarina/H-4906-2016	Ahmad, Muhammad S/0000-0003-1945-2739; Holmes, Elaine/0000-0002-0556-8389; Sebekova, Katarina/0000-0002-9641-9265; Sebekova, Katarina/0000-0002-9641-9265; HINDAWI, SALWA/0000-0003-3804-5434	Deanship of Scientific Research (DSR), King Abdulaziz University [2-141-35-HiCi]; Stratified Medicine Graduate Training Programme in Systems Medicine and Spectroscopic Profiling (STRATiGRAD); Dutch Science Organization (ZonMW-VENI Grant) [916.14.023]; Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University; Stratified Medicine Graduate Training Programme in Systems Medicine and Spectroscopic Profiling (STRATiGRAD); Dutch Science Organization (ZonMW-VENI Grant); Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, under grant no. (2-141-35-HiCi). T Kimhofer was supported by Stratified Medicine Graduate Training Programme in Systems Medicine and Spectroscopic Profiling (STRATiGRAD). Dennis Mook-Kanamori is supported by Dutch Science Organization (ZonMW-VENI Grant 916.14.023).; The authors thank all participants of this study. This article was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Ahmad MS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10198; Barat P, 2011, DIABETES CARE, V35, pe1; Conway B, 2010, DIABETES TECHNOL THE, V12, P339, DOI 10.1089/dia.2009.0152; de Vos LC, 2015, ARTERIOSCL THROM VAS, V35, P1532, DOI 10.1161/ATVBAHA.115.305407; Eny KM, 2015, DIABETES TECHNOL THE, V17, P726, DOI 10.1089/dia.2015.0017; Eny KM, 2014, DIABETOLOGIA, V57, P1623, DOI 10.1007/s00125-014-3286-9; Hangai M, 2016, J ATHEROSCLER THROMB; Hartog JWL, 2007, EUR J HEART FAIL, V9, P1146, DOI 10.1016/j.ejheart.2007.09.009; Hashimoto K, 2016, J DIABETES COMPLICAT; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Jochemsen BM, 2009, J FOOD NUTR RES-SLOV, V48, P51; Kessel L, 2002, DIABETOLOGIA, V45, P1457, DOI 10.1007/s00125-002-0925-3; Klenovics KS, 2014, DIABETIC MED, V31, P581, DOI 10.1111/dme.12326; Knowles JW, 2015, J CLIN INVEST, V125, P1739, DOI [10.1172/JCI74692, 10.1172/JCI74592]; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Krul-Poel YHM, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0250-z; Lutgers HL, 2009, DIABETOLOGIA, V52, P789, DOI 10.1007/s00125-009-1308-9; Lutgers HL, 2010, EUR J CLIN INVEST, V40, P812, DOI 10.1111/j.1365-2362.2010.02329.x; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meerwaldt R, 2007, DIABETES CARE, V30, P107, DOI 10.2337/dc06-1391; Mook-Kanamori MJ, 2013, DERM-ENDOCRINOL, V5, P325, DOI 10.4161/derm.26046; Nongnuch A, 2015, BRIT J NUTR, V113, P1040, DOI 10.1017/S0007114515000379; Podgorna E, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0543-6; R Core Team, R LANG ENV STAT COMP; Rajaobelina K, 2016, DIABETES-METAB RES; Sugisawa E, 2013, DIABETES CARE, V36, P2339, DOI 10.2337/dc12-1077; van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Vouillarmet J, 2013, DIABETES TECHNOL THE, V15, P601, DOI 10.1089/dia.2013.0009; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yamanaka M, 2016, J CLIN BIOCHEM NUTR, V58, P135, DOI 10.3164/jcbn.15-132; Yue X, 2011, DIABETIC MED, V28, P818, DOI 10.1111/j.1464-5491.2010.03217.x	33	12	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185175	10.1371/journal.pone.0185175	http://dx.doi.org/10.1371/journal.pone.0185175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931094	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700077
J	Foteinopoulos, P; Mulder, BM				Foteinopoulos, Panayiotis; Mulder, Bela M.			A microtubule-based minimal model for spontaneous and persistent spherical cell polarity	PLOS ONE			English	Article							END-TRACKING PROTEINS; YEAST; MEMBRANE; DYNAMICS; CYTOSKELETON; MECHANISMS	We propose a minimal model for the spontaneous and persistent generation of polarity in a spherical cell based on dynamic microtubules and a single mobile molecular component. This component, dubbed the polarity factor, binds to microtubules nucleated from a centrosome located in the center of the cell, is subsequently delivered to the cell membrane, where it diffuses until it unbinds. The only feedback mechanism we impose is that the residence time of the microtubules at the membrane increases with the local density of the polarity factor. We show analytically that this system supports a stable unipolar symmetry-broken state for a wide range of parameters. We validate the predictions of the model by 2D particle-based simulations. Our model provides a route towards the creation of polarity in a minimal cell-like environment using a biochemical reconstitution approach.	[Foteinopoulos, Panayiotis; Mulder, Bela M.] Inst AMOLF, Syst Biophys Dept, Amsterdam, Netherlands	AMOLF	Mulder, BM (corresponding author), Inst AMOLF, Syst Biophys Dept, Amsterdam, Netherlands.	mulder@amolf.nl			Foundation for Fundamental Research on Matter (FOM); Netherlands Organisation for Scientific Research (NWO)	Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work of BMM was supported by the research programme of the Foundation for Fundamental Research on Matter (FOM,www.fom.nl), which is part of the Netherlands Organisation for Scientific Research (NWO,www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Bressloff PC, 2015, SIAM J APPL MATH, V75, P652, DOI 10.1137/140990358; Bruce A, 2002, MOL BIOL CELL; BUENDIA B, 1992, J CELL BIOL, V116, P1431, DOI 10.1083/jcb.116.6.1431; Calvez V, 2012, SIAM J APPL MATH, V72, P594, DOI 10.1137/11083486X; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; Freisinger T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2795; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Good MC, 2013, SCIENCE, V342, P856, DOI 10.1126/science.1243147; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Hawkins RJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.040903; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002271; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Klunder B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003396; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Li Jian-Ming, 2012, Int J Mol Imaging, V2012, P253475, DOI 10.1155/2012/253475; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Milani M, 1998, P SOC PHOTO-OPT INS, V3256, P195, DOI 10.1117/12.307071; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Recouvreux P, 2016, P NATL ACAD SCI USA, V113, P1811, DOI 10.1073/pnas.1419248113; Schmidt N, 2012, J CELL BIOL, V198, P421, DOI 10.1083/jcb.201111130; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Su XL, 2013, NAT CELL BIOL, V15, P948, DOI 10.1038/ncb2801; Taberner N, 2015, METHOD CELL BIOL, V128, P1, DOI 10.1016/bs.mcb.2015.02.008; Taberner N, 2014, METHOD CELL BIOL, V120, P69, DOI 10.1016/B978-0-12-417136-7.00005-7; Thompson BJ, 2013, DEVELOPMENT, V140, P13, DOI 10.1242/dev.083634; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wu CF, 2015, ELIFE, V4, DOI 10.7554/eLife.11611	38	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184706	10.1371/journal.pone.0184706	http://dx.doi.org/10.1371/journal.pone.0184706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931032	gold, Green Published, Green Submitted			2022-12-26	WOS:000411314700028
J	Ryskov, AP; Osipov, FA; Omelchenko, AV; Semyenova, SK; Girnyk, AE; Korchagin, VI; Vergun, AA; Murphy, RW				Ryskov, Alexey P.; Osipov, Fedor A.; Omelchenko, Andrey V.; Semyenova, Seraphima K.; Girnyk, Anastasiya E.; Korchagin, Vitaly I.; Vergun, Andrey A.; Murphy, Robert W.			The origin of multiple clones in the parthenogenetic lizard species Darevskia rostombekowi	PLOS ONE			English	Article							CAUCASIAN ROCK LIZARD; HETERONOTIA-BINOEI GEKKONIDAE; CYTOCHROME-B GENE; MICROSATELLITE LOCI; ALLELIC VARIANTS; LACERTA; DIVERSITY; EVOLUTION; COMPLEX; SAURIA	The all-female Caucasian rock lizard Darevskia rostombekowi and other unisexual species of this genus reproduce normally via true parthenogenesis. Typically, diploid parthenogenetic reptiles exhibit some amount of clonal diversity. However, allozyme data from D.rostombekowi have suggested that this species consists of a single clone. Herein, we test this hypothesis by evaluating variation at three variable microsatellite loci for 42 specimens of D. rostombekowi from four populations in Armenia. Analyses based on single nucleotide polymorphisms of each locus reveal five genotypes or presumptive clones in this species. All individuals are heterozygous at the loci. The major clone occurs in 24 individuals and involves three populations. Four rare clones involve one or several individuals from one or two populations. Most variation owes to parent-specific single nucleotide polymorphisms, which occur as heterozygotes. This result fails to reject the hypothesis of a single hybridization founder event that resulted in the initial formation of one major clone. The other clones appear to have originated via post-formation microsatellite mutations of the major clone.	[Ryskov, Alexey P.; Osipov, Fedor A.; Semyenova, Seraphima K.; Girnyk, Anastasiya E.; Korchagin, Vitaly I.; Vergun, Andrey A.] Russian Acad Sci, Inst Gene Biol, Lab Genome Org, Moscow, Russia; [Osipov, Fedor A.; Vergun, Andrey A.] Moscow State Pedag Univ, Dept Biochem Mol Biol & Genet, Moscow, Russia; [Omelchenko, Andrey V.] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Grp Bioinformat & Modeling Biol Proc, Moscow, Russia; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON, Canada	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Moscow State University of Education; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Royal Ontario Museum	Ryskov, AP (corresponding author), Russian Acad Sci, Inst Gene Biol, Lab Genome Org, Moscow, Russia.	ryskov@mail.ru	Osipov, Fedor/AAC-2363-2022; Girnyk, Anastasiya/U-7872-2018; Omelchenko, Andrey V/E-8887-2014; Vergun, Andrey/I-4829-2016; Korchagin, Vitaly/B-8635-2011; Ryskov, Alexey/F-1179-2016	Osipov, Fedor/0000-0002-0904-1752; Girnyk, Anastasiya/0000-0001-9199-1281; Omelchenko, Andrey V/0000-0003-4512-4413; Vergun, Andrey/0000-0001-5255-7802; Korchagin, Vitaly/0000-0003-2264-6294; Ryskov, Alexey/0000-0002-4159-0671	Russian Science Foundation [14-14-00832]; Russian Foundation of Scientific Researches [17-04-00396]; RAS Program "Molecular and Cell Biology"	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation of Scientific Researches; RAS Program "Molecular and Cell Biology"	The work on DNA sequencing was supported by the Russian Science Foundation No 14-14-00832 (http://rscf.ru/en). The work on genotype revealing and characterization was supported by the Russian Foundation of Scientific Researches (grant No 17-04-00396) by the RAS Program "Molecular and Cell Biology" (http://rscf.ru/en). The work was conducted on the base of the Center for Collective Use, Institute of Gene Biology, Russian Academy of Sciences (GK-02.451.11.7060) (http://www.genebiology.ru/en/).; The work on DNA sequencing was supported by the Russian Science Foundation No 14-14-00832. The work on genotype revealing and characterization was supported by the Russian Foundation of Scientific Researches (grant No 17-04-00396) and by the RAS Program "Molecular and Cell Biology". The work was conducted on the base of the Center for Collective Use, Institute of Gene Biology, Russian Academy of Sciences (GK-02.451.11.7060). Authors thank to Felix Danielyan for help in field and for providing biological materials.	Abdala CS, 2016, COPEIA, V104, P487, DOI 10.1643/CH-15-381; Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Avise J., 2008, CLONALITY GENETICS E; Badaeva TN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002730; Booth W, 2016, BIOL J LINN SOC, V118, P172, DOI 10.1111/bij.12744; Cole CJ, 1988, AM MUS NOVIT, V2905, P1; Darevsky I., 1967, ROCK LIZARDS CAUCASU; Darevsky I.S., 1985, Biology of Reptilia, V15, P411; Darevsky I. S., 1993, SOVREMENNYE PROBLEMY, P89; DAREVSKY IS, 1958, DOKL AKAD NAUK SSSR+, V122, P730; Deakin JE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2774-3; DENSMORE LD, 1989, EVOLUTION, V43, P969, DOI 10.1111/j.1558-5646.1989.tb02543.x; Dessauer Herbert C., 1989, New York State Museum Bulletin, V466, P49; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freitas S, 2016, MOL PHYLOGENET EVOL, V102, P117, DOI 10.1016/j.ympev.2016.05.035; Freitas S, 2016, SYST BIODIVERS, V14, P184, DOI 10.1080/14772000.2015.1111267; Fu JZ, 2000, COPEIA, P432, DOI 10.1643/0045-8511(2000)000[0432:DOTCBG]2.0.CO;2; Fu JZ, 1998, J MOL EVOL, V46, P127, DOI 10.1007/PL00013146; Fu JZ, 2000, AMPHIBIA-REPTILIA, V21, P83, DOI 10.1163/156853800507291; Fu JZ, 1999, GENETICA, V105, P227, DOI 10.1023/A:1003865227108; Fujita MK, 2009, CYTOGENET GENOME RES, V127, P261, DOI 10.1159/000295177; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hedges S. Blair, 2014, Caribbean Herpetology, V49; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jancuchova-Laskova J, 2015, CURR ZOOL, V61, P155; Janko K, 2008, EVOLUTION, V62, P1264, DOI 10.1111/j.1558-5646.2008.00359.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kearney M, 2008, MOL ECOL, V17, P5257, DOI 10.1111/j.1365-294X.2008.03991.x; Korchagin VI, 2007, GENE, V392, P126, DOI 10.1016/j.gene.2006.11.020; Kupriyanova LA, 1999, CYTOLOGIA, V21, P1038; Kupriyanova LA, 1989, EVOLUTION ECOLOGY UN, V466, P289; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; MacCulloch RD, 1997, BIOCHEM SYST ECOL, V25, P33, DOI 10.1016/S0305-1978(96)00085-3; Macculloch Ross D., 1995, Amphibia-Reptilia, V16, P331, DOI 10.1163/156853895X00415; Malysheva D N, 2006, Dokl Biochem Biophys, V410, P304, DOI 10.1134/S1607672906050140; Manriquez-Moran NL, 2014, ZOOL SCI, V31, P14, DOI 10.2108/zsj.31.14; Martirosyan IA, 2002, RUSS J GENET+, V38, P691, DOI 10.1023/A:1016000219576; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1992, GENETICA, V87, P53, DOI 10.1007/BF00128773; MORITZ C, 1991, GENETICS, V129, P211; Murphy RW, 1997, GENETICA, V101, P125, DOI 10.1023/A:1018392603062; Murphy RW, 2000, ZOOL J LINN SOC-LOND, V130, P527, DOI 10.1006/zjls.1999.0241; Murphy RW, 1999, AMPHIBIA-REPTILIA, V20, P225; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Osipov FA, 2016, MOL GENET MICROBIOL+, V31, P69, DOI 10.3103/S0891416816020075; Parker E. Davis Jr, 1989, New York State Museum Bulletin, V466, P72; PARKER ED, 1979, EVOLUTION, V33, P1150, DOI 10.1111/j.1558-5646.1979.tb04769.x; PARKER ED, 1984, HERPETOLOGICA, V40, P245; PARKER ED, 1979, AM ZOOL, V19, P753; Pellegrino KCM, 2003, J HERPETOL, V37, P197, DOI 10.1670/0022-1511(2003)037[0197:TKOLPS]2.0.CO;2; Ryskov AR, 2008, INT REV CEL MOL BIO, V270, P319, DOI 10.1016/S1937-6448(08)01407-X; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarkhnishvili D, 2010, BIOL J LINN SOC, V101, P447, DOI 10.1111/j.1095-8312.2010.01498.x; Uetz P., 2021, REPTILE DATABASE; UZZELL T, 1975, COPEIA, P204; Vergun AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091674; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Vrijenhoek Robert C., 1989, New York State Museum Bulletin, V466, P19; VYAS DK, 1990, EVOLUTION, V44, P922, DOI 10.1111/j.1558-5646.1990.tb03814.x	61	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185161	10.1371/journal.pone.0185161	http://dx.doi.org/10.1371/journal.pone.0185161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931071	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700074
J	Padilla-Benavides, T; Nasipak, BT; Paskavitz, AL; Haokip, DT; Schnabl, JM; Nickerson, JA; Imbalzano, AN				Padilla-Benavides, Teresita; Nasipak, Brian T.; Paskavitz, Amanda L.; Haokip, Dominic T.; Schnabl, Jake M.; Nickerson, Jeffrey A.; Imbalzano, Anthony N.			Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; chromatin regulation; chromatin remodeling; phosphorylation; transcription; Brg1; SWI; SNF subunits; casein kinase 2; myoblast	CHROMATIN REMODELING COMPLEXES; SATELLITE CELLS; NUCLEAR SUBSTRUCTURE; SELF-RENEWAL; PROTEIN; PAX7; CK2; SUBUNIT; BRG1; COMPONENTS	Transcriptional regulation is modulated in part by chromatin-remodeling enzymes that control gene accessibility by altering chromatin compaction or nucleosome positioning. Brahma-related gene 1 (Brg1), a catalytic subunit of the mammalian SWI/SNF chromatin-remodeling enzymes, is required for both myoblast proliferation and differentiation, and the control of Brg1 phosphorylation by calcineurin, PKC1, and p38 regulates the transition to differentiation. However, we hypothesized that Brg1 activity might be regulated by additional kinases. Here, we report that Brg1 is also a target of casein kinase 2 (CK2), a serine/threonine kinase, in proliferating myoblasts. We found that CK2 interacts with Brg1, and mutation of putative phosphorylation sites to non-phosphorylatable (Ser to Ala, SA) or phosphomimetic residues (Ser to Glu, SE) reduced Brg1 phosphorylation by CK2. Although BRG1-deleted myoblasts that ectopically express the SA-Brg1 mutant proliferated similarly to the parental cells or cells ectopically expressing wild-type (WT) Brg1, ectopic expression of the SE-Brg1 mutant reduced proliferation and increased cell death, similar to observations from cells lacking Brg1. Moreover, pharmacological inhibition of CK2 increased myoblast proliferation. Furthermore, the Pax7 promoter, which controls expression of a key transcription factor required for myoblast proliferation, was in an inaccessible chromatin state in the SE-Brg1 mutant, suggesting that hyperphosphorylated Brg1 cannot remodel chromatin. WT-, SA-, and SE-Brg1 exhibited distinct differences in interacting with and affecting expression of the SWI/SNF subunits Baf155 and Baf170 and displayed differential sub-nuclear localization. Our results indicate that CK2-mediated phosphorylation of Brg1 regulates myoblast proliferation and provides insight into one mechanism by which composition of the mammalian SWI/SNF enzyme complex is regulated.	[Padilla-Benavides, Teresita; Nasipak, Brian T.; Paskavitz, Amanda L.; Haokip, Dominic T.; Schnabl, Jake M.; Imbalzano, Anthony N.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Med Sch, 364 Plantat St, Worcester, MA 01605 USA; [Nickerson, Jeffrey A.] Univ Massachusetts, Dept Pediat, Med Sch, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Imbalzano, AN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Pharmacol, Med Sch, 364 Plantat St, Worcester, MA 01605 USA.	anthony.imbalzano@umassmed.edu	Padilla-Benavides, Teresita/K-1968-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822	National Institutes of Health [GM56244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM56244. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bouazoune K, 2005, J BIOL CHEM, V280, P41912, DOI 10.1074/jbc.M507084200; Bourachot B, 2003, EMBO J, V22, P6505, DOI 10.1093/emboj/cdg621; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cui HH, 2016, NUCLEIC ACIDS RES, V44, P2538, DOI 10.1093/nar/gkv1244; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Dobson JR, 2017, J CELL PHYSIOL, V232, P1295, DOI 10.1002/jcp.25596; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Fawcett DW., 1966, ATLAS FINE STRUCTURE, P112; Flaus A, 2011, FEBS J, V278, P3579, DOI 10.1111/j.1742-4658.2011.08281.x; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; GERDES MG, 1994, J CELL BIOL, V126, P289, DOI 10.1083/jcb.126.2.289; Gonzalez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154919; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kimura A, 2014, J PROTEOME RES, V13, P4959, DOI 10.1021/pr500470h; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; Kwon SJ, 2015, ONCOGENE, V34, P351, DOI 10.1038/onc.2013.556; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZ P, 1993, J BIOL CHEM, V268, P2733; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; Mansouri A, 1996, DEVELOPMENT, V122, P831; Hernandez-Hernandez JM, 2013, NUCLEIC ACIDS RES, V41, P5704, DOI 10.1093/nar/gkt285; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Maya-Mendoza A, 2003, NUCLEIC ACIDS RES, V31, P6168, DOI 10.1093/nar/gkg825; Maya-Mendoza A, 2003, ANAL BIOCHEM, V313, P196, DOI 10.1016/S0003-2697(02)00611-5; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Motohashi N, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00001; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nasipak BT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8441; Nickerson JA, 2009, RNA BIOL, V6, P25, DOI 10.4161/rna.6.1.7563; Ohkawa Y, 2012, METHODS MOL BIOL, V798, P531, DOI 10.1007/978-1-61779-343-1_32; Olguin HC, 2011, BIOL RES, V44, P323, DOI /S0716-97602011000400002; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Padilla-Benavides T, 2015, J CELL PHYSIOL, V230, P2990, DOI 10.1002/jcp.25031; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PEPPERKOK R, 1991, EXP CELL RES, V197, P245, DOI 10.1016/0014-4827(91)90429-X; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Quaresma AJC, 2013, MOL BIOL CELL, V24, P1208, DOI 10.1091/mbc.E12-06-0450; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Sambasivan Ramkumar, 2015, Results Probl Cell Differ, V56, P191, DOI 10.1007/978-3-662-44608-9_9; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seldin DC, 2008, MOL CELL BIOCHEM, V316, P141, DOI 10.1007/s11010-008-9811-8; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Trembley JH, 2003, J BIOL CHEM, V278, P2265, DOI 10.1074/jbc.M207518200; Tripodi F, 2013, EUKARYOT CELL, V12, P1271, DOI 10.1128/EC.00117-13; Tyagi M, 2016, NUCLEUS-PHILA, V7, P388, DOI 10.1080/19491034.2016.1211217; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang YH, 2013, MOL CELL, V49, P283, DOI 10.1016/j.molcel.2012.10.028; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	81	17	17	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18592	18607		10.1074/jbc.M117.799676	http://dx.doi.org/10.1074/jbc.M117.799676			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939766	hybrid, Green Published			2022-12-26	WOS:000414958100017
J	Ha, YR; Kim, JH; Ryu, J; Lee, SJ				Ha, Young Ran; Kim, Jun Ho; Ryu, Jeongeun; Lee, Sang Joon			Superb feeding behavior of Aedes albopictus transmitting Zika virus	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANOPHELES-SINENSIS; MOSQUITOS; TRANSMISSION; INGESTION; ADHESION; SPREAD; SUSCEPTIBILITY; SPOROZOITES; INFECTION	Disease-mediated mosquitoes have been receiving much attention, as the World Health Organization recently declared the Zika virus a global public health emergency. Mosquitoes transmit pathogens that cause various tropical diseases including malaria, dengue fever and yellow fever as well as Zika virus. The vector efficiency of mosquitoes depends on their blood-feeding characteristics and the mechanics of their blood-sucking pump system, but only a few studies have attempted to investigate these key issues. In this study, we demonstrate the rapid and gluttonous liquid-feeding characteristics of Ae. albopictus which transmits Zika virus can be explained by similar proportion of two blood-sucking pumps and accelerated liquid intake driven by fast expanding of pumps. Our results provide insight into the vector efficiency of Ae. albopictus in terms of feeding velocity, pumping frequency, liquid-intake rate, and wall shear stress.	[Ha, Young Ran; Lee, Sang Joon] Pohang Univ Sci & Technol, Ctr Biofluid & Biomim Res, Pohang, South Korea; [Kim, Jun Ho; Ryu, Jeongeun; Lee, Sang Joon] Pohang Univ Sci & Technol, Dept Mech Engn, Ctr Biofluid & Biomim Res, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Ctr Biofluid & Biomim Res, Pohang, South Korea.; Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Dept Mech Engn, Ctr Biofluid & Biomim Res, Pohang, South Korea.	sjlee@postech.ac.kr	Lee, Sang Joon/AAG-2448-2019	LEE, SANG JOON/0000-0003-3286-5941	National Research Foundation of Korea grant - Korean government (MSIP) [2008-0061991]	National Research Foundation of Korea grant - Korean government (MSIP)	This work was supported by a National Research Foundation of Korea grant funded by the Korean government (MSIP) (No. 2008-0061991). URL: http://www.nrf.re.kr/eng/main. The funder had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Cator LJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0711; Cavalcante RR, 2006, MEM I OSWALDO CRUZ, V101, P85, DOI 10.1590/S0074-02762006000100016; El-Kirat-Chatel S, 2016, NANOSCALE HORIZ, V1, P69, DOI 10.1039/c5nh00049a; Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Harada F, 1975, JAP J SANIT ZOOL; Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; Junkum A, 2003, MEM I OSWALDO CRUZ, V98, P481, DOI 10.1590/S0074-02762003000400009; KASHIN P, 1966, J INSECT PHYSIOL, V12, P281, DOI 10.1016/0022-1910(66)90143-0; Kebaier C, 2006, AM J TROP MED HYG, V75, P1200, DOI 10.4269/ajtmh.2006.75.1200; Kikuchi K, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/6/064002; Kim BH, 2014, SENSOR ACTUAT A-PHYS, V209, P133, DOI 10.1016/j.sna.2014.01.016; Kim BH, 2013, J EXP BIOL, V216, P952, DOI 10.1242/jeb.072710; Kim BH, 2011, J EXP BIOL, V214, P1163, DOI 10.1242/jeb.048793; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Lee SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20464; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; Park JH, 2012, EMERG INFECT DIS, V18, P1525, DOI 10.3201/eid1809.111811; Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001; Poole-Smith BK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003462; ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035; Saeung A, 2014, SE ASIAN J TROP MED, V45, P588; Sant'Anna MRV, 2001, J INSECT PHYSIOL, V47, P1459, DOI 10.1016/S0022-1910(01)00136-6; SCHMIDT JM, 1991, J INSECT PHYSIOL, V37, P817, DOI 10.1016/0022-1910(91)90078-E; Schwarz US, 2015, SEMIN CELL DEV BIOL, V46, P82, DOI 10.1016/j.semcdb.2015.09.025; Sota T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131230; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; WEKESA JW, 1992, AM J TROP MED HYG, V47, P484, DOI 10.4269/ajtmh.1992.47.484; World Health Organization, 2016, ZIKA STRATEGIC RESPO	35	1	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184871	10.1371/journal.pone.0184871	http://dx.doi.org/10.1371/journal.pone.0184871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957351	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200020
J	Ito, T; Suzaki, K				Ito, Takao; Suzaki, Koichi			Universal detection of phytoplasmas and Xylella spp. by TaqMan singleplex and multiplex real-time PCR with dual priming oligonucleotides	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; RT-PCR; FASTIDIOSA; PLANT; ASSAYS	Phytoplasmas and Xylella spp. are bacteria that cause many economically important plant diseases worldwide. TaqMan probe-based quantitative real-time polymerase chain reaction (qPCR) assays have been utilized to universally detect phytoplasmas or Xylella fastidiosa. To develop a superior universal qPCR method, we used a dual priming oligonucleotide (DPO) with two annealing sites as a reverse primer to target the well-conserved bacterial 16S rDNA. The new qPCR assays universally detected various species of phytoplasmas and subspecies of X. fastidiosa as well as Xylella taiwanensis, and generally showed superior threshold cycle values when amplifying specific or non-specific products compared to current universal qPCR assays. The proposed qPCR assays were integrated to develop a multiplex qPCR assay that simultaneously detected phytoplasmas, Xylella spp., and an internal plant DNA positive control within 1 hour. This assay could detect a minimum of ten bacterial cells and was compatible with crude extractions used in the rapid screening of various plants. The amplicons were of sufficient lengths to be directly sequenced for preliminary identification, and the primers could be used in universal conventional PCR assays. Additionally, reverse DPO primers can be utilized to improve other probe-based qPCR assays.	[Ito, Takao; Suzaki, Koichi] Natl Agr & Food Res Org NARO, Inst Fruit Tree & Tea Sci, Div Grape & Persimmon Res, Higashihiroshima, Hiroshima, Japan	National Agriculture & Food Research Organization - Japan	Ito, T (corresponding author), Natl Agr & Food Res Org NARO, Inst Fruit Tree & Tea Sci, Div Grape & Persimmon Res, Higashihiroshima, Hiroshima, Japan.	itotaka@affrc.go..jp		Ito, Takao/0000-0002-2338-126X	Ministry of Agriculture, Forestry, and Fisheries of Japan [2508]	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a Grant-in-Aid for "Regulatory research projects for food safety, animal health and plant protection, no. 2508." from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Almeida RPP, 2015, PLANT DIS, V99, P1457, DOI 10.1094/PDIS-02-15-0159-FE; Anonymous, 2016, Bulletin OEPP, V46, P463, DOI 10.1111/epp.12327; Bertaccini A., 2014, American Journal of Plant Sciences, V5, P1763, DOI 10.4236/ajps.2014.512191; Chen JC, 2000, CURR MICROBIOL, V40, P29, DOI 10.1007/s002849910006; Christensen NM, 2004, MOL PLANT MICROBE IN, V17, P1175, DOI 10.1094/MPMI.2004.17.11.1175; Christensen Nynne Meyn, 2013, Methods Mol Biol, V938, P245, DOI 10.1007/978-1-62703-089-2_21; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; EUPHRESCO FruitPhytoInterlab Group, 2011, B INSECTOL, V64, P281; Firrao G., 1994, Phytopathologia Mediterranea, V33, P90; Forster RJ, 1997, APPL ENVIRON MICROB, V63, P1256, DOI 10.1128/AEM.63.4.1256-1260.1997; Francis M, 2006, EUR J PLANT PATHOL, V115, P203, DOI 10.1007/s10658-006-9009-4; Fujiwara K, 2016, J PLANT PATHOL, V98, P441, DOI 10.4454/JPP.V98I3.061; Harper SJ, 2010, PHYTOPATHOLOGY, V100, P1282, DOI 10.1094/PHYTO-06-10-0168; Hodgetts J, 2009, APPL ENVIRON MICROB, V75, P2945, DOI 10.1128/AEM.02610-08; IPPC, 2016, ISPM 27 ANN 12 PHYT; Kommedal O, 2012, J CLIN MICROBIOL, V50, P1289, DOI 10.1128/JCM.06269-11; Kube M, 2014, J MOL MICROB BIOTECH, V24, P19, DOI 10.1159/000354322; Li WB, 2013, J MICROBIOL METH, V92, P79, DOI 10.1016/j.mimet.2012.10.008; Loconsole G, 2014, J PLANT PATHOL, V96, P7; Maejima K, 2014, J GEN PLANT PATHOL, V80, P210, DOI 10.1007/s10327-014-0512-8; Malandraki I, 2015, J VIROL METHODS, V213, P12, DOI 10.1016/j.jviromet.2014.11.010; Marcelletti S, 2016, ARCH MICROBIOL, V198, P803, DOI 10.1007/s00203-016-1245-1; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; Nakaune R, 2006, J VIROL METHODS, V134, P244, DOI 10.1016/j.jviromet.2006.01.016; Rodrigues JLM, 2003, APPL ENVIRON MICROB, V69, P4249, DOI 10.1128/AEM.69.7.4249-4255.2003; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Su CC, 2016, INT J SYST EVOL MICR, V66, P4766, DOI 10.1099/ijsem.0.001426; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhao Y, 2016, INT J SYST EVOL MICR, V66, P2121, DOI 10.1099/ijsem.0.000999	29	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185427	10.1371/journal.pone.0185427	http://dx.doi.org/10.1371/journal.pone.0185427			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957362	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200056
J	Tjernberg, I; Hamsten, C; Apostolovic, D; van Hage, M				Tjernberg, Ivar; Hamsten, Carl; Apostolovic, Danijela; van Hage, Marianne			IgE reactivity to alpha-Gal in relation to Lyme borreliosis	PLOS ONE			English	Article							RED MEAT ALLERGY; TICK BITES; GALACTOSE-ALPHA-1,3-GALACTOSE; SWEDEN; ASSOCIATION; IDENTIFICATION; SENSITIZATION; ANTIBODIES; DIAGNOSIS; EUROPE	Background An association between tick bites, the development of immunoglobulin E (IgE) antibodies to galactose-alpha-1, 3-galactose (alpha-Gal) and red meat allergy has recently been reported. Here we wanted to elucidate the relation between tick exposure, IgE antibodies to alpha-Gal and Lyme borreliosis (LB). Methods In the highly LB endemic area of Kalmar County, Sweden, serum samples and health inquiries from 518 blood donors were included. All sera were investigated for multiple IgG antiBorrelia antibodies using a multiplex assay (recomBead, Mikrogen). In addition, three serially collected sera over a six month period from 148 patients with clinically defined erythema migrans (EM) were included. IgE antibodies against alpha-Gal were determined using ImmunoCAP (Thermo Fisher Scientific). Results In blood donors reporting previous LB (n = 124) IgE to alpha-Gal was found in 16%, while in donors denying previous LB but with multiple anti-Borrelia antibodies (n = 94; interpreted as asymptomatic LB) 10% were IgE alpha-Gal-positive. Finally, in donors without Borrelia antibodies denying previous LB (n = 300) 14% showed IgE to alpha-Gal. No significant difference in proportions among the groups were found. In EM patients, IgE to alpha-Gal was found in 32/148 (22%) at diagnosis, 31/148 (21%) after two-three months and 23/148 (16%) after six months. A significant reduction of proportion and level of IgE to alpha-Gal was found between the second and third sample (p< 0.01). A positive IgE anti alpha-Gal was more common among men compared with women both in blood donors and in EM patients (p <= 0.01). Conclusions IgE to alpha-Gal reactivity was common in a tick endemic area but showed no significant relation to previous LB. IgE anti-alpha-Gal reactivity in EM patients peaked within three months of diagnosis of EM, after which it waned indicating that recent tick exposure is of importance in alpha-Gal sensitization. Furthermore, IgE anti alpha-Gal was more common in men compared with women.	[Tjernberg, Ivar] Kalmar Cty Hosp, Dept Clin Chem & Transfus Med, Kalmar, Sweden; [Tjernberg, Ivar] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Hamsten, Carl; Apostolovic, Danijela; van Hage, Marianne] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden; [Hamsten, Carl; Apostolovic, Danijela; van Hage, Marianne] Univ Hosp, Stockholm, Sweden	Linkoping University; Karolinska Institutet	Tjernberg, I (corresponding author), Kalmar Cty Hosp, Dept Clin Chem & Transfus Med, Kalmar, Sweden.; Tjernberg, I (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	ivar.tjernberg@ltkalmar.se	Apostolovic, Danijela/J-6089-2019; van Hage, Marianne/A-9678-2017; Apostolovic, Danijela/Q-9067-2016	Apostolovic, Danijela/0000-0001-8388-6916; van Hage, Marianne/0000-0003-3091-1596; Apostolovic, Danijela/0000-0001-8388-6916; Tjernberg, Ivar/0000-0001-8657-2496	Thermo Fisher Scientific, Uppsala, Sweden; Swedish Asthma and Allergy Foundation; Stockholm County Council (ALF Medicin); Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Cancer and Allergy Foundation; King Gustaf V 80th Birthday Foundation; Hesselman Foundation; Konsul Th C Bergh Foundation; Magnus Bergvall Foundation; Medical Research Council in the South-east of Sweden	Thermo Fisher Scientific, Uppsala, Sweden; Swedish Asthma and Allergy Foundation; Stockholm County Council (ALF Medicin); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Cancer and Allergy Foundation; King Gustaf V 80th Birthday Foundation; Hesselman Foundation; Konsul Th C Bergh Foundation; Magnus Bergvall Foundation; Medical Research Council in the South-east of Sweden	This work was supported by Thermo Fisher Scientific, Uppsala, Sweden, and by research grants from the Swedish Asthma and Allergy Foundation, Stockholm County Council (ALF Medicin), Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Cancer and Allergy Foundation, the King Gustaf V 80th Birthday Foundation, the Hesselman Foundation, The Konsul Th C Bergh Foundation, the Magnus Bergvall Foundation and the Medical Research Council in the South-east of Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2016, INT J PARASITOL, V46, P213, DOI 10.1016/j.ijpara.2015.12.005; Armitage P., 2002, STAT METHODS MED RES; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Chinuki Y, 2016, ALLERGY, V71, P421, DOI 10.1111/all.12804; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Fischer J, 2017, ALLERGY; Geblod. nu, 2017, FACTS BLOOD BLOOD GR; Gonzalez-Quintela A, 2014, CLIN EXP ALLERGY, V44, P1061, DOI 10.1111/cea.12326; Hamsten C, 2013, ALLERGY, V68, P549, DOI 10.1111/all.12128; Hamsten C, 2013, J ALLERGY CLIN IMMUN, V132, P1431, DOI 10.1016/j.jaci.2013.07.050; Johansson M, 2017, APMIS; Kilpatrick AM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0117; Morisset M, 2012, ALLERGY, V67, P609, DOI 10.1111/j.1398-9995.2012.02799.x; Mullins RJ, 2012, J ALLERGY CLIN IMMUN, V129, P1334, DOI 10.1016/j.jaci.2012.02.038; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Rispens T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055566; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Tjernberg I, 2007, EUR J CLIN MICROBIOL, V26, P37, DOI 10.1007/s10096-006-0239-3; Tjernberg I, 2009, INT J MED MICROBIOL, V299, P439, DOI 10.1016/j.ijmm.2008.10.006; Van Nunen SA, 2009, MED J AUSTRALIA, V190, P510, DOI 10.5694/j.1326-5377.2009.tb02533.x; Wilhelmsson P, 2016, TICKS TICK-BORNE DIS, V7, P71, DOI 10.1016/j.ttbdis.2015.08.009; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433	25	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185723	10.1371/journal.pone.0185723	http://dx.doi.org/10.1371/journal.pone.0185723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953957	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300080
J	Yun, SD; Shah, NJ				Yun, Seong Dae; Shah, N. Jon			Whole-brain high in-plane resolution fMRI using accelerated EPIK for enhanced characterisation of functional areas at 3T	PLOS ONE			English	Article							ECHO; SENSITIVITY; KEYHOLE; TESLA	The relatively high imaging speed of EPI has led to its widespread use in dynamic MRI studies such as functional MRI. An approach to improve the performance of EPI, EPI with Keyhole (EPIK), has been previously presented and its use in fMRI was verified at 1.5T as well as 3T. The method has been proven to achieve a higher temporal resolution and smaller image distortions when compared to single-shot EPI. Furthermore, the performance of EPIK in the detection of functional signals was shown to be comparable to that of EPI. For these reasons, we were motivated to employ EPIK here for high-resolution imaging. The method was optimised to offer the highest possible in-plane resolution and slice coverage under the given imaging constraints: fixed TR/TE, FOV and acceleration factors for parallel imaging and partial Fourier techniques. The performance of EPIK was evaluated in direct comparison to the optimised protocol obtained from EPI. The two imaging methods were applied to visual fMRI experiments involving sixteen subjects. The results showed that enhanced spatial resolution with a whole-brain coverage was achieved by EPIK (1.00 mm x 1.00 mm; 32 slices) when compared to EPI (1.25 mm x 1.25 mm; 28 slices). As a consequence, enhanced characterisation of functional areas has been demonstrated in EPIK particularly for relatively small brain regions such as the lateral geniculate nucleus (LGN) and superior colliculus (SC); overall, a significantly increased t-value and activation area were observed from EPIK data. Lastly, the use of EPIK for fMRI was validated with the simulation of different types of data reconstruction methods.	[Yun, Seong Dae; Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med, Med Imaging Phys INM 4, Julich, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, JARA, Fac Med, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Shah, NJ (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med, Med Imaging Phys INM 4, Julich, Germany.; Shah, NJ (corresponding author), Rhein Westfal TH Aachen, JARA, Fac Med, Dept Neurol, Aachen, Germany.	n.j.shah@fz-juelich.de	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Yun, Seong Dae/0000-0001-7398-1899	Institute of Neuroscience and Medicine; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association [HA-314]	Institute of Neuroscience and Medicine; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association	For this work, Seong Dae Yun was funded fully by the internal organization (Institute of Neuroscience and Medicine). N. Jon Shah was funded in part internally and also in part externally by the Helmholtz Alliance ICEMED (HA-314) - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (website: http://icemed.helmholtz.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Except the funding sources declared above, there was no additional external funding received for this study.; For this work, Seong Dae Yun was funded fully by the internal organization. N. Jon Shah was funded in part internally and also in part externally by the Helmholtz Alliance ICEMED (HA -314) - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (website: http://icemed.helmholtz.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Except the funding sources declared above, there was no additional external funding received for this study. We would like to thank Tracy Warbrick and Claire Ryalls for proofreading the manuscript.	Budde J, 2014, MAGN RESON MED, V71, P209, DOI 10.1002/mrm.24656; De Martino F, 2011, NEUROIMAGE, V57, P1031, DOI 10.1016/j.neuroimage.2011.05.008; Du YPP, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/973972; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FEINBERG DA, 1994, MAGNET RESON MED, V32, P535, DOI 10.1002/mrm.1910320418; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAACKE EM, 1991, J MAGN RESON, V92, P126, DOI 10.1016/0022-2364(91)90253-P; Heidemann RM, 2012, MAGN RESON MED, V68, P1506, DOI 10.1002/mrm.24156; Hennel F, 1997, CONCEPT MAGNETIC RES, V9, P43, DOI 10.1002/(SICI)1099-0534(1997)9:1<43::AID-CMR4>3.0.CO;2-N; Kraemer M, 2014, Z MED PHYS, V24, P164, DOI 10.1016/j.zemedi.2013.12.003; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lutti A, 2013, MAGN RESON MED, V69, P1657, DOI 10.1002/mrm.24398; MCGIBNEY G, 1993, MAGNET RESON MED, V30, P51, DOI 10.1002/mrm.1910300109; Mintzopoulos D, 2009, OPEN MAGNETIC RESONA, V2, P57; Moeller S, 2006, J MAGN RESON IMAGING, V13, P313; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; RIEDERER SJ, 1988, MAGNET RESON MED, V8, P1, DOI 10.1002/mrm.1910080102; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Shah NJ., 2004, Imaging Process in the Spatial Frequency Space and Useful for Examining the Properties of Object. August, Patent No. [6781372, US6781372B2]; SHAH NJ, 2003, Patent No. 1996245; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Stocker T, 2005, HUM BRAIN MAPP, V25, P237, DOI 10.1002/hbm.20096; Todd N, 2016, NEUROIMAGE, V124, P32, DOI 10.1016/j.neuroimage.2015.08.056; VANVAALS JJ, 1993, JMRI-J MAGN RESON IM, V3, P671, DOI 10.1002/jmri.1880030419; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yun S, 2014, P 22 INT SOC MAGN RE; Yun SD, 2013, NEUROIMAGE, V73, P135, DOI 10.1016/j.neuroimage.2013.01.070; Zaitsev M, 2005, PHYS MED BIOL, V50, P4491, DOI 10.1088/0031-9155/50/19/005; Zaitsev M, 2001, MAGN RESON MED, V45, P109, DOI 10.1002/1522-2594(200101)45:1<109::AID-MRM1015>3.0.CO;2-X	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184759	10.1371/journal.pone.0184759	http://dx.doi.org/10.1371/journal.pone.0184759			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945780	Green Published, gold			2022-12-26	WOS:000411645100009
J	Li, HL; Crabbe, MJC; Xu, FL; Wang, WL; Ma, LH; Niu, RL; Gao, X; Li, XX; Zhang, P; Ma, X; Chen, HK				Li, Hailiang; Crabbe, M. James C.; Xu, Fuli; Wang, Weiling; Ma, Lihui; Niu, Ruilong; Gao, Xing; Li, Xingxing; Zhang, Pei; Ma, Xin; Chen, Haikui			Seasonal variations in carbon, nitrogen and phosphorus concentrations and C: N: P stoichiometry in different organs of a Larix principis- rupprechtii Mayr. plantation in the Qinling Mountains, China	PLOS ONE			English	Article							CO2 ENRICHMENT FACE; LEAF NITROGEN; NUTRIENT CONCENTRATION; DRY-MATTER; GROWTH; PLANTS; TERRESTRIAL; RESORPTION; TRAITS; RATIOS	Understanding how concentrations of elements and their stoichiometry change with plant growth and age is critical for predicting plant community responses to environmental change. We used long-term field experiments to explore how the leaf, stem and root carbon (C), nitrogen (N) and phosphorous (P) concentrations and their stoichiometry changed with growth and stand age in a L. principis-rupprechtii Mayr. plantation from 2012-2015 in the Qinling Mountains, China. Our results showed that the C, N and P concentrations and stoichiometric ratios in different tissues of larch stands were affected by stand age, organ type and sampling month and displayed multiple correlations with increased stand age in different growing seasons. Generally, leaf C and N concentrations were greatest in the fast-growing season, but leaf P concentrations were greatest in the early growing season. However, no clear seasonal tendencies in the stem and root C, N and P concentrations were observed with growth. In contrast to N and P, few differences were found in organ-specific C concentrations. Leaf N: P was greatest in the fast-growing season, while C: N and C: P were greatest in the late-growing season. No clear variations were observed in stem and root C: N, C: P and N: P throughout the entire growing season, but leaf N: P was less than 14, suggesting that the growth of larch stands was limited by N in our study region. Compared to global plant element concentrations and stoichiometry, the leaves of larch stands had higher C, P, C: N and C: P but lower N and N: P, and the roots had greater P and C: N but lower N, C: P and N: P. Our study provides baseline information for describing the changes in nutritional elements with plant growth, which will facilitates plantation forest management and restoration, and makes a valuable contribution to the global data pool on leaf nutrition and stoichiometry.	[Li, Hailiang; Xu, Fuli; Ma, Xin] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Crabbe, M. James C.] Univ Oxford, Wolfson Coll, Oxford, England; [Wang, Weiling; Niu, Ruilong; Gao, Xing; Li, Xingxing; Zhang, Pei] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Ma, Lihui] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Chen, Haikui] Beifang Univ Nationalities, Coll Biol Sci & Engn, Ningxia, Peoples R China; [Crabbe, M. James C.] Univ Bedfordshire, Inst Biomed & Environm Sci & Technol, Luton, Beds, England; [Xu, Fuli; Ma, Lihui] Chinese Acad Sci, Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; University of Oxford; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; North Minzu University; University of Bedfordshire; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Xu, FL (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.; Xu, FL (corresponding author), Chinese Acad Sci, Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	xfl@nwsuaf.edu.cn			National Program on Key Basic Research Project of China (973 Program) [2012CB416902]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Program on Key Basic Research Project of China (973 Program) (No. 2012CB416902).	Abbas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058179; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agren GI, 2004, ECOL LETT, V7, P185, DOI 10.1111/j.1461-0248.2004.00567.x; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bremmer J, 1982, AGRONOMY, P295; Dordas C, 2009, EUR J AGRON, V30, P129, DOI 10.1016/j.eja.2008.09.001; Du YX, 2011, ENVIRON EARTH SCI, V64, P299, DOI 10.1007/s12665-010-0847-1; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser Jim, 2002, Ecological Society of America Annual Meeting Abstracts, V87, P18; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Franklin O, 2002, FUNCT ECOL, V16, P727, DOI 10.1046/j.1365-2435.2002.00674.x; Gifford RM, 2000, PLANT SOIL, V224, P1, DOI 10.1023/A:1004790612630; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2008, OECOLOGIA, V155, P301, DOI 10.1007/s00442-007-0912-y; Hooker TD, 2003, ECOL APPL, V13, P299, DOI 10.1890/1051-0761(2003)013[0299:FECANA]2.0.CO;2; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Kim HY, 2011, PLANT SOIL, V342, P59, DOI 10.1007/s11104-010-0665-y; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Lannes LS, 2012, NEW PHYTOL, V196, P816, DOI 10.1111/j.1469-8137.2012.04363.x; Lei R.D., 1996, J NW FORESTRY COLL, V11, P43; Lelu-Walter MA, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008079; Li Yu-lin, 2010, Huanjing Kexue, V31, P1716; Liu Y, 2009, BOREAS, V38, P285, DOI 10.1111/j.1502-3885.2008.00065.x; Mahajan G, 2012, FIELD CROP RES, V134, P59, DOI 10.1016/j.fcr.2012.04.011; Markovic J., 2009, Biotechnology in Animal Husbandry, V25, P1225; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; Niklas KJ, 2005, AM J BOT, V92, P1256, DOI 10.3732/ajb.92.8.1256; Ning P, 2013, FIELD CROP RES, V144, P19, DOI 10.1016/j.fcr.2013.01.020; Orgeas J, 2003, PLANT ECOL, V164, P201, DOI 10.1023/A:1021278421821; Pretzsch H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5967; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sardans J, 2011, FOREST ECOL MANAG, V262, P2024, DOI 10.1016/j.foreco.2011.08.019; Sardans J, 2012, PLANT PHYSIOL, V160, P1741, DOI 10.1104/pp.112.208785; Schindler DW, 2003, NATURE, V423, P225, DOI 10.1038/423225b; [Tian Xingjun 田兴军], 2002, [植物生态学报, Acta Phytoecologica Sinica], V26, P257; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Wang Dong-zhi, 2015, Yingyong Shengtai Xuebao, V26, P3413; Wang LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118553; Wang ZN, 2014, PLANT SOIL, V383, P301, DOI 10.1007/s11104-014-2166-x; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Yang HM, 2011, BIOL FERT SOILS, V47, P377, DOI 10.1007/s00374-011-0543-7; Yang LX, 2007, FIELD CROP RES, V102, P141, DOI 10.1016/j.fcr.2007.03.004; Yang LX, 2007, FIELD CROP RES, V100, P189, DOI 10.1016/j.fcr.2006.07.003; Yang Y, 2011, GLOBAL ECOL BIOGEOGR, V20, P354, DOI 10.1111/j.1466-8238.2010.00602.x; Ye YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101776; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060360; Zhang LX, 2004, ACTA BOT SIN, V46, P259; Zheng SX, 2007, TREES-STRUCT FUNCT, V21, P357, DOI 10.1007/s00468-007-0129-z; Zhou Peng, 2010, Chinese Journal of Plant Ecology, V34, P7, DOI 10.3773/j.issn.1005-264x.2010.01.003; Ziadi N, 2007, AGRON J, V99, P833, DOI 10.2134/agronj2006.0199	60	20	25	12	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							0185163	10.1371/journal.pone.0185163	http://dx.doi.org/10.1371/journal.pone.0185163			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938020	Green Published, gold, Green Submitted			2022-12-26	WOS:000411524700020
J	Wang, JM; Ma, HY; Krishnamoorthy, RR; Yorio, T; He, SQ				Wang, Junming; Ma, Hai-Ying; Krishnamoorthy, Raghu R.; Yorio, Thomas; He, Shaoqing			A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; VASCULAR SMOOTH-MUSCLE; NF-KAPPA-B; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; AQUEOUS-HUMOR; COLLAGEN EXPRESSION; GENE-EXPRESSION; UP-REGULATION; ETB-RECEPTOR	c-Jun, c-Jun N-terminal kinase(JNK) and endothelin B (ETB) receptor have been shown to contribute to the pathogenesis of glaucoma. Previously, we reported that an increase of cJun and CCAAT/enhancer binding protein beta (C/EBP beta) immunohistostaining is associated with upregulation of the ETB receptor within the ganglion cell layer of rats with elevated intraocular pressure (IOP). In addition, both transcription factors regulate the expression of the ETB receptor in human non-pigmented ciliary epithelial cells (HNPE). The current study addressed the mechanisms by which ET-1 produced upregulation of ET receptors in primary rat retinal ganglion cells (RGCs) and HNPE cells. Treatment of ET-1 and ET-3 increased the immunocytochemical staining of c-Jun and C/EBP beta in primary rat RGCs and co-localization of both transcription factors was observed. A marked increase in DNA binding activity of AP-1 and C/EBP beta as well as elevated protein levels of c-Jun and c-Jun-N-terminal kinase (JNK) were detected following ET-1 treatment in HNPE cells. Overexpression of ETA or ETB receptor promoted the upregulation of c-Jun and also elevated its promoter activity. In addition, upregulation of C/EBP beta augmented DNA binding and mRNA expression of c-Jun, and furthermore, the interaction of c-Jun and C/EBP beta was confirmed using coimmunoprecipitation. Apoptosis of HNPE cells was identified following ET-1 treatment, and overexpression of the ETA or ETB receptor produced enhanced apoptosis. ET-1 mediated upregulation of c-Jun and C/EBP beta and their interaction may represent a novel mechanism contributing to the regulation of endothelin receptor expression. Reciprocally, c-Jun was also found to regulate the ET receptors and C/EBP beta appeared to play a regulatory role in promoting expression of c-Jun. Taken together, the data suggests that ET-1 triggers the upregulation of c-Jun through both ETA and ETB receptors, and conversely c-Jun also upregulates endothelin receptor expression, thereby generating a positive feed-forward loop of endothelin receptor activation and expression. This feed-forward regulation may contribute to RGC death and astrocyte proliferation following ET-1 treatment.	[Wang, Junming] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan, Hubei, Peoples R China; [Ma, Hai-Ying; Krishnamoorthy, Raghu R.; Yorio, Thomas; He, Shaoqing] Univ North Texas, Hlth Sci Ctr Ft Worth, North Texas Eye Res Inst, Ft Worth, TX 76107 USA	Huazhong University of Science & Technology; University of North Texas System; University of North Texas Denton	Yorio, T; He, SQ (corresponding author), Univ North Texas, Hlth Sci Ctr Ft Worth, North Texas Eye Res Inst, Ft Worth, TX 76107 USA.	Thomas.Yorio@unthsc.edu; Shaoqing.He@unthsc.edu	Wang, Junming/AAD-9636-2019		NIH [R01 EY019952-01, NIH/R01-EY019952-01]; Natural Science Foundation of China [81470632]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the NIH grant R01 EY019952-01 to RRK (http://grantome.com/grant/NIH/R01-EY019952-01) and the Natural Science Foundation of China to JW (No 81470632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Bagnato Anna, 2004, Cancer Treat Res, V119, P293; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bein K, 2011, AM J RESP CELL MOL, V45, P436, DOI 10.1165/rcmb.2010-0260OC; Byun JY, 2006, MOL VIS, V12, P949; Cattaruzza M, 2001, J BIOL CHEM, V276, P36999, DOI 10.1074/jbc.M105158200; Chen SL, 2003, AM J PHYSIOL-CELL PH, V284, pC263, DOI 10.1152/ajpcell.00192.2002; Chintalgattu V, 2004, J PHARMACOL EXP THER, V311, P691, DOI 10.1124/jpet.104.070151; Cho YH, 2003, MOL PHARMACOL, V63, P512, DOI 10.1124/mol.63.3.512; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Dey S, 2012, J BIOL CHEM, V287, P21936, DOI 10.1074/jbc.M112.351783; Dogra C, 2008, MOL CELL BIOCHEM, V312, P17, DOI 10.1007/s11010-008-9716-6; Drey LL, 2013, BIOTECHNIQUES, V55, P28, DOI 10.2144/000114056; Felx M, 2006, CLIN SCI, V110, P645, DOI 10.1042/CS20050286; Fernandes KA, 2012, NEUROBIOL DIS, V46, P393, DOI 10.1016/j.nbd.2012.02.003; Gonsalves C, 2010, J IMMUNOL, V185, P6253, DOI 10.4049/jimmunol.1000660; Goraca Anna, 2002, Endocr Regul, V36, P161; Grant K, 2003, BRIT J CANCER, V88, P163, DOI 10.1038/sj.bjc.6700750; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; He S, 2007, INVEST OPHTH VIS SCI, V48, P3737, DOI 10.1167/iovs.06-1138; He SQ, 2007, EXP BIOL MED, V232, P370; He SQ, 2015, INVEST OPHTH VIS SCI, V56, P6144, DOI 10.1167/iovs.15-16569; He SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079183; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Howell GR, 2014, NEUROBIOL DIS, V71, P44, DOI 10.1016/j.nbd.2014.07.016; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Hua H, 2001, DIABETES, V50, P2376, DOI 10.2337/diabetes.50.10.2376; HUANG SM, 1993, AM HEART J, V125, P589, DOI 10.1016/0002-8703(93)90208-Q; Iwai-Kanai E, 2004, MOL CELL BIOCHEM, V259, P163, DOI 10.1023/B:MCBI.0000021368.80389.b9; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kallberg ME, 2002, J GLAUCOMA, V11, P105; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Krishnamoorthy RR, 2008, CAN J PHYSIOL PHARM, V86, P380, DOI 10.1139/Y08-040; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Levkovitch-Verbin H, 2005, EXP EYE RES, V80, P663, DOI 10.1016/j.exer.2004.11.016; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; MARTINVASALLO P, 1989, J CELL PHYSIOL, V141, P243, DOI 10.1002/jcp.1041410203; McGrady NR, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0346-3; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; Minton AZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043199; Nambi P, 2001, Heart Fail Rev, V6, P335, DOI 10.1023/A:1011464510857; Narayan S, 2003, INVEST OPHTH VIS SCI, V44, P4885, DOI 10.1167/iovs.03-0387; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Noske W, 1997, GRAEF ARCH CLIN EXP, V235, P551, DOI 10.1007/BF00947082; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Prasanna G, 2005, PHARMACOL RES, V51, P41, DOI 10.1016/j.phrs.2004.04.006; Prasanna G, 2003, MOL CELL BIOCHEM, V253, P71, DOI 10.1023/A:1026005418874; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Rauh A, 2008, BRIT J PHARMACOL, V154, P13, DOI 10.1038/bjp.2008.92; Rosendorff C, 1997, CARDIOVASC DRUG THER, V10, P795, DOI 10.1007/BF00053038; Rozenberg JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078179; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Schorlemmer A, 2008, TRENDS CARDIOVAS MED, V18, P233, DOI 10.1016/j.tcm.2008.11.005; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; Shichiri M, 1998, MOL ENDOCRINOL, V12, P172, DOI 10.1210/me.12.2.172; Singh S, 2009, J BIOL CHEM, V284, P10409, DOI 10.1074/jbc.M809572200; Sokolovsky M, 1995, CELL MOL NEUROBIOL, V15, P561, DOI 10.1007/BF02071317; Sugden Peter H., 2005, Current Vascular Pharmacology, V3, P343, DOI 10.2174/157016105774329390; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Sun H, 2011, MOL VIS, V17, P864; Tezel G, 1997, J GLAUCOMA, V6, P83; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Urtatiz O, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00059; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wagner AH, 2000, MOL PHARMACOL, V58, P1333, DOI 10.1124/mol.58.6.1333; Wang X, 2009, EXP EYE RES, V88, P378, DOI 10.1016/j.exer.2008.09.009; Wang YJ, 2010, HEPATOLOGY, V52, P2118, DOI 10.1002/hep.23929; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; YIN J, 1992, MOL BRAIN RES, V14, P213, DOI 10.1016/0169-328X(92)90176-C; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Zhang XY, 2003, INVEST OPHTH VIS SCI, V44, P5301, DOI 10.1167/iovs.03-0463; Zhang XY, 2003, EXP EYE RES, V76, P261, DOI 10.1016/S0014-4835(02)00323-8	81	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185390	10.1371/journal.pone.0185390	http://dx.doi.org/10.1371/journal.pone.0185390			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938016	gold, Green Submitted, Green Published			2022-12-26	WOS:000411524700030
J	Gluck, JM; Herren, AW; Yechikov, S; Kao, HKJ; Khan, A; Phinney, BS; Chiamvimonvat, N; Chan, JW; Lieu, DK				Gluck, Jessica M.; Herren, Anthony W.; Yechikov, Sergey; Kao, Hillary K. J.; Khan, Ambereen; Phinney, Brett S.; Chiamvimonvat, Nipavan; Chan, James W.; Lieu, Deborah K.			Biochemical and biomechanical properties of the pacemaking sinoatrial node extracellular matrix are distinct from contractile left ventricular matrix	PLOS ONE			English	Article							SINUS NODE; GROWTH; COLLAGEN; ELASTIN	Extracellular matrix plays a role in differentiation and phenotype development of its resident cells. Although cardiac extracellular matrix from the contractile tissues has been studied and utilized in tissue engineering, extracellular matrix properties of the pacemaking sinoatrial node are largely unknown. In this study, the biomechanical properties and biochemical composition and distribution of extracellular matrix in the sinoatrial node were investigated relative to the left ventricle. Extracellular matrix of the sinoatrial node was found to be overall stiffer than that of the left ventricle and highly heterogeneous with interstitial regions composed of predominantly fibrillar collagens and rich in elastin. The extracellular matrix protein distribution suggests that resident pacemaking cardiomyocytes are enclosed in fibrillar collagens that can withstand greater tensile strength while the surrounding elastin-rich regions may undergo deformation to reduce the mechanical strain in these cells. Moreover, basement membrane-associated adhesion proteins that are ligands for integrins were of low abundance in the sinoatrial node, which may decrease force transduction in the pacemaking cardiomyocytes. In contrast to extracellular matrix of the left ventricle, extracellular matrix of the sinoatrial node may reduce mechanical strain and force transduction in pacemaking cardiomyocytes. These findings provide the criteria for a suitable matrix scaffold for engineering biopacemakers.	[Gluck, Jessica M.; Yechikov, Sergey; Kao, Hillary K. J.; Khan, Ambereen; Chiamvimonvat, Nipavan; Lieu, Deborah K.] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Herren, Anthony W.; Phinney, Brett S.] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Kao, Hillary K. J.; Khan, Ambereen] Calif State Univ Sacramento, Bridges Stem Cell Res Program, Sacramento, CA 95819 USA; [Chiamvimonvat, Nipavan] Northern Calif Hlth Care Syst, Dept Vet Affairs, Mather, CA USA; [Chan, James W.] Univ Calif Davis, Ctr Biophoton, Sacramento, CA 95817 USA; [Chan, James W.] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA; [Chan, James W.] Univ Calif Davis, Lab Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; California State University System; California State University Sacramento; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Lieu, DK (corresponding author), Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA.	dklieu@ucdavis.edu	Phinney, Brett/S-6404-2016	Phinney, Brett/0000-0003-3870-3302; Chiamvimonvat, Nipavan/0000-0001-9499-8817; Lieu, Deborah/0000-0002-3765-3203; Gluck, Jessica/0000-0002-6908-0809	California Institute for Regenerative Medicine (CIRM) Basic Biology Grant [RB4-05764]; UC Davis Academic Federation Innovative Development Award; National Institutes of Health (NIH) [R01 HL085727, R01 HL085844, TG2-01163]; Merit Review Award from the United States Department of Veteran Affairs Biomedical Laboratory Research &Development (BLRD) Service [I01 BX000576]; CIRM Postdoctoral Training Fellowship [TG2-01163]; NIH T32 Training Program in Basic and Translation Cardiovascular Science [NIH T32 HL086350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085727, T32HL086350, R01HL085844, R01HL137228] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576, I01CX001490] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) Basic Biology Grant; UC Davis Academic Federation Innovative Development Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Award from the United States Department of Veteran Affairs Biomedical Laboratory Research &Development (BLRD) Service; CIRM Postdoctoral Training Fellowship; NIH T32 Training Program in Basic and Translation Cardiovascular Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by California Institute for Regenerative Medicine (CIRM, https://www.cirm.ca.gov) Basic Biology Grant (RB4-05764) and UC Davis Academic Federation Innovative Development Award to DKL, National Institutes of Health (NIH, https://www.nih.gov) R01 HL085727, National Institutes of Health (NIH, https://www.nih.gov) R01 HL085844, and Merit Review Award (I01 BX000576) from the United States Department of Veteran Affairs Biomedical Laboratory Research &Development (BLRD, https://www.research.va.gov/services/blrd/) Service to NC. JMG has been supported by a CIRM (https://www.cirm.ca.gov) Postdoctoral Training Fellowship (TG2-01163) and a Postdoctoral Training Fellowship from National Institutes of Health (NIH, https://www.nih.gov) T32 Training Program in Basic and Translation Cardiovascular Science (NIH T32 HL086350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by California Institute for Regenerative Medicine (CIRM) Basic Biology Grant (RB4-05764) and UC Davis Academic Federation Innovative Development Award to DKL, NIH R01 HL085727, NIH R01 HL085844, and Merit Review Award (I01 BX000576) from the United States Department of Veteran Affairs Biomedical Laboratory Research & Development (BLRD) Service to NC. JMG has been supported by a CIRM Postdoctoral Training Fellowship (TG2-01163) and a Postdoctoral Training Fellowship from NIH T32 Training Program in Basic and Translation Cardiovascular Science (NIH T32 HL086350).	Ambrosi CM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071309; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Barallobre-Barreiro Javier, 2013, Methods Mol Biol, V1005, P215, DOI 10.1007/978-1-62703-386-2_17; Barallobre-Barreiro J, 2012, CIRCULATION, V125, P789, DOI 10.1161/CIRCULATIONAHA.111.056952; BASHEY RI, 1992, CIRC RES, V70, P1006, DOI 10.1161/01.RES.70.5.1006; Billiar KL, 2011, STUD MECHANOBIOL TIS, V4, P201, DOI 10.1007/8415_2010_30; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Csepe TA, 2016, PROG BIOPHYS MOL BIO, V120, P164, DOI 10.1016/j.pbiomolbio.2015.12.011; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Fedorov VV, 2010, J AM COLL CARDIOL, V56, P1386, DOI 10.1016/j.jacc.2010.03.098; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Fratzl P, 2008, COLLAGEN STRUCTURE M, pxviii, DOI DOI 10.1007/978-0-387-73906-9_1; Fujii T, 2000, J ORTHOP RES, V18, P87, DOI 10.1002/jor.1100180113; Gaetani R, 2015, CELL TRANSPLANT; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Herum KM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050053; Johnson TD, 2014, BIOMATER SCI-UK, V2, P735, DOI 10.1039/c3bm60283d; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Liu F, 2011, JOVE-J VIS EXP, DOI 10.3791/2911; Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nabipour A, 2012, TURK J VET ANIM SCI, V36, P463, DOI 10.3906/vet-0807-2; Oberwallner B, 2013, J BIOMEDICAL MAT R A; Oberwallner B, 2015, EUR J CARDIO-THORAC, V47, P416, DOI 10.1093/ejcts/ezu163; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Purslow P. P., 2008, P325, DOI 10.1007/978-0-387-73906-9_12; Rienks M, 2014, CIRC RES, V114, P872, DOI 10.1161/CIRCRESAHA.114.302533; RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHIRAISHI I, 1992, CIRCULATION, V85, P2176, DOI 10.1161/01.CIR.85.6.2176; Silver FH, 2001, CRIT REV BIOMED ENG, V29, P279, DOI 10.1615/CritRevBiomedEng.v29.i3.10; Silver Frederick H., 2006; van Essen GJ, 2009, J ANIM SCI, V87, P1991, DOI 10.2527/jas.2009-1860; van Putten S, 2016, J MOL CELL CARDIOL, V93, P133, DOI 10.1016/j.yjmcc.2015.11.025; Yanni J, 2010, J MOL CELL CARDIOL, V48, P653, DOI 10.1016/j.yjmcc.2009.08.023; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhu YX, 2011, J BIOMECH, V44, P2356, DOI 10.1016/j.jbiomech.2011.07.010	41	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185125	10.1371/journal.pone.0185125	http://dx.doi.org/10.1371/journal.pone.0185125			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934329	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900098
J	Mauriello, G; De Prisco, A; Di Prisco, G; La Storia, A; Caprio, E				Mauriello, Gianluigi; De Prisco, Annachiara; Di Prisco, Gennaro; La Storia, Antonietta; Caprio, Emilio			Microbial characterization of bee pollen from the Vesuvius area collected by using three different traps	PLOS ONE			English	Article							TAXONOMY; SPP.	Flower pollen is collected by honeybee foragers, adhered on their rear legs and transported into the hives in the form of pellets. Once in the hives, bee pollen is moisturised with nectar and bee mouth secretions and due to enzymatically modifications it becomes the so-called bee-bread, the protein reservoir of young bees. Bee pollen can be artificially removed from bee legs and collected by using specific systems, the bee pollen traps. Bee pollen is commercialized for human consumption as fresh product and after freezing or drying. Although bee pollen is nowadays largely consumed in developed countries, as food or food supplement according to local legislation, little is known on its safety related to microbiological hazards. In this work, we aimed to characterize for the first time the microbiological profile of Italian bee pollen in fresh, frozen and dried form collected along an entire harvesting season. Moreover, monthly microbiological analyses were performed on frozen (storage at -18 degrees C) and dried (storage at room temperature) bee pollen over a 4 months period. Further aim of this work was the evaluation of the possible impact on production level of three different traps used for pollen collection. Our results on microbial contamination of fresh and frozen bee pollen show that a more comprehensive microbiological risk assessment of bee pollen is required. On the other side, dried pollen showed very low microbial contamination and no pathogen survived after the drying process and during storage.	[Mauriello, Gianluigi; De Prisco, Annachiara; Di Prisco, Gennaro; La Storia, Antonietta; Caprio, Emilio] Univ Naples Federico II, Dept Agr Sci, Portici, Italy	University of Naples Federico II	Mauriello, G (corresponding author), Univ Naples Federico II, Dept Agr Sci, Portici, Italy.	giamauri@unina.it	De Prisco, Annachiara/GQI-2376-2022; De Prisco, Annachiara/GZL-8784-2022; Di Prisco, Gennaro/AGY-3511-2022; Mauriello, Gianluigi/D-2939-2016	Mauriello, Gianluigi/0000-0002-6876-6235				Almeida-Muradian LB, 2005, J FOOD COMPOS ANAL, V18, P105, DOI 10.1016/j.jfca.2003.10.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson KE, 2014, MOL ECOL, V23, P5904, DOI 10.1111/mec.12966; Belhadj H., 2012, ADV ENVIRON BIOL, V6, P1415; Blaiotta G, 2004, SYST APPL MICROBIOL, V27, P696, DOI 10.1078/0723202042369901; Brindza J., 2010, ACTA CHIM SLOVACA, V3, P95; Cabrera C, 2013, CIENC INVESTIG AGRAR, V40, P223, DOI 10.4067/S0718-16202013000100020; Campos MGR, 2008, J APICULT RES, V47, P154, DOI 10.3896/IBRA.1.47.2.12; Canale A, 2016, MATERIALS, P9; COLLIN S, 1995, J AGR FOOD CHEM, V43, P444, DOI 10.1021/jf00050a035; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; De Filippis F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089680; De-Melo AAM, 2015, LETT APPL MICROBIOL, V61, P477, DOI 10.1111/lam.12480; DeGrandi-Hoffman G, 2013, APIDOLOGIE, V44, P52, DOI 10.1007/s13592-012-0154-9; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Dimou M, 2006, J APICULT RES, V45, P42, DOI 10.1080/00218839.2006.11101312; Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12; Estevinho LM, 2012, INT J FOOD SCI TECH, V47, P429, DOI 10.1111/j.1365-2621.2011.02859.x; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3594; Feas X, 2012, MOLECULES, V17, P8359, DOI 10.3390/molecules17078359; Hervatin H, 2012, J FOOD PROT S, V75, pP3; Kacaniova M, 2011, J ENVIRON SCI HEAL B, V46, P623, DOI 10.1080/03601234.2011.589322; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Medina A, 2004, SYST APPL MICROBIOL, V27, P261, DOI 10.1078/072320204322881880; Metri BC, 2013, UROL ANNALS, V5, P312, DOI 10.4103/0974-7796.120295; Nardoni S, 2016, ANN AGR ENV MED, V23, P103, DOI 10.5604/12321966.1196862; Nogueira C, 2012, INT J MOL SCI, V13, P11173, DOI 10.3390/ijms130911173; Pidek I.A., 2004, ANN U M CURIESKLOD B, V49, P143; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Raja S., 2010, HALTERES, V1, P1; Seng P, 2016, INT J INFECT DIS, V45, P65, DOI 10.1016/j.ijid.2016.02.014; de Arruda VAS, 2013, FOOD CHEM TOXICOL, V51, P143, DOI 10.1016/j.fct.2012.09.019; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	33	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183208	10.1371/journal.pone.0183208	http://dx.doi.org/10.1371/journal.pone.0183208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934240	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900008
J	Rosso, M; Majem, B; Devis, L; Lapyckyj, L; Besso, MJ; Llaurado, M; Abascal, MF; Matos, ML; Lanau, L; Castellvi, J; Sanchez, JL; Benavente, AP; Gil-Moreno, A; Reventos, J; Margalef, AS; Rigau, M; Vazquez-Levin, MH				Rosso, Marina; Majem, Blanca; Devis, Laura; Lapyckyj, Lara; Besso, Maria Jose; Llaurado, Marta; Florencia Abascal, Maria; Laura Matos, Maria; Lanau, Lucia; Castellvi, Josep; Luis Sanchez, Jose; Perez Benavente, Asuncion; Gil-Moreno, Antonio; Reventos, Jaume; Santamaria Margalef, Anna; Rigau, Marina; Hebe Vazquez-Levin, Monica			E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness	PLOS ONE			English	Article							CELL-ADHESION; MESENCHYMAL TRANSITION; TUMOR PROGRESSION; CARCINOMA; EXPRESSION; METASTASIS; SPHEROIDS; PHENOTYPE; CHEMORESISTANCE; EPITHELIUM	Ovarian cancer (OC) is the fifth cancer death cause in women worldwide. The malignant nature of this disease stems from its unique dissemination pattern. Epithelial-to-mesenchymal transition (EMT) has been reported in OC and downregulation of Epithelial cadherin (E-cadherin) is a hallmark of this process. However, findings on the relationship between E-cadherin levels and OC progression, dissemination and aggressiveness are controversial. In this study, the evaluation of E-cadherin expression in an OC tissue microarray revealed its prognostic value to discriminate between advanced-and early-stage tumors, as well as serous tumors from other histologies. Moreover, E-cadherin, Neural cadherin (N-cadherin), cytokeratins and vimentin expression was assessed in TOV-112, SKOV-3, OAW-42 and OV-90 OC cell lines grown in monolayers and under anchorage-independent conditions to mimic ovarian tumor cell dissemination, and results were associated with cell aggressiveness. According to these EMT-related markers, cell lines were classified as mesenchymal (M; TOV-112), intermediate mesenchymal (IM; SKOV-3), intermediate epithelial (IE; OAW-42) and epithelial (E; OV-90). M-and IM-cells depicted the highest migration capacity when grown in monolayers, and aggregates derived from M-and IM-cell lines showed lower cell death, higher adhesion to extracellular matrices and higher invasion capacity than E- antigen 125 levels more than 500 U/mL and platinum-free intervals less than 6 months. Altogether, E-cadherin expression levels were found relevant for the assessment of OC progression and aggressiveness.and IE-aggregates. The analysis of E-cadherin, N-cadherin, cytokeratin 19 and vimentin mRNA levels in 20 advanced-stage high-grade serous human OC ascites showed an IM phenotype in all cases, characterized by higher proportions of N-to E-cadherin and vimentin to cytokeratin 19. In particular, higher E-cadherin mRNA levels were associated with cancer antigen 125 levels more than 500 U/mL and platinum-free intervals less than 6 months. Altogether, E-cadherin expression levels were found relevant for the assessment of OC progression and aggressiveness.	[Rosso, Marina; Lapyckyj, Lara; Besso, Maria Jose; Florencia Abascal, Maria; Laura Matos, Maria; Hebe Vazquez-Levin, Monica] CONICET FIBYME, Lab Estudios Interacc Celular Reprod & Canc, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina; [Majem, Blanca; Devis, Laura; Llaurado, Marta; Lanau, Lucia; Gil-Moreno, Antonio; Reventos, Jaume; Santamaria Margalef, Anna; Rigau, Marina] Vall Hebron Res Inst, Biomed Res Unit Gynecol, Barcelona, Spain; [Majem, Blanca; Devis, Laura; Llaurado, Marta; Lanau, Lucia; Gil-Moreno, Antonio; Reventos, Jaume; Santamaria Margalef, Anna; Rigau, Marina] Univ Hosp, Barcelona, Spain; [Castellvi, Josep] Vall Hebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Luis Sanchez, Jose; Perez Benavente, Asuncion; Gil-Moreno, Antonio] Vall Hebron Univ Hosp, Dept Gynecol Oncol, Barcelona, Spain; [Llaurado, Marta] Univ British Columbia, Ovarian Canc Res Team OvCaRe, Dept Obstet & Gynecol ( OBGYN), Vancouver, BC, Canada; [Reventos, Jaume] Generalitat Catalunya, Dept Hlth, Barcelona, Spain; [Rigau, Marina] Biomed Res Inst Bellvitge IDIBELL, Barcelona, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; University of British Columbia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Vazquez-Levin, MH (corresponding author), CONICET FIBYME, Lab Estudios Interacc Celular Reprod & Canc, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina.	mhvazl@gmail.com	BENAVENTE, ASUNCION PEREZ/C-5116-2014; Castellvi, Josep/C-5092-2014; Majem, Blanca/AAN-6687-2021; Jauregui, Laura Devis/ABH-5740-2020; Rosso, Marina/A-7886-2018; PEREZ BENAVENTE, ASUNCION/J-8272-2016; Gil-Moreno, Antonio/C-1122-2016	Castellvi, Josep/0000-0001-5745-9996; Rosso, Marina/0000-0002-1077-3088; PEREZ BENAVENTE, ASUNCION/0000-0003-1872-9003; Devis-Jauregui, Laura/0000-0003-3736-3983; Gil-Moreno, Antonio/0000-0003-1106-5590	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICTSU1072]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (Argentina) [PIP740]; Institute Nacional del Cancer (Argentina) [INC 2014-2015, INC 2016-2017]; Red Tematica de Investigacion Contra el Cancer Ministerio de Ciencia e Innovacion Espanol (RTICC) [RD12/0036/0035]; SGR Departament d'Univeristats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [SGR1330]; IRSES (International Research Staff Exchange Scheme) [269285]	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Institute Nacional del Cancer (Argentina); Red Tematica de Investigacion Contra el Cancer Ministerio de Ciencia e Innovacion Espanol (RTICC); SGR Departament d'Univeristats, Recerca i Societat de la Informacio de la Generalitat de Catalunya(Generalitat de Catalunya); IRSES (International Research Staff Exchange Scheme)	Studies were supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica; http://www.agencia.mincyt.gob.ar/) (Argentina) (Grant PICTSU1072), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); http://www.conicet.gov.ar/) (Argentina) (Grant PIP740) and Institute Nacional del Cancer (http://www.msal.gov.ar/inc/) (Argentina) (Grant INC 2014-2015 and INC 2016-2017) to MHVL; Red Tematica de Investigacion Contra el Cancer Ministerio de Ciencia e Innovacion Espanol (http://www.rticc.org/) (RTICC; RD12/0036/0035), SGR Departament d'Univeristats, Recerca i Societat de la Informacio de la Generalitat de Catalunya: 2014 (http://web.gencat.cat/ca/inici/) (SGR1330) to JR, and IRSES (International Research Staff Exchange Scheme; http://ec.europa/eu/research/ mariecurieactions/funded-projects/international-research-staff-exchange-scheme) (Ref. 269285) to JR and MHVL.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Alshenawy HA, 2010, ANN DIAGN PATHOL, V14, P387, DOI 10.1016/j.anndiagpath.2010.05.005; Amadori D., 1997, Frontiers in Bioscience (online), V2, pG8; Angst BD, 2001, J CELL SCI, V114, P629; Bacic B, 2013, ARCH GYNECOL OBSTET, V287, P1219, DOI 10.1007/s00404-012-2684-9; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Davidson B, 2000, J PATHOL, V192, P460; Davidson B, 2015, HUM PATHOL, V46, P1, DOI 10.1016/j.humpath.2014.10.004; ElMasri WM, 2009, CANCER TREAT RES, V149, P297, DOI 10.1007/978-0-387-98094-2_14; Ferlay J, 2013, IARC CANCERBASE; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jin MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103965; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lapyckyj L, 2010, J CELL PHYSIOL, V222, P596, DOI 10.1002/jcp.21974; Matos ML, 2017, J CELL PHYSIOL, V232, P1368, DOI 10.1002/jcp.25622; Liew PL, 2015, INT J CLIN EXP PATHO, V8, P5642; Llaurado M, 2012, INT J CANCER, V130, P1532, DOI 10.1002/ijc.26148; Nuti SV, 2014, ONCOTARGET, V5, P7260, DOI 10.18632/oncotarget.2428; Osman N, 2008, Ir Med J, V101, P245; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Pease JC, 2012, BIOL OPEN, V1, P622, DOI 10.1242/bio.2012653; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323; Roggiani F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091387; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schneider MR, 2015, BIOESSAYS, V37, P294, DOI 10.1002/bies.201400141; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Su YJ, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.17; Suidan RS, 2014, GYNECOL ONCOL, V134, P455, DOI 10.1016/j.ygyno.2014.07.002; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782	46	49	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184439	10.1371/journal.pone.0184439	http://dx.doi.org/10.1371/journal.pone.0184439			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934230	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900029
J	Toyoshima, K; Nakamura, M; Adachi, Y; Imaizumi, A; Hakamada, T; Abe, Y; Kaneko, E; Takahashi, S; Shimokado, K				Toyoshima, Kenji; Nakamura, Marie; Adachi, Yusuke; Imaizumi, Akira; Hakamada, Tomomi; Abe, Yasuko; Kaneko, Eiji; Takahashi, Soiciro; Shimokado, Kentaro			Increased plasma proline concentrations are associated with sarcopenia in the elderly	PLOS ONE			English	Article							AMINO-ACID PROFILE; SKELETAL-MUSCLE; METABOLISM; HEALTHY; EPIDEMIOLOGY; BIOMARKERS; DISEASE; PROTEIN; MEAT; MASS	Background and purpose Metabolome analyses have shown that plasma amino acid profiles reflect various pathological conditions, such as cancer and diabetes mellitus. It remains unclear, however, whether plasma amino acid profiles change in patients with sarcopenia. This study therefore aimed to investigate whether sarcopenia-specific changes occur in plasma amino acid profiles. Methods A total of 153 community-dwelling and seven institutionalized elderly individuals (56 men, 104 women; mean age, 77.7 +/- 7.0 years) were recruited for this cross-sectional analysis. We performed a comprehensive geriatric assessment, which included an evaluation of hand grip strength, gait speed, muscle mass and blood chemistry, including the concentration of 18 amino acids. Results Twenty-eight of the 160 participants met the criteria for sarcopenia established by the Asian Working Group on Sarcopenia in Older People. Univariate analysis revealed associations between the presence of sarcopenia and a higher plasma concentration of proline and glutamine, lower concentrations of histidine and tryptophan. Multivariable analysis revealed that a higher concentration of proline was the only variable independently associated with sarcopenia. Conclusions The plasma concentration of proline may be useful for understanding the underlying pathophysiology of sarcopenia.	[Toyoshima, Kenji; Nakamura, Marie; Hakamada, Tomomi; Abe, Yasuko; Kaneko, Eiji; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Grad Sch, Tokyo, Japan; [Adachi, Yusuke; Imaizumi, Akira] Corartion Incprporated, Inst Innovat, Ajinomoto, Kawasaki, Kanagawa, Japan; [Takahashi, Soiciro] Mituke Municipal Hosp, Mistuke, Niigata, Japan	Tokyo Medical & Dental University (TMDU); Ajinomoto Co Inc	Toyoshima, K (corresponding author), Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Grad Sch, Tokyo, Japan.	k.toyoshima.vasc@tmd.ac.jp		Imaizumi, Akira/0000-0002-8615-1007; toyoshima, kenji/0000-0002-1220-273X	 [1714]		This work was supported by University research fund #1714 to KS.	Altorf-van der Kuil W, 2013, BRIT J NUTR, V110, P810, DOI 10.1017/S0007114512005788; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Collino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056564; Delwing D, 2007, LIFE SCI, V81, P1645, DOI 10.1016/j.lfs.2007.09.031; Ferreira AGK, 2014, INT J BIOCHEM CELL B, V54, P20, DOI 10.1016/j.biocel.2014.05.027; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164877; Fukutake N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132223; Gu Y, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0408-1; He QH, 2011, FRONT BIOSCI-LANDMRK, V16, P2451, DOI 10.2741/3865; Hellmuth C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2108909; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Ilaiwy A, 2016, INT J BIOCHEM CELL B, V79, P80, DOI 10.1016/j.biocel.2016.08.012; Kinny-Koster B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159205; Lai HS, 2005, SEMIN CANCER BIOL, V15, P267, DOI 10.1016/j.semcancer.2005.04.003; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lustgarten MS, 2014, J GERONTOL A-BIOL, V69, P717, DOI 10.1093/gerona/glt152; MAHONEY F I, 1965, Md State Med J, V14, P61; Melton LJ, 2000, J AM GERIATR SOC, V48, P625; Meynial-Denis D, 2016, NUTR REV, V74, P225, DOI 10.1093/nutrit/nuv052; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; Moaddel R, 2016, J GERONTOL A; Montoliu I, 2014, AGING-US, V6, P9, DOI 10.18632/aging.100630; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Nakamura H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.32; Nakamura H, 2016, AM J HUM BIOL, V28, P236, DOI 10.1002/ajhb.22787; Ogawa S, 2014, J CLIN PSYCHIAT, V75, pE906, DOI 10.4088/JCP.13r08908; Ribel-Madsen A, 2016, PHYSL REPORTS, V4; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Schmidt JA, 2016, EUR J CLIN NUTR, V70, P306, DOI 10.1038/ejcn.2015.144; Shimbo K, 2010, BIOMED CHROMATOGR, V24, P683, DOI 10.1002/bmc.1346; Smolenska Z, 2016, BIOMARKERS, V21, P218, DOI 10.3109/1354750X.2015.1130746; Takashina C, 2016, NUTR METAB, V13, DOI 10.1186/s12986-015-0059-5; Toshima T, 2015, HEPATOL RES, V45, P1170, DOI 10.1111/hepr.12484; Wang G, 2014, J PROTEOME RES, V13, P2649, DOI 10.1021/pr5000895; Wang LL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40146; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	40	33	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185206	10.1371/journal.pone.0185206	http://dx.doi.org/10.1371/journal.pone.0185206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934309	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900122
J	Zhang, DZ; He, RZ; Li, SY; Wang, ZW				Zhang, Dezhi; He, Runzhong; Li, Shuangyan; Wang, Zhongwei			A multimodal logistics service network design with time windows and environmental concerns	PLOS ONE			English	Article							ROUTING PROBLEM; PROGRAMMING APPROACH; HUB LOCATION; OPTIMIZATION; MULTICOMMODITY; TRANSPORTATION; ALGORITHM; UNCERTAINTY; OPERATIONS; ALLOCATION	The design of a multimodal logistics service network with customer service time windows and environmental costs is an important and challenging issue. Accordingly, this work established a model to minimize the total cost of multimodal logistics service network design with time windows and environmental concerns. The proposed model incorporates CO2 emission costs to determine the optimal transportation mode combinations and investment selections for transfer nodes, which consider transport cost, transport time, carbon emission, and logistics service time window constraints. Furthermore, genetic and heuristic algorithms are proposed to set up the abovementioned optimal model. A numerical example is provided to validate the model and the abovementioned two algorithms. Then, comparisons of the performance of the two algorithms are provided. Finally, this work investigates the effects of the logistics service time windows and CO2 emission taxes on the optimal solution. Several important management insights are obtained.	[Zhang, Dezhi; He, Runzhong] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Li, Shuangyan; Wang, Zhongwei] Cent South Univ Forestry & Technol, Sch Transportat & Logist, Changsha, Hunan, Peoples R China	Central South University; Central South University of Forestry & Technology	Li, SY (corresponding author), Cent South Univ Forestry & Technol, Sch Transportat & Logist, Changsha, Hunan, Peoples R China.	lishuangyan585@163.com			Central South University Teacher Research Fund [2015JSJJ001]; Hunan Province Science and Technology Development Funds [2015RS4045]; Excellent youth project of Hunan Provincial Department of Education [15B261]; National Natural Science Foundation of China [71672193]	Central South University Teacher Research Fund; Hunan Province Science and Technology Development Funds; Excellent youth project of Hunan Provincial Department of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work that is described in this paper was supported by Central South University Teacher Research Fund (NO. 2015JSJJ001, DZZ receives funding), Hunan Province Science and Technology Development Funds (NO. 2015RS4045, SYL receives funding), Excellent youth project of Hunan Provincial Department of Education (NO. 15B261, SYL receives funding) and National Natural Science Foundation of China (NO. 71672193, DZZ receives funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the academic editor and two anonymous reviewers provided many comments that improved a previous version of this manuscript. The work that is described in this paper was supported by Central South University Teacher Research Fund (NO. 2015JSJJ001, DZZ receives funding), Hunan Province Science and Technology Development Funds (NO. 2015RS4045, SYL receives funding), Excellent youth project of Hunan Provincial Department of Education (NO. 15B261, SYL receives funding) and National Natural Science Foundation of China (NO. 71672193, DZZ receives funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alumur SA, 2012, OMEGA-INT J MANAGE S, V40, P927, DOI 10.1016/j.omega.2012.02.005; Aronsson H., 2006, International Journal of Logistics Management, V17, P394, DOI 10.1108/09574090610717545; Asgari N, 2013, TRANSPORT RES A-POL, V48, P1, DOI 10.1016/j.tra.2012.10.020; Bock S, 2010, EUR J OPER RES, V200, P733, DOI 10.1016/j.ejor.2009.01.046; Chang TS, 2008, COMPUT OPER RES, V35, P2877, DOI 10.1016/j.cor.2006.12.025; Dekker R, 2012, EUR J OPER RES, V219, P671, DOI 10.1016/j.ejor.2011.11.010; Ehmke JF, 2016, COMPUT OPER RES, V67, P34, DOI 10.1016/j.cor.2015.08.013; Elhedhli S, 2012, TRANSPORT RES D-TR E, V17, P370, DOI 10.1016/j.trd.2012.02.002; Fukasawa R, 2016, TRANSPORT RES B-METH, V94, P61, DOI 10.1016/j.trb.2016.09.006; Ganesh K, 2005, INT J ADV MANUF TECH, V26, P148, DOI [10.1007/s00170-003-1976-4, 10.1007/s00170-003-19764]; Haghani A, 1996, TRANSPORT RES A-POL, V30, P231, DOI 10.1016/0965-8564(95)00020-8; Harris I, 2014, TRANSPORT RES E-LOG, V66, P1, DOI 10.1016/j.tre.2014.01.010; Harris I, 2011, INT J PROD ECON, V131, P313, DOI 10.1016/j.ijpe.2010.03.005; He Q, 2014, INT J HYBRID INFORM, V7, P235; Huang YX, 2010, TRANSPORT RES E-LOG, V46, P820, DOI 10.1016/j.tre.2010.03.002; Ishfaq R, 2011, EUR J OPER RES, V210, P213, DOI 10.1016/j.ejor.2010.09.017; Jansen B, 2004, EUR J OPER RES, V156, P41, DOI 10.1016/j.ejor.2003.02.001; Jindal A., 2016, ANN OPER RES, P1; Kim D, 1997, COMPUT IND ENG, V33, P685, DOI 10.1016/S0360-8352(97)00222-2; Liotta G, 2015, INT J PROD ECON, V164, P351, DOI 10.1016/j.ijpe.2014.12.016; Lopes RB, 2016, COMPUT OPER RES, V70, P155, DOI 10.1016/j.cor.2016.01.006; McKinnon A., 2012, GREEN LOGISTICS IMPR; Moccia L, 2011, NETWORKS, V57, P53, DOI 10.1002/net.20383; Mohammadi M, 2017, EUR J OPER RES, V257, P792, DOI 10.1016/j.ejor.2016.07.054; Paraskevopoulos DC, 2016, TRANSPORT RES E-LOG, V85, P166, DOI 10.1016/j.tre.2015.10.007; Piecyk MI, 2010, INT J PROD ECON, V128, P31, DOI 10.1016/j.ijpe.2009.08.027; Qu Y, 2016, NETW SPAT ECON, V16, P303, DOI 10.1007/s11067-014-9227-9; Santoso T, 2005, EUR J OPER RES, V167, P96, DOI 10.1016/j.ejor.2004.01.046; Shaw K, 2016, COMPUT IND ENG, V98, P483, DOI 10.1016/j.cie.2016.06.011; SteadieSeifi M, 2014, EUR J OPER RES, V233, P1, DOI 10.1016/j.ejor.2013.06.055; Tyan JC, 2003, OMEGA-INT J MANAGE S, V31, P55, DOI 10.1016/S0305-0483(02)00094-4; Wang F, 2011, DECIS SUPPORT SYST, V51, P262, DOI 10.1016/j.dss.2010.11.020; Wang Y, 2013, J IND ENG MANAGEMENT, V6, P79; Wang Y, 2017, APPL SOFT COMPUT, V56, P143, DOI 10.1016/j.asoc.2017.02.025; Wang Y, 2015, EXPERT SYST APPL, V42, P5019, DOI 10.1016/j.eswa.2015.02.058; Wang Y, 2014, EXPERT SYST APPL, V41, P521, DOI 10.1016/j.eswa.2013.07.078; Wang ZT, 2015, EUR J OPER RES, V241, P478, DOI 10.1016/j.ejor.2014.09.012; Yang JH, 2016, J CLEAN PROD, V119, P223, DOI 10.1016/j.jclepro.2013.11.011; Zhang D, 2015, OPTIMAL LOCATION SIZ; Zhang Dezhi, 2016, TRANSPORTATION RES D; Zhang SZ, 2014, TRANSPORT RES D-TR E, V31, P85, DOI 10.1016/j.trd.2014.05.015	41	26	28	9	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185001	10.1371/journal.pone.0185001	http://dx.doi.org/10.1371/journal.pone.0185001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934272	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900074
J	Borkum, MS; Heckmann, JM; Manning, K; Dave, JA; Levitt, NS; Rayner, BL; Wearne, N				Borkum, M. S.; Heckmann, J. M.; Manning, K.; Dave, J. A.; Levitt, N. S.; Rayner, B. L.; Wearne, N.			High prevalence of "non-dipping" blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals	PLOS ONE			English	Article							NEUROPATHY; THERAPY; DISEASE; RISK; DYSFUNCTION; BIOMARKERS; MARKERS	Background HIV-infected individuals are at increased risk of tissue inflammation and accelerated vascular aging ('inflamm-aging'). Abnormal diurnal blood pressure (BP) rhythms such as non-dipping may contribute to an increased risk of cardiovascular and cerebrovascular events in HIV infected individuals. However, little data exists on ambulatory blood pressure (ABP) and measures of vascular stiffness in the black African HIV infected population. Methods This is a cross-sectional analysis of otherwise well, HIV infected outpatients on ART for >5 years. Study assessments included: 24hr ABP monitoring, pulse wave velocity (PWV) and central aortic systolic pressure (CASP) using a AtCor Medical Sphygmocor device, fasting lipogram, oral glucose tolerance test, high-sensitivity C-reactive protein (hsCRP) and anthropometric data. Patients completed a questionnaire of autonomic symptoms. CD4+ counts and viral loads were obtained from the National Laboratory results system. Results Sixty seven black participants were included in the analysis of whom 91% (n = 61) were female with a mean age of 42.2 +/- 8.6 years. The median duration on ART was 7.5 years (IQR = 6-10), 84% were virally supressed and the median CD4 count was 529.5cells/mm(3) (IQR = 372.0-686.5). The majority (67%) were classified as overweight and 76% had an increased waist circumference, yet only 88% of participants were normotensive. A hsCRP level in the high cardiovascular risk category was found in 68% of participants. The prevalence of non-dipping BP was 65%. Interestingly, there was no association on multivariable analysis between dipping status and traditional risk factors for non-dipping BP, such as: obesity, autonomic dysfunction and older age. Conclusion This relatively young cross-sectional sample of predominantly normotensive, but overweight black women on effective ART >5 years showed: a high prevalence of non-dipping BP, inflammation and vascular stiffness. Causality cannot be inferred but cardiovascular risk reduction should be emphasized in these patients.	[Borkum, M. S.; Rayner, B. L.; Wearne, N.] Univ Cape Town, Groote Schuur Hosp, Dept Nephrol & Hypertens, Cape Town, South Africa; [Heckmann, J. M.] Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Neurol, Cape Town, South Africa; [Manning, K.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Dave, J. A.; Levitt, N. S.] Univ Cape Town, Groote Schuur Hosp, Dept Endocrinol & Metab, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Borkum, MS (corresponding author), Univ Cape Town, Groote Schuur Hosp, Dept Nephrol & Hypertens, Cape Town, South Africa.	mborkum@gmail.com	Rayner, Brian/AAA-3174-2021	Dave, joel/0000-0003-3084-7408; Levitt, Naomi/0000-0001-6480-8066	Medical Research Council of South Africa; Astra Zeneca	Medical Research Council of South Africa(South African Medical Research Council); Astra Zeneca(AstraZeneca)	This study was supported by Medical Research Council of South Africa (NW, JH), Astra Zeneca (MB). Some research funding awarded from a commercial source: Astra Zeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Drs Cali Dogon and Simthandile Mazondwa for their invaluable assistance in the clinical testing. Medical Research Council of South Africa (NW and JMH) and Astra Zeneca (MB) research grants that made this study possible. Ms Noluthando Mgwayi, our fieldworker, for patient recruitment and language translation.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2016, J CLIN CELL IMMUNOL, V7; Bhatia M S, 2014, J Clin Diagn Res, V8, pWC01, DOI 10.7860/JCDR/2014/7725.4927; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Borkum M, 2014, CARDIOVASC J AFR, V25, P153, DOI 10.5830/CVJA-2014-029; Centner CM, 2017, MUSCLE NERVE; Dave JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151911; Deeks SG, 2011, HIV INFECT INFLAMMAT, V20; Dolan E, 2005, HYPERTENSION, V46; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Echeverria P, 2014, JAIDS-J ACQ IMM DEF, V65, P50, DOI 10.1097/QAI.0b013e3182a97c17; Fourie CMT, 2011, CARDIOVASC J AFR, V22, P117; Hypertension guideline working group, 2014, Cardiovasc J Afr, V25, P288, DOI 10.5830/CVJA-2014-062; Isiguzo G, 2016, NIGER J CARDIOL, V13, P33; Kent ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148920; Kent ST, 2017, J AM SOC HYPERTENS; Kilic H, 2013, BLOOD PRESSURE, V22, P45, DOI 10.3109/08037051.2012.694255; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; La De, 2013, BMC INFECT DIS, V13, P1471; Lazar JM, 2009, AIDS RES HUM RETROV, V25, P877, DOI 10.1089/aid.2008.0269; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maritz J, 2010, MUSCLE NERVE, V41, P599, DOI 10.1002/mus.21535; Morar N, 1998, J Cardiovasc Risk, V5, P313, DOI 10.1097/00043798-199810000-00005; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Profant J, 1999, HYPERTENSION, V33, P1099, DOI 10.1161/01.HYP.33.5.1099; Rider OJ, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0057-1; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Schattenkerk DWE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160243; Shiburi CP, 2006, AM J HYPERTENS, V19, P40, DOI 10.1016/j.amjhyper.2005.06.018; Stranieri A, 2013, ARTIF INTELL MED, V58, P185, DOI 10.1016/j.artmed.2013.04.007; van der Hoeven M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-31; Van der Watt JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-71; Vishwanath Arun, 2016, Indian J Sex Transm Dis AIDS, V37, P123; Wearne N, 2016, CLIN NEPHROL, V86, pS41, DOI 10.5414/CNP86S117; World Health Organization, 2006, NIT DIAGN DIAB MELL; Yehia BR, 2012, JAMA-J AM MED ASSOC, V308, P339, DOI 10.1001/jama.2012.5927; Zanni MV, 2014, NAT REV CARDIOL, V11, P728, DOI 10.1038/nrcardio.2014.167; Zilliox L, 2011, NEUROLOGY, V76, P1099, DOI 10.1212/WNL.0b013e3182120147	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185003	10.1371/journal.pone.0185003	http://dx.doi.org/10.1371/journal.pone.0185003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931072	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700055
J	Darling, NJ; Balmanno, K; Cook, SJ				Darling, Nicola J.; Balmanno, Kathryn; Cook, Simon J.			ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; ER STRESS; TRANSCRIPTION FACTOR; BH3-ONLY PROTEIN; MESSENGER-RNAS; UP-REGULATION; IN-VIVO; ACTIVATION; EXPRESSION; PHOSPHORYLATION	Disruption of protein folding in the endoplasmic reticulum (ER) causes ER stress. Activation of the unfolded protein response (UPR) acts to restore protein homeostasis or, if ER stress is severe or persistent, drive apoptosis, which is thought to proceed through the cell intrinsic, mitochondrial pathway. Indeed, cells that lack the key executioner proteins BAX and BAK are protected from ER stress-induced apoptosis. Here we show that chronic ER stress causes the progressive inhibition of the extracellular signal-regulated kinase (ERK1/2) signalling pathway. This is causally related to ER stress since reactivation of ERK1/2 can protect cells from ER stress-induced apoptosis whilst ERK1/2 pathway inhibition sensitises cells to ER stress. Furthermore, cancer cell lines harbouring constitutively active BRAF(V600E) are addicted to ERK1/2 signalling for protection against ER stress-induced cell death. ERK1/2 signalling normally represses the pro-death proteins BIM, BMF and PUMA and it has been proposed that ER stress induces BIM-dependent cell death. We found no evidence that ER stress increased the expression of these proteins; furthermore, BIM was not required for ER stress-induced death. Rather, ER stress caused the PERK-dependent inhibition of cap-dependent mRNA translation and the progressive loss of pro-survival proteins including BCL2, BCLXL and MCL1. Despite these observations, neither ERK1/2 activation nor loss of BAX/BAK could confer long-term clonogenic survival to cells exposed to ER stress. Thus, ER stress induces cell death by at least two biochemically and genetically distinct pathways: a classical BAX/BAK-dependent apoptotic response that can be inhibited by ERK1/2 signalling and an alternative ERK1/2- and BAX/BAK-independent cell death pathway.	[Darling, Nicola J.; Balmanno, Kathryn; Cook, Simon J.] Babraham Inst, Signalling Lab, Babraham Res Campus, Cambridge CB22 3AT, England; [Darling, Nicola J.] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Dundee	Darling, NJ; Cook, SJ (corresponding author), Babraham Inst, Signalling Lab, Babraham Res Campus, Cambridge CB22 3AT, England.; Darling, NJ (corresponding author), Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland.	n.j.darling@dundee.ac.uk; simon.cook@babraham.ac.uk		Cook, Simon/0000-0001-9087-1616; Balmanno, Kathryn/0000-0002-6417-3889; Darling, Nicola/0000-0001-7278-6012	Biotechnology and Biological Sciences Research Council PhD studentship (NJD); BBSRC Institute Strategic Programme Grant [BB/F015852/1, BBS/E/B/00000417, BBS/E/B/000C0413, BB/J004456/1, BB/P013384/1]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BBS/E/B/000C0417, BB/E02162X/1, BBS/E/B/000C0419, 981749, BBS/E/B/000C0433, BBS/E/B/0000H151, BBS/E/B/000C0432] Funding Source: researchfish; Cancer Research UK [14867] Funding Source: researchfish; BBSRC [BBS/E/B/000C0413, BBS/E/B/000C0417, BBS/E/B/000C0419, BBS/E/B/000C0433, BB/E02162X/1, BBS/E/B/000C0432] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council PhD studentship (NJD)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a Biotechnology and Biological Sciences Research Council PhD studentship (NJD) and by a BBSRC Institute Strategic Programme Grant (KB & SJC); Grant numbers: BB/F015852/1, BBS/E/B/00000417, BBS/E/B/000C0413, BB/J004456/1, BB/P013384/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to members of the Cook laboratory for advice and discussions; Dr Paul Smith (AstraZeneca) for provision of selumetinib and AZD8055 and Prof Noboru Mizushima (Tokyo Medical and Dental University, Tokyo, Japan) for providing immortalised WT and Atg5<SUP>-/-</SUP> MEFs. This study was supported by a Biotechnology and Biological Sciences Research Council PhD studentship (NJD) and by a BBSRC Institute Strategic Programme Grant (KB & SJC).	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Cai B, 1998, J CELL PHYSIOL, V177, P282, DOI 10.1002/(SICI)1097-4652(199811)177:2<282::AID-JCP10>3.0.CO;2-C; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Cook SJS, 2017, FEBS J; Cope CL, 2014, J CELL SCI, V127, P788, DOI 10.1242/jcs.137588; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586; Gupta S, 2012, FEBS LETT, V586, P4023, DOI 10.1016/j.febslet.2012.10.002; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Hiramatsu N, 2014, MOL BIOL CELL, V25, P1411, DOI 10.1091/mbc.E13-11-0664; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Janssen K, 2009, J CELL SCI, V122, P4481, DOI 10.1242/jcs.055772; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; LITTLE AS, 2011, SCI SIGNAL, V4, DOI DOI 10.1126/scisignal.2001752; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mahadevan NR, 2010, J INFLAMM RES, V3, P99, DOI 10.2147/JIR.S11190; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sale MJ, 2013, BIOCHEM J, V450, P285, DOI 10.1042/BJ20121212; Sandow JJ, 2014, CELL DEATH DIFFER, V21, P475, DOI 10.1038/cdd.2013.168; Saveljeva S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.548; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takayanagi S, 2013, CELL STRESS CHAPERON, V18, P11, DOI 10.1007/s12192-012-0351-5; Todd DE, 2004, ONCOGENE, V23, P3284, DOI 10.1038/sj.onc.1207467; Townsend KJ, 1999, J BIOL CHEM, V274, P1801, DOI 10.1074/jbc.274.3.1801; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Verfaillie T, 2013, BIOCHEM BIOPH RES CO, V438, P500, DOI 10.1016/j.bbrc.2013.07.107; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Wheeler MC, 2008, J IMMUNOL, V181, P256, DOI 10.4049/jimmunol.181.1.256; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	66	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184907	10.1371/journal.pone.0184907	http://dx.doi.org/10.1371/journal.pone.0184907			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931068	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700042
J	Desmet, C; van der Wiel, A; Brass, M				Desmet, Charlotte; van der Wiel, Alko; Brass, Marcel			Brain regions involved in observing and trying to interpret dog behaviour	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; MENTAL STATES; MIND; ATTRIBUTION; METAANALYSIS; PERCEPTION; THINKING; PROMPTS; WALKING; PEOPLE	Humans and dogs have interacted for millennia. As a result, humans (and especially dog owners) sometimes try to interpret dog behaviour. While there is extensive research on the brain regions that are involved in mentalizing about other peoples' behaviour, surprisingly little is known of whether we use these same brain regions to mentalize about animal behaviour. In this fMRI study we investigate whether brain regions involved in mentalizing about human behaviour are also engaged when observing dog behaviour. Here we show that these brain regions are more engaged when observing dog behaviour that is difficult to interpret compared to dog behaviour that is easy to interpret. Interestingly, these results were not only obtained when participants were instructed to infer reasons for the behaviour but also when they passively viewed the behaviour, indicating that these brain regions are activated by spontaneous mentalizing processes.	[Desmet, Charlotte; van der Wiel, Alko; Brass, Marcel] Univ Ghent, Dept Expt Psychol, Ghent, Belgium; [Desmet, Charlotte; van der Wiel, Alko; Brass, Marcel] Univ Ghent, Ghent Inst Funct & Metab Imaging brain, Ghent, Belgium; [van der Wiel, Alko] Katholieke Univ Leuven, Dept Work & Org Studies, Fac Econ & Business, Louvain, Belgium	Ghent University; Ghent University; KU Leuven	Brass, M (corresponding author), Univ Ghent, Dept Expt Psychol, Ghent, Belgium.; Brass, M (corresponding author), Univ Ghent, Ghent Inst Funct & Metab Imaging brain, Ghent, Belgium.	marcel.brass@ugent.be	Brass, Marcel/J-7082-2012	Brass, Marcel/0000-0002-3364-4019	Research Council of Ghent University [B/13089]	Research Council of Ghent University(Ghent University)	This work was supported by the Research Council of Ghent University under grant number B/13089 received by Charlotte Desmet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Research Council of Ghent University under grant number B/13089.	Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Desmet C, 2015, NEUROIMAGE, V122, P195, DOI 10.1016/j.neuroimage.2015.08.018; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Horowitz A, 2009, BEHAV PROCESS, V81, P447, DOI 10.1016/j.beproc.2009.03.014; Horowitz AC, 2007, ANTHROZOOS, V20, P23, DOI 10.2752/089279307780216650; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Kujala MV, 2012, PLOS ONE, P7; Lakestani N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134319; Liew SL, 2011, HUM BRAIN MAPP, V32, P1986, DOI 10.1002/hbm.21164; Mar RA, 2007, SOC COGN AFFECT NEUR, V2, P199, DOI 10.1093/scan/nsm011; Marsh LE, 2014, NEUROIMAGE, V103, P81, DOI 10.1016/j.neuroimage.2014.09.020; Meyer I, 2014, ANTHROZOOS, V27, P127, DOI 10.2752/175303714X13837396326576; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Prguda E, 2014, BEHAV PROCESS, V108, P80, DOI 10.1016/j.beproc.2014.09.012; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schirmer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074591; Schultz J, 2004, J COGNITIVE NEUROSCI, V16, P1695, DOI 10.1162/0898929042947874; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Urquiza-Haas EG, 2015, ANIM BEHAV, V109, P167, DOI 10.1016/j.anbehav.2015.08.011; Utz RL, 2014, SOC INDIC RES, V116, P327, DOI 10.1007/s11205-013-0299-6; van der Meer L, 2011, NEUROIMAGE, V56, P2364, DOI 10.1016/j.neuroimage.2011.03.053; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Wan M, 2012, PLOS ONE, V7	38	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0182721	10.1371/journal.pone.0182721	http://dx.doi.org/10.1371/journal.pone.0182721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931030	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700006
J	Tammana, D; Tammana, TVS				Tammana, Damayanti; Tammana, Trinadh Venkata Satish			Chlamydomonas FAP265 is a tubulin polymerization promoting protein, essential for flagellar reassembly and hatching of daughter cells from the sporangium	PLOS ONE			English	Article							ALPHA-TUBULIN; PROTEOMIC ANALYSIS; TPPP/P25; CILIUM; MICROTUBULES; REINHARDTII; BRAIN; P25; SYNUCLEINOPATHIES; DIFFERENTIATION	Tubulin polymerization promoting proteins (TPPPs) belong to a family of neomorphic moon lighting proteins, involved in various physiological and pathological conditions. In physiological conditions, TPPPs play an important role in microtubule dynamics regulating mitotic spindle assembly and in turn cell proliferation. In pathological situations, TPPPs interact with a-synuclein and beta-amyloid and promote their aggregation leading to Parkinson's disease and multiple system atrophy. Orthologs of TPPP family proteins were identified in ciliary proteomes from various organisms including Chlamydomonas but their role in ciliogenesis was not known. Here we showed that Flagellar Associated Protein, FAP265, a Chlamydomonas homologue of TPPP family proteins, localizes in the cytosol, at the basal bodies and in the flagella of vegetative Chlamydomonas cells. During cell division, the protein was found as a distinct spot in the nucleus and at the cleavage furrow which forms between the daughter cells. Further null mutants of Chlamydomonas FAP265 protein, fap265, showed severe defects in hatching from the mother sporangium. Daughter cells of fap265 were significantly larger in size compared with wild type cells. Moreover, the daughter cells present within the mother sporangium failed to form flagella before hatching. They reassembled their flagella only after hatching from the sporangium suggesting that FAP265 plays an important role in flagellar reassembly after cell division.	[Tammana, Damayanti; Tammana, Trinadh Venkata Satish] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India		Tammana, D; Tammana, TVS (corresponding author), Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	damayantitammana@gmail.com; tambiologicals@gmail.com	Tammana, T V Satish/ABF-2357-2021	Tammana, T V Satish/0000-0001-8366-5355; TAMMANA, DAMAYANTI/0000-0003-1678-6864	Science and Engineering Research Board, Department of Science and Technology, India [SBNS/LS-59/2014]; Department of Science and Technology, India [IFA12/LSBM39]	Science and Engineering Research Board, Department of Science and Technology, India; Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by the Science and Engineering Research Board, Department of Science and Technology, India, No. SBNS/LS-59/2014 to Dr. Damayanti Tammana and Department of Science and Technology, India No.: IFA12/LSBM39 to Dr. Trinadh Venkata Satish Tammana and the Dept. of IT, BT and S&T, GoK for infrastructural support provided to IBAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz Olivier, 2014, Cilia, V3, P9, DOI 10.1186/2046-2530-3-9; CAVALIER.T, 1974, J CELL SCI, V16, P529; Craige B, 2013, CURR PROTOC CELL BIO; Geremek M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088216; Gradilone SA, 2013, CANCER RES, V73, P2259, DOI 10.1158/0008-5472.CAN-12-2938; Harris EH, 1989, COMPREHENSIVE GUIDE, Vxiv; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Huang KY, 2004, MOL BIOL CELL, V15, P3605, DOI 10.1091/mbc.E04-01-0010; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; Kubo T, 2009, PLANT CELL PHYSIOL, V50, P572, DOI 10.1093/pcp/pcp016; Kurien BT, 2009, METHODS MOL BIOL, V536, P201, DOI 10.1007/978-1-59745-542-8_22; Lake V, 2003, PHOTOSYNTH RES, V77, P69, DOI 10.1023/A:1024955916194; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; NEWMAN SM, 1990, GENETICS, V126, P875; Olah J, 2013, CYTOSKELETON, V70, P677, DOI 10.1002/cm.21137; Olah J, 2014, BIOCHEM SOC T, V42, P1762, DOI 10.1042/BST20140257; Orosz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049276; Orosz F, 2009, INFECT GENET EVOL, V9, P1275, DOI 10.1016/j.meegid.2009.09.001; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Ran J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12917; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Staverosky JA, 2009, DEV DYNAM, V238, P685, DOI 10.1002/dvdy.21865; TAKAHASHI M, 1993, J NEUROCHEM, V60, P228, DOI 10.1111/j.1471-4159.1993.tb05842.x; TAKAHASHI M, 1991, FEBS LETT, V289, P37, DOI 10.1016/0014-5793(91)80903-G; Tammana TVS, 2008, MOL MICROBIOL, V70, P837, DOI 10.1111/j.1365-2958.2008.06448.x; Tammana TVS, 2013, J CELL SCI, V126, P5018, DOI 10.1242/jcs.133439; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2014, BBA-MOL BASIS DIS, V1842, P547, DOI 10.1016/j.bbadis.2014.01.009; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wood CR, 2013, CURR BIOL, V23, P906, DOI 10.1016/j.cub.2013.04.019; Zhou WB, 2010, MOL CELL BIOCHEM, V343, P231, DOI 10.1007/s11010-010-0518-2; Zhou WB, 2010, MOL CELL BIOCHEM, V333, P91, DOI 10.1007/s11010-009-0208-0	45	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185108	10.1371/journal.pone.0185108	http://dx.doi.org/10.1371/journal.pone.0185108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931065	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700070
J	Serio, J; Ropa, J; Chen, W; Mysliwski, M; Saha, N; Chen, L; Wang, J; Miao, H; Cierpicki, T; Grembecka, J; Muntean, AG				Serio, J.; Ropa, J.; Chen, W.; Mysliwski, M.; Saha, N.; Chen, L.; Wang, J.; Miao, H.; Cierpicki, T.; Grembecka, J.; Muntean, A. G.			The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia	ONCOGENE			English	Article							RNA-POLYMERASE-II; ACUTE MYELOID-LEUKEMIA; JAW TUMOR SYNDROME; ARGININE-METHYLTRANSFERASE; H2B UBIQUITYLATION; MOUSE DEVELOPMENT; GENE-EXPRESSION; CELLS; TRANSCRIPTION; METHYLATION	Acute myeloid leukemia (AML) is a disease associated with epigenetic dysregulation. 11q23 translocations involving the H3K4 methyltransferase MLL1 (KMT2A) generate oncogenic fusion proteins with deregulated transcriptional potential. The polymeraseassociated factor complex (PAFc) is an epigenetic co-activator complex that makes direct contact with MLL fusion proteins and is involved in AML, however, its functions are not well understood. Here, we explored the transcriptional targets regulated by the PAFc that facilitate leukemia by performing RNA-sequencing after conditional loss of the PAFc subunit Cdc73. We found Cdc73 promotes expression of an early hematopoietic progenitor gene program that prevents differentiation. Among the target genes, we confirmed the protein arginine methyltransferase Prmt5 is a direct target that is positively regulated by a transcriptional unit that includes the PAFc, MLL1, HOXA9 and STAT5 in leukemic cells. We observed reduced PRMT5-mediated H4R3me2s following excision of Cdc73 placing this histone modification downstream of the PAFc and revealing a novel mechanism between the PAFc and Prmt5. Knockdown or pharmacologic inhibition of Prmt5 causes a G1 arrest and reduced proliferation resulting in extended leukemic disease latency in vivo. Overall, we demonstrate the PAFc regulates Prmt5 to facilitate leukemic progression and is a potential therapeutic target for AMLs.	[Serio, J.; Ropa, J.; Chen, W.; Mysliwski, M.; Saha, N.; Chen, L.; Wang, J.; Miao, H.; Cierpicki, T.; Grembecka, J.; Muntean, A. G.] Univ Michigan, Dept Pathol, Med Sch, 7520B Med Sci Res Bldg 1,1301 Catherine Rd, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Muntean, AG (corresponding author), Univ Michigan, Dept Pathol, Med Sch, 7520B Med Sci Res Bldg 1,1301 Catherine Rd, Ann Arbor, MI 48109 USA.	andrewmu@umich.edu	Saha, Nirmalya/AEF-3616-2022	SAHA, NIRMALYA/0000-0002-5624-8879; Chen, Wei/0000-0002-8316-1728; Ropa, James/0000-0001-6120-1859; Muntean, Andrew/0000-0003-3034-0682	NIH [R00 CA158136]; American Society of Hematology Scholar Award; Leukemia Research Foundation award; American Cancer Society Scholar Award [RSG-15-046]; Children's Leukemia Research Association; NATIONAL CANCER INSTITUTE [R00CA158136, R01CA207272, T32CA140044, R01CA160467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Scholar Award; Leukemia Research Foundation award; American Cancer Society Scholar Award(American Cancer Society); Children's Leukemia Research Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Dong-Er Zhang (UCSD), Dr Wei Xu (University of Wisconsin), Dr Jean-Francois Rual and Dr Tao Xu (University of Michigan) for providing the Prmt1, Prmt4 and Prmt5 constructs, respectively, Dr Yali Dou (University of Michigan) for the MLLc antibody. This work was supported by NIH grants R00 CA158136 (AGM), an American Society of Hematology Scholar Award (AGM), a Leukemia Research Foundation award (AGM), an American Cancer Society Scholar Award RSG-15-046 (AGM) and Children's Leukemia Research Association (AGM).	Aplan PD, 2006, DNA REPAIR, V5, P1265, DOI 10.1016/j.dnarep.2006.05.034; Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Chen L, 2015, LEUKEMIA, V29, P1290, DOI 10.1038/leu.2015.18; Chen LL, 2016, ONCOTARGET, V7, P25208, DOI 10.18632/oncotarget.8199; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Cheung N, 2016, CANCER CELL, V29, P32, DOI 10.1016/j.ccell.2015.12.007; Collins CT, 2016, ONCOGENE, V35, P1090, DOI 10.1038/onc.2015.174; Daser A, 2005, SEMIN CANCER BIOL, V15, P175, DOI 10.1016/j.semcancer.2005.01.007; Dey P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026926; Garcia-Cuellar MP, 2016, CELL REP, V15, P310, DOI 10.1016/j.celrep.2016.03.018; Girardot M, 2014, NUCLEIC ACIDS RES, V42, P235, DOI 10.1093/nar/gkt884; Hanks S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5398; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jin YL, 2016, J CLIN INVEST, V126, P3961, DOI 10.1172/JCI85239; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Li Li, 2003, Cancer Immun, V3, P8; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Marjon K, 2016, CELL REP, V15, P574, DOI 10.1016/j.celrep.2016.03.043; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Miller CA, 2013, NEW ENGL J MED, V369, P1473, DOI 10.1056/NEJMc1308782; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Mongiardi MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15494; Moniaux N, 2006, ONCOGENE, V25, P3247, DOI 10.1038/sj.onc.1209353; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Muntean AG, 2013, BLOOD, V122, P1914, DOI 10.1182/blood-2013-02-486977; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Newey PJ, 2010, HUM MUTAT, V31, P295, DOI 10.1002/humu.21188; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Shia WJ, 2012, BLOOD, V119, P4953, DOI 10.1182/blood-2011-04-347476; Tarighat SS, 2016, LEUKEMIA, V30, P789, DOI 10.1038/leu.2015.308; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Van Oss SB, 2016, MOL CELL, V64, P815, DOI 10.1016/j.molcel.2016.10.008; Vu LP, 2013, CELL REP, V5, P1625, DOI 10.1016/j.celrep.2013.11.025; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yang H, 2016, ONCOTARGET, V7, P72131, DOI 10.18632/oncotarget.12351; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Youn MY, 2007, J BIOL CHEM, V282, P34727, DOI 10.1074/jbc.M705411200; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Zeng H, 2015, GENE DEV, V29, P2153, DOI 10.1101/gad.268722.115; Zhang BL, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0721-8; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	64	20	20	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					450	460		10.1038/onc.2017.337	http://dx.doi.org/10.1038/onc.2017.337			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28945229	Green Accepted			2022-12-26	WOS:000423331600004
J	Okada, M; Shi, YB				Okada, Morihiro; Shi, Yun-Bo			EVI and MDS/EVI are required for adult intestinal stem cell formation during postembryonic vertebrate development	FASEB JOURNAL			English	Article						stem cells; intestine; amphibian metamorphosis; organogenesis; Xenopus tropicalis	INTEGRATION SITE 1; XENOPUS-TROPICALIS; THYROID-HORMONE; GENE-EXPRESSION; SELF-RENEWAL; METAMORPHOSIS; ACTIVATION; PROLIFERATION; EPITHELIUM; REGULATOR	The gene ectopic viral integration site 1 (EVI) and its variant myelodysplastic syndrome 1 (MDS)/EVI encode zinc-finger proteins that have been recognized as important oncogenes in various types of cancer. In contrast to the established role of EVI and MDS/EVI in cancer development, their potential function during vertebrate postembryonic development, especially in organ-specific adult stem cells, is unclear. Amphibian metamorphosis is strikingly similar to postembryonic development around birth in mammals, with both processes taking place when plasma thyroid hormone (T3) levels are high. Using the T3-dependent metamorphosis in Xenopus tropicalis as a model, we show here that high levels of EVI and MDS/EVI are expressed in the intestine at the climax of metamorphosis and are induced by T3. By using the transcription activator-like effector nuclease gene editing technology, we have knocked out both EVI and MDS/EVI and have shown that EVI and MDS/EVI are not essential for embryogenesis and premetamorphosis in X. tropicalis. On the other hand, knocking out EVI and MDS/EVI causes severe retardation in the growth and development of the tadpoles during metamorphosis and leads to tadpole lethality at the climax of metamorphosis. Furthermore, the homozygous-knockout animals have reduced adult intestinal epithelial stem cell proliferation at the end of metamorphosis (for the few that survive through metamorphosis) or during T3-induced metamorphosis. These findings reveal a novel role of EVI and/or MDS/EVI in regulating the formationand/orproliferation of adult intestinal adult stem cells during postembryonic development in vertebrates.	[Okada, Morihiro; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bldg 18T Room 106,18 Lib Dr MSC 5431, Bethesda, MD 20892 USA.	shi@helix.nih.gov		Okada, Morihiro/0000-0001-6384-6917; Shi, Yun-Bo/0000-0002-6330-0639	Japan Society for the Promotion of Science Research Fellowship at the U.S. National Institutes of Health (NIH); Intramural Research Program of the NIH National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Research Fellowship at the U.S. National Institutes of Health (NIH); Intramural Research Program of the NIH National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	M.O. was supported, in part, by a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the U.S. National Institutes of Health (NIH). This work was supported by the Intramural Research Program of the NIH National Institute of Child Health and Human Development. The authors declare no conflicts of interest.	Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Gao JS, 2011, FEBS LETT, V585, P693, DOI 10.1016/j.febslet.2011.01.033; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Hasebe T, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-18; Ishizuya-Oka A, 2007, DEV DYNAM, V236, P3358, DOI 10.1002/dvdy.21291; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Kataoka K, 2012, CANCER SCI, V103, P1371, DOI 10.1111/j.1349-7006.2012.02303.x; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kumano K, 2010, J CELL PHYSIOL, V222, P282, DOI 10.1002/jcp.21953; Lei Y, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-21; Luu N, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-43; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Miller TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055585; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; Nakajima K, 2013, ZOOL SCI, V30, P455, DOI 10.2108/zsj.30.455; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nieuwkoop P.D., 1965, NORMAL TABLE XENOPUS; Okada M, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0065-3; Okada M, 2015, ENDOCRINOLOGY, V156, P3381, DOI 10.1210/en.2015-1190; Okada M, 2013, ZOOL SCI, V30, P154, DOI 10.2108/zsj.30.154; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Sterling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047407; Sun GH, 2014, ENDOCRINOLOGY, V155, P5024, DOI 10.1210/en.2014-1316; Sun GH, 2013, ENDOCRINOLOGY, V154, P4396, DOI 10.1210/en.2013-1432; Sun GH, 2012, INT J BIOL SCI, V8, P1217, DOI 10.7150/ijbs.5109; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Van Campenhout C, 2006, DEV BIOL, V294, P203, DOI 10.1016/j.ydbio.2006.02.040; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wen L, 2015, FASEB J, V29, P385, DOI 10.1096/fj.14-252171; Wen L, 2015, ENDOCRINOLOGY, V156, P721, DOI 10.1210/en.2014-1439; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	39	4	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					431	439		10.1096/fj.201700424R	http://dx.doi.org/10.1096/fj.201700424R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928245	Green Published			2022-12-26	WOS:000419172700038
J	Rebnord, T; Ostbye, T; Mmbaga, BT; Mchome, B; Lie, RT; Daltveit, AK				Rebnord, Tormod; Ostbye, Truls; Mmbaga, Blandina Theophil; Mchome, Bariki; Lie, Roiv Terje; Daltveit, Anne Kjersti			Time trends in management of HIV-positive pregnant women in Northern Tanzania: A registry-based study	PLOS ONE			English	Article								Objective To examine time trends in antenatal factors and delivery characteristics in Northern Tanzania, and relate these to national guidelines for HIV in pregnancy. Design Registry-based study. Setting Northern Tanzania, 2000-2014. Population or sample Deliveries (n = 33 346). Methods HIV-positive women were compared with HIV-negative women during four periods spanning changing national guidelines. Main outcome measures Known maternal HIV status, HIV treatment for woman, number of antenatal care (ANC) visits, routine folate/iron in pregnancy, anemia, delivery complications/interventions. Results We observed an increase in deliveries with known maternal HIV status and women receiving HIV treatment, and a decline in deliveries with positive maternal HIV status (p-values for trend <0.001). The proportion of women with less than four ANC visits increased to above 30 percent irrespective of HIV status. Use of routine folate/iron increased, corresponding to a decrease in anemia which was strongest in HIV-negative women. Incidence of elective caesarean section (CS) and emergency CS remained unchanged for HIV-positive women (7.1% and 25.5%, respectively, in the last period). Use of invasive procedures declined in both groups of women. Mothers who were young, single, had low education, high parity or lived in the rural area more often had indicators of poor antenatal care. Conclusions Increasing adherence to national guidelines over time was found for most selected outcomes. Still, a high occurrence of insufficient ANC, anemia and emergency CS call for efforts to explore and identify barriers that hinder optimal care.	[Rebnord, Tormod; Ostbye, Truls; Lie, Roiv Terje; Daltveit, Anne Kjersti] Univ Bergen, Fac Med & Dent, Dept Global Publ Hlth & Primary Care IGS, Bergen, Norway; [Ostbye, Truls] Duke Univ, Durham, NC USA; [Mmbaga, Blandina Theophil; Mchome, Bariki] Kilimanjaro Christian Med Univ Coll, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mmbaga, Blandina Theophil] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Lie, Roiv Terje; Daltveit, Anne Kjersti] Norwegian Inst Publ Hlth, Bergen, Norway	University of Bergen; Duke University; Kilimanjaro Christian Medical Centre; Norwegian Institute of Public Health (NIPH)	Rebnord, T (corresponding author), Univ Bergen, Fac Med & Dent, Dept Global Publ Hlth & Primary Care IGS, Bergen, Norway.	tormod03@gmail.com	Mmbaga, Blandina Theophil/AAR-8707-2021	Mmbaga, Blandina Theophil/0000-0002-5550-1916	Research Council of Norway (RCN); University of Bergen (UiB) through Medical Student Research Programme	Research Council of Norway (RCN)(Research Council of Norway); University of Bergen (UiB) through Medical Student Research Programme	Funding was provided by the Research Council of Norway (RCN) and the University of Bergen (UiB) through the Medical Student Research Programme.; The authors thank the KCMC administration and all the staff at KCMC Reproductive Health Department for the work with interviews, registration of the data and maintenance of the Birth Registry through all these years. The authors also thank the Research Council of Norway (RCN) and the University of Bergen (UiB) for funding and for the opportunity to make this study possible through the Medical Student Research Programme.	Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; [Anonymous], 2014, GAP REPORT 2014; [Anonymous], 2012, TANZ NAT GUID MAN HI; [Anonymous], BACKGR INF; [Anonymous], 2013, 2012 TANZ POP HOUS C; [Anonymous], 2016, FACT SHEET JOINT UN; [Anonymous], 2012, NAT GUID COMPR CAR P; [Anonymous], 2007, PREV MOTH CHILD TRAN; Babbel B., 2012, EVALUATING EQUITY PR; Bergsjo Per, 2007, East Afr J Public Health, V4, P1; Cho G, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-173; Gamell A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13775; Gupta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101893; Habib NA, 2008, BJOG-INT J OBSTET GY, V115, P616, DOI 10.1111/j.1471-0528.2008.01672.x; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Ministry of Health CD MoH/Zanzibar M of H- NBS/Tanzania NB of S- OCGS/Zanzibar O of CGS- ICF, 2016, TANZ DEM HLTH SURV M; Mwendo EM, 2014, TROP MED INT HEALTH, V19, P267, DOI 10.1111/tmi.12255; National Bureau of Statistics: Ministry of Finance & Office of Chief Government Statistician: President's Office Finance Economy and Development Planning, 2013, POP DISTR AG SEX; (NBS) NBoS, 2005, TANZ DEM HLTH SURV 2; (NBS) NBoS, 2011, TANZ DEM HLTH SURV 2; Nilsen C, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0087-1; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Read JS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005479; Research NIfM, 2008, EV INF POL MAK UN RE; Sorbye IK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-55; Tanzania Commission for AIDS (TACAIDS), 2012, NAT BEH CHANG COMM G; Tanzania Ministry of Health and Social Welfare, 2004, NAT GUID PREV MOTH C; Tanzania Ministry of Health and Social Welfare, 2013, NAT GUID COMPR CAR S; UNAIDS, 2014, GLOB AIDS RESP COUNT; UNICEF, 2012, EL NEW HIV INF CHILD; WHO, 2012, GUID DAIL IR FOL AC; Wilfert C, 2010, FDN SUPPORTED PMTCT; World Bank, PREV HIV TOT POP AG; World Bank, CONTR PREV AN METH W; World Bank, MAT MORT RAT MOD EST	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184362	10.1371/journal.pone.0184362	http://dx.doi.org/10.1371/journal.pone.0184362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957345	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200012
J	Reilly, AC; Guikema, SD; Zhu, LY; Igusa, T				Reilly, Allison C.; Guikema, Seth D.; Zhu, Laiyin; Igusa, Takeru			Evolution of vulnerability of communities facing repeated hazards	PLOS ONE			English	Article							HURRICANE DAMAGE; CLIMATE-CHANGE; FLOOD DAMAGE; POWER-SYSTEM; MODELS; RISK; DECISIONS; FLORIDA; SIMULATION; MITIGATION	The decisions that individuals make when recovering from and adapting to repeated hazards affect a region's vulnerability in future hazards. As such, community vulnerability is not a static property but rather a dynamic property dependent on behavioral responses to repeated hazards and damage. This paper is the first of its kind to build a framework that addresses the complex interactions between repeated hazards, regional damage, mitigation decisions, and community vulnerability. The framework enables researchers and regional planners to visualize and quantify how a community could evolve over time in response to repeated hazards under various behavioral scenarios. An illustrative example using parcellevel data from Anne Arundel County, Maryland-a county that experiences fairly frequent hurricanes-is presented to illustrate the methodology and to demonstrate how the interplay between individual choices and regional vulnerability is affected by the region's hurricane experience.	[Reilly, Allison C.] Univ Maryland, Dept Civil & Environm Engn, College Pk, MD 20742 USA; [Guikema, Seth D.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Zhu, Laiyin] Western Michigan Univ, Dept Geog, Kalamazoo, MI 49008 USA; [Igusa, Takeru] Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; Western Michigan University; Johns Hopkins University	Reilly, AC (corresponding author), Univ Maryland, Dept Civil & Environm Engn, College Pk, MD 20742 USA.	areilly2@umd.edu	Igusa, Takeru/A-3218-2010; Reilly, Allison/HGA-8219-2022; Zhu, Laiyin/AFR-8302-2022	Igusa, Takeru/0000-0002-3632-2867; Reilly, Allison/0000-0001-7209-3566	National Science Foundation (US) [1149460, 1331399]; Divn Of Social and Economic Sciences [1631409] Funding Source: National Science Foundation; Div Of Civil, Mechanical, & Manufact Inn [1621116] Funding Source: National Science Foundation	National Science Foundation (US)(National Science Foundation (NSF)); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work is funded by the National Science Foundation (US), grant numbers 1149460 and 1331399. The support of the sponsor is gratefully acknowledged. Any opinions, findings, conclusions or recommendations presented in this paper are those of the authors and do not necessarily reflect the view of the National Science Foundation, http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1980, UNDERSTANDING ATTITU; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; [Anonymous], 2010, 2010 TIGER LINE SHAP; [Anonymous], 2016, HIST HURR TRACKS; Barredo Jose I., 2010, Sustainability, V2, P1327, DOI 10.3390/su2051327; Berglund EZ, 2015, J WATER RES PLAN MAN, V141, DOI [10.1061/(ASCE)WR.1943-5452.0000544, 10.1061/(ASCE)WR.1943-5452.0000475]; Berrang-Ford L, 2011, GLOBAL ENVIRON CHANG, V21, P25, DOI 10.1016/j.gloenvcha.2010.09.012; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Brody SD, 2003, J PLAN EDUC RES, V23, P191, DOI 10.1177/0739456X03258635; Bubeck P, 2013, GLOBAL ENVIRON CHANG, V23, P1327, DOI 10.1016/j.gloenvcha.2013.05.009; Burby RJ, 2006, ANN AM ACAD POLIT SS, V604, P171, DOI 10.1177/0002716205284676; Carson JM, 2013, J RISK INSUR, V80, P309, DOI 10.1111/j.1539-6975.2012.01484.x; Chen X, 2008, J OPER RES SOC, V59, P25, DOI 10.1057/palgrave.jors.2602321; Chen XW, 2006, NAT HAZARDS, V38, P321, DOI 10.1007/s11069-005-0263-0; Dillon RL, 2011, RISK ANAL, V31, P440, DOI 10.1111/j.1539-6924.2010.01506.x; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; Epstein J.M., 1996, GROWING ARTIFICIAL S; Evans TP, 2004, J ENVIRON MANAGE, V72, P57, DOI 10.1016/j.jenvman.2004.02.008; FEMA (Federal Emergency Management Agency), 2015, HAZUS 2 1 TECHN US M; Fujimi T, 2013, RISK ANAL, V33, P1858, DOI 10.1111/risa.12086; Gencturk BE, 2007, FRAGILITY RELATIONSH; Herault A., 2009, COMPUT GEOSCI, V35, P1050, DOI [10.1016/j.cageo.2007.10.008, DOI 10.1016/J.CAGE0.2007.10.008]; Holland GJ, 2010, MON WEATHER REV, V138, P4393, DOI 10.1175/2010MWR3317.1; Irwin EG, 2001, AGR ECOSYST ENVIRON, V85, P7, DOI 10.1016/S0167-8809(01)00200-6; Jacobs RA, 2011, WIRES COGN SCI, V2, P8, DOI 10.1002/wcs.80; Jain VK, 2007, RISK ANAL, V27, P45, DOI 10.1111/j.1539-6924.2006.00858.x; Jain VK, 2007, J INFRASTRUCT SYST, V13, P31, DOI 10.1061/(ASCE)1076-0342(2007)13:1(31); Jain VK, 2004, NAT HAZARDS REV, V6, P88, DOI [DOI 10.1061/(ASCE)1527-6988(2005)6:2(88), 10.1061/(ASCE)1527-6988(2005)6:2(88)]; Kesete Y, 2014, RISK ANAL, V34, P1040, DOI 10.1111/risa.12227; Kleindorfer PR, 1999, RISK ANAL, V19, P727, DOI 10.1111/j.1539-6924.1999.tb00442.x; Knutson TR, 2008, NAT GEOSCI, V1, P359, DOI 10.1038/ngeo202; Kunreuther H, 1996, J RISK UNCERTAINTY, V12, P171, DOI 10.1007/BF00055792; Kunreuther H, 2013, CLIMATIC CHANGE, V118, P339, DOI 10.1007/s10584-012-0625-z; Legg M, 2013, J INFRASTRUCT SYST, V19, P1, DOI 10.1061/(ASCE)IS.1943-555X.0000106; Lempert R, 2002, P NATL ACAD SCI USA, V99, P7195, DOI 10.1073/pnas.072079399; Logan TM, 2017, HARD DEFENSES FAIL I; Ludy J, 2012, NAT HAZARDS, V61, P829, DOI 10.1007/s11069-011-0072-6; Lux T., 2000, INT J THEOR APPL FIN, V3, P675, DOI DOI 10.1142/S0219024900000826; Magliocca NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086179; Malamud BD, 2000, COMPUT SCI ENG, V2, P42, DOI 10.1109/5992.841795; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; Messner F, 2006, NATO SCI S SS IV EAR, V67, P149; Peacock WG, 2005, LANDSCAPE URBAN PLAN, V73, P120, DOI 10.1016/j.landurbplan.2004.11.004; Peng JZ, 2014, NAT HAZARDS, V74, P1043, DOI 10.1007/s11069-014-1231-3; Pinelli JP, 2004, J STRUCT ENG, V130, P1685, DOI 10.1061/(ASCE)0733-9445(2004)130:11(1685); Pita GL, 2013, J WIND ENG IND AEROD, V114, P96, DOI 10.1016/j.jweia.2012.12.004; Poussin JK, 2014, ENVIRON SCI POLICY, V40, P69, DOI 10.1016/j.envsci.2014.01.013; Rathfon D, 2013, DISASTERS, V37, P333, DOI 10.1111/j.1467-7717.2012.01305.x; Reilly A, 2017, P 27 EUR SAF REL C E, P2018; Reilly A, 2017, P 26 EUR SAF REL C E, P245; Reilly AC, 2017, P IEEE, V105, P1429, DOI 10.1109/JPROC.2017.2689720; Rubinstein A., 1998, MODELING BOUNDED RAT; Ryu H, 2008, P 14 WORLD C EARTHQ, p[12, 12]; Samanidou E, 2007, REP PROG PHYS, V70, P409, DOI 10.1088/0034-4885/70/3/R03; Sante I, 2010, LANDSCAPE URBAN PLAN, V96, P108, DOI 10.1016/j.landurbplan.2010.03.001; Saunders MA, 2008, NATURE, V451, P557, DOI 10.1038/nature06422; Scheitlin KN, 2011, THEOR APPL CLIMATOL, V105, P287, DOI 10.1007/s00704-010-0386-4; Simon A., 1972, DECISION ORG, P161, DOI DOI 10.1093/EREA/27.3.325; SIMON HA, 1990, ANNU REV PSYCHOL, V41, P1, DOI 10.1146/annurev.ps.41.020190.000245; Singhal A, 1996, J STRUCT ENG-ASCE, V122, P1459, DOI 10.1061/(ASCE)0733-9445(1996)122:12(1459); Smith B, 2000, CLIMATIC CHANGE, V45, P223, DOI 10.1023/A:1005661622966; Staid A, 2014, CLIMATIC CHANGE, V127, P535, DOI 10.1007/s10584-014-1272-3; Tonn G, 2017, AGENT BASED IN PRESS; Valbuena D, 2010, LANDSCAPE ECOL, V25, P185, DOI 10.1007/s10980-009-9380-6; van de Lindt JW, 2012, J PERFORM CONSTR FAC, V26, P739, DOI 10.1061/(ASCE)CF.1943-5509.0000270; Vickery P.J., 2006, NAT HAZARD REV, V7, P94, DOI 10.1061/(asce)1527-6988(2006)7:2(94); Vickery PJ, 2006, NAT HAZARD REV, V7, P82, DOI DOI 10.1061/(ASCE)1527-6988(2006)7:2(82); Weichselgartner J., 2001, DISASTER PREV MANAG, V10, P85, DOI [10.1108/09653560110388609, DOI 10.1108/09653560110388609]; Wilson GA, 2013, AREA, V45, P207, DOI 10.1111/area.12012; Yau SC, 2011, NAT HAZARDS REV, V12, P184, DOI 10.1061/(ASCE)NH.1527-6996.0000035; Zechman EM, 2011, RISK ANAL, V31, P758, DOI 10.1111/j.1539-6924.2010.01564.x	71	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0182719	10.1371/journal.pone.0182719	http://dx.doi.org/10.1371/journal.pone.0182719			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953893	gold, Green Submitted, Green Published			2022-12-26	WOS:000411980300004
J	Zhang, YJ; Kong, XQ; Dai, JL; Luo, Z; Li, ZH; Lu, HQ; Xu, SZ; Tang, W; Zhang, DM; Li, WJ; Xin, CS; Dong, HZ				Zhang, Yanjun; Kong, Xiangqiang; Dai, Jianlong; Luo, Zhen; Li, Zhenhuai; Lu, Hequan; Xu, Shizhen; Tang, Wei; Zhang, Dongmei; Li, Weijiang; Xin, Chengsong; Dong, Hezhong			Global gene expression in cotton (Gossypium hirsutum L.) leaves to waterlogging stress	PLOS ONE			English	Article							END RULE PATHWAY; ETHYLENE RESPONSE FACTORS; LOW INTERNAL OXYGEN; DEEP-WATER RICE; TRANSCRIPTION FACTOR; NITRIC-OXIDE; ALCOHOLIC FERMENTATION; SUBMERGENCE TOLERANCE; ARABIDOPSIS-THALIANA; SHOOT ELONGATION	Cotton is sensitive to waterlogging stress, which usually results in stunted growth and yield loss. To date, the molecular mechanisms underlying the responses to waterlogging in cotton remain elusive. Cotton was grown in a rain-shelter and subjected to 0 (control)-, 10-, 15- and 20-d waterlogging at flowering stage. The fourth-leaves on the main-stem from the top were sampled and immediately frozen in liquid nitrogen for physiological measurement. Global gene transcription in the leaves of 15-d waterlogged plants was analyzed by RNA-Seq. Seven hundred and ninety four genes were up-regulated and 1018 genes were down-regulated in waterlogged cotton leaves compared with non-waterlogged control. The differentially expressed genes were mainly related to photosynthesis, nitrogen metabolism, starch and sucrose metabolism, glycolysis and plant hormone signal transduction. KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis indicated that most genes related to flavonoid biosynthesis, oxidative phosphorylation, amino acid metabolism and biosynthesis as well as circadian rhythm pathways were differently expressed. Waterlogging increased the expression of anaerobic fermentation related genes, such as alcohol dehydrogenase (ADH), but decreased the leaf chlorophyll concentration and photosynthesis by down-regulating the expression of photosynthesis related genes. Many genes related to plant hormones and transcription factors were differently expressed under waterlogging stress. Most of the ethylene related genes and ethylene-responsive factor-type transcription factors were up-regulated under water-logging stress, suggesting that ethylene may play key roles in the survival of cotton under waterlogging stress.	[Zhang, Yanjun; Kong, Xiangqiang; Dai, Jianlong; Luo, Zhen; Li, Zhenhuai; Lu, Hequan; Xu, Shizhen; Tang, Wei; Zhang, Dongmei; Li, Weijiang; Xin, Chengsong; Dong, Hezhong] Shandong Acad Agr Sci, Cotton Res Ctr, Jinan, Shandong, Peoples R China; [Zhang, Yanjun; Dong, Hezhong] Shandong Univ, Sch Life Sci, Jinan, Shandong, Peoples R China; [Kong, Xiangqiang; Dong, Hezhong] Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Academy of Agricultural Sciences; Shandong University; Shandong Normal University	Kong, XQ; Dong, HZ (corresponding author), Shandong Acad Agr Sci, Cotton Res Ctr, Jinan, Shandong, Peoples R China.; Dong, HZ (corresponding author), Shandong Univ, Sch Life Sci, Jinan, Shandong, Peoples R China.; Kong, XQ; Dong, HZ (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China.	kongqiang_1995@163.com; donghz@saas.ac.cn			National Natural Science Foundation of China [31771718]; Natural Science Foundation of Shandong Province [ZR2015QZ03, ZR2014YL018]; earmarked fund for China Agricultural Research System [CARS-18-21]; Seed Project of Shandong Province; special fund for Taishan Scholars [Tspd20150213]; Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences [CXGC2016C04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); earmarked fund for China Agricultural Research System; Seed Project of Shandong Province; special fund for Taishan Scholars; Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences	This work was supported by the National Natural Science Foundation of China (31771718), the Natural Science Foundation of Shandong Province (ZR2015QZ03; ZR2014YL018), the earmarked fund for China Agricultural Research System (CARS-18-21), the Seed Project of Shandong Province (2014-cotton), the special fund for Taishan Scholars (Tspd20150213), the Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences (CXGC2016C04).	Ahmed S, 2006, ENVIRON EXP BOT, V57, P278, DOI 10.1016/j.envexpbot.2005.06.006; Allegre A, 2004, J EXP BOT, V55, P2625, DOI 10.1093/jxb/erh258; [Anonymous], 2013, THESIS; Ashraf MA, 2011, CROP PASTURE SCI, V62, P25, DOI 10.1071/CP09225; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai TH, 2011, J PLANT GROWTH REGUL, V30, P119, DOI 10.1007/s00344-010-9173-9; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bailey-Serres J, 2010, CURR OPIN PLANT BIOL, V13, P489, DOI 10.1016/j.pbi.2010.08.002; Bange MP, 2004, FIELD CROP RES, V88, P129, DOI 10.1016/j.fcr.2003.12.002; Bange MP, 2004, FIELD CROP RES, V87, P73, DOI 10.1016/j.fcr.2003.09.007; Barnawal D, 2012, PLANT PHYSIOL BIOCH, V58, P227, DOI 10.1016/j.plaphy.2012.07.008; Benschop JJ, 2006, PLANT PHYSIOL, V141, P1644, DOI 10.1104/pp.106.082636; Bieniawska Z., 2007, THESIS; Bologa KL, 2003, PLANT PHYSIOL, V132, P2058, DOI 10.1104/pp.103.022236; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Cao G, 2012, PROCEDIA ENGINEER, V28, P202, DOI 10.1016/j.proeng.2012.01.706; CASTONGUAY Y, 1993, PLANT CELL ENVIRON, V16, P695, DOI 10.1111/j.1365-3040.1993.tb00488.x; Chen T, 2016, FUNCTIONAL PLANT BIO, V43; Chen W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01044; Ding Fei, 2008, Agricultural Sciences in China, V7, P168, DOI 10.1016/S1671-2927(08)60036-X; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Nguyen D, 2016, PLANT MOL BIOL, V91, P727, DOI 10.1007/s11103-016-0481-8; Ellis MH, 2000, AUST J PLANT PHYSIOL, V27, P1041, DOI 10.1071/PP00052; Ellis MH, 1999, PLANT PHYSIOL, V119, P57, DOI 10.1104/pp.119.1.57; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Gallego-Giraldo C, 2014, PLANT J, V79, P1020, DOI 10.1111/tpj.12603; Geigenberger P, 2000, BIOL CHEM, V381, P723, DOI 10.1515/BC.2000.093; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Gibbs J, 2000, J EXP BOT, V51, P785, DOI 10.1093/jexbot/51.345.785; Gill SS, 2013, PLANT PHYSIOL BIOCH, V63, P254, DOI 10.1016/j.plaphy.2012.12.001; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Hamonts K, 2013, FEMS MICROBIOL ECOL, V83, P568, DOI 10.1111/1574-6941.12015; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; He CJ, 1996, PLANT PHYSIOL, V112, P463, DOI 10.1104/pp.112.2.463; Hess N, 2011, PHYSIOL PLANTARUM, V143, P41, DOI 10.1111/j.1399-3054.2011.01486.x; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; HODGSON AS, 1982, AUST J AGR RES, V33, P1019, DOI 10.1071/AR9821019; HOFFMANNBENNING S, 1992, PLANT PHYSIOL, V99, P1156, DOI 10.1104/pp.99.3.1156; Horchani F, 2010, ACTA PHYSIOL PLANT, V32, P1113, DOI 10.1007/s11738-010-0503-0; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; Jackson M.B., 1992, VEGETATION, V103, P167; Jain Veena, 2010, Physiology and Molecular Biology of Plants, V16, P241, DOI 10.1007/s12298-010-0025-7; Juntawong P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00658; Kato-Noguchi H, 2000, PHYSIOL PLANTARUM, V109, P28, DOI 10.1034/j.1399-3054.2000.100105.x; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Klok EJ, 2002, PLANT CELL, V14, P2481, DOI 10.1105/tpc.004747; Kozlowski T. T., 1984, Flooding and plant growth, P165; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Kuai J, 2015, EUR J AGRON, V67, P61, DOI 10.1016/j.eja.2015.03.005; Kumutha D, 2008, PLANT SCI, V175, P706, DOI 10.1016/j.plantsci.2008.07.013; Kursteiner O, 2003, PLANT PHYSIOL, V132, P968, DOI 10.1104/pp.102.016907; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Lee SC, 2011, NEW PHYTOL, V190, P457, DOI 10.1111/j.1469-8137.2010.03590.x; Lee YH, 2014, PLANT CELL REP, V33, P289, DOI 10.1007/s00299-013-1529-8; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Luo Z, 2008, CROP PROT, V27, P1485, DOI 10.1016/j.cropro.2008.06.006; Milroy SP, 2013, FIELD CROP RES, V140, P51, DOI 10.1016/j.fcr.2012.10.016; Mithran M, 2014, PLANT BIOLOGY, V16, P28, DOI 10.1111/plb.12005; MORRIS DA, 1993, J EXP BOT, V44, P807, DOI 10.1093/jxb/44.4.807; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUENCH DG, 1993, PHYSIOL PLANTARUM, V89, P165, DOI 10.1111/j.1399-3054.1993.tb01800.x; MUSGRAVE A, 1972, NATURE-NEW BIOL, V238, P93, DOI 10.1038/newbio238093a0; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Najeeb U, 2015, VALUATION CORPORATE, P55; Narsai R, 2009, PLANT PHYSIOL, V151, P306, DOI 10.1104/pp.109.142026; Oliveira HC, 2013, PLANT PHYSIOL BIOCH, V66, P141, DOI 10.1016/j.plaphy.2013.02.015; Oliveira HC, 2013, AMINO ACIDS, V44, P743, DOI 10.1007/s00726-012-1399-3; Perata P, 1997, ANN BOT-LONDON, V79, P49, DOI 10.1093/oxfordjournals.aob.a010306; Pierik R, 2005, ANN BOT-LONDON, V96, P533, DOI 10.1093/aob/mci208; Rivoal J, 1997, PLANT PHYSIOL, V114, P1021, DOI 10.1104/pp.114.3.1021; ROBERTS JKM, 1984, P NATL ACAD SCI-BIOL, V81, P3379, DOI 10.1073/pnas.81.11.3379; Sairam RK, 2009, J PLANT PHYSIOL, V166, P602, DOI 10.1016/j.jplph.2008.09.005; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; SETTER TL, 1994, ANN BOT-LONDON, V74, P273, DOI 10.1006/anbo.1994.1118; Shi HT, 2012, PLANT CELL PHYSIOL, V53, P344, DOI 10.1093/pcp/pcr181; Stohr C, 2001, PLANTA, V212, P835, DOI 10.1007/s004250000447; Tang Q., 1997, DPS DATA PROCESSING, P188; Thirunavukkarasu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070433; Voesenek LACJ, 2004, ECOLOGY, V85, P16, DOI 10.1890/02-740; Voesenek LACJ, 2003, ANN BOT-LONDON, V91, P205, DOI 10.1093/aob/mcf116; Wang LH, 2012, ACTA PHYSIOL PLANT, V34, P2241, DOI 10.1007/s11738-012-1024-9; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Wu WB, 2010, AGR SCI CHINA, V9, P101, DOI 10.1016/S1671-2927(09)60073-0; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yang SH, 2006, BIOCHEM BIOPH RES CO, V350, P685, DOI 10.1016/j.bbrc.2006.09.098; Zhang YJ, 2016, FIELD CROP RES, V194, P83, DOI 10.1016/j.fcr.2016.05.006; Zhang YJ, 2015, FIELD CROP RES, V179, P164, DOI 10.1016/j.fcr.2015.05.001; Zheng CF, 2009, PLANT SCI, V176, P575, DOI 10.1016/j.plantsci.2009.01.015	95	24	25	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185075	10.1371/journal.pone.0185075	http://dx.doi.org/10.1371/journal.pone.0185075			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953908	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300032
J	Sharif-Askari, FS; Sharif-Askari, NS; Javadi, M; Gholami, K				Sharif-Askari, Fatemeh Saheb; Sharif-Askari, Narjes Saheb; Javadi, Mohammadreza; Gholami, Kheirollah			Adverse drug reactions reported to the drug and poison information center of Tehran, Iran	PLOS ONE			English	Article							RISK-FACTORS; EVENTS; ERRORS	Background Burden of adverse drug reactions (ADRs), in home-environment and domestic settings, is unknown. Objective To discuss the epidemiology of reported ADRs to 13-Aban drug and poison information center (DPIC) and to discuss the burden of hospitalization caused by these ADRs from commonly implicated therapeutic groups. Methods A retrospective analysis of the yellow card schemes of suspected ADRs reported to the 13-Aban DPIC was conducted from 21 March 2013 to 21 November 2016 inclusive. Main outcome measures Characteristics of the ADRs, such as the sex and age of the patient, the therapeutic group involved, and the medical outcome of the exposure, were examined. ADR Hospitalization (ADRH) index was calculated for each drug group by dividing the number of ADR-related hospitalizations with total number of reported ADR cases (n = 748), and then multiplying by 100. Results ADRs were reported for 748 patients representing 5 cases per 1000 enquiries to the 13Aban DPIC over almost 4-years of the study period. Public were responsible for reporting every 4 out of 5 ADR cases (n = 651, 87%) and the remaining 1 out of 5 ADR cases was reported by the health care professionals (n = 97, 13%). Most of the ADRs had a medical outcome documented as having a minor effect or were minimally bothersome to the patients (n = 509, 68%), and less than 4.9% (n = 37) were documented as having a major effect or were life-threatening. Overall, 7.4% (n = 55) of ADRs were resulted in hospitalization. Antibacterials for systemic use represented the therapeutic group with the highest hospitalization index (1.7%). Conclusions The study concluded that ADRs to antibiotics are common and some of them resulted in hospitalization.	[Sharif-Askari, Fatemeh Saheb; Sharif-Askari, Narjes Saheb; Javadi, Mohammadreza; Gholami, Kheirollah] Univ Tehran Med Sci, Clin Pharm Dept, Fac Pharm, Tehran, Iran; [Javadi, Mohammadreza; Gholami, Kheirollah] Univ Tehran Med Sci, Res Ctr Rat Use Drugs, Karimkhan Zand Ave,Hafte Tir Sq, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences	Sharif-Askari, FS (corresponding author), Univ Tehran Med Sci, Clin Pharm Dept, Fac Pharm, Tehran, Iran.	dr.fatemeh.askari@gmail.com	Sharif-Askari, Narjes Saheb/I-1743-2019	Sharif-Askari, Narjes Saheb/0000-0003-0482-6777; Saheb Sharif-Askari, Fatemeh/0000-0001-8498-055X				Anderson C, 2011, BRIT J CLIN PHARMACO, V72, P806, DOI 10.1111/j.1365-2125.2011.03990.x; [Anonymous], 2016, IRAN CENSUS RESULTS; Bencheikh RS, 2009, BRIT J CLIN PHARMACO, V67, P687, DOI 10.1111/j.1365-2125.2009.03426.x; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Cassidy N, 2011, CLIN TOXICOL, V49, P485, DOI 10.3109/15563650.2011.587193; Egberts TCG, 1996, BRIT MED J, V313, P530; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Grootheest K, 2003, NETHERLANDS, V26; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; Hayes BD, 2009, J AM GERIATR SOC, V57, P653, DOI 10.1111/j.1532-5415.2008.02166.x; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Inacio P, 2016, BR J CLIN PHARM; Jarernsiripornkul N, 2002, BRIT J CLIN PHARMACO, V53, P318, DOI 10.1046/j.0306-5251.2001.01547.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Mey C, 2002, INT J CLIN PHARM TH, V40, P102; Mowry JB, 2015, CLIN TOXICOL, V53, P962, DOI 10.3109/15563650.2015.1102927; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Organization WH, 1972, REP WHO M HELD GEN 2; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Royal Pharmaceutical Society of Great B, 2002, BMJ BOOKS; Sarkar U, 2011, HEALTH SERV RES, V46, P1517, DOI 10.1111/j.1475-6773.2011.01269.x; Shalviri G, 2009, IRAN J PUBLIC HEALTH, V38, P162; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Vassilev ZP, 2009, AM J HLTH SYST PHARM, V66; Wester K, 2008, BRIT J CLIN PHARMACO, V65, P573, DOI 10.1111/j.1365-2125.2007.03064.x	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185450	10.1371/journal.pone.0185450	http://dx.doi.org/10.1371/journal.pone.0185450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950006	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000053
J	Wu, WH; Zhou, CF; Andres, B				Wu, Wen-Hao; Zhou, Chang-Fu; Andres, Brian			The toothless pterosaur Jidapterus edentus (Pterodactyloidea: Azhdarchoidea) from the Early Cretaceous Jehol Biota and its paleoecological implications	PLOS ONE			English	Article							JIUFOTANG FORMATION; HUAXIAPTERUS PTEROSAURIA; CHINA; TAPEJARIDAE; INFORMATION; DIVERSITY; TAXONOMY; GENUS	Background In the Early Cretaceous Jehol Biota, the toothless pterosaurs flourished with the chaoyangopterids and tapejarids playing a key role in understanding the early diversity and evolution of the Azhdarchoidea. Unlike the more diverse tapejarids, the rarer chaoyangopterids are characterized by a long and low rostrum, supporting a close relationship with the huge azhdarchids. Unfortunately, our knowledge is still limited in the osteology, paleoecology, and taxonomy of the Chaoyangopteridae. As one of the best preserved skeletons, the type and only specimen of Jidapterus edentus provides an opportunity to understand the morphology and paleoecology of the chaoyangopterids. Results Our study of the osteology of Jidapterus edentus reveals valuable information about the morphology of the Chaoyangopteridae such as a rostrum with a curved dorsal profile, high Rostral Index (RI), larger angle between the dorsal and postorbital processes of the jugal, sequentially shorter fourth to seventh cervical vertebrae, sternum with a plate wider than long, contact of the metacarpal I with the distal syncarpal, pneumatic foramen on first wing phalanx, hatchet-like postacetabular process with unconstricted neck and small dorsal process, distinctly concave anterior margin of pubis, subrectangular pubic plate with nearly parallel anterior and posterior margins, longer proximal phalanges of pedal digits III and IV, as well as reduced and less curved pedal unguals. These features further support the validity of Jidapterus edentus as a distinct species and the close relationship of the chaoyangopterids with the azhdarchids. Paleoecologically, the chaoyangopterids are probably like the azhdarchids, more terrestrial than the contemporaneous and putatively arboreal tapejarids, which may have been limited to the forest-dominated ecosystem of the Jehol Biota. Discussion The osteology of Jidapterus edentus further supports the close relationship of the Chaoyangopteridae with the Azhdarchidae in sharing a high RI value and reduced and mildly-curved pedal unguals, and it also implies a possible paleoecological similarity in their terrestrial capability. Combined with the putatively arboreal and herbivorous tapejarids, this distinct lifestyle of the chaoyangopterids provides new insights into the diversity of pterosaurs in the ecosystem of the Jehol Biota.	[Wu, Wen-Hao] Jilin Univ, Minist Educ, Key Lab Evolut Past Life & Environm Northeast Asi, Changchun, Jilin, Peoples R China; [Wu, Wen-Hao] Jilin Univ, Res Ctr Palaeontol & Stratig, Changchun, Jilin, Peoples R China; [Zhou, Chang-Fu] Shandong Univ Sci & Technol, Coll Earth Sci & Engn, Qingdao, Shandong, Peoples R China; [Zhou, Chang-Fu] Shenyang Normal Univ, Paleontol Inst, Shenyang, Liaoning, Peoples R China; [Andres, Brian] Univ Penn, Dept & Earth & Environm Sci, Philadelphia, PA 19104 USA	Jilin University; Jilin University; Shandong University of Science & Technology; Shenyang Normal University; University of Pennsylvania	Wu, WH (corresponding author), Jilin Univ, Minist Educ, Key Lab Evolut Past Life & Environm Northeast Asi, Changchun, Jilin, Peoples R China.; Wu, WH (corresponding author), Jilin Univ, Res Ctr Palaeontol & Stratig, Changchun, Jilin, Peoples R China.; Zhou, CF (corresponding author), Shandong Univ Sci & Technol, Coll Earth Sci & Engn, Qingdao, Shandong, Peoples R China.; Zhou, CF (corresponding author), Shenyang Normal Univ, Paleontol Inst, Shenyang, Liaoning, Peoples R China.	wenhao.wu@foxmail.com; zhoucf528@163.com	Wu, Wenhao/AAU-4325-2020	Andres, Brian/0000-0002-9958-0134; Wu, Wenhao/0000-0003-0970-9713; Zhou, Chang-Fu/0000-0002-3744-7573	Public Science and Technology Research Funds Projects of Land and Resources of China [201311120]; Liaoning Baiqianwan Talents Program [2014Q110]; National Natural Science Foundation of China [41202012]	Public Science and Technology Research Funds Projects of Land and Resources of China; Liaoning Baiqianwan Talents Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the Public Science and Technology Research Funds Projects of Land and Resources of China (No. 201311120) and Liaoning Baiqianwan Talents Program (No. 2014Q110) to CFZ, and National Natural Science Foundation of China (No. 41202012) to WHW. The funders had no role in study design, data collection and analysis, decision to pulish, or preparation of the manuscript.	Aires ASS, 2014, PALAEONTOLOGY, V57, P343, DOI 10.1111/pala.12069; Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Andres B, 2014, CURR BIOL, V24, P1011, DOI 10.1016/j.cub.2014.03.030; Andres B, 2012, EARTH ENV SCI T R SO, V103, P383, DOI 10.1017/S1755691013000303; Andres B, 2010, J VERTEBR PALEONTOL, V30, P163, DOI 10.1080/02724630903409220; [Anonymous], 1984, 33 C BRAS GEOL AN, V2, P578; Averianov A.O., 2010, P ZOOL I RAS, V314, P264; Bennett S. C., 2001, PALAEONTOGR ABT A, V260, P1; Bennett SC, 2007, J VERTEBR PALEONTOL, V27, P881, DOI 10.1671/0272-4634(2007)27[881:AAFOTP]2.0.CO;2; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Bennett SC, 2013, PALAEONTOL Z, V87, P269, DOI 10.1007/s12542-012-0159-8; Bennett SC, 2013, NEUES JAHRB GEOL P-A, V267, P23, DOI 10.1127/0077-7749/2012/0295; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Birn-Jeffery AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050555; Broom R, 1913, RECORDS ALBANY MUSEU, V2, P394; Buffetaut E, 1998, GEOL MAG, V135, P719, DOI 10.1017/S0016756898001575; Cai Zhengquan, 1994, Vertebrata Palasiatica, V32, P181; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Dong Z., 2003, GLOBAL GEOLOGY, V22, P1; Eck Kristina, 2011, Swiss Journal of Palaeontology, V130, P277, DOI 10.1007/s13358-011-0024-5; Elgin RA, 2012, HIST BIOL, V24, P586, DOI 10.1080/08912963.2011.613467; Elgin RA, 2011, SWISS J GEOSCI, V104, pS21, DOI 10.1007/s00015-011-0081-1; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Frey Eberhard, 2003, Geological Society Special Publication, V217, P55, DOI 10.1144/GSL.SP.2003.217.01.05; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hyder ES, 2014, ACTA PALAEONTOL POL, V59, P109, DOI 10.4202/app.2011.1109; Kaup SS, 1834, VERSUCH EINTHEILUNG, P311; Kellner A.W.A., 1989, Anais da Academia Brasileira de Ciencias, V61, P439; Kellner Alexander W.A., 2007, Boletim do Museu Nacional Nova Serie Geologia, V75, P1; Kellner Alexander Wilhelm Armin, 1994, Anais da Academia Brasileira de Ciencias, V66, P467; Kellner AWA, 2004, AMEGHINIANA, V41, P521; LEONARDI G, 1985, COLETANEA TRABALHOS, V27, P75; Liu DX, 2015, HIST BIOL, V27, P637, DOI 10.1080/08912963.2014.885962; Lu E J, 2006, PTEROSAURS CHINA BEI; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P301; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P453; Lu Jun-chang, 2006, Dizhi Tongbao, V25, P565; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P783; Lu Junchang, 2005, Geological Review (Beijing), V51, P458; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lu JC, 2008, NATURWISSENSCHAFTEN, V95, P891, DOI 10.1007/s00114-008-0397-5; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P683; Manzig PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100005; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Martill DM, 2013, CRETACEOUS RES, V43, P26, DOI 10.1016/j.cretres.2013.02.007; Martin-Silverstone E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160333; Naish D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058451; Nesov L.A., 1984, Paleontologicheskii Zhurnal, V1984, P47; Pinheiro FL, 2017, PEERJ, V5, DOI 10.7717/peerj.3285; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Plieninger F, 1901, PALAEONTOGRAPHICA, V48, P65; Quenstedt F.A., 1855, PTERODACTYLUS SUEVIC; Strong EE, 1999, CLADISTICS, V15, P363, DOI 10.1111/j.1096-0031.1999.tb00272.x; Unwin D., 2007, CRATO FOSSIL BEDS BR, P475, DOI 10.1017/CBO9780511535512.018; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Unwin David M., 1997, Historical Biology, V12, P199; Unwin David M., 1995, P69; Nova BCV, 2015, HIST BIOL, V27, P770, DOI 10.1080/08912963.2015.1007049; von Meyer CEH, 1854, MITTHEILUNGEN PROFES, P47; Vullo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038900; Wang Xiao-Lin, 2003, Vertebrata Palasiatica, V41, P34; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wang XL, 2006, GEOL J, V41, P405, DOI 10.1002/gj.1046; Wang XL, 2012, NATURWISSENSCHAFTEN, V99, P249, DOI 10.1007/s00114-012-0889-1; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wheeler Q, 2000, SPECIES CONCEPTS PHY; Witton M.P., 2013, PTEROSAURS NATURAL H, DOI DOI 10.1515/9781400847655; Witton MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002271; Witton MP, 2008, PALAEONTOLOGY, V51, P1289, DOI 10.1111/j.1475-4983.2008.00811.x; Zhou CF, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160672; Zhou CF, 2011, NEUES JAHRB GEOL P-A, V260, P265, DOI 10.1127/0077-7749/2011/0131; Zhou CF, 2010, NEUES JAHRB GEOL P-A, V257, P341, DOI 10.1127/0077-7749/2010/0081; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045; Zhou ZH, 2010, SCI CHINA EARTH SCI, V53, P1894, DOI 10.1007/s11430-010-4094-9	81	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185486	10.1371/journal.pone.0185486	http://dx.doi.org/10.1371/journal.pone.0185486			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950013	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000058
J	Jackson, E; Zhang, CX; Kiani, Z; Lisovsky, I; Tallon, B; Del Corpo, A; Gilbert, L; Bruneau, J; Thomas, R; Cote, P; Trottier, B; LeBlanc, R; Rouleau, D; Tremblay, C; Tsoukas, CM; Routy, JP; Ni, XY; Mabanga, T; Bernard, NF				Jackson, Elise; Zhang, Cindy Xinyu; Kiani, Zahra; Lisovsky, Irene; Tallon, Benjamin; Del Corpo, Alexa; Gilbert, Louise; Bruneau, Julie; Thomas, Rejean; Cote, Pierre; Trottier, Benoit; LeBlanc, Roger; Rouleau, Danielle; Tremblay, Cecile; Tsoukas, Christos M.; Routy, Jean-Pierre; Ni, Xiaoyan; Mabanga, Tsoarello; Bernard, Nicole F.		Montreal Primary Infect Study Grp	HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness	PLOS ONE			English	Article							MHC CLASS-I; UNINFECTED INDIVIDUALS; HAPLOTYPES CONTAIN; KIR2DL5 ALLELES; DRUG-USERS; HLA-C; DIVERSITY; REPERTOIRES; RECOGNITION; KIR3DS1	Previously, we showed that Killer Immunoglobulin-like Receptor (KIR) 3DS1 homozygotes (hmz) are more frequent in HIV exposed seronegative (HESN) than in recently HIV infected (HIV+) individuals. KIR3DS1 encodes an activating Natural Killer (NK) cell receptor (NKR). The link between KIR genotype and HIV outcomes likely arises from the function that NK cells acquire through expression of particular NKRs. An initial screen of 97 HESN and 123 HIV+ subjects for the frequency of KIR region gene carriage observed between-group differences for several telomeric KIR region loci. In a larger set of up to 106 HESN and 439 HIV+ individuals, more HESN than HIV+ subjects were KIR3DS1 homozygotes, lacked a full length KIR2DS4 gene and carried the telomeric group B KIR haplotype motif, TB01. TB01 is characterized by the presence of KIR3DS1, KIR2DL5A, KIR2DS3/5 and KIR2DS1, in linkage disequilibrium with each other. We assessed which of the TB01 encoded KIR gene products contributed to NK cell responsiveness by stimulating NK cells from 8 HIV seronegative KIR3DS1 and TB01 motif homozygotes with 721.221 HLA null cells and evaluating the frequency of KIR3DS1 +/-KIR2DL5 +/-, KIR3DS1 +/-KIR2DS1 +/-, KIR3DS1 +/-KIR2DS5 +/-NK cells secreting IFN-. and/or expressing CD107a. A higher frequency of NK cells expressing, versus not, KIR3DS1 responded to 721.221 stimulation. KIR2DL5A +, KIR2DS1 + and KIR2DS5 + NK cells did not contribute to 721.221 responses or modulate those by KIR3DS1 + NK cells. Thus, of the TB01 KIR gene products, only KIR3DS1 conferred responsiveness to HLA-null stimulation, demonstrating its ligation can activate ex vivo NK cells	[Jackson, Elise; Zhang, Cindy Xinyu; Kiani, Zahra; Lisovsky, Irene; Tallon, Benjamin; Del Corpo, Alexa; Gilbert, Louise; Tsoukas, Christos M.; Routy, Jean-Pierre; Ni, Xiaoyan; Mabanga, Tsoarello; Bernard, Nicole F.] McGill Univ, Hlth Ctr RI MUHC, Res Inst, Montreal, PQ, Canada; [Jackson, Elise; Zhang, Cindy Xinyu] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Kiani, Zahra; Lisovsky, Irene; Tallon, Benjamin; Tsoukas, Christos M.; Routy, Jean-Pierre; Bernard, Nicole F.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Bruneau, Julie] CHU Montreal, CR CHUM, Ctr Rech, Montreal, PQ, Canada; [Bruneau, Julie] Univ Montreal, Dept Family Med, Montreal, PQ, Canada; [Thomas, Rejean] Clin Med Actuel, Montreal, PQ, Canada; [Thomas, Rejean] CHUM, Montreal, PQ, Canada; [Cote, Pierre; Trottier, Benoit] Clin Med Quartier Latin, Montreal, PQ, Canada; [LeBlanc, Roger] Clin OPUS, Montreal, PQ, Canada; [Rouleau, Danielle; Tremblay, Cecile] Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Tsoukas, Christos M.; Routy, Jean-Pierre; Bernard, Nicole F.] MUHC, Chron Viral Illness Serv, Montreal, PQ, Canada; [Tsoukas, Christos M.; Routy, Jean-Pierre; Bernard, Nicole F.] MUHC, Div Clin Immunol, Montreal, PQ, Canada; [Routy, Jean-Pierre] MUHC, Div Hematol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Bernard, NF (corresponding author), McGill Univ, Hlth Ctr RI MUHC, Res Inst, Montreal, PQ, Canada.; Bernard, NF (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ, Canada.; Bernard, NF (corresponding author), MUHC, Chron Viral Illness Serv, Montreal, PQ, Canada.; Bernard, NF (corresponding author), MUHC, Div Clin Immunol, Montreal, PQ, Canada.	nicole.bernard@mcgill.ca	Ni, xiaoyan/GWU-8114-2022	Jackson, Elise/0000-0002-1321-8979	Canadian Institutes for Health Research [MOP-142494, MOP-103230]; Canadian HIV Trials Network [CTN-257]; Fonds de Recherche du Quebec-Sante, AIDS and Infectious Diseases Network infrastructure grant; Fonds de Recherche du Quebec-Sante AIDS and Infectious Diseases Network Ph.D. scholarship grant; Canadian Institutes for Health Research Ph.D. scholarship; Fonds de Recherche du Quebec-Sante	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials Network; Fonds de Recherche du Quebec-Sante, AIDS and Infectious Diseases Network infrastructure grant; Fonds de Recherche du Quebec-Sante AIDS and Infectious Diseases Network Ph.D. scholarship grant; Canadian Institutes for Health Research Ph.D. scholarship; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by Canadian Institutes for Health Research grants MOP-142494 and MOP-103230 to NFB; Canadian HIV Trials Network grant CTN-257 to J-PR; Fonds de Recherche du Quebec-Sante, AIDS and Infectious Diseases Network infrastructure grant to Dr. Nicole F. Bernard; Fonds de Recherche du Quebec-Sante AIDS and Infectious Diseases Network Ph.D. scholarship grant to IL; Canadian Institutes for Health Research Ph.D. scholarship to IL; Partial support from the Fonds de Recherche du Quebec-Sante to the Research Institute of the McGill University Health Center of which NFB and J-PR are members.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Beziat V, 2014, EUR J IMMUNOL, V44, P2192, DOI 10.1002/eji.201444464; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Bruneau J, 2011, AM J EPIDEMIOL, V173, P1049, DOI 10.1093/aje/kwq479; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Della Chiesa M, 2008, EUR J IMMUNOL, V38, P2284, DOI 10.1002/eji.200838434; Du Z, 2008, GENES IMMUN, V9, P470, DOI 10.1038/gene.2008.39; Estefania E, 2007, J IMMUNOL, V178, P4402, DOI 10.4049/jimmunol.178.7.4402; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gomez-Lozano N, 2007, EUR J IMMUNOL, V37, P1954, DOI 10.1002/eji.200737277; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Guerini FR, 2011, J INFECT DIS, V203, P1235, DOI 10.1093/infdis/jir020; de Sorrentino AH, 2013, IMMUNOLOGY, V140, P273, DOI 10.1111/imm.12137; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jennes W, 2013, BLOOD, V121, P1157, DOI 10.1182/blood-2012-09-455352; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Korner C, 2014, EUR J IMMUNOL, V44, P2938, DOI 10.1002/eji.201444751; Kulkarni S, 2010, METHODS MOL BIOL, V612, P365, DOI 10.1007/978-1-60761-362-6_25; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Manser AR, 2015, IMMUNOL REV, V267, P178, DOI 10.1111/imr.12316; Marsh SGE, 2003, HUM IMMUNOL, V64, P648, DOI 10.1016/S0198-8859(03)00067-3; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; Merino A, 2011, J INFECT DIS, V203, P487, DOI 10.1093/infdis/jiq075; Merino AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099353; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; O'Connor GM, 2015, J VIROL, V89, P5213, DOI 10.1128/JVI.03586-14; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Olvera A, 2015, AIDS, V29, P507, DOI 10.1097/QAD.0000000000000574; Ordonez D, 2008, GENES IMMUN, V9, P431, DOI 10.1038/gene.2008.34; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Song RJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003867; Stewart CA, 2005, P NATL ACAD SCI US; Tallon BJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110480; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Trowsdale J, 2015, IMMUNOL REV, V267, P117, DOI 10.1111/imr.12314; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; VandenBussche CJ, 2009, GENES IMMUN, V10, P162, DOI 10.1038/gene.2008.91; Vilches C, 2000, J IMMUNOL, V165, P6416, DOI 10.4049/jimmunol.165.11.6416; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Walzer T, 2005, BLOOD; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Yusa SI, 2004, J IMMUNOL, V172, P7385, DOI 10.4049/jimmunol.172.12.7385	63	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							0185160	10.1371/journal.pone.0185160	http://dx.doi.org/10.1371/journal.pone.0185160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938026	gold, Green Submitted, Green Published			2022-12-26	WOS:000411524700019
J	Soundy, J; Day, D				Soundy, Jennifer; Day, Darren			Selection of DNA aptamers specific for live Pseudomonas aeruginosa	PLOS ONE			English	Article							IN-VITRO SELECTION; CELL-SELEX; RESISTANCE; BACTERIA; BIOFILMS	Pseudomonas aeruginosa is an opportunistic pathogen that causes significant morbidity and mortality in immunocompromised patients, particular cystic fibrosis sufferers, burns victims, diabetics and neonates. It thrives in moist places where it forms biofilms that are exceedingly difficult to eradicate on hospital surfaces, in water supplies and implanted biomaterials. Using a live cell SELEX approach we selected DNA aptamers to P. aeruginosa grown as biofilms in microfluidic cells. From a pool of aptamer candidates showing tight binding a stem-loop structure was identified as being important for binding. Enhanced binding and increased specificity was achieved by truncating structures and generating chimeric aptamers from the pool of top candidates. The top candidates have low nanomo larbinding constants and high discrimination for P. aeruginosa over other Gram-negative bacteria. The aptamers bind both planktonic grown and biofilm grown cells. They do not have intrinsic bacteriostatic or bactericidal activity, but are ideal candidates for modification for use as aptamer-drug conjugates and in biosensors.	[Soundy, Jennifer; Day, Darren] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Victoria University Wellington	Day, D (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	darren.day@vuw.ac.nz		Soundy, Jennifer/0000-0002-5576-3529	Wellington Medical Research Foundation [2015/257]	Wellington Medical Research Foundation	This work was supported by the Wellington Medical Research Foundation (https://researchforlife.org,nz/), grant 2015/257 (DD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh N, 2013, NUCLEIC ACID THER, V23, P401, DOI 10.1089/nat.2013.0423; Bruno JG, 2013, PHARMACEUTICALS, V6, P340, DOI 10.3390/ph6030340; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Creach V, 2003, J MICROBIOL METH, V52, P19, DOI 10.1016/S0167-7012(02)00128-8; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Heiat M, 2017, BIOTECHNOL APPL BIOC, V64, P541, DOI 10.1002/bab.1507; Kolovskaya OS, 2013, J MED CHEM, V56, P1564, DOI 10.1021/jm301856j; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Savory N, 2014, J MICROBIOL METH, V104, P94, DOI 10.1016/j.mimet.2014.06.016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sun HG, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.32; Taylor PK, 2014, J BIOTECHNOL, V191, P121, DOI 10.1016/j.jbiotec.2014.09.003; Wang KY, 2011, EUR J CLIN MICROBIOL, V30, P273, DOI 10.1007/s10096-010-1074-0; Willyard C, 2017, NATURE, V543, P15, DOI 10.1038/nature.2017.21550; Ye M, 2012, INT J MOL SCI, V13, P3341, DOI 10.3390/ijms13033341; Zimbres FM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/731516; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	18	25	28	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185385	10.1371/journal.pone.0185385	http://dx.doi.org/10.1371/journal.pone.0185385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937998	Green Published, gold, Green Submitted			2022-12-26	WOS:000411524700029
J	Bi, YH; Fan, B; Wu, FC				Bi, Yanhong; Fan, Bin; Wu, Fuchao			Multiple Cayley-Klein metric learning	PLOS ONE			English	Article								As a specific kind of non-Euclidean metric lies in projective space, Cayley-Klein metric has been recently introduced in metric learning to deal with the complex data distributions in computer vision tasks. In this paper, we extend the original Cayley-Klein metric to the multiple Cayley-Klein metric, which is defined as a linear combination of several Cayley-Klein metrics. Since Cayley-Klein is a kind of non-linear metric, its combination could model the data space better, thus lead to an improved performance. We show how to learn a multiple Cayley-Klein metric by iterative optimization over single Cayley-Klein metric and their combination coefficients under the objective to maximize the performance on separating interclass instances and gathering intra-class instances. Our experiments on several benchmarks are quite encouraging.	[Bi, Yanhong; Fan, Bin; Wu, Fuchao] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Bi, Yanhong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fan, B (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	bfan@nlpr.ia.ac.cn	Fan, Bin/AAD-8307-2019		National Natural Science Foundation of China [61375043, 61472119, 61672032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 61375043, 61472119 and 61672032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NEURAL INF PROCESS S; [Anonymous], 2013, 30 INT C MACH LEARN; Bi YH, 2015, PROC CVPR IEEE, P2339, DOI 10.1109/CVPR.2015.7298847; Borsuk K., 1960, FDNS GEOMETRY; Cayley A., 1859, PHILOS T ROY SOC LON, V149, P61; Chechik G, 2010, J MACH LEARN RES, V11, P1109; Chunhua Shen, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2601, DOI 10.1109/CVPR.2011.5995447; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Coxeter HSM., 1957, NONEUCLIDEAN GEOMETR; Davis J. V., 2007, P 24 INT C MACH LEAR, P209, DOI DOI 10.1145/1273496.1273523; Domeniconi C, 2002, ADV NEUR IN, V14, P665; Frome A, 2007, IEEE I CONF COMP VIS, P94; Globerson A., 2005, NIPS; Goldberger J., 2004, ADV NEURAL INF PROCE, P1; Guillaumin M, 2009, IEEE I CONF COMP VIS, P498, DOI 10.1109/ICCV.2009.5459197; Han XF, 2015, PROC CVPR IEEE, P3279, DOI 10.1109/CVPR.2015.7298948; Hastie T, 1996, IEEE T PATTERN ANAL, V18, P607, DOI 10.1109/34.506411; Hu JL, 2014, PROC CVPR IEEE, P1875, DOI 10.1109/CVPR.2014.242; Huang ZW, 2014, PROC CVPR IEEE, P1677, DOI 10.1109/CVPR.2014.217; Klein F, 1928, VORLESUNGEN NICHT EU; Klein F., 1873, MATH ANN, V6, P112; Klein F., 1871, MATH ANN, V4, P573, DOI [10.1007/BF02100583, DOI 10.1007/BF02100583]; Kumar N, 2009, IEEE I CONF COMP VIS, P365, DOI 10.1109/ICCV.2009.5459250; Law MT, 2014, PROC CVPR IEEE, P1051, DOI 10.1109/CVPR.2014.138; Li Z., 2012, CVPR WORKSH, P45; Lu JW, 2014, IEEE T PATTERN ANAL, V36, P331, DOI 10.1109/TPAMI.2013.134; Lu ZY, 2013, INT CONF MACH LEARN, P583, DOI 10.1109/ICMLC.2013.6890359; MacQueen J. B., 1965, ANN MATH STAT; Noh Yung-kyun, 2010, ADV NEURAL INFORM PR, V23, P1822; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Peng J, 2002, INT C PATT RECOG, P33, DOI 10.1109/ICPR.2002.1047788; Semerci Murat, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference (ECML PKDD 2013). Proceedings: LNCS 8189, P675, DOI 10.1007/978-3-642-40991-2_43; Shen C., 2009, P 23 ANN C NEUR INF, P1007; Shi Y, 2014, AAAI CONF ARTIF INTE, P2078; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang J., 2012, NIPS, V25, P1610; Wang QL, 2014, LECT NOTES COMPUT SC, V8695, P456, DOI 10.1007/978-3-319-10584-0_30; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Xing E., 2002, ADV NEURAL INFORM PR, V15, P505, DOI DOI 10.5555/2968618.2968683; Xiong C, 2012, P 18 ACM SIGKDD INT, P958, DOI [10.1145/2339530.2339680, DOI 10.1145/2339530.2339680]; Yeung DY, 2007, IEEE T NEURAL NETWOR, V18, P141, DOI 10.1109/TNN.2006.883723; Yinjie Huang, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P224, DOI 10.1007/978-3-642-40994-3_15	43	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184865	10.1371/journal.pone.0184865	http://dx.doi.org/10.1371/journal.pone.0184865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934244	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900053
J	Hopkins, MJ; Chen, FY; Hu, SX; Zhang, ZF				Hopkins, Melanie J.; Chen, Feiyang; Hu, Shixue; Zhang, Zhifei			The oldest known digestive system consisting of both paired digestive glands and a crop from exceptionally preserved trilobites of the Guanshan Biota (Early Cambrian, China)	PLOS ONE			English	Article							ORDOVICIAN TRILOBITE; KAILI-BIOTA; BURGESS; FOSSILIZATION; LAGERSTATTE; ANATOMY; GUIZHOU	The early Cambrian Guanshan biota of eastern Yunnan, China, contains exceptionally preserved animals and algae. Most diverse and abundant are the arthropods, of which there are at least 11 species of trilobites represented by numerous specimens. Many trilobite specimens show soft-body preservation via iron oxide pseudomorphs of pyrite replacement. Here we describe digestive structures from two species of trilobite, Palaeolenus lantenoisi and Redlichia mansuyi. Multiple specimens of both species contain the preserved remains of an expanded stomach region (a "crop") under the glabella, a structure which has not been observed in trilobites this old, despite numerous examples of trilobite gut traces from other Cambrian Lagerstatten. In addition, at least one specimen of Palaeolenus lantenoisi shows the preservation of an unusual combination of digestive structures: a crop and paired digestive glands along the alimentary tract. This combination of digestive structures has also never been observed in trilobites this old, and is rare in general, with prior evidence of it from one juvenile trilobite specimen from the late Cambrian Orsten fauna of Sweden and possibly one adult trilobite specimen from the Early Ordovician Fezouata Lagerstatte. The variation in the fidelity of preservation of digestive structures within and across different Lagerstatten may be due to variation in the type, quality, and point of digestion of food among specimens in addition to differences in mode of preservation. The presence and combination of these digestive features in the Guanshan trilobites contradicts current models of how the trilobite digestive system was structured and evolved over time. Most notably, the crop is not a derived structure as previously proposed, although it is possible that the relative size of the crop increased over the evolutionary history of the clade.	[Hopkins, Melanie J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Chen, Feiyang; Zhang, Zhifei] Northwest Univ, Early Life Inst, State Key Lab Continental Dynam, Xian, Shaanxi, Peoples R China; [Chen, Feiyang; Zhang, Zhifei] Northwest Univ, Dept Geol, Xian, Shaanxi, Peoples R China; [Hu, Shixue] Chengdu Inst Geol & Mineral Resources, Chengdu, Sichuan, Peoples R China	American Museum of Natural History (AMNH); Northwest University Xi'an; Northwest University Xi'an	Hopkins, MJ (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.; Zhang, ZF (corresponding author), Northwest Univ, Early Life Inst, State Key Lab Continental Dynam, Xian, Shaanxi, Peoples R China.; Zhang, ZF (corresponding author), Northwest Univ, Dept Geol, Xian, Shaanxi, Peoples R China.	mhopkins@amnh.org; elizf@nwu.edu.cn	chen, feiyang/HDL-7230-2022	zhang, zhifei/0000-0003-0325-5116	National 973 Program [2013CB835002]; 111 Project of China [P201102007]; National Natural Science Foundation of China (NSFC) [41425008, 41621003]	National 973 Program(National Basic Research Program of China); 111 Project of China(Ministry of Education, China - 111 Project); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Fossil collection was partly financed by the National 973 Program (2013CB835002) and 111 Project of China (P201102007). This work represents a contribution to the research programmes from the National Natural Science Foundation of China (NSFC 41425008 and 41621003 to ZZ). The funders had no role in the study design, data collections and analysis, decision to publish, or preparation of the manuscript.r Thank you to J.-P Zhai and Z.-L Zhang for fossil preparation, and to Dr. H.-J. Gong for help with the scanning electron microscopy. Thank you to T.-Y. Park and an anonymous reviewer for comments that improved this manuscript, and to S. Kiel for editorial assistance. This study was financially supported by the National Natural Science Foundation of China (NSFC 41425008 and 41621003 to Z. Zhang and ELI group). Fossil collection was partly financed by the National 973 Program (2013CB835002) and 111 Project of China (P201102007).	Alberti Mirco, 2009, Mainzer Geowissenschaftliche Mitteilungen, V37, P23; Babcock Loren E., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P401; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P537, DOI 10.1111/j.1475-4983.2007.00656.x; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; CHATTERTON BDE, 1994, J PALEONTOL, V68, P294, DOI 10.1017/S0022336000022897; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Cisne J. L., 1981, PALAEONTOGRAPHICA AM, V9, P95; Corbacho Joan, 2011, Batalleria, V16, P16; Daley AC, 2016, ARTHROPOD STRUCT DEV, V45, P71, DOI 10.1016/j.asd.2015.09.004; Degan Shu, 1995, Beringeria Special Issue, V2, P203; Ebbestad JOR, 2013, GFF, V135, P18, DOI 10.1080/11035897.2012.737365; English Adam M., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P537; Eriksson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035625; Fatka O, 2015, EST J EARTH SCI, V64, P255, DOI 10.3176/earth.2015.32; Fatka O, 2013, B GEOSCI, V88, P95, DOI 10.3140/bull.geosci.1329; Fatka Oldrich, 2008, Cuadernos del Museo Geominero, V9, P117; Forchielli A, 2014, PALAEOGEOGR PALAEOCL, V398, P59, DOI 10.1016/j.palaeo.2013.08.001; Forchielli A, 2012, B GEOSCI, V87, P133, DOI 10.3140/bull.geosci.1225; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; Gaines R.R., 2014, PALEONTOL SOC PAP, V20, P123, DOI DOI 10.1017/S1089332600002837; Gaines RR, 2008, GEOLOGY, V36, P755, DOI 10.1130/G24961A.1; Gutierrez-Marco JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep39728; Hou XG, 2008, EARTH ENV SCI T R SO, V99, P213, DOI 10.1017/S1755691009008093; Hu S.X., 2013, THE GUANSHAN BIOTA; Hu SX, 2010, SCI CHINA EARTH SCI, V53, P1765, DOI 10.1007/s11430-010-4086-9; Hu SX, 2010, ACTA PALAEONTOL POL, V55, P495, DOI 10.4202/app.2009.1106; Ivantsov AY, 2000, PALEONTOL ZH, P50; Kordule Vratislav, 2006, Bulletin of Geosciences, V81, P277, DOI 10.3140/bull.geosci.2006.04.277; Lerosey-Aubril R, 2017, GONDWANA RES, V42, P264, DOI 10.1016/j.gr.2016.10.013; Lerosey-Aubril R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032934; Lerosey-Aubril R, 2011, LETHAIA, V44, P166, DOI 10.1111/j.1502-3931.2010.00233.x; Lin Jih-Pai, 2007, Memoir of the Association of Australasian Palaeontologists, V33, P179; Lin JP, 2006, PALAIOS, V21, P15, DOI 10.2110/palo.2004.p04-83; LUO H., 1999, EARLY CAMBRIAN CHENG; Luo H., 2008, EARLY CAMBRIAN MALON; Ortega-Hernandez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052623; Peteya JA, 2013, THESIS; Raymond P. E., 1920, MEM CONN ACAD ARTS S, V7, P1; Snajdr Milan, 1987, Casopis Narodniho Muzea v Praze Rada Prirodovedna, V156, P8; Sturmer W., 1973, Palaeontologische Z, V47, P104; Vannier J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4641; Volborth A, 1963, SERIE, V6, P1; Walcott CD, 1881, B MUS COMP ZOOL HARV, V8, P191; Whiteley T.E., 2002, TRILOBITES NEW YORK; Whittington H.B., 1980, Palaeontology (Oxford), V23, P171; WHITTINGTON HB, 1993, PHILOS T ROY SOC B, V339, P109, DOI 10.1098/rstb.1993.0008; Yuan J. L., 2002, TRILOBITE FAUNA KAIL; Zhang XL, 2003, PALAEONTOLOGY, V46, P447, DOI 10.1111/1475-4983.00307; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhao YL, 2005, ACTA GEOL SIN-ENGL, V79, P751; Zhu MY, 2005, PALAEOGEOGR PALAEOCL, V220, P31, DOI 10.1016/j.palaeo.2003.03.001; Zhu XJ, 2014, LETHAIA, V47, P66, DOI 10.1111/let.12041	53	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184982	10.1371/journal.pone.0184982	http://dx.doi.org/10.1371/journal.pone.0184982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934290	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900071
J	Fujise, K; Kikuchi, Y; Kokubu, E; Okamoto-Shibayama, K; Ishihara, K				Fujise, Kazutaka; Kikuchi, Yuichiro; Kokubu, Eitoyo; Okamoto-Shibayama, Kazuko; Ishihara, Kazuyuki			Effect of extracytoplasmic function sigma factors on autoaggregation, hemagglutination, and cell surface properties of Porphyromonas gingivalis	PLOS ONE			English	Article							ESCHERICHIA-COLI; PUTATIVE GLYCOSYLTRANSFERASE; OBLIGATE ANAEROBE; BIOFILM FORMATION; SECRETION SYSTEM; GENOME SEQUENCE; GENE-EXPRESSION; PROTEIN; VIRULENCE; CONSTRUCTION	Porphyromonas gingivalis is a bacterium frequently isolated from chronic periodontal lesions and is involved in the development of chronic periodontitis. To colonize the gingival crevice, P. gingivalis has to adapt to environmental stresses. Microbial gene expression is regulated by transcription factors such as those in two-component systems and extracytoplasmic function (ECF) sigma factors. ECF sigma factors are involved in the regulation of environmental stress response genes; however, the roles of individual ECF sigma factors are largely unknown. The purpose of this study was to investigate the functions, including autoaggregation, hemagglutination, gingipain activity, susceptibility to antimicrobial agents, and surface structure formation, of P. gingivalis ECF sigma factors encoded by SigP (PGN_0274), SigCH (PGN_0319), PGN_ 0450, PGN_ 0970, and SigH (PGN_1740). Various physiological aspects of the sigP mutant were affected; autoaggregation was significantly decreased at 60 min (p < 0.001), hemagglutination activity was markedly reduced, and enzymatic activities of Kgp and Rgps were significantly decreased (p < 0.001). The other mutants also showed approximately 50% reduction in Rgps activity. Kgp activity was significantly reduced in the sigH mutant (p < 0.001). No significant differences in susceptibilities to tetracycline and ofloxacin were observed in the mutants compared to those of the wild-type strain. However, the sigP mutant displayed an increased susceptibility to ampicillin, whereas the PGN_0450 and sigH mutants showed reduced susceptibility. Transmission electron microscopy images revealed increased levels of outer membrane vesicles formed at the cell surfaces of the sigP mutant. These results indicate that SigP is important for bacterial surface- associated activities, including gingipain activity, autoaggregation, hemagglutination, vesicle formation, and antimicrobial susceptibility.	[Fujise, Kazutaka; Kikuchi, Yuichiro; Kokubu, Eitoyo; Okamoto-Shibayama, Kazuko; Ishihara, Kazuyuki] Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, Tokyo, Japan; [Kikuchi, Yuichiro; Kokubu, Eitoyo; Ishihara, Kazuyuki] Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiyoda Ku, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College	Kikuchi, Y (corresponding author), Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, Tokyo, Japan.; Kikuchi, Y (corresponding author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiyoda Ku, Tokyo, Japan.	yukikuchi@tdc.ac.jp		Ishihara, Kazuyuki/0000-0002-6567-807X; KIKUCHI, YUICHIRO/0000-0001-7232-837X	Ministry of Education, Culture, Sports, Science and Technology of Japan [JP24592778, JP16K11461, JP26463171]; Tokyo Dental College; Grants-in-Aid for Scientific Research [15K11023] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Dental College; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant JP24592778 (to KI), JP16K11461 (to EK) and JP26463171 (to YK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and research funds from Tokyo Dental College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Dou Y, 2016, MOL ORAL MICROBIOL, V31, P270, DOI 10.1111/omi.12122; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Ebersole J L, 1995, Oral Dis, V1, P115; Eisenstark A, 1996, FREE RADICAL BIO MED, V21, P975, DOI 10.1016/S0891-5849(96)00154-2; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Gerits E, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1300366; Gicquel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080407; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gui MJ, 2016, MOL ORAL MICROBIOL, V31, P365, DOI 10.1111/omi.12134; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huett A, 2009, J IMMUNOL, V182, P4917, DOI 10.4049/jimmunol.0803050; Ikeda T, 2002, ANTIMICROB AGENTS CH, V46, P3257, DOI 10.1128/AAC.46.10.3257-3260.2002; Inoue T, 2015, NEW MICROBIOL, V38, P101; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Kikuchi Y, 2005, MICROBIOL-SGM, V151, P841, DOI 10.1099/mic.0.27589-0; Kikuchi Y, 2009, ORAL MICROBIOL IMMUN, V24, P377, DOI 10.1111/j.1399-302X.2009.00526.x; Kondo Y, 2010, INFECT IMMUN, V78, P2846, DOI 10.1128/IAI.01448-09; Krute CN, 2015, MICROBIOL-SGM, V161, P1136, DOI 10.1099/mic.0.000065; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; Mascher T, 2013, CURR OPIN MICROBIOL, V16, P148, DOI 10.1016/j.mib.2013.02.001; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Muller C, 2011, ANTIMICROB AGENTS CH, V55, P1211, DOI 10.1128/AAC.01252-10; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; NAITO Y, 1993, ORAL MICROBIOL IMMUN, V8, P195, DOI 10.1111/j.1399-302X.1993.tb00559.x; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Onozawa S, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-4; Osbourne DO, 2010, MICROBIOL-SGM, V156, P2180, DOI 10.1099/mic.0.038331-0; Ota K, 2017, ANAEROBE, V43, P82, DOI 10.1016/j.anaerobe.2016.12.006; Saito A, 2009, MICROB PATHOGENESIS, V47, P329, DOI 10.1016/j.micpath.2009.09.012; Sakai E, 2007, J BACTERIOL, V189, P3977, DOI 10.1128/JB.01691-06; Salje J, 2014, MICROBIOLOGYOPEN, V3, P426, DOI 10.1002/mbo3.176; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Taguchi Y, 2016, INFECT IMMUN, V84, P230, DOI 10.1128/IAI.01308-15; Tokuda M, 1996, INFECT IMMUN, V64, P4067, DOI 10.1128/IAI.64.10.4067-4073.1996; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; Xie H, 2012, INFECT IMMUN, V80, P3471, DOI 10.1128/IAI.00680-12; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x	55	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185027	10.1371/journal.pone.0185027	http://dx.doi.org/10.1371/journal.pone.0185027			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931045	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700060
J	Robinson, KP; Sim, TMC; Culloch, RM; Bean, TS; Aguilar, IC; Eisfeld, SM; Filan, M; Haskins, GN; Williams, G; Pierce, GJ				Robinson, Kevin P.; Sim, Texa M. C.; Culloch, Ross M.; Bean, Thomas S.; Aguilar, Isabel Cordoba; Eisfeld, Sonja M.; Filan, Miranda; Haskins, Gary N.; Williams, Genevieve; Pierce, Graham J.			Female reproductive success and calf survival in a North Sea coastal bottlenose dolphin (Tursiops truncatus) population	PLOS ONE			English	Article							ASSOCIATION PATTERNS; ANTHROPOID PRIMATES; MATERNAL SIZE; MORAY FIRTH; CONSEQUENCES; EXPOSURE; FITNESS; PARAMETERS; EXPRESSION; MANAGEMENT	Between-female variation in reproductive output provides a strong measure of individual fitness and a quantifiable measure of the health of a population which may be highly informative to management. In the present study, we examined reproductive traits in female bottlenose dolphins from the east coast of Scotland using longitudinal sightings data collected over twenty years. From a total of 102 females identified between 1997 and 2016, 74 mothers produced a collective total of 193 calves. Females gave birth from 6 to 13 years of age with a mean age of 8. Calves were produced during all study months, May to October inclusive, but showed a seasonal birth pulse corresponding to the regional peak in summer water temperatures. Approximately 83% (n = 116) of the calves of established fate were successfully raised to year 2-3. Of the known mortalities, similar to 45% were first-born calves. Calf survival rates were also lower in multiparous females who had previously lost calves. A mean interbirth interval (IBI) of 3.80 years (n = 110) and mean fecundity of 0.16 was estimated for the population. Calf loss resulted in shortened IBIs, whilst longer IBIs were observed in females assumed to be approaching reproductive senescence. Maternal age and size, breeding experience, dominance, individual associations, group size and other social factors, were all concluded to influence reproductive success (RS) in this population. Some females are likely more important than others for the future viability of the population. Consequently, a better knowledge of the demographic groups containing those females showing higher reproductive success would be highly desirable for conservation efforts aimed at their protection.	[Robinson, Kevin P.; Sim, Texa M. C.; Culloch, Ross M.; Bean, Thomas S.; Aguilar, Isabel Cordoba; Eisfeld, Sonja M.; Filan, Miranda; Haskins, Gary N.; Williams, Genevieve] CRRU, Banff, Scotland; [Sim, Texa M. C.; Pierce, Graham J.] Univ Aberdeen, Oceanlab, Newburgh, Scotland; [Pierce, Graham J.] Univ Aveiro, CESAM, Aveiro, Portugal; [Pierce, Graham J.] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Pierce, Graham J.] CSIC, Inst Invest Marinas, Vigo, Spain; [Culloch, Ross M.] Queens Univ Belfast, Sch Nat & Built Environm, Queens Univ, Marine Lab, Portaferry, North Ireland; [Eisfeld, Sonja M.] WDC, Chippenham, England; [Williams, Genevieve] James Cook Univ, Townsville, Qld, Australia	University of Aberdeen; Universidade de Aveiro; Universidade de Aveiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Queens University Belfast; James Cook University	Robinson, KP (corresponding author), CRRU, Banff, Scotland.	kev.robinson@crru.org.uk	Robinson, Kevin/H-3866-2019; Pierce, Graham/A-5404-2018	Pierce, Graham/0000-0002-4744-4501; Robinson, Kevin/0000-0001-8085-9752	Born Free Foundation	Born Free Foundation	We would like to thank our CRRU colleagues, volunteers, supporters and funders who have made this long-term monitoring study possible. There are too many individuals to list here, but we would very much like to thank the following past and present co-workers for field and logistical support: Michael Tetley, Marina Costa, Alessandro Ponzo, Joanne Weare, Nina Baumgartner, Benjamin Williams, Kathryn Dick, Konstantinos Margaris, Jamie Vaughan, Lilian Lieber, Helen Mitcheson, Nick Duthie, Connor Bamford, Andreas Fahlman, Elizabeth Pelonzi, Allan Whaley, Jenny Armstrong, Livia Zapponi. Jenny Spinou, Jack Borrett, Alejandro Herreo Palacio, Rebecca Hall, Grace Russell, Theofilos Sidiropoulos and Beatriz Gimenez-Reguera. We also acknowledge the Born Free Foundation (formerly Care for the Wild International) for their ongoing support, and our co-workers and colleagues at Aberdeen University, the Sea Mammal Research Unit, Scottish Agricultural College, Hebridean Whale & Dolphin Trust and Whale & Dolphin Conservation. The present examination forms part of a wider, long-term monitoring project of the coastally-occurring cetacean species in northeast Scotland. All survey work was carried-out under licence from Scottish Natural Heritage.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bansal R, 2005, DEV BRAIN RES, V156, P13, DOI 10.1016/j.devbrainres.2005.01.007; Brough TE, 2016, ENDANGER SPECIES RES, V29, P255, DOI 10.3354/esr00715; Cheney B, 2015, 21 BIENN C BIOL MAR; Cheney B, 2014, GLOB ECOL CONSERV, V2, P118, DOI 10.1016/j.gecco.2014.08.010; Cheney B, 2013, MAMMAL REV, V43, P71, DOI 10.1111/j.1365-2907.2011.00208.x; CHENEY D, 1986, SCIENCE, V234, P1361, DOI 10.1126/science.3538419; Civil MA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1796; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Culloch RM, 2008, J MAR BIOL ASSOC UK, V88, P1237, DOI 10.1017/S0025315408000210; Currey RJC, 2009, AQUAT CONSERV, V19, P658, DOI 10.1002/aqc.1015; Eisfeld S., 2003, THESIS; Eisfeld S. M., 2004, EUROPEAN RES CETACEA, V18, P60; FEDIGAN LM, 1995, AM J PRIMATOL, V37, P9, DOI 10.1002/ajp.1350370103; Filan M., 2015, THESIS; Frere CH, 2010, P NATL ACAD SCI USA, V107, P19949, DOI 10.1073/pnas.1007997107; Frere CH, 2010, P ROY SOC B-BIOL SCI, V277, P2667, DOI 10.1098/rspb.2010.0039; Fruet PF, 2015, MAR BIOL, V162, P661, DOI 10.1007/s00227-015-2613-0; Gero S., 2012, THESIS; Grasman KA, 2001, J TOXICOL ENV HEAL A, V62, P191, DOI 10.1080/009841001458307; Grellier K, 2003, CAN J ZOOL, V81, P1421, DOI 10.1139/Z03-132; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P60, DOI 10.1289/ehp.8053; Henderson SD, 2014, MAR MAMMAL SCI, V30, P1067, DOI 10.1111/mms.12109; IVERSON SJ, 1993, PHYSIOL ZOOL, V66, P61, DOI 10.1086/physzool.66.1.30158287; Kogi K, 2004, MAR MAMMAL SCI, V20, P510, DOI 10.1111/j.1748-7692.2004.tb01176.x; Krutzen M, 2004, MOL ECOL, V13, P1975, DOI 10.1111/j.1365-294X.2004.02192.x; Lande R., 2003, OXFORD SERIES ECOLOG; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Magrath RD, 1997, BEHAV ECOL SOCIOBIOL, V41, P185, DOI 10.1007/s002650050378; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mitani JC, 1997, BEHAV ECOL SOCIOBIOL, V40, P213, DOI 10.1007/s002650050335; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; Moller Luciana M., 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/498390; Murphy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131085; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; Proaktor G, 2008, ECOLOGY, V89, P2604, DOI 10.1890/07-0833.1; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1990, BEHAVIOUR, V115, P203, DOI 10.1163/156853990X00581; Quick N, 2014, 14D086 UK DEP EN CLI; Robinson Kevin P., 2007, Lutra, V50, P19; Robinson KP, 2014, MAR MAMMAL SCI, V30, P381, DOI 10.1111/mms.12023; Robinson Kevin P., 2012, Journal of Cetacean Research and Management, V12, P365; Ross C, 2000, FOLIA PRIMATOL, V71, P93, DOI 10.1159/000021733; Samuels A, 1997, MAR MAMMAL SCI, V13, P70, DOI 10.1111/j.1748-7692.1997.tb00613.x; Scott M.D., 1990, P235; SHINE R, 1988, AM NAT, V131, P124, DOI 10.1086/284778; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Sim TMC, 2015, THESIS; Steiner Aude, 2008, Aquatic Mammals, V34, P84, DOI 10.1578/AM.34.1.2008.84; Stockin KA, 2006, J MAR BIOL ASSOC UK, V86, P201, DOI 10.1017/S002531540601304X; THOMAS CD, 1990, CONSERV BIOL, V4, P324, DOI 10.1111/j.1523-1739.1990.tb00295.x; Thompson PM, 2011, 354 SNH SCOTT GOV; Urian KW, 1996, J MAMMAL, V77, P394, DOI 10.2307/1382814; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells R.S., 1987, Current Mammalogy, V1, P247; Whitehead H, 2000, CETACEAN SOCIETIES, P219; Willsteed E, 2017, SCI TOTAL ENVIRON, V577, P19, DOI 10.1016/j.scitotenv.2016.10.152; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wilson B, 2004, ANIM CONSERV, V7, P331, DOI 10.1017/S1367943004001581; Wright AJ, 2015, CONSERV BIOL, V29, P333, DOI 10.1111/cobi.12425; Yang JH, 2003, MOL BRAIN RES, V111, P123, DOI 10.1016/S0169-328X(02)00697-6	64	20	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185000	10.1371/journal.pone.0185000	http://dx.doi.org/10.1371/journal.pone.0185000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931081	gold, Green Accepted, Green Published			2022-12-26	WOS:000411314700054
J	Song, WW; Wang, M; Su, W; Lu, QW; Xiao, XH; Cai, J; Zhang, Z; Li, SQ; Li, PT; Gong, JW; Gong, WK; Shang, HH; Liu, AY; Li, JW; Chen, TT; Ge, Q; Shi, YZ; Yuan, YL				Song, Weiwu; Wang, Mi; Su, Wei; Lu, Quanwei; Xiao, Xianghui; Cai, Juan; Zhang, Zhen; Li, Shaoqi; Li, Pengtao; Gong, Juwu; Gong, Wankui; Shang, Haihong; Liu, Aiying; Li, Junwen; Chen, Tingting; Ge, Qun; Shi, Yuzhen; Yuan, Youlu			Genetic and phenotypic effects of chromosome segments introgressed from Gossypium barbadense into Gossypium hirsutum	PLOS ONE			English	Article							FIBER QUALITY TRAITS; ORYZA-SATIVA L.; UPLAND COTTON; SUBSTITUTION LINES; QTL ANALYSIS; LOCI; MAP; POPULATIONS; ENVIRONMENT; COMPONENTS	MBI9915 is an introgression cotton line with excellent fiber quality. It was obtained by advanced backcrossing and continuous inbreeding from an interspecific cross between the upland cotton (Gossypium hirsutum) cultivar CCRI36 as the recurrent parent and the sea island cotton (G. barbadense) cultivar Hai1, as the donor parent. To study the genetic effects of the introgressed chromosome segments in G. hirsutum, an F-2 secondary segregating population of 1537 individuals was created by crossing MBI9915 and CCRI36, and an F-2:3 population was created by randomly selecting 347 individuals from the F-2 generation. Quantitative trait locus (QTL) mapping and interaction for fiber length and strength were identified using IciMapping software. The genotype analysis showed that the recovery rate for MBI9915 was 97.9%, with a total 6 heterozygous segments and 13 homozygous segments. A total of 18 QTLs for fiber quality and 6 QTLs for yield related traits were detected using the two segregating generations. These QTLs were distributed across 7 chromosomes and collectively explained 0.81%-9.51% of the observed phenotypic variations. Six QTLs were consistently detected in two generations and 6 QTLs were identified in previous studies. A total of 13 pairs of interaction for fiber length and 13 pairs of interaction for fiber strength were identified in two generations. Among them, 3 pairs of interaction for fiber length and 3 pairs of interaction for fiber strength could be identified in all generations; 4 pairs of interactions affected fiber length and fiber strength simultaneously. The results clearly showed that 5 chromosome segments (Seg-5-1, Seg-7-1, Seg-8-1, Seg-20-2 and Seg-20-3) have important effects on fiber yield and quality. This study provides the useful information for gene cloning and marker-assisted breeding for excellent fiber related quality.	[Song, Weiwu; Su, Wei; Lu, Quanwei; Xiao, Xianghui; Cai, Juan; Zhang, Zhen; Li, Shaoqi; Li, Pengtao; Gong, Juwu; Gong, Wankui; Shang, Haihong; Liu, Aiying; Li, Junwen; Chen, Tingting; Ge, Qun; Shi, Yuzhen; Yuan, Youlu] Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, State Key Lab Cotton Biol,Key Lab Biol & Genet Br, Anyang, Henan, Peoples R China; [Song, Weiwu; Cai, Juan] Enshi Acad Agr Sci, Enshi, Hubei, Peoples R China; [Wang, Mi] Yangtze Univ, Coll Agr, Jingzhou, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Yangtze University	Shi, YZ; Yuan, YL (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, State Key Lab Cotton Biol,Key Lab Biol & Genet Br, Anyang, Henan, Peoples R China.	shiyzmb@126.com; yylcri@126.com	Gǒng, Wànkuí/AAL-5622-2020	Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31101188]; National Key R & D Program for Crop Breeding [2016YFD0100300]; National Agricultural Science and technology innovation project for CAAS;  [161016201733]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R & D Program for Crop Breeding; National Agricultural Science and technology innovation project for CAAS; 	The "study design, data collection and analysis of the manuscript" were done in 2013 and 2014, and were funded by the National Natural Science Foundation of China (31101188) (Years of support: 2012.01-2014.12); the "decision to publish, or preparation of the manuscript" were funded by National Key R & D Program for Crop Breeding (2016YFD0100300) (Years of support: 2016.06-2020.12) and the National Agricultural Science and technology innovation project for CAAS and the project of Director (161016201733) (Years of support: 2017.01-2017.12).	Cao ZB, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0393-3; Clement JD, 2012, FIELD CROP RES, V128, P1, DOI 10.1016/j.fcr.2011.12.002; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; Fang XM, 2017, THEOR APPL GENET, V130, P795, DOI 10.1007/s00122-017-2852-1; Guo LX, GENETIC ANAL FIBER Q; [贺道华 He Daohua], 2004, [棉花学报, Cotton Science], V16, P131; He R, 2014, EVALUATION IDENTIFYI, pS562; HUANG Z, 2003, GENETICS BREEDING CO; Jamshed M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2560-2; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Li AH, 2013, MOL BREEDING, V32, P1, DOI 10.1007/s11032-012-9807-7; Li BT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157978; Li M, 2011, THEOR APPL GENET, V123, P411, DOI 10.1007/s00122-011-1593-9; Liang Yan, 2010, Molecular Plant Breeding, V8, P221; Liao CY, 2001, THEOR APPL GENET, V103, P104, DOI 10.1007/s001220000528; [林忠旭 LIN Zhong-xu], 2009, [中国农业科学, Scientia Agricultura Sinica], V42, P3036; Liu DX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2605-6; Liu JY, 2000, ACTA BOT SIN, V42, P991; Liu SB, 2006, THEOR APPL GENET, V112, P1360, DOI 10.1007/s00122-006-0238-x; Liu TM, 2009, THEOR APPL GENET, V118, P1509, DOI 10.1007/s00122-009-0999-0; Luan M, 2009, PLANT BREEDING, V128, P671, DOI 10.1111/j.1439-0523.2009.01650.x; Ma LJ, EVALUATION QTL IDENT; [马麒 Ma Qi], 2014, [广东农业科学, Guangdong Agricultural Sciences], V41, P138; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2003, THEOR APPL GENET, V106, P384, DOI 10.1007/s00122-002-1025-y; Qian N., 2009, GENETIC DIVERSITY AS; REINISCH AJ, 1994, GENETICS, V138, P829; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Shi YZ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3128-x; Shi YZ, 2015, J INTEGR PLANT BIOL, V57, P450, DOI 10.1111/jipb.12288; Smith CW, 1997, CROP SCI, V37, P1775, DOI 10.2135/cropsci1997.0011183X003700060019x; Stelly DM, 2005, CROP SCI, V45, P2663, DOI 10.2135/cropsci2004.0642; Szalma SJ, 2007, THEOR APPL GENET, V114, P1211, DOI 10.1007/s00122-007-0512-6; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; Ujiie K, 2012, EUPHYTICA, V187, P325, DOI 10.1007/s10681-012-0660-x; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Wang FR, 2013, MOL BREEDING, V32, P547, DOI 10.1007/s11032-013-9888-y; Wang HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130742; Wang JK, 2006, GENET RES, V88, P93, DOI 10.1017/S0016672306008408; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; Wu Mao-Qing, 2003, Acta Genetica Sinica, V30, P443; Yang XL, 2015, EUPHYTICA, V201, P215, DOI 10.1007/s10681-014-1194-1; Zhai HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159101; Zhang J, 2000, COTTON SCI, V12, P267, DOI DOI 10.3969/J.ISSN.1002-7807.2000.05.012; [张金凤 Zhang Jinfeng], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P773; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhang ZS, 2011, THEOR APPL GENET, V123, P1075, DOI 10.1007/s00122-011-1649-x; Zhu WY, 2009, PLANT MOL BIOL REP, V27, P126, DOI 10.1007/s11105-008-0054-3; Zhu YaJuan, 2010, Acta Agronomica Sinica, V36, P1318, DOI 10.3724/SP.J.1006.2010.01318; 王鹏, 2008, [科学通报, Chinese Science Bulletin], V53, P1065	52	17	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184882	10.1371/journal.pone.0184882	http://dx.doi.org/10.1371/journal.pone.0184882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931074	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700040
J	Liu, Y; Chen, YY; Gong, Q; Lai, JS; Du, J; Deng, XC				Liu, Ya; Chen, Yeyu; Gong, Quan; Lai, Jiansheng; Du, Jun; Deng, Xiaochuan			Paternity assignment in the polyploid Acipenser dabryanus based on a novel microsatellite marker system	PLOS ONE			English	Article							YANGTZE-RIVER; SIBSHIP INFERENCE; GENETIC-STRUCTURE; STURGEON; EVOLUTION; TRANSCRIPTOME; PARENTAGE; PROGRAM; IDENTIFICATION; RELATEDNESS	Acipenser dabryanus is listed as a Critical Endangered species in the IUCN Red List and the first class protected animals in China. Fortunately, A. dabryanus specimens are being successfully bred in captivity for conservation. However, for effective ex situ conservation, we should be aware of the genetic diversity and the degree of relatedness of the individuals selected for breeding. In this study, we aimed at the development of novel and reliable microsatellites used for the genetic study of A. dabryanus. A total of 14,321 simple sequence repeats (SSRs) were detected by transcriptome sequencing and screening. We selected 20 novel and polymorphic microsatellites (non-dinucleotide) with good repeatability from the 100 tested loci for a subsequent genetic and paternity study. A set of captive broodstock (F1 stock, n = 43) and their offspring (F2 stock, n = 96) were used to examine the efficiency of the 20 SSRs for assigning parentage to offspring, with an allocation success of 91.7%. We also found that only a few families predominantly contributed to the progeny produced by the 43 breeders. In addition, mitochondrial DNA data showed that the captive broodstock (F1 individuals) had an excellent probability of the same lineage, implying that a high level of inbreeding may have occurred in these individuals. Our research provides useful information on genetic diversity and reproductive pattern of A. dabryanus, and the 20 SSRs developed in this study can be applied to the future breeding program to avoid inbreeding for this stock or other related species of Acipenseriformes.	[Liu, Ya; Chen, Yeyu; Gong, Quan; Lai, Jiansheng; Du, Jun; Deng, Xiaochuan] Sichuan Acad Agr Sci, Fishery Inst, Chengdu, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS)	Du, J; Deng, XC (corresponding author), Sichuan Acad Agr Sci, Fishery Inst, Chengdu, Sichuan, Peoples R China.	dujun9100@126.com; dxcddd@163.com			Project of Development of Microsatellite Derived; Acipenser dabryanus and its Application in Paternity Test [2017QNJJ-012]; Project of Screening of Sex linked Markers and Sex Determination Gene for Acipenser dabryanus Based on Transcriptome Sequencing Technology [2017QNJJ-013]; Project of Provincial 13th Five Years' Animal Breeding of Sichuan Province [2016NYZ0047]	Project of Development of Microsatellite Derived; Acipenser dabryanus and its Application in Paternity Test; Project of Screening of Sex linked Markers and Sex Determination Gene for Acipenser dabryanus Based on Transcriptome Sequencing Technology; Project of Provincial 13th Five Years' Animal Breeding of Sichuan Province	This work was supported by grants from the Project of Development of Microsatellite Derived from Acipenser dabryanus and its Application in Paternity Test (NO. 2017QNJJ-012, recipient: YL), the Project of Screening of Sex linked Markers and Sex Determination Gene for Acipenser dabryanus Based on Transcriptome Sequencing Technology (NO. 2017QNJJ-013, recipient: YYC) and the Project of Provincial 13th Five Years' Animal Breeding of Sichuan Province (NO. #2016NYZ0047, recipient: JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Honkola O, 2009, J EVOLUTION BIOL, V22, P1396, DOI 10.1111/j.1420-9101.2009.01765.x; [Anonymous], 2004, AQUACULTURE, V232, P165; BIRSTEIN VJ, 1993, CYTOMETRY, V14, P377, DOI 10.1002/cyto.990140406; BIRSTEIN VJ, 1987, GENETICA, V72, P3, DOI 10.1007/BF00126973; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P127, DOI 10.1023/A:1007366100353; Blonk RJW, 2009, AQUACULTURE, V289, P26, DOI 10.1016/j.aquaculture.2009.01.012; Buteler MI, 2002, J AM SOC HORTIC SCI, V127, P392, DOI 10.21273/JASHS.127.3.392; Chen YD, 2016, PHYSIOL GENOMICS, V48, P464, DOI 10.1152/physiolgenomics.00113.2015; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Congiu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018249; Du H, 2014, J APPL ICHTHYOL, V30, P1445, DOI 10.1111/jai.12591; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Fontana F, 2008, GENETICA, V132, P281, DOI 10.1007/s10709-007-9171-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hanson TR, 2008, MOL ECOL, V17, P2060, DOI 10.1111/j.1365-294X.2008.03726.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Leus K., 2013, ZOOL MIDDLE EAST, V54, P151; LI J, 2015, BOUND VALUE PRO 0110; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; Na-Nakorn U, 2010, AQUACULTURE, V306, P57, DOI 10.1016/j.aquaculture.2010.05.022; Porta J, 2006, AQUACULTURE, V251, P46, DOI 10.1016/j.aquaculture.2005.05.019; Postolache D, 2014, PLANT MOL BIOL REP, V32, P750, DOI 10.1007/s11105-013-0688-7; Que Y F, 2014, J GENET, V93, P1; Rajkov J, 2014, J HERED, V105, P521, DOI 10.1093/jhered/esu027; RASSMANN K, 1991, ELECTROPHORESIS, V12, P113, DOI 10.1002/elps.1150120205; Roques S, 2016, CONSERV GENET RESOUR, V8, P313, DOI 10.1007/s12686-016-0538-7; Rozen S., 1999, PRIMER3 WWW GEN USER; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tiffin P, 2002, J MOL EVOL, V54, P746, DOI 10.1007/s0023901-0074-1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Trippel EA, 2009, AQUACULTURE, V296, P27, DOI 10.1016/j.aquaculture.2009.08.002; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Wang JL, 2014, MOL ECOL RESOUR, V14, P541, DOI 10.1111/1755-0998.12210; Wang S., 1998, CHINA RED DATA BOOK; Wu JM, 2014, J APPL ICHTHYOL, V30, P1423, DOI 10.1111/jai.12597; Yue HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127332; Zeng Q, 2013, J APPL ICHTHYOL, V29, P1219, DOI 10.1111/jai.12278; Zhang H, 2011, J APPL ICHTHYOL, V27, P181, DOI 10.1111/j.1439-0426.2011.01674.x; Zhang SH, 2013, CONSERV GENET RESOUR, V5, P409, DOI 10.1007/s12686-012-9815-2; Zhang Si-Ming, 1999, Acta Zoologica Sinica, V45, P200; Zhao N, 2015, J APPL ICHTHYOL, V31, P614, DOI 10.1111/jai.12698; Zhuang P, 1997, ENVIRON BIOL FISH, V48, P257, DOI 10.1023/A:1007399729080	46	5	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185280	10.1371/journal.pone.0185280	http://dx.doi.org/10.1371/journal.pone.0185280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953941	gold, Green Published, Green Submitted			2022-12-26	WOS:000411980300051
J	Luo, T; Chen, H; Kassab, GS				Luo, Tong; Chen, Huan; Kassab, Ghassan S.			Resliced image space construction for coronary artery collagen fibers	PLOS ONE			English	Article							ELASTIN FIBERS; ARCHITECTURE	Collagen fibers play an important role in the biomechanics of the blood vessel wall. The objective of this study was to determine the 3D microstructure of collagen fibers in the media and adventitia of coronary arteries. We present a novel optimal angle consistence algorithm to reform image slices in the visualization and analysis of 3D collagen images. 3D geometry was reconstructed from resliced image space where the 3D skeleton was extracted as the primary feature for accurate reconstruction of geometrical parameters. Collagen fibers (range 80-200) were reconstructed from the porcine coronary artery wall for the measurement of various morphological parameters. Collagen waviness and diameters were 1.37 +/- 0.19 degrees and 2.61 +/- 0.89 mu m, respectively. The biaxial distributions of orientation had two different peaks at 110.7 +/- 25.2 degrees and 18.4 +/- 19.3 degrees. Results for width, waviness, and orientation were found to be in good agreement with manual measurements. In addition to accurately measuring 2D features more efficiently than the manual approach, the present method produced 3D features that could not be measured in the 2D manual approach. These additional parameters included the tilt angle (5.10 +/- 2.95 degrees) and cross-sectional area (CSA; 5.98 +/- 3.79 mu m(2)) of collagen fibers. These 3D collagen reconstructions provide accurate and reliable microstructure for biomechanical modeling of vessel wall mechanics.	[Luo, Tong; Chen, Huan; Kassab, Ghassan S.] Calif Med Innovat Inst, San Diego, CA 92121 USA		Kassab, GS (corresponding author), Calif Med Innovat Inst, San Diego, CA 92121 USA.	gkassab@calmi2.org			Micro-Mechanical Role of Hypertension in Intimal Hyperplasia [NIH/R01-HL117990-04]	Micro-Mechanical Role of Hypertension in Intimal Hyperplasia	This work was supported by Micro-Mechanical Role of Hypertension in Intimal Hyperplasia, http://grantome.com/grant/NIH/R01-HL117990-04, G.K.	ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141, DOI 10.1016/0735-1097(93)90429-5; Almutairi Y, 2016, P IEEE C COMP VIS PA; AZUMA T, 1971, JPN J PHYSIOL, V21, P27; B&AELIG;rentzen JA, 2001, IMPLEMENTATION FAST; Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626; Belongie S., 2017, RODRIGUES ROTATION F; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; BURTON AC, 1951, J APPL PHYSIOL, V4, P329, DOI 10.1152/jappl.1951.4.5.329; Chen H, 2013, J APPL PHYSIOL, V115, P1683, DOI 10.1152/japplphysiol.00601.2013; Chen H, 2011, BIOPHYS J, V101, P2555, DOI 10.1016/j.bpj.2011.10.043; Feng LQ, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0049-14.2014; Hassouna MS, 2007, IEEE T PATTERN ANAL, V29, P1563, DOI 10.1109/TPAMI.2007.1154; Hu WY, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026007; Kanitsar A, 2002, P C VIS 02; Kerschnitzki M, 2013, J BONE MINER RES, V28, P1837, DOI 10.1002/jbmr.1927; Klok F., 1986, Computer-Aided Geometric Design, V3, P217, DOI 10.1016/0167-8396(86)90039-7; LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Luo T, 2017, J MICROSC-OXFORD, V265, P121, DOI 10.1111/jmi.12470; Luo T, 2016, J MICROSCOPY; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; Schriefl AJ, 2013, QUANTIFICATION COLLA; Schriefl AJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0760; Spink DC Mark, 2015, NURBS; Van Uitert R, 2007, MED PHYS, V34, P627, DOI 10.1118/1.2409238; Xu T., 2015, SCI REPORTS, V5	28	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184972	10.1371/journal.pone.0184972	http://dx.doi.org/10.1371/journal.pone.0184972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953913	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300029
J	Jiang, YY; Li, FD; Wu, JH; Shi, YY; Gong, QG				Jiang, Yiyang; Li, Fudong; Wu, Jihui; Shi, Yunyu; Gong, Qingguo			Structural insights into substrate selectivity of ribosomal RNA methyltransferase RlmCD	PLOS ONE			English	Article							PEPTIDYL-TRANSFERASE CENTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; M(5)U METHYLTRANSFERASES; STREPTOCOCCUS-PNEUMONIAE; MACROLIDE ANTIBIOTICS; EXIT TUNNEL; RLMA(II); RECOGNITION; PROTEINS	RlmCD has recently been identified as the S-adenosyl methionine (SAM)-dependent methyltransferase responsible for the formation of m U-5 at U747 and U1939 of 23S ribosomal RNA in Streptococcus pneumoniae. In this research, we determine the high-resolution crystal structures of apo-form RlmCD and its complex with SAH. Using an in-vitro methyltransferase assay, we reveal the crucial residues for its catalytic functions. Furthermore, structural comparison between RlmCD and its structural homologue RumA, which only catalyzes the m (5)U1939 in Escherichia coli, implicates that a unique long linker in the central domain of RlmCD is the key factor in determining its substrate selectivity. Its significance in the enzyme activity of RlmCD is further confirmed by in-vitro methyltransferase assay.	[Gong, Qingguo] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gong, QG (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.	qgg@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010101, XDB08030302]; Chinese National Natural Science Foundation [31270782, 91540103, 31770805, 31330018]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010101 and XDB08030302]; Chinese National Natural Science Foundation [31270782, 91540103, 31770805 and 31330018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Auxilien S, 2011, RNA, V17, P45, DOI 10.1261/rna.2323411; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Cantara William A, 2011, Nucleic Acids Res, V39, pD195, DOI 10.1093/nar/gkq1028; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Das K, 2004, P NATL ACAD SCI USA, V101, P4041, DOI 10.1073/pnas.0400189101; Desmolaize B, 2011, NUCLEIC ACIDS RES, V39, P9368, DOI 10.1093/nar/gkr626; Englander MT, 2015, P NATL ACAD SCI USA, V112, P6038, DOI 10.1073/pnas.1424712112; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grosjean H, 2007, METHOD ENZYMOL, V425, P57, DOI 10.1016/S0076-6879(07)25003-7; Gupta P, 2016, NAT CHEM BIOL, V12, P153, DOI [10.1038/NCHEMBIO.1998, 10.1038/nchembio.1998]; Gustafsson C, 1998, J BACTERIOL, V180, P359, DOI 10.1128/JB.180.2.359-365.1998; Hirata A, 2016, NUCLEIC ACIDS RES, V44, P6377, DOI 10.1093/nar/gkw561; Johansson M, 2014, CELL REP, V7, P1534, DOI 10.1016/j.celrep.2014.04.034; Kannan K, 2011, ANN NY ACAD SCI, V1241, P33, DOI 10.1111/j.1749-6632.2011.06315.x; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lebars I, 2003, EMBO J, V22, P183, DOI 10.1093/emboj/cdg022; Lebars I, 2007, J MOL BIOL, V372, P525, DOI 10.1016/j.jmb.2007.06.068; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Lee TT, 2004, STRUCTURE, V12, P397, DOI 10.1016/j.str.2004.02.009; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Sergiev PV, 2008, J MOL BIOL, V375, P291, DOI 10.1016/j.jmb.2007.10.051; Shao ZH, 2014, NUCLEIC ACIDS RES, V42, P509, DOI 10.1093/nar/gkt869; Shoji T, 2015, NUCLEIC ACIDS RES, V43, P8964, DOI 10.1093/nar/gkv609; Sothiselvam S, 2014, P NATL ACAD SCI USA, V111, P9804, DOI 10.1073/pnas.1403586111; Takaya A, 2013, ANTIMICROB AGENTS CH, V57, P3789, DOI 10.1128/AAC.00164-13; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185226	10.1371/journal.pone.0185226	http://dx.doi.org/10.1371/journal.pone.0185226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949991	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000030
J	Zhang, HL; Cao, YP; Shang, C; Lie, JK; Wang, JL; Wu, ZY; Ma, LC; Qi, TX; Fu, CX; Bai, ZT; Hu, BZ				Zhang, Hailing; Cao, Yingping; Shang, Chen; Lie, Jikai; Wang, Jianli; Wu, Zhenying; Ma, Lichao; Qi, Tianxiong; Fu, Chunxiang; Bai, Zetao; Hu, Baozhong			Genome-wide characterization of GRAS family genes in Medicago truncatula reveals their evolutionary dynamics and functional diversification	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; ARABIDOPSIS-THALIANA; GIBBERELLIN RESPONSES; EXPRESSION ANALYSIS; PHYLOGENETIC TREES; RNA-SEQ; RICE; PROTEINS; REGULATOR	The GRAS gene family is a large plant-specific family of transcription factors that are involved in diverse processes during plant development. Medicago truncatula is an ideal model plant for genetic research in legumes, and specifically for studying nodulation, which is crucial for nitrogen fixation. In this study, 59 MtGRAS genes were identified and classified into eight distinct subgroups based on phylogenetic relationships. Motifs located in the C-termini were conserved across the subgroups, while motifs in the N-termini were subfamily specific. Gene duplication was the main evolutionary force for MtGRAS expansion, especially proliferation of the LISCL subgroup. Seventeen duplicated genes showed strong effects of purifying selection and diverse expression patterns, highlighting their functional importance and diversification after duplication. Thirty MtGRAS genes, including NSP1 and NSP2, were preferentially expressed in nodules, indicating possible roles in the process of nodulation. A transcriptome study, combined with gene expression analysis under different stress conditions, suggested potential functions of MtGRAS genes in various biological pathways and stress responses. Taken together, these comprehensive analyses provide basic information for understanding the potential functions of GRAS genes, and will facilitate further discovery of MtGRAS gene functions.	[Zhang, Hailing; Hu, Baozhong] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Zhang, Hailing; Shang, Chen; Lie, Jikai; Wang, Jianli] Heilongjiang Acad Agr Sci, Pratacultural Sci Inst, Harbin, Heilongjiang, Peoples R China; [Zhang, Hailing; Cao, Yingping; Wu, Zhenying; Ma, Lichao; Qi, Tianxiong; Fu, Chunxiang; Bai, Zetao] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Key Lab Biofuels, Qingdao, Peoples R China; [Cao, Yingping; Wu, Zhenying; Ma, Lichao; Qi, Tianxiong; Fu, Chunxiang; Bai, Zetao] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao Engn Res Ctr Biomass Resources & Environm, Qingdao, Peoples R China; [Hu, Baozhong] Harbin Univ, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Harbin University	Hu, BZ (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China.; Bai, ZT (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Key Lab Biofuels, Qingdao, Peoples R China.; Bai, ZT (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao Engn Res Ctr Biomass Resources & Environm, Qingdao, Peoples R China.; Hu, BZ (corresponding author), Harbin Univ, Harbin, Heilongjiang, Peoples R China.	baizt@qibebt.ac.cn; bzhu@neau.edu.cn	wang, jian/GVS-0711-2022; FF, switchgrass/AAI-2076-2020	Wu, Zhenying/0000-0003-1859-6431; Bai, Zetao/0000-0002-5524-6193	"100-Talent Program of the Chinese Academy of Sciences" foundation; National Science Foundation for Fostering Talents in Basic Research of China [J1210069]; Postdoc Youth Elite Project in Helongjiang province [LBH-TZ1209]; National Natural Science Foundation of Shandong province in China [ZR201702170122]	"100-Talent Program of the Chinese Academy of Sciences" foundation; National Science Foundation for Fostering Talents in Basic Research of China; Postdoc Youth Elite Project in Helongjiang province; National Natural Science Foundation of Shandong province in China	The work was supported by the "100-Talent Program of the Chinese Academy of Sciences" foundation, the National Science Foundation for Fostering Talents in Basic Research of China (J1210069), Postdoc Youth Elite Project in Helongjiang province (LBH-TZ1209) and the National Natural Science Foundation of Shandong province in China (ZR201702170122). The funders have participated in decision to publish and preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aubourg S, 1999, NUCLEIC ACIDS RES, V27, P628, DOI 10.1093/nar/27.2.628; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baudin M, 2015, PLANT PHYSIOL, V169, P2761, DOI 10.1104/pp.15.01144; Bolle C, 2000, GENE DEV, V14, P1269; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Day RB, 2004, PLANT MOL BIOL, V54, P261, DOI 10.1023/B:PLAN.0000028792.72343.ee; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Fan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125833; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Fortes AM, 2015, MOLECULES, V20, P9326, DOI 10.3390/molecules20059326; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Gao MJ, 2004, PLANT MOL BIOL, V55, P417, DOI 10.1007/s11103-004-0892-9; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Grimplet J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00353; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Heo JO, 2011, P NATL ACAD SCI USA, V108, P2166, DOI 10.1073/pnas.1012215108; Hirsch S, 2009, PLANT SIGNAL BEHAV, V4, P698, DOI 10.4161/psb.4.8.9176; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang W, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0590-6; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laloum T, 2014, PLANT J, V79, P757, DOI 10.1111/tpj.12587; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu XY, 2014, PLANT MOL BIOL REP, V32, P1129, DOI 10.1007/s11105-014-0721-5; Lu JX, 2015, MOL GENET GENOMICS, V290, P303, DOI 10.1007/s00438-014-0918-1; Ma HS, 2010, J EXP BOT, V61, P4011, DOI 10.1093/jxb/erq217; Ma ZX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004519; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miwa H, 2006, MOL PLANT MICROBE IN, V19, P914, DOI 10.1094/MPMI-19-0914; Morohashi K, 2003, J BIOL CHEM, V278, P20865, DOI 10.1074/jbc.M301712200; Park HJ, 2013, INT J MOL SCI, V14, P11871, DOI 10.3390/ijms140611871; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schulze S, 2010, PLANT J, V64, P668, DOI 10.1111/j.1365-313X.2010.04359.x; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Song XM, 2014, GENOMICS, V103, P135, DOI 10.1016/j.ygeno.2013.12.004; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Sui Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-11; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Tong HN, 2009, PLANT J, V58, P803, DOI 10.1111/j.1365-313X.2009.03825.x; Torres-Galea P, 2006, MOL GENET GENOMICS, V276, P13, DOI 10.1007/s00438-006-0123-y; Torres-Galea P, 2013, PLANT PHYSIOL, V161, P291, DOI 10.1104/pp.112.206607; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Wang Y, 2016, PEERJ, V4, DOI 10.7717/peerj.2388; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Wild M, 2012, PLANT CELL, V24, P3307, DOI 10.1105/tpc.112.101428; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Xu K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0532-3; Xu W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071004; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang DP, 2012, BIOINFORMATICS, V28, P2407, DOI 10.1093/bioinformatics/bts464; Zhang L, 2016, CHIN J NAT MEDICINES, V14, P161, DOI 10.1016/S1875-5364(16)30013-9; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	70	25	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185439	10.1371/journal.pone.0185439	http://dx.doi.org/10.1371/journal.pone.0185439			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945786	Green Submitted, gold, Green Published			2022-12-26	WOS:000411645100061
J	Garcia-Alles, LF; Lesniewska, E; Root, K; Aubry, N; Pocholle, N; Mendoza, CI; Bourillot, E; Barylyuk, K; Pompon, D; Zenobi, R; Reguera, D; Truan, G				Garcia-Alles, Luis F.; Lesniewska, Eric; Root, Katharina; Aubry, Nathalie; Pocholle, Nicolas; Mendoza, Carlos I.; Bourillot, Eric; Barylyuk, Konstantin; Pompon, Denis; Zenobi, Renato; Reguera, David; Truan, Gilles			Spontaneous non-canonical assembly of CcmK hexameric components from beta-carboxysome shells of cyanobacteria	PLOS ONE			English	Article							BACTERIAL MICROCOMPARTMENT SHELLS; GAMMA-CARBONIC ANHYDRASE; STRUCTURAL INSIGHTS; PROTEIN; ORGANELLE; ENCAPSULATION; CONSTRUCTION; MECHANISMS; PRINCIPLES; ENZYME	CcmK proteins are major constituents of icosahedral shells of beta-carboxysomes, a bacterial microcompartment that plays a key role for CO2 fixation in nature. Supported by the characterization of bidimensional (2D) layers of packed CcmK hexamers in crystal and electron microscopy structures, CcmK are assumed to be the major components of icosahedral flat facets. Here, we reassessed the validity of this model by studying CcmK isoforms from Synechocystis sp. PCC6803. Native mass spectrometry studies confirmed that CcmK are hexamers in solution. Interestingly, potential pre-assembled intermediates were also detected with CcmK2. Atomic-force microscopy (AFM) imaging under quasi-physiological conditions confirmed the formation of canonical flat sheets with CcmK4. Conversely, CcmK2 formed both canonical and striped-patterned patches, while CcmK1 assembled into remarkable supra-hexameric curved honeycomb-like mosaics. Mutational studies ascribed the propensity of CcmK1 to form round assemblies to a combination of two features shared by at least one CcmK isoform in most beta-cyanobacteria: a displacement of an alpha helical portion towards the hexamer edge, where a potential phosphate binding funnel forms between packed hexamers, and the presence of a short C-terminal extension in CcmK1. All-atom molecular dynamics supported a contribution of phosphate molecules sandwiched between hexamers to bend CcmK1 assemblies. Formation of supra-hexameric curved structures could be reproduced in coarse-grained simulations, provided that adhesion forces to the support were weak. Apart from uncovering unprecedented CcmK self-assembly features, our data suggest the possibility that transitions between curved and flat assemblies, following cargo maturation, could be important for the biogenesis of beta-carboxysomes, possibly also of other BMC.	[Garcia-Alles, Luis F.; Aubry, Nathalie; Pompon, Denis; Truan, Gilles] Univ Toulouse, CNRS, INRA, LISBP,INSA, Toulouse, France; [Lesniewska, Eric; Pocholle, Nicolas; Bourillot, Eric] Univ Bourgogne Franche Comte, CNRS, UMR 6303, ICB, Dijon, France; [Root, Katharina; Barylyuk, Konstantin; Zenobi, Renato] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Mendoza, Carlos I.] Univ Barcelona, Dept Fis Mat Condensada, Barcelona, Spain; [Mendoza, Carlos I.] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City, DF, Mexico; Univ Cambridge, Dept Biochem, Cambridge, England	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Barcelona; Universidad Nacional Autonoma de Mexico; University of Cambridge	Garcia-Alles, LF; Truan, G (corresponding author), Univ Toulouse, CNRS, INRA, LISBP,INSA, Toulouse, France.	lgarciaa@insa-toulouse.fr; gilles.truan@insa-toulouse.fr	Reguera, David/L-8580-2014; Truan, Gilles/C-7044-2019; Mendoza, Carlos I/A-6576-2009; bourillot, eric/B-4081-2017; Lesniewska, Eric/B-6523-2015	Reguera, David/0000-0001-6395-6112; Truan, Gilles/0000-0002-3560-8302; bourillot, eric/0000-0002-2445-490X; Garcia-Alles, Luis/0000-0002-1141-0393; Barylyuk, Konstantin/0000-0002-3580-0345; Lesniewska, Eric/0000-0002-8027-7223	Swiss National Science Foundation (SNF) [200020_159929]; Toulouse White Biotechnology; DGAPA-UNAM; DGAPA [IN-110516]; Spanish government [FIS2015-67837-P]; Feder grants;  [ANR-15-IDEX-03 PIA2/iSite-BFC];  [ANR-15-CE09-0002-02]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Toulouse White Biotechnology; DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); DGAPA; Spanish government(Spanish GovernmentEuropean Commission); Feder grants; ; 	LFGA, NA, DP and GT work was financed in part within the CarboYeast precompetitive project by Toulouse White Biotechnology. AFM work by EL, NP and EB was founded by ANR-15-IDEX-03 PIA2/iSite-BFC, ANR-15-CE09-0002-02 and Feder grants. KR, KB and RZ acknowledge financial support for mass spectrometry studies by the Swiss National Science Foundation (SNF, grant number 200020_159929). CIM received financial support provided by DGAPA-UNAM through a Sabbatical Fellowship and by grant DGAPA IN-110516. DR acknowledges funding from the Spanish government through grant FIS2015-67837-P (MINECO/FEDER, UE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Carlos I. Mendoza (CIM) appreciates the hospitality of Prof. David Reguera (DR) and the Departament de Fisica de la Materia Condensada, Universitat de Barcelona, where part of the simulation work was carried out during a sabbatical leave. CIM also acknowledges support provided by DGAPA-UNAM through a Sabbatical Fellowship.	Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Aznar M, 2016, J PHYS CHEM B, V120, P6147, DOI 10.1021/acs.jpcb.6b02150; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Cai F, 2015, ACS SYNTH BIOL, V4, P444, DOI 10.1021/sb500226j; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Cameron JC, 2013, CELL, V155, P1131, DOI 10.1016/j.cell.2013.10.044; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078285; Choudhary SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033210; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; de Araujo C, 2014, PHOTOSYNTH RES, V121, P135, DOI 10.1007/s11120-014-0018-4; Dryden KA, 2009, PROTEIN SCI, V18, P2629, DOI 10.1002/pro.272; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Faulkner M, 2017, NANOSCALE, V9, P10662, DOI 10.1039/c7nr02524f; Forouhar Farhad, 2007, Journal of Structural and Functional Genomics, V8, P37, DOI 10.1007/s10969-007-9018-3; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Gomez-Garcia MR, 2013, J BACTERIOL, V195, P3309, DOI 10.1128/JB.00207-13; Grason GM, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4962629; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kaneko Y, 2006, J BACTERIOL, V188, P805, DOI 10.1128/JB.188.2.805-808.2006; Keeling TJ, 2014, PHOTOSYNTH RES, V121, P125, DOI 10.1007/s11120-014-9973-z; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; Lawrence AD, 2014, ACS SYNTH BIOL, V3, P454, DOI 10.1021/sb4001118; Lidmar J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.051910; Lin MT, 2014, PLANT J, V79, P1, DOI 10.1111/tpj.12536; Mahalik JP, 2016, ACS NANO, V10, P5751, DOI 10.1021/acsnano.5b07805; Mallette E, 2017, J BIOL CHEM, V292, P1197, DOI 10.1074/jbc.M116.754093; Menon BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003570; Pang A, 2014, J BIOL CHEM, V289, P22377, DOI 10.1074/jbc.M114.569285; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Perlmutter JD, 2016, ELIFE, V5, DOI 10.7554/eLife.14078; Pitts AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048360; Ponstingl H, 2000, PROTEINS, V41, P47; Quin MB, 2016, APPL MICROBIOL BIOT, V100, P9187, DOI 10.1007/s00253-016-7737-8; Rae BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043871; Roberts EW, 2012, J BACTERIOL, V194, P787, DOI 10.1128/JB.06444-11; Rojas OJ, 2002, ADSORPTION POLYELECT; Samborska B, 2012, STRUCTURE, V20, P1353, DOI 10.1016/j.str.2012.05.013; San Martin C, 2002, NAT STRUCT BIOL, V9, P756, DOI 10.1038/nsb837; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sinha S, 2014, J MOL BIOL, V426, P2328, DOI 10.1016/j.jmb.2014.04.012; Sutter M, 2017, SCIENCE, V356, P1293, DOI 10.1126/science.aan3289; Sutter M, 2016, NANO LETT, V16, P1590, DOI 10.1021/acs.nanolett.5b04259; Takenoya M, 2010, J BACTERIOL, V192, P6056, DOI 10.1128/JB.00652-10; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tomchick DR, 1998, STRUCTURE, V6, P337, DOI 10.1016/S0969-2126(98)00036-7; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Uetrecht C, 2011, NAT CHEM, V3, P126, DOI 10.1038/NCHEM.947; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Zlotnick A, 2003, VIROLOGY, V315, P269, DOI 10.1016/S0042-6822(03)00586-5	64	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185109	10.1371/journal.pone.0185109	http://dx.doi.org/10.1371/journal.pone.0185109			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934279	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900092
J	Macdonald, SE; Nolan, MJ; Harman, K; Boulton, K; Hume, DA; Tomley, FM; Stabler, RA; Blake, DP				Macdonald, Sarah E.; Nolan, Matthew J.; Harman, Kimberley; Boulton, Kay; Hume, David A.; Tomley, Fiona M.; Stabler, Richard A.; Blake, Damer P.			Effects of Eimeria tenella infection on chicken caecal microbiome diversity, exploring variation associated with severity of pathology	PLOS ONE			English	Article							ENTERITIS PREDISPOSING FACTORS; COMPETITIVE-EXCLUSION PRODUCT; IN-VITRO INHIBITION; NECROTIC ENTERITIS; ESCHERICHIA-COLI; IMMUNE-RESPONSE; GUT MICROBIOTA; AVIAN EIMERIA; BACTEROIDES; POULTRY	Eimeria species cause the intestinal disease coccidiosis, most notably in poultry. While the direct impact of coccidiosis on animal health and welfare is clear, its influence on the enteric microbiota and by-stander effects on chicken health and production remains largely unknown, with the possible exception of Clostridium perfringens (necrotic enteritis). This study evaluated the composition and structure of the caecal microbiome in the presence or absence of a defined Eimeria tenella challenge infection in Cobb500 broiler chickens using 16S rRNA amplicon sequencing. The severity of clinical coccidiosis in individual chickens was quantified by caecal lesion scoring and microbial changes associated with different lesion scores identified. Following E. tenella infection the diversity of taxa within the caecal microbiome remained largely stable. However, infection induced significant changes in the abundance of some microbial taxa. The greatest changes were detected in birds displaying severe caecal pathology; taxa belonging to the order Enterobacteriaceae were increased, while taxa from Bacillales and Lactobacillales were decreased with the changes correlated with lesion severity. Significantly different profiles were also detected in infected birds which remained asymptomatic (lesion score 0), with taxa belonging to the genera Bacteroides decreased and Lactobacillus increased. Many differential taxa from the order Clostridiales were identified, with some increasing and others decreasing in abundance in Eimeria-infected animals. The results support the view that caecal microbiome dysbiosis associated with Eimeria infection contributes to disease pathology, and could be a target for intervention to mitigate the impact of coccidiosis on poultry productivity and welfare. This work highlights that E. tenella infection has a significant impact on the abundance of some caecal bacteria with notable differences detected between lesion score categories emphasising the importance of accounting for differences in caecal lesions when investigating the relationship between E. tenella and the poultry intestinal microbiome.	[Macdonald, Sarah E.; Nolan, Matthew J.; Harman, Kimberley; Tomley, Fiona M.; Blake, Damer P.] Univ London, Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield, Herts, England; [Boulton, Kay; Hume, David A.] Univ Edinburgh, Sch Vet Studies, Roslin Inst & Royal Dick, Edinburgh, Midlothian, Scotland; [Stabler, Richard A.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England	University of London; University of London Royal Veterinary College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Macdonald, SE; Blake, DP (corresponding author), Univ London, Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield, Herts, England.	smacdonald@rvc.ac.uk; dblake@rvc.ac.uk	Tomley, Fiona/GWM-9070-2022; Hume, David/N-6702-2019	Tomley, Fiona/0000-0003-2188-8013; Stabler, Richard/0000-0002-2402-6630; Macdonald, Sarah/0000-0003-4710-0191; Blake, Damer/0000-0003-1077-2306; Hume, David/0000-0002-2615-1478	 [BB/L00478X];  [BB/L004046]; BBSRC [BB/L004046/1, BB/L00478X/1, BBS/E/D/20002173, BB/L004003/1, BBS/E/D/20320000] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20002173, BB/L00478X/1, BB/L004003/1, BBS/E/D/20320000, BB/L004046/1] Funding Source: researchfish	; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by BB/L00478X, BB/L004046. http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angelakis E, 2016, MICROB PATHOG; [Anonymous], BIOINFORMATICS; ARAKAWA A, 1981, POULTRY SCI, V60, P2203, DOI 10.3382/ps.0602203; BAMBA T, 1995, J GASTROENTEROL, V30, P45; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake DP, 2014, TRENDS PARASITOL, V30, P12, DOI 10.1016/j.pt.2013.10.003; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bolger AM, 2014, BIOINFORMATICS; Boulton K, 2017, RESISTANCE IN PRESS; Carter A, 2017, VET MICROBIOL, V199, P100, DOI 10.1016/j.vetmic.2016.12.029; Chen CY, 2012, POULTRY SCI, V91, P2139, DOI 10.3382/ps.2012-02237; Chen C-Y, 2016, J ANIMAL RES NUTR, V1; Choi KY, 2015, ASIAN AUSTRAL J ANIM, V28, P1217, DOI 10.5713/ajas.15.0026; Clark EL, 2017, TRENDS PARASITOL, V33, P231, DOI 10.1016/j.pt.2016.08.007; Clark EL, 2016, INT J PARASITOL, V46, P537, DOI 10.1016/j.ijpara.2016.05.006; Clarke L, 2014, MEAT SCI, V97, P358, DOI 10.1016/j.meatsci.2014.01.004; Cordoni G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3289-7; Dalloul RA, 2005, COMP IMMUNOL MICROB, V28, P351, DOI 10.1016/j.cimid.2005.09.001; Dalloul RA, 2003, POULTRY SCI, V82, P62, DOI 10.1093/ps/82.1.62; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giannenas I, 2012, VET PARASITOL, V188, P31, DOI 10.1016/j.vetpar.2012.02.017; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Guardia S, 2011, POULTRY SCI, V90, P1878, DOI 10.3382/ps.2010-01311; Gyorke A, 2013, PARASITE, V20, DOI 10.1051/parasite/2013052; Hessenberger S, 2016, VET PARASITOL, V229, P93, DOI 10.1016/j.vetpar.2016.10.001; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Laurent F, 2001, INFECT IMMUN, V69, P2527, DOI 10.1128/IAI.69.4.2527-2534.2001; Lei F, 2012, APPL ENVIRON MICROB, V78, P5763, DOI 10.1128/AEM.00327-12; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Lynagh GR, 2000, VET IMMUNOL IMMUNOP, V76, P89, DOI 10.1016/S0165-2427(00)00203-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martynova-Van Kley M. A., 2012, International Journal of Poultry Science, V11, P747; Mcdougald LR, 1998, POULTRY SCI, V77, P1156, DOI 10.1093/ps/77.8.1156; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McReynolds J, 2009, POULTRY SCI, V88, P2075, DOI 10.3382/ps.2009-00106; Moore RJ, 2016, AVIAN PATHOL, V45, P275, DOI 10.1080/03079457.2016.1150587; Nakamura A, 2002, POULTRY SCI, V81, P1653, DOI 10.1093/ps/81.11.1653; NAMAVAR F, 1983, INFECT IMMUN, V40, P930, DOI 10.1128/IAI.40.3.930-935.1983; Nava G. M., 2005, Animal Health Research Reviews, V6, P105, DOI 10.1079/AHR2005103; Neuwirth E., 2014, RCOLORBREWER COLORBR; Nuotio L, 2013, POULTRY SCI, V92, P250, DOI 10.3382/ps.2012-02575; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Peek HW, 2011, VET QUART, V31, P143, DOI 10.1080/01652176.2011.605247; QIN ZR, 1995, POULTRY SCI, V74, P1, DOI 10.3382/ps.0740001; Reid AJ, 2014, GENOME RES, V24, P1676, DOI 10.1101/gr.168955.113; Ritzi MM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0397-y; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; ROTSTEIN OD, 1989, INFECT IMMUN, V57, P745, DOI 10.1128/IAI.57.3.745-753.1989; RStudio, 2015, RSTUDIO INT DEV R; Rubio LA, 2015, J ANIM PHYSIOL AN N, V99, P418, DOI 10.1111/jpn.12256; Schneitz C, 2016, POULTRY SCI, V95, P1125, DOI 10.3382/ps/pew020; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Stanley D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0388-6; Stanley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104739; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Sterzo EV, 2007, BRAZ J POULTRY SCI, V9, P69, DOI 10.1590/S1516-635X2007000100010; Tierney J, 2004, VET PARASITOL, V122, P171, DOI 10.1016/j.vetpar.2004.05.001; Uyeno Y, 2015, MICROBES ENVIRON, V30, P126, DOI 10.1264/jsme2.ME14176; Vasai F, 2014, POULTRY SCI, V93, P916, DOI 10.3382/ps.2013-03497; Verbeke W, 2007, ANAL CHIM ACTA, V586, P2, DOI 10.1016/j.aca.2006.07.065; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wu SB, 2014, VET MICROBIOL, V169, P188, DOI 10.1016/j.vetmic.2014.01.007; Wu ZG, 2016, DEV COMP IMMUNOL, V63, P206, DOI 10.1016/j.dci.2016.04.016; Yoon S.-H., 2016, INT J SYSTEMATIC EVO; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zhou ZY, 2017, EXP PARASITOL, V177, P73, DOI 10.1016/j.exppara.2017.04.007	80	61	64	18	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184890	10.1371/journal.pone.0184890	http://dx.doi.org/10.1371/journal.pone.0184890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934262	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900056
J	Jardel, S; Fabien, N; Hot, A; Vukusic, S; Tebib, J; Cottin, V; Seve, P; Laville, M; Belot, A; Durieu, I; Garnier, L; Coutant, F; Reynaud, Q; Lega, JC				Jardel, Sabine; Fabien, Nicole; Hot, Arnaud; Vukusic, Sandra; Tebib, Jacques; Cottin, Vincent; Seve, Pascal; Laville, Maurice; Belot, Alexandre; Durieu, Isabelle; Garnier, Lorna; Coutant, Frederic; Reynaud, Quitterie; Lega, Jean Christophe			Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey	PLOS ONE			English	Article							CONNECTIVE-TISSUE DISEASES; CLASSIFICATION CRITERIA; SJOGRENS-SYNDROME; RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; ANTIBODIES; CONSENSUS	Objective To assess in clinical practice the frequency and diagnosis associated with the SS-B-positive/SS-A negative autoantibody profile. Methods We analyzed a one-year consecutive population of 624 patients referred by clinicians to the immunology laboratory to investigate anti-SS-A and/or anti-SS-B autoantibodies, who were detected using luminex technology. Data were analyzed for patients with isolated anti-SS-B autoantibodies. The clinical characteristics and diagnosis of connective tissue diseases (CTD) were retrieved according to the international criteria. Results Among 1173 sera positive for anti-SS-A and/or anti-SS-B autoantibodies from 624 patients, we identified 84 patients (13.5%) that had isolated anti-SS-B. Among the 75 patients positive for anti-SS-B with known clinical data, 15 were diagnosed with a CTD (20%) including 4 systemic lupus erythematosus (5%), 4 rheumatoid arthritis (5%), 2 idiopathic inflammatory myositis (3%), 1 primary Sjogren's syndrome pSS (1%), 1 systemic sclerosis (1%), 2 undefined CTD (3%), and 1 mixed CTD (1%). Among the 60 other patients, 18 had non-CTD autoimmune diseases and 42 had non-autoimmune diseases. Within the CTD population, the presence of isolated anti-SS-B was not significantly associated to characteristic indicating a specific syndrome. There was no association between diagnosis of CTD and level of anti-SS-B autoantibodies (p = 0.70). Arthralgia was the more frequent sign and encountered in 10 patients (67%), of whom 3 had arthritis. Conclusion The presence of anti-SS-B, without anti-SS-A autoantibodies using luminex technology, was not associated with CTD, especially pSS, in daily clinical practice. Our data suggests that the SS-B serological profile is not contributive for the classification criteria of pSS.	[Jardel, Sabine; Durieu, Isabelle; Reynaud, Quitterie; Lega, Jean Christophe] Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Internal & Vasc Med, Lyon, France; [Fabien, Nicole; Garnier, Lorna; Coutant, Frederic] Hosp Civils Lyon, Dept Immunol, Ctr Hosp Lyon Sud, Lyon, France; [Hot, Arnaud] Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Edouard Herriot, Dept Internal Med & Vasc Med, Lyon, France; [Vukusic, Sandra] Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Dept Neurol A, Lyon, France; [Tebib, Jacques] Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Rheumatol, Lyon, France; [Cottin, Vincent] Claude Bernard Univ Lyon 1, Natl Reference Ctr Rare Pulm Dis, Dept Resp Med, Louis Pradel Hosp,Hosp Civils Lyon,UMR 754, Lyon, France; [Seve, Pascal] Claude Bernard Univ Lyon 1, Hop Croix Rousse, Hosp Civils Lyon, Dept Internal Med, Lyon, France; [Laville, Maurice] Claude Bernard Univ Lyon 1, Dept Nephrol, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Lyon, France; [Belot, Alexandre] Claude Bernard Univ Lyon 1, Pediat Nephrol Rheumatol, Dermatol Unit, Hosp Civils Lyon,INSERM,U1111,Hop Femme Mere Enfa, Lyon, France; [Lega, Jean Christophe] Claude Bernard Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Jardel, S (corresponding author), Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Internal & Vasc Med, Lyon, France.	sabinejardel@gmail.com	Belot, Alexandre/C-7378-2013; GARNIER, Lorna/ACB-8668-2022; Coutant, Frederic/J-6336-2019; Mainbourg, Sabine/V-1225-2019	Belot, Alexandre/0000-0003-4902-5332; Coutant, Frederic/0000-0003-2485-5284; Mainbourg, Sabine/0000-0003-4564-2931				Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Baer AN, 2015, ANN RHEUM DIS, V74, P1557, DOI 10.1136/annrheumdis-2014-206683; Cavazzana I, 2001, CLIN EXP RHEUMATOL, V19, P403; Davis JM, 2005, MEDICINE, V84, P208, DOI 10.1097/01.md.0000173181.87969.eb; Fauchais AL, 2010, AUTOIMMUN REV, V9, P595, DOI 10.1016/j.autrev.2010.05.004; Hoogendijk JE, 2003, 119 ENMC INT WORKSH, P337; Infantino M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/978202; Keech Catherine L., 1996, P789, DOI 10.1016/B978-044482383-0/50121-7; LOPEZLONGO FJ, 1994, J RHEUMATOL, V21, P1450; Mosca M, 1999, CLIN EXP RHEUMATOL, V17, P615; Peene I, 2002, ANN RHEUM DIS, V61, P1090, DOI 10.1136/ard.61.12.1090; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Quartuccio L, 2014, J AUTOIMMUN, V51, P75, DOI 10.1016/j.jaut.2013.10.002; Sharp GC, 1987, MIXED CONNECTIVE TIS, P23; Shiboski CH, 2017, ARTHRITIS RHEUMATOL, V69, P35, DOI 10.1002/art.39859; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; VENABLES PJW, 1989, CLIN EXP RHEUMATOL, V7, P181; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185104	10.1371/journal.pone.0185104	http://dx.doi.org/10.1371/journal.pone.0185104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931060	gold, Green Submitted, Green Published			2022-12-26	WOS:000411314700069
J	Price, SJ; Wadia, A; Wright, ON; Leung, WTM; Cunningham, AA; Lawson, B				Price, Stephen J.; Wadia, Alexandra; Wright, Owen N.; Leung, William T. M.; Cunningham, Andrew A.; Lawson, Becki			Screening of a long-term sample set reveals two Ranavirus lineages in British herpetofauna	PLOS ONE			English	Article							VIRUS 3-LIKE RANAVIRUS; MAJOR CAPSID PROTEIN; WORLD ORGANIZATION; SEQUENCE-ANALYSIS; ANIMAL HEALTH; IRIDOVIRUS; AMPHIBIANS; BULLFROGS; INFECTION; MORTALITY	Reports of severe disease outbreaks in amphibian communities in mainland Europe due to strains of the common midwife toad virus (CMTV)-like clade of Ranavirus are increasing and have created concern due to their considerable population impacts. In Great Britain, viruses in another clade of Ranavirus-frog virus 3 (FV3)-like-have caused marked declines of common frog (Rana temporaria) populations following likely recent virus introductions. The British public has been reporting mortality incidents to a citizen science project since 1992, with carcasses submitted for post-mortem examination, resulting in a long-term tissue archive spanning 25 years. We screened this archive for ranavirus (458 individuals from 228 incidents) using molecular methods and undertook preliminary genotyping of the ranaviruses detected. In total, ranavirus was detected in 90 individuals from 41 incidents focused in the north and south of England. The majority of detections involved common frogs (90%) but also another anuran, a caudate and a reptile. Most incidents were associated with FV3-like viruses but two, separated by 300 km and 16 years, involved CMTV-like viruses. These British CMTV-like viruses were more closely related to ranaviruses from mainland Europe than to each other and were estimated to have diverged at least 458 years ago. This evidence of a CMTV-like virus in Great Britain in 1995 represents the earliest confirmed case of a CMTV associated with amphibians and raises important questions about the history of ranavirus in Great Britain and the epidemiology of CMTV-like viruses. Despite biases present in the opportunistic sample used, this study also demonstrates the role of citizen science projects in generating resources for research and the value of maintaining long-term wildlife tissue archives.	[Price, Stephen J.] UCL Genet Inst, Gower St, London, England; [Price, Stephen J.; Wadia, Alexandra; Wright, Owen N.; Leung, William T. M.; Cunningham, Andrew A.; Lawson, Becki] ZSL, Inst Zool, Regents Pk, London, England; [Wadia, Alexandra] Univ York, York, N Yorkshire, England; [Wright, Owen N.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	University of London; University College London; University of York - UK; Cardiff University	Price, SJ (corresponding author), UCL Genet Inst, Gower St, London, England.; Price, SJ (corresponding author), ZSL, Inst Zool, Regents Pk, London, England.	s.price@ucl.ac.uk	Price, Stephen J./Q-1535-2019	Price, Stephen J./0000-0001-6983-6250; Wright, Owen/0000-0001-8983-4674; lawson, becki/0000-0003-1706-7140	Natural Environment Research Council [NE/M000338/1, NE/M000591/1, NE/M00080X/1]; European Research Council [260801-BIG-IDEA]; Department for Environment, Food Rural Affairs; Welsh Government through the Animal Plant & Health Agency's Diseases of Wildlife Scheme [ED 1600]; Esmee Fairbairn Foundation; Universities Federation for Animal Welfare; NERC [NE/M000338/1, NE/M000591/1, NE/M00080X/1]; ERC [260801-BIG-IDEA]; Defra	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Department for Environment, Food Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Welsh Government through the Animal Plant & Health Agency's Diseases of Wildlife Scheme; Esmee Fairbairn Foundation; Universities Federation for Animal Welfare; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC(European Research Council (ERC)European Commission); Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by Natural Environment Research Council (http://www.nerc.ac.uk) grants NE/M000338/1, NE/M000591/1 & NE/M00080X/1, and European Research Council (https://erc.europa.eu) grant 260801-BIG-IDEA. The Garden Wildlife Health project was funded by Department for Environment, Food & Rural Affairs (http://www.defra.gov.uk) and the Welsh Government through the Animal Plant & Health Agency's Diseases of Wildlife Scheme (Project ED 1600) within their Scanning Surveillance Programme; the Esmee Fairbairn Foundation (http://esmeefairbairn.org.uk/) and the Universities Federation for Animal Welfare (http://www.ufavf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NERC grants NE/M000338/1, NE/M000591/1 & NE/M00080X/1 and ERC grant 260801-BIG-IDEA. The Garden Wildlife Health project was funded by Defra (http://www.defra.gov.uk) and the Welsh Government through the Animal Plant & Health Agency's Diseases of Wildlife Scheme (Project ED 1600) within their Scanning Surveillance Programme; the Esmee Fairbairn Foundation (http://esmeefairbairn.org.uk/) and the Universities Federation for Animal Welfare (http://www.ufaw.org.uk).	Ariel E, 2009, DIS AQUAT ORGAN, V85, P7, DOI 10.3354/dao02060; Balseiro A, 2009, DIS AQUAT ORGAN, V84, P95, DOI 10.3354/dao02032; Black Y, 2017, J WILDLIFE DIS, V53, P509, DOI 10.7589/2016-08-176; Chen ZY, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-101; Cunningham A. A., 2001, INVESTIGATIONS MASS; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; Dong WZ, 2011, EMERG INFECT DIS, V17, P2388, DOI 10.3201/eid1712.101758; Duffus A. L. J., 2013, Herpetological Review, V44, P260; Duffus A. L. J., 2015, RANAVIRUSES LETHAL P, P9, DOI DOI 10.1007/978-3-319-13755-1; Duffus ALJ, 2017, J EMERG DIS VIROL, V3; Duffus Amanda L. J., 2014, Herpetological Review, V45, P608; Duffus ALJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00074.1; Duffus ALJ, 2013, J WILDLIFE DIS, V49, P464, DOI 10.7589/2012-05-147; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Griekspoor A, 2015, 4PEAKS; Holopainen R, 2009, DIS AQUAT ORGAN, V85, P81, DOI 10.3354/dao02074; Holopainen R, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01295-16; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyatt AD, 2000, ARCH VIROL, V145, P301, DOI 10.1007/s007050050025; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lawson B, 2015, ECOHEALTH, V12, P693, DOI 10.1007/s10393-015-1054-z; Leung WTM, 2017, J VIROL METHODS; Mao JH, 1997, VIROLOGY, V229, P212, DOI 10.1006/viro.1996.8435; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 1999, ARCH VIROL, V144, P1909, DOI 10.1007/s007050050714; Mavian C, 2012, J VIROL, V86, P11413, DOI 10.1128/JVI.01967-12; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Miaud C, 2016, J WILDLIFE DIS, V52, P242, DOI 10.7589/2015-05-113; North AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127037; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price SJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0952; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; R Core Team, 2021, R LANGUAGE ENV STAT; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rijks JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157473; Rosa GM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43260; Schloegel LM, 2010, DIS AQUAT ORGAN, V92, P101, DOI 10.3354/dao02140; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Sharifian-Fard M, 2011, EMERG INFECT DIS, V17, P2371, DOI 10.3201/eid1712.110236; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stohr AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118633; Tapiovaara H, 1998, DIS AQUAT ORGAN, V32, P185, DOI 10.3354/dao032185; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; UK Data Service Census Support, 2015, UK DAT SERV CENS SUP; Une Y, 2009, EMERG INFECT DIS, V15, P1146, DOI 10.3201/eid1507.081636; van Beurden SJ, 2014, GENOME ANNOUNC, V2; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027	50	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184768	10.1371/journal.pone.0184768	http://dx.doi.org/10.1371/journal.pone.0184768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931029	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700035
J	Randhawa, AK; Parikh, JS; Kuk, JL				Randhawa, Arshdeep K.; Parikh, Jash S.; Kuk, Jennifer L.			Trends in medication use by body mass index and age between 1988 and 2012 in the United States	PLOS ONE			English	Article							DISEASE RISK-FACTORS; OBESITY PARADOX; DEPRESSION; ADULTS; PRESCRIPTION	Objective Whether the increase in prescription medication use over time differs by age and obesity status is unclear. Method National Health and Nutrition Examination Survey (NHANES) between 1988 and 2012 was analyzed (n = 57,543). Findings Increased medication use over time was seen in older individuals of all body mass index (BMI) classes, with the most prominent increase in those with obesity (p<0.001). For example, older men (>= 65y) with obesity took 3.1 more medications between 1988 and 2012 versus 1.5 for normal weight older men. There were minimal differences in medication use over time in younger individuals. In men, the odds of taking antihypertensives, lipid-lowering medication, antidiabetics, and antidepressants increased with age, time and BMI wherein the association between age and medication use was magnified over time (age*time, p<0.05). In women, older women with overweight or obesity had a greater increase in the likelihood of antihypertensives and antidiabetics medication over time (BMI*time, p>0.05). Conclusion Older individuals of all BMI classes may be driving the increase in medication use over time. However, the rise in the likelihood of taking cardiometabolic medications over time was generally not different between those with or without obesity in men with some increases seen in older women. Further research may be required to assess accessibility and barriers to medication use among certain demographics.	[Randhawa, Arshdeep K.; Parikh, Jash S.; Kuk, Jennifer L.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada	York University - Canada	Kuk, JL (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.	jennkuk@yorku.ca			Canadian Institute of Health Research [131594]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research -#131594, http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PREVENTION C DC DIAG; Bennett W, 2011, COMPARATIVE EFFECTIV, P1; Carney RM, 2003, BIOL PSYCHIAT, V54, P241, DOI 10.1016/S0006-3223(03)00111-2; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; CDC National Center for Health Statistics, 2016, MEAS OUTP ANT PRESCR; Center for Disease Control and Prevention, 2016, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 2012, NAT CTR HLTH STAT DA; Chang J, 2016, J RES PHARM PRACT, V5, P149, DOI 10.4103/2279-042X.185706; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ehrt U, 2006, INT J GERIATR PSYCH, V21, P252, DOI 10.1002/gps.1456; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Gu Q, 2014, NCHS DATA BRIEF, P1; Gu Q, 2007, NCHS DATA BRIEF, V2010, P1, DOI DOI 10.1037/E665492010-001); Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kit BK, 2012, ANN EPIDEMIOL, V22, P112, DOI 10.1016/j.annepidem.2011.10.010; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Molenaar EA, 2008, DIABETES CARE, V31, P1367, DOI 10.2337/dc07-2413; Murphy SL, 2013, NATL VITAL STAT REP, P61; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wee CC, 2005, AM J PUBLIC HEALTH, V95, P159, DOI 10.2105/AJPH.2003.027946	28	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184089	10.1371/journal.pone.0184089	http://dx.doi.org/10.1371/journal.pone.0184089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931017	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700015
J	Jinnelov, A; Ali, L; Tinti, M; Guether, MLS; Ferguson, MAJ				Jinnelov, Anders; Ali, Liaqat; Tinti, Michele; Guether, Maria Lucia S.; Ferguson, Michael A. J.			Single-subunit oligosaccharyltransferases of Trypanosoma brucei display different and predictable peptide acceptor specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein biosynthesis; N-linked glycosylation; oligosaccharyltransferase; parasitology; Trypanosoma brucei; STT3; glycoproteomics; machine learning	VARIANT SURFACE GLYCOPROTEIN; LIFE-CYCLE STAGES; ASPARAGINE-LINKED OLIGOSACCHARIDES; N-GLYCOSYLATION; STRUCTURAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; ANTIGENIC VARIATION; MEMBRANE ANCHOR; PROTEIN; REVEALS	Trypanosoma brucei causes African trypanosomiasis and contains three full-length oligosaccharyltransferase (OST) genes; two of which, TbSTT3A and TbSTT3B, are expressed in the bloodstream form of the parasite. These OSTs have different peptide acceptor and lipid-linked oligosaccharide donor specificities, and trypanosomes do not follow many of the canonical rules developed for other eukaryotic N-glycosylation pathways, raising questions as to the basic architecture and detailed function of trypanosome OSTs. Here, we show by blue-native gel electrophoresis and stable isotope labeling in cell culture proteomics that the TbSTT3A and TbSTT3B proteins associate with each other in large complexes that contain no other detectable protein subunits. We probed the peptide acceptor specificities of the OSTs in vivo using a transgenic glycoprotein reporter system and performed glycoproteomics on endogenous parasite glycoproteins using sequential endoglycosidase H and peptide:N-glycosidase-F digestions. This allowed us to assess the relative occupancies of numerous N-glycosylation sites by endoglycosidase H-resistant N-glycans originating from Man(5)GlcNAc(2)-PP-dolichol transferred by TbSTT3A, and endoglycosidase H-sensitive N-glycans originating from Man(9)GlcNAc(2)-PP-dolichol transferred by TbSTT3B. Using machine learning, we assessed the features that best define TbSTT3A and TbSTT3B substrates in vivo and built an algorithm to predict the types of N-glycan most likely to predominate at all the putative N-glycosylation sites in the parasite proteome. Finally, molecular modeling was used to suggest why TbSTT3A has a distinct preference for sequons containing and/or flanked by acidic amino acid residues. Together, these studies provide insights into how a highly divergent eukaryote has re-wired protein N-glycosylation to provide protein sequence-specific N-glycan modifications. Data are available via ProteomeXchange with identifiers PXD007236, PXD007267, and PXD007268.	[Jinnelov, Anders; Ali, Liaqat; Tinti, Michele; Guether, Maria Lucia S.; Ferguson, Michael A. J.] Univ Dundee, Sch Life Sci, Wellcome Ctr Antiinfect Res, Dundee DD1 5EH, Scotland	University of Dundee	Ferguson, MAJ (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Ctr Antiinfect Res, Dundee DD1 5EH, Scotland.	m.a.j.ferguson@dundee.ac.uk		Tinti, Michele/0000-0002-0051-017X; Ferguson, Michael/0000-0003-1321-8714	Wellcome Trust [101842/Z13/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Wellcome Trust Investigator Award 101842/Z13/Z (to M. A. J. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Acosta-Serrano A, 1999, J BIOL CHEM, V274, P29763, DOI 10.1074/jbc.274.42.29763; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Allison H, 2014, MICROB CELL, V1, P325, DOI 10.15698/mic2014.10.170; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; Bandini G, 2012, MOL MICROBIOL, V85, P513, DOI 10.1111/j.1365-2958.2012.08124.x; BANGS JD, 1988, J BIOL CHEM, V263, P17697; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Boehm CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006063; Brandes N, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw133; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Castillo-Acosta VM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005851; Castillo-Acosta VM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003612; Castillo-Acosta VM, 2013, MOL MICROBIOL, V90, P665, DOI 10.1111/mmi.12359; Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Choi BK, 2012, APPL MICROBIOL BIOT, V95, P671, DOI 10.1007/s00253-012-4067-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damerow M, 2016, J BIOL CHEM, V291, P13834, DOI 10.1074/jbc.M116.733246; Damerow M, 2014, J BIOL CHEM, V289, P9328, DOI 10.1074/jbc.M114.555029; DEALMEIDA MLC, 1983, NATURE, V302, P349, DOI 10.1038/302349a0; Engstler M, 2005, J CELL SCI, V118, P2105, DOI 10.1242/jcs.02327; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Guther MLS, 2009, EUKARYOT CELL, V8, P1407, DOI 10.1128/EC.00178-09; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Izquierdo L, 2012, GLYCOBIOLOGY, V22, P696, DOI 10.1093/glycob/cws003; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Izquierdo L, 2009, EUKARYOT CELL, V8, P230, DOI 10.1128/EC.00361-08; Jackson AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002121; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; Kalb LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31212; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lingnau A, 1999, J CELL SCI, V112, P3061; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Maishman L, 2016, NUCLEIC ACIDS RES, V44, P10554, DOI 10.1093/nar/gkw751; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; Mehlert A, 2010, MOL BIOCHEM PARASIT, V174, P74, DOI 10.1016/j.molbiopara.2010.06.007; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Nagamune K, 2003, P NATL ACAD SCI USA, V100, P10682, DOI 10.1073/pnas.1833260100; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poljak K, 2017, J BIOL CHEM, V292, P20342, DOI 10.1074/jbc.M117.811133; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Schwede A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005259; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Steverding Dietmar, 2000, Parasitology International, V48, P191, DOI 10.1016/S1383-5769(99)00018-5; Tiengwe C, 2016, CELL MICROBIOL, V18, P1673, DOI 10.1111/cmi.12605; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Yan AX, 2005, P NATL ACAD SCI USA, V102, P7121, DOI 10.1073/pnas.0502669102; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	74	10	11	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20328	20341		10.1074/jbc.M117.810945	http://dx.doi.org/10.1074/jbc.M117.810945			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28928222	Green Published, hybrid			2022-12-26	WOS:000417696400035
J	Boonkasidecha, S; Kannan, PS; Kallapur, SG; Jobe, AH; Kemp, MW				Boonkasidecha, Suppawat; Kannan, Paranthaman Senthamarai; Kallapur, Suhas G.; Jobe, Alan H.; Kemp, Matthew W.			Fetal skin as a pro-inflammatory organ: Evidence from a primate model of chorioamnionitis	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; PRETERM LAMBS; EPIDERMAL-KERATINOCYTES; INTRAAMNIOTIC ENDOTOXIN; OVINE SKIN; LIPOPOLYSACCHARIDE; IL-1-BETA; RESPONSES; EXPOSURE	Background Intrauterine infection is a primary cause of preterm birth and fetal injury. The pro-inflammatory role of the fetal skin in the setting of intrauterine infection remains poorly characterized. Whether or not inflammation of the fetal skin occurs in primates remains unstudied. Accordingly, we hypothesized that: i) the fetal primate skin would mount a pro-inflammatory response to preterm birth associated pro-inflammatory agents (lipopolysaccharides from Escherichia coli, live Ureaplasma parvum, interleukin-1 beta) and; ii) that inhibiting interleukin-1 signaling would decrease the skin inflammatory response. Methods Rhesus macaques with singleton pregnancies received intraamniotic injections of either sterile saline (control) or one of three pro-inflammatory agonists: E. coli lipopolysaccharides, interluekin-1 beta or live U. parvum under ultrasound guidance. A fourth group of animals received both E. coli lipopolysaccharide and interleukin-1 signaling inhibitor interleukin-1 receptor antagonist (Anakinra) prior to delivery. Animals were surgically delivered at approximately 130 days' gestational age. Results Intraamniotic lipopolysaccharide caused an inflammatory skin response characterized by increases in interluekin-1 beta,-6 and -8 mRNA at 16 hours. There was a modest inflammatory response to U. parvum, but interleukin-1 beta alone caused no inflammatory response in the fetal skin. Intraamniotic Anakinra treatment of lipopolysaccharide-exposed animals significantly reduced skin inflammation. Conclusions Intraamniotic lipopolysaccharide and U. parvum were associated with modest increases in the expression of inflammatory mediators in primate fetal skin. Although administration of Interleukin-1 beta alone did not elicit an inflammatory response, lipopolysaccharide-driven skin inflammation was decreased following intraamniotic Anakinra therapy. These findings provide support for the role of the fetal skin in the development of the fetal inflammatory response.	[Boonkasidecha, Suppawat; Kannan, Paranthaman Senthamarai; Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH USA; [Boonkasidecha, Suppawat] Rangsit Univ, Div Neonatol, Dept Pediat, Queen Sirikit Natl Inst Child Hlth,Coll Med, Bangkok, Thailand; [Kallapur, Suhas G.; Jobe, Alan H.; Kemp, Matthew W.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Kemp, Matthew W.] Tohoku Univ Hosp, Ctr Perinatal & Neonatal Med, Sendai, Miyagi, Japan	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Rangsit University; University of Western Australia; Tohoku University	Kemp, MW (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia.; Kemp, MW (corresponding author), Tohoku Univ Hosp, Ctr Perinatal & Neonatal Med, Sendai, Miyagi, Japan.	matthew.kemp@uwa.edu.au	Senthamaraikannan, Paranthaman/H-3992-2018	Senthamaraikannan, Paranthaman/0000-0002-3333-3720				Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; Dimes P, 2012, SAVE CHILDREN WHO BO; ENK AH, 1993, J IMMUNOL, V150, P3698; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; GROVES RW, 1994, AM J PATHOL, V145, P1048; Jobe AH, 2000, AM J OBSTET GYNECOL, V182, P401, DOI 10.1016/S0002-9378(00)70231-6; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC; Kemp MW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00574; Kemp MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063355; Kemp MW, 2011, REPROD SCI, V18, P1128, DOI 10.1177/1933719111408114; Kemp MW, 2011, REPROD SCI, V18, P88, DOI 10.1177/1933719110380470; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; KRISTENSEN M, 1992, BRIT J DERMATOL, V127, P305, DOI 10.1111/j.1365-2133.1992.tb00446.x; Miller Lloyd S, 2008, Adv Dermatol, V24, P71; MIZUTANI H, 1991, J CLIN INVEST, V87, P1066, DOI 10.1172/JCI115067; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Senthamaraikannan P, 2016, J INFECT DIS, V214, P1597, DOI 10.1093/infdis/jiw408; Sugita K, 2007, CLIN EXP IMMUNOL, V147, P176, DOI 10.1111/j.1365-2249.2006.03258.x; Terui T, 1998, EXP DERMATOL, V7, P327, DOI 10.1111/j.1600-0625.1998.tb00332.x; Thaxton J. E., 2010, INFECT DIS OBSTET GY, V2010; Visscher M, 2014, ADV WOUND CARE, V3, P291, DOI 10.1089/wound.2013.0467; Wolfs TGAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018355; Zhang L, 2012, REPROD SCI, V19, P1181, DOI 10.1177/1933719112446079	28	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184938	10.1371/journal.pone.0184938	http://dx.doi.org/10.1371/journal.pone.0184938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957335	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200024
J	Falardeau, J; Johnson, RP; Pagotto, F; Wang, SY				Falardeau, Justin; Johnson, Roger P.; Pagotto, Franco; Wang, Siyun			Occurrence, characterization, and potential predictors of verotoxigenic Escherichia coli, Listeria monocytogenes, and Salmonella in surface water used for produce irrigation in the Lower Mainland of British Columbia, Canada	PLOS ONE			English	Article							VIRULENCE FACTORS; FRUIT; PREVALENCE; PATHOGENS; SPP.; OUTBREAK; RIVER; PCR; TRANSMISSION; DIVERSITY	Produce has become a major source of foodborne illness, and may become contaminated through surface water irrigation. The objectives of this study were to (i) determine the frequency of verotoxigenic E. coli (VTEC), Listeria monocytogenes, and Salmonella in surface waters used for irrigation in the Lower Mainland of British Columbia, (ii) assess the suitability of fecal coliforms and generic E. coli as hygiene indicators, and (iii) investigate the correlations of environmental factors with pathogen occurrence. Water samples were collected semi-monthly for 18 months from seven irrigation ditches across the Serpentine and Sumas watersheds. VTEC colonies on water filters were detected using a verotoxin colony immunoblot, and the presence of virulence genes vt1 and vt2 was ascertained via multiplex PCR. Detection of L. monocytogenes and Salmonella was completed using standard, Health Canada Compendium of Analytical Methods. Fecal coliforms and generic E. coli were enumerated by 3M (TM) Petrifilm (TM) and filtration methods, and meteorological and geographic data were collected from government records. VTEC, L. monocytogenes, and Salmonella were detected in 4.93%, 10.3%, and 2.69% of 223 samples, respectively. L. monocytogenes occurrence was greatest in the Serpentine watershed (x(2); p < 0.05), and was most common during the winter and fall (Fisher exact test; p < 0.05). Site dependence of VTEC and Salmonella occurrence was observed within watersheds (Fisher's exact test; p < 0.10). Pathogen occurrence correlated with fecal coliform counts (r = 0.448), while VTEC occurrence also correlated with precipitation over the five days before sampling (r = 0.239). The density of upstream livestock correlated with VTEC (r(s) = 0.812), and L. monocytogenes (r(s) = 0.841) detection. These data show that foodborne pathogens are present in the waters used for irrigation in the Lower Mainland of British Columbia, but their frequency may depend on spatial and temporal factors.	[Falardeau, Justin; Wang, Siyun] Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada; [Johnson, Roger P.] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Pagotto, Franco] Hlth Canada, Bur Microbial Hazards, Listeriosis Reference Serv, Ottawa, ON, Canada	University of British Columbia; Public Health Agency of Canada; Health Canada	Wang, SY (corresponding author), Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada.	siyun.wang@ubc.ca		Wang, Siyun/0000-0003-2468-2483				Angell K, 2021, EUR J POLIT THEORY, V20, P95, DOI 10.1177/1474885117741748; Angelo K. M., 2014, MMWR-MORBID MORTAL W, V64, P144; BC Centre for Disease Control, 2017, REP DIS DASHB; Benjamin L, 2013, INT J FOOD MICROBIOL, V165, P65, DOI 10.1016/j.ijfoodmicro.2013.04.003; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Bidol S. A., 2007, Morbidity and Mortality Weekly Report, V56, P909; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Budzinska K, 2012, POL J ENVIRON STUD, V21, P31; CanAgPlus, 2015, CANADAGAP FOOD SAF M; CDC, 2016, MULTISTATE OUTBREAK; Centers for Disease Control and Prevention (CDC), 2016, MULT OUTBR SALM POON; Chapin TK, 2014, J FOOD PROTECT, V77, P1919, DOI 10.4315/0362-028X.JFP-14-132; Chen Y, 2017, J CLIN MICROBIOL, V55, P931, DOI 10.1128/JCM.02140-16; Constantiniu S, 2002, J PREV MED, V10, P57; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00030; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Edge TA, 2012, J ENVIRON QUAL, V41, P21, DOI 10.2134/jeq2010.0253; Ewing W.H., 1986, EDWARDS EWINGS IDENT; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Fisher N, 2015, OUTBREAK ALERT 2015; Gannon VPJ, 2004, J TOXICOL ENV HEAL A, V67, P1643, DOI 10.1080/15287390490492421; Gazal S, 2014, INDIAN J MED MICROBI, V32, P57, DOI 10.4103/0255-0857.124308; Government of British Columbia. B. C, GOOD AGR PRACT GUID; Gu GY, 2013, CAN J MICROBIOL, V59, P339, DOI 10.1139/cjm-2013-0027; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; Honish L, 2001, Can Commun Dis Rep, V27, P151; Johnson JYM, 2003, CAN J MICROBIOL, V49, P326, DOI [10.1139/w03-046, 10.1139/W03-046]; Johnson RP, 2014, APPL ENVIRON MICROB, V80, P2166, DOI 10.1128/AEM.03391-13; Jokinen CC, 2012, J ENVIRON QUAL, V41, P242, DOI 10.2134/jeq2011.0203; Jokinen CC, 2010, J WATER HEALTH, V8, P374, DOI 10.2166/wh.2009.076; Jones LA, 2014, APPL ENVIRON MICROB, V80, P4814, DOI 10.1128/AEM.01012-14; Karama M, 2008, J CLIN MICROBIOL, V46, P3569, DOI 10.1128/JCM.01095-08; King LA, 2012, CLIN INFECT DIS, V54, P1588, DOI 10.1093/cid/cis255; Kozak GK, 2013, J FOOD PROTECT, V76, P173, DOI 10.4315/0362-028X.JFP-12-126; Lyautey E, 2007, CAN J MICROBIOL, V53, P1158, DOI 10.1139/W07-084; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; MARIANIKURKDJIAN P, 1993, J CLIN MICROBIOL, V31, P296, DOI 10.1128/JCM.31.2.296-301.1993; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; McLauchlin J, 2004, INT J FOOD MICROBIOL, V92, P15, DOI 10.1016/S0168-1605(03)00326-X; Muraoka R, 2007, JPN J INFECT DIS, V60, P410; Myers DN, US GEOLOGICAL SURVEY; Nadya S, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00036; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; OSHEA ML, 1992, CAN J MICROBIOL, V38, P267, DOI 10.1139/m92-045; Pachepsky Y, 2016, CRIT REV MICROBIOL, V42, P384, DOI 10.3109/1040841X.2014.954524; Pachepsky Y, 2011, ADV AGRON, V113, P73, DOI 10.1016/B978-0-12-386473-4.00007-5; Pagotto F, 2011, COMPENDIUM ANAL METH, V2; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Prager R, 2002, INFECT GENET EVOL, V1, P265, DOI 10.1016/S1567-1348(02)00032-1; Public Health Agency of Canada, 2016, PUBL HLTH NOT UPD OU; Public Health Agency of Canada, 2015, EX SUMM NAT ENT SURV; PulseNet International, 2013, STAND OP PROC PULSEN; Reid A., 2009, COMPENDIUM ANAL METH, V2; Sanchez S, 2014, EPIDEMIOL INFECT, V142, P1029, DOI 10.1017/S0950268813001842; SHIPP CR, 1980, J CLIN PATHOL, V33, P595, DOI 10.1136/jcp.33.6.595; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Steele M, 2004, J FOOD PROTECT, V67, P2839, DOI 10.4315/0362-028X-67.12.2839; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P588, DOI 10.1128/AEM.02491-12; Thomas M Kate, 2006, Can J Infect Dis Med Microbiol, V17, P229; US Food and Drug Administration, 2017, FSMA FIN RUL PROD SA; Uyttendaele M, 2015, COMPR REV FOOD SCI F, V14, P336, DOI 10.1111/1541-4337.12133; Vivant AL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00087; Wang X, 2013, CAN J INFECT DIS MED, V24, P102; World Health Organization, OUTBR E COL O104 H4; Ziebell KA, 2002, RES MICROBIOL, V153, P289, DOI 10.1016/S0923-2508(02)01322-0	70	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185437	10.1371/journal.pone.0185437	http://dx.doi.org/10.1371/journal.pone.0185437			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953937	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300067
J	Kwiatkowski, SC; Guerrero, PA; Hirota, S; Chen, ZH; Morales, JE; Aghi, M; McCarty, JH				Kwiatkowski, Sam C.; Guerrero, Paola A.; Hirota, Shinya; Chen, Zhihua; Morales, John E.; Aghi, Manish; McCarty, Joseph H.			Neuropilin-1 modulates TGF beta signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy	PLOS ONE			English	Article							ALPHA-V-BETA-8 INTEGRIN; MESENCHYMAL TRANSITION; VASCULAR MORPHOGENESIS; ANTIANGIOGENIC THERAPY; CELL INVASION; VEGF THERAPY; BRAIN-TUMORS; HUMAN GLIOMA; RECEPTOR; CANCER	Glioblastoma (GBM) is a rapidly progressive brain cancer that exploits the neural microenvironment, and particularly blood vessels, for selective growth and survival. Anti-angiogenic agents such as the vascular endothelial growth factor-A (VEGF-A) blocking antibody bevacizumab yield short-term benefits to patients due to blood vessel regression and stabilization of vascular permeability. However, tumor recurrence is common, and this is associated with acquired resistance to bevacizumab. The mechanisms that drive acquired resistance and tumor recurrence in response to anti-angiogenic therapy remain largely unknown. Here, we report that Neuropilin-1 (Nrp1) regulates GBM growth and invasion by balancing tumor cell responses to VEGF-A and transforming growth factor beta s (TGF beta s). Nrp1 is expressed in GBM cells where it promotes TGF beta receptor internalization and signaling via Smad transcription factors. GBM that recur after bevacizumab treatment show down-regulation of Nrp1 expression, indicating that altering the balance between VEGF-A and TGF beta signaling is one mechanism that promotes resistance to anti-angiogenic agents. Collectively, these data reveal that Nrp1 plays a critical role in balancing responsiveness to VEGF-A versus TGF beta to regulate GBM growth, progression, and recurrence after anti-vascular therapy.	[Kwiatkowski, Sam C.; Guerrero, Paola A.; Hirota, Shinya; Chen, Zhihua; Morales, John E.; McCarty, Joseph H.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Aghi, Manish] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco	McCarty, JH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.	jhmccarty@mdanderson.org			National Institute of Neurological Disease and Stroke [R01NS087635, R01NS078402, R01NS079697]; Cancer Prevention and Research Institute of Texas [RP140411]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079697] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disease and Stroke, R01NS087635. Joseph H. McCarty, https://www.ninds.nih.gov; National Institute of Neurological Disease and Stroke, R01NS078402. Joseph H. McCarty, https://www.ninds.nih.gov; The Cancer Prevention and Research Institute of Texas, RP140411. Joseph H. McCarty, http://www.cprit.state.tx.us; National Institute of Neurological Disease and Stroke, R01NS079697. Manish Aghi, https://www.ninds.nih.gov. For the above grants, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspalter IM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8264; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Carbonell WS, 2013, CANCER RES, V73, P3145, DOI 10.1158/0008-5472.CAN-13-0011; Chaudhary B, 2014, CANCER IMMUNOL IMMUN, V63, P81, DOI 10.1007/s00262-013-1500-0; Cheng SY, 1996, P NATL ACAD SCI USA, V93, P8502, DOI 10.1073/pnas.93.16.8502; Ellis LM, 2009, NATURE, V458, P290, DOI 10.1038/458290a; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hillman RT, 2011, GENE DEV, V25, P2333, DOI 10.1101/gad.173054.111; Hirota S, 2015, DEVELOPMENT, V142, P4363, DOI 10.1242/dev.113746; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Jahangiri A, 2013, CLIN CANCER RES, V19, P1773, DOI 10.1158/1078-0432.CCR-12-1281; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; Koch S, 2014, DEV CELL, V28, P633, DOI 10.1016/j.devcel.2014.02.010; Kofler N, 2016, CURR OPIN HEMATOL, V23, P260, DOI 10.1097/MOH.0000000000000233; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matkar PN, 2016, ONCOTARGET, V7, P69489, DOI 10.18632/oncotarget.11060; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; McCarty JH, 2004, DEVELOPMENT; McCarty JH, 2013, CLIN CANCER RES, V19, P1631, DOI 10.1158/1078-0432.CCR-13-0051; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Muhl L, 2017, J CELL SCI; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Patil V, 2015, ONCOTARGET, V6, P43452, DOI 10.18632/oncotarget.6171; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piao Y, 2013, CLIN CANCER RES, V19, P4392, DOI 10.1158/1078-0432.CCR-12-1557; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Reyes SB, 2013, MOL BIOL CELL, V24, P474, DOI 10.1091/mbc.E12-07-0521; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Rizzolio S, 2012, CANCER RES, V72, P5801, DOI 10.1158/0008-5472.CAN-12-0995; Sayegh ET, 2014, MOL NEUROBIOL, V49, P1212, DOI 10.1007/s12035-013-8593-5; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Tchaicha JH, 2010, ONCOGENE, V29, P4460, DOI 10.1038/onc.2010.199; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; van Meeteren LA, 2011, CURR PHARM BIOTECHNO, V12, P2108; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Wrana JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011197; Zhu JW, 2002, DEVELOPMENT, V129, P2891	52	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							0185065	10.1371/journal.pone.0185065	http://dx.doi.org/10.1371/journal.pone.0185065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938007	Green Published, Green Submitted, gold			2022-12-26	WOS:000411524700016
J	Belkaid, M; Cuperlier, N; Gaussier, P				Belkaid, Marwen; Cuperlier, Nicolas; Gaussier, Philippe			Emotional metacontrol of attention: Top-down modulation of sensorimotor processes in a robotic visual search task	PLOS ONE			English	Article							NOVELTY; SYSTEMS; BRAIN; MODEL	Emotions play a significant role in internal regulatory processes. In this paper, we advocate four key ideas. First, novelty detection can be grounded in the sensorimotor experience and allow higher order appraisal. Second, cognitive processes, such as those involved in self-assessment, influence emotional states by eliciting affects like boredom and frustration. Third, emotional processes such as those triggered by self-assessment influence attentional processes. Last, close emotion-cognition interactions implement an efficient feedback loop for the purpose of top-down behavior regulation. The latter is what we call 'Emotional Metacontrol'. We introduce a model based on artificial neural networks. This architecture is used to control a robotic system in a visual search task. The emotional metacontrol intervenes to bias the robot visual attention during active object recognition. Through a behavioral and statistical analysis, we show that this mechanism increases the robot performance and fosters the exploratory behavior to avoid deadlocks.	[Belkaid, Marwen; Cuperlier, Nicolas; Gaussier, Philippe] Univ Cergy Pontoise, ENSEA, CNRS, Univ Paris Seine,ETIS UMR 8051, Cergy Pontoise, France	Centre National de la Recherche Scientifique (CNRS); CY Cergy Paris Universite	Belkaid, M (corresponding author), Univ Cergy Pontoise, ENSEA, CNRS, Univ Paris Seine,ETIS UMR 8051, Cergy Pontoise, France.	marwen.belkaid@ensea.fr	Cuperlier, Nicolas/AAS-2637-2020; Belkaid, Marwen/AAF-7835-2021	Cuperlier, Nicolas/0000-0001-7610-3143; Belkaid, Marwen/0000-0003-2358-2560	MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche); Centre National de la Recherche Scientifique (CNRS); ANR DIRAC [ANR-13-ASTR-0018]; Ecole Doctorale "Science et Ingenierie" of the Universite de Cergy Pontoise	MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR DIRAC(French National Research Agency (ANR)); Ecole Doctorale "Science et Ingenierie" of the Universite de Cergy Pontoise	This research was supported by the MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche), the Centre National de la Recherche Scientifique (CNRS) and the ANR DIRAC ANR-13-ASTR-0018. MB was supported by The Ecole Doctorale "Science et Ingenierie" of the Universite de Cergy Pontoise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the reviewers for their comments, A. Jauffret for his contribution in previous works on the emotional metacontrol, R. Braud, A. Karaouzene and G. Mostafaoui for their advice regarding the visual processing system, and Nils and Orianne for providing the stuffed animals used in the experiment. This work was supported by ANR DIRAC ANR-13-ASTR-0018.	Arbib MA, 2004, TRENDS COGN SCI, V8, P554, DOI 10.1016/j.tics.2004.10.004; Arnold M.B., 1960, EMOTION PERSONALITY, V2; Balcetis E, 2009, PSYCHOL SCI; Belkaid M, P IEEE INT C INT ROB; Breazeal C, 2001, IEEE T SYST MAN CY A, V31, P443, DOI 10.1109/3468.952718; Brooks R. A., 1986, IEEE J ROBOTICS AUTO, V2; Canamero L., 2005, EMOTIONAL DEV; Coello Y, 2012, COGN PROCESS, V13, pS131, DOI 10.1007/s10339-012-0470-z; Csikszentmihalyi M., 1991, FLOW PSYCHOL OPTIMAL; Ethofer T, 2009, J COGNITIVE NEUROSCI, V21, P1255, DOI 10.1162/jocn.2009.21099; Fellous J.M., 2004, HUMAN EMOTIONS ROBOT, P39; Frings C, 2010, Q J EXP PSYCHOL, V63, P42, DOI 10.1080/17470210903156594; Gaussier P, 2004, LECT NOTES ARTIF INT, V3139, P243; Grandjean D, 2011, COGN TECHNOL, P441, DOI 10.1007/978-3-642-15184-2_23; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Hasson C., 2011, J BEHAV ROBOTICS, V2, P111, DOI DOI 10.2478/S13230-012-0005-4; Izard CE, 2010, EMOT REV, V2, P363, DOI 10.1177/1754073910374661; Jauffret A, 2013 IEEE 3 JOINT IN; Jauffret A, 2015, FRONT NEUROROBOTICS, V9, DOI 10.3389/fnbot.2015.00001; Jauffret A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00016; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Krichmar JL, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00001; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Lewis MD, 2005, BEHAV BRAIN SCI, V28, P169, DOI 10.1017/S0140525X0500004X; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Lones J, 2014 IEEE 4 JOINT IN; Lowe R, ROLE EMOTION ADAPTIV; Lowe R, 2007, LECT NOTES ARTIF INT, V4840, P1; Marsland S., 2003, NEURAL COMPUTING SUR, V3, P157; McGaugh JL, 2015, ANNU REV PSYCHOL, V66, P1, DOI 10.1146/annurev-psych-010814-014954; Morgado L, FLAIRS C, P245; Morgado L, 2007, LECT NOTES ARTIF INT, V4840, P59; Ognibene D, 2015, IEEE T AUTON MENT DE, V7, P3, DOI 10.1109/TAMD.2014.2341351; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ortony A., 1988, COGNITIVE STRUCTURE; Pessoa Luiz, 2010, Dialogues Clin Neurosci, V12, P433; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Scherer K.R., 2001, APPRAISAL PROCESSES, p92?120; SCHMIDHUBER J, 1991, IEEE IJCNN, P1458, DOI 10.1109/IJCNN.1991.170605; Tajadura-Jimenez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026083; Valdes-Conroy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049162; Wendt J, 2011, BIOL PSYCHOL, V86, P203, DOI 10.1016/j.biopsycho.2010.11.009; Widrow B, 1960, IRE WESCON, DOI DOI 10.21236/AD0241531; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	45	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184960	10.1371/journal.pone.0184960	http://dx.doi.org/10.1371/journal.pone.0184960			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934291	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900066
J	Benabid, M; Ghrab, J; Rhim, A; Ben-Romdhane, R; Aoun, K; Bouratbine, A				Benabid, Meriem; Ghrab, Jamila; Rhim, Adel; Ben-romdhane, Rania; Aoun, Karim; Bouratbine, Aida			Temporal dynamics and Leishmania infantum infection prevalence of Phlebotomus perniciosus (Diptera, Phlebotominae) in highly endemic areas of visceral leishmaniasis in Tunisia	PLOS ONE			English	Article							BLOOD FEEDING PREFERENCES; TIME PCR ASSAY; MITOCHONDRIAL INTROGRESSION; CANINE LEISHMANIASIS; VECTORS; PSYCHODIDAE; FOCUS; REGION; DNA; IDENTIFICATION	Phlebotomus perniciosus is one of the major vectors of Leishmania infantum in the Mediterranean basin. The aim of this work was (i) to provide information about abundance and temporal dynamics of this Larroussius species in a hot spot area of visceral leishmaniasis in Tunisia, (ii) to detect L. infantum DNA in wild caught female sandflies and (iii) to measure Phlebotomus perniciosus infection rate throughout the active season. Sandflies were collected monthly during one year using CDC miniature light-traps in house and in animal shelters. Male specimens were identified at species level according to morphological characters. Female specimens were conserved individually for molecular study. Leishmania infection was tested by kinetoplast DNA real-time PCR and ITS-1 PCR-sequencing. Subsequent sandfly species identification of infected specimens was done by mitochondrial cytochrome b sequencing. In one year period, overall 4,441 specimens (2230 males and 2211 females) were collected. Sandfly activity started in end-April and ended in early-November. Mean sandfly density in house was significantly lower than in animal shelters (51 +/- 50 versus 504 +/- 460 sandflies/CDC night, p<0.05). However, a higher proportion of females was found in house (58.4% versus 49.2%, p<0.001). Based on species identification of male specimens, Phlebotomus perniciosus was the dominant species (56% of the whole male sandfly fauna, p<0.0001). It showed two peaks of density in the active season, a sharp one in early May and a higher long lasting one from end-July to end-September. DNA was extracted from 190 female specimens randomly sampled and corresponding to 96 specimens from house and 94 from animal shelters. Twenty four female sandfly were infected by Leishmania infantum. All infected specimens were recognized as Phlebotomus perniciosus. Leishmania infantum infection rate in female sandflies was 2.3 fold higher in house than in animal shelters (17.7% versus 7.4%, p<0.05). In house, estimated number of infected specimens was the highest at the end of the active season. Abundance, dynamics of density and Leishmania infantum infection prevalence of Phlebotomus perniciosus in Tunisian hot spot of visceral leishmaniasis highlight the major role of this Phlebotominae species in L. infantum transmission.	[Benabid, Meriem; Ghrab, Jamila; Rhim, Adel; Ben-romdhane, Rania; Aoun, Karim; Bouratbine, Aida] Univ Tunis El Manar, Pasteur Inst Tunis, Dept Parasitol, Res Lab LR 11 IPT 06, Tunis, Tunisia; [Ghrab, Jamila] Univ Carthage, Higher Inst Sci & Technol Environm Borj Cedria, Dept Biotechnol, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage	Bouratbine, A (corresponding author), Univ Tunis El Manar, Pasteur Inst Tunis, Dept Parasitol, Res Lab LR 11 IPT 06, Tunis, Tunisia.	aida.bouratbine@pasteur.rns.tn			Ministry of Higher Education and Scientific Research, Tunisia in the setting of the Research Laboratory Medical Parasitology, Biotechnologies and Biomolecules (PMBB), Institut Pasteur of Tunis, Tunisia [LR11-IPT06]	Ministry of Higher Education and Scientific Research, Tunisia in the setting of the Research Laboratory Medical Parasitology, Biotechnologies and Biomolecules (PMBB), Institut Pasteur of Tunis, Tunisia	This study was supported by the Ministry of Higher Education and Scientific Research, Tunisia in the setting of the Research Laboratory Medical Parasitology, Biotechnologies and Biomolecules (PMBB), Institut Pasteur of Tunis, Tunisia (LR11-IPT06). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc E., 1972, PHLEBOTOMES REGION E; Afshar AA, 2014, ASIAN PAC J TROP MED, V7, P93, DOI 10.1016/S1995-7645(14)60002-X; Alten B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004458; Amora SSA, 2009, NEOTROP ENTOMOL, V38, P303, DOI 10.1590/S1519-566X2009000300001; Aoun K, 2009, MED MALADIES INFECT, V39, P775, DOI 10.1016/j.medmal.2009.08.010; Barhoumi W, 2015, ACTA TROP, V141, P73, DOI 10.1016/j.actatropica.2014.10.008; Ben-Ahmed K, 2009, AM J TROP MED HYG, V81, P40; BETTINI S, 1986, T ROY SOC TROP MED H, V80, P458, DOI 10.1016/0035-9203(86)90344-5; Boudabous R, 2012, J MED ENTOMOL, V49, P787, DOI 10.1603/ME11110; Branco S, 2013, ACTA TROP, V125, P339, DOI 10.1016/j.actatropica.2012.12.008; Carrillo E, 2013, TRENDS PARASITOL, V29, P579, DOI 10.1016/j.pt.2013.10.007; Casanova C, 2001, MEM I OSWALDO CRUZ, V96, P273, DOI 10.1590/S0074-02762001000200023; Chargui N, 2013, J VECTOR ECOL, V38, P1, DOI 10.1111/j.1948-7134.2013.12000.x; Chelbi I, 2012, B SOC PATHOL EXOT, P1; CROSET H, 1970, Annales de Parasitologie Humaine et Comparee, V45, P863; Croset H, 1978, ANN PARASITOLOGIE HU; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dolmatova A, 1971, NA LES PHLEBOTOMES D; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; Galvez R, 2010, ACTA TROP, V115, P95, DOI 10.1016/j.actatropica.2010.02.009; Garcia N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/318254; Ghrab J, 2006, PARASITE, V13, P23, DOI 10.1051/parasite/2006131023; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Ivarez A, 2017, ACTA TROPICA; Izri M, 1990, ANN PARASITOLOGIE HU, V65, P150; Jimenez M, 2013, PARASITOL RES, V112, P2453, DOI 10.1007/s00436-013-3406-3; Karayiannis S, 2015, PARASITOLOGY, V142, P1574, DOI 10.1017/S0031182015001158; Killick-Kendrick R, 1984, B SOC PATHOLOGIE E 2, V78, P747; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lisi O, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0560-0; Maia C, 2013, MEM I OSWALDO CRUZ, V108, P481, DOI 10.1590/S0074-0276108042013014; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Morillas Marquez F., 1991, Parassitologia (Rome), V33, P437; Myskova J, 2008, J MED ENTOMOL, V45, P133, DOI 10.1603/0022-2585(2008)45[133:LISFCO]2.0.CO;2; Oliveira F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00375; Pesson B, 2004, MED VET ENTOMOL, V18, P25, DOI 10.1111/j.0269-283x.2004.0471.x; Peyrefitte CN, 2013, VECTOR-BORNE ZOONOT, V13, P630, DOI 10.1089/vbz.2012.1169; Prudhomme J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1250-2; Ranasinghe S, 2008, T ROY SOC TROP MED H, V102, P875, DOI 10.1016/j.trstmh.2008.04.003; READY PD, 1991, MEM I OSWALDO CRUZ, V86, P41, DOI 10.1590/S0074-02761991000100008; RIOUX J-A, 1967, Annales de Parasitologie Humaine et Comparee, V42, P665; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Rossi E, 2008, ACTA TROP, V105, P158, DOI 10.1016/j.actatropica.2007.10.005; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Talbi FZ, 2015, PATHOLOGY RES INT, V2015; Testa JM, 2002, ACTA TROP, V84, P205, DOI 10.1016/S0001-706X(02)00187-0; van der Auwera G, 2015, CLIN MICROBIOL REV, V28, P265, DOI 10.1128/CMR.00104-14; Zoghami Z, 2014, ACTA TROP, V139, P32, DOI 10.1016/j.actatropica.2014.06.012	48	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184700	10.1371/journal.pone.0184700	http://dx.doi.org/10.1371/journal.pone.0184700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934263	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900040
J	Cavalcanti, AD; Meohas, W; Ribeiro, GD; Lopes, ACD; Gholamin, S; Razavi, M; Brunswick, THK; Avan, A; Guimaraes, JAM; Duarte, MEL; Kahn, SA				Cavalcanti, Amanda dos Santos; Meohas, Walter; Ribeiro, Gabriele de Oliveira; de Sa Lopes, Ana Cristina; Gholamin, Sharareh; Razavi, Mostafa; Kasai Brunswick, Tais Hanae; Avan, Amir; Matheus Guimaraes, Joao Antonio; Leite Duarte, Maria Eugenia; Kahn, Suzana Assad			Patient-derived osteosarcoma cells are resistant to methotrexate	PLOS ONE			English	Article							CANCER-STEM-CELLS; SARCOMA; METASTASIS	Osteosarcoma is the most common primary bone tumor in children and young adults. The median survival of osteosarcoma patients has not significantly improved since 1990, despite administration of different classes of chemotherapy agents, such as methotrexate, cisplatin and doxorubicin. Cancer stem cells (CSCs) are responsible for the resistance of osteosarcoma to chemotherapy and OCT4, SOX2 and SSEA4 have been used to identify CSCs in osteosarcoma. Here, we used low-passage patient-derived osteosarcoma cells and osteosarcoma cells directly isolated from patients before and after chemotherapy treatments to evaluate the effects of chemotherapy on stem cell markers expression. We demonstrate that primary osteosarcoma cells are resistant to methotrexate treatment and sensitive to cisplatin and doxorubicin in vitro. We also verified that cisplatin and doxorubicin reduce the expression of SOX2 and OCT4 in primary osteosarcoma cells whereas methotrexate does not alter SOX2 and OCT4 expression, however it increases SSEA4 expression in primary osteosarcoma cells. Finally, we found that, although the combination treatment cisplatin plus doxorubicin inhibited the in vivo growth of osteosarcoma cells in NOD-SCID gamma mice subcutaneously injected with SaOs2, the combination treatment cisplatin plus doxorubicin plus methotrexate did not inhibit the in vivo growth of these cells. These observations may provide an explanation for the poor response of osteosarcomas to chemotherapy and point to the need of reevaluating the therapeutic strategies for human osteosarcomas.	[Cavalcanti, Amanda dos Santos; Meohas, Walter; Ribeiro, Gabriele de Oliveira; de Sa Lopes, Ana Cristina; Matheus Guimaraes, Joao Antonio; Leite Duarte, Maria Eugenia; Kahn, Suzana Assad] Natl Inst Traumatol & Orthopaed, Res Div, Rio De Janeiro, RJ, Brazil; [Gholamin, Sharareh; Razavi, Mostafa; Kahn, Suzana Assad] Stanford Univ, Stanford Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kasai Brunswick, Tais Hanae] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, RJ, Brazil; [Kasai Brunswick, Tais Hanae] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil; [Avan, Amir] Mashhad Univ Med Sci, Sch Med, Dept Modern Sci & Technol, Mol Med Grp, Mashhad, Iran	Stanford University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Mashhad University Medical Science	Kahn, SA (corresponding author), Natl Inst Traumatol & Orthopaed, Res Div, Rio De Janeiro, RJ, Brazil.; Kahn, SA (corresponding author), Stanford Univ, Stanford Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	kahns@stanford.edu	Kasai-Brunswick, Tais Hanae/AAK-9905-2020	Gholamin, Sharareh/0000-0001-7425-6074; Razavi, Seyed-Mostafa/0000-0003-0812-6540; Cavalcanti, Amanda/0000-0002-8792-7524; Kasai-Brunswick, Tais Hanae/0000-0002-6361-5980; naseri, shahrokh/0000-0001-8974-2120	Pew Charitable Trusts; PEW Latin American Fellowship	Pew Charitable Trusts; PEW Latin American Fellowship	This study was supported by the Pew Charitable Trusts.; The authors thank Caetano Altafin and the PEW Latin American Fellowship (SAK) for the financial support and Vivaldo Moura-Neto for the intellectual contribution.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Assad K. S., 2016, MOL MED, V8, P511, DOI [10.15252/emmm.20150542127138566, DOI 10.15252/EMMM, DOI 10.15252/EMMM.201505421]; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Choong PF, 2014, INT J MED SCI, V11, P1154, DOI 10.7150/ijms.8281; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Creusot RJ, 2008, CLIN IMMUNOL, V127, P176, DOI 10.1016/j.clim.2007.12.009; Depau L, 2017, ONCOTARGET; Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667; Fujii H, 2009, INT J ONCOL, V34, P1381, DOI 10.3892/ijo_00000265; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Guo W, 1999, CLIN CANCER RES, V5, P621; Harris MB, 1998, J CLIN ONCOL, V16, P3641, DOI 10.1200/JCO.1998.16.11.3641; He AN, 2015, J CELL BIOCHEM, V116, P1719, DOI 10.1002/jcb.25131; Kahn SA, 2012, CURR TOP MED CHEM, V12, P2082; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Pautke C, 2004, ANTICANCER RES, V24, P3743; Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Siclari VA, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-78; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang Y, 2016, EXP THER MED, V12, P81, DOI 10.3892/etm.2016.3303; Yang CL, 2014, INT J MOL SCI, V15, P423, DOI 10.3390/ijms15010423; Zhang HX, 2013, STEM CELLS, V31, P433, DOI 10.1002/stem.1298; Zhang WG, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/765362	36	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184891	10.1371/journal.pone.0184891	http://dx.doi.org/10.1371/journal.pone.0184891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934267	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900057
J	Dimitropoulos, K; Barmpoutis, P; Zioga, C; Kamas, A; Patsiaoura, K; Grammalidis, N				Dimitropoulos, Kosmas; Barmpoutis, Panagiotis; Zioga, Christina; Kamas, Athanasios; Patsiaoura, Kalliopi; Grammalidis, Nikos			Grading of invasive breast carcinoma through Grassmannian VLAD encoding	PLOS ONE			English	Article							TEXTURE CLASSIFICATION; IMAGE-ANALYSIS; CANCER; DIAGNOSIS; ALGORITHMS	In this paper we address the problem of automated grading of invasive breast carcinoma through the encoding of histological images as VLAD (Vector of Locally Aggregated Descriptors) representations on the Grassmann manifold. The proposed method considers each image as a set of multidimensional spatially-evolving signals that can be efficiently modeled through a higher-order linear dynamical systems analysis. Subsequently, each H&E (Hematoxylin and Eosin) stained breast cancer histological image is represented as a cloud of points on the Grassmann manifold, while a vector representation approach is applied aiming to aggregate the Grassmannian points based on a locality criterion on the manifold. To evaluate the efficiency of the proposed methodology, two datasets with different characteristics were used. More specifically, we created a new medium-sized dataset consisting of 300 annotated images (collected from 21 patients) of grades 1, 2 and 3, while we also provide experimental results using a large dataset, namely BreaKHis, containing 7,909 breast cancer histological images, collected from 82 patients, of both benign and malignant cases. Experimental results have shown that the proposed method outperforms a number of state of the art approaches providing average classification rates of 95.8% and 91.38% with our dataset and the BreaKHis dataset, respectively.	[Dimitropoulos, Kosmas; Barmpoutis, Panagiotis; Grammalidis, Nikos] Ctr Res & Technol Hellas, Informat Technol Inst, Thessaloniki, Greece; [Zioga, Christina; Kamas, Athanasios; Patsiaoura, Kalliopi] Agios Pavlos Gen Hosp, Dept Pathol, Thessaloniki, Greece	Centre for Research & Technology Hellas	Grammalidis, N (corresponding author), Ctr Res & Technol Hellas, Informat Technol Inst, Thessaloniki, Greece.	ngramm@iti.gr	Grammalidis, Nikos/U-9411-2019	Grammalidis, Nikos/0000-0001-8465-6258; Dimitropoulos, Kosmas/0000-0003-1584-7047				Arfken G, 1985, GRAM SCHMIDT ORTHOGO, P516; Axelrod DE, 2008, CANCER INFORM, V6, P99; Coelho LP, 2010, LECT N BIOINFORMAT, V6004, P23, DOI 10.1007/978-3-642-13131-8_4; Costantini R, 2008, IEEE T IMAGE PROCESS, V17, P42, DOI 10.1109/TIP.2007.910956; Cruz-Roa A, 2014, SPIE MED IMAGING, P9041; Dimitropoulos K, INT C COMP VIS THEOR; Dimitropoulos K, IEEE T CIRCUITS SYST; Dimitropoulos K, 2017, IEEE T CIRC SYST VID, V27, P1143, DOI 10.1109/TCSVT.2016.2527340; Dimitropoulos K, 2017, SIGNAL IMAGE VIDEO P, V11, P145, DOI 10.1007/s11760-016-0913-6; Dimitropoulos K, 2015, IEEE T CIRC SYST VID, V25, P339, DOI 10.1109/TCSVT.2014.2339592; Doretto G, 2003, INT J COMPUT VISION, V51, P91, DOI 10.1023/A:1021669406132; Doyle S, IEEE INT S BIOM IM M; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filipczuk P, 2013, IEEE T MED IMAGING, V32, P2169, DOI 10.1109/TMI.2013.2275151; George YM, 2014, IEEE SYST J, V8, P949, DOI 10.1109/JSYST.2013.2279415; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hu SQ, 2015, 2015 8TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P702, DOI 10.1109/CISP.2015.7407968; Jegou H., 2010, COMPUTER VISION PATT; Kantorov V, P IEEE C COMP VIS PA; KARCHER H, 1977, COMMUN PUR APPL MATH, V30, P509, DOI 10.1002/cpa.3160300502; Komaki Kansei, 2006, Breast Cancer, V13, P249, DOI 10.2325/jbcs.13.249; Kowal M, 2013, COMPUT BIOL MED, V43, P1563, DOI 10.1016/j.compbiomed.2013.08.003; Litjens G, 2016, NATURE SCI REPORTS, V6; Martin RJ, 2000, IEEE T SIGNAL PROCES, V48, P1164, DOI 10.1109/78.827549; Michail E, 2014, IEEE ENG MED BIOL SO; Naik S, IEEE INT S BIOM IM M; Niwas SI, IEEE INT C IM SYST T; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Paramanandam M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162053; Petushi Sokol, 2006, BMC Med Imaging, V6, P14, DOI 10.1186/1471-2342-6-14; Ravichandran A, 2013, IEEE T PATTERN ANAL, V35, P342, DOI 10.1109/TPAMI.2012.83; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Rublee E., IEEE INT C COMP VIS; Siddiqi S., 2007, ADV NEURAL INFORM PR; Spanhol FA, INT JOINT C NEUR NET; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; Sudbo J, 2000, ANAL CELL PATHOL, V21, P71, DOI 10.1155/2000/389361; Tozeren A, 2007, BMC MED IMAGING, V7; Turaga P, 2011, IEEE T PATTERN ANAL, V33, P2273, DOI 10.1109/TPAMI.2011.52; VANOVERSCHEE P, 1994, AUTOMATICA, V30, P75, DOI 10.1016/0005-1098(94)90230-5; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Zamri MIP, 2016, COMPUT ELECTRON AGR, V124, P227, DOI 10.1016/j.compag.2016.04.004; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17	46	52	52	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185110	10.1371/journal.pone.0185110	http://dx.doi.org/10.1371/journal.pone.0185110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934283	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900093
J	Han, F; Zhuang, TT; Chen, JJ; Zhu, XL; Cai, YF; Lu, YP				Han, Fei; Zhuang, Ting-Ting; Chen, Jing-Jing; Zhu, Xiu-Ling; Cai, Ya-Fei; Lu, Ya-Ping			Novel derivative of Paeonol, Paeononlsilatie sodium, alleviates behavioral damage and hippocampal dendritic injury in Alzheimer's disease concurrent with cofilin1/phosphorylated-cofilin1 and RAC1/CDC42 alterations in rats	PLOS ONE			English	Article							AMYLOID CASCADE HYPOTHESIS; E/AMYLOID-BETA INTERACTION; LONG-TERM POTENTIATION; WILD-TYPE TAU; A-BETA; SYNAPTIC PLASTICITY; D-GALACTOSE; COFILIN PHOSPHORYLATION; COGNITIVE IMPAIRMENT; TRANSGENIC MICE	Alzheimer's disease (AD) is a typical hippocampal amnesia and the most common senile dementia. Many studies suggest that cognitive impairments are more closely correlated with synaptic loss than the burden of amyloid deposits in AD progression. To date, there is no effective treatment for this disease. Paeonol has been widely employed in traditional Chinese medicine. This compound improves learning behavior in an animal model; however, the mechanism remains unclear. In this study, Paeononlsilatie sodium (Pa), a derivative of Paeonol, attenuated D-galactose (D-gal) and AlCl3-induced behavioral damages in rats based on evaluations of the open field test (OFT), elevated plus maze test (EPMT), and Morris water maze test (MWMT). Pa increased the dendritic complexity and the density of dendritic spines. Correlation analysis indicated that morphological changes in neuronal dendrites are closely correlated with behavioral changes. Pa treatment reduced the production of A beta, affected the phosphorylation and redistribution of cofilin1 and inhibited rod-like formation in hippocampal neurons. The induction of D-gal and AlCl3 promoted the expression of RAC1/CDC42 expression; however, the tendency of gene expression was inhibited by pretreatment with Pa. Taken together, our results suggest that Pa may represent a novel therapeutic agent for the improvement of cognitive and emotional behaviors and dendritic morphology in an AD animal model.	[Han, Fei; Zhuang, Ting-Ting; Chen, Jing-Jing; Zhu, Xiu-Ling; Cai, Ya-Fei; Lu, Ya-Ping] Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China; [Zhu, Xiu-Ling] Wannan Med Coll, Dept Anat, Wuhu, Peoples R China	Anhui Normal University; Wannan Medical College	Lu, YP (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China.	yapinglu@ahnu.edu.cn	Cai, Yafei/S-7210-2019		National Natural Science Foundation of China [30470537]; Natural Science Foundation of Department of Education, Anhui Province [ZD2008006-1]; Innovation Team of Scientific Research Platform in Anhui Universities; Provincial Key Laboratory of Biotic Environment and Ecological Safety in Anhui	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Department of Education, Anhui Province; Innovation Team of Scientific Research Platform in Anhui Universities; Provincial Key Laboratory of Biotic Environment and Ecological Safety in Anhui	The present study was supported by National Natural Science Foundation of China (No. 30470537), Natural Science Foundation of Department of Education, Anhui Province (ZD2008006-1), Innovation Team of Scientific Research Platform in Anhui Universities, and Provincial Key Laboratory of Biotic Environment and Ecological Safety in Anhui. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Baj G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00018; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barone E, 2014, BBA-MOL BASIS DIS, V1842, P2500, DOI 10.1016/j.bbadis.2014.10.004; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Borbely E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/345305; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Bringas ME, 2013, NEUROSCIENCE, V241, P170, DOI 10.1016/j.neuroscience.2013.03.030; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Byrne KM, 2016, CELL SYST, V2, P38, DOI 10.1016/j.cels.2016.01.003; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dickstein DL, 2010, BRAIN STRUCT FUNCT, V214, P161, DOI 10.1007/s00429-010-0245-1; Ding Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154375; Du QA, 2010, CAN J PHYSIOL PHARM, V88, P1010, DOI [10.1139/Y10-077, 10.1139/y10-077]; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; EINSTEIN G, 1994, J NEUROSCI, V14, P5077; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Flores G, 2005, NEUROSCIENCE, V133, P463, DOI 10.1016/j.neuroscience.2005.02.021; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Goni F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013391; Guirado R, 2014, INT J NEUROPSYCHOPH, V17, P1635, DOI 10.1017/S1461145714000406; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Hsieh CL, 2006, J ETHNOPHARMACOL, V106, P208, DOI 10.1016/j.jep.2005.12.027; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu XY, 2003, ACTA NEUROPATHOL, V106, P213, DOI 10.1007/s00401-003-0720-3; Martinez-Tellez RI, 2009, SYNAPSE, V63, P794, DOI 10.1002/syn.20664; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jayant S, 2016, PHARMACOL BIOCHEM BE, V140, P39, DOI 10.1016/j.pbb.2015.11.006; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim S, 2015, NEUROBIOL AGING, V36, P3239, DOI 10.1016/j.neurobiolaging.2015.09.007; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Kolb B, 1998, NEUROSCI BIOBEHAV R, V22, P143, DOI 10.1016/S0149-7634(97)00008-0; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lazcano Z, 2014, SYNAPSE; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Li HY, 2017, PHYTOTHER RES, V31, P284, DOI 10.1002/ptr.5747; Li HY, 2016, J ETHNOPHARMACOL, V179, P162, DOI 10.1016/j.jep.2015.12.020; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23693; Li ZQ, 2012, J ETHNOPHARMACOL, V144, P305, DOI 10.1016/j.jep.2012.09.013; Liu JP, 2013, NEUROSCI LETT, V549, P63, DOI 10.1016/j.neulet.2013.06.002; Liu MH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00440; Liu MH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/651890; Lu YP, 2003, EXP NEUROL, V183, P482, DOI 10.1016/S0014-4886(03)00205-X; Luo Y, 2009, MECH AGEING DEV, V130, P248, DOI 10.1016/j.mad.2008.12.005; Ma QL, 2008, J BIOL CHEM, V283, P14132, DOI 10.1074/jbc.M708034200; Maiti P, 2015, NEUROSCI BIOBEHAV R, V59, P208, DOI 10.1016/j.neubiorev.2015.09.020; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MASLIAH E, 1991, NEURON, V6, P729, DOI 10.1016/0896-6273(91)90170-5; Mavroudis IA, 2011, INT J NEUROSCI, V121, P347, DOI 10.3109/00207454.2011.553753; Mendoza-Naranjo A, 2012, J ALZHEIMERS DIS, V29, P63, DOI 10.3233/JAD-2012-101575; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Paxinos G, 2007, RAT BRAIN STEREOTAXI, V6; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Sarazin M, 2007, NEUROLOGY, V69, P1859, DOI 10.1212/01.wnl.0000279336.36610.f7; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Sun ZZ, 2009, AGE, V31, P277, DOI 10.1007/s11357-009-9099-y; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tania N, 2011, BIOPHYS J, V100, P1883, DOI 10.1016/j.bpj.2011.02.036; Tao WW, 2016, PSYCHIAT RES, V238, P116, DOI 10.1016/j.psychres.2016.02.033; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tseng YT, 2012, SHOCK, V37, P312, DOI 10.1097/SHK.0b013e31823fe939; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang Y, 2013, J NEUROSCI, V33, P6423, DOI 10.1523/JNEUROSCI.5107-12.2013; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Xiao F, 2011, NEUROSCI BULL, V27, P143, DOI 10.1007/s12264-011-1028-2; Xiao Q, 2017, NEUROSCIENCE, V355, P61, DOI 10.1016/j.neuroscience.2017.04.050; Yang J, 2011, J ALZHEIMERS DIS, V24, P269, DOI 10.3233/JAD-2011-101401; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zhang Y, 2016, INT J BIOL MACROMOL, V92, P935, DOI 10.1016/j.ijbiomac.2016.08.008; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zhao Y, 2014, BRAIN RES BULL, V109, P61, DOI 10.1016/j.brainresbull.2014.09.008; Zhou J, 2011, BRAIN RES, V1388, P141, DOI 10.1016/j.brainres.2011.02.064	124	18	19	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185102	10.1371/journal.pone.0185102	http://dx.doi.org/10.1371/journal.pone.0185102			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934273	Green Published, gold, Green Submitted			2022-12-26	WOS:000411339900090
J	Ilboudo, PG; Huang, XX; Ngwira, B; Mwanyungwe, A; Mogasale, V; Mengel, MA; Cavailler, P; Gessner, BD; Le Gargasson, JB				Ilboudo, Patrick G.; Huang, Xiao Xian; Ngwira, Bagrey; Mwanyungwe, Abel; Mogasale, Vittal; Mengel, Martin A.; Cavailler, Philippe; Gessner, Bradford D.; Le Gargasson, Jean-Bernard			Cost-of-illness of cholera to households and health facilities in rural Malawi	PLOS ONE			English	Article							ENDEMIC CHOLERA; VACCINES; SURVEILLANCE; MOZAMBIQUE; EPIDEMIC; HAITI	Cholera remains an important public health problem in many low- and middle-income countries. Vaccination has been recommended as a possible intervention for the prevention and control of cholera. Evidence, especially data on disease burden, cost-of-illness, delivery costs and cost-effectiveness to support a wider use of vaccine is still weak. This study aims at estimating the cost-of-illness of cholera to households and health facilities in Machinga and Zomba Districts, Malawi. A cross-sectional study using retrospectively collected cost data was undertaken in this investigation. One hundred patients were purposefully selected for the assessment of the household cost-of-illness and four cholera treatment centres and one health facility were selected for the assessment conducted in health facilities. Data collected for the assessment in households included direct and indirect costs borne by cholera patients and their families while only direct costs were considered for the assessment conducted in health facilities. Whenever possible, descriptive and regression analysis were used to assess difference in mean costs between groups of patients. The average costs to patients' households and health facilities for treating an episode of cholera amounted to US $65.6 and US$59.7 in 2016 for households and health facilities, respectively equivalent to international dollars (I$) 249.9 and 227.5 the same year. Costs incurred in treating a cholera episode were proportional to duration of hospital stay. Moreover, 52% of households used coping strategies to compensate for direct and indirect costs imposed by the disease. Both households and health facilities could avert significant treatment expenditures through a broader use of pre-emptive cholera vaccination. These findings have direct policy implications regarding priority investments for the prevention and control of cholera.	[Ilboudo, Patrick G.] Agence Med Prevent, Abidjan, Cote Ivoire; [Huang, Xiao Xian; Le Gargasson, Jean-Bernard] Agence Med Prevent, Ferney Voltaire, France; [Ngwira, Bagrey; Mwanyungwe, Abel] Polytech, Blantyre, Malawi; [Mogasale, Vittal] Int Vaccine Inst, Seoul, South Korea; [Mengel, Martin A.; Cavailler, Philippe; Gessner, Bradford D.] Agence Med Prevent, Paris, France	Agence de Medecine Preventive; International Vaccine Institute; Agence de Medecine Preventive	Ilboudo, PG (corresponding author), Agence Med Prevent, Abidjan, Cote Ivoire.	gilboudo@aamp.org	Mogasale, Vittal/C-7853-2011; Mogasale, Vittal/HCH-7125-2022	Mogasale, Vittal/0000-0003-0596-8072	Bill and Melinda Gates Foundation [1106078]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We would like to acknowledge the financial support provided by the Bill and Melinda Gates Foundation (website: http/Amy) gatesfoundation orgtfr) through the project Cholera Targeted Investments to Answer Endemic Use Questions [grant number 1106078] awarded to MAM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; [Anonymous], 2015, WEEKLY EPIDEMIOLOGIC; Barzilay EJ, 2013, NEW ENGL J MED, V368, P599, DOI 10.1056/NEJMoa1204927; Bekolo CE, 2016, B WORLD HEALTH ORGAN, V94, P667, DOI 10.2471/BLT.15.166892; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; Clemens J, 2014, CURR TOP MICROBIOL, V379, P231, DOI 10.1007/82_2013_353; Conteh L, 2004, HEALTH POLICY PLANN, V19, P127, DOI 10.1093/heapol/czh015; Deen JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000173; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Gujral L, 2013, J INFECT DIS, V208, pS107, DOI 10.1093/infdis/jit212; IMF, 2017, **NON-TRADITIONAL**; IMF, 2016, WORLD EC OUTL SUBD D; Jefferson T., 2000, COST OF ILLNESS STUD, V2nd ed., P17; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Khonje A, 2012, MALAWI MED J, V24, P29; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-8; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Luquero FJ, 2016, EMERG INFECT DIS, V22, P410, DOI 10.3201/eid2203.141970; Malawi National Statistical Office, 2016, GEOHIVE MAL POP STAT; Mogasale V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005124; Mogasale V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004072; Nations Unies, 2015, PROJ DOC SOMM NAT UN; Poulos C, 2012, EPIDEMIOL INFECT, V140, P500, DOI 10.1017/S0950268811000513; Sack DA, 2006, J HEALTH POPUL NUTR, V24, P1; Sardar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081231; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; Schaetti C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001844; Thiem VD, 2003, J HEALTH POPUL NUTR, V21, P304; von Seidlein L, 2013, J INFECT DIS, V208, pS8, DOI 10.1093/infdis/jit194; WHO, 2016, WEEKLY EPIDEMIOLOGIC, P433; WHO, 2016, WORLD HLTH STAT 2016; World Health Organization, 2016, WHO PREQ VACC	35	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185041	10.1371/journal.pone.0185041	http://dx.doi.org/10.1371/journal.pone.0185041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934285	Green Submitted, Green Published, gold			2022-12-26	WOS:000411339900078
J	Wang, ZN; Oppegard, SC; Eddington, DT; Cheng, J				Wang, Zhinan; Oppegard, Shawn C.; Eddington, David T.; Cheng, Jun			Effect of localized hypoxia on Drosophila embryo development	PLOS ONE			English	Article							OXYGEN-UPTAKE RATE; MELANOGASTER EMBRYOS; ENGRAILED PROTEIN; METABOLIC-RATE; CELL-CULTURE; GRADIENTS; RESPONSES; DEVICE; MICROFLUIDICS; AMPLIFICATION	Environmental stress, such as oxygen deprivation, affects various cellular activities and developmental processes. In this study, we directly investigated Drosophila embryo development in vivo while cultured on a microfluidic device, which imposed an oxygen gradient on the developing embryos. The designed microfluidic device enabled both temporal and spatial control of the local oxygen gradient applied to the live embryos. Time-lapse live cell imaging was used to monitor the morphology and cellular migration patterns as embryos were placed in various geometries relative to the oxygen gradient. Results show that pole cell movement and tail retraction during Drosophila embryogenesis are highly sensitive to oxygen concentrations. Through modeling, we also estimated the oxygen permeability across the Drosophila embryonic layers for the first time using parameters measured on our oxygen control device.	[Wang, Zhinan; Oppegard, Shawn C.; Eddington, David T.; Cheng, Jun] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cheng, J (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	juncheng@uic.edu			National Science Foundation, Div Of Biological Infrastructure [1253060]; Searle Funds at The Chicago Community Trust; NSF DBI [1253060]; Chicago Biomedical Consortium from The Searle Funds at The Chicago Community Trust	National Science Foundation, Div Of Biological Infrastructure(National Science Foundation (NSF)); Searle Funds at The Chicago Community Trust; NSF DBI(National Science Foundation (NSF)); Chicago Biomedical Consortium from The Searle Funds at The Chicago Community Trust	This work was supported by the National Science Foundation, Div Of Biological Infrastructure, NO.1253060 to DE (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1253060) and the Searle Funds at The Chicago Community Trust # N/A. to JC (http:cct.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NSF DBI 1253060 and partly funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust.	BOWNES M, 1975, J EMBRYOL EXP MORPH, V33, P789; Burggren W, 2017, BIOL OPEN, V6, P471, DOI 10.1242/bio.023994; Burke DT, 1997, GENOME RES, V7, P189, DOI 10.1101/gr.7.3.189; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Camp JP, 2007, BIOTECHNOL PROGR, V23, P1485, DOI 10.1021/bp070308v; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Chang C, 2013, LAB CHIP, V13, P1817, DOI [10.1039/c3lc41418c, 10.1039/c3lc41418]; Chen YA, 2011, LAB CHIP, V11, P3626, DOI 10.1039/c1lc20325h; Cheng J, 1996, NUCLEIC ACIDS RES, V24, P380, DOI 10.1093/nar/24.2.380; Cohen CB, 1999, ANAL BIOCHEM, V273, P89, DOI 10.1006/abio.1999.4204; Costa M, 1993, DEV DROSOPHILA MELAN; Crowder RO, 1997, J MEMBRANE SCI, V134, P235, DOI 10.1016/S0376-7388(97)00112-9; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; DINARDO S, 1985, CELL, V43, P59, DOI 10.1016/0092-8674(85)90012-1; Douglas RM, 2005, AM J PHYSIOL-REG I, V288, pR511, DOI 10.1152/ajpregu.00520.2004; Douglas RM, 2001, AM J PHYSIOL-REG I, V280, pR1555, DOI 10.1152/ajpregu.2001.280.5.R1555; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; GROTE J, 1977, PFLUG ARCH EUR J PHY, V372, P37, DOI 10.1007/BF00582204; Hadd AG, 1997, ANAL CHEM, V69, P3407, DOI 10.1021/ac970192p; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; Heinrich EC, 2011, J EXP BIOL, V214, P1419, DOI 10.1242/jeb.051904; Jacobson SC, 1996, ANAL CHEM, V68, P720, DOI 10.1021/ac951230c; JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495; Jiao Z, 1997, BIOTECHNOL TECH, V11, P755, DOI 10.1023/A:1018452603510; Just M. Vlak, 1996, INSECT CELL CULTURES; KARR TL, 1989, DEVELOPMENT, V105, P605; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kirby B., 2010, MICRO NANOSCALE FLUI; Kirk JE, 1955, J GERONTOL, V10, P288, DOI 10.1093/geronj/10.3.288; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; MAIORELLA B, 1988, BIO-TECHNOL, V6, P1406, DOI 10.1038/nbt1288-1406; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Oppegard SC, 2013, BIOMED MICRODEVICES, V15, P407, DOI 10.1007/s10544-013-9737-0; Oppegard SC, 2010, LAB CHIP, V10, P2366, DOI 10.1039/c004856a; Oppegard SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006891; Owerkowicz T, 2009, J EXP BIOL, V212, P1237, DOI 10.1242/jeb.023945; Rebollo E, 2004, PLOS BIOL, V2, P54, DOI 10.1371/journal.pbio.0020008; Rushlow CA, 2012, CURR OPIN GENET DEV, V22, P542, DOI 10.1016/j.gde.2012.08.005; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Tyler M.S., 2000, DEV BIOL GUIDE EXPT; Van Voorhies WA, 2009, J EXP BIOL, V212, P3132, DOI 10.1242/jeb.031179; Vigne Paul, 2010, BMC Physiology, V10, P8, DOI 10.1186/1472-6793-10-8; Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]; WEIR MP, 1985, NATURE, V318, P433, DOI 10.1038/318433a0; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; WITTE L, 1977, J CHROMATOGR, V143, P329, DOI 10.1016/S0378-4347(00)80979-2; WONG TKK, 1994, CYTOTECHNOLOGY, V15, P157, DOI 10.1007/BF00762390; Zarndt R, 2015, AM J PHYSIOL-REG I, V309, pR1347, DOI 10.1152/ajpregu.00164.2015	52	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185267	10.1371/journal.pone.0185267	http://dx.doi.org/10.1371/journal.pone.0185267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934338	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900136
J	Chen, C; Li, LX; Peng, HP; Yang, YX				Chen, Chuan; Li, Lixiang; Peng, Haipeng; Yang, Yixian			Finite time synchronization of memristor-based Cohen-Grossberg neural networks with mixed delays	PLOS ONE			English	Article							EXPONENTIAL SYNCHRONIZATION; STABILITY	Finite time synchronization, which means synchronization can be achieved in a settling time, is desirable in some practical applications. However, most of the published results on finite time synchronization don't include delays or only include discrete delays. In view of the fact that distributed delays inevitably exist in neural networks, this paper aims to investigate the finite time synchronization of memristor-based Cohen-Grossberg neural networks (MCGNNs) with both discrete delay and distributed delay (mixed delays). By means of a simple feedback controller and novel finite time synchronization analysis methods, several new criteria are derived to ensure the finite time synchronization of MCGNNs with mixed delays. The obtained criteria are very concise and easy to verify. Numerical simulations are presented to demonstrate the effectiveness of our theoretical results.	[Chen, Chuan; Li, Lixiang; Peng, Haipeng; Yang, Yixian] Beijing Univ Posts & Telecommun, Informat Secur Ctr, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China; [Yang, Yixian] State Key Lab Publ Big Data, Guiyang 550025, Guizhou, Peoples R China	Beijing University of Posts & Telecommunications	Li, LX (corresponding author), Beijing Univ Posts & Telecommun, Informat Secur Ctr, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China.	li_lixiang2006@163.com	Li, lixiang/G-6222-2011	Li, lixiang/0000-0001-9949-8731; Li, Lixiang/0000-0001-8541-308X	National Key Research and Development Program [2016YFB0800602, 2016YFB0800604]; National Natural Science Foundation of China [61573067, 61771071, 61472045]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by the National Key Research and Development Program (Grant nos .2016YFB0800602 and 2016YFB0800604), and the National Natural Science Foundation of China (Grant Nos. 61573067, 61771071 and 61472045).	Abdurahman A, 2015, COGN NEURODYNAMICS, V9, P603, DOI 10.1007/s11571-015-9352-2; Aubin J.P., 1984, DIFFERENTIAL INCLUSI; Chen C., 2017, NEURAL PROCESSING LE; Chen CA, 2017, NEUROCOMPUTING, V235, P83, DOI 10.1016/j.neucom.2016.12.061; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Clarke FH, 1984, P INT C MATH ZUR 199, V5, P847; COHEN MA, 1983, IEEE T SYST MAN CYB, V13, P815, DOI 10.1109/TSMC.1983.6313075; Filippov A., 1988, DIFF EQUAT+; Han XM, 2016, NEUROCOMPUTING, V201, P40, DOI 10.1016/j.neucom.2015.11.103; Hu C, 2014, NEUROCOMPUTING, V143, P90, DOI 10.1016/j.neucom.2014.06.016; Itoh M, 2008, INT J BIFURCAT CHAOS, V18, P3183, DOI 10.1142/S0218127408022354; Jiao B, 2017, CHAOS, V27, DOI 10.1063/1.4978024; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Li LX, 2015, CHAOS SOLITON FRACT, V72, P20, DOI 10.1016/j.chaos.2015.01.005; Lin D, 2010, NEUROCOMPUTING, V73, P2873, DOI 10.1016/j.neucom.2010.08.008; Lin D, 2010, FUZZY SET SYST, V161, P2066, DOI 10.1016/j.fss.2010.03.006; Liu M, 2016, NEUROCOMPUTING, V194, P1, DOI 10.1016/j.neucom.2016.02.012; Liu QM, 2012, CHAOS, V22, DOI 10.1063/1.4745212; Mei GF, 2016, COMPLEXITY, V21, P417, DOI 10.1002/cplx.21755; Milanovic V, 1996, INT J BIFURCAT CHAOS, V6, P2571, DOI 10.1142/S0218127496001648; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Tan Z, 2001, INT J MOD PHYS C, V12, P19, DOI 10.1142/S0129183101001407; Tang Q, 2014, NEURAL COMPUT APPL, V24, P775, DOI 10.1007/s00521-012-1292-8; Tang Y, 1998, AUTOMATICA, V34, P51, DOI 10.1016/S0005-1098(97)00174-X; Tojtovska B, 2012, APPL MATH COMPUT, V219, P2289, DOI 10.1016/j.amc.2012.08.076; Wan Y, 2016, NEURAL NETWORKS, V73, P86, DOI 10.1016/j.neunet.2015.10.009; Wang CN, 2015, COMPLEXITY, V21, P370, DOI 10.1002/cplx.21572; Wang WP, 2014, NEURAL NETWORKS, V53, P8, DOI 10.1016/j.neunet.2014.01.010; Wang XY, 2007, CHAOS, V17, DOI 10.1063/1.2755420; Wang XY, 2009, COMMUN NONLINEAR SCI, V14, P3351, DOI 10.1016/j.cnsns.2009.01.010; Wang XY, 2008, PHYSICA A, V387, P3751, DOI 10.1016/j.physa.2008.02.020; Wang XY, 2008, PHYS LETT A, V372, P435, DOI 10.1016/j.physleta.2007.07.053; Wang ZD, 2006, IEEE T NEURAL NETWOR, V17, P814, DOI 10.1109/TNN.2006.872355; Wen SP, 2015, IEEE T NEUR NET LEAR, V26, P1493, DOI 10.1109/TNNLS.2014.2387355; Wu AL, 2012, NEURAL NETWORKS, V36, P1, DOI 10.1016/j.neunet.2012.08.009; Wu AL, 2013, COMMUN NONLINEAR SCI, V18, P373, DOI 10.1016/j.cnsns.2012.07.005; Xiao JY, 2017, NEUROCOMPUTING, V219, P431, DOI 10.1016/j.neucom.2016.09.049; Yang XS, 2016, IEEE T CYBERNETICS, V46, P3377, DOI 10.1109/TCYB.2015.2505903; Yang XS, 2015, IEEE T FUZZY SYST, V23, P2302, DOI 10.1109/TFUZZ.2015.2417973; Yang XS, 2015, J FRANKLIN I, V352, P4382, DOI 10.1016/j.jfranklin.2015.07.001; Yang XS, 2014, NEUROCOMPUTING, V143, P275, DOI 10.1016/j.neucom.2014.05.064; Yang XS, 2014, COGN NEURODYNAMICS, V8, P239, DOI 10.1007/s11571-013-9277-6; Yang XS, 2011, CHAOS SOLITON FRACT, V44, P817, DOI 10.1016/j.chaos.2011.06.006; Yu J, 2011, NEUROCOMPUTING, V74, P1776, DOI 10.1016/j.neucom.2011.02.015; Zhang H, 2017, IEEE T SYST MAN CY-S, V47, P885, DOI 10.1109/TSMC.2016.2523935; Zhang W, 2016, NEUROCOMPUTING, V173, P1066, DOI 10.1016/j.neucom.2015.08.063; Zheng CD, 2013, IEEE T NEUR NET LEAR, V24, P800, DOI 10.1109/TNNLS.2013.2244613; Zhu QX, 2012, FUZZY SET SYST, V203, P74, DOI 10.1016/j.fss.2012.01.005; Zhu QX, 2012, NONLINEAR DYNAM, V67, P829, DOI 10.1007/s11071-011-0029-z; Zhu QX, 2010, NONLINEAR DYNAM, V61, P517, DOI 10.1007/s11071-010-9668-8	50	8	8	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185007	10.1371/journal.pone.0185007	http://dx.doi.org/10.1371/journal.pone.0185007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931066	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700056
J	Bian, X; Gao, J; Luo, F; Rui, C; Zheng, T; Wang, D; Wang, Y; Roberts, TM; Liu, P; Zhao, JJ; Cheng, H				Bian, X.; Gao, J.; Luo, F.; Rui, C.; Zheng, T.; Wang, D.; Wang, Y.; Roberts, T. M.; Liu, P.; Zhao, J. J.; Cheng, H.			PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy	ONCOGENE			English	Article							NEGATIVE BREAST-CANCER; HOMOLOGOUS RECOMBINATION REPAIR; OVARIAN-CANCER; DNA-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; PROSTATE-CANCER; PI3K INHIBITOR; NUCLEAR PTEN; MUTANT-CELLS; OLAPARIB	Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as promising cancer therapeutics especially for tumors with deficient homologous recombination (HR) repair. However, as HR-deficient tumors represent only a small fraction of endometrial cancers, the therapeutic utility of PARP inhibitors is limited in this disease. Somatic loss of phosphatase and tensin homolog (PTEN), a tumor suppressor that counteracts phosphoinositide 3-kinase (PI3K) activity, is one of the most common genetic aberrations in endometrioid endometrial cancer. While previous works have identified the role of PTEN in DNA double-strand break repair, vulnerabilities of PTEN-deficient endometrioid endometrial cancers to PARP inhibition remain controversial. Here we find that PTENdeficient endometrioid endometrial cancer cells are not responsive to PARP inhibitor Olaparib alone, but instead show superior sensitivity to compound inhibition with PI3K inhibitor BKM120, as evidenced by reduced clonogenic cell growth and threedimensional (3D) spheroid disintegration. Mechanistically, PI3K blockade by BKM120 attenuated HR competency with.H2AX accumulation and reduced RAD51 and BRCA1 expression in Ishikawa, AN3CA and Nou-1 cells, but the same combination treatment led to enhanced phosphorylation of DNA-PK, a non-homologous end joining repair protein, in Hec-108 cells. Furthermore, we show that CRISPR/Cas9-mediated PTEN depletion rendered PTEN wild-type Hec-1A endometrioid endometrial cancer cells responsive to combined inhibition of PARP/PI3K, with concomitantly induced DNA damage accumulation and repair defects. The combination of BKM120 and Olaparib cooperated to inhibit tumor growth in a genetic mouse model of Pten-deficient endometrioid endometrial cancer. Together, these results suggest PI3K inhibition may be a plausible approach to expand the utility of PARP inhibitors to endometrioid endometrial cancers in a PTEN-deficient setting.	[Bian, X.; Gao, J.; Rui, C.; Wang, D.; Liu, P.; Cheng, H.] Dalian Med Univ, Inst Canc Stem Cell, Hosp 2, Canc Inst, Dalian, Peoples R China; [Luo, F.] Dalian Med Univ, Hosp 2, Dept Acute Abdomen Surg, Dalian, Peoples R China; [Zheng, T.] Dalian Med Univ, Coll Basic Med Sci, Dalian, Peoples R China; [Wang, Y.] Dalian Med Univ, Dept Obstet & Gynecol, Hosp 2, Dalian, Peoples R China; [Roberts, T. M.; Zhao, J. J.] Dana Farber Canc Inst, Dept Canc Biol, 450 Brookline Ave Smith 936, Boston, MA 02215 USA; [Liu, P.] Dalian Med Univ, Coll Pharm, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University; Harvard University; Dana-Farber Cancer Institute; Dalian Medical University	Zhao, JJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 450 Brookline Ave Smith 936, Boston, MA 02215 USA.; Cheng, H (corresponding author), Dalian Med Univ, Inst Canc, Hosp 2, Dalian 116023, Peoples R China.; Liu, P (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Dalian 116044, Peoples R China.	pixu_liu@dmu.edu.cn; jean_zhao@dfci.harvard.edu; hailingcheng_dmu@163.com			National Natural Science Foundation of China [81472447, 81672575, 81372853, 81572586, 81602274]; Liaoning Provincial Climbing Scholars Supporting Program of China; Liaoning Provincial Science and Technology Program for Oversea Talents; Provincial Natural Science Foundation of Liaoning [2014023002]; National Institutes of Health/National Cancer Institute (NIH/NCI) [P50 CA168504, CA187918, P50 CA165962, CA210057-01, CA172461-04]; Breast Cancer Research Foundation; DFCI SSCWC Program Project Grant; NATIONAL CANCER INSTITUTE [R01CA187918, P50CA165962, P50CA168504, R01CA172461, R35CA210057] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Provincial Climbing Scholars Supporting Program of China; Liaoning Provincial Science and Technology Program for Oversea Talents; Provincial Natural Science Foundation of Liaoning; National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; DFCI SSCWC Program Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China (No. 81472447 and No. 81672575 to H Cheng; No. 81372853 and No. 81572586 to P Liu; No. 81602274 to J Gao), Liaoning Provincial Climbing Scholars Supporting Program of China (H Cheng, P Liu), Liaoning Provincial Science and Technology Program for Oversea Talents (H Cheng), Provincial Natural Science Foundation of Liaoning (No. 2014023002 to P Liu), National Institutes of Health/National Cancer Institute (NIH/NCI) (P50 CA168504, CA187918, P50 CA165962, CA210057-01 and CA172461-04 to JJZ), and Breast Cancer Research Foundation and DFCI SSCWC Program Project Grant.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Cardillo TM, 2017, CLIN CANCER RES, V23, P3405, DOI 10.1158/1078-0432.CCR-16-2401; Cardnell RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152584; Chan SL, 2010, LANCET, V376, P211, DOI 10.1016/S0140-6736(10)61119-1; Cheng HL, 2014, CANCER RES, V74, P15, DOI 10.1158/0008-5472.CAN-13-0544; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Dedes KJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001538; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Forster MD, 2011, NAT REV CLIN ONCOL, V8, P302, DOI 10.1038/nrclinonc.2011.42; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gonzalez-Billalabeitia E, 2014, CANCER DISCOV, V4, P896, DOI 10.1158/2159-8290.CD-13-0230; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Janzen DM, 2013, MOL CANCER THER, V12, P2917, DOI 10.1158/1535-7163.MCT-13-0572; JOHNSON CV, 1991, METHOD CELL BIOL, V35, P73; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Juvekar A, 2012, CANCER DISCOV, V2, P1048, DOI 10.1158/2159-8290.CD-11-0336; Kim G, 2015, CLIN CANCER RES, V21, P4257, DOI 10.1158/1078-0432.CCR-15-0887; Konstantinopoulos PA, 2015, CANCER DISCOV, V5, P1137, DOI 10.1158/2159-8290.CD-15-0714; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Miyasaka A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-179; Mo W, 2016, CLIN CANCER RES, V22, P1699, DOI 10.1158/1078-0432.CCR-15-1772; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Okkenhaug K, 2016, CANCER DISCOV, V6, P1090, DOI 10.1158/2159-8290.CD-16-0716; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Swisher EM, 2017, LANCET ONCOL, V18, P75, DOI [10.1016/S1470-2045(16)30559-9, 10.1016/s1470-2045(16)30559-9]; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang D, 2016, GYNECOL ONCOL, V142, P548, DOI 10.1016/j.ygyno.2016.07.092; Wang D, 2016, ONCOTARGET, V7, P13153, DOI 10.18632/oncotarget.7549; Weigelt B, 2013, CLIN CANCER RES, V19, P3533, DOI 10.1158/1078-0432.CCR-12-3815	47	69	71	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					341	351		10.1038/onc.2017.326	http://dx.doi.org/10.1038/onc.2017.326			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28945226	Green Published, hybrid			2022-12-26	WOS:000422753900007
J	Shedlovskiy, D; Zinskie, JA; Gardner, E; Pestov, DG; Shcherbik, N				Shedlovskiy, Daniel; Zinskie, Jessica A.; Gardner, Ethan; Pestov, Dimitri G.; Shcherbik, Natalia			Endonucleolytic cleavage in the expansion segment 7 of 25S rRNA is an early marker of low-level oxidative stress in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidation-reduction (redox); oxidative stress; reactive oxygen species (ROS); redox signaling; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); ribosome; RNA degradation; RNA structure; Saccharomyces cerevisiae; stress response	UNFOLDED PROTEIN RESPONSE; EUKARYOTIC 80S RIBOSOME; OXIDIZED MESSENGER-RNA; PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; REGULATES APOPTOSIS; THIOL PEROXIDASE; QUALITY-CONTROL	The ability to detect and respond to oxidative stress is crucial to the survival of living organisms. In cells, sensing of increased levels of reactive oxygen species (ROS) activates many defensive mechanisms that limit or repair damage to cell components. The ROS-signaling responses necessary for cell survival under oxidative stress conditions remain incompletely understood, especially for the translational machinery. Here, we found that drug treatments or a genetic deficiency in the thioredoxin system that increase levels of endogenous hydrogen peroxide in the yeast Saccharomyces cerevisiae promote site-specific endonucleolytic cleavage in 25S ribosomal RNA (rRNA) adjacent to the c loop of the expansion segment 7 (ES7), a putative regulatory region located on the surface of the 60S ribosomal subunit. Our data also show that ES7c is cleaved at early stages of the gene expression program that enables cells to successfully counteract oxidative stress and is not a prerequisite or consequence of apoptosis. Moreover, the 60S subunits containing ES7c-cleaved rRNA cofractionate with intact subunits in sucrose gradients and repopulate polysomes after a short starvation-induced translational block, indicating their active role in translation. These results demonstrate that ES7c cleavage in rRNA is an early and sensitive marker of increased ROS levels in yeast cells and suggest that changes in ribosomes may be involved in the adaptive response to oxidative stress.	[Shedlovskiy, Daniel; Zinskie, Jessica A.; Gardner, Ethan; Pestov, Dimitri G.; Shcherbik, Natalia] Rowan Univ, Dept Cell Biol & Neurosci, Stratford, NJ 08084 USA; [Gardner, Ethan] Rowan Univ, Grad Sch Biomed Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University	Shcherbik, N (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	shcherna@rowan.edu		Pestov, Dimitri/0000-0002-1425-9879	National Institutes of Health [R01GM114308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM114308 (to N. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; AMROLIA P, 1989, J APPL TOXICOL, V9, P113, DOI 10.1002/jat.2550090208; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Brandes N, 2011, J BIOL CHEM, V286, P41893, DOI 10.1074/jbc.M111.296236; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Cook JA, 2004, SEMIN RADIAT ONCOL, V14, P259, DOI 10.1016/j.semradonc.2004.04.001; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Doronina VA, 2015, MOL MICROBIOL, V96, P163, DOI 10.1111/mmi.12930; FADOK VA, 1992, J IMMUNOL, V148, P2207; Farrugia G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00064; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Gu C, 2014, FEBS LETT, V588, P4287, DOI 10.1016/j.febslet.2014.09.038; Held KD, 1996, RADIAT RES, V145, P542, DOI 10.2307/3579272; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jacob AI, 2013, MOL CELL, V49, P427, DOI 10.1016/j.molcel.2012.11.025; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jin CY, 2014, MOL BIOL CELL, V25, P1396, DOI 10.1091/mbc.E13-09-0550; Kachur AV, 1997, RADIAT RES, V147, P409, DOI 10.2307/3579496; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; Lee JY, 2017, J MICROBIOL BIOTECHN, V27, P633, DOI 10.4014/jmb.1610.10045; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lucau-Danila A, 2005, MOL CELL BIOL, V25, P1860, DOI 10.1128/MCB.25.5.1860-1868.2005; Ludovico P, 2014, FEMS YEAST RES, V14, P33, DOI 10.1111/1567-1364.12070; Luidalepp H, 2016, J MOL BIOL, V428, P2237, DOI 10.1016/j.jmb.2016.01.033; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Mansour FH, 2013, ANAL BIOCHEM, V441, P18, DOI 10.1016/j.ab.2013.06.008; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Mirzaei H, 2006, J PROTEOME RES, V5, P3249, DOI 10.1021/pr060337l; MISRA HP, 1974, J BIOL CHEM, V249, P2151; Mroczek S, 2008, NUCLEIC ACIDS RES, V36, P2874, DOI 10.1093/nar/gkm1100; MUNDAY R, 1989, FREE RADICAL BIO MED, V7, P659, DOI 10.1016/0891-5849(89)90147-0; Nagano T, 2015, J BIOCHEM, V158, P165, DOI 10.1093/jb/mvv026; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nilsen Timothy W, 2015, Cold Spring Harb Protoc, V2015, P314, DOI 10.1101/pdb.prot081026; Nilsson J, 2007, J MOL BIOL, V369, P429, DOI 10.1016/j.jmb.2007.03.035; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Pestov Dimitri G, 2008, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2211s39; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Rakauskaite R, 2006, MOL CELL BIOL, V26, P8992, DOI 10.1128/MCB.01311-06; Ramos LMG, 2016, J MOL BIOL, V428, P4048, DOI 10.1016/j.jmb.2016.08.008; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Satheeshkumar K, 2011, CHEM-EUR J, V17, P4849, DOI 10.1002/chem.201003417; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shcherbik N, 2016, NUCLEIC ACIDS RES, V44, P6840, DOI 10.1093/nar/gkw566; Shedlovskiy D., 2017, RNA BIOL IN PRESS; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Sideri TC, 2011, J BIOL CHEM, V286, P38924, DOI 10.1074/jbc.M111.272419; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Simms CL, 2014, CELL REP, V9, P1256, DOI 10.1016/j.celrep.2014.10.042; Strich R, 2015, GENETICS, V200, P1003, DOI 10.1534/genetics.115.179150; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Tartier L, 2000, CELL DEATH DIFFER, V7, P1002, DOI 10.1038/sj.cdd.4400726; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wang MS, 2015, RNA, V21, P1240, DOI 10.1261/rna.051169.115; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	83	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18469	18485		10.1074/jbc.M117.800003	http://dx.doi.org/10.1074/jbc.M117.800003			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939771	Green Published, hybrid			2022-12-26	WOS:000414958100008
J	Gotta, V; Baumann, P; Ritz, N; Fuchs, A; Baer, G; Bonhoeffer, JM; Heininger, U; Szinnai, G; Bonhoeffer, J				Gotta, Verena; Baumann, Philipp; Ritz, Nicole; Fuchs, Aline; Baer, Gurli; Bonhoeffer, Jessica M.; Heininger, Ulrich; Szinnai, Gabor; Bonhoeffer, Jan		ProPAED Study Grp	Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections	PLOS ONE			English	Article							C-REACTIVE PROTEIN; WHITE BLOOD-CELL; ERYTHROCYTE SEDIMENTATION-RATE; COMMUNITY-ACQUIRED PNEUMONIA; CALCITONIN-I GENE; PNEUMOCOCCAL PNEUMONIA; CLINICAL-FEATURES; LEUKOCYTE COUNT; PROCALCITONIN; BACTERIAL	Background Knowledge of key drivers for antibiotic prescribing in pediatric lower respiratory tract infection (LRTI) could support rational antibiotic use. Thus, we aimed to determine the impact of clinical and laboratory factors on antibiotic prescribing in children and adolescents with febrile LRTI. Methods Pediatric patients from the standard care control group of a randomized controlled trial (ProPAED) investigating procalcitonin guided antibiotic treatment in febrile LRTI were included in a multivariate logistic regression analysis to evaluate the impact of laboratory and clinical factors on antibiotic prescribing. Results The standard care control group of the ProPAED study comprised 165 LRTI patients (median age: 2.7 years, range: 0.1-16), out of which 88 (55%) received antibiotic treatment. Factors significantly associated with antibiotic prescribing in patients with complete clinical and laboratory documentation (n = 158) were C-reactive protein (OR 5.8 for a 10-fold increase, 95% CI 2.2-14.9), white blood count beyond age-dependent reference range (OR 3.9, 95% CI 1.4-11.4), body temperature (OR 1.7 for an increase by 1 degrees C, 95% CI 1.02-2.68), and pleuritic pain (OR 2.8, 95% CI 1.1-7.6). Dyspnea (OR 0.3, 95% CI 0.1-0.7) and wheezing (OR 0.3, 95% CI 0.13-0.95) were inversely associated with antibiotic prescribing. Conclusion Laboratory markers were strong drivers of antibiotic prescribing in children with febrile lower respiratory tract infections, in spite of their known poor prediction of antibiotic need. Building on current guidelines for antibiotic treatment in children with febrile LRTI, a reliable decision algorithm for safe antibiotic withholding considering the laboratory and clinical factors evaluated in this study has the potential to further reduce antibiotic prescribing.	[Gotta, Verena; Ritz, Nicole; Fuchs, Aline] Univ Basel, Childrens Hosp, Dept Pediat Pharmacol & Pharmacometr, Basel, Switzerland; [Baumann, Philipp; Ritz, Nicole; Baer, Gurli; Heininger, Ulrich; Bonhoeffer, Jan] Univ Basel, Childrens Hosp, Dept Pediat Infect Dis & Vaccinol, Basel, Switzerland; [Bonhoeffer, Jessica M.] Univ Basel, Childrens Hosp, Basel, Switzerland; [Szinnai, Gabor] Univ Basel, Childrens Hosp, Dept Pediat Endocrinol & Diabetol, Basel, Switzerland; [Baumann, Philipp] Univ Childrens Hosp Zurich, Dept Intens Care Med & Neonatol, Zurich, Switzerland; [Bonhoeffer, Jessica M.] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University Children's Hospital Zurich; University Children's Hospital Zurich	Baumann, P (corresponding author), Univ Basel, Childrens Hosp, Dept Pediat Infect Dis & Vaccinol, Basel, Switzerland.; Baumann, P (corresponding author), Univ Childrens Hosp Zurich, Dept Intens Care Med & Neonatol, Zurich, Switzerland.	philipp.baumann@kispi.uzh.ch	Ritz, Nicole/G-2924-2015; Ritz, Nicole/L-1452-2019	Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Gotta, Verena/0000-0001-6254-5207				Ahmed MN, 2010, CLIN PEDIATR, V49, P542, DOI 10.1177/0009922809357786; Baer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068419; Balfour-Lynn IM, 2005, THORAX, V60, P1, DOI 10.1136/thx.2004.030676; Behrman R., 2004, NELSON TXB PEDIAT, V17th ed., P1481; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Chen SP, 2013, J CLIN VIROL, V56, P7, DOI 10.1016/j.jcv.2012.08.021; Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Davies HD, 1996, PEDIATR INFECT DIS J, V15, P600, DOI 10.1097/00006454-199607000-00008; Domenech VS, 2001, J INVEST MED, V49, P514, DOI 10.2310/6650.2001.33628; Don M, 2009, PEDIATR INT, V51, P91, DOI 10.1111/j.1442-200X.2008.02678.x; Elemraid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106051; Esposito S, 2011, RESP MED, V105, P1939, DOI 10.1016/j.rmed.2011.09.003; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Horwood J, 2016, BRIT J GEN PRACT, V66, pE207, DOI 10.3399/bjgp16X683821; Jakobsen KA, 2010, SCAND J PRIM HEALTH, V28, P229, DOI 10.3109/02813432.2010.506995; Johnson J, 2010, EMERG RADIOL, V17, P285, DOI 10.1007/s10140-009-0854-2; Koller D, 2013, INFECTION, V41, P121, DOI 10.1007/s15010-012-0302-1; Korppi M, 2004, PEDIATR INT, V46, P545, DOI 10.1111/j.1442-200x.2004.01947.x; Korppi M, 1997, EUR RESPIR J, V10, P1125, DOI 10.1183/09031936.97.10051125; KORPPI M, 1993, SCAND J INFECT DIS, V25, P435, DOI 10.3109/00365549309008524; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Lemaitre C, 2013, PEDIATR INFECT DIS J, V32, P1146, DOI 10.1097/INF.0b013e31829be1bb; Lin Chao-Jen, 2006, Journal of Microbiology Immunology and Infection, V39, P489; Lucas PJ, 2015, SCAND J PRIM HEALTH, V33, P11, DOI 10.3109/02813432.2015.1001942; McDonagh M, 2016, AHRQ PUBLICATION, V163; Moro ML, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-69; Muller B, 2004, CLIN INFECT DIS, V39, P1867, DOI 10.1086/426148; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; NOHYNEK H, 1995, PEDIATR INFECT DIS J, V14, P484, DOI 10.1097/00006454-199506000-00004; Organization WH, 2001, STAND INT CHEST RAD; Peltola V, 2006, J PEDIATR-US, V149, P721, DOI 10.1016/j.jpeds.2006.08.051; Prat C, 2003, PEDIATR INFECT DIS J, V22, P963, DOI 10.1097/01.inf.0000095197.72976.4f; Schuetz P, 2012, CLIN INFECT DIS, V55, P651, DOI 10.1093/cid/cis464; SHUTTLEWORTH DB, 1971, AM J DIS CHILD, V122, P393, DOI 10.1001/archpedi.1971.02110050063005; Stocker M, 2010, NEONATOLOGY, V97, P165, DOI 10.1159/000241296; Tabain I, 2012, PEDIATR INFECT DIS J, V31, P680, DOI 10.1097/INF.0b013e318256605e; van Buuren S, 2011, J STAT SOFTW, V45, P1; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wexler ID, 2006, PEDIATR PULM, V41, P726, DOI 10.1002/ppul.20383; World Health Organization, 2013, GUIDELINES MANAGEMEN	46	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185197	10.1371/journal.pone.0185197	http://dx.doi.org/10.1371/journal.pone.0185197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957358	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200032
J	Lanouette, G; Brodeur, J; Fournier, F; Martel, V; Vreysen, M; Caceres, C; Firlej, A				Lanouette, Genevieve; Brodeur, Jacques; Fournier, Francois; Martel, Veronique; Vreysen, Marc; Caceres, Carlos; Firlej, Annabelle			The sterile insect technique for the management of the spotted wing drosophila, Drosophila suzukii: Establishing the optimum irradiation dose	PLOS ONE			English	Article							MATSUMURA DIPTERA DROSOPHILIDAE; TEPHRITIDAE; INDUCTION; INVASION; VINEGAR; CHERRY; MODEL; PEST	The spotted wing drosophila Drosophila suzukii Matsumura (Diptera: Drosophilidae), a pest of berries stone fruits, invaded North America and Europe in 2008. Current control methods rely mainly on insecticides. The sterile insect technique (SIT) has potential as an additional control tactic for the integrated management of D. suzukii. As a step towards the development of the SIT, this study aimed at finding the optimum irradiation dose to sterilize D. suzukii under controlled laboratory conditions. Four-day-old D. suzukii pupae were irradiated 12 to 24 hours prior to adult emergence in a Co-60 Gamma Cell 220 and in a 137 Cs Gamma Cell 3000 with doses of 30, 50, 70, 80, 90, 100 or 120 Gy. Emergence rate (88.1%), percent of deformed flies (4.0%) and survival curves were not affected by the tested irradiation doses. However, some reproductive parameters of the flies were affected by irradiation. Females irradiated with a dose of 50 Gy or more had almost no fecundity. When non-irradiated females were mated with irradiated males, egg hatch decreased exponentially with irradiation dose from 82.6% for the untreated control males to 4.0% for males irradiated with 120 Gy. Mortality of F1 individuals from the irradiated treatment also occurred during larval and pupal stages, with an egg to adult survival of 0.2%. However, descendants produced by the irradiated generation were fertile. These results are an encouraging first experimental step towards the development of the SIT for the management of D. suzukii populations.	[Lanouette, Genevieve; Firlej, Annabelle] Inst Rech & Dev Agroenvironm, St Bruno De Montarville, PQ, Canada; [Brodeur, Jacques] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada; [Fournier, Francois] Coll Montmorency, Laval, PQ, Canada; [Martel, Veronique] Ressources Nat Canada, Ctr Foresterie Laurentides, Quebec City, PQ, Canada; [Vreysen, Marc; Caceres, Carlos] Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Seibersdorf, Austria	Universite de Montreal; Natural Resources Canada; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Lanouette, G (corresponding author), Inst Rech & Dev Agroenvironm, St Bruno De Montarville, PQ, Canada.	genevieve.lanouette@umontreal.ca	Martel, Véronique/Q-5127-2019	Martel, Véronique/0000-0001-8111-5931; Lanouette, Genevieve/0000-0003-4313-3447	Ministere de I'Education et de l'Enseignement superieur [IA113135]; Ministere de I'Agriculture, des Pecheries et de I'Alimentation du Quebec; Agriculture and Agri-food Canada	Ministere de I'Education et de l'Enseignement superieur; Ministere de I'Agriculture, des Pecheries et de I'Alimentation du Quebec; Agriculture and Agri-food Canada(Agriculture & Agri Food Canada)	This research, including M. Sc. scholarship, materials and part of travel costs to Austria have been realized with the financial support of the Programme Innov'Action agroalimentaire from the agreement Cultivons L'Avenir 2 concluded between the Ministere de I'Agriculture, des Pecheries et de I'Alimentation du Quebec (http://www.mapaq.gouvqu.ca) and Agriculture and Agri-food Canada (http://agr.gc.ca). Grant number is IA113135 received by AF. Travel costs have also been financed with the Scholarship for short-term university studies outside of Quebec from the Ministere de I'Education et de l'Enseignement superieur (http://www.education.gouv.qc.ca) received by GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinghi A, 2007, FLA ENTOMOL, V90, P96, DOI 10.1653/0015-4040(2007)90[96:IOSIAF]2.0.CO;2; AMERESEKERE RV, 1971, J ECON ENTOMOL, V64, P1074, DOI 10.1093/jee/64.5.1074; AMOAKO-ATTA B, 1976, Journal of the Kansas Entomological Society, V49, P133; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda M.P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; BROWER JH, 1975, ANN ENTOMOL SOC AM, V68, P1086, DOI 10.1093/aesa/68.6.1086; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Carpenter JE, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P115, DOI 10.1007/1-4020-4051-2_5; Cha DH, 2012, J CHEM ECOL, V38, P1419, DOI 10.1007/s10886-012-0196-5; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Cini A, 2012, B INSECTOL, V65, P149; COGBURN RR, 1973, J ECON ENTOMOL, V66, P745, DOI 10.1093/jee/66.3.745; Collins SR, 2008, J APPL ENTOMOL, V132, P398, DOI 10.1111/j.1439-0418.2008.01284.x; Cormier D., 2015, IOBC/WPRS Bulletin, V109, P181; Cossentine J, 2016, BIOL CONTROL, V103, P129, DOI 10.1016/j.biocontrol.2016.09.002; Cuthbertson Andrew G S, 2014, Insects, V5, P488, DOI 10.3390/insects5020488; Daane KM, 2016, J PEST SCI, V89, P823, DOI 10.1007/s10340-016-0740-0; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Farnsworth D, 2016, PEST MANAG SCI; Farnsworth DJ, 2014, THESIS; Follett PA, 2014, J ECON ENTOMOL, V107, P964, DOI 10.1603/EC14006; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Guerrieri E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147382; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Helinski MEH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S6; Hopper G. H. S., 1975, Journal of the Australian Entomological Society, V14, P175, DOI 10.1111/j.1440-6055.1975.tb02021.x; Jang M, 2016, PEST MANAG SCI; Kaspi R, 2003, ANN APPL BIOL, V143, P25, DOI 10.1111/j.1744-7348.2003.tb00265.x; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Knipling E.F., 1992, AGR HDB USDA; LACHANCE LE, 1970, CHROMOSOMA, V29, P20, DOI 10.1007/BF01183659; LACHANCE LE, 1984, MUTAT RES, V127, P49, DOI 10.1016/0027-5107(84)90139-8; Landolt PJ, 2012, J APPL ENTOMOL, V136, P148, DOI 10.1111/j.1439-0418.2011.01646.x; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Mitchell S, 1965, USDA TECH B, p[1, 33]; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Parker A, 2007, FLA ENTOMOL, V90, P88, DOI 10.1653/0015-4040(2007)90[88:SITAMF]2.0.CO;2; Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4; R Development Core Team, 2016, R LANG ENV STAT COMP; Renkema JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21432; Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P95, DOI 10.1007/1-4020-4051-2_4; Rogers MA, 2016, J YOUTH ADOLESCENCE, P1; Smirle MJ, 2017, PEST MANAG SCI, V73, P130, DOI 10.1002/ps.4310; Statistical Analysis Software Institute Inc, 2016, SAS 9 4 DAT MAN OV; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Toledo J, 2004, J ECON ENTOMOL, V97, P383, DOI 10.1603/0022-0493-97.2.383; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; Vreysen M. J. B., 2007, P723, DOI 10.1007/978-1-4020-6059-5_66; Walse SS, 2012, J ASIA-PAC ENTOMOL, V15, P451, DOI 10.1016/j.aspen.2012.05.003; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x	54	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0180821	10.1371/journal.pone.0180821	http://dx.doi.org/10.1371/journal.pone.0180821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957331	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200001
J	Wang, H; Zhang, WD; Gu, HL; Chen, WL; Zeng, M; Ji, CH; Song, RY; Zhang, GH				Wang, Heng; Zhang, Weidong; Gu, Honglang; Chen, Wanli; Zeng, Meng; Ji, Chihai; Song, Ruyue; Zhang, Guihong			Identification and characterization of two linear epitope motifs in hepatitis E virus ORF2 protein	PLOS ONE			English	Article							PEPTIDE-BASED IMMUNOASSAYS; CAPSID PROTEIN; MONOCLONAL-ANTIBODIES; HEV; NEUTRALIZATION; SWINE	Hepatitis E virus( HEV) is responsible for hepatitis E, which represents a global public health problem. HEV genotypes 3 and 4 are reported to be zoonotic, and animals are monitored for HEV infection in the interests of public hygiene and food safety. The development of novel diagnostic methods and vaccines for HEV in humans is thus important topics of research. Opening reading frame( ORF) 2 of HEV includes both linear and conformational epitopes and is regarded as the primary candidate for vaccines and diagnostic tests. We investigated the precise location of the HEV epitopes in the ORF2 protein. We prepared four monoclonal antibodies( mAbs) against genotype 4 ORF2 protein and identified two linear epitopes, G438IVIPHD444 and Y457DNQH461, corresponding to two of these mAbs using phage display biopanning technology. Both these epitopes were speculated to be universal to genotypes 1, 2, 3, 4, and avian HEVs. We also used two 12-mer fragments of ORF2 protein including these two epitopes to develop a peptide-based enzyme-linked immunosorbent assay( ELISA) to detect HEV in serum. This assay demonstrated good specificity but low sensitivity compared with the commercial method, indicating that these two epitopes could serve as potential candidate targets for diagnosis. Overall, these results further our understanding of the epitope distribution of HEV ORF2, and provide important information for the development of peptide-based immunodiagnostic tests to detect HEV in serum.	[Wang, Heng; Gu, Honglang; Chen, Wanli; Zeng, Meng; Ji, Chihai; Song, Ruyue; Zhang, Guihong] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Wang, Heng; Chen, Wanli; Zeng, Meng; Song, Ruyue] Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China; [Zhang, Weidong] Hosp South China Agr Univ, Guangzhou, Guangdong, Peoples R China; [Gu, Honglang; Ji, Chihai; Zhang, Guihong] MOA Key Lab Anim Vaccine Dev, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Wang, H; Zhang, GH (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.; Wang, H (corresponding author), Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China.; Zhang, GH (corresponding author), MOA Key Lab Anim Vaccine Dev, Guangzhou, Guangdong, Peoples R China.	wangheng2009@scau.edu.cn; guihongzh@scau.edu.cn			National Key Research and Development Program [2016YFD0500707]; Department of Education of Guangdong province [YQ201530]; Industry Technology System of Modern Agriculture Construction Fund [CARS-36]	National Key Research and Development Program; Department of Education of Guangdong province(National Natural Science Foundation of Guangdong Province); Industry Technology System of Modern Agriculture Construction Fund	This study was partially supported by the National Key Research and Development Program (2016YFD0500707) received by GZ and HW, http://service.most.gov.cn/, the Department of Education of Guangdong province (YQ201530) received by HW, http://gdjs.gdhed.edu.cn/main/main.php, and the Industry Technology System of Modern Agriculture Construction Fund (CARS-36) received by GZ, http://119.253.58.231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behloul N, 2015, INFECT GENET EVOL, V34, P211, DOI 10.1016/j.meegid.2015.06.026; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Dalton HR, 2016, TRANSFUS APHER SCI, V55, P271, DOI 10.1016/j.transci.2016.10.016; Gu H, 2015, CHINESE J VET MED, V51, P25; Gu Y, 2015, CELL RES, V25, P604, DOI 10.1038/cr.2015.34; Haqshenas G, 2002, J GEN VIROL, V83, P2201, DOI 10.1099/0022-1317-83-9-2201; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; LI F, 1994, J CLIN MICROBIOL, V32, P2060, DOI 10.1128/JCM.32.9.2060-2066.1994; Liu BQ, 2009, J BIOTECHNOL, V141, P91, DOI 10.1016/j.jbiotec.2009.02.005; Ma HX, 2009, J MED VIROL, V81, P1052, DOI 10.1002/jmv.21484; Meng JH, 2001, VIROLOGY, V288, P203, DOI 10.1006/viro.2001.1093; Njouom R, 2010, J CLIN VIROL, V49, P61, DOI 10.1016/j.jcv.2010.06.005; Osterman A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-28; Pavio N, 2015, CURR OPIN VIROL, V10, P34, DOI 10.1016/j.coviro.2014.12.006; Perez C, 2006, J MED VIROL, V78, P806, DOI 10.1002/jmv.20627; Riddell MA, 2000, J VIROL, V74, P8011, DOI 10.1128/JVI.74.17.8011-8017.2000; Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez AB, 2010, CANCER CHEMOTH PHARM, V66, P919, DOI 10.1007/s00280-009-1240-1; Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Tang ZM, 2015, VACCINE, V33, P3504, DOI 10.1016/j.vaccine.2015.05.065; Wang H, 2015, J VIROL METHODS, V222, P231, DOI 10.1016/j.jviromet.2015.04.026; Wang HL, 2015, 2015 IEEE 5TH ASIA-PACIFIC CONFERENCE ON SYNTHETIC APERTURE RADAR (APSAR), P108, DOI 10.1109/APSAR.2015.7306166; Wang XJ, 2015, J VIROL, V89, P5491, DOI 10.1128/JVI.00107-15; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	27	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184947	10.1371/journal.pone.0184947	http://dx.doi.org/10.1371/journal.pone.0184947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957334	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200025
J	Hossein, MS; Kunter, GM; El-Najjar, VF; Jaye, DL; Al-Kadhimi, Z; Taofeek, OK; Li, JM; Waller, EK				Hossein, Mohammad S.; Kunter, Ghada M.; El-Najjar, Vicky F.; Jaye, David L.; Al-Kadhimi, Zaid; Taofeek, Owonikoko K.; Li, Jian-Ming; Waller, Edmund K.			PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ANTIVIRAL IMMUNITY; BLOCKADE; EXPRESSION; CD4(+); TOLERANCE; LETHALITY; INFECTION; RESPONSES	The expression of checkpoint blockade molecules PD-1, PD-L1, CTLA-4, and foxp3 +CD25+CD4+ T cells (Tregs) regulate donor T cell activation and graft-vs-host disease (GvHD) in allogeneic hematopoietic stem cell transplant (allo-HSCT). Detailed kinetics of PD-1-, CTLA-4-, and PD-L1 expression on donor and host cells in GvHD target organs have not been well studied. Using an established GvHD model of allo-HSCT (B6 -> CB6F1), we noted transient increases of PD-1- and CTLA-4-expressing donor CD4+ and CD8+ T cells on day 10 post transplant in spleens of allo-HSCT recipients compared with syngeneic HSCT (syn-HSCT) recipients. In contrast, expression of PD-1- and CTLA-4 on donor T cells was persistently increased in bone marrow (BM) of allo-HSCT recipients compared with syn-HSCT recipients. Similar differential patterns of donor T cell immune response were observed in a minor histocompatibility (miHA) mismatched transplant model of GvHD. Despite higher PD-1 and CTLA-4 expression in BM, numbers of foxp3+ T cells and Tregs were much lower in allo-HSCT recipients compared with syn-HSCT recipients. PD-L1-expressing host cells were markedly decreased concomitant with elimination of residual host hematopoietic elements in spleens of allo-HSCT recipients. Allo-HSCT recipients lacking PD-L1 rapidly developed increased serum inflammatory cytokines and lethal acute GvHD compared with wild-type (WT) B6 allo-HSCT recipients. These data suggest that increased expression of checkpoint blockade molecules PD-1 and CTLA-4 on donor T cells is not sufficient to prevent GvHD, and that cooperation between checkpoint blockade signaling by host cells and donor Tregs is necessary to limit GvHD in allo-HSCT recipients.	[Hossein, Mohammad S.; Al-Kadhimi, Zaid; Taofeek, Owonikoko K.; Li, Jian-Ming; Waller, Edmund K.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol,Div Stem Cell & Bone Mar, Atlanta, GA 30322 USA; [Kunter, Ghada M.] Holzer Canc Ctr, Gallipolis, OH USA; [El-Najjar, Vicky F.; Jaye, David L.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University	Waller, EK (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol,Div Stem Cell & Bone Mar, Atlanta, GA 30322 USA.	ewaller@emory.edu	Waller, Edmund K/AAP-3055-2020	Waller, Edmund K./0000-0003-0816-6729; jaye, david/0000-0001-7977-6909	NIH grant [R01 CA188523]; NATIONAL CANCER INSTITUTE [R01CA188523] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant (R01 CA188523) to E.K.W.	Alderson KL, 2008, J IMMUNOL, V180, P2981, DOI 10.4049/jimmunol.180.5.2981; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrett AJ, 2010, EXPERT REV HEMATOL, V3, P429, DOI 10.1586/EHM.10.32; BEARMAN SI, 1988, J CLIN ONCOL, V6, P1562, DOI 10.1200/JCO.1988.6.10.1562; Beres AJ, 2012, J IMMUNOL, V189, P464, DOI 10.4049/jimmunol.1200886; Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cao TH, 2009, CELL IMMUNOL, V258, P65, DOI 10.1016/j.cellimm.2009.03.013; Dias SD, 2001, BLOOD, V97, P1134, DOI 10.1182/blood.V97.4.1134; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Duramad O, 2011, BIOL BLOOD MARROW TR, V17, P1154, DOI 10.1016/j.bbmt.2010.11.022; Fevery S, 2007, LEUKEMIA, V21, P1451, DOI 10.1038/sj.leu.2404720; Forghani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064837; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gao WD, 2003, TRANSPLANTATION, V76, P994, DOI 10.1097/01.TP.0000085010.39567.FB; Hossain MS, 2008, J IMMUNOL, V180, P6892, DOI 10.4049/jimmunol.180.10.6892; Hossain MS, 2007, BLOOD, V109, P4548, DOI 10.1182/blood-2006-04-017442; Hossain MS, 2011, J IMMUNOL, V187, P5130, DOI 10.4049/jimmunol.1101334; Hossain MS, 2005, BIOL BLOOD MARROW TR, V11, P169, DOI 10.1016/j.bbmt.2004.12.332; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Li JM, 2013, BLOOD, V121, P2347, DOI 10.1182/blood-2012-06-437640; MARTIN PJ, 1985, BLOOD, V66, P664; Matte-Martone C, 2008, BLOOD, V111, P3884, DOI 10.1182/blood-2007-11-125294; Miura Y, 2004, BLOOD, V104, P2187, DOI 10.1182/blood-2004-03-1040; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Panoskaltsis-Mortari A, 2004, BLOOD, V103, P3590, DOI 10.1182/blood-2003-08-2827; PIRSCH JD, 1986, ANN INTERN MED, V104, P619, DOI 10.7326/0003-4819-104-5-619; Raimondi G, 2007, CRIT REV IMMUNOL, V27, P61, DOI 10.1615/CritRevImmunol.v27.i1.50; Reddy P, 2008, BIOL BLOOD MARROW TR, V14, P129, DOI 10.1016/j.bbmt.2007.10.021; Riesner K, 2016, BONE MARROW TRANSPL, V51, P410, DOI 10.1038/bmt.2015.279; Roback JD, 2003, J IMMUNOL, V171, P6023, DOI 10.4049/jimmunol.171.11.6023; Saha A, 2013, BLOOD, V122, P3062, DOI 10.1182/blood-2013-05-500801; Sandner SE, 2005, J IMMUNOL, V174, P3408, DOI 10.4049/jimmunol.174.6.3408; Sandner SE, 2005, AM J TRANSPLANT, V5, P31, DOI 10.1111/j.1600-6143.2004.00640.x; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhang Y, 2002, J IMMUNOL, V169, P7111, DOI 10.4049/jimmunol.169.12.7111	48	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184254	10.1371/journal.pone.0184254	http://dx.doi.org/10.1371/journal.pone.0184254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953925	Green Published, gold, Green Submitted			2022-12-26	WOS:000411980300012
J	Juarez, M; Egoavil, C; Rodriguez-Soler, M; Hernandez-Illan, E; Guarinos, C; Garcia-Martinez, A; Alenda, C; Giner-Calabuig, M; Murcia, O; Mangas, C; Paya, A; Aparicio, JR; Ruiz, FA; Martinez, J; Casellas, JA; Soto, JL; Zapater, P; Jover, R				Juarez, Miriam; Egoavil, Cecilia; Rodriguez-Soler, Maria; Hernandez-illan, Eva; Guarinos, Carla; Garcia-Martinez, Araceli; Alenda, Cristina; Giner-Calabuig, Mar; Murcia, Oscar; Mangas, Carolina; Paya, Artemio; Aparicio, Jose R.; Ruiz, Francisco A.; Martinez, Juan; Casellas, Juan A.; Soto, Jose L.; Zapater, Pedro; Jover, Rodrigo			KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia	PLOS ONE			English	Article							MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; COLORECTAL-CANCER; SERRATED POLYPS; COLONOSCOPY SURVEILLANCE; ADENOMAS; SUBTYPES; FEATURES; LESIONS; PATHOGENESIS; POLYPECTOMY	Background & aims High-risk features of colonic polyps are based on size, number, and pathologic characteristics. Surveillance colonoscopy is often recommended according to these findings. This study aimed to determine whether the molecular characteristics of polyps might provide information about the risk of metachronous advanced neoplasia. Methodology We retrospectively included 308 patients with colonic polyps. A total of 995 polyps were collected and tested for somatic BRAF and KRAS mutations. Patients were classified into 3 subgroups, based on the polyp mutational profile at baseline, as follows: non-mutated polyps (Wild-type), at least one BRAF-mutated polyp, or at least one KRAS-mutated polyp. At surveillance, advanced adenomas were defined as adenomas >= 10 mm and/or with high grade dysplasia or a villous component. In contrast, advanced serrated polyps were defined as serrated polyps >= 10 mm in any location, located proximal to the splenic flexure with any size or with dysplasia. Results At baseline, 289 patients could be classified as wild-type (62.3%), BRAF mutated (14.9%), or KRAS mutated (22.8%). In the univariate analysis, KRAS mutations were associated with the development of metachronous advanced polyps (OR: 2.36, 95% CI: 1.22-4.58; P= 0.011), and specifically, advanced adenomas (OR: 2.42, 95% CI: 1.13-5.21; P= 0.023). The multivariate analysis, adjusted for age and sex, also showed associations with the development of metachronous advanced polyps (OR: 2.27, 95% CI: 1.15-4.46) and advanced adenomas (OR: 2.23, 95% CI: 1.02-4.85). Conclusions Our results suggested that somatic KRAS mutations in polyps represent a potential molecular marker for the risk of developing advanced neoplasia.	[Juarez, Miriam; Hernandez-illan, Eva; Guarinos, Carla; Garcia-Martinez, Araceli; Giner-Calabuig, Mar] Alicante Univ, Gen Hosp, Res Lab, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Alicante, Spain; [Juarez, Miriam; Alenda, Cristina; Paya, Artemio] Alicante Univ, Dept Pathol, Gen Hosp, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Alicante, Spain; [Rodriguez-Soler, Maria; Murcia, Oscar; Mangas, Carolina; Aparicio, Jose R.; Ruiz, Francisco A.; Martinez, Juan; Casellas, Juan A.; Jover, Rodrigo] Alicante Univ, Serv Digest Med, Gen Hosp, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Alicante, Spain; [Soto, Jose L.] Elche Univ, Gen Hosp, Mol Genet Lab, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Elche, Spain; [Zapater, Pedro] Alicante Univ, Gen Hosp, Clin Pharmacol Dept, Alicante Inst Hlth & Biomed Re,ISABIAL FISABIO Fd, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universitat d'Alacant	Jover, R (corresponding author), Alicante Univ, Serv Digest Med, Gen Hosp, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Alicante, Spain.	rodrigojover@gmail.com	Alenda, Cristina/AAR-3433-2020; Payá, Artemio/AFX-6518-2022; Egoavil, Cecilia/X-5134-2018; Soto, José Luis/AAC-6520-2020; Egoavil, Cecilia/ABG-8531-2020; Giner, Mar/GRM-8276-2022; Jover, Rodrigo/ABC-3258-2021; Zapater, Pedro/H-8450-2019	Egoavil, Cecilia/0000-0003-0166-4901; Egoavil, Cecilia/0000-0003-0166-4901; Giner, Mar/0000-0002-6267-3708; Jover, Rodrigo/0000-0003-3742-3413; Zapater, Pedro/0000-0001-7927-858X; Alenda, Cristina/0000-0002-0560-1759; Murcia, Oscar/0000-0003-3419-6067; Mangas-Sanjuan, Carolina/0000-0003-2611-1051; Aparicio Tormo, Jose Ramon/0000-0003-2245-4006; Garcia Martinez, Araceli/0000-0002-1052-1315; Soto, Jose Luis/0000-0003-0234-9188; Rodriguez Soler, Maria/0000-0001-5555-6418	Institute de Salud Carlos III [PI08/0726, INT-09/208, PI11/2630, INT-12-078, INT13-196, PI14/1386, FI12/00233]; FISABIO-ISABIAL foundation [UGP-13-221, UGP14-265]; Asociacion Espanola contra el Cancer [GCB13131592CAST]; AIGPA; Conselleria d'Educacio de la Generalitat Valenciana [VALi+d.EXP ACIF/2010/018, ACIF/2016/002]	Institute de Salud Carlos III(Instituto de Salud Carlos III); FISABIO-ISABIAL foundation; Asociacion Espanola contra el Cancer; AIGPA; Conselleria d'Educacio de la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This work was supported by the Institute de Salud Carlos III (PI08/0726, INT-09/208, PI11/ 2630, INT-12-078, INT13-196, PI14/1386), FISABIO-ISABIAL foundation (UGP-13-221, UGP14-265), the Asociacion Espanola contra el Cancer (Fundacion Cientifica GCB13131592CAST) and AIGPA, a private association that promotes research in gastrointestinal diseases in Alicante and also supported logistic aspects of the study, (this association declares no conflict of interest). Carla Guarinos and Mar Giner Calabuig received a predoctoral grant from Conselleria d'Educacio de la Generalitat Valenciana (VALi+d.EXP ACIF/2010/018, ACIF/2016/002) and Eva Hernandez-IIIan received a grant from Institute de Salud Carlos III (FI12/00233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2014, GUT LIVER, V8, P582, DOI 10.5009/gnl14248; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Bond JH, 2003, ENDOSCOPY, V35, P27, DOI 10.1055/s-2003-36410; Bouwens MWE, 2013, J CLIN GASTROENTEROL, V47, P734, DOI 10.1097/MCG.0b013e318293a656; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8, DOI 10.6004/jnccn.2010.0003; Carethers John M, 2015, J Dig Cancer Rep, V3, P5; Chen H, 2011, CANCER GENET-NY, V204, P245, DOI 10.1016/j.cancergen.2011.04.002; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Erichsen R, 2016, GASTROENTEROLOGY, V150, P895, DOI 10.1053/j.gastro.2015.11.046; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Guarinos C, 2013, CLIN GASTROENTEROL H, V11, P705, DOI 10.1016/j.cgh.2012.12.045; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hamilton SR, 2010, WHO CLASSIFICATION T, P134; Hassan C, 2013, ENDOSCOPY, V45, P842, DOI 10.1055/s-0033-1344548; Holme O, 2015, GUT, V64, P929, DOI 10.1136/gutjnl-2014-307793; Imperiale TF, 2010, GASTROENTEROLOGY, V138, P1642, DOI 10.1053/j.gastro.2010.03.027; Ishii T, 2011, AM J SURG PATHOL, V35, P212, DOI 10.1097/PAS.0b013e318205df20; Janjua HGR, 2015, APMIS, V123, P298, DOI 10.1111/apm.12355; Jass JR, 2006, HISTOPATHOLOGY, V49, P121, DOI 10.1111/j.1365-2559.2006.02466.x; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1999, J PATHOL, V187, P499, DOI 10.1002/(SICI)1096-9896(199904)187:5<499::AID-PATH309>3.0.CO;2-B; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kressner U, 1998, EUR J CANCER, V34, P518, DOI 10.1016/S0959-8049(97)10111-3; le Clercq CMC, 2015, GASTROINTEST ENDOSC, V82, P325, DOI 10.1016/j.gie.2014.12.052; le Clercq CMC, 2014, GUT, V63, P957, DOI 10.1136/gutjnl-2013-304880; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Lorentzen JA, 2016, CLIN MED INSIGHTS-PA, V9, P19, DOI [10.4137/CPath.s40143, 10.4137/CPath.S40143]; Maltzman T, 2001, GASTROENTEROLOGY, V121, P302, DOI 10.1053/gast.2001.26278; Martinez ME, 2012, ANN INTERN MED, V157, P856, DOI 10.7326/0003-4819-157-12-201212180-00005; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Nusko G, 1997, SCAND J GASTROENTERO, V32, P1035, DOI 10.3109/00365529709011221; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Oono Y, 2009, DIGEST DIS SCI, V54, P906, DOI 10.1007/s10620-008-0407-7; Phipps AI, 2015, GASTROENTEROLOGY, V148, P77, DOI 10.1053/j.gastro.2014.09.038; Pohl H, 2013, GASTROENTEROLOGY, V144, P74, DOI 10.1053/j.gastro.2012.09.043; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Robertson DJ, 2014, GUT, V63, P949, DOI 10.1136/gutjnl-2012-303796; Rosty C, 2013, J GASTROENTEROL, V48, P287, DOI 10.1007/s00535-012-0720-y; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schreiner MA, 2010, GASTROENTEROLOGY, V139, P1497, DOI 10.1053/j.gastro.2010.06.074; Sinicrope FA, 2015, GASTROENTEROLOGY, V148, P88, DOI 10.1053/j.gastro.2014.09.041; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Snover DC, 2010, WHO CLASSIFICATION T, P160; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Yadamsuren EA, 2012, PATHOL ONCOL RES, V18, P1077, DOI 10.1007/s12253-012-9547-3; Yamane LS, 2014, ONCOL REP, V32, P1419, DOI 10.3892/or.2014.3338; Yang HM, 2015, ARCH PATHOL LAB MED, V139, P730, DOI 10.5858/arpa.2014-0424-RA; Yuen ST, 2002, CANCER RES, V62, P6451	50	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184937	10.1371/journal.pone.0184937	http://dx.doi.org/10.1371/journal.pone.0184937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953955	Green Published, Green Submitted, gold			2022-12-26	WOS:000411980300027
J	Mukherjee, N; Choudhuri, SP; Delay, RJ; Delay, ER				Mukherjee, Nabanita; Choudhuri, Shreoshi Pal; Delay, Rona J.; Delay, Eugene R.			Cellular mechanisms of cyclophosphamideinduced taste loss in mice	PLOS ONE			English	Article							QUALITY-OF-LIFE; PATIENTS RECEIVING CHEMOTHERAPY; BUD CELLS; CANCER-CHEMOTHERAPY; RECEPTOR-CELLS; DIFFERENTIAL EXPRESSION; STEM/PROGENITOR CELLS; FUNGIFORM PAPILLAE; ALPHA-GUSTDUCIN; BREAST-CANCER	Many commonly prescribed chemotherapy drugs such as cyclophosphamide (CYP) have adverse side effects including disruptions in taste which can result in loss of appetite, malnutrition, poorer recovery and reduced quality of life. Previous studies in mice found evidence that CYP has a two- phase disturbance in taste behavior: a disturbance immediately following drug administration and a second which emerges several days later. In this study, we examined the processes by which CYP disturbs the taste system by examining the effects of the drug on taste buds and cells responsible for taste cell renewal using immunohistochemical assays. Data reported here suggest CYP has direct cytotoxic effects on lingual epithelium immediately following administration, causing an early loss of taste sensory cells. Types II and III cells in fungiform taste buds appear to be more susceptible to this effect than circumvallate cells. In addition, CYP disrupts the population of rapidly dividing cells in the basal layer of taste epithelium responsible for taste cell renewal, manifesting a disturbance days later. The loss of these cells temporarily retards the system's capacity to replace Type II and Type III taste sensory cells that survived the cytotoxic effects of CYP and died at the end of their natural lifespan. The timing of an immediate, direct loss of taste cells and a delayed, indirect loss without replacement of taste sensory cells are broadly congruent with previously published behavioral data reporting two periods of elevated detection thresholds for umami and sucrose stimuli. These findings suggest that chemotherapeutic disturbances in the peripheral mechanisms of the taste system may cause dietary challenges at a time when the cancer patient has significant need for well balanced, high energy nutritional intake.	[Delay, Eugene R.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; Univ Vermont, Vermont Chemosensory Grp, Burlington, VT USA; [Delay, Rona J.] Univ Colorado, Dept Dermatol, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Choudhuri, Shreoshi Pal] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX USA	University of Vermont; University of Vermont; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas	Delay, ER (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	edelay@uvm.edu	Choudhuri, Shreoshi Pal/I-4251-2019		National Institutes of Health [R01 DC012829 ERD]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the National Institutes of Health R01 DC012829 ERD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles TA, 2002, J CLIN ONCOL, V20, P485, DOI 10.1200/JCO.2002.20.2.485; Aihara E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17185; Asano-Miyoshi M, 2008, J MOL HISTOL, V39, P193, DOI 10.1007/s10735-007-9151-0; Barlow LA, 2015, DEVELOPMENT, V142, P3620, DOI 10.1242/dev.120394; Barlow LA, 2015, CURR TOP DEV BIOL, V111, P401, DOI 10.1016/bs.ctdb.2014.11.012; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bartoshuk L M, 1990, NCI Monogr, P179; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Bernhardson BM, 2008, SUPPORT CARE CANCER, V16, P275, DOI 10.1007/s00520-007-0319-7; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Bernhardt SJ, 1996, J PHYSL; BERNSTEIN IL, 1978, SCIENCE, V200, P1302, DOI 10.1126/science.663613; BERNSTEIN IL, 1980, PHYSIOL BEHAV, V25, P363, DOI 10.1016/0031-9384(80)90274-7; Boughter JD, 1997, J NEUROSCI, V17, P2852; Carozzi VA, 2010, EXP NEUROL, V226, P301, DOI 10.1016/j.expneurol.2010.09.004; Castillo D, 2014, DEVELOPMENT, V141, P2993, DOI 10.1242/dev.107631; Chambers MS, 2004, HEAD NECK-J SCI SPEC, V26, P796, DOI 10.1002/hed.20045; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Cho YK, 1998, CHEM SENSES, V23, P735, DOI 10.1093/chemse/23.6.735; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Cohen J, 2016, CURR PHARM DESIGN, V22, P2253, DOI 10.2174/1381612822666160216150812; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; Comeau TB, 2001, SUPPORT CARE CANCER, V9, P575, DOI 10.1007/s005200100279; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; de Vries YC, 2017, SUPPORT CARE CANCER, V25, P2581, DOI 10.1007/s00520-017-3668-x; Dorr W, 2003, INT J RADIAT BIOL, V79, P531, DOI 10.1080/09553002310001600925; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; Epstein JB, 2002, BONE MARROW TRANSPL, V30, P785, DOI 10.1038/sj.bmt.1703716; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Feng P, 2014, J NEUROSCI, V34, P2689, DOI 10.1523/JNEUROSCI.3074-13.2014; Feng P, 2014, CHEM SENSES, V39, P3, DOI 10.1093/chemse/bjt059; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; French CJ, 2009, FASEB J, V23, P1177, DOI 10.1096/fj.08-116509; Gaillard D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005208; Gaillard D, 2011, GENESIS, V49, P295, DOI 10.1002/dvg.20731; Girard BM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00020; Halyard Michele Y, 2009, J Support Oncol, V7, P68; Hong Jae Hee, 2009, J Support Oncol, V7, P58; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Hung DT, 1996, CHEM BIOL, V3, P623, DOI 10.1016/S1074-5521(96)90129-5; Hutton JL, 2007, J PAIN SYMPTOM MANAG, V33, P156, DOI 10.1016/j.jpainsymman.2006.07.017; Jezernik K, 2003, CELL BIOL INT, V27, P863, DOI 10.1016/S1065-6995(03)00175-6; Kaley TJ, 2009, BRIT J HAEMATOL, V145, P3, DOI 10.1111/j.1365-2141.2008.07558.x; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Klanjsek P, 2016, EUR J ONCOL NURS, V23, P24, DOI 10.1016/j.ejon.2016.03.003; Kumari A, 2015, J NEUROPHYSIOL, V113, P1034, DOI 10.1152/jn.00822.2014; Lehrer MS, 1998, J CELL SCI, V111, P2867; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; MATTES RD, 1987, CANCER, V60, P2576, DOI 10.1002/1097-0142(19871115)60:10<2576::AID-CNCR2820601038>3.0.CO;2-5; Miura H, 2004, CHEM SENSES, V29, P823, DOI 10.1093/chemse/bjh248; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Miura H, 2014, DEV DYNAM, V243, P1286, DOI [10.1002/DVDY.24121, 10.1002/dvdy.24121]; Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006; Mukherjee N, 2013, PLOS ONE, V8, P1; Mukherjee N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061607, 10.1371/annotation/5487e265-8175-47cb-b9a4-d85862a4a96f]; NELSON GM, 1993, J COMP NEUROL, V336, P507, DOI 10.1002/cne.903360404; Nguyen HM, 2012, J NEUROSCI, V32, P3474, DOI 10.1523/JNEUROSCI.4167-11.2012; Oakley B, 2004, J NEUROCYTOL, V33, P631, DOI 10.1007/s11068-005-3332-0; Oike H, 2006, J COMP NEUROL, V494, P876, DOI 10.1002/cne.20848; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Ponticelli E, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12633; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pumplin DW, 1999, J COMP NEUROL, V415, P230, DOI 10.1002/(SICI)1096-9861(19991213)415:2<230::AID-CNE7>3.0.CO;2-Y; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; Renken RJ, 2016, CLIN NUTR; Rha SY, 2016, SUPPORT CARE CANC; Schneider FT, 2010, AM J PATHOL, V177, P404, DOI 10.2353/ajpath.2010.091079; Sollars SI, 2002, J NEUROBIOL, V51, P223, DOI 10.1002/neu.10055; Spotten LE, 2017, ANN ONCOL; Stone LM, 2002, J NEUROSCI, V22, P4522, DOI 10.1523/JNEUROSCI.22-11-04522.2002; Takeda N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066314; Turcott JG, 2016, NUTR CANCER, V68, P241, DOI 10.1080/01635581.2016.1144075; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Wagland R, 2016, SUPPORT CARE CANCER, V24, P4901, DOI 10.1007/s00520-016-3346-4; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; WITT M, 1992, HISTOCHEMISTRY, V98, P173, DOI 10.1007/BF00315876; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Yang H, 2015, CANCER MED-US, V4, P245, DOI 10.1002/cam4.350; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Zabernigg A, 2010, ONCOLOGIST, V15, P913, DOI 10.1634/theoncologist.2009-0333; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	89	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185473	10.1371/journal.pone.0185473	http://dx.doi.org/10.1371/journal.pone.0185473			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950008	Green Published, Green Submitted, gold			2022-12-26	WOS:000411671000056
J	Huang, SL; Hsieh, CL; Wu, RM; Lu, WS				Huang, Sheau-Ling; Hsieh, Ching-Lin; Wu, Ruey-Meei; Lu, Wen-Shian			Test-retest reliability and minimal detectable change of the Beck Depression Inventory and the Taiwan Geriatric Depression Scale in patients with Parkinson's disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; STATISTICAL-METHODS; MEASUREMENT ERROR; DIFFERENCE; AGREEMENT; VALIDITY; GRIP	Background The Beck Depression Inventory II (BDI-II) and the Taiwan Geriatric Depression Scale (TGDS) are self-report scales used for assessing depression in patients with Parkinson's disease (PD) and geriatric people. The minimal detectable change (MDC) represents the least amount of change that indicates real difference (i.e., beyond random measurement error) for a single subject. Our aim was to investigate the test-retest reliability and MDC of the BDI-II and the TGDS in people with PD. Methods Seventy patients were recruited from special clinics for movement disorders at a medical center. The patients' mean age was 67.7 years, and 63.0% of the patients were male. All patients were assessed with the BDI-II and the TGDS twice, 2 weeks apart. We used the intraclass correlation coefficient (ICC) to determine the reliability between test and retest. We calculated the MDC based on standard error of measurement. The MDC% was calculated (i.e., by dividing the MDC by the possible maximal score of the measure). Results The test-retest reliabilities of the BDI-II/TGDS were high (ICC = 0.86/0.89). The MDCs (MDC% s) of the BDI-II and TGDS were 8.7 (13.8%) and 5.4 points (18.0%), respectively. Both measures had acceptable to nearly excellent random measurement errors. Conclusions The test-retest reliabilities of the BDI-II and the TGDS are high. The MDCs of both measures are acceptable to nearly excellent in people with PD. These findings imply that the BDI-II and the TGDS are suitable for use in a research context and in clinical settings to detect real change in a single subject.	[Huang, Sheau-Ling; Hsieh, Ching-Lin] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei, Taiwan; [Huang, Sheau-Ling; Hsieh, Ching-Lin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Div Occupat Therapy, Taipei, Taiwan; [Wu, Ruey-Meei] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lu, Wen-Shian] Chung Shan Med Univ, Sch Occupat Therapy, Taichung, Taiwan; [Lu, Wen-Shian] Chung Shan Med Univ Hosp, Occupational Therapy Room, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lu, WS (corresponding author), Chung Shan Med Univ, Sch Occupat Therapy, Taichung, Taiwan.; Lu, WS (corresponding author), Chung Shan Med Univ Hosp, Occupational Therapy Room, Taichung, Taiwan.	weenshian.lu@gmail.com	Hsieh, Ching-Lin/G-6057-2011	Hsieh, Ching-Lin/0000-0001-9468-9969; Lu, Wen-Shian/0000-0002-5101-9778; Wu, Ruey-Meei/0000-0002-4947-5467; HUANG, SHEAU-LING/0000-0002-2675-2302				Aarsland D, 2002, ACTA PSYCHIAT SCAND, V106, P161, DOI 10.1034/j.1600-0447.2002.2e009.x; Aarsland D, 1999, INT J GERIATR PSYCH, V14, P866, DOI 10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.3.CO;2-Q; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Beaton DE, 2002, CURR OPIN RHEUMATOL, V14, P109, DOI 10.1097/00002281-200203000-00006; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chang Y. S., 2006, TAIWAN GERIATRICS GE, V2, P21; Coles ME, 2001, DEPRESS ANXIETY, V14, P145, DOI 10.1002/da.1057; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Jette AM, 2007, J REHABIL MED, V39, P585, DOI 10.2340/16501977-0119; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Leentjens AFG, 2004, J GERIATR PSYCH NEUR, V17, P120, DOI 10.1177/0891988704267456; LEVIN BE, 1988, J NEUROL NEUROSUR PS, V51, P1401, DOI 10.1136/jnnp.51.11.1401; Liao Y. C., 2004, TAIWANESE J PSYCHIAT, V18, P30; Liu WM, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S88968; Nocera Joe R, 2013, J Yoga Phys Ther, V3, DOI 10.4172/2157-7595.1000137; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Prince B, 1980, Physiother Can, V32, P201; Schreuders TAR, 2003, PHYS THER, V83, P806, DOI 10.1093/ptj/83.9.806; Schuck P, 2003, INT J REHABIL RES, V26, P85, DOI 10.1097/00004356-200306000-00002; Segal DL, 2008, BEHAV MODIF, V32, P3, DOI 10.1177/0145445507303833; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smidt N, 2002, ARCH PHYS MED REHAB, V83, P1145, DOI 10.1053/apmr.2002.33728; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Su TP, 2004, AUST NZ J PSYCHIAT, V38, P706, DOI 10.1111/j.1440-1614.2004.01444.x; Visser M, 2006, MOVEMENT DISORD, V21, P668, DOI 10.1002/mds.20792	29	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184823	10.1371/journal.pone.0184823	http://dx.doi.org/10.1371/journal.pone.0184823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945776	gold, Green Published, Green Submitted			2022-12-26	WOS:000411645100011
J	Gonzalez-Carranza, ZH; Zhang, XB; Peters, JL; Boltz, V; Szecsi, J; Bendahmane, M; Roberts, JA				Gonzalez-Carranza, Zinnia H.; Zhang, Xuebin; Peters, Janny L.; Boltz, Veronique; Szecsi, Judit; Bendahmane, Mohammed; Roberts, Jeremy A.			HAWAIIAN SKIRT controls size and floral organ number by modulating CUC1 and CUC2 expression	PLOS ONE			English	Article							CUP-SHAPED-COTYLEDON; EARLY FLOWER DEVELOPMENT; SHOOT APICAL MERISTEM; ARABIDOPSIS-THALIANA; MICRORNA REGULATION; GENES; BOUNDARY; GROWTH; SEPARATION; PLANTS	The Arabidopsis thaliana F-box gene HAWAIIAN SKIRT (HWS) affects organ growth and the timing of floral organ abscission. The loss-of-function hws-1 mutant exhibits fused sepals and increased organ size. To understand the molecular mechanisms of HWS during plant development, we mutagenized hws-1 seeds with ethylmethylsulphonate (EMS) and screened for mutations suppressing hws-1 associated phenotypes. We isolated the shs1/ hws-1 (suppressor of hws-1) mutant in which hws-1 sepal fusion phenotype was suppressed. The shs1/hws-1 mutant carries a G -> A nucleotide substitution in the MIR164 binding site of CUP-SHAPED COTYLEDON 1 (CUC1) mRNA. CUC1 and CUP-SHAPED COTYLEDON 2 (CUC2) transcript levels were altered in shs1, renamed cuc1-1D, and in hws-1 mutant. Genetic interaction analyses using single, double and triple mutants of cuc1-1D, cuc2-1D (a CUC2 mutant similar to cuc1-1D), and hws-1, demonstrate that HWS, CUC1 and CUC2 act together to control floral organ number. Loss of function of HWS is associated with larger petal size due to alterations in cell proliferation and mitotic growth, a role shared with the CUC1 gene.	[Gonzalez-Carranza, Zinnia H.; Zhang, Xuebin; Roberts, Jeremy A.] Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Sutton Bonington Campus, Loughborough, Leics, England; [Peters, Janny L.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Mol Plant Physiol, Nijmegen, Netherlands; [Boltz, Veronique; Szecsi, Judit; Bendahmane, Mohammed] Univ Lyon, Ecole Normale Super Lyon, Lab Reprod & Dev Plantes, Lyon, France; [Zhang, Xuebin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Roberts, Jeremy A.] Univ Plymouth, Fac Sci & Engn, Sch Biol & Marine Sci, Plymouth, Devon, England	University of Nottingham; Radboud University Nijmegen; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); United States Department of Energy (DOE); Brookhaven National Laboratory; University of Plymouth	Gonzalez-Carranza, ZH (corresponding author), Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Sutton Bonington Campus, Loughborough, Leics, England.	zinnia.gonzalez@nottingham.ac.uk	Peters, Janny L./K-7745-2013; Bendahmane, Mohammed/AAX-1296-2020	Peters, Janny L./0000-0002-1081-5209; Bendahmane, Mohammed/0000-0003-1661-1060; Gonzalez-Carranza, Zinnia Haydee/0000-0002-9127-3252	University of Nottingham; Radboud University Nijmegen; French "Agence Nationale de la Recherche" [ANR-09-BLAN-0006, ANR13-BSV7-0014]	University of Nottingham; Radboud University Nijmegen; French "Agence Nationale de la Recherche"(French National Research Agency (ANR))	This work was supported by funds from the University of Nottingham, Radboud University Nijmegen and the French "Agence Nationale de la Recherche" (grants ANR-09-BLAN-0006 and ANR13-BSV7-0014 to MB).	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Aida M, 1999, DEVELOPMENT, V126, P1563; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bogre L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-226; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Breuil-Broyer S, 2004, PLANT J, V38, P182, DOI 10.1111/j.1365-313X.2004.02026.x; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dash M, 2015, PLANT J, V84, P335, DOI 10.1111/tpj.13002; Dinh Thanh Theresa, 2014, Methods Mol Biol, V1110, P127, DOI 10.1007/978-1-4614-9408-9_6; Gaillochet C, 2015, CURR OPIN PLANT BIOL, V23, P91, DOI 10.1016/j.pbi.2014.11.002; Gazquez A, 2017, NEW PHYTOL, V215, P299, DOI 10.1111/nph.14573; Gonzalez-Carranza ZH, 2007, PLANT PHYSIOL, V144, P1370, DOI 10.1104/pp.106.092288; Hepworth J, 2014, CURR OPIN PLANT BIOL, V17, P36, DOI 10.1016/j.pbi.2013.11.005; Huang TB, 2012, DEVELOPMENT, V139, P2161, DOI 10.1242/dev.075069; Ishida T, 2000, PLANT CELL PHYSIOL, V41, P60, DOI 10.1093/pcp/41.1.60; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Katayama N, 2010, PLANT CELL, V22, P2131, DOI 10.1105/tpc.109.073189; Kim ES, 2016, PHYSIOL PLANTARUM, V157, P221, DOI 10.1111/ppl.12443; Krizek BA, 2006, PLANT J, V45, P369, DOI 10.1111/j.1365-313X.2005.02633.x; Lampugnani ER, 2013, DEVELOPMENT, V140, P185, DOI 10.1242/dev.084582; Lampugnani ER, 2012, PLANT J, V71, P724, DOI 10.1111/j.1365-313X.2012.05023.x; Landrein B, 2015, ELIFE, V4, DOI [10.7554/eLife.07811, 10.7554/eLife.07811.001]; Lang PLM, 2017, BIORXIV; Larue CT, 2009, PLANT J, V58, P450, DOI 10.1111/j.1365-313X.2009.03796.x; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Laufs P, 2003, DEVELOPMENT, V130, P785, DOI 10.1242/dev.00295; Levin JZ, 1998, GENETICS, V149, P579; Leyser HMO, 1992, ARABIDOPSIS COMPLEAT, P9; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Nahar MAU, 2012, PLANT CELL PHYSIOL, V53, P1134, DOI 10.1093/pcp/pcs057; Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002; Powell AE, 2012, CURR BIOL, V22, pR360, DOI 10.1016/j.cub.2012.02.010; Rast MI, 2008, CURR OPIN GENET DEV, V18, P287, DOI 10.1016/j.gde.2008.05.005; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Spinelli SV, 2011, PLANT PHYSIOL, V156, P1894, DOI 10.1104/pp.111.177709; Szecsi Judit, 2014, Methods Mol Biol, V1110, P191, DOI 10.1007/978-1-4614-9408-9_8; Takada S, 2001, DEVELOPMENT, V128, P1127; Takada S, 2004, DEVELOPMENT, V132, P1555; Takeda S, 2011, PLANT J, V66, P1066, DOI 10.1111/j.1365-313X.2011.04571.x; Weigel D, 1995, ANNU REV GENET, V29, P19, DOI 10.1146/annurev.ge.29.120195.000315; Weigel D., 2002, ARABIDOPSIS LAB MANU; Yu HY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030317	47	19	21	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185106	10.1371/journal.pone.0185106	http://dx.doi.org/10.1371/journal.pone.0185106			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934292	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000411339900091
J	Laut, L; Martins, MVA; Frontalini, F; Ballalai, JM; Belart, P; Habib, R; Fontana, LF; Clemente, IMMM; Lorini, ML; Mendonca, JG; Laut, VM; Figueiredo, MDL				Laut, Lazaro; Alves Martins, Maria Virginia; Frontalini, Fabrizio; Ballalai, Joao M.; Belart, Pierre; Habib, Renan; Fontana, Luiz F.; Clemente, Iara M. M. M.; Lorini, Maria Lucia; Mendonca Filho, Joao G.; Laut, Vanessa M.; Lima Figueiredo, Marcos de Souza			Assessment of the trophic state of a hypersaline-carbonatic environment: Vermelha Lagoon (Brazil)	PLOS ONE			English	Article							PARTICULATE ORGANIC-MATTER; RIO-DE-JANEIRO; BIOCHEMICAL-COMPOSITION; SPATIAL INTERPOLATION; MICROBIAL MATS; GUANABARA BAY; FORAMINIFERAL ASSEMBLAGES; SURUI MANGROVE; SEDIMENTS; SEA	Vermelha Lagoon is a hypersaline shallow transitional ecosystem in the state of Rio de Janeiro (Brazil). This lagoon is located in the protected area of Massambaba, between the cities of Araruama and Saquarema (Brazil), and displays two quite uncommon particularities: it exhibits carbonate sedimentation and displays the development of Holocene stromatolites. Due to both particularities, the salt industry and property speculation have been, increasingly, generating anthropic pressures on this ecosystem. This study aims to apply a multiproxy approach to evaluate the trophic state of Vermelha Lagoon based on physicochemical parameters and geochemical data for the quantification and qualification of organic matter (OM), namely total organic carbon (TOC), total sulfur (TS), total phosphorus (TP) and biopolymeric carbon (BPC), including carbohydrates (CHO), lipids (LIP) and proteins (PTN). The CHO/TOC ratio values suggest that OM supplied to the sediment is of autochthonous origin and results, essentially, from microbial activity. The cluster analyses allowed the identification of four regions in Vermelha Lagoon. The Region I included stations located in shallow areas of the eastern sector of Vermelha lagoon affected by the impact of the artificial channel of connection with Araruama Lagoon. The Region II, under the influence of salt pans, is characterized by the highest values of BPC, namely CHO promoted by microbiological activity. The Region III include stations spread through the lagoon with high values of dissolved oxygen and lower values of TP. Stromatolites and microbial mattes growth was observed in some stations of this sector. Region IV, where the highest values of TOC and TS were found, represents depocenters of organic matter, located in general in depressed areas. Results of this work evidences that the Vermelha Lagoon is an eutrophic but alkaline and well oxygenated environment (at both water column and surface sediment) where the autotrophic activity is greater than heterotrophic one. These particular conditions make this a special and rare ecosystem.	[Laut, Lazaro; Ballalai, Joao M.; Belart, Pierre; Habib, Renan] Univ Fed Estado Rio de Janeiro UNIRIO, Lab Micropaleontol LabMicro, Rio De Janeiro, RJ, Brazil; [Alves Martins, Maria Virginia; Clemente, Iara M. M. M.] Univ Estado Rio De Janeiro, Dept Estratig & Paleontol, Rio De Janeiro, RJ, Brazil; [Alves Martins, Maria Virginia] Univ Aveiro, Unidade Invest GeoBioTec, Dept Geociencias, Aveiro, Portugal; [Frontalini, Fabrizio] Univ Urbino Carlo Bo, Dipartimento Sci Pure & Applicate DiSPeA, Urbino, Italy; [Fontana, Luiz F.; Mendonca Filho, Joao G.] Univ Fed Rio de Janeiro, Lab Palinofacies & Facies Organ LAFO, Rio de Janeiro, RJ, Brazil; [Lorini, Maria Lucia] Univ Fed Estado Rio de Janeiro UNIRIO, Dept Ciencias Nat, Rio De Janeiro, RJ, Brazil; [Laut, Vanessa M.] Univ Fed Fluminense, Programa Posgrad Biol Marinha & Ambientes Costeir, Inst Biol, Niteroi, RJ, Brazil; [Lima Figueiredo, Marcos de Souza] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Biodiversidade Neotrop, Rio De Janeiro, RJ, Brazil	Universidade Federal do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade de Aveiro; University of Urbino; Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Estado do Rio de Janeiro	Laut, L (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Lab Micropaleontol LabMicro, Rio De Janeiro, RJ, Brazil.	lazaro.laut@gmail.com	Frontalini, Fabrizio/C-4819-2008; Figueiredo, Marcos S. L./A-9720-2014; Martins, Maria Virginia Alves/O-2893-2013; Laut, Lazaro L.M./K-4782-2012; Belart, Pierre/ABB-4130-2021; Laut, Lazaro/O-4193-2019; Filho, João Graciano Mendonça/C-2098-2013; Alves Martins, Maria Virginia/AAD-3531-2021	Frontalini, Fabrizio/0000-0002-0425-9306; Figueiredo, Marcos S. L./0000-0003-0558-911X; Martins, Maria Virginia Alves/0000-0001-8348-8862; Laut, Lazaro L.M./0000-0002-5637-1930; Laut, Lazaro/0000-0002-5637-1930; Filho, João Graciano Mendonça/0000-0001-8997-0270; Alves Martins, Maria Virginia/0000-0001-8348-8862; Ballalai, Joao Marcelo/0000-0002-8896-6816; Lorini, MariaLucia/0000-0002-7783-093X; Dias, Pierre/0000-0003-1508-5564	National Council of Technological and Scientific Development - CNPq (Universal Project) [445830/2014-0]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (Biota Project) [E26/11.399/2012]; CNPq	National Council of Technological and Scientific Development - CNPq (Universal Project)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (Biota Project); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was financed by the National Council of Technological and Scientific Development - CNPq (Universal Project 445830/2014-0) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (Biota Project E26/11.399/2012). The authors would like to thank CNPq for the Scientific Initiation Fellowships (PIBC Program) given to Joao M. Ballalai and Renan Habib. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N., 1974, GEOMORFOLOGIA, V43, P1; Martins MVA, 2016, MAR POLLUT BULL, V105, P161, DOI 10.1016/j.marpolbul.2016.02.032; ASPILA KI, 1976, ANALYST, V101, P187, DOI 10.1039/an9760100187; ASTM International, 2008, D4239 ASTM, V552, P6; Azpurua M, 2010, PROG ELECTROMA RES M, V14, P135, DOI 10.2528/PIERM10083103; Baptista Neto J. A., 2005, REV TAMOIOS, V2, P6; Barroso LV, 1987, B FUNDACAO BRASILEIR, P30; Borges AC, 2009, MAR POLLUT BULL, V58, P1750, DOI 10.1016/j.marpolbul.2009.07.025; Borja A, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 1: CLASSIFICATION OF ESTUARINE AND NEARSHORE COASTAL ECOSYSTEMS, P125; Borrego J, 1998, J COASTAL RES, V14, P1276; Cartes JE, 2002, PROG OCEANOGR, V53, P29, DOI 10.1016/S0079-6611(02)00023-X; Chai-Coetzer CL, 2011, THORAX, V66, P213, DOI 10.1136/thx.2010.152801; Coe HHG, 2010, 6 SEM LAT AM GEOGR F, P1; Coelho-Souza SA, 2012, BRAZ J OCEANOGR, V60, P353, DOI 10.1590/S1679-87592012000300008; Cotano U, 2006, MAR POLLUT BULL, V52, P404, DOI 10.1016/j.marpolbul.2005.09.027; da Silva FS, 2008, BRAZ J OCEANOGR, V56, P13, DOI 10.1590/S1679-87592008000100002; DANOVARO R, 1993, DEEP-SEA RES PT I, V40, P953, DOI 10.1016/0967-0637(93)90083-F; Danovaro R, 1997, ESTUAR COAST SHELF S, V44, P723, DOI 10.1006/ecss.1996.0135; Danovaro R, 1999, J SEA RES, V42, P117, DOI 10.1016/S1385-1101(99)00024-6; Datta DK, 1999, ORG GEOCHEM, V30, P75, DOI 10.1016/S0146-6380(98)00203-4; de la Lanza-Espino G., 2011, UNIV CIENC, V27, P145; Debenay JP, 2001, J FORAMIN RES, V31, P133, DOI 10.2113/0310133; Dell'Anno A, 2002, MAR POLLUT BULL, V44, P611, DOI 10.1016/S0025-326X(01)00302-2; Demergasso C, 2003, REV CHIL HIST NAT, V76, P485; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dugdale R. C., 1988, OCEANOL ACTA, V9, P178; FABIANO M, 1995, CONT SHELF RES, V15, P1453, DOI 10.1016/0278-4343(94)00088-5; FABIANO M, 1994, HYDROBIOLOGIA, V277, P71, DOI 10.1007/BF00016755; Fabiano M, 1999, SCI MAR, V63, P89, DOI 10.3989/scimar.1999.63s189; Fontana LF, 2010, AN ACAD BRAS CIENC, V82, P1013, DOI 10.1590/S0001-37652010000400022; Fontana LF, 2010, MAR POLLUT BULL, V60, P1674, DOI 10.1016/j.marpolbul.2010.06.049; Fritz S. C., 2010, The diatoms: applications for the environmental and earth sciences, P186; GERCHAKO.SM, 1972, LIMNOL OCEANOGR, V17, P938, DOI 10.4319/lo.1972.17.6.0938; Goovaerts P, 2000, J HYDROL, V228, P113, DOI 10.1016/S0022-1694(00)00144-X; Gremare A, 1997, MAR ECOL PROG SER, V150, P195, DOI 10.3354/meps150195; Gremare A, 2002, MAR ECOL PROG SER, V234, P85, DOI 10.3354/meps234085; Grotzinger J, 2013, UNDERSTANDING EARTH; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HENRICHS SM, 1995, MAR CHEM, V49, P127, DOI 10.1016/0304-4203(95)00012-G; Herminda L., 2005, AN I GEOCIENCIAS, V28, P59, DOI [10.11137/2005_2_59-70, DOI 10.11137/2005_2_59-70]; HOHN A, 1986, SCI TOTAL ENVIRON, V58, P175, DOI 10.1016/0048-9697(86)90086-0; Horodysky RJ, 1997, J SEDIMENT PETROL, V47, P680; Isla E, 2006, J MARINE SYST, V60, P255, DOI 10.1016/j.jmarsys.2006.01.006; Keblouti M, 2012, ENRGY PROCED, V18, P468, DOI 10.1016/j.egypro.2012.05.058; Koroleff F., 1976, METHODS SEAWATER ANA, P134; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; LOPES CEA, 1986, SCI TOTAL ENVIRON, V58, P55, DOI 10.1016/0048-9697(86)90075-6; Mansur KL, 2012, GEOPARQUES BRASIL PR, P687; MARSH JB, 1966, J LIPID RES, V7, P574; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Martins M. V., 2015, PLOS ONE; Clemente IMMM, 2015, J COASTAL RES, V31, P1190, DOI 10.2112/JCOASTRES-D-14-00104.1; Laut LLM, 2016, J SEDIMENT ENVIRON, V1, P297, DOI 10.12957/jse.2016.25903; Mendontha-Filho JG., 2003, ANUARIO I GEOCIENCIA, V26, P69, DOI 10.11137/2003_0_69-78; MWATHA WE, 1993, INT J SYST BACTERIOL, V43, P401, DOI 10.1099/00207713-43-3-401; Oliveira L., 1955, MEMORIAS I O CRUZ, V53, P171, DOI [10.1590/S0074-02761955000200004, DOI 10.1590/S0074-02761955000200004]; Paez-Osuna F, 1998, ENVIRON POLLUT, V102, P321, DOI 10.1016/S0269-7491(98)00045-1; PETRUCIO MM, 1998, ECOLOGIA LAGOAS COST, P135; Petrucio MM, 1998, ECOLOGIA LAGOAS COST, P2; Primo PBS., 2002, LAGOA ARARUAMA PERFI; Pusceddu A, 1999, HYDROBIOLOGIA, V397, P59, DOI 10.1023/A:1003690313842; RICE DL, 1982, MAR ECOL PROG SER, V9, P153, DOI 10.3354/meps009153; Silva FS, 2011, ANUARIO I GEOCIENCIA, V34, P52; Silva FS, 2010, ANU I GEOCIENCIAS, V33, P24; Silva FS, 2001, INTERACAO HOMEM MEIO, P85; Silva FS, 2011, ANU I GEOCIENCIAS, V34, P33; Silva L. H. Silva E., 2004, Revista Brasileira de Paleontologia, V7, P193; Siqueira GW., 2006, ARQ CIENCIAS MAR FOR, V39, P18; Stein R., 1991, ACCUMULATION ORGANIC; Teodoro AC, 2010, MAR POLLUT BULL, V60, P536, DOI 10.1016/j.marpolbul.2009.11.011; TERZOPOULOS D, 1988, IEEE T PATTERN ANAL, V10, P417, DOI 10.1109/34.3908; Tucker M. E., 1990, CARBONATE SEDIMENTOL, P164; Vasconcelos C, 2006, SEDIMENT GEOL, V185, P175, DOI 10.1016/j.sedgeo.2005.12.022; Vasconcelos C, 1997, J SEDIMENT RES, V67, P378; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998	75	15	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184819	10.1371/journal.pone.0184819	http://dx.doi.org/10.1371/journal.pone.0184819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934270	Green Published, Green Submitted, gold			2022-12-26	WOS:000411339900047
J	Ong, CT; Wong, YS; Sung, SF; Wu, CS; Hsu, YC; Su, YH; Hung, LC				Ong, Cheung-Ter; Wong, Yi-Sin; Sung, Sheng-Feng; Wu, Chi-Shun; Hsu, Yung-Chu; Su, Yu-Hsiang; Hung, Ling-Chien			Sex-related differences in the risk factors for in-hospital mortality and outcomes of ischemic stroke patients in rural areas of Taiwan	PLOS ONE			English	Article							CLINICAL PRESENTATION; GENDER-DIFFERENCES; ATRIAL-FIBRILLATION; CARE; MANAGEMENT; SEVERITY; EPIDEMIOLOGY; PREDICTORS; DEATH	Background and purpose Sex-related differences in the clinical presentation and outcomes of stroke patients are issues that have attracted increased interest from the scientific community. The present study aimed to investigate sex-related differences in the risk factors for in-hospital mortality and outcome in ischemic stroke patients. Methods A total of 4278 acute ischemic stroke patients admitted to a stroke unit between January 1, 2007 and December 31, 2014 were included in the study. We considered demographic characteristics, clinical characteristics, co-morbidities, and complications, among others, as factors that may affect clinical presentation and in-hospital mortality. Good and poor outcomes were defined as modified Ranking Score (mRS)<= 2 and mRS>2. Neurological deterioration (ND) was defined as an increase of National Institutes of Health Stroke Score (NIHSS) >= 4 points. Hemorrhagic transformation (HT) was defined as signs of hemorrhage in cranial CT or MRI scans. Transtentorial herniation was defined by brain edema, as seen in cranial CT or MRI scans, associated with the onset of acute unilateral or bilateral papillary dilation, loss of reactivity to light, and decline of >= 2 points in the Glasgow coma scale score. Results Of 4278 ischemic stroke patients (women 1757, 41.1%), 269 (6.3%) received thrombolytic therapy. The in hospital mortality rate was 3.35% (139/4278) [4.45% (80/1757) for women and 2.34% (59/2521) for men, p < 0.01]. At discharge, 41.2% (1761/4278) of the patients showed good outcomes [35.4% (622/1757) for women and 45.2% (1139/2521) for men]. Six months after stroke, 56.1% (1813/3231) showed good outcomes [47.4% (629/1328) for women and 62.2% (1184/1903) for men, p < 0.01]. Atrial fibrillation (AF), diabetes mellitus, stroke history, and old age were factors contributing to poor outcomes in men and women. Hypertension was associated with poor outcomes in women but not in men in comparison with patients without hypertension. Stroke severity and increased intracranial pressure were associated with increased in-hospital mortality in men and women. AF was associated with increased in-hospital mortality in women but not in men compared with patients without AF. Conclusion The in-hospital mortality rate was not significantly different between women and men. Functional outcomes at discharge and six months after stroke were poorer in women than in men. Hypertension is an independent factor causing poorer outcomes in women than in men. AF is an independent factor affecting sex differences in hospital mortality in women.	[Ong, Cheung-Ter; Sung, Sheng-Feng; Wu, Chi-Shun; Hsu, Yung-Chu; Su, Yu-Hsiang; Hung, Ling-Chien] Chia Yi Christian Hosp, Dept Neurol, Chiayi, Taiwan; [Ong, Cheung-Ter] Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chia- Yi, Taiwan; [Wong, Yi-Sin] Chia Yi Christian Hosp, Dept Family Med, Chia- Yi, Taiwan		Ong, CT (corresponding author), Chia Yi Christian Hosp, Dept Neurol, Chiayi, Taiwan.; Ong, CT (corresponding author), Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chia- Yi, Taiwan.	ctong98@yahoo.com.tw		Ong, Cheung-Ter/0000-0003-1814-4371				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Arboix A, 1998, CEREBROVASC DIS, V8, P8, DOI 10.1159/000015809; Boehme AK, 2014, J STROKE CEREBROVASC, V23, pE255, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.003; Candelise L, 2007, LANCET, V369, P299, DOI 10.1016/S0140-6736(07)60152-4; Chang Yeu-Jhy, 2008, Acta Neurol Taiwan, V17, P275; Chen CJ, 2015, NEUROLOGY, V85, P1980, DOI 10.1212/WNL.0000000000002176; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gall SL, 2010, NEUROLOGY, V74, P975, DOI 10.1212/WNL.0b013e3181d5a48f; Gray LJ, 2007, STROKE, V38, P2960, DOI 10.1161/STROKEAHA.107.488304; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Heuschmann PU, 2004, JAMA-J AM MED ASSOC, V292, P1831, DOI 10.1001/jama.292.15.1831; Irie F, 2015, STROKE, V46, P471, DOI 10.1161/STROKEAHA.114.006739; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Koton S, 2013, INT J CARDIOL, V168, P4081, DOI 10.1016/j.ijcard.2013.07.019; Lewsey JD, 2009, STROKE, V40, P1038, DOI 10.1161/STROKEAHA.108.542787; Li OL, 2016, STROKE, V47, P255, DOI 10.1161/STROKEAHA.115.010485; Martin RC, 2017, AM J CARDIOL, V119, P256, DOI 10.1016/j.amjcard.2016.09.049; Ong CT, 2016, THER CLIN RISK MANAG, V12, P1057, DOI 10.2147/TCRM.S105703; Ong CT, 2014, J CHIN MED ASSOC, V77, P179, DOI 10.1016/j.jcma.2014.02.002; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Santalucia P, 2013, EUR J INTERN MED, V24, P167, DOI 10.1016/j.ejim.2012.10.004; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Stuart-Shor EM, 2009, STROKE, V40, P1121, DOI 10.1161/STROKEAHA.108.543371; [王军 Wang Jun], 2012, [中国电力, Electric Power], V45, P31; Yoshida K, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004999; Yu CS, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00174	29	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185361	10.1371/journal.pone.0185361	http://dx.doi.org/10.1371/journal.pone.0185361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934363	gold, Green Published, Green Submitted			2022-12-26	WOS:000411339900151
J	Axen, I; Kwak, L; Hagberg, J; Jensen, I				Axen, Iben; Kwak, Lydia; Hagberg, Jan; Jensen, Irene			Does physical activity buffer insomnia due to back and neck pain?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; SLEEP DISTURBANCE; HEALTH; QUALITY; DISABILITY; WORK; ACCELEROMETER; QUESTIONNAIRE; METAANALYSIS; PREDICTION	Introduction Musculoskeletal pain is highly prevalent and a burden to society, recurrent and persistent low back pain (LBP) and neck pain (NP) being the most common conditions. They are associated with other poor health outcomes such as sleep problems. Physical activity (PA) prevents LBP and NP, but the direct effect on sleep is unclear. This study explored the effect of pain on insomnia, and examined if adherence to moderate-to-high intensity levels of PA influenced this relationship. Methods In this prospective observational study, 1821 workers were followed over 3 years. Data included self-rated measures of LBP and NP, insomnia and level and amount of PA. Pain variables were used in a "risk profile" for future sick-listing, insomnia was categorized into those with and without such problems, and adherence to PA was defined as reporting moderate-to-high levels in two consecutive years. In Poisson regression models, individuals with pain risk profiles were analysed according to PA adherence for the outcome insomnia. Repeated measurements allowed control for prior pain. Results In this mainly male working population, individuals with a risk profile for LBP and NP had a significant increased risk (RR = 1.5) of developing insomnia one year later when not adhering to moderate-to-high levels of PA. Among those not reporting prior pain, the risk was even larger (RR = 2.5). Generalizability may be restricted to relatively healthy males. The individuals who reported a pain risk profile two consecutive years did not get the buffer effect from adhering to moderate-to-high levels of PA in terms of developing insomnia.	[Axen, Iben; Kwak, Lydia; Hagberg, Jan; Jensen, Irene] Karolinska Inst, Inst Environm Med, Unit Intervent & Implementat Worker Hlth, Nobels V 13, Stockholm, Sweden	Karolinska Institutet	Axen, I (corresponding author), Karolinska Inst, Inst Environm Med, Unit Intervent & Implementat Worker Hlth, Nobels V 13, Stockholm, Sweden.	iben.axen@ki.se	Jensen, Irene B/B-6012-2012; Axén, Iben/AAC-8638-2020	Jensen, Irene B/0000-0003-1745-866X; Axén, Iben/0000-0001-5251-5995; Kwak, Lydia/0000-0003-3117-6765				Alfoldi P, 2017, J REHABIL MED, V49, P63, DOI 10.2340/16501977-2162; [Anonymous], WHO GUID BAS TRAIN S; Axen I, 2016, CLIN J PAIN, V32, P254, DOI 10.1097/AJP.0000000000000249; Axen I, 2013, BEST PRACT RES CL RH, V27, P601, DOI 10.1016/j.berh.2013.10.004; Baker S, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0593-5; Benjaminsson A, 2007, J REHABIL MED, V39, P640, DOI 10.2340/16501977-0104; Bergstrom C, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-81; Bergstrom G, 2008, WORK, V31, P167; Bevan S, 2015, BEST PRACT RES CL RH, V29, P356, DOI 10.1016/j.berh.2015.08.002; Campbell P, 2013, SLEEP, V36, P1693, DOI 10.5665/sleep.3130; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Ekblom-Bak E, 2011, MOTIONSVANOR FYSISK; Ekman M, 2005, ACTA ORTHOP, V76, P275, DOI 10.1080/00016470510030698; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Hagstromer M, 2015, J SCI MED SPORT, V18, P553, DOI 10.1016/j.jsams.2014.07.012; Pueyo MJ, 2012, GAC SANIT, V26, P30, DOI 10.1016/j.gaceta.2011.03.008; Kanagasabai T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0227-z; Kovacs FM, 2005, SPINE, V30, P1786, DOI 10.1097/01.brs.0000172159.47152.dc; Kubo K, 2010, J STRENGTH COND RES, V24, P322, DOI 10.1519/JSC.0b013e3181c865e2; Leboeuf-Yde C, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-39; Lohela M, 2009, J OCCUP ENVIRON MED, V51, P195, DOI 10.1097/JOM.0b013e318192bd2c; March L, 2014, BEST PRACT RES CL RH, V28, P353, DOI 10.1016/j.berh.2014.08.002; National Sleep Foundation, WHAT IS INS; Nordin S, 2013, SCAND J PSYCHOL, V54, P112, DOI 10.1111/sjop.12029; Odegard SS, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-24; Picavet HSJ, 2011, MED SCI SPORT EXER, V43, P74, DOI 10.1249/MSS.0b013e3181e57a6a; Rubio-Arias JA, 2017, MATURITAS, V100, P49, DOI 10.1016/j.maturitas.2017.04.003; Saragiotto BT, 2016, BR J SPORTS MED; Schur EA, 2007, J GEN INTERN MED, V22, P818, DOI 10.1007/s11606-007-0140-5; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Tang NKY, 2015, SLEEP, V38, P1751, DOI 10.5665/sleep.5158; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van de Water ATM, 2011, MANUAL THER, V16, P550, DOI 10.1016/j.math.2011.05.004; Von Korff M, 1990, PAIN, V279, P91, DOI DOI 10.1016/0304-3959(90)91125-3; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wannstrom I, 2009, SCAND J PSYCHOL, V50, P231, DOI 10.1111/j.1467-9450.2008.00697.x; Yang H, 2016, SPINE	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184288	10.1371/journal.pone.0184288	http://dx.doi.org/10.1371/journal.pone.0184288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931026	Green Published, gold, Green Submitted			2022-12-26	WOS:000411314700017
J	Zhu, RH; Zheng, ZC; Li, TX; Zhang, XZ; He, SQ; Wang, YD; Liu, T; Li, W				Zhu, Renhuan; Zheng, Zicheng; Li, Tingxuan; Zhang, Xizhou; He, Shuqin; Wang, Yongdong; Liu, Tao; Li, Wei			Dynamics of soil organic carbon mineralization in tea plantations converted from farmland at Western Sichuan, China	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; CO2 PRODUCTION; HILLY REGION; RESPIRATION; MOISTURE; DECOMPOSITION; RESPONSES; AVAILABILITY; FRACTIONS; BIOCHAR	Climate warming and land use change are some of the drivers affecting soil organic carbon (SOC) dynamics. The Grain for Green Project, local natural resources, and geographical conditions have resulted in farmland conversion into tea plantations in the hilly region of Western Sichuan. However, the effect of such land conversion on SOC mineralization remains unknown. In order to understand the temperature sensitivity of SOC decomposition in tea plantations converted from farmland, this study considered the different years (i.e., 2-3, 9-10, and 16-17 years) of tea plantations converted from farmland as the study site, and soil was incubated for 28 days at 15 degrees C, 25 degrees C, and 35 degrees C to measure the soil respiration rate, amount, and temperature coefficient (Q(10)). Temperature and land use type interactively affected the SOC mineralization rate, and the cumulative amount of SOC mineralization in all the plots was the largest at 35 degrees C. SOC mineralization was greater and more sensitive to temperature changes in the farmland than in the tea plantations. Compared with the control, tea plantation soils showed lower SOC mineralization rate and cumulative mineralization amount. The 16-17-year-old tea plantation with a low SOC mineralization amount and high SOC content revealed the benefits of carbon sequestration enhancement obtained by converting farmland into tea plantations. The first-order kinetic equation described SOC mineralization dynamics well. Farmland conversion into tea plantations appeared to reduce the potentially mineralizable carbon pool, and the age of tea plantations also had an effect on the SOC mineralization and sequestration. The relatively weak SOC mineralization temperature sensitivity of the tea plantation soils suggested that the SOC pool of the tea plantation soils was less vulnerable to warming than that of the control soils.	[Zhu, Renhuan; Zheng, Zicheng; Li, Tingxuan; Zhang, Xizhou; Wang, Yongdong; Liu, Tao; Li, Wei] Sichuan Agr Univ, Coll Resources Sci, Chengdu, Sichuan, Peoples R China; [He, Shuqin] Sichuan Agr Univ, Coll Forestry, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zheng, ZC (corresponding author), Sichuan Agr Univ, Coll Resources Sci, Chengdu, Sichuan, Peoples R China.	zichengzheng@126.com	Zheng, Zicheng/J-6463-2019	Zheng, zicheng/0000-0002-2743-9174	National Natural Science Foundation [41271307]; Science and Technology Support Program in Sichuan [2013NZ0044]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program in Sichuan	The work was supported by National Natural Science Foundation (no. 41271307), Science and Technology Support Program in Sichuan (no. 2013NZ0044).; The work was supported by National Natural Science Foundation (No. 41271307), Science and Technology Support Program in Sichuan (No. 2013NZ0044). The authors would like to thank Craig Stapleton who gives valuable suggestions on the manuscript.	Alvarez R, 2000, SOIL SCI SOC AM J, V64, P184, DOI 10.2136/sssaj2000.641184x; [Anonymous], 2013, ACTA PEDOLOGICA SINI; Arevalo CBM, 2012, SOIL SCI SOC AM J, V76, P241, DOI 10.2136/sssaj2011.0126; Bahn M, 2008, ECOSYSTEMS, V11, P1352, DOI 10.1007/s10021-008-9198-0; Canali S, 2004, BIOL FERT SOILS, V40, P206, DOI 10.1007/s00374-004-0759-x; Chang SX, 2016, BIOL FERT SOILS, V52, P629, DOI 10.1007/s00374-016-1104-x; Chen CP, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0147-5; Craine JM, 2013, BIOGEOCHEMISTRY, V113, P359, DOI 10.1007/s10533-012-9762-8; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Fan DM, 2017, J ZHEJIANG UNIV-SC B, V18, P99, DOI [10.1631/jzus.B1600044, 10.1631/jzus.b1600044]; Fang YY, 2014, AGR ECOSYST ENVIRON, V191, P158, DOI 10.1016/j.agee.2014.02.018; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Ghosh A, 2016, AGR ECOSYST ENVIRON, V233, P202, DOI 10.1016/j.agee.2016.09.010; Gillabel J, 2010, GLOBAL CHANGE BIOL, V16, P2789, DOI 10.1111/j.1365-2486.2009.02132.x; Grellier S, 2017, SCI TOTAL ENVIRON, V593, P654, DOI [10.1016/j.scitotenv2017.03.204, 10.1016/j.scitotenv.2017.03.204]; Haddix ML, 2011, SOIL SCI SOC AM J, V75, P56, DOI 10.2136/sssaj2010.0118; HOWARD DM, 1993, SOIL BIOL BIOCHEM, V25, P1537, DOI 10.1016/0038-0717(93)90008-Y; Jia Juan, 2015, Acta Ecologica Sinica - International Journal, V35, P1; Jin XB, 2008, AUST J SOIL RES, V46, P273, DOI 10.1071/SR07144; Kaschuk G, 2010, SOIL BIOL BIOCHEM, V42, P1, DOI 10.1016/j.soilbio.2009.08.020; Khan SH, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.706; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Li DJ, 2013, SOIL BIOL BIOCHEM, V67, P24, DOI 10.1016/j.soilbio.2013.07.008; Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep28235; [李玮 Li Wei], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1642; [刘合明 Liu Heming], 2008, [生态环境, Ecology and Environment], V17, P2046; Liu YQ, 2012, FOREST ECOL MANAG, V285, P77, DOI 10.1016/j.foreco.2012.08.019; Lu, 2000, SOIL ANAL METHODS AG; Lu SB, 2017, J SOIL SEDIMENT, V17, P985, DOI 10.1007/s11368-016-1602-3; Moscatelli MC, 2007, SOIL TILL RES, V97, P51, DOI 10.1016/j.still.2007.08.007; Munoz-Rojas M, 2015, AGR ECOSYST ENVIRON, V202, P8, DOI 10.1016/j.agee.2014.12.014; Qiu Xi, 2016, Chinese Journal of Plant Ecology, V40, P236; Shen JG, 1992, T CSAE, V8, P35; Sierra CA, 2015, J ADV MODEL EARTH SY, V7, P335, DOI 10.1002/2014MS000358; SPARLING GP, 1986, SOIL BIOL BIOCHEM, V18, P363, DOI 10.1016/0038-0717(86)90039-8; Sun JN, 2016, SCI TOTAL ENVIRON, V569, P390, DOI 10.1016/j.scitotenv.2016.06.082; Sun SH, 2013, PLANT SOIL, V372, P597, DOI 10.1007/s11104-013-1758-1; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Taylor PG, 2017, ECOL LETT, V20, P779, DOI 10.1111/ele.12765; Tian QX, 2017, SOIL BIOL BIOCHEM, V109, P135, DOI 10.1016/j.soilbio.2017.02.009; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Updegraff K, 2001, ECOL APPL, V11, P311; van Wesemael B, 2011, PLANT SOIL, V338, P247, DOI 10.1007/s11104-010-0567-z; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wang GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053914; Wang QK, 2016, ECOSYSTEMS, V19, P450, DOI 10.1007/s10021-015-9941-2; Wang SQ, 2016, ECOL ENG, V90, P113, DOI 10.1016/j.ecoleng.2016.01.046; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071986; [吴健利 Wu Jianli], 2016, [农业环境科学学报, Journal of Agro-Environment Science], V35, P1006; Yang L, 2007, J ENVIRON MANAGE, V85, P690, DOI 10.1016/j.jenvman.2006.09.011; Yang Y.J, 2004, TEA CULTIVATION CHIN; Zhang J, 2011, EUR J SOIL SCI, V62, P863, DOI 10.1111/j.1365-2389.2011.01394.x	54	10	12	7	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185271	10.1371/journal.pone.0185271	http://dx.doi.org/10.1371/journal.pone.0185271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931064	Green Submitted, Green Published, gold			2022-12-26	WOS:000411314700080
